PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Iwanaga, R; Ozono, E; Fujisawa, J; Ikeda, MA; Okamura, N; Huang, Y; Ohtani, K				Iwanaga, R.; Ozono, E.; Fujisawa, J.; Ikeda, M. A.; Okamura, N.; Huang, Y.; Ohtani, K.			Activation of the cyclin D2 and cdk6 genes through NF-kappa B is critical for cell-cycle progression induced by HTLV-I Tax	ONCOGENE			English	Article						HTLV-I; Tax; cell cycle; E2F; cyclin D2; cdk6	VIRUS TYPE-I; ONCOGENE PRODUCT TAX; TYPE-1 TAX; PROTEIN; TRANSFORMATION; MECHANISMS	Human T-cell leukemia virus type I (HTLV-I) can infect a variety of cell types, so the cause of T-cell-specific oncogenesis remains to be elucidated. The trans-activator protein Tax of HTLV-I can promote cell-cycle progression in resting T cells along with induction of cyclin D2 and cyclin-dependent kinase (cdk6) gene expression. Here, we found that Tax cannot induce cell-cycle progression in resting fibroblasts and analysed the molecular basis of the cell-type specificity. Tax activated cyclin D2 and cdk6 promoters in T cells, but not in fibroblasts, depending on its ability to activate the transcription factor nuclear factor (NF)-kappa B. Expression of cyclin D2 and CDK6 activated the transcription factor E2F, which is essential for cell-cycle progression, in both T cells and fibroblasts. Short-hairpin RNA (shRNA)-mediated inhibition of cyclin D2 and CDK6 induction suppressed Tax-induced activation of E2F in T cells. Finally, shRNA-mediated downregulation of NF-kappa B p65 or p100 expression reduced Tax-induced activation of cyclin D2 and/or cdk6 promoters and cell-cycle progression in T cells. These results indicate that Tax-induced cell-cycle progression in T cells is mediated, at least in part, through cell-type-specific activation of the cyclin D2 and cdk6 genes through NF-kappa B and may be important for the cell-type-specific oncogenesis.	[Ohtani, K.] Tokyo Med & Dent Univ, Human Gene Sci Ctr, Bunkyo Ku, Tokyo 1138510, Japan; [Iwanaga, R.; Okamura, N.] Tokyo Med & Dent Univ, Grad Sch Hlth Sci, Lab Microbiol & Immunol, Tokyo 1138510, Japan; [Ozono, E.; Ikeda, M. A.] Tokyo Med & Dent Univ, Grad Sch, Sect Mol Embryol, Tokyo, Japan; [Fujisawa, J.] Kansai Med Univ, Dept Microbiol, Osaka, Japan; [Huang, Y.] E China Univ Sci & Technol, Sch Pharm, Dept Pharmaceut Sci, Shanghai 200237, Peoples R China	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Kansai Medical University; East China University of Science & Technology	Ohtani, K (corresponding author), Tokyo Med & Dent Univ, Human Gene Sci Ctr, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	kiyo.gene@cmn.tmd.ac.jp		Ozono, Eiko/0000-0002-3919-205X				Huang YP, 2001, ONCOGENE, V20, P1094, DOI 10.1038/sj.onc.1204198; Inoue J, 2007, CANCER SCI, V98, P268, DOI 10.1111/j.1349-7006.2007.00389.x; Iwanaga R, 2001, ONCOGENE, V20, P2055, DOI 10.1038/sj.onc.1204304; LEE B, 1989, TOHOKU J EXP MED, V157, P1, DOI 10.1620/tjem.157.1; Manel N, 2003, CELL, V115, P449, DOI 10.1016/S0092-8674(03)00881-X; NAKAMURA M, 1989, J BIOL CHEM, V264, P20189; Neuveut C, 1998, MOL CELL BIOL, V18, P3620, DOI 10.1128/MCB.18.6.3620; Ohtani K, 2000, J BIOL CHEM, V275, P11154, DOI 10.1074/jbc.275.15.11154; OHTANI K, 1987, EMBO J, V6, P389, DOI 10.1002/j.1460-2075.1987.tb04767.x; Ohtani K, 1998, J BIOL CHEM, V273, P14119, DOI 10.1074/jbc.273.23.14119; Schmitt I, 1998, J VIROL, V72, P633, DOI 10.1128/JVI.72.1.633-640.1998; Sun SC, 2005, ONCOGENE, V24, P5952, DOI 10.1038/sj.onc.1208969; Yamaoka S, 1996, EMBO J, V15, P873, DOI 10.1002/j.1460-2075.1996.tb00422.x; Yoshida M, 2005, ONCOGENE, V24, P5931, DOI 10.1038/sj.onc.1208981	14	44	46	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 18	2008	27	42					5635	5642		10.1038/onc.2008.174	http://dx.doi.org/10.1038/onc.2008.174			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	349KX	18504428				2022-12-25	WOS:000259280800009
J	Calvo, A; Catena, R; Noble, MS; Carbott, D; Gil-Bazo, I; Gonzalez-Moreno, O; Huh, JI; Sharp, R; Qiu, TH; Anver, MR; Merlino, G; Dickson, RB; Johnson, MD; Green, JE				Calvo, A.; Catena, R.; Noble, M. S.; Carbott, D.; Gil-Bazo, I.; Gonzalez-Moreno, O.; Huh, J-I; Sharp, R.; Qiu, T-H; Anver, M. R.; Merlino, G.; Dickson, R. B.; Johnson, M. D.; Green, J. E.			Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis	ONCOGENE			English	Article						metastasis; vascular endothelial growth factor; transgenic mice; mammary cancer; tenascin-C	BREAST-CANCER METASTASIS; TRANSGENIC MICE; MOUSE MAMMARY; MYC; ANGIOGENESIS; EXPRESSION; PROGNOSIS; LAMININ-5; MIGRATION; INVASION	Metastasis is the primary cause of death in patients with breast cancer. Overexpression of c-myc in humans correlates with metastases, but transgenic mice only show low rates of micrometastases. We have generated transgenic mice that overexpress both c-myc and vascular endothelial growth factor (VEGF) (Myc/VEGF) in the mammary gland, which develop high rates of pulmonary macrometastases. Gene expression pro. ling revealed a set of deregulated genes in Myc/VEGF tumors compared to Myc tumors associated with the increased metastatic phenotype. Cross-comparisons between this set of genes with a human breast cancer lung metastasis gene signature identified five common targets: tenascin-C (TNC), matrix metalloprotease-2, collagen-6-A1, mannosidase-alpha-1A and HLA-DPA1. Signaling blockade or knockdown of TNC in MDA-MB-435 cells resulted in a significant impairment of cell migration and anchorage-independent cell proliferation. Mice injected with clonal MDA-MB-435 cells with reduced expression of TNC demonstrated a signifiant decrease (P < 0.05) in (1) primary tumor growth; (2) tumor relapse after surgical removal of the primary tumor and (3) incidence of lung metastasis. Our results demonstrate that VEGF induces complex alterations in tissue architecture and gene expression. The TNC signaling pathway plays an important role in mammary tumor growth and metastases, suggesting that TNC may be a relevant target for therapy against metastatic breast cancer.	[Calvo, A.; Huh, J-I; Sharp, R.; Qiu, T-H; Merlino, G.; Green, J. E.] NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA; [Calvo, A.; Catena, R.; Gil-Bazo, I.; Gonzalez-Moreno, O.] Univ Navarra, Ctr Appl Med Res CIMA, Div Oncol, E-31080 Pamplona, Spain; [Calvo, A.; Catena, R.; Gil-Bazo, I.; Gonzalez-Moreno, O.] Univ Navarra, Dept Histol & Pathol, E-31080 Pamplona, Spain; [Noble, M. S.; Carbott, D.; Dickson, R. B.; Johnson, M. D.] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20007 USA; [Gil-Bazo, I.] Univ Navarra Clin, Dept Oncol, Pamplona, Spain; [Anver, M. R.] Frederick Canc Res & Dev Ctr, Pathol & Histol Lab, SAIC, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Navarra; University of Navarra; Georgetown University; University of Navarra; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Johnson, MD (corresponding author), NCI, Dr Lab Canc Biol & Genet, NIH, Bldg 37 Room 4054 37 Convent Dr, Bethesda, MD 20892 USA.	Johnsom@georgetown.edu; jegreen@nih.gov	Calvo, Alfonso/V-7945-2017; Gil-Bazo, Ignacio/E-4581-2019	Calvo, Alfonso/0000-0003-4074-4242; Gil-Bazo, Ignacio/0000-0002-2626-5109; , Janet/0000-0001-9020-6982	Intramural Research Program of the NIH; National Cancer Institute; Center for Cancer Research; NIH [NO1-CO-12400, R01 CA72460, 2R01 CA104963, 2 R01 AG14963-06]; Susan G Komen Foundation; DOD Breast Cancer Program [DAMD17-01-1-0255]; ISCIII-RETIC [RD06/0020]; Fulbright-MEC fellowship; Spanish MEC fellowship; NATIONAL CANCER INSTITUTE [ZIABC005740, ZIABC011229, Z01BC010871] Funding Source: NIH RePORTER	Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G Komen Foundation(Susan G. Komen Breast Cancer Foundation); DOD Breast Cancer Program(United States Department of Defense); ISCIII-RETIC(Instituto de Salud Carlos III); Fulbright-MEC fellowship; Spanish MEC fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank Ms Mercedes Calvo for manuscript preparation, Victor Segura and Elizabeth Guruceaga (CEIT and Tecnun, Pamplona, Spain) for their help in bioinformatic analysis, GlaxoSmithKline for the GW654652 compound, Dr Rene Bernards (The Netherlands Cancer Institute) for the pMSCV-Delta 3<SUP>1</SUP>LTR vector, Dr Linda Metheny-Barlow (at the LCCC) for helpful discussions, Edward C Rosfjord and Sandra L Deming and Gloria Chepko for contributions to the initial Myc/VEGF crossbreeding study. This research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research, with funds from NIH(to GM) under Contract No. NO1-CO-12400, a grant from the Susan G Komen Foundation (to RBD), a grant from the DOD Breast Cancer Program DAMD17-01-1-0255 (to MDJ), NIH R01 CA72460 (to RBD), NIH 2R01 CA104963 (to RBD) ISCIII-RETIC (RD06/0020, to AC) and a Fulbright-MEC fellowship (AC); O G-M was supported by a Spanish MEC fellowship, and RBD by an NIH grant 2 R01 AG14963-06.	Adams J, 2000, CANCER RES, V60, P2898; AMUNDADOTTIR LT, 1995, CELL GROWTH DIFFER, V6, P737; Calvo A, 2002, CANCER RES, V62, P5325; Chiquet-Ehrismann R, 2003, J PATHOL, V200, P488, DOI 10.1002/path.1415; De Paola F, 2002, INT J CANCER, V98, P228, DOI 10.1002/ijc.10118; Deming SL, 2000, BRIT J CANCER, V83, P1688, DOI 10.1054/bjoc.2000.1522; Eckhardt BL, 2005, MOL CANCER RES, V3, P1; Ferrara N, 1999, KIDNEY INT, V56, P794, DOI 10.1046/j.1523-1755.1999.00610.x; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Giannelli G, 2001, CLIN EXP METASTAS, V18, P439; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Huh JI, 2005, ONCOGENE, V24, P790, DOI 10.1038/sj.onc.1208221; Hundley JE, 1997, CANCER RES, V57, P600; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; JHAPPAN C, 1990, CELL, V61, P1137, DOI 10.1016/0092-8674(90)90076-Q; Kalembeyi I, 2003, INT J CANCER, V105, P53, DOI 10.1002/ijc.11037; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Miralem T, 2001, ONCOGENE, V20, P5511, DOI 10.1038/sj.onc.1204753; Miyazaki K, 2006, CANCER SCI, V97, P91, DOI 10.1111/j.1349-7006.2006.00150.x; Noel A, 2004, J CLIN PATHOL, V57, P577, DOI 10.1136/jcp.2003.014472; Pei XF, 2004, IN VITRO CELL DEV-AN, V40, P14; PYKE C, 1994, AM J PATHOL, V145, P782; Qiu TH, 2004, CANCER RES, V64, P5973, DOI 10.1158/0008-5472.CAN-04-0242; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Schmitz AAP, 2000, EXP CELL RES, V261, P1, DOI 10.1006/excr.2000.5049; Schoeffner DJ, 2005, LAB INVEST, V85, P608, DOI 10.1038/labinvest.3700258; Shih SC, 2002, AM J PATHOL, V161, P35, DOI 10.1016/S0002-9440(10)64154-5; Stamenkovic I, 2000, SEMIN CANCER BIOL, V10, P415, DOI 10.1006/scbi.2000.0379; Suyama E, 2003, P NATL ACAD SCI USA, V100, P5616, DOI 10.1073/pnas.1035850100; Talts JF, 1999, J CELL SCI, V112, P1855; Tsunoda T, 2003, AM J PATHOL, V162, P1857, DOI 10.1016/S0002-9440(10)64320-9; Yamamoto H, 2001, CLIN CANCER RES, V7, P896; Zagzag D, 2002, CANCER RES, V62, P2660; Zagzag D, 2002, HISTOL HISTOPATHOL, V17, P301, DOI 10.14670/HH-17.301	35	61	67	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 11	2008	27	40					5373	5384		10.1038/onc.2008.155	http://dx.doi.org/10.1038/onc.2008.155			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	346UW	18504437	Green Accepted, Green Published			2022-12-25	WOS:000259096100010
J	Yao, XH; Chen, XC; Cottonham, C; Xu, L				Yao, Xiaohao; Chen, Xiaochu; Cottonham, Charisa; Xu, Lan			Preferential utilization of Imp7/8 in nuclear import of Smads	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA; PROTEINS; SIGNAL; COMPLEXES; CYTOPLASM; DYNAMICS; RECEPTOR; EXPORT	Trafficking of Smad proteins between the cytoplasm and nucleus is a critical component of transforming growth factor beta(TGF-beta) signal transduction. Smad4 translocates into the nucleus either in response to TGF-beta stimulation or when its nuclear export is blocked by leptomycin B (LMB). We demonstrate that both TGF-beta-induced and basal state spontaneous nuclear import of Smad4 require importin 7 and 8 (Imp7,8). Our data suggest that in the nuclear import of Smad4, the role of Imp8 is irreplaceable by Imp7, and that Smads preferentially bind Imp8. Interestingly, in contrast to its mammalian counterpart Smad4, Drosophila Medea appears to utilize different mechanisms for TGF-beta-induced or basal state nuclear accumulation, with the latter independent of Msk (Drosophila Imp7/8) function. In addition, overexpression of Imp8 alone was sufficient to cause an increased concentration of Smad1,3 and 4 in the nucleus, but had very limited effects on Smad2. These observations suggest selective involvement of Imp8/Msk in nuclear import of different Smads under different conditions.	[Yao, Xiaohao; Chen, Xiaochu; Cottonham, Charisa; Xu, Lan] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Xu, L (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St,Rm 308, Worcester, MA 01605 USA.	lan.xu@umassmed.edu			NATIONAL CANCER INSTITUTE [R01CA108509] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA108509] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baker SE, 2002, GENETICS, V162, P285; Chen HB, 2005, J BIOL CHEM, V280, P21329, DOI 10.1074/jbc.M500362200; Das P, 1998, DEVELOPMENT, V125, P1519; Dean KA, 2001, J CELL SCI, V114, P3479; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Freedman ND, 2004, MOL BIOL CELL, V15, P2276, DOI 10.1091/mbc.E03-11-0839; Gorlich D, 1997, J CELL BIOL, V138, P65, DOI 10.1083/jcb.138.1.65; Itoh S, 1998, J BIOL CHEM, V273, P29195, DOI 10.1074/jbc.273.44.29195; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; Jakel S, 1999, EMBO J, V18, P2411, DOI 10.1093/emboj/18.9.2411; Jayaraman L, 2000, J BIOL CHEM, V275, P40710, DOI 10.1074/jbc.M005799200; Kurisaki A, 2001, MOL BIOL CELL, V12, P1079, DOI 10.1091/mbc.12.4.1079; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Pierreux CE, 2000, MOL CELL BIOL, V20, P9041, DOI 10.1128/MCB.20.23.9041-9054.2000; Reguly T, 2003, TRENDS CELL BIOL, V13, P216, DOI 10.1016/S0962-8924(03)00075-8; Schmierer B, 2005, MOL CELL BIOL, V25, P9845, DOI 10.1128/MCB.25.22.9845-9858.2005; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Watanabe M, 2000, EMBO REP, V1, P176, DOI 10.1093/embo-reports/kvd029; Xiao Z, 2000, J BIOL CHEM, V275, P23425, DOI 10.1074/jbc.C000345200; Xu L, 2002, MOL CELL, V10, P271, DOI 10.1016/S1097-2765(02)00586-5; Xu L, 2000, NAT CELL BIOL, V2, P559, DOI 10.1038/35019649; Xu L, 2004, NAT REV MOL CELL BIO, V5, P209, DOI 10.1038/nrm1331; Xu L, 2003, J BIOL CHEM, V278, P42569, DOI 10.1074/jbc.M307601200; Xu L, 2007, J CELL BIOL, V178, P981, DOI 10.1083/jcb.200703106; Zhang SP, 2007, MOL CELL BIOL, V27, P4488, DOI 10.1128/MCB.01636-06	26	55	61	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22867	22874		10.1074/jbc.M801320200	http://dx.doi.org/10.1074/jbc.M801320200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18519565	hybrid, Green Published			2022-12-25	WOS:000258321000054
J	Bartos, JD; Willmott, LJ; Binz, SK; Wold, MS; Bambara, RA				Bartos, Jeremy D.; Willmott, Lyndsay J.; Binz, Sara K.; Wold, Marc S.; Bambara, Robert A.			Catalysis of strand annealing by replication protein A derives from its strand melting properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 NUCLEOCAPSID PROTEIN; NUCLEIC-ACID CHAPERONE; OKAZAKI FRAGMENT MATURATION; DNA-BINDING PROTEIN; COMPLEX-FORMATION; RAD52 PROTEIN; RECA PROTEIN; IN-VITRO; HELICASE; RPA	Eukaryotic DNA-binding protein replication protein A (RPA) has a strand melting property that assists polymerases and helicases in resolving DNA secondary structures. Curiously, previous results suggested that human RPA (hRPA) promotes undesirable recombination by facilitating annealing of flaps produced transiently during DNA replication; however, the mechanism was not understood. We designed a series of substrates, representing displaced DNA flaps generated during maturation of Okazaki fragments, to investigate the strand annealing properties of RPA. Until cleaved by FEN1 (flap endonuclease 1), such flaps can initiate homologous recombination. hRPA inhibited annealing of strands lacking secondary structure but promoted annealing of structured strands. Apparently, both processes primarily derive from the strand melting properties of hRPA. These properties slowed the spontaneous annealing of unstructured single strands, which occurred efficiently without hRPA. However, structured strands without hRPA displayed very slow spontaneous annealing because of stable intramolecular hydrogen bonding. hRPA appeared to transiently melt the single strands so that they could bind to form double strands. In this way, melting ironically promoted annealing. Time course measurements in the presence of hRPA suggest that structured single strands achieve an equilibrium with double strands, a consequence of RPA driving both annealing and melting. Promotion of annealing reached a maximum at a specific hRPA concentration, presumably when all structured single-stranded DNA was melted. Results suggest that displaced flaps with secondary structure formed during Okazaki fragment maturation can be melted by hRPA and subsequently annealed to a complementary ectopic DNA site, forming recombination intermediates that can lead to genomic instability.	[Bartos, Jeremy D.; Bambara, Robert A.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Willmott, Lyndsay J.] Univ Rochester, Sch Med & Dent, Dept Obstet & Gynecol, Rochester, NY 14642 USA; [Binz, Sara K.; Wold, Marc S.] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA	University of Rochester; University of Rochester; University of Iowa	Bambara, RA (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	Robert_Bambara@urmc.rochester.edu	Wold, Marc/F-5806-2010	Wold, Marc/0000-0002-4580-1624	NCI NIH HHS [T32 CA 09363] Funding Source: Medline; NIGMS NIH HHS [GM 024441, R01 GM044721, GM 44721] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044721, R01GM024441] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Bae KH, 2003, NUCLEIC ACIDS RES, V31, P3006, DOI 10.1093/nar/gkg422; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Bartos JD, 2006, J BIOL CHEM, V281, P32227, DOI 10.1074/jbc.M606310200; Bastin-Shanower SA, 2001, J BIOL CHEM, V276, P36446, DOI 10.1074/jbc.M104386200; Beltz H, 2004, J MOL BIOL, V338, P711, DOI 10.1016/j.jmb.2004.03.019; Bochkareva E, 2001, EMBO J, V20, P612, DOI 10.1093/emboj/20.3.612; Bochkareva E, 2002, EMBO J, V21, P1855, DOI 10.1093/emboj/21.7.1855; Boule JB, 2007, NUCLEIC ACIDS RES, V35, P5809, DOI 10.1093/nar/gkm613; Brosh RM, 2000, J BIOL CHEM, V275, P23500, DOI 10.1074/jbc.M001557200; Brosh RM, 1999, J BIOL CHEM, V274, P18341, DOI 10.1074/jbc.274.26.18341; BUDD ME, 1995, J BIOL CHEM, V270, P26766, DOI 10.1074/jbc.270.45.26766; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; Cui S, 2004, NUCLEIC ACIDS RES, V32, P2158, DOI 10.1093/nar/gkh540; Daughdrill GW, 2001, NUCLEIC ACIDS RES, V29, P3270, DOI 10.1093/nar/29.15.3270; de Laat WL, 1998, GENE DEV, V12, P2598, DOI 10.1101/gad.12.16.2598; DeMott MS, 1998, J BIOL CHEM, V273, P27492, DOI 10.1074/jbc.273.42.27492; Doherty KM, 2005, J BIOL CHEM, V280, P29494, DOI 10.1074/jbc.M500653200; FAIRMAN MP, 1988, EMBO J, V7, P1211, DOI 10.1002/j.1460-2075.1988.tb02933.x; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Gao H, 2007, NAT STRUCT MOL BIOL, V14, P208, DOI 10.1038/nsmb1205; Garcia PL, 2004, EMBO J, V23, P2882, DOI 10.1038/sj.emboj.7600301; Garg P, 2004, GENE DEV, V18, P2764, DOI 10.1101/gad.1252304; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Iftode C, 2000, BIOCHEMISTRY-US, V39, P11970, DOI 10.1021/bi0005761; Jin YH, 2003, J BIOL CHEM, V278, P1626, DOI 10.1074/jbc.M209803200; Kao HI, 2004, J BIOL CHEM, V279, P50840, DOI 10.1074/jbc.M409231200; Kao HI, 2004, J BIOL CHEM, V279, P15014, DOI 10.1074/jbc.M313216200; Kao HI, 2003, CRIT REV BIOCHEM MOL, V38, P433, DOI 10.1080/10409230390259382; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P97, DOI 10.1016/0022-2836(87)90630-9; Lao Y, 1999, BIOCHEMISTRY-US, V38, P3974, DOI 10.1021/bi982371m; Levin JG, 2005, PROG NUCLEIC ACID RE, V80, P217, DOI 10.1016/S0079-6603(05)80006-6; LONN U, 1990, CANCER RES, V50, P3141; Machwe A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-1; MacNeill SA, 2001, CURR BIOL, V11, pR842, DOI 10.1016/S0960-9822(01)00500-0; MUNIYAPPA K, 1984, P NATL ACAD SCI-BIOL, V81, P2757, DOI 10.1073/pnas.81.9.2757; Murante RS, 1995, J BIOL CHEM, V270, P30377, DOI 10.1074/jbc.270.51.30377; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Opresko PL, 2001, J BIOL CHEM, V276, P44677, DOI 10.1074/jbc.M107548200; Pestryakov PE, 2004, NUCLEIC ACIDS RES, V32, P1894, DOI 10.1093/nar/gkh346; Peyret N, 2000, THESIS WAYNE STATE U; Ranalli TA, 2002, J BIOL CHEM, V277, P1719, DOI 10.1074/jbc.M109053200; Rossi ML, 2006, J BIOL CHEM, V281, P26051, DOI 10.1074/jbc.M604805200; Rossi ML, 2006, CHEM REV, V106, P453, DOI 10.1021/cr040497l; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Shen JC, 2003, MECH AGEING DEV, V124, P921, DOI 10.1016/S0047-6374(03)00164-7; Shinohara A, 1998, GENES CELLS, V3, P145, DOI 10.1046/j.1365-2443.1998.00176.x; Sugiyama T, 1997, J BIOL CHEM, V272, P7940, DOI 10.1074/jbc.272.12.7940; Sugiyama T, 1998, P NATL ACAD SCI USA, V95, P6049, DOI 10.1073/pnas.95.11.6049; TSUCHIHASHI Z, 1994, J VIROL, V68, P5863, DOI 10.1128/JVI.68.9.5863-5870.1994; Urbaneja MA, 2002, J MOL BIOL, V318, P749, DOI 10.1016/S0022-2836(02)00043-8; Van Komen S, 2003, J BIOL CHEM, V278, P44331, DOI 10.1074/jbc.M307256200; Williams MC, 2001, P NATL ACAD SCI USA, V98, P6121, DOI 10.1073/pnas.101033198; WOBBE CR, 1987, P NATL ACAD SCI USA, V84, P1834, DOI 10.1073/pnas.84.7.1834; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; WOLD MS, 1988, P NATL ACAD SCI USA, V85, P2523, DOI 10.1073/pnas.85.8.2523; YOU JC, 1994, J BIOL CHEM, V269, P31491; Yuzhakov A, 1999, EMBO J, V18, P6189, DOI 10.1093/emboj/18.21.6189; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	62	11	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21758	21768		10.1074/jbc.M800856200	http://dx.doi.org/10.1074/jbc.M800856200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18522944	Green Published, hybrid			2022-12-25	WOS:000257898800049
J	Nabavi, S; Nellimarla, S; Nazar, RN				Nabavi, Sadeq; Nellimarla, Srinivas; Nazar, Ross N.			Post-transcriptional regulation of the U3 small nucleolar RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMIDS; RIBONUCLEOPROTEIN; GENES; TRANSFORMATION; MATURATION; PROTEIN; CLONING	A high copy shuttle vector was used to express a "tagged" U3 small nucleolar RNA (snoRNA) gene in Schizosaccharomyces pombe to examine regulatory responses to a high gene dosage. RNA analyses utilizing reverse transcription-PCR amplification and restriction fragment length polymorphism indicated that the tagged gene was both proportionally and highly expressed and that downstream processing and/or termination were critical to U3 snoRNA stability. In contrast, direct measurements of the total cellular U3 snoRNA showed essentially normal levels of mature RNA, although measurements of precursor levels confirmed a highly expressed gene construct. Taken together, the results indicated that the steady state amounts of mature U3 snoRNA were primarily regulated at the post-transcriptional level. This regulatory mechanism prevents over-accumulation of the cellular U3 snoRNA and can efficiently degrade mutant RNA molecules. Together with past studies on other 3' extended RNA precursors, the results support post-transcriptional regulation as a quality control mechanism in which appropriate amounts of functional RNA are stabilized by protein interaction while excess or defective RNA is rapidly degraded. Precursor processing in vitro and mutational analyses were consistent with this model.	[Nabavi, Sadeq; Nellimarla, Srinivas; Nazar, Ross N.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Nazar, RN (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	rnnazar@uoguelph.ca		Nabavi, Sadegh/0000-0002-3940-1210				ABOUELELA S, 1998, EMBO J, V13, P3738; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Bernstein KA, 2004, EUKARYOT CELL, V3, P1619, DOI 10.1128/EC.3.6.1619-1626.2004; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Dunbar DA, 1997, MOL CELL BIOL, V17, P5803, DOI 10.1128/MCB.17.10.5803; Granneman S, 2004, MOL CELL BIOL, V24, P8600, DOI 10.1128/MCB.24.19.8600-8610.2004; Gutz H, 1974, HDB GENETICS, P395, DOI 10.1007/978-1-4899-1710-2_25; HENNIGHAUSEN L, 1987, METHOD ENZYMOL, V152, P721; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; JAZWINSKI SM, 1990, METHOD ENZYMOL, V182, P154; Kienzle N, 1996, BIOTECHNIQUES, V20, P612; Kufel J, 2003, NUCLEIC ACIDS RES, V31, P6788, DOI 10.1093/nar/gkg904; LEADER DJ, 1994, BBA-GENE STRUCT EXPR, V1219, P145, DOI 10.1016/0167-4781(94)90257-7; Lee SJ, 1999, MOL CELL BIOL, V19, P5441; Lee Y, 2003, J BIOL CHEM, V278, P6635, DOI 10.1074/jbc.M212220200; LEE Y, 1995, J BIOL CHEM, V270, P28003; Lee Y, 1997, J BIOL CHEM, V272, P15206, DOI 10.1074/jbc.272.24.15206; LOSSON R, 1983, CELL, V32, P371, DOI 10.1016/0092-8674(83)90456-7; MANGIN M, 1985, SCIENCE, V229, P272, DOI 10.1126/science.2409601; MEAD DA, 1986, PROTEIN ENG, V1, P67, DOI 10.1093/protein/1.1.67; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; Nabavi S, 2005, ANAL BIOCHEM, V345, P346, DOI 10.1016/j.ab.2005.06.033; Nazar RN, 2004, IUBMB LIFE, V56, P457, DOI 10.1080/15216540400010867; NAZAR RN, 1991, J BIOL CHEM, V266, P4562; NAZAR RN, 2007, FASEB J, V21; Noonberg SB, 1996, J BIOL CHEM, V271, P10477, DOI 10.1074/jbc.271.18.10477; OKAZAKI K, 1990, NUCLEIC ACIDS RES, V18, P6485, DOI 10.1093/nar/18.22.6485; Osheim YN, 2004, MOL CELL, V16, P943, DOI 10.1016/j.molcel.2004.11.031; Rose M. D., 1990, METHODS YEAST GENETI, P140; Samarsky DA, 1998, MOL CELL BIOL, V18, P3431, DOI 10.1128/MCB.18.6.3431; Sambrook J, 2001, MOL CLONING LAB MANU; Seipelt RL, 1999, NUCLEIC ACIDS RES, V27, P587, DOI 10.1093/nar/27.2.587; SELINGER DA, 1992, MOL BIOL EVOL, V9, P297; STEELE WJ, 1965, J BIOL CHEM, V240, P1742; Watkins NJ, 2004, MOL CELL, V16, P789, DOI 10.1016/j.molcel.2004.11.012; Watkins NJ, 1996, RNA, V2, P118; Zhou DW, 1999, RNA, V5, P1083, DOI 10.1017/S1355838299990726	37	5	5	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21404	21410		10.1074/jbc.M802189200	http://dx.doi.org/10.1074/jbc.M802189200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18522942	hybrid			2022-12-25	WOS:000257898800011
J	Steiner, K; Novotny, R; Werz, DB; Zarschler, K; Seeberger, PH; Hofinger, A; Kosma, P; Schaffer, C; Messner, P				Steiner, Kerstin; Novotny, Rene; Werz, Daniel B.; Zarschler, Kristof; Seeberger, Peter H.; Hofinger, Andreas; Kosma, Paul; Schaeffer, Christina; Messner, Paul			Molecular basis of S-layer glycoprotein glycan biosynthesis in Geobacillus stearothermophilus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-LINKED GLYCOSYLATION; BINDING CASSETTE TRANSPORTER; L-RHAMNOSE BIOSYNTHESIS; ESCHERICHIA-COLI; NRS 2004/3A; PROTEIN GLYCOSYLATION; GENE-CLUSTER; BACTERIAL OLIGOSACCHARYLTRANSFERASE; FUNCTIONAL-CHARACTERIZATION; SUBSTRATE-SPECIFICITY	The Gram-positive bacterium Geobacillus stearothermophilus NRS 2004/3a possesses a cell wall containing an oblique surface layer ( S-layer) composed of glycoprotein subunits. O-Glycans with the structure [-> 2)-alpha-L-Rhap-(1 -> 3)-beta-L-Rhap-(1 -> 2)-alpha-L-Rhap-(1 ->](n) (=) (13-18), a 2-O-methyl group capping the terminal repeating unit at the nonreducing end and a -> 2)-alpha-L- Rhap-[(1 -> 3)-alpha-L-Rhap](n) (=) (1-2)(1 -> 3)- adaptor are linked via a beta-D-Galp residue to distinct sites of the S-layer protein SgsE. S-layer glycan biosynthesis is encoded by a polycistronic slg ( surface layer glycosylation) gene cluster. Four assigned glycosyltransferases named WsaC-WsaF, were investigated by a combined biochemical and NMR approach, starting from synthetic octyl-linked saccharide precursors. We demonstrate that three of the enzymes are rhamnosyltransferases that are responsible for the transfer of L-rhamnose from a dTDP-beta-L-Rha precursor to the nascent S-layer glycan, catalyzing the formation of the alpha 1,3-(WsaC and WsaD) and beta 1,2-linkages (WsaF) present in the adaptor saccharide and in the repeating units of the mature S-layer glycan, respectively. These enzymes work in concert with a multifunctional methylrhamnosyltransferase (WsaE). The N-terminal portion of WsaE is responsible for the Sadenosylmethionine-dependent methylation reaction of the terminal alpha 1,3- linked L-rhamnose residue, and the central and C-terminal portions are involved in the transfer of L-rhamnose from dTDP-beta-L-rhamnose to the adaptor saccharide to form the alpha 1,2- and alpha 1,3- linkages during S-layer glycan chain elongation, with the methylation and the glycosylation reactions occurring independently. Characterization of these enzymes thus reveals the complete molecular basis for S-layer glycan biosynthesis.	[Steiner, Kerstin; Novotny, Rene; Zarschler, Kristof; Schaeffer, Christina; Messner, Paul] Univ Nat Resources & Appl Life Sci, Ctr NanoBiotechnol, Vienna, Austria; [Hofinger, Andreas; Kosma, Paul] Univ Nat Resources & Appl Life Sci, Dept Chem, Vienna, Austria; [Werz, Daniel B.; Seeberger, Peter H.] Swiss Fed Inst Technol, Organ Chem Lab, Zurich, Switzerland	University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna; Swiss Federal Institutes of Technology Domain; ETH Zurich	Schaffer, C (corresponding author), Univ Nat Resources & Appl Life Sci, Ctr NanoBiotechnol, Vienna, Austria.	christina.schaeffer@boku.ac.at; paul.messner@boku.ac.at	Kosma, Paul/Y-7443-2019; Zarschler, Kristof/A-3276-2015; Schäffer, Christina/V-3404-2018; Messner, Paul/Q-5345-2017	Kosma, Paul/0000-0001-5342-7161; Zarschler, Kristof/0000-0002-7571-4732; Schäffer, Christina/0000-0003-1613-7258; Messner, Paul/0000-0002-3246-5801	Austrian Science Fund FWF [P 18013, P 19047] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF))		ADACHI S, 1965, J CHROMATOGR, V17, P295, DOI 10.1016/S0021-9673(00)99871-6; BOCK K, 1994, J BIOL CHEM, V269, P7137; Charnock SJ, 1999, BIOCHEMISTRY-US, V38, P6380, DOI 10.1021/bi990270y; Clarke BR, 2004, J BIOL CHEM, V279, P35709, DOI 10.1074/jbc.M404738200; Cuthbertson L, 2005, J BIOL CHEM, V280, P30310, DOI 10.1074/jbc.M504371200; Cuthbertson L, 2007, P NATL ACAD SCI USA, V104, P19529, DOI 10.1073/pnas.0705709104; Eichler J, 2005, MICROBIOL MOL BIOL R, V69, P393, DOI 10.1128/MMBR.69.3.393-425.2005; Elliott S, 2003, NAT BIOTECHNOL, V21, P414, DOI 10.1038/nbt799; Faridmoayer A, 2007, J BACTERIOL, V189, P8088, DOI 10.1128/JB.01318-07; FOLCH J, 1957, J BIOL CHEM, V226, P497; Furstner A, 1999, J AM CHEM SOC, V121, P7814, DOI 10.1021/ja991361l; Geremia RA, 1996, BIOCHEM J, V318, P133, DOI 10.1042/bj3180133; Glover KJ, 2005, P NATL ACAD SCI USA, V102, P14255, DOI 10.1073/pnas.0507311102; Graninger M, 2002, APPL ENVIRON MICROB, V68, P3708, DOI 10.1128/AEM.68.8.3708-3715.2002; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Kahlig H, 2005, J BIOL CHEM, V280, P20292, DOI 10.1074/jbc.M501724200; Keenleyside WJ, 2001, J BACTERIOL, V183, P77, DOI 10.1128/JB.183.1.77-85.2001; Kido N, 1998, MOL MICROBIOL, V27, P1213, DOI 10.1046/j.1365-2958.1998.00765.x; KIDO N, 1995, J BACTERIOL, V177, P2178, DOI 10.1128/jb.177.8.2178-2187.1995; Kowarik M, 2006, SCIENCE, V314, P1148, DOI 10.1126/science.1134351; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Love KR, 2004, ANGEW CHEM INT EDIT, V43, P602, DOI 10.1002/anie.200352539; Messner P, 2008, CARBOHYD RES, V343, P1934, DOI 10.1016/j.carres.2007.12.025; MORONA R, 1995, MOL MICROBIOL, V18, P209, DOI 10.1111/j.1365-2958.1995.mmi_18020209.x; Novotny R, 2003, GLYCOCONJUGATE J, V20, P435, DOI 10.1023/B:GLYC.0000038290.74944.65; Novotny R, 2004, MICROBIOL-SGM, V150, P953, DOI 10.1099/mic.0.26672-0; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Power PM, 2003, FEMS MICROBIOL LETT, V218, P211, DOI 10.1111/j.1574-6968.2003.tb11520.x; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Riley JG, 2005, GLYCOBIOLOGY, V15, P605, DOI 10.1093/glycob/cwi038; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Rush JS, 1997, GLYCOBIOLOGY, V7, P315, DOI 10.1093/glycob/7.2.315; SAXENA IM, 1995, J BACTERIOL, V177, P1419, DOI 10.1128/jb.177.6.1419-1424.1995; Schaffer C, 2007, SMALL, V3, P1549, DOI 10.1002/smll.200700200; Schaffer C, 1999, GLYCOBIOLOGY, V9, P407, DOI 10.1093/glycob/9.4.407; Schaffer C, 2004, GLYCOBIOLOGY, V14, p31R, DOI 10.1093/glycob/cwh064; Schaffer C, 2002, J BIOL CHEM, V277, P6230, DOI 10.1074/jbc.M108873200; Schuster B, 2006, MINI-REV MED CHEM, V6, P909, DOI 10.2174/138955706777935026; Seeberger PH, 2007, NATURE, V446, P1046, DOI 10.1038/nature05819; Sharon N, 2004, GLYCOBIOLOGY, V14, p53R, DOI 10.1093/glycob/cwh122; Sleytr UB, 2007, FEMS MICROBIOL LETT, V267, P131, DOI 10.1111/j.1574-6968.2006.00573.x; Sleytr UB, 2007, FEBS J, V274, P323, DOI 10.1111/j.1742-4658.2006.05606.x; STEINER K, 2007, SMALL IN PRESS; Steiner K, 2007, J BACTERIOL, V189, P2590, DOI 10.1128/JB.01592-06; Steiner K, 2006, J BACTERIOL, V188, P7914, DOI 10.1128/JB.00802-06; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Sugiyama T, 1998, J BACTERIOL, V180, P2775, DOI 10.1128/JB.180.10.2775-2778.1998; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Szymanski CM, 2003, TRENDS MICROBIOL, V11, P233, DOI 10.1016/S0966-842X(03)00079-9; Tarbouriech N, 2001, J MOL BIOL, V314, P655, DOI 10.1006/jmbi.2001.5159; Valvano MA, 2003, FRONT BIOSCI-LANDMRK, V8, pS452, DOI 10.2741/1079; Vinogradov E, 2002, J BIOL CHEM, V277, P25070, DOI 10.1074/jbc.M202683200; Wacker M, 2006, P NATL ACAD SCI USA, V103, P7088, DOI 10.1073/pnas.0509207103; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Wang QH, 2007, BIOTECHNOL BIOENG, V98, P842, DOI 10.1002/bit.21462; Weerapana E, 2005, J AM CHEM SOC, V127, P13766, DOI 10.1021/ja054265v; Werz DB, 2007, ACS CHEM BIOL, V2, P685, DOI 10.1021/cb700178s; Werz DB, 2005, ANGEW CHEM INT EDIT, V44, P6315, DOI 10.1002/anie.200502615; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Wolucka BA, 1998, GLYCOBIOLOGY, V8, P955, DOI 10.1093/glycob/8.10.955; Young NM, 2002, J BIOL CHEM, V277, P42530, DOI 10.1074/jbc.M206114200	61	40	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21120	21133		10.1074/jbc.M801833200	http://dx.doi.org/10.1074/jbc.M801833200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18515358	hybrid, Green Published			2022-12-25	WOS:000257746100054
J	Bugreev, DV; Brosh, RM; Mazin, AV				Bugreev, Dmitry V.; Brosh, Robert M., Jr.; Mazin, Alexander V.			RECQ1 possesses DNA branch migration activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; ROTHMUND-THOMSON-SYNDROME; BLOOMS-SYNDROME HELICASE; REPLICATION PROTEIN-A; SYNDROME GENE-PRODUCT; HUMAN RAD54 PROTEIN; HOMOLOGOUS RECOMBINATION; BIOCHEMICAL-CHARACTERIZATION; HOLLIDAY JUNCTIONS; WERNERS-SYNDROME	RecQ helicases are essential for the maintenance of genome stability. Five members of the RecQ family have been found in humans, including RECQ1, RECQ5, BLM, WRN, and RECQ4; the last three are associated with human diseases. At this time, only BLM and WRN helicases have been extensively characterized, and the information on the other RecQ helicases has only started to emerge. Our current paper is focused on the biochemical properties of human RECQ1 helicase. Recent cellular studies have shown that RECQ1 may participate in DNA repair and homologous recombination, but the exact mechanisms of how RECQ1 performs its cellular functions remain largely unknown. Whereas RECQ1 possesses poor helicase activity, we found here that the enzyme efficiently promotes DNA branch migration. Further analysis revealed that RECQ1 catalyzes unidirectional three- stranded branch migration with a 3'-> 5' polarity. We show that this RECQ1 activity is instrumental in specific disruption of joint molecules (D- loops) formed by a 5' single- stranded DNA invading strand, which may represent dead end intermediates of homologous recombination in vivo. The newly found enzymatic properties of the RECQ1 helicase may have important implications for the function of RECQ1 in maintenance of genomic stability.	[Bugreev, Dmitry V.; Mazin, Alexander V.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19102 USA; [Bugreev, Dmitry V.] Russian Acad Sci, Siberian Branch, Inst Chem Biol & Fundamental Med, Novosibirsk 630090, Russia; [Brosh, Robert M., Jr.] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA	Drexel University; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Mazin, AV (corresponding author), Drexel Univ, Coll Med, Dept Biochem & Mol Biol, 245 N 15th St,NCB Rm 10103, Philadelphia, PA 19102 USA.	amazin@drexelmed.edu			NATIONAL CANCER INSTITUTE [R56CA100839, R01CA100839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000741] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [CA 100839] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams MD, 2003, SCIENCE, V299, P265, DOI 10.1126/science.1077198; Agarwal S, 2006, DNA REPAIR, V5, P1075, DOI 10.1016/j.dnarep.2006.05.029; Bachrati CZ, 2006, NUCLEIC ACIDS RES, V34, P2269, DOI 10.1093/nar/gkl258; Bachrati CZ, 2003, BIOCHEM J, V374, P577, DOI 10.1042/BJ20030491; Bjergbaek L, 2002, SWISS MED WKLY, V132, P433; Branzei D, 2007, GENE DEV, V21, P3019, DOI 10.1101/gad.1624707; Brosh RM, 2000, J BIOL CHEM, V275, P23500, DOI 10.1074/jbc.M001557200; Brosh RM, 1999, J BIOL CHEM, V274, P18341, DOI 10.1074/jbc.274.26.18341; Brosh RM, 2001, J BIOL CHEM, V276, P3024, DOI 10.1074/jbc.M006784200; Brosh RM, 2007, NUCLEIC ACIDS RES, V35, P7527, DOI 10.1093/nar/gkm1008; Bugreev DV, 2007, GENE DEV, V21, P3085, DOI 10.1101/gad.1609007; Bugreev DV, 2007, NAT STRUCT MOL BIOL, V14, P746, DOI 10.1038/nsmb1268; Bugreev DV, 2006, NATURE, V442, P590, DOI 10.1038/nature04889; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; BUGREEV DV, 2006, NATURE PROTOCOLS; Cheok CF, 2005, NUCLEIC ACIDS RES, V33, P3932, DOI 10.1093/nar/gki712; Constantinou A, 2000, EMBO REP, V1, P80, DOI 10.1093/embo-reports/kvd004; Cui S, 2003, J BIOL CHEM, V278, P1424, DOI 10.1074/jbc.M209407200; Cui S, 2004, NUCLEIC ACIDS RES, V32, P2158, DOI 10.1093/nar/gkh540; Doherty KM, 2005, J BIOL CHEM, V280, P28085, DOI 10.1074/jbc.M500265200; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; EPSTEIN CJ, 1966, MEDICINE, V45, P177, DOI 10.1097/00005792-196605000-00001; Garcia PL, 2004, EMBO J, V23, P2882, DOI 10.1038/sj.emboj.7600301; GERMAN J, 1995, DERMATOL CLIN, V13, P7, DOI 10.1016/S0733-8635(18)30101-3; GERMAN J, 1993, MEDICINE, V72, P393, DOI 10.1097/00005792-199311000-00003; Hanada K, 2007, CELL MOL LIFE SCI, V64, P2306, DOI 10.1007/s00018-007-7121-z; Harmon FG, 2001, J BIOL CHEM, V276, P232, DOI 10.1074/jbc.M006555200; Harrigan JA, 2003, BIOCHIMIE, V85, P1185, DOI 10.1016/j.biochi.2003.10.006; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hu Y, 2007, GENE DEV, V21, P3073, DOI 10.1101/gad.1609107; Johnson FB, 2000, CANCER RES, V60, P1162; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; Karow JK, 1997, J BIOL CHEM, V272, P30611, DOI 10.1074/jbc.272.49.30611; Kawabe T, 2000, ONCOGENE, V19, P4764, DOI 10.1038/sj.onc.1203841; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Lindor NM, 2000, AM J MED GENET, V90, P223, DOI 10.1002/(SICI)1096-8628(20000131)90:3<223::AID-AJMG7>3.0.CO;2-Z; Machwe A, 2005, J BIOL CHEM, V280, P23397, DOI 10.1074/jbc.M414130200; Macris MA, 2006, DNA REPAIR, V5, P172, DOI 10.1016/j.dnarep.2005.09.005; Mazin AV, 2000, EMBO J, V19, P1148, DOI 10.1093/emboj/19.5.1148; Mazina OM, 2007, J BIOL CHEM, V282, P21068, DOI 10.1074/jbc.M701992200; Mazina OM, 2004, J BIOL CHEM, V279, P52042, DOI 10.1074/jbc.M410244200; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; McVey M, 2004, P NATL ACAD SCI USA, V101, P15694, DOI 10.1073/pnas.0406157101; Muzzolini L, 2007, PLOS BIOL, V5, P157, DOI 10.1371/journal.pbio.0050020; Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885; Opresko PL, 2004, J BIOL CHEM, V279, P18099, DOI 10.1074/jbc.R300034200; Ozsoy AZ, 2001, NUCLEIC ACIDS RES, V29, P2986, DOI 10.1093/nar/29.14.2986; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; PURANAM KL, 1994, J BIOL CHEM, V269, P29838; SEKI M, 1994, NUCLEIC ACIDS RES, V22, P4566, DOI 10.1093/nar/22.22.4566; Seki T, 1997, BIOCHEM BIOPH RES CO, V234, P48, DOI 10.1006/bbrc.1997.6535; Sharma S, 2005, J BIOL CHEM, V280, P28072, DOI 10.1074/jbc.M500264200; Sharma S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001297; Sharma S, 2007, MOL CELL BIOL, V27, P1784, DOI 10.1128/MCB.01620-06; Shereda RD, 2007, J BIOL CHEM, V282, P19247, DOI 10.1074/jbc.M608011200; Stewart E, 1997, EMBO J, V16, P2682, DOI 10.1093/emboj/16.10.2682; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; van Brabant AJ, 2000, BIOCHEMISTRY-US, V39, P14617, DOI 10.1021/bi0018640; Wang LL, 2001, AM J MED GENET, V102, P11, DOI 10.1002/1096-8628(20010722)102:1<11::AID-AJMG1413>3.0.CO;2-A; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Whitby MC, 2005, BIOCHEM SOC T, V33, P1451, DOI 10.1042/BST0331451; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Wu L, 2006, ANNU REV GENET, V40, P279, DOI 10.1146/annurev.genet.40.110405.090636; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258	68	61	62	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20231	20242		10.1074/jbc.M801582200	http://dx.doi.org/10.1074/jbc.M801582200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18495662	Green Published, hybrid			2022-12-25	WOS:000257565300039
J	Cambi, A; Netea, MG; Mora-Montes, HM; Gow, NAR; Hato, SV; Lowman, DW; Kullberg, BJ; Torensma, R; Williams, DL; Figdor, CG				Cambi, Alessandra; Netea, Mihai G.; Mora-Montes, Hector M.; Gow, Neil A. R.; Hato, Stanleyson V.; Lowman, Douglas W.; Kullberg, Bart-Jan; Torensma, Ruurd; Williams, David L.; Figdor, Carl G.			Dendritic cell interaction with Candida albicans critically depends on N-linked mannan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE-DERIVED MACROPHAGES; TOLL-LIKE RECEPTORS; LECTINS DC-SIGN; WALL MANNAN; SEROTYPE-B; SACCHAROMYCES-CEREVISIAE; SURFACE HYDROPHOBICITY; MONOCLONAL-ANTIBODY; PATHOGENIC YEASTS; STRUCTURAL BASIS	The fungus Candida albicans is the most common cause of mycotic infections in immunocompromised hosts. Little is known about the initial interactions between Candida and immune cell receptors, because a detailed characterization at the structural level is lacking. Antigen-presenting dendritic cells (DCs), strategically located at mucosal surfaces and in the skin, may play an important role in anti-Candida protective immunity. However, the contribution of the various Candida-associated molecular patterns and their counter-receptors to DC function remains unknown. Here, we demonstrate that two C-type lectins, DC-SIGN and the macrophage mannose receptor, specifically mediate C. albicans binding and internalization by human DCs. Moreover, by combining a range of C. albicans glycosylation mutants with receptor-specific blocking and cytokine production assays, we determined that N-linked mannan but not O-linked or phosphomannan is the fungal carbohydrate structure specifically recognized by both C-type lectins on human DCs and directly influences the production of the proinflammatory cytokine IL-6. Better insight in the carbohydrate recognition profile of C-type lectins will ultimately provide relevant information for the development of new drugs targeting specific fungal cell wall antigens.	[Cambi, Alessandra; Hato, Stanleyson V.; Torensma, Ruurd; Figdor, Carl G.] Radboud Univ Nijmegen, Nijmegen Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Tumor Immunol, NL-6500 HB Nijmegen, Netherlands; [Netea, Mihai G.; Kullberg, Bart-Jan] Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Med, NL-6500 HB Nijmegen, Netherlands; [Netea, Mihai G.; Kullberg, Bart-Jan] Radboud Univ Nijmegen, Univ Nijmegen, Nijmegen Med Ctr, Ctr Infect Dis, NL-6500 HB Nijmegen, Netherlands; [Mora-Montes, Hector M.; Gow, Neil A. R.] Univ Aberdeen, Sch Med Sci, Inst Med Sci, Aberdeen, Scotland; [Lowman, Douglas W.] Eastman Chem Co, Corp Analyt Serv, Kingsport, TN 37662 USA; [Lowman, Douglas W.; Williams, David L.] E Tennessee State Univ, James H Quillen Coll Med, Dept Surg, Johnson City, TN 37614 USA	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Aberdeen; Eastman Chemical Company; East Tennessee State University	Figdor, CG (corresponding author), Radboud Univ Nijmegen, Nijmegen Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Tumor Immunol, Postbox 9101, NL-6500 HB Nijmegen, Netherlands.	c.figdor@ncmls.ru.nl	Mora-Montes, Hector/A-8312-2010; Montes, Hector Manuel Mora/H-1729-2014; Torensma, Ruurd/C-2853-2009; Netea, Mihai/N-5155-2014; Kullberg, BJ/C-8520-2013; Figdor, Carl G/A-4232-2010; GOW, Neil/AAS-5323-2021; Cambi, Alessandra/L-4242-2015	Montes, Hector Manuel Mora/0000-0001-6973-0595; Torensma, Ruurd/0000-0002-0555-7903; Kullberg, BJ/0000-0002-6813-8167; Figdor, Carl G/0000-0002-2366-9212; GOW, Neil/0000-0002-2776-5850; Cambi, Alessandra/0000-0003-1597-1582	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI045829] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053522] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 45829] Funding Source: Medline; NIGMS NIH HHS [GM 53522] Funding Source: Medline; Wellcome Trust [080088] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission)		AbiSaid D, 1997, CLIN INFECT DIS, V24, P1122, DOI 10.1086/513663; Bates EEM, 1999, J IMMUNOL, V163, P1973; Bates S, 2006, J BIOL CHEM, V281, P90, DOI 10.1074/jbc.M510360200; Bates S, 2005, J BIOL CHEM, V280, P23408, DOI 10.1074/jbc.M502162200; Bleijs DA, 2000, J CELL SCI, V113, P391; Bystricky S, 2003, IMMUNOL LETT, V85, P251, DOI 10.1016/S0165-2478(02)00241-9; Calderone Richard A., 1993, Trends in Microbiology, V1, P55, DOI 10.1016/0966-842X(93)90033-N; Cambi A, 2004, J CELL BIOL, V164, P145, DOI 10.1083/jcb.200306112; Cambi A, 2003, CURR OPIN CELL BIOL, V15, P539, DOI 10.1016/j.ceb.2003.08.004; Cambi A, 2003, EUR J IMMUNOL, V33, P532, DOI 10.1002/immu.200310029; Choi W, 2003, YEAST, V20, P1053, DOI 10.1002/yea.1022; Chorvatovicova D, 1999, MUTAT RES-GEN TOX EN, V444, P117, DOI 10.1016/S1383-5718(99)00102-3; Coleman DC, 1997, AIDS, V11, P557, DOI 10.1097/00002030-199705000-00002; Cutler JE, 2005, CURR MOL MED, V5, P383, DOI 10.2174/1566524054022576; Dromer F, 2002, ANTIMICROB AGENTS CH, V46, P3869, DOI 10.1128/AAC.46.12.3869-3876.2002; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Feinberg H, 2007, J BIOL CHEM, V282, P4202, DOI 10.1074/jbc.M609689200; FONZI WA, 1993, GENETICS, V134, P717; Forsyth CB, 1996, CELL IMMUNOL, V170, P91, DOI 10.1006/cimm.1996.0138; Geijtenbeek TBH, 1999, BLOOD, V94, P754, DOI 10.1182/blood.V94.2.754.414k11_754_764; Geijtenbeek TBH, 2002, J BIOL CHEM, V277, P11314, DOI 10.1074/jbc.M111532200; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Guo M, 2000, HUM IMMUNOL, V61, P729, DOI 10.1016/S0198-8859(00)00144-0; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; Han Y, 2000, INFECT IMMUN, V68, P1649, DOI 10.1128/IAI.68.3.1649-1654.2000; Han YM, 1998, INFECT IMMUN, V66, P5771, DOI 10.1128/IAI.66.12.5771-5776.1998; Hobson RP, 2004, J BIOL CHEM, V279, P39628, DOI 10.1074/jbc.M405003200; HOFFMAN RE, 1988, MAGN RESON CHEM, V26, P523, DOI 10.1002/mrc.1260260617; HUCKERBY TN, 1983, ORG MAGN RESONANCE, V21, P67, DOI 10.1002/omr.1270210118; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kath F, 1999, ANGEW MAKROMOL CHEM, V268, P69; Klis FM, 2001, MED MYCOL, V39, P1, DOI 10.1080/744118876; KOBAYASHI H, 1992, CARBOHYD RES, V231, P317, DOI 10.1016/0008-6215(92)84028-Q; KOGAN G, 1988, CARBOHYD RES, V172, P243, DOI 10.1016/S0008-6215(00)90858-9; KOGAN G, 1990, CARBOHYD POLYM, V14, P65, DOI 10.1016/0144-8617(90)90007-F; Lam JS, 2005, J IMMUNOL, V175, P7496, DOI 10.4049/jimmunol.175.11.7496; Lowman DW, 2003, CARBOHYD RES, V338, P1491, DOI 10.1016/S0008-6215(03)00169-1; MARODI L, 1991, J IMMUNOL, V146, P2783; Masuoka J, 2004, INFECT IMMUN, V72, P6230, DOI 10.1128/IAI.72.11.6230-6236.2004; Masuoka J, 2004, CLIN MICROBIOL REV, V17, P281, DOI 10.1128/CMR.17.2.281-310.2004; McNeil MM, 2001, CLIN INFECT DIS, V33, P641, DOI 10.1086/322606; Meyer-Wentrup F, 2007, J IMMUNOL, V178, P154, DOI 10.4049/jimmunol.178.1.154; Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200; MULLER A, 1995, J CHROMATOGR B, V666, P283, DOI 10.1016/0378-4347(94)00575-P; Munro CA, 2005, J BIOL CHEM, V280, P1051, DOI 10.1074/jbc.M411413200; Netea MG, 2004, MICROBES INFECT, V6, P985, DOI 10.1016/j.micinf.2004.05.013; Netea MG, 2004, J LEUKOCYTE BIOL, V75, P749, DOI 10.1189/jlb.1103543; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; Newman SL, 2001, INFECT IMMUN, V69, P6813, DOI 10.1128/IAI.69.11.6813-6822.2001; PRETUS HA, 1991, J PHARMACOL EXP THER, V257, P500; ROMANI N, 1994, J EXP MED, V180, P83, DOI 10.1084/jem.180.1.83; SHIBATA N, 1995, J BIOL CHEM, V270, P1113, DOI 10.1074/jbc.270.3.1113; Shibata N, 2007, BIOCHEM J, V404, P365, DOI 10.1042/BJ20070081; Singleton DR, 2005, EUKARYOT CELL, V4, P639, DOI 10.1128/EC.4.4.639-648.2005; THOMPSON HL, 1992, CLIN EXP IMMUNOL, V87, P316, DOI 10.1111/j.1365-2249.1992.tb02994.x; Torosantucci A, 2005, J EXP MED, V202, P597, DOI 10.1084/jem.20050749; Van Liempt E, 2004, J BIOL CHEM, V279, P33161, DOI 10.1074/jbc.M404988200; Wu XY, 2005, J ORG CHEM, V70, P7381, DOI 10.1021/jo051065t	59	167	170	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20590	20599		10.1074/jbc.M709334200	http://dx.doi.org/10.1074/jbc.M709334200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18482990	Green Published, hybrid			2022-12-25	WOS:000257565300071
J	Evans, JP; Niemevz, F; Buldain, G; de Montellano, PO				Evans, John P.; Niemevz, Fernando; Buldain, Graciela; de Montellano, Paul Ortiz			Isoporphyrin intermediate in heme oxygenase catalysis - Oxidation of alpha-meso-phenylheme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORSERADISH-PEROXIDASE; CHEMICAL OXIDATION; REACTION REGIOSPECIFICITY; ELECTRONIC CONTROL; PROTOPORPHYRIN-IX; MECHANISM; BILIVERDIN; INHIBITION; INACTIVATION; COMPLEX	Human heme oxygenase-1 (hHO-1) catalyzes the O-2- and NADPH-dependent oxidation of heme to biliverdin, CO, and free iron. The first step involves regiospecific insertion of an oxygen atom at the alpha-meso carbon by a ferric hydroperoxide and is predicted to proceed via an isoporphyrin pi-cation intermediate. Here we report spectroscopic detection of a transient intermediate during oxidation by hHO-1 of alpha-meso-phenylheme-IX, alpha-meso-(p-methylphenyl)-mesoheme-III, and alpha-meso-(p-trifluoromethylphenyl)mesoheme-III. In agreement with previous experiments (Wang, J., Niemevz, F., Lad, L., Huang, L., Alvarez, D. E., Buldain, G., Poulos, T. L., and Ortiz de Montellano, P. R. (2004) J. Biol. Chem. 279, 42593-42604), only the alpha-biliverdin isomer is produced with concomitant formation of the corresponding benzoic acid. The transient intermediate observed in the NADPH-P450 reductase-catalyzed reaction accumulated when the reaction was supported by H2O2 and exhibited the absorption maxima at 435 and 930 nm characteristic of an isoporphyrin. Product analysis by reversed phase high performance liquid chromatography and liquid chromatography electrospray ionization mass spectrometry of the product generated with H2O2 identified it as an isoporphyrin that, on quenching, decayed to benzoylbiliverdin. In the presence of H-2 O-18(2), one labeled oxygen atom was incorporated into these products. The hHO-1-isoporphyrin complexes were found to have half-lives of 1.7 and 2.4 h for the p-trifluoromethyl- and p- methyl-substituted phenylhemes, respectively. The addition of NADPH-P450 reductase to the H2O2-generated hHO-1-isoporphyrin complex produced alpha-biliverdin, confirming its role as a reaction intermediate. Identification of an isoporphyrin intermediate in the catalytic sequence of hHO-1, the first such intermediate observed in hemoprotein catalysis, completes our understanding of the critical first step of heme oxidation.	[Evans, John P.; de Montellano, Paul Ortiz] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Niemevz, Fernando; Buldain, Graciela] Univ Buenos Aires, Dept Quim Organ, Fac Farm & Bioquim, Buenos Aires, DF, Argentina	University of California System; University of California San Francisco; University of Buenos Aires	de Montellano, PO (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, 600 16th St, San Francisco, CA 94158 USA.	ortiz@cgl.ucsf.edu			NIDDK NIH HHS [R01 DK030297, DK30297] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030297] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Asano N, 2007, J ORG CHEM, V72, P5320, DOI 10.1021/jo070692a; ATOR MA, 1989, J BIOL CHEM, V264, P9250; BAGGER S, 1971, ACTA CHEM SCAND, V25, P976, DOI 10.3891/acta.chem.scand.25-0976; Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; Berberat PO, 2005, CLIN CANCER RES, V11, P3790, DOI 10.1158/1078-0432.CCR-04-2159; BONNETT R, 1973, J CHEM SOC PERK T 1, P881, DOI 10.1039/p19730000881; CHOE YS, 1991, J BIOL CHEM, V266, P8523; Colas C, 2003, CHEM REV, V103, P2305, DOI 10.1021/cr0204303; Davydov R, 2003, J AM CHEM SOC, V125, P16208, DOI 10.1021/ja038923s; de Montellano PRO, 2000, CURR OPIN CHEM BIOL, V4, P221; Dierks EA, 1998, BIOCHEMISTRY-US, V37, P1839, DOI 10.1021/bi972458s; DOCHERTY JC, 1984, J BIOL CHEM, V259, P3066; DOLPHIN D, 1970, J AM CHEM SOC, V92, P743, DOI 10.1021/ja00706a076; FRYDMAN RB, 1981, BIOCHEMISTRY-US, V20, P5177, DOI 10.1021/bi00521a012; Furci LM, 2007, J MED CHEM, V50, P3804, DOI 10.1021/jm0700969; GOLD A, 1984, INORG CHEM, V23, P2932, DOI 10.1021/ic00187a007; Hildebrandt A G, 1978, Methods Enzymol, V52, P342; Kim HP, 2006, ANNU REV PHARMACOL, V46, P411, DOI 10.1146/annurev.pharmtox.46.120604.141053; Kumar D, 2005, J AM CHEM SOC, V127, P8204, DOI 10.1021/ja0446956; Lad L, 2003, J MOL BIOL, V330, P527, DOI 10.1016/S0022-2836(03)00578-3; Lightning LK, 2001, J BIOL CHEM, V276, P10612, DOI 10.1074/jbc.M010349200; Liu Y, 2000, J BIOL CHEM, V275, P34501, DOI 10.1074/jbc.M004245200; Liu Y, 1997, J BIOL CHEM, V272, P6909, DOI 10.1074/jbc.272.11.6909; NAKAJIMA R, 1980, J BIOL CHEM, V255, P2067; Niemevz F, 2004, J PORPHYR PHTHALOCYA, V8, P989, DOI 10.1142/S1088424604000350; Niemevz F, 2002, HETEROCYCLES, V57, P697; Niemevz F, 2008, SYNTHESIS-STUTTGART, P875, DOI 10.1055/s-2008-1032203; Ongayi O, 2003, CHEM COMMUN, P2298, DOI 10.1039/b306586c; Raner GM, 2000, J INORG BIOCHEM, V81, P153, DOI 10.1016/S0162-0134(00)00098-2; Robinsohn AE, 2000, HETEROCYCLES, V53, P2127; SANO S, 1986, P NATL ACAD SCI USA, V83, P531, DOI 10.1073/pnas.83.3.531; Schuller DJ, 1999, NAT STRUCT BIOL, V6, P860; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Stocker R, 2006, CIRCULATION, V114, P2178, DOI 10.1161/CIRCULATIONAHA.105.598698; Sugishima M, 2004, J MOL BIOL, V341, P7, DOI 10.1016/j.jmb.2004.05.048; TAKAHASHI S, 1995, J AM CHEM SOC, V117, P6002, DOI 10.1021/ja00127a013; Torpey J, 1996, J AM CHEM SOC, V118, P9172, DOI 10.1021/ja9623469; Torpey J, 1997, J BIOL CHEM, V272, P22008, DOI 10.1074/jbc.272.35.22008; Torpey J, 1996, J BIOL CHEM, V271, P26067, DOI 10.1074/jbc.271.42.26067; Unno M, 2007, NAT PROD REP, V24, P553, DOI 10.1039/b604180a; Wang JL, 2006, BIOCHEMISTRY-US, V45, P61, DOI 10.1021/bi051645k; Wang JL, 2004, J BIOL CHEM, V279, P42593, DOI 10.1074/jbc.M406346200; WILKS A, 1995, BIOCHEMISTRY-US, V34, P4421, DOI 10.1021/bi00013a034; WILKS A, 1994, J BIOL CHEM, V269, P29553; WILKS A, 1993, J BIOL CHEM, V268, P22357; WISEMAN JS, 1982, J BIOL CHEM, V257, P6328; Yamauchi T, 2005, CHEM COMMUN, P1309, DOI 10.1039/b414299c; Zhou H, 2000, J AM CHEM SOC, V122, P8311, DOI 10.1021/ja0002868	48	25	26	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19530	19539		10.1074/jbc.M709685200	http://dx.doi.org/10.1074/jbc.M709685200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18487208	hybrid, Green Published			2022-12-25	WOS:000257387600039
J	Macia, E; Partisani, M; Favard, C; Mortier, E; Zimmermann, P; Carlier, MF; Gounon, P; Luton, F; Franco, M				Macia, Eric; Partisani, Mariagrazia; Favard, Cyril; Mortier, Eva; Zimmermann, Pascale; Carlier, Marie-France; Gounon, Pierre; Luton, Frederic; Franco, Michel			The pleckstrin homology domain of the Arf6-specific exchange factor EFA6 localizes to the plasma membrane by interacting with phosphatidylinositol 4,5-bisphosphate and F-actin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR-6; NUCLEOTIDE EXCHANGE; STRUCTURAL BASIS; ARF6; PHOSPHOINOSITIDES; PROTEINS; BINDING; GOLGI; ASSOCIATION; ACTIVATION	The Arf6-specific exchange factor EFA6 coordinates membrane trafficking with actin cytoskeleton remodeling. It localizes to the plasma membrane where it catalyzes Arf6 activation and induces the formation of actin-based membrane ruffles. We have shown previously that the pleckstrin homology (PH) domain of EFA6 was responsible for its membrane localization. In this study we looked for the partners of the PH domain at the plasma membrane. Mutations of the conserved basic residues suspected to be involved in the binding to phosphoinositides redistribute EFA6-PH to the cytosol. In addition, phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2) breakdown also leads to the solubilization of EFA6-PH. Direct binding measured by surface plasmon resonance gives an apparent affinity of similar to 0.5 mu M EFA6-PH for PI(4,5)P-2. Moreover, we observed in vitro that the catalytic activity of EFA6 is strongly increased by PI(4,5)P-2. These results indicate that the plasma membrane localization of EFA6-PH is based on its interaction with PI(4,5) P2, and this interaction is necessary for an optimal catalytic activity of EFA6. Furthermore, we demonstrated by fluorescence recovery after photobleaching and Triton X-100 detergent solubility experiments that in addition to the phophoinositides, EFA6-PH is linked to the actin cytoskeleton. We observed both in vivo and in vitro that EFA6-PH interacts directly with F-actin. Finally, we demonstrated that EFA6 could bind simultaneously filamentous actin and phospholipids vesicles. Our results explain how the exchange factor EFA6 via its PH domain could coordinate at the plasma membrane actin cytoskeleton organization with membrane trafficking.	[Macia, Eric; Partisani, Mariagrazia; Luton, Frederic; Franco, Michel] Univ Nice Sophia Antipolis, CNRS, UMR 6097, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France; [Favard, Cyril] CNRS, UMR 6133, Inst Fresnel, F-13397 Marseille 20, France; [Mortier, Eva; Zimmermann, Pascale] Univ Louvain, Dept Human Genet, B-3000 Louvain, Belgium; [Carlier, Marie-France] CNRS Univ, UPR 3082, Lab Enzymol & Biol Struct, F-91198 Gif Sur Yvette, France; [Gounon, Pierre] Univ Nice Sophia Antipolis, Ctr Commun Microscopie Appl, F-06103 Nice 2, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Cote d'Azur	Franco, M (corresponding author), Univ Nice Sophia Antipolis, CNRS, UMR 6097, Inst Pharmacol Mol & Cellulaire, 660 Route Lucioles, F-06560 Valbonne, France.	franco@ipmc.cnrs.fr	Luton, Frederic/N-7673-2017; Macia, Eric/AAW-2964-2021; Zimmermann, Pascale/P-4190-2017; FRANCO, michel/AAA-9735-2021; Favard, Cyril/P-6392-2016; Franco, Michel/ABH-4993-2020	Favard, Cyril/0000-0002-8304-2980; Franco, Michel/0000-0003-1853-8661; macia, eric/0000-0003-3686-2000				AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Bertagnolo V, 2007, CARCINOGENESIS, V28, P1638, DOI 10.1093/carcin/bgm078; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Carman CV, 2000, J BIOL CHEM, V275, P10443, DOI 10.1074/jbc.275.14.10443; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Causeret M, 2005, MOL BIOL CELL, V16, P2168, DOI 10.1091/mbc.E04-09-0829; Cenni V, 2003, CELL MOL LIFE SCI, V60, P2710, DOI 10.1007/s00018-003-3349-4; Chavrier P, 2001, METHOD ENZYMOL, V329, P272; Claing A, 2001, J BIOL CHEM, V276, P42509, DOI 10.1074/jbc.M108399200; Cohen LA, 2007, MOL BIOL CELL, V18, P2244, DOI 10.1091/mbc.E06-11-0998; Czech MP, 2000, CELL, V100, P603, DOI 10.1016/S0092-8674(00)80696-0; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Decressac S, 2004, EMBO REP, V5, P1171, DOI 10.1038/sj.embor.7400292; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; DiNitto JP, 2007, MOL CELL, V28, P569, DOI 10.1016/j.molcel.2007.09.017; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Franco M, 1999, EMBO J, V18, P1480, DOI 10.1093/emboj/18.6.1480; Franco M, 1998, P NATL ACAD SCI USA, V95, P9926, DOI 10.1073/pnas.95.17.9926; FRANCO M, 1995, J BIOL CHEM, V270, P1337, DOI 10.1074/jbc.270.3.1337; FRANCO M, 1993, J BIOL CHEM, V268, P24531; Golebiewska U, 2008, MOL BIOL CELL, V19, P1663, DOI 10.1091/mbc.E07-12-1208; Haubert D, 2007, EMBO J, V26, P3308, DOI 10.1038/sj.emboj.7601778; Hofmann I, 2007, CURR BIOL, V17, P711, DOI 10.1016/j.cub.2007.03.007; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Honda A, 2005, J CELL BIOL, V168, P1039, DOI 10.1083/jcb.200409138; Klarlund JK, 2000, J BIOL CHEM, V275, P32816, DOI 10.1074/jbc.M002435200; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Lemmon MA, 2004, BIOCHEM SOC T, V32, P707, DOI 10.1042/BST0320707; Lemmon MA, 2007, BIOCHEM SOC SYMP, V74, P81, DOI 10.1042/BSS2007c08; Lietzke SE, 2000, MOL CELL, V6, P385, DOI 10.1016/S1097-2765(00)00038-1; Luton F, 2004, MOL BIOL CELL, V15, P1134, DOI 10.1091/mbc.E03-10-0751; Macia E, 2000, BIOCHEMISTRY-US, V39, P5893, DOI 10.1021/bi992795w; Mortier E, 2005, EMBO J, V24, P2556, DOI 10.1038/sj.emboj.7600722; PITCHER JA, 1995, J BIOL CHEM, V270, P11707, DOI 10.1074/jbc.270.20.11707; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Roth MG, 2004, PHYSIOL REV, V84, P699, DOI 10.1152/physrev.00033.2003; Sakagami H, 2007, EUR J NEUROSCI, V25, P618, DOI 10.1111/j.1460-9568.2007.05345.x; Shinotsuka C, 2002, BIOCHEM BIOPH RES CO, V294, P254, DOI 10.1016/S0006-291X(02)00456-4; SOUMPASIS DM, 1983, BIOPHYS J, V41, P95, DOI 10.1016/S0006-3495(83)84410-5; SZOKA F, 1978, P NATL ACAD SCI USA, V75, P4194, DOI 10.1073/pnas.75.9.4194; TOCANNE JF, 1994, PROG LIPID RES, V33, P203, DOI 10.1016/0163-7827(94)90027-2; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Yao LB, 1999, J BIOL CHEM, V274, P19752, DOI 10.1074/jbc.274.28.19752; Zhao XH, 2006, J CELL SCI, V119, P3743, DOI 10.1242/jcs.03173	44	40	41	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19836	19844		10.1074/jbc.M800781200	http://dx.doi.org/10.1074/jbc.M800781200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18490450	hybrid			2022-12-25	WOS:000257387600067
J	May, T; Eccleston, L; Herrmann, S; Hauser, H; Goncalves, J; Wirth, D				May, Tobias; Eccleston, Lee; Herrmann, Sabrina; Hauser, Hansjoerg; Goncalves, Jorge; Wirth, Dagmar			Bimodal and Hysteretic Expression in Mammalian Cells from a Synthetic Gene Circuit	PLOS ONE			English	Article								In order to establish cells and organisms with predictable properties, synthetic biology makes use of controllable, synthetic genetic devices. These devices are used to replace or to interfere with natural pathways. Alternatively, they may be interlinked with endogenous pathways to create artificial networks of higher complexity. While these approaches have been already successful in prokaryotes and lower eukaryotes, the implementation of such synthetic cassettes in mammalian systems and even animals is still a major obstacle. This is mainly due to the lack of methods that reliably and efficiently transduce synthetic modules without compromising their regulation properties. To pave the way for implementation of synthetic regulation modules in mammalian systems we utilized lentiviral transduction of synthetic modules. A synthetic positive feedback loop, based on the Tetracycline regulation system was implemented in a lentiviral vector system and stably integrated in mammalian cells. This gene regulation circuit yields a bimodal expression response. Based on experimental data a mathematical model based on stochasticity was developed which matched and described the experimental findings. Modelling predicted a hysteretic expression responsewhich was verified experimentally. Thereby supporting the idea that the system is driven by stochasticity. The results presented here highlight that the combination of three independent tools/methodologies facilitate the reliable installation of synthetic gene circuits with predictable expression characteristics in mammalian cells and organisms.			May, T (corresponding author), Helmholtz Ctr Infect Res, Dept Gene Regulat & Differentiat, Braunschweig, Germany.	dagmar.wirth@helmholtz-hzi.de	Goncalves, Jorge/GYD-3756-2022; Goncalves, Jorge M/GRN-8101-2022	Goncalves, Jorge M/0000-0002-5228-6165	Math-Works Scholarship; Nuffield Foundation; EPSRC; Bundesministerium fur Bildung und Forschung [0313940]; DFG [WI2648]; Helmholtz Association; EU [513769]	Math-Works Scholarship; Nuffield Foundation; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); Helmholtz Association(Helmholtz Association); EU(European Commission)	Lee Eccleston would like to thank The MathWorks for their funding through The Math-Works Scholarship. Jorge Goncalves would like to thank the Nuffield Foundation and EPSRC for their support and funding. The work of Tobias May, Hansjorg Hauser and Dagmar Wirth was supported by the Bundesministerium fur Bildung und Forschung (BMBF FKZ 0313940), the DFG (WI2648) and the Helmholtz Association (SBCancer). Further support was obtained from EU (Clinigene and FlpFlex (513769)).	Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Arkin A, 1998, GENETICS, V149, P1633; Baron U, 1999, P NATL ACAD SCI USA, V96, P1013, DOI 10.1073/pnas.96.3.1013; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Becskei A, 2004, NAT CELL BIOL, V6, P451, DOI 10.1038/ncb1124; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Delenda C, 2004, J GENE MED, V6, pS125, DOI 10.1002/jgm.501; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Fiering S, 2000, BIOESSAYS, V22, P381, DOI 10.1002/(SICI)1521-1878(200004)22:4<381::AID-BIES8>3.0.CO;2-E; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Hat B, 2007, J STAT PHYS, V128, P511, DOI 10.1007/s10955-006-9218-4; Hoang T, 2004, ONCOGENE, V23, P7188, DOI 10.1038/sj.onc.1207937; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kay MA, 2001, NAT MED, V7, P33, DOI 10.1038/83324; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Kramer BP, 2005, P NATL ACAD SCI USA, V102, P9517, DOI 10.1073/pnas.0500345102; Kramer BP, 2004, NAT BIOTECHNOL, V22, P867, DOI 10.1038/nbt980; Kringstein AM, 1998, P NATL ACAD SCI USA, V95, P13670, DOI 10.1073/pnas.95.23.13670; Legewie S, 2006, PLOS COMPUT BIOL, V2, P1061, DOI 10.1371/journal.pcbi.0020120; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Loew R, 2004, MOL THER, V9, P738, DOI 10.1016/j.ymthe.2004.02.010; Magee JA, 2003, CANCER CELL, V3, P273, DOI 10.1016/S1535-6108(03)00047-3; Markusic D, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni062; May T, 2006, CYTOTECHNOLOGY, V50, P109, DOI 10.1007/s10616-006-9007-6; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Podtschaske M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000935; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Rossi FMV, 2000, MOL CELL, V6, P723, DOI 10.1016/S1097-2765(00)00070-8; Schucht R, 2006, MOL THER, V14, P285, DOI 10.1016/j.ymthe.2005.12.003; Serfling E, 2006, TRENDS IMMUNOL, V27, P461, DOI 10.1016/j.it.2006.08.005; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; Weber W, 2007, P NATL ACAD SCI USA, V104, P2643, DOI 10.1073/pnas.0606398104; Weber W, 2006, J GENE MED, V8, P535, DOI 10.1002/jgm.903; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Wiznerowicz M, 2005, TRENDS BIOTECHNOL, V23, P42, DOI 10.1016/j.tibtech.2004.11.001; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089	49	44	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2372	10.1371/journal.pone.0002372	http://dx.doi.org/10.1371/journal.pone.0002372			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523635	Green Published, Green Submitted, gold			2022-12-25	WOS:000262614300057
J	Rogers, LJ; Vallortigara, G				Rogers, Lesley J.; Vallortigara, Giorgio			From Antenna to Antenna: Lateral Shift of Olfactory Memory Recall by Honeybees	PLOS ONE			English	Article							APIS-MELLIFERA; BRAIN; ASYMMETRY; ADVANTAGES; INPUT; SIDES; LOBES	Honeybees, Apis mellifera, readily learn to associate odours with sugar rewards and we show here that recall of the olfactory memory, as demonstrated by the bee extending its proboscis when presented with the trained odour, involves first the right and then the left antenna. At 1-2 hour after training using both antennae, recall is possible mainly when the bee uses its right antenna but by 6 hours after training a lateral shift has occurred and the memory can now be recalled mainly when the left antenna is in use. Long-term memory one day after training is also accessed mainly via the left antenna. This time-dependent shift from right to left antenna is also seen as side biases in responding to odour presented to the bee's left or right side. Hence, not only are the cellular events of memory formation similar in bees and vertebrate species but also the lateralized networks involved may be similar. These findings therefore seem to call for remarkable parallel evolution and suggest that the proper functioning of memory formation in a bilateral animal, either vertebrate or invertebrate, requires lateralization of processing.	[Rogers, Lesley J.] Univ New England, Ctr Neurosci & Anim Behav, Armidale, NSW, Australia; [Vallortigara, Giorgio] Univ Trent, Ctr Mind Brain Sci, Rovereto, Italy	University of New England; University of Trento	Rogers, LJ (corresponding author), Univ New England, Ctr Neurosci & Anim Behav, Armidale, NSW, Australia.	lrogers@une.edu.au	Rogers, Lesley J./Y-5722-2019	Rogers, Lesley J./0000-0002-9956-1769	University of New England Faculty Grant and a Project EDCBNL; Commission of the European Communities	University of New England Faculty Grant and a Project EDCBNL; Commission of the European Communities(European Commission)	This research was supported by a University of New England Faculty Grant and a Project EDCBNL (Evolution and Development of Cognitive, Behavioural and Neural Lateralization - 2006/2009) Grant, supported by the Commission of the European Communities (Programme "Integrating and strengthening the European Research Area"; Initiative "What it means to be human") to G.V.	Ades C, 2002, J INSECT BEHAV, V15, P563, DOI 10.1023/A:1016337418472; Andrew RJ, 1999, BEHAV BRAIN RES, V98, P289, DOI 10.1016/S0166-4328(98)00095-3; BATSON JD, 1992, J COMP PSYCHOL, V106, P114, DOI 10.1037/0735-7036.106.2.114; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; CIPOLLANETO J, 1982, EXP BRAIN RES, V48, P22; CLAYTON N, 1993, J COMP PHYSIOL A, V171, P799, DOI 10.1007/BF00213076; Galizia CG, 1998, EUR J NEUROSCI, V10, P2964, DOI 10.1111/j.1460-9568.1998.00303.x; Heuts BA, 2005, BEHAV BRAIN SCI, V28, P601, DOI 10.1017/S0140525X05350102; Kells AR, 2001, J INSECT BEHAV, V14, P47, DOI 10.1023/A:1007897512570; Komischke B, 2003, BEHAV BRAIN RES, V145, P135, DOI 10.1016/S0166-4328(03)00105-0; Letzkus P, 2008, BIOL LETTERS, V4, P16, DOI 10.1098/rsbl.2007.0466; Letzkus P, 2006, CURR BIOL, V16, P1471, DOI 10.1016/j.cub.2006.05.060; Menzel R, 2001, LEARN MEMORY, V8, P53, DOI 10.1101/lm.38801; MOORE D, 1983, BIOL BULL, V164, P471, DOI 10.2307/1541256; Pascual A, 2004, NATURE, V427, P605, DOI 10.1038/427605a; Rogers LJ, 2004, P ROY SOC B-BIOL SCI, V271, pS420, DOI 10.1098/rsbl.2004.0200; Rogers LJ, 2002, ADV STUD BEHAV, V31, P107, DOI 10.1016/S0065-3454(02)80007-9; Rogers LJ., 2002, COMP VERTEBRATE LATE; Sandoz JC, 2003, NEUROSCIENCE, V120, P1137, DOI 10.1016/S0306-4522(03)00384-1; Sandoz JC, 2002, LEARN MEMORY, V9, P337, DOI 10.1101/lm.50502; Vallortigara G, 2005, BEHAV BRAIN SCI, V28, P575, DOI 10.1017/S0140525X05000105; Zhang SW, 2006, J EXP BIOL, V209, P4420, DOI 10.1242/jeb.02522	22	107	109	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2340	10.1371/journal.pone.0002340	http://dx.doi.org/10.1371/journal.pone.0002340			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	396TO	18523636	Green Published, Green Submitted, gold			2022-12-25	WOS:000262614300033
J	Angulo-Barturen, I; Jimenez-Diaz, MB; Mulet, T; Rullas, J; Herreros, E; Ferrer, S; Jimenez, E; Mendoza, A; Regadera, J; Rosenthal, PJ; Bathurst, I; Pompliano, DL; de las Heras, FG; Gargallo-Viola, D				Angulo-Barturen, Inigo; Belen Jimenez-Diaz, Maria; Mulet, Teresa; Rullas, Joaquin; Herreros, Esperanza; Ferrer, Santiago; Jimenez, Elena; Mendoza, Alfonso; Regadera, Javier; Rosenthal, Philip J.; Bathurst, Ian; Pompliano, David L.; Gomez de las Heras, Federico; Gargallo-Viola, Domingo			A Murine Model of falciparum-Malaria by In Vivo Selection of Competent Strains in Non-Myelodepleted Mice Engrafted with Human Erythrocytes	PLOS ONE			English	Article								To counter the global threat caused by Plasmodium falciparum malaria, new drugs and vaccines are urgently needed. However, there are no practical animal models because P. falciparum infects human erythrocytes almost exclusively. Here we describe a reliable falciparum murine model of malaria by generating strains of P. falciparum in vivo that can infect immunodeficient mice engrafted with human erythrocytes. We infected NODscid/beta 2m-/- mice engrafted with human erythrocytes with P. falciparum obtained from in vitro cultures. After apparent clearance, we obtained isolates of P. falciparum able to grow in peripheral blood of engrafted NODscid/beta 2m-/- mice. Of the isolates obtained, we expanded in vivo and established the isolate Pf3D7(0087/N9) as a reference strain for model development. Pf3D7(0087/N9) caused productive persistent infections in 100% of engrafted mice infected intravenously. The infection caused a relative anemia due to selective elimination of human erythrocytes by a mechanism dependent on parasite density in peripheral blood. Using this model, we implemented and validated a reproducible assay of antimalarial activity useful for drug discovery. Thus, our results demonstrate that P. falciparum contains clones able to grow reproducibly in mice engrafted with human erythrocytes without the use of myeloablative methods.	[Angulo-Barturen, Inigo; Belen Jimenez-Diaz, Maria; Mulet, Teresa; Rullas, Joaquin; Herreros, Esperanza; Ferrer, Santiago; Jimenez, Elena; Mendoza, Alfonso; Gomez de las Heras, Federico; Gargallo-Viola, Domingo] GlaxoSmithKline Inc, ID CEDD, Dis Developing World, Madrid, Spain; [Regadera, Javier] Univ Autonoma Madrid, Fac Med, Dept Anat, Histol & Neurosci, Madrid, Spain; [Rosenthal, Philip J.] Univ Calif San Francisco, San Francisco General Hosp, Dept Med, San Francisco, CA USA; [Bathurst, Ian] MMV, Geneva, Switzerland; [Pompliano, David L.] GlaxoSmithKline Inc, ID CEDD, Collegeville, PA USA	GlaxoSmithKline; Autonomous University of Madrid; University of California System; University of California San Francisco; GlaxoSmithKline	Angulo-Barturen, I (corresponding author), GlaxoSmithKline Inc, ID CEDD, Dis Developing World, Madrid, Spain.	inigo.x.angulo@gsk.com	Ferrer-Bazaga, Santiago/AAA-7749-2021; Mendoza-Losana, Alfonso/AAF-4383-2021; Herreros, Esperanza/GQH-7182-2022	Ferrer-Bazaga, Santiago/0000-0002-6672-551X; Mendoza-Losana, Alfonso/0000-0003-2493-4118; 	GlaxoSmithKline-Diseases of the Developing World	GlaxoSmithKline-Diseases of the Developing World	Maria Belen Jimenez-Diaz, Teresa Mulet and Joaquin Rullas were funded by Medicines for Malaria Venture Miniportfolio Agreement with GlaxoSmithKline-Diseases of the Developing World	Angulo I, 2000, BLOOD, V95, P212; [Anonymous], 1999, HDB ANIMAL MODELS IN; BADELL E, 1995, PARASITOL TODAY, V11, P235, DOI 10.1016/0169-4758(95)80088-3; Badell E, 2000, J EXP MED, V192, P1653, DOI 10.1084/jem.192.11.1653; Barry AE, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030034; BELL CA, 1990, ANTIMICROB AGENTS CH, V34, P1381, DOI 10.1128/AAC.34.7.1381; Bogdanova A, 2007, BLOOD, V110, P762, DOI 10.1182/blood-2006-12-063602; Bouharoun-Tayoun H, 2004, EXP PARASITOL, V108, P47, DOI 10.1016/j.exppara.2004.07.004; Bray PG, 2003, TRENDS PARASITOL, V19, P232, DOI 10.1016/S1471-4922(03)00069-2; BURWELL EL, 1953, AM J PHYSIOL, V172, P718, DOI 10.1152/ajplegacy.1953.172.3.718; Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; Christianson SW, 1997, J IMMUNOL, V158, P3578; DAS BP, 1977, J MED CHEM, V20, P531, DOI 10.1021/jm00214a014; DEBRUIN D, 1994, P NATL ACAD SCI USA, V91, P619, DOI 10.1073/pnas.91.2.619; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; Dondorp AM, 2000, PARASITOL TODAY, V16, P228, DOI 10.1016/S0169-4758(00)01666-5; Druilhe P, 2005, PLOS MED, V2, P1135, DOI 10.1371/journal.pmed.0020344; Ekvall H, 2003, CURR OPIN HEMATOL, V10, P108, DOI 10.1097/00062752-200303000-00002; Fidock DA, 2004, NAT REV DRUG DISCOV, V3, P509, DOI 10.1038/nrd1416; Foley M, 1997, INT J PARASITOL, V27, P231, DOI 10.1016/S0020-7519(96)00152-X; FREY T, 1995, CYTOMETRY, V21, P265, DOI 10.1002/cyto.990210307; FROIDEVAUX S, 1991, J IMMUNOL METHODS, V137, P275, DOI 10.1016/0022-1759(91)90034-D; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; Gysin Jurg, 1998, P419; HAUGLAND RP, 1996, HDB FLUORESCENT PROB, P143; He HZ, 2002, TRANSPLANTATION, V73, P853, DOI 10.1097/00007890-200203270-00005; HEISCHKEIL R, 1971, Zeitschrift fuer Tropenmedizin und Parasitologie, V22, P243; IRWIN S, 1968, PSYCHOPHARMACOLOGIA, V13, P222, DOI 10.1007/BF00401402; Jimenez-Diaz MB, 2005, CYTOM PART A, V67A, P27, DOI 10.1002/cyto.a.20169; Kina T, 2000, BRIT J HAEMATOL, V109, P280, DOI 10.1046/j.1365-2141.2000.02037.x; KLOTZ FW, 1987, J EXP MED, V165, P1713, DOI 10.1084/jem.165.6.1713; Kollet O, 2000, BLOOD, V95, P3102, DOI 10.1182/blood.V95.10.3102.010k14_3102_3105; Landau Irene, 1998, P401; Lavazec C, 2006, NUCLEIC ACIDS RES, V34, P6696, DOI 10.1093/nar/gkl942; Layez C, 2005, BLOOD, V106, P3632, DOI 10.1182/blood-2005-04-1574; Levy JE, 2000, J CLIN INVEST, V105, P1209, DOI 10.1172/JCI9635; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; MOHAN K, 1998, MALARIA PARASITE BIO, P467; MOORE JM, 1995, J EXP MED, V181, P2265, DOI 10.1084/jem.181.6.2265; Moreno A, 2006, INT J PARASITOL, V36, P361, DOI 10.1016/j.ijpara.2005.10.012; Moreno A, 2001, ANTIMICROB AGENTS CH, V45, P1847, DOI 10.1128/AAC.45.6.1847-1853.2001; Moreno A, 2007, TRENDS PARASITOL, V23, P254, DOI 10.1016/j.pt.2007.04.004; Motulsky H. A., 2003, FITTING MODELS BIOLO; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Pichler J, 2002, CYTOMETRY, V50, P231, DOI 10.1002/cyto.10125; Price RN, 2001, AM J TROP MED HYG, V65, P614, DOI 10.4269/ajtmh.2001.65.614; Rajan TV, 1996, PARASITOL TODAY, V12, P479, DOI 10.1016/S0169-4758(96)10066-1; Ridley RG, 2002, NATURE, V415, P686, DOI 10.1038/415686a; ROWE AW, 1968, CRYOBIOLOGY, V5, P119, DOI 10.1016/S0011-2240(68)80154-3; Sabater AM, 2005, PARASITOL RES, V95, P97, DOI 10.1007/s00436-004-1249-7; Sanni Latifu A, 2002, Methods Mol Med, V72, P57, DOI 10.1385/1-59259-271-6:57; SCHLICHTHERLE M, METHODS MALARIA RES, P5; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Su XZ, 1998, EXP PARASITOL, V89, P262, DOI 10.1006/expr.1998.4299; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; TSUJI M, 1995, VACCINE, V13, P1389, DOI 10.1016/0264-410X(95)00081-B; WEATHERALL DJ, 1983, CIBA F SYMP, V94, P74; WILLIMANN K, 1995, J EXP MED, V182, P643, DOI 10.1084/jem.182.3.643; Yacoub-Youssef H, 2005, TRANSPL IMMUNOL, V15, P157, DOI 10.1016/j.trim.2005.07.002; Yeramian P, 2005, J INFECT DIS, V192, P319, DOI 10.1086/430928	62	110	120	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2252	10.1371/journal.pone.0002252	http://dx.doi.org/10.1371/journal.pone.0002252			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493601	Green Published, gold, Green Submitted			2022-12-25	WOS:000262258700056
J	Angov, E; Hillier, CJ; Kincaid, RL; Lyon, JA				Angov, Evelina; Hillier, Collette J.; Kincaid, Randall L.; Lyon, Jeffrey A.			Heterologous Protein Expression Is Enhanced by Harmonizing the Codon Usage Frequencies of the Target Gene with those of the Expression Host	PLOS ONE			English	Article								Synonymous codon replacement can change protein structure and function, indicating that protein structure depends on DNA sequence. During heterologous protein expression, low expression or formation of insoluble aggregates may be attributable to differences in synonymous codon usage between expression and natural hosts. This discordance may be particularly important during translation of the domain boundaries ( link/end segments) that separate elements of higher ordered structure. Within such regions, ribosomal progression slows as the ribosome encounters clusters of infrequently used codons that preferentially encode a subset of amino acids. To replicate the modulation of such localized translation rates during heterologous expression, we used known relationships between codon usage frequencies and secondary protein structure to develop an algorithm ("codon harmonization'') for identifying regions of slowly translated mRNA that are putatively associated with link/end segments. It then recommends synonymous replacement codons having usage frequencies in the heterologous expression host that are less than or equal to the usage frequencies of native codons in the native expression host. For protein regions other than these putative link/end segments, it recommends synonymous substitutions with codons having usage frequencies matched as nearly as possible to the native expression system. Previous application of this algorithm facilitated E. coli expression, manufacture and testing of two Plasmodium falciparum vaccine candidates. Here we describe the algorithm in detail and apply it to E. coli expression of three additional P. falciparum proteins. Expression of the "recoded'' genes exceeded that of the native genes by 4- to 1,000-fold, representing levels suitable for vaccine manufacture. The proteins were soluble and reacted with a variety of functional conformation-specific mAbs suggesting that they were folded properly and had assumed native conformation. Codon harmonization may further provide a general strategy for improving the expression of soluble functional proteins during heterologous expression in hosts other than E. coli.	[Angov, Evelina; Hillier, Collette J.; Lyon, Jeffrey A.] Walter Reed Army Inst Res, Div Malaria Vaccine Dev, Silver Spring, MD 20910 USA; [Kincaid, Randall L.] Veritas Inc, Rockville, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Angov, E (corresponding author), Walter Reed Army Inst Res, Div Malaria Vaccine Dev, Silver Spring, MD 20910 USA.	Evelina.angov@us.army.mil			United States Agency for International Development [936 6001, AAG-P-00-98-00006, AAG-P-00-98-00005]; United States Army Medical Research and Materiel Command	United States Agency for International Development(United States Agency for International Development (USAID)); United States Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	This work was supported by the United States Agency for International Development, Project Number 936 6001, Award Number AAG-P-00-98-00006, Award Number AAG-P-00-98-00005, and by the United States Army Medical Research and Materiel Command.	Adzhubei AA, 1996, FEBS LETT, V399, P78, DOI 10.1016/S0014-5793(96)01287-2; ANDERSSON SGE, 1990, MICROBIOL REV, V54, P198, DOI 10.1128/MMBR.54.2.198-210.1990; Angov E, 2003, MOL BIOCHEM PARASIT, V128, P195, DOI 10.1016/S0166-6851(03)00077-X; Baram D, 2005, FEBS LETT, V579, P948, DOI 10.1016/j.febslet.2004.11.063; Berisio R, 2003, NAT STRUCT BIOL, V10, P366, DOI 10.1038/nsb915; BULMER M, 1987, NATURE, V325, P728, DOI 10.1038/325728a0; BURGHAUS PA, 1994, MOL BIOCHEM PARASIT, V64, P165, DOI 10.1016/0166-6851(94)90144-9; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; CHEN GFT, 1990, NUCLEIC ACIDS RES, V18, P1465, DOI 10.1093/nar/18.6.1465; Darko CA, 2005, INFECT IMMUN, V73, P287, DOI 10.1128/IAI.73.1.287-297.2005; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Etchells SA, 2004, NAT STRUCT MOL BIOL, V11, P391, DOI 10.1038/nsmb0504-391; Ferbitz L, 2004, NATURE, V431, P590, DOI 10.1038/nature02899; Frank J, 1995, BIOCHEM CELL BIOL, V73, P757, DOI 10.1139/o95-084; FRANK J, 1995, NATURE, V376, P441, DOI 10.1038/376441a0; GOUY M, 1982, NUCLEIC ACIDS RES, V10, P7055, DOI 10.1093/nar/10.22.7055; Hillier CJ, 2005, INFECT IMMUN, V73, P2109, DOI 10.1128/IAI.73.4.2109-2115.2005; Hoffmann A, 2006, J BIOL CHEM, V281, P6539, DOI 10.1074/jbc.M512345200; IKEMURA T, 1981, J MOL BIOL, V146, P1, DOI 10.1016/0022-2836(81)90363-6; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kleizen B, 2005, MOL CELL, V20, P277, DOI 10.1016/j.molcel.2005.09.007; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; Kramer G, 2001, INT J BIOCHEM CELL B, V33, P541, DOI 10.1016/S1357-2725(01)00044-9; Kurland C, 1996, CURR OPIN BIOTECH, V7, P489, DOI 10.1016/S0958-1669(96)80050-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lindsley D, 2003, MOL MICROBIOL, V48, P1267, DOI 10.1046/j.1365-2958.2003.03514.x; LOCHER CP, 1993, VACCINE, V11, P1119, DOI 10.1016/0264-410X(93)90072-6; Lu JL, 2005, NAT STRUCT MOL BIOL, V12, P1123, DOI 10.1038/nsmb1021; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Netzer WJ, 1998, TRENDS BIOCHEM SCI, V23, P68, DOI 10.1016/S0968-0004(97)01171-7; Oresic M, 1998, J MOL BIOL, V281, P31, DOI 10.1006/jmbi.1998.1921; Pan WQ, 1999, NUCLEIC ACIDS RES, V27, P1094, DOI 10.1093/nar/27.4.1094; Phoenix DA, 1997, FEMS MICROBIOL LETT, V155, P63, DOI 10.1016/S0378-1097(97)00367-4; PURVIS IJ, 1987, J MOL BIOL, V193, P413, DOI 10.1016/0022-2836(87)90230-0; Sauna ZE, 2007, CANCER RES, V67, P9609, DOI 10.1158/0008-5472.CAN-07-2377; Sauna ZE, 2007, PHARMACOGENOMICS, V8, P527, DOI 10.2217/14622416.8.6.527; Singh S, 2003, INFECT IMMUN, V71, P6766, DOI 10.1128/IAI.71.12.6766-6774.2003; Svetlov MS, 2006, PROTEIN SCI, V15, P242, DOI 10.1110/ps.051752506; TANABE K, 1987, J MOL BIOL, V195, P273, DOI 10.1016/0022-2836(87)90649-8; Thanaraj TA, 1996, PROTEIN SCI, V5, P1973, DOI 10.1002/pro.5560051003; Thanaraj TA, 1996, PROTEIN SCI, V5, P1594, DOI 10.1002/pro.5560050814; VARENNE S, 1984, J MOL BIOL, V180, P549, DOI 10.1016/0022-2836(84)90027-5; WEBER JL, 1987, GENE, V52, P103, DOI 10.1016/0378-1119(87)90399-4; WOLIN SL, 1988, EMBO J, V7, P3559, DOI 10.1002/j.1460-2075.1988.tb03233.x; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; ZHANG SP, 1994, J THEOR BIOL, V170, P339, DOI 10.1006/jtbi.1994.1196	47	190	201	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2189	10.1371/journal.pone.0002189	http://dx.doi.org/10.1371/journal.pone.0002189			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478103	Green Published, gold, Green Submitted			2022-12-25	WOS:000262172800053
J	Yang, J; Song, K; Krebs, TL; Jackson, MW; Danielpour, D				Yang, J.; Song, K.; Krebs, T. L.; Jackson, M. W.; Danielpour, D.			Rb/E2F4 and Smad2/3 link survivin to TGF-beta-induced apoptosis and tumor progression	ONCOGENE			English	Article						prostate cancer; promoter regulation; apoptosis; CDE; CHR; E2F	GROWTH-FACTOR-BETA; EPITHELIAL-CELL LINES; PROSTATE-CANCER CELLS; TRANSCRIPTIONAL REPRESSION; MALIGNANT-TRANSFORMATION; C-MYC; RECEPTOR; EXPRESSION; ACTIVATION; MECHANISMS	Survivin is a prosurvival protein overexpressed in many cancers through mechanisms that remain poorly explored, and is implicated in control of tumor progression and resistance to cancer chemotherapeutics. Here, we report a critical role for survivin in the induction of apoptosis by transforming growth factor-beta (TGF-beta). We show that TGF-beta rapidly downregulates survivin expression in prostate epithelial cells, through a unique mechanism of transcriptional suppression involving Smads 2 and 3, Rb/E2F4, and the cell-cycle repressor elements CDE and CHR. This TGF-beta response is triggered through a Smad2/3-dependent hypophosphorylation of Rb and the subsequent association of the Rb/E2F4 repressive complex to CDE/CHR elements in the proximal region of the survivin promoter. Viral-mediated gene delivery experiments, involving overexpressing or silencing survivin, reveal critical roles of survivin in apoptosis induced by TGF-b alone or in cooperation with cancer therapeutic agents. We propose a novel TGF-beta/Rb/survivin axis with a putative role in the functional switch of TGF-beta from tumor suppressor to tumor promoter.	[Yang, J.; Song, K.; Krebs, T. L.; Danielpour, D.] Case Western Reserve Univ, Div Gen Med Sci Oncol, Case Sch Med, Cleveland, OH 44106 USA; [Yang, J.] Case Western Reserve Univ, Case Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Jackson, M. W.] Case Western Reserve Univ, Case Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Danielpour, D.] Case Western Reserve Univ, Case Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Danielpour, D (corresponding author), Case Western Reserve Univ, Div Gen Med Sci Oncol, Case Sch Med, Wolstein Res Bldg,2103 Cornell Rd,Room 3532, Cleveland, OH 44106 USA.	dxd49@case.edu			Gene Expression and Genotyping Facility; Case Comprehensive Cancer Center [P30 CA43703]; NCI [R01CA092102, R01CA102074]; NATIONAL CANCER INSTITUTE [P30CA043703, R01CA102074, R01CA092102] Funding Source: NIH RePORTER	Gene Expression and Genotyping Facility; Case Comprehensive Cancer Center; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Gene Expression and Genotyping Facility, the Flow Cytometry Core Facility of the Case Comprehensive Cancer Center (P30 CA43703). Grant support: NCI grants R01CA092102 and R01CA102074 (to D Danielpour).	Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Altieri DC, 2003, ONCOGENE, V22, P8581, DOI 10.1038/sj.onc.1207113; Bello D, 1997, CARCINOGENESIS, V18, P1215, DOI 10.1093/carcin/18.6.1215; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Chipuk JE, 2001, J BIOL CHEM, V276, P26614, DOI 10.1074/jbc.M100913200; Chipuk JE, 2002, J BIOL CHEM, V277, P1240, DOI 10.1074/jbc.M108855200; DANIELPOUR D, 1994, CANCER RES, V54, P3413; Danielpour D, 2006, CYTOKINE GROWTH F R, V17, P59, DOI 10.1016/j.cytogfr.2005.09.007; Danielpour D, 2005, EUR J CANCER, V41, P846, DOI 10.1016/j.ejca.2004.12.027; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Frederick JP, 2004, MOL CELL BIOL, V24, P2546, DOI 10.1128/MCB.24.6.2546-2559.2004; Harbour JW, 2000, NAT CELL BIOL, V2, pE65, DOI 10.1038/35008695; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hilger-Eversheim K, 2000, GENE, V260, P1, DOI 10.1016/S0378-1119(00)00454-6; Hsing AY, 1996, CANCER RES, V56, P5146; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Jackson MW, 2005, J CELL SCI, V118, P1821, DOI 10.1242/jcs.02307; Jarrard DF, 2002, CANCER LETT, V185, P191, DOI 10.1016/S0304-3835(02)00282-3; Jiang YY, 2004, J BIOL CHEM, V279, P40511, DOI 10.1074/jbc.M404496200; Kishi H, 2004, J UROLOGY, V171, P1855, DOI 10.1097/01.ju.0000120317.88372.03; Knudsen KE, 1999, ONCOGENE, V18, P5239, DOI 10.1038/sj.onc.1202910; Le Cam L, 1999, EMBO J, V18, P1878, DOI 10.1093/emboj/18.7.1878; Liston P, 2003, ONCOGENE, V22, P8568, DOI 10.1038/sj.onc.1207101; Liu NS, 1997, NUCLEIC ACIDS RES, V25, P4915, DOI 10.1093/nar/25.24.4915; Lucibello FC, 1997, NUCLEIC ACIDS RES, V25, P4921, DOI 10.1093/nar/25.24.4921; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Pennati M, 2004, ONCOGENE, V23, P386, DOI 10.1038/sj.onc.1207071; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Shariat SF, 2004, CANCER, V100, P751, DOI 10.1002/cncr.20039; Sharma A, 2007, CANCER RES, V67, P6192, DOI 10.1158/0008-5472.CAN-06-4424; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Song K, 2003, J BIOL CHEM, V278, P38342, DOI 10.1074/jbc.M304583200; Song K, 2003, CANCER RES, V63, P4358; Song KY, 2006, EMBO J, V25, P58, DOI 10.1038/sj.emboj.7600917; Tang BW, 1999, CANCER RES, V59, P4834; Taylor WR, 2001, J BIOL CHEM, V276, P1998, DOI 10.1074/jbc.M005101200; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Wajapeyee N, 2006, J BIOL CHEM, V281, P16207, DOI 10.1074/jbc.M600539200; Wang H, 2005, J BIOL CHEM, V280, P5154, DOI 10.1074/jbc.M411575200; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhang M, 2005, ONCOGENE, V24, P2474, DOI 10.1038/sj.onc.1208490	44	52	55	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 11	2008	27	40					5326	5338		10.1038/onc.2008.165	http://dx.doi.org/10.1038/onc.2008.165			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	346UW	18504435	Green Accepted			2022-12-25	WOS:000259096100005
J	Vincent, T; Kukalev, A; Andang, M; Pettersson, R; Percipalle, P				Vincent, T.; Kukalev, A.; Andang, M.; Pettersson, R.; Percipalle, P.			The glycogen synthase kinase (GSK) 3 beta represses RNA polymerase I transcription	ONCOGENE			English	Article						GSK3 beta; PTEN; rDNA; Pol I transcription; cell proliferation; tumour suppressors	TUMOR SUPPRESSION; PTEN; GLYCOGEN-SYNTHASE-KINASE-3-BETA; PHOSPHORYLATION; KINASE-3-BETA; INHIBITOR; PATHWAYS; HOMOLOG; COMPLEX; PROTEIN	Several oncogenic proteins and tumour suppressors target the RNA polymerase I and interfere with rRNA synthesis. Here, we show that the glycogen synthase kinase (GSK) 3 beta, which phosphorylates the tumour suppressor PTEN (phosphatase and tensin homologue deleted on chromosome 10), is selectively enriched in nucleoli of RAS-transformed cells. Immunoprecipitation and chromatin immunoprecipitation assays performed on epithelial and endothelial cells transformed with oncogenic RAS show that GSK3 beta and PTEN are part of the same complex and associate with promoter and coding region of the rDNA. An active GSK3 beta mutant abolished nucleolar BrUTP incorporation and associated with the member of the selectivity factor 1 complex TAF(I)110. Finally, GSK3 beta inhibition upregulated 45S, 18S and 28S rRNA synthesis in RAS-transformed epithelial cells as revealed by semiquantitative real-time PCR and promoted cellular proliferation. Our results underscore a repressive function for GSK3 beta in rRNA biogenesis supporting its role as a tumour supressor.	[Kukalev, A.; Percipalle, P.] Karolinska Inst, Dept Cell & Mol Biol, Med Nobel Inst, S-17177 Stockholm, Sweden; [Vincent, T.; Pettersson, R.] Karolinska Inst, Stockholm Branch, Ludwig Inst Canc Res, S-17177 Stockholm, Sweden; [Andang, M.] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Ludwig Institute for Cancer Research; Karolinska Institutet	Percipalle, P (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Med Nobel Inst, Box 285,Nobels Vag 3, S-17177 Stockholm, Sweden.	piergiorgio.percipalle@ki.se	Andäng, Michael/GRE-9898-2022; VIncent, Theresa/HDN-9575-2022	Vincent, Theresa/0000-0002-7248-066X; Andang, Michael/0000-0002-2886-7891	Swedish Research Council (Vetenskapsra det); Cancerfonden; Lars Hiertas Minne Foundation; Jeansson Foundation	Swedish Research Council (Vetenskapsra det)(Swedish Research Council); Cancerfonden(Swedish Cancer Society); Lars Hiertas Minne Foundation; Jeansson Foundation	We thank J Arbiser (Emory University, USA) and H Beug ( Institute of Molecular Pathology, Vienna) for providing EpRAS and SVR cells. This work was supported by grants from the Swedish Research Council (Vetenskapsra det), Cancerfonden, the Lars Hiertas Minne Foundation and the Jeansson Foundation to PP.	Al-Khouri AM, 2005, J BIOL CHEM, V280, P35195, DOI 10.1074/jbc.M503045200; Arbiser JL, 1997, P NATL ACAD SCI USA, V94, P861, DOI 10.1073/pnas.94.3.861; Bachelder RE, 2005, J CELL BIOL, V168, P29, DOI 10.1083/jcb.200409067; Baker SJ, 2007, CELL, V128, P25, DOI 10.1016/j.cell.2006.12.023; Bijur GN, 2003, NEUROREPORT, V14, P2415, DOI 10.1097/00001756-200312190-00025; Chu EC, 2004, MED SCI MONITOR, V10, pRA235; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; DOMINGUEZ I, 1995, P NATL ACAD SCI USA, V92, P8498, DOI 10.1073/pnas.92.18.8498; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Leslie NR, 2004, BIOCHEM J, V382, P1, DOI 10.1042/BJ20040825; Ma C, 2007, CANCER RES, V67, P7756, DOI 10.1158/0008-5472.CAN-06-4665; Mayer C, 2005, CELL CYCLE, V4, P1036, DOI 10.4161/cc.4.8.1925; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Morisco C, 2000, J BIOL CHEM, V275, P14466, DOI 10.1074/jbc.275.19.14466; Percipalle P, 2006, EMBO REP, V7, P525, DOI 10.1038/sj.embor.7400657; Salas TR, 2003, J BIOL CHEM, V278, P41338, DOI 10.1074/jbc.M302972200; Savino TM, 1999, J CELL SCI, V112, P1889; Seither P, 1996, GENOMICS, V37, P135, DOI 10.1006/geno.1996.0531; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Tseng AS, 2006, CHEM BIOL, V13, P957, DOI 10.1016/j.chembiol.2006.08.004; Wang YM, 2006, J INFRARED MILLIM W, V25, P50; White RJ, 2005, NAT REV MOL CELL BIO, V6, P69, DOI 10.1038/nrm1551; Zhang C, 2005, MOL CELL BIOL, V25, P6899, DOI 10.1128/MCB.25.16.6899-6911.2005	25	21	21	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2008	27	39					5254	5259		10.1038/onc.2008.152	http://dx.doi.org/10.1038/onc.2008.152			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	344GO	18490923				2022-12-25	WOS:000258915100009
J	Oakley, AJ; Yamada, T; Liu, D; Coggan, M; Clark, AG; Board, PG				Oakley, Aaron J.; Yamada, Tetsuo; Liu, Dan; Coggan, Marjorie; Clark, Alan G.; Board, Philip G.			The identification and structural characterization of C7orf24 as gamma-glutamyl cyclotransferase - An essential enzyme in the gamma-glutamyl cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-MODIFICATION; HUMAN-ERYTHROCYTES; PROTEIN; GLUTAMYLCYCLOTRANSFERASE; INTEGRATION; ACID; AMINOPEPTIDASE; CLASSIFICATION; PURIFICATION; GLUTATHIONE	The hypothetical protein C7orf24 has been implicated as a cancer marker with a potential role in cell proliferation. We have identified C7orf24 as gamma-glutamyl cyclotransferase (GGCT) that catalyzes the formation of 5-oxoproline (pyroglutamic acid) from gamma-glutamyl dipeptides and potentially plays a significant role in glutathione homeostasis. In the present study we have identified the first cDNA clones encoding a gamma-glutamyl cyclotransferase. The GGCT gene is located on chromosome 7p14-15 and consists of four exons that span 8 kb. The primary sequence is 188 amino acids in length and is unlike any protein of known function. We crystallized functional recombinant gamma-glutamyl cyclotransferase and determined its structure at 1.7 angstrom resolution. The enzyme is a dimer of 20,994-Da subunits. The topology of GGCT is unrelated to other enzymes associated with cyclotransferase-like activity. The fold was originally classified as "BtrG-like," a small family that only includes structures of hypothetical proteins from Mus musculus, Escherichia coli, Pyrococcus horikoshii, and Arabidopsis thaliana. Since this is the first member of this family with a defined function, we propose to refer to this structure as the gamma-glutamyl cyclotransferase fold. We have identified a potential active site pocket that contains a highly conserved glutamic acid (Glu(98)) and propose that it acts as a general acid/base in the reaction mechanism. Mutation of Glu(98) to Ala or Gln completely inactivates the enzyme without altering the overall fold.	[Yamada, Tetsuo; Liu, Dan; Coggan, Marjorie; Board, Philip G.] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; [Oakley, Aaron J.] Australian Natl Univ, Res Sch Chem, Canberra, ACT 2601, Australia; [Clark, Alan G.] Victoria Univ Wellington, Sch Biol Sci, Wellington 6140, New Zealand	Australian National University; John Curtin School of Medical Research; Australian National University; Victoria University Wellington	Board, PG (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, POB 334, Canberra, ACT 2601, Australia.	Philip.Board@anu.edu.au	Oakley, Aaron/A-9464-2013	Oakley, Aaron/0000-0002-4764-014X				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BOARD PG, 1980, HUM HERED, V30, P248, DOI 10.1159/000153137; BOARD PG, 1978, J LAB CLIN MED, V91, P127; BOARD PG, 1978, BIOCHEM J, V173, P427, DOI 10.1042/bj1730427; Bzymek KP, 2004, J BIOL CHEM, V279, P31018, DOI 10.1074/jbc.M404035200; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fundoiano-Hershcovitz Y, 2004, FEBS LETT, V571, P192, DOI 10.1016/j.febslet.2004.07.001; Huang KF, 2005, P NATL ACAD SCI USA, V102, P13117, DOI 10.1073/pnas.0504184102; Hubbard TJP, 1997, NUCLEIC ACIDS RES, V25, P236, DOI 10.1093/nar/25.1.236; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kageyama S, 2007, PROTEOM CLIN APPL, V1, P192, DOI 10.1002/prca.200600468; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X; Li YY, 2005, CHEM BIOL, V12, P665, DOI 10.1016/j.chembiol.2005.04.010; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; MEISTER A, 1973, SCIENCE, V180, P33, DOI 10.1126/science.180.4081.33; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; ORLOWSKI M, 1969, BIOCHEMISTRY-US, V8, P1048, DOI 10.1021/bi00831a036; ORLOWSKI M, 1973, J BIOL CHEM, V248, P2836; ORLOWSKI M, 1971, BIOCHEMISTRY-US, V10, P372, DOI 10.1021/bi00779a003; Ristoff E, 1998, CHEM-BIOL INTERACT, V112, P113, DOI 10.1016/S0009-2797(97)00155-5; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; STEINKAMP R, 1987, PHYSIOL PLANTARUM, V69, P499, DOI 10.1111/j.1399-3054.1987.tb09231.x; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TULCHIN N, 1981, GENETICS, V99, P109; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; WELLNER VP, 1974, P NATL ACAD SCI USA, V71, P2505, DOI 10.1073/pnas.71.6.2505; Wintjens R, 2006, J MOL BIOL, V357, P457, DOI 10.1016/j.jmb.2005.12.029; WOLFERSBERGER MG, 1974, J INVEST DERMATOL, V62, P587, DOI 10.1111/1523-1747.ep12679440; Xu L, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-275; Zhang CL, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-202	37	98	102	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22031	22042		10.1074/jbc.M803623200	http://dx.doi.org/10.1074/jbc.M803623200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18515354	hybrid			2022-12-25	WOS:000258114700022
J	Betzenhauser, MJ; Wagner, LE; Iwai, M; Michikawa, T; Mikoshiba, K; Yule, DI				Betzenhauser, Matthew J.; Wagner, Larry E., II; Iwai, Miwako; Michikawa, Takayuki; Mikoshiba, Katsuhiko; Yule, David I.			ATP modulation of Ca2+ release by type-2 and type-3 inositol (1,4,5)-triphosphate receptors - Differing ATP sensitivities and molecular determinants of action	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING-SITES; 1,4,5-TRISPHOSPHATE RECEPTOR; FUNCTIONAL-CHARACTERIZATION; ADENINE-NUCLEOTIDES; PLASMA-MEMBRANE; CALCIUM-RELEASE; CHANNELS; PHOSPHORYLATION; ACTIVATION; PROTEIN	ATP enhances Ca2+ release from inositol (1,4,5)-trisphosphate receptors (InsP(3)R). However, the three isoforms of InsP(3)R are reported to respond to ATP with differing sensitivities. Ca2+ release through InsP(3)R(1) is positively regulated at lower ATP concentrations than InsP(3)R(3), and InsP(3)R(2) has been reported to be insensitive to ATP modulation. We have reexamined these differences by studying the effects of ATP on InsP(3)R(2) and InsP(3)R(3) expressed in isolation on a null background in DT40 InsP(3)R knock-out cells. We report that the Ca2+-releasing activity as well as the single channel open probability of InsP(3)R(2) was enhanced by ATP, but only at submaximal InsP(3) levels. Further, InsP(3)R(2) was more sensitive to ATP modulation than InsP(3)R(3) under similar experimental conditions. Mutations in the ATPB sites of InsP(3)R(2) and InsP(3)R(3) were generated, and the functional consequences of these mutations were tested. Surprisingly, mutation of the ATPB site in InsP(3)R(3) had no effect on ATP modulation, suggesting an additional locus for the effects of ATP on this isoform. In contrast, ablation of the ATPB site of InsP(3)R(2) eliminated the enhancing effects of ATP. Furthermore, this mutation had profound effects on the patterns of intracellular calcium signals, providing evidence for the physiological significance of ATP binding to InsP(3)R(2).	[Betzenhauser, Matthew J.; Wagner, Larry E., II; Yule, David I.] Univ Rochester, Med Ctr, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Iwai, Miwako] Univ Tokyo, Inst Med Sci, Dept Basic Med Sci, Div Mol Neurobiol, Tokyo, Japan; [Michikawa, Takayuki; Mikoshiba, Katsuhiko] RIKEN, Brain Sci Inst, Brain Dev Res Grp, Dev Neurobiol Lab, Saitama, Japan	University of Rochester; University of Tokyo; RIKEN	Yule, DI (corresponding author), 601 Elmwood Ave,Box 711, Rochester, NY 14625 USA.	David_Yule@urmc.rochester.edu	Mikoshiba, Katsuhiko/N-7943-2015		NIDCR NIH HHS [R01 DE 016999, T32 DE 07202] Funding Source: Medline; NIDDK NIH HHS [R01 DK 054568] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007202, R01DE016999] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054568] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABE K, 1987, J NEUROCHEM, V48, P503, DOI 10.1111/j.1471-4159.1987.tb04121.x; Antcliff JF, 2005, EMBO J, V24, P229, DOI 10.1038/sj.emboj.7600487; BEZPROZVANNY I, 1993, NEURON, V10, P1175, DOI 10.1016/0896-6273(93)90065-Y; Bezprozvanny I, 2005, CELL CALCIUM, V38, P261, DOI 10.1016/j.ceca.2005.06.030; BLONDEL O, 1993, J BIOL CHEM, V268, P11356; Boehning D, 2000, J BIOL CHEM, V275, P21492, DOI 10.1074/jbc.M001724200; DANOFF SK, 1991, P NATL ACAD SCI USA, V88, P2951, DOI 10.1073/pnas.88.7.2951; Dellis O, 2008, J BIOL CHEM, V283, P751, DOI 10.1074/jbc.M706960200; Dellis O, 2006, SCIENCE, V313, P229, DOI 10.1126/science.1125203; Dong K, 2005, EMBO J, V24, P1318, DOI 10.1038/sj.emboj.7600626; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; Hamada K, 2003, J BIOL CHEM, V278, P52881, DOI 10.1074/jbc.M309743200; Hamada K, 2002, J BIOL CHEM, V277, P21115, DOI 10.1074/jbc.C200244200; Hiratsuka T, 2003, EUR J BIOCHEM, V270, P3479, DOI 10.1046/j.1432-1033.2003.03748.x; Holtzclaw LA, 2002, GLIA, V39, P69, DOI 10.1002/glia.10085; Ignoul S, 2005, AM J PHYSIOL-CELL PH, V289, pC1369, DOI 10.1152/ajpcell.00282.2005; IINO M, 1991, J GEN PHYSIOL, V98, P681, DOI 10.1085/jgp.98.4.681; Iwai M, 2005, J BIOL CHEM, V280, P10305, DOI 10.1074/jbc.M413824200; Li C, 2007, P NATL ACAD SCI USA, V104, P12565, DOI 10.1073/pnas.0702489104; Maes K, 1999, CELL CALCIUM, V25, P143, DOI 10.1054/ceca.1998.0011; Maes K, 2001, J BIOL CHEM, V276, P3492, DOI 10.1074/jbc.M006082200; Maes K, 2000, CELL CALCIUM, V27, P257, DOI 10.1054/ceca.2000.0121; Mak DOD, 1999, J BIOL CHEM, V274, P22231, DOI 10.1074/jbc.274.32.22231; Mak DOD, 2001, J GEN PHYSIOL, V117, P447, DOI 10.1085/jgp.117.5.447; Missiaen L, 1997, BIOCHEM J, V325, P661, DOI 10.1042/bj3250661; Miyakawa T, 1999, EMBO J, V18, P1303, DOI 10.1093/emboj/18.5.1303; Patel S, 1999, CELL CALCIUM, V25, P247, DOI 10.1054/ceca.1999.0021; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Schug ZT, 2008, J BIOL CHEM, V283, P2939, DOI [10.1074/jbc.M706645200, 10.1074/jbc.M802716200]; SUDHOF TC, 1991, EMBO J, V10, P3199, DOI 10.1002/j.1460-2075.1991.tb04882.x; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; TAKATA M, 1995, J EXP MED, V182, P907, DOI 10.1084/jem.182.4.907; Trapp S, 2003, EMBO J, V22, P2903, DOI 10.1093/emboj/cdg282; Tu HP, 2005, BIOPHYS J, V88, P1046, DOI 10.1529/biophysj.104.049593; Tu HP, 2002, BIOPHYS J, V82, P1995, DOI 10.1016/S0006-3495(02)75548-3; Tucker SJ, 1998, EMBO J, V17, P3290, DOI 10.1093/emboj/17.12.3290; Uchida K, 2003, J BIOL CHEM, V278, P16551, DOI 10.1074/jbc.M300646200; Vanoye CG, 2002, J BIOL CHEM, V277, P23260, DOI 10.1074/jbc.M112004200; Wagner LE, 2006, J BIOL CHEM, V281, P17410, DOI 10.1074/jbc.M601340200; Wagner LE, 2004, J BIOL CHEM, V279, P46242, DOI 10.1074/jbc.M405849200; Wang Wenyan, 2002, Methods Mol Biol, V182, P37; WIERENGA RK, 1983, NATURE, V302, P842, DOI 10.1038/302842a0; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; Zhang XJ, 1999, BIOCHEM J, V340, P519, DOI 10.1042/0264-6021:3400519	46	61	62	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21579	21587		10.1074/jbc.M801680200	http://dx.doi.org/10.1074/jbc.M801680200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18505727	hybrid, Green Published			2022-12-25	WOS:000257898800031
J	Basilico, C; Arnesano, A; Galluzzo, M; Comoglio, PM; Michieli, P				Basilico, Cristina; Arnesano, Addolorata; Galluzzo, Maria; Comoglio, Paolo M.; Michieli, Paolo			A high affinity hepatocyte growth factor-binding site in the immunoglobulin-like region of met	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITOR; RECEPTOR TYROSINE KINASE; C-MET; FACTOR/SCATTER FACTOR; SCATTER-FACTOR; MONOCLONAL-ANTIBODIES; LIVER-REGENERATION; LENTIVIRAL VECTORS; ANTITUMOR-ACTIVITY; GENE-TRANSFER	Hepatocyte growth factor (HGF) and its high affinity receptor, the tyrosine kinase Met, play a key role in embryo development and tumor invasion. Both HGF and Met are established targets for cancer therapy. However, the mechanism of their interaction is complex and remains elusive. HGF is secreted as a monomeric precursor (pro-HGF) that binds to but does not activate Met. Mature HGF is a alpha/beta heterodimer containing a high affinity Met-binding site in the alpha-chain (HGF-alpha) and a low affinity Met-binding site in the alpha-chain (HGF-alpha). The extracellular portion of Met contains a semaphorin (Sema) domain, a cysteine-rich hinge (plexin-semaphorin-integrin), and four immunoglobulin-like domains ( immunoglobulin-like regions in plexins and transcription factors (IPT) 1-4). HGF-beta binds to Sema through a low affinity contact. The domain of Met responsible for high affinity binding to HGF-alpha has not been identified yet. Here we show that this long sought after binding site lies in the immunoglobulin-like region of Met and more precisely in IPT 3 and 4. We also show that IPT 3 and 4 are sufficient to transmit the signal for kinase activation to the cytoplasm, although the lack of Sema makes the receptor equally sensitive to mature HGF and pro-HGF. Finally, we provide evidence that soluble Met-derived proteins containing either the low affinity or high affinity HGF-binding site antagonize HGF-induced invasive growth both in vitro and in xenografts. These data suggest that the immunoglobulin-like region of Met cooperates with the Sema domain in binding to HGF and in controlling Met kinase activity. Although the IPT-HGF-alpha interaction provides binding strength, the Sema-HGF-beta contact confers selective sensitivity to the active form of the ligand.	[Basilico, Cristina; Arnesano, Addolorata; Galluzzo, Maria; Comoglio, Paolo M.; Michieli, Paolo] Univ Turin, Sch Med, Div Mol Oncol, Inst Canc Res & Treatment, I-10060 Turin, Italy	University of Turin	Michieli, P (corresponding author), Univ Turin, Sch Med, Div Mol Oncol, Inst Canc Res & Treatment, SP 142,Km 3-95, I-10060 Turin, Italy.	paolo.michieli@ircc.it	Basilico, Cristina/A-3253-2011; Michieli, Paolo/A-2588-2011	Michieli, Paolo/0000-0002-3093-8871; Comoglio, Paolo/0000-0002-7056-5328	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Berthou S, 2004, ONCOGENE, V23, P5387, DOI 10.1038/sj.onc.1207691; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Bork P, 1999, TRENDS BIOCHEM SCI, V24, P261, DOI 10.1016/S0968-0004(99)01416-4; Borowiak M, 2004, P NATL ACAD SCI USA, V101, P10608, DOI 10.1073/pnas.0403412101; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Burgess T, 2006, CANCER RES, V66, P1721, DOI 10.1158/0008-5472.CAN-05-3329; BUSSOLINO F, 1992, J CELL BIOL, V119, P629, DOI 10.1083/jcb.119.3.629; Cao B, 2001, P NATL ACAD SCI USA, V98, P7443, DOI 10.1073/pnas.131200498; Christensen JG, 2005, CANCER LETT, V225, P1, DOI 10.1016/j.canlet.2004.09.044; Christensen JG, 2003, CANCER RES, V63, P7345; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Gherardi E, 2006, P NATL ACAD SCI USA, V103, P4046, DOI 10.1073/pnas.0509040103; Gherardi E, 2003, P NATL ACAD SCI USA, V100, P12039, DOI 10.1073/pnas.2034936100; GIORDANO S, 1989, NATURE, V339, P155, DOI 10.1038/339155a0; HARTMANN G, 1992, P NATL ACAD SCI USA, V89, P11574, DOI 10.1073/pnas.89.23.11574; Holmes O, 2007, J MOL BIOL, V367, P395, DOI 10.1016/j.jmb.2006.12.061; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Kim KJ, 2006, CLIN CANCER RES, V12, P1292, DOI 10.1158/1078-0432.CCR-05-1793; Kirchhofer D, 2004, J BIOL CHEM, V279, P39915, DOI 10.1074/jbc.M404795200; Kirchhofer D, 2007, P NATL ACAD SCI USA, V104, P5306, DOI 10.1073/pnas.0700184104; Knudsen BS, 2008, CURR OPIN GENET DEV, V18, P87, DOI 10.1016/j.gde.2008.02.001; KOMADA M, 1993, FEBS LETT, V328, P25, DOI 10.1016/0014-5793(93)80958-W; Kong-Beltran M, 2004, CANCER CELL, V6, P75, DOI 10.1016/j.ccr.2004.06.013; Kozlov G, 2004, BIOCHEM BIOPH RES CO, V321, P234, DOI 10.1016/j.bbrc.2004.06.132; LOKKER NA, 1992, EMBO J, V11, P2503, DOI 10.1002/j.1460-2075.1992.tb05315.x; LONGATI P, 1994, ONCOGENE, V9, P49; Ma PC, 2005, CANCER RES, V65, P1479, DOI 10.1158/0008-5472.CAN-04-2650; Martens T, 2006, CLIN CANCER RES, V12, P6144, DOI 10.1158/1078-0432.CCR-05-1418; Matsumoto K, 2001, KIDNEY INT, V59, P2023, DOI 10.1046/j.1523-1755.2001.00717.x; Matsumoto K, 2003, CANCER SCI, V94, P321, DOI 10.1111/j.1349-7006.2003.tb01440.x; Matsumoto K, 1998, J BIOL CHEM, V273, P22913, DOI 10.1074/jbc.273.36.22913; Mazzone M, 2004, J CLIN INVEST, V114, P1418, DOI 10.1172/JCI200422235; Michieli P, 2004, CANCER CELL, V6, P61, DOI 10.1016/j.ccr.2004.05.032; Michieli P, 2002, NAT BIOTECHNOL, V20, P488, DOI 10.1038/nbt0502-488; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; NAKAMURA T, 1994, MOLECULAR AND CELLULAR BASIS FOR CELL TO CELL INTERACTION: ITS SIGNIFICANCE IN CANCER, P195; NALDINI L, 1995, J BIOL CHEM, V270, P603, DOI 10.1074/jbc.270.2.603; NALDINI L, 1991, ONCOGENE, V6, P501; Niemann HH, 2007, CELL, V130, P235, DOI 10.1016/j.cell.2007.05.037; Ohmichi H, 1996, AM J PHYSIOL-LUNG C, V270, pL1031, DOI 10.1152/ajplung.1996.270.6.L1031; Petrelli A, 2006, P NATL ACAD SCI USA, V103, P5090, DOI 10.1073/pnas.0508156103; Puri N, 2007, CANCER RES, V67, P3529, DOI 10.1158/0008-5472.CAN-06-4416; Ruco LP, 1996, J PATHOL, V180, P266, DOI 10.1002/(SICI)1096-9896(199611)180:3<266::AID-PATH658>3.0.CO;2-Q; Sattler M, 2003, CANCER RES, V63, P5462; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0; Stamos J, 2004, EMBO J, V23, P2325, DOI 10.1038/sj.emboj.7600243; TEMPEST PR, 1988, BRIT J CANCER, V58, P3, DOI 10.1038/bjc.1988.150; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; Vigna E, 2000, J GENE MED, V2, P308; Zou HY, 2007, CANCER RES, V67, P4408, DOI 10.1158/0008-5472.CAN-06-4443	52	94	106	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21267	21277		10.1074/jbc.M800727200	http://dx.doi.org/10.1074/jbc.M800727200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18495663	Green Published, hybrid			2022-12-25	WOS:000257746100068
J	Nakano, M; Imamura, H; Toei, M; Tamakoshi, M; Yoshida, M; Yokoyama, K				Nakano, Masahiro; Imamura, Hiromi; Toei, Masashi; Tamakoshi, Masatada; Yoshida, Masasuke; Yokoyama, Ken			ATP hydrolysis and synthesis of a rotary motor V-ATPase from Thermus thermophilus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-BOUND ATPASE; CATALYTIC SITE; ALPHA(3)BETA(3)GAMMA COMPLEX; INHIBITORY MGADP; BACILLUS PS3; ROTATION; F-1-ATPASE; PURIFICATION; F1-ATPASE; SYNTHASE	Vacuolar-type H+-ATPase (V-ATPase) catalyzes ATP synthesis and hydrolysis coupled with proton translocation across membranes via a rotary motor mechanism. Here we report biochemical and biophysical catalytic properties of V-ATPase from Thermus thermophilus. ATP hydrolysis of V-ATPase was severely inhibited by entrapment of Mg-ADP in the catalytic site. In contrast, the enzyme was very active for ATP synthesis (similar to 70 s(-1)) with the K-m values for ADP and phosphate being 4.7 +/- 0.5 and 460 +/- 30 mu M, respectively. Single molecule observation showed V-ATPase rotated in a 120 degrees stepwise manner, and analysis of dwelling time allowed the binding rate constant k(on) for ATP to be estimated (similar to 1.1 x 10(6) M-1 s(-1)), which was much lower than the k(on) (= V-max/K-m) for ADP (similar to 1.4 x 10(7) M-1 s(-1)). The slower kon ATP than kon ADP and strong Mg-ADP inhibition may contribute to prevent wasteful consumption of ATP under in vivo conditions when the proton motive force collapses.	[Nakano, Masahiro; Toei, Masashi; Yoshida, Masasuke; Yokoyama, Ken] Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Imamura, Hiromi] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan; [Imamura, Hiromi] Japan Sci & Technol Agcy, PRESTO, Chiyoda Ku, Tokyo 1020075, Japan; [Tamakoshi, Masatada] Tokai Univ Pharm & Life Sci, Dept Mol Biol, Tokyo 1920392, Japan; [Yoshida, Masasuke; Yokoyama, Ken] Natl Musuem Emerging Sci & Innovat, Japan Sci & Technol Agcy, ATP Synthesis Regulat Project, ICORP, Tokyo 1350064, Japan	Tokyo Institute of Technology; Osaka University; Japan Science & Technology Agency (JST); Tokai University; Japan Science & Technology Agency (JST)	Yokoyama, K (corresponding author), Tokyo Inst Technol, Chem Resources Lab, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268503, Japan.	yokoyama.k.ab@m.titech.ac.jp	Yokoyama, Ken/AAJ-3582-2020; Nakano, Masahiro/A-5249-2012; Imamura, Hiromi/AAD-5109-2019	Yokoyama, Ken/0000-0002-6813-1096; Nakano, Masahiro/0000-0002-1558-3259; Imamura, Hiromi/0000-0002-1896-0443				Allison WS, 1996, J BIOENERG BIOMEMBR, V28, P433, DOI 10.1007/BF02113985; Feniouk Boris A., 2008, V45, P279, DOI 10.1007/400_2007_043; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Hirata T, 2000, J BIOL CHEM, V275, P386, DOI 10.1074/jbc.275.1.386; Hirata T, 2003, J BIOL CHEM, V278, P23714, DOI 10.1074/jbc.M302756200; Hirono-Hara Y, 2001, P NATL ACAD SCI USA, V98, P13649, DOI 10.1073/pnas.241365698; Imamura H, 2005, P NATL ACAD SCI USA, V102, P17929, DOI 10.1073/pnas.0507764102; Imamura H, 2004, J BIOL CHEM, V279, P18085, DOI 10.1074/jbc.M314204200; Imamura H, 2003, P NATL ACAD SCI USA, V100, P2312, DOI 10.1073/pnas.0436796100; INATOMI K, 1986, J BACTERIOL, V167, P837, DOI 10.1128/jb.167.3.837-841.1986; Itoh H, 2004, NATURE, V427, P465, DOI 10.1038/nature02212; Jault JM, 1996, J BIOL CHEM, V271, P28818, DOI 10.1074/jbc.271.46.28818; Jault JM, 1995, BIOCHEMISTRY-US, V34, P16412, DOI 10.1021/bi00050a023; Kakinuma Y, 1999, J BIOENERG BIOMEMBR, V31, P7, DOI 10.1023/A:1005499126939; Kinosita K, 2000, PHILOS T R SOC B, V355, P473, DOI 10.1098/rstb.2000.0589; KONISHI J, 1987, J BIOCHEM, V102, P1379, DOI 10.1093/oxfordjournals.jbchem.a122184; Matsui T, 1997, J BIOL CHEM, V272, P8215, DOI 10.1074/jbc.272.13.8215; MILGROM YM, 1990, BIOCHIM BIOPHYS ACTA, V1020, P43, DOI 10.1016/0005-2728(90)90091-H; NANBA T, 1987, J BIOCHEM-TOKYO, V102, P591, DOI 10.1093/oxfordjournals.jbchem.a122092; Nishizaka T, 2004, NAT STRUCT MOL BIOL, V11, P142, DOI 10.1038/nsmb721; Sakaki N, 2005, BIOPHYS J, V88, P2047, DOI 10.1529/biophysj.104.054668; Tamakoshi M, 1999, FEMS MICROBIOL LETT, V173, P431, DOI 10.1016/S0378-1097(99)00101-9; Tamakoshi M, 1997, J BACTERIOL, V179, P4811, DOI 10.1128/jb.179.15.4811-4814.1997; Toei M, 2007, P NATL ACAD SCI USA, V104, P20256, DOI 10.1073/pnas.0706914105; TSUTSUMI S, 1991, BIOCHIM BIOPHYS ACTA, V1098, P13, DOI 10.1016/0005-2728(91)90003-7; Ueno H, 2005, P NATL ACAD SCI USA, V102, P1333, DOI 10.1073/pnas.0407857102; Yokoyama K, 2003, J BIOL CHEM, V278, P24255, DOI 10.1074/jbc.M303104200; YOKOYAMA K, 1990, J BIOL CHEM, V265, P21946; Yokoyama K, 1998, J BIOL CHEM, V273, P20504, DOI 10.1074/jbc.273.32.20504; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509; Zharova TV, 2004, J BIOL CHEM, V279, P12319, DOI 10.1074/jbc.M311397200; ZHOU JM, 1988, BIOCHEMISTRY-US, V27, P5129, DOI 10.1021/bi00414a027	33	48	49	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20789	20796		10.1074/jbc.M801276200	http://dx.doi.org/10.1074/jbc.M801276200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18492667	Green Published, hybrid			2022-12-25	WOS:000257746100020
J	Sikorra, S; Henke, T; Galli, T; Binz, T				Sikorra, Stefan; Henke, Tina; Galli, Thierry; Binz, Thomas			Substrate recognition mechanism of VAMP/synaptobrevin-cleaving clostridial neurotoxins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOTULINUM TYPE-B; MEMBRANE-PROTEIN; SEROTYPE-A; LIGHT-CHAIN; PLASMA-MEMBRANE; TETANUS TOXIN; CLEAVAGE; RESIDUES; SPECIFICITY; IDENTIFICATION	Botulinum neurotoxins (BoNTs) and tetanus neurotoxin (TeNT) inhibit neurotransmitter release by proteolyzing a single peptide bond in one of the three soluble N-ethylmaleimide- sensitive factor attachment protein receptors SNAP-25, syntaxin, and vesicle-associated membrane protein (VAMP)/synaptobrevin. TeNT and BoNT/B, D, F, and G of the seven known BoNTs cleave the synaptic vesicle protein VAMP/synaptobrevin. Except for BoNT/B and TeNT, they cleave unique peptide bonds, and prior work suggested that different substrate segments are required for the interaction of each toxin. Although the mode of SNAP-25 cleavage by BoNT/A and E has recently been studied in detail, the mechanism of VAMP/synaptobrevin proteolysis is fragmentary. Here, we report the determination of all substrate residues that are involved in the interaction with BoNT/B, D, and F and TeNT by means of systematic mutagenesis of VAMP/synaptobrevin. For each of the toxins, three or more residues clustered at an N-terminal site remote from the respective scissile bond are identified that affect solely substrate binding. These exosites exhibit different sizes and distances to the scissile peptide bonds for each neurotoxin. Substrate segments C-terminal of the cleavage site (P4-P4')do not play a role in the catalytic process. Mutation of residues in the proximity of the scissile bond exclusively affects the turnover number; however, the importance of individual positions at the cleavage sites varied for each toxin. The data show that, similar to the SNAP-25 proteolyzing BoNT/A and E, VAMP/synaptobrevin-specific clostridial neurotoxins also initiate substrate interaction, employing an exosite located N-terminal of the scissile peptide bond.	[Sikorra, Stefan; Henke, Tina; Binz, Thomas] Hannover Med Sch, Inst Biochem, D-30623 Hannover, Germany; [Galli, Thierry] INSERM, Avenir Team, F-75005 Paris, France; [Galli, Thierry] Univ Paris 06, CNRS, UMR7592, Inst Jacques Monod, F-75005 Paris, France; [Galli, Thierry] Univ Paris 07, F-75005 Paris, France	Hannover Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Binz, T (corresponding author), Hannover Med Sch, Inst Biochem, D-30623 Hannover, Germany.	binz.thomas@mh-hannover.de	Galli, Thierry/G-8842-2011; Galli, Thierry/Q-2249-2019	Galli, Thierry/0000-0001-8514-7455; Galli, Thierry/0000-0001-8514-7455				Advani RJ, 1998, J BIOL CHEM, V273, P10317, DOI 10.1074/jbc.273.17.10317; Agarwal R, 2005, BIOCHEMISTRY-US, V44, P8291, DOI 10.1021/bi050253a; Breidenbach MA, 2004, NATURE, V432, P925, DOI 10.1038/nature03123; Chen S, 2006, J BIOL CHEM, V281, P10906, DOI 10.1074/jbc.M513032200; Chen S, 2007, J BIOL CHEM, V282, P25540, DOI 10.1074/jbc.M701922200; Chen S, 2007, J BIOL CHEM, V282, P9621, DOI 10.1074/jbc.M611211200; Cornille F, 1997, J BIOL CHEM, V272, P3459, DOI 10.1074/jbc.272.6.3459; Evans ER, 2005, TOXICON, V46, P446, DOI 10.1016/j.toxicon.2005.06.006; Filippini F, 2001, TRENDS BIOCHEM SCI, V26, P407, DOI 10.1016/S0968-0004(01)01861-8; FORAN P, 1994, BIOCHEMISTRY-US, V33, P15365, DOI 10.1021/bi00255a017; Fu ZJ, 2006, BIOCHEMISTRY-US, V45, P8903, DOI 10.1021/bi060786z; Galli T, 1998, MOL BIOL CELL, V9, P1437, DOI 10.1091/mbc.9.6.1437; Humeau Y, 2000, BIOCHIMIE, V82, P427, DOI 10.1016/S0300-9084(00)00216-9; Jin RS, 2007, BIOCHEMISTRY-US, V46, P10685, DOI 10.1021/bi701162d; Niemann Heiner, 1994, Trends in Cell Biology, V4, P179, DOI 10.1016/0962-8924(94)90203-8; Pellizzari R, 1996, J BIOL CHEM, V271, P20353, DOI 10.1074/jbc.271.34.20353; Pellizzari R, 1997, FEBS LETT, V409, P339, DOI 10.1016/S0014-5793(97)00482-1; Proux-Gillardeaux V, 2005, TRAFFIC, V6, P366, DOI 10.1111/j.1600-0854.2005.00288.x; SCHIAVO G, 1995, J BIOL CHEM, V270, P10566, DOI 10.1074/jbc.270.18.10566; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Schiavo Giampietro, 1994, Seminars in Cell Biology, V5, P221, DOI 10.1006/scel.1994.1028; Schmidt JJ, 2005, BIOCHEMISTRY-US, V44, P4067, DOI 10.1021/bi0477642; SHONE CC, 1993, EUR J BIOCHEM, V217, P965, DOI 10.1111/j.1432-1033.1993.tb18327.x; Sikorra S, 2006, J MOL BIOL, V357, P574, DOI 10.1016/j.jmb.2005.12.075; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Vaidyanathan VV, 1999, J NEUROCHEM, V72, P327, DOI 10.1046/j.1471-4159.1999.0720327.x; Washbourne P, 1997, FEBS LETT, V418, P1, DOI 10.1016/S0014-5793(97)01328-8; Wictome M, 1996, FEBS LETT, V386, P133, DOI 10.1016/0014-5793(96)00431-0; YAMASAKI S, 1994, J BIOL CHEM, V269, P12764	29	48	57	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21145	21152		10.1074/jbc.M800610200	http://dx.doi.org/10.1074/jbc.M800610200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18511418	Green Published, hybrid			2022-12-25	WOS:000257746100056
J	Tacchini, L; Gammella, E; De Ponti, C; Recalcati, S; Cairo, G				Tacchini, Lorenza; Gammella, Elena; De Ponti, Cristina; Recalcati, Stefania; Cairo, Gaetano			Role of HIF-1 and NF-kappa B transcription factors in the modulation of transferrin receptor by inflammatory and anti-inflammatory signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; HYPOXIA-INDUCIBLE FACTOR-1; IRON-REGULATORY PROTEIN-2; NITRIC-OXIDE PRODUCTION; FERRITIN SYNTHESIS; FACTOR-ALPHA; OXIDATIVE STRESS; GENE-EXPRESSION; FACTOR-I; POSTTRANSCRIPTIONAL REGULATION	Inflammation generates various changes in body iron homeostasis, including iron sequestration in the reticuloendothelial system with ensuing hypoferremia and anemia of chronic disease. Increased iron accumulation is caused by hepcidin-mediated down-regulation of the iron export protein ferroportin and higher iron uptake. However, enhanced iron acquisition by macrophages cannot be accounted for by the previously reported transferrin receptor (TfR1) down-regulation in macrophages exposed to lipopolysaccharide (LPS)/interferon gamma (IFN gamma) because it impairs a major iron uptake mechanism. Because TfR1 is up-regulated by the hypoxia-inducible factor (HIF-1), we investigated the effect of inflammatory and anti-inflammatory signals on HIF-1-mediated TfR1 gene expression. Exposure of mouse macrophages (RAW 264.7 and J774A. 1 cells or peritoneal macrophages) to LPS/IFN gamma up-regulated NF-kappa B, which in turn rapidly and transiently activated HIF-1-dependent TfR1 expression and iron uptake. Activation of an anti-inflammatory pathway by pre-exposure to the adenosine A(2A) receptor agonist CGS21680 prevented the inducing effect of LPS/IFN gamma on HIF-1 and TfR1 expression by inhibiting NF-kappa B activity, whereas treatment with CGS21680 alone increased HIF-1-mediated TfR1 expression by means of an NF-kappa B-independent signaling pathway. In conclusion, an interplay of the HIF-1 and NF-kappa B pathways controls TfR1 transcription in inflammation. The consequent changes in TfR1 expression may be involved in modulating iron retention in inflammatory macrophages, thus possibly contributing to the development of hypoferremia in the early phases preceding the down-regulation of macrophage ferroportin by hepcidin.	[Tacchini, Lorenza; Gammella, Elena; De Ponti, Cristina; Recalcati, Stefania; Cairo, Gaetano] Univ Milan, Inst Gen Pathol, I-20133 Milan, Italy	University of Milan	Cairo, G (corresponding author), Univ Milan, Inst Gen Pathol, Via Mangiagalli 31, I-20133 Milan, Italy.	gaetano.cairo@unimi.it	Cairo, Gaetano/M-5104-2016; Gammella, Elena/M-5037-2016; Tacchini, Lorenza/L-1418-2016; recalcati, stefania/M-5045-2016	Cairo, Gaetano/0000-0002-8147-4720; Gammella, Elena/0000-0001-9921-8664; Tacchini, Lorenza/0000-0002-4863-178X; recalcati, stefania/0000-0002-2115-8283				Agani F, 1998, MOL PHARMACOL, V54, P749, DOI 10.1124/mol.54.5.749; Alberghini A, 2005, J BIOL CHEM, V280, P30120, DOI 10.1074/jbc.M500971200; An JB, 2005, MOL CELL BIOL, V25, P7546, DOI 10.1128/MCB.25.17.7546-7556.2005; Andrews NC, 2007, ANNU REV PHYSIOL, V69, P69, DOI 10.1146/annurev.physiol.69.031905.164337; BERTINI R, 1989, J LEUKOCYTE BIOL, V46, P254, DOI 10.1002/jlb.46.3.254; Bianchi L, 1999, NUCLEIC ACIDS RES, V27, P4223, DOI 10.1093/nar/27.21.4223; Blouin CC, 2004, BLOOD, V103, P1124, DOI 10.1182/blood-2003-07-2427; Bonello S, 2007, ARTERIOSCL THROM VAS, V27, P755, DOI 10.1161/01.ATV.0000258979.92828.bc; BYRD TF, 1993, J CLIN INVEST, V91, P969, DOI 10.1172/JCI116318; Cairo G, 2006, GENES NUTR, V1, P25, DOI 10.1007/BF02829934; Cairo G, 2002, FREE RADICAL BIO MED, V32, P1237, DOI 10.1016/S0891-5849(02)00825-0; Cairo G, 2000, BIOCHEM J, V352, P241, DOI 10.1042/0264-6021:3520241; CAIRO G, 1995, J BIOL CHEM, V270, P700, DOI 10.1074/jbc.270.2.700; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; De Ponti C, 2007, J LEUKOCYTE BIOL, V82, P392, DOI 10.1189/jlb.0107060; Delaby C, 2005, BLOOD, V106, P3979, DOI 10.1182/blood-2005-06-2398; Dery MAC, 2005, INT J BIOCHEM CELL B, V37, P535, DOI 10.1016/j.biocel.2004.08.012; Frede S, 2006, BIOCHEM J, V396, P517, DOI 10.1042/BJ20051839; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; GUTTEBERG TJ, 1989, SCAND J INFECT DIS, V21, P709, DOI 10.3109/00365548909021701; Hasko G, 2004, TRENDS IMMUNOL, V25, P33, DOI 10.1016/j.it.2003.11.003; Hasko G, 1996, J IMMUNOL, V157, P4634; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; Kemna E, 2005, BLOOD, V106, P1864, DOI 10.1182/blood-2005-03-1159; Khoury J, 2007, J CLIN INVEST, V117, P703, DOI 10.1172/JCI30049; Kim S, 1999, J BIOL CHEM, V274, P33035, DOI 10.1074/jbc.274.46.33035; Kim S, 2000, J BIOL CHEM, V275, P6220, DOI 10.1074/jbc.275.9.6220; Kim SW, 2002, P NATL ACAD SCI USA, V99, P12214, DOI 10.1073/pnas.192316099; Knutson M, 2003, CRIT REV BIOCHEM MOL, V38, P61, DOI 10.1080/713609210; KONIJN AM, 1981, BRIT J HAEMATOL, V49, P361, DOI 10.1111/j.1365-2141.1981.tb07238.x; Kung AL, 2004, CANCER CELL, V6, P33, DOI 10.1016/j.ccr.2004.06.009; KVIETIKOVA I, 1995, NUCLEIC ACIDS RES, V23, P4542, DOI 10.1093/nar/23.22.4542; Laftah AH, 2006, BIOCHEM J, V397, P61, DOI 10.1042/BJ20060215; Leipuviene R, 2007, CELL MOL LIFE SCI, V64, P2945, DOI 10.1007/s00018-007-7198-4; Linden J, 2005, MOL PHARMACOL, V67, P1385, DOI 10.1124/mol.105.011783; Liu XB, 2005, BLOOD CELL MOL DIS, V35, P47, DOI 10.1016/j.bcmd.2005.04.006; Lok CN, 1999, J BIOL CHEM, V274, P24147, DOI 10.1074/jbc.274.34.24147; Ludwiczek S, 2003, BLOOD, V101, P4148, DOI 10.1182/blood-2002-08-2459; Majumdar S, 2003, ONCOGENE, V22, P1206, DOI 10.1038/sj.onc.1206184; Martin L, 2006, J PHARMACOL EXP THER, V316, P71, DOI 10.1124/jpet.105.091868; Mi Z, 2008, CELL CYCLE, V7, P232, DOI 10.4161/cc.7.2.5193; Min HW, 2000, LIFE SCI, V66, P1781, DOI 10.1016/S0024-3205(00)00502-6; MOLDAWER LL, 1989, FASEB J, V3, P1637, DOI 10.1096/fasebj.3.5.2784116; Mulero V, 1999, BLOOD, V94, P2383, DOI 10.1182/blood.V94.7.2383.419k20_2383_2389; MULLNER EW, 1989, CELL, V58, P373, DOI 10.1016/0092-8674(89)90851-9; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth ZH, 2005, J IMMUNOL, V175, P8260, DOI 10.4049/jimmunol.175.12.8260; Nemeth ZH, 2003, BIOCHEM BIOPH RES CO, V312, P883, DOI 10.1016/j.bbrc.2003.11.006; Nishi K, 2008, ANTIOXID REDOX SIGN, V10, P983, DOI 10.1089/ars.2007.1825; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Perkins ND, 2000, TRENDS BIOCHEM SCI, V25, P434, DOI 10.1016/S0968-0004(00)01617-0; Peyssonnaux C, 2006, BLOOD, V107, P3727, DOI 10.1182/blood-2005-06-2259; Ramanathan M, 2007, MOL BIOL CELL, V18, P14, DOI 10.1091/mbc.E06-07-0596; Recalcati S, 1998, BLOOD, V91, P1059, DOI 10.1182/blood.V91.3.1059.1059_1059_1066; Rivera S, 2005, BLOOD, V106, P2196, DOI 10.1182/blood-2005-04-1766; Scortegagna M, 2008, BLOOD, V111, P3343, DOI 10.1182/blood-2007-10-115758; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Tacchini L, 2004, CARCINOGENESIS, V25, P2089, DOI 10.1093/carcin/bgh227; Tacchini L, 2003, EXP CELL RES, V290, P391, DOI 10.1016/S0014-4827(03)00348-3; Tacchini L, 2002, HEPATOLOGY, V36, P103, DOI 10.1053/jhep.2002.33997; Tacchini L, 1999, J BIOL CHEM, V274, P24142, DOI 10.1074/jbc.274.34.24142; Taramelli D, 2000, LAB INVEST, V80, P1781, DOI 10.1038/labinvest.3780189; Theurl I, 2008, BLOOD, V111, P2392, DOI 10.1182/blood-2007-05-090019; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; TSUJI Y, 1991, J BIOL CHEM, V266, P7257; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; WANG GL, 1993, BLOOD, V82, P3610; Weiss G, 2005, BEST PRACT RES CL HA, V18, P183, DOI 10.1016/j.beha.2004.09.001; Xiong SG, 2003, J BIOL CHEM, V278, P17646, DOI 10.1074/jbc.M210905200; Yang FM, 2002, J BIOL CHEM, V277, P39786, DOI 10.1074/jbc.M201485200; Zhou J, 2004, CANCER RES, V64, P9041, DOI 10.1158/0008-5472.CAN-04-1437	72	86	96	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20674	20686		10.1074/jbc.M800365200	http://dx.doi.org/10.1074/jbc.M800365200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18519569	hybrid, Green Published			2022-12-25	WOS:000257746100008
J	Beloglazova, N; Brown, G; Zimmerman, MD; Proudfoot, M; Makarova, KS; Kudritska, M; Kochinyan, S; Wang, S; Chruszcz, M; Minor, W; Koonin, EV; Edwards, AM; Savchenko, A; Yakunin, AF				Beloglazova, Natalia; Brown, Greg; Zimmerman, Matthew D.; Proudfoot, Michael; Makarova, Kira S.; Kudritska, Marina; Kochinyan, Samvel; Wang, Shuren; Chruszcz, Maksymilian; Minor, Wladek; Koonin, Eugene V.; Edwards, Aled M.; Savchenko, Alexei; Yakunin, Alexander F.			A novel family of sequence-specific endoribonucleases associated with the clustered regularly interspaced short palindromic repeats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROVIDES ACQUIRED-RESISTANCE; MESSENGER-RNA INTERFERASES; ELECTRON-DENSITY MAPS; ESCHERICHIA-COLI; STREPTOCOCCUS-THERMOPHILUS; MYCOBACTERIUM-TUBERCULOSIS; DEFENSE-MECHANISM; CELL-DEATH; IDENTIFICATION; CRISPR	Clustered regularly interspaced short palindromic repeats (CRISPRs) together with the associated CAS proteins protect microbial cells from invasion by foreign genetic elements using presently unknown molecular mechanisms. All CRISPR systems contain proteins of the CAS2 family, suggesting that these uncharacterized proteins play a central role in this process. Here we show that the CAS2 proteins represent a novel family of endoribonucleases. Six purified CAS2 proteins from diverse organisms cleaved single-stranded RNAs preferentially within U-rich regions. A representative CAS2 enzyme, SSO1404 from Sulfolobus solfataricus, cleaved the phosphodiester linkage on the 3'-side and generated 5'-phosphate- and 3'-hydroxyl-terminated oligonucleotides. The crystal structure of SSO1404 was solved at 1.6 angstrom resolution revealing the first ribonuclease with a ferredoxin-like fold. Mutagenesis of SSO1404 identified six residues (Tyr-9, Asp-10, Arg-17, Arg-19, Arg-31, and Phe-37) that are important for enzymatic activity and suggested that Asp-10 might be the principal catalytic residue. Thus, CAS2 proteins are sequence-specific endoribonucleases, and we propose that their role in the CRISPR-mediated anti-phage defense might involve degradation of phage or cellular mRNAs.	[Beloglazova, Natalia; Brown, Greg; Proudfoot, Michael; Kudritska, Marina; Kochinyan, Samvel; Edwards, Aled M.; Savchenko, Alexei; Yakunin, Alexander F.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; [Beloglazova, Natalia; Brown, Greg; Proudfoot, Michael; Kudritska, Marina; Kochinyan, Samvel; Edwards, Aled M.; Savchenko, Alexei; Yakunin, Alexander F.] Max Bell Res Ctr 5R407, Ontario Canc Inst, Toronto, ON M5G 2C4, Canada; [Zimmerman, Matthew D.; Wang, Shuren; Chruszcz, Maksymilian; Minor, Wladek] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Zimmerman, Matthew D.; Kudritska, Marina; Wang, Shuren; Chruszcz, Maksymilian; Minor, Wladek; Edwards, Aled M.; Savchenko, Alexei] Argonne Natl Lab, Midwest Ctr Struct Gen, Biosci Div, Argonne, IL 60439 USA; [Makarova, Kira S.; Koonin, Eugene V.] Natl Inst Hlth, Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Virginia; United States Department of Energy (DOE); Argonne National Laboratory; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Yakunin, AF (corresponding author), Univ Toronto, Banting & Best Dept Med Res, 112 Coll St, Toronto, ON M5G 1L6, Canada.	a.iakounine@utoronto.ca	Zimmerman, Matthew D/N-9489-2013; Minor, Wladek/F-3096-2014; Yakunin, Alexander/J-1519-2014; Chruszcz, Maksymilian/E-6407-2011	Zimmerman, Matthew D/0000-0002-6274-9493; Minor, Wladek/0000-0001-7075-7090; Chruszcz, Maksymilian/0000-0001-7521-5485; Edwards, Aled/0000-0002-4782-6016; Yakunin, Alexander/0000-0003-0813-6490	Intramural NIH HHS Funding Source: Medline; NIGMS NIH HHS [GM 62414, GM 074942] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM062414, U54GM074942] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM000061] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beitz E, 2000, BIOINFORMATICS, V16, P135, DOI 10.1093/bioinformatics/16.2.135; Berkner K L, 1980, Methods Enzymol, V65, P28; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Callaghan AJ, 2005, NATURE, V437, P1187, DOI 10.1038/nature04084; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Draper DE, 1999, J MOL BIOL, V293, P255, DOI 10.1006/jmbi.1999.2991; Ebihara A, 2006, PROTEIN SCI, V15, P1494, DOI 10.1110/ps.062131106; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Gerdes K, 2000, J BACTERIOL, V182, P561, DOI 10.1128/JB.182.3.561-572.2000; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; GROENEN PMA, 1993, MOL MICROBIOL, V10, P1057, DOI 10.1111/j.1365-2958.1993.tb00976.x; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; Hazan R, 2004, MOL GENET GENOMICS, V272, P227, DOI 10.1007/s00438-004-1048-y; Hoe N, 1999, EMERG INFECT DIS, V5, P254, DOI 10.3201/eid0502.990210; HOLM L, 1994, PROTEINS, V19, P165, DOI 10.1002/prot.340190302; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Inouye M, 2006, J CELL PHYSIOL, V209, P670, DOI 10.1002/jcp.20801; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KATZ ME, 1994, J BACTERIOL, V176, P2663, DOI 10.1128/JB.176.9.2663-2669.1994; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Lillestol Reidun K., 2006, Archaea, V2, P59, DOI 10.1155/2006/542818; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Masepohl B, 1996, BBA-GENE STRUCT EXPR, V1307, P26, DOI 10.1016/0167-4781(96)00040-1; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mironova NL, 2007, NUCLEIC ACIDS RES, V35, P2356, DOI 10.1093/nar/gkm143; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mojica FJM, 2000, MOL MICROBIOL, V36, P244, DOI 10.1046/j.1365-2958.2000.01838.x; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NISHIKAWA S, 1987, BIOCHEMISTRY-US, V26, P8620, DOI 10.1021/bi00400a019; NOVOGRODSKY A, 1966, J BIOL CHEM, V241, P2933; OLINS PO, 1989, J BIOL CHEM, V264, P16973; ORENGO CA, 1994, NATURE, V372, P631, DOI 10.1038/372631a0; Parreira R, 1996, MOL MICROBIOL, V19, P221, DOI 10.1046/j.1365-2958.1996.371896.x; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Poirot O, 2004, NUCLEIC ACIDS RES, V32, pW37, DOI 10.1093/nar/gkh382; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Proudfoot M, 2008, J MOL BIOL, V375, P301, DOI 10.1016/j.jmb.2007.10.060; Ramakrishnan V, 1998, TRENDS BIOCHEM SCI, V23, P208, DOI 10.1016/S0968-0004(98)01214-6; Redko Y, 2003, J BIOL CHEM, V278, P44001, DOI 10.1074/jbc.M306760200; Rosenbaum G, 2006, J SYNCHROTRON RADIAT, V13, P30, DOI 10.1107/S0909049505036721; Saida F, 2003, NUCLEIC ACIDS RES, V31, P2751, DOI 10.1093/nar/gkg377; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Tang TH, 2005, MOL MICROBIOL, V55, P469, DOI 10.1111/j.1365-2958.2004.04428.x; Tang TH, 2002, P NATL ACAD SCI USA, V99, P7536, DOI 10.1073/pnas.112047299; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P1937, DOI 10.1107/S0907444902016438; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Worrall JAR, 2007, CURR OPIN STRUC BIOL, V17, P128, DOI 10.1016/j.sbi.2006.12.001; Zhang JJ, 2004, J BIOL CHEM, V279, P20678, DOI 10.1074/jbc.M314284200; ZHANG JR, 1992, P NATL ACAD SCI USA, V89, P2605, DOI 10.1073/pnas.89.7.2605; Zhang RG, 2001, STRUCTURE, V9, P1095, DOI 10.1016/S0969-2126(01)00675-X; Zhang YL, 2005, J BIOL CHEM, V280, P26080, DOI 10.1074/jbc.M502050200; Zhu L, 2006, J BIOL CHEM, V281, P18638, DOI 10.1074/jbc.M512693200	64	143	180	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20361	20371		10.1074/jbc.M803225200	http://dx.doi.org/10.1074/jbc.M803225200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18482976	hybrid, Green Published			2022-12-25	WOS:000257565300052
J	Sheridan, DL; Kong, Y; Parker, SA; Dalby, KN; Turk, BE				Sheridan, Douglas L.; Kong, Yong; Parker, Sirlester A.; Dalby, Kevin N.; Turk, Benjamin E.			Substrate discrimination among mitogen-activated protein kinases through distinct docking sequence motifs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE; EPIDERMAL-GROWTH-FACTOR; MAP KINASE; STRUCTURAL BASIS; C-JUN; PHOSPHORYLATION; SPECIFICITY; PEPTIDE; SITES; ERK	Mitogen-activated protein kinases (MAPKs) mediate cellular responses to a wide variety of extracellular stimuli. MAPK signal transduction cascades are tightly regulated, and individual MAPKs display exquisite specificity in recognition of their target substrates. All MAPK family members share a common phosphorylation site motif, raising questions as to how substrate specificity is achieved. Here we describe a peptide library screen to identify sequence requirements of the DEF site (docking site for ERK FXF), a docking motif separate from the phosphorylation site. We show that MAPK isoforms recognize DEF sites with unique sequences and identify two key residues on the MAPK that largely dictate sequence specificity. Based on these observations and computational docking studies, we propose a revised model for MAPK interaction with substrates containing DEF sites. Variations in DEF site sequence requirements provide one possible mechanism for encoding complex target specificity among MAPK isoforms.	[Sheridan, Douglas L.; Parker, Sirlester A.; Turk, Benjamin E.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Kong, Yong] Yale Univ, Sch Med, WM Keck Fdn Biotechnol Resource Lab, New Haven, CT 06520 USA; [Dalby, Kevin N.] Univ Texas Austin, Coll Pharm, Div Med Chem, Austin, TX 78712 USA	Yale University; Yale University; University of Texas System; University of Texas Austin	Turk, BE (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, POB 208066,333 Cedar St, New Haven, CT 06520 USA.	ben.turk@yale.edu	Dalby, Kevin N/A-1905-2013; Kong, Yong/B-5105-2014	Dalby, Kevin N/0000-0001-9272-5129; Kong, Yong/0000-0002-2881-5274	NCI NIH HHS [T32 CA009085-33] Funding Source: Medline; NIGMS NIH HHS [GM59802, GM079498] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059802, R01GM079498] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen MD, 2006, ACS CHEM BIOL, V1, P371, DOI 10.1021/cb600202f; Bax B, 2001, STRUCTURE, V9, P1143, DOI 10.1016/S0969-2126(01)00679-7; Benes CH, 2005, CELL, V121, P271, DOI 10.1016/j.cell.2005.02.019; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Biondi RM, 2003, BIOCHEM J, V372, P1, DOI 10.1042/BJ20021641; Callaway KA, 2006, BIOCHEMISTRY-US, V45, P13719, DOI 10.1021/bi0610451; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Chang CI, 2002, MOL CELL, V9, P1241, DOI 10.1016/S1097-2765(02)00525-7; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Dajani R, 2003, EMBO J, V22, P494, DOI 10.1093/emboj/cdg068; Dimitri CA, 2005, CURR BIOL, V15, P1319, DOI 10.1016/j.cub.2005.06.037; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Fantz DA, 2001, J BIOL CHEM, V276, P27256, DOI 10.1074/jbc.M102512200; Fecher LA, 2007, J CLIN ONCOL, V25, P1606, DOI 10.1200/JCO.2006.06.0442; Fernandes N, 2007, ACS CHEM BIOL, V2, P665, DOI 10.1021/cb700158q; Fujii K, 2004, P NATL ACAD SCI USA, V101, P13744, DOI 10.1073/pnas.0401881101; Galanis A, 2001, J BIOL CHEM, V276, P965, DOI 10.1074/jbc.M007697200; Goldsmith EJ, 2007, CHEM REV, V107, P5065, DOI 10.1021/cr068221w; Green Harry M., 2005, BMC Chemical Biology, V5, P1, DOI 10.1186/1472-6769-5-1; Hancock CN, 2005, J MED CHEM, V48, P4586, DOI 10.1021/jm0501174; Hastie CJ, 2006, NAT PROTOC, V1, P968, DOI 10.1038/nprot.2006.149; Hawkins J, 2000, ARCH BIOCHEM BIOPHYS, V382, P310, DOI 10.1006/abbi.2000.2005; Heo JS, 2004, EMBO J, V23, P2185, DOI 10.1038/sj.emboj.7600212; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Kallunki T, 1996, CELL, V87, P929, DOI 10.1016/S0092-8674(00)81999-6; Khokhlatchev A, 1997, J BIOL CHEM, V272, P11057; Kim YG, 2007, ANGEW CHEM INT EDIT, V46, P5408, DOI 10.1002/anie.200700195; Knebel A, 2001, EMBO J, V20, P4360, DOI 10.1093/emboj/20.16.4360; Lee T, 2004, MOL CELL, V14, P43, DOI 10.1016/S1097-2765(04)00161-3; Ley R, 2005, J BIOL CHEM, V280, P17657, DOI 10.1074/jbc.M412342200; Lin YW, 2006, J BIOL CHEM, V281, P915, DOI 10.1074/jbc.M508720200; LIU S, 2006, P NATL ACAD SCI USA, V281, P38834; MacKenzie SJ, 2000, J BIOL CHEM, V275, P16609, DOI 10.1074/jbc.275.22.16609; Manke IA, 2005, MOL CELL, V17, P37, DOI 10.1016/j.molcel.2004.11.021; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Matsubayashi Y, 2001, J BIOL CHEM, V276, P41755, DOI 10.1074/jbc.M106012200; Mitsushima M, 2004, J BIOL CHEM, V279, P34570, DOI 10.1074/jbc.M402304200; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Pouchain D, 2007, ACS CHEM BIOL, V2, P810, DOI 10.1021/cb700199k; Rainey MA, 2005, J AM CHEM SOC, V127, P10494, DOI 10.1021/ja052915p; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Sato M, 2007, ANAL CHEM, V79, P2570, DOI 10.1021/ac062171d; Schutkowski M, 2004, ANGEW CHEM INT EDIT, V43, P2671, DOI 10.1002/anie.200453900; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Snead JL, 2007, CHEM BIOL, V14, P1261, DOI 10.1016/j.chembiol.2007.09.011; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Tcherkezian J, 2005, MOL CELL BIOL, V25, P6314, DOI 10.1128/MCB.25.15.6314-6329.2005; Turk BE, 2006, NAT PROTOC, V1, P375, DOI 10.1038/nprot.2006.57; Vinciguerra M, 2004, J BIOL CHEM, V279, P9634, DOI 10.1074/jbc.M308721200; Whitehurst AW, 2002, P NATL ACAD SCI USA, V99, P7496, DOI 10.1073/pnas.112495999; Yang SH, 1999, MOL CELL BIOL, V19, P4028; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0; Zhang GY, 2005, EXPERT OPIN INV DRUG, V14, P1373, DOI 10.1517/13543784.14.11.1373; Zhao M, 1999, MOL CELL BIOL, V19, P21; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9; Zhou TJ, 2006, STRUCTURE, V14, P1011, DOI 10.1016/j.str.2006.04.006	63	107	107	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19511	19520		10.1074/jbc.M801074200	http://dx.doi.org/10.1074/jbc.M801074200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18482985	hybrid, Green Published			2022-12-25	WOS:000257387600037
J	Hatzifoti, C; Bacon, A; Marriott, H; Laing, P; Heath, AW				Hatzifoti, Caterina; Bacon, Andrew; Marriott, Helen; Laing, Peter; Heath, Andrew W.			Liposomal Co-Entrapment of CD40mAb Induces Enhanced IgG Responses against Bacterial Polysaccharide and Protein	PLOS ONE			English	Article								Background: Antibody against CD40 is effective in enhancing immune responses to vaccines when chemically conjugated to the vaccine antigen. Unfortunately the requirement for chemical conjugation presents some difficulties in vaccine production and quality control which are compounded when multivalent vaccines are required. We explore here an alternative to chemical conjugation, involving the co-encapsulation of CD40 antibody and antigens in liposomal vehicles. Methodology/Principal Findings: Anti-mouse CD40 mAb or isotype control mAb were co-entrapped individually in cationic liposomal vehicles with pneumococcal polysaccharides or diphtheria and tetanus toxoids. Retention of CD40 binding activity upon liposomal entrapment was assessed by ELISA and flow cytometry. After subcutaneous immunization of BALB/c female mice, anti-polysaccharide and DT/TT responses were measured by ELISA. Simple co-encapsulation of CD40 antibody allowed for the retention of CD40 binding on the liposome surface, and also produced vaccines with enhanced imunogenicity. Antibody responses against both co-entrapped protein in the form of tetanus toxoid, and Streptococcus pneumoniae capsular polysaccharide, were enhanced by co-encapsulation with CD40 antibody. Surprisingly, liposomal encapsulation also appeared to decrease the toxicity of high doses of CD40 antibody as assessed by the degree of splenomegaly induced. Conclusions/Significance: Liposomal co-encapsulation with CD40 antibody may represent a practical means of producing more immunogenic multivalent vaccines and inducing IgG responses against polysaccharides without the need for conjugation.	[Hatzifoti, Caterina; Heath, Andrew W.] Adjuvantix Ltd, Sheffield, S Yorkshire, England; [Bacon, Andrew; Laing, Peter] Lipoxen Ltd, London, England; [Marriott, Helen] Univ Sheffield, Unit Resp Med, Sheffield, S Yorkshire, England; [Heath, Andrew W.] Univ Sheffield, Unit Infect & Immun, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield	Hatzifoti, C (corresponding author), Adjuvantix Ltd, Sheffield, S Yorkshire, England.	a.w.heath@sheffield.ac.uk		Bacon, Andrew/0000-0002-9099-9158; Marriott, Helen/0000-0003-1070-0054	BBSRC SBRI	BBSRC SBRI(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding for the study was provided to Adjuvantix Ltd and Lipoxen Ltd by a BBSRC SBRI grant. The BBSRC SBRI grant was awarded in response to an application by the two companies and the study was designed jointly by the two companies.	ALLISON AC, 1974, NATURE, V252, P252, DOI 10.1038/252252a0; Barr TA, 1999, INFECT IMMUN, V67, P3637, DOI 10.1128/IAI.67.7.3637-3640.1999; Barr TA, 2006, VACCINE, V24, P3399, DOI 10.1016/j.vaccine.2006.02.022; Barr TA, 2005, VACCINE, V23, P3477, DOI 10.1016/j.vaccine.2004.12.025; Barr TA, 2003, IMMUNOLOGY, V109, P87, DOI 10.1046/j.1365-2567.2003.01634.x; Barr TA, 2001, IMMUNOLOGY, V102, P39, DOI 10.1046/j.1365-2567.2001.01148.x; Berner V, 2007, NAT MED, V13, P354, DOI 10.1038/nm1554; Carlring J, 2004, VACCINE, V22, P3323, DOI 10.1016/j.vaccine.2004.02.043; Dullforce P, 1998, NAT MED, V4, P88, DOI 10.1038/nm0198-088; Garner C V, 1989, Contrib Microbiol Immunol, V10, P11; GREWAL IS, 1995, NATURE, V378, P617, DOI 10.1038/378617a0; Grewal IS, 1996, IMMUNOL REV, V153, P85, DOI 10.1111/j.1600-065X.1996.tb00921.x; Kirby C J, 1984, J Microencapsul, V1, P33, DOI 10.3109/02652048409031535; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; LEE CJ, 1981, REV INFECT DIS, V3, P323; Presky DH, 1996, ANN NY ACAD SCI, V795, P390, DOI 10.1111/j.1749-6632.1996.tb52702.x; Randall TD, 1998, IMMUNITY, V8, P733, DOI 10.1016/S1074-7613(00)80578-6; Tutt AL, 2002, J IMMUNOL, V168, P2720, DOI 10.4049/jimmunol.168.6.2720; WEINBERG GA, 1988, J PEDIATR-US, V113, P621, DOI 10.1016/S0022-3476(88)80369-X; WESSELS MR, 1989, J EXP MED, V169, P2121, DOI 10.1084/jem.169.6.2121; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6	21	7	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2368	10.1371/journal.pone.0002368	http://dx.doi.org/10.1371/journal.pone.0002368			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523585	Green Accepted, Green Published, gold			2022-12-25	WOS:000262614300054
J	Hodge, JJ; Stanewsky, R				Hodge, James J.; Stanewsky, Ralf			Function of the Shaw Potassium Channel within the Drosophila Circadian Clock	PLOS ONE			English	Article							PIGMENT-DISPERSING FACTOR; PACEMAKER NEURONS; DELAYED RECTIFIER; BEHAVIORAL RHYTHMS; GENETIC-ANALYSIS; OUTPUT; CELLS; OSCILLATORS; MODULATION; EXPRESSION	Background: In addition to the molecular feedback loops, electrical activity has been shown to be important for the function of networks of clock neurons in generating rhythmic behavior. Most studies have used over-expression of foreign channels or pharmacological manipulations that alter membrane excitability. In order to determine the cellular mechanisms that regulate resting membrane potential (RMP) in the native clock of Drosophila we modulated the function of Shaw, a widely expressed neuronal potassium (K+) channel known to regulate RMP in Drosophila central neurons. Methodology/Principal Findings: We show that Shaw is endogenously expressed in clock neurons. Differential use of clock gene promoters was employed to express a range of transgenes that either increase or decrease Shaw function in different clusters of clock neurons. Under LD conditions, increasing Shaw levels in all clock neurons (LNv, LNd, DN1, DN2 and DN3), or in subsets of clock neurons (LNd and DNs or DNs alone) increases locomotor activity at night. In free-running conditions these manipulations result in arrhythmic locomotor activity without disruption of the molecular clock. Reducing Shaw in the DN alone caused a dramatic lengthening of the behavioral period. Changing Shaw levels in all clock neurons also disrupts the rhythmic accumulation and levels of Pigment Dispersing Factor (PDF) in the dorsal projections of LNv neurons. However, changing Shaw levels solely in LNv neurons had little effect on locomotor activity or rhythmic accumulation of PDF. Conclusions/Significance: Based on our results it is likely that Shaw modulates pacemaker and output neuronal electrical activity that controls circadian locomotor behavior by affecting rhythmic release of PDF. The results support an important role of the DN clock neurons in Shaw-mediated control of circadian behavior. In conclusion, we have demonstrated a central role of Shaw for coordinated and rhythmic output from clock neurons.	[Hodge, James J.] Univ Bristol, Sch Med Sci, Dept Physiol & Pharmacol, Bristol BS8 1TD, Avon, England; [Hodge, James J.; Stanewsky, Ralf] Queen Mary Univ London, Sch Biol & Chem Sci, London, England	University of Bristol; University of London; Queen Mary University London	Hodge, JJ (corresponding author), Univ Bristol, Sch Med Sci, Dept Physiol & Pharmacol, Bristol BS8 1TD, Avon, England.	james.hodge@bristol.ac.uk	Stanewsky, Ralf/ABB-9193-2021	Hodge, James/0000-0003-4741-2363; Stanewsky, Ralf/0000-0001-8238-6864	EMBO [337-2006]; BBSRC [BBE0208281]; European Commission EUCLOCK Integrated Project; NIH [R01 MH067284, P30 NS045713, S10 RR16780]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR016780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045713] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/E020828/1] Funding Source: researchfish; BBSRC [BB/E020828/1] Funding Source: UKRI	EMBO(European Molecular Biology Organization (EMBO)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Commission EUCLOCK Integrated Project; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by an EMBO short term fellowship (337-2006) to JH, BBSRC grant (BBE0208281) and a European Commission EUCLOCK Integrated Project (FP6) to RS and a grant from the NIH to Leslie Griffith (R01 MH067284) and The Brandeis Confocal Facility (supported by US NIH P30 NS045713 and S10 RR16780).	BRAND AH, 1993, DEVELOPMENT, V118, P401; Brown TM, 2007, PROG NEUROBIOL, V82, P229, DOI 10.1016/j.pneurobio.2007.05.002; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; Colwell CS, 2006, NAT NEUROSCI, V9, P985, DOI 10.1038/nn0806-985; de Jeu M, 1998, NEUROREPORT, V9, P3725, DOI 10.1097/00001756-199811160-00028; Fernandez MD, 2007, P NATL ACAD SCI USA, V104, P5650, DOI 10.1073/pnas.0608260104; Deng QW, 2005, J NEUROSCI, V25, P11531, DOI 10.1523/JNEUROSCI.3672-05.2005; Giordano E, 2002, GENETICS, V160, P637; Harrisingh MC, 2007, J NEUROSCI, V27, P12489, DOI 10.1523/JNEUROSCI.3680-07.2007; Helfrich-Forster C, 2007, J COMP NEUROL, V500, P47, DOI 10.1002/cne.21146; Helfrich-Forster C, 2005, NEURON, V48, P161, DOI 10.1016/j.neuron.2005.10.004; Hodge JJL, 2006, NEURON, V51, P327, DOI 10.1016/j.neuron.2006.06.020; Hodge JJL, 2005, J NEUROBIOL, V63, P235, DOI 10.1002/neu.20126; Itri JN, 2005, NAT NEUROSCI, V8, P650, DOI 10.1038/nn1448; Jaramillo AM, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-3; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Kaneko M, 2000, J NEUROBIOL, V43, P207, DOI 10.1002/(SICI)1097-4695(20000605)43:3<207::AID-NEU1>3.0.CO;2-0; Kuhlman SJ, 2004, EUR J NEUROSCI, V20, P1113, DOI 10.1111/j.1460-9568.2004.03555.x; KYRIACOU CP, 1985, NATURE, V314, P171, DOI 10.1038/314171a0; Lear BC, 2005, NEURON, V48, P965, DOI 10.1016/j.neuron.2005.10.030; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-1; Lundkvist GB, 2005, METHOD ENZYMOL, V393, P623, DOI 10.1016/S0076-6879(05)93033-4; Maywood ES, 2006, CURR BIOL, V16, P599, DOI 10.1016/j.cub.2006.02.023; Meredith AL, 2006, NAT NEUROSCI, V9, P1041, DOI 10.1038/nn1740; Michel S, 1999, J BIOL RHYTHM, V14, P141, DOI 10.1177/074873099129000533; MICHEL S, 1993, SCIENCE, V259, P239, DOI 10.1126/science.8421785; Murad A, 2007, NEURON, V53, P689, DOI 10.1016/j.neuron.2007.01.034; Nitabach MN, 2006, J NEUROSCI, V26, P479, DOI 10.1523/JNEUROSCI.3915-05.2006; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Nitabach MN, 2005, METHOD ENZYMOL, V393, P682, DOI 10.1016/S0076-6879(05)93036-X; Nitabach MN, 2005, J NEUROBIOL, V62, P1, DOI 10.1002/neu.20053; Park D, 2006, J NEUROPHYSIOL, V95, P3955, DOI 10.1152/jn.00117.2006; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Pennartz CMA, 2002, NATURE, V416, P286, DOI 10.1038/nature728; Persson MGS, 2001, J NEUROBIOL, V48, P19, DOI 10.1002/neu.1040; Rieger D, 2006, J NEUROSCI, V26, P2531, DOI 10.1523/JNEUROSCI.1234-05.2006; SHAFER OT, 2008, NEURON IN PRESS; Sheeba V, 2008, J NEUROPHYSIOL, V99, P976, DOI 10.1152/jn.00930.2007; Sheeba V, 2008, J NEUROSCI, V28, P217, DOI 10.1523/JNEUROSCI.4087-07.2008; Stanewsky R, 2003, J NEUROBIOL, V54, P111, DOI 10.1002/neu.10164; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Stoleru D, 2007, CELL, V129, P207, DOI 10.1016/j.cell.2007.02.038; TSUNODA S, 1995, J NEUROSCI, V15, P1741, DOI 10.1523/JNEUROSCI.15-03-01741.1995; TSUNODA S, 1995, J NEUROSCI, V15, P5209; Veleri S, 2003, CURR BIOL, V13, P1758, DOI 10.1016/j.cub.2003.09.030; WEI A, 1990, SCIENCE, V248, P599, DOI 10.1126/science.2333511; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Wulbeck C, 2005, GENETICS, V169, P751, DOI 10.1534/genetics.104.036244	49	34	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2274	10.1371/journal.pone.0002274	http://dx.doi.org/10.1371/journal.pone.0002274			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509535	gold, Green Submitted, Green Published			2022-12-25	WOS:000262268500019
J	Monsuur, AJ; de Bakker, PIW; Zhernakova, A; Pinto, D; Verduijn, W; Romanos, J; Auricchio, R; Lopez, A; van Heel, DA; Crusius, JBA; Wijmenga, C				Monsuur, Alienke J.; de Bakker, Paul I. W.; Zhernakova, Alexandra; Pinto, Dalila; Verduijn, Willem; Romanos, Jihane; Auricchio, Renata; Lopez, Ana; van Heel, David A.; Crusius, J. Bart A.; Wijmenga, Cisca			Effective Detection of Human Leukocyte Antigen Risk Alleles in Celiac Disease Using Tag Single Nucleotide Polymorphisms	PLOS ONE			English	Article								Background: The HLA genes, located in the MHC region on chromosome 6p21.3, play an important role in many autoimmune disorders, such as celiac disease (CD), type 1 diabetes (T1D), rheumatoid arthritis, multiple sclerosis, psoriasis and others. Known HLA variants that confer risk to CD, for example, include DQA1*05/DQB1*02 (DQ2.5) and DQA1*03/DQB1*0302 (DQ8). To diagnose the majority of CD patients and to study disease susceptibility and progression, typing these strongly associated HLA risk factors is of utmost importance. However, current genotyping methods for HLA risk factors involve many reactions, and are complicated and expensive. We sought a simple experimental approach using tagging SNPs that predict the CD-associated HLA risk factors. Methodology: Our tagging approach exploits linkage disequilibrium between single nucleotide polymorphism (SNPs) and the CD-associated HLA risk factors DQ2.5 and DQ8 that indicate direct risk, and DQA1*0201/DQB1*0202 (DQ2.2) and DQA1*0505/DQB1*0301 (DQ7) that attribute to the risk of DQ2.5 to CD. To evaluate the predictive power of this approach, we performed an empirical comparison of the predicted DQ types, based on these six tag SNPs, with those executed with current validated laboratory typing methods of the HLA-DQA1 and -DQB1 genes in three large cohorts. The results were validated in three European celiac populations. Conclusion: Using this method, only six SNPs were needed to predict the risk types carried by >95% of CD patients. We determined that for this tagging approach the sensitivity was >0.991, specificity >0.996 and the predictive value >0.948. Our results show that this tag SNP method is very accurate and provides an excellent basis for population screening for CD. This method is broadly applicable in European populations.	[Monsuur, Alienke J.; Zhernakova, Alexandra; Pinto, Dalila; Wijmenga, Cisca] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [de Bakker, Paul I. W.] MIT, Broad Inst Harvard, Cambridge, MA USA; [Verduijn, Willem] Leiden Univ Med Ctr LUMC, Dept Immunohematol & Blood Transfusion, Sect Immunogenet & Transplant Immunol, Leiden, Netherlands; [Romanos, Jihane; Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Genet Dept, Groningen, Netherlands; [Auricchio, Renata] Univ Federico Naples 2, Dept Pediat, European Lab Investigat Food Induced Dis, Naples, Italy; [Lopez, Ana] Fdn Investigac Hosp La Fe, Pediat Gastroenterol Unit, Valencia, Spain; [van Heel, David A.] Barts & London Queen Marys Sch Med & Dent, Inst Cell & Mol Sci, London, England; [Crusius, J. Bart A.] Vrije Univ, Med Ctr, Dept Pathol, Amsterdam, Netherlands; [de Bakker, Paul I. W.] Brigham and Womens Hosp, Harvard Partners Ctr Genet & Genom, Div Genet, Boston, MA USA	Utrecht University; Utrecht University Medical Center; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Leiden University; Leiden University Medical Center (LUMC); University of Groningen; University of Naples Federico II; University of London; Queen Mary University London; Vrije Universiteit Amsterdam; Harvard University	Monsuur, AJ (corresponding author), Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands.	c.wijmenga@umcutrecht.nl	Zhernakova, Alexandra/ABA-9372-2020; de Bakker, Paul IW/B-8730-2009; Wijmenga, Cisca/AAE-7719-2019; Wijmenga, Cisca/D-2173-2009; Romanos, Jihane/F-7372-2012; AURICCHIO, RENATA/AAC-7718-2022; Pinto, Dalila/C-4218-2016	de Bakker, Paul IW/0000-0001-7735-7858; Wijmenga, Cisca/0000-0002-5635-1614; Pinto, Dalila/0000-0002-8769-0846; van Heel, David/0000-0002-0637-2265; Zhernakova, Alexandra/0000-0002-4574-0841	Netherlands Organization for Scientific Research [902-22-094, 912-02-028]; Dutch Digestive Disease Foundation [97-44, 03-06]; KP6 EU [036383]; Coeliac Disease Consortium; Dutch government [BSIK03009]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch Digestive Disease Foundation; KP6 EU; Coeliac Disease Consortium; Dutch government	This study was supported by grants from the Netherlands Organization for Scientific Research (grants 902-22-094 and 912-02-028), the Dutch Digestive Disease Foundation (grants 97-44 and 03-06), a KP6 EU grant (036383, PREVENTCD) and the Coeliac Disease Consortium, an innovative cluster approved by the Netherlands Genomics Initiative and partially funded by the Dutch government (grant BSIK03009). The funders had no role in study design, data collection and analysis, decisions to publish, or preparation of the manuscript.	Al-Toma A, 2006, CLIN GASTROENTEROL H, V4, P315, DOI 10.1016/j.cgh.2005.12.011; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bourgey M, 2007, GUT, V56, P1054, DOI 10.1136/gut.2006.108530; BUYSE I, 1993, TISSUE ANTIGENS, V41, P1, DOI 10.1111/j.1399-0039.1993.tb01970.x; CARRINGTON M, 1992, HUM IMMUNOL, V33, P208, DOI 10.1016/0198-8859(92)90073-V; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Ghodke Y, 2005, EUR J EPIDEMIOL, V20, P475, DOI 10.1007/s10654-005-5081-x; Jones EY, 2006, NAT REV IMMUNOL, V6, P271, DOI 10.1038/nri1805; Karell K, 2003, HUM IMMUNOL, V64, P469, DOI 10.1016/S0198-8859(03)00027-2; Koning F, 2005, GASTROENTEROLOGY, V129, P1294, DOI 10.1053/j.gastro.2005.07.030; Lie BA, 2005, CURR OPIN IMMUNOL, V17, P526, DOI 10.1016/j.coi.2005.07.001; Louka AS, 2003, TISSUE ANTIGENS, V61, P105, DOI 10.1034/j.1399-0039.2003.00017.x; LUNDIN KEA, 1994, HUM IMMUNOL, V41, P285, DOI 10.1016/0198-8859(94)90047-7; LUNDIN KEA, 1993, J EXP MED, V178, P187, DOI 10.1084/jem.178.1.187; Margaritte-Jeannin P, 2004, TISSUE ANTIGENS, V63, P562, DOI 10.1111/j.0001-2815.2004.00237.x; Mearin ML, 2005, BEST PRACT RES CL GA, V19, P441, DOI 10.1016/j.bpg.2005.02.004; Monsuur AJ, 2005, NAT GENET, V37, P1341, DOI 10.1038/ng1680; OLERUP O, 1992, TISSUE ANTIGENS, V39, P225, DOI 10.1111/j.1399-0039.1992.tb01940.x; Reinton N, 2006, J IMMUNOL METHODS, V316, P125, DOI 10.1016/j.jim.2006.08.008; RONNINGEN KS, 1991, TISSUE ANTIGENS, V37, P105, DOI 10.1111/j.1399-0039.1991.tb01854.x; SOLLID LM, 1989, J EXP MED, V169, P345, DOI 10.1084/jem.169.1.345; Vader LW, 2002, J EXP MED, V195, P643, DOI 10.1084/jem.20012028; Vader W, 2003, P NATL ACAD SCI USA, V100, P12390, DOI 10.1073/pnas.2135229100; Van Belzen MJ, 2003, GASTROENTEROLOGY, V125, P1032, DOI 10.1016/S0016-5085(03)01205-8; van Belzen MJ, 2004, GENES IMMUN, V5, P215, DOI 10.1038/sj.gene.6364061; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Verduyn W, 1996, TISSUE ANTIGENS, V48, P80, DOI 10.1111/j.1399-0039.1996.tb02611.x; WALKERSMITH JA, 1990, ARCH DIS CHILD, V65, P909, DOI 10.1136/adc.65.8.909	29	116	123	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2270	10.1371/journal.pone.0002270	http://dx.doi.org/10.1371/journal.pone.0002270			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509540	Green Published, gold			2022-12-25	WOS:000262268500016
J	Witton, MP; Naish, D				Witton, Mark P.; Naish, Darren			A Reappraisal of Azhdarchid Pterosaur Functional Morphology and Paleoecology	PLOS ONE			English	Article							GIANT PTEROSAUR; CERVICAL-VERTEBRAE; BODY-MASS; FLIGHT; PTERODACTYLOIDEA; BIRDS; CHINA; ARCHOSAURIA; REPTILIA; BEHAVIOR	Azhdarchid pterosaurs were among the most widespread and successful of pterosaur clades, but their paleoecology remains controversial. Morphological features common to all azhdarchids include a long, shallow rostrum; elongate, cylindrical cervical vertebrae that formed a long and unusually inflexible neck; and proportionally short wings with an abbreviated fourth phalanx. While azhdarchids have been imagined as vulture-like scavengers, sediment probers, swimmers, waders, aerial predators, or stork-like generalists, most recent authors have regarded them as skim-feeders, trawling their lower jaws through water during flight and seizing aquatic prey from the water's surface. Although apparently widely accepted, the skim-feeding model lacks critical support from anatomy and functional morphology. Azhdarchids lack the many cranial specialisations exhibited by extant skim-feeding birds, most notably the laterally compressed lower jaw and shock absorbing apparatus required for this feeding style. Well-preserved azhdarchid skulls are rare, but their rostra and lower jaws appear to have been sub-triangular in cross-section, and thus dissimilar to those of skim-feeders and sediment probers. Taphonomic data indicates that azhdarchids predominately inhabited inland settings, and azhdarchid morphology indicates that they were poorly suited for all proposed lifestyles bar wading and terrestrial foraging. However, azhdarchid footprints show that their feet were relatively small, padded and slender, and thus not well suited for wading. We argue that azhdarchids were stork-or ground hornbill-like generalists, foraging in diverse environments for small animals and carrion. Proficient terrestrial abilities and a relatively inflexible neck are in agreement with this interpretation.	[Witton, Mark P.; Naish, Darren] Univ Portsmouth, Sch Earth & Environm Sci, Portsmouth, Hants, England	University of Portsmouth	Witton, MP (corresponding author), Univ Portsmouth, Sch Earth & Environm Sci, Portsmouth, Hants, England.	Mark.Witton@port.ac.uk	Witton, Mark/B-9368-2013					Andres B, 2008, PALAEONTOLOGY, V51, P453, DOI 10.1111/j.1475-4983.2008.00761.x; ARAMBOURG C, 1954, CR HEBD ACAD SCI, V238, P133; Arambourg C., 1959, NOTES MGMOIRES MOYEN, V7, P229; Arthur S. C., 1921, Auk Lancaster Pa, V38, P566; Ashmole N.P, 1971, AVIAN BIOL, VI, P223; Atanassov Momchil N., 2002, Journal of Vertebrate Paleontology, V22, p33A; Averianov A.O., 2007, Paleontologicheskii Zhurnal, V2, P73; Averianov AO, 2005, PALEONTOL J+, V39, P433; Averianov AO, 2004, PALEONTOL J+, V38, P669; Averianov AO, 2004, PALEONTOL J+, V38, P426; Bakhurina Natalia N., 1995, Historical Biology, V10, P197; Behrensmeyer AK, 2001, PALAEOBIOLOGY, VII, P318; Bennett S. C., 2003, RIV MUSEO CIVICO SCI, V22, P9; Bennett S. Christopher, 2003, Geological Society Special Publication, V217, P191, DOI 10.1144/GSL.SP.2003.217.01.12; Bennett S. Christopher, 1991, Records of the Western Australian Museum, V15, P435; Bennett S. Christopher, 2001, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V260, P1; BOCK WALTER J., 1960, AUK, V77, P19; Bonde Niels, 2003, Geological Society Special Publication, V217, P217, DOI 10.1144/GSL.SP.2003.217.01.13; BRAMWELL CD, 1974, PHILOS T R SOC B, V267, P503, DOI 10.1098/rstb.1974.0007; Brower J.C., 1983, Journal of Vertebrate Paleontology, V3, P84; BROWER JC, 1981, U KANSAS PALEONTOLOG, V105, P1; Buffetaut E, 2001, CR ACAD SCI II A, V333, P357, DOI 10.1016/S1251-8050(01)01630-5; Buffetaut E, 1996, B SOC GEOL FR, V167, P753; Buffetaut E, 1997, GEOL MAG, V134, P553, DOI 10.1017/S0016756897007449; Buffetaut Eric, 2003, Geological Society Special Publication, V217, P91, DOI 10.1144/GSL.SP.2003.217.01.09; Buffetaut Eric, 1999, Estudios del Museo de Ciencias Naturales de Alava, V14, P289; Cai Zhengquan, 1994, Vertebrata Palasiatica, V32, P181; Chatterjee S., 2004, GEOLOGICAL SOC AM SP, V376, P1, DOI DOI 10.1130/0-8137-2376-0.1; Christiansen P, 1999, J MORPHOL, V239, P167, DOI 10.1002/(SICI)1097-4687(199902)239:2<167::AID-JMOR5>3.0.CO;2-8; Codorniu Laura, 2007, P143; Company J, 1999, GEOL MIJNBOUW, V78, P319, DOI 10.1023/A:1003851316054; CURRIE PJ, 1995, CAN J EARTH SCI, V32, P922, DOI 10.1139/e95-077; CURRIE PJ, 1982, CAN J EARTH SCI, V19, P894, DOI 10.1139/e82-074; FREY E, 1998, NEUES JB GEOLOGIE PA, V20, P421; Frey Eberhard, 2003, Geological Society Special Publication, V217, P267, DOI 10.1144/GSL.SP.2003.217.01.15; Frey Eberhard, 2003, Geological Society Special Publication, V217, P233, DOI 10.1144/GSL.SP.2003.217.01.14; Frey Eberhard, 2000, Archaeopteryx, V18, P1; Frey Eberhard, 1996, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V199, P221; Godfrey SJ, 2005, LIFE O PAST, P292; GRAF W, 1995, J ANAT, V186, P55; Hankin E. H., 1914, Aeronautical Journal, V18, P324; Harris MA, 1997, J ZOOL, V241, P381, DOI 10.1111/j.1469-7998.1997.tb01966.x; HAZLEHURST GA, 1992, PALEOBIOLOGY, V18, P447, DOI 10.1017/S009483730001099X; Henderson MD, 2006, J VERTEBR PALEONTOL, V26, P192, DOI 10.1671/0272-4634(2006)26[192:AAPCVF]2.0.CO;2; Heptonstall W.B., 1971, SCOTTISH J GEOLOGY, V7, P61, DOI [10.1144/sjg07010061, DOI 10.1144/SJG07010061]; Hertel F, 1995, AUK, V112, P890, DOI 10.2307/4089021; HOWSE SCB, 1986, ZOOL J LINN SOC-LOND, V88, P307, DOI 10.1111/j.1096-3642.1986.tb02249.x; Humphries S, 2007, PLOS BIOL, V5, P1647, DOI 10.1371/journal.pbio.0050204; Hwang KG, 2002, GEOL MAG, V139, P421, DOI 10.1017/S0016756802006647; Ikegami Naoki, 2000, Paleontological Research, V4, P165; KAHL MP, 1987, COLON WATERBIRD, V10, P131, DOI 10.2307/1521251; Kellner Alexander W.A., 2003, Geological Society Special Publication, V217, P105, DOI 10.1144/GSL.SP.2003.217.01.10; Kellner Alexander Wilhelm Armin, 1996, American Museum Novitates, V3175, P1; Kellner AWA, 2004, AMEGHINIANA, V41, P521; Kellner AWA, 1996, J VERTEBR PALEONTOL, V16, P222, DOI 10.1080/02724634.1996.10011310; KELLNER AWA, 1996, J VERTEBR PALEONTOL, V16, pA45; LANGSTON W, 1981, SCI AM, V244, P92; LAWSON DA, 1975, SCIENCE, V187, P947, DOI 10.1126/science.187.4180.947; LEDERER RJ, 1972, WILSON BULL, V84, P193; LEHMAN TM, 1996, TEXAS J VERTEBRATE P, V16, pA48; Lockley Martin G., 2003, Geological Society Special Publication, V217, P297, DOI 10.1144/GSL.SP.2003.217.01.18; Lu JC, 2005, ACTA GEOL SIN-ENGL, V79, P301; Lu Jun-Chang, 2002, Memoir of the Fukui Prefectural Dinosaur Museum, V1, P19; Lu Junchang, 2006, Journal of the Paleontological Society of Korea, V22, P239; Lu JC, 2006, ACTA GEOL SIN-ENGL, V80, P315; Lyman RL., 1994, VERTEBRATE TAPHONOMY, DOI [DOI 10.1017/CBO9781139878302, 10.1017/CBO9781139878302]; MARDEN JH, 1994, AM J PHYSIOL, V266, pR1077, DOI 10.1152/ajpregu.1994.266.4.R1077; Martill DM, 2006, PALAEONTOLOGY, V49, P925, DOI 10.1111/j.1475-4983.2006.00575.x; Martill David M., 1997, Geology Today, V13, P71; Martill David M., 1998, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V207, P57; Mateer NJ, 1975, B GEOLOGICAL I U UPP, V6, P23; Mazin Jean-Michel, 2003, Geological Society Special Publication, V217, P283, DOI 10.1144/GSL.SP.2003.217.01.17; McGowen Michael R., 2002, Paleobios, V22, P1; MONTEILLET J, 1982, CR ACAD SCI II, V295, P409; MURRY PA, 1991, J PALEONTOL, V65, P167, DOI 10.1017/S0022336000020291; Nebel S, 2005, ANIM BIOL, V55, P235, DOI 10.1163/1570756054472818; Nessov LA., 1984, PALAEONTOL Z, V1, P47; Norberg UML, 2000, J EXP BIOL, V203, P651; Obata I., 1972, Memoirs Natn Sci Mus Tokyo, VNo. 5, P213; Osi A, 2005, ACTA PALAEONTOL POL, V50, P777; PADIAN K, 1995, CR ACAD SCI II, V320, P77; PADIAN K, 1988, NAT HIST, V97, P58; Padian K., 1984, J VERTEBR PALEONTOL, V4, P516, DOI DOI 10.1080/02724634.1984.10012027; Parris DC, 2004, SE GEOLOGY, V43, P52; Paul G.S., 1991, Modern Geology, V16, P69; Paul G. S., 2002, DINOSAURS AIR EVOLUT; PAUL GS, 1987, NATURE, V328, P481, DOI 10.1038/328481a0; Paul GS, 1987, DINOSAURS PAST PRESE, V2, P4; PENNYCUICK CJ, 1972, IBIS, V114, P178, DOI 10.1111/j.1474-919X.1972.tb02603.x; PENNYCUICK CJ, 1971, J EXP BIOL, V55, P13; Pereda Suberbiola X, 2003, GEOLOGICAL SOC SPECI, V217, P79; Piersma T, 1998, P ROY SOC B-BIOL SCI, V265, P1377, DOI 10.1098/rspb.1998.0445; Potter J. K., 1932, Auk, V49, P477; PRANGE HD, 1979, AM NAT, V113, P103, DOI 10.1086/283367; Prieto I.R., 1998, COLOQUIOS PALEONTOLO, V49, P129; Rayner J.M.V., 1988, Current Ornithology, V5, P1; Rodriguez-de la Rosa Ruben A., 2003, Geological Society Special Publication, V217, P275, DOI 10.1144/GSL.SP.2003.217.01.16; SAEGUSA H, 2004, 111 ANN M GEOL SOC J; Schumacher G. H., 1973, P101; SEAMANS TW, 1995, IBIS, V137, P424; Shelley EL, 2004, CONDOR, V106, P395, DOI 10.1650/7424; Shipman, 1998, TAKING WING ARCHAEOP; STEIN RS, 1975, J PALEONTOL, V49, P534; Storer R. W., 1971, AVIAN BIOL, P150; SUBERBIOLA XP, 2007, AZHDARCHID PTEROSAUR; Templin RJ, 2000, PROG AEROSP SCI, V36, P393, DOI 10.1016/S0376-0421(00)00007-5; TOMKINS IVAN T., 1951, AUK, V68, P236; TOMKINS IVANR, 1963, AUK, V80, P549; Travaini A, 1998, J ZOOL, V246, P175, DOI 10.1111/j.1469-7998.1998.tb00146.x; Unwin D.M., 2007, ANN REPORT FUKADA GE, V8, P149; Unwin D. M, 2005, PTEROSAURS DEEP TIME; Unwin David M., 2003, Geological Society Special Publication, V217, P139, DOI 10.1144/GSL.SP.2003.217.01.11; Unwin David M., 2000, P420; Unwin David M., 1997, Historical Biology, V12, P199; Unwin DM, 1996, LETHAIA, V29, P373, DOI 10.1111/j.1502-3931.1996.tb01673.x; UNWIN DM, 1994, NATURE, V371, P62, DOI 10.1038/371062a0; UNWIN DM, 1988, PAL ASS ANN C AST; Unwin DM, 1997, PALEONTOLOGICAL SOC, V2, P43, DOI [10.1080/08912969709386563, DOI 10.1080/08912969709386563]; Veldmeijer Andre J., 2003, Scripta Geologica, V125, P35; VIDAL PP, 1986, EXP BRAIN RES, V61, P549; WALLACE MP, 1987, AUK, V104, P290, DOI 10.1093/auk/104.2.290; Wang XL, 2006, GEOL J, V41, P405, DOI 10.1002/gj.1046; Wang XL, 2002, CHINESE SCI BULL, V47, P226, DOI 10.1360/02tb9054; Wang XL, 2005, NATURE, V437, P875, DOI 10.1038/nature03982; Wedel MJ, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P201; Wellnhofer P., 1988, Historical Biology, V1, P3; Wellnhofer P, 1991, ILLUSTRATED ENCY PTE; Wellnhofer Peter, 1999, Palaeontologische Zeitschrift, V73, P133; Western D., 1980, P41; Wild Rupert, 1993, Rivista del Museo Civico di Scienze Naturali "Enrico Caffi", V16, P95; Wilkinson MT, 2006, P ROY SOC B-BIOL SCI, V273, P119, DOI 10.1098/rspb.2005.3278; WITHERS PC, 1977, J EXP BIOL, V70, P13; WITMER LM, 1991, PALEOBIOLOGY, V17, P95, DOI 10.1017/S0094837300010435; Witmer LM., 1987, 4 S MES TERR EC SHOR, P230; Witton Mark, 2007, Geology Today, V23, P33, DOI 10.1111/j.1365-2451.2007.00596.x; Zeffer A, 2003, BIOL J LINN SOC, V79, P461, DOI 10.1046/j.1095-8312.2003.00200.x; Zusi RL, 1962, PUBLICATIONS NUTTAL, V3; [No title captured]	138	102	103	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2271	10.1371/journal.pone.0002271	http://dx.doi.org/10.1371/journal.pone.0002271			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509539	Green Submitted, Green Published, gold			2022-12-25	WOS:000262268500017
J	Zenon, A; Ben Hamed, S; Duhamel, JR; Olivier, E				Zenon, Alexandre; Ben Hamed, Suliann; Duhamel, Jean-Rene; Olivier, Etienne			Spatial and Temporal Dynamics of Attentional Guidance during Inefficient Visual Search	PLOS ONE			English	Article							FOCAL ATTENTION; GUIDED SEARCH; TIME-COURSE; POP-OUT; RESOLUTION; FEATURES; MODEL; TASK; VISION; ACUITY	Spotting a prey or a predator is crucial in the natural environment and relies on the ability to extract quickly pertinent visual information. The experimental counterpart of this behavior is visual search (VS) where subjects have to identify a target amongst several distractors. In difficult VS tasks, it has been found that the reaction time (RT) is influenced by salience factors, such as the target-distractor similarity, and this finding is usually regarded as evidence for a guidance of attention by preattentive mechanisms. However, the use of RT measurements, a parameter which depends on multiple factors, allows only very indirect inferences about the underlying attentional mechanisms. The purpose of the present study was to determine the influence of salience factors on attentional guidance during VS, by measuring directly attentional allocation. We studied attention allocation by using a dual covert VS task in subjects who had 1) to detect a target amongst different items and 2) to report letters briefly flashed inside those items at different delays. As predicted, we showed that parallel processes guide attention towards the most relevant item by virtue of both goal-directed and stimulus-driven factors, and we demonstrated that this attentional selection is a prerequisite for target detection. In addition, we show that when the target is characterized by two features (conjunction VS), the goal-directed effects of both features are initially combined into a unique salience value, but at a later stage, grouping phenomena interact with the salience computation, and lead to the selection of a whole group of items. These results, in line with Guided Search Theory, show that efficient and rapid preattentive processes guide attention towards the most salient item, allowing to reduce the number of attentional shifts needed to find the target.	[Zenon, Alexandre; Olivier, Etienne] Univ Catholique Louvain, Neurophysiol Lab, B-1200 Brussels, Belgium; [Ben Hamed, Suliann; Duhamel, Jean-Rene] CNRS, Inst Sci Cognitives, Bron, France	Universite Catholique Louvain; Centre National de la Recherche Scientifique (CNRS)	Zenon, A (corresponding author), Univ Catholique Louvain, Neurophysiol Lab, B-1200 Brussels, Belgium.	alexandre.zenon@uclouvain.bc	Zénon, Alexandre/AGN-7203-2022; Duhamel, Jean-René/M-4723-2017; Ben Hamed, Suliann/O-6070-2014	Zénon, Alexandre/0000-0001-7989-1261; Duhamel, Jean-René/0000-0003-0210-1027; Ben Hamed, Suliann/0000-0003-1510-7284	Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA); Universite catholique de Louvain (FSR); Fonds de la Recherche Scientifique Medicale (FRSM); Fondation Medicale Reine Elisabeth FMRE	Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA)(Fonds de la Recherche Scientifique - FNRS); Universite catholique de Louvain (FSR); Fonds de la Recherche Scientifique Medicale (FRSM)(Fonds de la Recherche Scientifique - FNRS); Fondation Medicale Reine Elisabeth FMRE	A.Z. is a research assistant supported by a grant from the Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA). This project was supported by research grants from the Universite catholique de Louvain (FSR), the Fonds de la Recherche Scientifique Medicale (FRSM) and the Fondation Medicale Reine Elisabeth (FMRE).	Beirne RO, 2005, VISUAL NEUROSCI, V22, P79, DOI 10.1017/S0952523805221119; Carrasco M, 2001, P NATL ACAD SCI USA, V98, P5363, DOI 10.1073/pnas.081074098; CAVE KR, 1990, COGNITIVE PSYCHOL, V22, P225, DOI 10.1016/0010-0285(90)90017-X; DUNCAN J, 1994, NATURE, V369, P313, DOI 10.1038/369313a0; DUNCAN J, 1995, PERCEPT PSYCHOPHYS, V57, P117, DOI 10.3758/BF03211854; Eckstein MP, 2000, PERCEPT PSYCHOPHYS, V62, P425, DOI 10.3758/BF03212096; EGETH HE, 1984, J EXP PSYCHOL HUMAN, V10, P32, DOI 10.1037/0096-1523.10.1.32; Enns JT, 2004, VISION RES, V44, P1321, DOI 10.1016/j.visres.2003.10.024; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; Hubner R, 2001, PERCEPT PSYCHOPHYS, V63, P945, DOI 10.3758/BF03194514; Intriligator J, 2001, COGNITIVE PSYCHOL, V43, P171, DOI 10.1006/cogp.2001.0755; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Joseph JS, 1997, NATURE, V387, P805, DOI 10.1038/42940; Kim MS, 1999, J GEN PSYCHOL, V126, P326, DOI 10.1080/00221309909595370; Kim MS, 2001, VISION RES, V41, P611, DOI 10.1016/S0042-6989(00)00285-6; Kim MS, 1995, PSYCHOL SCI, V6, P376, DOI 10.1111/j.1467-9280.1995.tb00529.x; Lamy D, 2003, PSYCHON B REV, V10, P621, DOI 10.3758/BF03196524; Li FF, 2002, P NATL ACAD SCI USA, V99, P9596, DOI 10.1073/pnas.092277599; Mackeben M, 1999, SPATIAL VISION, V12, P51, DOI 10.1163/156856899X00030; MALJKOVIC V, 1994, MEM COGNITION, V22, P657, DOI 10.3758/BF03209251; Maljkovic V, 1996, PERCEPT PSYCHOPHYS, V58, P977, DOI 10.3758/BF03206826; MILLODOT M, 1974, VISION RES, V14, P1497, DOI 10.1016/0042-6989(74)90031-5; Moore CM, 1996, PSYCHON B REV, V3, P360, DOI 10.3758/BF03210761; Navalpakkam V, 2005, VISION RES, V45, P205, DOI 10.1016/j.visres.2004.07.042; Nothdurft HC, 1999, VISION RES, V39, P2305, DOI 10.1016/S0042-6989(99)00006-1; Olivers CNL, 2003, J EXP PSYCHOL HUMAN, V29, P650, DOI 10.1037/0096-1523.29.3.650; Palmer J, 2000, VISION RES, V40, P1227, DOI 10.1016/S0042-6989(99)00244-8; Razpurker-Apfeld I, 2007, PERCEPT PSYCHOPHYS, V69, P732, DOI 10.3758/BF03193775; ROVAMO J, 1982, INVEST OPHTH VIS SCI, V23, P666; Schulz MF, 2003, PSYCHOL SCI, V14, P26, DOI 10.1111/1467-9280.01414; SPERLING G, 1960, PSYCHOL MONOGR, V74, P1, DOI 10.1037/h0093759; TREISMAN A, 1982, J EXP PSYCHOL HUMAN, V8, P194, DOI 10.1037/0096-1523.8.2.194; VanRullen R, 2004, J COGNITIVE NEUROSCI, V16, P4, DOI 10.1162/089892904322755502; Verghese P, 2001, NEURON, V31, P523, DOI 10.1016/S0896-6273(01)00392-0; WOLFE J, 1998, J ANTI-AGING MED, V1, P9; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419; Wolfe JM, 2003, TRENDS COGN SCI, V7, P70, DOI 10.1016/S1364-6613(02)00024-4; Wolfe JM, 2004, NAT REV NEUROSCI, V5, P495, DOI 10.1038/nrn1411; Zar J. H., 1996, BIOSTATISTICAL ANAL	39	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2219	10.1371/journal.pone.0002219	http://dx.doi.org/10.1371/journal.pone.0002219			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	391UK	18493320	Green Published, Green Submitted, gold			2022-12-25	WOS:000262258700027
J	Li, DN; Li, H; Ou, CY; Lu, Y; Sun, YT; Yang, B; Qin, ZD; Zhou, ZJ; Li, SL; Jin, L				Li, Dongna; Li, Hui; Ou, Caiying; Lu, Yan; Sun, Yuantian; Yang, Bo; Qin, Zhendong; Zhou, Zhenjian; Li, Shilin; Jin, Li			Paternal Genetic Structure of Hainan Aborigines Isolated at the Entrance to East Asia	PLOS ONE			English	Article								Background: At the southern entrance to East Asia, early population migration has affected most of the Y-chromosome variations of East Asians. Methodology/Principal Findings: To assess the isolated genetic structure of Hainan Island and the original genetic structure at the southern entrance, we studied the Y chromosome diversity of 405 Hainan Island aborigines from all the six populations, who have little influence of the recent mainland population relocations and admixtures. Here we report that haplogroups O1a* and O2a* are dominant among Hainan aborigines. In addition, the frequency of the mainland dominant haplogroup O3 is quite low among these aborigines, indicating that they have lived rather isolated. Clustering analyses suggests that the Hainan aborigines have been segregated since about 20 thousand years ago, after two dominant haplogroups entered East Asia (31 to 36 thousand years ago). Conclusions/Significance: Our results suggest that Hainan aborigines have been isolated at the entrance to East Asia for about 20 thousand years, whose distinctive genetic characteristics could be used as important controls in many population genetic studies.	[Li, Dongna; Ou, Caiying; Sun, Yuantian; Zhou, Zhenjian] Hainan Med Coll, Dept Biol, Haikou, Hainan, Peoples R China; [Li, Hui; Lu, Yan; Qin, Zhendong; Li, Shilin; Jin, Li] Fudan Univ, Sch Life Sci, MOE Key Lab Contemporary Anthropol, Shanghai, Peoples R China; [Li, Hui] Yale Univ, Sch Med, Dept Genet, New Haven, CT USA; [Yang, Bo] Third Military Med Univ, Dept Anat, Chongqing, Peoples R China	Hainan Medical University; Fudan University; Yale University; Army Medical University	Li, DN (corresponding author), Hainan Med Coll, Dept Biol, Haikou, Hainan, Peoples R China.	LiHui.Fudan@gmail.com	Anthropology, MOE KeyLab Fudan/A-9454-2010; Li, Hui/A-2014-2010; Jin, Li/M-5063-2019; Jin, Li/C-1468-2009	Jin, Li/0000-0002-4546-2415	National Natural Science Foundation of China [30460056]; Ministry of Education of PRC Science and Technology Research Key Project Fund [204160]; Genographic Project	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of PRC Science and Technology Research Key Project Fund; Genographic Project	This study was supported by the National Natural Science Foundation of China (No. 30460056), Ministry of Education of PRC Science and Technology Research Key Project Fund (No. 204160), and the Genographic Project.	Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Capelli C, 2001, AM J HUM GENET, V68, P432, DOI 10.1086/318205; CHEN SJ, 2002, P INT S ANTHR STUD F; Ellis N, 2002, GENOME RES, V12, P339; Gordon R. G., 2005, ETHNOLOGUE LANGUAGES, V15th; HAO SD, 2003, RETROSPECTION PROSPE, V4, P291; Hao SDHB, 1998, SANYA LUOBIDONG SITE; Hurles ME, 2005, AM J HUM GENET, V76, P894, DOI 10.1086/430051; *INT SOC GEN GEN, 2007, Y DNA HAPL TREE 2007; Jin L, 2000, NAT REV GENET, V1, P126, DOI 10.1038/35038565; Karafev TM, 2005, HUM BIOL, V77, P93, DOI 10.1353/hub.2005.0030; Kayser M, 2006, MOL BIOL EVOL, V23, P2234, DOI 10.1093/molbev/msl093; LI H, 2005, THESIS FUDAN U SHANG; Li H, 2007, HUM GENET, V122, P383, DOI 10.1007/s00439-007-0407-2; Li H, 2007, AM J HUM GENET, V81, P842, DOI 10.1086/521201; Mona S, 2007, MOL BIOL EVOL, V24, P2546, DOI 10.1093/molbev/msm187; NEI M, 1993, MOL BIOL EVOL, V10, P927; Shi H, 2005, AM J HUM GENET, V77, P408, DOI 10.1086/444436; Shi Y., 1989, QUESTION QUATERNARY; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Su B, 2000, P NATL ACAD SCI USA, V97, P8225, DOI 10.1073/pnas.97.15.8225; Su B, 2000, HUM GENET, V107, P582, DOI 10.1007/s004390000406; Thurgood G., 1994, OCEAN LING, V33, P345; Wang XPWJ., 2004, CHINA HLAI; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; Wen B, 2004, NATURE, V431, P302, DOI 10.1038/nature02878; Wen B, 2004, AM J HUM GENET, V74, P856, DOI 10.1086/386292; Wilson IJ, 2003, J R STAT SOC A STAT, V166, P155, DOI 10.1111/1467-985X.00264; Xiao Chun-Jie, 2000, Acta Genetica Sinica, V27, P1; Xing GY, 2004, HAINAN ARCH, V3, P43; Zhang F, 2007, PHILOS T R SOC B, V362, P987, DOI 10.1098/rstb.2007.2028; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911	32	35	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2168	10.1371/journal.pone.0002168	http://dx.doi.org/10.1371/journal.pone.0002168			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478090	Green Submitted, gold, Green Published			2022-12-25	WOS:000262172800033
J	Kitagawa, M; Aonuma, M; Lee, SH; Fukutake, S; McCormick, F				Kitagawa, M.; Aonuma, M.; Lee, S. H.; Fukutake, S.; McCormick, F.			E2F-1 transcriptional activity is a critical determinant of Mdm2 antagonist-induced apoptosis in human tumor cell lines	ONCOGENE			English	Article						E2F-1; p53; Mdm2 antagonist; apoptosis; Nutlin-3	S-PHASE ENTRY; P53 PATHWAY; P53-DEPENDENT APOPTOSIS; P73; ACTIVATION; EXPRESSION; INDUCTION; P14(ARF); NUTLIN-3; LEADS	Nutlin-3 is a selective inhibitor of the p53-Mdm2 interaction, and inhibits growth in most tumor cells with wild-type p53. However, it only induces apoptosis in subsets of tumor cells. We report that the apoptotic response induced by Nutlin-3 correlates with its antitumor effects in xenograft models in athymic mice. We have investigated signals that sensitize cells to undergo apoptosis induced by Nutlin-3. We demonstrate that adenovirus E1A increases Nutlin-3-induced apoptosis through pRb inhibition in mouse embryonic fibroblast cells in a p53-dependent manner. Consistent with this, pRb depletion by siRNA transfection with Nutlin-3 synergistically increases apoptosis in HCT116 human colon cancer cells, which are insensitive to induction of apoptosis by Nutlin-3 alone. As pRb is a key negative regulator of E2F, we asked whether E2F transcriptional activity determines the apoptotic response of cancer cells to Nutlin-3. We demonstrate that transcriptional activity of E2F correlates with the apoptotic response to Nutlin-3 in various tumor cells and depletion of E2F-1 suppresses Nutlin-3-induced apoptosis in cells possessing high transcriptional activity of E2F, including retinoblastoma cells harboring mutated Rb with wild-type p53. Furthermore, we report that expression of the p53 homologue p73, a target of E2F-1, is markedly increased by Nutlin-3 in Rb-mutated tumor cells harboring wild-type p53. Depletion of p73 by siRNA transfection suppresses Nutlin-3-induced apoptosis in these cells. Taken together, our results demonstrate that E2F-1 transcriptional activity is a critical determinant of Mdm2 antagonist-induced apoptosis and p73 is important for E2F-1-mediated apoptosis induced by Nutlin-3, especially in tumor cells with mutated Rb. Furthermore, our results suggest that tumor cells, including Rb mutated cells, which harbor wildtype p53 and high E2F transcriptional activity, could be a good target for Mdm2 antagonist therapy.	[Kitagawa, M.; Lee, S. H.; McCormick, F.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94115 USA; [Kitagawa, M.; Lee, S. H.; McCormick, F.] Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94115 USA; [Kitagawa, M.; Aonuma, M.; Fukutake, S.] Daiichi Sankyo Co Ltd, Kasai R&D Ctr, Tokyo, Japan	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; Daiichi Sankyo Company Limited	McCormick, F (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, 2340 Sutter St N315,UCSF Box 0128, San Francisco, CA 94115 USA.	mccormick@cc.ucsf.edu						Ambrosini G, 2007, ONCOGENE, V26, P3473, DOI 10.1038/sj.onc.1210136; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; BROCKMANN D, 1995, CURR TOP MICROBIOL, V199, P81; Chen LH, 1999, MOL MED, V5, P21, DOI 10.1007/BF03402136; Coll-Mulet L, 2006, BLOOD, V107, P4109, DOI 10.1182/blood-2005-08-3273; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Holmberg C, 1998, ONCOGENE, V17, P143, DOI 10.1038/sj.onc.1201915; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; Kojima K, 2005, BLOOD, V106, P3150, DOI 10.1182/blood-2005-02-0553; Lau LMS, 2008, ONCOGENE, V27, P997, DOI 10.1038/sj.onc.1210707; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Nicholson SA, 2001, CANCER RES, V61, P5636; Patton JT, 2006, CANCER RES, V66, P3169, DOI 10.1158/0008-5472.CAN-05-3832; Putzer BM, 2000, CELL DEATH DIFFER, V7, P177, DOI 10.1038/sj.cdd.4400618; QIN XQ, 1994, P NATL ACAD SCI USA, V91, P10918, DOI 10.1073/pnas.91.23.10918; Samuelson AV, 1997, P NATL ACAD SCI USA, V94, P12094, DOI 10.1073/pnas.94.22.12094; Secchiero P, 2006, BLOOD, V107, P4122, DOI 10.1182/blood-2005-11-4465; Semizarov D, 2004, NUCLEIC ACIDS RES, V32, P3836, DOI 10.1093/nar/gkh714; SHAN B, 1994, MOL CELL BIOL, V14, P8166, DOI 10.1128/MCB.14.12.8166; Stanelle J, 2006, TRENDS MOL MED, V12, P177, DOI 10.1016/j.molmed.2006.02.002; Stiewe T, 2000, NAT GENET, V26, P464, DOI 10.1038/82617; Stuhmer T, 2005, BLOOD, V106, P3609, DOI 10.1182/blood-2005-04-1489; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; Van Maerken T, 2006, CANCER RES, V66, P9646, DOI 10.1158/0008-5472.CAN-06-0792; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wade M, 2006, J BIOL CHEM, V281, P33036, DOI 10.1074/jbc.M605405200; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	31	73	74	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 11	2008	27	40					5303	5314		10.1038/onc.2008.164	http://dx.doi.org/10.1038/onc.2008.164			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	346UW	18521084				2022-12-25	WOS:000259096100003
J	Qian, H; Robertson, AP; Powell-Coffman, JA; Martin, RJ				Qian, Hai; Robertson, Alan P.; Powell-Coffman, Jo Anne; Martin, Richard J.			Levamisole resistance resolved at the single-channel level in Caenorhabditis elegans	FASEB JOURNAL			English	Article						resistance; LEV-10; LEV-8; LEV-1; nAChR	ACETYLCHOLINE-RECEPTOR; GENE ENCODES; IDENTIFICATION; ACTIVATION; MUSCLE	Sydney Brenner promoted Caenorhabditis elegans as a model organism, and subsequent investigations pursued resistance to the nicotinic anthelmintic drug levamisole in C. elegans at a genetic level. These studies have advanced our understanding of genes associated with neuromuscular transmission and resistance to the antinematodal drug. In lev-8 and lev-1 mutant C. elegans, levamisole resistance is associated with reductions in levamisole-activated whole muscle cell currents. Although lev-8 and lev- 1 are known to code for nicotinic acetylcholine receptor (nAChR) subunits, an explanation for why these currents get smaller is not available. In wild-type adults, nAChRs aggregate at neuromuscular junctions and are not accessible for single-channel recording. Here we describe a use of LEV-10 knockouts, in which aggregation is lost, to make in situ recordings of nAChR channel currents. Our observations provide an explanation for levamisole resistance produced by LEV-8 and LEV-1 mutants at the single-channel level.	[Qian, Hai; Robertson, Alan P.; Martin, Richard J.] Iowa State Univ, Dept Biomed Sci, Ames, IA 50011 USA; [Powell-Coffman, Jo Anne] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA	Iowa State University; Iowa State University	Martin, RJ (corresponding author), Iowa State Univ, Dept Biomed Sci, Ames, IA 50011 USA.	rjmartin@iastate.edu	/A-1783-2011	/0000-0003-2422-1847; Powell-Coffman, Jo Anne/0000-0001-9164-7499	National Institute of Allergy and Infectious Diseases [R01 AI047194]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047194] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Drs. Jean-Louis Bessereau and Thomas Boulin for providing mutant strains, primers and advice and Dr. Janet Richmond for encouragement and for showing us the dissection method. The project was supported by grant R01 AI047194 from the National Institute of Allergy and Infectious Diseases to R.J.M. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases of the National Institutes of Health.	Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; BRENNER S, 1974, GENETICS, V77, P71; Culetto E, 2004, J BIOL CHEM, V279, P42476, DOI 10.1074/jbc.M404370200; Fleming JT, 1997, J NEUROSCI, V17, P5843; Gally C, 2004, NATURE, V431, P578, DOI 10.1038/nature02893; Gottschalk A, 2005, EMBO J, V24, P2566, DOI 10.1038/sj.emboj.7600741; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Levandoski MM, 2005, INT J PARASITOL, V35, P925, DOI 10.1016/j.ijpara.2005.03.007; LEWIS JA, 1980, GENETICS, V95, P905; LEWIS JA, 1980, NEUROSCIENCE, V5, P967, DOI 10.1016/0306-4522(80)90180-3; Prichard RK, 2007, PARASITOLOGY, V134, P1087, DOI 10.1017/S003118200700008X; Qian H, 2006, FASEB J, V20, P2606, DOI 10.1096/fj.06-6264fje; Rayes D, 2007, MOL PHARMACOL, V71, P1407, DOI 10.1124/mol.106.033514; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Robertson AP, 1999, FASEB J, V13, P749, DOI 10.1096/fasebj.13.6.749; ROBERTSON SJ, 1993, BRIT J PHARMACOL, V108, P170, DOI 10.1111/j.1476-5381.1993.tb13458.x; ROBERTSON SJ, 1993, PESTIC SCI, V37, P293, DOI 10.1002/ps.2780370310; Towers PR, 2005, J NEUROCHEM, V93, P1, DOI 10.1111/j.1471-4159.2004.02951.x; WHITE JG, 1983, COLD SPRING HARB SYM, V48, P633, DOI 10.1101/SQB.1983.048.01.067; Williams DC, 2005, GENETICS, V169, P1779, DOI 10.1534/genetics.104.038265; Wolstenholme AJ, 2004, TRENDS PARASITOL, V20, P469, DOI 10.1016/j.pt.2004.07.010	21	53	60	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2008	22	9					3247	3254		10.1096/fj.08-110502	http://dx.doi.org/10.1096/fj.08-110502			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	342CD	18519804	Green Published			2022-12-25	WOS:000258761300017
J	Wei, JS; Song, YK; Durinck, S; Chen, QR; Cheuk, ATC; Tsang, P; Zhang, Q; Thiele, CJ; Slack, A; Shohet, J; Khan, J				Wei, J. S.; Song, Y. K.; Durinck, S.; Chen, Q-R; Cheuk, A. T. C.; Tsang, P.; Zhang, Q.; Thiele, C. J.; Slack, A.; Shohet, J.; Khan, J.			The MYCN oncogene is a direct target of miR-34a	ONCOGENE			English	Article						microRNA; miR-34a; MYCN; 1p36 LOH; neuroblastoma; translation regulation	TUMOR-SUPPRESSOR GENE; HUMAN NEUROBLASTOMA-CELLS; N-MYC; EXPRESSION PROFILES; FREQUENT DELETIONS; CONSENSUS REGION; TRANSGENIC MICE; NERVOUS-SYSTEM; CHROMOSOME 1P; APOPTOSIS	Loss of 1p36 heterozygosity commonly occurs with MYCN amplification in neuroblastoma tumors, and both are associated with an aggressive phenotype. Database searches identified five microRNAs that map to the commonly deleted region of 1p36 and we hypothesized that the loss of one or more of these microRNAs contributes to the malignant phenotype of MYCN-amplified tumors. By bioinformatic analysis, we identified that three out of the five microRNAs target MYCN and of these miR-34a caused the most significant suppression of cell growth through increased apoptosis and decreased DNA synthesis in neuroblastoma cell lines with MYCN amplification. Quantitative RT-PCR showed that neuroblastoma tumors with 1p36 loss expressed lower level of miR-34a than those with normal copies of 1p36. Furthermore, we demonstrated that MYCN is a direct target of miR-34a. Finally, using a series of mRNA expression pro. ling experiments, we identified other potential direct targets of miR-34a, and pathway analysis demonstrated that miR- 34a suppresses cell-cycle genes and induces several neural-related genes. This study demonstrates one important regulatory role of miR-34a in cell growth and MYCN suppression in neuroblastoma.	[Wei, J. S.; Song, Y. K.; Durinck, S.; Chen, Q-R; Cheuk, A. T. C.; Tsang, P.; Zhang, Q.; Khan, J.] Natl Canc Inst, Oncogenom Sect, Pediat Oncol Branch, Adv Technol Ctr, Gaithersburg, MD 20892 USA; [Chen, Q-R] NCI, Adv Biomed Comp Ctr, SAIC Frederick Inc, Frederick, MD 21701 USA; [Thiele, C. J.] Natl Canc Inst, Cell & Mol Biol Sect, Pediat Oncol Branch, Bethesda, MD USA; [Slack, A.; Shohet, J.] Baylor Coll Med, Dept Pediat, Hematol Oncol Sect, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Baylor College of Medicine	Khan, J (corresponding author), Natl Canc Inst, Oncogenom Sect, Pediat Oncol Branch, Adv Technol Ctr, Room 134E,8717 Grovemont Circle, Gaithersburg, MD 20892 USA.	khanjav@mail.nih.gov	Khan, Javed/P-9157-2014		Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [Z01BC010788, ZIASC010366, ZIABC011001, ZIABC011002] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Joon-Yong Chung and Xinyu Wen, MS for their excellent technical support. We also thank Dr John Maris, Dr Wendy London (Children's Oncology Group, Philadelphia, PA, USA) and Dr Steven Qualman (Cooperative Human Tissue Network, Columbus, OH, USA) for the NB tumor samples, and for invaluable discussion of this study with Dr John Maris and his group. This study is supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the US government.	Abel F, 2004, INT J ONCOL, V25, P1297; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Attiyeh EF, 2005, NEW ENGL J MED, V353, P2243, DOI 10.1056/NEJMoa052399; BADER SA, 1991, CELL GROWTH DIFFER, V2, P245; Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; Barbashina V, 2005, CLIN CANCER RES, V11, P1119; Bartel B, 2003, PLANT PHYSIOL, V132, P709, DOI 10.1104/pp.103.023630; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bieche I, 1998, ONCOL REP, V5, P267; BLACKWELL TK, 1993, MOL CELL BIOL, V13, P5216, DOI 10.1128/MCB.13.9.5216; BRODEUR GM, 1977, CANCER-AM CANCER SOC, V40, P2256, DOI 10.1002/1097-0142(197711)40:5<2256::AID-CNCR2820400536>3.0.CO;2-1; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen QR, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-70; Cheung TH, 2005, GYNECOL ONCOL, V96, P510, DOI 10.1016/j.ygyno.2004.10.035; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Eggert A, 2002, EUR J CANCER, V38, P92, DOI 10.1016/S0959-8049(01)00347-1; Ejeskar K, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-161; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; FONG CT, 1989, P NATL ACAD SCI USA, V86, P3753, DOI 10.1073/pnas.86.10.3753; Guo C, 1999, ONCOGENE, V18, P4948, DOI 10.1038/sj.onc.1202887; HASHIMOTO N, 1995, GENE CHROMOSOME CANC, V14, P295, DOI 10.1002/gcc.2870140408; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Henrich KO, 2006, CLIN CANCER RES, V12, P131, DOI 10.1158/1078-0432.CCR-05-1431; Hogarty MD, 2000, MED PEDIATR ONCOL, V35, P512, DOI 10.1002/1096-911X(20001201)35:6<512::AID-MPO2>3.0.CO;2-D; HOSOI G, 1994, CANCER, V73, P3087, DOI 10.1002/1097-0142(19940615)73:12<3087::AID-CNCR2820731230>3.0.CO;2-9; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kang JH, 2006, BIOCHEM BIOPH RES CO, V351, P192, DOI 10.1016/j.bbrc.2006.10.020; KOHL NE, 1984, SCIENCE, V226, P1335, DOI 10.1126/science.6505694; Kong Xiao-Tang, 1999, Neoplasia (New York), V1, P80, DOI 10.1038/sj.neo.7900010; LAHTI JM, 1994, NAT GENET, V7, P370, DOI 10.1038/ng0794-370; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Maris JM, 1997, EUR J CANCER, V33, P1991, DOI 10.1016/S0959-8049(97)00279-7; Maris JM, 2000, J CLIN ONCOL, V18, P1888, DOI 10.1200/JCO.2000.18.9.1888; Maris JM, 2001, MED PEDIATR ONCOL, V36, P32, DOI 10.1002/1096-911X(20010101)36:1<32::AID-MPO1009>3.0.CO;2-0; Mathysen D, 2004, EUR J CANCER, V40, P1255, DOI 10.1016/j.ejca.2004.01.013; Mori N, 1998, BLOOD, V92, P3405, DOI 10.1182/blood.V92.9.3405.421k44_3405_3409; Mosse YP, 2005, GENE CHROMOSOME CANC, V43, P390, DOI 10.1002/gcc.20198; Nara K, 2007, INT J ONCOL, V30, P1189; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Ozaki T, 2005, CANCER LETT, V228, P29, DOI 10.1016/j.canlet.2004.12.050; Poetsch M, 1998, CANCER GENET CYTOGEN, V104, P146, DOI 10.1016/S0165-4608(97)00471-8; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; SCHWAB M, 1988, P NATL ACAD SCI USA, V85, P9585, DOI 10.1073/pnas.85.24.9585; Slack A, 2005, P NATL ACAD SCI USA, V102, P731, DOI 10.1073/pnas.0405495102; Strieder V, 2003, J BIOL CHEM, V278, P2983, DOI 10.1074/jbc.M207596200; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thompson PM, 2003, ONCOGENE, V22, P1002, DOI 10.1038/sj.onc.1206211; Valentijn LJ, 2005, CANCER RES, V65, P3136, DOI 10.1158/0008-5472.CAN-04-2469; VOGAN K, 1993, CANCER RES, V53, P5269; Wei J.S., 2002, DNA MICROARRAYS MOL, P110; Wei JS, 2005, ONCOGENE, V24, P7976, DOI 10.1038/sj.onc.1208947; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; White PS, 2005, ONCOGENE, V24, P2684, DOI 10.1038/sj.onc.1208306; WHITE PS, 1995, P NATL ACAD SCI USA, V92, P5520, DOI 10.1073/pnas.92.12.5520; WOO CM, 2007, PEDIAT BLOOD CANC, V50, P208; ZIMMERMAN KA, 1986, NATURE, V319, P780, DOI 10.1038/319780a0; Zindy F, 2006, P NATL ACAD SCI USA, V103, P11579, DOI 10.1073/pnas.0604727103	66	222	231	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2008	27	39					5204	5213		10.1038/onc.2008.154	http://dx.doi.org/10.1038/onc.2008.154			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	344GO	18504438	Green Accepted			2022-12-25	WOS:000258915100004
J	Gao, ZB; Xiong, QJ; Sun, HY; Li, M				Gao, Zhaobing; Xiong, Qiaojie; Sun, Haiyan; Li, Min			Desensitization of chemical activation by auxiliary subunits - Convergence of molecular determinants critical for augmenting KCNQ1 potassium channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-QT SYNDROME; I-KS CHANNELS; K+ CHANNEL; CARDIAC-ARRHYTHMIA; ANTICONVULSANT RETIGABINE; CHROMANOL 293B; LANGE-NIELSEN; MINK; KVLQT1; RECTIFIER	Chemical openers for KCNQ potassium channels are useful probes both for understanding channel gating and for developing therapeutics. The five KCNQ isoforms (KCNQ1 to KCNQ5, or Kv7.1 to Kv7.5) are differentially localized. Therefore, the molecular specificity of chemical openers is an important subject of investigation. Native KCNQ1 normally exists in complex with auxiliary subunits known as KCNE. In cardiac myocytes, the KCNQ1-KCNE1 (IsK or minK) channel is thought to underlie the I-Ks current, a component critical for membrane repolarization during cardiac action potential. Hence, the molecular and pharmacological differences between KCNQ1 and KCNQ1-KCNE1 channels have been important topics. Zinc pyrithione (ZnPy) is a newly identified KCNQ channel opener, which potently activates KCNQ2, KCNQ4, and KCNQ5. However, the ZnPy effects on cardiac KCNQ1 potassium channels remain largely unknown. Here we show that ZnPy effectively augments the KCNQ1 current, exhibiting an increase in current amplitude, reduction of inactivation, and slowing of both activation and deactivation. Some of these are reminiscent of effects by KCNE1. In addition, neither the heteromultimeric KCNQ1-KCNE1 channels nor native IKs current displayed any sensitivity to ZnPy, indicating that the static occupancy by a KCNE subunit desensitizes the reversible effects by a chemical opener. Site-directed mutagenesis of KCNQ1 reveals that residues critical for the potentiation effects by either ZnPy or KCNE are clustered together in the S6 region overlapping with the critical gating determinants. Thus, the convergence of potentiation effects and molecular determinants critical for both an auxiliary subunit and a chemical opener argue for a mechanistic overlap in causing potentiation.	[Li, Min] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Li, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, BRB311,733 N Broadway, Baltimore, MD 21205 USA.	minli@jhmi.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070959, R01GM078579] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM078579, GM070959] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbott G W, 2001, Mol Interv, V1, P95; Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Akao M, 2001, CIRC RES, V88, P1267, DOI 10.1161/hh1201.092094; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Bendahhou S, 2005, CARDIOVASC RES, V67, P529, DOI 10.1016/j.cardiores.2005.02.014; Bett GCL, 2006, J PHYSIOL-LONDON, V576, P755, DOI 10.1113/jphysiol.2006.116012; Blackburn-Munro G, 2005, CNS DRUG REV, V11, P1, DOI 10.1111/j.1527-3458.2005.tb00033.x; Busch AE, 1996, PFLUG ARCH EUR J PHY, V432, P1094, DOI 10.1007/s004240050240; Chouabe C, 2000, CARDIOVASC RES, V45, P971, DOI 10.1016/S0008-6363(99)00411-3; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; Ding SH, 2005, J GEN PHYSIOL, V126, P213, DOI 10.1085/jgp.200509287; Duggal P, 1998, CIRCULATION, V97, P142, DOI 10.1161/01.CIR.97.2.142; FATOPE MO, 2001, DRUGS, V4, P93; Grunnet M, 2005, BIOCHEM BIOPH RES CO, V328, P1146, DOI 10.1016/j.bbrc.2005.01.071; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Jensen HS, 2007, BIOPHYS J, V92, P2747, DOI 10.1529/biophysj.106.101287; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Kang JS, 2005, MOL PHARMACOL, V67, P827, DOI 10.1124/mol.104.006577; Kelly BL, 2003, NAT STRUCT BIOL, V10, P280, DOI 10.1038/nsb908; Kerst G, 2002, J MEMBRANE BIOL, V186, P89, DOI 10.1007/s00232-001-0138-6; Manderfield LJ, 2008, FEBS J, V275, P1336, DOI 10.1111/j.1742-4658.2008.06294.x; Melman YF, 2004, NEURON, V42, P927, DOI 10.1016/j.neuron.2004.06.001; Melman YF, 2001, J BIOL CHEM, V276, P6439, DOI 10.1074/jbc.M010713200; Menuz K, 2007, SCIENCE, V318, P815, DOI 10.1126/science.1146317; Miceli F, 2008, CURR OPIN PHARMACOL, V8, P65, DOI 10.1016/j.coph.2007.10.003; Morin TJ, 2008, P NATL ACAD SCI USA, V105, P1478, DOI 10.1073/pnas.0710366105; Napolitano C, 2000, J CARDIOVASC ELECTR, V11, P691, DOI 10.1111/j.1540-8167.2000.tb00033.x; NILIUS B, 1987, GEN PHYSIOL BIOPHYS, V6, P409; Panaghie G, 2006, J PHYSIOL-LONDON, V570, P455, DOI 10.1113/jphysiol.2005.100644; Peretz A, 2005, MOL PHARMACOL, V67, P1053, DOI 10.1124/mol.104.007112; Piccini M, 1999, GENOMICS, V60, P251, DOI 10.1006/geno.1999.5904; Porter RJ, 2007, NEUROLOGY, V68, P1197, DOI 10.1212/01.wnl.0000259034.45049.00; Porter RJ, 2007, NEUROTHERAPEUTICS, V4, P149, DOI 10.1016/j.nurt.2006.11.012; Pusch M, 1998, PFLUG ARCH EUR J PHY, V437, P172, DOI 10.1007/s004240050765; Roden DM, 1996, CIRCULATION, V94, P1996, DOI 10.1161/01.CIR.94.8.1996; Romey G, 1997, J BIOL CHEM, V272, P16713, DOI 10.1074/jbc.272.27.16713; Salata JJ, 1998, MOL PHARMACOL, V54, P220, DOI 10.1124/mol.54.1.220; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Sanguinetti MC, 1999, ANN NY ACAD SCI, V868, P406, DOI 10.1111/j.1749-6632.1999.tb11302.x; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schenzer A, 2005, J NEUROSCI, V25, P5051, DOI 10.1523/JNEUROSCI.0128-05.2005; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; Seebohm G, 2003, CIRC RES, V93, P941, DOI 10.1161/01.RES.0000102866.67863.2B; Seebohm G, 2001, J BIOL CHEM, V276, P13600, DOI 10.1074/jbc.M008373200; Seebohm G, 2006, BIOPHYS J, V90, P2235, DOI 10.1529/biophysj.105.067165; Sesti F, 1998, J GEN PHYSIOL, V112, P651, DOI 10.1085/jgp.112.6.651; Splawski I, 1997, NAT GENET, V17, P338, DOI 10.1038/ng1197-338; Tapper AR, 2001, J BIOL CHEM, V276, P38249; Tikhonov DB, 2004, BIOPHYS J, V87, P1526, DOI 10.1529/biophysj.103.037770; Tristani-Firouzi M, 1998, J PHYSIOL-LONDON, V510, P37, DOI 10.1111/j.1469-7793.1998.037bz.x; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Tyson J, 1997, HUM MOL GENET, V6, P2179, DOI 10.1093/hmg/6.12.2179; Wang HS, 2000, MOL PHARMACOL, V57, P1218; Wuttke TV, 2005, MOL PHARMACOL, V67, P1009, DOI 10.1124/mol.104.010793; Xiong QJ, 2008, TRENDS PHARMACOL SCI, V29, P99, DOI 10.1016/j.tips.2007.11.010; Xiong QJ, 2008, P NATL ACAD SCI USA, V105, P3128, DOI 10.1073/pnas.0712256105; Xiong QJ, 2007, NAT CHEM BIOL, V3, P287, DOI 10.1038/nchembio874; Xu J, 1998, TRENDS CARDIOVAS MED, V8, P229, DOI 10.1016/S1050-1738(98)00011-5; Yang YS, 1998, J GEN PHYSIOL, V112, P665, DOI 10.1085/jgp.112.6.665; ZENG JL, 1995, CIRC RES, V77, P140, DOI 10.1161/01.RES.77.1.140	60	29	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22649	22658		10.1074/jbc.M802426200	http://dx.doi.org/10.1074/jbc.M802426200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18490447	hybrid, Green Published			2022-12-25	WOS:000258321000034
J	Nelson, SW; Kumar, R; Benkovic, SJ				Nelson, Scott W.; Kumar, Ravindra; Benkovic, Stephen J.			RNA primer handoff in bacteriophage T4 DNA replication - The role of single-stranded DNA-binding protein and polymerase accessory proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELICASE-LOADING PROTEIN; OKAZAKI FRAGMENT; LEADING-STRAND; COOH TERMINUS; MINICIRCLE SUBSTRATE; PRIMASE-HELICASE; GENE-59 PROTEIN; GP41 HELICASE; T4 HELICASE; COMPLEX	In T4 phage, coordinated leading and lagging strand DNA synthesis is carried out by an eight-protein complex termed the replisome. The control of lagging strand DNA synthesis depends on a highly dynamic replisome with several proteins entering and leaving during DNA replication. Here we examine the role of single-stranded binding protein (gp32) in the repetitive cycles of lagging strand synthesis. Removal of the protein-interacting domain of gp32 results in a reduction in the number of primers synthesized and in the efficiency of primer transfer to the polymerase. We find that the primase protein is moderately processive, and this processivity depends on the presence of full-length gp32 at the replication fork. Surprisingly, we find that an increase in the efficiency of primer transfer to the clamp protein correlates with a decrease in the dissociation rate of the primase from the replisome. These findings result in a revised model of lagging strand DNA synthesis where the primase remains as part of the replisome after each successful cycle of Okazaki fragment synthesis. A delay in primer transfer results in an increased probability of the primase dissociating from the replication fork. The interplay between gp32, primase, clamp, and clamp loader dictates the rate and efficiency of primer synthesis, polymerase recycling, and primer transfer to the polymerase.	[Nelson, Scott W.; Kumar, Ravindra; Benkovic, Stephen J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Benkovic, SJ (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	sjb1@psu.edu			NIGMS NIH HHS [GM013306] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBERTS BM, 1982, COLD SPRING HARB SYM, V47, P655, DOI 10.1101/SQB.1983.047.01.077; ALBERTS BM, 1987, PHILOS T ROY SOC B, V317, P395, DOI 10.1098/rstb.1987.0068; BARRY J, 1994, J BIOL CHEM, V269, P33049; Benkovic SJ, 2001, ANNU REV BIOCHEM, V70, P181, DOI 10.1146/annurev.biochem.70.1.181; BURKE RL, 1985, J BIOL CHEM, V260, P1711; BURKE RL, 1980, J BIOL CHEM, V255, P1484; Carver TE, 1997, BIOCHEMISTRY-US, V36, P14409, DOI 10.1021/bi971423p; CHA TA, 1990, BIOCHEMISTRY-US, V29, P1791, DOI 10.1021/bi00459a018; Chastain PD, 2000, MOL CELL, V6, P803, DOI 10.1016/S1097-2765(05)00093-6; Dudas KC, 2005, J BIOL CHEM, V280, P21561, DOI 10.1074/jbc.m502351200; GIEDROC DP, 1990, J BIOL CHEM, V265, P11444; HACKER KJ, 1994, J BIOL CHEM, V269, P24221; HINTON DM, 1987, J BIOL CHEM, V262, P10873; Jones CE, 2004, J BIOL CHEM, V279, P12067, DOI 10.1074/jbc.M313840200; Kaboord BF, 1996, BIOCHEMISTRY-US, V35, P1084, DOI 10.1021/bi9520747; KABOORD BF, 1993, P NATL ACAD SCI USA, V90, P10881, DOI 10.1073/pnas.90.22.10881; Kadyrov FA, 2002, NUCLEIC ACIDS RES, V30, P4387, DOI 10.1093/nar/gkf576; Kadyrov FA, 2001, J BIOL CHEM, V276, P29559, DOI 10.1074/jbc.M101310200; Kato M, 2003, MOL CELL, V11, P1349, DOI 10.1016/S1097-2765(03)00195-3; KRASSA KB, 1991, P NATL ACAD SCI USA, V88, P4010, DOI 10.1073/pnas.88.9.4010; Lefebvre SD, 1999, J BIOL CHEM, V274, P22830, DOI 10.1074/jbc.274.32.22830; Lionnet T, 2007, P NATL ACAD SCI USA, V104, P19790, DOI 10.1073/pnas.0709793104; Ma YJ, 2004, J BIOL CHEM, V279, P19035, DOI 10.1074/jbc.M311738200; Morrical SW, 1996, J BIOL CHEM, V271, P20198, DOI 10.1074/jbc.271.33.20198; Nelson SW, 2006, J BIOL CHEM, V281, P8697, DOI 10.1074/jbc.M512185200; Nossal NG, 1995, METHOD ENZYMOL, V262, P560; NOSSAL NG, 1992, FASEB J, V6, P871, DOI 10.1096/fasebj.6.3.1310946; RICHARDSON RW, 1989, J BIOL CHEM, V264, P4732; Salinas F, 2000, P NATL ACAD SCI USA, V97, P7196, DOI 10.1073/pnas.97.13.7196; Sambrook J, 1989, MOL CLONING LAB MANU, P431; Schrock RD, 1996, J BIOL CHEM, V271, P16678, DOI 10.1074/jbc.271.28.16678; SHAMOO Y, 1995, NATURE, V376, P362, DOI 10.1038/376362a0; Smiley RD, 2006, BIOCHEMISTRY-US, V45, P7990, DOI 10.1021/bi0603322; Trakselis MA, 2003, J BIOL CHEM, V278, P49839, DOI 10.1074/jbc.M307405200; Villemain JL, 2000, J BIOL CHEM, V275, P31496, DOI 10.1074/jbc.M002902200; Waidner LA, 2001, J BIOL CHEM, V276, P2509, DOI 10.1074/jbc.M007778200; Xi J, 2005, BIOCHEMISTRY-US, V44, P7747, DOI 10.1021/bi047296w; Yang JS, 2006, MOL CELL, V21, P153, DOI 10.1016/j.molcel.2005.11.029; Yang JS, 2005, J BIOL CHEM, V280, P25416, DOI 10.1074/jbc.M501847200; Yang JS, 2004, P NATL ACAD SCI USA, V101, P8289, DOI 10.1073/pnas.0402625101; Yang JS, 2003, J BIOL CHEM, V278, P49828, DOI 10.1074/jbc.M307406200; YOUNG MC, 1994, J MOL BIOL, V235, P1447, DOI 10.1006/jmbi.1994.1100; Yuzhakov A, 1999, CELL, V96, P153, DOI 10.1016/S0092-8674(00)80968-X; Zhang ZQ, 2005, P NATL ACAD SCI USA, V102, P3254, DOI 10.1073/pnas.0500327102; Zhuang ZH, 2006, BIOCHEMISTRY-US, V45, P7976, DOI 10.1021/bi0601205	45	23	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22838	22846		10.1074/jbc.M802762200	http://dx.doi.org/10.1074/jbc.M802762200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18511422	Green Published, hybrid			2022-12-25	WOS:000258321000051
J	Bailly, A; Sovero, V; Vincenzetti, V; Santelia, D; Bartnik, D; Koenig, BW; Mancuso, S; Martinoia, E; Geisler, M				Bailly, Aurelien; Sovero, Valpuri; Vincenzetti, Vincent; Santelia, Diana; Bartnik, Dirk; Koenig, Bernd W.; Mancuso, Stefano; Martinoia, Enrico; Geisler, Markus			Modulation of P-glycoproteins by auxin transport inhibitors is mediated by interaction with immunophilins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANT ABC TRANSPORTERS; ENERGY-TRANSFER BRET; ARABIDOPSIS-THALIANA; PLASMA-MEMBRANE; CRYSTAL-STRUCTURE; CUCURBITA-PEPO; TWISTED DWARF1; BINDING SITES; LATERAL ROOT; ACID-BINDING	The immunophilin-like FKBP42 TWISTED DWARF1 (TWD1) has been shown to control plant development via the positive modulation of ABCB/P-glycoprotein (PGP)-mediated transport of the plant hormone auxin. TWD1 functionally interacts with two closely related proteins, ABCB1/PGP1 and ABCB19/PGP19/MDR1, both of which exhibit the ability to bind to and be inhibited by the synthetic auxin transport inhibitor N-1-naphylphtalamic acid (NPA). They are also inhibited by flavonoid compounds, which are suspected modulators of auxin transport. The mechanisms by which flavonoids and NPA interfere with auxin efflux components are unclear. We report here the specific disruption of PGP1-TWD1 interaction by NPA and flavonoids using bioluminescence resonance energy transfer with flavonoids functioning as a classical established inhibitor of mammalian and plant PGPs. Accordingly, TWD1 was shown to mediate modulation of PGP1 efflux activity by these auxin transport inhibitors. NPA bound to both PGP1 and TWD1 but was excluded from the PGP1-TWD1 complex expressed in yeast, suggesting a transient mode of action in planta. As a consequence, auxin fluxes and gravitropism in twd1 roots are less affected by NPA treatment, whereas TWD1 gain-of-function promotes root bending. Our data support a novel model for the mode of drug-mediated P-glycoprotein regulation mediated via protein-protein interaction with immunophilin-like TWD1.	[Bailly, Aurelien; Sovero, Valpuri; Vincenzetti, Vincent; Santelia, Diana; Martinoia, Enrico; Geisler, Markus] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Bailly, Aurelien; Sovero, Valpuri; Vincenzetti, Vincent; Santelia, Diana; Martinoia, Enrico; Geisler, Markus] Univ Zurich, Zurich Basel Plant Sci Ctr, CH-8008 Zurich, Switzerland; [Bartnik, Dirk; Koenig, Bernd W.] Res Ctr Julich, Inst Nuerosci & Biophys, D-52425 Julich, Germany; [Mancuso, Stefano] Univ Florence, Dept Hort, I-50019 Sesto Fiorentino, Italy	University of Zurich; University of Zurich; Helmholtz Association; Research Center Julich; University of Florence	Geisler, M (corresponding author), Univ Zurich, Inst Plant Biol, Zollikerstr 107, CH-8008 Zurich, Switzerland.	markus.geisler@botinst.uzh.ch	Koenig, Bernd W/B-4315-2008; Santelia, Diana/AAQ-3967-2020; Geisler, Markus M/B-3921-2012; Martinoia, Enrico/AAH-8712-2021; Mancuso, Stefano/G-6515-2012	Koenig, Bernd W/0000-0002-5300-6276; Geisler, Markus M/0000-0002-6641-5810; Mancuso, Stefano/0000-0003-1752-3986				Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Bailly A, 2006, PLANT SIGNAL BEHAV, V1, P277, DOI 10.4161/psb.1.6.3531; Bernasconi P, 1996, PHYSIOL PLANTARUM, V96, P205, DOI 10.1111/j.1399-3054.1996.tb00203.x; Blakeslee JJ, 2005, CURR OPIN PLANT BIOL, V8, P494, DOI 10.1016/j.pbi.2005.07.014; Blakeslee JJ, 2007, PLANT CELL, V19, P131, DOI 10.1105/tpc.106.040782; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Bouchard R, 2006, J BIOL CHEM, V281, P30603, DOI 10.1074/jbc.M604604200; Brown DE, 2001, PLANT PHYSIOL, V126, P524, DOI 10.1104/pp.126.2.524; BRUNN SA, 1992, PLANT PHYSIOL, V98, P101, DOI 10.1104/pp.98.1.101; BUER CS, 2007, PLANT PHYSL; Chelu MG, 2004, TRENDS CARDIOVAS MED, V14, P227, DOI 10.1016/j.tcm.2004.06.003; Conseil G, 1998, P NATL ACAD SCI USA, V95, P9831, DOI 10.1073/pnas.95.17.9831; COX DN, 1994, PLANT CELL, V6, P1941, DOI 10.1105/tpc.6.12.1941; Dean M, 2005, METHOD ENZYMOL, V400, P409, DOI 10.1016/S0076-6879(05)00024-8; Fanghanel J, 2004, FRONT BIOSCI-LANDMRK, V9, P3453, DOI 10.2741/1494; Gehret AU, 2006, J BIOL CHEM, V281, P20698, DOI 10.1074/jbc.M513642200; Geisler M, 2006, FEBS LETT, V580, P1094, DOI 10.1016/j.febslet.2005.11.054; Geisler M, 2005, PLANT J, V44, P179, DOI 10.1111/j.1365-313X.2005.02519.x; Geisler M, 2004, MOL BIOL CELL, V15, P3393, DOI 10.1091/mbc.E03-11-0831; Geisler M, 2003, MOL BIOL CELL, V14, P4238, DOI 10.1091/mbc.E02-10-0698; Geisler M, 2007, TRENDS PLANT SCI, V12, P465, DOI 10.1016/j.tplants.2007.08.015; Gil P, 2001, GENE DEV, V15, P1985, DOI 10.1101/gad.905201; Granzin J, 2006, J MOL BIOL, V364, P799, DOI 10.1016/j.jmb.2006.09.052; Hemenway CS, 1996, J BIOL CHEM, V271, P18527, DOI 10.1074/jbc.271.31.18527; Hossel D, 2005, PLANT BIOLOGY, V7, P41, DOI 10.1055/s-2004-830475; JACOBS M, 1988, SCIENCE, V241, P346, DOI 10.1126/science.241.4863.346; Kamphausen T, 2002, PLANT J, V32, P263, DOI 10.1046/j.1365-313X.2002.01420.x; Kerr ID, 2007, BIOCHEM J, V401, P613, DOI 10.1042/BJ20061411; LEWIS DR, 2007, PLANT CELL, V19; Lomax Terri L., 1995, P509; Luschnig C, 1998, GENE DEV, V12, P2175, DOI 10.1101/gad.12.14.2175; Luschnig C, 2001, CURR BIOL, V11, pR831, DOI 10.1016/S0960-9822(01)00497-3; Mancuso S, 2005, ANAL BIOCHEM, V341, P344, DOI 10.1016/j.ab.2005.03.054; Martinoia E, 2002, PLANTA, V214, P345, DOI 10.1007/s004250100661; MICHALKE W, 1992, PLANTA, V187, P254, DOI 10.1007/BF00201948; Morris DA, 2000, PLANT GROWTH REGUL, V32, P161, DOI 10.1023/A:1010701527848; Morris ME, 2006, LIFE SCI, V78, P2116, DOI 10.1016/j.lfs.2005.12.003; Multani DS, 2003, SCIENCE, V302, P81, DOI 10.1126/science.1086072; Murphy A, 2000, PLANTA, V211, P315, DOI 10.1007/s004250000300; Murphy AS, 2002, PLANT PHYSIOL, V128, P935, DOI 10.1104/pp.010519; Noh B, 2001, PLANT CELL, V13, P2441, DOI 10.1105/tpc.13.11.2441; Ottenschlager I, 2003, P NATL ACAD SCI USA, V100, P2987, DOI 10.1073/pnas.0437936100; Peer WA, 2004, PLANT CELL, V16, P1898, DOI 10.1105/tpc.021501; Peer WA, 2001, PLANT PHYSIOL, V126, P536, DOI 10.1104/pp.126.2.536; Peer WA, 2007, TRENDS PLANT SCI, V12, P556, DOI 10.1016/j.tplants.2007.10.003; Petrasek J, 2006, SCIENCE, V312, P914, DOI 10.1126/science.1123542; Petrasek J, 2003, PLANT PHYSIOL, V131, P254, DOI 10.1104/pp.012740; Rashotte AM, 2000, PLANT PHYSIOL, V122, P481, DOI 10.1104/pp.122.2.481; Rojas-Pierce M, 2007, CHEM BIOL, V14, P1366, DOI 10.1016/j.chembiol.2007.10.014; Romano P, 2005, NEW PHYTOL, V166, P753, DOI 10.1111/j.1469-8137.2005.01373.x; Ruegger M, 1997, PLANT CELL, V9, P745, DOI 10.1105/tpc.9.5.745; Santelia D, 2005, FEBS LETT, V579, P5399, DOI 10.1016/j.febslet.2005.08.061; Scheidt HA, 2007, EUR BIOPHYS J BIOPHY, V36, P393, DOI 10.1007/s00249-006-0094-2; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; SUSSMAN MR, 1980, PLANT PHYSIOL, V66, P1074, DOI 10.1104/pp.66.6.1074; Taylor LP, 2005, CURR OPIN PLANT BIOL, V8, P317, DOI 10.1016/j.pbi.2005.03.005; Terasaka K, 2005, PLANT CELL, V17, P2922, DOI 10.1105/tpc.105.035816; VERRIER PJ, 2008, TRENDS PLANT SCI; Vieten A, 2007, TRENDS PLANT SCI, V12, P160, DOI 10.1016/j.tplants.2007.03.006; Weiergraber OH, 2006, FEBS LETT, V580, P251, DOI 10.1016/j.febslet.2005.12.007; Xu Y, 1999, P NATL ACAD SCI USA, V96, P151, DOI 10.1073/pnas.96.1.151; Zhang SZ, 2005, BIOCHEM PHARMACOL, V70, P627, DOI 10.1016/j.bcp.2005.05.017	62	133	138	4	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21817	21826		10.1074/jbc.M709655200	http://dx.doi.org/10.1074/jbc.M709655200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18499676	hybrid, Green Accepted			2022-12-25	WOS:000257898800055
J	Damian, M; Mary, S; Martin, A; Pin, JP; Baneres, JL				Damian, Marjorie; Mary, Sophie; Martin, Aimee; Pin, Jean-Philippe; Baneres, Jean-Louis			G protein activation by the leukotriene B-4 receptor dimer - Evidence for an absence of trans-activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED-RECEPTOR; ALLOSTERIC INTERACTIONS; CONFORMATIONAL-CHANGES; HORMONE-RECEPTORS; GPCR FUNCTION; CROSS-TALK; BINDING; AGONIST; COEXPRESSION; RECONSTITUTION	There is compelling evidence that G protein-coupled receptors exist as homo- and heterodimers, but the way these assemblies function at the molecular level remains unclear. We used here the purified leukotriene B-4 receptor BLT1 stabilized in its dimeric state to analyze how a receptor dimer activates G proteins. For this, we produced heterodimers between the wild-type BLT1 and a BLT1/ALXR chimera. The latter is no longer activated by leukotriene B-4 but is still activated by ALXR agonists. In this heterodimer, agonist binding to either one of the two protomers induced asymmetric conformational changes within the receptor dimer. Of importance, no G protein activation was observed when using a dimer where the ligand-loaded protomer was not able to trigger GDP/GTP exchange due to specific mutations in its third intracellular loop, establishing that the conformation of the agonist-free protomer is not competent for G protein activation. Taken together, these data indicate that although ligand binding to one protomer in the heterodimer is associated with cross-conformational changes, a trans-activation mechanism where the ligand-free subunit would trigger GDP/GTP exchange cannot be considered in this case for G protein activation. This observation sheds light into the way GPCR dimers, in particular heterodimers, could activate their cognate G proteins.	[Baneres, Jean-Louis] Univ Montpellier I, Fac Pharm, CNRS, Inst Biomol Max Mousseron,UMR5247, F-34093 Montpellier 5, France; [Damian, Marjorie; Mary, Sophie; Martin, Aimee; Baneres, Jean-Louis] Univ Montpellier 2, CNRS, Inst Biomol Max Mousseron, UMR5247, F-34093 Montpellier 5, France; [Pin, Jean-Philippe] Univ Montpellier I, CNRS, Inst Genom Fonctionnelle, UMR5203, F-34093 Montpellier 5, France; [Pin, Jean-Philippe] Univ Montpellier 2, CNRS, Inst Genom Fonctionnelle, UMR5203, F-34093 Montpellier 5, France; [Pin, Jean-Philippe] INSERM, U661, F-34094 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Baneres, JL (corresponding author), Univ Montpellier I, Fac Pharm, CNRS, Inst Biomol Max Mousseron,UMR5247, 15 Av Ch Flahault,BP 14491, F-34093 Montpellier 5, France.	jean-louis.baneres@univ-montp1.fr	Pin, Jean-Philippe/Y-6668-2019	Pin, Jean-Philippe/0000-0002-1423-345X; Baneres, jean-louis/0000-0001-7078-1285				Albizu L, 2006, MOL PHARMACOL, V70, P1783, DOI 10.1124/mol.106.025684; Baneres JL, 2003, J MOL BIOL, V329, P815, DOI 10.1016/S0022-2836(03)00439-X; Baneres JL, 2003, J MOL BIOL, V329, P801, DOI 10.1016/S0022-2836(03)00438-8; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; Bockaert J, 2002, INT REV CYTOL, V212, P63; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Brock C, 2007, J BIOL CHEM, V282, P33000, DOI 10.1074/jbc.M702542200; Carrillo JJ, 2003, J BIOL CHEM, V278, P42578, DOI 10.1074/jbc.M306165200; Chiang N, 2000, J EXP MED, V191, P1197, DOI 10.1084/jem.191.7.1197; Chiang N, 2006, PHARMACOL REV, V58, P463, DOI 10.1124/pr.58.3.4; Chinault SL, 2004, J BIOL CHEM, V279, P16091, DOI 10.1074/jbc.M311099200; Damian M, 2006, EMBO J, V25, P5693, DOI 10.1038/sj.emboj.7601449; Durroux T, 2005, TRENDS PHARMACOL SCI, V26, P376, DOI 10.1016/j.tips.2005.05.006; Duthey B, 2002, J BIOL CHEM, V277, P3236, DOI 10.1074/jbc.M108900200; El-Asmar L, 2005, MOL PHARMACOL, V67, P460, DOI 10.1124/mol.104.003624; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; Filipek S, 2004, PHOTOCH PHOTOBIO SCI, V3, P628, DOI 10.1039/b315661c; Galvez T, 2001, EMBO J, V20, P2152, DOI 10.1093/emboj/20.9.2152; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Glass M, 1999, MOL PHARMACOL, V56, P1362, DOI 10.1124/mol.56.6.1362; Goudet C, 2005, J BIOL CHEM, V280, P24380, DOI 10.1074/jbc.M502642200; Hlavackova V, 2005, EMBO J, V24, P499, DOI 10.1038/sj.emboj.7600557; Ji IH, 2002, MOL ENDOCRINOL, V16, P1299, DOI 10.1210/me.16.6.1299; Kniazeff J, 2004, NAT STRUCT MOL BIOL, V11, P706, DOI 10.1038/nsmb794; Kobilka BK, 2007, BBA-BIOMEMBRANES, V1768, P794, DOI 10.1016/j.bbamem.2006.10.021; Kuniyeda K, 2007, J BIOL CHEM, V282, P3998, DOI 10.1074/jbc.M610540200; KUROSE H, 1991, BIOCHEMISTRY-US, V30, P3335, DOI 10.1021/bi00227a024; MAGGIO R, 1993, P NATL ACAD SCI USA, V90, P3103, DOI 10.1073/pnas.90.7.3103; Masuda K, 2003, J BIOL CHEM, V278, P24552, DOI 10.1074/jbc.M302801200; Mesnier D, 2004, J BIOL CHEM, V279, P49664, DOI 10.1074/jbc.M404941200; Monnot C, 1996, J BIOL CHEM, V271, P1507, DOI 10.1074/jbc.271.3.1507; Osuga Y, 1997, J BIOL CHEM, V272, P25006, DOI 10.1074/jbc.272.40.25006; Pin JP, 2007, PHARMACOL REV, V59, P5, DOI 10.1124/pr.59.1.5; ROSS JBA, 1992, P NATL ACAD SCI USA, V89, P12023, DOI 10.1073/pnas.89.24.12023; Snook LA, 2006, J PHARMACOL EXP THER, V318, P683, DOI 10.1124/jpet.106.101220; Sohy D, 2007, J BIOL CHEM, V282, P30062, DOI 10.1074/jbc.M705302200; Springael JY, 2007, PHARMACOL THERAPEUT, V115, P410, DOI 10.1016/j.pharmthera.2007.06.004; Springael JY, 2006, MOL PHARMACOL, V69, P1652, DOI 10.1124/mol.105.019414; Springael JY, 2005, CYTOKINE GROWTH F R, V16, P611, DOI 10.1016/j.cytogfr.2005.05.005; Stanasila L, 2003, J BIOL CHEM, V278, P40239, DOI 10.1074/jbc.M306085200; Terrillon S, 2004, P NATL ACAD SCI USA, V101, P1548, DOI 10.1073/pnas.0305322101; Urizar E, 2005, EMBO J, V24, P1954, DOI 10.1038/sj.emboj.7600686; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; White JF, 2007, P NATL ACAD SCI USA, V104, P12199, DOI 10.1073/pnas.0705312104; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Wilson SJ, 2007, ARTERIOSCL THROM VAS, V27, P290, DOI 10.1161/01.ATV.0000252667.53790.4e; WYMAN J, 1990, BINDING LINKAGE FUNC, P33	48	40	40	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21084	21092		10.1074/jbc.M710419200	http://dx.doi.org/10.1074/jbc.M710419200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18490452	Green Published, hybrid			2022-12-25	WOS:000257746100050
J	Kalman, K; Nemeth-Cahalan, KL; Froger, A; Hall, JE				Kalman, Katalin; Nemeth-Cahalan, Karin L.; Froger, Alexandrine; Hall, James E.			Phosphorylation determines the calmodulin-mediated Ca2+ response and water permeability of AQP0	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PKC-GAMMA; LENS; PROTEIN; AQUAPORIN-0; MOUSE; MICE; DIFFERENTIATION; TRANSPARENCY; ARCHITECTURE; TERMINUS	In Xenopus oocytes, the water permeability of AQP0 (P-f) increases with removal of external calcium, an effect that is mediated by cytoplasmic calmodulin (CaM) bound to the C terminus of AQP0. To investigate the effects of serine phosphorylation on CaM-mediated Ca2+ regulation of Pf, we tested the effects of kinase activation, CaM inhibition, and a series of mutations in the C terminus CaM binding site. Calcium regulation of AQP0 Pf manifests four distinct phenotypes: Group 1, with high Pf upon removal of external Ca2+ (wild-type, S229N, R233A, S235A, S235K, K238A, and R241E); Group 2, with high Pf in elevated ( 5 mM) external Ca2+ (S235D and R241A); Group 3, with high Pf and no Ca2+ regulation (S229D, S231N, S231D, S235N, and S235N/I236S); and Group 4, with low Pf and no Ca2+ regulation ( protein kinase A and protein kinase C activators, S229D/S235D and S235N/I236S). Within each group, we tested whether CaM binding mediates the phenotype, as shown previously for wild-type AQP0. In the presence of calmidazolium, a CaM inhibitor, S235D showed high Pf and no Ca2+ regulation, suggesting that S235D still binds CaM. Contrarily, S229D showed a decrease in recruitment of CaM, suggesting that S229D is unable to bind CaM. Taken together, our results suggest a model in which CaM acts as an inhibitor of AQP0 P-f. CaM binding is associated with a low P-f state, and a lack of CaM binding is associated with a high P-f state. Pathological conditions of inappropriate phosphorylation or calcium/CaM regulation could induce P-f changes contributing to the development of a cataract.	[Kalman, Katalin; Nemeth-Cahalan, Karin L.; Froger, Alexandrine; Hall, James E.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA	University of California System; University of California Irvine	Kalman, K (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA.	kkalman@uci.edu; jhall@uci.edu	Hall, James E/K-6306-2012		NEI NIH HHS [EY 5661] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Al-Ghoul KJ, 2003, ANAT REC PART A, V273A, P714, DOI 10.1002/ar.a.10080; Ball LE, 2004, BIOCHEMISTRY-US, V43, P9856, DOI 10.1021/bi0496034; Donaldson P, 2001, NEWS PHYSIOL SCI, V16, P118; Ervin LA, 2005, INVEST OPHTH VIS SCI, V46, P627, DOI 10.1167/iovs.04-0894; Francis P, 2000, BRIT J OPHTHALMOL, V84, P1376, DOI 10.1136/bjo.84.12.1376; GARLAND D, 1985, P NATL ACAD SCI USA, V82, P653, DOI 10.1073/pnas.82.3.653; GIRSCH SJ, 1991, CURR EYE RES, V10, P839, DOI 10.3109/02713689109013880; Gonen T, 2005, NATURE, V438, P633, DOI 10.1038/nature04321; Hanson SRA, 2000, EXP EYE RES, V71, P195, DOI 10.1006/exer.2000.0868; Harries WEC, 2004, P NATL ACAD SCI USA, V101, P14045, DOI 10.1073/pnas.0405274101; Iyengar L, 2007, DIFFERENTIATION, V75, P662, DOI 10.1111/j.1432-0436.2007.00167.x; JOHNSON KR, 1986, J CELL BIOL, V102, P1334, DOI 10.1083/jcb.102.4.1334; Kalman K, 2006, BBA-BIOMEMBRANES, V1758, P1094, DOI 10.1016/j.bbamem.2006.01.015; Lan L, 1998, BIOCHEM J, V330, P1149, DOI 10.1042/bj3301149; Lin DB, 2006, J EXP BIOL, V209, P4371, DOI 10.1242/jeb.02524; Lin H, 2007, MOL VIS, V13, P1822; Maddala R, 2007, DIFFERENTIATION, V75, P713, DOI 10.1111/j.1432-0436.2007.00173.x; Mathias RT, 2007, J MEMBRANE BIOL, V216, P1, DOI 10.1007/s00232-007-9019-y; Mathias RT, 2004, EXP EYE RES, V78, P689, DOI 10.1016/j.exer.2003.07.001; Mathias RT, 1997, PHYSIOL REV, V77, P21, DOI 10.1152/physrev.1997.77.1.21; Menko AS, 2002, EXP EYE RES, V75, P485, DOI 10.1006/exer.2002.2057; Nemeth-Cahalan KL, 2007, J GEN PHYSIOL, V130, P457, DOI 10.1085/jgp.200709826; Nemeth-Cahalan KL, 2004, J GEN PHYSIOL, V123, P573, DOI 10.1085/jgp.200308990; Nemeth-Cahalan KL, 2000, J BIOL CHEM, V275, P6777, DOI 10.1074/jbc.275.10.6777; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; Rose KML, 2008, BIOCHEMISTRY-US, V47, P339, DOI 10.1021/bi701980t; Shiels A, 2000, FASEB J, V14, P2207, DOI 10.1096/fj.99-1071com; Shiels A, 1996, NAT GENET, V12, P212, DOI 10.1038/ng0296-212; Shiels A, 2001, PHYSIOL GENOMICS, V7, P179, DOI 10.1152/physiolgenomics.00078.2001; Smith R.S., 2002, SYSTEMATIC EVALUATIO; Varadaraj K, 2005, INVEST OPHTH VIS SCI, V46, P1393, DOI 10.1167/iovs.04-1217; Zampighi GA, 2005, INVEST OPHTH VIS SCI, V46, P3247, DOI 10.1167/iovs.04-1504	32	30	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21278	21283		10.1074/jbc.M801740200	http://dx.doi.org/10.1074/jbc.M801740200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18508773	hybrid, Green Published			2022-12-25	WOS:000257746100069
J	Sweeney, SM; Orgel, JP; Fertala, A; McAuliffe, JD; Turner, KR; Di Lullo, GA; Chen, S; Antipova, O; Perumal, S; Ala-Kokko, L; Forlino, A; Cabral, WA; Barnes, AM; Marini, JC; Antonio, JDS				Sweeney, Shawn M.; Orgel, Joseph P.; Fertala, Andrzej; McAuliffe, Jon D.; Turner, Kevin R.; Di Lullo, Gloria A.; Chen, Steven; Antipova, Olga; Perumal, Shiamalee; Ala-Kokko, Leena; Forlino, Antonella; Cabral, Wayne A.; Barnes, Aileen M.; Marini, Joan C.; Antonio, James D. San			Candidate cell and matrix interaction domains on the collagen fibril, the predominant protein of vertebrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPERFECTA/EHLERS-DANLOS-SYNDROME; AMINO-ACID-SEQUENCE; I COLLAGEN; OSTEOGENESIS-IMPERFECTA; BINDING-SITES; TRIPLE-HELIX; INTEGRINS ALPHA(1)BETA(1); DENTIN PHOSPHOPHORYN; COL1A1 MUTATION; GER SEQUENCE	Type I collagen, the predominant protein of vertebrates, polymerizes with type III and V collagens and non-collagenous molecules into large cable-like fibrils, yet how the fibril interacts with cells and other binding partners remains poorly understood. To help reveal insights into the collagen structure-function relationship, a data base was assembled including hundreds of type I collagen ligand binding sites and mutations on a two-dimensional model of the fibril. Visual examination of the distribution of functional sites, and statistical analysis of mutation distributions on the fibril suggest it is organized into two domains. The "cell interaction domain" is proposed to regulate dynamic aspects of collagen biology, including integrin-mediated cell interactions and fibril remodeling. The "matrix interaction domain" may assume a structural role, mediating collagen cross-linking, proteoglycan interactions, and tissue mineralization. Molecular modeling was used to superimpose the positions of functional sites and mutations from the two-dimensional fibril map onto a three-dimensional x-ray diffraction structure of the collagen microfibril in situ, indicating the existence of domains in the native fibril. Sequence searches revealed that major fibril domain elements are conserved in type I collagens through evolution and in the type II/XI collagen fibril predominant in cartilage. Moreover, the fibril domain model provides potential insights into the genotype-phenotype relationship for several classes of human connective tissue diseases, mechanisms of integrin clustering by fibrils, the polarity of fibril assembly, heterotypic fibril function, and connective tissue pathology in diabetes and aging.	[Turner, Kevin R.; Di Lullo, Gloria A.; Antonio, James D. San] Thomas Jefferson Univ, Cardeza Fdn Hematol Res, Philadelphia, PA 19107 USA; [Turner, Kevin R.; Di Lullo, Gloria A.; Antonio, James D. San] Thomas Jefferson Univ, Dept Med, Philadelphia, PA 19107 USA; [Sweeney, Shawn M.] Univ Penn, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Orgel, Joseph P.; Antipova, Olga; Perumal, Shiamalee] IIT, Dept Biol Chem & Phys Sci, Ctr Synchrotron Radiat Res & Instrumentat, Chicago, IL 60616 USA; [Fertala, Andrzej] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA; [McAuliffe, Jon D.] Univ Penn, Wharton Sch, Dept Stat, Philadelphia, PA 19104 USA; [Chen, Steven] Finch Univ Hlth Sci Chicago Med Sch, N Chicago, IL 60064 USA; [Ala-Kokko, Leena] Univ Oulu, Bioctr, Collagen Res Unit, Oulu, Finland; [Ala-Kokko, Leena] Univ Oulu, Dept Med Biochem & Mol Biol, Oulu, Finland; [Ala-Kokko, Leena] Connect Tissue Gene Tests, Allentown, PA 18103 USA; [Forlino, Antonella] Univ Pavia, Dept Biochem A Castellani, I-27100 Pavia, Italy; [Forlino, Antonella; Cabral, Wayne A.; Barnes, Aileen M.; Marini, Joan C.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bone & Extracellular Matrix Branch, Natl Inst Hlth, Bethesda, MD 20892 USA	Jefferson University; Jefferson University; University of Pennsylvania; Illinois Institute of Technology; Jefferson University; University of Pennsylvania; Chicago Medical School; University of Oulu; University of Oulu; University of Pavia; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Antonio, JDS (corresponding author), Thomas Jefferson Univ, Cardeza Fdn Hematol Res, Rm 809 Curtis,1015 Walnut St, Philadelphia, PA 19107 USA.	james.sanantonio@jefferson.edu	Forlino, Antonella/H-5385-2015	Forlino, Antonella/0000-0002-6385-1182; Barnes, Aileen/0000-0001-8021-4997	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000408] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR008630] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053590, R29HL053590] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR049604, R01AR048544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103622] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR008630-08, RR 08630, P41 RR008630-127842, P41 RR008630] Funding Source: Medline; NHLBI NIH HHS [R01 HL053590-08, HL 053590] Funding Source: Medline; NIAMS NIH HHS [AR 049604, R01 AR048544, R01 AR048544-04, R21 AR049604-03, AR 048544] Funding Source: Medline; NIGMS NIH HHS [P41 GM103622] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ayad S, 1998, EXTRACELLULAR MATRIX; Baronas-Lowell D, 2004, J BIOL CHEM, V279, P952, DOI 10.1074/jbc.M305989200; BRENNAN M, 1989, J BIOL CHEM, V264, P20947; BYERS PH, 1991, J MED GENET, V28, P433, DOI 10.1136/jmg.28.7.433; Cabral WA, 2005, J BIOL CHEM, V280, P19259, DOI 10.1074/jbc.M414698200; Cabral WA, 2007, HUM MUTAT, V28, P396, DOI 10.1002/humu.20456; CHAPMAN JA, 1974, CONNECT TISSUE RES, V2, P137, DOI 10.3109/03008207409152099; Chen J, 2001, AM J PHYSIOL-RENAL, V281, pF71, DOI 10.1152/ajprenal.2001.281.1.F71; CHEN JM, 1995, J BIOMOL STRUCT DYN, V12, P1129, DOI 10.1080/07391102.1995.10508804; Christopher NA, 1996, COMPUT CHEM, V20, P339, DOI 10.1016/0097-8485(95)00075-5; Collagen Linsenmayer T. F., 1991, CELL BIOL EXTRACELLU; Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Eyre DR, 2004, J BIOL CHEM, V279, P2568, DOI 10.1074/jbc.M311653200; Farndale RW, 2008, BIOCHEM SOC T, V36, P241, DOI 10.1042/BST0360241; FUJISAWA R, 1994, CONNECT TISSUE RES, V31, P1, DOI 10.3109/03008209409005630; Gensure RC, 2005, J CLIN INVEST, V115, P1250, DOI 10.1172/JCI200522760; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Hay E.D., 1991, CELL BIOL EXTRACELLU, DOI 10.1007/978-1-4615-3770-0; Holmes DF, 2001, P NATL ACAD SCI USA, V98, P7307, DOI 10.1073/pnas.111150598; Holtkotter O, 2002, J BIOL CHEM, V277, P10789, DOI 10.1074/jbc.M112307200; Huq NL, 2005, ARCH ORAL BIOL, V50, P807, DOI 10.1016/j.archoralbio.2005.02.002; Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453; Kadler KE, 1996, BIOCHEM J, V316, P1; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; Knight CG, 1998, J BIOL CHEM, V273, P33287, DOI 10.1074/jbc.273.50.33287; Koide T, 2002, J BIOL CHEM, V277, P6178, DOI 10.1074/jbc.M106497200; Konitsiotis AD, 2008, J BIOL CHEM, V283, P6861, DOI 10.1074/jbc.M709290200; Korkko J, 1998, AM J HUM GENET, V62, P98, DOI 10.1086/301689; Lauer-Fields JL, 2000, J BIOL CHEM, V275, P13282, DOI 10.1074/jbc.275.18.13282; Lee Kwang-Soo, 2006, Hum Mutat, V27, P599, DOI 10.1002/humu.9423; Lisman T, 2006, BLOOD, V108, P3753, DOI 10.1182/blood-2006-03-011965; Makareeva E, 2006, J BIOL CHEM, V281, P6463, DOI 10.1074/jbc.M511830200; Makareeva E, 2008, J BIOL CHEM, V283, P4787, DOI 10.1074/jbc.M705773200; Malfait F, 2007, HUM MUTAT, V28, P387, DOI 10.1002/humu.20455; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; McCarthy AD, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-16; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; NERMUT MV, 1988, EMBO J, V7, P4093, DOI 10.1002/j.1460-2075.1988.tb03303.x; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; Orgel JP, 2000, STRUCT FOLD DES, V8, P137, DOI 10.1016/S0969-2126(00)00089-7; Pallos D, 2001, ARCH ORAL BIOL, V46, P459, DOI 10.1016/S0003-9969(00)00130-8; Paul RG, 1996, INT J BIOCHEM CELL B, V28, P1297, DOI 10.1016/S1357-2725(96)00079-9; Paul RG, 1999, INT J BIOCHEM CELL B, V31, P653, DOI 10.1016/S1357-2725(99)00023-0; Persikov AV, 2005, J BIOL CHEM, V280, P19343, DOI 10.1074/jbc.M501657200; Perumal S, 2008, P NATL ACAD SCI USA, V105, P2824, DOI 10.1073/pnas.0710588105; Piez K.A., 1984, EXTRACELLULAR MATRIX; Pollitt R, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9430; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; PROCKOP DJ, 1984, NEW ENGL J MED, V311, P376, DOI 10.1056/NEJM198408093110606; REIGLE KL, 2008, J CELL BIOC IN PRESS; Reyes CD, 2004, J BIOMED MATER RES A, V69A, P591, DOI 10.1002/jbm.a.30034; SANANTONIO JD, 1994, J CELL BIOL, V125, P1179, DOI 10.1083/jcb.125.5.1179; Scott JE, 1997, CELL BIOCHEM FUNCT, V15, P283, DOI 10.1002/(SICI)1099-0844(199712)15:4<283::AID-CBF752>3.0.CO;2-B; SCOTT JE, 1988, BIOCHEM J, V252, P313, DOI 10.1042/bj2520313; SHAW LM, 1991, TRENDS BIOCHEM SCI, V16, P191, DOI 10.1016/0968-0004(91)90074-6; Siljander PRM, 2004, J BIOL CHEM, V279, P47763, DOI 10.1074/jbc.M404685200; Sweeney SM, 2003, J BIOL CHEM, V278, P30516, DOI 10.1074/jbc.M304237200; Thomas EK, 2005, J BIOL CHEM, V280, P22596, DOI 10.1074/jbc.M501155200; Tsilibary EC, 2003, J PATHOL, V200, P537, DOI 10.1002/path.1439; VOGEL KG, 1985, J BIOL CHEM, V260, P9298; Wang H, 2005, ANAL CHEM, V77, P6765, DOI 10.1021/ac051349d; Ward L M, 2001, Hum Mutat, V17, P434, DOI 10.1002/humu.1124; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; Xu Y, 2000, J BIOL CHEM, V275, P38981, DOI 10.1074/jbc.M007668200; Yang CL, 2004, BIODRUGS, V18, P103, DOI 10.2165/00063030-200418020-00004; Yoneyama T, 2004, STROKE, V35, P443, DOI 10.1161/01.STR.0000110788.45858.DC; Zhang WM, 2003, J BIOL CHEM, V278, P7270, DOI 10.1074/jbc.M210313200	68	209	217	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21187	21197		10.1074/jbc.M709319200	http://dx.doi.org/10.1074/jbc.M709319200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18487200	Green Published, hybrid			2022-12-25	WOS:000257746100061
J	McCaw, JM; Wood, JG; McCaw, CT; McVernon, J				McCaw, James M.; Wood, James G.; McCaw, Christopher T.; McVernon, Jodie			Impact of Emerging Antiviral Drug Resistance on Influenza Containment and Spread: Influence of Subclinical Infection and Strategic Use of a Stockpile Containing One or Two Drugs	PLOS ONE			English	Article							A VIRUS-INFECTION; ZANAMIVIR RESISTANCE; CONTACT PATTERNS; B VIRUSES; OSELTAMIVIR; EMERGENCE; TRANSMISSION; MODEL; H5N1; HOUSEHOLD	Background: Wide-scale use of antiviral agents in the event of an influenza pandemic is likely to promote the emergence of drug resistance, with potentially deleterious effects for outbreak control. We explored factors promoting resistance within a dynamic infection model, and considered ways in which one or two drugs might be distributed to delay the spread of resistant strains or mitigate their impact. Methods and Findings: We have previously developed a novel deterministic model of influenza transmission that simulates treatment and targeted contact prophylaxis, using a limited stockpile of antiviral agents. This model was extended to incorporate subclinical infections, and the emergence of resistant virus strains under the selective pressure imposed by various uses of one or two antiviral agents. For a fixed clinical attack rate, R-0 rises with the proportion of subclinical infections thus reducing the number of infections amenable to treatment or prophylaxis. In consequence, outbreak control is more difficult, but emergence of drug resistance is relatively uncommon. Where an epidemic may be constrained by use of a single antiviral agent, strategies that combine treatment and prophylaxis are most effective at controlling transmission, at the cost of facilitating the spread of resistant viruses. If two drugs are available, using one drug for treatment and the other for prophylaxis is more effective at preventing propagation of mutant strains than either random allocation or drug cycling strategies. Our model is relatively straightforward, and of necessity makes a number of simplifying assumptions. Our results are, however, consistent with the wider body of work in this area and are able to place related research in context while extending the analysis of resistance emergence and optimal drug use within the constraints of a finite drug stockpile. Conclusions: Combined treatment and prophylaxis represents optimal use of antiviral agents to control transmission, at the cost of drug resistance. Where two drugs are available, allocating different drugs to cases and contacts is likely to be most effective at constraining resistance emergence in a pandemic scenario.	[McCaw, James M.; McCaw, Christopher T.; McVernon, Jodie] Univ Melbourne, Vaccine & Immunisat Res Grp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Wood, James G.] Univ New South Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Wood, James G.] University of Sydney, Childrens Hospital at Westmead, Natl Ctr Immunisat Res & Surveillance Vaccine, Sydney, NSW, Australia	Murdoch Children's Research Institute; University of Melbourne; University of New South Wales Sydney; University of Sydney	McCaw, JM (corresponding author), Univ Melbourne, Vaccine & Immunisat Res Grp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia.	jamesm@unimelb.edu.au		McVernon, Jodie/0000-0001-9774-1961; McCaw, James/0000-0002-2452-3098	National Health and Medical Research Council (NHMRC) [358425]; Urgent Research [410224]; Training Fellowship [359238]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Urgent Research; Training Fellowship	Funding support was provided by the National Health and Medical Research Council (NHMRC) through Capacity Building (Grant 358425), Urgent Research (Grant 410224) and Training Fellowship (J McVernon, Grant 359238) Schemes.	Alexander ME, 2007, P R SOC B, V274, P1675, DOI 10.1098/rspb.2007.0422; ALNAKIB W, 1986, J ANTIMICROB CHEMOTH, V18, P119, DOI 10.1093/jac/18.1.119; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P149; Aoki FY, 2003, J ANTIMICROB CHEMOTH, V51, P123, DOI 10.1093/jac/dkg007; BEAN WJ, 1989, J INFECT DIS, V159, P1050, DOI 10.1093/infdis/159.6.1050; Bridges CB, 2000, J INFECT DIS, V181, P344, DOI 10.1086/315213; *CDC, 2008, FLUVIEW WEEK 13; DAVIS LE, 1970, AM J EPIDEMIOL, V92, P240, DOI 10.1093/oxfordjournals.aje.a121203; Debarre F, 2007, J R SOC INTERFACE, V4, P893, DOI 10.1098/rsif.2007.1126; Edmunds WJ, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-10; Edmunds WJ, 1997, P ROY SOC B-BIOL SCI, V264, P949, DOI 10.1098/rspb.1997.0131; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2003, J ANTIMICROB CHEMOTH, V51, P977, DOI 10.1093/jac/dkg136; Fick J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000986; FOX JP, 1982, AM J EPIDEMIOL, V116, P228, DOI 10.1093/oxfordjournals.aje.a113408; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Govorkova EA, 2007, ANTIMICROB AGENTS CH, V51, P1414, DOI 10.1128/AAC.01312-06; Gubareva LV, 1998, J INFECT DIS, V178, P1257, DOI 10.1086/314440; HALL CE, 1973, AM J EPIDEMIOL, V98, P365, DOI 10.1093/oxfordjournals.aje.a121566; Halloran ME, 2007, AM J EPIDEMIOL, V165, P212, DOI 10.1093/aje/kwj362; Hayden FG, 2004, J INFECT DIS, V189, P440, DOI 10.1086/381128; Hayden FG, 1999, NEW ENGL J MED, V341, P1336, DOI 10.1056/NEJM199910283411802; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Herlocher ML, 2004, J INFECT DIS, V190, P1627, DOI 10.1086/424572; HURT A, 2007, COMMUN DIS IN PRESS; Jackson D, 2005, J ANTIMICROB CHEMOTH, V55, P162, DOI 10.1093/jac/dkh528; Katz JM, 1999, J INFECT DIS, V180, P1763, DOI 10.1086/315137; Kawai N, 2007, J INFECTION, V55, P267, DOI 10.1016/j.jinf.2007.05.176; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Lackenby A, 2008, EURO SURVEILL, V13; Langford C, 2002, MED HIST, V46, P1; Lipsitch M, 2007, PLOS MED, V4, P111, DOI 10.1371/journal.pmed.0040015; Mathews JD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001220; Mccaw JM, 2007, MATH BIOSCI, V209, P336, DOI 10.1016/j.mbs.2007.02.003; Moghadas SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001839; Nicoll A., 2008, EURO SURVEILL, V13; Regoes RR, 2006, SCIENCE, V312, P389, DOI 10.1126/science.1122947; Stilianakis NI, 1998, J INFECT DIS, V177, P863, DOI 10.1086/515246; Vynnycky E, 2008, EPIDEMIOL INFECT, V136, P166, DOI 10.1017/S0950268807008369; Wallinga J, 1999, TRENDS MICROBIOL, V7, P372, DOI 10.1016/S0966-842X(99)01546-2; Xu Y, 2007, J THEOR BIOL, V248, P179, DOI 10.1016/j.jtbi.2007.05.009; Zurcher T, 2006, J ANTIMICROB CHEMOTH, V58, P723, DOI 10.1093/jac/dkl321	42	45	47	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2362	10.1371/journal.pone.0002362	http://dx.doi.org/10.1371/journal.pone.0002362			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523549	gold, Green Published, Green Submitted			2022-12-25	WOS:000262614300049
J	Kalil, AC; Sun, JF				Kalil, Andre C.; Sun, Junfeng			Why Are Clinicians Not Embracing the Results from Pivotal Clinical Trials in Severe Sepsis? A Bayesian Analysis	PLOS ONE			English	Article							ACTIVATED PROTEIN-C; INTENSIVE INSULIN THERAPY; RESPIRATORY-DISTRESS-SYNDROME; HIGH-DOSE METHYLPREDNISOLONE; VOLUME VENTILATORY STRATEGY; MAXIMIZING OXYGEN DELIVERY; END-EXPIRATORY PRESSURE; GOAL-DIRECTED THERAPY; CRITICALLY-ILL; SEPTIC SHOCK	Background: Five pivotal clinical trials (Intensive Insulin Therapy; Recombinant Human Activated Protein C [rhAPC]; Low-Tidal Volume; Low-Dose Steroid; Early Goal-Directed Therapy [EGDT]) demonstrated mortality reduction in patients with severe sepsis and expert guidelines have recommended them to clinical practice. Yet, the adoption of these therapies remains low among clinicians. Objectives: We selected these five trials and asked: Question 1-What is the current probability that the new therapy is not better than the standard of care in my patient with severe sepsis? Question 2-What is the current probability of reducing the relative risk of death (RRR) of my patient with severe sepsis by meaningful clinical thresholds (RRR > 15% > 20% > 25%)? Methods: Bayesian methodologies were applied to this study. Odds ratio (OR) was considered for Question 1, and RRR was used for Question 2. We constructed prior distributions (enthusiastic; mild, moderate, and severe skeptic) based on various effective sample sizes of other relevant clinical trials (unfavorable evidence). Posterior distributions were calculated by combining the prior distributions and the data from pivotal trials (favorable evidence). Main Findings: Answer 1-The analysis based on mild skeptic prior shows beneficial results with the Intensive Insulin, rhAPC, and Low-Tidal Volume trials, but not with the Low-Dose Steroid and EGDT trials. All trials' results become unacceptable by the analyses using moderate or severe skeptic priors. Answer 2-If we aim for a RRR. 15%, the mild skeptic analysis shows that the current probability of reducing death by this clinical threshold is 88% for the Intensive Insulin, 62-65% for the Low-Tidal Volume, rhAPC, EGDT trials, and 17% for the Low-Dose Steroid trial. The moderate and severe skeptic analyses show no clinically meaningful reduction in the risk of death for all trials. If we aim for a RRR > 20% or > 25%, all probabilities of benefits become lower independent of the degree of skepticism. Conclusions: Our clinical threshold analysis offers a new bedside tool to be directly applied to the care of patients with severe sepsis. Our results demonstrate that the strength of evidence (statistical and clinical) is weak for all trials, particularly for the Low-Dose Steroid and EGDT trials. It is essential to replicate the results of each of these five clinical trials in confirmatory studies if we want to provide patient care based on scientifically sound evidence.	[Kalil, Andre C.] Univ Nebraska Med Ctr, Dept Internal Med, Omaha, NE 68198 USA; [Sun, Junfeng] Univ Nebraska, Coll Publ Hlth, Dept Biostat, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System	Kalil, AC (corresponding author), Univ Nebraska Med Ctr, Dept Internal Med, Omaha, NE 68198 USA.	akalil@unmc.edu						Abraham E, 2005, NEW ENGL J MED, V353, P1332, DOI 10.1056/NEJMoa050935; Abroug F, 2002, NEW ENGL J MED, V346, P1025; Alia I, 1999, CHEST, V115, P453, DOI 10.1378/chest.115.2.453; Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Annane D, 2003, CRIT CARE MED, V31, P1868, DOI 10.1097/01.CCM.0000063445.91548.20; Barton P, 2004, PEDIATRICS, V113, P7, DOI 10.1542/peds.113.1.7; Bernard GR, 2001, CRIT CARE MED, V29, P2051, DOI 10.1097/00003246-200111000-00003; Bernard GR, 2004, CHEST, V125, P2206, DOI 10.1378/chest.125.6.2206; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Biffl W, 2007, J TRAUMA, V62, P1375; Bollaert PE, 1998, CRIT CARE MED, V26, P645, DOI 10.1097/00003246-199804000-00010; BONE RC, 1987, NEW ENGL J MED, V317, P653, DOI 10.1056/NEJM198709103171101; Briegel J, 1999, CRIT CARE MED, V27, P723, DOI 10.1097/00003246-199904000-00025; Brochard L, 1998, AM J RESP CRIT CARE, V158, P1831, DOI 10.1164/ajrccm.158.6.9801044; BROPHY JM, 1995, JAMA-J AM MED ASSOC, V273, P871, DOI 10.1001/jama.273.11.871; Brower RG, 1999, CRIT CARE MED, V27, P1492, DOI 10.1097/00003246-199908000-00015; Brower RG, 2004, NEW ENGL J MED, V351, P327; BROWNER WS, 1987, JAMA-J AM MED ASSOC, V257, P2459, DOI 10.1001/jama.257.18.2459; Burton PR, 1998, J EPIDEMIOL COMMUN H, V52, P318, DOI 10.1136/jech.52.5.318; Clayton SB, 2006, CRIT CARE MED, V34, P2974, DOI 10.1097/01.CCM.0000248906.10399.CF; Davidoff F, 1999, ANN INTERN MED, V130, P1019, DOI 10.7326/0003-4819-130-12-199906150-00022; De Block C, 2006, DIABETES CARE, V29, P1750, DOI 10.2337/dc05-2353; de Durante G, 2002, AM J RESP CRIT CARE, V165, P1271, DOI 10.1164/rccm.2105050; Deans KJ, 2005, CRIT CARE MED, V33, P1141, DOI 10.1097/01.CCM.0000162384.71993.A3; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Diamond GA, 2004, J AM COLL CARDIOL, V43, P1929, DOI 10.1016/j.jacc.2004.01.035; Eichacker PQ, 2006, NEW ENGL J MED, V355, P1640, DOI 10.1056/NEJMp068197; Eichacker PQ, 2002, AM J RESP CRIT CARE, V166, P1197, DOI 10.1164/rccm.200204-302OC; Eichacker PQ, 2005, CRIT CARE MED, V33, P2426, DOI 10.1097/01.CCM.0000183002.26587.FF; Eichacker PQ, 2002, AM J RESP CRIT CARE, V166, P1510, DOI 10.1164/rccm.200208-956OC; Ellger B, 2008, ANAESTHESIST, V57, P43, DOI 10.1007/s00101-007-1285-7; Friedrich JO, 2006, CRIT CARE, V10, DOI 10.1186/cc5022; Friedrich JO, 2006, NEW ENGL J MED, V354, P94; Gandhi GY, 2007, ANN INTERN MED, V146, P233, DOI 10.7326/0003-4819-146-4-200702200-00002; GATTINONI L, 1995, NEW ENGL J MED, V333, P1025, DOI 10.1056/NEJM199510193331601; Gill CJ, 2005, BRIT MED J, V330, P1080, DOI 10.1136/bmj.330.7499.1080; Goldstein B, 2006, PEDIATR CRIT CARE ME, V7, P200, DOI 10.1097/01.PCC.0000217470.68764.36; Goodman SN, 2005, CLIN TRIALS, V2, P282, DOI 10.1191/1740774505cn098oa; Goodman SN, 1999, ANN INTERN MED, V130, P995, DOI 10.7326/0003-4819-130-12-199906150-00008; Greenland S, 2006, INT J EPIDEMIOL, V35, P765, DOI 10.1093/ije/dyi312; Group CS, 1963, JAMA-J AM MED ASSOC, V183, P462, DOI DOI 10.1001/JAMA.1963.63700060029012; Hamrahian AH, 2004, NEW ENGL J MED, V350, P1629, DOI 10.1056/NEJMoa020266; Harrell FE, 2001, INT J TECHNOL ASSESS, V17, P17, DOI 10.1017/S0266462301104034; HAYES MA, 1994, NEW ENGL J MED, V330, P1717, DOI 10.1056/NEJM199406163302404; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Ho BCH, 2006, CRIT CARE, V10, DOI 10.1186/cc4918; KLASTERSKY J, 1971, NEW ENGL J MED, V284, P1248, DOI 10.1056/NEJM197106032842206; Lacherade JC, 2007, INTENS CARE MED, V33, P814, DOI 10.1007/s00134-007-0543-0; Lin SM, 2006, SHOCK, V26, P551, DOI 10.1097/01.shk.0000232271.09440.8f; Loisa P, 2007, CRIT CARE, V11, DOI 10.1186/cc5696; LUCAS CE, 1984, ARCH SURG-CHICAGO, V119, P537; LUCE JM, 1988, AM REV RESPIR DIS, V138, P62, DOI 10.1164/ajrccm/138.1.62; Mackenzie AF, 2005, INTENS CARE MED, V31, P1624, DOI 10.1007/s00134-005-2829-4; Marik PE, 2002, NEW ENGL J MED, V346, P1025; Mitchell I, 2006, INTENS CARE MED, V32, P867, DOI 10.1007/s00134-006-0135-4; Nadel S, 2007, LANCET, V369, P836, DOI 10.1016/S0140-6736(07)60411-5; Natanson Charles, 2002, ACP J Club, V136, P90; PEDUZZI P, 1987, NEW ENGL J MED, V317, P659; Petersen JL, 2004, JAMA-J AM MED ASSOC, V292, P89, DOI 10.1001/jama.292.1.89; Ricard JD, 2003, AM J RESP CRIT CARE, V167, P1297, DOI 10.1164/rccm.2303003; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; RUBENFELD GD, 2001, AM J RESP CRIT CARE; Sarkar Samir, 2002, N Engl J Med, V346, P1025; Schultz MJ, 2006, PLOS MED, V3, P2177, DOI 10.1371/journal.pmed.0030456; Schultz MJ, 2005, J CRIT CARE, V20, P199, DOI 10.1016/j.jcrc.2005.05.007; SCHUMER W, 1976, ANN SURG, V184, P333, DOI 10.1097/00000658-197609000-00011; Siraux V, 2005, CRIT CARE MED, V33, P2479, DOI 10.1097/01.CCM.0000185641.87051.7C; Spiegelhalter D J, 2000, Health Technol Assess, V4, P1; Spiegelhalter DJ, 1999, BRIT MED J, V319, P508, DOI 10.1136/bmj.319.7208.508; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; SPRUNG CL, 1984, NEW ENGL J MED, V311, P1137, DOI 10.1056/NEJM198411013111801; Sterne JAC, 2001, BMJ-BRIT MED J, V322, P226, DOI 10.1136/bmj.322.7280.226; Stewart TE, 1998, NEW ENGL J MED, V338, P355, DOI 10.1056/NEJM199802053380603; THOMPSON WL, 1976, CLIN RES, V24, pA258; Tobin MJ, 2003, AM J RESP CRIT CARE, V168, P511, DOI 10.1164/rccm.2307001; Toschlog EA, 2007, J TRAUMA, V62, P1370, DOI 10.1097/TA.0b013e318047b7dc; TUCHSCHMIDT J, 1992, CHEST, V102, P216, DOI 10.1378/chest.102.1.216; Van den Berghe G, 2003, CRIT CARE MED, V31, P359, DOI 10.1097/01.CCM.0000045568.12881.10; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Villar J, 2006, CRIT CARE MED, V34, P1311, DOI 10.1097/01.CCM.0000215598.84885.01; Vriesendorp TM, 2006, CRIT CARE MED, V34, P96, DOI 10.1097/01.CCM.0000194536.89694.06; Warren HS, 2002, NEW ENGL J MED, V347, P1027, DOI 10.1056/NEJMsb020574; Wiedermann CJ, 2006, INTENS CARE MED, V32, P604, DOI 10.1007/s00134-006-0086-9; Wiedermann CJ, 2005, WIEN KLIN WOCHENSCHR, V117, P442, DOI 10.1007/s00508-005-0396-x; XIAOZHI W, 2007, CHIN CRIT CARE MED, V18, P661; Yildiz O, 2002, CRIT CARE, V6, P251, DOI 10.1186/cc1498; Yu MH, 1998, CRIT CARE MED, V26, P1011, DOI 10.1097/00003246-199806000-00018; YU MH, 1993, CRIT CARE MED, V21, P830, DOI 10.1097/00003246-199306000-00009; 2002, N ENGL J MED, V342, P1301	92	36	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2291	10.1371/journal.pone.0002291	http://dx.doi.org/10.1371/journal.pone.0002291			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509455	gold, Green Submitted, Green Published			2022-12-25	WOS:000262268500031
J	Castoe, TA; Jiang, ZJ; Gu, WJ; Wang, ZO; Pollock, DD				Castoe, Todd A.; Jiang, Zhi J.; Gu, Wanjun; Wang, Zhengyuan O.; Pollock, David D.			Adaptive Evolution and Functional Redesign of Core Metabolic Proteins in Snakes	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; MITOCHONDRIAL-DNA SEQUENCES; MOLECULAR EVOLUTION; PHYLOGENETIC ANALYSIS; SUBSTITUTION RATES; PROTON; AMPHISBAENIANS; ADAPTATION; RESIDUES; PROGRAM	Background: Adaptive evolutionary episodes in core metabolic proteins are uncommon, and are even more rarely linked to major macroevolutionary shifts. Methodology/Principal Findings: We conducted extensive molecular evolutionary analyses on snake mitochondrial proteins and discovered multiple lines of evidence suggesting that the proteins at the core of aerobic metabolism in snakes have undergone remarkably large episodic bursts of adaptive change. We show that snake mitochondrial proteins experienced unprecedented levels of positive selection, coevolution, convergence, and reversion at functionally critical residues. We examined Cytochrome C oxidase subunit I (COI) in detail, and show that it experienced extensive modification of normally conserved residues involved in proton transport and delivery of electrons and oxygen. Thus, adaptive changes likely altered the flow of protons and other aspects of function in CO, thereby influencing fundamental characteristics of aerobic metabolism. We refer to these processes as "evolutionary redesign" because of the magnitude of the episodic bursts and the degree to which they affected core functional residues. Conclusions/Significance: The evolutionary redesign of snake COI coincided with adaptive bursts in other mitochondrial proteins and substantial changes in mitochondrial genome structure. It also generally coincided with or preceded major shifts in ecological niche and the evolution of extensive physiological adaptations related to lung reduction, large prey consumption, and venom evolution. The parallel timing of these major evolutionary events suggests that evolutionary redesign of metabolic and mitochondrial function may be related to, or underlie, the extreme changes in physiological and metabolic efficiency, flexibility, and innovation observed in snake evolution.	[Castoe, Todd A.; Gu, Wanjun; Pollock, David D.] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO USA; [Jiang, Zhi J.; Wang, Zhengyuan O.] Louisiana State Univ, Biol Comp & Visualizat Ctr, Dept Bioll Sci, Baton Rouge, LA USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Louisiana State University System; Louisiana State University	Castoe, TA (corresponding author), Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO USA.	David.Pollock@uchsc.edu	Pollock, David D/M-4740-2016; Wang, Zhengyuan/GWV-6069-2022; wang, zhengyuan/HGA-0435-2022; Gu, Wanjun/B-3998-2010; Gu, Wanjun/P-5389-2019	Pollock, David D/0000-0002-7627-4214; wang, zhengyuan/0000-0002-8447-9674; Gu, Wanjun/0000-0003-4501-0539	NIH [LM009451, GM065612, GM065580]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R33GM065612, R24GM065580, R21GM065612] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM009451] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Support is gratefully acknowledged from an NIH training grant LM009451 (TAC) and NIH grants GM065612 and GM065580 (DDP). These funding sources had no role whatsoever in the design, conduct, collection, analysis, interpretation, or preparation of the manuscript.	Adkins RM, 1996, MOL BIOL EVOL, V13, P1393, DOI 10.1093/oxfordjournals.molbev.a025586; Andersen JB, 2005, NATURE, V434, P37, DOI 10.1038/434037a; Andrews TD, 1998, J MOL EVOL, V47, P249, DOI 10.1007/PL00006382; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Coates M, 2000, TRENDS ECOL EVOL, V15, P503, DOI 10.1016/S0169-5347(00)01999-6; Dalziel AC, 2006, J MOL EVOL, V62, P319, DOI 10.1007/s00239-005-0110-7; Dong S, 2005, J MOL EVOL, V61, P12, DOI 10.1007/s00239-004-0190-9; FETTER JR, 1995, P NATL ACAD SCI USA, V92, P1604, DOI 10.1073/pnas.92.5.1604; Fry BG, 2005, GENOME RES, V15, P403, DOI 10.1101/gr.3228405; Fry BG, 2006, NATURE, V439, P584, DOI 10.1038/nature04328; Greene H. W., 1997, SNAKES EVOLUTION MYS; Grossman LI, 2001, MOL PHYLOGENET EVOL, V18, P26, DOI 10.1006/mpev.2000.0890; Holman, 2000, FOSSIL SNAKES N AM O; Jiang ZJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-123; Kumazawa Y, 2004, DNA RES, V11, P137, DOI 10.1093/dnares/11.2.137; Kumazawa Y, 1996, MOL BIOL EVOL, V13, P1242, DOI 10.1093/oxfordjournals.molbev.a025690; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lynch VJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-2; McClellan DA, 2005, MOL BIOL EVOL, V22, P437, DOI 10.1093/molbev/msi028; Mccue MD, 2007, ZOOLOGY, V110, P318, DOI 10.1016/j.zool.2007.02.004; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; MUSE SV, 1994, MOL BIOL EVOL, V11, P715; Pesole G, 1999, J MOL EVOL, V48, P427, DOI 10.1007/PL00006487; Pollock DD, 1999, J MOL BIOL, V287, P187, DOI 10.1006/jmbi.1998.2601; Pond SK, 2005, MOL BIOL EVOL, V22, P2375, DOI 10.1093/molbev/msi232; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Qian J, 2004, BIOCHEMISTRY-US, V43, P5748, DOI 10.1021/bi036279o; Raina SZ, 2005, GENOME RES, V15, P665, DOI 10.1101/gr.3128605; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Russell F. E., 1967, ANIMAL TOXINS COLLEC; SECOR SM, 1995, J EXP BIOL, V198, P1313; Secor SM, 1998, NATURE, V395, P659, DOI 10.1038/27131; Shimokata K, 2007, P NATL ACAD SCI USA, V104, P4200, DOI 10.1073/pnas.0611627104; Slack KE, 2003, GENE, V302, P43, DOI 10.1016/S0378111902010533; STEWART CB, 1987, NATURE, V330, P401, DOI 10.1038/330401a0; THOMAS JW, 1993, BIOCHEMISTRY-US, V32, P10923, DOI 10.1021/bi00091a048; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Townsend TM, 2004, SYST BIOL, V53, P735, DOI 10.1080/10635150490522340; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Tsukihara T, 2003, P NATL ACAD SCI USA, V100, P15304, DOI 10.1073/pnas.2635097100; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; Vidal N, 2005, CR BIOL, V328, P1000, DOI 10.1016/j.crvi.2005.10.001; Wang ZYO, 2005, METHOD ENZYMOL, V395, P779, DOI 10.1016/S0076-6879(05)95040-4; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yoshikawa S, 2006, BBA-BIOENERGETICS, V1757, P1110, DOI 10.1016/j.bbabio.2006.06.004	47	93	93	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2201	10.1371/journal.pone.0002201	http://dx.doi.org/10.1371/journal.pone.0002201			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493604	Green Published, Green Submitted, gold			2022-12-25	WOS:000262258700010
J	Hunter, JH; Pang, CKT; Gujjar, R; Rathod, PK				Hunter, Joshua H.; Pang, Cullen K. T.; Gujjar, Ramesh; Rathod, Pradipsinh K.			Kinetics and Ligand-Binding Preferences of Mycobacterium tuberculosis Thymidylate Synthases, ThyA and ThyX	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; CATALYTIC MECHANISM; DIHYDROOROTATE DEHYDROGENASE; FUNCTIONAL-ANALYSIS; SELECTIVE ACTIVITY; MALARIA PARASITE; ACTIVE-SITE; DRUG DESIGN; INHIBITORS; FLAVIN	Background: Mycobacterium tuberculosis kills approximately 2 million people each year and presents an urgent need to identify new targets and new antitubercular drugs. Thymidylate synthase (TS) enzymes from other species offer good targets for drug development and the M. tuberculosis genome contains two putative TS enzymes, a conventional ThyA and a flavin-based ThyX. In M. tuberculosis, both TS enzymes have been implicated as essential for growth, either based on drug-resistance studies or genome-wide mutagenesis screens. To facilitate future small molecule inhibitors against these proteins, a detailed enzymatic characterization was necessary. Methodology/Principal Findings: After cloning, overexpression, and purification, the thymidylate-synthesizing ability of ThyA and ThyX gene products were directly confirmed by HPLC analysis of reaction products and substrate saturation kinetics were established. 5-Fluoro-2'-deoxyuridine 5'-monophosphate (FdUMP) was a potent inhibitor of both ThyA and ThyX, offering important clues to double-targeting strategies. In contrast, the folate-based 1843U89 was a potent inhibitor of ThyA but not ThyX suggesting that it should be possible to find ThyX-specific antifolates. A turnover-dependent kinetic assay, combined with the active-site titration approach of Ackermann and Potter, revealed that both M. tuberculosis enzymes had very low k(cat) values. One possible explanation for the low catalytic activity of M. tuberculosis ThyX is that its true biological substrates remain to be identified. Alternatively, this slow-growing pathogen, with low demands for TMP, may have evolved to down-regulate TS activities by altering the turnover rate of individual enzyme molecules, perhaps to preserve total protein quantities for other purposes. In many organisms, TS is often used as a part of larger complexes of macromolecules that control replication and DNA repair. Conclusions/Significance: Thus, the present enzymatic characterization of ThyA and ThyX from M. tuberculosis provides a framework for future development of cell-active inhibitors and the biological roles of these TS enzymes in M. tuberculosis.	[Hunter, Joshua H.; Pang, Cullen K. T.; Gujjar, Ramesh; Rathod, Pradipsinh K.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Rathod, Pradipsinh K.] Univ Washington, Dept Glob Hlth, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Hunter, JH (corresponding author), Univ Washington, Dept Chem, Seattle, WA 98195 USA.	rathod@chem.washington.edu			NIH [AI26912, AI60360]; Ellison Medical Foundation [Senior Scholar Award in Global Infectious Diseases]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026912, P01AI060360, R29AI026912] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants AI26912 and AI60360 and a Senior Scholar Award in Global Infectious Diseases from the Ellison Medical Foundation (PKR).	ACKERMANN WW, 1949, P SOC EXP BIOL MED, V72, P1; Agrawal N, 2004, BIOCHEMISTRY-US, V43, P10295, DOI 10.1021/bi0490439; Baldwin J, 2005, J BIOL CHEM, V280, P21847, DOI 10.1074/jbc.M501100200; Baldwin J, 2002, J BIOL CHEM, V277, P41827, DOI 10.1074/jbc.M206854200; CARRERAS CW, 1995, ANNU REV BIOCHEM, V64, P721, DOI 10.1146/annurev.bi.64.070195.003445; CHA S, 1975, BIOCHEM PHARMACOL, V24, P2177, DOI 10.1016/0006-2952(75)90050-7; CHA S, 1975, BIOCHEM PHARMACOL, V24, P2187, DOI 10.1016/0006-2952(75)90051-9; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; CHU E, 1993, P NATL ACAD SCI USA, V90, P517, DOI 10.1073/pnas.90.2.517; CHU E, 1991, P NATL ACAD SCI USA, V88, P8977, DOI 10.1073/pnas.88.20.8977; CURTIN NJ, 1991, CANCER RES, V51, P2346; DAVISSON VJ, 1989, J BIOL CHEM, V264, P9145; DEV IK, 1994, J BIOL CHEM, V269, P1873; DOLNICK BJ, 1977, J BIOL CHEM, V252, P7697; du Toit LC, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-118; Gattis SG, 2005, J AM CHEM SOC, V127, P832, DOI 10.1021/ja0432214; GOMEZ ZM, 1990, ANTIMICROB AGENTS CH, V34, P1371, DOI 10.1128/AAC.34.7.1371; Graziani S, 2004, J BIOL CHEM, V279, P54340, DOI 10.1074/jbc.M409121200; Graziani S, 2006, J BIOL CHEM, V281, P24048, DOI 10.1074/jbc.M600745200; Griffin J, 2005, J BIOL CHEM, V280, P5456, DOI 10.1074/jbc.M412415200; HARDY LW, 1987, SCIENCE, V235, P448, DOI 10.1126/science.3099389; Harper C, 2007, NAT MED, V13, P309, DOI 10.1038/nm0307-309; HekmatNejad M, 1996, ANTIMICROB AGENTS CH, V40, P1628, DOI 10.1128/AAC.40.7.1628; INGRAHAM HA, 1986, BIOCHEMISTRY-US, V25, P3225, DOI 10.1021/bi00359a022; Jiang L, 2000, ANTIMICROB AGENTS CH, V44, P1047, DOI 10.1128/AAC.44.4.1047-1050.2000; Keeler Emmett, 2006, Nature, V444 Suppl 1, P49, DOI 10.1038/nature05446; Kuhn P, 2002, PROTEINS, V49, P142, DOI 10.1002/prot.10202; Leduc D, 2004, P NATL ACAD SCI USA, V101, P7252, DOI 10.1073/pnas.0401365101; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Myllykallio H, 2002, SCIENCE, V297, P105, DOI 10.1126/science.1072113; PENDERGAST W, 1994, J MED CHEM, V37, P838, DOI 10.1021/jm00032a019; PHILLIPS MA, 2008, J MED CHEM IN PRESS; RATHOD PK, 1992, ANTIMICROB AGENTS CH, V36, P704, DOI 10.1128/AAC.36.4.704; RATHOD PK, 1989, ANTIMICROB AGENTS CH, V33, P1090, DOI 10.1128/AAC.33.7.1090; Rengarajan J, 2004, MOL MICROBIOL, V53, P275, DOI 10.1111/j.1365-2958.2004.04120.x; Sampathkumar P, 2005, J MOL BIOL, V352, P1091, DOI 10.1016/j.jmb.2005.07.071; Sampathkumar P, 2006, J MOL BIOL, V360, P1, DOI 10.1016/j.jmb.2006.04.061; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Stout TJ, 1999, BIOCHEMISTRY-US, V38, P1607, DOI 10.1021/bi9815896; Touroutoglou N, 1996, CLIN CANCER RES, V2, P227; Ulmer JE, 2008, J BACTERIOL, V190, P2056, DOI 10.1128/JB.01094-07; Van Triest B, 2000, ANN ONCOL, V11, P385, DOI 10.1023/A:1008351221345; WHITAKER JR, 1963, ANAL CHEM, V35, P1950, DOI 10.1021/ac60205a048; Zhang K, 2002, SCIENCE, V296, P545, DOI 10.1126/science.1068274	46	29	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2237	10.1371/journal.pone.0002237	http://dx.doi.org/10.1371/journal.pone.0002237			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493582	gold, Green Published, Green Submitted			2022-12-25	WOS:000262258700045
J	Makovski, T; Vazquez, GA; Jiang, YV				Makovski, Tal; Vazquez, Gustavo A.; Jiang, Yuhong V.			Visual Learning in Multiple-Object Tracking	PLOS ONE			English	Article								Background: Tracking moving objects in space is important for the maintenance of spatiotemporal continuity in everyday visual tasks. In the laboratory, this ability is tested using the Multiple Object Tracking ( MOT) task, where participants track a subset of moving objects with attention over an extended period of time. The ability to track multiple objects with attention is severely limited. Recent research has shown that this ability may improve with extensive practice (e.g., from action videogame playing). However, whether tracking also improves in a short training session with repeated trajectories has rarely been investigated. In this study we examine the role of visual learning in multiple-object tracking and characterize how varieties of attention interact with visual learning. Methodology/Principal Findings: Participants first conducted attentive tracking on trials with repeated motion trajectories for a short session. In a transfer phase we used the same motion trajectories but changed the role of tracking targets and nontargets. We found that compared with novel trials, tracking was enhanced only when the target subset was the same as that used during training. Learning did not transfer when the previously trained targets and nontargets switched roles or mixed up. However, learning was not specific to the trained temporal order as it transferred to trials where the motion was played backwards. Conclusions/Significance: These findings suggest that a demanding task of tracking multiple objects can benefit from learning of repeated motion trajectories. Such learning potentially facilitates tracking in natural vision, although learning is largely confined to the trajectories of attended objects. Furthermore, we showed that learning in attentive tracking relies on relational coding of all target trajectories. Surprisingly, learning was not specific to the trained temporal context, probably because observers have learned motion paths of each trajectory independently of the exact temporal order.	[Makovski, Tal; Vazquez, Gustavo A.; Jiang, Yuhong V.] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; [Vazquez, Gustavo A.] Univ Santiago, Dept Psychol, Santiago, Spain; [Jiang, Yuhong V.] Univ Minnesota, Ctr Cognitive Sci, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; Universidade de Santiago de Compostela; University of Minnesota System; University of Minnesota Twin Cities	Makovski, T (corresponding author), Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA.	tal.makovski@gmail.com		Makovski, Tal/0000-0002-6670-5834	NSF [0733764]; NIH [071788]	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported in part by NSF 0733764 and NIH 071788. These grants provided financial support but the funders had no other roles.	ALVAREZ GA, 2007, J VISION; Chun MM, 1998, COGNITIVE PSYCHOL, V36, P28, DOI 10.1006/cogp.1998.0681; Chun MM, 1999, PSYCHOL SCI, V10, P360, DOI 10.1111/1467-9280.00168; Fiser J, 2001, PSYCHOL SCI, V12, P499, DOI 10.1111/1467-9280.00392; Jiang YH, 2004, PERCEPT PSYCHOPHYS, V66, P454, DOI 10.3758/BF03194893; Jones J, 2007, PSYCHON B REV, V14, P295, DOI 10.3758/BF03194067; Keane BP, 2006, COGNITIVE PSYCHOL, V52, P346, DOI 10.1016/j.cogpsych.2005.12.001; KUNAR MA, WE USE CONTEXT UNPUB; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; OGAWA H, 2002, TECHNICAL REPORT ATT, V1, P1; Olson IR, 2001, J EXP PSYCHOL LEARN, V27, P1299, DOI 10.1037/0278-7393.27.5.1299; PYLYSHYN Z, 1989, COGNITION, V32, P65, DOI 10.1016/0010-0277(89)90014-0; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Shim WM, 2008, PSYCHON B REV, V15, P390, DOI 10.3758/PBR.15.2.390; TOMBU M, COGNITION IN PRESS; Turk-Browne NB, 2005, J EXP PSYCHOL GEN, V134, P552, DOI 10.1037/0096-3445.134.4.552; YANTIS S, 1992, COGNITIVE PSYCHOL, V24, P295, DOI 10.1016/0010-0285(92)90010-Y	17	26	28	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2228	10.1371/journal.pone.0002228	http://dx.doi.org/10.1371/journal.pone.0002228			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	391UK	18493599	Green Submitted, gold, Green Published			2022-12-25	WOS:000262258700036
J	Ohnishi, Y; Tamura, Y; Yoshida, M; Tokunaga, K; Hohjoh, H				Ohnishi, Yusuke; Tamura, Yoshiko; Yoshida, Mariko; Tokunaga, Katsushi; Hohjoh, Hirohiko			Enhancement of Allele Discrimination by Introduction of Nucleotide Mismatches into siRNA in Allele-Specific Gene Silencing by RNAi	PLOS ONE			English	Article								Allele-specific gene silencing by RNA interference (RNAi) is therapeutically useful for specifically inhibiting the expression of disease-associated alleles without suppressing the expression of corresponding wild-type alleles. To realize such allele-specific RNAi (ASP-RNAi), the design and assessment of small interfering RNA (siRNA) duplexes conferring ASP-RNAi is vital; however, it is also difficult. In a previous study, we developed an assay system to assess ASP-RNAi with mutant and wildtype reporter alleles encoding the Photinus and Renilla luciferase genes. In line with experiments using the system, we realized that it is necessary and important to enhance allele discrimination between mutant and corresponding wild-type alleles. Here, we describe the improvement of ASP-RNAi against mutant alleles carrying single nucleotide variations by introducing base substitutions into siRNA sequences, where original variations are present in the central position. Artificially mismatched siRNAs or short-hairpin RNAs (shRNAs) against mutant alleles of the human Prion Protein (PRNP) gene, which appear to be associated with susceptibility to prion diseases, were examined using this assessment system. The data indicates that introduction of a one-base mismatch into the siRNAs and shRNAs was able to enhance discrimination between the mutant and wild-type alleles. Interestingly, the introduced mismatches that conferred marked improvement in ASP-RNAi, appeared to be largely present in the guide siRNA elements, corresponding to the 'seed region' of microRNAs. Due to the essential role of the 'seed region' of microRNAs in their association with target RNAs, it is conceivable that disruption of the base-pairing interactions in the corresponding seed region, as well as the central position (involved in cleavage of target RNAs), of guide siRNA elements could influence allele discrimination. In addition, we also suggest that nucleotide mismatches at the 3'-ends of sense-strand siRNA elements, which possibly increase the assembly of antisensestrand (guide) siRNAs into RNA-induced silencing complexes (RISCs), may enhance ASP-RNAi in the case of inert siRNA duplexes. Therefore, the data presented here suggest that structural modification of functional portions of an siRNA duplex by base substitution could greatly influence allele discrimination and gene silencing, thereby contributing to enhancement of ASP-RNAi.	[Ohnishi, Yusuke; Tamura, Yoshiko; Yoshida, Mariko; Hohjoh, Hirohiko] NCNP, Natl Inst Neurosci, Dept Mol Genet, Tokyo, Japan; [Ohnishi, Yusuke; Tokunaga, Katsushi] Univ Tokyo, Grad Sch Med, Dept Human Genet, Tokyo, Japan	National Center for Neurology & Psychiatry - Japan; University of Tokyo	Ohnishi, Y (corresponding author), NCNP, Natl Inst Neurosci, Dept Mol Genet, Tokyo, Japan.	hohjohh@ncnp.go.jp			Ministry of Health, Labor, Welfare in Japan; Japan Society for the Promotion of Science [Research Fellowships, Grant-in-Aid]	Ministry of Health, Labor, Welfare in Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by research grants from the Ministry of Health, Labor, Welfare in Japan, and from Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists, and also by a Grant-in-Aid from the Japan Society for the Promotion of Science.	Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bonini NM, 2005, NEURON, V48, P715, DOI 10.1016/j.neuron.2005.11.008; Caplen NJ, 2004, GENE THER, V11, P1241, DOI 10.1038/sj.gt.3302324; Chen SG, 1997, NAT MED, V3, P1009, DOI 10.1038/nm0997-1009; Collinge J, 1997, HUM MOL GENET, V6, P1699, DOI 10.1093/hmg/6.10.1699; Denovan-Wright EM, 2006, GENE THER, V13, P525, DOI 10.1038/sj.gt.3302664; Du Q, 2005, NUCLEIC ACIDS RES, V33, P1671, DOI 10.1093/nar/gki312; Dykxhoorn DM, 2003, NAT REV MOL CELL BIO, V4, P457, DOI 10.1038/nrm1129; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Hohjoh H, 2004, FEBS LETT, V557, P193, DOI 10.1016/S0014-5793(03)01492-3; HSIAO K, 1989, NATURE, V338, P342, DOI 10.1038/338342a0; Jackson GS, 2001, J CLIN PATHOL-MOL PA, V54, P393; Karagiannis TC, 2005, CANCER GENE THER, V12, P787, DOI 10.1038/sj.cgt.7700857; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Maxwell MM, 2004, P NATL ACAD SCI USA, V101, P3178, DOI 10.1073/pnas.0308726100; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Miller VM, 2004, NUCLEIC ACIDS RES, V32, P661, DOI 10.1093/nar/gkh208; Miller VM, 2003, P NATL ACAD SCI USA, V100, P7195, DOI 10.1073/pnas.1231012100; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; Ohnishi Y, 2005, BIOCHEM BIOPH RES CO, V329, P516, DOI 10.1016/j.bbrc.2005.02.012; Ohnishi Yusuke, 2006, J RNAi Gene Silencing, V2, P154; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Raoul C, 2005, NAT MED, V11, P423, DOI 10.1038/nm1207; Rodriguez-Lebron E, 2006, GENE THER, V13, P576, DOI 10.1038/sj.gt.3302702; Schwarz DS, 2006, PLOS GENET, V2, P1307, DOI 10.1371/journal.pgen.0020140; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Singer O, 2005, NAT NEUROSCI, V8, P1343, DOI 10.1038/nn1531; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; Victor M, 2002, EMBO REP, V3, P50, DOI 10.1093/embo-reports/kvf006; Wood M, 2007, PLOS GENET, V3, P845, DOI 10.1371/journal.pgen.0030109; Xia HB, 2004, NAT MED, V10, P816, DOI 10.1038/nm1076; Yamada M, 1999, NEUROLOGY, V53, P181, DOI 10.1212/WNL.53.1.181; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434	35	44	50	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2248	10.1371/journal.pone.0002248	http://dx.doi.org/10.1371/journal.pone.0002248			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493311	Green Published, Green Submitted, gold			2022-12-25	WOS:000262258700055
J	Yang, Y; Iwanaga, K; Raso, MG; Wislez, M; Hanna, AE; Wieder, ED; Molldrem, JJ; Wistuba, II; Powis, G; Demayo, FJ; Kim, CF; Kurie, JM				Yang, Yanan; Iwanaga, Kentaro; Raso, Maria Gabriela; Wislez, Marie; Hanna, Amy E.; Wieder, Eric D.; Molldrem, Jeffrey J.; Wistuba, Ignacio I.; Powis, Garth; Demayo, Francesco J.; Kim, Carla F.; Kurie, Jonathan M.			Phosphatidylinositol 3-Kinase Mediates Bronchioalveolar Stem Cell Expansion in Mouse Models of Oncogenic K-ras-Induced Lung Cancer	PLOS ONE			English	Article								Background: Non-small cell lung cancer (NSCLC) is the most common cause of cancer-related death in Western countries. Developing more effective NSCLC therapeutics will require the elucidation of the genetic and biochemical bases for this disease. Bronchioalveolar stem cells (BASCs) are a putative cancer stem cell population in mouse models of oncogenic K-ras-induced lung adenocarcinoma, an histologic subtype of NSCLC. The signals activated by oncogenic K-ras that mediate BASC expansion have not been fully defined. Methodology/Principal Findings: We used genetic and pharmacologic approaches to modulate the activity of phosphatidylinositol 3-kinase (PI3K), a key mediator of oncogenic K-ras, in two genetic mouse models of lung adenocarcinoma. Oncogenic K-ras-induced BASC accumulation and tumor growth were blocked by treatment with a small molecule PI3K inhibitor and enhanced by inactivation of phosphatase and tensin homologue deleted from chromosome 10, a negative regulator of PI3K. Conclusions/Significance: We conclude that PI3K is a critical regulator of BASC expansion, supporting treatment strategies to target PI3K in NSCLC patients.	[Yang, Yanan; Iwanaga, Kentaro; Hanna, Amy E.; Wistuba, Ignacio I.; Kurie, Jonathan M.] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Raso, Maria Gabriela; Wistuba, Ignacio I.] Univ Texas M D Anderson Canc Ctr, Dept Pathol, Houston, TX USA; [Wislez, Marie] Univ Paris 06, UFR Pierre Marie Curie, Hop Tenon, Assistance Publ Hop Paris AP HP, Paris, France; [Wieder, Eric D.; Molldrem, Jeffrey J.] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplant Res, Houston, TX USA; [Powis, Garth] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX USA; [Demayo, Francesco J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX USA; [Kim, Carla F.] Harvard Med Sch, Harvard Stem Cell Inst, Dept Genet, Childrens Hosp Stem Cell Program, Boston, MA USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; Harvard University; Harvard Medical School	Yang, Y (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA.	jkurie@mdanderson.org	Yang, Yanan/F-1592-2010; DeMayo, Francesco/C-6255-2019; raso, maria/AAS-2118-2020; Raso, Maria Gabriela/J-9898-2019	DeMayo, Francesco/0000-0002-9480-7336; raso, maria/0000-0003-2105-5556; wislez, marie/0000-0001-7518-7859	 [R01 CA117965];  [R01 CA105155];  [U01 CA105352]; NATIONAL CANCER INSTITUTE [R01CA117965, U01CA105352, R01CA105155, P50CA070907] Funding Source: NIH RePORTER	; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	R01 CA117965, R01 CA105155, U01 CA105352	Angulo B, 2008, J PATHOL, V214, P347, DOI 10.1002/path.2267; Aviel-Ronen S, 2006, CLIN LUNG CANCER, V8, P30, DOI 10.3816/CLC.2006.n.030; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Forgacs E, 1998, ONCOGENE, V17, P1557, DOI 10.1038/sj.onc.1202070; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Ihle NT, 2004, MOL CANCER THER, V3, P763; Iwanaga K, 2008, CANCER RES, V68, P1119, DOI 10.1158/0008-5472.CAN-07-3117; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Ji H, 2006, ONCOGENE, V25, P2105, DOI 10.1038/sj.onc.1209237; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Marsit CJ, 2005, HUM PATHOL, V36, P768, DOI 10.1016/j.humpath.2005.05.006; Mori M, 1996, CANCER, V77, P665, DOI 10.1002/(SICI)1097-0142(19960215)77:4<665::AID-CNCR12>3.0.CO;2-Z; Rawlins EL, 2006, DEVELOPMENT, V133, P2455, DOI 10.1242/dev.02407; Soria JC, 2002, CLIN CANCER RES, V8, P1178; Wislez M, 2005, CANCER RES, V65, P3226, DOI 10.1158/0008-5472.CAN-04-4420; Xia DR, 2007, J BIOL CHEM, V282, P3507, DOI 10.1074/jbc.M610141200; Yanagi S, 2007, J CLIN INVEST, V117, P2929, DOI 10.1172/JCI31854; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703	24	63	64	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2220	10.1371/journal.pone.0002220	http://dx.doi.org/10.1371/journal.pone.0002220			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493606	gold, Green Submitted, Green Published			2022-12-25	WOS:000262258700028
J	Huang, J; Ma, L; Yang, F; Fei, SZ; Li, LJ				Huang, Jing; Ma, Lu; Yang, Fei; Fei, Shui-zhang; Li, Lijia			45S rDNA Regions Are Chromosome Fragile Sites Expressed as Gaps In Vitro on Metaphase Chromosomes of Root-Tip Meristematic Cells in Lolium spp	PLOS ONE			English	Article							RIBOSOMAL DNA; HOMOZYGOUS DELETIONS; GENE AMPLIFICATION; COMMON; CHECKPOINT; BREAKAGE; CANCER; REARRANGEMENTS; SEQUENCE; CLONING	Background: In humans, chromosome fragile sites are regions that are especially prone to forming non-staining gaps, constrictions or breaks in one or both of the chromatids on metaphase chromosomes either spontaneously or following partial inhibition of DNA synthesis and have been well identified. So far, no plant chromosome fragile sites similar to those in human chromosomes have been reported. Methods and Results: During the course of cytological mapping of rDNA on ryegrass chromosomes, we found that the number of chromosomes plus chromosome fragments was often more than the expected 14 in most cells for Lolium perenne L. cv. Player by close cytological examination using a routine chromosome preparation procedure. Further fluorescent in situ hybridization (FISH) using 45S rDNA as a probe indicated that the root-tip cells having more than a 14-chromosome plus chromosome fragment count were a result of chromosome breakage or gap formation in vitro (referred to as chromosome lesions) at 45S rDNA sites, and 86% of the cells exhibited chromosome breaks or gaps and all occurred at the sites of 45S rDNA in Lolium perenne L. cv. Player, as well as in L. multiflorum Lam. cv. Top One. Chromatin depletion or decondensation occurred at various locations within the 45S rDNA regions, suggesting heterogeneity of lesions of 45S rDNA sites with respect to their position within the rDNA region. Conclusions: The chromosome lesions observed in this study are very similar cytologically to that of fragile sites observed in human chromosomes, and thus we conclude that the high frequency of chromosome lesions in vitro in Lolium species is the result of the expression of 45S rDNA fragile sites. Possible causes for the spontaneous expression of fragile sites and their potential biological significance are discussed.	[Huang, Jing; Ma, Lu; Yang, Fei; Li, Lijia] Wuhan Univ, Coll Life Sci, Key Lab, Minist Educ MOE Plant Dev Biol, Wuhan 430072, Peoples R China; [Fei, Shui-zhang] Iowa State Univ, Dept Horticult & Interdept Plant Physiol, Mol Biol, Ames, IA USA	Wuhan University; Iowa State University	Huang, J (corresponding author), Wuhan Univ, Coll Life Sci, Key Lab, Minist Educ MOE Plant Dev Biol, Wuhan 430072, Peoples R China.	ljli@whu.edu.cn		Huang, Jing/0000-0001-6411-8356; Ma, Lu/0000-0001-5271-0686	National Natural Science Foundation of China [30771204]; Program for New Century Excellent Talents in University [NCET-07-0634]; Natural Science Foundation of Hubei Province [2005ABA097]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	This research was supported by grants from the National Natural Science Foundation of China (No. 30771204), Program for New Century Excellent Talents in University (NCET-07-0634) and the Natural Science Foundation of Hubei Province (No. 2005ABA097).	Arlt MF, 2004, MOL CELL BIOL, V24, P6701, DOI 10.1128/mcb.24.15.6701-6709.2004; Boldog F, 1997, HUM MOL GENET, V6, P193, DOI 10.1093/hmg/6.2.193; BOLDOG FL, 1994, GENE CHROMOSOME CANC, V11, P216, DOI 10.1002/gcc.2870110403; BUTLER DK, 1992, GENETICS, V131, P581; Buttel I, 2004, ANN NY ACAD SCI, V1028, P14, DOI 10.1196/annals.1322.002; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Cimprich KA, 2003, CURR BIOL, V13, pR231, DOI 10.1016/S0960-9822(03)00158-1; Coffee B, 2002, AM J HUM GENET, V71, P923, DOI 10.1086/342931; CONCONI A, 1989, CELL, V57, P753, DOI 10.1016/0092-8674(89)90790-3; Coquelle A, 1997, CELL, V89, P215, DOI 10.1016/S0092-8674(00)80201-9; Culligan K, 2004, PLANT CELL, V16, P1091, DOI 10.1105/tpc.018903; Durand-Dubief M, 2007, EMBO J, V26, P2477, DOI 10.1038/sj.emboj.7601690; Earley K, 2006, GENE DEV, V20, P1283, DOI 10.1101/gad.1417706; Fan QC, 2000, NUCLEIC ACIDS RES, V28, P895, DOI 10.1093/nar/28.4.895; Gatei M, 2001, ONCOGENE, V20, P289, DOI 10.1038/sj.onc.1204111; Gericke GS, 1999, MED HYPOTHESES, V52, P201, DOI 10.1054/mehy.1997.0643; Glover TW, 2006, CANCER LETT, V232, P4, DOI 10.1016/j.canlet.2005.08.032; GLOVER TW, 1984, HUM GENET, V67, P136, DOI 10.1007/BF00272988; Gu YH, 1996, NAT GENET, V13, P109, DOI 10.1038/ng0596-109; Handt O, 2000, CHROMOSOME RES, V8, P677, DOI 10.1023/A:1026737203447; Huang Y, 2002, NUCLEIC ACIDS RES, V30, P1465, DOI 10.1093/nar/30.7.1465; Huebner K, 2001, NAT REV CANCER, V1, P214, DOI 10.1038/35106058; LAIRD C, 1987, TRENDS GENET, V3, P274, DOI 10.1016/0168-9525(87)90268-X; Lamming DW, 2006, SCIENCE, V312, DOI 10.1126/science.1124767; Lawrence RJ, 2004, MOL CELL, V13, P599, DOI 10.1016/S1097-2765(04)00064-4; Li LJ, 2001, THEOR APPL GENET, V102, P658, DOI 10.1007/s001220051694; MAGENIS RE, 1970, SCIENCE, V170, P85, DOI 10.1126/science.170.3953.85; McStay B, 2006, GENE DEV, V20, P1207, DOI 10.1101/gad.1436906; Mishmar D, 1998, P NATL ACAD SCI USA, V95, P8141, DOI 10.1073/pnas.95.14.8141; Morgan W. G., 2000, Cytologia (Tokyo), V65, P173, DOI 10.1508/cytologia.65.173; NELSON DL, 1995, SEMIN CELL BIOL, V6, P5, DOI 10.1016/1043-4682(95)90009-8; PERKINS DD, 1995, GENETICS, V141, P909; POMPONI MG, 1994, AM J MED GENET, V51, P447, DOI 10.1002/ajmg.1320510428; Popescu NC, 2003, CANCER LETT, V192, P1, DOI 10.1016/S0304-3835(02)00596-7; RAMANATHAN B, 1989, J BIOL CHEM, V264, P11026; RASSOOL FV, 1991, P NATL ACAD SCI USA, V88, P6657, DOI 10.1073/pnas.88.15.6657; Richards RI, 2001, TRENDS GENET, V17, P339, DOI 10.1016/S0168-9525(01)02303-4; Ried K, 2000, HUM MOL GENET, V9, P1651, DOI 10.1093/hmg/9.11.1651; ROBERTFORTEL I, 1993, CHROMOSOMA, V102, P146, DOI 10.1007/BF00387729; SCHUBERT I, 1985, CHROMOSOMA, V92, P143, DOI 10.1007/BF00328466; Schwartz M, 2006, CANCER LETT, V232, P13, DOI 10.1016/j.canlet.2005.07.039; Siroky J, 2003, CHROMOSOMA, V112, P116, DOI 10.1007/s00412-003-0251-7; SONG YC, 1995, THEOR APPL GENET, V90, P113, DOI 10.1007/BF00221003; Sutherland GR, 1998, TRENDS GENET, V14, P501, DOI 10.1016/S0168-9525(98)01628-X; SUTHERLAND GR, 1984, AM J HUM GENET, V36, P110; Thomas HM, 2001, CHROMOSOME RES, V9, P585, DOI 10.1023/A:1012499303514; Thomas HM, 1996, CHROMOSOME RES, V4, P486, DOI 10.1007/BF02261775; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Wang YH, 2006, CANCER LETT, V232, P70, DOI 10.1016/j.canlet.2005.07.040; Wang YH, 1996, J BIOL CHEM, V271, P22937, DOI 10.1074/jbc.271.38.22937; WINFIELD MO, 1995, GENOME, V38, P869, DOI 10.1139/g95-115; YAO MC, 1981, CELL, V24, P765, DOI 10.1016/0092-8674(81)90102-1; Yarden RI, 2002, NAT GENET, V30, P285, DOI 10.1038/ng837; Yu S, 1997, CELL, V88, P367, DOI 10.1016/S0092-8674(00)81875-9	54	64	69	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2167	10.1371/journal.pone.0002167	http://dx.doi.org/10.1371/journal.pone.0002167			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478113	Green Published, gold, Green Submitted			2022-12-25	WOS:000262172800032
J	Ranuncolo, SM; Wang, L; Polo, JM; Dell'Oso, T; Dierov, J; Gaymes, TJ; Rassool, F; Carroll, M; Melnick, A				Ranuncolo, Stella Maris; Wang, Ling; Polo, Jose M.; Dell'Oso, Tania; Dierov, Jamil; Gaymes, Terry J.; Rassool, Feyruz; Carroll, Martin; Melnick, Ari			BCL6-mediated attenuation of DNA damage sensing triggers growth arrest and senescence through a p53-dependent pathway in a cell context-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTER B-CELLS; LYMPHOMA-CELLS; BCL6; EXPRESSION; DIFFERENTIATION; ACTIVATION; ATR; APOPTOSIS; TUMORIGENESIS; PATHOGENESIS	The BCL6 oncogenic transcriptional repressor is required for development of germinal center centroblasts, which undergo simultaneous genetic recombination and massive clonal expansion. Although BCL6 is required for survival of centroblasts, its expression in earlier B-cells is toxic. Understanding these opposing effects could provide critical insight into normal B-cell biology and lymphomagenesis. We examined the transcriptional and biological effects of BCL6 in various primary cells. BCL6 repression of ATR was previously shown to play a critical role in the centroblast phenotype. Likewise, we found that BCL6 could impose an ATR-dependent phenotype of attenuated DNA damage sensing and repair in primary fibroblasts and B-cells. BCL6 induced true genomic instability because DNA repair was delayed and was qualitatively impaired, which could be critical for BCL6-induced lymphomagenesis. Although BCL6 can directly repress TP53 in centroblasts, BCL6 induced TP53 expression in primary fibroblasts and B-cells, and these cells underwent p53-dependent growth arrest and senescence in the presence of physiological levels of BCL6. This differential ability to trigger a functional p53 response explains at least in part the different biological response to BCL6 expression in centroblasts versus other cells. The data suggest that targeted re-activation of TP53 could be of therapeutic value in centroblast-derived lymphomas.	[Ranuncolo, Stella Maris; Wang, Ling; Polo, Jose M.; Dell'Oso, Tania; Melnick, Ari] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Dierov, Jamil; Carroll, Martin] Univ Penn, Div Hematol Oncol, Philadelphia, PA 19104 USA; [Rassool, Feyruz] Univ Maryland, Sch Med, Dept Radiat Oncol, Baltimore, MD 21201 USA; [Gaymes, Terry J.] Kings Coll London, Dept Haematol Med, Leukaem Sci Labs, Rayne Inst, London SE5 9NU, England	Yeshiva University; Albert Einstein College of Medicine; University of Pennsylvania; University System of Maryland; University of Maryland Baltimore; University of London; King's College London	Melnick, A (corresponding author), Weill Cornell Sch Med, Div Hematol & Med Oncol, 1300 York Ave, New York, NY 10065 USA.	amm2014@med.cornell.edu	Melnick, Ari/AAA-5763-2020	Polo, Jose M/0000-0002-2531-778X; Ranuncolo, Stella/0000-0001-7775-9048	NCI NIH HHS [R01 CA104348, R01 CA100885] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA100885, R01CA104348] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Albagli O, 1999, ONCOGENE, V18, P5063, DOI 10.1038/sj.onc.1202892; Albagli-Curiel O, 2003, ONCOGENE, V22, P507, DOI 10.1038/sj.onc.1206152; Allman D, 1996, BLOOD, V87, P5257, DOI 10.1182/blood.V87.12.5257.bloodjournal87125257; Baron BW, 2004, P NATL ACAD SCI USA, V101, P14198, DOI 10.1073/pnas.0406138101; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Boggs K, 2006, ONCOGENE, V25, P555, DOI 10.1038/sj.onc.1209076; Cattoretti G, 2005, CANCER CELL, V7, P445, DOI 10.1016/j.ccr.2005.03.037; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Fujita N, 2004, CELL, V119, P75, DOI 10.1016/j.cell.2004.09.014; Garcia-Muse T, 2005, EMBO J, V24, P4345, DOI 10.1038/sj.emboj.7600896; Gil VS, 2007, BLOOD, V110, p118A; He B, 2004, J IMMUNOL, V172, P3268, DOI 10.4049/jimmunol.172.5.3268; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; Kumagai T, 1999, ONCOGENE, V18, P467, DOI 10.1038/sj.onc.1202306; Kuo TC, 2007, J EXP MED, V204, P819, DOI 10.1084/jem.20062104; Kusam S, 2004, ONCOGENE, V23, P839, DOI 10.1038/sj.onc.1207065; Kusam S, 2003, J IMMUNOL, V170, P2435, DOI 10.4049/jimmunol.170.5.2435; Oh SM, 2004, ONCOGENE, V23, P8282, DOI 10.1038/sj.onc.1208021; Parekh S, 2007, BLOOD, V110, P2067, DOI 10.1182/blood-2007-01-069575; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pasqualucci L, 2008, NAT GENET, V40, P108, DOI 10.1038/ng.2007.35; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; Polo JM, 2004, NAT MED, V10, P1329, DOI 10.1038/nm1134; Polo JM, 2007, P NATL ACAD SCI USA, V104, P3207, DOI 10.1073/pnas.0611399104; Ranuncolo SM, 2007, NAT IMMUNOL, V8, P705, DOI 10.1038/ni1478; Schmitt CA, 2003, NAT REV CANCER, V3, P286, DOI 10.1038/nrc1044; Shechter D, 2005, CELL CYCLE, V4, P235; Shvarts A, 2002, GENE DEV, V16, P681, DOI 10.1101/gad.929302; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Yamochi T, 1999, ONCOGENE, V18, P487, DOI 10.1038/sj.onc.1202334; Ye BH, 2000, CANCER INVEST, V18, P356, DOI 10.3109/07357900009012179; Zhang H, 2001, BBA-MOL CELL RES, V1540, P188, DOI 10.1016/S0167-4889(01)00128-8	35	30	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22565	22572		10.1074/jbc.M803490200	http://dx.doi.org/10.1074/jbc.M803490200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18524763	hybrid, Green Published			2022-12-25	WOS:000258321000025
J	Udagawa, T; Nemoto, N; Wilkinson, CRM; Narashimhan, J; Jiang, L; Watt, S; Zook, A; Jones, N; Wek, RC; Bahler, J; Asano, K				Udagawa, Tsuyoshi; Nemoto, Naoki; Wilkinson, Caroline R. M.; Narashimhan, Jana; Jiang, Li; Watt, Stephen; Zook, Aaron; Jones, Nic; Wek, Ronald C.; Bahler, Jurg; Asano, Katsura			Int6/eIF3e promotes general translation and Atf1 abundance to modulate Sty1 MAPK-dependent stress response in fission yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHIZOSACCHAROMYCES-POMBE; TRANSCRIPTIONAL RESPONSE; 2-CYS PEROXIREDOXIN; PROTEIN-KINASE; EIF3; INTEGRATION; ACTIVATION; RESISTANCE; EXPRESSION; INT-6	int-6 is one of the frequent integration sites for mouse mammary tumor viruses. Although its product is the e-subunit of translation initiation factor eIF3, other evidence indicates that it interacts with proteasomes or other proteins to regulate protein stability. Here we report that the fission yeast int6(+) is required for overcoming stress imposed by histidine starvation, using the drug 3-aminotriazole (3AT). Microarray and complementary Northern studies using wild-type, int6 Delta or gcn2 Delta mutants indicate that 3AT-treated wild-type yeast induces core environmental stress response (CESR) genes in addition to typical general amino acid control (GAAC) genes whose transcription depends on the eIF2 kinase, Gcn2. In agreement with this, Sty1 MAPK and its target transcription factor Atf1, which signal the CESR, are required for overcoming 3AT-induced starvation. We find that Int6 is required for maintaining the basal level of Atf1 and for rapid transcriptional activation of the CESR on 3AT-insult. Pulse labeling experiments indicate that int6 Delta significantly slows down de novo protein synthesis. Moreover, Atf1 protein half-life was reduced in int6 Delta cells. These effects would account for the compromised Atf1 activity on 3AT-induced stress. Thus, the robust protein synthesis promoted by intact eIF3 appears to be a part of the requisites for sound Sty1 MAPK-dependent signaling governed by the activity of the Atf1 transcription factor.	[Udagawa, Tsuyoshi; Nemoto, Naoki; Zook, Aaron; Asano, Katsura] Kansas State Univ, Div Biol, Mol Cellular & Dev Biol Program, Manhattan, KS 66506 USA; [Wilkinson, Caroline R. M.; Jones, Nic] Univ Manchester, Paterson Inst Canc Res, Canc Res UK Cell Regulat Lab, Manchester M20 4BX, Lancs, England; [Narashimhan, Jana; Jiang, Li; Wek, Ronald C.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Watt, Stephen; Bahler, Jurg] Wellcome Trust Sanger Inst, Canc Res UK Fiss Yeast Funct Genom Grp, Cambridge CB10 1HH, England	Kansas State University; Paterson Institute for Cancer Research; University of Manchester; Indiana University System; Indiana University-Purdue University Indianapolis; Wellcome Trust Sanger Institute	Asano, K (corresponding author), Kansas State Univ, Div Biol, Mol Cellular & Dev Biol Program, Ackert Hall, Manhattan, KS 66506 USA.	kasano@ksu.edu	Bahler, Jurg/B-4572-2009	Bahler, Jurg/0000-0003-4036-1532	Cancer Research UK [12485] Funding Source: researchfish; Cancer Research UK [A6517, C9546/A6517] Funding Source: Medline; NCRR NIH HHS [P20 RR016475] Funding Source: Medline; NIGMS NIH HHS [GM49164, GM67481] Funding Source: Medline; Wellcome Trust [077118] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049164, R29GM049164] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akiyoshi Y, 2001, J BIOL CHEM, V276, P10056, DOI 10.1074/jbc.M010188200; Asano K, 1998, J BIOL CHEM, V273, P18573, DOI 10.1074/jbc.273.29.18573; Asano K, 1997, J BIOL CHEM, V272, P23477, DOI 10.1074/jbc.272.38.23477; Bhoumik A, 2004, P NATL ACAD SCI USA, V101, P4222, DOI 10.1073/pnas.0400195101; Bozonet SM, 2005, J BIOL CHEM, V280, P23319, DOI 10.1074/jbc.M502757200; Buchsbaum S, 2007, ONCOGENE, V26, P5132, DOI 10.1038/sj.onc.1210314; Callahan R, 2000, ONCOGENE, V19, P992, DOI 10.1038/sj.onc.1203276; Chen DR, 2008, MOL BIOL CELL, V19, P308, DOI 10.1091/mbc.E07-08-0735; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Chen L, 2007, J BIOL CHEM, V282, P12707, DOI 10.1074/jbc.M700423200; Crane R, 2000, MOL BIOL CELL, V11, P3993, DOI 10.1091/mbc.11.11.3993; Degols G, 1996, MOL CELL BIOL, V16, P2870; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Durand-Dubief M, 2007, EMBO J, V26, P2477, DOI 10.1038/sj.emboj.7601690; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Harrison C, 2005, EMBO J, V24, P599, DOI 10.1038/sj.emboj.7600536; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Huguier S, 1998, MOL CELL BIOL, V18, P7020, DOI 10.1128/MCB.18.12.7020; Humphrey T, 1998, GENETICS, V148, P1731; Ikner A, 2005, MUTAT RES-FUND MOL M, V569, P13, DOI 10.1016/j.mrfmmm.2004.09.006; Kanoh J, 1996, GENES CELLS, V1, P391, DOI 10.1046/j.1365-2443.1996.d01-247.x; KEENEY JB, 1994, GENETICS, V136, P849; Lawrence CL, 2007, J BIOL CHEM, V282, P5160, DOI 10.1074/jbc.M608526200; LeFebvre AK, 2006, J BIOL CHEM, V281, P22917, DOI 10.1074/jbc.M605418200; Li Y, 2000, ONCOGENE, V19, P1002, DOI 10.1038/sj.onc.1203273; Lyne R, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-27; Masutani M, 2007, EMBO J, V26, P3373, DOI 10.1038/sj.emboj.7601765; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Penkett CJ, 2006, NUCLEIC ACIDS RES, V34, pW330, DOI 10.1093/nar/gkl311; Phan L, 1998, MOL CELL BIOL, V18, P4935, DOI 10.1128/MCB.18.8.4935; Quinn J, 2002, MOL BIOL CELL, V13, P805, DOI 10.1091/mbc.01-06-0288; Reiter W, 2008, J BIOL CHEM, V283, P9945, DOI 10.1074/jbc.M710428200; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; Smith DA, 2002, J BIOL CHEM, V277, P33411, DOI 10.1074/jbc.M204593200; Tanay A, 2005, P NATL ACAD SCI USA, V102, P7203, DOI 10.1073/pnas.0502521102; Ueda M, 2003, FEMS MICROBIOL LETT, V219, P93, DOI 10.1016/S0378-1097(02)01201-6; Veal EA, 2004, MOL CELL, V15, P129, DOI 10.1016/j.molcel.2004.06.021; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Watanabe Y, 1996, MOL CELL BIOL, V16, P704; Wilkinson MG, 1998, GENE DEV, V12, P1391, DOI 10.1101/gad.12.10.1391; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Yamada T, 2004, EMBO J, V23, P1792, DOI 10.1038/sj.emboj.7600138; Yen HCS, 2003, CELL, V112, P207, DOI 10.1016/S0092-8674(03)00043-6; Zhan K, 2004, GENETICS, V168, P1867, DOI 10.1534/genetics.104.031443; Zhan K, 2002, MOL CELL BIOL, V22, P7134, DOI 10.1128/MCB.22.20.7134-7146.2002; Zhou CS, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-14	48	33	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22063	22075		10.1074/jbc.M710017200	http://dx.doi.org/10.1074/jbc.M710017200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18502752	Green Published, hybrid			2022-12-25	WOS:000258114700025
J	Lopez-Contreras, AJ; Ramos-Molina, B; Cremades, A; Penafiel, R				Lopez-Contreras, Andres J.; Ramos-Molina, Bruno; Cremades, Asuncion; Penafiel, Rafael			Antizyme inhibitor 2 (AZIN2/ODCp) stimulates polyamine uptake in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORNITHINE-DECARBOXYLASE ANTIZYME; ARGININE DECARBOXYLASE; FEEDBACK REPRESSION; HOMOLOGOUS PROTEIN; GENE-EXPRESSION; TISSUE-CULTURE; INHIBITOR; TRANSPORT; GROWTH; CANCER	One of the processes that regulate intracellular levels of polyamines in mammalian cells is polyamine uptake. We have measured polyamine uptake in COS7 cells for putrescine, spermidine, and spermine, obtaining K-m values of 4.5, 1.0, and 0.8 mu M, respectively. Treatment of nonconfluent cells with cycloheximide stimulated polyamine uptake and prevented the inhibitory effect found in cells preloaded with polyamines, suggesting the existence of a feedback repression mechanism mediated by antizymes. Transient transfected cells with mutated antizyme forms of AZ1, AZ2, and AZ3, which do not require frameshifting, showed a total blockade of polyamine uptake. Transfection of COS7 cells with mouse or human AZIN2, a novel member of the antizyme inhibitor family, recently characterized by our group, markedly stimulated polyamine uptake and counteracted the action of any of the three antizymes in co-transfected cells. The stimulatory effect of AZIN2 on polyamine uptake was abrogated when the putative antizyme binding sequence, formed by residues 117-140 in AZIN2, was deleted. Real time reverse transcriptionPCR analysis of antizyme inhibitor transcripts revealed that in brain and testes AZIN2 is more expressed than AZIN1, especially in the testes where the relative expression was about 25-fold higher. Collectively, our results clearly indicate that AZIN2 affects polyamine homeostasis not only by increasing ornithine decarboxylase activity but also by stimulating polyamine uptake, through negating the inhibitory effect of the antizymes. This finding may have physiological relevance, mostly in testes where AZ3 and AZIN2 are mainly expressed.	[Lopez-Contreras, Andres J.; Ramos-Molina, Bruno; Penafiel, Rafael] Univ Murcia, Fac Med, Dept Biochem & Mol Biol B & Immunol, E-30100 Murcia, Spain; [Cremades, Asuncion] Univ Murcia, Fac Med, Dept Pharmacol, E-30100 Murcia, Spain	University of Murcia; University of Murcia	Penafiel, R (corresponding author), Univ Murcia, Fac Med, Dept Biochem & Mol Biol B & Immunol, Campus Espinardo, E-30100 Murcia, Spain.	rapegar@um.es	Ramos-Molina, Bruno/K-8303-2019; Lopez-Contreras, Andres J/AAA-1110-2020; Molina, Bruno Ramos/A-4574-2017; Penafiel, Rafael/H-2660-2015; Ramos-Molina, Bruno/L-7876-2015	Ramos-Molina, Bruno/0000-0001-6804-5449; Molina, Bruno Ramos/0000-0001-6804-5449; Penafiel, Rafael/0000-0002-5816-1056; Lopez-Contreras, Andres Joaquin/0000-0002-5517-7327				AUVINEN M, 1992, NATURE, V360, P355, DOI 10.1038/360355a0; Bercovich Z, 2004, J BIOL CHEM, V279, P54097, DOI 10.1074/jbc.M410234200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243; Childs AC, 2003, CELL MOL LIFE SCI, V60, P1394, DOI 10.1007/s00018-003-2332-4; Choi KS, 2005, BIOCHEM BIOPH RES CO, V328, P206, DOI 10.1016/j.bbrc.2004.11.172; Coffino P, 2001, NAT REV MOL CELL BIO, V2, P188, DOI 10.1038/35056508; Cohen S.S., 1998, GUIDE POLYAMINES, V1st ed.; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; HAKOVIRTA H, 1993, MOL ENDOCRINOL, V7, P1430, DOI 10.1210/me.7.11.1430; Hayashi S, 1996, TRENDS BIOCHEM SCI, V21, P27, DOI 10.1016/0968-0004(96)80882-6; Igarashi K, 1999, BIOCHEM J, V344, P633, DOI 10.1042/0264-6021:3440633; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; Ivanov IP, 2000, P NATL ACAD SCI USA, V97, P4808, DOI 10.1073/pnas.070055897; Ivanov IP, 1998, GENOMICS, V52, P119, DOI 10.1006/geno.1998.5434; Johnson TD, 1996, TRENDS PHARMACOL SCI, V17, P22, DOI 10.1016/0165-6147(96)81566-5; Jung MH, 2000, GENOMICS, V69, P281, DOI 10.1006/geno.2000.6338; Kanerva K, 2008, BIOCHEM J, V409, P187, DOI 10.1042/BJ20071004; Keren-Paz A, 2006, ONCOGENE, V25, P5163, DOI 10.1038/sj.onc.1209521; Kim SW, 2006, J CELL SCI, V119, P2853, DOI 10.1242/jcs.02966; KITANI T, 1989, BIOCHIM BIOPHYS ACTA, V991, P44, DOI 10.1016/0304-4165(89)90026-3; LI XQ, 1992, MOL CELL BIOL, V12, P3556, DOI 10.1128/MCB.12.8.3556; Lopez-Contreras AJ, 2006, J BIOL CHEM, V281, P30896, DOI 10.1074/jbc.M602840200; Mangold U, 2006, CELL MOL LIFE SCI, V63, P2095, DOI 10.1007/s00018-005-5583-4; Mangold U, 2005, IUBMB LIFE, V57, P671, DOI 10.1080/15216540500307031; Mangold U, 2005, BIOCHEM J, V385, P21, DOI 10.1042/BJ20040547; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; MITCHELL JLA, 1992, BIOCHEM BIOPH RES CO, V186, P81, DOI 10.1016/S0006-291X(05)80778-8; MITCHELL JLA, 1994, BIOCHEM J, V299, P19, DOI 10.1042/bj2990019; Mitchell JLA, 2004, BIOCHEM J, V384, P271, DOI 10.1042/BJ20040972; Murakami Y, 1996, J BIOL CHEM, V271, P3340, DOI 10.1074/jbc.271.7.3340; Nilsson J, 2000, BIOCHEM J, V346, P699, DOI 10.1042/0264-6021:3460699; PEGG AE, 1988, CANCER RES, V48, P759; Pegg AE, 2006, J BIOL CHEM, V281, P14529, DOI 10.1074/jbc.R500031200; Pitkanen LT, 2001, BIOCHEM BIOPH RES CO, V287, P1051, DOI 10.1006/bbrc.2001.5703; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schaner ME, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-26; Seiler N, 1996, INT J BIOCHEM CELL B, V28, P843, DOI 10.1016/1357-2725(96)00021-0; Seiler N, 2004, AMINO ACIDS, V26, P217, DOI 10.1007/s00726-004-0070-z; Snapir Z, 2008, BIOCHEM J, V410, P613, DOI 10.1042/BJ20071423; Soulet D, 2002, BIOCHEM J, V367, P347, DOI 10.1042/BJ20020764; SUZUKI T, 1994, P NATL ACAD SCI USA, V91, P8930, DOI 10.1073/pnas.91.19.8930; Takahashi Y, 2005, J BIOL CHEM, V280, P24195, DOI 10.1074/jbc.M411913200; Thomas T, 2001, CELL MOL LIFE SCI, V58, P244, DOI 10.1007/PL00000852; Tosaka Y, 2000, GENES CELLS, V5, P265, DOI 10.1046/j.1365-2443.2000.00324.x; van Duin M, 2005, GENE CHROMOSOME CANC, V44, P438, DOI 10.1002/gcc.20259; Wallace HM, 2003, BIOCHEM J, V376, P1, DOI 10.1042/BJ20031327; Zhu C, 1999, J BIOL CHEM, V274, P26425, DOI 10.1074/jbc.274.37.26425; Zhu MY, 2004, BBA-GEN SUBJECTS, V1670, P156, DOI 10.1016/j.bbagen.2003.11.006	49	31	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20761	20769		10.1074/jbc.M801024200	http://dx.doi.org/10.1074/jbc.M801024200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18508777	Green Published, hybrid			2022-12-25	WOS:000257746100017
J	Telci, D; Wang, Z; Li, X; Verderio, EAM; Humphries, MJ; Baccarini, M; Basaga, H; Griffin, M				Telci, Dilek; Wang, Zhuo; Li, Xiaoling; Verderio, Elisabetta A. M.; Humphries, Martin J.; Baccarini, Manuela; Basaga, Huveyda; Griffin, Martin			Fibronectin-tissue transglutaminase matrix rescues RGD-impaired cell adhesion through syndecan-4 and beta(1) integrin co-signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SWISS 3T3 FIBROBLASTS; HEPARIN-BINDING SITE; KINASE-C-ALPHA; EXTRACELLULAR-MATRIX; PKC-ALPHA; DOMAIN; EXPRESSION; MIGRATION; MOTILITY; ENZYME	Human ChlR1 (hChlR1), a member of the DEAD/DEAH subfamily of helicases, was shown to interact with components of the cohesin complex and play a role in sister chromatid cohesion. In order to study the biochemical and biological properties of hChlR1, we purified the protein from 293 cells and demonstrated that hChlR1 possesses DNA-dependent ATPase and helicase activities. This helicase translocates on single-stranded DNA in the 5' to 3' direction in the presence of ATP and, to a lesser extent, dATP. Its unwinding activity requires a 5'-single-stranded region for helicase loading, since flush-ended duplex structures do not support unwinding. The helicase activity of hChlR1 is capable of displacing duplex regions up to 100 bp, which can be extended to 500 bp by RPA or the cohesion establishment factor, the Ctf18-RFC (replication factor C) complex. We show that hChlR1 interacts with the hCtf18-RFC complex, human proliferating cell nuclear antigen, and hFen1. The interactions between Fen1 and hChlR1 stimulate the flap endonuclease activity of Fen1. Selective depletion of either hChlR1 or Fen1 by targeted small interfering RNA treatment results in the precocious separation of sister chromatids. These findings are consistent with a role of hChlR1 in the establishment of sister chromatid cohesion and suggest that its action may contribute to lagging strand processing events important in cohesion.	[Telci, Dilek; Wang, Zhuo; Li, Xiaoling; Griffin, Martin] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Telci, Dilek; Basaga, Huveyda] Sabanci Univ, Fac Engn & Nat Sci, Biol Sci & Bioengn Program, TR-34956 Istanbul, Turkey; [Verderio, Elisabetta A. M.] Nottingham Trent Univ, Sch Biomed & Nat Sci, Nottingham NG11 8NS, England; [Humphries, Martin J.] Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England; [Baccarini, Manuela] Max F Perutz Labs, Dept Microbiol & Immunol, A-1030 Vienna, Austria	Aston University; Sabanci University; Nottingham Trent University; University of Manchester; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Griffin, M (corresponding author), Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England.	M.Griffin@aston.ac.uk	Verderio, Elisabetta/H-2789-2016; Telci, Dilek/N-5053-2019; Baccarini, Manuela/B-6481-2014; Telci, Dilek/B-5880-2017	Verderio, Elisabetta/0000-0001-9153-8997; Telci, Dilek/0000-0002-2793-6533; Baccarini, Manuela/0000-0002-3033-391X; Telci, Dilek/0000-0002-2793-6533; Griffin, Martin/0000-0003-3824-306X; WANG, ZHUO/0000-0002-2212-8318; Humphries, Martin/0000-0002-4331-6967				AESCHLIMANN D, 1994, THROMB HAEMOSTASIS, V71, P402; Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Balklava Z, 2002, J BIOL CHEM, V277, P16567, DOI 10.1074/jbc.M109836200; Bass MD, 2007, J CELL BIOL, V177, P527, DOI 10.1083/jcb.200610076; Bass MD, 2002, BIOCHEM J, V368, P1, DOI 10.1042/BJ20021228; Belkin AM, 2001, J BIOL CHEM, V276, P18415, DOI 10.1074/jbc.M010135200; Bloom L, 1999, MOL BIOL CELL, V10, P1521, DOI 10.1091/mbc.10.5.1521; Chau DYS, 2005, BIOMATERIALS, V26, P6518, DOI 10.1016/j.biomaterials.2005.04.017; Couchman JR, 2001, INT REV CYTOL, V207, P113; Dovas A, 2006, J CELL SCI, V119, P2837, DOI 10.1242/jcs.03020; Ehrenreiter K, 2005, J CELL BIOL, V168, P955, DOI 10.1083/jcb.200409162; FASSLER R, 1995, GENE DEV, V9, P1896, DOI 10.1101/gad.9.15.1896; Fok JY, 2006, MOL CANCER THER, V5, P1493, DOI 10.1158/1535-7163.MCT-06-0083; FREUND KF, 1994, BIOCHEMISTRY-US, V33, P10109, DOI 10.1021/bi00199a039; Gambetti S, 2005, BIOCHIMIE, V87, P551, DOI 10.1016/j.biochi.2005.01.012; Gaudry CA, 1999, J BIOL CHEM, V274, P30707, DOI 10.1074/jbc.274.43.30707; GRIFFIN M, 1979, BRIT J EXP PATHOL, V60, P653; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; Haroon ZA, 1999, FASEB J, V13, P1787, DOI 10.1096/fasebj.13.13.1787; HARSFALVI J, 1987, BIOCHIM BIOPHYS ACTA, V923, P42, DOI 10.1016/0304-4165(87)90123-1; Humphries MJ, 2004, BIOCHEM SOC T, V32, P822, DOI 10.1042/BST0320822; Johnson TS, 2003, J AM SOC NEPHROL, V14, P2052, DOI 10.1097/01.ASN.0000079614.63463.DD; Johnson TS, 1999, J AM SOC NEPHROL, V10, P2146; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Leblanc A, 1999, PROTEIN EXPRES PURIF, V17, P89, DOI 10.1006/prep.1999.1107; Lim ST, 2003, J BIOL CHEM, V278, P13795, DOI 10.1074/jbc.M208300200; McFall AJ, 1997, J BIOL CHEM, V272, P12901, DOI 10.1074/jbc.272.20.12901; McFall AJ, 1998, J BIOL CHEM, V273, P28270, DOI 10.1074/jbc.273.43.28270; Midwood KS, 2004, INT J BIOCHEM CELL B, V36, P1031, DOI 10.1016/j.biocel.2003.12.003; Mirza A, 1997, AM J PHYSIOL-GASTR L, V272, pG281, DOI 10.1152/ajpgi.1997.272.2.G281; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Mostafavi-Pour Z, 2003, J CELL BIOL, V161, P155, DOI 10.1083/jcb.200210176; Mostafavi-Pour Z, 2001, MATRIX BIOL, V20, P63, DOI 10.1016/S0945-053X(00)00131-1; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; Parsons M, 2002, MOL CELL BIOL, V22, P5897, DOI 10.1128/MCB.22.16.5897-5911.2002; Piacentini M, 2005, PROG EXP TUMOR RES, V38, P58; Saito Y, 2007, J BIOL CHEM, V282, P34929, DOI 10.1074/jbc.M705608200; Shi Q, 2003, MOL BIOL CELL, V14, P4306, DOI 10.1091/mbc.E03-01-0046; Skill NJ, 2004, J BIOL CHEM, V279, P47754, DOI 10.1074/jbc.M402698200; Takahashi H, 2000, J BIOL CHEM, V275, P23589, DOI 10.1074/jbc.M003526200; Telci D, 2006, FRONT BIOSCI-LANDMRK, V11, P867, DOI 10.2741/1843; Thodeti CK, 2003, J BIOL CHEM, V278, P9576, DOI 10.1074/jbc.M208937200; Thomazy VA, 1999, CELL DEATH DIFFER, V6, P146, DOI 10.1038/sj.cdd.4400464; Verderio E, 1998, EXP CELL RES, V239, P119, DOI 10.1006/excr.1997.3874; Verderio EAM, 2004, AMINO ACIDS, V26, P387, DOI 10.1007/s00726-004-0094-4; Verderio EAM, 2003, J BIOL CHEM, V278, P42604, DOI 10.1074/jbc.M303303200; Wilcox-Adelman SA, 2002, J BIOL CHEM, V277, P32970, DOI 10.1074/jbc.M201283200; WOODS A, 1986, EMBO J, V5, P665, DOI 10.1002/j.1460-2075.1986.tb04265.x; Woods A, 2000, ARCH BIOCHEM BIOPHYS, V374, P66, DOI 10.1006/abbi.1999.1607	50	97	100	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20937	20947		10.1074/jbc.M801763200	http://dx.doi.org/10.1074/jbc.M801763200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18499669	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000257746100036
J	Moulton, VR; Kyttaris, VC; Juang, YT; Chowdhury, B; Tsokos, GC				Moulton, Vaishali R.; Kyttaris, Vasileios C.; Juang, Yuang-Taung; Chowdhury, Bhabadeb; Tsokos, George C.			The RNA-stabilizing protein HuR regulates the expression of zeta chain of the human T cell receptor-associated CD3 complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; SPLICED 3'-UNTRANSLATED REGION; MESSENGER-RNA; TCR-ZETA; DECREASED EXPRESSION; BINDING-PROTEINS; TCR/CD3 COMPLEX; IL-2 PRODUCTION; DOWN-REGULATION	T cell dysfunction is crucial to the pathogenesis of systemic lupus erythematosus (SLE); however, the molecular mechanisms involved in the deficient expression of the T cell receptor-associated CD3 zeta chain in SLE are not clear. SLE T cells express abnormally increased levels of an alternatively spliced isoform of CD3 zeta that lacks a 562-bp region in its 3'-untranslated region (UTR). We showed previously that two adenosine/uridine-rich elements (ARE) in this splice-deleted region of CD3 zeta transcript are critical for the mRNA stability and protein expression of CD3 zeta. In this study we show for the first time that the mRNA-stabilizing protein HuR binds to these two ARE bearing regions of CD3 zeta 3'-UTR. Knockdown of HuR resulted in decreased expression of the CD3 zeta chain, whereas overexpression led to the increase of CD3 zeta chain levels. Additionally, overexpression of HuR in human T cells resulted in increased mRNA stability of CD3 zeta. Our results identify the 3'-UTR of CD3 zeta as a novel target for the mRNA-stabilizing protein HuR. Thus, the absence of two critical AREs in the alternatively spliced CD3 zeta 3'-UTR found in SLE T cells may result in decreased HuR binding, representing a possible molecular mechanism contributing to the reduced stability and expression of CD3 zeta zeta in SLE.	[Moulton, Vaishali R.; Kyttaris, Vasileios C.; Juang, Yuang-Taung; Tsokos, George C.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Rheumatol,Dept Med, Boston, MA 02115 USA; [Chowdhury, Bhabadeb] NIAID, NIH, Lab Mol Immunol, Bethesda, MD 20892 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Tsokos, GC (corresponding author), 3330 Brookline Ave,E-CLS 937, Boston, MA 02115 USA.	gtsokos@bidmc.harvard.edu	tsokos, george C/O-3360-2013	tsokos, george C/0000-0001-9589-2360	NIAID NIH HHS [R01 AI 42269, R01 AI042269] Funding Source: Medline; NIAMS NIH HHS [K23 AR055672-01A1, K23 AR055672] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR055672] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Blaxall BC, 2000, MOL CARCINOGEN, V28, P76; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Chen YIG, 2007, NUCLEIC ACIDS RES, V35, P3928, DOI 10.1093/nar/gkm347; Chowdhury B, 2005, J BIOL CHEM, V280, P18959, DOI 10.1074/jbc.M501048200; Chowdhury B, 2006, J IMMUNOL, V177, P8248, DOI 10.4049/jimmunol.177.11.8248; Cok SJ, 2004, J BIOL CHEM, V279, P8196, DOI 10.1074/jbc.M308475200; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; de Silanes IL, 2003, ONCOGENE, V22, P7146, DOI 10.1038/sj.onc.1206862; Dean JLE, 2001, MOL CELL BIOL, V21, P721, DOI 10.1128/MCB.21.3.721-730.2001; Denkert C, 2004, CLIN CANCER RES, V10, P5580, DOI 10.1158/1078-0432.CCR-04-0070; Denkert C, 2004, CANCER RES, V64, P189, DOI 10.1158/0008-5472.CAN-03-1987; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Ford LP, 1999, GENE DEV, V13, P188, DOI 10.1101/gad.13.2.188; Gao M, 2001, EMBO J, V20, P1134, DOI 10.1093/emboj/20.5.1134; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Gorospe M, 2003, CELL CYCLE, V2, P412, DOI 10.4161/cc.2.5.491; Juang YT, 2002, J IMMUNOL, V169, P6048, DOI 10.4049/jimmunol.169.10.6048; Juang YT, 2005, J CLIN INVEST, V115, P996, DOI 10.1172/JCI22854; Keene JD, 2001, P NATL ACAD SCI USA, V98, P7018, DOI 10.1073/pnas.111145598; Kiledjian M, 1997, MOL CELL BIOL, V17, P4870, DOI 10.1128/MCB.17.8.4870; Krishnan S, 2003, J IMMUNOL, V170, P4189, DOI 10.4049/jimmunol.170.8.4189; Krishnan S, 2005, J IMMUNOL, V175, P3417, DOI 10.4049/jimmunol.175.5.3417; Kyttaris VC, 2005, CURR OPIN RHEUMATOL, V17, P518, DOI 10.1097/01.bor.0000170479.01451.ab; Kyttaris VC, 2004, J IMMUNOL, V173, P3557, DOI 10.4049/jimmunol.173.5.3557; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; Linker K, 2005, NUCLEIC ACIDS RES, V33, P4813, DOI 10.1093/nar/gki797; Ma WJ, 1997, NUCLEIC ACIDS RES, V25, P3564, DOI 10.1093/nar/25.18.3564; MAYEDA A, 1992, CELL, V68, P365, DOI 10.1016/0092-8674(92)90477-T; Michael WM, 1997, EMBO J, V16, P3587, DOI 10.1093/emboj/16.12.3587; Nambiar MP, 2003, ARTHRITIS RHEUM, V48, P1948, DOI 10.1002/art.11072; Nambiar MP, 2001, J AUTOIMMUN, V16, P133, DOI 10.1006/jaut.2000.0475; Nambiar MP, 2001, ARTHRITIS RHEUM, V44, P1336, DOI 10.1002/1529-0131(200106)44:6<1336::AID-ART226>3.0.CO;2-8; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Park SM, 2000, MOL CELL BIOL, V20, P4765, DOI 10.1128/MCB.20.13.4765-4772.2000; Seko Y, 2006, AUTOIMMUN REV, V5, P299, DOI 10.1016/j.autrev.2005.10.013; Sengupta S, 2003, J BIOL CHEM, V278, P25227, DOI 10.1074/jbc.M301813200; Tolnay M, 2000, BIOCHEM J, V348, P151, DOI 10.1042/0264-6021:3480151; Tsokos GC, 2003, TRENDS IMMUNOL, V24, P259, DOI 10.1016/S1471-4906(03)00100-5; Tsuzaka K, 2005, J IMMUNOL, V174, P3518, DOI 10.4049/jimmunol.174.6.3518; VASSILOPOULOS D, 1995, J IMMUNOL, V155, P2269; Wang WG, 2000, EMBO J, V19, P2340, DOI 10.1093/emboj/19.10.2340; WEISSMAN AM, 1988, P NATL ACAD SCI USA, V85, P9709, DOI 10.1073/pnas.85.24.9709	44	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20037	20044		10.1074/jbc.M710434200	http://dx.doi.org/10.1074/jbc.M710434200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18505733	Green Published, hybrid			2022-12-25	WOS:000257565300019
J	Zhang, NY; Tang, ZY; Liu, CW				Zhang, Nan-Yan; Tang, Zhiyong; Liu, Chang-Wei			alpha-synuclein protofibrils inhibit 26 S proteasome-mediated protein degradation - Understanding the cytotoxicity of protein protofibrils in neurodegenerative disease pathogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL PARKINSONS-DISEASE; SOLUBLE AMYLOID OLIGOMERS; INCLUSION-BODY FORMATION; LEWY BODIES; POLYUBIQUITIN CHAINS; LOCUS TRIPLICATION; CELL-DEATH; AGGREGATION; MUTATION; PATHWAY	The impaired ubiquitin- proteasome activity is believed to be one of the leading factors that contribute to Parkinson disease pathogenesis partially by causing alpha-synuclein aggregation. However, the relationship between alpha- synuclein aggregation and the impaired proteasome activity is yet unclear. In this study, we examined the effects of three soluble alpha-synuclein species (monomer, dimer, and protofibrils) on the degradation activity of the 26 S proteasome by reconstitution of proteasomal degradation using highly purified 26 S proteasomes and model substrates. We found that none of the three soluble alpha-synuclein species impaired the three distinct peptidase activities of the 26 S proteasome when using fluorogenic peptides as substrates. In striking contrast, alpha-synuclein protofibrils, but not monomer and dimer, markedly inhibited the ubiquitin-independent proteasomal degradation of unstructured proteins and ubiquitin-dependent degradation of folded proteins when present at 5-fold molar excess to the 26 S proteasome. Together these results indicate that alpha-synuclein protofibrils have a pronounced inhibitory effect on 26 S proteasome-mediated protein degradation. Because alpha-synuclein is a substrate of the proteasome, impaired proteasomal activity could further cause alpha-synuclein accumulation/aggregation, thus creating a vicious cycle and leading to Parkinson disease pathogenesis. Furthermore we found that alpha-synuclein protofibrils bound both the 26 S proteasome and substrates of the 26 S proteasome. Accordingly we propose that the inhibitory effect of alpha-synuclein protofibrils on 26 S proteasomal degradation might result from impairing substrate translocation by binding the proteasome or sequestrating proteasomal substrates by binding the substrates.	[Zhang, Nan-Yan; Liu, Chang-Wei] Univ Colorado Denver, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Tang, Zhiyong] Natl Ctr Nanosci & Technol, Beijing 10080, Peoples R China	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Chinese Academy of Sciences; National Center for Nanoscience & Technology - China	Liu, CW (corresponding author), Univ Colorado Denver, Sch Med, Dept Biochem & Mol Genet, POB 6511,Mail Stop 8101, Aurora, CO 80045 USA.	Changwei.liu@uchsc.edu	tang, zhiyong/A-8563-2008; li, zhiyuan/HGD-9581-2022	tang, zhiyong/0000-0003-0610-0064; 				Bennett MC, 1999, J BIOL CHEM, V274, P33855, DOI 10.1074/jbc.274.48.33855; Borissenko L, 2007, CHEM REV, V107, P687, DOI 10.1021/cr0502504; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen L, 2006, NEUROBIOL DIS, V23, P120, DOI 10.1016/j.nbd.2006.02.004; Chen QH, 2005, J BIOL CHEM, V280, P30009, DOI 10.1074/jbc.M501308200; Chen XY, 2004, MOL CELL, V16, P839, DOI 10.1016/j.molcel.2004.11.011; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; DeMartino GN, 1996, J BIOL CHEM, V271, P3112, DOI 10.1074/jbc.271.6.3112; deRijk MC, 1997, J NEUROL NEUROSUR PS, V62, P10, DOI 10.1136/jnnp.62.1.10; Ding TT, 2002, BIOCHEMISTRY-US, V41, P10209, DOI 10.1021/bi020139h; Fernagut PO, 2004, NEUROBIOL DIS, V17, P123, DOI 10.1016/j.nbd.2004.07.001; Fornai F, 2003, J NEUROSCI, V23, P8955; Fujita M, 2007, J BIOL CHEM, V282, P5736, DOI 10.1074/jbc.M606175200; Ghee M, 2000, J NEUROCHEM, V75, P2221, DOI 10.1046/j.1471-4159.2000.0752221.x; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Ii K, 1997, J NEUROPATH EXP NEUR, V56, P125, DOI 10.1097/00005072-199702000-00002; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kisselev AF, 1999, J BIOL CHEM, V274, P3363, DOI 10.1074/jbc.274.6.3363; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kristiansen M, 2007, MOL CELL, V26, P175, DOI 10.1016/j.molcel.2007.04.001; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; KUZUHARA S, 1988, ACTA NEUROPATHOL, V75, P345, DOI 10.1007/BF00687787; Lee HJ, 2002, J BIOL CHEM, V277, P48976, DOI 10.1074/jbc.M208192200; Lee VMY, 2006, NEURON, V52, P33, DOI 10.1016/j.neuron.2006.09.026; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Lin Pei-Yin, 2007, Mol Cancer, V6, P16, DOI 10.1186/1476-4598-6-16; Lindersson E, 2004, J BIOL CHEM, V279, P12924, DOI 10.1074/jbc.M306390200; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; Liu CW, 2005, J BIOL CHEM, V280, P22670, DOI 10.1074/jbc.M501508200; Lo BC, 2002, P NATL ACAD SCI USA, V99, P10813; Martin-Clemente B, 2004, J BIOL CHEM, V279, P52984, DOI 10.1074/jbc.M409028200; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; McNaught KS, 2002, NEUROREPORT, V13, P1437, DOI 10.1097/00001756-200208070-00018; McNaught KS, 2002, J NEUROCHEM, V81, P301, DOI 10.1046/j.1471-4159.2002.00821.x; McNaught KS, 2003, EXP NEUROL, V179, P38, DOI 10.1006/exnr.2002.8050; McNaught KSP, 2004, ANN NEUROL, V56, P149, DOI 10.1002/ana.20186; Miller DW, 2004, NEUROLOGY, V62, P1835, DOI 10.1212/01.WNL.0000127517.33208.F4; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Piotrowski J, 1997, J BIOL CHEM, V272, P23712, DOI 10.1074/jbc.272.38.23712; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Rechsteiner M, 2005, TRENDS CELL BIOL, V15, P27, DOI 10.1016/j.tcb.2004.11.003; Roy S, 2007, MOL CANCER THER, V6, P2696, DOI 10.1158/1535-7163.MCT-07-0104; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; Shults CW, 2006, P NATL ACAD SCI USA, V103, P1661, DOI 10.1073/pnas.0509567103; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Snyder H, 2003, J BIOL CHEM, V278, P11753, DOI 10.1074/jbc.M208641200; Souza JM, 2000, J BIOL CHEM, V275, P18344, DOI 10.1074/jbc.M000206200; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tanaka Y, 2001, HUM MOL GENET, V10, P919, DOI 10.1093/hmg/10.9.919; Tang Zhanyun, 2004, Methods Mol Biol, V281, P227; Tofaris GK, 2001, FEBS LETT, V509, P22, DOI 10.1016/S0014-5793(01)03115-5; TSENG BP, 2007, NEUROBIOL A IN PRESS; Uversky VN, 2007, J NEUROCHEM, V103, P17, DOI 10.1111/j.1471-4159.2007.04764.x; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	69	84	87	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20288	20298		10.1074/jbc.M710560200	http://dx.doi.org/10.1074/jbc.M710560200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18502751	hybrid			2022-12-25	WOS:000257565300045
J	Lee, JH; Culver, G; Carpenter, S; Dobbs, D				Lee, Jae-Hyung; Culver, Gloria; Carpenter, Susan; Dobbs, Drena			Analysis of the EIAV Rev-Responsive Element (RRE) Reveals a Conserved RNA Motif Required for High Affinity Rev Binding in Both HIV-1 and EIAV	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SECONDARY STRUCTURE; NUCLEOTIDE-SEQUENCE; NUCLEAR EXPORT; MESSENGER-RNA; FUNCTIONAL-ANALYSIS; STRUCTURED REGION; WEB SERVER; PROTEIN; INFORMATION	A cis-acting RNA regulatory element, the Rev-responsive element (RRE), has essential roles in replication of lentiviruses, including human immunodeficiency virus (HIV-1) and equine infection anemia virus ( EIAV). The RRE binds the viral transacting regulatory protein, Rev, to mediate nucleocytoplasmic transport of incompletely spliced mRNAs encoding viral structural genes and genomic RNA. Because of its potential as a clinical target, RRE-Rev interactions have been well studied in HIV-1; however, detailed molecular structures of Rev-RRE complexes in other lentiviruses are still lacking. In this study, we investigate the secondary structure of the EIAV RRE and interrogate regulatory protein-RNA interactions in EIAV Rev-RRE complexes. Computational prediction and detailed chemical probing and footprinting experiments were used to determine the RNA secondary structure of EIAV RRE-1, a 555 nt region that provides RRE function in vivo. Chemical probing experiments confirmed the presence of several predicted loop and stem-loop structures, which are conserved among 140 EIAV sequence variants. Footprinting experiments revealed that Rev binding induces significant structural rearrangement in two conserved domains characterized by stable stem-loop structures. Rev binding region-1 (RBR-1) corresponds to a genetically-defined Rev binding region that overlaps exon 1 of the EIAV rev gene and contains an exonic splicing enhancer (ESE). RBR-2, characterized for the first time in this study, is required for high affinity binding of EIAV Rev to the RRE. RBR-2 contains an RNA structural motif that is also found within the high affinity Rev binding site in HIV-1 (stem-loop IIB), and within or near mapped RRE regions of four additional lentiviruses. The powerful integration of computational and experimental approaches in this study has generated a validated RNA secondary structure for the EIAV RRE and provided provocative evidence that high affinity Rev binding sites of HIV-1 and EIAV share a conserved RNA structural motif. The presence of this motif in phylogenetically divergent lentiviruses suggests that it may play a role in highly conserved interactions that could be targeted in novel anti-lentiviral therapies.	[Lee, Jae-Hyung; Dobbs, Drena] Iowa State Univ, Bioinformat & Computat Biol Program, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA; [Culver, Gloria] Univ Rochester, Dept Biol, Rochester, NY USA; [Carpenter, Susan] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA USA	Iowa State University; University of Rochester; Washington State University	Lee, JH (corresponding author), Iowa State Univ, Bioinformat & Computat Biol Program, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA.	jhlee777@iastate.edu	Lee, Jae-Hyung/AAI-9813-2020; Lee, Jae-Hyung/E-6827-2011	Lee, Jae-Hyung/0000-0002-5085-6988; Dobbs, Drena/0000-0003-4404-9554	U.S. Public Health Service, National Institutes of Health [CA97936, GM066387]; National Research Initiative of the USDA Cooperative State Research, Education, and Extension Service [2002-35204-12699]; Center for Integrated Animal Genomics at Iowa State University; NATIONAL CANCER INSTITUTE [R21CA097936, R01CA128568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R33GM066387, R21GM066387] Funding Source: NIH RePORTER	U.S. Public Health Service, National Institutes of Health(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); National Research Initiative of the USDA Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Center for Integrated Animal Genomics at Iowa State University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by U.S. Public Health Service, National Institutes of Health Grants CA97936, GM066387, National Research Initiative of the USDA Cooperative State Research, Education, and Extension Service Grant 2002-35204-12699, and the Center for Integrated Animal Genomics at Iowa State University. Sponsors played no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Battiste JL, 1996, SCIENCE, V273, P1547, DOI 10.1126/science.273.5281.1547; Belshan M, 2000, MOL CELL BIOL, V20, P3550, DOI 10.1128/MCB.20.10.3550-3557.2000; Belshan M, 1998, J VIROL, V72, P4421, DOI 10.1128/JVI.72.5.4421-4426.1998; Belshan M, 2001, VIROLOGY, V279, P185, DOI 10.1006/viro.2000.0696; Blencowe BJ, 2000, TRENDS BIOCHEM SCI, V25, P106, DOI 10.1016/S0968-0004(00)01549-8; Chaitin Gregory J., 1982, ENCY STAT SCI, V1, P38; Chung HK, 2001, J BIOL CHEM, V276, P18960, DOI 10.1074/jbc.M008996200; COOK KS, 1991, NUCLEIC ACIDS RES, V19, P1577, DOI 10.1093/nar/19.7.1577; CULLEN BR, 1992, MICROBIOL REV, V56, P375, DOI 10.1128/MMBR.56.3.375-394.1992; Culver GM, 2000, METHOD ENZYMOL, V318, P461; Daelemans D, 2002, P NATL ACAD SCI USA, V99, P14440, DOI 10.1073/pnas.212285299; DILLON PJ, 1990, J VIROL, V64, P4428, DOI 10.1128/JVI.64.9.4428-4437.1990; Ding Y, 2004, NUCLEIC ACIDS RES, V32, pW135, DOI 10.1093/nar/gkh449; EHRESMANN C, 1987, NUCLEIC ACIDS RES, V15, P9109, DOI 10.1093/nar/15.22.9109; Ernst RK, 1997, MOL CELL BIOL, V17, P135, DOI 10.1128/MCB.17.1.135; Foley B. T, 2000, HIV SEQUENCE COMPEND, P35; FRIDELL RA, 1993, J VIROL, V67, P7317, DOI 10.1128/JVI.67.12.7317-7323.1993; Fridell RA, 1996, P NATL ACAD SCI USA, V93, P4421, DOI 10.1073/pnas.93.9.4421; GIVER L, 1993, NUCLEIC ACIDS RES, V21, P5509, DOI 10.1093/nar/21.23.5509; Gontarek RR, 1996, MOL CELL BIOL, V16, P2325; Hamm TE, 1999, J VIROL, V73, P5741, DOI 10.1128/JVI.73.7.5741-5747.1999; Han KS, 2003, NUCLEIC ACIDS RES, V31, P3432, DOI 10.1093/nar/gkg539; Harris ME, 1998, MOL CELL BIOL, V18, P3889, DOI 10.1128/MCB.18.7.3889; HEAPHY S, 1990, CELL, V60, P685, DOI 10.1016/0092-8674(90)90671-Z; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hofacker IL, 2002, J MOL BIOL, V319, P1059, DOI 10.1016/S0022-2836(02)00308-X; Hope TJ, 1999, ARCH BIOCHEM BIOPHYS, V365, P186, DOI 10.1006/abbi.1999.1207; IWAI S, 1992, NUCLEIC ACIDS RES, V20, P6465, DOI 10.1093/nar/20.24.6465; Jain C, 2001, MOL CELL, V7, P603, DOI 10.1016/S1097-2765(01)00207-6; Katzourakis A, 2007, P NATL ACAD SCI USA, V104, P6261, DOI 10.1073/pnas.0700471104; KAWAKAMI T, 1987, VIROLOGY, V158, P300, DOI 10.1016/0042-6822(87)90202-9; KJEMS J, 1992, EMBO J, V11, P1119, DOI 10.1002/j.1460-2075.1992.tb05152.x; KJEMS J, 1991, P NATL ACAD SCI USA, V88, P683, DOI 10.1073/pnas.88.3.683; KJEMS J, 1991, HIV 1 REV CELL, V67, P169; LE SY, 1994, NUCLEIC ACIDS RES, V22, P3966, DOI 10.1093/nar/22.19.3966; LE SY, 1990, NUCLEIC ACIDS RES, V18, P1613, DOI 10.1093/nar/18.6.1613; Lee JH, 2006, J VIROL, V80, P3844, DOI 10.1128/JVI.80.8.3844-3852.2006; LEE SW, 1994, J VIROL, V68, P8254, DOI 10.1128/JVI.68.12.8254-8264.1994; Lesnik MA, 2002, MED RES REV, V22, P617, DOI 10.1002/med.10027; Liao HJ, 2004, VIROLOGY, V323, P131, DOI 10.1016/j.virol.2003.12.028; Macke TJ, 2001, NUCLEIC ACIDS RES, V29, P4724, DOI 10.1093/nar/29.22.4724; MANN DA, 1994, J MOL BIOL, V241, P193, DOI 10.1006/jmbi.1994.1488; MARTARANO L, 1994, J VIROL, V68, P3102, DOI 10.1128/JVI.68.5.3102-3111.1994; Mathews DH, 2006, CURR OPIN STRUC BIOL, V16, P270, DOI 10.1016/j.sbi.2006.05.010; Mathews DH, 2006, J MOL BIOL, V359, P526, DOI 10.1016/j.jmb.2006.01.067; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Mathews DH, 2002, J MOL BIOL, V317, P191, DOI 10.1006/jmbi.2001.5351; Mathews DH, 2004, RNA, V10, P1178, DOI 10.1261/rna.7650904; Mealey RH, 2004, J VIROL, V78, P9295, DOI 10.1128/JVI.78.17.9295-9305.2004; MERRYMAN C, 1998, FOOTPRINTING MODIFIC; MOAZED D, 1986, J MOL BIOL, V187, P399, DOI 10.1016/0022-2836(86)90441-9; OLSEN HS, 1990, GENE DEV, V4, P1357, DOI 10.1101/gad.4.8.1357; Peleg O, 2002, AIDS RES HUM RETROV, V18, P867, DOI 10.1089/08892220260190353; Pollard VW, 1998, ANNU REV MICROBIOL, V52, P491, DOI 10.1146/annurev.micro.52.1.491; POWERS T, 1995, RNA, V1, P194; Rossi JJ, 2007, NAT BIOTECHNOL, V25, P1444, DOI 10.1038/nbt1367; RUSHLOW K, 1986, VIROLOGY, V155, P309, DOI 10.1016/0042-6822(86)90195-9; SALTARELLI M, 1990, VIROLOGY, V179, P347, DOI 10.1016/0042-6822(90)90303-9; SCHNEIDER TD, 1986, J MOL BIOL, V188, P415, DOI 10.1016/0022-2836(86)90165-8; SCHNEIDER TD, 1989, NUCLEIC ACIDS RES, V17, P659, DOI 10.1093/nar/17.2.659; SCHWARTZ S, 1990, J VIROL, V64, P2519, DOI 10.1128/JVI.64.6.2519-2529.1990; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; STEPHENS RM, 1990, J VIROL, V64, P3716, DOI 10.1128/JVI.64.8.3716-3725.1990; STEPHENS RM, 1992, J MOL BIOL, V228, P1124, DOI 10.1016/0022-2836(92)90320-J; Stoltzfus CM, 2006, CURR HIV RES, V4, P43, DOI 10.2174/157016206775197655; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TILEY LS, 1992, J VIROL, V66, P3609, DOI 10.1128/JVI.66.6.3609-3615.1992; TILEY LS, 1992, P NATL ACAD SCI USA, V89, P758, DOI 10.1073/pnas.89.2.758; Wang ZF, 2006, MOL CELL, V23, P61, DOI 10.1016/j.molcel.2006.05.018; XU RS, 1993, MOL CELL BIOL, V13, P3660, DOI 10.1128/MCB.13.6.3660; ZAPP ML, 1991, P NATL ACAD SCI USA, V88, P7734, DOI 10.1073/pnas.88.17.7734; ZAPP ML, 1989, NATURE, V342, P714, DOI 10.1038/342714a0; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	74	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2272	10.1371/journal.pone.0002272	http://dx.doi.org/10.1371/journal.pone.0002272			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523581	Green Published, Green Submitted, gold			2022-12-25	WOS:000262614300004
J	Ponti, G; Peretto, P; Bonfanti, L				Ponti, Giovanna; Peretto, Paolo; Bonfanti, Luca			Genesis of Neuronal and Glial Progenitors in the Cerebellar Cortex of Peripuberal and Adult Rabbits	PLOS ONE			English	Article								Adult neurogenesis in mammals is restricted to some brain regions, in contrast with other vertebrates in which the genesis of new neurons is more widespread in different areas of the nervous system. In the mammalian cerebellum, neurogenesis is thought to be limited to the early postnatal period, coinciding with end of the granule cell genesis and disappearance of the external granule cell layer (EGL). We recently showed that in the rabbit cerebellum the EGL is replaced by a proliferative layer called 'subpial layer' (SPL) which persists beyond puberty on the cerebellar surface. Here we investigated what happens in the cerebellar cortex of peripuberal rabbits by using endogenous and exogenously-administered cell proliferation antigens in association with a cohort of typical markers for neurogenesis. We show that cortical cell progenitors extensively continue to be generated herein. Surprisingly, this neurogenic process continues to a lesser extent in the adult, even in the absence of a proliferative SPL. We describe two populations of newly generated cells, involving neuronal cells and multipolar, glia-like cells. The genesis of neuronal precursors is restricted to the molecular layer, giving rise to cells immunoreactive for GABA, and for the transcription factor Pax2, a marker for GABAergic cerebellar interneuronal precursors of neuroepithelial origin that ascend through the white matter during early postnatal development. The multipolar cells are Map5+, contain Olig2 and Sox2 transcription factors, and are detectable in all cerebellar layers. Some dividing Sox2+ cells are Bergmann glia cells. All the cortical newly generated cells are independent from the SPL and from granule cell genesis, the latter ending before puberty. This study reveals that adult cerebellar neurogenesis can exist in some mammals. Since rabbits have a longer lifespan than rodents, the protracted neurogenesis within its cerebellar parenchyma could be a suitable model for studying adult nervous tissue permissiveness in mammals.	[Ponti, Giovanna; Bonfanti, Luca] Univ Turin, Dept Vet Morphophysiol, Grugliasco, Italy; [Peretto, Paolo] Univ Turin, Dept Anim & Human Biol, Turin, Italy; [Peretto, Paolo; Bonfanti, Luca] Neurosci Inst Turin, Turin, Italy; [Bonfanti, Luca] Natl Inst Neurosci, Turin, Italy	University of Turin; University of Turin	Ponti, G (corresponding author), Univ Turin, Dept Vet Morphophysiol, Grugliasco, Italy.	luca.bonfanti@unito.it	Bonfanti, Luca/AAW-2997-2021; Ponti, Giovanna/B-7796-2013	Ponti, Giovanna/0000-0002-0911-7606; Peretto, Paolo Marcello/0000-0001-9747-6379	Compagnia di San Paolo (Progetto NEUROTRANSPLANT); Regione Piemonte; Fondazione Mariani; University of Turin	Compagnia di San Paolo (Progetto NEUROTRANSPLANT)(Compagnia di San Paolo); Regione Piemonte(Regione Piemonte); Fondazione Mariani; University of Turin	This work was supported by Compagnia di San Paolo (Progetto NEUROTRANSPLANT), Regione Piemonte, Fondazione Mariani, and University of Turin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham H, 2001, INT J DEV NEUROSCI, V19, P53, DOI 10.1016/S0736-5748(00)00065-4; Aguirre AA, 2004, J CELL BIOL, V165, P575, DOI 10.1083/jcb.200311141; ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; Altman J, 1997, DEV CEREBELLAR SYSTE; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; BONFANTI L, 1992, NEUROSCIENCE, V49, P419, DOI 10.1016/0306-4522(92)90107-D; Bonfanti L, 2008, VET J, V175, P310, DOI 10.1016/j.tvjl.2007.01.023; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Butt AM, 2005, J ANAT, V207, P695, DOI 10.1111/j.1469-7580.2005.00458.x; Butt AM, 2002, J NEUROCYTOL, V31, P551, DOI 10.1023/A:1025751900356; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Cheng AW, 1999, DEV BRAIN RES, V113, P107, DOI 10.1016/S0165-3806(99)00006-1; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Dusart I, 1999, J COMP NEUROL, V408, P399; Engelkamp D, 1999, DEVELOPMENT, V126, P3585; Episkopou V, 2005, TRENDS NEUROSCI, V28, P219, DOI 10.1016/j.tins.2005.03.003; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; FUJITA S, 1966, J COMP NEUROL, V128, P191, DOI 10.1002/cne.901280206; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gordon-Weeks PR, 2000, MICROSC RES TECHNIQ, V48, P63, DOI 10.1002/(SICI)1097-0029(20000115)48:2<63::AID-JEMT2>3.0.CO;2-1; Gould E, 2007, NAT REV NEUROSCI, V8, P481, DOI 10.1038/nrn2147; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Ito M, 2006, PROG NEUROBIOL, V78, P272, DOI 10.1016/j.pneurobio.2006.02.006; Jones A, 1996, J NEUROCHEM, V67, P907; Komuro H, 2001, J NEUROSCI, V21, P527, DOI 10.1523/JNEUROSCI.21-02-00527.2001; Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768; Leto K, 2006, J NEUROSCI, V26, P11682, DOI 10.1523/JNEUROSCI.3656-06.2006; Leuner B, 2007, P NATL ACAD SCI USA, V104, P17169, DOI 10.1073/pnas.0708228104; Ligon KL, 2006, GLIA, V54, P1, DOI 10.1002/glia.20273; Lindsey BW, 2006, PROG NEUROBIOL, V80, P281, DOI 10.1016/j.pneurobio.2006.11.007; Lossi L, 1995, J ANAT, V187, P709; Luo J, 2006, AGING CELL, V5, P139, DOI 10.1111/j.1474-9726.2006.00197.x; Luzzati F, 2006, J NEUROSCI, V26, P609, DOI 10.1523/JNEUROSCI.4371-05.2006; Luzzati F, 2003, P NATL ACAD SCI USA, V100, P13036, DOI 10.1073/pnas.1735482100; Luzzati F, 2007, NEURODEGENER DIS, V4, P322, DOI 10.1159/000101889; Maricich SM, 1999, J NEUROBIOL, V41, P281, DOI 10.1002/(SICI)1097-4695(19991105)41:2<281::AID-NEU10>3.0.CO;2-5; Mellor JR, 1998, J NEUROSCI, V18, P2822; MENEZES JRL, 1994, J NEUROSCI, V14, P5399; Nacher J, 2001, EUR J NEUROSCI, V14, P629, DOI 10.1046/j.0953-816x.2001.01683.x; Ngwenya LB, 2005, J HISTOCHEM CYTOCHEM, V53, P821, DOI 10.1369/jhc.4A6605.2005; Nishiyama A, 2007, NEUROSCIENTIST, V13, P62, DOI 10.1177/1073858406295586; Nothias F, 1996, J COMP NEUROL, V368, P317, DOI 10.1002/(SICI)1096-9861(19960506)368:3<317::AID-CNE1>3.0.CO;2-8; Ohyu J, 1997, BRAIN DEV-JPN, V19, P541, DOI 10.1016/S0387-7604(97)00075-2; Peretto P, 1999, BRAIN RES BULL, V49, P221, DOI 10.1016/S0361-9230(99)00037-4; Ponti G, 2006, J COMP NEUROL, V498, P491, DOI 10.1002/cne.21043; Ponti G, 2006, DEV BIOL, V294, P168, DOI 10.1016/j.ydbio.2006.02.037; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; Rakic P, 2004, NATURE, V427, P685, DOI 10.1038/427685a; Rao MS, 2004, EUR J NEUROSCI, V19, P234, DOI 10.1111/j.0953-816X.2003.03123.x; Rosslenbroich V, 2005, EXP CELL RES, V310, P434, DOI 10.1016/j.yexcr.2005.08.005; SAFAEI R, 1989, J MOL NEUROSCI, V1, P189, DOI 10.1007/BF02918906; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; SMITH KR, 1963, J COMP NEUROL, V121, P459, DOI 10.1002/cne.901210312; Sottile V, 2006, BRAIN RES, V1099, P8, DOI 10.1016/j.brainres.2006.04.127; SPACEK J, 1973, J NEUROCYTOL, V2, P407, DOI 10.1007/BF01103798; Stottmann RW, 1998, J COMP NEUROL, V395, P121; Takayama C, 2004, NEUROSCI RES, V50, P447, DOI 10.1016/j.neures.2004.08.012; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; TUCKER RP, 1988, DEV BIOL, V130, P423, DOI 10.1016/0012-1606(88)90338-7; VIERECK C, 1989, J NEUROSCI, V9, P3547; VOUYIOUKLIS DA, 1993, J NEUROSCI RES, V35, P257, DOI 10.1002/jnr.490350305; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; Weisheit G, 2006, EUR J NEUROSCI, V24, P466, DOI 10.1111/j.1460-9568.2006.04915.x; Weyer A, 2003, J NEUROSCI RES, V73, P400, DOI 10.1002/jnr.10655; Wu HY, 2001, MOL CELL NEUROSCI, V17, P292, DOI 10.1006/mcne.2000.0941; Yamasaki T, 2001, DEVELOPMENT, V128, P3133; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3; Zupanc GKH, 2006, J COMP PHYSIOL A, V192, P649, DOI 10.1007/s00359-006-0104-y	71	88	90	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2366	10.1371/journal.pone.0002366	http://dx.doi.org/10.1371/journal.pone.0002366			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523645	Green Submitted, Green Published, gold			2022-12-25	WOS:000262614300052
J	Schikora, A; Carreri, A; Charpentier, E; Hirt, H				Schikora, Adam; Carreri, Alessandro; Charpentier, Emmanuelle; Hirt, Heribert			The Dark Side of the Salad: Salmonella typhimurium Overcomes the Innate Immune Response of Arabidopsis thaliana and Shows an Endopathogenic Lifestyle	PLOS ONE			English	Article							SALICYLIC-ACID; LISTERIA-MONOCYTOGENES; DEFENSE RESPONSES; MPK4 ACTIVATION; GENE; PATHOGEN; PLANTS; HOST; PSEUDOMONAS; FLAGELLIN	Salmonella enterica serovar typhimurium contaminated vegetables and fruits are considerable sources of human infections. Bacteria present in raw plant-derived nutrients cause salmonellosis, the world wide most spread food poisoning. This facultative endopathogen enters and replicates in host cells and actively suppresses host immune responses. Although Salmonella survives on plants, the underlying bacterial infection mechanisms are only poorly understood. In this report we investigated the possibility to use Arabidopsis thaliana as a genetically tractable host system to study Salmonella-plant interactions. Using green fluorescent protein (GFP) marked bacteria, we show here that Salmonella can infect various Arabidopsis tissues and proliferate in intracelullar cellular compartments. Salmonella infection of Arabidopsis cells can occur via intact shoot or root tissues resulting in wilting, chlorosis and eventually death of the infected organs. Arabidopsis reacts to Salmonella by inducing the activation of mitogen-activated protein kinase (MAPK) cascades and enhanced expression of pathogenesis related (PR) genes. The induction of defense responses fails in plants that are compromised in ethylene or jasmonic acid signaling or in the MKK3-MPK6 MAPK pathway. These findings demonstrate that Arabidopsis represents a true host system for Salmonella, offering unique possibilities to study the interaction of this human pathogen with plants at the molecular level for developing novel drug targets and addressing current safety issues in human nutrition.	[Schikora, Adam; Hirt, Heribert] Univ Evry Val Essonne, CNRS, INRA, Unite Rech Genom Vegetale, Evry, France; [Carreri, Alessandro; Hirt, Heribert] Max F Perutz Lab, Dept Plant Mol Biol, Vienna, Austria; [Charpentier, Emmanuelle] Max F Perutz Lab, Dept Microbiol & Immunobiol, Vienna, Austria	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay	Schikora, A (corresponding author), Univ Evry Val Essonne, CNRS, INRA, Unite Rech Genom Vegetale, Evry, France.	Heribert.Hirt@evry.inra.fr	Schikora, Adam/B-4842-2014; Hirt, Heribert/A-2061-2013	Schikora, Adam/0000-0002-0869-6423; 	Austrian Science Fund; Centre National de Recherche France	Austrian Science Fund(Austrian Science Fund (FWF)); Centre National de Recherche France	Austrian Science Fund, Centre National de Recherche France	Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; BECKERS GJM, 2006, FINE TUNING PLANT DE, P1; BENT AF, 1992, MOL PLANT MICROBE IN, V5, P372, DOI 10.1094/MPMI-5-372; Brandl MT, 2006, ANNU REV PHYTOPATHOL, V44, P367, DOI 10.1146/annurev.phyto.44.070505.143359; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Desikan R, 2001, PLANT PHYSIOL, V126, P1579, DOI 10.1104/pp.126.4.1579; Doczi R, 2007, PLANT CELL, V19, P3266, DOI 10.1105/tpc.106.050039; Dong YM, 2003, APPL ENVIRON MICROB, V69, P1783, DOI 10.1128/AEM.69.3.1783-1790.2003; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Fellbrich G, 2002, PLANT J, V32, P375, DOI 10.1046/j.1365-313X.2002.01454.x; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; Guignot J, 2004, J CELL SCI, V117, P1033, DOI 10.1242/jcs.00949; HALIM VA, 2006, ROLE SALICYLIC ACID, P307; Heck S, 2003, PLANT J, V36, P342, DOI 10.1046/j.1365-313X.2003.01881.x; Holden DW, 2002, TRAFFIC, V3, P161, DOI 10.1034/j.1600-0854.2002.030301.x; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; Ichimura K, 2006, J BIOL CHEM, V281, P36969, DOI 10.1074/jbc.M605319200; Iniguez AL, 2005, MOL PLANT MICROBE IN, V18, P169, DOI 10.1094/MPMI-18-0169; Jablasone J, 2005, INT J FOOD MICROBIOL, V99, P7, DOI 10.1016/j.ijfoodmicro.2004.06.011; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jung C, 2007, PLANT CELL REP, V26, P1053, DOI 10.1007/s00299-007-0311-1; Lapidot A, 2006, INT J FOOD MICROBIOL, V109, P229, DOI 10.1016/j.ijfoodmicro.2006.01.012; Lee J, 2001, PLANT CELL, V13, P1079, DOI 10.1105/tpc.13.5.1079; MCGRATH R, 1998, PLANT PHYSIOL BIOCH, V14, P119; Menke FLH, 2004, PLANT CELL, V16, P897, DOI 10.1105/tpc.015552; Meszaros T, 2006, PLANT J, V48, P485, DOI 10.1111/j.1365-313X.2006.02888.x; Nakagami H, 2005, TRENDS PLANT SCI, V10, P339, DOI 10.1016/j.tplants.2005.05.009; Nakagami H, 2006, J BIOL CHEM, V281, P38697, DOI 10.1074/jbc.M605293200; Navarro L, 2004, PLANT PHYSIOL, V135, P1113, DOI 10.1104/pp.103.036749; Nicholson FA, 2005, BIORESOURCE TECHNOL, V96, P135, DOI 10.1016/j.biortech.2004.02.030; Nuhse TS, 2000, J BIOL CHEM, V275, P7521, DOI 10.1074/jbc.275.11.7521; Penninckx IAMA, 1996, PLANT CELL, V8, P2309, DOI 10.1105/tpc.8.12.2309; Prithiviraj B, 2005, PLANT J, V42, P417, DOI 10.1111/j.1365-313X.2005.02385.x; Samelis J, 2003, J APPL MICROBIOL, V95, P563, DOI 10.1046/j.1365-2672.2003.02013.x; Suarez-Rodriguez MC, 2007, PLANT PHYSIOL, V143, P661, DOI 10.1104/pp.106.091389; Takahashi F, 2007, PLANT CELL, V19, P805, DOI 10.1105/tpc.106.046581; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Waterman SR, 2003, CELL MICROBIOL, V5, P501, DOI 10.1046/j.1462-5822.2003.00294.x; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Xu LH, 2002, PLANT CELL, V14, P1919, DOI 10.1105/tpc.003368; Zimmerli L, 2004, PLANT J, V40, P633, DOI 10.1111/j.1365-313X.2004.02236.x; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	46	120	125	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2279	10.1371/journal.pone.0002279	http://dx.doi.org/10.1371/journal.pone.0002279			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509467	Green Published, Green Submitted, gold			2022-12-25	WOS:000262268500023
J	Titz, B; Rajagopala, SV; Goll, J; Hauser, R; McKevitt, MT; Palzkill, T; Uetz, P				Titz, Bjoern; Rajagopala, Seesandra V.; Goll, Johannes; Haeuser, Roman; McKevitt, Matthew T.; Palzkill, Timothy; Uetz, Peter			The Binary Protein Interactome of Treponema pallidum - The Syphilis Spirochete	PLOS ONE			English	Article								Protein interaction networks shed light on the global organization of proteomes but can also place individual proteins into a functional context. If we know the function of bacterial proteins we will be able to understand how these species have adapted to diverse environments including many extreme habitats. Here we present the protein interaction network for the syphilis spirochete Treponema pallidum which encodes 1,039 proteins, 726 (or 70%) of which interact via 3,649 interactions as revealed by systematic yeast two-hybrid screens. A high-confidence subset of 991 interactions links 576 proteins. To derive further biological insights from our data, we constructed an integrated network of proteins involved in DNA metabolism. Combining our data with additional evidences, we provide improved annotations for at least 18 proteins (including TP0004, TP0050, and TP0183 which are suggested to be involved in DNA metabolism). We estimate that this "minimal'' bacterium contains on the order of 3,000 protein interactions. Profiles of functional interconnections indicate that bacterial proteins interact more promiscuously than eukaryotic proteins, reflecting the non-compartmentalized structure of the bacterial cell. Using our high-confidence interactions, we also predict 417,329 homologous interactions ("interologs'') for 372 completely sequenced genomes and provide evidence that at least one third of them can be experimentally confirmed.	[Titz, Bjoern; Rajagopala, Seesandra V.; Goll, Johannes; Haeuser, Roman; Uetz, Peter] Forschungszentrum Karlsruhe, Inst Genet, Karlsburg, Germany; [Rajagopala, Seesandra V.; Uetz, Peter] Inst Genom Res, J Craig Venter Inst, Rockville, MD USA; [McKevitt, Matthew T.; Palzkill, Timothy] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX USA	Helmholtz Association; Karlsruhe Institute of Technology; J. Craig Venter Institute; Baylor College of Medicine	Titz, B (corresponding author), Forschungszentrum Karlsruhe, Inst Genet, Karlsburg, Germany.	uetz@jcvi.org	Titz, Bjoern/G-6317-2017; Uetz, Peter/A-7119-2012; Titz, Björn/B-9516-2008	Titz, Bjoern/0000-0003-4414-4105; Uetz, Peter/0000-0001-6194-4927; Rajagopala, Seesandra/0000-0001-7176-5770	DFG [Ue 50/4-1]; J Craig Venter Institute; NIH [AI45842]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045842] Funding Source: NIH RePORTER	DFG(German Research Foundation (DFG)); J Craig Venter Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	PU was funded by the DFG (grant Ue 50/4-1) and by the J Craig Venter Institute. Tim Palzkill was funded by NIH grant NIH AI45842. Although the project has been proposed to the funders, they have taken no subsequent role in the design, conduct, or publication of the study.	Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; BOUBRIK F, 1995, P NATL ACAD SCI USA, V92, P3958, DOI 10.1073/pnas.92.9.3958; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Connelly JC, 1998, P NATL ACAD SCI USA, V95, P7969, DOI 10.1073/pnas.95.14.7969; Deaconescu AM, 2007, CURR OPIN STRUC BIOL, V17, P96, DOI 10.1016/j.sbi.2007.01.005; Deka RK, 2006, J BIOL CHEM, V281, P8072, DOI 10.1074/jbc.M511405200; Edwards AM, 2002, TRENDS GENET, V18, P529, DOI 10.1016/S0168-9525(02)02763-4; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Gaillard M, 2006, J BACTERIOL, V188, P1999, DOI 10.1128/JB.188.5.1999-2013.2006; Galperin MY, 2004, NUCLEIC ACIDS RES, V32, P5452, DOI 10.1093/nar/gkh885; Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Goll J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-223; Harmon FG, 1998, GENE DEV, V12, P1134, DOI 10.1101/gad.12.8.1134; Harmon FG, 2001, J BIOL CHEM, V276, P232, DOI 10.1074/jbc.M006555200; Heller RC, 2005, MOL CELL, V17, P733, DOI 10.1016/j.molcel.2005.01.019; HUISMAN O, 1989, J BACTERIOL, V171, P3704, DOI 10.1128/jb.171.7.3704-3712.1989; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Matthews LR, 2001, GENOME RES, V11, P2120, DOI 10.1101/gr.205301; McKevitt M, 2003, GENOME RES, V13, P1665, DOI 10.1101/gr.288103; Noens EE, 2007, MOL MICROBIOL, V64, P1244, DOI 10.1111/j.1365-2958.2007.05732.x; Noirot-Gros MF, 2002, P NATL ACAD SCI USA, V99, P8342, DOI 10.1073/pnas.122040799; Parrish JR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r130; Peeling RW, 2004, NAT REV MICROBIOL, V2, P448, DOI 10.1038/nrmicro911; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Rajagopala SV, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100166; Sato S, 2007, DNA RES, V14, P207, DOI 10.1093/dnares/dsm021; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharan R, 2005, P NATL ACAD SCI USA, V102, P1974, DOI 10.1073/pnas.0409522102; Shimoda Y, 2008, DNA RES, V15, P13, DOI 10.1093/dnares/dsm028; Sikder D, 2001, J MOL BIOL, V306, P669, DOI 10.1006/jmbi.2000.4384; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; TAKAHASHI S, 1979, CAN J BIOCHEM CELL B, V57, P855, DOI 10.1139/o79-105; Titz B, 2006, J BACTERIOL, V188, P7700, DOI 10.1128/JB.00820-06; Trautinger BW, 2005, MOL CELL, V19, P247, DOI 10.1016/j.molcel.2005.06.004; Uchiyama I, 2007, NUCLEIC ACIDS RES, V35, pD343, DOI 10.1093/nar/gkl978; Uetz P, 2006, SCIENCE, V311, P239, DOI 10.1126/science.1116804; UMEZU K, 1993, J MOL BIOL, V230, P1145, DOI 10.1006/jmbi.1993.1231; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Yoshida Y, 1999, J BIOL CHEM, V274, P16933, DOI 10.1074/jbc.274.24.16933	43	76	78	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2292	10.1371/journal.pone.0002292	http://dx.doi.org/10.1371/journal.pone.0002292			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509523	Green Submitted, Green Published, gold			2022-12-25	WOS:000262268500032
J	Jiang, H; Vogt, PK				Jiang, H.; Vogt, P. K.			Constitutively active Rheb induces oncogenic transformation	ONCOGENE			English	Article						Rheb; PI 3-kinase; Akt; TOR; S6-kinase; 4E-binding protein	PROTEIN-KINASE B; CELL-CYCLE PROGRESSION; SMALL GTPASE-RHEB; MAMMALIAN TARGET; FKBP12-RAPAMYCIN-ASSOCIATED PROTEIN; PROTEASOMAL DEGRADATION; NUCLEAR-LOCALIZATION; RAPAMYCIN MTOR; RAF KINASE; ACTIVATION	Rheb (Ras-homolog enriched in brain) is a component of the phosphatidylinositol 3-kinase (PI3K) target of rapamycin (TOR) signa ling pathway, functioning as a positive regulator of TOR. Constitutively active mutants of Rheb induce oncogenic transformation in cell culture. The transformed cells are larger and contain more protein than their normal counterparts. They show constitutive phosphorylation of the ribosomal protein S6 kinase and the eukaryotic initiation factor 4E-binding protein 1, two downstream targets of TOR. The TOR-specific inhibitor rapamycin strongly interferes with transformation induced by constitutively active Rheb, suggesting that TOR activity is essential for the oncogenic effects of mutant Rheb. Rheb-induced transformation is also dependent on a C-terminal farnesylation signal that mediates localization to a cellular membrane. An engineered N-terminal myristylation signal can substitute for the farnesylation. Immunofluorescence localizes wild-type and mutant Rheb to vesicular structures in the cytoplasm, overlapping with the endoplasmic reticulum.	[Jiang, H.; Vogt, P. K.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Scripps Research Institute	Jiang, H (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10550 N Torrey Pines Rd,BCC 239, La Jolla, CA 92037 USA.	hjiang@scripps.edu	Vogt, Peter K./R-7547-2019	Vogt, Peter K./0000-0002-4519-7500	National Cancer Institute; NATIONAL CANCER INSTITUTE [P01CA078045, R01CA107094, R01CA078230] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Lynn Ueno, Dr Marco Gymnopoulos, Dr Peiging Sun and Dr William B Kiosses (Core Microscopy, The Scripps Research Institute) for expert technical assistance. This study was supported by grants from the National Cancer Institute. This article is numbered 19286 in the Scripps Research Institute.	Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; Aoki M, 1998, P NATL ACAD SCI USA, V95, P14950, DOI 10.1073/pnas.95.25.14950; Aoki M, 2004, P NATL ACAD SCI USA, V101, P13613, DOI 10.1073/pnas.0405454101; Aoki M, 2004, Curr Top Microbiol Immunol, V279, P321; Bader AG, 2008, ONCOGENE, V27, P1179, DOI 10.1038/sj.onc.1210719; Bader AG, 2003, P NATL ACAD SCI USA, V100, P12384, DOI 10.1073/pnas.2135336100; Bader AG, 2005, MOL CELL BIOL, V25, P2095, DOI 10.1128/MCB.25.6.2095-2106.2005; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Basso AD, 2005, J BIOL CHEM, V280, P31101, DOI 10.1074/jbc.M503763200; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; BISTER K, 1977, VIROLOGY, V82, P431, DOI 10.1016/0042-6822(77)90017-4; BOS TJ, 1990, GENE DEV, V4, P1677, DOI 10.1101/gad.4.10.1677; Briaud I, 2005, J BIOL CHEM, V280, P2282, DOI 10.1074/jbc.M412179200; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Buerger C, 2006, BIOCHEM BIOPH RES CO, V344, P869, DOI 10.1016/j.bbrc.2006.03.220; Cahill CM, 2001, J BIOL CHEM, V276, P13402, DOI 10.1074/jbc.M010042200; Castro AF, 2003, J BIOL CHEM, V278, P32493, DOI 10.1074/jbc.C300226200; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Chang HW, 1997, SCIENCE, V276, P1848, DOI 10.1126/science.276.5320.1848; Clark GJ, 1997, J BIOL CHEM, V272, P10608; Cohen SB, 2001, ONCOGENE, V20, P141, DOI 10.1038/sj.onc.1204077; Cunningham MA, 2004, MOL ENDOCRINOL, V18, P1756, DOI 10.1210/me.2004-0071; Dan HC, 2002, J BIOL CHEM, V277, P35364, DOI 10.1074/jbc.M205838200; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Davletov B, 1998, J BIOL CHEM, V273, P19093, DOI 10.1074/jbc.273.30.19093; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Drenan RM, 2004, J BIOL CHEM, V279, P772, DOI 10.1074/jbc.M305912200; DUFF RG, 1969, VIROLOGY, V39, P18, DOI 10.1016/0042-6822(69)90344-4; Furukawa-Hibi Y, 2002, J BIOL CHEM, V277, P26729, DOI 10.1074/jbc.C200256200; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Gromov PS, 1995, FEBS LETT, V377, P221, DOI 10.1016/0014-5793(95)01349-0; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hers I, 2005, BIOCHEM J, V388, P713, DOI 10.1042/BJ20041531; Himly M, 1998, VIROLOGY, V248, P295, DOI 10.1006/viro.1998.9290; Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528; HUGHES SH, 1987, J VIROL, V61, P3004, DOI 10.1128/JVI.61.10.3004-3012.1987; Im E, 2002, ONCOGENE, V21, P6356, DOI 10.1038/sj.onc.1205792; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Karbowniczek M, 2004, J BIOL CHEM, V279, P29930, DOI 10.1074/jbc.M402591200; Karbowniczek M, 2006, J BIOL CHEM, V281, P25447, DOI 10.1074/jbc.M605273200; Kim JE, 2000, P NATL ACAD SCI USA, V97, P14340, DOI 10.1073/pnas.011511898; Lawlor MA, 2001, J CELL SCI, V114, P2903; Li Y, 2004, MOL CELL BIOL, V24, P7965, DOI 10.1128/MCB.24.18.7965-7975.2004; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200; Mach KE, 2000, GENETICS, V155, P611; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Patel PH, 2003, J CELL SCI, V116, P3601, DOI 10.1242/jcs.00661; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Sabatini DM, 1999, SCIENCE, V284, P1161, DOI 10.1126/science.284.5417.1161; SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815; Saito K, 2005, J BIOCHEM, V137, P423, DOI 10.1093/jb/mvi046; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Shah OJ, 2006, MOL CELL BIOL, V26, P6425, DOI 10.1128/MCB.01254-05; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Sonderegger CK, 2003, ONCOGENE, V22, P1749, DOI 10.1038/sj.onc.1206308; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Takahashi K, 2005, J BIOL CHEM, V280, P32768, DOI 10.1074/jbc.M506280200; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Urano J, 2005, MOL MICROBIOL, V58, P1074, DOI 10.1111/j.1365-2958.2005.04877.x; Urano J, 2001, METHOD ENZYMOL, V333, P217; Urano J, 2000, J BIOL CHEM, V275, P11198, DOI 10.1074/jbc.275.15.11198; van Slegtenhorst M, 2004, J BIOL CHEM, V279, P12706, DOI 10.1074/jbc.M313874200; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; YAMAGATA K, 1994, J BIOL CHEM, V269, P16333; Yan LJ, 2006, J BIOL CHEM, V281, P19793, DOI 10.1074/jbc.C600028200; Yang WL, 2001, MOL MICROBIOL, V41, P1339, DOI 10.1046/j.1365-2958.2001.02599.x; Yee WM, 1997, MOL CELL BIOL, V17, P921, DOI 10.1128/MCB.17.2.921; Zhang XW, 2002, J BIOL CHEM, V277, P28127, DOI 10.1074/jbc.M202625200; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	80	51	52	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2008	27	43					5729	5740		10.1038/onc.2008.180	http://dx.doi.org/10.1038/onc.2008.180			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	352HM	18521078	Green Accepted			2022-12-25	WOS:000259487100008
J	Talukder, AH; Li, DQ; Manavathi, B; Kumar, R				Talukder, A. H.; Li, D-Q; Manavathi, B.; Kumar, R.			Serine 28 phosphorylation of NRIF3 confers its co-activator function for estrogen receptor-alpha transactivation	ONCOGENE			English	Article						NRIF3; Pak1; ER alpha; phosphorylation	ACTIVATED PROTEIN-KINASE; BREAST-CANCER CELLS; TRANSCRIPTIONAL ACTIVATION; IN-VITRO; INDEPENDENT GROWTH; NUCLEAR RECEPTORS; TYROSINE KINASE; DNA-BINDING; ESTRADIOL; INSULIN	NRIF3 is an estrogen-inducible nuclear receptor coregulator that stimulates estrogen receptor-alpha (ER alpha) transactivation functions and associates with the endogenous ER and its target gene promoter. p21-activated protein kinase 1 (Pak1) phosphorylates ER alpha at Ser305 and this modification is important in ER alpha transactivation function. Although ERa transactivation functions are regulated by co-activator activity of NRIF3, it remains unclear whether Pak1 could impact ER functions via a posttranslational modi. cation of NRIF3. Here, we report that Pak1 phosphorylates NRIF3 at Serine28 and that NRIF3 binds to Pak1 in vitro and in vivo. We found that NRIF3 phosphorylation, co-activator activity and association with ER alpha increased following Pak1 phosphorylation of NRIF3's Ser28 and that activated ER alpha-Ser305 and NRIF3-Ser28 cooperatively support transactivation of ER alpha. NRIF3 expression increased significantly in cells with inducible Pak1 expression. We found that NRIF3 and ER alpha interaction, subcellular localization and ER alpha transactivation activity all increased in cells expressing the Pak1 phosphorylation-mimicking mutant NRIF3-Ser28Glu. Consistently, the NRIF3-Ser28Glu mutant exhibited an enhanced recruitment to the endogenous ER target genes and increased expression following estrogen stimulation. Finally, breast cancer cells with stable overexpression of NRIF3 showed increased proliferation and enhanced anchorage-independent growth. These findings suggest that NRIF3-Ser28 is a physiologic target of Pak1 signaling and contributes to the enhanced NRIF3 co-activator activity, leading to coordinated potentiation of ER alpha transactivation, its target gene expression and estrogen responsiveness of breast cancer cells.	[Talukder, A. H.; Li, D-Q; Manavathi, B.; Kumar, R.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Kumar, R.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine	Kumar, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA.	rkumar@mdanderson.org		Manavathi, Bramanandam/0000-0002-1797-398X	NIH [CA90970, CA098823]; NATIONAL CANCER INSTITUTE [R01CA090970, R01CA098823] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Christopher J Barnes and Suresh Rayala for the confocal microscopy and western blotting, respectively. This study was supported by the NIH grants CA90970 and CA098823 to RK.	ALI S, 1993, EMBO J, V12, P1153, DOI 10.1002/j.1460-2075.1993.tb05756.x; ARNOLD SF, 1995, J STEROID BIOCHEM, V55, P163, DOI 10.1016/0960-0760(95)00177-2; ARNOLD SF, 1995, J STEROID BIOCHEM, V52, P159, DOI 10.1016/0960-0760(94)00166-J; ARNOLD SF, 1994, MOL ENDOCRINOL, V8, P1208, DOI 10.1210/me.8.9.1208; ARNOLD SF, 1995, MOL ENDOCRINOL, V9, P24, DOI 10.1210/me.9.1.24; ARONICA SM, 1993, MOL ENDOCRINOL, V7, P743, DOI 10.1210/me.7.6.743; Balasenthil S, 2004, J BIOL CHEM, V279, P1422, DOI 10.1074/jbc.M309937200; Bunone G, 1996, EMBO J, V15, P2174, DOI 10.1002/j.1460-2075.1996.tb00571.x; CASTORIA G, 1993, BIOCHEMISTRY-US, V32, P1740, DOI 10.1021/bi00058a007; de Mora JF, 2000, MOL CELL BIOL, V20, P5041, DOI 10.1128/MCB.20.14.5041-5047.2000; Freedman LP, 1999, CELL, V97, P5, DOI 10.1016/S0092-8674(00)80708-4; Glass CK, 2000, GENE DEV, V14, P121; Hermanson O, 2002, TRENDS ENDOCRIN MET, V13, P55, DOI 10.1016/S1043-2760(01)00527-6; IGNARTROWBRIDGE DM, 1993, MOL ENDOCRINOL, V7, P992, DOI 10.1210/me.7.8.992; JOEL PB, 1995, MOL ENDOCRINOL, V9, P1041, DOI 10.1210/me.9.8.1041; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Kumar R, 2002, J CELL PHYSIOL, V193, P133, DOI 10.1002/jcp.10167; Lazaro JB, 2002, GENE DEV, V16, P1792, DOI 10.1101/gad.U-9988R; LEGOFF P, 1994, J BIOL CHEM, V269, P4458; Li DS, 1999, MOL CELL BIOL, V19, P7191; Li DS, 2001, MOL CELL BIOL, V21, P8371, DOI 10.1128/MCB.21.24.8371-8384.2001; MA ZQ, 1994, MOL ENDOCRINOL, V8, P910, DOI 10.1210/me.8.7.910; METZGER D, 1995, MOL ENDOCRINOL, V9, P579, DOI 10.1210/me.9.5.579; ONATE SA, 1995, SCIENCE, V270, P1354; Patrone C, 1996, MOL ENDOCRINOL, V10, P499, DOI 10.1210/me.10.5.499; Pierce KL, 2001, ONCOGENE, V20, P1532, DOI 10.1038/sj.onc.1204184; PIETRAS RJ, 1995, ONCOGENE, V10, P2435; Rowan BG, 2000, MOL CELL BIOL, V20, P8720, DOI 10.1128/MCB.20.23.8720-8730.2000; Spiegelman BM, 2004, CELL, V119, P157, DOI 10.1016/j.cell.2004.09.037; Talukder AH, 2004, MOL CELL BIOL, V24, P6581, DOI 10.1128/mcb.24.15.6581-6591.2004; Vadlamudi RK, 2000, J BIOL CHEM, V275, P36238, DOI 10.1074/jbc.M002138200; Wang RA, 2002, EMBO J, V21, P5437, DOI 10.1093/emboj/cdf543; Wang ZY, 2000, P NATL ACAD SCI USA, V97, P13549, DOI 10.1073/pnas.260463097; Wu RC, 2005, ENDOCR REV, V26, P393, DOI 10.1210/er.2004-0018; Wu RC, 2002, MOL CELL BIOL, V22, P3549, DOI 10.1128/MCB.22.10.3549-3561.2002; Wu RC, 2004, MOL CELL, V15, P937, DOI 10.1016/j.molcel.2004.08.019	37	8	9	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2008	27	39					5233	5242		10.1038/onc.2008.151	http://dx.doi.org/10.1038/onc.2008.151			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	344GO	18521086	Green Accepted			2022-12-25	WOS:000258915100007
J	Wang, LK; Nair, PA; Shuman, S				Wang, Li Kai; Nair, Pravin A.; Shuman, Stewart			Structure-guided mutational analysis of the OB, HhH, and BRCT domains of Escherichia coli DNA ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENYLATE INTERMEDIATE; MYCOBACTERIUM-TUBERCULOSIS; LIGATION; POLYNUCLEOTIDES; CRYSTAL; RV3014C; BINDING	NAD(+)-dependent DNA ligases (LigAs) are ubiquitous in bacteria and essential for growth. LigA enzymes have a modular structure in which a central catalytic core composed of nucleotidyltransferase and oligonucleotide-binding (OB) domains is linked via a tetracysteine zinc finger to distal helix-hairpin-helix (HhH) and BRCT (BRCA1-like C-terminal) domains. The OB and HhH domains contribute prominently to the protein clamp formed by LigA around nicked duplex DNA. Here we conducted a structure-function analysis of the OB and HhH domains of Escherichia coli LigA by alanine scanning and conservative substitutions, entailing 43 mutations at 22 amino acids. We thereby identified essential functional groups in the OB domain that engage the DNA phosphodiester backbone flanking the nick (Arg(333)); penetrate the minor grove and distort the nick (Val(383) and Ile(384)); or stabilize the OB fold (Arg(379)). The essential constituents of the HhH domain include: four glycines (Gly(455), Gly(489), Gly(521), Gly(553)), which bind the phosphate backbone across the minor groove at the outer margins of the LigA-DNA interface; Arg(487), which penetrates the minor groove at the outer margin on the 3'-OH side of the nick; and Arg(446), which promotes protein clamp formation via contacts to the nucleotidyltransferase domain. We find that the BRCT domain is required in its entirety for effective nick sealing and AMP-dependent supercoil relaxation.	[Wang, Li Kai; Nair, Pravin A.; Shuman, Stewart] Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Shuman, S (corresponding author), Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA.	s-shuman@ski.mskcc.org			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063611] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM63611] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Benarroch D, 2006, VIROLOGY, V353, P133, DOI 10.1016/j.virol.2006.04.032; Feng H, 2004, BIOCHEMISTRY-US, V43, P12648, DOI 10.1021/bi049451c; Gajiwala KS, 2004, STRUCTURE, V12, P1449, DOI 10.1016/j.str.2004.05.017; GUMPORT RI, 1971, P NATL ACAD SCI USA, V68, P2559, DOI 10.1073/pnas.68.10.2559; Jeon HJ, 2004, FEMS MICROBIOL LETT, V237, P111, DOI 10.1016/j.femsle.2004.06.018; Kaczmarek FS, 2001, J BACTERIOL, V183, P3016, DOI 10.1128/JB.183.10.3016-3024.2001; Lee JY, 2000, EMBO J, V19, P1119, DOI 10.1093/emboj/19.5.1119; Lim JH, 2001, ARCH BIOCHEM BIOPHYS, V388, P253, DOI 10.1006/abbi.2001.2291; LITTLE JW, 1967, P NATL ACAD SCI USA, V58, P2004, DOI 10.1073/pnas.58.5.2004; Liu PF, 2004, NUCLEIC ACIDS RES, V32, P4503, DOI 10.1093/nar/gkh781; Lu J, 2004, BBA-PROTEINS PROTEOM, V1701, P37, DOI 10.1016/j.bbapap.2004.06.008; MODRICH P, 1972, J BIOL CHEM, V247, P6370; Nandakumar J, 2007, MOL CELL, V26, P257, DOI 10.1016/j.molcel.2007.02.026; OLIVERA BM, 1968, P NATL ACAD SCI USA, V61, P237, DOI 10.1073/pnas.61.1.237; Shuman S, 2004, CURR OPIN STRUC BIOL, V14, P757, DOI 10.1016/j.sbi.2004.10.006; Singleton MR, 1999, STRUCTURE, V7, P35, DOI 10.1016/S0969-2126(99)80007-0; Sriskanda V, 1999, NUCLEIC ACIDS RES, V27, P3953, DOI 10.1093/nar/27.20.3953; Sriskanda V, 2001, NUCLEIC ACIDS RES, V29, P4930, DOI 10.1093/nar/29.24.4930; Sriskanda V, 2001, J BIOL CHEM, V276, P36100, DOI 10.1074/jbc.M105643200; SRISKANDA V, 2002, J BIOL CHEM, V277, P9685; Srivastava SK, 2007, PROTEINS, V69, P97, DOI 10.1002/prot.21457; Srivastava SK, 2005, J BIOL CHEM, V280, P30273, DOI 10.1074/jbc.M503780200; Timson DJ, 1999, J MOL BIOL, V285, P73, DOI 10.1006/jmbi.1998.2302; Wilkinson A, 2005, BBA-PROTEINS PROTEOM, V1749, P113, DOI 10.1016/j.bbapap.2005.03.003; Zhu H, 2005, J BIOL CHEM, V280, P12137, DOI 10.1074/jbc.M413685200	25	15	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23343	23352		10.1074/jbc.M802945200	http://dx.doi.org/10.1074/jbc.M802945200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18515356	hybrid, Green Published			2022-12-25	WOS:000258455400044
J	Li, M; Gustchina, A; Alexandratos, J; Wlodawer, A; Wunschmann, S; Kepley, CL; Chapman, MD; Pomes, A				Li, Mi; Gustchina, Alla; Alexandratos, Jerry; Wlodawer, Alexander; Wunschmann, Sabina; Kepley, Christopher L.; Chapman, Martin D.; Pomes, Anna			Crystal structure of a dimerized cockroach allergen Bla g 2 complexed with a monoclonal antibody	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRASS-POLLEN ALLERGEN; IGE-BINDING EPITOPES; MAJOR ALLERGEN; BIRCH POLLEN; PROTEIN; ASTHMA; CRYSTALLOGRAPHY; SENSITIZATION; REFINEMENT; REACTIVITY	The crystal structure of a 1: 1complex between the German cockroach allergen Bla g 2 and the Fab' fragment of a monoclonal antibody 7C11 was solved at 2.8-angstrom resolution. Bla g 2 binds to the antibody through four loops that include residues 60 -70, 83 -86, 98 -100, and 129 -132. Cation-Pi interactions exist between Lys65, Arg-83, and Lys-132 in Bla g 2 and several tyrosines in 7C11. In the complex with Fab ', Bla g 2 forms a dimer, which is stabilized by a quasi-four-helix bundle comprised of an alpha-helix and a helical turn from each allergen monomer, exhibiting a novel dimerization mode for an aspartic protease. A disulfide bridge between C51a and C113, unique to the aspartic protease family, connects the two helical elements within each Bla g 2 monomer, thus facilitating formation of the bundle. Mutation of these cysteines, as well as the residues Asn-52, Gln-110, and Ile-114, involved in hydrophobic interactions within the bundle, resulted in a protein that did not dimerize. The mutant proteins induced less beta hexosaminidase release from mast cells than the wild-type Bla g 2, suggesting a functional role of dimerization in allergenicity. Because 7C11 shares a binding epitope with IgE, the information gained by analysis of the crystal structure of its complex provided guidance for site-directed mutagenesis of the allergen epitope. We have now identified key residues involved in IgE antibody binding; this information will be useful for the design of vaccines for immunotherapy.	[Li, Mi; Gustchina, Alla; Alexandratos, Jerry; Wlodawer, Alexander] NCI, Macromol Crystallog Lab, NIH, Frederick, MD 21702 USA; [Li, Mi] SAIC Frederick, Basic Res Program, Frederick, MD 21702 USA; [Wunschmann, Sabina; Chapman, Martin D.; Pomes, Anna] INDOOR Biotechnol Inc, Charlottesville, VA 22903 USA; [Kepley, Christopher L.] Univ Hlth Syst, Sch Med, Richmond, VA 23298 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; INDOOR Biotechnologies	Gustchina, A (corresponding author), NCI, Macromol Crystallog Lab, NIH, Bldg 539, Frederick, MD 21702 USA.	alla@ncifcrf.gov	Pomés, Anna/H-7010-2019	Pomés, Anna/0000-0002-8729-1829; Chapman, Martin/0000-0002-0845-3632	NATIONAL CANCER INSTITUTE [ZIABC010348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077653] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [N01-CO-12400] Funding Source: Medline; NIAID NIH HHS [R01 AI077653] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARRUDA LK, 1995, J BIOL CHEM, V270, P19563, DOI 10.1074/jbc.270.33.19563; Arruda LK, 2001, J ALLERGY CLIN IMMUN, V107, P419, DOI 10.1067/mai.2001.112854; Ball T, 1999, FASEB J, V13, P1277, DOI 10.1096/fasebj.13.11.1277; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burks AW, 1997, EUR J BIOCHEM, V245, P334, DOI 10.1111/j.1432-1033.1997.t01-1-00334.x; DAVIES DR, 1988, J BIOL CHEM, V263, P10541; de Halleux S, 2006, J ALLERGY CLIN IMMUN, V117, P571, DOI 10.1016/j.jaci.2005.11.032; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flicker S, 2000, J IMMUNOL, V165, P3849, DOI 10.4049/jimmunol.165.7.3849; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Guruprasad K, 1996, PROTEIN ENG, V9, P849, DOI 10.1093/protein/9.10.849; Gustchina A, 2005, J MOL BIOL, V348, P433, DOI 10.1016/j.jmb.2005.02.062; Jaskolski M, 2007, ACTA CRYSTALLOGR D, V63, P611, DOI 10.1107/S090744490700978X; Kaiser L, 2007, J MOL BIOL, V370, P714, DOI 10.1016/j.jmb.2007.04.074; Kepley CL, 2004, J BIOL CHEM, V279, P35139, DOI 10.1074/jbc.M404318200; Lascombe MB, 2000, J BIOL CHEM, V275, P21572, DOI 10.1074/jbc.M002854200; Livesay DR, 2004, PROTEIN ENG DES SEL, V17, P463, DOI 10.1093/protein/gzh058; Maleki SJ, 2000, J IMMUNOL, V164, P5844, DOI 10.4049/jimmunol.164.11.5844; Mirza O, 2000, J IMMUNOL, V165, P331, DOI 10.4049/jimmunol.165.1.331; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niemi M, 2007, STRUCTURE, V15, P1413, DOI 10.1016/j.str.2007.09.012; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padavattan S, 2007, J MOL BIOL, V368, P742, DOI 10.1016/j.jmb.2007.02.036; Pomes A, 2002, EUR J BIOCHEM, V269, P3086, DOI 10.1046/j.1432-1033.2002.02990.x; Pomes A, 2002, AM J RESP CRIT CARE, V165, P391, DOI 10.1164/ajrccm.165.3.2104027; Ponstingl H, 2000, PROTEINS, V41, P47; Reese G, 2007, J ALLERGY CLIN IMMUN, V119, P944, DOI 10.1016/j.jaci.2006.11.699; Rosenstreich DL, 1997, NEW ENGL J MED, V336, P1356, DOI 10.1056/NEJM199705083361904; Satinover SM, 2005, J ALLERGY CLIN IMMUN, V115, P803, DOI 10.1016/j.jaci.2005.01.018; SIELECKI AR, 1990, J MOL BIOL, V214, P143, DOI 10.1016/0022-2836(90)90153-D; Spangfort MD, 2003, J IMMUNOL, V171, P3084, DOI 10.4049/jimmunol.171.6.3084; Sporik R, 1999, THORAX, V54, P675, DOI 10.1136/thx.54.8.675; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Wunschmann S, 2005, J ALLERGY CLIN IMMUN, V116, P140, DOI 10.1016/j.jaci.2005.04.024	35	67	70	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22806	22814		10.1074/jbc.M800937200	http://dx.doi.org/10.1074/jbc.M800937200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18519566	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000258321000048
J	Reddy, T; Ding, J; Li, XJ; Sykes, BD; Rainey, JK; Fliegel, L				Reddy, Tyler; Ding, Jie; Li, Xiuju; Sykes, Brian D.; Rainey, Jan K.; Fliegel, Larry			Structural and functional characterization of transmembrane segment IX of the NHE1 isoform of the Na+/H+ exchanger	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SCANNING MUTAGENESIS; PROTEIN SECONDARY STRUCTURE; SYNTHETIC PEPTIDES; LACTOSE PERMEASE; PORE; RESIDUES; CHANNEL; HELIX; IDENTIFICATION; RECEPTOR	The Na+/H+ exchanger isoform 1 (NHE1) is an integral membrane protein that regulates intracellular pH by removing one intracellular H+ in exchange for one extracellular Na+. It has a large N-terminal membrane domain of 12 transmembrane segments and an intracellular C-terminal regulatory domain. We characterized the cysteine accessibility of amino acids of the putative transmembrane segment IX ( residues 339-363). Each residue was mutated to cysteine in a functional cysteine-less NHE1 protein. Of 25 amino acids mutated, 5 were inactive or nearly so after mutation to cysteine. Several of these showed aberrant targeting to the plasma membrane and reduced expression of the intact protein, whereas others were expressed and targeted correctly but had defective NHE1 function. Of the active mutants, Glu(346) and Ser(351) were inhibited >70% by positively charged [2-( trimethylammonium)ethyl] methanethiosulfonate but not by anionic [2-sulfonatoethyl] methanethiosulfonate, suggesting that they are pore lining and make up part of the cation conduction pathway. Both mutants also had decreased affinity for Na+ and decreased activation by intracellular protons. The structure of a peptide representing amino acids 338-365 was determined by using high resolution NMR in dodecylphosphocholine micelles. The structure contained two helical regions ( amino acids Met(340)-Ser(344) and Ile(353)-Ser(359)) kinked with a large bend angle around a pivot point at amino acid Ser(351). The results suggest that transmembrane IX is critical with pore-lining residues and a kink at the functionally important residue Ser(351).	[Ding, Jie; Li, Xiuju; Sykes, Brian D.; Fliegel, Larry] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Rainey, Jan K.] Dalhousie Univ, Dept Chem, Halifax, NS B3H 1X5, Canada; [Reddy, Tyler; Rainey, Jan K.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 1X5, Canada	University of Alberta; Dalhousie University; Dalhousie University	Fliegel, L (corresponding author), Univ Alberta, Dept Biochem, 347 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	lfliegel@ualberta.ca	Reddy, Tyler/GPJ-9670-2022; Rainey, Jan K/C-1927-2008	Rainey, Jan K/0000-0003-0793-5573				AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Damberg P, 2001, METHOD ENZYMOL, V339, P271, DOI 10.1016/S0076-6879(01)39318-7; DAVIS JH, 1983, BIOCHEMISTRY-US, V22, P5298, DOI 10.1021/bi00292a008; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Dibrov P, 1998, FEBS LETT, V424, P1, DOI 10.1016/S0014-5793(98)00119-7; Ding J, 2007, CAN J PHYSIOL PHARM, V85, P319, DOI 10.1139/Y06-081; Ding J, 2006, J BIOL CHEM, V281, P29817, DOI 10.1074/jbc.M606152200; Doering AE, 1998, J BIOL CHEM, V273, P778, DOI 10.1074/jbc.273.2.778; DUNTEN RL, 1993, BIOCHEMISTRY-US, V32, P12644, DOI 10.1021/bi00210a012; Fliegel L, 2001, BASIC RES CARDIOL, V96, P301, DOI 10.1007/s003950170036; GODDARD TD, 2001, SPARKY, V3; GRINSTEIN S, 1989, BIOCHIM BIOPHYS ACTA, V988, P73, DOI 10.1016/0304-4157(89)90004-X; Haug T, 2004, J GEN PHYSIOL, V124, P173, DOI 10.1085/jgp.200308949; He MM, 1996, BIOCHEMISTRY-US, V35, P12909, DOI 10.1021/bi960876b; HENRY GD, 1994, METHOD ENZYMOL, V239, P515; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; Hunt JF, 1997, BIOCHEMISTRY-US, V36, P15156, DOI 10.1021/bi970146j; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; HYBERTS SG, 1992, PROTEIN SCI, V1, P736, DOI 10.1002/pro.5560010606; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Karmazyn M., 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P323, DOI 10.2174/1568006054553417; Karmazyn M, 2003, HYPERTENSION, V42, P1171, DOI 10.1161/01.HYP.0000102863.23854.0B; Katragadda M, 2001, BIOPHYS J, V81, P1029, DOI 10.1016/S0006-3495(01)75760-8; Katragadda M, 2001, J PEPT RES, V58, P79, DOI 10.1034/j.1399-3011.2001.00904.x; Khadilkar A, 2001, J BIOL CHEM, V276, P43792, DOI 10.1074/jbc.M106659200; Landau M, 2007, J BIOL CHEM, V282, P37854, DOI 10.1074/jbc.M705460200; Lang HJ, 2003, SODIUM-HYDROGEN EXCHANGER: FROM MOLECULE TO ITS ROLE IN DISEASE, P239; LAUTERWEIN J, 1979, BIOCHIM BIOPHYS ACTA, V556, P244, DOI 10.1016/0005-2736(79)90046-4; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; Li XJ, 2004, BIOCHEMISTRY-US, V43, P16477, DOI 10.1021/bi048538v; Liu J, 2000, NEURON, V28, P899, DOI 10.1016/S0896-6273(00)00162-8; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; MAO D, 1982, BIOCHEMISTRY-US, V21, P4960, DOI 10.1021/bi00263a020; MATTSON G, 1993, MOL BIOL REP, V17, P167, DOI 10.1007/BF00986726; Mentzer RM, 2003, ANN THORAC SURG, V75, pS700, DOI 10.1016/S0003-4975(02)04700-8; Moncoq K, 2008, J BIOL CHEM, V283, P4145, DOI 10.1074/jbc.M704844200; Murtazina R, 2001, EUR J BIOCHEM, V268, P4674, DOI 10.1046/j.1432-1327.2001.02391.x; Naider F, 2005, BIOPOLYMERS, V80, P199, DOI 10.1002/bip.20183; Noel J, 2003, BIOCHEMISTRY-US, V42, P15361, DOI 10.1021/bi035296a; OBLATTMONTAL M, 1994, P NATL ACAD SCI USA, V91, P1495, DOI 10.1073/pnas.91.4.1495; Orlowski J, 1996, J BIOL CHEM, V271, P19922, DOI 10.1074/jbc.271.33.19922; Paradiso A, 2004, BREAST CANCER RES, V6, pR616, DOI 10.1186/bcr922; Poet M, 2001, EMBO J, V20, P5595, DOI 10.1093/emboj/20.20.5595; POUYSSEGUR J, 1984, P NATL ACAD SCI-BIOL, V81, P4833, DOI 10.1073/pnas.81.15.4833; Rainey JK, 2006, BIOCHEM CELL BIOL, V84, P918, DOI 10.1139/O06-178; REITHMEIER RAF, 1992, STRUCTURE BIOL MEMBR, P337; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SHORODE L, 1996, NA H EXCHANGER, P101; Silva NLCL, 1997, PFLUG ARCH EUR J PHY, V433, P792, DOI 10.1007/s004240050347; Slepkov ER, 2005, J BIOL CHEM, V280, P17863, DOI 10.1074/jbc.M409608200; Slepkov ER, 2004, BIOCHEM J, V379, P31, DOI 10.1042/BJ20030884; Slotboom DJ, 2001, J BIOL CHEM, V276, P10775, DOI 10.1074/jbc.M011064200; Sreerama N, 1999, PROTEIN SCI, V8, P370; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; Tang XB, 1999, J BIOL CHEM, V274, P3557, DOI 10.1074/jbc.274.6.3557; Wakabayashi S, 2000, J BIOL CHEM, V275, P7942, DOI 10.1074/jbc.275.11.7942; WANG DH, 1995, AM J PHYSIOL-CELL PH, V269, pC392, DOI 10.1152/ajpcell.1995.269.2.C392; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wigley WC, 1998, BIOCHEMISTRY-US, V37, P844, DOI 10.1021/bi972293n; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; YAN RT, 1995, P NATL ACAD SCI USA, V92, P5973, DOI 10.1073/pnas.92.13.5973	65	33	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22018	22030		10.1074/jbc.M803447200	http://dx.doi.org/10.1074/jbc.M803447200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18508767	hybrid			2022-12-25	WOS:000258114700021
J	Moniot, S; Bruno, S; Vonrhein, C; Didierjean, C; Boschi-Muller, S; Vas, M; Bricogne, G; Branlant, G; Mozzarelli, A; Corbier, C				Moniot, Sebastien; Bruno, Stefano; Vonrhein, Clemens; Didierjean, Claude; Boschi-Muller, Sandrine; Vas, Maria; Bricogne, Gerard; Branlant, Guy; Mozzarelli, Andrea; Corbier, Catherine			Trapping of the thioacylglyceraldehyde-3-phosphate dehydrogenase intermediate from Bacillus stearothermophilus - Direct evidence for a flip-flop mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYLATING GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; PHOSPHATE-BINDING SITES; CRYSTAL-STRUCTURE; HOLO-GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; D-GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; ESCHERICHIA-COLI; MICROSPECTROPHOTOMETRY; REACTIVITY; NAD	The crystal structure of the thioacylenzyme intermediate of the phosphorylating glyceraldehyde-3-phosphate dehydrogenase (GAPDH) from Bacillus stearothermophilus has been solved at 1.8 angstrom resolution. Formation of the intermediate was obtained by diffusion of the natural substrate within the crystal of the holoenzyme in the absence of inorganic phosphate. To define the soaking conditions suitable for the isolation and accumulation of the intermediate, a microspectrophotometric characterization of the reaction of GAPDH in single crystals was carried out, following NADH formation at 340 nm. When compared with the structure of the Michaelis complex (Didierjean, C., Corbier, C., Fatih, M., Favier, F., Boschi-Muller, S., Branlant, G., and Aubry, A. (2003) J. Biol. Chem. 278, 12968-12976) the 206-210 loop is shifted and now forms part of the so-called "new P-i" site. The locations of both the O1 atom and the C3-phosphate group of the substrate are also changed. Altogether, the results provide evidence for the flipping of the C3-phosphate group occurring concomitantly or after the redox step.	[Moniot, Sebastien; Didierjean, Claude; Corbier, Catherine] Univ Henri Poincare, CNRS, UMR 7036, Lab Cristallog & Modelisat Mat & Biol, F-54506 Vandoeuvre Les Nancy, France; [Boschi-Muller, Sandrine; Branlant, Guy] Univ Henri Poincare, CNRS, UMR 7567, Lab Maturat ARN & Enzymol Mol, F-54506 Vandoeuvre Les Nancy, France; [Corbier, Catherine] Nancy Univ, Fac Sci,EA 3998, Univ Henri Poincare,Unite Rech Anim & Fonctionnal, Equipe Proteolyse & Biofonctional Proteines & Pep, F-54506 Vandoeuvre Les Nancy, France; [Mozzarelli, Andrea] Univ Parma, Unit Natl Inst Biostruct & Biosyst, I-43100 Parma, Italy; [Vonrhein, Clemens; Bricogne, Gerard] Global Phasing Ltd, Sheraton House, Cambridge CB3 0AX, England; [Vas, Maria] Hungarian Acad Sci, Inst Enzymol, Biol Res Ctr, H-1518 Budapest, Hungary	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Universite de Lorraine; University of Parma; Global Phasing Limited; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Research Centre for Natural Sciences	Corbier, C (corresponding author), Univ Henri Poincare, CNRS, UMR 7036, Lab Cristallog & Modelisat Mat & Biol, F-54506 Vandoeuvre Les Nancy, France.	catherine.corbier@scbiol.uhp-nancy.fr	Mozzarelli, Andrea/C-3615-2014; DIDIERJEAN, Claude/L-1493-2013; Bruno, Stefano/A-4582-2011	Mozzarelli, Andrea/0000-0003-3762-0062; DIDIERJEAN, Claude/0000-0002-3176-8974; Bruno, Stefano/0000-0002-7890-2472; Boschi, Sandrine/0000-0001-8962-4749				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERNI R, 1977, J MOL BIOL, V110, P405, DOI 10.1016/S0022-2836(77)80079-X; Boschi-Muller S, 1999, ARCH BIOCHEM BIOPHYS, V363, P259, DOI 10.1006/abbi.1998.1080; Bourgeois D, 2005, CURR OPIN STRUC BIOL, V15, P538, DOI 10.1016/j.sbi.2005.08.002; Bricogne G., 1996, MACROMOLECULAR REFIN, P85; BUEHNER M, 1974, J MOL BIOL, V82, P563, DOI 10.1016/0022-2836(74)90249-6; BYERS LD, 1978, ARCH BIOCHEM BIOPHYS, V186, P335, DOI 10.1016/0003-9861(78)90443-5; Castilho MS, 2003, BIOCHEMISTRY-US, V42, P7143, DOI 10.1021/bi0206107; Cobessi D, 2000, J MOL BIOL, V300, P141, DOI 10.1006/jmbi.2000.3824; CORBIER C, 1994, BIOCHEMISTRY-US, V33, P3260, DOI 10.1021/bi00177a017; Didierjean C, 2003, J BIOL CHEM, V278, P12968, DOI 10.1074/jbc.M211040200; Duee E, 1996, J MOL BIOL, V257, P814, DOI 10.1006/jmbi.1996.0204; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P. R., 1993, P CCP4 STUD WEEK DAT, P114; HARRIGAN PJ, 1974, BIOCHEM J, V143, P353, DOI 10.1042/bj1430353; HARRIS JI, 1976, ENZYMES, pCH13; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KIM HD, 1995, BIOCHEMISTRY-US, V34, P14975, DOI 10.1021/bi00046a004; KORNDORFER I, 1995, J MOL BIOL, V246, P511, DOI 10.1006/jmbi.1994.0103; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Michels S, 1996, EUR J BIOCHEM, V235, P641, DOI 10.1111/j.1432-1033.1996.00641.x; MORAS D, 1975, J BIOL CHEM, V250, P9137; MOZZARELLI A, 1982, J BIOL CHEM, V257, P6739; MOZZARELLI A, 1989, J BIOL CHEM, V264, P15774; Mozzarelli A, 1996, ANNU REV BIOPH BIOM, V25, P343; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pearson AR, 2004, CURR OPIN STRUC BIOL, V14, P656, DOI 10.1016/j.sbi.2004.10.007; RACKER E, 1952, J BIOL CHEM, V198, P731; RAMAKRISHNAN C, 1965, BIOPHYS J, V5, P909, DOI 10.1016/S0006-3495(65)86759-5; ROSSI GL, 1971, J MOL BIOL, V55, P215, DOI 10.1016/0022-2836(71)90193-8; SEGAL HL, 1953, J BIOL CHEM, V204, P265; SKARZYNSKI T, 1987, J MOL BIOL, V193, P171, DOI 10.1016/0022-2836(87)90635-8; SOUKRI A, 1989, BIOCHEMISTRY-US, V28, P2586, DOI 10.1021/bi00432a036; Talfournier F, 1998, EUR J BIOCHEM, V252, P447, DOI 10.1046/j.1432-1327.1998.2520447.x; TRENTHAM DR, 1971, BIOCHEM J, V122, P59, DOI 10.1042/bj1220059; TRENTHAM DR, 1971, BIOCHEM J, V122, P71, DOI 10.1042/bj1220071; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VAS M, 1979, J BIOL CHEM, V254, P8480; Yun M, 2000, BIOCHEMISTRY-US, V39, P10702, DOI 10.1021/bi9927080	39	30	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21693	21702		10.1074/jbc.M802286200	http://dx.doi.org/10.1074/jbc.M802286200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18480053	hybrid, Green Published			2022-12-25	WOS:000257898800043
J	Wagner, MW; Li, LS; Morales, JC; Galindo, CL; Garner, HR; Bornmann, WG; Boothman, DA				Wagner, Mark W.; Li, Long Shan; Morales, Julio C.; Galindo, Cristi L.; Garner, Harold R.; Bornmann, William G.; Boothman, David A.			Role of c-Abl kinase in DNA mismatch repair-dependent G(2) cell cycle checkpoint arrest responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUN NH2-TERMINAL KINASE; APOPTOTIC RESPONSE; METHYLATING AGENTS; DEFICIENT CELLS; PROTEIN-KINASE; COLON-CANCER; DAMAGE; BRCA1; PHOSPHORYLATION; ACTIVATION	Current published data suggest that DNA mismatch repair (MMR) triggers prolonged G(2) cell cycle checkpoint arrest after alkylation damage from N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) by activating ATR (ataxia telangiectasia-Rad3-related kinase). However, analyses of isogenic MMR-proficient and MMR-deficient human RKO colon cancer cells revealed that although ATR/Chk1 signaling controlled G(2) arrest in MMR-deficient cells, ATR/Chk1 activation was not involved in MMR-dependent G(2) arrest. Instead, we discovered that disrupting c-Abl activity using STI571 (Gleevec (TM), a c-Abl inhibitor) or stable c-Abl knockdown abolished MMR-dependent p73 alpha stabilization, induction of GADD45 alpha protein expression, and G(2) arrest. In addition, inhibition of c-Abl also increased the survival of MNNG-exposed MMR-proficient cells to a level comparable with MMR-deficient cells. Furthermore, knocking down GADD45 alpha( but not p73 alpha) protein levels affected MMR-dependent G(2) arrest responses. Thus, MMR-dependent G(2) arrest responses triggered by MNNG are dependent on a human MLH1/c-Abl/GADD45 alpha signaling pathway and activity. Furthermore, our data suggest that caution should be taken with therapies targeting c-Abl kinase because increased survival of mutator phenotypes may be an unwanted consequence.	[Wagner, Mark W.; Li, Long Shan; Morales, Julio C.; Boothman, David A.] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Program Cell Stress & Canc Nanomed, Lab Mol Stress Responses, Dallas, TX 75390 USA; [Galindo, Cristi L.; Garner, Harold R.] Univ Texas SW Med Ctr Dallas, McDermott Ctr Human Growth & Dev, Dept Biochem, Div Translat Res, Dallas, TX 75390 USA; [Galindo, Cristi L.; Garner, Harold R.] Univ Texas SW Med Ctr Dallas, McDermott Ctr Human Growth & Dev, Dept Internal Med, Div Translat Res, Dallas, TX 75390 USA; [Wagner, Mark W.] Case Western Reserve Univ, Dept Environm Hlth Sci, Cleveland, OH 44106 USA; [Bornmann, William G.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Case Western Reserve University; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Boothman, DA (corresponding author), Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Program Cell Stress & Canc Nanomed, Lab Mol Stress Responses, 5323 Harry Hines Blvd,ND2-210K, Dallas, TX 75390 USA.	David.Boothman@UTSouthwestern.edu	Boothman, David/Q-7776-2019	Morales, Julio/0000-0002-0854-7866	NCI NIH HHS [R01 CA 83196, P30 CA142543] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA083196, P30CA142543] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Adamson AW, 2005, MOL BIOL CELL, V16, P1513, DOI 10.1091/mbc.E04-02-0089; Bacher JW, 2004, DIS MARKERS, V20, P237, DOI 10.1155/2004/136734; Bawa S, 2003, GENE, V315, P177, DOI 10.1016/S0378-1119(03)00737-6; Buermeyer AB, 1999, ANNU REV GENET, V33, P533, DOI 10.1146/annurev.genet.33.1.533; Burgess MR, 2006, THESCIENTIFICWORLDJO, V6, P918, DOI 10.1100/tsw.2006.184; Davis TW, 1998, CANCER RES, V58, P767; Duckett DR, 1999, P NATL ACAD SCI USA, V96, P12384, DOI 10.1073/pnas.96.22.12384; FESQUET D, 1993, EMBO J, V12, P3111, DOI 10.1002/j.1460-2075.1993.tb05980.x; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Foray N, 2002, MOL CELL BIOL, V22, P4020, DOI 10.1128/MCB.22.12.4020-4032.2002; Gong JG, 1999, NATURE, V399, P806; GOULD KL, 1991, EMBO J, V10, P3297, DOI 10.1002/j.1460-2075.1991.tb04894.x; HAWN MT, 1995, CANCER RES, V55, P3721; Hirose Y, 2004, J NEUROSURG, V100, P1060, DOI 10.3171/jns.2004.100.6.1060; Hirose Y, 2003, MOL CELL BIOL, V23, P8306, DOI 10.1128/MCB.23.22.8306-8315.2003; Hollander MC, 1999, NAT GENET, V23, P176, DOI 10.1038/13802; Jeggo PA, 2006, DNA REPAIR, V5, P1192, DOI 10.1016/j.dnarep.2006.05.011; Kamath R, 2007, MOL PHARMACOL, V71, P61, DOI 10.1124/mol.106.026575; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Kim WJ, 2007, J BIOL CHEM, V282, P32021, DOI 10.1074/jbc.M701451200; Li LS, 2008, J BIOL CHEM, V283, P21394, DOI 10.1074/jbc.M709954200; Loeb LA, 1997, SCIENCE, V277, P1449, DOI 10.1126/science.277.5331.1449; Lynch HT, 1996, CANCER, V78, P1149, DOI 10.1002/(SICI)1097-0142(19960915)78:6<1149::AID-CNCR1>3.3.CO;2-Q; Meyers M, 2001, CANCER RES, V61, P5193; Nehme A, 1999, BRIT J CANCER, V79, P1104, DOI 10.1038/sj.bjc.6690176; Nehme A, 1997, CANCER RES, V57, P3253; Nghiem P, 2002, J BIOL CHEM, V277, P4428, DOI 10.1074/jbc.M106113200; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; Paull TT, 2001, P NATL ACAD SCI USA, V98, P6086, DOI 10.1073/pnas.111125998; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; Stojic L, 2004, GENE DEV, V18, P1331, DOI 10.1101/gad.294404; Tront JS, 2006, CANCER RES, V66, P8448, DOI 10.1158/0008-5472.CAN-06-2013; Veigl ML, 1998, P NATL ACAD SCI USA, V95, P8698, DOI 10.1073/pnas.95.15.8698; Vella V, 2003, J BIOL CHEM, V278, P25151, DOI 10.1074/jbc.M301962200; Wang Q, 2001, ONCOGENE, V20, P4640, DOI 10.1038/sj.onc.1204625; Wang XW, 1999, P NATL ACAD SCI USA, V96, P3706, DOI 10.1073/pnas.96.7.3706; Wang Y, 2000, GENE DEV, V14, P927; Yamane K, 2007, CANCER RES, V67, P6286, DOI 10.1158/0008-5472.CAN-06-2205; Yi W, 2006, CANCER RES, V66, P151, DOI 10.1158/0008-5472.CAN-05-3019; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704	41	27	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21382	21393		10.1074/jbc.M709953200	http://dx.doi.org/10.1074/jbc.M709953200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18480061	Green Published, hybrid			2022-12-25	WOS:000257898800009
J	Farina, A; Shin, JH; Kim, DH; Bermudez, VP; Kelman, Z; Seo, YS; Hurwitz, J				Farina, Andrea; Shin, Jae-Ho; Kim, Do-Hyung; Bermudez, Vladimir P.; Kelman, Zvi; Seo, Yeon-Soo; Hurwitz, Jerard			Studies with the human cohesin establishment factor, ChlR1 - Association of ChlR1 with Ctf18-RFC and Fen1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID COHESION; DNA-POLYMERASE-ALPHA; NONRANDOM CHROMOSOME LOSS; IN-SITU HYBRIDIZATION; SACCHAROMYCES-CEREVISIAE; SCHIZOSACCHAROMYCES-POMBE; REPLICATION FORK; COMPLEX REQUIRES; BINDING PROTEIN; FISSION YEAST	Human ChlR1 (hChlR1), a member of the DEAD/DEAH subfamily of helicases, was shown to interact with components of the cohesin complex and play a role in sister chromatid cohesion. In order to study the biochemical and biological properties of hChlR1, we purified the protein from 293 cells and demonstrated that hChlR1 possesses DNA-dependent ATPase and helicase activities. This helicase translocates on single-stranded DNA in the 5' to 3' direction in the presence of ATP and, to a lesser extent, dATP. Its unwinding activity requires a 5'-single-stranded region for helicase loading, since flush-ended duplex structures do not support unwinding. The helicase activity of hChlR1 is capable of displacing duplex regions up to 100 bp, which can be extended to 500 bp by RPA or the cohesion establishment factor, the Ctf18-RFC (replication factor C) complex. We show that hChlR1 interacts with the hCtf18-RFC complex, human proliferating cell nuclear antigen, and hFen1. The interactions between Fen1 and hChlR1 stimulate the flap endonuclease activity of Fen1. Selective depletion of either hChlR1 or Fen1 by targeted small interfering RNA treatment results in the precocious separation of sister chromatids. These findings are consistent with a role of hChlR1 in the establishment of sister chromatid cohesion and suggest that its action may contribute to lagging strand processing events important in cohesion.	[Farina, Andrea; Bermudez, Vladimir P.; Hurwitz, Jerard] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA; [Shin, Jae-Ho; Kelman, Zvi] Univ Maryland, Inst Biotechnol, Rockville, MD 20850 USA; [Kim, Do-Hyung; Seo, Yeon-Soo] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea	Memorial Sloan Kettering Cancer Center; University System of Maryland; University of Maryland Baltimore; Korea Advanced Institute of Science & Technology (KAIST)	Hurwitz, J (corresponding author), 1275 York Ave,Box 97, New York, NY 10065 USA.	j-hurwitz@ski.mskcc.org	Seo, Yeonsoo/C-1605-2011		NIGMS NIH HHS [GM 27440, GM 34559] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034559, R01GM034559] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amann J, 1997, J BIOL CHEM, V272, P3823, DOI 10.1074/jbc.272.6.3823; Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P10237, DOI 10.1073/pnas.1434308100; Bylund GO, 2005, MOL CELL BIOL, V25, P5445, DOI 10.1128/MCB.25.13.5445-5455.2005; Chastain PD, 2003, J BIOL CHEM, V278, P21276, DOI 10.1074/jbc.M301573200; Chestukhin A, 2003, P NATL ACAD SCI USA, V100, P4574, DOI 10.1073/pnas.0730733100; GERRING SL, 1990, EMBO J, V9, P4347, DOI 10.1002/j.1460-2075.1990.tb07884.x; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; HABER JE, 1974, GENETICS, V78, P843; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Hanna JS, 2001, MOL CELL BIOL, V21, P3144, DOI 10.1128/MCB.21.9.3144-3158.2001; Hirota Y, 2000, NUCLEIC ACIDS RES, V28, P917, DOI 10.1093/nar/28.4.917; Holloway SL, 2000, NUCLEIC ACIDS RES, V28, P3056, DOI 10.1093/nar/28.16.3056; Inoue A, 2007, CELL CYCLE, V6, P1646, DOI 10.4161/cc.6.13.4411; Ishiai M, 1996, J BIOL CHEM, V271, P20868, DOI 10.1074/jbc.271.34.20868; Kim J, 2005, NUCLEIC ACIDS RES, V33, P4078, DOI 10.1093/nar/gki728; Kim JH, 2006, NUCLEIC ACIDS RES, V34, P1854, DOI 10.1093/nar/gkl102; Kohler A, 1997, J CELL SCI, V110, P1051; Lee JK, 2001, P NATL ACAD SCI USA, V98, P54, DOI 10.1073/pnas.98.1.54; Lengronne A, 2006, MOL CELL, V23, P787, DOI 10.1016/j.molcel.2006.08.018; Leversha MA, 2001, METH MOL B, V175, P109; LIRAS P, 1978, GENETICS, V88, P651; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; Mayer ML, 2004, MOL BIOL CELL, V15, P1736, DOI 10.1091/mbc.E03-08-0619; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Moldovan GL, 2006, MOL CELL, V23, P723, DOI 10.1016/j.molcel.2006.07.007; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Parish JL, 2006, J CELL SCI, V119, P4857, DOI 10.1242/jcs.03262; Park K, 1998, J BIOL CHEM, V273, P5260, DOI 10.1074/jbc.273.9.5260; Petronczki M, 2004, J CELL SCI, V117, P3547, DOI 10.1242/jcs.01231; ROCCHI M, 1991, GENOMICS, V9, P517, DOI 10.1016/0888-7543(91)90419-F; Shin JH, 2003, J BIOL CHEM, V278, P49053, DOI 10.1074/jbc.M308599200; Shiomi Y, 2004, GENES CELLS, V9, P279, DOI 10.1111/j.1356-9597.2004.00724.x; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Skibbens RV, 2004, GENETICS, V166, P33, DOI 10.1534/genetics.166.1.33; Tanaka K, 2000, MOL CELL BIOL, V20, P3459, DOI 10.1128/MCB.20.10.3459-3469.2000; Tsutsui Y, 2005, CURR GENET, V48, P34, DOI 10.1007/s00294-005-0584-2; Uhlmann F, 1996, P NATL ACAD SCI USA, V93, P6521, DOI 10.1073/pnas.93.13.6521; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Williams DR, 2002, EUKARYOT CELL, V1, P758, DOI 10.1128/EC.1.5.758-773.2002; Wittmeyer J, 1997, MOL CELL BIOL, V17, P4178, DOI 10.1128/MCB.17.7.4178; Zheng L, 2007, MOL CELL BIOL, V27, P3176, DOI 10.1128/MCB.01652-06; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607	44	81	86	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20925	20936		10.1074/jbc.M802696200	http://dx.doi.org/10.1074/jbc.M802696200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18499658	hybrid, Green Published			2022-12-25	WOS:000257746100035
J	Thiele, B; Rieder, O; Jehmlich, N; von Bergen, M; Muller, M; Boll, M				Thiele, Baerbel; Rieder, Oliver; Jehmlich, Nico; von Bergen, Martin; Mueller, Michael; Boll, Matthias			Aromatizing cyclohexa-1,5-diene-1-carbonyl-coenzyme a oxidase - Characterization and its role in anaerobic aromatic metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BENZOYL-COA REDUCTASE; OLD-YELLOW-ENZYME; DRIVEN ELECTRON-TRANSFER; GEOBACTER-METALLIREDUCENS; SYNTROPHUS-ACIDITROPHICUS; NITROGEN-FIXATION; CLOSTRIDIUM-AMINOVALERICUM; AZOTOBACTER-VINELANDII; CRYSTAL-STRUCTURE; KEY ENZYME	Benzoyl-CoA reductases (BCRs) are key enzymes of anaerobic aromatic metabolism in facultatively anaerobic bacteria. The highly oxygen-sensitive enzymes catalyze the ATP-dependent reductive dearomatization of the substrate, yielding cyclohexa-1,5- diene-1-carbonyl-CoA (1,5-dienoyl-CoA). In extracts from anaerobically grown denitrifying Thauera aromatica, we detected a benzoate-induced, benzoyl-CoA-forming, 1,5-dienoylCoA: acceptor oxidoreductase activity. This activity co-purified with BCR but could be partially separated from it by hydroxyapatite chromatography. After activity staining on native gels, a monomeric protein with a subunit molecular weight of M-r 76,000 was identified. Mass spectrometric analysis of tryptic digests identified peptides from NADH oxidases/2,4dienoyl- CoA reductases/"old yellow" enzymes. The UV-visible spectrum of the enriched enzyme suggested the presence of flavin and Fe/S-cofactors, and it was bleached upon the addition of 1,5-dienoyl-CoA. The enzyme had a high affinity for dioxygen as electron acceptor (K-m = 10 mu M) and therefore is referred to as 1,5-dienoyl-CoA oxidase (DCO). The likely product formed from dioxygen reduction was H2O. DCO was highly specific for 1,5-dienoyl-CoA (K-m = 27 mu M). The initial rate of DCO followed a Nernst curve with half-maximal activity at + 10 mV. We propose that DCO provides protection for the extremely oxygen-sensitive BCR enzyme when the bacterium degrades aromatic compounds at the edge of steep oxygen gradients. The redox-dependent switch in DCO guarantees that DCO is only active during oxidative stress and circumvents futile dearomatization/rearomatization reactions catalyzed by BCR and DCO.	[Thiele, Baerbel; Boll, Matthias] Univ Leipzig, Inst Biochem, D-04103 Leipzig, Germany; [Rieder, Oliver; Mueller, Michael] Univ Freiburg, Inst Pharmaceut & Med Chem, D-79104 Freiburg, Germany; [Jehmlich, Nico; von Bergen, Martin] UFZ Helmholtz Ctr Environm Res, D-04318 Leipzig, Germany	Leipzig University; University of Freiburg; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Boll, M (corresponding author), Univ Leipzig, Inst Biochem, Bruderstr 34, D-04103 Leipzig, Germany.	boll@uni-leipzig.de	Jehmlich, Nico/B-5403-2009; Jehmlich, Nico/D-9041-2015; von Bergen, Martin/D-7960-2011	Jehmlich, Nico/0000-0002-5638-6868; Jehmlich, Nico/0000-0002-5638-6868; von Bergen, Martin/0000-0003-2732-2977				ANDERS HJ, 1995, INT J SYST BACTERIOL, V45, P327, DOI 10.1099/00207713-45-2-327; Benndorf D, 2007, ISME J, V1, P224, DOI 10.1038/ismej.2007.39; Berman-Frank I, 2003, RES MICROBIOL, V154, P157, DOI 10.1016/S0923-2508(03)00029-9; BLANC PY, 1961, HELV CHIM ACTA, V44, P607, DOI 10.1002/hlca.19610440227; Boll M, 1995, EUR J BIOCHEM, V234, P921, DOI 10.1111/j.1432-1033.1995.921_a.x; Boll M, 2000, J BIOL CHEM, V275, P21889, DOI 10.1074/jbc.M001833200; Boll M, 2005, J MOL MICROB BIOTECH, V10, P132, DOI 10.1159/000091560; Boll M, 2005, BBA-BIOENERGETICS, V1707, P34, DOI 10.1016/j.bbabio.2004.01.009; Boll M, 1998, EUR J BIOCHEM, V251, P946, DOI 10.1046/j.1432-1327.1998.2510946.x; Boll M, 2000, J BIOL CHEM, V275, P31857, DOI 10.1074/jbc.M001508200; Brige A, 2006, BIOCHEM J, V394, P335, DOI 10.1042/BJ20050979; Buckel W, 2004, CURR OPIN CHEM BIOL, V8, P462, DOI 10.1016/j.cbpa.2004.07.001; Diaz E, 2004, INT MICROBIOL, V7, P173; Egland PG, 1997, P NATL ACAD SCI USA, V94, P6484, DOI 10.1073/pnas.94.12.6484; EIKMANNS U, 1991, EUR J BIOCHEM, V198, P263, DOI 10.1111/j.1432-1033.1991.tb16010.x; FAY P, 1992, MICROBIOL REV, V56, P340, DOI 10.1128/MMBR.56.2.340-373.1992; Fitzpatrick TB, 2003, J BIOL CHEM, V278, P19891, DOI 10.1074/jbc.M211778200; Fuchs G, 2008, ANN NY ACAD SCI, V1125, P82, DOI 10.1196/annals.1419.010; Gibson J, 2002, ANNU REV MICROBIOL, V56, P345, DOI 10.1146/annurev.micro.56.012302.160749; GIBSON KJ, 1992, APPL ENVIRON MICROB, V58, P696, DOI 10.1128/AEM.58.2.696-698.1992; GROSS GG, 1966, Z NATURFORSCH PT B, VB 21, P683; HECHT HJ, 1995, NAT STRUCT BIOL, V2, P1109, DOI 10.1038/nsb1295-1109; Jackson BE, 1999, ARCH MICROBIOL, V171, P107, DOI 10.1007/s002030050685; Kawasaki S, 2005, APPL ENVIRON MICROB, V71, P8442, DOI 10.1128/AEM.71.12.8442-8450.2005; Kengen SWM, 2003, EUR J BIOCHEM, V270, P2885, DOI 10.1046/j.1432-1033.2003.03668.x; KUEHNE ME, 1959, J AM CHEM SOC, V81, P4278, DOI 10.1021/ja01525a042; Liang XQ, 2000, ARCH BIOCHEM BIOPHYS, V380, P373, DOI 10.1006/abbi.2000.1941; LOVLEY DR, 1993, ARCH MICROBIOL, V159, P336, DOI 10.1007/BF00290916; McInerney MJ, 2007, P NATL ACAD SCI USA, V104, P7600, DOI 10.1073/pnas.0610456104; Mobitz H, 2004, BIOCHEMISTRY-US, V43, P1376, DOI 10.1021/bi0358871; Mobitz H, 2002, BIOCHEMISTRY-US, V41, P1752, DOI 10.1021/bi0113770; Modis Y, 1998, STRUCTURE, V6, P957, DOI 10.1016/S0969-2126(98)00098-7; Mouttaki H, 2007, APPL ENVIRON MICROB, V73, P930, DOI 10.1128/AEM.02227-06; Peters F, 2004, J BACTERIOL, V186, P2156, DOI 10.1128/JB.186.7.2156-2163.2004; Peters F, 2007, J BACTERIOL, V189, P1055, DOI 10.1128/JB.01467-06; Poole RK, 1997, BIOSCIENCE REP, V17, P303, DOI 10.1023/A:1027336712748; Rabus R, 2005, ARCH MICROBIOL, V183, P27, DOI 10.1007/s00203-004-0742-9; RIGBY JH, 1989, J ORG CHEM, V54, P224, DOI 10.1021/jo00262a047; SCHACHTER D, 1953, J BIOL CHEM, V203, P925; Schmitz RA, 2002, J MOL MICROB BIOTECH, V4, P235; STOTT K, 1993, J BIOL CHEM, V268, P6097; Tolosa L, 2002, BIOTECHNOL BIOENG, V80, P594, DOI 10.1002/bit.10409; Unciuleac M, 2001, P NATL ACAD SCI USA, V98, P13619, DOI 10.1073/pnas.241375598; VAZ ADN, 1995, BIOCHEMISTRY-US, V34, P4246, DOI 10.1021/bi00013a014; Williams RE, 2002, MICROBIOL-SGM, V148, P1607, DOI 10.1099/00221287-148-6-1607; Wischgoll S, 2005, MOL MICROBIOL, V58, P1238, DOI 10.1111/j.1365-2958.2005.04909.x; Zhang DY, 2001, J BIOL CHEM, V276, P13622, DOI 10.1074/jbc.M011315200	47	28	28	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20713	20721		10.1074/jbc.M802841200	http://dx.doi.org/10.1074/jbc.M802841200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18505724	Green Published, hybrid			2022-12-25	WOS:000257746100012
J	Ulijasz, AT; Cornilescu, G; von Stetten, D; Kaminski, S; Mroginski, MA; Zhang, JR; Bhaya, D; Hildebrandt, P; Vierstra, RD				Ulijasz, Andrew T.; Cornilescu, Gabriel; von Stetten, David; Kaminski, Steve; Mroginski, Maria Andrea; Zhang, Junrui; Bhaya, Devaki; Hildebrandt, Peter; Vierstra, Richard D.			Characterization of two thermostable cyanobacterial phytochromes reveals global movements in the chromophore-binding domain during photoconversion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CONFORMATIONAL-CHANGES; RESONANCE RAMAN ANALYSIS; HISTIDINE KINASES; AGROBACTERIUM-TUMEFACIENS; RECOMBINANT PHYTOCHROME; STRUCTURAL-CHANGES; CPH1 PHYTOCHROME; MICROBIAL MAT; PROTEIN; LIGHT	Photointerconversion between the red light-absorbing (Pr) form and the far-red light-absorbing (Pfr) form is the central feature that allows members of the phytochrome (Phy) superfamily to act as reversible switches in light perception. Whereas the chromophore structure and surrounding binding pocket of Pr have been described, those for Pfr have remained enigmatic for various technical reasons. Here we describe a novel pair of Phys from two thermophilic cyanobacteria, Synechococcus sp. OS-A and OS-B', that overcome several of these limitations. Like other cyanobacterial Phys, SyA-Cph1 and SyB-Cph1 covalently bind the bilin phycocyanobilin via their cGMP phosphodiesterase/ adenyl cyclase/FhlA (GAF) domains and then assume the photointerconvertible Pr and Pfr states with absorption maxima at 630 and 704 nm, respectively. However, they are naturally missing the N-terminal Per/Arndt/Sim domain common to others in the Phy superfamily. Importantly, truncations containing only the GAF domain are monomeric, photochromic, and remarkably thermostable. Resonance Raman and NMR spectroscopy show that all four pyrrole ring nitrogens of phycocyanobilin are protonated both as Pr and following red light irradiation, indicating that the GAF domain by itself can complete the Pr to Pfr photocycle. H-1-N-15 two-dimensional NMR spectra of isotopically labeled preparations of the SyB-Cph1 GAF domain revealed that a number of amino acids change their environment during photoconversion of Pr to Pfr, which can be reversed by subsequent photoconversion back to Pr. Through three-dimensional NMR spectroscopy before and after light photoexcitation, it should now be possible to define the movements of the chromophore and binding pocket during photoconversion. We also generated a series of strongly red fluorescent derivatives of SyB-Cph1, which based on their small size and thermostability may be useful as cell biological reporters.	[Ulijasz, Andrew T.; Zhang, Junrui; Vierstra, Richard D.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Cornilescu, Gabriel] Univ Wisconsin, Natl Magnet Resonance Facil, Madison, WI 53706 USA; [von Stetten, David; Kaminski, Steve; Mroginski, Maria Andrea; Hildebrandt, Peter] Tech Univ Berlin, D-10623 Berlin, Germany; [Bhaya, Devaki] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Technical University of Berlin; Carnegie Institution for Science	Vierstra, RD (corresponding author), Univ Wisconsin, Dept Genet, 425-G Henry Mall, Madison, WI 53706 USA.	vierstra@wisc.edu	Zhang, Junrui/J-2684-2012; Cornilescu, Gabriel/H-3113-2011; Hildebrandt, Peter/J-5658-2014	Cornilescu, Gabriel/0000-0002-1204-8904; Hildebrandt, Peter/0000-0003-1030-5900; von Stetten, David/0000-0001-7906-9788; Ulijasz, Andrew/0000-0003-0739-1297; Kaminski, Steve/0000-0002-0047-8819	NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR008438, S10RR002781, P41RR002301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM066326] Funding Source: NIH RePORTER	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allewalt JP, 2006, APPL ENVIRON MICROB, V72, P544, DOI 10.1128/AEM.72.1.544-550.2006; Andel F, 1996, BIOCHEMISTRY-US, V35, P15997, DOI 10.1021/bi962175k; Bhaya D, 2001, P NATL ACAD SCI USA, V98, P7540, DOI 10.1073/pnas.131201098; Bhaya D, 2007, ISME J, V1, P703, DOI 10.1038/ismej.2007.46; Bhoo SH, 2001, NATURE, V414, P776, DOI 10.1038/414776a; Blumenstein A, 2005, CURR BIOL, V15, P1833, DOI 10.1016/j.cub.2005.08.061; Borucki B, 2005, J BIOL CHEM, V280, P34358, DOI 10.1074/jbc.M505493200; CHERRY JR, 1993, PLANT CELL, V5, P565, DOI 10.1105/tpc.5.5.565; Collins BK, 2004, ACTA CRYSTALLOGR D, V60, P1674, DOI 10.1107/S090744490401844X; Davis SJ, 1999, SCIENCE, V286, P2517, DOI 10.1126/science.286.5449.2517; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; EDGERTON MD, 1992, PLANT CELL, V4, P161, DOI 10.1105/tpc.4.2.161; Esteban B, 2005, BIOCHEMISTRY-US, V44, P450, DOI 10.1021/bi0484365; Falk H., 1989, CHEM LINEAR OLIGOPYR; Fischer AJ, 2005, BIOCHEMISTRY-US, V44, P15203, DOI 10.1021/bi051633z; Fischer AJ, 2004, P NATL ACAD SCI USA, V101, P17334, DOI 10.1073/pnas.0407645101; FODOR SPA, 1990, BIOCHEMISTRY-US, V29, P11141, DOI 10.1021/bi00502a018; Foerstendorf H, 2001, BIOCHEMISTRY-US, V40, P14952, DOI 10.1021/bi0156916; Gambetta GA, 2001, P NATL ACAD SCI USA, V98, P10566, DOI 10.1073/pnas.191375198; Giraud E, 2005, J BIOL CHEM, V280, P32389, DOI 10.1074/jbc.M506890200; Giraud E, 2002, NATURE, V417, P202, DOI 10.1038/417202a; GRIMM R, 1988, PLANTA, V174, P396, DOI 10.1007/BF00959526; Hahn J, 2006, FEBS J, V273, P1415, DOI 10.1111/j.1742-4658.2006.05164.x; Hahn J, 2007, CHEMBIOCHEM, V8, P2249, DOI 10.1002/cbic.200700256; Inomata K, 2005, J BIOL CHEM, V280, P24491, DOI 10.1074/jbc.M504710200; Ishizuka T, 2007, PLANT CELL PHYSIOL, V48, P1385, DOI 10.1093/pcp/pcm106; Karniol B, 2005, BIOCHEM J, V392, P103, DOI 10.1042/BJ20050826; Karniol B, 2004, J BACTERIOL, V186, P445, DOI 10.1128/JB.186.2.445-453.2004; Karniol B, 2003, P NATL ACAD SCI USA, V100, P2807, DOI 10.1073/pnas.0437914100; Kilian O, 2007, APPL ENVIRON MICROB, V73, P4268, DOI 10.1128/AEM.00201-07; Kneip C, 1999, BIOCHEMISTRY-US, V38, P15185, DOI 10.1021/bi990688w; LAGARIAS JC, 1985, J BIOL CHEM, V260, P2415; Lamparter T, 2003, J BIOL CHEM, V278, P33786, DOI 10.1074/jbc.M305563200; Lamparter T, 1997, P NATL ACAD SCI USA, V94, P11792, DOI 10.1073/pnas.94.22.11792; Lapko VN, 1998, BIOCHEMISTRY-US, V37, P12526, DOI 10.1021/bi980834i; Li XQ, 1997, J BIOL CHEM, V272, P28545, DOI 10.1074/jbc.272.45.28545; LIMBACH HH, 1984, J AM CHEM SOC, V106, P4059, DOI 10.1021/ja00326a044; Miller AE, 2006, P NATL ACAD SCI USA, V103, P11136, DOI 10.1073/pnas.0604724103; MIZUTANI Y, 1994, BIOCHEMISTRY-US, V33, P153, DOI 10.1021/bi00167a020; Mroginski MA, 2004, J AM CHEM SOC, V126, P16734, DOI 10.1021/ja043959l; Mroginski MA, 2007, ACCOUNTS CHEM RES, V40, P258, DOI 10.1021/ar6000523; Murgida DH, 2007, BIOPHYS J, V93, P2410, DOI 10.1529/biophysj.107.108092; Natori C, 2007, PHOTOCH PHOTOBIO SCI, V6, P83, DOI 10.1039/b611077k; Noack S, 2007, BIOCHEMISTRY-US, V46, P4164, DOI 10.1021/bi602419x; Park CM, 2000, BIOCHEMISTRY-US, V39, P10840, DOI 10.1021/bi992831r; Park CM, 2000, BIOCHEMISTRY-US, V39, P6349, DOI 10.1021/bi992916s; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; Quail PH, 1997, PLANT CELL ENVIRON, V20, P657, DOI 10.1046/j.1365-3040.1997.d01-108.x; Remberg A, 1997, BIOCHEMISTRY-US, V36, P13389, DOI 10.1021/bi971563z; Riek R, 1999, P NATL ACAD SCI USA, V96, P4918, DOI 10.1073/pnas.96.9.4918; RIVERA M, 1995, ANAL BIOCHEM, V230, P295, DOI 10.1006/abio.1995.1477; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Rohmer T, 2006, J PHYS CHEM B, V110, P20580, DOI 10.1021/jp062454+; RUDIGER W, 1983, P NATL ACAD SCI-BIOL, V80, P6244, DOI 10.1073/pnas.80.20.6244; Scheer H., 1984, TECHNIQUES PHOTOMORP, P227, DOI [10.5282/ubm/epub.2167, DOI 10.5282/UBM/EPUB.2167]; Scheerer P, 2006, J STRUCT BIOL, V153, P97, DOI 10.1016/j.jsb.2005.11.002; Shlyk-Kerner O, 2006, NATURE, V442, P827, DOI 10.1038/nature04947; SMITH H, 1995, ANNU REV PLANT PHYS, V46, P289, DOI 10.1146/annurev.pp.46.060195.001445; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Strauss HM, 2005, FEBS LETT, V579, P3970, DOI 10.1016/j.febslet.2005.06.025; Strauss HM, 2005, BIOCHEMISTRY-US, V44, P8244, DOI 10.1021/bi050457r; Ulijasz AT, 1996, J BACTERIOL, V178, P6305, DOI 10.1128/jb.178.21.6305-6309.1996; van Thor JJ, 2006, BIOPHYS J, V91, P1811, DOI 10.1529/biophysj.106.084335; VENTERS RA, 1991, BIOCHEMISTRY-US, V30, P4491, DOI 10.1021/bi00232a017; Vierstra RD, 2005, HANDBOOK OF PHOTOSENSORY RECEPTORS, P171, DOI 10.1002/352760510X.ch8; von Stetten D, 2007, J BIOL CHEM, V282, P2116, DOI 10.1074/jbc.M608878200; VONSTETTEN D, 2008, ANGEW CHEM IN PRESS; Wagner JR, 2008, J BIOL CHEM, V283, P12212, DOI 10.1074/jbc.M709355200; Wagner JR, 2007, J BIOL CHEM, V282, P12298, DOI 10.1074/jbc.M611824200; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; Wang LY, 1999, J BACTERIOL, V181, P1211, DOI 10.1128/JB.181.4.1211-1219.1999; Wexler M, 2000, J BIOL CHEM, V275, P16717, DOI 10.1074/jbc.M000800200; Wu SH, 2000, BIOCHEMISTRY-US, V39, P13487, DOI 10.1021/bi001123z; Yang X, 2007, P NATL ACAD SCI USA, V104, P12571, DOI 10.1073/pnas.0701737104; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505; Yu HT, 1999, P NATL ACAD SCI USA, V96, P332, DOI 10.1073/pnas.96.2.332	76	46	50	0	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21251	21266		10.1074/jbc.M801592200	http://dx.doi.org/10.1074/jbc.M801592200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18480055	hybrid, Green Published			2022-12-25	WOS:000257746100067
J	Yoshikawa, F; Sato, Y; Tohyama, K; Akagi, T; Hashikawa, T; Nagakura-Takagi, Y; Sekine, Y; Morita, N; Baba, H; Suzuki, Y; Sugano, S; Sato, A; Furuichi, T				Yoshikawa, Fumio; Sato, Yumi; Tohyama, Koujiro; Akagi, Takumi; Hashikawa, Tsutomu; Nagakura-Takagi, Yuko; Sekine, Yukiko; Morita, Noriyuki; Baba, Hiroko; Suzuki, Yutaka; Sugano, Sumio; Sato, Akira; Furuichi, Teiichi			Opalin, a transmembrane sialylglycoprotein located in the central nervous system myelin paranodal loop membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING SITE; TIGHT JUNCTIONS; E-CADHERIN; LANTERMAN INCISURES; ADHERENS JUNCTIONS; GAP-JUNCTIONS; SCHWANN-CELLS; PROTEIN; BRAIN; ACID	In contrast to compact myelin, the series of paranodal loops located in the outermost lateral region of myelin is non-compact; the intracellular space is filled by a continuous channel of cytoplasm, the extracellular surfaces between neighboring loops keep a definite distance, but the loop membranes have junctional specializations. Although the proteins that form compact myelin have been well studied, the protein components of paranodal loop membranes are not fully understood. This report describes the biochemical characterization and expression of Opalin as a novel membrane protein in paranodal loops. Mouse Opalin is composed of a short N-terminal extracellular domain (amino acid residues 1-30), a transmembrane domain (residues 31-53), and a long C-terminal intracellular domain (residues 54-143). Opalin is enriched in myelin of the central nervous system, but not that of the peripheral nervous system of mice. Enzymatic deglycosylation showed that myelin Opalin contained N-and O-glycans, and that the O-glycans, at least, had negatively charged sialic acids. We identified two N-glycan sites at Asn-6 and Asn-12 and an O-glycan site at Thr-14 in the extracellular domain. Site-directed mutations at the glycan sites impaired the cell surface localization of Opalin. In addition to the somata and processes of oligodendrocytes, Opalin immunoreactivity was observed in myelinated axons in a spiral fashion, and was concentrated in the paranodal loop region. Immunogold electron microscopy demonstrated that Opalin was localized at particular sites in the paranodal loop membrane. These results suggest a role for highly sialylglycosylated Opalin in an intermembranous function of the myelin paranodal loops in the central nervous system.	[Yoshikawa, Fumio; Sato, Yumi; Nagakura-Takagi, Yuko; Sekine, Yukiko; Morita, Noriyuki; Sato, Akira; Furuichi, Teiichi] RIKEN, Brain Sci Inst, Lab Mol Neurogenesis, Wako, Saitama 3510198, Japan; [Akagi, Takumi; Hashikawa, Tsutomu] RIKEN, Brain Sci Inst, Lab Neural Architecture, Wako, Saitama 3510198, Japan; [Tohyama, Koujiro; Akagi, Takumi] Iwate Med Univ, Ctr Electron Microscopy & Bio Imaging Res, Morioka, Iwate 0208505, Japan; [Baba, Hiroko] Tokyo Univ Pharm & Life Sci, Hachioji, Tokyo 1920392, Japan; [Sugano, Sumio] Univ Tokyo, Dept Frontier Sci, Tokyo 1088639, Japan	RIKEN; RIKEN; Iwate Medical University; Tokyo University of Pharmacy & Life Sciences; University of Tokyo	Furuichi, T (corresponding author), RIKEN, Brain Sci Inst, Lab Mol Neurogenesis, Wako, Saitama 3510198, Japan.	tfuruichi@brain.riken.jp	Furuichi, Teiichi/B-5086-2014	Furuichi, Teiichi/0000-0002-9676-1888				Akagi T, 2006, J NEUROSCI METH, V153, P276, DOI 10.1016/j.jneumeth.2005.11.007; Aruga J, 2007, J NEUROCHEM, V102, P1533, DOI 10.1111/j.1471-4159.2007.04583.x; Bangsow T, 1998, EUR J BIOCHEM, V256, P24, DOI 10.1046/j.1432-1327.1998.2560024.x; BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; BOISON D, 1994, P NATL ACAD SCI USA, V91, P11709, DOI 10.1073/pnas.91.24.11709; Crocker PR, 2002, CURR OPIN STRUC BIOL, V12, P609, DOI 10.1016/S0959-440X(02)00375-5; Dugas JC, 2006, J NEUROSCI, V26, P10967, DOI 10.1523/JNEUROSCI.2572-06.2006; FANNON AM, 1995, J CELL BIOL, V129, P189, DOI 10.1083/jcb.129.1.189; Filbin MT, 2003, NAT REV NEUROSCI, V4, P1019, DOI 10.1038/nrn1288; Gow A, 1999, CELL, V99, P649, DOI 10.1016/S0092-8674(00)81553-6; Huang J, 2006, MOL BIOL CELL, V17, P3187, DOI 10.1091/mbc.E05-12-1122; Itoh K, 2002, BRAIN RES PROTOC, V10, P23; Johnson D, 2004, J BIOL CHEM, V279, P44303, DOI 10.1074/jbc.M408900200; Kamasawa N, 2005, NEUROSCIENCE, V136, P65, DOI 10.1016/j.neuroscience.2005.08.027; Kleopa KA, 2004, GLIA, V47, P346, DOI 10.1002/glia.20043; Li X, 2004, NEUROSCIENCE, V126, P611, DOI 10.1016/j.neuroscience.2004.03.063; MATTHIEU JM, 1986, J CELL BIOL, V103, P2673, DOI 10.1083/jcb.103.6.2673; Menichella DM, 2001, MOL CELL NEUROSCI, V18, P606, DOI 10.1006/mcne.2001.1041; Miyamoto T, 2005, J CELL BIOL, V169, P527, DOI 10.1083/jcb.200501154; Morita K, 1999, J CELL BIOL, V145, P579, DOI 10.1083/jcb.145.3.579; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nagy JI, 2004, BRAIN RES REV, V47, P191, DOI 10.1016/j.brainresrev.2004.05.005; Nobile C, 2002, GENE, V282, P87, DOI 10.1016/S0378-1119(01)00846-0; Norton W T, 1974, Methods Enzymol, V31, P435; Orthmann-Murphy JL, 2007, J NEUROSCI, V27, P13949, DOI 10.1523/JNEUROSCI.3395-07.2007; Otto VI, 2004, J BIOL CHEM, V279, P35201, DOI 10.1074/jbc.M404947200; Pedraza L, 2001, NEURON, V30, P335, DOI 10.1016/S0896-6273(01)00306-3; Poliak S, 1999, NEURON, V24, P1037, DOI 10.1016/S0896-6273(00)81049-1; Poliak S, 2002, J CELL BIOL, V159, P361, DOI 10.1083/jcb.200207050; RECIOPINTO E, 1990, NEURON, V5, P675, DOI 10.1016/0896-6273(90)90221-Z; ROACH A, 1983, CELL, V34, P799, DOI 10.1016/0092-8674(83)90536-6; Rosenbluth J, 2006, GLIA, V54, P172, DOI 10.1002/glia.20370; Rutishauser U, 1996, TRENDS NEUROSCI, V19, P422; Salzer JL, 2003, NEURON, V40, P297, DOI 10.1016/S0896-6273(03)00628-7; Scherer SS, 1995, J NEUROSCI, V15, P8281; Shiraishi Y, 1999, J NEUROSCI, V19, P8389; Spiegel I, 2002, MOL MEMBR BIOL, V19, P95, DOI 10.1080/09687680210130009; Suzuki Y, 1997, GENE, V200, P149, DOI 10.1016/S0378-1119(97)00411-3; Tiwari-Woodruff SK, 2001, J CELL BIOL, V153, P295, DOI 10.1083/jcb.153.2.295; TOKUYASU KT, 1989, HISTOCHEM J, V21, P163, DOI 10.1007/BF01007491; TRAPP BD, 1989, J CELL BIOL, V109, P2417, DOI 10.1083/jcb.109.5.2417; Tricaud N, 2005, J NEUROSCI, V25, P3259, DOI 10.1523/JNEUROSCI.5168-04.2005; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Yoshikawa F, 1999, J BIOL CHEM, V274, P328, DOI 10.1074/jbc.274.1.328; Yoshikawa F, 1996, J BIOL CHEM, V271, P18277, DOI 10.1074/jbc.271.30.18277; Young P, 2002, MOL CELL NEUROSCI, V21, P341, DOI 10.1006/mcne.2002.1177	47	38	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20830	20840		10.1074/jbc.M801314200	http://dx.doi.org/10.1074/jbc.M801314200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18490449	hybrid, Green Published			2022-12-25	WOS:000257746100025
J	Chavez-Gutierrez, L; Tolia, A; Maes, E; Li, T; Wong, PC; de Strooper, B				Chavez-Gutierrez, Lucia; Tolia, Alexandra; Maes, Elke; Li, Tong; Wong, Philip C.; de Strooper, Bart			Glu(332) in the Nicastrin ectodomain is essential for gamma-secretase complex maturation but not for its activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; EXOPEPTIDASE SPECIFICITY; TERMINAL FRAGMENT; FOLD RECOGNITION; PRESENILIN; PEN-2; TRAFFICKING; APH-1; TELENCEPHALIN; GENTHREADER	The gamma-secretase complex is responsible for the proteolysis of integral membrane proteins. Nicastrin has been proposed to operate as the substrate receptor of the complex with the glutamate 332 (Glu(333) in human) serving as the anionic binding site for the alpha-amino-terminal group of substrates. The putative binding site is located within the aminopeptidase-like domain of Nicastrin. The Glu(332) is proposed to function as the counterpart of the exopeptidase Glu located in the active site of these peptidases. Although Glu(332) could bind the alpha-amino-terminal group of substrates, we hypothesized, in analogy with M28-aminopeptidases, that other residues in the putative binding site of Nicastrin should participate in the interaction as well. Surprisingly, mutagenesis of these residues affected the in vivo processing of APP and Notch substrates only weakly. In addition, the E332Q mutation, which completely abolishes the anionic alpha-amino-terminal binding function, remained fully active. When we introduced the previously characterized E332A mutation, we found strongly decreased gamma-secretase complex levels, but the remaining complex appeared as active as the wild-type complex. We confirmed in two independent in vitro assays that the specific enzymatic activity of the E332A mutant was comparable with that of the wild-type complex. Thus, Glu(332) crucially affects complex maturation rather than substrate recognition. Moreover other Nicastrin mutants, designed to either impede or alter substantially the putative binding pocket, affected only marginally gamma-secretase activity. Consequently, these studies indicate that the main role of the Glu(332) is in the maturation and assembly of gamma-secretase rather than in the recognition of the substrates.	[Chavez-Gutierrez, Lucia; Tolia, Alexandra; Maes, Elke; de Strooper, Bart] Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium; [Chavez-Gutierrez, Lucia; Tolia, Alexandra; Maes, Elke; de Strooper, Bart] VIB, Dept Mol & Dev Genet, B-3000 Louvain, Belgium; [Li, Tong; Wong, Philip C.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA	KU Leuven; Flanders Institute for Biotechnology (VIB); Johns Hopkins University	de Strooper, B (corresponding author), Katholieke Univ Leuven, Ctr Human Genet, Herestr 49, B-3000 Louvain, Belgium.	Bart.deStrooper@med.kuleuven.be	Chávez-Gutiérrez, Lucía/E-2657-2017; de+Strooper, Bart/Z-1638-2019; De Strooper, Bart/F-6507-2012	De Strooper, Bart/0000-0001-5455-5819				Annaert W, 2002, ANNU REV CELL DEV BI, V18, P25, DOI 10.1146/annurev.cellbio.18.020402.142302; Annaert WG, 2001, NEURON, V32, P579, DOI 10.1016/S0896-6273(01)00512-8; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Capell A, 2005, J BIOL CHEM, V280, P6471, DOI 10.1074/jbc.M409106200; Chen FS, 2001, NAT CELL BIOL, V3, P751, DOI 10.1038/35087069; Chen JX, 2007, J BIOL CHEM, V282, P36862, DOI 10.1074/jbc.M706720200; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Esselens C, 2004, J CELL BIOL, V166, P1041, DOI 10.1083/jcb.200406060; Fagan R, 2001, TRENDS BIOCHEM SCI, V26, P213, DOI 10.1016/S0968-0004(01)01789-3; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P323, DOI 10.1021/bi035748j; Giannetti AM, 2003, PLOS BIOL, V1, P341, DOI 10.1371/journal.pbio.0000051; Goutte C, 2002, DEV CELL, V3, P6, DOI 10.1016/S1534-5807(02)00213-7; Goutte C, 2000, DEVELOPMENT, V127, P2481; Greenblatt HM, 1997, J MOL BIOL, V265, P620, DOI 10.1006/jmbi.1996.0729; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Hu Y, 2003, J CELL BIOL, V161, P685, DOI 10.1083/jcb.200304014; Huang KF, 2005, P NATL ACAD SCI USA, V102, P13117, DOI 10.1073/pnas.0504184102; Iturrioz X, 2001, BIOCHEMISTRY-US, V40, P14440, DOI 10.1021/bi011409j; Jones DT, 1999, J MOL BIOL, V287, P797, DOI 10.1006/jmbi.1999.2583; Kakuda N, 2006, J BIOL CHEM, V281, P14776, DOI 10.1074/jbc.M513453200; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; LaVoie MJ, 2003, J BIOL CHEM, V278, P37213, DOI 10.1074/jbc.M303941200; Lawrence CM, 1999, SCIENCE, V286, P779, DOI 10.1126/science.286.5440.779; Li T, 2003, J NEUROSCI, V23, P3272; Lleo A, 2008, CURR TOP MED CHEM, V8, P9; Luciani N, 1998, BIOCHEMISTRY-US, V37, P686, DOI 10.1021/bi971705p; McGuffin LJ, 2003, BIOINFORMATICS, V19, P874, DOI 10.1093/bioinformatics/btg097; Michiels F, 2002, NAT BIOTECHNOL, V20, P1154, DOI 10.1038/nbt746; Nyabi O, 2003, J BIOL CHEM, V278, P43430, DOI 10.1074/jbc.M306957200; Prokop S, 2004, J BIOL CHEM, V279, P23255, DOI 10.1074/jbc.M401789200; Reiland V, 2004, ACTA CRYSTALLOGR D, V60, P1738, DOI 10.1107/S0907444904018281; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shirotani K, 2004, J NEUROCHEM, V89, P1520, DOI 10.1111/j.1471-4159.2004.02447.x; Shirotani K, 2003, J BIOL CHEM, V278, P16474, DOI 10.1074/jbc.C300095200; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Tholander F, 2005, J BIOL CHEM, V280, P33477, DOI 10.1074/jbc.M506821200; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Vazeux G, 1998, BIOCHEM J, V334, P407, DOI 10.1042/bj3340407; Walsh DM, 2004, PROTEIN PEPTIDE LETT, V11, P213, DOI 10.2174/0929866043407174; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Yuan H, 1999, J NEUROSCI METH, V88, P45, DOI 10.1016/S0165-0270(99)00011-4	47	96	99	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20096	20105		10.1074/jbc.M803040200	http://dx.doi.org/10.1074/jbc.M803040200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18502756	hybrid, Green Published			2022-12-25	WOS:000257565300026
J	Coffin, SR; Reich, NO				Coffin, Stephanie R.; Reich, Norbert O.			Modulation of Escherichia coli DNA methyltransferase activity by biologically derived GATC-flanking sequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESTRICTION-ENDONUCLEASE ECORV; SEQA PROTEIN; ADENINE METHYLTRANSFERASE; REPLICATION INITIATION; HAEMOPHILUS-INFLUENZAE; DAM METHYLTRANSFERASE; FACILITATED DIFFUSION; PYRIMIDINE REGULATION; METHYLATION STATUS; CRYSTAL-STRUCTURE	Escherichia coli DNA adenine methyltransferase (EcoDam) methylates the N-6 position of the adenine in the sequence 5'-GATC-3' and plays vital roles in gene regulation, mismatch repair, and DNA replication. It remains unclear how the small number of critical GATC sites involved in the regulation of replication and gene expression are differentially methylated, whereas the similar to 20,000 GATCs important for mismatch repair and dispersed throughout the genome are extensively methylated. Our prior work, limited to the pap regulon, showed that methylation efficiency is controlled by sequences immediately flanking the GATC sites. We extend these studies to include GATC sites involved in diverse gene regulatory and DNA replication pathways as well as sites previously shown to undergo differential in vivo methylation but whose function remains to be assigned. EcoDam shows no change in affinity with variations in flanking sequences derived from these sources, but methylation kinetics varied 12-fold. A-tracts immediately adjacent to the GATC site contribute significantly to these differences in methylation kinetics. Interestingly, only when the poly(A) is located 5' of the GATC are the changes in methylation kinetics revealed. Preferential methylation is obscured when two GATC sites are positioned on the same DNA molecule, unless both sites are surrounded by large amounts of nonspecific DNA. Thus, facilitated diffusion and sequences immediately flanking target sites contribute to higher order specificity for EcoDam; we suggest that the diverse biological roles of the enzyme are in part regulated by these two factors, which may be important for other enzymes that sequence-specifically modify DNA.	[Coffin, Stephanie R.; Reich, Norbert O.] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA; [Reich, Norbert O.] Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Reich, NO (corresponding author), Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA.	reich@chem.ucsb.edu			NIGMS NIH HHS [GM 53763] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053763] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allan BW, 1999, J BIOL CHEM, V274, P19269, DOI 10.1074/jbc.274.27.19269; Alonso A, 2005, J BACTERIOL, V187, P7901, DOI 10.1128/JB.187.23.7901-7911.2005; Bach T, 2005, J MOL BIOL, V350, P7, DOI 10.1016/j.jmb.2005.04.055; BERGERAT A, 1989, J BIOL CHEM, V264, P4064; BESTOR TH, 1994, CURR OPIN CELL BIOL, V6, P380, DOI 10.1016/0955-0674(94)90030-2; Bheemanaik S, 2006, BIOCHEM J, V399, P177, DOI 10.1042/BJ20060854; BLYN LB, 1990, EMBO J, V9, P4045, DOI 10.1002/j.1460-2075.1990.tb07626.x; Brendler T, 1999, EMBO J, V18, P2304, DOI 10.1093/emboj/18.8.2304; CAMPBELL JL, 1990, CELL, V62, P967, DOI 10.1016/0092-8674(90)90271-F; Casadesus J, 2006, MICROBIOL MOL BIOL R, V70, P830, DOI 10.1128/MMBR.00016-06; CHARLIER D, 1995, J MOL BIOL, V250, P383, DOI 10.1006/jmbi.1995.0384; CHARLIER D, 1995, J MOL BIOL, V250, P392, DOI 10.1006/jmbi.1995.0385; Cheng XD, 2001, NUCLEIC ACIDS RES, V29, P3784, DOI 10.1093/nar/29.18.3784; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Eberhard J, 2001, FEMS MICROBIOL LETT, V195, P223, DOI 10.1016/S0378-1097(01)00014-3; Ellenberger T, 1997, STRUCTURE, V5, P153, DOI 10.1016/S0969-2126(97)00174-3; Faiger H, 2006, NUCLEIC ACIDS RES, V34, P104, DOI 10.1093/nar/gkj414; Hales LM, 1996, NUCLEIC ACIDS RES, V24, P1780, DOI 10.1093/nar/24.9.1780; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; HALFORD SE, 1980, BIOCHEM J, V191, P581, DOI 10.1042/bj1910581; Han JS, 2004, J BIOL CHEM, V279, P30236, DOI 10.1074/jbc.M402612200; Heithoff DM, 1999, SCIENCE, V284, P967, DOI 10.1126/science.284.5416.967; HERMAN GE, 1982, J BIOL CHEM, V257, P2605; Hernday AD, 2003, MOL CELL, V12, P947, DOI 10.1016/S1097-2765(03)00383-6; Heusipp G, 2007, INT J MED MICROBIOL, V297, P1, DOI 10.1016/j.ijmm.2006.10.002; Horton JR, 2006, J MOL BIOL, V358, P559, DOI 10.1016/j.jmb.2006.02.028; JACK WE, 1982, P NATL ACAD SCI-BIOL, V79, P4010, DOI 10.1073/pnas.79.13.4010; Jeltsch A, 1996, EMBO J, V15, P5104, DOI 10.1002/j.1460-2075.1996.tb00891.x; Julio SM, 2001, INFECT IMMUN, V69, P7610, DOI 10.1128/IAI.69.12.7610-7615.2001; Kang S, 1999, J BIOL CHEM, V274, P11463, DOI 10.1074/jbc.274.17.11463; Lobner-Olesen A, 2005, CURR OPIN MICROBIOL, V8, P154, DOI 10.1016/j.mib.2005.02.009; Lobner-Olesen A, 2003, P NATL ACAD SCI USA, V100, P4672, DOI 10.1073/pnas.0538053100; LOBNEROLESEN A, 1992, MOL MICROBIOL, V6, P1841, DOI 10.1111/j.1365-2958.1992.tb01356.x; LU M, 1994, CELL, V77, P413, DOI 10.1016/0092-8674(94)90156-2; MacDonald D, 2001, J MOL BIOL, V306, P1081, DOI 10.1006/jmbi.2001.4447; Mashhoon N, 2004, J BIOL CHEM, V279, P52075, DOI 10.1074/jbc.M408182200; Mashhoon N, 2006, J BIOMOL SCREEN, V11, P497, DOI 10.1177/1087057106287933; NELSON HCM, 1987, NATURE, V330, P221, DOI 10.1038/330221a0; Oshima T, 2002, MOL MICROBIOL, V45, P673, DOI 10.1046/j.1365-2958.2002.03037.x; Packer MJ, 2000, J MOL BIOL, V295, P71, DOI 10.1006/jmbi.1999.3236; Packer MJ, 2000, J MOL BIOL, V295, P85, DOI 10.1006/jmbi.1999.3237; Peterson SN, 2006, J MOL BIOL, V355, P459, DOI 10.1016/j.jmb.2005.11.003; PIEKAROWICZ A, 1975, ACTA MICROBIOL POL, V7, P51; Polaczek P, 1998, MOL GEN GENET, V258, P488, DOI 10.1007/s004380050759; RUSSELL DW, 1987, CELL, V50, P1071, DOI 10.1016/0092-8674(87)90173-5; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Skarstad K, 2000, MOL MICROBIOL, V36, P1319, DOI 10.1046/j.1365-2958.2000.01943.x; SLATER S, 1995, CELL, V82, P927, DOI 10.1016/0092-8674(95)90272-4; SMITH DW, 1985, EMBO J, V4, P1319, DOI 10.1002/j.1460-2075.1985.tb03779.x; Stanford NP, 2000, EMBO J, V19, P6546, DOI 10.1093/emboj/19.23.6546; Surby MA, 1996, BIOCHEMISTRY-US, V35, P2209, DOI 10.1021/bi951884f; Surby MA, 1996, BIOCHEMISTRY-US, V35, P2201, DOI 10.1021/bi951883n; SURBY MA, 1992, ABSTRACTS PAPERS AM, V203; Tavazoie S, 1998, NAT BIOTECHNOL, V16, P566, DOI 10.1038/nbt0698-566; TAYLOR JD, 1992, BIOCHEMISTRY-US, V31, P90, DOI 10.1021/bi00116a014; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Travers AA, 2004, PHILOS T R SOC A, V362, P1423, DOI 10.1098/rsta.2004.1390; Urig S, 2002, J MOL BIOL, V319, P1085, DOI 10.1016/S0022-2836(02)00371-6; VANCLEVE MD, 1992, BIOCHEMISTRY-US, V31, P334, DOI 10.1021/bi00117a004; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; WANG MX, 1992, NATURE, V360, P606, DOI 10.1038/360606a0; Watson ME, 2004, MOL MICROBIOL, V53, P651, DOI 10.1111/j.1365-2958.2004.04140.x; Wenz C, 1998, BIOCHEMISTRY-US, V37, P2234, DOI 10.1021/bi9719197; WILSON GG, 1991, ANNU REV GENET, V25, P585, DOI 10.1146/annurev.ge.25.120191.003101; WINKLER FK, 1993, EMBO J, V12, P1781, DOI 10.1002/j.1460-2075.1993.tb05826.x; Wu H, 2006, ORAL MICROBIOL IMMUN, V21, P238, DOI 10.1111/j.1399-302X.2006.00284.x; Yang Z, 2003, NAT STRUCT BIOL, V10, P849, DOI 10.1038/nsb973; Youngblood B, 2006, J BIOL CHEM, V281, P26821, DOI 10.1074/jbc.M603388200; Zinoviev VV, 2007, BIOL CHEM, V388, P1199, DOI 10.1515/BC.2007.142; ZYSKIND JW, 1986, CELL, V46, P489, DOI 10.1016/0092-8674(86)90873-1	72	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20106	20116		10.1074/jbc.M802502200	http://dx.doi.org/10.1074/jbc.M802502200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18502761	Green Published, hybrid			2022-12-25	WOS:000257565300027
J	De Donatis, A; Comito, G; Buricchi, F; Vinci, MC; Parenti, A; Caselli, A; Camici, G; Manao, G; Ramponi, G; Cirri, P				De Donatis, Alina; Comito, Giusy; Buricchi, Francesca; Vinci, Maria C.; Parenti, Astrid; Caselli, Anna; Camici, Guido; Manao, Giampaolo; Ramponi, Giampietro; Cirri, Paolo			Proliferation versus migration in platelet-derived growth factor signaling - The key role of endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL-ADHESION KINASE; FACTOR BETA-RECEPTOR; CELL-MIGRATION; PROTEIN-KINASE; IN-VIVO; PDGF; INHIBITION; ENDOSOMES; GTPASES; INTERNALIZATION	It is common knowledge that platelet-derived growth factor (PDGF) is a critical regulator of mesenchymal cell migration and proliferation. Nevertheless, these two cellular responses are mutually exclusive. To solve this apparent contradiction, we studied the behavior of NIH3T3 fibroblasts in response to increasing concentrations of PDGF. We found that there is strong cell proliferation induction only with PDGF concentrations > 5 ng/ml, whereas the cell migration response arises starting from 1 ng/ml and is negligible at higher PDGF concentrations. According to these phenotypic evidences, our data indicate that cells display a differential activation of the main signaling pathways in response to PDGF as a function of the stimulation dose. At low PDGF concentrations, there is maximal activation of signaling pathways linked to cytoskeleton rearrangement needed for cell motility, whereas high PDGF concentrations activate pathways linked to mitogenesis induction. Our results suggest a mechanism by which cells switch from a migrating to a proliferating phenotype sensing the increasing gradient of PDGF. In addition, we propose that the cell decision to proliferate or migrate relies on different endocytotic routes of the PDGF receptor in response to different PDGF concentrations.	[De Donatis, Alina; Comito, Giusy; Buricchi, Francesca; Caselli, Anna; Camici, Guido; Manao, Giampaolo; Ramponi, Giampietro; Cirri, Paolo] Univ Florence, Dipartimento Sci Biochim, I-50134 Florence, Italy; [Vinci, Maria C.; Parenti, Astrid] Univ Florence, Dipartimento Farmacol Preclin & Clin, I-50134 Florence, Italy	University of Florence; University of Florence	Cirri, P (corresponding author), Univ Florence, Dipartimento Sci Biochim, Viale Morgagni 50, I-50134 Florence, Italy.	paolo.cirri@unifi.it	Caselli, Anna/O-7512-2014; Vinci, Maria Cristina/E-7401-2016; Camici, Giovanni/H-1631-2018	Caselli, Anna/0000-0001-8140-3415; Vinci, Maria Cristina/0000-0001-6323-147X; Camici, Giovanni/0000-0002-0523-0695; Parenti, Astrid/0000-0002-7980-6853; Comito, Giuseppina/0000-0002-4614-067X				Birukova AA, 2007, FASEB J, V21, P2776, DOI 10.1096/fj.06-7660com; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Collado M, 2000, J BIOL CHEM, V275, P21960, DOI 10.1074/jbc.M000759200; Desire L, 2005, J BIOL CHEM, V280, P37516, DOI 10.1074/jbc.M507913200; Even-Ram S, 2005, CURR OPIN CELL BIOL, V17, P524, DOI 10.1016/j.ceb.2005.08.015; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hoch RV, 2003, DEVELOPMENT, V130, P4769, DOI 10.1242/dev.00721; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; MORI S, 1992, J BIOL CHEM, V267, P6429; MORI S, 1994, J BIOL CHEM, V269, P4917; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Narumiya S, 2000, METHOD ENZYMOL, V325, P273; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Parenti A, 1996, BRIT J PHARMACOL, V119, P619, DOI 10.1111/j.1476-5381.1996.tb15718.x; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Polo S, 2006, CELL, V124, P897, DOI 10.1016/j.cell.2006.02.025; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ren XD, 2000, J CELL SCI, V113, P3673; Roberts M, 2001, CURR BIOL, V11, P1392, DOI 10.1016/S0960-9822(01)00442-0; Ronnstrand L, 2001, INT J CANCER, V91, P757, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1136>3.0.CO;2-J; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; SORKIN A, 1991, J CELL BIOL, V112, P469, DOI 10.1083/jcb.112.3.469; Tallquist M, 2004, CYTOKINE GROWTH F R, V15, P205, DOI 10.1016/j.cytogfr.2004.03.003; Wang Y, 2004, J BIOL CHEM, V279, P8038, DOI 10.1074/jbc.M311494200; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x	36	102	106	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					19948	19956		10.1074/jbc.M709428200	http://dx.doi.org/10.1074/jbc.M709428200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18499659	hybrid			2022-12-25	WOS:000257565300010
J	Lauer-Fields, JL; Whitehead, JK; Li, S; Hammer, RP; Brew, K; Fields, GB				Lauer-Fields, Janelle L.; Whitehead, John K.; Li, Shunzi; Hammer, Robert P.; Brew, Keith; Fields, Gregg B.			Selective modulation of matrix metalloproteinase 9 (MMP-9) functions via exosite inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRO-MATRIX METALLOPROTEINASE-2; FIBRONECTIN-LIKE DOMAIN; C-TERMINAL DOMAIN; TISSUE INHIBITOR; COLLAGENOLYTIC ACTIVITY; FLUOROGENIC SUBSTRATE; MODEL PEPTIDES; GELATINASE-A; I COLLAGEN; ACTIVATION	Unregulated activities of the matrix metalloproteinase (MMP) family have been implicated in primary and metastatic tumor growth, angiogenesis, and pathological degradation of extracellular matrix components, such as collagen and laminin. However, clinical trials with small molecule MMP inhibitors have been largely unsuccessful, with a lack of selectivity considered particularly problematic. Enhanced selectivity could be achieved by taking advantage of differences in substrate secondary binding sites (exosites) within the MMP family. In this study, triple-helical substrates and triple-helical transition state analog inhibitors have been utilized to dissect the roles of potential exosites in MMP-9 collagenolytic behavior. Substrate and inhibitor sequences were based on either the alpha 1(V) 436-450 collagen region, which is hydrolyzed at the Gly down arrow Val bond selectively by MMP-2 and MMP-9, or the Gly down arrow Leu cleavage site within the consensus interstitial collagen sequence alpha 1(I-III) 769-783, which is hydrolyzed by MMP-1, MMP-2, MMP-8, MMP-9, MMP-13, and MT1-MMP. Exosites within the MMP-9 fibronectin II inserts were found to be critical for interactions with type V collagen model substrates and inhibitors and to participate in interactions with an interstitial (types I-III) collagen model inhibitor. A triple-helical peptide incorporating a fibronectin II insert-binding sequence was constructed and found to selectively inhibit MMP-9 type V collagen-based activities compared with interstitial collagen-based activities. This represents the first example of differential inhibition of collagenolytic activities and was achieved via an exosite-binding triple-helical peptide.	[Lauer-Fields, Janelle L.; Fields, Gregg B.] Florida Atlantic Univ, Dept Chem & Biochem, Boca Raton, FL 33431 USA; [Lauer-Fields, Janelle L.; Brew, Keith] Florida Atlantic Univ, Coll Biomed Sci, Boca Raton, FL 33431 USA; [Whitehead, John K.; Li, Shunzi; Hammer, Robert P.] Louisiana State Univ, Dept Chem, Baton Rouge, LA 70803 USA	State University System of Florida; Florida Atlantic University; State University System of Florida; Florida Atlantic University; Louisiana State University System; Louisiana State University	Fields, GB (corresponding author), Florida Atlantic Univ, Dept Chem & Biochem, 777 Glades Rd, Boca Raton, FL 33431 USA.	fieldsg@fau.edu	Brew, Keith/A-6746-2009; Brew, Keith/W-1643-2019	Brew, Keith/0000-0003-1306-1032; 	NATIONAL CANCER INSTITUTE [R01CA098799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040994] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA098799, CA 98799] Funding Source: Medline; NIAMS NIH HHS [R01 AR040994-15A1, R01 AR040994] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AIMES RT, 1995, J BIOL CHEM, V270, P5872, DOI 10.1074/jbc.270.11.5872; Beck K, 2000, P NATL ACAD SCI USA, V97, P4273, DOI 10.1073/pnas.070050097; Bigg HF, 2007, FEBS J, V274, P1246, DOI 10.1111/j.1742-4658.2007.05669.x; Chen EI, 2002, J BIOL CHEM, V277, P4485, DOI 10.1074/jbc.M109469200; Chung L, 2000, J BIOL CHEM, V275, P29610, DOI 10.1074/jbc.M004039200; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; CLARK IM, 1989, BIOCHEM J, V263, P201, DOI 10.1042/bj2630201; COLLIER IE, 1992, J BIOL CHEM, V267, P6776; DeSouza SJ, 1996, FASEB J, V10, P927, DOI 10.1096/fasebj.10.8.8666171; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Elkins PA, 2002, ACTA CRYSTALLOGR D, V58, P1182, DOI 10.1107/S0907444902007849; Falconi M, 2003, J COMPUT AID MOL DES, V17, P837, DOI 10.1023/B:JCAM.0000021883.44532.75; FIELDS GB, 1991, J THEOR BIOL, V153, P585, DOI 10.1016/S0022-5193(05)80157-2; Fingleton B, 2007, CURR PHARM DESIGN, V13, P333, DOI 10.2174/138161207779313551; GIOLA M, 2007, J MOL BIOL, V368, P1101; Hamze AB, 2007, PROTEIN SCI, V16, P1905, DOI 10.1110/ps.072978507; Holmgren SK, 1998, NATURE, V392, P666, DOI 10.1038/33573; Holmgren SK, 1999, CHEM BIOL, V6, P63, DOI 10.1016/S1074-5521(99)80003-9; Hurst DR, 2004, BIOCHEM J, V377, P775, DOI 10.1042/bj20031067; ITOH Y, 1995, BIOCHEM J, V308, P645, DOI 10.1042/bj3080645; Iyer S, 2006, J MOL BIOL, V362, P78, DOI 10.1016/j.jmb.2006.06.079; KNAUPER V, 1993, BIOCHEM J, V291, P847; Knauper V, 1997, J BIOL CHEM, V272, P7608, DOI 10.1074/jbc.272.12.7608; Lauer-Fields J, 2007, J AM CHEM SOC, V129, P10408, DOI 10.1021/ja0715849; Lauer-Fields Janelle L, 2004, J Biomol Tech, V15, P305; Lauer-Fields JL, 2000, J BIOL CHEM, V275, P13282, DOI 10.1074/jbc.275.18.13282; Lauer-Fields JL, 2003, J BIOL CHEM, V278, P18140, DOI 10.1074/jbc.M211330200; Lauer-Fields JL, 2002, BIOL CHEM, V383, P1095, DOI 10.1515/BC.2002.118; Lauer-Fields JL, 2001, BIOCHEMISTRY-US, V40, P5795, DOI 10.1021/bi0101190; LAUERFIELDS JL, 2008, BIOORG MED IN PRESS; Luque I, 2000, PROTEINS, P63; Malkar NB, 2003, BIOMACROMOLECULES, V4, P518, DOI 10.1021/bm0256597; Malkar NB, 2002, BIOCHEMISTRY-US, V41, P6054, DOI 10.1021/bi012071w; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; Minond D, 2004, BIOCHEMISTRY-US, V43, P11474, DOI 10.1021/bi048938i; Minond D, 2007, BIOCHEMISTRY-US, V46, P3724, DOI 10.1021/bi062199j; Minond D, 2006, J BIOL CHEM, V281, P38302, DOI 10.1074/jbc.M606004200; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; Morrison CJ, 2006, J BIOL CHEM, V281, P26528, DOI 10.1074/jbc.M603331200; MURPHY G, 1992, J BIOL CHEM, V267, P9612; NAGASE H, 1994, J BIOL CHEM, V269, P20952; Neumann U, 2004, ANAL BIOCHEM, V328, P166, DOI 10.1016/j.ab.2003.12.035; O'Farrell TJ, 1998, ARCH BIOCHEM BIOPHYS, V354, P24, DOI 10.1006/abbi.1998.0662; O'Farrell TJ, 2000, J BIOL CHEM, V275, P27964; OHARE MC, 1995, BIOCHEM BIOPH RES CO, V216, P329, DOI 10.1006/bbrc.1995.2628; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; Ottl J, 2000, CHEM BIOL, V7, P119, DOI 10.1016/S1074-5521(00)00077-6; Overall CM, 2007, STRUCTURE, V15, P1159, DOI 10.1016/j.str.2007.10.001; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Patterson ML, 2001, FEBS LETT, V503, P158, DOI 10.1016/S0014-5793(01)02723-5; Persikov AV, 2000, BIOCHEMISTRY-US, V39, P14960, DOI 10.1021/bi001560d; Persikov AV, 2004, PROTEIN SCI, V13, P893, DOI 10.1110/ps.03501704; Persikov AV, 2000, BIOPOLYMERS, V55, P436, DOI 10.1002/1097-0282(2000)55:6<436::AID-BIP1019>3.0.CO;2-D; Pickford AR, 1997, STRUCTURE, V5, P359, DOI 10.1016/S0969-2126(97)00193-7; Rosenblum G, 2007, STRUCTURE, V15, P1227, DOI 10.1016/j.str.2007.07.019; Ruben AJ, 2006, CHEM BIOL DRUG DES, V67, P2, DOI 10.1111/j.1747-0285.2005.00314.x; Song FY, 2006, FRONT BIOSCI-LANDMRK, V11, P3100, DOI 10.2741/2036; STEFFENSEN B, 1995, J BIOL CHEM, V270, P11555, DOI 10.1074/jbc.270.19.11555; Suzuki K, 1998, BIOL CHEM, V379, P185, DOI 10.1515/bchm.1998.379.2.185; Tam EM, 2004, J BIOL CHEM, V279, P43336, DOI 10.1074/jbc.M407186200; Woessner J.F., 2000, PROTEIN PROFILE SER; Xu XP, 2007, BIOCHEM J, V406, P147, DOI 10.1042/BJ20070591; Xu XP, 2005, BIOCHEM J, V392, P127, DOI 10.1042/BJ20050650; Yu YC, 1998, J AM CHEM SOC, V120, P9979, DOI 10.1021/ja981654z; Yu YC, 1996, J AM CHEM SOC, V118, P12515, DOI 10.1021/ja9627656	66	76	79	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20087	20095		10.1074/jbc.M801438200	http://dx.doi.org/10.1074/jbc.M801438200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18499673	Green Published, hybrid			2022-12-25	WOS:000257565300025
J	Watanabe, S; Saimura, M; Makino, K				Watanabe, Seiya; Saimura, Masayuki; Makino, Keisuke			Eukaryotic and bacterial gene clusters related to an alternative pathway of nonphosphorylated L-rhamnose metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-FUCOSE METABOLISM; L-ARABINOSE METABOLISM; CLASS-II ALDOLASE; ENZYMATIC-ACTIVITIES; ENOLASE SUPERFAMILY; ESCHERICHIA-COLI; 2-KETO-3-DEOXY-L-ARABONATE ALDOLASE; BIOCHEMICAL-CHARACTERIZATION; GLUCOSE-DEHYDROGENASE; EVOLUTIONARY INSIGHT	The Entner-Doudoroff (ED) pathway is a classic central pathway of D-glucose metabolism in all three phylogenetic domains. On the other hand, Archaea and/or bacteria possess several modified versions of the ED pathway, in which non-phosphorylated intermediates are involved. Several fungi, including Pichia stipitis and Debaryomyces hansenii, possess an alternative pathway of L-rhamnose metabolism, which is different from the known bacterial pathway. Gene cluster related to this hypothetical pathway was identified by bioinformatic analysis using the metabolic enzymes involved in analogous sugar pathways to the ED pathway. Furthermore, the homologous gene cluster was found not only in many other fungi but also several bacteria, including Azotobacter vinelandii. Four putative metabolic genes, LRA1-4, were cloned, overexpressed in Escherichia coli, and purified. Substrate specificity and kinetic analysis revealed that nonphosphorylated intermediates related to L-rhamnose are significant active substrates for the purified LRA1-4 proteins. Furthermore, L-2-keto-3-deoxyrhamnonate was structurally identified as both reaction products of dehydration by LRA3 and aldol condensation by LRA4. These results suggested that the LRA1-4 genes encode L-rhamnose 1-dehydrogenase, L-rhamnono-gamma-lactonase, L-rhamnonate dehydratase, and L-KDR aldolase, respectively, by which L-rhamnose is converted into pyruvate and L-lactaldehyde through analogous reaction steps to the ED pathway. There was no evolutionary relationship between L-KDR aldolases from fungi and bacteria.	[Watanabe, Seiya; Saimura, Masayuki; Makino, Keisuke] Kyoto Univ, Inst Adv Energy, Kyoto 6110011, Japan; [Watanabe, Seiya; Saimura, Masayuki; Makino, Keisuke] New Energy & Ind Technol Dev Org Gokasho, Kyoto 6110011, Japan; [Makino, Keisuke] Kyoto Univ, Innovat Collaborat Ctr, Sakyo Ku, Kyoto 6068501, Japan; [Watanabe, Seiya; Makino, Keisuke] Japan Sci & Technol Agcy, CREST, Kyoto 6110011, Japan	Kyoto University; Kyoto University; Japan Science & Technology Agency (JST)	Watanabe, S (corresponding author), Kyoto Univ, Inst Adv Energy, Kyoto 6110011, Japan.	irab@iae.kyoto-u.ac.jp						Ahmed H, 2005, BIOCHEM J, V390, P529, DOI 10.1042/BJ20041711; BADIA J, 1991, J BACTERIOL, V173, P5144, DOI 10.1128/jb.173.16.5144-5150.1991; Barbosa JARG, 2000, J MOL BIOL, V303, P405, DOI 10.1006/jmbi.2000.4138; Brouns SJJ, 2006, J BIOL CHEM, V281, P27378, DOI 10.1074/jbc.M605549200; DAHMS AS, 1972, J BIOL CHEM, V247, P2228; DAHMS AS, 1972, J BIOL CHEM, V247, P2233; DAHMS AS, 1969, BIOCHEM BIOPH RES CO, V36, P809, DOI 10.1016/0006-291X(69)90681-0; DAHMS AS, 1972, J BIOL CHEM, V247, P2222; DAHMS AS, 1972, J BIOL CHEM, V247, P2238; EGAN SM, 1993, J MOL BIOL, V234, P87, DOI 10.1006/jmbi.1993.1565; Elshafei AM, 2001, ENZYME MICROB TECH, V29, P76, DOI 10.1016/S0141-0229(01)00346-5; GENNADY PM, 2002, HDB DETECTION ENZYME, P27; Halak S, 2007, J BACTERIOL, V189, P6998, DOI 10.1128/JB.00611-07; Holm L, 1997, PROTEINS, V28, P72, DOI 10.1002/(SICI)1097-0134(199705)28:1<72::AID-PROT7>3.0.CO;2-L; Hosoya S, 2002, FEMS MICROBIOL LETT, V210, P193, DOI 10.1111/j.1574-6968.2002.tb11180.x; HUFF E, 1959, J BIOL CHEM, V234, P1060; Izard T, 2000, EMBO J, V19, P3849, DOI 10.1093/emboj/19.15.3849; Johnsen U, 2004, J BACTERIOL, V186, P6198, DOI 10.1128/JB.186.18.6198-6207.2004; Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamble FJ, 2004, FEBS LETT, V576, P133, DOI 10.1016/j.febslet.2004.08.074; Lamble HJ, 2003, J BIOL CHEM, V278, P34066, DOI 10.1074/jbc.M305818200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACGEE J, 1954, J BIOL CHEM, V210, P617; Masai E, 1999, J BACTERIOL, V181, P55, DOI 10.1128/JB.181.1.55-62.1999; Moore S, 1940, J BIOL CHEM, V133, P293; OTANI M, 1986, J BACTERIOL, V167, P148, DOI 10.1128/jb.167.1.148-152.1986; Peekhaus N, 1998, J BACTERIOL, V180, P3495, DOI 10.1128/JB.180.14.3495-3502.1998; Poysti NJ, 2007, MICROBIOL-SGM, V153, P727, DOI 10.1099/mic.0.29148-0; Rakus JF, 2007, BIOCHEMISTRY-US, V46, P12896, DOI 10.1021/bi701703w; Rea D, 2007, J MOL BIOL, V373, P866, DOI 10.1016/j.jmb.2007.06.048; RIGO LU, 1985, CAN J MICROBIOL, V31, P817, DOI 10.1139/m85-153; Sambrook J, 2001, MOL CLONING LAB MANU; Samland AK, 2006, APPL MICROBIOL BIOT, V71, P253, DOI 10.1007/s00253-006-0422-6; Siebers B, 2005, CURR OPIN MICROBIOL, V8, P695, DOI 10.1016/j.mib.2005.10.014; Stephens C, 2007, J BACTERIOL, V189, P2181, DOI 10.1128/JB.01438-06; Toda Tosifusa, 1997, Japanese Journal of Electrophoresis, V41, P13; TWERDOCHLIB AL, 1994, CAN J MICROBIOL, V40, P896, DOI 10.1139/m94-144; Wang WJ, 2005, BIOCHEMISTRY-US, V44, P9447, DOI 10.1021/bi050607y; Watanabe S, 2006, J BIOL CHEM, V281, P2612, DOI 10.1074/jbc.M506477200; Watanabe S, 2007, J BIOL CHEM, V282, P6685, DOI 10.1074/jbc.M611057200; Watanabe S, 2006, J BIOL CHEM, V281, P33521, DOI 10.1074/jbc.M606727200; Watanabe S, 2006, J BIOL CHEM, V281, P28876, DOI 10.1074/jbc.M602585200; Yamamoto K, 2001, J BIOCHEM, V129, P303, DOI 10.1093/oxfordjournals.jbchem.a002858; Yew WS, 2007, BIOCHEMISTRY-US, V46, P9564, DOI 10.1021/bi7008882; Yew WS, 2006, BIOCHEMISTRY-US, V45, P14582, DOI 10.1021/bi061687o	46	52	54	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20372	20382		10.1074/jbc.M801065200	http://dx.doi.org/10.1074/jbc.M801065200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18505728	hybrid			2022-12-25	WOS:000257565300053
J	Yue, XP; Li, X; Nguyen, HT; Chin, DR; Sullivan, DE; Lasky, JA				Yue, Xinping; Li, Xian; Nguyen, Hong T.; Chin, Dawn R.; Sullivan, Deborah E.; Lasky, Joseph A.			Transforming growth factor-beta 1 induces heparan sulfate 6-O-endosulfatase 1 expression in vitro and in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; PULMONARY-FIBROSIS; TUMOR-GROWTH; BINDING; QSULF1; SITES; FGF; IDENTIFICATION; PROLIFERATION; MYOFIBROBLAST	Transforming growth factor (TGF)-beta 1 plays an important role in the development of pulmonary fibrosis. In this study we examined the relationship between TGF-beta 1 stimulation and the expression of heparan sulfate (HS) 6-O-endosulfatase 1 (Sulf1) in cultured normal human lung fibroblasts (NHLFs) and in murine lungs in vivo. By removing 6-O-sulfates from specific HS intrachain sites on the cell surface, Sulf1 has been shown to modulate the activities of many HS binding growth factors and morphogens including fibroblast growth factor (FGF)-2. Real time reverse transcription-PCR analysis revealed that TGF-beta 1 increased Sulf1 expression in NHLFs in a dose- and time-dependent manner which was accompanied by a decrease in 6-O-sulfated disaccharides as revealed by high performance liquid chromatography analysis. Decreased ERK activation after FGF-2 stimulation was observed in TGF-beta 1-treated NHLFs compared with control cells without changes in HS-dependent FGF-2 binding or FGF-2 center dot FR1c complex formation. To study the function of Sulf1, negative control or Sulf1-specific small interference RNA (siRNA)-transfected NHLFs were stimulated with TGF-beta 1. Enhanced Smad2/3 phosphorylation and elevated total Smad2 protein level were observed in Sulf1 siRNA-transfected cells and were accompanied by enhanced expression of alpha-smooth muscle actin and fibronectin. In addition, Sulf1 siRNA transfection enhanced the anti-proliferative effect of TGF-beta 1. Finally Sulf1 expression was up-regulated in the lungs of mice treated with adenovirus encoding active TGF-beta 1. Taken together, our data indicate that Sulf1 is a TGF-beta 1-responsive gene both in vitro and in vivo and may function as a negative regulator of TGF-beta 1-induced fibrogenesis.	[Yue, Xinping; Li, Xian; Nguyen, Hong T.; Chin, Dawn R.; Lasky, Joseph A.] Tulane Univ, Hlth Sci Ctr, Dept Med, Sect Pulm Dis Crit Care & Environm Med, New Orleans, LA 70112 USA; [Sullivan, Deborah E.] Tulane Univ, Hlth Sci Ctr, Dept Microbiol & Immunol, New Orleans, LA 70112 USA	Tulane University; Tulane University	Lasky, JA (corresponding author), Tulane Univ, Hlth Sci Ctr, Dept Med, Pulm Sect, SL-9,1430 Tulane Ave, New Orleans, LA 70112 USA.	jlasky@tulane.edu			NHLBI NIH HHS [T32 HL 007973, HL 083480] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007973, R01HL083480] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Allen BL, 2003, J CELL BIOL, V163, P637, DOI 10.1083/jcb.200307053; Brickman YG, 1998, J BIOL CHEM, V273, P4350, DOI 10.1074/jbc.273.8.4350; BROEKELMANN TJ, 1991, P NATL ACAD SCI USA, V88, P6642, DOI 10.1073/pnas.88.15.6642; Chen LG, 2004, J BIOL CHEM, V279, P15715, DOI 10.1074/jbc.C300430200; Chen YL, 2005, AM J PATHOL, V167, P1699, DOI 10.1016/S0002-9440(10)61252-7; Dai YM, 2005, J BIOL CHEM, V280, P40066, DOI 10.1074/jbc.M508136200; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Feyzi E, 1998, J BIOL CHEM, V273, P13395, DOI 10.1074/jbc.273.22.13395; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; Habuchi H, 2007, J BIOL CHEM, V282, P15578, DOI 10.1074/jbc.M607434200; Hetzel M, 2005, LUNG, V183, P225, DOI 10.1007/s00408-004-2534-z; Jayson GC, 1998, J BIOL CHEM, V273, P51, DOI 10.1074/jbc.273.1.51; Khalil N, 1996, AM J RESP CELL MOL, V14, P131, DOI 10.1165/ajrcmb.14.2.8630262; KUHN C, 1991, AM J PATHOL, V138, P1257; Lai JP, 2006, GASTROENTEROLOGY, V130, P2130, DOI 10.1053/j.gastro.2006.02.056; Lai JP, 2004, GASTROENTEROLOGY, V126, P231, DOI 10.1053/j.gastro.2003.09.043; Lakatos HF, 2006, EXP LUNG RES, V32, P181, DOI 10.1080/01902140600817465; Lamanna WC, 2007, J BIOTECHNOL, V129, P290, DOI 10.1016/j.jbiotec.2007.01.022; Lamanna WC, 2006, BIOCHEM J, V400, P63, DOI 10.1042/BJ20060848; Lasky JA, 2000, ENVIRON HEALTH PERSP, V108, P751, DOI 10.2307/3454412; Lindquist JN, 2000, AM J PHYSIOL-GASTR L, V279, pG471, DOI 10.1152/ajpgi.2000.279.3.G471; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyon M, 1997, J BIOL CHEM, V272, P18000, DOI 10.1074/jbc.272.29.18000; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; MCCAFFREY TA, 1992, J CELL PHYSIOL, V152, P430, DOI 10.1002/jcp.1041520226; MCCAFFREY TA, 1994, J CELL PHYSIOL, V159, P51, DOI 10.1002/jcp.1041590108; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Nakato H, 2002, BBA-GEN SUBJECTS, V1573, P312, DOI 10.1016/S0304-4165(02)00398-7; Ohto T, 2002, GENES CELLS, V7, P173, DOI 10.1046/j.1356-9597.2001.00502.x; Phan SH, 2002, CHEST, V122, p286S, DOI 10.1378/chest.122.6_suppl.286S; RAGHOW R, 1989, J CLIN INVEST, V84, P1836, DOI 10.1172/JCI114369; Rapraeger AC, 2002, METHOD CELL BIOL, V69, P83, DOI 10.1016/S0091-679X(02)69009-0; Safaiyan F, 1998, EUR J BIOCHEM, V252, P576, DOI 10.1046/j.1432-1327.1998.2520576.x; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590; Sullivan DE, 2005, AM J RESP CELL MOL, V32, P342, DOI 10.1165/rcmb.2004-0288OC; Uchimura Kenji, 2006, BMC Biochem, V7, P2, DOI 10.1186/1471-2091-7-2; Viviano BL, 2004, J BIOL CHEM, V279, P5604, DOI 10.1074/jbc.M310691200; Walz A, 1997, DEVELOPMENT, V124, P2421; Wang SW, 2004, P NATL ACAD SCI USA, V101, P4833, DOI 10.1073/pnas.0401028101; Warshamana GS, 2002, INT J EXP PATHOL, V83, P183, DOI 10.1046/j.1365-2613.2002.00229.x; Yue XP, 2004, GLYCOBIOLOGY, V14, P745, DOI 10.1093/glycob/cwh083; Zhang HY, 1996, AM J PATHOL, V148, P527; Zhang HY, 1999, AM J RESP CELL MOL, V21, P658, DOI 10.1165/ajrcmb.21.6.3720; ZHANG K, 1994, AM J PATHOL, V145, P114; Zhao JS, 2002, AM J PHYSIOL-LUNG C, V282, pL585, DOI 10.1152/ajplung.00151.2001	49	50	50	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20397	20407		10.1074/jbc.M802850200	http://dx.doi.org/10.1074/jbc.M802850200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18503048	Green Published, hybrid			2022-12-25	WOS:000257565300055
J	Saint-Georges, Y; Garcia, M; Delaveau, T; Jourdren, L; Le Crom, S; Lemoine, S; Tanty, V; Devaux, F; Jacq, C				Saint-Georges, Yann; Garcia, Mathilde; Delaveau, Thierry; Jourdren, Laurent; Le Crom, Stephane; Lemoine, Sophie; Tanty, Veronique; Devaux, Frederic; Jacq, Claude			Yeast Mitochondrial Biogenesis: A Role for the PUF RNA-Binding Protein Puf3p in mRNA Localization	PLOS ONE			English	Article								The asymmetric localization of mRNA plays an important role in coordinating posttranscriptional events in eukaryotic cells. We investigated the peripheral mitochondrial localization of nuclear-encoded mRNAs (MLR) in various conditions in which the mRNA binding protein context and the translation efficiency were altered. We identified Puf3p, a Pumilio family RNA-binding protein, as the first trans-acting factor controlling the MLR phenomenon. This allowed the characterization of two classes of genes whose mRNAs are translated to the vicinity of mitochondria. Class I mRNAs (256 genes) have a Puf3p binding motif in their 3'UTR region and many of them have their MLR properties deeply affected by PUF3 deletion. Conversely, mutations in the Puf3p binding motif alter the mitochondrial localization of BCS1 mRNA. Class II mRNAs (224 genes) have no Puf3p binding site and their asymmetric localization is not affected by the absence of PUF3. In agreement with a co-translational import process, we observed that the presence of puromycin loosens the interactions between most of the MLR-mRNAs and mitochondria. Unexpectedly, cycloheximide, supposed to solidify translational complexes, turned out to destabilize a class of mRNA-mitochondria interactions. Classes I and II mRNAs, which are therefore transported to the mitochondria through different pathways, correlated with different functional modules. Indeed, Class I genes code principally for the assembly factors of respiratory chain complexes and the mitochondrial translation machinery (ribosomes and translation regulators). Class II genes encode proteins of the respiratory chain or proteins involved in metabolic pathways. Thus, MLR, which is intimately linked to translation control, and the activity of mRNA-binding proteins like Puf3p, may provide the conditions for a fine spatiotemporal control of mitochondrial protein import and mitochondrial protein complex assembly. This work therefore provides new openings for the global study of mitochondria biogenesis.	[Saint-Georges, Yann; Garcia, Mathilde; Delaveau, Thierry; Devaux, Frederic; Jacq, Claude] Ecole Normale Super, CNRS, Genet Mol Lab, UMR8541, Paris, France; [Jourdren, Laurent; Le Crom, Stephane; Lemoine, Sophie; Tanty, Veronique; Jacq, Claude] Ecole Normale Super, Plateforme Transcriptome IFR36, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Saint-Georges, Y (corresponding author), Ecole Normale Super, CNRS, Genet Mol Lab, UMR8541, Paris, France.	frederic.devaux@ens.fr; claude.jacq@ens.fr	DEVAUX, Frédéric/N-2288-2019; Saint-Georges-Chaumet, Yann/AAL-1204-2021; Le Crom, Stéphane/P-4176-2016	DEVAUX, Frédéric/0000-0002-0039-9096; Saint-Georges-Chaumet, Yann/0000-0002-1123-254X; Le Crom, Stéphane/0000-0002-0534-7797; Jourdren, Laurent/0000-0003-4253-1048	French Ministry of Research [ANR-BLAN06-1-135513]	French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This work was supported by the French Ministry of Research grants ANR-BLAN06-1-135513 (Funding support only).	ADELMAN MR, 1973, J CELL BIOL, V56, P206, DOI 10.1083/jcb.56.1.206; Bonnefoy N, 2000, MOL GEN GENET, V262, P1036, DOI 10.1007/PL00008646; Chartrand P, 2002, MOL CELL, V10, P1319, DOI 10.1016/S1097-2765(02)00694-9; de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706; Diehn M, 2000, NAT GENET, V25, P58, DOI 10.1038/75603; Foat BC, 2005, P NATL ACAD SCI USA, V102, P17675, DOI 10.1073/pnas.0503803102; Fontanesi F, 2006, AM J PHYSIOL-CELL PH, V291, pC1129, DOI 10.1152/ajpcell.00233.2006; Garcia M, 2007, MOL BIOL CELL, V18, P362, DOI 10.1091/mbc.E06-09-0827; GARCIA M, 2007, BIOL MIM, P505; Garcia-Rodriguez LJ, 2007, J CELL BIOL, V176, P197, DOI 10.1083/jcb.200606054; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Gu W, 2004, GENE DEV, V18, P1452, DOI 10.1101/gad.1189004; Halbeisen RE, 2008, CELL MOL LIFE SCI, V65, P798, DOI 10.1007/s00018-007-7447-6; Hook BA, 2007, J BIOL CHEM, V282, P15430, DOI 10.1074/jbc.M611253200; Jackson JS, 2004, RNA, V10, P1625, DOI 10.1261/rna.7270204; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; KELLEMS RE, 1972, J BIOL CHEM, V247, P8043; KELLEMS RE, 1975, J CELL BIOL, V65, P1, DOI 10.1083/jcb.65.1.1; KELLEMS RE, 1974, J BIOL CHEM, V249, P3304; Lemoine S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-467; Marc P, 2002, EMBO REP, V3, P159, DOI 10.1093/embo-reports/kvf025; Martinez-Diez M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000107; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Naithani S, 2003, MOL BIOL CELL, V14, P324, DOI 10.1091/mbc.E02-08-0490; Olivas W, 2000, EMBO J, V19, P6602, DOI 10.1093/emboj/19.23.6602; Perocchi F, 2006, PLOS GENET, V2, P1612, DOI 10.1371/journal.pgen.0020170; Prokisch H, 2004, PLOS BIOL, V2, P795, DOI 10.1371/journal.pbio.0020160; Sacconi S, 2003, PEDIATR RES, V53, P224, DOI 10.1203/01.PDR.0000048100.91730.6A; Saint-Georges Y, 2002, J BIOL CHEM, V277, P49397, DOI 10.1074/jbc.M207219200; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ulbricht RJ, 2008, RNA, V14, P246, DOI 10.1261/rna.847408; Zeviani M, 2003, CURR OPIN GENET DEV, V13, P262, DOI 10.1016/S0959-437X(03)00052-2; [No title captured]	35	168	170	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2293	10.1371/journal.pone.0002293	http://dx.doi.org/10.1371/journal.pone.0002293			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523582	gold, Green Published, Green Submitted			2022-12-25	WOS:000262614300009
J	Bhattacharya, C; Aggarwal, S; Kumar, M; Ali, A; Matin, A				Bhattacharya, Chitralekha; Aggarwal, Sita; Kumar, Madhu; Ali, Amatul; Matin, Angabin			Mouse Apolipoprotein B Editing Complex 3 (APOBEC3) Is Expressed in Germ Cells and Interacts with Dead-End (DND1)	PLOS ONE			English	Article								Background: The dead-end (Dnd1) gene is essential for maintaining the viability of germ cells. Inactivation of Dnd1 results in sterility and testicular tumors. The Dnd1 encoded protein, DND1, is able to bind to the 3'-untranslated region (UTR) of messenger RNAs (mRNAs) to displace micro-RNA (miRNA) interaction with mRNA. Thus, one function of DND1 is to prevent miRNA mediated repression of mRNA. We report that DND1 interacts specifically with APOBEC3. APOBEC3 is a multifunctional protein. It inhibits retroviral replication. In addition, recent studies show that APOBEC3 interacts with cellular RNA-binding proteins and to mRNA to inhibit miRNA-mediated repression of mRNA. Methodology/Principal Findings: Here we show that DND1 specifically interacts with another cellular protein, APOBEC3. We present our data which shows that DND1 co-immunoprecipitates APOBEC3 from mammalian cells and also endogenous APOBEC3 from mouse gonads. Whether the two proteins interact directly remains to be elucidated. We show that both DND1 and APOBEC3 are expressed in germ cells and in the early gonads of mouse embryo. Expression of fluorescently-tagged DND1 and APOBEC3 indicate they localize to the cytoplasm and when DND1 and APOBEC3 are expressed together in cells, they sequester near peri-nuclear sites. Conclusions/Significance: The 39-UTR of mRNAs generally encode multiple miRNA binding sites as well as binding sites for a variety of RNA binding proteins. In light of our findings of DND1-APOBEC3 interaction and taking into consideration reports that DND1 and APOBEC3 bind to mRNA to inhibit miRNA mediated repression, our studies implicate a possible role of DND1-APOBEC3 interaction in modulating miRNA-mediated mRNA repression. The interaction of DND1 and APOBEC3 could be one mechanism for maintaining viability of germ cells and for preventing germ cell tumor development.	[Bhattacharya, Chitralekha; Aggarwal, Sita; Kumar, Madhu; Ali, Amatul; Matin, Angabin] Univ Texas MD Anderson Canc Ctr, Dept Canc Genet, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Bhattacharya, C (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Genet, Houston, TX 77030 USA.	amatin@mdanderson.org			National Cancer Institute [CA093754]; David Carmine Cancer Research Fund; NATIONAL CANCER INSTITUTE [R01CA093754] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); David Carmine Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Cancer Institute grant CA093754, David Carmine Cancer Research Fund	Anant S, 2003, TRENDS MOL MED, V9, P147, DOI 10.1016/S1471-4914(03)00032-7; Bhattacharya C, 2007, BIOCHEM BIOPH RES CO, V355, P194, DOI 10.1016/j.bbrc.2007.01.138; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; Bogerd HP, 2006, NUCLEIC ACIDS RES, V34, P89, DOI 10.1093/nar/gkj416; Bogerd HP, 2004, P NATL ACAD SCI USA, V101, P3770, DOI 10.1073/pnas.0307713101; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; De Miguel MP, 2003, METHOD ENZYMOL, V365, P353; Delebecque F, 2006, J VIROL, V80, P605, DOI 10.1128/JVI.80.2.605-614.2006; Esnault C, 2005, NATURE, V433, P430, DOI 10.1038/nature03238; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; Hakata Y, 2006, J BIOL CHEM, V281, P36624, DOI 10.1074/jbc.M604980200; Hammond S, 2007, MAMM GENOME, V18, P832, DOI 10.1007/s00335-007-9075-8; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Horvay K, 2006, DEV BIOL, V291, P1, DOI 10.1016/j.ydbio.2005.06.013; Huang J, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705116200; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Ketting RF, 2007, CELL, V131, P1226, DOI 10.1016/j.cell.2007.12.004; Kinomoto M, 2007, NUCLEIC ACIDS RES, V35, P2955, DOI 10.1093/nar/gkm181; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kobayashi M, 2004, J VIROL, V78, P8238, DOI 10.1128/JVI.78.15.8238-8244.2004; Kozak SL, 2006, J BIOL CHEM, V281, P29105, DOI 10.1074/jbc.M601901200; Lellek H, 2000, J BIOL CHEM, V275, P19848, DOI 10.1074/jbc.M001786200; Liao W, 1999, BIOCHEM BIOPH RES CO, V260, P398, DOI 10.1006/bbrc.1999.0925; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mangeat B, 2004, J BIOL CHEM, V279, P14481, DOI 10.1074/jbc.C400060200; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Matin A, 2007, CELL MOL LIFE SCI, V64, P1317, DOI 10.1007/s00018-007-6433-3; Mehta A, 2000, MOL CELL BIOL, V20, P1846, DOI 10.1128/MCB.20.5.1846-1854.2000; Mikl MC, 2005, MOL CELL BIOL, V25, P7270, DOI 10.1128/MCB.25.16.7270-7277.2005; Mishima Y, 2006, CURR BIOL, V16, P2135, DOI 10.1016/j.cub.2006.08.086; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Petersen-Mahrt S, 2005, IMMUNOL REV, V203, P80, DOI 10.1111/j.0105-2896.2005.00232.x; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Rogozin IB, 2005, CELL CYCLE, V4, P1281, DOI 10.4161/cc.4.9.1994; Russell RA, 2005, J VIROL, V79, P8724, DOI 10.1128/JVI.79.14.8724-8731.2005; SAKURAI T, 1995, DEV GROWTH DIFFER, V37, P293, DOI 10.1046/j.1440-169X.1995.t01-2-00007.x; Sasada A, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-32; Schrofelbauer R, 2004, P NATL ACAD SCI USA, V101, P3927, DOI 10.1073/pnas.0307132101; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stenglein MD, 2006, J BIOL CHEM, V281, P16837, DOI 10.1074/jbc.M602367200; Turelli P, 2004, SCIENCE, V303, P1829, DOI 10.1126/science.1092066; Weidinger G, 2003, CURR BIOL, V13, P1429, DOI 10.1016/S0960-9822(03)00537-2; Wichroski MJ, 2006, PLOS PATHOG, V2, pe41, DOI DOI 10.1371/journal.ppat.0020041; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Wylie C, 2000, CURR OPIN GENET DEV, V10, P410, DOI 10.1016/S0959-437X(00)00105-2; Yabuta Y, 2006, BIOL REPROD, V75, P705, DOI 10.1095/biolreprod.106.053686; Youngren KK, 2005, NATURE, V435, P360, DOI 10.1038/nature03595; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004; Zhu R, 2007, ANN NY ACAD SCI, V1120, P181, DOI 10.1196/annals.1411.006	58	20	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2315	10.1371/journal.pone.0002315	http://dx.doi.org/10.1371/journal.pone.0002315			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509452	Green Published, gold, Green Submitted			2022-12-25	WOS:000262268500043
J	Fisher, BL; Smith, MA				Fisher, Brian L.; Smith, M. Alex			A Revision of Malagasy Species of Anochetus Mayr and Odontomachus Latreille (Hymenoptera: Formicidae)	PLOS ONE			English	Article							TAXONOMIC INFLATION; MOLECULAR EVOLUTION; MITOCHONDRIAL-DNA; GENETIC-STRUCTURE; CONSERVATION; SYSTEMATICS; DISPERSAL; SEQUENCES; BARCODES; ANTS	Species inventories are essential for documenting global diversity and generating necessary material for taxonomic study and conservation planning. However, for inventories to be immediately relevant, the taxonomic process must reduce the time to describe and identify specimens. To address these concerns for the inventory of arthropods across the Malagasy region, we present here a collaborative approach to taxonomy where collectors, morphologists and DNA barcoders using cytochrome c oxidase 1 (CO1) participate collectively in a team-driven taxonomic process. We evaluate the role of DNA barcoding as a tool to accelerate species identification and description. This revision is primarily based on arthropod surveys throughout the Malagasy region from 1992 to 2006. The revision is based on morphological and CO1 DNA barcode analysis of 500 individuals. In the region, five species of Anochetus (A. boltoni sp. nov., A. goodmani sp. nov., A. grandidieri, and A. madagascarensis from Madagascar, and A. pattersoni sp. nov. from Seychelles) and three species of Odontomachus (O. coquereli, O. troglodytes and O. simillimus) are recognized. DNA barcoding (using cytochrome c oxidase 1 (CO1)) facilitated caste association and type designation, and highlighted population structure associated with reproductive strategy, biogeographic and evolutionary patterns for future exploration This study provides an example of collaborative taxonomy, where morphology is combined with DNA barcoding. We demonstrate that CO1 DNA barcoding is a practical tool that allows formalized alpha-taxonomy at a speed, detail, precision, and scale unattainable by employing morphology alone.	[Fisher, Brian L.] Calif Acad Sci, Dept Entomol, San Francisco, CA 94118 USA; [Smith, M. Alex] Univ Guelph, Biodiversity Inst Ontario, Guelph, ON, Canada	California Academy of Sciences; University of Guelph	Fisher, BL (corresponding author), Calif Acad Sci, Dept Entomol, San Francisco, CA 94118 USA.	bfisher@calacademy.org; salex@uoguelph.ca	Fisher, Brian L./S-9374-2019; Smith, M Alex/B-4468-2013; 赵, 鹏/B-8401-2009	Smith, M Alex/0000-0002-8650-2575; Fisher, Brian/0000-0002-4653-3270	WWF-US [INT 9998672]; National Science Foundation [DEB-0344731]; Fonds quebecois de la recherche sur la nature et les technologies [postdoctoral fellowship]; Gordon and Betty Moore Foundation; Ontario Genomics Institute; Canada Foundation for Innovation; Ontario Innovation Trust; NSERC	WWF-US; National Science Foundation(National Science Foundation (NSF)); Fonds quebecois de la recherche sur la nature et les technologies(FQRNT); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Ontario Genomics Institute; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Innovation Trust; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for the research was provided to BLF by WWF-US and National Science Foundation under Grant No. INT 9998672 and DEB-0344731, and a Fonds quebecois de la recherche sur la nature et les technologies B3 postdoctoral fellowship to MAS. Laboratory analyses were graciously supported by grants to P.D.N. Hebert from the Gordon and Betty Moore Foundation, Genome Canada through the Ontario Genomics Institute, the Canada Foundation for Innovation, the Ontario Innovation Trust and NSERC.	ANDRE E, 1887, REV ENTOMOLOGIE CAEN, V6, P280; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Brady SG, 2006, P NATL ACAD SCI USA, V103, P18172, DOI 10.1073/pnas.0605858103; Braig HR, 1998, J BACTERIOL, V180, P2373, DOI 10.1128/JB.180.9.2373-2378.1998; BROWN W L JR, 1978, Studia Entomologica, V20, P549; BROWN W L JR, 1976, Studia Entomologica, V19, P67; Caccone A, 2001, EVOLUTION, V55, P122; Colombel P., 1971, Annales Fac Sci Univ fed Cameroun, VNo. 6,1971, P53; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; CRAWLEY WC, 1915, ANN MAG NAT HIST, V15, P232; DeSalle R, 2004, NAT REV GENET, V5, P702, DOI 10.1038/nrg1425; Dick CW, 2004, MOL ECOL, V13, P3775, DOI 10.1111/j.1365-294X.2004.02374.x; Doums C, 2002, MOL ECOL, V11, P2251, DOI 10.1046/j.1365-294X.2002.01619.x; EMERY C, 1898, B SOC ENTOMOLOGICA I, V31, P263; Farrell BD, 2001, MOL PHYLOGENET EVOL, V18, P467, DOI 10.1006/mpev.2000.0888; Fisher Brian L., 2005, Proceedings of the California Academy of Sciences, V56, P86; Forel A., 1918, Bulletin de la Societe Vaudoise, V52; Forel A, 1912, T LINN SOC LOND, V15, P159, DOI DOI 10.1111/J.1096-3642.1912.TB00096.X; FOREL A, 1891, HIST PHYS NATURELLE; FOREL A, 1887, MITTEILUNGEN SCHWEIZ, V7, P381, DOI DOI 10.5962/BHL.PART.4555; Forel A ug., 1913, Zoologische Jahrbuecher Jena Abteilungen f Systematik, V36; Giraud T, 2000, MOL ECOL, V9, P1835, DOI 10.1046/j.1365-294x.2000.01085.x; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; HAJIBABAEI M, 2005, PHILOS T ROYAL SOC B; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Harris DJ, 2005, TRENDS ECOL EVOL, V20, P6, DOI 10.1016/j.tree.2004.11.004; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; Isaac NJB, 2004, TRENDS ECOL EVOL, V19, P464, DOI 10.1016/j.tree.2004.06.004; Ji YJ, 2003, MOL ECOL NOTES, V3, P581, DOI 10.1046/j.1471-8286.2003.00519.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lou M, 2007, MOL ECOL NOTES, V7, P908, DOI 10.1111/j.1471-8286.2007.01904.x; Molet M, 2007, INSECT SOC, V54, P183, DOI 10.1007/s00040-007-0930-0; Ouellette GD, 2006, MOL PHYLOGENET EVOL, V40, P359, DOI 10.1016/j.ympev.2006.03.017; Patek SN, 2006, P NATL ACAD SCI USA, V103, P12787, DOI 10.1073/pnas.0604290103; Polaszek A, 2005, NATURE, V437, P477, DOI 10.1038/437477a; Polaszek Andrew, 2005, Bulletin of Zoological Nomenclature, V62, P210; Pyle RL, 2008, ZOOTAXA, P3, DOI 10.11646/zootaxa.1671.1.2; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; ROGER J, 1861, BERLINER ENTOMOLOGIS, V5, P1, DOI DOI 10.5281/ZENODO.25617; Ross KG, 1997, GENETICS, V147, P643; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANTSCHI F., 1928, REV ZOOL BOT AFRICAINES, V16, P54; SANTSCHI F, 1914, INSECTES HYMENOPTERE, V2, P41; Saux C, 2004, MOL PHYLOGENET EVOL, V33, P457, DOI 10.1016/j.ympev.2004.06.017; Seifert KA, 2007, P NATL ACAD SCI USA, V104, P3901, DOI 10.1073/pnas.0611691104; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; SMITH F, 1858, CATALOGUE HYMENOPT 6; SMITH F, 1860, J P LINNEAN SOC LOND, V5, P57, DOI DOI 10.1111/J.1096-3642.1860.TB01021.X; Smith MA, 2007, P NATL ACAD SCI USA, V104, P4967, DOI 10.1073/pnas.0700050104; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Smith MA, 2005, PHILOS T R SOC B, V360, P1825, DOI 10.1098/rstb.2005.1714; Sonnenberg R, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-6; TAJIMA F, 1989, GENETICS, V123, P585; Wheeler W. M., 1922, Bulletin of the American Museum of Natural History, V45, P39; Wilme L, 2006, SCIENCE, V312, P1063, DOI 10.1126/science.1122806; WILSON EO, 1959, B MUS COMP ZOOL HARV, V120, P483	61	104	110	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e1787	10.1371/journal.pone.0001787	http://dx.doi.org/10.1371/journal.pone.0001787			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509544	gold, Green Published			2022-12-25	WOS:000262268500001
J	Ishak, HD; Dumbacher, JP; Anderson, NL; Keane, JJ; Valkiunas, G; Haig, SM; Tell, LA; Sehgal, RNM				Ishak, Heather D.; Dumbacher, John P.; Anderson, Nancy L.; Keane, John J.; Valkiunas, Gediminas; Haig, Susan M.; Tell, Lisa A.; Sehgal, Ravinder N. M.			Blood Parasites in Owls with Conservation Implications for the Spotted Owl (Strix occidentalis)	PLOS ONE			English	Article							MALARIA PLASMODIUM-RELICTUM; NORTH-AMERICAN BIRDS; HOST IMMUNE DEFENSE; AVIAN MALARIA; REPRODUCTIVE SUCCESS; BARRED OWL; EMBRYONIC-DEVELOPMENT; HAWAII AMAKIHI; NEW-JERSEY; HEMATOZOA	The three subspecies of Spotted Owl (Northern, Strix occidentalis caurina; California, S. o. occidentalis; and Mexican, S. o. lucida) are all threatened by habitat loss and range expansion of the Barred Owl (S. varia). An unaddressed threat is whether Barred Owls could be a source of novel strains of disease such as avian malaria (Plasmodium spp.) or other blood parasites potentially harmful for Spotted Owls. Although Barred Owls commonly harbor Plasmodium infections, these parasites have not been documented in the Spotted Owl. We screened 111 Spotted Owls, 44 Barred Owls, and 387 owls of nine other species for haemosporidian parasites (Leucocytozoon, Plasmodium, and Haemoproteus spp.). California Spotted Owls had the greatest number of simultaneous multi-species infections (44%). Additionally, sequencing results revealed that the Northern and California Spotted Owl subspecies together had the highest number of Leucocytozoon parasite lineages (n = 17) and unique lineages (n = 12). This high level of sequence diversity is significant because only one Leucocytozoon species (L. danilewskyi) has been accepted as valid among all owls, suggesting that L. danilewskyi is a cryptic species. Furthermore, a Plasmodium parasite was documented in a Northern Spotted Owl for the first time. West Coast Barred Owls had a lower prevalence of infection (15%) when compared to sympatric Spotted Owls (S. o. caurina 52%, S. o. occidentalis 79%) and Barred Owls from the historic range (61%). Consequently, Barred Owls on the West Coast may have a competitive advantage over the potentially immune compromised Spotted Owls.	[Ishak, Heather D.; Dumbacher, John P.; Sehgal, Ravinder N. M.] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA; [Dumbacher, John P.] Calif Acad Sci, Dept Ornithol & Mammal, San Francisco, CA USA; [Anderson, Nancy L.] Lindsay Wildlife Museum, Walnut Creek, CA USA; [Keane, John J.] USDA, Forest Serv Pacific SW Res Stn, Sierra Nevada Res Ctr, Davis, CA USA; [Valkiunas, Gediminas] Vilnius Univ, Inst Ecol, Vilnius, Lithuania; [Haig, Susan M.] USGS, Forest & Rangeland Ecosyst Sci Ctr, Corvallis, OR USA; [Tell, Lisa A.] Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA USA	California State University System; San Francisco State University; California Academy of Sciences; United States Department of Agriculture (USDA); United States Forest Service; Vilnius University; United States Department of the Interior; United States Geological Survey; University of California System; University of California Davis	Ishak, HD (corresponding author), San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA.	heatherishak@gmail.com	SEHGAL, Ravinder/F-9216-2010; Dumbacher, John/B-5280-2009	Dumbacher, John/0000-0001-8942-1554; SEHGAL, Ravinder/0000-0002-5255-4641	UC Davis [K12GM00679]; San Francisco State University [K12GM00679]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000679] Funding Source: NIH RePORTER	UC Davis; San Francisco State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Ravinder N. M. Sehgal, Heather Ishak, and this research were supported in part by an NIGMS MORE Institutional Research and Academic Career Development Award to UC Davis and San Francisco State University, grant number K12GM00679.	Appleby BM, 1999, FUNCT ECOL, V13, P315, DOI 10.1046/j.1365-2435.1999.00319.x; Atkinson CT, 2001, J WILDLIFE DIS, V37, P20, DOI 10.7589/0090-3558-37.1.20; Atkinson CT, 1995, PARASITOLOGY, V111, pS59, DOI 10.1017/S003118200007582X; Atkinson CT, 2000, J WILDLIFE DIS, V36, P197, DOI 10.7589/0090-3558-36.2.197; Beadell JS, 2006, P ROY SOC B-BIOL SCI, V273, P2935, DOI 10.1098/rspb.2006.3671; Beadell JS, 2004, MOL ECOL, V13, P3829, DOI 10.1111/j.1365-294X.2004.02363.x; Bensch S, 2000, P ROY SOC B-BIOL SCI, V267, P1583, DOI 10.1098/rspb.2000.1181; Bensch S, 2004, EVOLUTION, V58, P1617, DOI 10.1111/j.0014-3820.2004.tb01742.x; Clarabuch Oriol, 1999, Biologia e Conservazione della Fauna, V102, P113; COURTNEY SP, 2004, SCI EVALUATION STATU, P1; Dark SJ, 1998, AUK, V115, P50, DOI 10.2307/4089110; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; DASZAK P, 2003, J PARASITOL, V89, pS37; Davidar P, 2006, AUK, V123, P141, DOI 10.1642/0004-8038(2006)123[0141:AMIMSF]2.0.CO;2; Dawson RD, 2000, AUK, V117, P373, DOI 10.1642/0004-8038(2000)117[0373:EOHPOC]2.0.CO;2; DEREDEC A, 2001, OECOLOGIA, V126, P193; Deviche P, 2001, J EXP ZOOL, V289, P456, DOI 10.1002/jez.1027; Dulfa R, 1996, J AVIAN BIOL, V27, P83, DOI [10.2307/3676964, DOI 10.2307/3676964]; Durrant KL, 2006, ORNITHOL MONOGR, P98; Dyrcz A, 2005, AUK, V122, P558, DOI 10.1642/0004-8038(2005)122[0558:MRSICW]2.0.CO;2; Fallon SM, 2003, EVOLUTION, V57, P606, DOI 10.1111/j.0014-3820.2003.tb01552.x; Fauci AS, 2003, NAT MED, V9, P839, DOI 10.1038/nm0703-839; FORRESTER DJ, 1994, J RAPTOR RES, V28, P226; FUNK CW, 2008, P ROY SOC LO B UNPUB; Gatton ML, 2004, INFECT IMMUN, V72, P6538, DOI 10.1128/IAI.72.11.6538-6545.2004; GODFREY RD, 1987, J WILDLIFE DIS, V23, P558, DOI 10.7589/0090-3558-23.4.558; Gotelli NJ, 2006, ECOSIM NULL MODELS S; GRANT JAMES, 1966, MURRELET, V47, P39, DOI 10.2307/3536439; GREINER EC, 1975, CAN J ZOOL, V53, P1762, DOI 10.1139/z75-211; GUTIERREZ RJ, 1989, J WILDLIFE DIS, V25, P614, DOI 10.7589/0090-3558-25.4.614; GUTIERREZ RJ, 2004, SCI EVALUATION STATU, P1; GUTIERREZ RJ, 1995, AM ORNITHOLOGISTS UN; Hakkarainen H, 1998, OECOLOGIA, V114, P574, DOI 10.1007/s004420050482; HART JW, 1949, J PARASITOL, V35, P79, DOI 10.2307/3273390; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hellgren O, 2007, J PARASITOL, V93, P889, DOI 10.1645/GE-1051R1.1; Hellgren O, 2007, MOL ECOL, V16, P1281, DOI 10.1111/j.1365-294X.2007.03227.x; HUME M, 2007, GLOBE MAIL, pA5; Hunter DB, 1997, J WILDLIFE DIS, V33, P486, DOI 10.7589/0090-3558-33.3.486; Kilpatrick AM, 2006, AUK, V123, P764, DOI 10.1642/0004-8038(2006)123[764:EOCAMP]2.0.CO;2; Kilpatrick AM, 2006, PLOS BIOL, V4, P606, DOI 10.1371/journal.pbio.0040082; KIRKPATRICK CE, 1985, J WILDLIFE DIS, V21, P1, DOI 10.7589/0090-3558-21.1.1; Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628; KORPIMAKI E, 1993, FUNCT ECOL, V7, P420, DOI 10.2307/2390029; Korpimaki E, 1995, ECOSCIENCE, V2, P335, DOI 10.1080/11956860.1995.11682301; Krone O, 2001, ACTA PROTOZOOL, V40, P281; LAHAYE W, 2004, SCI EVALUATION STATU, P2; Leppert LL, 2004, J WILDLIFE DIS, V40, P316, DOI 10.7589/0090-3558-40.2.316; Levy S, 1999, NAT HIST, V108, P28; Lierz M, 2002, BERL MUNCH TIERARZTL, V115, P43; Mackinnon MJ, 2000, P NATL ACAD SCI USA, V97, P12661, DOI 10.1073/pnas.220267997; MADDISON D, 2002, MACCLADE 4 03 PPC AN; Malmqvist B, 2004, P ROY SOC B-BIOL SCI, V271, pS152, DOI 10.1098/rsbl.2003.0120; Marzal A, 2005, OECOLOGIA, V142, P541, DOI 10.1007/s00442-004-1757-2; MERINO S, 1999, P 22 INT ORN C DURB, P2158; Mikaelian I., 1991, Point Veterinaire, V22, P857; MILTGEN F, 1981, ANN PARASIT HUM COMP, V56, P123; Molaei G, 2006, EMERG INFECT DIS, V12, P468, DOI 10.3201/eid1203.051004; Moller AP, 2004, J EVOLUTION BIOL, V17, P603, DOI 10.1111/j.1420-9101.2004.00694.x; Moller AP, 1998, EVOL ECOL, V12, P945, DOI 10.1023/A:1006516222343; Monahan William B., 2007, Ornithological Monographs, V63, P55, DOI 10.1642/0078-6594(2007)63[55:DDOIAH]2.0.CO;2; Noon BR, 2002, AUK, V119, P311, DOI 10.1642/0004-8038(2002)119[0311:SRATSO]2.0.CO;2; Nordling D, 1998, P ROY SOC B-BIOL SCI, V265, P1291, DOI 10.1098/rspb.1998.0432; OLSEN GH, 1985, J AM VET MED ASSOC, V187, P1204; Oppliger A, 1998, ECOL LETT, V1, P129; Palinauskas V, 2007, ZOOTAXA, P39, DOI 10.11646/zootaxa.1626.1.3; PEIRCE MA, 1983, AVIAN PATHOL, V12, P443, DOI 10.1080/03079458308436189; PEIRCE MA, 1983, J NAT HIST, V17, P813, DOI 10.1080/00222938300770621; Perkins SL, 2002, J PARASITOL, V88, P972, DOI 10.1645/0022-3395(2002)088[0972:AMPOMP]2.0.CO;2; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rappole JH, 2006, EMERG INFECT DIS, V12, P1486, DOI 10.3201/eid1210.051577; Remple JD, 2004, J AVIAN MED SURG, V18, P75, DOI 10.1647/2003-008; Richard FA, 2002, J PARASITOL, V88, P819, DOI 10.1645/0022-3395(2002)088[0819:ACAOPB]2.0.CO;2; Ricklefs RE, 2004, SYST BIOL, V53, P111, DOI 10.1080/10635150490264987; RICKLEFS RE, 1992, P NATL ACAD SCI USA, V89, P4722, DOI 10.1073/pnas.89.10.4722; SACCHI L, 1984, ANN PARASIT HUM COMP, V59, P219, DOI 10.1051/parasite/1984593219; SAKAI H, 2005, PARK SCI, V24, P50; SAKAI H, 2005, PARK SCI, V24, P24; Sanz JJ, 2001, AUK, V118, P750, DOI 10.1642/0004-8038(2001)118[0750:FHIRHS]2.0.CO;2; Scheuerlein A, 2004, P ROY SOC B-BIOL SCI, V271, P1363, DOI 10.1098/rspb.2004.2726; Seed, 2001, PARASITISM DIVERSITY; Sehgal RNM, 2006, J PARASITOL, V92, P375, DOI 10.1645/GE-656R.1; Sehgal RNM, 2005, J VET MED SCI, V67, P295, DOI 10.1292/jvms.67.295; Shea K, 2000, ECOL LETT, V3, P150, DOI 10.1046/j.1461-0248.2000.00124.x; Stjernman M, 2004, P ROY SOC B-BIOL SCI, V271, P2387, DOI 10.1098/rspb.2004.2883; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Szymanski MM, 2005, J PARASITOL, V91, P768, DOI 10.1645/GE-417R1.1; TAYLOR AL, 1976, CONDOR, V78, P560, DOI 10.2307/1367110; Telford SR, 1997, J PARASITOL, V83, P932, DOI 10.2307/3284292; TELFORD SR, 1992, SYST PARASITOL, V22, P17, DOI 10.1007/BF00009632; Tella JL, 1999, P NATL ACAD SCI USA, V96, P1785, DOI 10.1073/pnas.96.4.1785; Valkiunas G, 2006, J PARASITOL, V92, P418, DOI 10.1645/GE-3547RN.1; Valkiunas G, 2001, J PARASITOL, V87, P930, DOI 10.1645/0022-3395(2001)087[0930:ACOTBP]2.0.CO;2; Valkiunas G, 2005, AVIAN MALARIA PARASI; WETMORE PSYCHE W., 1941, JOUR PARASITOL, V27, P379, DOI 10.2307/3272625; WILLIAMS NA, 1978, CAN J ZOOL, V56, P596, DOI 10.1139/z78-086; Woodworth BL, 2005, P NATL ACAD SCI USA, V102, P1531, DOI 10.1073/pnas.0409454102; YEZERINAC SM, 1995, J ANIM ECOL, V64, P528, DOI 10.2307/5655; Ziman M, 2004, J WILDLIFE DIS, V40, P137, DOI 10.7589/0090-3558-40.1.137; 1990, FED REG 6, V55, P123	100	56	58	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2304	10.1371/journal.pone.0002304	http://dx.doi.org/10.1371/journal.pone.0002304			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509541	gold, Green Published			2022-12-25	WOS:000262268500039
J	Majorovits, E; Nejmeddine, M; Tanaka, Y; Taylor, GP; Fuller, SD; Bangham, CRM				Majorovits, Endre; Nejmeddine, Mohamed; Tanaka, Yuetsu; Taylor, Graham P.; Fuller, Stephen D.; Bangham, Charles R. M.			Human T-Lymphotropic Virus-1 Visualized at the Virological Synapse by Electron Tomography	PLOS ONE			English	Article								Human T-lymphotropic virus 1 (HTLV-1) is transmitted directly between cells via an organized cell-cell contact called a virological synapse (VS) [1,2]. The VS has been studied by light microscopy, but the ultrastructure of the VS and the nature of the transmitted viral particle have remained unknown. Cell-free enveloped virions of HTLV-1 are undetectable in the serum of individuals infected with the human T-lymphotropic virus 1 (HTLV-1) and during in vitro culture of naturally infected lymphocytes. However, the viral envelope protein is required for infectivity of HTLV-1, suggesting that complete, enveloped HTLV-1 virions are transferred across the synapse. Here, we use electron tomography combined with immunostaining of viral protein to demonstrate the presence of enveloped HTLV-1 particles within the VS formed between naturally infected lymphocytes. We show in 3D that HTLV-1 particles can be detected in multiple synaptic clefts at different locations simultaneously within the same VS. The synaptic clefts are surrounded by the tightly apposed plasma membranes of the two cells. HTLV-1 virions can contact the recipient cell membrane before detaching from the infected cell. The results show that the HTLV-1 virological synapse that forms spontaneously between lymphocytes of HTLV-1 infected individuals allows direct cell-cell transmission of the virus by triggered, directional release of enveloped HTLV-1 particles into confined intercellular spaces.	[Majorovits, Endre; Fuller, Stephen D.] Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford, England; [Nejmeddine, Mohamed; Bangham, Charles R. M.] Imperial Coll London, Wright Fleming Inst, Dept Immunol, London, England; [Tanaka, Yuetsu] Univ Ryukyus, Grad Sch, Fac Med, Dept Immunol, Okinawa, Japan; [Taylor, Graham P.] Imperial Coll London, Wright Fleming Inst, Dept Genito Urinary GU Med & Commun Dis, London, England	University of Oxford; Wellcome Centre for Human Genetics; Imperial College London; University of the Ryukyus; Imperial College London	Majorovits, E (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford, England.	stephen@strubi.ox.ac.uk; c.bangham@imperial.ac.uk		Bangham, Charles/0000-0003-2624-3599; Nejmeddine, Mohamed/0000-0003-0160-2727	Wellcome Trust UK [H5RCYV0, 064766]; National Center for Research Resources of the National Institutes of Health [RR00592]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000592] Funding Source: NIH RePORTER	Wellcome Trust UK(Wellcome Trust); National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was funded by the Wellcome Trust UK (grant number H5RCYV0 to S.D.F.; grant number 064766 to C.R.M.B.) and supported in part by grant RR00592 from the National Center for Research Resources of the National Institutes of Health to A. Hoenger.	Bangham CRM, 2003, J GEN VIROL, V84, P3177, DOI 10.1099/vir.0.19334-0; Barnard AL, 2005, BLOOD, V106, P988, DOI 10.1182/blood-2004-07-2850; BIBERFELD P, 1975, EXP CELL RES, V94, P79, DOI 10.1016/0014-4827(75)90533-9; Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143; Delamarre L, 1999, J VIROL, V73, P9659, DOI 10.1128/JVI.73.11.9659-9663.1999; Derse D, 2001, J VIROL, V75, P8461, DOI 10.1128/JVI.75.18.8461-8468.2001; FAN N, 1992, J CLIN MICROBIOL, V30, P905, DOI 10.1128/JCM.30.4.905-910.1992; Fuller SD, 1997, CURR BIOL, V7, P729, DOI 10.1016/S0960-9822(06)00331-9; GEIGER B, 1982, J CELL BIOL, V95, P137, DOI 10.1083/jcb.95.1.137; GESSAIN A, 1985, LANCET, V2, P407; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hanon E, 2000, IMMUNITY, V13, P657, DOI 10.1016/S1074-7613(00)00065-0; Hanon E, 2000, BLOOD, V95, P1386, DOI 10.1182/blood.V95.4.1386.004k22_1386_1392; Igakura T, 2003, SCIENCE, V299, P1713, DOI 10.1126/science.1080115; Jolly C, 2004, J EXP MED, V199, P283, DOI 10.1084/jem.20030648; KIRCHHAUSEN T, 1993, J LEUKOCYTE BIOL, V53, P342, DOI 10.1002/jlb.53.3.342; KOYANAGI Y, 1993, VIROLOGY, V196, P25, DOI 10.1006/viro.1993.1451; Lucic V, 2005, ANNU REV BIOCHEM, V74, P833, DOI 10.1146/annurev.biochem.73.011303.074112; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; MIYAUCHI M, 1990, J ELECTRON MICROSC, V39, P145; NAGY K, 1983, INT J CANCER, V32, P321, DOI 10.1002/ijc.2910320310; Nejmeddine M, 2005, J BIOL CHEM, V280, P29653, DOI 10.1074/jbc.M502639200; OSAME M, 1986, LANCET, V1, P1031; RICHARDSON JH, 1990, J VIROL, V64, P5682, DOI 10.1128/JVI.64.11.5682-5687.1990; Sandberg K, 2003, J STRUCT BIOL, V144, P61, DOI 10.1016/j.jsb.2003.09.013; Shuh M, 1999, VIROLOGY, V262, P442, DOI 10.1006/viro.1999.9909; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; TANAKA Y, 1986, INT J CANCER, V37, P35, DOI 10.1002/ijc.2910370107; Uchiyama T, 1997, ANNU REV IMMUNOL, V15, P15, DOI 10.1146/annurev.immunol.15.1.15; UCHIYAMA T, 1977, BLOOD, V50, P481, DOI 10.1182/blood.V50.3.481.481; WEISS A, 1984, J IMMUNOL, V133, P123; Yang YT, 2004, MOL CELL, V14, P269, DOI 10.1016/S1097-2765(04)00204-7	34	72	78	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2251	10.1371/journal.pone.0002251	http://dx.doi.org/10.1371/journal.pone.0002251			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509526	Green Published, Green Submitted, gold			2022-12-25	WOS:000262268500005
J	Purushothaman, S; Gupta, G; Srivastava, R; Ramu, VG; Surolia, A				Purushothaman, Sudha; Gupta, Garima; Srivastava, Richa; Ramu, Vasanthakumar Ganga; Surolia, Avadhesha			Ligand Specificity of Group I Biotin Protein Ligase of Mycobacterium tuberculosis	PLOS ONE			English	Article								Background: Fatty acids are indispensable constituents of mycolic acids that impart toughness & permeability barrier to the cell envelope of M. tuberculosis. Biotin is an essential co-factor for acetyl-CoA carboxylase (ACC) the enzyme involved in the synthesis of malonyl-CoA, a committed precursor, needed for fatty acid synthesis. Biotin carboxyl carrier protein (BCCP) provides the co-factor for catalytic activity of ACC. Methodology/Principal Findings: BPL/BirA (Biotin Protein Ligase), and its substrate, biotin carboxyl carrier protein (BCCP) of Mycobacterium tuberculosis (Mt) were cloned and expressed in E. coli BL21. In contrast to EcBirA and PhBPL, the similar to 29.5 kDa MtBPL exists as a monomer in native, biotin and bio-5'AMP liganded forms. This was confirmed by molecular weight profiling by gel filtration on Superdex S-200 and Dynamic Light Scattering (DLS). Computational docking of biotin and bio-5'AMP to MtBPL show that adenylation alters the contact residues for biotin. MtBPL forms 11 H-bonds with biotin, relative to 35 with bio-5'AMP. Docking simulations also suggest that bio-5'AMP hydrogen bonds to the conserved 'GRGRRG' sequence but not biotin. The enzyme catalyzed transfer of biotin to BCCP was confirmed by incorporation of radioactive biotin and by Avidin blot. The K(m) for BCCP was similar to 5.2 mu M and similar to 420 nM for biotin. MtBPL has low affinity (K(b) = 1.06 x 10(-6) M) for biotin relative to EcBirA but their K(m) are almost comparable suggesting that while the major function of MtBPL is biotinylation of BCCP, tight binding of biotin/bio-5'AMP by EcBirA is channeled for its repressor activity. Conclusions/Significance: These studies thus open up avenues for understanding the unique features of MtBPL and the role it plays in biotin utilization in M. tuberculosis.	[Purushothaman, Sudha; Gupta, Garima; Srivastava, Richa; Ramu, Vasanthakumar Ganga; Surolia, Avadhesha] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Surolia, Avadhesha] Natl Inst Immunol, New Delhi, India	Indian Institute of Science (IISC) - Bangalore; Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Purushothaman, S (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	surolia@nii.res.in		Ramu, Vasanthakumar/0000-0002-3397-8051	Department of Biotechnology (DBT), Government of India [Centre of excellence grant]; DBT; Department of Science and Technology, Government of India [J.C. Bose Fellow]	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); DBT(Department of Biotechnology (DBT) India); Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work was supported by Centre of excellence grant from the Department of Biotechnology (DBT), Government of India to A.S. and by another DBT grant to A.S. A.S. is also J.C. Bose Fellow of the Department of Science and Technology, Government of India.	Bagautdinov B, 2005, J MOL BIOL, V353, P322, DOI 10.1016/j.jmb.2005.08.032; BARRY BR, 1992, SCIENCE, V257, P1055; Brown PH, 2005, BIOCHEMISTRY-US, V44, P3112, DOI 10.1021/bi047792k; Brown PH, 2004, J MOL BIOL, V337, P857, DOI 10.1016/j.jmb.2004.01.041; Chapman-Smith A, 1999, TRENDS BIOCHEM SCI, V24, P359, DOI 10.1016/S0968-0004(99)01438-3; Chapman-Smith A, 1999, J NUTR, V129, p477S, DOI 10.1093/jn/129.2.477S; Chapman-Smith A, 1999, J BIOL CHEM, V274, P1449, DOI 10.1074/jbc.274.3.1449; Choi-Rhee E, 2003, J BIOL CHEM, V278, P30806, DOI 10.1074/jbc.M302507200; Clarke DJ, 2003, EUR J BIOCHEM, V270, P1277, DOI 10.1046/j.1432-1033.2003.03493.x; Cole ST, 2007, BIOCHEM SOC T, V35, P1321, DOI 10.1042/BST0351321; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cox H, 2003, LANCET, V362, P1858, DOI 10.1016/S0140-6736(03)14918-5; JOHNSSON K, 1995, J AM CHEM SOC, V117, P5009, DOI 10.1021/ja00122a038; Kwon K, 2000, PROTEIN SCI, V9, P1530, DOI 10.1110/ps.9.8.1530; Kwon K, 2002, PROTEIN SCI, V11, P558, DOI 10.1110/ps.33502; LANE MD, 1964, J BIOL CHEM, V239, P2865; Marrakchi H, 2000, MICROBIOL-UK, V146, P289, DOI 10.1099/00221287-146-2-289; MUKHOPADHYAY B, 2001, J BAC, V183, P3802; Polyak SW, 1999, J BIOL CHEM, V274, P32847, DOI 10.1074/jbc.274.46.32847; Reche P, 1998, BIOCHEM J, V329, P589, DOI 10.1042/bj3290589; Reche P, 1999, EMBO J, V18, P2673, DOI 10.1093/emboj/18.10.2673; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Streaker ED, 2003, J MOL BIOL, V325, P937, DOI 10.1016/S0022-2836(02)01308-6; Streaker ED, 2006, BIOCHEMISTRY-US, V45, P6417, DOI 10.1021/bi052599r; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Weaver LH, 2001, P NATL ACAD SCI USA, V98, P6045, DOI 10.1073/pnas.111128198; WILSON KP, 1992, P NATL ACAD SCI USA, V89, P9257, DOI 10.1073/pnas.89.19.9257; WINDER F G, 1970, Journal of General Microbiology, V63, P41; WINDER FG, 1979, BIOCHEM J, V117, pP127; Wood ZA, 2006, J MOL BIOL, V357, P509, DOI 10.1016/j.jmb.2005.12.066; Wu SC, 2004, ANAL BIOCHEM, V331, P340, DOI 10.1016/j.ab.2004.03.056; Xu Y, 1995, BIOCHEMISTRY-US, V34, P16624, DOI 10.1021/bi00051a010; Xu Y, 1996, BIOCHEMISTRY-US, V35, P1783, DOI 10.1021/bi952269e; Xu Y, 1996, BIOCHEMISTRY-US, V35, P5509, DOI 10.1021/bi9600658	35	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2320	10.1371/journal.pone.0002320	http://dx.doi.org/10.1371/journal.pone.0002320			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509457	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000262268500047
J	Saeed, M; Roeffen, W; Alexander, N; Drakeley, CJ; Targett, GAT; Sutherland, CJ				Saeed, Maha; Roeffen, Will; Alexander, Neal; Drakeley, Christopher J.; Targett, Geoffrey A. T.; Sutherland, Colin J.			Plasmodium falciparum Antigens on the Surface of the Gametocyte-Infected Erythrocyte	PLOS ONE			English	Article							MALARIA TRANSMISSION; VARIANT ANTIGENS; ANTIBODIES; CHILDREN; CHLOROQUINE; EXPRESSION; ARTESUNATE; PROTECTION; IMMUNITY; REDUCTION	Background: The asexual blood stages of the human malaria parasite Plasmodium falciparum produce highly immunogenic polymorphic antigens that are expressed on the surface of the host cell. In contrast, few studies have examined the surface of the gametocyte-infected erythrocyte. Methodology/Principal Findings: We used flow cytometry to detect antibodies recognising the surface of live cultured erythrocytes infected with gametocytes of P. falciparum strain 3D7 in the plasma of 200 Gambian children. The majority of children had been identified as carrying gametocytes after treatment for malaria, and each donated blood for mosquito-feeding experiments. None of the plasma recognised the surface of erythrocytes infected with developmental stages of gametocytes (I-IV), but 66 of 194 (34.0%) plasma contained IgG that recognised the surface of erythrocytes infected with mature (stage V) gametocytes. Thirty-four (17.0%) of 200 plasma tested recognised erythrocytes infected with trophozoites and schizonts, but there was no association with recognition of the surface of gametocyte-infected erythrocytes (odds ratio 1.08, 95% C.I. 0.434-2.57; P = 0.851). Plasma antibodies with the ability to recognise gametocyte surface antigens (GSA) were associated with the presence of antibodies that recognise the gamete antigen Pfs 230, but not Pfs48/45. Antibodies recognising GSA were associated with donors having lower gametocyte densities 4 weeks after antimalarial treatment. Conclusions/Significance: We provide evidence that GSA are distinct from antigens detected on the surface of asexual 3D7 parasites. Our findings suggest a novel strategy for the development of transmission-blocking vaccines.	[Saeed, Maha; Alexander, Neal; Drakeley, Christopher J.; Targett, Geoffrey A. T.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Roeffen, Will; Sutherland, Colin J.] Radboud Univ Nijmegen Med Ctr, Nijmegen, Netherlands	University of London; London School of Hygiene & Tropical Medicine; Radboud University Nijmegen	Saeed, M (corresponding author), London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England.	colin.sutherland@lshtm.ac.uk	Roeffen, W.F.G./L-4607-2015; Sutherland, Colin/AAN-3939-2020	Sutherland, Colin/0000-0003-1592-6407	Wellcome Trust [061910, ISRCTN11805747]; UK Medical Research Council; Gates Malaria Partnership; Council for Assisting Refugee Academics (CARA); UK Health Protection Agency; Medical Research Council [G0700837] Funding Source: researchfish; MRC [G0700837] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Gates Malaria Partnership; Council for Assisting Refugee Academics (CARA); UK Health Protection Agency; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust (Project # 061910; ISRCTN11805747), the UK Medical Research Council, and the Gates Malaria Partnership. MS is supported by the Council for Assisting Refugee Academics (CARA). CJS is supported by the UK Health Protection Agency. None of these bodies played any role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.	BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Billker O, 2000, PARASITOLOGY, V120, P547, DOI 10.1017/S0031182099005946; BOUDIN C, 1993, AM J TROP MED HYG, V48, P700, DOI 10.4269/ajtmh.1993.48.700; BRANNAN LR, 1994, P ROY SOC B-BIOL SCI, V256, P71, DOI 10.1098/rspb.1994.0051; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; Day KP, 1998, MOL BIOCHEM PARASIT, V93, P167, DOI 10.1016/S0166-6851(98)00040-1; Delrieu I, 2002, MOL BIOCHEM PARASIT, V121, P11, DOI 10.1016/S0166-6851(02)00016-6; Dodoo D, 2001, INFECT IMMUN, V69, P3713, DOI 10.1128/IAI.69.6.3713-3718.2001; Drakeley CJ, 2000, T ROY SOC TROP MED H, V94, P472, DOI 10.1016/S0035-9203(00)90056-7; Drakeley CJ, 2006, PARASITE IMMUNOL, V28, P185, DOI 10.1111/j.1365-3024.2005.00818.x; Drakeley CJ, 2004, TROP MED INT HEALTH, V9, P53, DOI 10.1046/j.1365-3156.2003.01169.x; Dunyo S, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010020; Epstein JE, 2007, CURR OPIN MOL THER, V9, P12; Fivelman QL, 2007, MOL BIOCHEM PARASIT, V154, P119, DOI 10.1016/j.molbiopara.2007.04.008; Giha HA, 2000, IMMUNOL LETT, V71, P117, DOI 10.1016/S0165-2478(99)00173-X; GRAVES PM, 1988, INFECT IMMUN, V56, P2818, DOI 10.1128/IAI.56.11.2818-2821.1988; GUPTA SK, 1985, J PROTOZOOL, V32, P91, DOI 10.1111/j.1550-7408.1985.tb03020.x; Hallett RL, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010015; Hayward RE, 1999, P NATL ACAD SCI USA, V96, P4563, DOI 10.1073/pnas.96.8.4563; Jensen ATR, 2004, J EXP MED, V199, P1179, DOI 10.1084/jem.20040274; MARSH K, 1989, T ROY SOC TROP MED H, V83, P293, DOI 10.1016/0035-9203(89)90478-1; McRobert L, 2004, INFECT IMMUN, V72, P6597, DOI 10.1128/IAI.72.11.6597-6602.2004; MENDIS KN, 1987, INFECT IMMUN, V55, P369, DOI 10.1128/IAI.55.2.369-372.1987; MILTENYI S, 1990, CYTOMETRY, V11, P231, DOI 10.1002/cyto.990110203; Muhia DK, 2001, MOL MICROBIOL, V42, P553, DOI 10.1046/j.1365-2958.2001.02665.x; Ofori MF, 2002, INFECT IMMUN, V70, P2982, DOI 10.1128/IAI.70.6.2982-2988.2002; PONNUDURAI T, 1986, PARASITOLOGY, V93, P263, DOI 10.1017/S003118200005143X; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; Roeffen W, 1996, PARASITE IMMUNOL, V18, P103, DOI 10.1046/j.1365-3024.1996.d01-54.x; ROEFFEN W, 1995, INFECT IMMUN, V63, P467, DOI 10.1128/IAI.63.2.467-471.1995; Rogers NJ, 2000, INFECT IMMUN, V68, P3455, DOI 10.1128/IAI.68.6.3455-3462.2000; Sharp S, 2006, EUKARYOT CELL, V5, P1206, DOI 10.1128/EC.00029-06; SINDEN RE, 1979, PARASITOLOGY, V79, P277, DOI 10.1017/S003118200005335X; SMALLEY ME, 1981, T ROY SOC TROP MED H, V75, P103, DOI 10.1016/0035-9203(81)90019-5; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Staalsoe T, 1999, CYTOMETRY, V35, P329, DOI 10.1002/(SICI)1097-0320(19990401)35:4&lt;329::AID-CYTO5&gt;3.0.CO;2-Y; Staalsoe T, 2003, PARASITE IMMUNOL, V25, P421, DOI 10.1111/j.1365-3024.2003.00652.x; Sutherland CJ, 2005, PLOS MED, V2, P338, DOI 10.1371/journal.pmed.0020092; Sutherland CJ, 2003, AM J TROP MED HYG, V69, P19, DOI 10.4269/ajtmh.2003.69.19; Sutherland CJ, 2002, AM J TROP MED HYG, V67, P578, DOI 10.4269/ajtmh.2002.67.578; Targett G, 2001, J INFECT DIS, V183, P1254, DOI 10.1086/319689; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Van Der Kolk M, 2005, PARASITOLOGY, V130, P13, DOI 10.1017/S0031182004006067; van Schaijk BCL, 2006, MOL BIOCHEM PARASIT, V149, P216, DOI 10.1016/j.molbiopara.2006.05.015	44	55	55	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2280	10.1371/journal.pone.0002280	http://dx.doi.org/10.1371/journal.pone.0002280			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509532	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000262268500024
J	Rasgon, JL				Rasgon, Jason L.			Stable Isotope Analysis Can Potentially Identify Completely-Digested Bloodmeals in Mosquitoes	PLOS ONE			English	Article								Background: Vertebrate bloodfeeding is a critical component of a mosquito's ability to transmit pathogens that cause diseases such as malaria, dengue fever and viral encephalitis. Due to degradation by the digestive process, current methods to identify mosquito bloodmeal sources are only useful for approximately 36 hours post-feeding. A critical need exists for technologies to extend this window and gain a more complete picture of mosquito feeding behavior for epidemiological studies. Stable isotopes are useful for investigating organism feeding behavior because the isotopic ratio of an organism's tissues reflects that of the material it ingests. Methodology/Principal Findings: Proof-of-principle data indicates that after bloodfeeding, Aedes albopictus mosquitoes acquire diagnostic Carbon and Nitrogen stable isotope profiles from their vertebrate hosts that can be accurately identified one week post-feeding, approximately 4 days after the entire bloodmeal has been digested. Total C/N ratio served as a biomarker marker for bloodfeeding (P < 0.02), while delta N was the most informative variable which could distinguish between unfed, chicken-fed and human-fed mosquitoes (P < 0.01). By plotting C/N vs. delta N, all feeding treatments could be identified in a double-blind analysis. Conclusions/Significance: These proof-of-principle experiments indicate that analysis of stable isotopes can be used to distinguish bloodfed from unfed mosquitoes, and also distinguish between different vertebrate bloodmeal sources even after all blood has been digested. The development of stable isotope-based assays for mosquito bloodmeal identification may be a powerful tool to investigate mosquito feeding ecology and the dynamics of vector-borne pathogens.	[Rasgon, Jason L.] Johns Hopkins Univ, Johns Hopkins Malaria Res Inst, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA	Johns Hopkins University	Rasgon, JL (corresponding author), Johns Hopkins Univ, Johns Hopkins Malaria Res Inst, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA.	jrasgon@jhsph.edu		Rasgon, Jason/0000-0002-4050-8429	Johns Hopkins Malaria Research Institute	Johns Hopkins Malaria Research Institute	Funding was provided by the Johns Hopkins Malaria Research Institute.	Andreadis TG, 2004, VECTOR-BORNE ZOONOT, V4, P360, DOI 10.1089/vbz.2004.4.360; BEIER JC, 1988, J MED ENTOMOL, V25, P9, DOI 10.1093/jmedent/25.1.9; Boakye DA, 1999, MED VET ENTOMOL, V13, P282, DOI 10.1046/j.1365-2915.1999.00193.x; CHOW E, 1993, J AM MOSQUITO CONTR, V9, P196; Chow-Shaffer E, 2000, J MED ENTOMOL, V37, P492, DOI 10.1603/0022-2585-37.4.492; DYE C, 1992, ANNU REV ENTOMOL, V37, P1, DOI 10.1146/annurev.en.37.010192.000245; Gaye-Siessegger J, 2004, OECOLOGIA, V138, P175, DOI 10.1007/s00442-003-1429-7; Gomes LAM, 2001, MEM I OSWALDO CRUZ, V96, P693, DOI 10.1590/S0074-02762001000500020; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; GRUPE G, 1990, SCI TOTAL ENVIRON, V90, P227, DOI 10.1016/0048-9697(90)90195-Z; Hobson KA, 2004, OECOLOGIA, V141, P477, DOI 10.1007/s00442-004-1671-7; Iko WM, 2003, ISOT ENVIRON HEALT S, V39, P159, DOI 10.1080/1025601031000108679; Kent RJ, 2005, AM J TROP MED HYG, V73, P336, DOI 10.4269/ajtmh.2005.73.336; Kilpatrick AM, 2005, EMERG INFECT DIS, V11, P425, DOI 10.3201/eid1103.040364; Kuno G, 1995, EPIDEMIOL REV, V17, P321, DOI 10.1093/oxfordjournals.epirev.a036196; Kutz FW, 2003, J AM MOSQUITO CONTR, V19, P190; Lee JH, 2002, AM J TROP MED HYG, V66, P599, DOI 10.4269/ajtmh.2002.66.599; MONATH TP, 1994, P NATL ACAD SCI USA, V91, P2395, DOI 10.1073/pnas.91.7.2395; Mukabana WR, 2002, TRENDS PARASITOL, V18, P505, DOI 10.1016/S1471-4922(02)02364-4; Sardelis MR, 2002, J AM MOSQUITO CONTR, V18, P284; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; TEMPELIS CH, 1963, AM J TROP MED HYG, V12, P825, DOI 10.4269/ajtmh.1963.12.825; WADA E, 1991, CRIT REV FOOD SCI, V30, P361, DOI 10.1080/10408399109527547; Werner RA, 2001, RAPID COMMUN MASS SP, V15, P501, DOI 10.1002/rcm.258	24	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2198	10.1371/journal.pone.0002198	http://dx.doi.org/10.1371/journal.pone.0002198			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493314	Green Published, gold, Green Submitted			2022-12-25	WOS:000262258700007
J	Sinnayah, P; Jobst, EE; Rathner, JA; Caldera-Siu, AD; Tonelli-Lemos, L; Eusterbrock, AJ; Enriori, PJ; Pothos, EN; Grove, KL; Cowley, MA				Sinnayah, Puspha; Jobst, Erin E.; Rathner, Joseph A.; Caldera-Siu, Angela D.; Tonelli-Lemos, Luciana; Eusterbrock, Aaron J.; Enriori, Pablo J.; Pothos, Emmanuel N.; Grove, Kevin L.; Cowley, Michael A.			Feeding Induced by Cannabinoids Is Mediated Independently of the Melanocortin System	PLOS ONE			English	Article							DECREASES EXTRACELLULAR DOPAMINE; MELANIN-CONCENTRATING HORMONE; VENTRAL TEGMENTAL AREA; FOOD-INTAKE; RECEPTOR ANTAGONIST; NUCLEUS-ACCUMBENS; WEIGHT-LOSS; FOS EXPRESSION; BRAIN REWARD; SR 141716	Background: Cannabinoids, the active components of marijuana, stimulate appetite, and cannabinoid receptor-1 (CB1-R) antagonists suppress appetite and promote weight loss. Little is known about how CB1-R antagonists affect the central neurocircuitry, specifically the melanocortin system that regulates energy balance. Methodology/Principal Findings: Here, we show that peripherally administered CB1-R antagonist (AM251) or agonist equally suppressed or stimulated feeding respectively in A(y), which lack a functional melanocortin system, and wildtype mice, demonstrating that cannabinoid effects on feeding do not require melanocortin circuitry. CB1-R antagonist or agonist administered into the ventral tegmental area (VTA) equally suppressed or stimulated feeding respectively, in both genotypes. In addition, peripheral and central cannabinoid administration similarly induced c-Fos activation in brain sites suggesting mediation via motivational dopaminergic circuitry. Amperometry-detected increases in evoked dopamine (DA) release by the CB1-R antagonist in nucleus accumbens slices indicates that AM251 modulates DA release from VTA terminals. Conclusions/Significance: Our results demonstrate that the effects of cannabinoids on energy balance are independent of hypothalamic melanocortin circuitry and is primarily driven by the reward system.	[Sinnayah, Puspha; Jobst, Erin E.; Tonelli-Lemos, Luciana; Eusterbrock, Aaron J.; Enriori, Pablo J.; Grove, Kevin L.; Cowley, Michael A.] Oregon Hlth & Sci Univ, Div Neurosci, Oregon Natl Primate Res Ctr, Portland, OR 97201 USA; [Jobst, Erin E.] Pacific Univ, Sch Physical Therapy, Hillsboro, OR USA; [Rathner, Joseph A.] Neurol Sci Inst, Beaverton, OR USA; [Caldera-Siu, Angela D.; Pothos, Emmanuel N.] Tufts Univ, Sch Med, Dept Pharmacol & Expt Therapeut & Program Neurosci, Boston, MA USA; [Cowley, Michael A.] Monash Univ, Fac Med, Dept Physiol, Clayton, Vic, Australia	Oregon Health & Science University; Oregon National Primate Research Center; Tufts University; Monash University	Sinnayah, P (corresponding author), Oregon Hlth & Sci Univ, Div Neurosci, Oregon Natl Primate Res Ctr, Portland, OR 97201 USA.	michael.cowley@med.monash.edu.au	Cowley, Michael A/B-9428-2008; Sinnayah, Puspha/M-4351-2014	Cowley, Michael A/0000-0001-7811-134X; Sinnayah, Puspha/0000-0002-9811-7236; Pothos, Emmanuel/0000-0001-8825-7852; Rathner, Joseph/0000-0002-8734-9402	National Institutes of Health [RR0163, DK62202, DK60685, DK065872]; Tufts Center for Neuroscience Research [P30 NS047243]; Tufts GRASP Center [P30 DK34928]; Medical Foundation [Smith Family New Investigator Award]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062202, P30DK034928, R01DK065872, R56DK062202, R01DK060685] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047243] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tufts Center for Neuroscience Research; Tufts GRASP Center; Medical Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health (RR0163, DK62202 and DK60685). The work in the Pothos laboratory was supported by DK065872, P30 NS047243 (Tufts Center for Neuroscience Research), P30 DK34928 (Tufts GRASP Center) and a Smith Family New Investigator Award through the Medical Foundation. OHSU and Dr. Cowley have a significant financial interest in Orexigen Therapeutics Inc., a company that may have a commercial interest in the results of this research and technology. This potential conflict has been reviewed and managed by the OHSU Conflict of Interest in Research Committee and the Integrity Program Oversight Council.	Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; Alonso R, 1999, NEUROSCIENCE, V91, P607, DOI 10.1016/S0306-4522(98)00675-7; Arnold JC, 2001, BRAIN RES, V921, P240, DOI 10.1016/S0006-8993(01)03127-4; Arnone M, 1997, PSYCHOPHARMACOLOGY, V132, P104, DOI 10.1007/s002130050326; Borgland SL, 2006, NEURON, V49, P589, DOI 10.1016/j.neuron.2006.01.016; Cerri M, 2005, NEUROSCIENCE, V135, P627, DOI 10.1016/j.neuroscience.2005.06.039; Cheer JF, 2004, J NEUROSCI, V24, P4393, DOI 10.1523/JNEUROSCI.0529-04.2004; Cheer JF, 2003, NEUROPHARMACOLOGY, V44, P633, DOI 10.1016/S0028-3908(03)00029-7; Clegg DJ, 2002, ENDOCRINOLOGY, V143, P2995, DOI 10.1210/en.143.8.2995; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cota D, 2006, BRAIN RES REV, V51, P85, DOI 10.1016/j.brainresrev.2005.10.004; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Enriori PJ, 2007, CELL METAB, V5, P181, DOI 10.1016/j.cmet.2007.02.004; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Gardner EL, 2005, PHARMACOL BIOCHEM BE, V81, P263, DOI 10.1016/j.pbb.2005.01.032; Hagan MM, 2001, ENDOCRINOLOGY, V142, P1050, DOI 10.1210/en.142.3.1050; Hentges ST, 2005, J NEUROSCI, V25, P9746, DOI 10.1523/JNEUROSCI.2769-05.2005; HERNANDEZ L, 1988, PHYSIOL BEHAV, V44, P599, DOI 10.1016/0031-9384(88)90324-1; Hildebrandt AL, 2003, EUR J PHARMACOL, V462, P125, DOI 10.1016/S0014-2999(03)01343-8; HO J, 2007, CANNABINOID INDUCED; Huang H, 2007, J NEUROSCI, V27, P4870, DOI 10.1523/JNEUROSCI.0732-07.2007; IVERSON L, 2000, SCI MARIJUANA OXFORD; Jamshidi N, 2001, BRIT J PHARMACOL, V134, P1151, DOI 10.1038/sj.bjp.0704379; Jo YH, 2005, NEURON, V48, P1055, DOI 10.1016/j.neuron.2005.10.021; Kask A, 1998, BIOCHEM BIOPH RES CO, V245, P90, DOI 10.1006/bbrc.1998.8389; Korotkova TM, 2003, J NEUROSCI, V23, P7; Madden CJ, 2004, AM J PHYSIOL-REG I, V286, pR320, DOI 10.1152/ajpregu.00515.2003; Mahler SV, 2007, NEUROPSYCHOPHARMACOL, V32, P2267, DOI 10.1038/sj.npp.1301376; Molavi B, 2006, CURR OPIN CARDIOL, V21, P479, DOI 10.1097/01.hco.0000240586.76344.f5; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Paladini CA, 2003, P NATL ACAD SCI USA, V100, P2866, DOI 10.1073/pnas.0138018100; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Phillips AG, 2003, NEUROSCI BIOBEHAV R, V27, P543, DOI 10.1016/j.neubiorev.2003.09.002; Pothos EN, 1995, OBES RES, V3, pS525, DOI 10.1002/j.1550-8528.1995.tb00222.x; POTHOS EN, 1995, J NEUROSCI, V15, P6640; Pothos EN, 1998, APPETITE, V31, P405, DOI 10.1006/appe.1998.0210; Pritchard LE, 2005, PEPTIDES, V26, P1759, DOI 10.1016/j.peptides.2004.11.036; Roitman MF, 2004, J NEUROSCI, V24, P1265, DOI 10.1523/JNEUROSCI.3823-03.2004; Simiand J, 1998, BEHAV PHARMACOL, V9, P179; Singh ME, 2004, NEUROPHARMACOLOGY, V47, P1157, DOI 10.1016/j.neuropharm.2004.08.008; Skuladottir GV, 1999, BRIT J PHARMACOL, V126, P27, DOI 10.1038/sj.bjp.0702264; Solinas M, 2007, PHARMACOL RES, V56, P393, DOI 10.1016/j.phrs.2007.09.005; STELLAR E, 1954, PSYCHOL REV, V61, P5, DOI 10.1037/0033-295X.101.2.301; Szabo B, 2002, EUR J NEUROSCI, V15, P2057, DOI 10.1046/j.1460-9568.2002.02041.x; TOWELL A, 1988, PSYCHOPHARMACOLOGY, V96, P135, DOI 10.1007/BF02431545; Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X; Verty ANA, 2004, ENDOCRINOLOGY, V145, P3224, DOI 10.1210/en.2004-0059; Vickers SP, 2003, PSYCHOPHARMACOLOGY, V167, P103, DOI 10.1007/s00213-002-1384-8; Williams G, 2001, PHYSIOL BEHAV, V74, P683, DOI 10.1016/S0031-9384(01)00612-6; Wu XF, 2000, NEUROPHARMACOLOGY, V39, P391, DOI 10.1016/S0028-3908(99)00140-9; Zangen A, 2006, J NEUROSCI, V26, P4901, DOI 10.1523/JNEUROSCI.3554-05.2006; Zhou D, 2004, PHARMACOL BIOCHEM BE, V77, P117, DOI 10.1016/j.pbb.2003.10.015	55	28	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2202	10.1371/journal.pone.0002202	http://dx.doi.org/10.1371/journal.pone.0002202			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493584	gold, Green Accepted, Green Published			2022-12-25	WOS:000262258700011
J	Toledo, JC; Bosworth, CA; Hennon, SW; Mahtani, HA; Bergonia, HA; Lancaster, JR				Toledo, Jose C., Jr.; Bosworth, Charles A.; Hennon, Seth W.; Mahtani, Harry A.; Bergonia, Hector A.; Lancaster, Jack R., Jr.			Nitric Oxide-induced Conversion of Cellular Chelatable Iron into Macromolecule-bound Paramagnetic Dinitrosyliron Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON SPIN RESONANCE; GLUTATHIONE TRANSFERASE SUPERFAMILY; CYTOTOXIC ACTIVATED MACROPHAGES; THIOL-CONTAINING LIGANDS; INTRACELLULAR FREE IRON; IN-VIVO; OXIDATIVE STRESS; S-NITROSOTHIOLS; STIMULATED MACROPHAGES; MAMMALIAN-CELLS	One of the most important biological reactions of nitric oxide (nitrogen monoxide, (NO)-N-center dot) is its reaction with transition metals, of which iron is the major target. This is confirmed by the ubiquitous formation of EPR-detectable g = 2.04 signals in cells, tissues, and animals upon exposure to both exogenous and endogenous (NO)-N-center dot. The source of the iron for these dinitrosyliron complexes (DNIC), and its relationship to cellular iron homeostasis, is not clear. Evidence has shown that the chelatable iron pool (CIP) may be at least partially responsible for this iron, but quantitation and kinetic characterization have not been reported. In the murine cell line RAW 264.7, (NO)-N-center dot reacts with the CIP similarly to the strong chelator salicylaldehyde isonicotinoyl hydrazone (SIH) in rapidly releasing iron from the iron-calcein complex. SIH pretreatment prevents DNIC formation from (NO)-N-center dot, and SIH added during the (NO)-N-center dot treatment "freezes" DNIC levels, showing that the complexes are formed from the CIP, and they are stable (resistant to SIH). DNIC formation requires free (NO)-N-center dot, because addition of oxyhemoglobin prevents formation from either (NO)-N-center dot donor or S-nitrosocysteine, the latter treatment resulting in 100-fold higher intracellular nitrosothiol levels. EPR measurement of the CIP using desferroxamine shows quantitative conversion of CIP into DNIC by (NO)-N-center dot. In conclusion, the CIP is rapidly and quantitatively converted to paramagnetic large molecular mass DNIC from exposure to free (NO)-N-center dot but not from cellular nitrosothiol. These results have important implications for the antioxidative actions of (NO)-N-center dot and its effects on cellular iron homeostasis.	[Toledo, Jose C., Jr.; Bosworth, Charles A.; Mahtani, Harry A.; Lancaster, Jack R., Jr.] Univ Alabama Birmingham, Ctr Free Rad Biol, Birmingham, AL 35294 USA; [Toledo, Jose C., Jr.; Mahtani, Harry A.; Lancaster, Jack R., Jr.] Univ Alabama Birmingham, Dept Anesthesiol, Birmingham, AL 35294 USA; [Bosworth, Charles A.; Lancaster, Jack R., Jr.] Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA; [Lancaster, Jack R., Jr.] Univ Alabama Birmingham, Dept Environm Hlth Sci, Birmingham, AL 35294 USA; [Hennon, Seth W.] Mt Union Coll, Dept Biol, Alliance, OH 44601 USA; [Hennon, Seth W.] Mt Union Coll, Dept Chem, Alliance, OH 44601 USA; [Bergonia, Hector A.] Univ Utah, Dept Med, Salt Lake City, UT 84132 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Mount Union; University of Mount Union; Utah System of Higher Education; University of Utah	Lancaster, JR (corresponding author), Univ Alabama Birmingham, Ctr Free Rad Biol, 901,19th St, Birmingham, AL 35294 USA.	doctorno@uab.edu	Toledo, Jose C/J-4360-2015; Sochanowicz, Barbara/V-3890-2018	Sochanowicz, Barbara/0000-0002-7348-8356; Toledo Junior, Jose Carlos/0000-0003-0818-0846	National Institutes of Health [HL71189, HL074391]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074391, R01HL071189] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL71189 and HL074391 (to J.R.L.). This work was also supported by a Conselho Nacional de Desenvolvimento Cientifico e Tecnologico grant (to J.C.T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Bezerra CWB, 1999, INORG CHEM, V38, P5660, DOI 10.1021/ic990210g; Branca M, 1997, MAGN RESON CHEM, V35, P687, DOI 10.1002/(SICI)1097-458X(199711)35:10<687::AID-OMR152>3.0.CO;2-Z; BRENNAN MJ, 1966, P SOC EXP BIOL MED, V123, P715; BREUER W, 1995, J BIOL CHEM, V270, P24209, DOI 10.1074/jbc.270.41.24209; BUTLER AR, 1988, ADV INORG CHEM, V32, P335, DOI 10.1016/S0898-8838(08)60235-4; BUTLER AR, 1985, POLYHEDRON, V4, P303, DOI 10.1016/S0277-5387(00)84503-9; Cabantchik ZI, 1996, ANAL BIOCHEM, V233, P221, DOI 10.1006/abio.1996.0032; CASTRO L, 1994, J BIOL CHEM, V269, P29409; Cesareo E, 2005, J BIOL CHEM, V280, P42172, DOI 10.1074/jbc.M507916200; Cook JA, 1996, ANAL BIOCHEM, V238, P150, DOI 10.1006/abio.1996.0268; CORBETT JA, 1993, P NATL ACAD SCI USA, V90, P1731, DOI 10.1073/pnas.90.5.1731; Costanzo S, 2001, INORG CHIM ACTA, V318, P1, DOI 10.1016/S0020-1693(01)00402-9; D'Autreaux B, 2004, J AM CHEM SOC, V126, P6005, DOI 10.1021/ja031671a; Dalsgaard T, 2007, AM J PHYSIOL-HEART C, V292, pH3072, DOI 10.1152/ajpheart.01298.2006; De Maria F, 2003, J BIOL CHEM, V278, P42283, DOI 10.1074/jbc.M305568200; DRAPIER JC, 1986, J CLIN INVEST, V78, P790, DOI 10.1172/JCI112642; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; EMERY T, 1980, NATURE, V287, P776, DOI 10.1038/287776a0; Epsztejn S, 1997, ANAL BIOCHEM, V248, P31, DOI 10.1006/abio.1997.2126; Feelisch M, 2002, FASEB J, V16, P1775, DOI 10.1096/fj.02-0363com; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Ford PC, 2002, CHEM REV, V102, P993, DOI 10.1021/cr0000271; HAUSLADEN A, 1994, J BIOL CHEM, V269, P29405; HENRY Y, 1991, EUR BIOPHYS J, V20, P1; HENRY Y, 1997, EPR SPECTROSCOPY NIT; HIBBS JB, 1988, BIOCHEM BIOPH RES CO, V157, P87, DOI 10.1016/S0006-291X(88)80015-9; Ignarro LJ, 2000, NITRIC OXIDE BIOL PA; ISENBERG I, 1964, PHYSIOL REV, V44, P487, DOI 10.1152/physrev.1964.44.3.487; Kagan VE, 2001, ANTIOXID REDOX SIGN, V3, P189, DOI 10.1089/152308601300185160; Kakhlon O, 2002, FREE RADICAL BIO MED, V33, P1037, DOI 10.1016/S0891-5849(02)01006-7; KANNER J, 1991, ARCH BIOCHEM BIOPHYS, V289, P130, DOI 10.1016/0003-9861(91)90452-O; Kennedy MC, 1997, J BIOL CHEM, V272, P20340, DOI 10.1074/jbc.272.33.20340; KENNEDY MC, 1993, BIOCHEM BIOPH RES CO, V196, P632, DOI 10.1006/bbrc.1993.2296; KOSAKA H, 1989, CARCINOGENESIS, V10, P563, DOI 10.1093/carcin/10.3.563; KOZLOV AV, 1992, FREE RADICAL BIO MED, V13, P9, DOI 10.1016/0891-5849(92)90159-E; Kruszewski M, 2003, MUTAT RES-FUND MOL M, V531, P81, DOI 10.1016/j.mrfmmm.2003.08.004; Lancaster JR, 2006, CHEM RES TOXICOL, V19, P1160, DOI 10.1021/tx060061w; LANCASTER JR, 1990, P NATL ACAD SCI USA, V87, P1223, DOI 10.1073/pnas.87.3.1223; LANGREHR JM, 1993, TRANSPLANTATION, V55, P1205, DOI 10.1097/00007890-199306000-00001; LEAF CD, 1989, CANCER SURV, V8, P323; Lewandowska H, 2007, J BIOL INORG CHEM, V12, P345, DOI 10.1007/s00775-006-0192-8; Lo Bello M, 2001, J BIOL CHEM, V276, P42138; MCDONALD CC, 1965, J AM CHEM SOC, V87, P3319, DOI 10.1021/ja01093a007; Meyron-Holtz EG, 2004, SCIENCE, V306, P2087, DOI 10.1126/science.1103786; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; MIWA M, 1987, CARCINOGENESIS, V8, P955, DOI 10.1093/carcin/8.7.955; Muller B, 1996, BRIT J PHARMACOL, V119, P1281, DOI 10.1111/j.1476-5381.1996.tb16034.x; Pantopoulos K, 1996, MOL CELL BIOL, V16, P3781; Pedersen JZ, 2007, J BIOL CHEM, V282, P6364, DOI 10.1074/jbc.M609905200; PELLAT C, 1990, BIOCHEM BIOPH RES CO, V166, P119, DOI 10.1016/0006-291X(90)91919-J; Petrat F, 2002, BIOL CHEM, V383, P489, DOI 10.1515/BC.2002.051; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; SALERNO JC, 1976, BIOCHEM BIOPH RES CO, V73, P833, DOI 10.1016/0006-291X(76)90884-6; STADLER J, 1993, ARCH BIOCHEM BIOPHYS, V302, P4, DOI 10.1006/abbi.1993.1173; Thomas DD, 2001, P NATL ACAD SCI USA, V98, P355, DOI 10.1073/pnas.98.1.355; Turella P, 2003, J BIOL CHEM, V278, P42294, DOI 10.1074/jbc.M305569200; Vanin AF, 1997, BIOFIZIKA+, V42, P10; VANIN AF, 1992, BIOCHIM BIOPHYS ACTA, V1135, P275, DOI 10.1016/0167-4889(92)90231-Y; Vanin AF, 2007, NITRIC OXIDE-BIOL CH, V16, P82, DOI 10.1016/j.niox.2006.07.005; VITHAYATHIL AJ, 1965, NATURE, V207, P1246, DOI 10.1038/2071246a0; Wang J, 2005, MOL CELL BIOL, V25, P1347, DOI 10.1128/MCB.25.4.1347-1353.2005; Watts RN, 2006, P NATL ACAD SCI USA, V103, P7670, DOI 10.1073/pnas.0602515103; Woodmansee AN, 2002, METHOD ENZYMOL, V349, P3, DOI 10.1016/S0076-6879(02)49316-0; WOOLUM JC, 1968, BIOCHIM BIOPHYS ACTA, V160, P311, DOI 10.1016/0005-2795(68)90204-3; Zhang YH, 2005, FREE RADICAL BIO MED, V38, P831, DOI 10.1016/j.freeradbiomed.2004.12.016; Zhang YH, 2004, P NATL ACAD SCI USA, V101, P7891, DOI 10.1073/pnas.0401167101	66	85	87	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 24	2008	283	43					28926	28933		10.1074/jbc.M707862200	http://dx.doi.org/10.1074/jbc.M707862200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	362EB	18480062	Green Published, hybrid			2022-12-25	WOS:000260179900018
J	Bertucci, F; Orsetti, B; Negre, V; Finetti, P; Rouge, C; Ahomadegbe, JC; Bibeau, F; Mathieu, MC; Treilleux, I; Jacquemier, J; Ursule, L; Martinec, A; Wang, Q; Benard, J; Puisieux, A; Birnbaum, D; Theillet, C				Bertucci, F.; Orsetti, B.; Negre, V.; Finetti, P.; Rouge, C.; Ahomadegbe, J-C; Bibeau, F.; Mathieu, M-C; Treilleux, I.; Jacquemier, J.; Ursule, L.; Martinec, A.; Wang, Q.; Benard, J.; Puisieux, A.; Birnbaum, D.; Theillet, C.			Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles	ONCOGENE			English	Article						breast cancer; DNA microarray; genetic profiles; array-CGH	MICROARRAY ANALYSIS; CANCER; PATTERNS; HYBRIDIZATION; DIFFERENTIATION; IDENTIFICATION; ASSOCIATION; SUBCLASSES; SURVIVAL; SUBTYPES	Invasive ductal carcinomas (IDCs) and invasive lobular carcinomas (ILCs) are the two major pathological types of breast cancer. Epidemiological and histoclinical data suggest biological differences, but little is known about the molecular alterations involved in ILCs. We undertook a comparative large-scale study by both array-compared genomic hybridization and cDNA microarray of a set of 50 breast tumors (21 classic ILCs and 29 IDCs) selected on homogeneous histoclinical criteria. Results were validated on independent tumor sets, as well as by quantitative RT-PCR. ILCs and IDCs presented differences at both the genomic and expression levels with ILCs being less rearranged and heterogeneous than IDCs. Supervised analysis defined a 75-BACs signature discriminating accurately ILCs from IDCs. Expression profiles identified two subgroups of ILCs: typical ILCs (similar to 50%), which were homogeneous and displayed a normal-like molecular pattern, and atypical ILCs, more heterogeneous with features intermediate between ILCs and IDCs. Supervised analysis identified a 75-gene expression signature that discriminated ILCs from IDCs, with many genes involved in cell adhesion, motility, apoptosis, protein folding, extracellular matrix and protein phosphorylation. Although ILCs and IDCs share common alterations, our data show that ILCs and IDCs could be distinguished on the basis of their genomic and expression profiles suggesting that they evolve along distinct genetic pathways.	[Bertucci, F.; Finetti, P.; Jacquemier, J.; Birnbaum, D.] Inst J Paoli I Calmettes, Ctr Cancerol Marseille, INSERM, UMR891, F-13009 Marseille, France; [Orsetti, B.; Negre, V.; Rouge, C.; Bibeau, F.; Ursule, L.; Theillet, C.] INSERM, CRLC Val Aurelle Paul Lamarque, IRCM, U896, F-34298 Montpellier 5, France; [Ahomadegbe, J-C] Univ Paris 11, UPRES 3535, Inst Gustave Roussy, Villejuif, France; [Bibeau, F.] CRLC Val Aurelle Paul Larmarque, Lab Anatomopathol, Montpellier, France; [Mathieu, M-C] Inst Gustave Roussy, Dept Biopathol, Villejuif, France; [Treilleux, I.] Ctr Leon Berard, Lab Anatomopathol, F-69373 Lyon, France; [Martinec, A.] Ipsogen SA, Marseille Luminy, France; [Wang, Q.; Puisieux, A.] Ctr Leon Berard, Oncol Mol Lab, F-69373 Lyon, France; [Benard, J.] CNRS, Inst Gustave Roussy, UMR 8126, Villejuif, France; [Puisieux, A.] Ctr Leon Berard, INSERM, U590, F-69373 Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut Paoli-Calmette (IPC); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); UNICANCER; Gustave Roussy; UNICANCER; Centre Leon Berard; UNICANCER; Centre Leon Berard; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard	Theillet, C (corresponding author), INSERM, CRLC Val Aurelle Paul Lamarque, IRCM, U896, Rue Croix Verte, F-34298 Montpellier 5, France.	theillet@valdorel.fnclcc.fr	Theillet, Charles/O-7634-2018; Finetti, Pascal/O-8669-2017	Finetti, Pascal/0000-0002-2674-3123; Birnbaum, Daniel/0000-0001-7920-9883; Theillet, Charles/0000-0001-5555-2759; PUISIEUX, Alain/0000-0002-9938-3798; Bertucci, Francois/0000-0002-0157-0959	INSERM; Association de Recherche sur le Cancer (ARC) [5102]; Institut National du Cancer; Canceropoles PACA; Grand Sud Ouest	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association de Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Institut National du Cancer(Institut National du Cancer (INCA) France); Canceropoles PACA; Grand Sud Ouest	This study was developed as part of a joint program Developpement d'outils de diagnostic moleculaire en Cancerologie: Applications aux cancers du sein' Ministere de l'Enseignement Superieur, de la Recherche et de la Technologie and Federation Nationale des Centres de Lutte Contre le Cancer and was supported by funds from INSERM, the Association de Recherche sur le Cancer (ARC), grant 5102, Institut National du Cancer, Canceropoles PACA and Grand Sud Ouest. The help of the Genopole Montpellier Languedoc-Roussillon is gratefully acknowledged. We thank Pr Dominique Maraninchi and Dr Claude Mawas for setting up this work and Mrs Sophie Tourpin for technical help.	Bertucci F, 2004, ONCOGENE, V23, P2564, DOI 10.1038/sj.onc.1207361; Bertucci F, 2006, OMICS, V10, P429, DOI 10.1089/omi.2006.10.429; Berx G, 1995, EMBO J, V14, P6107, DOI 10.1002/j.1460-2075.1995.tb00301.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Flagiello D, 1998, GENE CHROMOSOME CANC, V23, P300, DOI 10.1002/(SICI)1098-2264(199812)23:4<300::AID-GCC4>3.0.CO;2-N; Fridlyand J, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-96; Gunther K, 2001, J PATHOL, V193, P40, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH745>3.0.CO;2-N; Hicks J, 2006, GENOME RES, V16, P1465, DOI 10.1101/gr.5460106; Jacquemier J, 2005, CANCER RES, V65, P767; Katz A, 2007, LANCET ONCOL, V8, P55, DOI 10.1016/S1470-2045(06)71011-7; Korkola JE, 2003, CANCER RES, V63, P7167; LAMOVEC J, 1991, J SURG ONCOL, V48, P28, DOI 10.1002/jso.2930480106; Li CI, 2003, JAMA-J AM MED ASSOC, V289, P1421, DOI 10.1001/jama.289.11.1421; Loo LWM, 2004, CANCER RES, V64, P8541, DOI 10.1158/0008-5472.CAN-04-1992; Loveday RL, 2000, INT J CANCER, V86, P494, DOI 10.1002/(SICI)1097-0215(20000515)86:4<494::AID-IJC8>3.3.CO;2-F; Orsetti B, 2006, BRIT J CANCER, V95, P1439, DOI 10.1038/sj.bjc.6603433; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; SastreGarau X, 1996, CANCER, V77, P113, DOI 10.1002/(SICI)1097-0142(19960101)77:1<113::AID-CNCR19>3.0.CO;2-8; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stange DE, 2006, CLIN CANCER RES, V12, P345, DOI 10.1158/1078-0432.CCR-05-1633; Toikkanen S, 1997, BRIT J CANCER, V76, P1234, DOI 10.1038/bjc.1997.540; Turashvili G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-55; Zhao HJ, 2004, MOL BIOL CELL, V15, P2523, DOI 10.1091/mbc.E03-11-0786	24	85	87	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP 11	2008	27	40					5359	5372		10.1038/onc.2008.158	http://dx.doi.org/10.1038/onc.2008.158			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	346UW	18490921	Green Submitted, Green Accepted			2022-12-25	WOS:000259096100009
J	Liu, Y; Matthews, KS; Bondos, SE				Liu, Ying; Matthews, Kathleen S.; Bondos, Sarah E.			Multiple intrinsically disordered sequences alter DNA binding by the homeodomain of the Drosophila Hox protein Ultrabithorax	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-COMPOSITION; FUNCTIONAL SPECIFICITY; TRANSCRIPTION FACTORS; LAC REPRESSOR; TARGET GENE; IN-VITRO; EXTRADENTICLE; RECOGNITION; EVOLUTION; BODY	During animal development, distinct tissues, organs, and appendages are specified through differential gene transcription by Hox transcription factors. However, the conserved Hox homeodomains bind DNA with high affinity yet low specificity. We have therefore explored the structure of the Drosophila melanogaster Hox protein Ultrabithorax and the impact of its nonhomeodomain regions on DNA binding properties. Computational and experimental approaches identified several conserved, intrinsically disordered regions outside the homeodomain of Ultrabithorax that impact DNA binding by the homeodomain. Full-length Ultrabithorax bound to target DNA 2.5-fold weaker than its isolated homeodomain. Using N-terminal and C-terminal deletion mutants, we demonstrate that the YPWM region and the disordered microexons (termed the I1 region) inhibit DNA binding similar to 2-fold, whereas the disordered I2 region inhibits homeodomain-DNA interaction a further similar to 40-fold. Binding is restored almost to homeodomain affinity by the mostly disordered N-terminal 174 amino acids (R region) in a length-dependent manner. Both the I2 and R regions contain portions of the activation domain, functionally linking DNA binding and transcription regulation. Given that (i) the I1 region and a portion of the R region alter homeodomain-DNA binding as a function of pH and (ii) an internal deletion within I1 increases Ultrabithorax-DNA affinity, I1 must directly impact homeodomain-DNA interaction energetics. However, I2 appears to indirectly affect DNA binding in a manner countered by the N terminus. The amino acid sequences of I2 and much of the I1 and R regions vary significantly among Ultrabithorax orthologues, potentially diversifying Hox-DNA interactions.	[Bondos, Sarah E.] Texas A& M Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77843 USA; [Liu, Ying; Matthews, Kathleen S.; Bondos, Sarah E.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Rice University	Bondos, SE (corresponding author), Texas A& M Hlth Sci Ctr, Dept Mol & Cellular Med, 258 Reynolds Med Bldg, College Stn, TX 77843 USA.	SEBondos@medicine.tamhsc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022441] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 22441] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Batra-Safferling R, 2006, J BIOL CHEM, V281, P1449, DOI 10.1074/jbc.M505012200; BEACHY PA, 1993, MOL CELL BIOL, V13, P6941, DOI 10.1128/MCB.13.11.6941; Billeter M, 1996, PROG BIOPHYS MOL BIO, V66, P211, DOI 10.1016/S0079-6107(97)00006-0; Bondos SE, 2006, MOL CELL PROTEOMICS, V5, P824, DOI 10.1074/mcp.M500256-MCP200; Bondos SE, 2006, CURR ANAL CHEM, V2, P157, DOI 10.2174/157341106776359140; Bondos SE, 2004, J BIOL CHEM, V279, P26433, DOI 10.1074/jbc.M312842200; Bondos SE, 2003, ANAL BIOCHEM, V316, P223, DOI 10.1016/S0003-2697(03)00059-9; Bondos SE, 2001, CRIT REV EUKAR GENE, V11, P145; Brooks DJ, 2002, MOL CELL PROTEOMICS, V1, P125, DOI 10.1074/mcp.M100001-MCP200; Carr A, 1999, EMBO J, V18, P1598, DOI 10.1093/emboj/18.6.1598; Chan SK, 1996, EMBO J, V15, P2476, DOI 10.1002/j.1460-2075.1996.tb00605.x; CHAN SK, 1994, CELL, V78, P603, DOI 10.1016/0092-8674(94)90525-8; Chang CP, 1997, MOL CELL BIOL, V17, P81, DOI 10.1128/MCB.17.1.81; CREIGHTON TE, 1993, PROTEINS STRUCTURES, P173; Damante G, 1996, EMBO J, V15, P4992, DOI 10.1002/j.1460-2075.1996.tb00879.x; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; DRAGANESCU A, 1995, J MOL BIOL, V250, P595, DOI 10.1006/jmbi.1995.0401; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; EKKER SC, 1994, EMBO J, V13, P3551, DOI 10.1002/j.1460-2075.1994.tb06662.x; EKKER SC, 1991, EMBO J, V10, P1179, DOI 10.1002/j.1460-2075.1991.tb08058.x; Fontana A, 1997, J MOL BIOL, V266, P223, DOI 10.1006/jmbi.1996.0787; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Frazee RW, 2002, J MOL BIOL, V323, P665, DOI 10.1016/S0022-2836(02)00996-8; FURUKUBOTOKUNAGA K, 1993, P NATL ACAD SCI USA, V90, P6360, DOI 10.1073/pnas.90.13.6360; GALANG CK, 1993, MOL CELL BIOL, V13, P4609, DOI 10.1128/MCB.13.8.4609; Galant R, 2002, DEVELOPMENT, V129, P3115; Galant R, 2002, NATURE, V415, P910, DOI 10.1038/nature717; Garvie CW, 2002, J BIOL CHEM, V277, P45529, DOI 10.1074/jbc.M206327200; Gebelein B, 2004, NATURE, V431, P653, DOI 10.1038/nature02946; Gebelein B, 2002, DEV CELL, V3, P487, DOI 10.1016/S1534-5807(02)00257-5; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; Gellon G, 1998, BIOESSAYS, V20, P116, DOI 10.1002/(SICI)1521-1878(199802)20:2<116::AID-BIES4>3.3.CO;2-N; Gianni S, 2003, P NATL ACAD SCI USA, V100, P13286, DOI 10.1073/pnas.1835776100; Graba Y, 1997, BIOESSAYS, V19, P379, DOI 10.1002/bies.950190505; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; Hersh BM, 2005, DEVELOPMENT, V132, P1567, DOI 10.1242/dev.01737; HOEY T, 1988, NATURE, V332, P858, DOI 10.1038/332858a0; HOLMQUIS.B, 1973, BIOCHEMISTRY-US, V12, P4409, DOI 10.1021/bi00746a018; Hubbard S, 2001, PROTEOLYTIC ENZYMES, P248; Hughes CL, 2002, EVOL DEV, V4, P459, DOI 10.1046/j.1525-142X.2002.02034.x; Iakoucheva LM, 2001, PROTEIN SCI, V10, P1353, DOI 10.1110/ps.40101; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; JOHNSON FB, 1992, GENE DEV, V6, P2177, DOI 10.1101/gad.6.11.2177; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Joshi R, 2007, CELL, V131, P530, DOI 10.1016/j.cell.2007.09.024; KALIONIS B, 1993, MECH DEVELOP, V43, P57, DOI 10.1016/0925-4773(93)90023-Q; Karsten R., 1997, BIF FUTURA, V12, P20; KNELLER DG, 1990, J MOL BIOL, V214, P171, DOI 10.1016/0022-2836(90)90154-E; LARONDELEBLANC NA, 2008, GENE DEV, V17, P2060; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Li LK, 1997, BIOCHEMISTRY-US, V36, P7003, DOI 10.1021/bi962966m; Li LK, 1996, BIOCHEMISTRY-US, V35, P9832, DOI 10.1021/bi9606049; Li XL, 1999, DEVELOPMENT, V126, P5581; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Linding R, 2004, J MOL BIOL, V342, P345, DOI 10.1016/j.jmb.2004.06.088; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Lopez AJ, 1996, ROUX ARCH DEV BIOL, V205, P450, DOI 10.1007/BF00377226; LOPEZ AJ, 1991, P NATL ACAD SCI USA, V88, P9924, DOI 10.1073/pnas.88.22.9924; Mann RS, 2000, ANNU REV CELL DEV BI, V16, P243, DOI 10.1146/annurev.cellbio.16.1.243; Mann RS, 1996, TRENDS GENET, V12, P258, DOI 10.1016/0168-9525(96)10026-3; Marshall SA, 2002, J MOL BIOL, V316, P189, DOI 10.1006/jmbi.2001.5326; MASTICK GS, 1995, GENETICS, V139, P349; Merabet S, 2005, TRENDS GENET, V21, P477, DOI 10.1016/j.tig.2005.07.001; Merabet S, 2003, DEV CELL, V4, P761, DOI 10.1016/S1534-5807(03)00126-6; Merabet S, 2007, P NATL ACAD SCI USA, V104, P16946, DOI 10.1073/pnas.0705832104; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Nagi AD, 1997, FOLD DES, V2, P67, DOI 10.1016/S1359-0278(97)00007-2; OGATA RT, 1978, P NATL ACAD SCI USA, V75, P5851, DOI 10.1073/pnas.75.12.5851; Passner JM, 1999, NATURE, V397, P714, DOI 10.1038/17833; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Petukhov M, 1998, J MOL BIOL, V278, P279, DOI 10.1006/jmbi.1998.1682; PLATT T, 1973, J BIOL CHEM, V248, P110; QIAN YQ, 1992, P NATL ACAD SCI USA, V89, P10738, DOI 10.1073/pnas.89.22.10738; Remacle S, 2002, NUCLEIC ACIDS RES, V30, P2663, DOI 10.1093/nar/gkf372; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Romero PR, 2006, P NATL ACAD SCI USA, V103, P8390, DOI 10.1073/pnas.0507916103; Ronshaugen M, 2002, NATURE, V415, P914, DOI 10.1038/nature716; Sen TZ, 2005, BIOINFORMATICS, V21, P2787, DOI 10.1093/bioinformatics/bti408; Shiga Y, 2002, DEVELOPMENT, V129, P3555; Singh GP, 2007, PROTEINS, V68, P602, DOI 10.1002/prot.21497; Steinmetz MO, 1998, EMBO J, V17, P1883, DOI 10.1093/emboj/17.7.1883; SUBRAMANIAM V, 1994, GENETICS, V136, P979; Swint-Kruse L, 2004, METHOD ENZYMOL, V379, P188; Tan XX, 2002, BIOCHEMISTRY-US, V41, P2774, DOI 10.1021/bi011967y; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Tour E, 2005, DEVELOPMENT, V132, P5271, DOI 10.1242/dev.02138; Tourasse NJ, 2000, MOL BIOL EVOL, V17, P656, DOI 10.1093/oxfordjournals.molbev.a026344; TRIEZENBERG SJ, 1995, CURR OPIN GENET DEV, V5, P190, DOI 10.1016/0959-437X(95)80007-7; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Vertessy BG, 1997, PROTEINS, V28, P568, DOI 10.1002/(SICI)1097-0134(199708)28:4<568::AID-PROT10>3.0.CO;2-E; Vigano MA, 1998, MOL CELL BIOL, V18, P6201, DOI 10.1128/MCB.18.11.6201; Walsh CM, 2007, DEVELOPMENT, V134, P3585, DOI 10.1242/dev.009522; Wang H, 2002, J BIOL CHEM, V277, P2225, DOI 10.1074/jbc.M109430200; Weatherbee SD, 1998, GENE DEV, V12, P1474, DOI 10.1101/gad.12.10.1474; WHITE RAH, 1984, CELL, V39, P163, DOI 10.1016/0092-8674(84)90202-2; WHITE SH, 1994, ANNU REV BIOPH BIOM, V23, P407, DOI 10.1146/annurev.bb.23.060194.002203; Xu ZB, 2004, J BIOL CHEM, V279, P50401, DOI 10.1074/jbc.M409216200; ZHANG W, 1994, ONCOGENE, V9, P2513; ZHOU NE, 1992, BIOCHEMISTRY-US, V31, P5739, DOI 10.1021/bi00140a008	99	70	72	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20874	20887		10.1074/jbc.M800375200	http://dx.doi.org/10.1074/jbc.M800375200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18508761	hybrid, Green Published			2022-12-25	WOS:000257746100030
J	Shimada, M; Greer, PA; McMahon, AP; Bouxsein, ML; Schipani, E				Shimada, Masako; Greer, Peter A.; McMahon, Andrew P.; Bouxsein, Mary L.; Schipani, Ernestina			In vivo targeted deletion of calpain small subunit, Capn4, in cells of the osteoblast lineage impairs cell proliferation, differentiation, and bone formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-RELATED PEPTIDE; C-FOS EXPRESSION; PARATHYROID-HORMONE; BINDING PROTEIN; TRABECULAR BONE; GROWTH; MOUSE; MICE; RECEPTOR; SYSTEM	Calpains are intracellular cysteine proteases, which include widely expressed mu- and m-calpains (1). Both mu-calpains and m-calpains are heterodimers consisting of a large catalytic subunit and a small regulatory subunit. The calpain small subunit encoded by the gene Capn4 directly binds to the intracellular C-terminal tail (C-tail) of the receptor for parathyroid hormone and parathyroid hormone-related peptide and modulates its cellular functions in osteoblasts in vitro (2). To investigate a potential role of the calpain small subunit in osteoblasts in vivo, we generated osteoblast-specific Capn4 knock-out mice using the Cre-LoxP system (3). Mutant mice had smaller bodies with shorter limbs, reduced trabecular bone with thinner cortices, and decreased osteoblast number. In vitro analysis confirmed that deletion of Capn4 in osteoblasts severely affected multiple osteoblast functions including proliferation, differentiation, and matrix mineralization. Collectively, our findings provide the first in vivo demonstration that the calpain small subunit is essential for proper osteoblast activity and bone remodeling.	[Shimada, Masako; Schipani, Ernestina] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Shimada, Masako; Schipani, Ernestina] Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA; [Greer, Peter A.] Queens Univ, Canc Res Inst, Kingston, ON K7L 3N6, Canada; [McMahon, Andrew P.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Bouxsein, Mary L.] Beth Israel Deaconess Med Ctr, Orthopaed Biomech Lab, Boston, MA 02215 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Queens University - Canada; Harvard University; Harvard University; Beth Israel Deaconess Medical Center	Shimada, M (corresponding author), Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA.	shimada@helix.mgh.harvard.edu	McMahon, Andrew P/ABE-7520-2020		NCRR NIH HHS [S10 RR017868] Funding Source: Medline; NIDDK NIH HHS [R01 DK072102, R01 DK 72102] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072102] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahdjoudj S, 2005, EXP CELL RES, V303, P138, DOI 10.1016/j.yexcr.2004.09.013; Arthur JSC, 2000, MOL CELL BIOL, V20, P4474, DOI 10.1128/MCB.20.12.4474-4481.2000; Arthur JSC, 1998, BBA-PROTEIN STRUCT M, V1388, P247, DOI 10.1016/S0167-4838(98)00166-6; Bouxsein ML, 2005, J BONE MINER RES, V20, P1085, DOI 10.1359/JBMR.050307; Bouxsein ML, 2005, J BONE MINER RES, V20, P635, DOI 10.1359/JBMR.041204; Calvi LM, 2001, J CLIN INVEST, V107, P277, DOI 10.1172/JCI11296; Carragher NO, 2002, MOL CELL BIOL, V22, P257, DOI 10.1128/MCB.22.1.257-269.2002; CAUBET JF, 1988, BIOL CELL, V64, P101, DOI 10.1016/0248-4900(88)90100-1; Choi YH, 1997, J BIOL CHEM, V272, P28479, DOI 10.1074/jbc.272.45.28479; CONG JY, 1989, J BIOL CHEM, V264, P10096; Demiralp B, 2002, ENDOCRINOLOGY, V143, P4038, DOI 10.1210/en.2002-220221; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gori F, 2001, J BIOL CHEM, V276, P46515, DOI 10.1074/jbc.M105757200; Kronenberg HM, 1998, RECENT PROG HORM RES, V53, P283; Lee K, 1996, ENDOCRINOLOGY, V137, P5109, DOI 10.1210/en.137.11.5109; LEE K, 1994, ENDOCRINOLOGY, V134, P441, DOI 10.1210/en.134.1.441; Liu XM, 2007, P NATL ACAD SCI USA, V104, P2259, DOI 10.1073/pnas.0604153104; Marzia M, 2006, J BIOL CHEM, V281, P9745, DOI 10.1074/jbc.M513516200; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; MURRAY EJB, 1994, EXP CELL RES, V215, P241, DOI 10.1006/excr.1994.1339; Murray EJB, 1997, METABOLISM, V46, P1090, DOI 10.1016/S0026-0495(97)90284-5; Murray SS, 1997, EXP CELL RES, V233, P297, DOI 10.1006/excr.1997.3550; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Okahashi N, 2004, INFECT IMMUN, V72, P1706, DOI 10.1128/IAI.72.3.1706-1714.2004; Pearman AT, 1996, J BIOL CHEM, V271, P25715, DOI 10.1074/jbc.271.41.25715; Pfander D, 2004, DEVELOPMENT, V131, P2497, DOI 10.1242/dev.01138; REEVE J, 1976, LANCET, V1, P1035; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Schipani Ernestina, 2003, Birth Defects Research, V69, P352, DOI 10.1002/bdrc.10028; Shimada M, 2005, ENDOCRINOLOGY, V146, P2336, DOI 10.1210/en.2004-1637; SHIMADA M, 1993, J BIOL CHEM, V268, P17924; STERNBERG N, 1981, J MOL BIOL, V150, P467, DOI 10.1016/0022-2836(81)90375-2; Tan Y, 2006, GENESIS, V44, P297, DOI 10.1002/dvg.20216; TRAM KKT, 1993, KIDNEY INT, V43, P693, DOI 10.1038/ki.1993.99; TRAM KKT, 1993, BIOCHEM MOL BIOL INT, V29, P981; Tyson DR, 1999, ENDOCRINOLOGY, V140, P1255, DOI 10.1210/en.140.3.1255; Zhang WL, 1997, ONCOGENE, V14, P255, DOI 10.1038/sj.onc.1200841; Zimmerman UJP, 2000, IUBMB LIFE, V50, P63	39	34	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21002	21010		10.1074/jbc.M710354200	http://dx.doi.org/10.1074/jbc.M710354200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18515801	hybrid, Green Published			2022-12-25	WOS:000257746100042
J	Tran, AX; Trent, MS; Whitfield, C				Tran, An X.; Trent, M. Stephen; Whitfield, Chris			The LptA protein of Escherichia coli is a periplasmic lipid a-binding protein involved in the lipopolysaccharide export pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL OUTER-MEMBRANE; CELL-ENVELOPE BIOGENESIS; GRAM-NEGATIVE BACTERIA; SALMONELLA-TYPHIMURIUM; POLYACRYLAMIDE GELS; INNER-MEMBRANE; MSBA; IDENTIFICATION; BIOSYNTHESIS; TRANSPORT	The LptA protein of Escherichia coli has been implicated in the transport of lipopolysaccharide (LPS) from the inner membrane to the outer membrane. Here we provide evidence that LptA binds structurally diverse LPS substrates in vitro and demonstrate that it interacts specifically with the lipid A domain of LPS. These results are consistent with LptA playing a chaperone role in the transport of LPS across the periplasm and have implications for possible assembly models.	[Tran, An X.; Whitfield, Chris] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Trent, M. Stephen] Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA	University of Guelph; University System of Georgia; Augusta University	Whitfield, C (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	cwhitfie@uoguelph.ca			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064184, R01AI076322] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI 076322, R01 AI076322-01, R01 AI 064184, R01 AI064184, R01 AI076322, R01 AI064184-02] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		APEL D, 2007, BIOCH BIOPH IN PRESS; Basu SS, 1999, J BIOL CHEM, V274, P11139, DOI 10.1074/jbc.274.16.11139; BAYER ME, 1968, J GEN MICROBIOL, V53, P395, DOI 10.1099/00221287-53-3-395; BELUNIS CJ, 1992, J BIOL CHEM, V267, P9988; BINOTTO J, 1991, CAN J MICROBIOL, V37, P474, DOI 10.1139/m91-078; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Braun M, 2002, MOL MICROBIOL, V45, P1289, DOI 10.1046/j.1365-2958.2002.03091.x; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Clementz T, 1996, J BIOL CHEM, V271, P12095, DOI 10.1074/jbc.271.20.12095; Clementz T, 1997, J BIOL CHEM, V272, P10353; Collins RF, 2007, P NATL ACAD SCI USA, V104, P2390, DOI 10.1073/pnas.0607763104; Cronan JE, 2003, ANNU REV MICROBIOL, V57, P203, DOI 10.1146/annurev.micro.57.030502.090851; Cuthbertson L, 2007, P NATL ACAD SCI USA, V104, P19529, DOI 10.1073/pnas.0705709104; Doerrler WT, 2006, MOL MICROBIOL, V60, P542, DOI 10.1111/j.1365-2958.2006.05130.x; Doerrler WT, 2004, J BIOL CHEM, V279, P45102, DOI 10.1074/jbc.M408106200; Doerrler WT, 2002, J BIOL CHEM, V277, P36697, DOI 10.1074/jbc.M205857200; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Eswaran J, 2004, CURR OPIN STRUC BIOL, V14, P741, DOI 10.1016/j.sbi.2004.10.003; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Ghosh AS, 2005, J BACTERIOL, V187, P1913, DOI 10.1128/JB.187.6.1913-1922.2005; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; KELLENBERGER E, 1990, MOL MICROBIOL, V4, P697, DOI 10.1111/j.1365-2958.1990.tb00640.x; Koronakis V, 2004, ANNU REV BIOCHEM, V73, P467, DOI 10.1146/annurev.biochem.73.011303.074104; KUNZ DA, 1981, J BACTERIOL, V146, P179, DOI 10.1128/JB.146.1.179-191.1981; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIU D, 1994, MICROBIOL-UK, V140, P49, DOI 10.1099/13500872-140-1-49; Mamat U, 2008, MOL MICROBIOL, V67, P633, DOI 10.1111/j.1365-2958.2007.06074.x; Meredith TC, 2006, ACS CHEM BIOL, V1, P33, DOI 10.1021/cb0500015; MUHLRADT PF, 1973, EUR J BIOCHEM, V35, P471, DOI 10.1111/j.1432-1033.1973.tb02861.x; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Polissi A, 1996, MOL MICROBIOL, V20, P1221, DOI 10.1111/j.1365-2958.1996.tb02642.x; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; RAETZ CRH, 1990, J BIOL CHEM, V265, P1235; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Reynolds CM, 2005, J BIOL CHEM, V280, P21202, DOI 10.1074/jbc.M500964200; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; Ruiz N, 2008, P NATL ACAD SCI USA, V105, P5537, DOI 10.1073/pnas.0801196105; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SPERANDEO P, 2008, J BACTERIOL IN PRESS; Sperandeo P, 2007, J BACTERIOL, V189, P244, DOI 10.1128/JB.01126-06; Sperandeo P, 2006, RES MICROBIOL, V157, P547, DOI 10.1016/j.resmic.2005.11.014; Taniguchi N, 2005, J BIOL CHEM, V280, P34481, DOI 10.1074/jbc.M507388200; Taniguchi N, 2008, J BIOL CHEM, V283, P8538, DOI 10.1074/jbc.M800026200; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Tefsen B, 2005, J BIOL CHEM, V280, P35961, DOI 10.1074/jbc.M509026200; Tefsen B, 2005, J BIOL CHEM, V280, P4504, DOI 10.1074/jbc.M409259200; Tokuda H, 2004, BBA-MOL CELL RES, V1693, P5, DOI 10.1016/j.bbamcr.2004.02.005; Trent MS, 2006, J ENDOTOXIN RES, V12, P205, DOI 10.1179/096805106X118825; Trent MS, 2001, J BIOL CHEM, V276, P9083, DOI 10.1074/jbc.M010730200; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; WESTPHAL O, 1965, METHODS CARBOHYDR RE, V5, P91; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103	58	66	68	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20342	20349		10.1074/jbc.M802503200	http://dx.doi.org/10.1074/jbc.M802503200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18480051	Green Published, hybrid			2022-12-25	WOS:000257565300050
J	Giudici, C; Raynal, N; Wiedemann, H; Cabral, WA; Marini, JC; Timpl, R; Bachinger, HP; Farndale, RW; Sasaki, T; Tenni, R				Giudici, Camilla; Raynal, Nicolas; Wiedemann, Hanna; Cabral, Wayne A.; Marini, Joan C.; Timpl, Rupert; Baechinger, Hans Peter; Farndale, Richard W.; Sasaki, Takako; Tenni, Ruggero			Mapping of SPARC/BM-40/osteonectin-binding sites on fibrillar collagens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-HELICAL PEPTIDES; VON-WILLEBRAND-FACTOR; MATRIX PROTEIN BM-40; BINDING-SITES; I COLLAGEN; AFFINITY BINDING; STRUCTURAL BASIS; PROCOLLAGEN-I; OSTEOGENESIS IMPERFECTA; DIRECTED MUTAGENESIS	The 33-kDa matrix protein SPARC (BM-40, osteonectin) binds several collagen types with moderate affinity. The collagen-binding site resides in helix alpha A of the extracellular calcium-binding domain of SPARC and is partially masked by helix alpha C. Previously, we found that the removal of helix alpha C caused a 10-fold increase in the affinity of SPARC for collagen, and we identified amino acids crucial for binding by site-directed mutagenesis. In this study, we used rotary shadowing, CNBr peptides, and synthetic peptides to map binding sites of SPARC onto collagens I, II, and III. Rotary shadowing and electron microscopy of SPARC-collagen complexes identified a major binding site similar to 180 nm from the C terminus of collagen. SPARC binding was also detected with lower frequency near the matrix metalloproteinase cleavage site. These data fit well with our analysis of SPARC binding to CNBr peptides, denaturation of which abolished binding, indicating triple-helical conformation of collagen to be essential. SPARC binding was substantially decreased in two of seven alpha 2(I) mutant procollagen I samples and after N-acetylation of Lys/Hyl side chains in wild-type collagen. Synthetic peptides of collagen III were used to locate the binding sites, and we found SPARC binding activity in a synthetic triple-helical peptide containing the sequence GPOGPSGPRGQOGVMGFOGPKGNDGAO (where O indicates 4-hydroxyproline), with affinity for SPARC comparable with that of procollagen III. This sequence is conserved among alpha chains of collagens I, II, III, and V. In vitro collagen fibrillogenesis was delayed in the presence of SPARC, suggesting that SPARC might modulate collagen fibril assembly in vivo.	[Baechinger, Hans Peter; Sasaki, Takako] Shriners Hosp Children, Portland Res Ctr, Portland, OR 97239 USA; [Giudici, Camilla; Wiedemann, Hanna; Sasaki, Takako] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Giudici, Camilla; Tenni, Ruggero] Univ Pavia, Dept Biochem A Castellani, I-27100 Pavia, Italy; [Raynal, Nicolas; Farndale, Richard W.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Cabral, Wayne A.; Marini, Joan C.] NICHD, Bone & Extracellular Matrix Branch, NIH, Bethesda, MD 20892 USA; [Baechinger, Hans Peter; Sasaki, Takako] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Max Planck Society; University of Pavia; University of Cambridge; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Oregon Health & Science University	Sasaki, T (corresponding author), Shriners Hosp Children, Portland Res Ctr, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	txs@shcc.org			Medical Research Council [G0400701] Funding Source: Medline; Wellcome Trust Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000408] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000408] Funding Source: NIH RePORTER; MRC [G0400701] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Altmann F, 1999, GLYCOCONJUGATE J, V16, P109, DOI 10.1023/A:1026488408951; AUMAILLEY M, 1989, EUR J BIOCHEM, V184, P241, DOI 10.1111/j.1432-1033.1989.tb15013.x; Barker TH, 2005, J BIOL CHEM, V280, P36483, DOI 10.1074/jbc.M504663200; Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Bradshaw AD, 2003, J INVEST DERMATOL, V120, P949, DOI 10.1046/j.1523-1747.2003.12241.x; Bradshaw AD, 2002, J HISTOCHEM CYTOCHEM, V50, P1; Bradshaw AD, 2001, J CLIN INVEST, V107, P1049, DOI 10.1172/JCI12939; Brekken Rolf A., 2001, Matrix Biology, V19, P816; Brodsky B, 1995, FASEB J, V9, P1537, DOI 10.1096/fasebj.9.15.8529832; BROWM JC, 1995, INT ARCH ALLERGY IMM, V107, P484, DOI 10.1159/000237090; Delany AM, 2003, ENDOCRINOLOGY, V144, P2588, DOI 10.1210/en.2002-221044; Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; ENGEL J, 1994, METHOD ENZYMOL, V245, P469; FERTALA A, 1994, BIOCHEM J, V298, P31, DOI 10.1042/bj2980031; Forlino A, 1998, MATRIX BIOL, V17, P575, DOI 10.1016/S0945-053X(98)90109-3; Gara SK, 2008, J BIOL CHEM, V283, P10658, DOI 10.1074/jbc.M709540200; Gilmour DT, 1998, EMBO J, V17, P1860, DOI 10.1093/emboj/17.7.1860; GIRARD JP, 1995, IMMUNITY, V2, P113, DOI 10.1016/1074-7613(95)90083-7; Giudici C, 2003, FEBS LETT, V547, P170, DOI 10.1016/S0014-5793(03)00715-4; GUERMAH M, 1991, P NATL ACAD SCI USA, V88, P4503, DOI 10.1073/pnas.88.10.4503; Hohenester E, 1996, NAT STRUCT BIOL, V3, P67, DOI 10.1038/nsb0196-67; Hohenester E, 1997, EMBO J, V16, P3778, DOI 10.1093/emboj/16.13.3778; HOHENESTER E, 2004, HDB METALLOPROTEINS, V3, P509; Horii K, 2006, BLOOD, V108, P936, DOI 10.1182/blood-2006-01-010215; Hosokawa N, 1998, J BIOCHEM-TOKYO, V124, P654, DOI 10.1093/oxfordjournals.jbchem.a022162; Ichikawa O, 2007, EMBO J, V26, P4168, DOI 10.1038/sj.emboj.7601833; JOHNSTON IG, 1990, NEURON, V4, P165, DOI 10.1016/0896-6273(90)90452-L; Kaufmann B, 2004, GLYCOBIOLOGY, V14, P609, DOI 10.1093/glycob/cwh063; KELM RJ, 1991, J BIOL CHEM, V266, P9632; Knauper V, 1996, J BIOL CHEM, V271, P1544, DOI 10.1074/jbc.271.3.1544; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; Konitsiotis AD, 2008, J BIOL CHEM, V283, P6861, DOI 10.1074/jbc.M709290200; KUIVANIEMI H, 1991, FASEB J, V5, P2052, DOI 10.1096/fasebj.5.7.2010058; Leitinger B, 2007, MATRIX BIOL, V26, P146, DOI 10.1016/j.matbio.2006.10.007; LIGHTFOOT SJ, 1992, J BIOL CHEM, V267, P25521; Lisman T, 2006, BLOOD, V108, P3753, DOI 10.1182/blood-2006-03-011965; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; Maurer P, 1997, CELL MOL LIFE SCI, V53, P478, DOI 10.1007/s000180050059; MAURER P, 1995, J MOL BIOL, V253, P347, DOI 10.1006/jmbi.1995.0557; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; NISCHT R, 1991, EUR J BIOCHEM, V200, P529, DOI 10.1111/j.1432-1033.1991.tb16214.x; Norose K, 1998, INVEST OPHTH VIS SCI, V39, P2674; OLSEN BR, 1999, GUIDEBOOK EXTRACELLU, P380; Prockop DJ, 1998, J BIOL CHEM, V273, P15598, DOI 10.1074/jbc.273.25.15598; Raynal N, 2006, J BIOL CHEM, V281, P3821, DOI 10.1074/jbc.M509818200; Rentz TJ, 2007, J BIOL CHEM, V282, P22062, DOI 10.1074/jbc.M700167200; Rossi A, 1996, BIOCHEMISTRY-US, V35, P6048, DOI 10.1021/bi9518151; Rossi A, 1997, J MOL BIOL, V269, P488, DOI 10.1006/jmbi.1997.1046; Sasaki T, 1997, J BIOL CHEM, V272, P9237; Sasaki T, 1998, EMBO J, V17, P1625, DOI 10.1093/emboj/17.6.1625; Sasaki T, 1999, MATRIX BIOL, V18, P499, DOI 10.1016/S0945-053X(99)00041-4; Shah NK, 1996, BIOCHEMISTRY-US, V35, P10262, DOI 10.1021/bi960046y; Siljander PRM, 2004, J BIOL CHEM, V279, P47763, DOI 10.1074/jbc.M404685200; Sullivan MM, 2006, J BIOL CHEM, V281, P27621, DOI 10.1074/jbc.M510507200; Tenni R, 2002, EUR J BIOCHEM, V269, P1428, DOI 10.1046/j.1432-1033.2002.02784.x; Veit G, 2006, J BIOL CHEM, V281, P3494, DOI 10.1074/jbc.M509333200; VOGEL BE, 1988, J BIOL CHEM, V263, P19249; Wang H, 2006, MATRIX BIOL, V25, P20, DOI 10.1016/j.matbio.2005.09.004; Wang H, 2005, ANAL CHEM, V77, P6765, DOI 10.1021/ac051349d; WANG Q, 1993, J BIOL CHEM, V268, P25162; XIE RL, 1995, J BIOL CHEM, V270, P23212, DOI 10.1074/jbc.270.39.23212; Yan Q, 1999, J HISTOCHEM CYTOCHEM, V47, P1495, DOI 10.1177/002215549904701201	63	75	77	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19551	19560		10.1074/jbc.M710001200	http://dx.doi.org/10.1074/jbc.M710001200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18487610	hybrid, Green Published			2022-12-25	WOS:000257387600041
J	Qi, J; Forgac, M				Qi, Jie; Forgac, Michael			Function and subunit interactions of the N-terminal domain of subunit a (Vph1p) of the yeast V-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR H+-ATPASE; MEDIATED CROSS-LINKING; 3-DIMENSIONAL STRUCTURE; MUTATIONAL ANALYSIS; 100-KDA; LOCALIZATION; DISSOCIATION; EXPRESSION; ROTATION; ISOFORMS	The vacuolar (H+)-ATPases (V-ATPases) are ATP-dependent proton pumps that operate by a rotary mechanism in which ATP hydrolysis drives rotation of a ring of proteolipid subunits relative to subunit a within the integral V-0 domain. In vivo dissociation of the V-ATPase (an important regulatory mechanism) generates a V-0 domain that does not passively conduct protons. EM analysis indicates that the N-terminal domain of subunit a approaches the rotary subunits in free V-0, suggesting a possible mechanism of silencing passive proton transport. To test the hypothesis that the N-terminal domain inhibits passive proton flux by preventing rotation of the proteolipid ring in free V-0, factor Xa cleavage sites were introduced between the N- and C-terminal domains of subunit a (the Vph1p isoform in yeast) to allow its removal in vitro after isolation of vacuolar membranes. The mutant Vph1p gave rise to a partially uncoupled V-ATPase complex. Cleavage with factor Xa led to further loss of coupling of proton transport and ATP hydrolysis. Removal of the N-terminal domain by cleavage with factor Xa and treatment with KNO3 and MgATP did not, however, lead to an increase in passive proton conductance by free V-0, suggesting that removal of the N-terminal domain is not sufficient to facilitate passive proton conductance through V-0. Photoactivated cross-linking using the cysteine reagent maleimido benzophenone and single cysteine mutants of subunit a demonstrated the proximity of specific sites within the N-terminal domain and subunits E and G of the peripheral stalk. These results suggest that a localized region of the N-terminal domain (residues 347-369) is important in anchoring the peripheral stator in V1V0.	[Qi, Jie; Forgac, Michael] Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA	Tufts University	Forgac, M (corresponding author), Tufts Univ, Sch Med, Dept Physiol, 136 Harrison Ave, Boston, MA 02111 USA.	Michael.forgac@tufts.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034478, R01GM034478] Funding Source: NIH RePORTER; NIDDK NIH HHS [P30 DK034928, DK34928] Funding Source: Medline; NIGMS NIH HHS [R01 GM034478, GM34478, R37 GM034478] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADACHI I, 1990, J BIOL CHEM, V265, P960; Arata Y, 2002, BIOCHEMISTRY-US, V41, P11301, DOI 10.1021/bi0262449; Arata Y, 2002, J BIOL CHEM, V277, P3357, DOI 10.1074/jbc.M109967200; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Cross RL, 2004, FEBS LETT, V576, P1, DOI 10.1016/j.febslet.2004.08.065; FENG Y, 1992, J BIOL CHEM, V267, P5817; Fillingame RH, 2002, BBA-BIOENERGETICS, V1555, P29, DOI 10.1016/S0005-2728(02)00250-5; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gruenberg J, 2006, NAT REV MOL CELL BIO, V7, P495, DOI 10.1038/nrm1959; Hirata T, 2003, J BIOL CHEM, V278, P23714, DOI 10.1074/jbc.M302756200; Imamizu H, 2003, P NATL ACAD SCI USA, V100, P5461, DOI 10.1073/pnas.0835746100; Inoue T, 2005, J BIOL CHEM, V280, P27896, DOI 10.1074/jbc.M504890200; Iwata M, 2004, P NATL ACAD SCI USA, V101, P59, DOI 10.1073/pnas.0305165101; Jefferies KC, 2008, J BIOL CHEM, V283, P4512, DOI 10.1074/jbc.M707144200; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Kawasaki-Nishi S, 2001, P NATL ACAD SCI USA, V98, P12397, DOI 10.1073/pnas.221291798; Landolt-Marticorena C, 2000, J BIOL CHEM, V275, P15449, DOI 10.1074/jbc.M000207200; Leng XH, 1999, J BIOL CHEM, V274, P14655, DOI 10.1074/jbc.274.21.14655; Liu JZ, 1996, BIOCHEMISTRY-US, V35, P10938, DOI 10.1021/bi9608065; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu M, 2004, J BIOL CHEM, V279, P8732, DOI 10.1074/jbc.M303871200; Lu M, 2007, J BIOL CHEM, V282, P24495, DOI 10.1074/jbc.M702598200; MacLeod KJ, 1998, J BIOL CHEM, V273, P150, DOI 10.1074/jbc.273.1.150; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; MORIYAMA Y, 1992, J EXP BIOL, V172, P171; Nelson N, 2003, J BIOENERG BIOMEMBR, V35, P281, DOI 10.1023/A:1025768529677; Nishi T, 2000, J BIOL CHEM, V275, P6824, DOI 10.1074/jbc.275.10.6824; Parra KJ, 2000, J BIOL CHEM, V275, P21761, DOI 10.1074/jbc.M002305200; Parra KJ, 1996, J BIOL CHEM, V271, P19592, DOI 10.1074/jbc.271.32.19592; Pietrement C, 2006, BIOL REPROD, V74, P185, DOI 10.1095/biolreprod.105.043752; PUOPOLO K, 1992, J BIOL CHEM, V267, P5171; Qi J, 2007, J BIOL CHEM, V282, P24743, DOI 10.1074/jbc.M700663200; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Seol JH, 2001, NAT CELL BIOL, V3, P384, DOI 10.1038/35070067; Shao E, 2004, J BIOL CHEM, V279, P48663, DOI 10.1074/jbc.M408278200; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Smardon AM, 2002, J BIOL CHEM, V277, P13831, DOI 10.1074/jbc.M200682200; Smardon AM, 2007, J BIOL CHEM, V282, P26185, DOI 10.1074/jbc.M703627200; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Vik SB, 2000, BBA-BIOENERGETICS, V1458, P457, DOI 10.1016/S0005-2728(00)00094-3; Voss M, 2007, J BIOL CHEM, V282, P33735, DOI 10.1074/jbc.M703368200; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003; Wilkens S, 2004, J BIOL CHEM, V279, P41942, DOI 10.1074/jbc.M407821200; Wilkens S, 2001, J BIOL CHEM, V276, P44064, DOI 10.1074/jbc.M106579200; Xu T, 2001, J BIOL CHEM, V276, P24855, DOI 10.1074/jbc.M100637200; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509; ZHANG JM, 1992, J BIOL CHEM, V267, P9773	53	34	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19274	19282		10.1074/jbc.M802442200	http://dx.doi.org/10.1074/jbc.M802442200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18492665	hybrid, Green Published			2022-12-25	WOS:000257387600013
J	Dobel, C; Putsche, C; Zwitserlood, P; Junghofer, M				Dobel, Christian; Putsche, Christian; Zwitserlood, Pienie; Junghoefer, Markus			Early Left-Hemispheric Dysfunction of Face Processing in Congenital Prosopagnosia: An MEG Study	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; HUMAN EXTRASTRIATE CORTEX; HUMAN FUSIFORM GYRUS; DEVELOPMENTAL PROSOPAGNOSIA; DETAILED EXPLORATION; INVERTED FACES; IMPAIRED FACE; RECOGNITION; PERCEPTION; BRAIN	Background: Congenital prosopagnosia is a severe face perception impairment which is not acquired by a brain lesion and is presumably present from birth. It manifests mostly by an inability to recognise familiar persons. Electrophysiological research has demonstrated the relevance to face processing of a negative deflection peaking around 170 ms, labelled accordingly as N170 in the electroencephalogram (EEG) and M170 in magnetoencephalography (MEG). The M170 was shown to be sensitive to the inversion of faces and to familiarity-two factors that are assumed to be crucial for congenital prosopagnosia. In order to locate the cognitive dysfunction and its neural correlates, we investigated the time course of neural activity in response to these manipulations. Methodology: Seven individuals with congenital prosopagnosia and seven matched controls participated in the experiment. To explore brain activity with high accuracy in time, we recorded evoked magnetic fields (275 channel whole head MEG) while participants were looking at faces differing in familiarity (famous vs. unknown) and orientation (upright vs. inverted). The underlying neural sources were estimated by means of the least square minimum-norm-estimation (L2-MNE) approach. Principal Findings: The behavioural data corroborate earlier findings on impaired configural processing in congenital prosopagnosia. For the M170, the overall results replicated earlier findings, with larger occipito-temporal brain responses to inverted than upright faces, and more right-than left-hemispheric activity. Compared to controls, participants with congenital prosopagnosia displayed a general decrease in brain activity, primarily over left occipitotemporal areas. This attenuation did not interact with familiarity or orientation. Conclusions: The study substantiates the finding of an early involvement of the left hemisphere in symptoms of prosopagnosia. This might be related to an efficient and overused featural processing strategy which serves as a compensation of impaired configural processing.	[Dobel, Christian; Putsche, Christian; Zwitserlood, Pienie; Junghoefer, Markus] Munster Univ Hosp, Inst Biomagnetism & Biosignalanal, Munster, Germany; [Dobel, Christian; Putsche, Christian; Zwitserlood, Pienie; Junghoefer, Markus] Westfalische Wilhelms Univ Munster, Otto Creutzfeldt Ctr, Munster, Germany; [Zwitserlood, Pienie] Westfalische Wilhelms Univ Munster, Dept Psychol, Munster, Germany	University of Munster; University of Munster; University of Munster	Dobel, C (corresponding author), Munster Univ Hosp, Inst Biomagnetism & Biosignalanal, Munster, Germany.	cdobel@uni-muenster.de	Junghoefer, Markus/AAA-2892-2021	Junghoefer, Markus/0000-0002-8532-2986				Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; Avidan G, 2005, J COGNITIVE NEUROSCI, V17, P1150, DOI 10.1162/0898929054475145; Barton JJS, 2004, BRAIN, V127, P1706, DOI 10.1093/brain/awh194; Behrmann M, 2005, J COGNITIVE NEUROSCI, V17, P1130, DOI 10.1162/0898929054475154; Behrmann M, 2005, TRENDS COGN SCI, V9, P180, DOI 10.1016/j.tics.2005.02.011; Behrmann M, 2007, CEREB CORTEX, V17, P2354, DOI 10.1093/cercor/bhl144; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bentin S, 1999, NEUROREPORT, V10, P823, DOI 10.1097/00001756-199903170-00029; Bentin S, 2007, J COGNITIVE NEUROSCI, V19, P132, DOI 10.1162/jocn.2007.19.1.132; Bobes MA, 2004, COGN NEUROPSYCHOL, V21, P691, DOI 10.1080/02643290342000258; BODAMER J, 1947, Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr, V118, P6, DOI 10.1007/BF00352849; Buttle H, 2003, PERCEPT PSYCHOPHYS, V65, P1296, DOI 10.3758/BF03194853; Collishaw SM, 2000, PERCEPTION, V29, P893, DOI 10.1068/p2949; DAMASIO AR, 1982, NEUROLOGY, V32, P331, DOI 10.1212/WNL.32.4.331; DAMASIO AR, 1990, ANNU REV NEUROSCI, V13, P89, DOI 10.1146/annurev.ne.13.030190.000513; de Gelder B, 1998, VISION RES, V38, P2855, DOI 10.1016/S0042-6989(97)00458-6; de Gelder B, 2000, NEUROREPORT, V11, P3145, DOI 10.1097/00001756-200009280-00021; De Haan EHF, 1999, J CLIN EXP NEUROPSYC, V21, P312, DOI 10.1076/jcen.21.3.312.917; Dobel C, 2007, CORTEX, V43, P718, DOI 10.1016/S0010-9452(08)70501-X; Duchaine B, 2005, J COGNITIVE NEUROSCI, V17, P249, DOI 10.1162/0898929053124857; Duchaine BC, 2004, NEURON, V43, P469, DOI 10.1016/j.neuron.2004.08.006; Duchaine BC, 2000, NEUROREPORT, V11, P79, DOI 10.1097/00001756-200001170-00016; Duchaine BC, 2006, COGN NEUROPSYCHOL, V23, P714, DOI 10.1080/02643290500441296; Eimer M, 2000, CLIN NEUROPHYSIOL, V111, P694, DOI 10.1016/S1388-2457(99)00285-0; Eimer M, 1999, NEUROREPORT, V10, P255, DOI 10.1097/00001756-199902050-00010; Farah M.J., 1990, VISUAL AGNOSIA DISOR; FARAH MJ, 1995, NEUROPSYCHOLOGIA, V33, P661, DOI 10.1016/0028-3932(95)00002-K; FARAH MJ, 1995, VISION RES, V35, P2089, DOI 10.1016/0042-6989(94)00273-O; FAST K, FAMOUS FACE IN PRESS; Gauthier I, 1997, VISION RES, V37, P1673, DOI 10.1016/S0042-6989(96)00286-6; Hadjikhani N, 2002, HUM BRAIN MAPP, V16, P176, DOI 10.1002/hbm.10043; Halgren E, 2000, CEREB CORTEX, V10, P69, DOI 10.1093/cercor/10.1.69; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Harris AM, 2005, NEUROPSYCHOLOGIA, V43, P2125, DOI 10.1016/j.neuropsychologia.2005.03.017; Hasson U, 2003, J COGNITIVE NEUROSCI, V15, P419, DOI 10.1162/089892903321593135; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Itier RJ, 2004, NEUROREPORT, V15, P1261, DOI 10.1097/01.wnr.0000127827.73576.d8; Kanwisher N, 2000, NAT NEUROSCI, V3, P759, DOI 10.1038/77664; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kennerknecht I, 2006, AM J MED GENET A, V140A, P1617, DOI 10.1002/ajmg.a.31343; Kloth N, 2006, EUR J NEUROSCI, V24, P3317, DOI 10.1111/j.1460-9568.2006.05211.x; Kress T, 2003, NEUROSCI LETT, V352, P133, DOI 10.1016/j.neulet.2003.08.047; Le Grand R, 2006, BRAIN COGNITION, V61, P139, DOI 10.1016/j.bandc.2005.11.005; Linkenkaer-Hansen K, 1998, NEUROSCI LETT, V253, P147, DOI 10.1016/S0304-3940(98)00586-2; Marotta JJ, 2002, COGN NEUROPSYCHOL, V19, P31, DOI 10.1080/02643290143000079; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; McKone E, 2007, TRENDS COGN SCI, V11, P8, DOI 10.1016/j.tics.2006.11.002; McMullen PA, 2000, NEUROCASE, V6, P403, DOI 10.1080/13554790008402711; MCNEIL JE, 1993, Q J EXP PSYCHOL-A, V46, P1, DOI 10.1080/14640749308401064; Minnebusch DA, 2007, EUR J NEUROSCI, V25, P2234, DOI 10.1111/j.1460-9568.2007.05451.x; Moscovitch M, 1997, J COGNITIVE NEUROSCI, V9, P555, DOI 10.1162/jocn.1997.9.5.555; Righart R, 2007, P NATL ACAD SCI USA, V104, P17234, DOI 10.1073/pnas.0707753104; Robbins R, 2003, COGNITION, V88, P79, DOI 10.1016/S0010-0277(03)00020-9; Rossion B, 2000, NEUROREPORT, V11, P69, DOI 10.1097/00001756-200001170-00014; Rossion B, 2000, J COGNITIVE NEUROSCI, V12, P793, DOI 10.1162/089892900562606; ROSSION B, 2000, BEHAV COGN NEUROSCI, V1, P63; Schweinberger SR, 2004, NEUROREPORT, V15, P1501, DOI 10.1097/01.wnr.0000131675.00319.42; Schweinberger SR, 2003, CORTEX, V39, P9, DOI 10.1016/S0010-9452(08)70071-6; Steeves JKE, 2006, NEUROPSYCHOLOGIA, V44, P594, DOI 10.1016/j.neuropsychologia.2005.06.013; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; TARR MJ, 1989, COGNITIVE PSYCHOL, V21, P233, DOI 10.1016/0010-0285(89)90009-1; THOMPSON P, 1980, PERCEPTION, V9, P483, DOI 10.1068/p090483; van Turennout M, 2003, CEREB CORTEX, V13, P381, DOI 10.1093/cercor/13.4.381; Warrington E, 1992, TESTBATTERIE VISUELL; Watanabe S, 2003, NEUROSCIENCE, V116, P879, DOI 10.1016/S0306-4522(02)00752-2; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474	67	29	32	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2326	10.1371/journal.pone.0002326	http://dx.doi.org/10.1371/journal.pone.0002326			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	396TO	18523592	Green Submitted, Green Published, gold			2022-12-25	WOS:000262614300021
J	Emes, RD; Yang, ZH				Emes, Richard D.; Yang, Ziheng			Duplicated Paralogous Genes Subject to Positive Selection in the Genome of Trypanosoma brucei	PLOS ONE			English	Article								Background: Whole genome studies have highlighted duplicated genes as important substrates for adaptive evolution. We have investigated adaptive evolution in this class of genes in the human parasite Trypanosoma brucei, as indicated by the ratio of non-synonymous (amino-acid changing) to synonymous (amino acid retaining) nucleotide substitution rates. Methodology/Principal Findings: We have identified duplicated genes that are most rapidly evolving in this important human parasite. This is the first attempt to investigate adaptive evolution in this species at the codon level. We identify 109 genes within 23 clusters of paralogous gene expansions to be subject to positive selection. Conclusions/Significance: Genes identified include surface antigens in both the mammalian and insect host life cycle stage suggesting that competitive interaction is not solely with the adaptive immune system of the mammalian host. Also surface transporters related to drug resistance and genes related to developmental progression are detected. We discuss how adaptive evolution of these genes may highlight lineage specific processes essential for parasite survival. We also discuss the implications of adaptive evolution of these targets for parasite biology and control.	[Emes, Richard D.] Keele Univ, Inst Sci & Technol Med, Stoke On Trent, Staffs, England; [Emes, Richard D.; Yang, Ziheng] UCL, Dept Biol, London, England	Keele University; University of London; University College London	Emes, RD (corresponding author), Keele Univ, Inst Sci & Technol Med, Stoke On Trent, Staffs, England.	r.d.emes@hfac.keele.ac.uk	Yang, Ziheng/C-1358-2008; Emes, Richard D/C-5341-2008	Emes, Richard D/0000-0001-6855-5481	MRC UK Bioinformatics Training Fellowship; BBSRC; Medical Research Council [G90/112] Funding Source: researchfish; MRC [G90/112] Funding Source: UKRI	MRC UK Bioinformatics Training Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by an MRC UK Bioinformatics Training Fellowship to RDE, and a BBSRC grant to ZY.	Acosta-Serrano A, 1999, J BIOL CHEM, V274, P29763, DOI 10.1074/jbc.274.42.29763; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anisimova M, 2003, GENETICS, V164, P1229; Anisimova M, 2002, MOL BIOL EVOL, V19, P950, DOI 10.1093/oxfordjournals.molbev.a004152; Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945; Audran R, 2005, INFECT IMMUN, V73, P8017, DOI 10.1128/IAI.73.12.8017-8026.2005; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bieger B, 2000, ACTA CRYSTALLOGR D, V56, P359, DOI 10.1107/S0907444900000287; Bieger B, 2001, EMBO J, V20, P433, DOI 10.1093/emboj/20.3.433; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; de Koning HP, 2001, ACTA TROP, V80, P245, DOI 10.1016/S0001-706X(01)00177-2; de Oliveira T, 2004, GENETICS, V167, P1047, DOI 10.1534/genetics.103.018135; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Emes RD, 2003, HUM MOL GENET, V12, P701, DOI 10.1093/hmg/ddg078; Fitzpatrick DA, 2005, J MOL EVOL, V61, P90, DOI 10.1007/s00239-004-0290-6; FRAIDENRAICH D, 1993, P NATL ACAD SCI USA, V90, P10140, DOI 10.1073/pnas.90.21.10140; Fraidenraich Diego, 1993, Biological Research, V26, P279; Haag J, 1998, MOL BIOCHEM PARASIT, V91, P37, DOI 10.1016/S0166-6851(97)00185-0; Hertz-Fowler C, 2007, TRYPANOSOMES GENOME; Hurles M, 2004, PLOS BIOL, V2, P900, DOI 10.1371/journal.pbio.0020206; Jackson AP, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-26; Joshi PB, 2002, MOL BIOCHEM PARASIT, V120, P33, DOI 10.1016/S0166-6851(01)00432-7; JUKES T H, 1969, P21; Magnusson U, 2004, J BIOL CHEM, V279, P8747, DOI 10.1074/jbc.M311890200; Maser P, 1999, SCIENCE, V285, P242, DOI 10.1126/science.285.5425.242; Matovu E, 2001, MOL BIOCHEM PARASIT, V117, P73, DOI 10.1016/S0166-6851(01)00332-2; McGwire BS, 2003, INFECT IMMUN, V71, P1008, DOI 10.1128/IAI.71.2.1008-1010.2003; Nielsen R, 1998, GENETICS, V148, P929; O'Hara BP, 2000, PROTEIN ENG, V13, P129, DOI 10.1093/protein/13.2.129; Osier FHA, 2007, PARASITE IMMUNOL, V29, P387, DOI 10.1111/j.1365-3024.2007.00951.x; Otto SP, 2002, ADV GENET, V46, P451; PEARL L, 1994, EMBO J, V13, P5810, DOI 10.1002/j.1460-2075.1994.tb06924.x; Polley SD, 2007, J INFECT DIS, V195, P279, DOI 10.1086/509806; Rambaut A, 2004, NAT REV GENET, V5, P52, DOI 10.1038/nrg1246; SACK JS, 1989, J MOL BIOL, V206, P193, DOI 10.1016/0022-2836(89)90532-9; Saul A, 2007, J INFECT DIS, V195, P171, DOI 10.1086/509813; Seebeck T, 2001, INT J PARASITOL, V31, P491, DOI 10.1016/S0020-7519(01)00164-3; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Stevens JR, 2001, ADV PARASIT, V48, P1, DOI 10.1016/S0065-308X(01)48003-1; Suzuki Y, 2004, GENE, V328, P127, DOI 10.1016/j.gene.2003.11.020; Swanson WJ, 2003, MOL BIOL EVOL, V20, P18, DOI 10.1093/oxfordjournals.molbev.a004233; Urwyler S, 2005, PLOS PATHOG, V1, P225, DOI 10.1371/journal.ppat.0010022; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; Wong WSW, 2004, GENETICS, V168, P1041, DOI 10.1534/genetics.104.031153; Yang Z, 2006, COMPUTATIONAL MOL EV, DOI [10.1093/acprof:oso/9780198567028.001.0001, DOI 10.1093/ACPROF:OSO/9780198567028.001.0001]; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; ZIEGELBAUER K, 1992, J BIOL CHEM, V267, P10791	57	27	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2295	10.1371/journal.pone.0002295	http://dx.doi.org/10.1371/journal.pone.0002295			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509460	Green Published, gold, Green Submitted			2022-12-25	WOS:000262268500034
J	Melchior, L; Kivisild, T; Lynnerup, N; Dissing, J				Melchior, Linea; Kivisild, Toomas; Lynnerup, Niels; Dissing, Jorgen			Evidence of Authentic DNA from Danish Viking Age Skeletons Untouched by Humans for 1,000 Years	PLOS ONE			English	Article							MTDNA HAPLOGROUP-X; ANCIENT HUMAN DNA; MITOCHONDRIAL-DNA; MISCODING LESIONS; ENZYMATIC AMPLIFICATION; MOLECULAR-CLONING; HUMAN-POPULATIONS; PHASE-ANALYSIS; HUMAN REMAINS; FOSSIL BONES	Background: Given the relative abundance of modern human DNA and the inherent impossibility for incontestable proof of authenticity, results obtained on ancient human DNA have often been questioned. The widely accepted rules regarding ancient DNA work mainly affect laboratory procedures, however, pre-laboratory contamination occurring during excavation and archaeological-/anthropological handling of human remains as well as rapid degradation of authentic DNA after excavation are major obstacles. Methodology/Principal Findings: We avoided some of these obstacles by analyzing DNA from ten Viking Age subjects that at the time of sampling were untouched by humans for 1,000 years. We removed teeth from the subjects prior to handling by archaeologists and anthropologists using protective equipment. An additional tooth was removed after standard archaeological and anthropological handling. All pre-PCR work was carried out in a "clean-laboratory" dedicated solely to ancient DNA work. Mitochondrial DNA was extracted and overlapping fragments spanning the HVR-1 region as well as diagnostic sites in the coding region were PCR amplified, cloned and sequenced. Consistent results were obtained with the "unhandled" teeth and there was no indication of contamination, while the latter was the case with half of the "handled" teeth. The results allowed the unequivocal assignment of a specific haplotype to each of the subjects, all haplotypes being compatible in their character states with a phylogenetic tree drawn from present day European populations. Several of the haplotypes are either infrequent or have not been observed in modern Scandinavians. The observation of haplogroup I in the present study (<2% in modern Scandinavians) supports our previous findings of a pronounced frequency of this haplogroup in Viking and Iron Age Danes. Conclusion: The present work provides further evidence that retrieval of ancient human DNA is a possible task provided adequate precautions are taken and well-considered sampling is applied.	[Melchior, Linea; Dissing, Jorgen] Univ Copenhagen, Inst Forens Med, Res Lab, Copenhagen, Denmark; [Kivisild, Toomas] Univ Cambridge, Leverhulme Ctr Human Evol Stud, Cambridge, England; [Lynnerup, Niels] Univ Copenhagen, Inst Forensic Med, Lab Biol Anthropol, Copenhagen, Denmark	University of Copenhagen; University of Cambridge; University of Copenhagen	Melchior, L (corresponding author), Univ Copenhagen, Inst Forens Med, Res Lab, Copenhagen, Denmark.	joergen.dissing@forensic.ku.dk	Kivisild, Toomas/P-5889-2017	Kivisild, Toomas/0000-0002-6297-7808	VELUX FOUNDATION	VELUX FOUNDATION(Velux Fonden)	This work was supported by external funding from the VELUX FOUNDATION. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock GJ, 2001, P NATL ACAD SCI USA, V98, P537, DOI 10.1073/pnas.98.2.537; Allard MW, 2002, J FORENSIC SCI, V47, P1215; Andreasson H, 2002, BIOTECHNIQUES, V33, P402, DOI 10.2144/02332rr07; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 2004, AM J HUM GENET, V75, P919, DOI 10.1086/425180; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Behar DM, 2006, AM J HUM GENET, V78, P487, DOI 10.1086/500307; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Brooks S, 1990, HUM EVOL, V5, P227, DOI DOI 10.1007/BF02437238; Brotherton P, 2007, NUCLEIC ACIDS RES, V35, P5717, DOI 10.1093/nar/gkm588; Brown MD, 1998, AM J HUM GENET, V63, P1852, DOI 10.1086/302155; Buikstra J. E., 1994, STANDARDS DATA COLLE; Caramelli D, 2003, P NATL ACAD SCI USA, V100, P6593, DOI 10.1073/pnas.1130343100; Coble MD, 2004, INT J LEGAL MED, V118, P137, DOI 10.1007/s00414-004-0427-6; Cooper A, 2000, SCIENCE, V289, P1139; Di Benedetto G, 2000, EUR J HUM GENET, V8, P669, DOI 10.1038/sj.ejhg.5200514; Dissing J, 2007, FORENSIC SCI INT, V166, P21, DOI 10.1016/j.forsciint.2006.03.020; Gilbert MTP, 2007, NUCLEIC ACIDS RES, V35, P1, DOI 10.1093/nar/gkl483; Gilbert MTR, 2007, AM J PHYS ANTHROPOL, V133, P847, DOI 10.1002/ajpa.20602; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Gilbert MTP, 2003, AM J HUM GENET, V72, P48, DOI 10.1086/345379; Haak W, 2005, SCIENCE, V310, P1016, DOI 10.1126/science.1118725; Handt O, 1996, AM J HUM GENET, V59, P368; Helgason A, 2001, AM J HUM GENET, V68, P723, DOI 10.1086/318785; HIGUCHI R, 1984, NATURE, V312, P282, DOI 10.1038/312282a0; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; ISCAN MY, 1985, J FORENSIC SCI, V30, P853; ISCAN MY, 1984, J FORENSIC SCI, V29, P1094; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kolman CJ, 2000, AM J PHYS ANTHROPOL, V111, P5; Kuch M, 2007, AM J PHYS ANTHROPOL, V132, P594, DOI 10.1002/ajpa.20536; Lalueza-Fox C, 2004, P ROY SOC B-BIOL SCI, V271, P941, DOI 10.1098/rspb.2004.2698; Loogvali EL, 2004, MOL BIOL EVOL, V21, P2012, DOI 10.1093/molbev/msh209; Malmstrom H, 2007, MOL BIOL EVOL, V24, P998, DOI 10.1093/molbev/msm015; Melchior L, 2008, AM J PHYS ANTHROPOL, V135, P206, DOI 10.1002/ajpa.20721; Miles A.E.W., 1963, DENT ANTHR, P191, DOI DOI 10.1016/B978-0-08-009823-4.50015-X; MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263, DOI 10.1101/SQB.1986.051.01.032; PAABO S, 1985, NATURE, V314, P644, DOI 10.1038/314644a0; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; PAABO S, 1989, P NATL ACAD SCI USA, V86, P1939, DOI 10.1073/pnas.86.6.1939; PAABO S, 1985, J ARCHAEOL SCI, V12, P411, DOI 10.1016/0305-4403(85)90002-0; Pakendorf B, 2005, ANNU REV GENOM HUM G, V6, P165, DOI 10.1146/annurev.genom.6.080604.162249; Pruvost M, 2007, P NATL ACAD SCI USA, V104, P739, DOI 10.1073/pnas.0610257104; Rasmussen EM, 2002, FORENSIC SCI INT, V129, P209, DOI 10.1016/S0379-0738(02)00276-1; Reidla M, 2003, AM J HUM GENET, V73, P1178, DOI 10.1086/379380; Richard C, 2007, ANN HUM BIOL, V34, P68, DOI 10.1080/03014460601076098; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; Rudbeck L, 2005, AM J PHYS ANTHROPOL, V128, P424, DOI 10.1002/ajpa.20294; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Salamon M, 2005, P NATL ACAD SCI USA, V102, P13783, DOI 10.1073/pnas.0503718102; Sampietro ML, 2006, MOL BIOL EVOL, V23, P1801, DOI 10.1093/molbev/msl047; Sampietro ML, 2005, ANN HUM GENET, V69, P535, DOI 10.1111/j.1529-8817.2005.00194.x; Smith DG, 1999, AM J PHYS ANTHROPOL, V110, P271, DOI 10.1002/(SICI)1096-8644(199911)110:3<271::AID-AJPA2>3.0.CO;2-C; Topf AL, 2006, MOL BIOL EVOL, V23, P152, DOI 10.1093/molbev/msj013; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Vernesi C, 2004, AM J HUM GENET, V74, P694, DOI 10.1086/383284; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; Willerslev E, 2003, SCIENCE, V300, P791, DOI 10.1126/science.1084114; [No title captured]	61	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2214	10.1371/journal.pone.0002214	http://dx.doi.org/10.1371/journal.pone.0002214			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	391XW	18509537	Green Published, gold, Green Submitted			2022-12-25	WOS:000262268500002
J	Oneda, B; Lods, N; Lottaz, D; Becker-Pauly, C; Stocker, W; Pippin, J; Huguenin, M; Ambort, D; Marti, HP; Sterchi, EE				Oneda, Beatrice; Lods, Nadege; Lottaz, Daniel; Becker-Pauly, Christoph; Stoecker, Walter; Pippin, Jeffrey; Huguenin, Maya; Ambort, Daniel; Marti, Hans-Peter; Sterchi, Erwin E.			Metalloprotease Meprin beta in Rat Kidney: Glomerular Localization and Differential Expression in Glomerulonephritis	PLOS ONE			English	Article								Meprin (EC 3.4.24.18) is an oligomeric metalloendopeptidase found in microvillar membranes of kidney proximal tubular epithelial cells. Here, we present the first report on the expression of meprin beta in rat glomerular epithelial cells and suggest a potential involvement in experimental glomerular disease. We detected meprin beta in glomeruli of immunostained rat kidney sections on the protein level and by quantitative RT-PCR of laser-capture microdissected glomeruli on the mRNA level. Using immuno-gold staining we identified the membrane of podocyte foot processes as the main site of meprin beta expression. The glomerular meprin beta expression pattern was altered in anti-Thy 1.1 and passive Heymann nephritis (PHN). In addition, the meprin beta staining pattern in the latter was reminiscent of immunostaining with the sheep anti-Fx1A antiserum, commonly used in PHN induction. Using Western blot and immunoprecipitation assays we demonstrated that meprin beta is recognized by Fx1A antiserum and may therefore represent an auto-antigen in PHN. In anti-Thy 1.1 glomerulonephritis we observed a striking redistribution of meprin beta in tubular epithelial cells from the apical to the basolateral side and the cytosol. This might point to an involvement of meprin beta in this form of glomerulonephritis.	[Oneda, Beatrice; Lods, Nadege; Lottaz, Daniel; Huguenin, Maya; Ambort, Daniel; Sterchi, Erwin E.] Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland; [Becker-Pauly, Christoph; Stoecker, Walter] Johannes Gutenberg Univ Mainz, Inst Zool, Mainz, Germany; [Pippin, Jeffrey] Univ Washington, Div Nephrol, Seattle, WA USA; [Marti, Hans-Peter] Univ Bern, Div Nephrol Hypertens, Inselspital, Bern, Switzerland	University of Bern; Johannes Gutenberg University of Mainz; University of Washington; University of Washington Seattle; University of Bern	Oneda, B (corresponding author), Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland.	erwin.sterchi@mci.unibe.ch	Stöcker, Walter/AAB-9704-2019; Becker-Pauly, Christoph/B-7569-2011	Stöcker, Walter/0000-0002-1515-6994; 	SNF [3100A0-100772, 3200B0-100429, 3200B0-114054/1]	SNF	This work was supported by grants from the SNF to EES (3100A0-100772) and HPM (No. 3200B0-100429 and 3200B0-114054/1 resp.). The funding bodies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate M, 2003, KIDNEY INT, V63, P764, DOI 10.1046/j.1523-1755.2003.00791.x; Akagi Y, 1996, KIDNEY INT, V50, P148, DOI 10.1038/ki.1996.297; Asanuma K, 2002, KIDNEY INT, V62, P822, DOI 10.1046/j.1523-1755.2002.00539.x; BAKER PJ, 1989, AM J PATHOL, V135, P185; Becker C, 2003, BIOL CHEM, V384, P825, DOI 10.1515/BC.2003.092; Becker-Pauly C, 2007, J INVEST DERMATOL, V127, P1115, DOI 10.1038/sj.jid.5700675; Bertenshaw GP, 2003, J BIOL CHEM, V278, P2522, DOI 10.1074/jbc.M208808200; Bertenshaw GP, 2001, J BIOL CHEM, V276, P13248, DOI 10.1074/jbc.M011414200; Berthier CC, 2006, KIDNEY INT, V69, P358, DOI 10.1038/sj.ki.5000049; BEYNON RJ, 1983, SCIENCE, V219, P1351, DOI 10.1126/science.6338590; Bond JS, 2005, FEBS LETT, V579, P3317, DOI 10.1016/j.febslet.2005.03.045; BOND JS, 1986, CURR TOP CELL REGUL, V28, P263; BOND JS, 1995, PROTEIN SCI, V4, P1247, DOI 10.1002/pro.5560040701; Carmago S, 2002, KIDNEY INT, V61, P959, DOI 10.1046/j.1523-1755.2002.00209.x; Chestukhin A, 1997, J BIOL CHEM, V272, P3153, DOI 10.1074/jbc.272.6.3153; CHOUDRY Y, 1991, BIOCHEM J, V280, P57, DOI 10.1042/bj2800057; CRAIG SS, 1987, AM J PHYSIOL, V253, pC535, DOI 10.1152/ajpcell.1987.253.4.C535; DANSCHER G, 1981, HISTOCHEMISTRY, V71, P81, DOI 10.1007/BF00592572; Duffy MJ, 2003, THROMB HAEMOSTASIS, V89, P622; Eldering JA, 1997, EUR J BIOCHEM, V247, P920, DOI 10.1111/j.1432-1033.1997.00920.x; FARQUHAR MG, 1995, J AM SOC NEPHROL, V6, P35; FLOEGE J, 1991, KIDNEY INT, V40, P477, DOI 10.1038/ki.1991.235; FLOEGE J, 1993, KIDNEY INT, V43, P369, DOI 10.1038/ki.1993.55; Harvey SJ, 2007, AM J PATHOL, V171, P139, DOI 10.2353/ajpath.2007.061116; Hengst JA, 2004, J BIOL CHEM, V279, P34856, DOI 10.1074/jbc.M405774200; Herzog C, 2005, CYTOKINE, V31, P394, DOI 10.1016/j.cyto.2005.06.012; HERZOG C, 2007, KIDNEY INT; HEYMANN W, 1959, P SOC EXP BIOL MED, V100, P660; JOHNSON RJ, 1995, KIDNEY INT, V47, P62, DOI 10.1038/ki.1995.7; KAMATA K, 1985, J IMMUNOL, V135, P2400; KERJASCHKI D, 1987, J EXP MED, V166, P109, DOI 10.1084/jem.166.1.109; KERJASCHKI D, 1983, J EXP MED, V157, P667, DOI 10.1084/jem.157.2.667; Kerjaschki D, 1996, J AM SOC NEPHROL, V7, P2518; Kieran NE, 2003, KIDNEY INT, V64, P480, DOI 10.1046/j.1523-1755.2003.00106.x; Killar L, 1999, ANN NY ACAD SCI, V878, P442, DOI 10.1111/j.1749-6632.1999.tb07701.x; Kohler D, 2000, FEBS LETT, V465, P2, DOI 10.1016/S0014-5793(99)01712-3; Kruse MN, 2004, BIOCHEM J, V378, P383, DOI 10.1042/BJ20031163; Lahdenkari AT, 2004, J AM SOC NEPHROL, V15, P2611, DOI 10.1097/01.ASN.0000139478.03463.D9; LE Q, 1991, AM J PHYSIOL, V260, pF555, DOI 10.1152/ajprenal.1991.260.4.F555; Lottaz D, 1999, EUR J BIOCHEM, V259, P496, DOI 10.1046/j.1432-1327.1999.00071.x; LOVETT DH, 1992, AM J PATHOL, V141, P85; MARTI HP, 1992, BIOCHEM J, V285, P899, DOI 10.1042/bj2850899; MARTI HP, 1994, AM J PATHOL, V144, P82; Martin J, 2001, J AM SOC NEPHROL, V12, P88, DOI 10.1681/ASN.V12188; McMillan JI, 1996, J CLIN INVEST, V97, P1094, DOI 10.1172/JCI118502; Mundel P, 1999, EXP NEPHROL, V7, P160; Norman LP, 2003, MOL CELL BIOL, V23, P1221, DOI 10.1128/MCB.23.4.1221-1230.2003; Rao VH, 2006, AM J PATHOL, V169, P32, DOI 10.2353/ajpath.2006.050896; Ricardo SD, 1996, AM J PHYSIOL-RENAL, V270, pF669, DOI 10.1152/ajprenal.1996.270.4.F669; Sadlier DM, 2004, J BIOL CHEM, V279, P29670, DOI 10.1074/jbc.M313408200; SALANT DJ, 1989, KIDNEY INT, V35, P976, DOI 10.1038/ki.1989.81; Sato T, 1968, J Electron Microsc (Tokyo), V17, P158; Shankland SJ, 1996, KIDNEY INT, V50, P116, DOI 10.1038/ki.1996.294; Steinmann-Niggli K, 1998, J AM SOC NEPHROL, V9, P397; STERCHI EE, 1988, ARCH BIOCHEM BIOPHYS, V265, P105, DOI 10.1016/0003-9861(88)90376-1; STERCHI EE, 1983, J PEDIATR GASTR NUTR, V2, P539, DOI 10.1097/00005176-198302030-00024; STERCHI EE, 1982, CLIN SCI, V62, P557, DOI 10.1042/cs0620557; STERCHI EE, 1988, ARCH BIOCHEM BIOPHYS, V265, P119, DOI 10.1016/0003-9861(88)90377-3; TRACHTMAN H, 1995, BIOCHEM BIOPH RES CO, V208, P498, DOI 10.1006/bbrc.1995.1366; Turck J, 1996, J BIOL CHEM, V271, P15074, DOI 10.1074/jbc.271.25.15074; Villa JP, 2003, BIOCHEM SOC SYMP, V70, P53, DOI 10.1042/bss0700053; Villa JP, 2003, J BIOL CHEM, V278, P42545, DOI 10.1074/jbc.M303718200; Walker PD, 1998, KIDNEY INT, V53, P1673, DOI 10.1046/j.1523-1755.1998.00949.x; Zeisberg M, 2006, PLOS MED, V3, P535, DOI 10.1371/journal.pmed.0030100	64	25	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2278	10.1371/journal.pone.0002278	http://dx.doi.org/10.1371/journal.pone.0002278			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509531	Green Published, gold, Green Accepted			2022-12-25	WOS:000262268500022
J	Tang, F; Liu, W; Zhang, F; Xin, ZT; Wei, MT; Zhang, PH; Yang, H; Ly, H; Cao, WC				Tang, Fang; Liu, Wei; Zhang, Fang; Xin, Zhong-Tao; Wei, Mao-Ti; Zhang, Pan-He; Yang, Hong; Ly, Hinh; Cao, Wu-Chun			IL-12 RB1 Genetic Variants Contribute to Human Susceptibility to Severe Acute Respiratory Syndrome Infection among Chinese	PLOS ONE			English	Article								Background: Cytokines play important roles in antiviral action. We examined whether polymorphisms of interleukin (IL)-12 receptor B1 (IL-12RB1) affect the susceptibility to and outcome of severe acute respiratory syndrome (SARS). Methods: A case-control study was carried out in Chinese SARS patients and healthy controls. The genotypes of 4SNPs on IL-12 RB1 gene, +705A/G,+1158T/C, +1196G/C and +1664 C/T, were determined by PCR-RFLP. Haplotypes were estimated from the genotype data using the expectation-maximisation algorithm. Results: Comparison between patients and close contacts showed that individuals with the +1664 C/T (CT and TT) genotype had a 2.09-fold (95% confidence interval [CI], 1.90-7.16) and 2.34-fold (95% CI, 1.79-13.37) increased risk of developing SARS, respectively. For any of the other three polymorphisms, however, no significant difference can be detected in allele or genotype frequencies between patients and controls. Additionally, estimation of the frequencies of multiple-locus haplotypes revealed potential risk haplotypes (GCCT) for SARS infection. Conclusions: Our data indicate that genetic variants of IL12RB1 confer genetic susceptibility to SARS infection, but not necessary associated with the progression of the disease in Chinese population.	[Tang, Fang; Zhang, Fang; Yang, Hong; Cao, Wu-Chun] Beijing Inst Microbiol & Epidemiol, Beijing, Peoples R China; [Liu, Wei; Zhang, Pan-He; Cao, Wu-Chun] State Key Lab Pathogen & Biosecurity, Beijing, Peoples R China; [Xin, Zhong-Tao; Ly, Hinh] Emory Univ, Sch Med, Pathol & Lab Med Dept, Atlanta, GA USA; [Wei, Mao-Ti] Affiliated Hosp APFCP Med Coll, Tianjin, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Emory University	Tang, F (corresponding author), Beijing Inst Microbiol & Epidemiol, Beijing, Peoples R China.	caowc@nic.bmi.ac.cn			National Science Fund for Distinguished Scholars [30725032]; Commission of the European Community [003824]	National Science Fund for Distinguished Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Commission of the European Community(European Commission)	This work was supported by the grants from the National Science Fund for Distinguished Scholars (No. 30725032) and the Commission of the European Community, as part of the project Effective and Acceptable Strategies for the Control of SARS and New Emerging Infections in China and Europe (Contract No. 003824). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Booth CM, 2003, JAMA-J AM MED ASSOC, V289, P2801, DOI 10.1001/jama.289.21.JOC30885; Cameron MJ, 2007, J VIROL, V81, P8692, DOI 10.1128/JVI.00527-07; Caragol I, 2003, CLIN INFECT DIS, V37, P302, DOI 10.1086/375587; Chan JWM, 2003, THORAX, V58, P686, DOI 10.1136/thorax.58.8.686; Chan KYK, 2007, J INFECT DIS, V196, P271, DOI 10.1086/518892; Chiu RWK, 2004, CLIN CHEM, V50, P1683, DOI 10.1373/clinchem.2004.035436; Chong WP, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-82; CHUA AO, 1994, J IMMUNOL, V153, P128; Dorman SE, 2000, CYTOKINE GROWTH F R, V11, P321, DOI 10.1016/S1359-6101(00)00010-1; Fieschi C, 2003, J EXP MED, V197, P527, DOI 10.1084/jem.20021769; He J, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-106; Ip WKE, 2005, J INFECT DIS, V191, P1697, DOI 10.1086/429631; Itoyama S, 2005, AM J MED GENET A, V136A, P52, DOI 10.1002/ajmg.a.30779; Itoyama S, 2004, BIOCHEM BIOPH RES CO, V323, P1124, DOI 10.1016/j.bbrc.2004.08.208; KENNEDY MK, 1994, EUR J IMMUNOL, V24, P2271, DOI 10.1002/eji.1830241002; Lau YL, 2005, CURR OPIN IMMUNOL, V17, P404, DOI 10.1016/j.coi.2005.05.009; Leal SM, 2005, GENET EPIDEMIOL, V29, P204, DOI 10.1002/gepi.20086; Lee HW, 2005, RESPIRATION, V72, P365, DOI 10.1159/000086249; MANETTI R, 1994, J EXP MED, V179, P1273, DOI 10.1084/jem.179.4.1273; Ng MW, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-50; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Peiris JSM, 2004, NAT MED, V10, pS88, DOI 10.1038/nm1143; Presky DH, 1995, RES IMMUNOL, V146, P439, DOI 10.1016/0923-2494(96)83013-6; Sakai T, 2001, BLOOD, V97, P2688, DOI 10.1182/blood.V97.9.2688; Staretz-Haham O, 2003, CLIN INFECT DIS, V37, P137, DOI 10.1086/375229; Trinchieri G, 1998, Int Rev Immunol, V16, P365, DOI 10.3109/08830189809043002; Van Reeth K, 2002, VET IMMUNOL IMMUNOP, V87, P161, DOI 10.1016/S0165-2427(02)00047-8; *WHO, 2003, CAS DEF SURV SEV RES; Wong CK, 2004, CLIN EXP IMMUNOL, V136, P95, DOI 10.1111/j.1365-2249.2004.02415.x; Zhang HX, 2005, J INFECT DIS, V192, P1355, DOI 10.1086/491479	30	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2183	10.1371/journal.pone.0002183	http://dx.doi.org/10.1371/journal.pone.0002183			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478121	Green Published, gold, Green Submitted			2022-12-25	WOS:000262172800048
J	Thomas, ML; Simmons, LW				Thomas, Melissa L.; Simmons, Leigh W.			Rival Male Relatedness Does Not Affect Ejaculate Allocation as Predicted by Sperm Competition Theory	PLOS ONE			English	Article							MALE CRICKETS ADJUST; OLFACTORY MEMORY; KIN RECOGNITION; EVOLUTION; SELF; VIABILITY; QUALITY; NUMBERS; CUES	When females are sexually promiscuous, the intensity of sperm competition for males depends on how many partners females mate with. To maximize fitness, males should adjust their copulatory investment in relation to this intensity. However, fitness costs associated with sperm competition may not only depend on how many males a female has mated with, but also how related rival males are. According to theoretical predictions, males should adjust their copulatory investment in response to the relatedness of their male rival, and transfer more sperm to females that have first mated with a non-sibling male than females that have mated to a related male. Here, for the first time, we empirically test this theory using the Australian field cricket Teleogryllus oceanicus. We expose male crickets to sperm competition from either a full sibling or non-sibling male, by using both the presence of a rival male and the rival male's actual competing ejaculate as cues. Contrary to predictions, we find that males do not adjust ejaculates in response to the relatedness of their male rival. Instead, males with both full-sibling and non-sibling rivals allocate sperm of similar quality to females. This lack of kin biased behaviour is independent of any potentially confounding effect of strong competition between close relatives; kin biased behaviour was absent irrespective of whether males were raised in full sibling or mixed relatedness groups.	[Thomas, Melissa L.; Simmons, Leigh W.] Univ Western Australia, Ctr Evolutionary Biol, Sch Anim Biol, Crawley, Australia	University of Western Australia	Thomas, ML (corresponding author), Univ Western Australia, Ctr Evolutionary Biol, Sch Anim Biol, Crawley, Australia.	mlthomas@cyllene.uwa.edu.au	Simmons, Leigh W/B-1815-2011	Simmons, Leigh W/0000-0003-0562-1474	Australian Research Council; University of Western Australia; West Australian Centres of Excellence in Science and Innovation Program	Australian Research Council(Australian Research Council); University of Western Australia; West Australian Centres of Excellence in Science and Innovation Program	This work was supported by funding from the Australian Research Council, the University of Western Australia, and the West Australian Centres of Excellence in Science and Innovation Program. These organisations had no role except to provide funding.	Bourke A. F., 1995, SOCIAL EVOLUTION ANT; Cameron E, 2007, AM NAT, V169, pE158, DOI 10.1086/516718; Cornwallis CK, 2007, AM NAT, V170, P758, DOI 10.1086/521955; Dunlap WP, 1996, PSYCHOL METHODS, V1, P170, DOI 10.1037/1082-989X.1.2.170; Fellowes MDE, 1998, ECOL ENTOMOL, V23, P223, DOI 10.1046/j.1365-2311.1998.00128.x; Garcia-Gonzalez F, 2005, CURR BIOL, V15, P271, DOI 10.1016/j.cub.2005.01.032; Gardner A, 2007, CURR BIOL, V17, pR810, DOI 10.1016/j.cub.2007.07.030; Griffin AS, 2003, SCIENCE, V302, P634, DOI 10.1126/science.1089402; HALPIN ZT, 1991, KIN RECOGNITION, P220; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hauber ME, 2001, TRENDS NEUROSCI, V24, P609, DOI 10.1016/S0166-2236(00)01916-0; Hedges L.V., 1985, STAT METHODS META AN; Ivy TM, 2005, P ROY SOC B-BIOL SCI, V272, P2475, DOI 10.1098/rspb.2005.3222; Kilgallon SJ, 2005, BIOL LETTERS, V1, P253, DOI 10.1098/rsbl.2005.0324; LACY RC, 1983, AM NAT, V121, P489, DOI 10.1086/284078; MacDiarmid AB, 1999, BEHAV ECOL SOCIOBIOL, V46, P14, DOI 10.1007/s002650050587; Marconato A, 1996, ANIM BEHAV, V52, P971, DOI 10.1006/anbe.1996.0245; Matsumoto Y, 2002, J COMP PHYSIOL A, V188, P295, DOI 10.1007/s00359-002-0303-0; Matsumoto Y, 2006, BIOL LETT-UK, V2, P608, DOI 10.1098/rsbl.2006.0540; Parker GA, 2000, P ROY SOC B-BIOL SCI, V267, P1027, DOI 10.1098/rspb.2000.1106; Poiani A, 2006, BEHAV ECOL SOCIOBIOL, V60, P289, DOI 10.1007/s00265-006-0178-0; REEVE HK, 1989, AM NAT, V133, P407, DOI 10.1086/284926; Rousset F, 2007, EVOLUTION, V61, P2320, DOI 10.1111/j.1558-5646.2007.00191.x; Sherman Paul W., 1997, P69; Simmons L. W., 2001, MG BEH ECOL; Simmons LW, 2007, BIOL LETTERS, V3, P520, DOI 10.1098/rsbl.2007.0328; Simmons LW, 2006, MOL ECOL, V15, P3817, DOI 10.1111/j.1365-294X.2006.03035.x; Simmons LW, 2005, SCIENCE, V310, P1119; SIMMONS LW, 1990, ANIM BEHAV, V40, P192, DOI 10.1016/S0003-3472(05)80683-9; Simmons LW, 2003, BEHAV ECOL, V14, P539, DOI 10.1093/beheco/arg038; Snook RR, 2005, TRENDS ECOL EVOL, V20, P46, DOI 10.1016/j.tree.2004.10.011; Starks PT, 2004, ANN ZOOL FENN, V41, P689; Thomas ML, 2007, AM NAT, V170, P190, DOI 10.1086/519404; THOMAS ML, J EXPT BIOL; Tsutsui ND, 2004, ANN ZOOL FENN, V41, P713; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8; West SA, 2001, NATURE, V409, P510, DOI 10.1038/35054057; West SA, 2002, SCIENCE, V296, P72, DOI 10.1126/science.1065507; Wiens JD, 2006, CONDOR, V108, P253, DOI 10.1093/condor/108.2.253	39	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2151	10.1371/journal.pone.0002151	http://dx.doi.org/10.1371/journal.pone.0002151			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478102	Green Submitted, Green Published, gold			2022-12-25	WOS:000262172800016
J	Dupret, D; Revest, JM; Koehl, M; Ichas, F; De Giorgi, F; Costet, P; Abrous, DN; Piazza, PV				Dupret, David; Revest, Jean-Michel; Koehl, Muriel; Ichas, Francois; De Giorgi, Francesca; Costet, Pierre; Abrous, Djoher Nora; Piazza, Pier Vincenzo			Spatial Relational Memory Requires Hippocampal Adult Neurogenesis	PLOS ONE			English	Article							GENERATED GRANULE CELLS; DENTATE GYRUS; SYNAPTIC PLASTICITY; ENVIRONMENTAL ENRICHMENT; ENHANCES NEUROGENESIS; PATTERN SEPARATION; PLACE NAVIGATION; PROGENITOR CELLS; TRANSGENIC MICE; SWIMMING POOL	The dentate gyrus of the hippocampus is one of the few regions of the mammalian brain where new neurons are generated throughout adulthood. This adult neurogenesis has been proposed as a novel mechanism that mediates spatial memory. However, data showing a causal relationship between neurogenesis and spatial memory are controversial. Here, we developed an inducible transgenic strategy allowing specific ablation of adult-born hippocampal neurons. This resulted in an impairment of spatial relational memory, which supports a capacity for flexible, inferential memory expression. In contrast, less complex forms of spatial knowledge were unaltered. These findings demonstrate that adult-born neurons are necessary for complex forms of hippocampus-mediated learning.	[Dupret, David; Revest, Jean-Michel; Koehl, Muriel; De Giorgi, Francesca; Abrous, Djoher Nora; Piazza, Pier Vincenzo] Inst F Magendie, INSERM, U862, Bordeaux, France; [Dupret, David; Revest, Jean-Michel; Koehl, Muriel; De Giorgi, Francesca; Abrous, Djoher Nora; Piazza, Pier Vincenzo] Univ Bordeaux 2, Bordeaux, France; [Ichas, Francois] Univ Bordeaux 2, Inst Bergonie, INSERM E347, Bordeaux, France; [Costet, Pierre] Univ Bordeaux 2, Lab Transgenese, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UNICANCER; Institut Bergonie; UDICE-French Research Universities; Universite de Bordeaux	Dupret, D (corresponding author), Inst F Magendie, INSERM, U862, Bordeaux, France.	abrous@bordeaux.inserm.fr; piazza@bordeaux.inserm.fr	Koehl, Muriel/C-3698-2011; Koehl, Muriel/ABI-2043-2020; Ichas, François/ABD-8277-2020; Abrous, Nora-Djoher/N-6977-2017	Koehl, Muriel/0000-0002-7601-1422; Koehl, Muriel/0000-0002-7601-1422; Ichas, François/0000-0001-8184-5248; abrous, nora/0000-0002-8589-305X; Dupret, David/0000-0002-0040-1766; De Giorgi, Francesca/0000-0003-4850-3582	INSERM; Agence Nationale pour la Recherche; University of Bordeaux 2	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale pour la Recherche(French National Research Agency (ANR)); University of Bordeaux 2	This work was supported by INSERM, Agence Nationale pour la Recherche (to DNA) and University of Bordeaux 2.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; ABROUS DN, 2007, NEUROGENESI IN PRESS; Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; Ambrogini P, 2000, NEUROSCI LETT, V286, P21, DOI 10.1016/S0304-3940(00)01074-0; Becker S, 2005, HIPPOCAMPUS, V15, P722, DOI 10.1002/hipo.20095; Broadbent NJ, 2006, LEARN MEMORY, V13, P187, DOI 10.1101/lm.134706; Bruel-Jungerman E, 2006, J NEUROSCI, V26, P5888, DOI 10.1523/JNEUROSCI.0782-06.2006; Clark RE, 2005, HIPPOCAMPUS, V15, P340, DOI 10.1002/hipo.20076; De Giorgi F, 2002, FASEB J, V16, P607, DOI 10.1096/fj.01-0269fje; Desmedt A, 1998, J NEUROSCI, V18, P480; Desmedt A, 2003, EUR J NEUROSCI, V17, P1953, DOI 10.1046/j.1460-9568.2003.02615.x; Dobrossy MD, 2003, MOL PSYCHIATR, V8, P974, DOI 10.1038/sj.mp.4001419; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Drapeau E, 2007, J NEUROSCI, V27, P6037, DOI 10.1523/JNEUROSCI.1031-07.2007; Dupret D, 2005, EUR J NEUROSCI, V22, P778, DOI 10.1111/j.1460-9568.2005.04262.x; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; EICHENBAUM H, 1990, J NEUROSCI, V10, P3531; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Fan Y, 2007, EUR J NEUROSCI, V25, P38, DOI 10.1111/j.1460-9568.2006.05269.x; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; GRAY JA, 1983, NEUROSCI BIOBEHAV R, V7, P119, DOI 10.1016/0149-7634(83)90014-3; Hairston IS, 2005, J NEUROPHYSIOL, V94, P4224, DOI 10.1152/jn.00218.2005; HOFMANN SL, 1988, SCIENCE, V239, P1277, DOI 10.1126/science.3344433; Jeltsch H, 2001, NEUROBIOL LEARN MEM, V76, P81, DOI 10.1006/nlme.2000.3986; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kesner RP, 2007, PROG BRAIN RES, V163, P567, DOI 10.1016/S0079-6123(07)63030-1; Kitabatake Y, 2007, NEUROSURG CLIN N AM, V18, P105, DOI 10.1016/j.nec.2006.10.008; Kroll KL, 1996, DEVELOPMENT, V122, P3173; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Laplagne DA, 2006, PLOS BIOL, V4, P2349, DOI 10.1371/journal.pbio.0040409; Lemaire V, 2000, P NATL ACAD SCI USA, V97, P11032, DOI 10.1073/pnas.97.20.11032; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Leuner B, 2006, HIPPOCAMPUS, V16, P216, DOI 10.1002/hipo.20153; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Lindsten T, 2003, J NEUROSCI, V23, P11112; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; MANIER M, 1991, NEUROSCIENCE, V42, P427, DOI 10.1016/0306-4522(91)90386-3; Manns JR, 2007, NEURON, V56, P530, DOI 10.1016/j.neuron.2007.08.017; Martin SJ, 2005, NEUROPSYCHOLOGIA, V43, P609, DOI 10.1016/j.neuropsychologia.2004.07.007; Martin SJ, 2002, HIPPOCAMPUS, V12, P609, DOI 10.1002/hipo.10107; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; Meshi D, 2006, NAT NEUROSCI, V9, P729, DOI 10.1038/nn1696; Mitsuhashi T, 2001, P NATL ACAD SCI USA, V98, P6435, DOI 10.1073/pnas.111051398; Mohapel P, 2005, NEUROBIOL AGING, V26, P939, DOI 10.1016/j.neurobiolaging.2004.07.015; Montaron MF, 2006, NEUROBIOL AGING, V27, P645, DOI 10.1016/j.neurobiolaging.2005.02.014; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Moses SN, 2006, HIPPOCAMPUS, V16, P43, DOI 10.1002/hipo.20131; Nakayama T, 2002, PHARMACOL BIOCHEM BE, V71, P119, DOI 10.1016/S0091-3057(01)00634-7; NANRY KP, 1989, BEHAV BRAIN RES, V35, P45, DOI 10.1016/S0166-4328(89)80007-5; Nixon K, 2004, J NEUROSCI, V24, P9714, DOI 10.1523/JNEUROSCI.3063-04.2004; Nolte C, 2001, GLIA, V33, P72; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Plumpe T, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-77; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Rao MS, 2004, EUR J NEUROSCI, V19, P234, DOI 10.1111/j.0953-816X.2003.03123.x; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Rolls ET, 2006, PROG NEUROBIOL, V79, P1, DOI 10.1016/j.pneurobio.2006.04.005; Rolls ET, 1996, HIPPOCAMPUS, V6, P601, DOI 10.1002/(SICI)1098-1063(1996)6:6<601::AID-HIPO5>3.0.CO;2-J; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Scharfman HE., 2007, DENTATE GYRUS COMPRE; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Shastri L, 2002, TRENDS COGN SCI, V6, P162, DOI 10.1016/S1364-6613(02)01868-5; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Steiner B, 2006, GLIA, V54, P805, DOI 10.1002/glia.20407; Sun W, 2004, J NEUROSCI, V24, P11205, DOI 10.1523/JNEUROSCI.1436-04.2004; SUTHERLAND RJ, 1989, PSYCHOBIOLOGY, V17, P129; SUTHERLAND RJ, 1984, CAN J PSYCHOL, V38, P322, DOI 10.1037/h0080832; Teixeira CM, 2006, J NEUROSCI, V26, P7555, DOI 10.1523/JNEUROSCI.1068-06.2006; TEYLER TJ, 1986, BEHAV NEUROSCI, V100, P147, DOI 10.1037/0735-7044.100.2.147; Truong K, 2001, CURR OPIN STRUC BIOL, V11, P573, DOI 10.1016/S0959-440X(00)00249-9; Wang S, 2000, J NEUROBIOL, V42, P248, DOI 10.1002/(SICI)1097-4695(20000205)42:2<248::AID-NEU8>3.3.CO;2-A; WHISHAW IQ, 1986, J COMP PSYCHOL, V100, P422, DOI 10.1037/0735-7036.100.4.422; Winocur G, 2006, HIPPOCAMPUS, V16, P296, DOI 10.1002/hipo.20163; Wojtowicz JM, 2006, HIPPOCAMPUS, V16, P261, DOI 10.1002/hipo.20158; Xavier GF, 1999, HIPPOCAMPUS, V9, P668, DOI 10.1002/(SICI)1098-1063(1999)9:6<668::AID-HIPO8>3.0.CO;2-9	81	449	462	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2008	3	4							e1959	10.1371/journal.pone.0001959	http://dx.doi.org/10.1371/journal.pone.0001959			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	370XD	18509506	gold, Green Published, Green Submitted			2022-12-25	WOS:000260795500029
J	Ndengele, MM; Cuzzocrea, S; Esposito, E; Mazzon, E; Di Paola, R; Matuschak, GM; Salvemini, D				Ndengele, Michael M.; Cuzzocrea, Salvatore; Esposito, Emanuela; Mazzon, Emanuela; Di Paola, Rosanna; Matuschak, George M.; Salvemini, Daniela			Cyclooxygenases 1 and 2 contribute to peroxynitrite-mediated inflammatory pain hypersensitivity	FASEB JOURNAL			English	Article						superoxide; nitric oxide; PGE2; COX-1; COX-2; hyperalgesia	ASPIRIN-LIKE DRUGS; INDUCED PAW EDEMA; NF-KAPPA-B; NITRIC-OXIDE; PROSTAGLANDIN BIOSYNTHESIS; SUPEROXIDE-DISMUTASE; INDUCED HYPERALGESIA; PROTEIN-KINASE; HAIRY SKIN; RAT	Peroxynitrite (ONOO-), the reaction product of the interaction between superoxide (O2(center dot-)) and nitric oxide (center dot NO), is a potent proinflammatory and cytotoxic nitrooxidative species. Its role as a mediator of hyperalgesia (clinically defined as an augmented sensitivity to painful stimuli) is not known. In light of the known proinflammatory properties of ONOO-, our study addressed its potential involvement in the development of hyperalgesia associated with tissue damage and inflammation. Intraplantar injection in rats of the ONOO- precursor O2(center dot-) (1 mu M) led to the development of thermal hyperalgesia associated with a profound localized inflammatory response. Both events were blocked by L-NAME (N-G-nitro-L-arginine methyl ester, 3-30 mg/kg), a nitric oxide synthase inhibitor, or by FeTM-4-PyP5+ [Fe(III) 5,10,15,20-tetrakis(N-methylpyridinium-4-yl) porphyrin, 3-30 mg/kg], an ONOO- decomposition catalyst. These results suggested that locally synthesized ONOO- produced in situ by O-2(center dot-) and center dot NO is key in the development of inflammatory hyperalgesia. The direct link between ONOO- and hyperalgesia was further supported by demonstrating that intraplantar injection of soluble ONOO- itself ( 1 mu M) similarly led to inflammatory hyperalgesia. ONOO- generated by the interaction between exogenous administration of O2(center dot-) and endogenous center dot NO, or provided by direct injection of ONOO-, activated the transcription factor NF-kappa B in paw tissues, enhancing expression of the inducible but not the constitutive cyclooxygenase enzyme (COX-2 and COX-1, respectively). ONOO--mediated hyperalgesia was blocked in a dose-dependent manner by intraperitoneal injections of indomethacin (10 mg/kg), a nonselective COX-1/COX-2 inhibitor, or NS398 [N-(2-cyclohexyloxy-4-nitrophenyl) methanesulfonamide; 10 mg/kg] a selective COX-2 inhibitor, as well as by an anti-prostaglandin (PG) E-2 antibody (200 mu g). In another established model of inflammation-related hyperalgesia by intraplantar injection of carrageenan in rats, inhibition of ONOO- with FeTM-4-PyP5+ (3-30 mg/kg) inhibited the development of hyperalgesia and the release of PGE(2) in paw tissue exudates. Furthermore, FeTM-4-PyP5+ synergized with indomethacin and NS397 (1-10 together, these data show for the first time that ONOO- is a potent mediator of inflammation-derived hyperalgesia operating via the COX-to-PGE(2) pathway. These results provide a pharmacological rationale for the development of inhibitors of peroxynitrite biosynthesis as novel nonnarcotic analgesics. The broad implications of our study are that dual inhibition of both ONOO- formation and COX activity may provide an alternative therapeutic approach to the management of pain: effective analgesia with reduced side-effects typically associated with the use of COX inhibitors.	[Ndengele, Michael M.; Matuschak, George M.; Salvemini, Daniela] St Louis Univ, Sch Med, Dept Internal Med, Div Pulm Crit Care & Sleep Med, St Louis, MO 63104 USA; [Cuzzocrea, Salvatore] Univ Messina, Sch Med, Dept Clin & Expt Med & Pharmacol, Messina, Italy; [Cuzzocrea, Salvatore; Esposito, Emanuela; Mazzon, Emanuela; Di Paola, Rosanna] IRCCS Ctr Neurolesi Bonino Pulejo, Messina, Italy	Saint Louis University; University of Messina; IRCCS Bonino Pulejo	Salvemini, D (corresponding author), St Louis Univ, Sch Med, Dept Internal Med, Div Pulm Crit Care & Sleep Med, 1402 S Grand Blvd,Deslodge Towers,7th Floor, St Louis, MO 63104 USA.	salvemd@slu.edu	Mazzon, Emanuela/AAL-4334-2020; di paola, rosanna/U-4356-2019	di paola, rosanna/0000-0001-6725-8581; mazzon, emanuela/0000-0002-5073-717X; Esposito, Emanuela/0000-0002-2663-6387				Aley KO, 1998, J NEUROSCI, V18, P7008; Andrew D, 1999, J NEUROPHYSIOL, V82, P2649, DOI 10.1152/jn.1999.82.5.2649; BATINICHABERLE I, 2007, 5 INT C PER REACT NI; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Bethea JR, 1998, J NEUROSCI, V18, P3251; Bezerra MM, 2007, N-S ARCH PHARMACOL, V374, P265, DOI 10.1007/s00210-006-0123-9; Brune K, 1994, Drugs, V47 Suppl 5, P21, DOI 10.2165/00003495-199400475-00005; Buritova J, 1996, BRAIN RES, V715, P217, DOI 10.1016/0006-8993(95)01574-4; Cheng HF, 2006, AM J PHYSIOL-RENAL, V290, pF1391, DOI 10.1152/ajprenal.00315.2005; COLLIER HOJ, 1972, NATURE-NEW BIOL, V236, P141, DOI 10.1038/newbio236141a0; Cuzzocrea S, 2007, KIDNEY INT, V71, P290, DOI 10.1038/sj.ki.5002058; D'Acquisto F, 2000, GENE THER, V7, P1731, DOI 10.1038/sj.gt.3301295; DAVIS KD, 1993, J NEUROPHYSIOL, V69, P1071, DOI 10.1152/jn.1993.69.4.1071; EBLE JN, 1971, NATURE, V231, P181, DOI 10.1038/231181a0; Eligini S, 2001, BRIT J PHARMACOL, V133, P1163, DOI 10.1038/sj.bjp.0704163; Esposito E, 2005, ENDOCRINOLOGY, V146, P3301, DOI 10.1210/en.2005-0375; FERREIRA SH, 1978, PROSTAGLANDINS, V16, P31, DOI 10.1016/0090-6980(78)90199-5; FERREIRA SH, 1972, NATURE-NEW BIOL, V240, P200, DOI 10.1038/newbio240200a0; FUTAKI N, 1993, GEN PHARMACOL, V24, P105, DOI 10.1016/0306-3623(93)90018-S; Gius D, 1999, TOXICOL LETT, V106, P93, DOI 10.1016/S0378-4274(99)00024-7; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; Guay J, 2004, J BIOL CHEM, V279, P24866, DOI 10.1074/jbc.M403106200; Guhring H, 2000, J NEUROSCI, V20, P6714, DOI 10.1523/JNEUROSCI.20-17-06714.2000; Habib A, 1997, J IMMUNOL, V158, P3845; Haddad JJ, 2002, BRIT J PHARMACOL, V135, P520, DOI 10.1038/sj.bjp.0704467; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hirata T, 1997, BRIT J PHARMACOL, V122, P447, DOI 10.1038/sj.bjp.0701399; Ibuki T, 1997, PAIN, V70, P125, DOI 10.1016/S0304-3959(96)03283-6; KHASAR SG, 1995, NEUROSCIENCE, V67, P189, DOI 10.1016/0306-4522(94)00632-F; Khattab MM, 2006, EUR J PHARMACOL, V548, P167, DOI 10.1016/j.ejphar.2006.08.007; Kim SF, 2005, SCIENCE, V310, P1966, DOI 10.1126/science.1119407; Landino LM, 1996, P NATL ACAD SCI USA, V93, P15069, DOI 10.1073/pnas.93.26.15069; MARKEY CM, 1987, J BIOL CHEM, V262, P6266; MARTIN HA, 1987, NEUROSCIENCE, V22, P651, DOI 10.1016/0306-4522(87)90360-5; MASFERRER JL, 1994, P NATL ACAD SCI USA, V91, P3228, DOI 10.1073/pnas.91.8.3228; Matata BM, 2002, J BIOL CHEM, V277, P2330, DOI 10.1074/jbc.M106393200; McInnis J, 2002, J PHARMACOL EXP THER, V301, P478, DOI 10.1124/jpet.301.2.478; Milne B, 2001, ANESTH ANALG, V93, P728, DOI 10.1097/00000539-200109000-00037; Mitchell JA, 2006, NAT REV DRUG DISCOV, V5, P75, DOI 10.1038/nrd1929; MNICH SJ, 1995, J IMMUNOL, V155, P4437; Mollace V, 2005, PHARMACOL REV, V57, P217, DOI 10.1124/pr.57.2.1; MONCADA S, 1975, EUR J PHARMACOL, V31, P250, DOI 10.1016/0014-2999(75)90047-3; MONCADA S, 1991, PHARMACOL REV, V43, P109; MONCADA S, 1973, NATURE, V246, P217, DOI 10.1038/246217a0; Morioka N, 2002, NEUROPHARMACOLOGY, V43, P868, DOI 10.1016/S0028-3908(02)00143-0; Muscoli C, 2004, PAIN, V111, P96, DOI 10.1016/j.pain.2004.06.004; Muscoli C, 2007, J CLIN INVEST, V117, P3530, DOI 10.1172/JCI32420; Ndengele MM, 2005, SHOCK, V23, P186, DOI 10.1097/01.shk.0000144130.36771.d6; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Perkins DJ, 1999, J LEUKOCYTE BIOL, V65, P792, DOI 10.1002/jlb.65.6.792; Ridger VC, 1997, BRIT J PHARMACOL, V122, P1083, DOI 10.1038/sj.bjp.0701498; RUEFF A, 1993, NEUROSCIENCE, V54, P527, DOI 10.1016/0306-4522(93)90272-H; Salvemini D, 1996, BRIT J PHARMACOL, V118, P829, DOI 10.1111/j.1476-5381.1996.tb15475.x; Salvemini D, 1998, P NATL ACAD SCI USA, V95, P2659, DOI 10.1073/pnas.95.5.2659; Salvemini D, 1998, DRUG NEWS PERSPECT, V11, P204; SALVEMINI D, 1993, P NATL ACAD SCI USA, V90, P7240, DOI 10.1073/pnas.90.15.7240; Salvemini D, 1996, EUR J PHARMACOL, V303, P217, DOI 10.1016/0014-2999(96)00140-9; Salvemini D, 2001, BRIT J PHARMACOL, V132, P815, DOI 10.1038/sj.bjp.0703841; Sandrini G, 2002, NEUROSCI LETT, V317, P135, DOI 10.1016/S0304-3940(01)02447-8; SCHAIBLE HG, 1988, J PHYSIOL-LONDON, V403, P91, DOI 10.1113/jphysiol.1988.sp017240; SEIBERT K, 1994, P NATL ACAD SCI USA, V91, P12013, DOI 10.1073/pnas.91.25.12013; Smith CJ, 1998, P NATL ACAD SCI USA, V95, P13313, DOI 10.1073/pnas.95.22.13313; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; TAIWO YO, 1991, NEUROSCIENCE, V44, P131, DOI 10.1016/0306-4522(91)90255-M; TAIWO YO, 1990, NEUROSCIENCE, V38, P757, DOI 10.1016/0306-4522(90)90068-F; Tassorelli C, 2006, EUR J PHARMACOL, V534, P103, DOI 10.1016/j.ejphar.2006.01.023; Trostchansky A, 2007, FREE RADICAL BIO MED, V42, P1029, DOI 10.1016/j.freeradbiomed.2007.01.009; Tsatsanis C, 2006, INT J BIOCHEM CELL B, V38, P1654, DOI 10.1016/j.biocel.2006.03.021; Virag L, 2003, TOXICOL LETT, V140, P113, DOI 10.1016/S0378-4274(02)00508-8; VonKnethen A, 1997, FASEB J, V11, P887; Wang ZQ, 2004, J PHARMACOL EXP THER, V309, P869, DOI 10.1124/jpet.103.064154; Warner TD, 2004, FASEB J, V18, P790, DOI 10.1096/fj.03-0645rev; WILLIAMS TJ, 1973, NATURE, V246, P215, DOI 10.1038/246215a0; WILLIS AL, 1973, PROSTAG OTH LIPID M, V3, P353, DOI 10.1016/0090-6980(73)90073-7; YAKSH TL, 1993, AGENT ACTION SUPPL, V41, P89; Yang TX, 2006, AM J PHYSIOL-RENAL, V291, pF891, DOI 10.1152/ajprenal.00512.2005; Zhang Y, 1997, J PHARMACOL EXP THER, V283, P1069	77	71	74	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2008	22	9					3154	3164		10.1096/fj.08-108159	http://dx.doi.org/10.1096/fj.08-108159			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	342CD	18497304				2022-12-25	WOS:000258761300008
J	Curfs, DMJ; Ghesquiere, SAI; Vergouwe, MN; van der Made, I; Gijbels, MJJ; Greaves, DR; Verbeek, JS; Hofker, MH; De Winther, MPJ				Curfs, Danielle M. J.; Ghesquiere, Stijn A. I.; Vergouwe, Monique N.; van der Made, Ingeborg; Gijbels, Marion J. J.; Greaves, David R.; Verbeek, J. Sjef; Hofker, Marten H.; De Winther, Menno P. J.			Macrophage secretory phospholipase A(2) group X enhances anti-inflammatory responses, promotes lipid accumulation, and contributes to aberrant lung pathology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-DEFICIENT MICE; LOW-DENSITY-LIPOPROTEIN; ARACHIDONIC-ACID; PULMONARY SURFACTANT; PROSTAGLANDIN E-2; GENE-EXPRESSION; GROUP-V; A(2); IIA; CELLS	Secreted phospholipase A2 group X (sPLA(2)-X) is one of the most potent enzymes of the phospholipase A(2) lipolytic enzyme superfamily. Its high catalytic activity toward phosphatidylcholine (PC), the major phospholipid of cell membranes and low-density lipoproteins (LDL), has implicated sPLA(2)-X in chronic inflammatory conditions such as atherogenesis. We studied the role of sPLA(2)-X enzyme activity in vitro and in vivo, by generating sPLA(2)-X-overexpressing macrophages and transgenic macrophage-specific sPLA(2)-X mice. Our results show that sPLA(2)-X expression inhibits macrophage activation and inflammatory responses upon stimulation, characterized by reduced cell adhesion and nitric oxide production, a decrease in tumor necrosis factor (TNF), and an increase in interleukin (IL)-10. These effects were mediated by an increase in IL-6, and enhanced production of prostaglandin E-2 (PGE(2)) and 15-deoxy-Delta 12,14-prostaglandin J(2) (PGJ(2)). Moreover, we found that overexpression of active sPLA(2)-X in macrophages strongly increases foam cell formation upon incubation with native LDL but also oxidized LDL (oxLDL), which is mediated by enhanced expression of scavenger receptor CD36. Transgenic sPLA(2)-X mice died neonatally because of severe lung pathology characterized by interstitial pneumonia with massive granulocyte and surfactant-laden macrophage infiltration. We conclude that overexpression of the active sPLA(2)-X enzyme results in enhanced foam cell formation but reduced activation and inflammatory responses in macrophages in vitro. Interestingly, enhanced sPLA(2)-X activity in macrophages in vivo leads to fatal pulmonary defects, suggesting a crucial role for sPLA(2)-X in inflammatory lung disease.	[Curfs, Danielle M. J.; Ghesquiere, Stijn A. I.; Vergouwe, Monique N.; van der Made, Ingeborg; Gijbels, Marion J. J.; Hofker, Marten H.; De Winther, Menno P. J.] Maastricht Univ, Cardiovasc Res Inst, Dept Mol Genet, NL-6229 ER Maastricht, Netherlands; [Gijbels, Marion J. J.] Maastricht Univ, Cardiovasc Res Inst, Dept Mol Genet, NL-6229 ER Maastricht, Netherlands; [Greaves, David R.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Verbeek, J. Sjef] Leiden Univ, Med Ctr, Dept Human Genet, NL-2333 ZC Leiden, Netherlands; [Hofker, Marten H.] Univ Groningen, Univ Med Ctr Groningen, Pathol Lab, NL-9713 AV Groningen, Netherlands; [Hofker, Marten H.] Univ Med Ctr Groningen, Lab Med, NL-9713 AV Groningen, Netherlands	Maastricht University; Maastricht University; University of Oxford; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen; University of Groningen	Curfs, DMJ (corresponding author), Maastricht Univ, Cardiovasc Res Inst, Dept Mol Genet, Univ Singel 50, NL-6229 ER Maastricht, Netherlands.	d.curfs@gen.unimaas.nl	de Winther, Menno/E-8721-2012	de Winther, Menno/0000-0002-4038-6636; Greaves, David/0000-0003-2856-9410				Arbibe L, 1998, J CLIN INVEST, V102, P1152, DOI 10.1172/JCI3236; Balsinde J, 2002, FEBS LETT, V531, P2, DOI 10.1016/S0014-5793(02)03413-0; Bezzine S, 2000, J BIOL CHEM, V275, P3179, DOI 10.1074/jbc.275.5.3179; Bostrom MA, 2007, ARTERIOSCL THROM VAS, V27, P600, DOI 10.1161/01.ATV.0000257133.60884.44; Cernak I, 1996, J TRAUMA, V40, pS148, DOI 10.1097/00005373-199603001-00032; Cupillard L, 1997, J BIOL CHEM, V272, P15745, DOI 10.1074/jbc.272.25.15745; Cuzzocrea S, 2004, INTENS CARE MED, V30, P1935, DOI 10.1007/s00134-004-2353-y; Daniels CB, 2001, COMP BIOCHEM PHYS A, V129, P9, DOI 10.1016/S1095-6433(01)00303-8; Ghesquiere SAI, 2005, CARDIOVASC TOXICOL, V5, P161, DOI 10.1385/CT:5:2:161; Ghesquiere SAI, 2005, J LIPID RES, V46, P201, DOI 10.1194/jlr.M400253-JLR200; Gough PJ, 2001, IMMUNOLOGY, V103, P351, DOI 10.1046/j.1365-2567.2001.01256.x; Groeneweg M, 2006, J LIPID RES, V47, P2259, DOI 10.1194/jlr.M600181-JLR200; Hallstrand TS, 2007, AM J RESP CRIT CARE, V176, P1072, DOI 10.1164/rccm.200707-1088OC; Hanasaki K, 2002, J BIOL CHEM, V277, P29116, DOI 10.1074/jbc.M202867200; Hanasaki K, 1999, J BIOL CHEM, V274, P34203, DOI 10.1074/jbc.274.48.34203; Helliwell RJA, 2004, PROSTAG LEUKOTR ESS, V70, P101, DOI 10.1016/j.plefa.2003.04.002; Henderson WR, 2007, J EXP MED, V204, P865, DOI 10.1084/jem.20070029; Hendriks WL, 1996, BIOCHEM J, V314, P563, DOI 10.1042/bj3140563; Hinson RM, 1996, P NATL ACAD SCI USA, V93, P4885, DOI 10.1073/pnas.93.10.4885; Hogan B, 1994, MANIPULATING MOUSE E; Karabina SA, 2006, FASEB J, V20, P2547, DOI 10.1096/fj.06-6018fje; Laine VJO, 1999, J IMMUNOL, V162, P7402; Masuda S, 2005, BIOCHEM J, V387, P27, DOI 10.1042/BJ20041307; Morioka Y, 2000, ARCH BIOCHEM BIOPHYS, V381, P31, DOI 10.1006/abbi.2000.1977; NOGEE LM, 1994, J CLIN INVEST, V93, P1860, DOI 10.1172/JCI117173; Ohtsuki M, 2006, J BIOL CHEM, V281, P36420, DOI 10.1074/jbc.M607975200; Saiga A, 2001, BBA-MOL CELL BIOL L, V1530, P67, DOI 10.1016/S1388-1981(00)00167-0; Schmidt H. H. W., 1996, METHODS NITRIC OXIDE, P491; Shinomiya S, 2001, BIOCHEM PHARMACOL, V61, P1153, DOI 10.1016/S0006-2952(01)00586-X; Simpson KS, 1999, MOL REPROD DEV, V53, P179, DOI 10.1002/(SICI)1098-2795(199906)53:2&lt;179::AID-MRD7&gt;3.0.CO;2-P; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Tietge UJF, 2005, J LIPID RES, V46, P1604, DOI 10.1194/jlr.M400469-JLR200; Touqui L, 2003, ACTA PHARMACOL SIN, V24, P1292; Valentin E, 1999, J BIOL CHEM, V274, P31195, DOI 10.1074/jbc.274.44.31195; Wang HB, 2002, J CLIN ENDOCR METAB, V87, P2629, DOI 10.1210/jc.87.6.2629; Webb NR, 2003, ARTERIOSCL THROM VAS, V23, P263, DOI 10.1161/01.ATV.0000051701.90972.E5; Weinrauch Y, 1998, J CLIN INVEST, V102, P633, DOI 10.1172/JCI3121; Whitsett JA, 2002, NEW ENGL J MED, V347, P2141, DOI 10.1056/NEJMra022387; Williams JA, 1997, J BIOL CHEM, V272, P25693, DOI 10.1074/jbc.272.41.25693; Yan ZP, 2004, CELL IMMUNOL, V232, P116, DOI 10.1016/j.cellimm.2005.03.001	40	59	61	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21640	21648		10.1074/jbc.M710584200	http://dx.doi.org/10.1074/jbc.M710584200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18511424	hybrid			2022-12-25	WOS:000257898800037
J	Dallabrida, SM; Ismail, NS; Pravda, EA; Parodi, EM; Dickie, R; Durand, EM; Lai, J; Cassiola, F; Rogers, RA; Rupnick, MA				Dallabrida, Susan M.; Ismail, Nesreen S.; Pravda, Elke A.; Parodi, Emily M.; Dickie, Renee; Durand, Ellen M.; Lai, Jean; Cassiola, Flavia; Rogers, Rick A.; Rupnick, Maria A.			Integrin binding angiopoietin-1 monomers reduce cardiac hypertrophy	FASEB JOURNAL			English	Article						cardiac myocytes; endothelial cells; integrinlinked kinase; AMP-activated protein kinase; Tie2	ACTIVATED PROTEIN-KINASE; TYROSINE KINASE; ENDOTHELIAL-CELLS; RECEPTOR-BINDING; TIE2 RECEPTOR; GENE-TRANSFER; EXPRESSION; LIGAND; GROWTH; HEART	Angiopoietins were thought to be endothelial cell-specific via the tie2 receptor. We showed that angiopoietin-1 (ang1) also interacts with integrins on cardiac myocytes (CMs) to increase survival. Because ang1 monomers bind and activate integrins (not tie2), we determined their function in vivo. We examined monomer and multimer expressions during physiological and pathological cardiac remodeling and overexpressed ang1 monomers in phenylephrine-induced cardiac hypertrophy. Cardiac ang1 levels (mRNA, protein) increased during postnatal development and decreased with phenylephrine-induced cardiac hypertrophy, whereas tie2 phosphorylations were unchanged. We found that most or all of the changes during cardiac remodeling were in monomers, offering an explanation for unchanged tie2 activity. Heart tissue contains abundant ang1 monomers and few multimers (Western blotting). We generated plasmids that produce ang1 monomers (ang1-256), injected them into mice, and confirmed cardiac expression (immunohistochemistry, RT-PCR). Ang1 monomers localize to CMs, smooth muscle cells, and endothelial cells. In phenylephrine-induced cardiac hypertrophy, ang1-256 reduced left ventricle (LV)/tibia ratios, fetal gene expressions (atrial and brain natriuretic peptides, skeletal actin, beta-myosin heavy chain), and fibrosis (collagen III), and increased LV prosurvival signaling (akt, MAPK(p42/44)), and AMPK(T172). However, tie2 phosphorylations were unchanged. Ang1-256 increased integrin-linked kinase, a key regulator of integrin signaling and cardiac health. Collectively, these results.	[Dallabrida, Susan M.; Ismail, Nesreen S.; Pravda, Elke A.; Parodi, Emily M.; Durand, Ellen M.; Cassiola, Flavia; Rogers, Rick A.; Rupnick, Maria A.] Childrens Hosp, Vasc Biol Div, Boston, MA 02115 USA; [Dallabrida, Susan M.; Rupnick, Maria A.] Harvard Univ, Med Sch Affiliates, Boston, MA 02115 USA; [Dickie, Renee; Lai, Jean; Rogers, Rick A.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Dallabrida, Susan M.; Ismail, Nesreen S.; Pravda, Elke A.; Parodi, Emily M.; Durand, Ellen M.; Cassiola, Flavia; Rogers, Rick A.; Rupnick, Maria A.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Dallabrida, Susan M.; Ismail, Nesreen S.; Pravda, Elke A.; Parodi, Emily M.; Durand, Ellen M.; Cassiola, Flavia; Rogers, Rick A.; Rupnick, Maria A.] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital	Rupnick, MA (corresponding author), Childrens Hosp, Vasc Biol Div, 1 Blackfan Cir,Karp Bldg RB 11-211, Boston, MA 02115 USA.	maria.rupnick@childrens.harvard.edu			NATIONAL CANCER INSTITUTE [R21CA107976, P01CA045548] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL071840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK063970] Funding Source: NIH RePORTER; NCI NIH HHS [R21 CA107976-02, P01 CA045548-20, R21 CA107976-01, R21-CA107976-01, P01-CA45548, R21 CA107976, P01 CA045548] Funding Source: Medline; NHLBI NIH HHS [K02 HL071840, K02 HL071840-04, K02-HL071840-01, K02 HL071840-05] Funding Source: Medline; NIDDK NIH HHS [K01 DK063970-02, K01-DK063970-01, K01 DK063970-03, K01 DK063970] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baba HA, 2003, CARDIOVASC RES, V59, P390, DOI 10.1016/S0008-6363(03)00393-6; Bragonzi A, 1999, GENE THER, V6, P1995, DOI 10.1038/sj.gt.3301039; Carlson TR, 2001, J BIOL CHEM, V276, P26516, DOI 10.1074/jbc.M100282200; Cascone I, 2005, J CELL BIOL, V170, P993, DOI 10.1083/jcb.200507082; Chemin I, 1998, J VIRAL HEPATITIS, V5, P369, DOI 10.1046/j.1365-2893.1998.00126.x; Chen Shi-lin, 2003, Zhonghua Yi Xue Za Zhi, V83, P637; Cho CH, 2004, P NATL ACAD SCI USA, V101, P5547, DOI 10.1073/pnas.0307574101; Cho CH, 2004, P NATL ACAD SCI USA, V101, P5553, DOI 10.1073/pnas.0307575101; Dallabrida SM, 2005, CIRC RES, V96, DOI 10.1161/01.RES.0000158285.57191.60; Dallabrida SM, 2003, BIOCHEM BIOPH RES CO, V311, P563, DOI 10.1016/j.bbrc.2003.10.007; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Davis S, 2003, NAT STRUCT BIOL, V10, P38, DOI 10.1038/nsb880; DUMONT DJ, 1992, ONCOGENE, V7, P1471; Fedak PWM, 2005, CARDIOVASC PATHOL, V14, P49, DOI 10.1016/j.carpath.2005.01.005; Ferrari S, 1999, BBA-GENE STRUCT EXPR, V1447, P219, DOI 10.1016/S0167-4781(99)00153-0; Goede V, 1998, LAB INVEST, V78, P1385; Hannigan GE, 2007, CIRC RES, V100, P1408, DOI 10.1161/01.RES.0000265233.40455.62; Hardie DG, 2004, J CLIN INVEST, V114, P465, DOI 10.1172/JCI200422683; Kemp BE, 1999, TRENDS BIOCHEM SCI, V24, P22, DOI 10.1016/S0968-0004(98)01340-1; Kim I, 1999, INVEST OPHTH VIS SCI, V40, P2115; Kim KT, 2005, J BIOL CHEM, V280, P20126, DOI 10.1074/jbc.M500292200; KIM NN, 1995, AM J PHYSIOL-ENDOC M, V269, pE426, DOI 10.1152/ajpendo.1995.269.3.E426; KORHONEN J, 1992, BLOOD, V80, P2548; Latronico MVG, 2004, ANN NY ACAD SCI, V1015, P250, DOI 10.1196/annals.1302.021; MCMAHON DK, 1994, AM J PHYSIOL, V266, pC1795, DOI 10.1152/ajpcell.1994.266.6.C1795; Mitcheson JS, 1998, CARDIOVASC RES, V39, P280, DOI 10.1016/S0008-6363(98)00128-X; Procopio WN, 1999, J BIOL CHEM, V274, P30196, DOI 10.1074/jbc.274.42.30196; Ravingerova T, 2003, MOL CELL BIOCHEM, V247, P127, DOI 10.1023/A:1024119224033; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; Sandhu R, 2004, CARDIOVASC RES, V64, P115, DOI 10.1016/j.cardiores.2004.05.013; Schoenfeld JR, 1998, J MOL CELL CARDIOL, V30, P2269, DOI 10.1006/jmcc.1998.0787; Siddiqui AJ, 2003, BIOCHEM BIOPH RES CO, V310, P1002, DOI 10.1016/j.bbrc.2003.09.111; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Takahashi K, 2003, MOL THER, V8, P584, DOI 10.1016/S1525-0016(03)00230-2; Weber CC, 2005, J BIOL CHEM, V280, P22445, DOI 10.1074/jbc.M410367200; White DE, 2006, GENE DEV, V20, P2355, DOI 10.1101/gad.1458906; Wong AL, 1997, CIRC RES, V81, P567, DOI 10.1161/01.RES.81.4.567; Xu Y, 2001, J BIOL CHEM, V276, P34990, DOI 10.1074/jbc.M103661200	38	36	37	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2008	22	8					3010	3023		10.1096/fj.07-100966	http://dx.doi.org/10.1096/fj.07-100966			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	332NI	18502941	Green Accepted, Green Published			2022-12-25	WOS:000258089300041
J	Drose, S; Brandt, U				Droese, Stefan; Brandt, Ulrich			The mechanism of mitochondrial superoxide production by the cytochrome bc(1) complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; CYCLE BYPASS REACTIONS; Q(O) SITE; UBIHYDROQUINONE OXIDATION; HEART-MITOCHONDRIA; HYDROGEN-PEROXIDE; ELECTRON-TRANSFER; REDOX STATE; BEEF-HEART; COENZYME-Q	Production of reactive oxygen species (ROS) by the mitochondrial respiratory chain is considered to be one of the major causes of degenerative processes associated with oxidative stress. Mitochondrial ROS has also been shown to be involved in cellular signaling. It is generally assumed that ubisemiquinone formed at the ubiquinol oxidation center of the cytochrome bc(1) complex is one of two sources of electrons for superoxide formation in mitochondria. Here we show that superoxide formation at the ubiquinol oxidation center of the membrane-bound or purified cytochrome bc(1) complex is stimulated by the presence of oxidized ubiquinone indicating that in a reverse reaction the electron is transferred onto oxygen from reduced cytochrome b(L) via ubiquinone rather than during the forward ubiquinone cycle reaction. In fact, from mechanistic studies it seems unlikely that during normal catalysis the ubisemiquinone intermediate reaches significant occupancies at the ubiquinol oxidation site. We conclude that cytochrome bc(1) complex-linked ROS production is primarily promoted by a partially oxidized rather than by a fully reduced ubiquinone pool. The resulting mechanism of ROS production offers a straightforward explanation of how the redox state of the ubiquinone pool could play a central role in mitochondrial redox signaling.	[Droese, Stefan; Brandt, Ulrich] Goethe Univ Frankfurt, Sch Med, Mol Bioenerget Grp, D-60590 Frankfurt, Germany	Goethe University Frankfurt	Brandt, U (corresponding author), Goethe Univ Frankfurt, Sch Med, Mol Bioenerget Grp, Cluster Excellence Frankfurt Macromol Complexes, D-60590 Frankfurt, Germany.	brandt@zbc.kgu.de	Dröse, Stefan/E-4903-2010; Brandt, Ulrich/GLV-1242-2022; Brandt, Ulrich/C-4406-2008	Dröse, Stefan/0000-0002-9361-9034; Brandt, Ulrich/0000-0003-1869-6811; Brandt, Ulrich/0000-0003-1869-6811				ABERG F, 1992, ARCH BIOCHEM BIOPHYS, V295, P230, DOI 10.1016/0003-9861(92)90511-T; Bell EL, 2007, J CELL BIOL, V177, P1029, DOI 10.1083/jcb.200609074; BENZI G, 1995, NEUROBIOL AGING, V16, P661, DOI 10.1016/0197-4580(95)00066-N; BOVERIS A, 1976, BIOCHEM J, V156, P435, DOI 10.1042/bj1560435; Brandt U, 1998, BBA-BIOENERGETICS, V1365, P261, DOI 10.1016/S0005-2728(98)00078-4; BRANDT U, 1994, CRIT REV BIOCHEM MOL, V29, P165, DOI 10.3109/10409239409086800; CADENAS E, 1977, ARCH BIOCHEM BIOPHYS, V180, P248, DOI 10.1016/0003-9861(77)90035-2; Cape JL, 2005, J BIOL CHEM, V280, P34654, DOI 10.1074/jbc.M507616200; Cape JL, 2007, P NATL ACAD SCI USA, V104, P7887, DOI 10.1073/pnas.0702621104; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Crofts AR, 2004, BBA-BIOENERGETICS, V1655, P77, DOI 10.1016/j.bbabio.2003.10.012; DEVRIES S, 1981, J BIOL CHEM, V256, P1996; Drose S, 2006, J BIOL CHEM, V281, P23733, DOI 10.1074/jbc.M602570200; Emerit J, 2004, BIOMED PHARMACOTHER, V58, P39, DOI 10.1016/j.biopha.2003.11.004; ENGEL WD, 1983, H-S Z PHYSIOL CHEM, V364, P1753, DOI 10.1515/bchm2.1983.364.2.1753; ERECINSKA M, 1976, ARCH BIOCHEM BIOPHYS, V174, P143, DOI 10.1016/0003-9861(76)90333-7; Forquer I, 2006, J BIOL CHEM, V281, P38459, DOI 10.1074/jbc.M605119200; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; Galinier A, 2004, FEBS LETT, V578, P53, DOI 10.1016/j.febslet.2004.10.067; Galkin A, 2005, J BIOL CHEM, V280, P30129, DOI 10.1074/jbc.M504709200; Horvat S, 2006, J NEUROCHEM, V99, P937, DOI 10.1111/j.1471-4159.2006.04134.x; Kudin AP, 2005, BIOMED PHARMACOTHER, V59, P163, DOI 10.1016/j.biopha.2005.03.012; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Muller F, 2002, BIOCHEMISTRY-US, V41, P7866, DOI 10.1021/bi025581e; Muller FL, 2003, BIOCHEMISTRY-US, V42, P6493, DOI 10.1021/bi0342160; Okun JG, 1999, J BIOL CHEM, V274, P2625, DOI 10.1074/jbc.274.5.2625; Osyczka A, 2005, TRENDS BIOCHEM SCI, V30, P176, DOI 10.1016/j.tibs.2005.02.001; Osyczka A, 2004, NATURE, V427, P607, DOI 10.1038/nature02242; Snyder CH, 2000, J BIOL CHEM, V275, P13535, DOI 10.1074/jbc.275.18.13535; Sun H, 2003, ARCH BIOCHEM BIOPHYS, V419, P198, DOI 10.1016/j.abb.2003.08.028; Vanden Hoek TL, 1998, J BIOL CHEM, V273, P18092, DOI 10.1074/jbc.273.29.18092; WAN YP, 1975, BIOCHEM BIOPH RES CO, V63, P11, DOI 10.1016/S0006-291X(75)80003-9; WIKSTROM MK, 1972, BIOCHIM BIOPHYS ACTA, V283, P403, DOI 10.1016/0005-2728(72)90258-7; Zhang HB, 2007, BBA-BIOENERGETICS, V1767, P883, DOI 10.1016/j.bbabio.2007.04.004	35	279	284	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21649	21654		10.1074/jbc.M803236200	http://dx.doi.org/10.1074/jbc.M803236200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18522938	hybrid			2022-12-25	WOS:000257898800038
J	Laukkarinen, JM; Weiss, ER; van Acker, GJD; Steer, ML; Perides, G				Laukkarinen, Johanna M.; Weiss, Eric R.; van Acker, Gijs J. D.; Steer, Michael L.; Perides, George			Protease-activated receptor-2 exerts contrasting model-specific effects on acute experimental pancreatitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACINAR-CELLS; RAT; CHOLECYSTOKININ; TAUROCHOLATE; OSCILLATIONS; PROTECTION; SECRETION; CARBACHOL; RESPONSES; DISEASE	Protease-activated receptor-2 (PAR2) is a 7-transmembrane G-protein-coupled tethered ligand receptor that is expressed by pancreatic acinar and ductal cells. It can be physiologically activated by trypsin. Previously reported studies (Namkung, W., Han, W., Luo, X., Muallem, S., Cho, K. H., Kim, K. H., and Lee, M. G. (2004) Gastroenterology 126, 1844-1859; Sharma, A., Tao, X., Gopal, A., Ligon, B., Andrade-Gordon, P., Steer, M. L., and Perides, G. (2005) Am. J. Physiol. 288, G388-G395) have shown that PAR2 activation exerts a protective effect on the experimental model of pancreatitis induced by supramaximal secretagogue (caerulein) stimulation. We now show that PAR2 exerts a worsening effect on a different model of experimental pancreatitis, i. e. one induced by retrograde pancreatic ductal infusion of bile salts. In vitro studies using freshly prepared pancreatic acini show that genetic deletion of PAR2 reduces bile salt-induced pathological calcium transients, acinar cell injury, and activation of c-Jun N-terminal kinase, whereas genetic deletion of PAR2 has the opposite or no effect on these pancreatitis-related events when they are elicited, in vitro, by caerulein stimulation. Studies employing a combination of trypsin inhibition and activation of PAR2 with the activating peptide SLIGRL show that all these differences indeed depend on the activation of PAR2. These studies are the first to report that a single perturbation can have model-specific and opposite effects on pancreatitis, and they underscore the importance of performing mechanistic pancreatitis studies using two dissimilar models of the disease to detect idiosyncratic, model-specific events. We suggest PAR2 activation exerts a worsening effect on the severity of clinical pancreatitis and that interventions interfering with PAR2 activation may be of benefit in the treatment of patients with severe pancreatitis.	[Laukkarinen, Johanna M.; Weiss, Eric R.; van Acker, Gijs J. D.; Steer, Michael L.; Perides, George] Tufts Med Ctr, Dept Surg 37, Boston, MA 02111 USA; [Laukkarinen, Johanna M.] Tampere Univ Hosp, Dept Gastroenterol & Alimentary Tract Surg, Tampere 33520, Finland	Tufts Medical Center; Tampere University; Tampere University Hospital	Perides, G (corresponding author), Tufts Med Ctr, Dept Surg 37, 750 Washington St, Boston, MA 02111 USA.	gperides@tufts-nemc.org			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031396, R37DK031396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA015410] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA 015410] Funding Source: Medline; NIDDK NIH HHS [DK 031396] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ACOSTA JM, 1974, NEW ENGL J MED, V290, P484, DOI 10.1056/NEJM197402282900904; AHO HJ, 1980, SCAND J GASTROENTERO, V15, P411, DOI 10.3109/00365528009181493; Damiano BP, 1999, J PHARMACOL EXP THER, V288, P671; Fischer L, 2007, AM J PHYSIOL-GASTR L, V292, pG875, DOI 10.1152/ajpgi.00558.2005; Frossard JL, 1999, GASTROENTEROLOGY, V116, P694, DOI 10.1016/S0016-5085(99)70192-7; GLASBRENNER B, 1993, HEPATO-GASTROENTEROL, V40, P517; Grady T, 1998, AM J PHYSIOL-GASTR L, V275, pG1010, DOI 10.1152/ajpgi.1998.275.5.G1010; Kim JY, 2002, GASTROENTEROLOGY, V122, P1941, DOI 10.1053/gast.2002.33617; LAMPEL M, 1977, VIRCHOWS ARCH A, V373, P97, DOI 10.1007/BF00432156; Laukkarinen JM, 2007, GUT, V56, P1590, DOI 10.1136/gut.2007.124230; LEACH SD, 1991, J CLIN INVEST, V87, P362, DOI 10.1172/JCI114995; LIGNON MF, 1988, GASTRIN CHOLECYSTOKI, P57; Mooren FC, 2003, J BIOL CHEM, V278, P9361, DOI 10.1074/jbc.M207454200; Namkung W, 2004, GASTROENTEROLOGY, V126, P1844, DOI 10.1053/j.gastro.2004.03.019; Nguyen TD, 1999, J CLIN INVEST, V103, P261, DOI 10.1172/JCI2539; Opie EL, 1901, B JOHNS HOPKINS HOSP, V12, P182; Opie EL, 1901, AM J MED SCI, V121, P27, DOI 10.1097/00000441-190101000-00002; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Saluja AK, 1997, GASTROENTEROLOGY, V113, P304, DOI 10.1016/S0016-5085(97)70108-2; Sharma A, 2005, AM J PHYSIOL-GASTR L, V289, pG686, DOI 10.1152/ajpgi.00342.2004; Sharma A, 2005, AM J PHYSIOL-GASTR L, V288, pG388, DOI 10.1152/ajpgi.00341.2004; Singh VP, 2007, GUT, V56, P958, DOI 10.1136/gut.2006.094268; SJODIN L, 1991, J PHYSIOL-LONDON, V444, P763; Steer ML, 2005, CLINICAL PANCREATOLOGY: FOR PRACTISING GASTROENTEROLOGISTS AND SURGEONS, P10; Van Acker GJD, 2007, J BIOL CHEM, V282, P22140, DOI 10.1074/jbc.M702225200; Wittel UA, 2008, PANCREAS, V36, pE9, DOI 10.1097/MPA.0b013e3181575103; YULE DI, 1992, J BIOL CHEM, V267, P13830	27	32	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20703	20712		10.1074/jbc.M801779200	http://dx.doi.org/10.1074/jbc.M801779200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18511423	hybrid, Green Published			2022-12-25	WOS:000257746100011
J	Lin, CP; Ban, Y; Lyu, YL; Desai, SD; Liu, LF				Lin, Chao-Po; Ban, Yi; Lyu, Yi Lisa; Desai, Shyamal D.; Liu, Leroy F.			A ubiquitin-proteasome pathway for the repair of topoisomerase I-DNA covalent complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; RNA-POLYMERASE-II; CLEAVABLE COMPLEXES; REPLICATION FORKS; PROTEIN-KINASE; TUMOR-CELLS; CAMPTOTHECIN; PHOSPHORYLATION; DEGRADATION; DAMAGE	Reversible topoisomerase I (Top1)-DNA cleavage complexes are the key DNA lesion induced by anticancer camptothecins (e.g. topotecan and irinotecan) as well as structurally perturbed DNAs (e.g. oxidatively damaged DNA, UV-irradiated DNA, alkylated DNA, uracil-substituted DNA, mismatched DNA, gapped and nicked DNA, and DNA with abasic sites). Top1 cleavage complexes arrest transcription and trigger transcription-dependent degradation of Top1, a phenomenon termed Top1 down-regulation. In the current study, we have investigated the role of Top1 down-regulation in the repair of Top1 cleavage complexes. Using quiescent (serum-starved) human WI-38 cells, camptothecin (CPT) was shown to induce Top1 down-regulation, which paralleled the induction of DNA single-strand breaks (SSBs) (assayed by comet assays) and ATM autophosphorylation (at Ser-1981). Interestingly, Top1 down-regulation, induction of DNA SSBs and ATM autophosphorylation were all abolished by the proteasome inhibitor MG132. Furthermore, studies using immunoprecipitation and dominant-negative ubiquitin mutants have suggested a specific requirement for the assembly of Lys-48-linked polyubiquitin chains for CPT-induced Top1 down-regulation. In contrast to the effect of proteasome inhibition, inactivation of PARP1 was shown to increase the amount of CPT-induced SSBs and the level of ATM autophosphorylation. Together, these results support a model in which Top1 cleavage complexes arrest transcription and activate a ubiquitin-proteasome pathway leading to the degradation of Top1 cleavage complexes. Degradation of Top1 cleavage complexes results in the exposure of Top1-concealed SSBs for repair through a PARP1-dependent process.	[Lin, Chao-Po; Ban, Yi; Lyu, Yi Lisa; Desai, Shyamal D.; Liu, Leroy F.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Liu, LF (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, 675 Hoes Ln, Piscataway, NJ 08854 USA.	lliu@umdnj.edu		Lin, Chao-Po/0000-0002-1457-1635; Liu, Leroy/0000-0001-9396-763X	NCI NIH HHS [CA 39662] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA039662] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aleo E, 2006, CANCER RES, V66, P9235, DOI 10.1158/0008-5472.CAN-06-0702; Almeida KH, 2007, DNA REPAIR, V6, P695, DOI 10.1016/j.dnarep.2007.01.009; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Daroui P, 2004, J BIOL CHEM, V279, P14587, DOI 10.1074/jbc.M311370200; DARPA P, 1990, CANCER RES, V50, P6919; Desai SD, 2003, MOL CELL BIOL, V23, P2341, DOI 10.1128/MCB.23.7.2341-2350.2003; Desai SD, 1997, J BIOL CHEM, V272, P24159, DOI 10.1074/jbc.272.39.24159; Desai SD, 2001, CANCER RES, V61, P5926; DIMRI GP, 1994, J BIOL CHEM, V269, P16180; EARNSHAW WC, 1985, J CELL BIOL, V100, P1706, DOI 10.1083/jcb.100.5.1706; El-Khamisy SF, 2005, NATURE, V434, P108, DOI 10.1038/nature03314; El-Khamisy SF, 2007, DNA REPAIR, V6, P1485, DOI 10.1016/j.dnarep.2007.04.015; Furuta T, 2003, J BIOL CHEM, V278, P20303, DOI 10.1074/jbc.M300198200; Gillette TG, 2004, P NATL ACAD SCI USA, V101, P5904, DOI 10.1073/pnas.0305411101; HOLM C, 1989, CANCER RES, V49, P6365; Hoyt MA, 2004, CELL MOL LIFE SCI, V61, P1596, DOI 10.1007/s00018-004-4133-9; HSIANG YH, 1988, CANCER RES, V48, P3230; HSIANG YH, 1989, CANCER RES, V49, P5077; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Ismail IH, 2005, J BIOL CHEM, V280, P4649, DOI 10.1074/jbc.M411588200; KATYAL S, 2007, EMBO J; Kinyamu HK, 2007, MOL CELL BIOL, V27, P4891, DOI 10.1128/MCB.02162-06; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; Lyu YL, 2007, CANCER RES, V67, P8839, DOI 10.1158/0008-5472.CAN-07-1649; Malanga M, 2004, J BIOL CHEM, V279, P5244, DOI 10.1074/jbc.C300437200; Mao Y, 2001, J BIOL CHEM, V276, P40652, DOI 10.1074/jbc.M104009200; Morris EJ, 1996, J CELL BIOL, V134, P757, DOI 10.1083/jcb.134.3.757; NORBURY C, 1991, EMBO J, V10, P3321, DOI 10.1002/j.1460-2075.1991.tb04896.x; Plo I, 2003, DNA REPAIR, V2, P1087, DOI 10.1016/S1568-7864(03)00116-2; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pourquier P, 1999, J BIOL CHEM, V274, P8516, DOI 10.1074/jbc.274.13.8516; Rass U, 2007, CELL, V130, P991, DOI 10.1016/j.cell.2007.08.043; Roninson IB, 2001, DRUG RESIST UPDATE, V4, P303, DOI 10.1054/drup.2001.0213; Shao RG, 1999, EMBO J, V18, P1397, DOI 10.1093/emboj/18.5.1397; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; Smith LM, 2005, CLIN CANCER RES, V11, P8449, DOI 10.1158/1078-0432.CCR-05-1224; Thiriet C, 2005, MOL CELL, V18, P617, DOI 10.1016/j.molcel.2005.05.008; TSAO YP, 1992, CANCER RES, V52, P1823; TSAO YP, 1993, CANCER RES, V53, P5908; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; Wu JX, 1997, NUCLEIC ACIDS RES, V25, P4181, DOI 10.1093/nar/25.21.4181; Yu H, 1999, J BIOL CHEM, V274, P36852, DOI 10.1074/jbc.274.52.36852; Zhang AL, 2006, J BIOL CHEM, V281, P35997, DOI 10.1074/jbc.M604149200; ZHANG H, 1990, CANCER CELL-MON REV, V2, P23; Zhang HF, 2004, CANCER RES, V64, P1114, DOI 10.1158/0008-5472.CAN-03-2858	48	79	79	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21074	21083		10.1074/jbc.M803493200	http://dx.doi.org/10.1074/jbc.M803493200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18515798	hybrid, Green Published			2022-12-25	WOS:000257746100049
J	Singh, A; Gebhart, M; Fritsch, R; Sinnegger-Brauns, MJ; Poggiani, C; Hoda, JC; Engel, J; Romanin, C; Striessnig, J; Koschak, A				Singh, Anamika; Gebhart, Mathias; Fritsch, Reinhard; Sinnegger-Brauns, Martina J.; Poggiani, Chiara; Hoda, Jean-Charles; Engel, Jutta; Romanin, Christoph; Striessnig, Joerg; Koschak, Alexandra			Modulation of voltage- and Ca2+-dependent gating of Ca(v)1.3 L-type calcium channels by alternative splicing of a C-terminal regulatory domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUDITORY HAIR-CELLS; CA2+ CHANNELS; AUTOINHIBITORY DOMAIN; ALPHA(1C) SUBUNIT; BINDING-PROTEINS; SKELETAL-MUSCLE; BETA-SUBUNIT; RAT-BRAIN; INACTIVATION; MICE	Low voltage activation of Ca(V)1.3 L-type Ca2+ channels controls excitability in sensory cells and central neurons as well as sinoatrial node pacemaking. Ca(V)1.3-mediated pacemaking determines neuronal vulnerability of dopaminergic striatal neurons affected in Parkinson disease. We have previously found that in Ca(V)1.4 L-type Ca2+ channels, activation, voltage, and calcium-dependent inactivation are controlled by an intrinsic distal C-terminal modulator. Because alternative splicing in the Ca(V)1.3 alpha 1 subunit C terminus gives rise to a long (Ca(V)1.3(42)) and a short form (Ca(V)1.3(42A)), we investigated if a C-terminal modulatory mechanism also controls Ca(V)1.3 gating. The biophysical properties of both splice variants were compared after heterologous expression together with beta 3 and alpha 2 delta 1 subunits in HEK-293 cells. Activation of calcium current through Ca(V)1.3(42A) channels was more pronounced at negative voltages, and inactivation was faster because of enhanced calcium-dependent inactivation. By investigating several Ca(V)1.3 channel truncations, we restricted the modulator activity to the last 116 amino acids of the C terminus. The resulting Ca(V)1.3(Delta C116) channels showed gating properties similar to Ca(V)1.3(42A) that were reverted by co-expression of the corresponding C-terminal peptide C-116. Fluorescence resonance energy transfer experiments confirmed an intramolecular protein interaction in the C terminus of Ca(V)1.3 channels that also modulates calmodulin binding. These experiments revealed a novel mechanism of channel modulation enabling cells to tightly control Ca(V)1.3 channel activity by alternative splicing. The absence of the C-terminal modulator in short splice forms facilitates Ca(V)1.3 channel activation at lower voltages expected to favor Ca(V)1.3 activity at threshold voltages as required for modulation of neuronal firing behavior and sinoatrial node pacemaking.	[Singh, Anamika; Gebhart, Mathias; Sinnegger-Brauns, Martina J.; Poggiani, Chiara; Hoda, Jean-Charles; Striessnig, Joerg; Koschak, Alexandra] Univ Innsbruck, Inst Pharm Pharmacol & Toxicol, A-6020 Innsbruck, Austria; [Singh, Anamika; Gebhart, Mathias; Sinnegger-Brauns, Martina J.; Poggiani, Chiara; Hoda, Jean-Charles; Striessnig, Joerg; Koschak, Alexandra] Univ Innsbruck, Ctr Mol Biosci, A-6020 Innsbruck, Austria; [Fritsch, Reinhard; Romanin, Christoph] Univ Linz, Inst Biophys, A-4040 Linz, Austria; [Engel, Jutta] Univ Tubingen, Inst Physiol, D-72076 Tubingen, Germany; [Engel, Jutta] Univ Tubingen, Tubingen Hearing Res Ctr, D-72076 Tubingen, Germany	University of Innsbruck; University of Innsbruck; Johannes Kepler University Linz; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Singh, A (corresponding author), Univ Innsbruck, Inst Pharm Pharmacol & Toxicol, Peter Mayr Str 1-1, A-6020 Innsbruck, Austria.		Romanin, Christoph/D-5399-2009; Striessnig, Joerg/S-9334-2017; Tuluc, Petronel/C-2527-2011	Romanin, Christoph/0000-0003-3756-4136; Striessnig, Joerg/0000-0002-9406-7120; Bhargava, Anamika/0000-0002-1048-3427; Brauns, Martina/0000-0002-0547-2731	Austrian Science Fund FWF [P 17159] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF))		Bean BP, 2007, NATURE, V447, P1059, DOI 10.1038/4471059a; Calin-Jageman I, 2007, J NEUROSCI, V27, P1374, DOI 10.1523/JNEUROSCI.5191-06.2007; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Cui GY, 2007, J PHYSIOL-LONDON, V585, P791, DOI 10.1113/jphysiol.2007.142307; Ganesan AN, 2006, CIRC RES, V98, pE11, DOI 10.1161/01.RES.0000202692.23001.e2; Gao TY, 2001, J BIOL CHEM, V276, P21089, DOI 10.1074/jbc.M008000200; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Grabner M, 1998, P NATL ACAD SCI USA, V95, P1903, DOI 10.1073/pnas.95.4.1903; HALLING DB, 2006, SCI STKE, pERU; Hell JW, 1996, P NATL ACAD SCI USA, V93, P3362, DOI 10.1073/pnas.93.8.3362; Helton TD, 2005, J NEUROSCI, V25, P10247, DOI 10.1523/JNEUROSCI.1089-05.2005; Hibino H, 2002, NEURON, V34, P411, DOI 10.1016/S0896-6273(02)00667-0; Huber I, 2000, BIOCHEM J, V347, P829, DOI 10.1042/0264-6021:3470829; HUI A, 1991, NEURON, V7, P35, DOI 10.1016/0896-6273(91)90072-8; Hulme JT, 2006, P NATL ACAD SCI USA, V103, P16574, DOI 10.1073/pnas.0607294103; Hulme JT, 2006, J PHYSIOL-LONDON, V576, P87, DOI 10.1113/jphysiol.2006.111799; Hulme JT, 2005, P NATL ACAD SCI USA, V102, P5274, DOI 10.1073/pnas.0409885102; Hulme JT, 2002, J BIOL CHEM, V277, P4079, DOI 10.1074/jbc.M109814200; Kepplinger KJF, 2000, FEBS LETT, V477, P161, DOI 10.1016/S0014-5793(00)01791-9; Koschak A, 2001, J BIOL CHEM, V276, P22100, DOI 10.1074/jbc.M101469200; Koschak A, 2007, J NEUROSCI, V27, P3855, DOI 10.1523/JNEUROSCI.4028-06.2007; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Lipscombe D, 2004, J NEUROPHYSIOL, V92, P2633, DOI 10.1152/jn.00486.2004; Mangoni ME, 2003, P NATL ACAD SCI USA, V100, P5543, DOI 10.1073/pnas.0935295100; Matthes J, 2004, N-S ARCH PHARMACOL, V369, P554, DOI 10.1007/s00210-004-0940-7; Michna M, 2003, J PHYSIOL-LONDON, V553, P747, DOI 10.1113/jphysiol.2003.053256; Olson PA, 2005, J NEUROSCI, V25, P1050, DOI 10.1523/JNEUROSCI.3327-04.2005; Pichler M, 1997, J BIOL CHEM, V272, P13877, DOI 10.1074/jbc.272.21.13877; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Qu YX, 2005, AM J PHYSIOL-HEART C, V288, pH2123, DOI 10.1152/ajpheart.01023.2004; Safa P, 2001, J BIOL CHEM, V276, P38727, DOI 10.1074/jbc.M103724200; Shen YR, 2006, J NEUROSCI, V26, P10690, DOI 10.1523/JNEUROSCI.2093-06.2006; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Soldatov NM, 1997, J BIOL CHEM, V272, P3560, DOI 10.1074/jbc.272.6.3560; Striessnig J, 2007, J PHYSIOL-LONDON, V585, P643, DOI 10.1113/jphysiol.2007.147140; Wahl-Schott C, 2006, P NATL ACAD SCI USA, V103, P15657, DOI 10.1073/pnas.0604621103; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; Yang PS, 2006, J NEUROSCI, V26, P10677, DOI 10.1523/JNEUROSCI.3236-06.2006; Zhang H, 2005, J NEUROSCI, V25, P1037, DOI 10.1523/JNEUROSCI.4554-04.2005; Zhang H, 2006, EUR J NEUROSCI, V23, P2297, DOI 10.1111/j.1460-9568.2006.04734.x	43	95	97	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20733	20744		10.1074/jbc.M802254200	http://dx.doi.org/10.1074/jbc.M802254200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18482979	hybrid, Green Published			2022-12-25	WOS:000257746100014
J	Dutta, D; Chalissery, J; Sen, R				Dutta, Dipak; Chalissery, Jisha; Sen, Ranjan			Transcription termination factor Rho prefers catalytically active elongation complexes for releasing RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI RHO; STRUCTURAL BASIS; DEPENDENT TERMINATION; BINDING DOMAIN; POLYMERASE; MECHANISM; INHIBITION; PROTEIN; SITE; SEQUENCE	RNA polymerase pauses at different DNA sequences during transcription elongation, and this pausing is associated with distinct conformational state(s) of the elongation complex (EC). Transcription termination by the termination factor Rho, an RNA- dependent molecular motor, requires pausing of the EC in the termination zone of Rho- dependent terminators. We hypothesized that the conformational state(s) of the EC associated with this pausing would influence the action of Rho. Analyses of the pausing behavior of the EC at the termination points of two well known Rho- dependent terminators revealed that Rho prefers actively transcribing complexes for termination. RNA release kinetics from stalled ECs showed that the rate of RNA release by Rho was reduced if the EC was irreversibly backtracked, if its RNA exit channel was modified by an RNA hairpin, or the bridge helix/trigger loop movement in its active site was perturbed. These defects were overcome significantly by enhancing the rate of ATP hydrolysis either by increasing the concentration of ATP or by using a Rho mutant with higher ATPase activity. We propose that the force generated from ATP hydrolysis of Rho is the key factor in dislodging the EC through its molecular motor action, and this process is facilitated when the EC is in a catalytically competent state, undergoing rapid "Brownian ratchet" motion.	[Dutta, Dipak; Chalissery, Jisha; Sen, Ranjan] Ctr DNA Fingerprinting & Diagnost, Lab Transcript Biol, Hyderabad 500076, Andhra Pradesh, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD)	Sen, R (corresponding author), Ctr DNA Fingerprinting & Diagnost, Lab Transcript Biol, ECIL Rd,Nacharam, Hyderabad 500076, Andhra Pradesh, India.	rsen@cdfd.org.in	Chalissery, Jisha/AAI-3438-2021	Chalissery, Jisha/0000-0002-1738-2987	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALIFANO P, 1991, CELL, V64, P553; Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; Banerjee S, 2006, J MICROBIOL, V44, P11; Bar-Nahum G, 2005, CELL, V120, P183, DOI 10.1016/j.cell.2004.11.045; BEAR DG, 1988, J MOL BIOL, V199, P623, DOI 10.1016/0022-2836(88)90306-3; BRENNAN CA, 1987, CELL, V48, P945, DOI 10.1016/0092-8674(87)90703-3; Chalissery J, 2007, J MOL BIOL, V371, P855, DOI 10.1016/j.jmb.2007.06.013; Chan CL, 1997, J MOL BIOL, V268, P54, DOI 10.1006/jmbi.1997.0935; Cheeran A, 2005, J MOL BIOL, V352, P28, DOI 10.1016/j.jmb.2005.06.052; CHEN CYA, 1987, J BIOL CHEM, V262, P11292; Ciampi M.S., 2006, MICROBIOLOGY, V152, P2525; FARNHAM PJ, 1982, CELL, V29, P945, DOI 10.1016/0092-8674(82)90457-3; HOWARD BH, 1976, J BIOL CHEM, V251, P2520; KASSAVETIS GA, 1981, J BIOL CHEM, V256, P2777; King RA, 2003, METHOD ENZYMOL, V371, P207; Landick R, 2006, BIOCHEM SOC T, V34, P1062, DOI 10.1042/BST0341062; LAUS LF, 1983, J BIOL CHEM, V258, P9391; MIWA Y, 1995, J MOL BIOL, V254, P815, DOI 10.1006/jmbi.1995.0658; MODRAK D, 1994, BIOCHEMISTRY-US, V33, P8292, DOI 10.1021/bi00193a016; Mooney RA, 1998, J BACTERIOL, V180, P3265, DOI 10.1128/JB.180.13.3265-3275.1998; MORGAN WD, 1985, NUCLEIC ACIDS RES, V13, P3739, DOI 10.1093/nar/13.10.3739; MORGAN WD, 1983, J BIOL CHEM, V258, P9553; Nudler E, 2002, GENES CELLS, V7, P755, DOI 10.1046/j.1365-2443.2002.00563.x; Pani B, 2006, J BIOL CHEM, V281, P26491, DOI 10.1074/jbc.M603982200; PERIERA S, 1995, J MOL BIOL, V251, P36; RICHARDSON JP, 1993, CRIT REV BIOCHEM MOL, V28, P1, DOI 10.3109/10409239309082571; Richardson JP, 2003, CELL, V114, P157, DOI 10.1016/S0092-8674(03)00554-3; Richardson JP, 2002, BBA-GENE STRUCT EXPR, V1577, P251, DOI 10.1016/S0167-4781(02)00456-6; Richardson LV, 1996, J BIOL CHEM, V271, P21597, DOI 10.1074/jbc.271.35.21597; Schwartz A, 2007, J BIOL CHEM, V282, P31469, DOI 10.1074/jbc.M706935200; SHIGESADA K, 1980, NUCLEIC ACIDS RES, V8, P3355, DOI 10.1093/nar/8.15.3355; Skordalakes E, 2003, CELL, V114, P135, DOI 10.1016/S0092-8674(03)00512-9; Skordalakes E, 2006, CELL, V127, P553, DOI 10.1016/j.cell.2006.08.051; Sosunov V, 2003, EMBO J, V22, P2234, DOI 10.1093/emboj/cdg193; Temiakov D, 2005, MOL CELL, V19, P655, DOI 10.1016/j.molcel.2005.07.020; Toulokhonov I, 2003, MOL CELL, V12, P1125, DOI 10.1016/S1097-2765(03)00439-8; Toulokhonov I, 2001, SCIENCE, V292, P730, DOI 10.1126/science.1057738; Toulokhonov I, 2007, MOL CELL, V27, P406, DOI 10.1016/j.molcel.2007.06.008; Tuske S, 2005, CELL, V122, P541, DOI 10.1016/j.cell.2005.07.017; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; Vassylyev DG, 2005, NAT STRUCT MOL BIOL, V12, P1086, DOI 10.1038/nsmb1015; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Wei RR, 2001, J MOL BIOL, V314, P1007, DOI 10.1006/jmbi.2000.5207; Wei RR, 2001, J BIOL CHEM, V276, P28380, DOI 10.1074/jbc.M102444200; WILSON KS, 1994, J MOL BIOL, V244, P36, DOI 10.1006/jmbi.1994.1702; Xu Y, 2002, J BIOL CHEM, V277, P30023, DOI 10.1074/jbc.M111009200; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611; ZALATAN F, 1993, J BIOL CHEM, V268, P17051	49	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20243	20251		10.1074/jbc.M801926200	http://dx.doi.org/10.1074/jbc.M801926200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18482981	hybrid			2022-12-25	WOS:000257565300040
J	Gratz, N; Siller, M; Schaljo, B; Pirzada, ZA; Gattermeier, I; Vojtek, I; Kirschning, CJ; Wagner, H; Charpentier, E; Kovarik, P; Akira, S				Gratz, Nina; Siller, Maria; Schaljo, Barbara; Pirzada, Zaid A.; Gattermeier, Irene; Vojtek, Ivo; Kirschning, Carsten J.; Wagner, Hermann; Charpentier, Emmanuelle; Kovarik, Pavel; Akira, Shizuo			Group A streptococcus activates type I interferon production and MyD88-dependent signaling without involvement of TLR2, TLR4, and TLR9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNE-RESPONSE; TANK-BINDING KINASE-1; NF-KAPPA-B; STREPTOLYSIN-O; VIRAL-INFECTION; MYCOBACTERIUM-TUBERCULOSIS; LISTERIA-MONOCYTOGENES; INTRACELLULAR BACTERIA; HUMAN MACROPHAGES; GENE-EXPRESSION	Bacterial pathogens are recognized by the innate immune system through pattern recognition receptors, such as Toll-like receptors (TLRs). Engagement of TLRs triggers signaling cascades that launch innate immune responses. Activation of MAPKs and NF-kappa B, elements of the major signaling pathways induced by TLRs, depends in most cases on the adaptor molecule MyD88. In addition, Gram-negative or intracellular bacteria elicit MyD88-independent signaling that results in production of type I interferon (IFN). Here we show that in mouse macrophages, the activation of MyD88-dependent signaling by the extracellular Gram-positive human pathogen group A streptococcus (GAS; Streptococcus pyogenes) does not require TLR2, a receptor implicated in sensing of Gram-positive bacteria, or TLR4 and TLR9. Redundant engagement of either of these TLR molecules was excluded by using TLR2/4/9 triple-deficient macrophages. We further demonstrate that infection of macrophages by GAS causes IRF3 (interferon-regulatory factor 3)-dependent, MyD88-independent production of IFN. Surprisingly, IFN is induced also by GAS lacking slo and sagA, the genes encoding cytolysins that were shown to be required for IFN production in response to other Gram-positive bacteria. Our data indicate that (i) GAS is recognized by a MyD88-dependent receptor other than any of those typically used by bacteria, and (ii) GAS as well as GAS mutants lacking cytolysin genes induce type I IFN production by similar mechanisms as bacteria requiring cytoplasmic escape and the function of cytolysins.	[Gratz, Nina; Siller, Maria; Schaljo, Barbara; Pirzada, Zaid A.; Gattermeier, Irene; Vojtek, Ivo; Charpentier, Emmanuelle; Kovarik, Pavel] Univ Vienna, Dept Microbiol & Immunobiol, Max F Perutz Labs, A-1030 Vienna, Austria; [Kirschning, Carsten J.; Wagner, Hermann] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany; [Akira, Shizuo] Osaka Univ, Res Inst Microbial Dis, Dept Host Def, Suita, Osaka 5650871, Japan	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Technical University of Munich; Osaka University	Charpentier, E (corresponding author), Univ Vienna, Dept Microbiol & Immunobiol, Max F Perutz Labs, Dr Bohr Gasse 9, A-1030 Vienna, Austria.	emanuelle.charpentier@univie.ac.at; pavel.kovarik@univie.ac.at	Akira, Shizuo/C-3134-2009; Kovarik, Pavel/D-1184-2014	Kovarik, Pavel/0000-0003-2956-0944	Austrian Science Fund FWF [I 288, F 2805, P 17238] Funding Source: Medline; Austrian Science Fund (FWF) [F 2805] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))		Abel B, 2002, J IMMUNOL, V169, P3155, DOI 10.4049/jimmunol.169.6.3155; Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alcamo E, 2001, J IMMUNOL, V167, P1592, DOI 10.4049/jimmunol.167.3.1592; Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; ALOUF JE, 1980, PHARMACOL THERAPEUT, V11, P661, DOI 10.1016/0163-7258(80)90045-5; BACCARINI M, 1985, J IMMUNOL, V134, P2658; Beres SB, 2006, P NATL ACAD SCI USA, V103, P7059, DOI 10.1073/pnas.0510279103; Beres SB, 2004, P NATL ACAD SCI USA, V101, P11833, DOI 10.1073/pnas.0404163101; Bisno AL, 2003, LANCET INFECT DIS, V3, P191, DOI 10.1016/S1473-3099(03)00576-0; CAPARON MG, 1991, INFECT IMMUN, V59, P1811, DOI 10.1128/IAI.59.5.1811-1817.1991; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Chhatwal GS, 2005, TRENDS MOL MED, V11, P152, DOI 10.1016/j.molmed.2005.02.001; Cho KH, 2005, MOL MICROBIOL, V57, P1545, DOI 10.1111/j.1365-2958.2005.04786.x; Decker T, 2005, NAT REV IMMUNOL, V5, P675, DOI 10.1038/nri1684; Delbridge LM, 2007, CURR OPIN IMMUNOL, V19, P10, DOI 10.1016/j.coi.2006.11.005; Ferwerda G, 2005, PLOS PATHOG, V1, P279, DOI 10.1371/journal.ppat.0010034; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gao JJ, 1998, J IMMUNOL, V161, P4803; Gavrilin MA, 2006, P NATL ACAD SCI USA, V103, P141, DOI 10.1073/pnas.0504271103; Gerdes N, 2002, J EXP MED, V195, P245, DOI 10.1084/jem.20011022; Glaccum MB, 1997, J IMMUNOL, V159, P3364; Glomski IJ, 2007, CELL MICROBIOL, V9, P502, DOI 10.1111/j.1462-5822.2006.00806.x; Goldmann O, 2004, INFECT IMMUN, V72, P2956, DOI 10.1128/IAI.72.5.2956-2963.2004; Hakansson A, 2005, P NATL ACAD SCI USA, V102, P5192, DOI 10.1073/pnas.0408721102; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Henneke P, 2002, J IMMUNOL, V169, P3970, DOI 10.4049/jimmunol.169.7.3970; Hoshino K, 1999, J IMMUNOL, V162, P3749; HUG H, 1988, MOL CELL BIOL, V8, P3065, DOI 10.1128/MCB.8.8.3065; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Karaghiosoff M, 2000, IMMUNITY, V13, P549, DOI 10.1016/S1074-7613(00)00054-6; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Kotb M, 2002, NAT MED, V8, P1398, DOI 10.1038/nm800; Kovarik P, 1998, EMBO J, V17, P3660, DOI 10.1093/emboj/17.13.3660; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Lee KS, 2007, CELL IMMUNOL, V245, P103, DOI 10.1016/j.cellimm.2007.04.003; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Levy DE, 2002, J EXP MED, V195, pF15, DOI 10.1084/jem.20020075; Mangold M, 2004, MOL MICROBIOL, V53, P1515, DOI 10.1111/j.1365-2958.2004.04222.x; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Medina Eva, 2005, Briefings in Functional Genomics & Proteomics, V4, P248, DOI 10.1093/bfgp/4.3.248; Miettinen M, 2000, J IMMUNOL, V164, P3733, DOI 10.4049/jimmunol.164.7.3733; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nizet V, 2002, TRENDS MICROBIOL, V10, P575, DOI 10.1016/S0966-842X(02)02473-3; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; O'Riordan M, 2002, P NATL ACAD SCI USA, V99, P13861, DOI 10.1073/pnas.202476699; Ozoren N, 2006, J IMMUNOL, V176, P4337, DOI 10.4049/jimmunol.176.7.4337; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Park C, 2000, IMMUNITY, V13, P795, DOI 10.1016/S1074-7613(00)00077-7; Park JM, 2004, J EXP MED, V200, P1647, DOI 10.1084/jem.20041215; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; PORTNOY DA, 1992, INFECT IMMUN, V60, P2710, DOI 10.1128/IAI.60.7.2710-2717.1992; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Ruiz N, 1998, MOL MICROBIOL, V27, P337, DOI 10.1046/j.1365-2958.1998.00681.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Senftleben U, 2001, IMMUNITY, V14, P217, DOI 10.1016/S1074-7613(01)00104-2; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Sierig G, 2003, INFECT IMMUN, V71, P446, DOI 10.1128/IAI.71.1.446-455.2003; Staali L, 2003, CELL MICROBIOL, V5, P253, DOI 10.1046/j.1462-5822.2003.00272.x; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Stockinger S, 2004, J IMMUNOL, V173, P7416, DOI 10.4049/jimmunol.173.12.7416; Stockinger S, 2002, J IMMUNOL, V169, P6522, DOI 10.4049/jimmunol.169.11.6522; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Taniguchi T, 2002, CURR OPIN IMMUNOL, V14, P111, DOI 10.1016/S0952-7915(01)00305-3; Thulin P, 2006, PLOS MED, V3, P371, DOI 10.1371/journal.pmed.0030053; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Vazquez N, 2006, J LEUKOCYTE BIOL, V80, P1136, DOI 10.1189/jlb.0306206; Virtaneva K, 2005, P NATL ACAD SCI USA, V102, P9014, DOI 10.1073/pnas.0503671102; Wei XQ, 1999, J IMMUNOL, V163, P2821; Xu DM, 1998, J EXP MED, V188, P1485, DOI 10.1084/jem.188.8.1485; Yasuda K, 2005, J IMMUNOL, V174, P6129, DOI 10.4049/jimmunol.174.10.6129	76	69	70	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					19879	19887		10.1074/jbc.M802848200	http://dx.doi.org/10.1074/jbc.M802848200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18480050	hybrid, Green Published			2022-12-25	WOS:000257565300002
J	Mullen, JR; Brill, SJ				Mullen, Janet R.; Brill, Steven J.			Activation of the Slx5-Slx8 ubiquitin ligase by poly-small ubiquitin-like modifier conjugates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SGS1 DNA HELICASE; SUMO ISOPEPTIDASE; PROTEIN; COMPLEX; RECOMBINATION; REPAIR; SUMOYLATION; PCNA; REPLICATION; PATHWAY	Protein sumoylation is a regulated process that is important for the health of human and yeast cells. In budding yeast, a subset of sumoylated proteins is targeted for ubiquitination by a conserved heterodimeric ubiquitin (Ub) ligase, Slx5-Slx8, which is needed to suppress the accumulation of high molecular weight small ubiquitin-like modifier (SUMO) conjugates. Structure-function analysis indicates that the Slx5-Slx8 complex contains multiple SUMO-binding domains that are collectively required for in vivo function. To determine the specificity of Slx5-Slx8, we assayed its Ub ligase activity using sumoylated Siz2 as an in vitro substrate. In contrast to unsumoylated or multisumoylated Siz2, substrates containing poly-SUMO conjugates were efficiently ubiquitinated by Slx5-Slx8. Although Siz2 itself was ubiquitinated, the bulk of the Ub was conjugated to SUMO residues. Slx5-Slx8 primarily mono-ubiquitinated the N-terminal SUMO moiety of the chain. These data indicate that the Slx5-Slx8 Ub ligase is stimulated by poly-SUMO conjugates and that it can ubiquitinate a poly-SUMO chain.	[Mullen, Janet R.; Brill, Steven J.] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Brill, SJ (corresponding author), Rutgers State Univ, Ctr Adv Biotechnol & Med, 679 Hoes Lane, Piscataway, NJ 08854 USA.	brill@mbcl.rutgers.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071268] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM071268, R01 GM071268-09, GM 071268] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ardley HC, 2005, ESSAYS BIOCHEM, V41, P15, DOI 10.1042/EB0410015; Bencsath KP, 2002, J BIOL CHEM, V277, P47938, DOI 10.1074/jbc.M207442200; Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; Burgess RC, 2007, MOL CELL BIOL, V27, P6153, DOI 10.1128/MCB.00787-07; Bylebyl GR, 2003, J BIOL CHEM, V278, P44113, DOI 10.1074/jbc.M308357200; Chen XL, 2005, MOL CELL BIOL, V25, P4311, DOI 10.1128/MCB.25.10.4311-4320.2005; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hochstrasser M, 2001, CELL, V107, P5, DOI 10.1016/S0092-8674(01)00519-0; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Ii T, 2007, CELL CYCLE, V6, P2800, DOI 10.4161/cc.6.22.4882; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kosoy A, 2007, J BIOL CHEM, V282, P20388, DOI 10.1074/jbc.M702652200; Li SJ, 2000, MOL CELL BIOL, V20, P2367, DOI 10.1128/MCB.20.7.2367-2377.2000; Li SJ, 2003, J CELL BIOL, V160, P1069, DOI 10.1083/jcb.200212052; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Li T, 2007, DNA REPAIR, V6, P1679, DOI 10.1016/j.dnarep.2007.06.004; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Maeda D, 2004, DNA REPAIR, V3, P335, DOI 10.1016/j.dnarep.2003.11.011; Mullen JR, 2001, GENETICS, V157, P103; Mullen JR, 2000, GENETICS, V154, P1101; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Rose MD., 1990, METHODS YEAST GENETI; Sacher M, 2006, NAT CELL BIOL, V8, P1284, DOI 10.1038/ncb1488; Soustelle C, 2004, MOL CELL BIOL, V24, P5130, DOI 10.1128/MCB.24.12.5130-5143.2004; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Torres-Rosell J, 2007, NAT CELL BIOL, V9, P923, DOI 10.1038/ncb1619; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; Wang Z, 2006, GENETICS, V172, P1499, DOI 10.1534/genetics.105.052811; Xie Y, 2007, J BIOL CHEM, V282, P34176, DOI 10.1074/jbc.M706025200; Yang LT, 2006, NUCLEIC ACIDS RES, V34, P5541, DOI 10.1093/nar/gkl685; Zhang CY, 2006, DNA REPAIR, V5, P336, DOI 10.1016/j.dnarep.2005.10.010; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102	41	79	83	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					19912	19921		10.1074/jbc.M802690200	http://dx.doi.org/10.1074/jbc.M802690200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18499666	hybrid, Green Published			2022-12-25	WOS:000257565300006
J	Rezaie, AR; Bae, JS; Manithody, C; Qureshi, SH; Yang, LK				Rezaie, Alireza R.; Bae, Jong-Sup; Manithody, Chandrashekhara; Qureshi, Shabir H.; Yang, Likui			Protein Z-dependent protease inhibitor binds to the C-terminal domain of protein Z	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-X/XA; ACTIVE-SITE; FACTOR-XA; COMPLEX; PLASMA; ACTIVATION; THROMBIN; MUTANTS; CALCIUM; SERPIN	Protein Z (PZ) is a multidomain vitamin K-dependent plasma protein that functions as a cofactor to promote the inactivation of factor Xa (fXa) by PZ-dependent protease inhibitor (ZPI) by three orders of magnitude. To understand the mechanism by which PZ improves the reactivity of fXa with ZPI, we expressed wild-type PZ, PZ lacking the gamma-carboxyglutamic acid domain (GD-PZ), and a chimeric PZ mutant in which both Gla and EGF-like domains of the molecule were substituted with identical domains of fXa. The ZPI binding and the cofactor function of the PZ derivatives were characterized in both binding and kinetic assays. The binding assay indicated that all PZ derivatives interact with ZPI with a similar dissociation constant (KD) of similar to 7 nM. However, the apparent KD for the chimeric PZ-mediated ZPI inhibition of fXa was elevated 6-fold on PC/PS vesicles and its capacity to function as a cofactor to accelerate the ZPI inhibition of fXa was also decreased 6-fold. The cofactor activity of GD-PZ was dramatically impaired; however, the deletion mutant exhibited a normal cofactor function in solution. A chimeric activated protein C mutant containing the Gla domain of fXa was susceptible to inhibition by ZPI in the presence of PZ. These results suggest that: (i) the ZPI interactive site of PZ is located within the C-terminal domain of the cofactor and (ii) a specific interaction between the Gla domains of PZ and fXa contributes similar to 6-fold to the acceleration of the ZPI inhibition of fXa on phospholipid membranes.	St Louis Univ, Sch Med, Dept Biochem & Mol Biol, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA	Saint Louis University	Rezaie, AR (corresponding author), St Louis Univ, Sch Med, Dept Biochem & Mol Biol, Edward A Doisy Dept Biochem & Mol Biol, 1100 S Grand Blvd, St Louis, MO 63104 USA.	rezaiear@slu.edu	Bae, Jong-Sup/AAU-9724-2020; Qureshi, Shabir H/B-3610-2014		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062565, R01HL068571] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 68571, HL 62565] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BROZE GJ, 1984, J CLIN INVEST, V73, P933, DOI 10.1172/JCI111317; Chen L, 2004, PROTEIN SCI, V13, P431, DOI 10.1110/ps.03406904; Han X, 1999, BIOCHEMISTRY-US, V38, P11073, DOI 10.1021/bi990641a; Han X, 2000, BLOOD, V96, P3049; Han X, 1998, P NATL ACAD SCI USA, V95, P9250, DOI 10.1073/pnas.95.16.9250; Heeb MJ, 2005, J BIOL CHEM, V280, P33819, DOI 10.1074/jbc.M506502200; HUSTEN EJ, 1987, J BIOL CHEM, V262, P12953; ICHINOSE A, 1990, BIOCHEM BIOPH RES CO, V172, P1139, DOI 10.1016/0006-291X(90)91566-B; Kemkes-Matthes B, 2002, THROMB RES, V106, P183, DOI 10.1016/S0049-3848(02)00181-0; Kittur FS, 2004, J BIOL CHEM, V279, P24189, DOI 10.1074/jbc.M402302200; OLSON ST, 1992, J BIOL CHEM, V267, P12528; Qureshi SH, 2007, BIOCHEM J, V407, P427, DOI 10.1042/BJ20070735; Rezaie AR, 2006, BIOCHEMISTRY-US, V45, P9427, DOI 10.1021/bi060820+; Rezaie AR, 2005, J BIOL CHEM, V280, P32722, DOI 10.1074/jbc.M505517200; REZAIE AR, 1992, J BIOL CHEM, V267, P26104; SEJIMA H, 1990, BIOCHEM BIOPH RES CO, V171, P661, DOI 10.1016/0006-291X(90)91197-Z; SMIRNOV MD, 1994, J BIOL CHEM, V269, P816; Tabatabai A, 2001, THROMB HAEMOSTASIS, V85, P655, DOI 10.1055/s-0037-1615649; WATER N, 2005, BRIT J HAEMATOL, V129, P561; Yang LK, 2007, THROMB HAEMOSTASIS, V97, P899, DOI 10.1160/TH06-12-0697	20	33	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					19922	19926		10.1074/jbc.M802639200	http://dx.doi.org/10.1074/jbc.M802639200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18502758	Green Published, hybrid			2022-12-25	WOS:000257565300007
J	Miller, CA; Leonard, HS; Pinsky, IG; Turner, BM; Williams, SR; Harrison, L; Fletcher, AF; Shen, GZ; Bryant, DA; Schluchter, WM				Miller, Crystal A.; Leonard, Heidi S.; Pinsky, Ivan G.; Turner, Brandy M.; Williams, Shervonda R.; Harrison, Leon, Jr.; Fletcher, Ariane F.; Shen, Gaozhong; Bryant, Donald A.; Schluchter, Wendy M.			Biogenesis of phycobiliproteins - III. CpcM is the asparagine methyltransferase for phycobiliprotein beta-subunits in cyanobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-N-METHYLASPARAGINE; SYNECHOCOCCUS SP PCC-7002; MASTIGOCLADUS-LAMINOSUS; ENERGY-TRANSFER; C-PHYCOCYANIN; ALPHA-SUBUNIT; POSTTRANSLATIONAL METHYLATION; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; BILIN LYASE	All phycobiliproteins contain a conserved, post-translational modification on asparagine 72 of their beta-subunits. Methylation of this Asn to produce gamma-N-methylasparagine has been shown to increase energy transfer efficiency within the phycobilisome and to prevent photoinhibition. We report here the biochemical characterization of the product of sll0487, which we have named cpcM, from the cyanobacterium Synechocystis sp. PCC 6803. Recombinant apo-phycocyanin and apo-allophycocyanin subunits were used as the substrates for assays with [methyl-H-3]S-adenosylmethionine and recombinant CpcM. CpcM methylated the beta-subunits of phycobiliproteins (CpcB, ApcB, and ApcF) and did not methylate the corresponding alpha-subunits (CpcA, ApcA, and ApcD), although they are similar in primary and tertiary structure. CpcM preferentially methylated its CpcB substrate after chromophorylation had occurred at Cys(82). CpcM exhibited lower activity on trimeric phycocyanin after complete chromophorylation and oligomerization had occurred. Based upon these in vitro studies, we conclude that this post-translational modification probably occurs after chromophorylation but before trimer assembly in vivo.	[Miller, Crystal A.; Leonard, Heidi S.; Pinsky, Ivan G.; Turner, Brandy M.; Williams, Shervonda R.; Harrison, Leon, Jr.; Fletcher, Ariane F.; Schluchter, Wendy M.] Univ New Orleans, Dept Biol Sci, New Orleans, LA 70148 USA; [Shen, Gaozhong; Bryant, Donald A.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	University of Louisiana System; University of New Orleans; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Schluchter, WM (corresponding author), Univ New Orleans, Dept Biol Sci, New Orleans, LA 70148 USA.	wschluch@uno.edu	Schluchter, Wendy/G-9662-2013					Adir N, 2003, J BIOL CHEM, V278, P25926, DOI 10.1074/jbc.M302838200; [Anonymous], [No title captured]; APT KE, 1995, J MOL BIOL, V248, P79, DOI 10.1006/jmbi.1995.0203; ARCIERO DM, 1988, J BIOL CHEM, V263, P18343; Ashby MK, 1999, PHOTOSYNTH RES, V61, P169, DOI 10.1023/A:1006217201666; BRYANT DA, 1979, ARCH MICROBIOL, V123, P113, DOI 10.1007/BF00446810; Cai YA, 2001, ANAL BIOCHEM, V290, P186, DOI 10.1006/abio.2000.4979; Clarke S, 2002, P NATL ACAD SCI USA, V99, P1104, DOI 10.1073/pnas.042004099; DELORIMIER RM, 1992, PLANT PHYSIOL, V98, P1003, DOI 10.1104/pp.98.3.1003; Ducret A, 1996, EUR J BIOCHEM, V236, P1010, DOI 10.1111/j.1432-1033.1996.01010.x; DUCRET A, 1994, EUR J BIOCHEM, V221, P563, DOI 10.1111/j.1432-1033.1994.tb18769.x; DUERRING M, 1988, FEBS LETT, V236, P167, DOI 10.1016/0014-5793(88)80308-9; FAIRCHILD CD, 1994, J BIOL CHEM, V269, P8686; FAIRCHILD CD, 1992, P NATL ACAD SCI USA, V89, P7017, DOI 10.1073/pnas.89.15.7017; FUGLISTALLER P, 1987, BIOL CHEM H-S, V368, P353, DOI 10.1515/bchm3.1987.368.1.353; GANTT E, 1972, J CELL BIOL, V54, P313, DOI 10.1083/jcb.54.2.313; GLAUSER M, 1993, PHOTOCHEM PHOTOBIOL, V57, P344, DOI 10.1111/j.1751-1097.1993.tb02298.x; GLAZER AN, 1984, BIOCHIM BIOPHYS ACTA, V768, P29, DOI 10.1016/0304-4173(84)90006-5; GLAZER AN, 1989, J BIOL CHEM, V264, P1; KEHRY MR, 1982, J BIOL CHEM, V257, P378; KLOTZ AV, 1987, J BIOL CHEM, V262, P17350; KLOTZ AV, 1993, J ORG CHEM, V58, P6985, DOI 10.1021/jo00077a014; KLOTZ AV, 1986, J BIOL CHEM, V261, P5891; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAXSON P, 1989, BIOCHIM BIOPHYS ACTA, V977, P40, DOI 10.1016/S0005-2728(89)80007-6; Nakahigashi K, 2002, P NATL ACAD SCI USA, V99, P1473, DOI 10.1073/pnas.032488499; Polevoda B, 2007, MOL MICROBIOL, V65, P590, DOI 10.1111/j.1365-2958.2007.05831.x; RAPS S, 1990, PLANT PHYSIOL, V92, P358, DOI 10.1104/pp.92.2.358; Reuter W, 1999, P NATL ACAD SCI USA, V96, P1363, DOI 10.1073/pnas.96.4.1363; RUMBELI R, 1987, BIOL CHEM H-S, V368, P1, DOI 10.1515/bchm3.1987.368.1.1; RUMBELI R, 1987, FEBS LETT, V221, P1, DOI 10.1016/0014-5793(87)80341-1; Saunee NA, 2008, J BIOL CHEM, V283, P7513, DOI 10.1074/jbc.M708165200; SCHIRMER T, 1986, J MOL BIOL, V188, P651, DOI 10.1016/S0022-2836(86)80013-4; Schluchter WM, 1997, J BIOL CHEM, V272, P13562, DOI 10.1074/jbc.272.21.13562; SHEN G, 2008, J BACTERIOL IN PRESS; Shen G, 2008, J BIOL CHEM, V283, P7503, DOI 10.1074/jbc.M708164200; Shen G, 2006, J BIOL CHEM, V281, P17768, DOI 10.1074/jbc.M602563200; Sidler W. A., 1994, MOL BIOL CYANOBACTER, P139, DOI [10.1007/978-94-011-0227-8_7, DOI 10.1007/978-94-011-0227-8_7]; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SWANSON RV, 1990, J MOL BIOL, V214, P787, DOI 10.1016/0022-2836(90)90293-U; THOMAS BA, 1995, BIOCHEMISTRY-US, V34, P3758, DOI 10.1021/bi00011a034; THOMAS BA, 1993, BIOCHIM BIOPHYS ACTA, V1143, P104, DOI 10.1016/0005-2728(93)90222-2; Tooley AJ, 2001, P NATL ACAD SCI USA, V98, P10560, DOI 10.1073/pnas.181340998; WEHRMEYER W, 1983, PHOTOSYNTHETIC PROKA, P1; WESTERMANN M, 1994, ARCH MICROBIOL, V162, P222, DOI 10.1007/s002030050129; WILBANKS SM, 1989, J BIOL CHEM, V264, P17860; YAMANAKA G, 1978, J BIOL CHEM, V253, P8303; Zhao J., 1992, RES PHOTOSYNTHESIS, V1, P25; Zhao JD, 2001, BBA-BIOENERGETICS, V1505, P248, DOI 10.1016/S0005-2728(01)00175-X; ZHOU JH, 1992, J BIOL CHEM, V267, P16138	50	21	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19293	19300		10.1074/jbc.M802734200	http://dx.doi.org/10.1074/jbc.M802734200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18482977	hybrid			2022-12-25	WOS:000257387600015
J	Reyes-Turcu, FE; Shanks, JR; Komander, D; Wilkinson, KD				Reyes-Turcu, Francisca E.; Shanks, John R.; Komander, David; Wilkinson, Keith D.			Recognition of polyubiquitin isoforms by the multiple ubiquitin binding modules of isopeptidase T	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBA DOMAIN; DEUBIQUITINATING ENZYME; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; PROTEIN; CHAINS; COMPLEX; FAMILY; TETRAUBIQUITIN; MONOUBIQUITIN	The conjugation of polyubiquitin to target proteins acts as a signal that regulates target stability, localization, and function. Several ubiquitin binding domains have been described, and while much is known about ubiquitin binding to the isolated domains, little is known with regard to how the domains interact with polyubiquitin in the context of full-length proteins. Isopeptidase T(IsoT/USP5) is a deubiquitinating enzyme that is largely responsible for the disassembly of unanchored polyubiquitin in the cell. IsoT has four ubiquitin binding domains: a zinc finger domain (ZnF UBP), which binds the proximal ubiquitin, a UBP domain that forms the active site, and two ubiquitin-associated (UBA) domains whose roles are unknown. Here, we show that the UBA domains are involved in binding two different polyubiquitin isoforms, linear and K48-linked. Using isothermal titration calorimetry, we show that IsoT has at least four ubiquitin binding sites for both polyubiquitin isoforms. The thermodynamics of the interactions reveal that the binding is enthalpy-driven. Mutation of the UBA domains suggests that UBA1 and UBA2 domains of IsoT interact with the third and fourth ubiquitins in both polyubiquitin isoforms, respectively. These data suggest that recognition of the polyubiquitin isoforms by IsoT involves considerable conformational mobility in the polyubiquitin ligand, in the enzyme, or in both.	[Reyes-Turcu, Francisca E.; Shanks, John R.; Wilkinson, Keith D.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Komander, David] Inst Canc Res, London SW3 6JB, England	Emory University; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Wilkinson, KD (corresponding author), Emory Univ, Sch Med, Dept Biochem, 4017 Rollins Res Bldg,1510 Clifton Rd, Atlanta, GA 30322 USA.	genekdw@emory.edu			NIGMS NIH HHS [GM075426, GM30308] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM075426, R01GM030308] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amerik AY, 1997, EMBO J, V16, P4826; AnsariLari MA, 1996, GENOME RES, V6, P314, DOI 10.1101/gr.6.4.314; Avvakumov GV, 2006, J BIOL CHEM, V281, P38061, DOI 10.1074/jbc.M606704200; BAKER RT, 1987, NUCLEIC ACIDS RES, V15, P443, DOI 10.1093/nar/15.2.443; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; COOK WJ, 1994, J MOL BIOL, V236, P601, DOI 10.1006/jmbi.1994.1169; Dang LC, 1998, BIOCHEMISTRY-US, V37, P1868, DOI 10.1021/bi9723360; Daniel JA, 2004, J BIOL CHEM, V279, P1867, DOI 10.1074/jbc.C300494200; Doelling JH, 2001, PLANT J, V27, P393, DOI 10.1046/j.1365-313X.2001.01106.x; Eddins MJ, 2007, J MOL BIOL, V367, P204, DOI 10.1016/j.jmb.2006.12.065; Gabriel JM, 2002, BIOCHEMISTRY-US, V41, P13755, DOI 10.1021/bi026096m; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Haririnia A, 2007, J MOL BIOL, V368, P753, DOI 10.1016/j.jmb.2007.02.037; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/0968-0004(96)30015-7; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Hunter CA, 2003, CHEM BIOL, V10, P1023, DOI 10.1016/j.chembiol.2003.10.009; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Komander D, 2008, MOL CELL, V29, P451, DOI 10.1016/j.molcel.2007.12.018; Kozlov G, 2007, J BIOL CHEM, V282, P35787, DOI 10.1074/jbc.M705655200; Lacombe T, 2002, FEBS LETT, V531, P469, DOI 10.1016/S0014-5793(02)03586-X; Larsen CN, 1998, BIOCHEMISTRY-US, V37, P3358, DOI 10.1021/bi972274d; Lindsey DF, 1998, J BIOL CHEM, V273, P29178, DOI 10.1074/jbc.273.44.29178; Lowe ED, 2006, ACTA CRYSTALLOGR D, V62, P177, DOI 10.1107/S0907444905037777; Melandri F, 1996, BIOCHEMISTRY-US, V35, P12893, DOI 10.1021/bi9612935; Mueller TD, 2004, J BIOL CHEM, V279, P11926, DOI 10.1074/jbc.M312865200; Mueller TD, 2002, J MOL BIOL, V319, P1243, DOI 10.1016/S0022-2836(02)00302-9; Ohno A, 2005, STRUCTURE, V13, P521, DOI 10.1016/j.str.2005.01.011; OZKAYNAK E, 1987, EMBO J, V6, P1429, DOI 10.1002/j.1460-2075.1987.tb02384.x; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Phillips CL, 2001, ACTA CRYSTALLOGR D, V57, P341, DOI 10.1107/S090744490001800X; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2001, MOL CELL, V8, P499, DOI 10.1016/S1097-2765(01)00347-1; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Raasi Shahri, 2005, V301, P47; Renatus M, 2006, STRUCTURE, V14, P1293, DOI 10.1016/j.str.2006.06.012; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Russell Nathaniel S., 2005, V301, P207; STEIN RL, 1995, BIOCHEMISTRY-US, V34, P12616, DOI 10.1021/bi00039a017; Swanson KA, 2006, J MOL BIOL, V358, P713, DOI 10.1016/j.jmb.2006.02.059; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Timms KM, 1998, GENE, V217, P101, DOI 10.1016/S0378-1119(98)00341-2; Trempe JF, 2005, EMBO J, V24, P3178, DOI 10.1038/sj.emboj.7600797; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Varadan R, 2005, MOL CELL, V18, P687, DOI 10.1016/j.molcel.2005.05.013; Varadan R, 2002, J MOL BIOL, V324, P637, DOI 10.1016/S0022-2836(02)01198-1; WIBORG O, 1985, EMBO J, V4, P755, DOI 10.1002/j.1460-2075.1985.tb03693.x; WILKINSON KD, 1995, BIOCHEMISTRY-US, V34, P14535, DOI 10.1021/bi00044a032; Williams DH, 2004, J MOL BIOL, V340, P373, DOI 10.1016/j.jmb.2004.04.056	55	100	101	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19581	19592		10.1074/jbc.M800947200	http://dx.doi.org/10.1074/jbc.M800947200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18482987	hybrid, Green Published			2022-12-25	WOS:000257387600044
J	Korukottu, J; Schneider, R; Vijayan, V; Lange, A; Pongs, O; Becker, S; Baldus, M; Zweckstetter, M				Korukottu, Jegannath; Schneider, Robert; Vijayan, Vinesh; Lange, Adam; Pongs, Olaf; Becker, Stefan; Baldus, Marc; Zweckstetter, Markus			High-Resolution 3D Structure Determination of Kaliotoxin by Solid-State NMR Spectroscopy	PLOS ONE			English	Article								High-resolution solid-state NMR spectroscopy can provide structural information of proteins that cannot be studied by X-ray crystallography or solution NMR spectroscopy. Here we demonstrate that it is possible to determine a protein structure by solid-state NMR to a resolution comparable to that by solution NMR. Using an iterative assignment and structure calculation protocol, a large number of distance restraints was extracted from H-1/H-1 mixing experiments recorded on a single uniformly labeled sample under magic angle spinning conditions. The calculated structure has a coordinate precision of 0.6 angstrom and 1.3 angstrom for the backbone and side chain heavy atoms, respectively, and deviates from the structure observed in solution. The approach is expected to be applicable to larger systems enabling the determination of high-resolution structures of amyloid or membrane proteins.	[Korukottu, Jegannath; Schneider, Robert; Vijayan, Vinesh; Lange, Adam; Becker, Stefan; Baldus, Marc; Zweckstetter, Markus] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, Gottingen, Germany; [Pongs, Olaf] Inst Neurale Signalverarbeitung, Zentrum Mol Neurobiol, Hamburg, Germany	Max Planck Society; University of Hamburg; University Medical Center Hamburg-Eppendorf	Korukottu, J (corresponding author), Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, Gottingen, Germany.	maba@mpibpc.mpg.de; mzwecks@gwdg.de	Schneider, Robert/C-1868-2013; Baldus, Marc/C-2737-2009	Schneider, Robert/0000-0003-3279-5365; Baldus, Marc/0000-0001-7068-5613; Zweckstetter, Markus/0000-0002-2536-6581; vijayan, vinesh/0000-0001-5483-1860; Lange, Adam/0000-0002-7534-5973	Max Planck society; EU-NMR; DFG;  [BA1700/5-1];  [PO137/36-1];  [ZW71/2-1];  [ZW71/3-1]	Max Planck society(Max Planck SocietyFoundation CELLEX); EU-NMR; DFG(German Research Foundation (DFG)); ; ; ; 	This work was supported by the Max Planck society, the EU through EU-NMR and the DFG through grants BA1700/5-1, PO137/36-1, ZW71/2-1 and ZW71/3-1.	ANDREW ER, 1958, NATURE, V182, P1659, DOI 10.1038/1821659a0; Andronesi OC, 2004, J BIOMOL NMR, V30, P253, DOI 10.1007/s10858-004-3452-3; Baldus M, 2007, J BIOMOL NMR, V39, P73, DOI 10.1007/s10858-007-9177-3; BAX A, 1990, J MAGN RESON, V86, P304, DOI 10.1016/0022-2364(90)90262-8; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Castellani F, 2002, NATURE, V420, P98, DOI 10.1038/nature01070; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fossi M, 2005, ANGEW CHEM INT EDIT, V44, P6151, DOI 10.1002/anie.200501884; Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896; Gairi M, 1997, J PEPT SCI, V3, P314, DOI 10.1002/(SICI)1099-1387(199707)3:4<314::AID-PSC117>3.0.CO;2-E; Glaubitz C, 1998, J MAGN RESON, V130, P305, DOI 10.1006/jmre.1997.1344; Griffin RG, 1998, NAT STRUCT BIOL, V5, P508, DOI 10.1038/749; Grishaev A, 2004, J AM CHEM SOC, V126, P7281, DOI 10.1021/ja0319994; Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176; Jaroniec CP, 2004, P NATL ACAD SCI USA, V101, P711, DOI 10.1073/pnas.0304849101; Kainosho M, 2006, NATURE, V440, P52, DOI 10.1038/nature04525; Kuszewski J, 2004, J AM CHEM SOC, V126, P6258, DOI 10.1021/ja049786h; Lange A, 2006, NATURE, V440, P959, DOI 10.1038/nature04649; Lange A, 2005, ANGEW CHEM INT EDIT, V44, P2089, DOI 10.1002/anie.200462516; Lange A, 2003, J AM CHEM SOC, V125, P12640, DOI 10.1021/ja034555g; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Luca S, 2003, ACCOUNTS CHEM RES, V36, P858, DOI 10.1021/ar020232y; MACURA S, 1980, MOL PHYS, V41, P95, DOI 10.1080/00268978000102601; Nomura K, 1999, J AM CHEM SOC, V121, P4064, DOI 10.1021/ja984330j; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Pickford AR, 2004, CHEM REV, V104, P3557, DOI 10.1021/cr0304018; Rienstra CM, 2002, P NATL ACAD SCI USA, V99, P10260, DOI 10.1073/pnas.152346599; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Tycko R, 2001, ANNU REV PHYS CHEM, V52, P575, DOI 10.1146/annurev.physchem.52.1.575; Zech SG, 2005, J AM CHEM SOC, V127, P8618, DOI 10.1021/ja0503128; Zhou DH, 2007, ANGEW CHEM INT EDIT, V46, P8380, DOI 10.1002/anie.200702905; Zweckstetter M, 2008, NAT PROTOC, V3, P679, DOI 10.1038/nprot.2008.36	34	29	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2359	10.1371/journal.pone.0002359	http://dx.doi.org/10.1371/journal.pone.0002359			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523586	gold, Green Published, Green Submitted			2022-12-25	WOS:000262614300046
J	Li, HJ; Smolen, GA; Beers, LF; Xia, L; Gerald, W; Wang, J; Haber, DA; Lee, SB				Li, Hongjie; Smolen, Gromoslaw A.; Beers, Lisa F.; Xia, Li; Gerald, William; Wang, Joanne; Haber, Daniel A.; Lee, Sean Bong			Adenosine Transporter ENT4 Is a Direct Target of EWS/WT1 Translocation Product and Is Highly Expressed in Desmoplastic Small Round Cell Tumor	PLOS ONE			English	Article								Background: Desmoplastic Small Round Cell Tumor (DSRCT) is a highly aggressive malignancy that affects mainly adolescents and young adults. A defining characteristic of DSRCT is a specific chromosomal translocation, t(11;22)(p13;q12), that fuses EWS with WT1, leading to a production of two isoforms of chimeric transcription factor, EWS/WT1(-KTS) and EWS/WT1(+KTS). The chimeric proteins are thought to play critical roles in various stages of oncogenesis through aberrant transcription of different genes, but only a few of these genes have been identified. Methodology/Principal Findings: We report the identification of a new target of EWS/WT1, ENT4 (equilibrative nucleoside transporter 4) which encodes a pH-dependent adenosine transporter. ENT4 is transcriptionally activated by both isoforms of EWS/WT1 as evidenced by promoter-reporter and chromatin immunoprecipitation (ChIP) analyses. Furthermore, ENT4 is highly and specifically expressed in primary tumors of DSRCT as well as in a DSRCT cell line, JN-DSRCT-1. Treatment of JN-DSRCT1 cells with adenosine analogs, such as 2-chloro-2'-deoxyadenosine (2-CdA), resulted in an increased cytotoxic response in dose- and pH-dependent manner. Conclusions/Significance: Our detailed analyses of a novel target of EWS/WT1 in DSRCT reveal an insight into the oncogenic mechanism of EWS-fusion chromosomal translocation gene products and provide a new marker for DSRCT. Furthermore, identification of ENT4 as a highly expressed transcript in DSRCT may represent an attractive pathway for targeting chemotherapeutic drugs into DSRCT.	[Li, Hongjie; Beers, Lisa F.; Lee, Sean Bong] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20824 USA; [Smolen, Gromoslaw A.; Haber, Daniel A.] Massachusetts Gen Hosp Canc Ctr, Harvard Med Sch, Charlestown, MA USA; [Xia, Li; Wang, Joanne] Univ Washington, Dept Pharmaceut, Seattle, WA USA; [Gerald, William] Memorial Sloan Kettering Canc Ctr, Dept Pathol, New York, NY USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Harvard University; Massachusetts General Hospital; University of Washington; University of Washington Seattle; Memorial Sloan Kettering Cancer Center	Li, HJ (corresponding author), NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20824 USA.	seanL@intra.niddk.nih.gov		Lee, Sean/0000-0001-6211-3498	Intramural Research Program of the NIH, NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056002, ZIADK056003] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Intramural Research Program of the NIH, NIDDK (S.B.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Adair TH, 2005, AM J PHYSIOL-REG I, V289, pR283, DOI 10.1152/ajpregu.00840.2004; Azuma M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000979; Baldwin SA, 2005, J BIOL CHEM, V280, P15880, DOI 10.1074/jbc.M414337200; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; Barnes K, 2006, CIRC RES, V99, P510, DOI 10.1161/01.RES.0000238359.18495.42; Bertolotti A, 1996, EMBO J, V15, P5022, DOI 10.1002/j.1460-2075.1996.tb00882.x; Bor YC, 2006, GENE DEV, V20, P1597, DOI 10.1101/gad.1402306; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Elwi AN, 2006, BIOCHEM CELL BIOL, V84, P844, DOI 10.1139/O06-198; Engel K, 2004, J BIOL CHEM, V279, P50042, DOI 10.1074/jbc.M407913200; Finkeltov I, 2002, ONCOGENE, V21, P1890, DOI 10.1038/sj.onc.1205042; Galmarini CM, 2002, LANCET ONCOL, V3, P415, DOI 10.1016/S1470-2045(02)00788-X; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gerald WL, 2005, SEMIN CANCER BIOL, V15, P197, DOI 10.1016/j.semcancer.2005.01.005; Gerald WL, 1998, J CLIN ONCOL, V16, P3028, DOI 10.1200/JCO.1998.16.9.3028; GERALD WL, 1991, AM J SURG PATHOL, V15, P499, DOI 10.1097/00000478-199106000-00001; GERALD WL, 1995, P NATL ACAD SCI USA, V92, P1028, DOI 10.1073/pnas.92.4.1028; HABER DA, 1991, P NATL ACAD SCI USA, V88, P9618, DOI 10.1073/pnas.88.21.9618; Hoffman MA, 1997, J CLIN ONCOL, V15, P1138, DOI 10.1200/JCO.1997.15.3.1138; Ito E, 2003, AM J PATHOL, V163, P2165, DOI 10.1016/S0002-9440(10)63573-0; Kim HS, 2007, J BIOL CHEM, V282, P16278, DOI 10.1074/jbc.M700215200; Kim J, 1998, ONCOGENE, V16, P1021, DOI 10.1038/sj.onc.1201616; Kim J, 1998, ONCOGENE, V16, P1973, DOI 10.1038/sj.onc.1201716; Kong W, 2004, CURR DRUG METAB, V5, P63, DOI 10.2174/1389200043489162; Kushner BH, 1996, J CLIN ONCOL, V14, P1526, DOI 10.1200/JCO.1996.14.5.1526; LADANYI M, 1994, CANCER RES, V54, P2837; Lae ME, 2002, AM J SURG PATHOL, V26, P823, DOI 10.1097/00000478-200207000-00001; Lee SB, 1997, NAT GENET, V17, P309, DOI 10.1038/ng1197-309; Lee SB, 2001, EXP CELL RES, V264, P74, DOI 10.1006/excr.2000.5131; Li HJ, 2007, J CLIN INVEST, V117, P1314, DOI 10.1172/JCI31222; LIU SQ, 1995, NAT MED, V1, P267, DOI 10.1038/nm0395-267; MAY WA, 1993, MOL CELL BIOL, V13, P7393, DOI 10.1128/MCB.13.12.7393; Miret S, 2006, J BIOMOL SCREEN, V11, P184, DOI 10.1177/1087057105283787; Morrison AA, 2006, BIOCHEM CELL BIOL, V84, P789, DOI 10.1139/O06-065; Nishio J, 2002, LAB INVEST, V82, P1175, DOI 10.1097/01.LAB.0000028059.92642.03; OHNO T, 1994, ONCOGENE, V9, P3087; Palmer RE, 2002, CANCER CELL, V2, P497, DOI 10.1016/S1535-6108(02)00205-2; RAUSCHER FJ, 1990, SCIENCE, V250, P1259, DOI 10.1126/science.2244209; Reddy JC, 1996, BBA-REV CANCER, V1287, P1, DOI 10.1016/0304-419X(95)00014-7; Reynolds PA, 2003, GENE DEV, V17, P2094, DOI 10.1101/gad.1110703; Rivera MN, 2005, NAT REV CANCER, V5, P699, DOI 10.1038/nrc1696; SAVEN A, 1994, NEW ENGL J MED, V330, P691; Spratlin J, 2004, CLIN CANCER RES, V10, P6956, DOI 10.1158/1078-0432.CCR-04-0224; Wong JC, 2002, ONCOGENE, V21, P2009, DOI 10.1038/sj.onc.1205262; Xia L, 2007, AM J PHYSIOL-RENAL, V292, pF682, DOI 10.1152/ajprenal.00302.2006	45	32	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2353	10.1371/journal.pone.0002353	http://dx.doi.org/10.1371/journal.pone.0002353			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523561	Green Submitted, Green Published, gold			2022-12-25	WOS:000262614300041
J	Petrunia, IV; Frolova, OY; Komarova, TV; Kiselev, SL; Citovsky, V; Dorokhov, YL				Petrunia, Igor V.; Frolova, Olga Y.; Komarova, Tatiana V.; Kiselev, Sergey L.; Citovsky, Vitaly; Dorokhov, Yuri L.			Agrobacterium tumefaciens-Induced Bacteraemia Does Not Lead to Reporter Gene Expression in Mouse Organs	PLOS ONE			English	Article								Agrobacterium tumefaciens is the main plant biotechnology gene transfer tool with host range which can be extended to non-plant eukaryotic organisms under laboratory conditions. Known medical cases of Agrobacterium species isolation from bloodstream infections necessitate the assessment of biosafety-related risks of A. tumefaciens encounters with mammalian organisms. Here, we studied the survival of A. tumefaciens in bloodstream of mice injected with bacterial cultures. Bacterial titers of 10 8 CFU were detected in the blood of the injected animals up to two weeks after intravenous injection. Agrobacteria carrying Cauliflower mosaic virus (CaMV) 35S promoter-based constructs and isolated from the injected mice retained their capacity to promote green fluorescent protein (GFP) synthesis in Nicotiana benthamiana leaves. To examine whether or not the injected agrobacteria are able to express in mouse organs, we used an intron-containing GFP (GFPi) reporter driven either by a cytomegalovirus (CMV) promoter or by a CaMV 35S promoter. Western and northern blot analyses as well as RT-PCR analysis of liver, spleen and lung of mice injected with A. tumefaciens detected neither GFP protein nor its transcripts. Thus, bacteraemia induced in mice by A. tumefaciens does not lead to detectible levels of genetic transformation of mouse organs.	[Petrunia, Igor V.; Frolova, Olga Y.; Komarova, Tatiana V.; Dorokhov, Yuri L.] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia; [Citovsky, Vitaly] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY USA; [Kiselev, Sergey L.; Dorokhov, Yuri L.] Russian Acad Sci, NI Vavilov Inst Gen Genet, Moscow, Russia	Lomonosov Moscow State University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Russian Academy of Sciences; Vavilov Institute of General Genetics	Petrunia, IV (corresponding author), Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia.	dorokhov@genebee.msu.su	Komarova, Tatiana V./D-5824-2012; Kiselev, Sergey/AAO-1247-2020; Dorokhov, Yuri L/D-3565-2012	Komarova, Tatiana V./0000-0001-6558-8755; Dorokhov, Yuri L/0000-0002-4066-8940; kiselev, sergey/0000-0001-7921-6987; Citovsky, Vitaly/0000-0003-2024-6844	Russian Foundation for Basic Research [06-08-01473]; NIH; NSF; NRI USDA CSREE; BARD; BSF; CDR-USAID	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NRI USDA CSREE(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); BARD; BSF(US-Israel Binational Science Foundation); CDR-USAID(United States Agency for International Development (USAID))	This work was partly supported by Russian Foundation for Basic Research (grant 06-08-01473). The work in the VC laboratory is supported by grants from NIH, NSF, NRI USDA CSREE, BARD, BSF, and CDR-USAID.	ALNOR D, 1994, CLIN INFECT DIS, V18, P914, DOI 10.1093/clinids/18.6.914; Amaya RA, 2003, PEDIATR INFECT DIS J, V22, P183; Bulgakov Victor P., 2006, Biotechnology Journal, V1, P454, DOI 10.1002/biot.200500045; Chalandon Y, 2000, BONE MARROW TRANSPL, V26, P101, DOI 10.1038/sj.bmt.1702470; Christakis GB, 2006, J MED MICROBIOL, V55, P1453, DOI 10.1099/jmm.0.46411-0; Dorokhov YL, 2006, J GEN VIROL, V87, P2693, DOI 10.1099/vir.0.82095-0; Dorokhov YL, 2006, FEBS LETT, V580, P3872, DOI 10.1016/j.febslet.2006.06.013; EDMOND MB, 1993, CLIN INFECT DIS, V16, P388, DOI 10.1093/clind/16.3.388; Giammanco GM, 2004, INFECT CONT HOSP EP, V25, P885, DOI 10.1086/502315; Giddings G, 2000, NAT BIOTECHNOL, V18, P1151, DOI 10.1038/81132; HULSE M, 1993, CLIN INFECT DIS, V16, P112, DOI 10.1093/clinids/16.1.112; Klein RL, 2002, EXP NEUROL, V176, P66, DOI 10.1006/exnr.2002.7942; Kunik T, 2001, P NATL ACAD SCI USA, V98, P1871, DOI 10.1073/pnas.041327598; Lacroix B, 2006, TRENDS GENET, V22, P29, DOI 10.1016/j.tig.2005.10.004; Manfredi R, 1999, MICROBIOLOGICA, V22, P375; McCullen CA, 2006, ANNU REV CELL DEV BI, V22, P101, DOI 10.1146/annurev.cellbio.22.011105.102022; Newell CA, 2000, MOL BIOTECHNOL, V16, P53, DOI 10.1385/MB:16:1:53; Paphitou NI, 2003, INFECTION, V31, P421, DOI 10.1007/s15010-003-3175-5; Peiris K, 2006, J HOSP INFECT, V62, P250, DOI 10.1016/j.jhin.2005.06.022; Sacchetti A, 2001, J CELL BIOCHEM, P117; Siegman-Igra Y, 2005, J HOSP INFECT, V60, P122, DOI 10.1016/j.jhin.2004.11.021; SWANN RA, 1985, J CLIN PATHOL, V38, P1293, DOI 10.1136/jcp.38.11.1293; Tzfira T, 2006, CURR OPIN BIOTECH, V17, P147, DOI 10.1016/j.copbio.2006.01.009	23	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2352	10.1371/journal.pone.0002352	http://dx.doi.org/10.1371/journal.pone.0002352			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523638	gold, Green Published, Green Submitted			2022-12-25	WOS:000262614300040
J	Wagner, W; Horn, P; Castoldi, M; Diehlmann, A; Bork, S; Saffrich, R; Benes, V; Blake, J; Pfister, S; Eckstein, V; Ho, AD				Wagner, Wolfgang; Horn, Patrick; Castoldi, Mirco; Diehlmann, Anke; Bork, Simone; Saffrich, Rainer; Benes, Vladimir; Blake, Jonathon; Pfister, Stefan; Eckstein, Volker; Ho, Anthony D.			Replicative Senescence of Mesenchymal Stem Cells: A Continuous and Organized Process	PLOS ONE			English	Article							MARROW STROMAL CELLS; HUMAN BONE-MARROW; LIFE-SPAN; MICRORNA EXPRESSION; INTERNATIONAL-SOCIETY; PROGENITOR CELLS; CORD BLOOD; DIFFERENTIATION; EXPANSION; TELOMERASE	Mesenchymal stem cells (MSC) comprise a promising tool for cellular therapy. These cells are usually culture expanded prior to their application. However, a precise molecular definition of MSC and the sequel of long-term in vitro culture are yet unknown. In this study, we have addressed the impact of replicative senescence on human MSC preparations. Within 43 to 77 days of cultivation (7 to 12 passages), MSC demonstrated morphological abnormalities, enlargement, attenuated expression of specific surface markers, and ultimately proliferation arrest. Adipogenic differentiation potential decreased whereas the propensity for osteogenic differentiation increased. mRNA expression profiling revealed a consistent pattern of alterations in the global gene expression signature of MSC at different passages. These changes are not restricted to later passages, but are continuously acquired with increasing passages. Genes involved in cell cycle, DNA replication and DNA repair are significantly down-regulated in late passages. Genes from chromosome 4q21 were over-represented among differentially regulated transcripts. Differential expression of 10 genes has been verified in independent donor samples as well as in MSC that were isolated under different culture conditions. Furthermore, miRNA expression profiling revealed an up-regulation of hsa-mir-371, hsa-mir-369-5P, hsa-mir-29c, hsa-mir-499 and hsa-let-7f upon in vitro propagation. Our studies indicate that replicative senescence of MSC preparations is a continuous process starting from the first passage onwards. This process includes far reaching alterations in phenotype, differentiation potential, global gene expression patterns, and miRNA profiles that need to be considered for therapeutic application of MSC preparations.	[Wagner, Wolfgang; Horn, Patrick; Diehlmann, Anke; Bork, Simone; Saffrich, Rainer; Eckstein, Volker; Ho, Anthony D.] Heidelberg Univ, Dept Med 5, Heidelberg, Germany; [Wagner, Wolfgang] Heidelberg Univ, Dept Physiol & Pathophysiol, Heidelberg, Germany; [Benes, Vladimir; Blake, Jonathon] European Mol Biol Lab, Genom Core Facil, Heidelberg, Germany; [Castoldi, Mirco; Pfister, Stefan] Heidelberg Univ, Dept Pediat Oncol, Heidelberg, Germany; [Bork, Simone] Heidelberg Acad Sci & Humanities, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg	Wagner, W (corresponding author), Heidelberg Univ, Dept Med 5, Bergheimer Str 58, Heidelberg, Germany.	wolfgang_wagner@med.uni-heidelberg.de	Pfister, Stefan M/F-6860-2013	Pfister, Stefan M/0000-0002-5447-5322; Wagner, Wolfgang/0000-0002-1971-3217; Ho, Anthony D./0000-0002-1656-0833; Benes, Vladimir/0000-0002-0352-2547; Saffrich, Rainer/0000-0002-0547-4550	German Ministry of Education and Research (BMBF) [EP-S19T01]; German Research Foundation DFG [HO 914/7-1]; Joachim Siebeneicher-Stiftung; Academy of Sciences and Humanities, Heidelberg	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation DFG(German Research Foundation (DFG)); Joachim Siebeneicher-Stiftung; Academy of Sciences and Humanities, Heidelberg	This work was supported by the German Ministry of Education and Research (BMBF) within the National Genome Research Network NGFN-2 (EP-S19T01) and within the supporting program cell based regenerative medicine (START-MSC), the German Research Foundation DFG (HO 914/7-1), the Joachim Siebeneicher-Stiftung, Germany and the Academy of Sciences and Humanities, Heidelberg (WIN-Kolleg).	Abdelmagid SM, 2007, J CELL PHYSIOL, V210, P26, DOI 10.1002/jcp.20841; Banfi A, 2000, EXP HEMATOL, V28, P707, DOI 10.1016/S0301-472X(00)00160-0; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baxter MA, 2004, STEM CELLS, V22, P675, DOI 10.1634/stemcells.22-5-675; Blake J, 2006, BIOINFORMATICS, V22, P765, DOI 10.1093/bioinformatics/btk022; Boehm M, 2005, SCIENCE, V310, P1954, DOI 10.1126/science.1115596; Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14; Bryce SD, 2002, NEOPLASIA, V4, P544, DOI 10.1038/sj.neo.7900268; Castoldi M, 2006, RNA, V12, P913, DOI 10.1261/rna.2332406; Castoldi M, 2007, METHODS, V43, P146, DOI 10.1016/j.ymeth.2007.04.009; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Colter DC, 2000, P NATL ACAD SCI USA, V97, P3213, DOI 10.1073/pnas.070034097; Cristofalo VJ, 1998, P NATL ACAD SCI USA, V95, P10614, DOI 10.1073/pnas.95.18.10614; Di Donna S, 2003, MOL CANCER RES, V1, P643; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Fehrer C, 2005, EXP GERONTOL, V40, P926, DOI 10.1016/j.exger.2005.07.006; Fehrer C, 2007, AGING CELL, V6, P745, DOI 10.1111/j.1474-9726.2007.00336.x; HAUNER H, 1989, J CLIN INVEST, V84, P1663, DOI 10.1172/JCI114345; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Hayflick L, 2007, ANN NY ACAD SCI, V1100, P1, DOI 10.1196/annals.1395.001; HAYNESWORTH SE, 1992, BONE, V13, P69, DOI 10.1016/8756-3282(92)90363-2; Hennig T, 2007, J CELL PHYSIOL, V211, P682, DOI 10.1002/jcp.20977; Ho AD, 2005, EMBO REP, V6, pS35, DOI 10.1038/sj.embor.7400436; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Ibanez-Ventoso C, 2006, AGING CELL, V5, P235, DOI 10.1111/j.1474-9726.2006.00210.x; Ihrie RA, 2005, CELL, V120, P843, DOI 10.1016/j.cell.2005.01.008; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Kogler G, 2004, J EXP MED, V200, P123, DOI 10.1084/jem.20040440; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Mareschi K, 2006, J CELL BIOCHEM, V97, P744, DOI 10.1002/jcb.20681; Niemeyer P, 2004, CELLS TISSUES ORGANS, V177, P68, DOI 10.1159/000079182; NING Y, 1991, P NATL ACAD SCI USA, V88, P5635, DOI 10.1073/pnas.88.13.5635; Noer A, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-18; O'Hare MJ, 2001, P NATL ACAD SCI USA, V98, P646, DOI 10.1073/pnas.98.2.646; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Puca AA, 2001, P NATL ACAD SCI USA, V98, P10505, DOI 10.1073/pnas.181337598; Reyes M, 2001, BLOOD, V98, P2615, DOI 10.1182/blood.V98.9.2615; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schoch G, 2006, PLOS MED, V3, P236, DOI 10.1371/journal.pmed.0030014; Schwartz RE, 2002, J CLIN INVEST, V109, P1291, DOI 10.1172/JCI200215182; Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wagner W, 2006, EXP HEMATOL, V34, P536, DOI 10.1016/j.exphem.2006.01.002; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Wagner W, 2007, STEM CELL REV, V3, P239, DOI 10.1007/s12015-007-9001-1; Wagner WG, 2007, STEM CELLS, V25, P2638, DOI 10.1634/stemcells.2007-0280; Weibel J, 2006, ANN NY ACAD SCI, V1067, P317, DOI 10.1196/annals.1354.043; Williams AE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-172; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhang H, 2003, P NATL ACAD SCI USA, V100, P3251, DOI 10.1073/pnas.2627983100	58	758	804	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2213	10.1371/journal.pone.0002213	http://dx.doi.org/10.1371/journal.pone.0002213			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493317	Green Published, gold, Green Submitted			2022-12-25	WOS:000262258700022
J	Yoon, J; Lee, KS; Park, JS; Yu, K; Paik, SG; Kang, YK				Yoon, Jeongheon; Lee, Kyu-Sun; Park, Jung Sun; Yu, Kweon; Paik, Sang-Gi; Kang, Yong-Kook			dSETDB1 and SU(VAR)3-9 Sequentially Function during Germline-Stem Cell Differentiation in Drosophila melanogaster	PLOS ONE			English	Article								Germline-stem cells (GSCs) produce gametes and are thus true "immortal stem cells''. In Drosophila ovaries, GSCs divide asymmetrically to produce daughter GSCs and cystoblasts, and the latter differentiate into germline cysts. Here we show that the histone-lysine methyltransferase dSETDB1, located in pericentric heterochromatin, catalyzes H3-K9 trimethylation in GSCs and their immediate descendants. As germline cysts differentiate into egg chambers, the dSETDB1 function is gradually taken over by another H3-K9-specific methyltransferase, SU(VAR)3-9. Loss-of-function mutations in dsetdb1 or Su(var)3-9 abolish both H3K9me3 and heterochromatin protein-1 (HP1) signals from the anterior germarium and the developing egg chambers, respectively, and cause localization of H3K9me3 away from DNA-dense regions in most posterior germarium cells. These results indicate that dSETDB1 and SU(VAR)3-9 act together with distinct roles during oogenesis, with dsetdb1 being of particular importance due to its GSC-specific function and more severe mutant phenotype.	[Yoon, Jeongheon; Lee, Kyu-Sun; Park, Jung Sun; Yu, Kweon; Kang, Yong-Kook] KRIBB, Ctr Regenerat Med, Taejon, South Korea; [Yoon, Jeongheon; Paik, Sang-Gi] Chungnam Natl Univ, Dept Biol, Taejon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungnam National University	Yoon, J (corresponding author), KRIBB, Ctr Regenerat Med, Taejon, South Korea.	ykkang@kribb.re.kr		Yu, Kweon/0000-0002-4942-2576	KRIBB Research Initiative Program [KGM1310713]	KRIBB Research Initiative Program	This work was supported by KRIBB Research Initiative Program (KGM1310713).	Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Brinster RL, 2002, SCIENCE, V296, P2174, DOI 10.1126/science.1071607; Clough E, 2007, DEVELOPMENT, V134, P157, DOI 10.1242/dev.02698; COOLEY L, 1994, SCIENCE, V266, P590, DOI 10.1126/science.7939713; de Cuevas M, 1997, ANNU REV GENET, V31, P405, DOI 10.1146/annurev.genet.31.1.405; Deng W, 2001, INT REV CYTOL, V203, P93; Dodge JE, 2004, MOL CELL BIOL, V24, P2478, DOI 10.1128/MCB.24.6.2478-2486.2004; Donovan PJ, 2001, NATURE, V414, P92, DOI 10.1038/35102154; Ebert A, 2004, GENE DEV, V18, P2973, DOI 10.1101/gad.323004; Forbes AJ, 1996, DEVELOPMENT, V122, P3283; HAY B, 1988, CELL, V55, P577, DOI 10.1016/0092-8674(88)90216-4; Ichimura T, 2005, J BIOL CHEM, V280, P13928, DOI 10.1074/jbc.M413654200; Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232; JAMES TC, 1989, EUR J CELL BIOL, V50, P170; Jia ST, 2004, CELL, V119, P469, DOI 10.1016/j.cell.2004.10.020; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; King R. C., 1970, OVARIAN DEV DROSOPHI; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Larsson J, 2004, P NATL ACAD SCI USA, V101, P9728, DOI 10.1073/pnas.0400978101; Larsson J, 2001, P NATL ACAD SCI USA, V98, P6273, DOI 10.1073/pnas.111581298; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Locke J, 2000, GENETICS, V155, P1175; MARGOLIS J, 1995, DEVELOPMENT, V121, P3797; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mis J, 2006, MOL GENET GENOMICS, V275, P513, DOI 10.1007/s00438-006-0116-x; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Pidoux AL, 2005, PHILOS T R SOC B, V360, P569, DOI 10.1098/rstb.2004.1611; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Riddle NC, 2006, CHROMOSOME RES, V14, P405, DOI 10.1007/s10577-006-1061-6; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Seum C, 2007, PLOS GENET, V3, P709, DOI 10.1371/journal.pgen.0030076; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; SPRADLING AC, 1993, CELL, V72, P649, DOI 10.1016/0092-8674(93)90393-5; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Stabell M, 2006, NUCLEIC ACIDS RES, V34, P4609, DOI 10.1093/nar/gkl640; Surani MA, 2001, NATURE, V414, P122, DOI 10.1038/35102186; Tachibana M, 2007, EMBO J, V26, P3346, DOI 10.1038/sj.emboj.7601767; TSCHIERSCH B, 1994, EMBO J, V13, P3822, DOI 10.1002/j.1460-2075.1994.tb06693.x; Tzeng TY, 2007, P NATL ACAD SCI USA, V104, P12691, DOI 10.1073/pnas.0705534104; Uchimura Y, 2006, J BIOL CHEM, V281, P23180, DOI 10.1074/jbc.M602280200; Wang HB, 2003, MOL CELL, V12, P475, DOI 10.1016/j.molcel.2003.08.007; Yang L, 2002, ONCOGENE, V21, P148, DOI 10.1038/sj.onc.1204998; Zhang Y, 2001, NATURE, V410, P599, DOI 10.1038/35069099	53	54	55	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2234	10.1371/journal.pone.0002234	http://dx.doi.org/10.1371/journal.pone.0002234			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493619	Green Submitted, Green Published, gold			2022-12-25	WOS:000262258700042
J	Ilmonen, P; Kotrschal, A; Penn, DJ				Ilmonen, Petteri; Kotrschal, Alexander; Penn, Dustin J.			Telomere Attrition Due to Infection	PLOS ONE			English	Article								Background: Telomeres-the terminal caps of chromosomes-become shorter as individuals age, and there is much interest in determining what causes telomere attrition since this process may play a role in biological aging. The leading hypothesis is that telomere attrition is due to inflammation, exposure to infectious agents, and other types of oxidative stress, which damage telomeres and impair their repair mechanisms. Several lines of evidence support this hypothesis, including observational findings that people exposed to infectious diseases have shorter telomeres. Experimental tests are still needed, however, to distinguish whether infectious diseases actually cause telomere attrition or whether telomere attrition increases susceptibility to infection. Experiments are also needed to determine whether telomere erosion reduces longevity. Methodology/Principal Findings: We experimentally tested whether repeated exposure to an infectious agent, Salmonella enterica, causes telomere attrition in wild-derived house mice (Mus musculus musculus). We repeatedly infected mice with a genetically diverse cocktail of five different S. enterica strains over seven months, and compared changes in telomere length with sham-infected sibling controls. We measured changes in telomere length of white blood cells (WBC) after five infections using a real-time PCR method. Our results show that repeated Salmonella infections cause telomere attrition in WBCs, and particularly for males, which appeared less disease resistant than females. Interestingly, we also found that individuals having long WBC telomeres at early age were relatively disease resistant during later life. Finally, we found evidence that more rapid telomere attrition increases mortality risk, although this trend was not significant. Conclusions/Significance: Our results indicate that infectious diseases can cause telomere attrition, and support the idea that telomere length could provide a molecular biomarker for assessing exposure and ability to cope with infectious diseases.	[Ilmonen, Petteri; Kotrschal, Alexander; Penn, Dustin J.] Austrian Acad Sci, Konrad Lorenz Inst Ethol, A-1010 Vienna, Austria	Austrian Academy of Sciences	Ilmonen, P (corresponding author), Austrian Acad Sci, Konrad Lorenz Inst Ethol, A-1010 Vienna, Austria.	p.ilmonen@klivv.oeaw.ac.at	Kotrschal, Alexander/ABB-8987-2021; Kotrschal, Alexander/AEV-1376-2022	Kotrschal, Alexander/0000-0003-3473-1402	Austrian Academy of Sciences	Austrian Academy of Sciences	The work was funded by the Austrian Academy of Sciences. There were no sponsors or funders which would have played any role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript	Aikata H, 2000, GASTROENTEROLOGY, V118, pA905, DOI 10.1016/S0016-5085(00)85756-X; Blackburn EH, 2005, FEBS LETT, V579, P859, DOI 10.1016/j.febslet.2004.11.036; Callicott RJ, 2006, COMPARATIVE MED, V56, P17; Campisi J, 2003, EXP GERONTOL, V38, P5, DOI 10.1016/S0531-5565(02)00152-3; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Goronzy JJ, 2006, EXP GERONTOL, V41, P246, DOI 10.1016/j.exger.2005.12.002; Grabowski P, 2005, BLOOD, V105, P4807, DOI 10.1182/blood-2004-11-4394; Hayflick L, 2000, BRIT J CANCER, V83, P841, DOI 10.1054/bjoc.2000.1296; Hemann MT, 2000, NUCLEIC ACIDS RES, V28, P4474, DOI 10.1093/nar/28.22.4474; Herrera E, 2000, EMBO J, V19, P472, DOI 10.1093/emboj/19.3.472; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Kotrschal A, 2007, BIOL LETTERS, V3, P128, DOI 10.1098/rsbl.2006.0594; Kregel KC, 2007, AM J PHYSIOL-REG I, V292, pR18, DOI 10.1152/ajpregu.00327.2006; Liaudet L, 2002, INFECT IMMUN, V70, P192, DOI 10.1128/IAI.70.1.192-198.2002; Martin-Ruiz C, 2006, ANN NEUROL, V60, P174, DOI 10.1002/ana.20869; Martin-Ruiz CM, 2005, AGING CELL, V4, P287, DOI 10.1111/j.1474-9726.2005.00171.x; MCCLEARN GE, 1997, ILAR J, V38; Miller RA, 2002, EXP BIOL MED, V227, P500, DOI 10.1177/153537020222700715; Pauliny A, 2006, MOL ECOL, V15, P1681, DOI 10.1111/j.1365-294X.2006.02862.x; Pawelec G, 2005, IMMUNOL REV, V205, P257, DOI 10.1111/j.0105-2896.2005.00271.x; Penn DJ, 2002, P NATL ACAD SCI USA, V99, P11260, DOI 10.1073/pnas.162006499; Ravindran R, 2005, IMMUNOLOGY, V114, P450, DOI 10.1111/j.1365-2567.2005.02140.x; RICE WR, 1994, TRENDS ECOL EVOL, V9, P235, DOI 10.1016/0169-5347(94)90258-5; Satyanarayana A, 2003, EMBO J, V22, P4003, DOI 10.1093/emboj/cdg367; Sekoguchi S, 2007, J GASTROEN HEPATOL, V22, P182, DOI 10.1111/j.1440-1746.2006.04454.x; Sheppard M, 2003, CELL MICROBIOL, V5, P593, DOI 10.1046/j.1462-5822.2003.00296.x; Valenzuela HF, 2002, CLIN IMMUNOL, V105, P117, DOI 10.1006/clim.2002.5271; Vallejo AN, 2004, TRENDS MOL MED, V10, P119, DOI 10.1016/j.molmed.2004.01.002; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; von Zglinicki T, 2005, CURR MOL MED, V5, P197; von Zglinicki T, 2001, EXP GERONTOL, V36, P1049, DOI 10.1016/S0531-5565(01)00111-5; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; WENG NP, 1995, P NATL ACAD SCI USA, V92, P11091, DOI 10.1073/pnas.92.24.11091; Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com	36	117	119	16	695	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2143	10.1371/journal.pone.0002143	http://dx.doi.org/10.1371/journal.pone.0002143			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478110	Green Published, gold, Green Submitted			2022-12-25	WOS:000262172800008
J	Niewiarowski, PH; Lopez, S; Ge, L; Hagan, E; Dhinojwala, A				Niewiarowski, Peter H.; Lopez, Stephanie; Ge, Liehui; Hagan, Emily; Dhinojwala, Ali			Sticky Gecko Feet: The Role of Temperature and Humidity	PLOS ONE			English	Article								Gecko adhesion is expected to be temperature insensitive over the range of temperatures typically experienced by geckos. Previous work is limited and equivocal on whether this expectation holds. We tested the temperature dependence of adhesion in Tokay and Day geckos and found that clinging ability at 12 degrees C was nearly double the clinging ability at 32 degrees C. However, rather than confirming a simple temperature effect, our data reveal a complex interaction between temperature and humidity that can drive differences in adhesion by as much as two-fold. Our findings have important implications for inferences about the mechanisms underlying the exceptional clinging capabilities of geckos, including whether performance of free-ranging animals is based solely on a dry adhesive model. An understanding of the relative contributions of van der Waals interactions and how humidity and temperature variation affects clinging capacities will be required to test hypotheses about the evolution of gecko toepads and is relevant to the design and manufacture of synthetic mimics.	[Niewiarowski, Peter H.; Lopez, Stephanie] Univ Akron, Dept Biol, Program Integrated Biosci, Akron, OH 44325 USA; [Ge, Liehui; Hagan, Emily; Dhinojwala, Ali] Univ Akron, Dept Polymer Sci, Akron, OH USA	University System of Ohio; University of Akron; University System of Ohio; University of Akron	Niewiarowski, PH (corresponding author), Univ Akron, Dept Biol, Program Integrated Biosci, Akron, OH 44325 USA.	phn@uakron.edu	Ge, Liehui/N-7881-2015; niewiarowski, peter/AAA-7060-2022	niewiarowski, peter/0000-0002-8952-3013; Ge, Liehui/0000-0002-1990-5681	Integrated Bioscience Program, University of Akron [DMR 0353746]; NSF-NIRT [0609077]	Integrated Bioscience Program, University of Akron; NSF-NIRT(National Science Foundation (NSF))	Partial support for this project was provided by the Integrated Bioscience Program, University of Akron (PHN and AD), by E.H. research experience for undergraduates (DMR 0353746) and NSF-NIRT 0609077 (AD).	Alibardi L, 2005, TISSUE CELL, V37, P423, DOI 10.1016/j.tice.2005.05.005; Alibardi L, 2003, TISSUE CELL, V35, P288, DOI 10.1016/S0040-8166(03)00050-8; Alibardi L, 2007, J ANAT, V211, P104, DOI 10.1111/j.1469-7580.2007.00752.x; Angilletta MJ, 2002, J THERM BIOL, V27, P249, DOI 10.1016/S0306-4565(01)00094-8; Autumn K, 2006, AM SCI, V94, P124, DOI 10.1511/2006.58.124; Autumn K, 2002, INTEGR COMP BIOL, V42, P1081, DOI 10.1093/icb/42.6.1081; Bergmann PJ, 2005, J EXP ZOOL PART A, V303A, P785, DOI 10.1002/jez.a.210; Hawthorn AC, 2003, J EXP BIOL, V206, P3905, DOI 10.1242/jeb.00618; Hawthorn AC, 2002, BIOL J LINN SOC, V77, P1, DOI 10.1046/j.1095-8312.2002.00099.x; Huber G, 2005, P NATL ACAD SCI USA, V102, P16293, DOI 10.1073/pnas.0506328102; HUEY RB, 1989, PHYSIOL ZOOL, V62, P488, DOI 10.1086/physzool.62.2.30156181; Irschick DJ, 1996, BIOL J LINN SOC, V59, P21, DOI 10.1111/j.1095-8312.1996.tb01451.x; Irschick DJ, 2006, J COMP PHYSIOL A, V192, P1169, DOI 10.1007/s00359-006-0145-2; Kim TW, 2008, J R SOC INTERFACE, V5, P319, DOI 10.1098/rsif.2007.1078; Losos J.B., 1990, Asiatic Herpetological Research, V3, P54; MADERSON P F A, 1970, Forma et Functio, V3, P179; Pianka ER, 2005, BIOESSAYS, V27, P647, DOI 10.1002/bies.20237; Qian LM, 2003, TRIBOL LETT, V15, P169, DOI 10.1023/A:1024868532575; Russell AP, 2002, INTEGR COMP BIOL, V42, P1154, DOI 10.1093/icb/42.6.1154; Sun WX, 2005, BIOPHYS J, V89, pL14, DOI 10.1529/biophysj.105.065268; Toni M, 2007, J PROTEOME RES, V6, P1792, DOI 10.1021/pr060626+; WILLIAMS EE, 1982, SCIENCE, V215, P1509, DOI 10.1126/science.215.4539.1509	22	98	99	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2192	10.1371/journal.pone.0002192	http://dx.doi.org/10.1371/journal.pone.0002192			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478106	gold, Green Published, Green Submitted			2022-12-25	WOS:000262172800056
J	Salehi, A; Abaraviciene, SM; Jimenez-Feltstrom, J; Ostenson, CG; Efendic, S; Lundquist, I				Salehi, Albert; Abaraviciene, Sandra Meidute; Jimenez-Feltstrom, Javier; Ostenson, Claes-Goran; Efendic, Suad; Lundquist, Ingmar			Excessive Islet NO Generation in Type 2 Diabetic GK Rats Coincides with Abnormal Hormone Secretion and Is Counteracted by GLP-1	PLOS ONE			English	Article								Background: A distinctive feature of type 2 diabetes is inability of insulin-secreting beta-cells to properly respond to elevated glucose eventually leading to beta-cell failure. We have hypothesized that an abnormally increased NO production in the pancreatic islets might be an important factor in the pathogenesis of b-cell dysfunction. Principal Findings: We show now that islets of type 2 spontaneous diabetes in GK rats display excessive NO generation associated with abnormal iNOS expression in insulin and glucagon cells, increased ncNOS activity, impaired glucose-stimulated insulin release, glucagon hypersecretion, and impaired glucose-induced glucagon suppression. Pharmacological blockade of islet NO production by the NOS inhibitor N(G)-nitro-L-arginine methyl ester ( L-NAME) greatly improved hormone secretion from GK islets suggesting islet NOS activity being an important target to inactivate for amelioration of islet cell function. The incretin hormone GLP-1, which is used in clinical practice suppressed iNOS and ncNOS expression and activity with almost full restoration of insulin release and partial restoration of glucagon release. GLP-1 suppression of iNOS expression was reversed by PKA inhibition but unaffected by the proteasome inhibitor MG132. Injection of glucose plus GLP-1 in the diabetic rats showed that GLP-1 amplified the insulin response but induced a transient increase and then a poor depression of glucagon. Conclusion: The results suggest that abnormally increased NO production within islet cells is a significant player in the pathogenesis of type 2 diabetes being counteracted by GLP-1 through PKA-dependent, nonproteasomal mechanisms.	[Salehi, Albert; Abaraviciene, Sandra Meidute; Jimenez-Feltstrom, Javier] UMAS, Dept Clin Sci, Div Endocrine Pharmacol, Karolinska Inst, Stockholm, Sweden; [Ostenson, Claes-Goran; Efendic, Suad] Lund Univ, Karolinska Inst, Dept Mol Med, Stockholm, Sweden; [Lundquist, Ingmar] Karolinska Inst, Dept Expt Med Sci, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Lund University; Karolinska Institutet	Salehi, A (corresponding author), UMAS, Dept Clin Sci, Div Endocrine Pharmacol, Karolinska Inst, Stockholm, Sweden.	S_Albert.Salehi@med.lu.se	Salehi, Albert/F-7768-2018	Salehi, Albert/0000-0001-6120-3539	Swedish Science Council [04X-20029]; Medical Faculty (University of Lund); NOVO Nordic; Swedish Diabetes Foundations	Swedish Science Council; Medical Faculty (University of Lund); NOVO Nordic; Swedish Diabetes Foundations	This study was supported by the Swedish Science Council (04X-20029), the Medical Faculty (University of Lund), NOVO Nordic, Magnus Bergvall, Albert Pahlsson, Crafoord and Swedish Diabetes Foundations.	Ahren B, 2004, J CLIN ENDOCR METAB, V89, P2078, DOI 10.1210/jc.2003-031907; AHREN B, 1982, DIABETOLOGIA, V22, P258, DOI 10.1007/BF00281302; Akesson B, 1999, J ENDOCRINOL, V163, P39, DOI 10.1677/joe.0.1630039; Akesson B, 1999, ENDOCRINE, V11, P99, DOI 10.1385/ENDO:11:1:99; Akesson B, 1999, J PHYSIOL-LONDON, V515, P463, DOI 10.1111/j.1469-7793.1999.463ac.x; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Alm P, 1999, DIABETOLOGIA, V42, P978, DOI 10.1007/s001250051256; AMMON HPT, 1985, CELL BIOCHEM FUNCT, V3, P157, DOI 10.1002/cbf.290030302; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Drucker DJ, 2003, ENDOCRINOLOGY, V144, P5145, DOI 10.1210/en.2003-1147; Efendic S, 2004, HORM METAB RES, V36, P742, DOI 10.1055/s-2004-826157; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; Eliasson L, 2003, J GEN PHYSIOL, V121, P181, DOI 10.1085/jgp.20028707; GROSS R, 1995, BRIT J PHARMACOL, V116, P1965, DOI 10.1111/j.1476-5381.1995.tb16399.x; GUENIFI A, 1995, PANCREAS, V10, P148, DOI 10.1097/00006676-199503000-00007; HEDING LG, 1966, SIMPLIFIED INSULIN R, P345; Henningsson R, 1999, DIABETES, V48, P66, DOI 10.2337/diabetes.48.1.66; Henningsson R, 2002, AM J PHYSIOL-CELL PH, V283, pC296, DOI 10.1152/ajpcell.00537.2001; Henningsson R, 2001, AM J PHYSIOL-CELL PH, V280, pC1242, DOI 10.1152/ajpcell.2001.280.5.C1242; Henningsson R, 2000, AM J PHYSIOL-ENDOC M, V279, pE95, DOI 10.1152/ajpendo.2000.279.1.E95; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jiang BB, 2004, J BIOL CHEM, V279, P1323, DOI 10.1074/jbc.M307521200; Jimenez-Feltstrom J, 2005, CELL TISSUE RES, V319, P221, DOI 10.1007/s00441-004-1013-4; Kaneko Y, 2003, AM J PHYSIOL-CELL PH, V284, pC1215, DOI 10.1152/ajpcell.00223.2002; Kaniuk NA, 2007, DIABETES, V56, P930, DOI 10.2337/db06-1160; Kitiphongspattana K, 2005, J BIOL CHEM, V280, P15727, DOI 10.1074/jbc.M410876200; Lajoix AD, 2004, DIABETES, V53, P1467, DOI 10.2337/diabetes.53.6.1467; Lajoix AD, 2001, DIABETES, V50, P1311, DOI 10.2337/diabetes.50.6.1311; Mori T, 2001, METABOLISM, V50, P703, DOI 10.1053/meta.2001.23301; Mosen H, 2006, J ENDOCRINOL, V190, P681, DOI 10.1677/joe.1.06890; Musial A, 2001, J BIOL CHEM, V276, P24268, DOI 10.1074/jbc.M100725200; Novelli M, 2004, MOL CELL ENDOCRINOL, V219, P77, DOI 10.1016/j.mce.2004.01.010; OSTENSON CG, 1993, DIABETOLOGIA, V36, P3, DOI 10.1007/BF00399086; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; PANAGIOTIDIS G, 1995, BRIT J PHARMACOL, V114, P289, DOI 10.1111/j.1476-5381.1995.tb13225.x; PANAGIOTIDIS G, 1992, DIABETES RES CLIN PR, V18, P167, DOI 10.1016/0168-8227(92)90142-E; Qader SS, 2007, AM J PHYSIOL-ENDOC M, V292, pE1447, DOI 10.1152/ajpendo.00172.2006; Salehi A, 1996, AM J PHYSIOL-CELL PH, V270, pC1634, DOI 10.1152/ajpcell.1996.270.6.C1634; Salehi A, 2001, ENDOCRINE, V16, P97, DOI 10.1385/ENDO:16:2:097; Salehi A, 2003, HORM METAB RES, V35, P48, DOI 10.1055/s-2003-38391; Salehi A, 1999, ENDOCRINOLOGY, V140, P3045, DOI 10.1210/en.140.7.3045; Salehi A, 1998, CELL SIGNAL, V10, P645, DOI 10.1016/S0898-6568(98)00005-9; SHAFRIR E, 1992, DIABETES METAB REV, V8, P179, DOI 10.1002/dmr.5610080302; Smukler SR, 2002, DIABETES, V51, P3450, DOI 10.2337/diabetes.51.12.3450; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P8087, DOI 10.1073/pnas.89.17.8087; Takamura T, 1998, J BIOL CHEM, V273, P2493, DOI 10.1074/jbc.273.5.2493; TSUURA Y, 1993, DIABETES, V42, P1446, DOI 10.2337/diabetes.42.10.1446; TSUURA Y, 1994, J GEN PHYSIOL, V104, P1079, DOI 10.1085/jgp.104.6.1079; UNGER RH, 1976, DIABETES, V25, P136, DOI 10.2337/diab.25.2.136; Weber SM, 2004, AM J PHYSIOL-ENDOC M, V287, pE1171, DOI 10.1152/ajpendo.00331.2004	51	40	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2165	10.1371/journal.pone.0002165	http://dx.doi.org/10.1371/journal.pone.0002165			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478125	gold, Green Published, Green Submitted			2022-12-25	WOS:000262172800030
J	Zeki, S; Hulme, OJ; Roulston, B; Atiyah, M				Zeki, Semir; Hulme, Oliver J.; Roulston, Barrie; Atiyah, Michael			The Encoding of Temporally Irregular and Regular Visual Patterns in the Human Brain	PLOS ONE			English	Article								In the work reported here, we set out to study the neural systems that detect predictable temporal patterns and departures from them. We used functional magnetic resonance imaging (fMRI) to locate activity in the brains of subjects when they viewed temporally regular and irregular patterns produced by letters, numbers, colors and luminance. Activity induced by irregular sequences was located within dorsolateral prefrontal cortex, including an area that was responsive to irregular patterns regardless of the type of visual stimuli producing them. Conversely, temporally regular arrangements resulted in activity in the right frontal lobe (medial frontal gyrus), in the left orbito-frontal cortex and in the left pallidum. The results show that there is an abstractive system in the brain for detecting temporal irregularity, regardless of the source producing it.	[Zeki, Semir; Hulme, Oliver J.; Roulston, Barrie] UCL, Wellcome Lab Neurobiol, Dept Anat, London, England; [Atiyah, Michael] Univ Edinburgh, Sch Math, Edinburgh, Midlothian, Scotland	University of London; University College London; University of Edinburgh	Zeki, S (corresponding author), UCL, Wellcome Lab Neurobiol, Dept Anat, London, England.	zeki.pa@ucl.ac.uk	Zeki, Semir/AAA-1789-2020; Hulme, Oliver J/I-2997-2016	Hulme, Oliver J/0000-0003-3139-4324	Wellcome Trust, London, UK	Wellcome Trust, London, UK(Wellcome Trust)	Funded by the Wellcome Trust, London, UK. The Trust did not participate in any stage of the study.	Bartels A, 2000, EUR J NEUROSCI, V12, P172, DOI 10.1046/j.1460-9568.2000.00905.x; Clark VP, 2000, J NEUROPHYSIOL, V83, P3133, DOI 10.1152/jn.2000.83.5.3133; Fletcher PC, 2001, NAT NEUROSCI, V4, P1043, DOI 10.1038/nn733; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; Fuster JM, 2000, NATURE, V405, P347, DOI 10.1038/35012613; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; KAISER PK, 1971, J OPT SOC AM, V61, P966, DOI 10.1364/JOSA.61.000966; Kirino E, 2000, J NEUROSCI, V20, P6612, DOI 10.1523/JNEUROSCI.20-17-06612.2000; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; McCarthy G, 1997, J NEUROPHYSIOL, V77, P1630, DOI 10.1152/jn.1997.77.3.1630; McKeefry DJ, 1997, BRAIN, V120, P2229, DOI 10.1093/brain/120.12.2229; Rao SC, 1997, SCIENCE, V276, P821, DOI 10.1126/science.276.5313.821; Self MW, 2005, CEREB CORTEX, V15, P1270, DOI 10.1093/cercor/bhi010; Stevens AA, 2000, MAGN RESON IMAGING, V18, P495, DOI 10.1016/S0730-725X(00)00128-4; Wandell BA, 1999, NEURON, V24, P901, DOI 10.1016/S0896-6273(00)81037-5; Zeki S, 1998, BRAIN, V121, P1669, DOI 10.1093/brain/121.9.1669; ZEKI S, 1991, J NEUROSCI, V11, P641; Zeki S, 2005, PHILOS T R SOC B, V360, P1145, DOI 10.1098/rstb.2005.1666	19	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2180	10.1371/journal.pone.0002180	http://dx.doi.org/10.1371/journal.pone.0002180			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478105	Green Published, gold, Green Submitted			2022-12-25	WOS:000262172800045
J	Lu, DC; Zhang, H; Zador, Z; Verkman, AS				Lu, Daniel C.; Zhang, Hua; Zador, Zsolt; Verkman, A. S.			Impaired olfaction in mice lacking aquaporin-4 water channels	FASEB JOURNAL			English	Article						smell; water permeability; olfactogram	MULTIPLE-SCLEROSIS; ORTHOGONAL ARRAYS; RETINAL FUNCTION; KNOCKOUT MICE; BRAIN; CELLS; K+; EPITHELIUM; MUCOSA; KIR4.1	Aquaporin-4 (AQP4) is a water-selective transport protein expressed in glial cells throughout the central nervous system. AQP4 deletion in mice produces alterations in several neuroexcitation phenomena, including hearing, vision, epilepsy, and cortical spreading depression. Here, we report defective olfaction and electroolfactogram responses in AQP4-null mice. Immunofluorescence indicated strong AQP4 expression in supportive cells of the nasal olfactory epithelium. The olfactory epithelium in AQP4-null mice had identical appearance, but did not express AQP4, and had similar to 12-fold reduced osmotic water permeability. Behavioral analysis showed greatly impaired olfaction in AQP4-null mice, with latency times of 17 +/- 0.7 vs. 55 +/- 5 s in wild-type vs. AQP4-null mice in a buried food pellet test, which was confirmed using an olfactory maze test. Electroolfactogram voltage responses to multiple odorants were reduced in AQP4-null mice, with maximal responses to triethylamine of 0.80 +/- 0.07 vs. 0.28 +/- 0.03 mV. Similar olfaction and electroolfactogram defects were found in outbred (CD1) and inbred (C57/b16) mouse genetic backgrounds. Our results establish AQP4 as a novel determinant of olfaction, the deficiency of which probably impairs extracellular space K+ buffering in the olfactory epithelium.	[Lu, Daniel C.; Zhang, Hua; Zador, Zsolt; Verkman, A. S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Lu, Daniel C.; Zhang, Hua; Zador, Zsolt; Verkman, A. S.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Lu, Daniel C.; Zador, Zsolt] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Verkman, AS (corresponding author), Univ Calif San Francisco, Dept Med, 1246 Hlth Sci E Tower, San Francisco, CA 94143 USA.	alan.verkman@ucsf.edu		zador, zsolt/0000-0003-4297-616X; Zador, Zsolt/0000-0001-9767-3372	U. S. National Institutes of Health [DK35124, EY13574, EB00415, HL59198, DK72517, HL73856]; Research Development Program; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059198, R01HL073856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000415, R37EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072517, R01DK035124, R37DK035124] Funding Source: NIH RePORTER	U. S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Development Program; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank L. Qian for mouse breeding and genotype analysis. This work was supported by grants from the U. S. National Institutes of Health (DK35124, EY13574, EB00415, HL59198, DK72517, and HL73856) and Research Development Program and Drug Discovery grants from the Cystic Fibrosis Foundation.	Ablimit A, 2006, ARCH HISTOL CYTOL, V69, P1, DOI 10.1679/aohc.69.1; Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P13615, DOI 10.1073/pnas.2336064100; Auguste KI, 2007, FASEB J, V21, P108, DOI 10.1096/fj.06-6848com; Binder DK, 2006, GLIA, V53, P631, DOI 10.1002/glia.20318; Binder DK, 2004, J NEUROSCI, V24, P8049, DOI 10.1523/JNEUROSCI.2294-04.2004; Binder DK, 2004, NEUROREPORT, V15, P259, DOI 10.1097/00001756-200402090-00009; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; Da T, 2004, INVEST OPHTH VIS SCI, V45, P4477, DOI 10.1167/iovs.04-0940; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; Doty RL, 1997, NEW ENGL J MED, V336, P1918, DOI 10.1056/NEJM199706263362617; EDWARDS DA, 1972, BEHAV BIOL, V7, P823, DOI 10.1016/S0091-6773(72)80174-3; Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004; ESPOSITO G, 2007, HUM MOL GENET; GETCHELL ML, 1984, ANAT REC, V208, P553, DOI 10.1002/ar.1092080411; Gheusi C, 2000, P NATL ACAD SCI USA, V97, P1823, DOI 10.1073/pnas.97.4.1823; HEMDAL P, 1993, NEUROPSYCHOLOGIA, V31, P977, DOI 10.1016/0028-3932(93)90152-P; HENKIN R. I., 1966, LIFE SCI, V5, P331, DOI 10.1016/0024-3205(66)90018-X; HOFFER A, 1962, AM J PSYCHIAT, V119, P72; KHAYARI A, 1991, BRAIN RES, V539, P1, DOI 10.1016/0006-8993(91)90679-P; LANCET D, 1993, P NATL ACAD SCI USA, V90, P3715, DOI 10.1073/pnas.90.8.3715; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Li J, 2002, INVEST OPHTH VIS SCI, V43, P573; Li J, 2001, J BIOL CHEM, V276, P31233, DOI 10.1074/jbc.M104368200; Lien CW, 1999, BIOSCI BIOTECH BIOCH, V63, P1553, DOI 10.1271/bbb.63.1553; Ma TH, 1997, J CLIN INVEST, V100, P957, DOI 10.1172/JCI231; Magzoub M, 2006, J PHYS CHEM B, V110, P21216, DOI 10.1021/jp0633392; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Nagelhus EA, 2004, NEUROSCIENCE, V129, P905, DOI 10.1016/j.neuroscience.2004.08.053; Nathan BP, 2004, BEHAV BRAIN RES, V150, P1, DOI 10.1016/S0166-4328(03)00219-5; Nomura T, 2004, ARCH HISTOL CYTOL, V67, P159, DOI 10.1679/aohc.67.159; OTTOSON D, 1956, ACTA PHYSL SCAND S, V35, P122; Padmawar P, 2005, NAT METHODS, V2, P825, DOI 10.1038/NMETH801; Papadopoulos MC, 2004, NEUROSCIENCE, V129, P1011, DOI 10.1016/j.neuroscience.2004.05.044; Paunio T, 2001, HUM MOL GENET, V10, P3037, DOI 10.1093/hmg/10.26.3037; Rash JE, 2005, J NEUROCYTOL, V34, P307, DOI 10.1007/s11068-005-8360-2; Roemer SF, 2007, BRAIN, V130, P1194, DOI 10.1093/brain/awl371; Ruiz-Ederra J, 2007, J BIOL CHEM, V282, P21866, DOI 10.1074/jbc.M703236200; Saadoun S, 2005, J CELL SCI, V118, P5691, DOI 10.1242/jcs.02680; Schaefer ML, 2000, J NEUROSCI, V20, P4809; Scott JW, 1996, J NEUROPHYSIOL, V75, P2036, DOI 10.1152/jn.1996.75.5.2036; Solenov E, 2004, AM J PHYSIOL-CELL PH, V286, pC426, DOI 10.1152/ajpcell.00298.2003; Sorbo JG, 2007, FEBS LETT, V581, P4884, DOI 10.1016/j.febslet.2007.09.018; TEICHER MH, 1977, SCIENCE, V198, P635, DOI 10.1126/science.918660; TROTIER D, 1986, BRAIN RES, V374, P205, DOI 10.1016/0006-8993(86)90413-0; TUCKER D, 1965, COLD SPRING HARB SYM, V30, P207, DOI 10.1101/SQB.1965.030.01.023; Verbavatz JM, 1997, J CELL SCI, V110, P2855; Weiler E, 2005, J NEUROCYTOL, V34, P217, DOI 10.1007/s11068-005-8355-z; Yang BX, 1996, J BIOL CHEM, V271, P4577; ZADOR Z, 2007, FASEB J, V22, P326; Zhang H, 2008, MOL CELL NEUROSCI, V37, P1, DOI 10.1016/j.mcn.2007.08.007; Zhang RR, 2008, SMART STRUCT SYST, V4, P1	51	69	81	2	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2008	22	9					3216	3223		10.1096/fj.07-104836	http://dx.doi.org/10.1096/fj.07-104836			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	342CD	18511552	Green Published			2022-12-25	WOS:000258761300014
J	Singh, S; Mccoy, JG; Zhang, C; Bingman, CA; Phillips, GN; Thorson, JS				Singh, Shanteri; McCoy, Jason G.; Zhang, Changsheng; Bingman, Craig A.; Phillips, George N., Jr.; Thorson, Jon S.			Structure and mechanism of the rebeccamycin sugar 4 '-O-Methyltransferase RebM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOSYNTHETIC GENE-CLUSTER; ADENOSYL-L-METHIONINE; CRYSTAL-STRUCTURE; O-METHYLTRANSFERASE; SUBSTRATE-SPECIFICITY; TANDEM ACTION; INDOLOCARBAZOLE; STAUROSPORINE; GENERATION; REFINEMENT	The 2.65-angstrom crystal structure of the rebeccamycin 4'-O-methyltransferase RebM in complex with S-adenosyl-L-homocysteine revealed RebM to adopt a typical S-adenosylmethionine-binding fold of small molecule O-methyltransferases (O-MTases) and display a weak dimerization domain unique to MTases. Using this structure as a basis, the RebM substrate binding model implicated a predominance of nonspecific hydrophobic interactions consistent with the reported ability of RebM to methylate a wide range of indolocarbazole surrogates. This model also illuminated the three putative RebM catalytic residues (His(140)/(141) and Asp(166)) subsequently found to be highly conserved among sequence-related natural product O-MTases from GC-rich bacteria. Interrogation of these residues via sitedirected mutagenesis in RebM demonstrated His(140) and Asp(166) to be most important for catalysis. This study revealsRebMto be a member of the general acid/ base-dependent O-MTases and, as the first crystal structure for a sugar O-MTase, may also present a template toward the future engineering of natural product MTases for combinatorial applications.	[McCoy, Jason G.; Bingman, Craig A.; Phillips, George N., Jr.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Singh, Shanteri; Zhang, Changsheng; Thorson, Jon S.] Univ Wisconsin, Natl Drug Discovery Grp, Madison, WI 53705 USA; [Singh, Shanteri; Zhang, Changsheng; Thorson, Jon S.] Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Phillips, GN (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	phillips@biochem.wisc.edu; jsthorson@pharmacy.wisc.edu	Zhang, Changsheng/B-5965-2012; Thorson, Jon S/L-3696-2013	Zhang, Changsheng/0000-0003-2349-3138; Thorson, Jon S/0000-0002-7148-0721; Singh, Shanteri/0000-0003-0960-4794	NATIONAL CANCER INSTITUTE [R01CA084374, U19CA113297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052218] Funding Source: NIH RePORTER; NCI NIH HHS [CA84374, U19 CA113297] Funding Source: Medline; NIAID NIH HHS [AI52218] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akinaga S, 2000, ANTI-CANCER DRUG DES, V15, P43; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bailly C, 2000, CURR MED CHEM, V7, P39, DOI 10.2174/0929867003375489; BAUER NJ, 1988, J BIOL CHEM, V263, P15619; Boissier F, 2006, J BIOL CHEM, V281, P4434, DOI 10.1074/jbc.M510250200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferrer JL, 2005, PLANT PHYSIOL, V137, P1009, DOI 10.1104/pp.104.048751; Fu ZJ, 1996, BIOCHEMISTRY-US, V35, P11985, DOI 10.1021/bi961068n; Gao QJ, 2006, CHEM BIOL, V13, P733, DOI 10.1016/j.chembiol.2006.05.009; Howard-Jones AR, 2006, J AM CHEM SOC, V128, P12289, DOI 10.1021/ja063898m; Howard-Jones AR, 2005, BIOCHEMISTRY-US, V44, P15652, DOI 10.1021/bi051706e; Huang CYF, 2002, J BIOL CHEM, V277, P34367, DOI 10.1074/jbc.M202468200; INOUYE M, 1994, GENE, V141, P121; Jansson A, 2004, J BIOL CHEM, V279, P41149, DOI 10.1074/jbc.M407081200; Jansson A, 2003, J MOL BIOL, V334, P269, DOI 10.1016/j.jmb.2003.09.061; Kleywegt GJ, 2007, ACTA CRYSTALLOGR D, V63, P94, DOI [10.1107/S0907444906022657, 10.1107/S907444906022657]; Klimasauskas S, 2007, TRENDS BIOTECHNOL, V25, P99, DOI 10.1016/j.tibtech.2007.01.006; KREUZMAN AJ, 1988, J BIOL CHEM, V263, P15626; Long BH, 2000, EXPERT OPIN THER PAT, V10, P635, DOI 10.1517/13543776.10.5.635; Lukinavicius G, 2007, J AM CHEM SOC, V129, P2758, DOI 10.1021/ja0691876; Martin JL, 2002, CURR OPIN STRUC BIOL, V12, P783, DOI 10.1016/S0959-440X(02)00391-3; Martin JL, 2001, STRUCTURE, V9, P977, DOI 10.1016/S0969-2126(01)00662-1; Meyers CLF, 2004, BIOCHEMISTRY-US, V43, P15022, DOI 10.1021/bi048457z; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishizawa T, 2005, J BACTERIOL, V187, P2084, DOI 10.1128/JB.187.6.2084-2092.2005; Onaka H, 2003, BIOSCI BIOTECH BIOCH, V67, P127, DOI 10.1271/bbb.67.127; Oster LM, 2006, J MOL BIOL, V358, P546, DOI 10.1016/j.jmb.2006.02.004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Palma PN, 2006, MOL PHARMACOL, V70, P143, DOI 10.1124/mol.106.023119; Pi N, 2004, P NATL ACAD SCI USA, V101, P10036, DOI 10.1073/pnas.0403526101; Prudhomme M, 2003, EUR J MED CHEM, V38, P123, DOI 10.1016/S0223-5234(03)00011-4; Prudhomme M, 2000, CURR MED CHEM, V7, P1189, DOI 10.2174/0929867003374138; Prudhomme Michelle, 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P509; Rodriguez L, 2001, J BACTERIOL, V183, P5358, DOI 10.1128/JB.183.18.5358-5363.2001; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; Salas AP, 2005, MOL MICROBIOL, V58, P17, DOI 10.1111/j.1365-2958.2005.04777.x; Sanchez C, 2002, CHEM BIOL, V9, P519, DOI 10.1016/S1074-5521(02)00126-6; Sanchez C, 2006, NAT PROD REP, V23, P1007, DOI 10.1039/b601930g; Sanchez C, 2006, J IND MICROBIOL BIOT, V33, P560, DOI 10.1007/s10295-006-0092-5; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Sreenath HK, 2005, PROTEIN EXPRES PURIF, V40, P256, DOI 10.1016/j.pep.2004.12.022; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Weeks CM, 2003, METHOD ENZYMOL, V374, P37, DOI 10.1016/S0076-6879(03)74003-8; Weller RL, 2005, ORG LETT, V7, P2141, DOI 10.1021/ol0504749; Xu J, 2003, ARCH BIOCHEM BIOPHYS, V411, P277, DOI 10.1016/S0003-9861(03)00004-3; Yeh E, 2005, P NATL ACAD SCI USA, V102, P3960, DOI 10.1073/pnas.0500755102; Zhang C, 2006, CHEMBIOCHEM, V7, P795, DOI 10.1002/cbic.200500504; Zhang CS, 2006, J AM CHEM SOC, V128, P2760, DOI 10.1021/ja056231t; Zhang X, 2000, EMBO J, V19, P3509, DOI 10.1093/emboj/19.14.3509; Zubieta C, 2002, PLANT CELL, V14, P1265, DOI 10.1105/tpc.001412; Zubieta C, 2001, NAT STRUCT BIOL, V8, P271, DOI 10.1038/85029	56	48	51	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22628	22636		10.1074/jbc.M800503200	http://dx.doi.org/10.1074/jbc.M800503200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18502766	Green Published, hybrid			2022-12-25	WOS:000258321000032
J	Jiang, DW; Chen, WQ; Xiao, JM; Wang, RW; Kong, HH; Jones, PP; Zhang, L; Fruen, B; Chen, SRW				Jiang, Dawei; Chen, Wenqian; Xiao, Jianmin; Wang, Ruiwu; Kong, Huihui; Jones, Peter P.; Zhang, Lin; Fruen, Bradley; Chen, S. R. Wayne			Reduced threshold for luminal Ca2+ activation of RyR1 underlies a causal mechanism of porcine malignant hyperthermia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL CORE DISEASE; MUSCLE RYANODINE RECEPTOR; SKELETAL SARCOPLASMIC-RETICULUM; CALCIUM-RELEASE CHANNEL; DANTROLENE SODIUM; VENTRICULAR-TACHYCARDIA; SUDDEN-DEATH; MUTATIONS; HALOTHANE; STORE	Naturally occurring mutations in the skeletal muscle Ca2+ release channel/ryanodine receptor RyR1 are linked to malignant hyperthermia (MH), a life-threatening complication of general anesthesia. Although it has long been recognized that MH results from uncontrolled or spontaneous Ca2+ release from the sarcoplasmic reticulum, how MH RyR1 mutations render the sarcoplasmic reticulum susceptible to volatile anestheticinduced spontaneous Ca2+ release is unclear. Here we investigated the impact of the porcine MH mutation, R615C, the human equivalent of which also causes MH, on the intrinsic properties of the RyR1 channel and the propensity for spontaneous Ca2+ release during store Ca2+ overload, a process we refer to as store overload-induced Ca2+ release (SOICR). Single channel analyses revealed that the R615C mutation markedly enhanced the luminal Ca2+ activation of RyR1. Moreover, HEK293 cells expressing the R615C mutant displayed a reduced threshold for SOICR compared with cells expressing wild type RyR1. Furthermore, the MH-triggering agent, halothane, potentiated the response of RyR1 to luminal Ca2+ and SOICR. Conversely, dantrolene, an effective treatment for H, suppressed SOICR in HEK293 cells expressing the R615C mutant, but not in cells expressing an RyR2 mutant. These data suggest that the R615C mutation confers MH susceptibility by reducing the threshold for luminal Ca2+ activation and SOICR, whereas volatile anesthetics trigger MH by further reducing the threshold, and dantrolene suppresses MH by increasing the SOICR threshold. Together, our data support a view in which altered luminal Ca2+ regulation of RyR1 represents a primary causal mechanism of MH.	[Jiang, Dawei; Chen, Wenqian; Xiao, Jianmin; Wang, Ruiwu; Kong, Huihui; Jones, Peter P.; Zhang, Lin; Chen, S. R. Wayne] Univ Calgary, Dept Physiol & Biophys, Libin Cardiovasc Inst Alberta, Calgary, AB T2N 4N1, Canada; [Jiang, Dawei; Chen, Wenqian; Xiao, Jianmin; Wang, Ruiwu; Kong, Huihui; Jones, Peter P.; Zhang, Lin; Chen, S. R. Wayne] Univ Calgary, Dept Biochem & Mol Biol, Libin Cardiovasc Inst Alberta, Calgary, AB T2N 4N1, Canada; [Fruen, Bradley] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	Libin Cardiovascular Institute Of Alberta; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Minnesota System; University of Minnesota Twin Cities	Chen, SRW (corresponding author), 3300 Hosp Dr, NW, Calgary, AB T2N 4N1, Canada.	swchen@ucalgary.ca	Jones, Peter P/G-2618-2013; Kong, Huihui/F-9024-2012	Jones, Pete/0000-0001-7977-1737	NHLBI NIH HHS [1R01 HL 75210, R01 HL 076433] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075210, R01HL076433] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Balog EM, 2001, BIOPHYS J, V81, P2050, DOI 10.1016/S0006-3495(01)75854-7; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Cherednichenko G, 2008, MOL PHARMACOL, V73, P1203, DOI 10.1124/mol.107.043299; Dietze B, 2000, J PHYSIOL-LONDON, V526, P507, DOI 10.1111/j.1469-7793.2000.t01-1-00507.x; Dirksen RT, 2004, BIOPHYS J, V87, P3193, DOI 10.1529/biophysj.104.049447; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; FILL M, 1990, BIOPHYS J, V57, P471, DOI 10.1016/S0006-3495(90)82563-7; FOSTER PS, 1989, BRIT J ANAESTH, V62, P566, DOI 10.1093/bja/62.5.566; Fruen BR, 1997, J BIOL CHEM, V272, P26965, DOI 10.1074/jbc.272.43.26965; FUJII J, 1991, SCIENCE, V253, P448, DOI 10.1126/science.1862346; Gyorke S, 2008, CARDIOVASC RES, V77, P245, DOI 10.1093/cvr/cvm038; HAINAUT K, 1974, NATURE, V252, P728, DOI 10.1038/252728a0; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Housmans PR, 2000, ANAL BIOCHEM, V284, P60, DOI 10.1006/abio.2000.4688; Jiang DW, 2004, P NATL ACAD SCI USA, V101, P13062, DOI 10.1073/pnas.0402388101; Jiang DW, 2005, CIRC RES, V97, P1173, DOI 10.1161/01.RES.0000192146.85173.4b; Kobayashi S, 2005, J BIOL CHEM, V280, P6580, DOI 10.1074/jbc.M408375200; Laver DR, 1997, BIOPHYS J, V73, P1913, DOI 10.1016/S0006-3495(97)78222-5; Loke J, 1998, AM J MED, V104, P470, DOI 10.1016/S0002-9343(98)00108-9; Louis CF, 2001, BIOSCIENCE REP, V21, P155, DOI 10.1023/A:1013644107519; Lyfenko AD, 2004, BIOCHEM BIOPH RES CO, V322, P1256, DOI 10.1016/j.bbrc.2004.08.031; MACLENNAN DH, 1992, SCIENCE, V256, P789, DOI 10.1126/science.1589759; McCarthy TV, 2000, HUM MUTAT, V15, P410, DOI 10.1002/(SICI)1098-1004(200005)15:5<410::AID-HUMU2>3.0.CO;2-D; Mickelson JR, 1996, PHYSIOL REV, V76, P537, DOI 10.1152/physrev.1996.76.2.537; Murayama T, 2007, BIOCHEM J, V402, P349, DOI 10.1042/BJ20061040; Nelson TE, 1996, ANESTHESIOLOGY, V84, P1368, DOI 10.1097/00000542-199606000-00013; NELSON TE, 1975, ANESTHESIOLOGY, V42, P301, DOI 10.1097/00000542-197503000-00011; NELSON TE, 1991, J PHARMACOL EXP THER, V256, P645; NELSON TE, 1983, J CLIN INVEST, V72, P862, DOI 10.1172/JCI111057; Nelson Thomas E., 2002, Current Molecular Medicine (Hilversum), V2, P347, DOI 10.2174/1566524023362429; OHNISHI ST, 1983, FEBS LETT, V161, P103; OKUMURA F, 1980, BRIT J ANAESTH, V52, P377, DOI 10.1093/bja/52.4.377; OTSU K, 1994, J BIOL CHEM, V269, P9413; Owen VJ, 1997, AM J PHYSIOL-CELL PH, V272, pC203, DOI 10.1152/ajpcell.1997.272.1.C203; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Paul-Pletzer K, 2002, J BIOL CHEM, V277, P34918, DOI 10.1074/jbc.M205487200; Priori SG, 2005, J CLIN INVEST, V115, P2033, DOI 10.1172/JCI25664; Robinson R, 2006, HUM MUTAT, V27, P977, DOI 10.1002/humu.20356; Rudolf R, 2006, J CELL BIOL, V173, P187, DOI 10.1083/jcb.200601160; Sampieri A, 2005, J BIOL CHEM, V280, P24804, DOI 10.1074/jbc.M501487200; SHOMER NH, 1993, AM J PHYSIOL, V264, pC125, DOI 10.1152/ajpcell.1993.264.1.C125; Sitsapesan R, 1997, J MEMBRANE BIOL, V159, P179, DOI 10.1007/s002329900281; Szentesi P, 2001, J GEN PHYSIOL, V118, P355, DOI 10.1085/jgp.118.4.355; Tong JF, 1999, BIOCHEM J, V343, P39, DOI 10.1042/0264-6021:3430039; Tong JF, 1997, J BIOL CHEM, V272, P26332, DOI 10.1074/jbc.272.42.26332; Treves S, 2005, NEUROMUSCULAR DISORD, V15, P577, DOI 10.1016/j.nmd.2005.06.008; TREVES S, 1994, BIOCHEM J, V301, P661, DOI 10.1042/bj3010661; Tripathy A, 1996, BIOPHYS J, V70, P2600, DOI 10.1016/S0006-3495(96)79831-4; VANWINKLE WB, 1976, SCIENCE, V193, P1130, DOI 10.1126/science.959824; Yang TZ, 2003, J BIOL CHEM, V278, P25722, DOI 10.1074/jbc.M302165200; Zhang YF, 2005, J PHARMACOL EXP THER, V314, P94, DOI 10.1124/jpet.105.084046; Zhao XL, 2006, J BIOL CHEM, V281, P33477, DOI 10.1074/jbc.M602306200	52	39	39	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20813	20820		10.1074/jbc.M801944200	http://dx.doi.org/10.1074/jbc.M801944200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18505726	Green Published, hybrid			2022-12-25	WOS:000257746100023
J	Hou, XY; Xu, SQ; Maitland-Toolan, KA; Sato, K; Jiang, BB; Ido, YS; Lan, F; Walsh, K; Wierzbicki, M; Verbeuren, TJ; Cohen, RA; Zang, MW				Hou, Xiuyun; Xu, Shanqin; Maitland-Toolan, Karlene A.; Sato, Kaori; Jiang, Bingbing; Ido, Yasuo; Lan, Fan; Walsh, Kenneth; Wierzbicki, Michel; Verbeuren, Tony J.; Cohen, Richard A.; Zang, Mengwei			SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE ACTIVATORS; FATTY-ACID OXIDATION; GLUCOSE-HOMEOSTASIS; HEPG2 CELLS; MITOCHONDRIAL-FUNCTION; MASTER SWITCH; LIFE-SPAN; METFORMIN; LKB1; PHOSPHORYLATION	Resveratrol may protect against metabolic disease through activating SIRT1 deacetylase. Because we have recently defined AMPK activation as a key mechanism for the beneficial effects of polyphenols on hepatic lipid accumulation, hyperlipidemia, and atherosclerosis in type 1 diabetic mice, we hypothesize that polyphenol-activated SIRT1 acts upstream of AMPK signaling and hepatocellular lipid metabolism. Here we show that polyphenols, including resveratrol and the synthetic polyphenol S17834, increase SIRT1 deacetylase activity, LKB1 phosphorylation at Ser(428), and AMPK activity. Polyphenols substantially prevent the impairment in phosphorylation of AMPK and its downstream target, ACC (acetyl-CoA carboxylase), elevation in expression of FAS (fatty acid synthase), and lipid accumulation in human HepG2 hepatocytes exposed to high glucose. These effects of polyphenols are largely abolished by pharmacological and genetic inhibition of SIRT1, suggesting that the stimulation of AMPK and lipid-lowering effect of polyphenols depend on SIRT1 activity. Furthermore, adenoviral overexpression of SIRT1 stimulates the basal AMPK signaling in HepG2 cells and in the mouse liver. AMPK activation by SIRT1 also protects against FAS induction and lipid accumulation caused by high glucose. Moreover, LKB1, but not CaMKK beta, is required for activation of AMPK by polyphenols and SIRT1. These findings suggest that SIRT1 functions as a novel upstream regulator for LKB1/AMPK signaling and plays an essential role in the regulation of hepatocyte lipid metabolism. Targeting SIRT1/LKB1/AMPK signaling by polyphenols may have potential therapeutic implications for dyslipidemia and accelerated atherosclerosis in diabetes and age-related diseases.	[Hou, Xiuyun; Xu, Shanqin; Maitland-Toolan, Karlene A.; Jiang, Bingbing; Cohen, Richard A.; Zang, Mengwei] Boston Univ, Sch Med, Vasc Biol Unit, Boston, MA 02118 USA; [Sato, Kaori; Walsh, Kenneth] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Mol Cardiol Unit, Boston, MA 02118 USA; [Ido, Yasuo; Lan, Fan] Boston Univ, Endocrinol Sect, Boston, MA 02118 USA; [Wierzbicki, Michel; Verbeuren, Tony J.] Inst Rech Servier, F-92150 Suresnes, France	Boston University; Boston University; Boston University; Servier; Institut de Recherches Internationales Servier	Zang, MW (corresponding author), Boston Univ, Sch Med, Vasc Biol Unit, X704,650 Albany St, Boston, MA 02118 USA.	mwzang1@bu.edu		Ido, Yasuo/0000-0002-3036-9971; Zang, Mengwei/0000-0002-2502-2586; /0000-0002-1070-6408	NHLBI NIH HHS [P01 HL 68758] Funding Source: Medline; NIA NIH HHS [R01 AG 27080] Funding Source: Medline; NIDDK NIH HHS [R01 DK 76942] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL068758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027080] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Alcendor RR, 2004, CIRC RES, V95, P971, DOI 10.1161/01.RES.0000147557.75257.ff; Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Chau-Van C, 2007, ENDOCRINOLOGY, V148, P507, DOI 10.1210/en.2006-1237; CIANFLONE K, 1992, ARTERIOSCLER THROMB, V12, P271, DOI 10.1161/01.ATV.12.3.271; Curtis R, 2006, AGING CELL, V5, P119, DOI 10.1111/j.1474-9726.2006.00205.x; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Hardie DG, 2004, REV ENDOCR METAB DIS, V5, P119, DOI 10.1023/B:REMD.0000021433.63915.bb; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hirao M, 2003, J BIOL CHEM, V278, P52773, DOI 10.1074/jbc.M308966200; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lee Y, 2002, P NATL ACAD SCI USA, V99, P11848, DOI 10.1073/pnas.182420899; Leibiger IB, 2006, NAT MED, V12, P34, DOI 10.1038/nm0106-34; Liao W, 2006, ENDOCRINOLOGY, V147, P2245, DOI 10.1210/en.2005-1638; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mao J, 2006, P NATL ACAD SCI USA, V103, P8552, DOI 10.1073/pnas.0603115103; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; Nakajima K, 2000, J BIOL CHEM, V275, P20880, DOI 10.1074/jbc.M905410199; Narbonne P, 2006, DEVELOPMENT, V133, P611, DOI 10.1242/dev.02232; Park SH, 2002, J APPL PHYSIOL, V92, P2475, DOI 10.1152/japplphysiol.00071.2002; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Postic C, 2004, DIABETES METAB, V30, P398, DOI 10.1016/S1262-3636(07)70133-7; Reznick RM, 2007, CELL METAB, V5, P151, DOI 10.1016/j.cmet.2007.01.008; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Ruderman N, 2004, NAT REV DRUG DISCOV, V3, P340, DOI 10.1038/nrd1344; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xie M, 2006, P NATL ACAD SCI USA, V103, P17378, DOI 10.1073/pnas.0604708103; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490; Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188; Zang MW, 2004, J BIOL CHEM, V279, P47898, DOI 10.1074/jbc.M408149200; Zang MW, 2003, MOL PHARMACOL, V63, P993, DOI 10.1124/mol.63.5.993; Zang MW, 2002, J BIOL CHEM, V277, P4395, DOI 10.1074/jbc.M110000200; Zang MW, 2001, J BIOL CHEM, V276, P25157, DOI 10.1074/jbc.M100152200; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	57	618	657	5	109	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20015	20026		10.1074/jbc.M802187200	http://dx.doi.org/10.1074/jbc.M802187200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18482975	Green Published, hybrid			2022-12-25	WOS:000257565300017
J	Elder, BD; Athanasiou, KA				Elder, Benjamin D.; Athanasiou, Kyriacos A.			Synergistic and Additive Effects of Hydrostatic Pressure and Growth Factors on Tissue Formation	PLOS ONE			English	Article							ARTICULAR-CARTILAGE CONSTRUCTS; INTERVERTEBRAL DISC CELLS; MESSENGER-RNA EXPRESSION; SMOOTH-MUSCLE-CELLS; IN-VITRO; II COLLAGEN; ENGINEERED CARTILAGE; CONTACT PRESSURES; MATRIX SYNTHESIS; MECHANICAL STIMULATION	Background: Hydrostatic pressure ( HP) is a significant factor in the function of many tissues, including cartilage, knee meniscus, temporomandibular joint disc, intervertebral disc, bone, bladder, and vasculature. Though studies have been performed in assessing the role of HP in tissue biochemistry, to the best of our knowledge, no studies have demonstrated enhanced mechanical properties from HP application in any tissue. Methodology/Principal Findings: The objective of this study was to determine the effects of hydrostatic pressure (HP), with and without growth factors, on the biomechanical and biochemical properties of engineered articular cartilage constructs, using a two-phased approach. In phase I, a 363 full-factorial design of HP magnitude (1, 5, 10 MPa) and frequency (0, 0.1, 1 Hz) was used, and the best two treatments were selected for use in phase II. Static HP at 5 MPa and 10 MPa resulted in significant 95% and 96% increases, respectively, in aggregate modulus (H(A)), with corresponding increases in GAG content. These regimens also resulted in significant 101% and 92% increases in Young's modulus (E(Y)), with corresponding increases in collagen content. Phase II employed a 363 full-factorial design of HP (no HP, 5 MPa static, 10 MPa static) and growth factor application (no GF, BMP-2+IGF-I, TGF-beta 1). The combination of 10 MPa static HP and TGF-beta 1 treatment had an additive effect on both H(A) and E(Y), as well as a synergistic effect on collagen content. This group demonstrated a 164% increase in H(A), a 231% increase in EY, an 85% increase in GAG/wet weight (WW), and a 173% increase in collagen/WW, relative to control. Conclusions/Significance: To our knowledge, this is the first study to demonstrate increases in the biomechanical properties of tissue from pure HP application, using a cartilage model. Furthermore, it is the only study to demonstrate additive or synergistic effects between HP and growth factors on tissue functional properties. These findings are exciting as coupling HP stimulation with growth factor application has allowed for the formation of tissue engineered constructs with biomechanical and biochemical properties spanning native tissue values.	[Elder, Benjamin D.; Athanasiou, Kyriacos A.] Rice Univ, Dept Bioengn, Houston, TX 77251 USA	Rice University	Elder, BD (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77251 USA.	athanasiou@rice.edu			NIH NIAMS [R01 AR053286]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053286] Funding Source: NIH RePORTER	NIH NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was performed with funding from NIH NIAMS R01 AR053286.	AFOKE NYP, 1987, J BONE JOINT SURG BR, V69, P536, DOI 10.1302/0301-620X.69B4.3611154; Almarza AJ, 2006, TISSUE ENG, V12, P1285, DOI 10.1089/ten.2006.12.1285; ATHANASIOU KA, 1994, J ORTHOPAED RES, V12, P340, DOI 10.1002/jor.1100120306; Aufderheide AC, 2007, TISSUE ENG, V13, P2195, DOI 10.1089/ten.2006.0291; Bachrach NM, 1998, J BIOMECH, V31, P445, DOI 10.1016/S0021-9290(98)00035-9; Benson V, 1998, Vital Health Stat 10, P1; Blunk T, 2002, TISSUE ENG, V8, P73, DOI 10.1089/107632702753503072; Bonassar LJ, 2001, J ORTHOP RES, V19, P11, DOI 10.1016/S0736-0266(00)00004-8; Brown AN, 2000, TISSUE ENG, V6, P297, DOI 10.1089/107632700418029; Browning JA, 1999, ACTA PHYSIOL SCAND, V166, P39; Buckwalter JA, 1998, J ORTHOP SPORT PHYS, V28, P192, DOI 10.2519/jospt.1998.28.4.192; BUCKWALTER JA, 1979, PARK RIDGE, P405; Darling EM, 2005, CELL TISSUE RES, V322, P463, DOI 10.1007/s00441-005-0020-4; Elder BD, 2008, J ORTHOP RES, V26, P238, DOI 10.1002/jor.20480; Gooch KJ, 2002, TISSUE ENG, V8, P591, DOI 10.1089/107632702760240517; Govinden R, 2003, PHARMACOL THERAPEUT, V98, P257, DOI 10.1016/S0163-7258(03)00035-4; HALL AC, 1991, J ORTHOPAED RES, V9, P1, DOI 10.1002/jor.1100090102; Hall AC, 1999, J CELL PHYSIOL, V178, P197, DOI 10.1002/(SICI)1097-4652(199902)178:2<197::AID-JCP9>3.0.CO;2-3; HODGE WA, 1989, J BONE JOINT SURG AM, V71A, P1378, DOI 10.2106/00004623-198971090-00015; HOROWITZ SB, 1988, J CELL PHYSIOL, V135, P425, DOI 10.1002/jcp.1041350309; Hu JC, 2006, TISSUE ENG, V12, P1337, DOI 10.1089/ten.2006.12.1337; Hu JC, 2006, TISSUE ENG, V12, P969, DOI 10.1089/ten.2006.12.969; HUBERTI HH, 1984, J BONE JOINT SURG AM, V66A, P715, DOI 10.2106/00004623-198466050-00010; Ikenoue T, 2003, J ORTHOPAED RES, V21, P110, DOI 10.1016/S0736-0266(02)00091-8; Kasra M, 2006, J ORTHOP RES, V24, P1967, DOI 10.1002/jor.20253; Khalafi A, 2007, J ORTHOP RES, V25, P293, DOI 10.1002/jor.20329; Kornblatt JA, 2002, BBA-PROTEIN STRUCT M, V1595, P30, DOI 10.1016/S0167-4838(01)00333-8; Lee MS, 2003, J RHEUMATOL, V30, P326; Lee MS, 2003, J ORTHOPAED RES, V21, P117, DOI 10.1016/S0736-0266(02)00085-2; Mauck RL, 2003, TISSUE ENG, V9, P597, DOI 10.1089/107632703768247304; Miyanishi K, 2006, TISSUE ENG, V12, P2253, DOI 10.1089/ten.2006.12.2253; Miyanishi K, 2006, TISSUE ENG, V12, P1419, DOI 10.1089/ten.2006.12.1419; Mizuno S, 2005, AM J PHYSIOL-CELL PH, V288, pC329, DOI 10.1152/ajpcell.00131.2004; Mizuno S, 2002, J CELL PHYSIOL, V193, P319, DOI 10.1002/jcp.10180; MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202; Muller-Marschhausen K, 2008, AM J PHYSIOL-CELL PH, V294, pC324, DOI 10.1152/ajpcell.00319.2007; Nowlan NC, 2008, J BIOMECH, V41, P249, DOI 10.1016/j.jbiomech.2007.09.031; PARKKINEN JJ, 1993, ARCH BIOCHEM BIOPHYS, V300, P458, DOI 10.1006/abbi.1993.1062; Pietila K, 1999, CELLS TISSUES ORGANS, V164, P30, DOI 10.1159/000016640; Reza AT, 2008, ANN BIOMED ENG, V36, P204, DOI 10.1007/s10439-007-9407-6; ROSENBERG L, 1971, J BONE JOINT SURG AM, VA 53, P69, DOI 10.2106/00004623-197153010-00007; Saini S, 2004, TISSUE ENG, V10, P825, DOI 10.1089/1076327041348545; Shimizu M, 1997, CELL STRUCT FUNCT, V22, P309, DOI 10.1247/csf.22.309; Slinker BK, 1998, J MOL CELL CARDIOL, V30, P723, DOI 10.1006/jmcc.1998.0655; Smith RL, 2004, CLIN ORTHOP RELAT R, pS89, DOI 10.1097/01.blo.0000143938.30681.9d; Smith RL, 1996, J ORTHOP RES, V14, P53, DOI 10.1002/jor.1100140110; Smith RL, 2000, J REHABIL RES DEV, V37, P153; Stover J, 2007, ANN BIOMED ENG, V35, P1585, DOI 10.1007/s10439-007-9331-9; Suzuki T, 2006, BIORHEOLOGY, V43, P611; Takahashi A, 1997, BRAIN RES PROTOC, V1, P70, DOI 10.1016/S1385-299X(96)00013-X; TAKEMITSU Y, 1961, KYUSHU J MED SCI, P251; Toyoda T, 2003, BIORHEOLOGY, V40, P79; Toyoda T, 2003, ARTHRITIS RHEUM, V48, P2865, DOI 10.1002/art.11250; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Wuertz K, 2007, J ORTHOP RES, V25, P1513, DOI 10.1002/jor.20436	55	103	104	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2341	10.1371/journal.pone.0002341	http://dx.doi.org/10.1371/journal.pone.0002341			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523560	gold, Green Published, Green Submitted			2022-12-25	WOS:000262614300034
J	Fudge, D; Russell, D; Beriault, D; Moore, W; Lane, EB; Vogl, AW				Fudge, Douglas; Russell, David; Beriault, Dan; Moore, Whitney; Lane, E. Birgitte; Vogl, A. Wayne			The Intermediate Filament Network in Cultured Human Keratinocytes Is Remarkably Extensible and Resilient	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; LIVING CELLS; MICROTUBULES; LETHALITY; KERATIN-8; INSIGHTS; FIBERS	The prevailing model of the mechanical function of intermediate filaments in cells assumes that these 10 nm diameter filaments make up networks that behave as entropic gels, with individual intermediate filaments never experiencing direct loading in tension. However, recent work has shown that single intermediate filaments and bundles are remarkably extensible and elastic in vitro, and therefore well-suited to bearing tensional loads. Here we tested the hypothesis that the intermediate filament network in keratinocytes is extensible and elastic as predicted by the available in vitro data. To do this, we monitored the morphology of fluorescently-tagged intermediate filament networks in cultured human keratinocytes as they were subjected to uniaxial cell strains as high as 133%. We found that keratinocytes not only survived these high strains, but their intermediate filament networks sustained only minor damage at cell strains as high as 100%. Electron microscopy of stretched cells suggests that intermediate filaments are straightened at high cell strains, and therefore likely to be loaded in tension. Furthermore, the buckling behavior of intermediate filament bundles in cells after stretching is consistent with the emerging view that intermediate filaments are far less stiff than the two other major cytoskeletal components F-actin and microtubules. These insights into the mechanical behavior of keratinocytes and the cytokeratin network provide important baseline information for current attempts to understand the biophysical basis of genetic diseases caused by mutations in intermediate filament genes.	[Fudge, Douglas; Vogl, A. Wayne] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada; [Fudge, Douglas; Beriault, Dan; Moore, Whitney] Univ Guelph, Dept Integrat Biol, Guelph, ON, Canada; [Russell, David; Lane, E. Birgitte] Univ Dundee, Coll Life Sci, Canc Res UK Cell Structure Res Grp, Dundee, Scotland	University of British Columbia; University of Guelph; University of Dundee	Fudge, D (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada.	dfudge@uoguelph.ca	Fudge, Douglas/I-6860-2016	Fudge, Douglas/0000-0001-9569-1374	Canadian Institute of Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada (NSERC) [postdoctoral fellowship, Discovery Grant]; Cancer Research UK [C26/A6694]	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Cancer Research UK(Cancer Research UK)	This work was supported by a Canadian Institute of Health Research (CIHR) Operating Grant (AWV), a Natural Sciences and Engineering Research Council of Canada (NSERC) postdoctoral fellowship (DF), an NSERC Discovery Grant (DF), and a Cancer Research UK grant to EBL and DR (no. C26/A6694).	BARIBAULT H, 1993, GENE DEV, V7, P1191, DOI 10.1101/gad.7.7a.1191; BLANK IH, 1952, J INVEST DERMATOL, V18, P433, DOI 10.1038/jid.1952.52; Bousquet O, 2001, J CELL BIOL, V155, P747, DOI 10.1083/jcb.200104063; Brangwynne CP, 2006, J CELL BIOL, V173, P733, DOI 10.1083/jcb.200601060; Bray D, 2001, CELL MOVEMENTS MOL M; BRODLAND GW, 1990, J BIOMECH ENG-T ASME, V112, P319, DOI 10.1115/1.2891190; Costa KD, 2002, CELL MOTIL CYTOSKEL, V52, P266, DOI 10.1002/cm.10056; Coulombe PA, 2004, NAT CELL BIOL, V6, P699, DOI 10.1038/ncb0804-699; Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102; Fraser R.D.B., 1972, KERATINS THEIR COMPO; FUCHS E, 1992, P NATL ACAD SCI USA, V89, P6906, DOI 10.1073/pnas.89.15.6906; Fudge DS, 2003, BIOPHYS J, V85, P2015, DOI 10.1016/S0006-3495(03)74629-3; Hesse M, 2000, EMBO J, V19, P5060, DOI 10.1093/emboj/19.19.5060; Howard J., 2001, MECH MOTOR PROTEINS; JANMEY PA, 1991, J CELL BIOL, V113, P155, DOI 10.1083/jcb.113.1.155; KRAUSE AW, 1984, J HISTOCHEM CYTOCHEM, V32, P1084, DOI 10.1177/32.10.6090533; Kreplak L, 2005, J MOL BIOL, V354, P569, DOI 10.1016/j.jmb.2005.09.092; Kreplak L, 2001, BIOPOLYMERS, V58, P526, DOI 10.1002/1097-0282(20010415)58:5<526::AID-BIP1028>3.0.CO;2-L; Kreplak L, 2007, BIOESSAYS, V29, P26, DOI 10.1002/bies.20514; Loranger A, 1997, AM J PATHOL, V151, P1673; Ma LL, 1999, J BIOL CHEM, V274, P19145, DOI 10.1074/jbc.274.27.19145; Mahaffy RE, 2000, PHYS REV LETT, V85, P880, DOI 10.1103/PhysRevLett.85.880; Morley SM, 2003, BRIT J DERMATOL, V149, P46, DOI 10.1046/j.1365-2133.2003.05493.x; Moussa M, 2006, J EQUINE VET SCI, V26, P529, DOI 10.1016/j.jevs.2006.09.009; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; Russell D, 2004, J CELL SCI, V117, P5233, DOI 10.1242/jcs.01407; Yamada S, 2003, J STRUCT BIOL, V143, P45, DOI 10.1016/S1047-8477(03)00101-1; Yoon KH, 2001, J CELL BIOL, V153, P503, DOI 10.1083/jcb.153.3.503; Yoon M, 1998, J CELL BIOL, V143, P147, DOI 10.1083/jcb.143.1.147	29	48	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2327	10.1371/journal.pone.0002327	http://dx.doi.org/10.1371/journal.pone.0002327			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523546	Green Submitted, gold, Green Published			2022-12-25	WOS:000262614300022
J	Mooshagian, E; Kaplan, J; Zaidel, E; Iacoboni, M				Mooshagian, Eric; Kaplan, Jonas; Zaidel, Eran; Iacoboni, Marco			Fast Visuomotor Processing of Redundant Targets: The Role of the Right Temporo-Parietal Junction	PLOS ONE			English	Article							SIMPLE REACTION-TIME; INTERHEMISPHERIC NEURAL SUMMATION; SPLIT BRAIN; DIVIDED ATTENTION; COACTIVATION; FACILITATION; NEGLECT	Parallel processing of multiple sensory stimuli is critical for efficient, successful interaction with the environment. An experimental approach to studying parallel processing in sensorimotor integration is to examine reaction times to multiple copies of the same stimulus. Reaction times to bilateral copies of light flashes are faster than to single, unilateral light flashes. These faster responses may be due to 'statistical facilitation' between independent processing streams engaged by the two copies of the light flash. On some trials, however, reaction times are faster than predicted by statistical facilitation. This indicates that a neural 'coactivation' of the two processing streams must have occurred. Here we use fMRI to investigate the neural locus of this coactivation. Subjects responded manually to the detection of unilateral light flashes presented to the left or right visual hemifield, and to the detection of bilateral light flashes. We compared the bilateral trials where subjects' reaction times exceeded the limit predicted by statistical facilitation to bilateral trials that did not exceed the limit. Activity in the right temporo-parietal junction was higher in those bilateral trials that showed coactivation than in those that did not. These results suggest the neural coactivation observed in visuomotor integration occurs at a cognitive rather than sensory or motor stage of processing.	[Mooshagian, Eric; Zaidel, Eran] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; [Zaidel, Eran; Iacoboni, Marco] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA USA; [Kaplan, Jonas; Iacoboni, Marco] Univ Calif Los Angeles, David Geffen Sch Med, Neuropsychiat Inst, Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Mooshagian, E (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA.	emooshag@ucla.edu		Mooshagian, Eric/0000-0001-5998-8445	NIH [MH63680, RR12169, RR13642, RR00865]; Brain Mapping Medical Research Organization; Brain Mapping Support Foundation; Pierson-Lovelace Foundation; The Ahmanson Foundation; William M. and Linda R. Dietel Philanthropic Fund at the Northern Piedmont Community Foundation; Tamkin Foundation; Jennifer Jones-Simon Foundation; Capital Group Companies Charitable Foundation; Northstar Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR012169, M01RR000865, P41RR013642] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain Mapping Medical Research Organization; Brain Mapping Support Foundation; Pierson-Lovelace Foundation; The Ahmanson Foundation; William M. and Linda R. Dietel Philanthropic Fund at the Northern Piedmont Community Foundation; Tamkin Foundation; Jennifer Jones-Simon Foundation; Capital Group Companies Charitable Foundation; Northstar Fund; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Supported in part by NIH grant MH63680 to M.I. For generous support the authors wish to thank the Brain Mapping Medical Research Organization, Brain Mapping Support Foundation, Pierson-Lovelace Foundation, The Ahmanson Foundation, William M. and Linda R. Dietel Philanthropic Fund at the Northern Piedmont Community Foundation, Tamkin Foundation, Jennifer Jones-Simon Foundation, Capital Group Companies Charitable Foundation, Robson Family and Northstar Fund. The project described was also supported by Grant Numbers RR12169, RR13642 and RR00865 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH); its contents are solely the responsibility of the authors and do not necessarily represent the official views of NIMH, NCRR or NIH.	BEHRENS T, 2003, HUM BRAIN MAPP; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Cavina-Pratesi C, 2001, J EXP PSYCHOL HUMAN, V27, P932, DOI 10.1037//0096-1523.27.4.932; Corballis MC, 1998, BRAIN, V121, P1795, DOI 10.1093/brain/121.9.1795; Corballis MC, 2002, J COGNITIVE NEUROSCI, V14, P1151, DOI 10.1162/089892902760807168; Corballis MC, 2002, NEUROPSYCHOLOGIA, V40, P423, DOI 10.1016/S0028-3932(01)00097-5; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Forster B, 2002, EXP BRAIN RES, V143, P480, DOI 10.1007/s00221-002-1017-9; GIRAY M, 1993, J EXP PSYCHOL HUMAN, V19, P1278, DOI 10.1037/0096-1523.19.6.1278; GRICE GR, 1992, PERCEPT PSYCHOPHYS, V51, P437, DOI 10.3758/BF03211639; Iacoboni M, 2000, BRAIN, V123, P759, DOI 10.1093/brain/123.4.759; Iacoboni M, 2003, EUR J NEUROSCI, V17, P1981, DOI 10.1046/j.1460-9568.2003.02602.x; LUCK SJ, 2005, INTRO EVENT RELATED, pR12; Meister IG, 2006, NEUROSCIENCE, V142, P119, DOI 10.1016/j.neuroscience.2006.06.023; MILLER J, 1986, PERCEPT PSYCHOPHYS, V40, P331, DOI 10.3758/BF03203025; MILLER J, 1982, COGNITIVE PSYCHOL, V14, P247, DOI 10.1016/0010-0285(82)90010-X; Miniussi C, 1998, J COGNITIVE NEUROSCI, V10, P216, DOI 10.1162/089892998562663; Molholm S, 2002, COGNITIVE BRAIN RES, V14, P115, DOI 10.1016/S0926-6410(02)00066-6; Mort DJ, 2003, BRAIN, V126, P1986, DOI 10.1093/brain/awg200; Murray MM, 2001, NEUROPSYCHOLOGIA, V39, P828, DOI 10.1016/S0028-3932(01)00004-5; RAAB DH, 1962, T NEW YORK ACAD SCI, V24, P574, DOI 10.1111/j.2164-0947.1962.tb01433.x; REUTERLORENZ PA, 1995, J EXP PSYCHOL HUMAN, V21, P211, DOI 10.1037/0096-1523.21.2.211; Roser M, 2002, NEUROPSYCHOLOGIA, V40, P1300, DOI 10.1016/S0028-3932(01)00219-6; Savazzi S, 2002, CURR BIOL, V12, P403, DOI 10.1016/S0960-9822(02)00688-7; Schroter H, 2007, PSYCHON B REV, V14, P39, DOI 10.3758/BF03194025; Todd J.W., 1912, REACTION MULTIPLE ST; Vallar G, 2001, NEUROIMAGE, V14, pS52, DOI 10.1006/nimg.2001.0822	27	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2348	10.1371/journal.pone.0002348	http://dx.doi.org/10.1371/journal.pone.0002348			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	396TO	18523591	Green Published, gold, Green Submitted			2022-12-25	WOS:000262614300039
J	Ausseil, J; Desmaris, N; Bigou, S; Attali, R; Corbineau, S; Vitry, S; Parent, M; Cheillan, D; Fuller, M; Maire, I; Vanier, MT; Heard, JM				Ausseil, Jerome; Desmaris, Nathalie; Bigou, Stephanie; Attali, Ruben; Corbineau, Sebastien; Vitry, Sandrine; Parent, Mathieu; Cheillan, David; Fuller, Maria; Maire, Irene; Vanier, Marie-Therese; Heard, Jean-Michel			Early Neurodegeneration Progresses Independently of Microglial Activation by Heparan Sulfate in the Brain of Mucopolysaccharidosis IIIB Mice	PLOS ONE			English	Article								Background: In mucopolysaccharidosis type IIIB, a lysosomal storage disease causing early onset mental retardation in children, the production of abnormal oligosaccharidic fragments of heparan sulfate is associated with severe neuropathology and chronic brain inflammation. We addressed causative links between the biochemical, pathological and inflammatory disorders in a mouse model of this disease. Methodology/Principal Findings: In cell culture, heparan sulfate oligosaccharides activated microglial cells by signaling through the Toll-like receptor 4 and the adaptor protein MyD88. CD11b positive microglial cells and three-fold increased expression of mRNAs coding for the chemokine MIP1a were observed at 10 days in the brain cortex of MPSIIIB mice, but not in MPSIIIB mice deleted for the expression of Toll-like receptor 4 or the adaptor protein MyD88, indicating early priming of microglial cells by heparan sulfate oligosaccharides in the MPSIIIB mouse brain. Whereas the onset of brain inflammation was delayed for several months in doubly mutant versus MPSIIIB mice, the onset of disease markers expression was unchanged, indicating similar progression of the neurodegenerative process in the absence of microglial cell priming by heparan sulfate oligosaccharides. In contrast to younger mice, inflammation in aged MPSIIIB mice was not affected by TLR4/MyD88 deficiency. Conclusions/Significance: These results indicate priming of microglia by HS oligosaccharides through the TLR4/MyD88 pathway. Although intrinsic to the disease, this phenomenon is not a major determinant of the neurodegenerative process. Inflammation may still contribute to neurodegeneration in late stages of the disease, albeit independent of TLR4/MyD88. The results support the view that neurodegeneration is primarily cell autonomous in this pediatric disease.	[Ausseil, Jerome; Desmaris, Nathalie; Attali, Ruben; Corbineau, Sebastien; Vitry, Sandrine; Parent, Mathieu; Heard, Jean-Michel] Inst Pasteur, Dept Neurosci, INSERM, Unite Retrovirus & Transfert Genet,U622, Paris, France; [Bigou, Stephanie] Hop Paris, Assistance Publ, Hop Bicetre, INSERM U802, Serv Neurol Pediat, Le Kremlin Bicetre, France; [Cheillan, David; Maire, Irene] CBPE, Groupement Hosp Est, Bron, France; [Fuller, Maria] Children, Youth & Womens Hlth Serv, Adelaide, SA, Australia; [Vanier, Marie-Therese] Fac Med Laennec, INSERM U820, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm)	Ausseil, J (corresponding author), Inst Pasteur, Dept Neurosci, INSERM, Unite Retrovirus & Transfert Genet,U622, Paris, France.	jmheard@pasteur.fr	Ausseil, Jerome/AAA-4703-2019	Ausseil, Jerome/0000-0002-3059-9777; Vitry, Sandrine/0000-0003-4693-7694; cheillan, david/0000-0001-9535-2567; Bigou, Stephanie/0000-0002-6328-0703	Association Francaise contre les myopathies; Institut Pasteur	Association Francaise contre les myopathies(Association Francaise contre les Myopathies); Institut Pasteur(European Commission)	This work was supported by a joint program of the Association Francaise contre les myopathies and the Institut Pasteur.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Bamberger ME, 2003, J NEUROSCI, V23, P2665; Baudry M, 2003, EXP NEUROL, V184, P887, DOI 10.1016/S0014-4886(03)00345-5; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Chen HL, 2005, ANN NEUROL, V58, P963, DOI 10.1002/ana.20682; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; CONSTANTOPOULOS G, 1985, J NEUROCHEM, V45, P1213, DOI 10.1111/j.1471-4159.1985.tb05544.x; Cressant A, 2004, J NEUROSCI, V24, P10229, DOI 10.1523/JNEUROSCI.3558-04.2004; Cunningham C, 2005, NEUROBIOL DIS, V18, P258, DOI 10.1016/j.nbd.2004.08.015; Desmaris N, 2004, ANN NEUROL, V56, P68, DOI 10.1002/ana.20150; Etminan M, 2003, BMJ-BRIT MED J, V327, P128, DOI 10.1136/bmj.327.7407.128; Fuller M, 2004, PEDIATR RES, V56, P733, DOI 10.1203/01.PDR.0000141987.69757.DD; Gieselmann V, 2003, ACTA PAEDIATR, V92, P74, DOI 10.1080/08035320310000528; Gieselmann V, 2003, ACTA PAEDIATR, V92, P45, DOI 10.1080/08035250310000537; Heldermon CD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000772; Hoshino K, 1999, J IMMUNOL, V162, P3749; Jeyakumar M, 2003, BRAIN, V126, P974, DOI 10.1093/brain/awg089; Johnson GB, 2002, J IMMUNOL, V168, P5233, DOI 10.4049/jimmunol.168.10.5233; Jou I, 2006, AM J PATHOL, V168, P1619, DOI 10.2353/ajpath.2006.050924; Li HH, 1999, P NATL ACAD SCI USA, V96, P14505, DOI 10.1073/pnas.96.25.14505; Li HH, 2002, J NEUROSCI RES, V69, P30, DOI 10.1002/jnr.10278; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; MARSH J, 1985, CLIN GENET, V27, P258; MASUDA H, 1981, INT J BIOCHEM, V13, P603; Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x; Moisse K, 2006, BBA-MOL BASIS DIS, V1762, P1083, DOI 10.1016/j.bbadis.2006.03.001; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Ohmi K, 2003, P NATL ACAD SCI USA, V100, P1902, DOI 10.1073/pnas.252784899; Perry VH, 2007, NAT REV IMMUNOL, V7, P161, DOI 10.1038/nri2015; PIRAUD M, 1993, CLIN CHIM ACTA, V221, P171, DOI 10.1016/0009-8981(93)90031-X; Qin S, 2006, J NEUROSCI, V26, P3345, DOI 10.1523/JNEUROSCI.5186-05.2006; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Ryazantsev S, 2007, MOL GENET METAB, V90, P393, DOI 10.1016/j.ymgme.2006.11.006; SAIFER A, 1974, CLIN CHEM, V20, P538; Salvetti A, 1998, HUM GENE THER, V9, P695, DOI 10.1089/hum.1998.9.5-695; Sano R, 2005, BLOOD, V106, P2259, DOI 10.1182/blood-2005-03-1189; Sapp E, 2001, J NEUROPATH EXP NEUR, V60, P161, DOI 10.1093/jnen/60.2.161; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Sheng WS, 2000, CLIN IMMUNOL, V96, P243, DOI 10.1006/clim.2000.4905; Simpson D, 2000, MOL VIS, V6, P178; Stagi M, 2005, J NEUROSCI, V25, P352, DOI 10.1523/JNEUROSCI.3887-04.2005; Takeuchi H, 2005, J BIOL CHEM, V280, P10444, DOI 10.1074/jbc.M413863200; Tsuji D, 2005, J NEUROCHEM, V92, P1497, DOI 10.1111/j.1471-4159.2005.02986.x; Villani GRD, 2007, J NEUROSCI RES, V85, P612, DOI 10.1002/jnr.21134; Wada R, 2000, P NATL ACAD SCI USA, V97, P10954, DOI 10.1073/pnas.97.20.10954; Walkley SU, 2004, SEMIN CELL DEV BIOL, V15, P433, DOI 10.1016/j.semcdb.2004.03.002; WHITLEY CB, 1989, CLIN CHEM, V35, P2074; Wilms H, 2003, FASEB J, V17, P500, DOI 10.1096/fj.02-0314fje; Wu YP, 2004, P NATL ACAD SCI USA, V101, P8425, DOI 10.1073/pnas.0400625101; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com; Zhao HG, 1996, P NATL ACAD SCI USA, V93, P6101, DOI 10.1073/pnas.93.12.6101; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440; Zipp F, 2006, TRENDS NEUROSCI, V29, P518, DOI 10.1016/j.tins.2006.07.006	54	93	95	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2296	10.1371/journal.pone.0002296	http://dx.doi.org/10.1371/journal.pone.0002296			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509511	gold, Green Published, Green Submitted			2022-12-25	WOS:000262268500035
J	Bagci, EZ; Vodovotz, Y; Billiar, TR; Ermentrout, B; Bahar, I				Bagci, Elife Z.; Vodovotz, Yoram; Billiar, Timothy R.; Ermentrout, Bard; Bahar, Ivet			Computational Insights on the Competing Effects of Nitric Oxide in Regulating Apoptosis	PLOS ONE			English	Article								Despite the establishment of the important role of nitric oxide (NO) on apoptosis, a molecular-level understanding of the origin of its dichotomous pro- and anti-apoptotic effects has been elusive. We propose a new mathematical model for simulating the effects of nitric oxide (NO) on apoptosis. The new model integrates mitochondria-dependent apoptotic pathways with NO-related reactions, to gain insights into the regulatory effect of the reactive NO species N2O3, non-heme iron nitrosyl species (FeLnNO), and peroxynitrite (ONOO-). The biochemical pathways of apoptosis coupled with NO-related reactions are described by ordinary differential equations using mass-action kinetics. In the absence of NO, the model predicts either cell survival or apoptosis (a bistable behavior) with shifts in the onset time of apoptotic response depending on the strength of extracellular stimuli. Computations demonstrate that the relative concentrations of anti- and proapoptotic reactive NO species, and their interplay with glutathione, determine the net anti- or pro- apoptotic effects at long time points. Interestingly, transient effects on apoptosis are also observed in these simulations, the duration of which may reach up to hours, despite the eventual convergence to an anti- apoptotic state. Our computations point to the importance of precise timing of NO production and external stimulation in determining the eventual pro- or anti- apoptotic role of NO.	[Bagci, Elife Z.; Bahar, Ivet] Univ Pittsburgh, McGowan Inst Regenerat Med, Dept Computat Biol, Pittsburgh, PA 15260 USA; [Bagci, Elife Z.] Univ Pittsburgh, McGowan Inst Regenerat Med, Dept Biochem & Mol Genet, Pittsburgh, PA USA; [Vodovotz, Yoram; Billiar, Timothy R.] Univ Pittsburgh, McGowan Inst Regenerat Med, Sch Med, Dept Surg, Pittsburgh, PA USA; [Vodovotz, Yoram] Univ Pittsburgh, McGowan Inst Regenerat Med, Ctr Inflammation & Regenerat Modeling, Pittsburgh, PA USA; [Ermentrout, Bard] Univ Pittsburgh, Dept Math, Arts & Sci, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bagci, EZ (corresponding author), Univ Pittsburgh, McGowan Inst Regenerat Med, Dept Computat Biol, Pittsburgh, PA 15260 USA.	bahar@ccbb.pitt.edu; bard@math.pitt.edu	Bagci, Elife Zerrin/A-9660-2016; bagci, elife/B-9032-2012; Bahar, Ivet/AAH-2921-2020	Bagci, Elife/0000-0001-5920-0400	National Institutes of Health [1P20-GM065805]; NSF [DMS0513500]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM065805] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	IB gratefully acknowledges the support from National Institutes of Health award No. 1P20-GM065805. GBE was supported by NSF DMS0513500.	Afshar RK, 2004, INORG CHEM, V43, P5736, DOI 10.1021/ic040057c; ALBINA JE, 1993, J IMMUNOL, V150, P5080; Aldridge BB, 2006, IEE P SYST BIOL, V153, P425, DOI 10.1049/ip-syb:20050065; Antunes F, 1996, FREE RADICAL BIO MED, V21, P917, DOI 10.1016/S0891-5849(96)00185-2; Bagci EZ, 2006, BIOPHYS J, V90, P1546, DOI 10.1529/biophysj.105.068122; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Benhar M, 2005, NAT CELL BIOL, V7, P645, DOI 10.1038/ncb0705-645; Bentele M, 2004, J CELL BIOL, V166, P839, DOI 10.1083/jcb.200404158; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Buerk DG, 2001, ANNU REV BIOMED ENG, V3, P109, DOI 10.1146/annurev.bioeng.3.1.109; Bulotta S, 2001, J BIOL CHEM, V276, P6529, DOI 10.1074/jbc.M006535200; Ceneviva GD, 1998, AM J PHYSIOL-LUNG C, V275, pL717, DOI 10.1152/ajplung.1998.275.4.L717; Chen T, 2005, HEPATOLOGY, V42, P598, DOI 10.1002/hep.20813; CZAPSKI G, 1995, FREE RADICAL BIO MED, V19, P785, DOI 10.1016/0891-5849(95)00081-8; De Visscher G, 2005, J NEUROTRAUM, V22, P793; Denicola A, 1996, ARCH BIOCHEM BIOPHYS, V333, P49, DOI 10.1006/abbi.1996.0363; Dimmeler S, 1997, J EXP MED, V185, P601, DOI 10.1084/jem.185.4.601; Dimmeler S, 1997, CIRC RES, V81, P970; Eissing T, 2004, J BIOL CHEM, V279, P36892, DOI 10.1074/jbc.M404893200; Ermentrout B., 2002, SIMULATING ANAL ANIM, V14; Fadeel B, 1999, BIOCHEM BIOPH RES CO, V266, P699, DOI 10.1006/bbrc.1999.1888; FIELDEN EM, 1974, BIOCHEM J, V139, P49, DOI 10.1042/bj1390049; Fussenegger M, 2000, NAT BIOTECHNOL, V18, P768, DOI 10.1038/77589; Ghafourifar P, 2005, METHOD ENZYMOL, V396, P424, DOI 10.1016/S0076-6879(05)96036-9; Gorren ACF, 1996, ARCH BIOCHEM BIOPHYS, V330, P219, DOI 10.1006/abbi.1996.0247; Hofseth LJ, 2003, P NATL ACAD SCI USA, V100, P143, DOI 10.1073/pnas.0237083100; Hu TM, 2006, PHARM RES-DORDR, V23, P1702, DOI 10.1007/s11095-006-9031-4; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; Jones CM, 2002, FREE RADICAL BIO MED, V32, P982, DOI 10.1016/S0891-5849(02)00791-8; Jourd'heuil D, 1998, BIOCHEM BIOPH RES CO, V244, P525, DOI 10.1006/bbrc.1998.8227; Keshive M, 1996, CHEM RES TOXICOL, V9, P988, DOI 10.1021/tx960036y; Kim PKM, 2005, CELL MOL BIOL, V51, P229; Kim PKM, 2004, BIOL CHEM, V385, P11, DOI 10.1515/BC.2004.002; Kim PKM, 2001, INT IMMUNOPHARMACOL, V1, P1421, DOI 10.1016/S1567-5769(01)00088-1; Kim YM, 1997, J BIOL CHEM, V272, P1402, DOI 10.1074/jbc.272.2.1402; Kim YM, 1997, J BIOL CHEM, V272, P31138, DOI 10.1074/jbc.272.49.31138; Kim YM, 2000, J BIOL CHEM, V275, P10954, DOI 10.1074/jbc.275.15.10954; KOPPENOL WH, 1992, CHEM RES TOXICOL, V5, P834, DOI 10.1021/tx00030a017; Lancaster JR, 1997, NITRIC OXIDE-BIOL CH, V1, P18, DOI 10.1006/niox.1996.0112; LANCASTER JR, 1994, P NATL ACAD SCI USA, V91, P8137, DOI 10.1073/pnas.91.17.8137; Legewie S, 2006, PLOS COMPUT BIOL, V2, P1061, DOI 10.1371/journal.pcbi.0020120; Li JR, 1997, BIOCHEM BIOPH RES CO, V240, P419, DOI 10.1006/bbrc.1997.7672; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; LICHT WR, 1988, CARCINOGENESIS, V9, P365, DOI 10.1093/carcin/9.3.365; Mannick JB, 1999, SCIENCE, V284, P651, DOI 10.1126/science.284.5414.651; MESSMER UK, 1995, MOL PHARMACOL, V47, P757; Messmer UK, 1996, BIOCHEM J, V319, P299, DOI 10.1042/bj3190299; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; Pou S, 1999, BBA-GEN SUBJECTS, V1427, P216, DOI 10.1016/S0304-4165(99)00014-8; Pourzand C, 1999, P NATL ACAD SCI USA, V96, P6751, DOI 10.1073/pnas.96.12.6751; Radi R, 2002, BIOL CHEM, V383, P401, DOI 10.1515/BC.2002.044; Radi R., 2000, BIOL CHEM PEROXYNITR, P57; Rehm M, 2002, J BIOL CHEM, V277, P24506, DOI 10.1074/jbc.M110789200; Rehm M, 2006, EMBO J, V25, P4338, DOI 10.1038/sj.emboj.7601295; Rossig L, 1999, J BIOL CHEM, V274, P6823, DOI 10.1074/jbc.274.11.6823; Sanfilippo CM, 2003, INT REV IMMUNOL, V22, P327, DOI 10.1080/08830180305211; SARIH M, 1993, BIOCHEM BIOPH RES CO, V191, P503, DOI 10.1006/bbrc.1993.1246; Sarti P, 2003, IUBMB LIFE, V55, P605, DOI 10.1080/15216540310001628726; Siehs C, 2002, BIOINFORMATICS, V18, P67, DOI 10.1093/bioinformatics/18.1.67; Sies H, 1997, J BIOL CHEM, V272, P27812, DOI 10.1074/jbc.272.44.27812; Squadrito GL, 1998, FREE RADICAL BIO MED, V25, P392, DOI 10.1016/S0891-5849(98)00095-1; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0; Stucki JW, 2005, J THEOR BIOL, V234, P123, DOI 10.1016/j.jtbi.2004.11.011; THOMSON L, 1995, ARCH BIOCHEM BIOPHYS, V319, P491, DOI 10.1006/abbi.1995.1321; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Tyas L, 2000, EMBO REP, V1, P266, DOI 10.1093/embo-reports/kvd050; Tzeng E, 1997, SURGERY, V122, P255, DOI 10.1016/S0039-6060(97)90016-7; Vieira HLA, 2001, ONCOGENE, V20, P4305, DOI 10.1038/sj.onc.1204575; Vieira HLA, 2000, CELL DEATH DIFFER, V7, P1146, DOI 10.1038/sj.cdd.4400778; Vodovotz Y, 2004, CURR MOL MED, V4, P753, DOI 10.2174/1566524043359944; Wang YN, 2002, ANN NY ACAD SCI, V962, P415, DOI 10.1111/j.1749-6632.2002.tb04085.x; Weller R, 2003, AM J PHYSIOL-CELL PH, V284, pC1140, DOI 10.1152/ajpcell.00462.2002; WINK DA, 1994, CHEM RES TOXICOL, V7, P519, DOI 10.1021/tx00040a007; Wink David A., 1999, P245; ZHANG W, 2006, AM J PHYSL IN PRESS	78	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2249	10.1371/journal.pone.0002249	http://dx.doi.org/10.1371/journal.pone.0002249			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509469	gold, Green Published, Green Submitted			2022-12-25	WOS:000262268500003
J	Guerra, L; Carr, HS; Richter-Dahlfors, A; Masucci, MG; Thelestam, M; Frost, JA; Frisan, T				Guerra, Lina; Carr, Heather S.; Richter-Dahlfors, Agneta; Masucci, Maria G.; Thelestam, Monica; Frost, Jeffrey A.; Frisan, Teresa			A Bacterial Cytotoxin Identifies the RhoA Exchange Factor Net1 as a Key Effector in the Response to DNA Damage	PLOS ONE			English	Article								Background: Exposure of adherent cells to DNA damaging agents, such as the bacterial cytolethal distending toxin (CDT) or ionizing radiations (IR), activates the small GTPase RhoA, which promotes the formation of actin stress fibers and delays cell death. The signalling intermediates that regulate RhoA activation and promote cell survival are unknown. Principal Findings: We demonstrate that the nuclear RhoA-specific Guanine nucleotide Exchange Factor (GEF) Net1 becomes dephosphorylated at a critical inhibitory site in cells exposed to CDT or IR. Expression of a dominant negative Net1 or Net1 knock down by iRNA prevented RhoA activation, inhibited the formation of stress fibers, and enhanced cell death, indicating that Net1 activation is required for this RhoA-mediated responses to genotoxic stress. The Net1 and RhoA-dependent signals involved activation of the Mitogen-Activated Protein Kinase p38 and its downstream target MAPK-activated protein kinase 2. Significance: Our data highlight the importance of Net1 in controlling RhoA and p38 MAPK mediated cell survival in cells exposed to DNA damaging agents and illustrate a molecular pathway whereby chronic exposure to a bacterial toxin may promote genomic instability.	[Guerra, Lina; Masucci, Maria G.; Thelestam, Monica; Frisan, Teresa] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Richter-Dahlfors, Agneta] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Carr, Heather S.; Frost, Jeffrey A.] Univ Texas Hlth Sci Ctr Houston, Dept Integrative Biol & Pharmacol, Houston, TX USA	Karolinska Institutet; Karolinska Institutet; University of Texas System; University of Texas Health Science Center Houston	Guerra, L (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden.	Teresa.Frisan@ki.se	Frisan, Teresa/H-8444-2019; Masucci, Maria/AAC-6666-2019	Frisan, Teresa/0000-0002-1209-0942; Masucci, Maria/0000-0002-5541-2809; Frost, Jeffrey/0000-0001-9722-1536; Richter-Dahlfors, Agneta/0000-0002-5479-7591	Swedish Research Council; Swedish Cancer Society; Ake-Wiberg Foundation; Karolinska Institutet; European Community Integrated Project on Infection and Cancer (INCA); Susan G. Komen Breast Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA116356] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Ake-Wiberg Foundation; Karolinska Institutet(Karolinska Institutet); European Community Integrated Project on Infection and Cancer (INCA)(Institut National du Cancer (INCA) France); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Swedish Research Council, Swedish Cancer Society, the Ake-Wiberg Foundation, Karolinska Institutet, the European Community Integrated Project on Infection and Cancer (INCA), Susan G. Komen Breast Cancer Foundation. None of the funding agencies contributed to design, conduct or analyze the data in this study.	Alberts AS, 2005, J BIOL CHEM, V280, P12152, DOI 10.1074/jbc.M405073200; Alberts AS, 1998, EMBO J, V17, P4075, DOI 10.1093/emboj/17.14.4075; Bhowmick NA, 2003, P NATL ACAD SCI USA, V100, P15548, DOI 10.1073/pnas.2536483100; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Chan AML, 1996, ONCOGENE, V12, P1259; Cohen P, 1997, TRENDS CELL BIOL, V7, P353, DOI 10.1016/S0962-8924(97)01105-7; Cortes-Bratti X, 2001, J BIOL CHEM, V276, P5296, DOI 10.1074/jbc.M008527200; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; Elwell CA, 2000, MOL MICROBIOL, V37, P952, DOI 10.1046/j.1365-2958.2000.02070.x; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Frisan T, 2003, CELL MICROBIOL, V5, P695, DOI 10.1046/j.1462-5822.2003.00311.x; Guerra L, 2005, CELL MICROBIOL, V7, P921, DOI 10.1111/j.1462-5822.2005.00520.x; Jaffe AB, 2005, CURR BIOL, V15, P405, DOI 10.1016/j.cub.2004.12.082; Kamaraju SK, 2005, J BIOL CHEM, V280, P1024, DOI 10.1074/jbc.M403960200; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Lara-Tejero M, 2000, SCIENCE, V290, P354, DOI 10.1126/science.290.5490.354; Lara-Tejero M, 2001, INFECT IMMUN, V69, P4358, DOI 10.1128/IAI.69.7.4358-4365.2001; Lax AJ, 2005, NAT REV MICROBIOL, V3, P343, DOI 10.1038/nrmicro1130; Lax AJ, 2007, TRENDS MOL MED, V13, P91, DOI 10.1016/j.molmed.2007.01.001; Lee JC, 1999, PHARMACOL THERAPEUT, V82, P389, DOI 10.1016/S0163-7258(99)00008-X; Li LQ, 2002, CELL MICROBIOL, V4, P87, DOI 10.1046/j.1462-5822.2002.00174.x; Marches O, 2003, MOL MICROBIOL, V50, P1553, DOI 10.1046/j.1365-2958.2003.03821.x; Marinissen MT, 2001, GENE DEV, V15, P535, DOI 10.1101/gad.855801; Nesic D, 2004, NATURE, V429, P429, DOI 10.1038/nature02532; Oswald E, 2005, CURR OPIN MICROBIOL, V8, P83, DOI 10.1016/j.mib.2004.12.011; Qin HJ, 2005, J BIOL CHEM, V280, P7603, DOI 10.1074/jbc.M412141200; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Schmidt A, 2002, J BIOL CHEM, V277, P14581, DOI 10.1074/jbc.M111108200; SCOTT DA, 1994, INFECT IMMUN, V62, P244, DOI 10.1128/IAI.62.1.244-251.1994; Shen X, 2001, J BIOL CHEM, V276, P15362, DOI 10.1074/jbc.M009534200; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Thelestam M, 2005, REV PHYSIOL BIOCH P, V152, P111, DOI 10.1007/s10254-004-0030-8; Zywietz A, 2001, J BIOL CHEM, V276, P3840, DOI 10.1074/jbc.M007819200	34	55	56	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2254	10.1371/journal.pone.0002254	http://dx.doi.org/10.1371/journal.pone.0002254			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509476	Green Published, gold			2022-12-25	WOS:000262268500006
J	Weedall, GD; Polley, SD; Conway, DJ				Weedall, Gareth D.; Polley, Spencer D.; Conway, David J.			Gene-Specific Signatures of Elevated Non-Synonymous Substitution Rates Correlate Poorly across the Plasmodium Genus	PLOS ONE			English	Article								Background: Comparative genome analyses of parasites allow large scale investigation of selective pressures shaping their evolution. An acute limitation to such analysis of Plasmodium falciparum is that there is only very partial low-coverage genome sequence of the most closely related species, the chimpanzee parasite P. reichenowi. However, if orthologous genes have been under similar selective pressures throughout the Plasmodium genus then positive selection on the P. falciparum lineage might be predicted to some extent by analysis of other lineages. Principal Findings: Here, three independent pairs of closely related species in different sub-generic clades (P. falciparum and P. reichenowi; P. vivax and P. knowlesi; P. yoelii and P. berghei) were compared for a set of 43 candidate ligand genes considered likely to be under positive directional selection and a set of 102 control genes for which there was no selective hypothesis. The ratios of non-synonymous to synonymous substitutions (dN/dS) were significantly elevated in the candidate ligand genes compared to control genes in each of the three clades. However, the rank order correlation of dN/dS ratios for individual candidate genes was very low, less than the correlation for the control genes. Significance: The inability to predict positive selection on a gene in one lineage by identifying elevated dN/dS ratios in the orthologue within another lineage needs to be noted, as it reflects that adaptive mutations are generally rare events that lead to fixation in individual lineages. Thus it is essential to complete the genome sequences of particular species of phylogenetic importance, such as P. reichenowi.	[Weedall, Gareth D.; Polley, Spencer D.; Conway, David J.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Conway, David J.] MRC Labs, Banjul, Gambia	University of London; London School of Hygiene & Tropical Medicine; MRC Laboratory Molecular Biology	Weedall, GD (corresponding author), London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England.	gweedall@hotmail.com	Polley, Spencer/F-7766-2013	Weedall, Gareth/0000-0002-8927-1063; Conway, David/0000-0002-8711-3037	UK Medical Research Council PhD studentship; Wellcome Trust [074695/Z/04/B]	UK Medical Research Council PhD studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported in part by a UK Medical Research Council PhD studentship for GDW, and Wellcome Trust programme grant 074695/Z/04/B to DJC.	Arisue N, 2007, J MOL EVOL, V65, P82, DOI 10.1007/s00239-006-0253-1; Black CG, 2003, MOL BIOCHEM PARASIT, V127, P59, DOI 10.1016/S0166-6851(02)00308-0; BORRE MB, 1991, MOL BIOCHEM PARASIT, V49, P119, DOI 10.1016/0166-6851(91)90135-S; Burns JM, 1999, INFECT IMMUN, V67, P675, DOI 10.1128/IAI.67.2.675-680.1999; Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; CERAMI C, 1992, CELL, V70, P1021, DOI 10.1016/0092-8674(92)90251-7; Chattopadhyay R, 2003, J BIOL CHEM, V278, P25977, DOI 10.1074/jbc.M300865200; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Cowman AF, 2000, FEBS LETT, V476, P84, DOI 10.1016/S0014-5793(00)01703-8; Dessens JT, 2001, INFECT IMMUN, V69, P4041, DOI 10.1128/IAI.69.6.4041-4047.2001; Dessens JT, 1999, EMBO J, V18, P6221, DOI 10.1093/emboj/18.22.6221; Dessens JT, 2003, MOL MICROBIOL, V49, P319, DOI 10.1046/j.1365-2958.2003.03566.x; Eksi S, 2006, MOL MICROBIOL, V61, P991, DOI 10.1111/j.1365-2958.2006.05284.x; ESCALANTE AA, 1994, P NATL ACAD SCI USA, V91, P11373, DOI 10.1073/pnas.91.24.11373; FREVERT U, 1993, J EXP MED, V177, P1287, DOI 10.1084/jem.177.5.1287; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gaur D, 2007, P NATL ACAD SCI USA, V104, P17789, DOI 10.1073/pnas.0708772104; Ghai M, 2002, MOL BIOCHEM PARASIT, V123, P35, DOI 10.1016/S0166-6851(02)00123-8; Gilberger TW, 2003, J BIOL CHEM, V278, P14480, DOI 10.1074/jbc.M211446200; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Hisaeda H, 2000, INFECT IMMUN, V68, P6618, DOI 10.1128/IAI.68.12.6618-6623.2000; HOWARD RF, 1990, EXP PARASITOL, V71, P330, DOI 10.1016/0014-4894(90)90038-E; Hughes AL, 2005, MOL BIOCHEM PARASIT, V142, P170, DOI 10.1016/j.molbiopara.2005.02.014; Ishino T, 2006, MOL MICROBIOL, V59, P1175, DOI 10.1111/j.1365-2958.2005.05014.x; Ishino T, 2005, MOL MICROBIOL, V58, P1264, DOI 10.1111/j.1365-2958.2005.04801.x; Jeffares DC, 2007, NAT GENET, V39, P120, DOI 10.1038/ng1931; Kadota K, 2004, P NATL ACAD SCI USA, V101, P16310, DOI 10.1073/pnas.0406187101; Kaneko O, 2005, MOL BIOCHEM PARASIT, V143, P20, DOI 10.1016/j.molbiopara.2005.05.003; Kaneko O, 2002, MOL BIOCHEM PARASIT, V121, P275, DOI 10.1016/S0166-6851(02)00042-7; Kariu T, 2006, MOL MICROBIOL, V59, P1369, DOI 10.1111/j.1365-2958.2005.05024.x; Kariu T, 2002, J EXP MED, V195, P1317, DOI 10.1084/jem.20011876; Kato K, 2005, P NATL ACAD SCI USA, V102, P5552, DOI 10.1073/pnas.0501594102; Kushwaha A, 2002, MOL BIOCHEM PARASIT, V122, P45, DOI 10.1016/S0166-6851(02)00077-4; Li XR, 2004, J BIOL CHEM, V279, P5765, DOI 10.1074/jbc.M308716200; Ling IT, 2004, MOL MICROBIOL, V52, P107, DOI 10.1111/j.1365-2958.2003.03969.x; Ling IT, 2003, MOL BIOCHEM PARASIT, V127, P47, DOI 10.1016/S0166-6851(02)00302-X; LUSTIGMAN S, 1988, MOL BIOCHEM PARASIT, V30, P217, DOI 10.1016/0166-6851(88)90090-4; Maier AG, 2003, NAT MED, V9, P87, DOI 10.1038/nm807; Marshall VM, 1997, INFECT IMMUN, V65, P4460, DOI 10.1128/IAI.65.11.4460-4467.1997; Marshall VM, 1998, MOL BIOCHEM PARASIT, V94, P13, DOI 10.1016/S0166-6851(98)00045-0; McCormick CJ, 1999, MOL BIOCHEM PARASIT, V100, P111, DOI 10.1016/S0166-6851(99)00052-3; Mu JB, 2002, NATURE, V418, P323, DOI 10.1038/nature00836; Mu JB, 2007, NAT GENET, V39, P126, DOI 10.1038/ng1924; MULLER HM, 1993, EMBO J, V12, P2881, DOI 10.1002/j.1460-2075.1993.tb05950.x; Narum DL, 2002, MOL BIOCHEM PARASIT, V119, P159, DOI 10.1016/S0166-6851(01)00428-5; Nielsen R, 2001, HEREDITY, V86, P641, DOI 10.1046/j.1365-2540.2001.00895.x; Pearce JA, 2005, MOL BIOCHEM PARASIT, V139, P141, DOI 10.1016/j.molbiopara.2004.09.012; Perkins SL, 2002, J PARASITOL, V88, P972, DOI 10.1645/0022-3395(2002)088[0972:AMPOMP]2.0.CO;2; Preiser P, 2004, INFECT IMMUN, V72, P3604, DOI 10.1128/IAI.72.6.3604-3608.2004; QUAKYI IA, 1987, J IMMUNOL, V139, P4213; Rich SM, 2003, ADV PARASIT, V54, P255, DOI 10.1016/S0065-308X(03)54005-2; RIDLEY RG, 1991, MOL BIOCHEM PARASIT, V47, P245, DOI 10.1016/0166-6851(91)90184-8; Sanders PR, 2006, INFECT IMMUN, V74, P4330, DOI 10.1128/IAI.00054-06; Sanders PR, 2005, J BIOL CHEM, V280, P40169, DOI 10.1074/jbc.M509631200; Shi QF, 2006, MOL BIOCHEM PARASIT, V149, P231, DOI 10.1016/j.molbiopara.2006.06.002; Siden-Kiamos I, 2006, MOL MICROBIOL, V60, P1355, DOI 10.1111/j.1365-2958.2006.05189.x; Sidjanski SP, 1997, MOL BIOCHEM PARASIT, V90, P33, DOI 10.1016/S0166-6851(97)00124-2; Silvie O, 2004, J BIOL CHEM, V279, P9490, DOI 10.1074/jbc.M311331200; Sterkers Y, 2007, J INFECT DIS, V196, P617, DOI 10.1086/519685; Stoeckert CJ, 2006, TRENDS PARASITOL, V22, P543, DOI 10.1016/j.pt.2006.09.005; Stubbs J, 2005, SCIENCE, V309, P1384, DOI 10.1126/science.1115257; Sultan AA, 1997, CELL, V90, P511, DOI 10.1016/S0092-8674(00)80511-5; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Thompson J, 2004, MOL BIOCHEM PARASIT, V134, P225, DOI 10.1016/j.molbiopara.2003.12.003; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thompson JK, 2001, MOL MICROBIOL, V41, P47, DOI 10.1046/j.1365-2958.2001.02484.x; Tomas AM, 2001, EMBO J, V20, P3975, DOI 10.1093/emboj/20.15.3975; Topolska AE, 2004, J BIOL CHEM, V279, P4648, DOI 10.1074/jbc.M307859200; Trenholme KR, 2000, P NATL ACAD SCI USA, V97, P4029, DOI 10.1073/pnas.040561197; Triglia T, 2000, MOL MICROBIOL, V38, P706, DOI 10.1046/j.1365-2958.2000.02175.x; Tsai YL, 2001, INFECT IMMUN, V69, P4048, DOI 10.1128/IAI.69.6.4048-4054.2001; van Dijk MR, 2001, CELL, V104, P153, DOI 10.1016/S0092-8674(01)00199-4; van Schaijk BCL, 2006, MOL BIOCHEM PARASIT, V149, P216, DOI 10.1016/j.molbiopara.2006.05.015; Volkman SK, 2007, NAT GENET, V39, P113, DOI 10.1038/ng1930; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yuda M, 1999, J EXP MED, V190, P1711, DOI 10.1084/jem.190.11.1711; Yuda M, 2001, MOL BIOCHEM PARASIT, V116, P65, DOI 10.1016/S0166-6851(01)00304-8	78	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2281	10.1371/journal.pone.0002281	http://dx.doi.org/10.1371/journal.pone.0002281			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509456	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000262268500025
J	Jakobsdottir, J; Conley, YP; Weeks, DE; Ferrell, RE; Gorin, MB				Jakobsdottir, Johanna; Conley, Yvette P.; Weeks, Daniel E.; Ferrell, Robert E.; Gorin, Michael B.			C2 and CFB Genes in Age-Related Maculopathy and Joint Action with CFH and LOC387715 Genes	PLOS ONE			English	Article							COMPLEMENT-FACTOR-H; HTRA1 PROMOTER POLYMORPHISM; MACULAR DEGENERATION; CIGARETTE-SMOKING; Y402H VARIANT; JAPANESE POPULATION; SUSCEPTIBILITY LOCI; GEOGRAPHIC ATROPHY; HEMICENTIN-1 GENES; STRONG ASSOCIATION	Background: Age-related maculopathy (ARM) is a common cause of visual impairment in the elderly populations of industrialized countries and significantly affects the quality of life of those suffering from the disease. Variants within two genes, the complement factor H (CFH) and the poorly characterized LOC387715 (ARMS2), are widely recognized as ARM risk factors. CFH is important in regulation of the alternative complement pathway suggesting this pathway is involved in ARM pathogenesis. Two other complement pathway genes, the closely linked complement component receptor (C2) and complement factor B (CFB), were recently shown to harbor variants associated with ARM. Methods/Principal Findings: We investigated two SNPs in C2 and two in CFB in independent case-control and family cohorts of white subjects and found rs547154, an intronic SNP in C2, to be significantly associated with ARM in both our case-control (P-value 0.00007) and family data (P-value 0.00001). Logistic regression analysis suggested that accounting for the effect at this locus significantly (P-value 0.002) improves the fit of a genetic risk model of CFH and LOC387715 effects only. Modeling with the generalized multifactor dimensionality reduction method showed that adding C2 to the two-factor model of CFH and LOC387715 increases the sensitivity (from 63% to 73%). However, the balanced accuracy increases only from 71% to 72%, and the specificity decreases from 80% to 72%. Conclusions/Significance: C2/CFB significantly influences AMD susceptibility and although accounting for effects at this locus does not dramatically increase the overall accuracy of the genetic risk model, the improvement over the CFH-LOC387715 model is statistically significant.	[Jakobsdottir, Johanna; Weeks, Daniel E.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Conley, Yvette P.] Univ Pittsburgh, Sch Nursing, Dept Hlth Promot & Dev, Pittsburgh, PA USA; [Conley, Yvette P.; Weeks, Daniel E.; Ferrell, Robert E.; Gorin, Michael B.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA USA; [Gorin, Michael B.] Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Dept Ophthalmol, Los Angeles, CA USA; [Gorin, Michael B.] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Jakobsdottir, J (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA.	gorin@jsei.ucla.edu	Weeks, Daniel E/B-2995-2012	Weeks, Daniel E/0000-0001-9410-7228; Jakobsdottir, Johanna/0000-0002-8019-9683	NEI [R01EY009859]; The Steinbach Foundation, New York; Research to Prevent Blindness, New York; Eye and Ear Foundation of Pittsburgh; American Health Assistance Foundation, Clarksburg, Maryland; Jules Stein Eye Institute, Los Angeles, California; NATIONAL EYE INSTITUTE [R01EY009859] Funding Source: NIH RePORTER	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); The Steinbach Foundation, New York; Research to Prevent Blindness, New York(Research to Prevent Blindness (RPB)); Eye and Ear Foundation of Pittsburgh; American Health Assistance Foundation, Clarksburg, Maryland; Jules Stein Eye Institute, Los Angeles, California; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by NEI grant R01EY009859, The Steinbach Foundation, New York, Research to Prevent Blindness, New York, the Eye and Ear Foundation of Pittsburgh, American Health Assistance Foundation, Clarksburg, Maryland, and the Jules Stein Eye Institute, Los Angeles, California (all to M.B.G.).	Baird PN, 2006, INVEST OPHTH VIS SCI, V47, P4194, DOI 10.1167/iovs.05-1285; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Browning SR, 2005, GENET EPIDEMIOL, V28, P110, DOI 10.1002/gepi.20051; Cameron DJ, 2007, CELL CYCLE, V6, P1122, DOI 10.4161/cc.6.9.4157; Chen LJ, 2006, MOL VIS, V12, P1536; Conley YP, 2005, HUM MOL GENET, V14, P1991, DOI 10.1093/hmg/ddi204; Conley YP, 2006, HUM MOL GENET, V15, P3206, DOI 10.1093/hmg/ddl396; DeAngelis MM, 2007, ARCH OPHTHALMOL-CHIC, V125, P49, DOI 10.1001/archopht.125.1.49; Despriet DDG, 2006, JAMA-J AM MED ASSOC, V296, P301, DOI 10.1001/jama.296.3.301; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Dinu V, 2007, GENET EPIDEMIOL, V31, P224, DOI 10.1002/gepi.20204; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Ennis S, 2007, BRIT J OPHTHALMOL, V91, P966, DOI 10.1136/bjo.2007.114090; Fisher SA, 2007, BRIT J OPHTHALMOL, V91, P576, DOI 10.1136/bjo.2006.105577; Francis PJ, 2007, HUM HERED, V63, P212, DOI 10.1159/000100046; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Fuse N, 2006, AM J OPHTHALMOL, V142, P1074, DOI 10.1016/j.ajo.2006.07.030; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Gorin MB, 2007, ARCH OPHTHALMOL-CHIC, V125, P21, DOI 10.1001/archopht.125.1.21; Gotoh N, 2006, HUM GENET, V120, P139, DOI 10.1007/s00439-006-0187-0; Hageman GS, 1999, MOL VIS, V5; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hughes AE, 2006, NAT GENET, V38, P1173, DOI 10.1038/ng1890; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Johnson LV, 2000, EXP EYE RES, V70, P441, DOI 10.1006/exer.1999.0798; Johnson LV, 2001, EXP EYE RES, V73, P887, DOI 10.1006/exer.2001.1094; Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104; Kaur I, 2006, INVEST OPHTH VIS SCI, V47, P3729, DOI 10.1167/iovs.05-1430; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lau LI, 2006, INVEST OPHTH VIS SCI, V47, P3242, DOI 10.1167/iovs.05-1532; Li M, 2006, NAT GENET, V38, P1049, DOI 10.1038/ng1871; Lou XY, 2007, AM J HUM GENET, V80, P1125, DOI 10.1086/518312; Magnusson KP, 2006, PLOS MED, V3, P109, DOI 10.1371/journal.pmed.0030005; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; Mori K, 2007, INVEST OPHTH VIS SCI, V48, P5315, DOI 10.1167/iovs.07-0426; Mori K, 2007, J HUM GENET, V52, P636, DOI 10.1007/s10038-007-0162-1; Mukhopadhyay N, 2004, HUM HERED, V58, P175, DOI 10.1159/000083545; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Narayanan R, 2007, OPHTHALMOLOGY, V114, P1327, DOI 10.1016/j.ophtha.2006.10.035; North BV, 2005, HUM HERED, V59, P79, DOI 10.1159/000085222; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Okamoto H, 2006, MOL VIS, V12, P156; R Development Core Team, 2005, R LANG ENV STAT COMP; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Ross RJ, 2007, INVEST OPHTH VIS SCI, V48, P1128, DOI 10.1167/iovs.06-0999; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Schaumberg DA, 2007, ARCH OPHTHALMOL-CHIC, V125, P55, DOI 10.1001/archopht.125.1.55; Schaumberg DA, 2006, INVEST OPHTH VIS SCI, V47, P2336, DOI 10.1167/iovs.05-1456; Schmidt S, 2006, AM J HUM GENET, V78, P852, DOI 10.1086/503822; Seddon JM, 2007, JAMA-J AM MED ASSOC, V297, P1793, DOI 10.1001/jama.297.16.1793; Seddon Johanna M., 2004, International Ophthalmology Clinics, V44, P17, DOI 10.1097/00004397-200404440-00004; Seitsonen S, 2006, MOL VIS, V12, P796; Sepp T, 2006, INVEST OPHTH VIS SCI, V47, P536, DOI 10.1167/iovs.05-1143; Simonelli F, 2006, BRIT J OPHTHALMOL, V90, P1142, DOI 10.1136/bjo.2006.096487; Sivaprasad S, 2007, ARCH OPHTHALMOL-CHIC, V125, P515, DOI 10.1001/archopht.125.4.515; Souied EH, 2005, MOL VIS, V11, P1135; Spencer KL, 2007, HUM MOL GENET, V16, P1986, DOI 10.1093/hmg/ddm146; Tanimoto S, 2007, NEUROSCI LETT, V414, P71, DOI 10.1016/j.neulet.2006.12.011; Tedeschi-Blok N, 2007, OPHTHALMOLOGY, V114, P99, DOI 10.1016/j.ophtha.2006.07.043; THOMPSON CL, 2007, HUM MOL GENET; Thornton J, 2005, EYE, V19, P935, DOI 10.1038/sj.eye.6701978; Tuo JS, 2006, P NATL ACAD SCI USA, V103, P9256, DOI 10.1073/pnas.0603485103; Uka J, 2006, RETINA-J RET VIT DIS, V26, P985, DOI 10.1097/01.iae.0000244068.18520.3e; van Leeuwen R, 2003, EUR J EPIDEMIOL, V18, P845, DOI 10.1023/A:1025643303914; WANG JJ, 2007, LOC387715 POLYMORPHI; WARNES G, 2006, POPULATION GENETICS; Weeks DE, 2000, HUM MOL GENET, V9, P1329, DOI 10.1093/hmg/9.9.1329; Weeks DE, 2004, AM J HUM GENET, V75, P174, DOI 10.1086/422476; Wegscheider BJ, 2007, OPHTHALMOLOGY, V114, P738, DOI 10.1016/j.ophtha.2006.07.048; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; YATES JR, 2007, COMPLEMENT C3 VARIAN; Yoshida T, 2007, MOL VIS, V13, P545; Zareparsi S, 2005, AM J HUM GENET, V77, P149, DOI 10.1086/431426	78	73	88	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2199	10.1371/journal.pone.0002199	http://dx.doi.org/10.1371/journal.pone.0002199			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493315	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000262258700008
J	Natsume, T; Tsutsui, Y; Sutani, T; Dunleavy, EM; Pidoux, AL; Iwasaki, H; Shirahige, K; Allshire, RC; Yamao, F				Natsume, Toyoaki; Tsutsui, Yasuhiro; Sutani, Takashi; Dunleavy, Elaine M.; Pidoux, Alison L.; Iwasaki, Hiroshi; Shirahige, Katsuhiko; Allshire, Robin C.; Yamao, Fumiaki			A DNA Polymerase alpha Accessory Protein, Mcl1, Is Required for Propagation of Centromere Structures in Fission Yeast	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; CENP-A; HISTONE DEACETYLATION; EPIGENETIC CONTROL; REPLICATION; HETEROCHROMATIN; COMPLEX; KINETOCHORE; ESTABLISHMENT; DOMAINS	Specialized chromatin exists at centromeres and must be precisely transmitted during DNA replication. The mechanisms involved in the propagation of these structures remain elusive. Fission yeast centromeres are composed of two chromatin domains: the central CENP-A(Cnp1) kinetochore domain and flanking heterochromatin domains. Here we show that fission yeast Mcl1, a DNA polymerase alpha (Pol alpha) accessory protein, is critical for maintenance of centromeric chromatin. In a screen for mutants that alleviate both central domain and outer repeat silencing, we isolated several cos mutants, of which cos1 is allelic to mcl1. The mcl1-101 mutation causes reduced CENP-A(Cnp1) in the central domain and an aberrant increase in histone acetylation in both domains. These phenotypes are also observed in a mutant of swi7(+), which encodes a catalytic subunit of Pol alpha. Mcl1 forms S-phase-specific nuclear foci, which colocalize with those of PCNA and Pol alpha. These results suggest that Mcl1 and Pol alpha are required for propagation of centromere chromatin structures during DNA replication.	[Natsume, Toyoaki; Tsutsui, Yasuhiro; Yamao, Fumiaki] Natl Inst Genet, Div Mutagenesis, Mishima, Shizuoka, Japan; [Sutani, Takashi; Shirahige, Katsuhiko] Tokyo Inst Technol, Ctr Biol Resources & Informat, Lab Genome Structure & Function, Yokohama, Kanagawa, Japan; [Dunleavy, Elaine M.; Pidoux, Alison L.; Allshire, Robin C.] Univ Edinburgh, Sch Biol Sci, Inst Cell Biol, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland; [Iwasaki, Hiroshi] Yokohama City Univ, Int Grad Sch Arts & Sci, Div Mol & Cellular Biol, Yokohama, Kanagawa, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Tokyo Institute of Technology; University of Edinburgh; Yokohama City University	Natsume, T (corresponding author), Natl Inst Genet, Div Mutagenesis, Mishima, Shizuoka, Japan.	ytsutsui@lab.nig.ac.jp	Iwasaki, Hiroshi/Y-7946-2018; Natsume, Toyoaki/S-1936-2018	Iwasaki, Hiroshi/0000-0002-0153-6873; Natsume, Toyoaki/0000-0002-3544-4491; Sutani, Takashi/0000-0002-9959-9513; Allshire, Robin/0000-0002-8005-3625	Ministry of Education, Culture, Sports, Science, and Technology of Japan [Grants-in Aids]; Wellcome Trust [065061/Z, 069286]; Association for International Cancer Research [00-0297]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Wellcome Trust(Wellcome TrustEuropean Commission); Association for International Cancer Research	Grants-in Aids from the Ministry of Education, Culture, Sports, Science, and Technology of Japan Wellcome Trust Program Grant 065061/Z and 069286/AICR: Association for International Cancer Research Grant: 00-0297	Ahmed S, 2001, J BIOL CHEM, V276, P47814, DOI 10.1074/jbc.M109186200; ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Baum M, 2006, P NATL ACAD SCI USA, V103, P14877, DOI 10.1073/pnas.0606958103; Berezney R, 2000, CHROMOSOMA, V108, P471, DOI 10.1007/s004120050399; Castillo AG, 2007, PLOS GENET, V3, P1264, DOI 10.1371/journal.pgen.0030121; Chen ES, 2003, MOL CELL, V11, P175, DOI 10.1016/S1097-2765(03)00011-X; Dunleavy EM, 2007, MOL CELL, V28, P1029, DOI 10.1016/j.molcel.2007.10.010; Ekwall K, 1999, GENETICS, V153, P1153; EKWALL K, 1995, SCIENCE, V269, P1429, DOI 10.1126/science.7660126; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; Ekwall K, 1996, J CELL SCI, V109, P2637; Freeman-Cook LL, 2005, GENETICS, V169, P1243, DOI 10.1534/genetics.104.032714; Freeman-Cook LL, 1999, MOL BIOL CELL, V10, P3171, DOI 10.1091/mbc.10.10.3171; Furuyama T, 2006, P NATL ACAD SCI USA, V103, P6172, DOI 10.1073/pnas.0601686103; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gregan J, 2007, CURR BIOL, V17, P1190, DOI 10.1016/j.cub.2007.06.044; Grewal SIS, 1998, GENETICS, V150, P563; Hanna JS, 2001, MOL CELL BIOL, V21, P3144, DOI 10.1128/MCB.21.9.3144-3158.2001; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Karpen GH, 1997, TRENDS GENET, V13, P489, DOI 10.1016/S0168-9525(97)01298-5; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Kim SM, 2003, GENE DEV, V17, P330, DOI 10.1101/gad.1046203; Kitamura E, 2006, CELL, V125, P1297, DOI 10.1016/j.cell.2006.04.041; KOUPRINA N, 1993, YEAST, V9, P11, DOI 10.1002/yea.320090103; KOUPRINA N, 1992, MOL CELL BIOL, V12, P5736, DOI 10.1128/MCB.12.12.5736; Lejeune E, 2007, CURR BIOL, V17, P1219, DOI 10.1016/j.cub.2007.06.028; Lengronne A, 2006, MOL CELL, V23, P787, DOI 10.1016/j.molcel.2006.08.018; Mamnun YM, 2006, BIOCHEM BIOPH RES CO, V350, P125, DOI 10.1016/j.bbrc.2006.09.024; MARSCHALL LG, 1995, J CELL BIOL, V128, P445, DOI 10.1083/jcb.128.4.445; Meister P, 2003, NUCLEIC ACIDS RES, V31, P5064, DOI 10.1093/nar/gkg719; MILES J, 1992, P NATL ACAD SCI USA, V89, P1276, DOI 10.1073/pnas.89.4.1276; MILES J, 1992, MOL CELL BIOL, V12, P5724, DOI 10.1128/MCB.12.12.5724; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morris CA, 2007, CELL, V128, P647, DOI 10.1016/j.cell.2007.02.002; Mythreye K, 2003, J CELL BIOL, V160, P833, DOI 10.1083/jcb.200211116; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nakayama J, 2001, EMBO J, V20, P2857, DOI 10.1093/emboj/20.11.2857; Okuno Y, 1997, NUCLEIC ACIDS RES, V25, P530, DOI 10.1093/nar/25.3.530; Partridge J.F., 1999, PRACT APPROACH SER, P38; Partridge JF, 2000, GENE DEV, V14, P783; Pidoux A, 2004, METHODS, V33, P252, DOI 10.1016/j.ymeth.2003.11.021; Pidoux AL, 2004, CHROMOSOME RES, V12, P521, DOI 10.1023/B:CHRO.0000036586.81775.8b; Pidoux AL, 2003, J CELL BIOL, V161, P295, DOI 10.1083/jcb.200212110; Pidoux AL, 2000, J CELL SCI, V113, P4177; POLIZZI C, 1991, J CELL BIOL, V112, P191, DOI 10.1083/jcb.112.2.191; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Saitoh S, 1997, CELL, V90, P131, DOI 10.1016/S0092-8674(00)80320-7; Shelby RD, 2000, J CELL BIOL, V151, P1113, DOI 10.1083/jcb.151.5.1113; Sullivan KF, 2001, CURR OPIN GENET DEV, V11, P182, DOI 10.1016/S0959-437X(00)00177-5; Suter B, 2004, GENETICS, V167, P579, DOI 10.1534/genetics.103.024851; Taddei A, 1999, J CELL BIOL, V147, P1153, DOI 10.1083/jcb.147.6.1153; Takahashi K, 2005, PHILOS T R SOC B, V360, P595, DOI 10.1098/rstb.2004.1614; TAKAHASHI K, 1992, MOL BIOL CELL, V3, P819, DOI 10.1091/mbc.3.7.819; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Tsutsui Y, 2005, CURR GENET, V48, P34, DOI 10.1007/s00294-005-0584-2; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; Walfridsson J, 2005, NUCLEIC ACIDS RES, V33, P2868, DOI 10.1093/nar/gki579; Williams DR, 2005, EUKARYOT CELL, V4, P166, DOI 10.1128/EC.4.1.166-177.2005; Williams DR, 2002, EUKARYOT CELL, V1, P758, DOI 10.1128/EC.1.5.758-773.2002; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Zhang J, 1998, J PORPHYR PHTHALOCYA, V2, P93, DOI 10.1002/(SICI)1099-1409(199803/04)2:2<93::AID-JPP81>3.3.CO;2-O; Zhang Y, 1997, CELL, V89, P357, DOI 10.1016/S0092-8674(00)80216-0; Zhou YJ, 2004, MOL CELL BIOL, V24, P9568, DOI 10.1128/MCB.24.21.9568-9579.2004	68	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2221	10.1371/journal.pone.0002221	http://dx.doi.org/10.1371/journal.pone.0002221			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493607	Green Submitted, Green Published, gold			2022-12-25	WOS:000262258700029
J	Sahni, M; Verma, N; Narula, D; Varghese, RM; Sreenivas, V; Puliyel, JM				Sahni, Mohit; Verma, Neeraj; Narula, D.; Varghese, Raji Mathew; Sreenivas, V.; Puliyel, Jacob M.			Missing Girls in India: Infanticide, Feticide and Made-to-Order Pregnancies? Insights from Hospital-Based Sex-Ratio-at-Birth over the Last Century	PLOS ONE			English	Article							HEPATITIS-B VIRUS; SELECTIVE ABORTIONS; MORTALITY; CHILDREN; WOMEN	Background: There are 44 million missing women in India. Gender bias; neglect of girls, infanticides and feticides are responsible. The sex ratio at birth can be used to examine the influence of antenatal sex selection on the sex ratio. Materials and Methods: Records from 321,991 deliveries at one hospital over 11 decades were utilized. The middle year in each decade was taken as representative of the decade. Data from 33,524 deliveries were then analyzed. Data for each decade was combined with that of previous decades and compared to the data of subsequent decades to look for any change in the trend. Sex ratio in the second children against sex of the first child was studied separately. Results: The mean sex ratio for the 110 years examined was 910 girls to 1000 boys (95% CI; 891 to 930). The sex ratio dropped significantly from 935 (CI: 905 to 967) before 1979, to 892 (CI: 868 to 918) after 1980 (P = 0.04). The sex ratio in the second child was significantly lower if the first child was a girl [716 (CI: 672 to 762] (P < 0.001). On the other hand, there was an excess of girls born to mothers whose first child was boy [1140 girls per 1000 boys (CI: 1072 to 1212 P < 0.001)]. Conclusions: The sex ratio fell significantly after 1980 when ultra sound machines for antenatal sex determination became available. The sex ratio in second children if the first was a girl was even lower. Sex selective abortions after antenatal sex determination are thus implicated. However data on second children especially the excess of girls born to mothers who have a previous boy seen in the decade before the advent of antenatal ultra sound machines, suggests that other means of sex selection are also used.	[Sahni, Mohit; Verma, Neeraj; Narula, D.; Varghese, Raji Mathew; Puliyel, Jacob M.] St Stephens Hosp, Dept Neonatol & Pediat, Delhi, India; [Sreenivas, V.] All India Inst Med Sci, Dept Biostat, New Delhi, India	St. Stephen's Hospital; All India Institute of Medical Sciences (AIIMS) New Delhi	Puliyel, JM (corresponding author), St Stephens Hosp, Dept Neonatol & Pediat, Delhi, India.	puliyel@vsnl.com	Hizukuri, Tatiana/H-6593-2016					Arnold F, 2002, POPUL DEV REV, V28, P759, DOI 10.1111/j.1728-4457.2002.00759.x; BAGGA C, 2005, TIMES INDIA     0714; CHALNAZARIAN A, 1988, J BIOSOC SCI, V20, P357; Chatterjee M, 1990, REPORT INDIAN WOMEN; Das Gupta M, 2005, POPUL DEV REV, V31, P529; DasGupta M, 1997, POP STUD-J DEMOG, V51, P307, DOI 10.1080/0032472031000150076; DREW JS, 1978, SCIENCE, V201, P687, DOI 10.1126/science.566954; DREW JS, 1986, HUM BIOL, V58, P115; Fukuda M, 2002, LANCET, V359, P1407, DOI 10.1016/S0140-6736(02)08362-9; GANGADHARAN S, 1991, EC TIMES        0418; GEORGE S, 1998, SEARCH B, V12, P18; GEORGE S, FEMALE INFANTICIDE T; George SM, 2006, LANCET, V367, P1725, DOI 10.1016/S0140-6736(06)68758-8; George SM, 2002, REPROD HEALTH MATTER, V10, P190, DOI 10.1016/S0968-8080(02)00034-4; GHOSH S, 1987, B NUTR FDN INDIA, V8, P4; Grover A, 2006, LANCET, V367, P1726, DOI 10.1016/S0140-6736(06)68760-6; Hesketh T, 2006, P NATL ACAD SCI USA, V103, P13271, DOI 10.1073/pnas.0602203103; HESSER JE, 1975, HUM BIOL, V47, P415; JAISING I, 2004, PRECONCEPTION PRENAT; James WH, 1996, J THEOR BIOL, V180, P271, DOI 10.1006/jtbi.1996.0102; Jha P, 2006, LANCET, V367, P211, DOI 10.1016/S0140-6736(06)67930-0; Kankova S, 2007, NATURWISSENSCHAFTEN, V94, P122, DOI 10.1007/s00114-006-0166-2; Khanna R, 2003, BRIT MED J, V327, P126, DOI 10.1136/bmj.327.7407.126; KLASEN S, 1994, WORLD DEV, V22, P1061, DOI 10.1016/0305-750X(94)90148-1; LEIDL P, 2005, SILENT SPRINGS TRAGE; Oster E, 2005, J POLIT ECON, V113, P1163, DOI 10.1086/498588; PATEL V, 1989, B CONCERN ASIA SCHOL, V21, P2, DOI 10.1080/14672715.1989.10413186; RAMANAMMA A, 1980, SOC SCI MED-MED ANTH, V14, P107, DOI 10.1016/0160-7987(80)90059-9; SEN A, 1992, BRIT MED J, V304, P587, DOI 10.1136/bmj.304.6827.587; Sen A, 2003, BMJ-BRIT MED J, V327, P1297, DOI 10.1136/bmj.327.7427.1297; Sen Amartya, 2001, FRONTLINE, V18, P4; Sudha S, 1999, DEV CHANGE, V30, P585, DOI 10.1111/1467-7660.00130; TANDON BN, 1991, INDIAN J MED RES-A, V93, P337; *UN WORLD POP PROS, 200 REV HIGHL; *UNFPA, 2001, SEX SEL AB FERT DEC; VISARIA P, 1991, EC TIMES        0418; WALDRON I, 1993, SOC SCI MED, V36, P451, DOI 10.1016/0277-9536(93)90407-U; WILLIAMS RJ, 1992, SOC BIOL, V39, P285; ZENG Y, 1993, POPUL DEV REV, V19, P283; CENSUS INDIA 2001 PR	40	40	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2224	10.1371/journal.pone.0002224	http://dx.doi.org/10.1371/journal.pone.0002224			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	391UK	18493614	Green Published, Green Submitted, gold			2022-12-25	WOS:000262258700032
J	Schulp, AS; Al-Wosabi, M; Stevens, NJ				Schulp, Anne S.; Al-Wosabi, Mohammed; Stevens, Nancy J.			First Dinosaur Tracks from the Arabian Peninsula	PLOS ONE			English	Article								Background: The evolutionary history of Mesozoic terrestrial vertebrates from the Arabian Peninsula is virtually unknown. Despite vast exposures of rocky outcrops, only a handful of fossils have yet been described from the region. Here we report a multi-taxon dinosaur track assemblage near Madar village, 47 km north of Sana'a, Republic of Yemen. This represents the first dinosaur tracksite from the Arabian Peninsula, and the only multi-taxon dinosaur ichnosite in the Middle East. Methodology/Findings: Measurements were taken directly from trackway impressions, following standard ichnological conventions. The presence of bipedal trackmakers is evidenced by a long series of pes imprints preserving smoothly rounded posterior margins, no evidence of a hallux, bluntly rounded digit tips and digital divarication angles characteristic of ornithopod dinosaurs. Nearby, eleven parallel quadrupedal trackways document a sauropod herd that included large and small individuals traveling together. Based on the morphology of manus impressions along with a narrow-gauged stance, the quadrupedal trackways were made by non-titanosauriform neosauropods. Additional isolated tracks and trackways of sauropod and ornithopod dinosaurs are preserved nearby. Conclusions/Significance: Taken together, these discoveries present the most evocative window to date into the evolutionary history of dinosaurs of the Arabian Peninsula. Given the limited Mesozoic terrestrial record from the region, this discovery is of both temporal and geographic significance, and massive exposures of similarly-aged outcrops nearby offer great promise for future discoveries.	[Schulp, Anne S.] Nat Hist Museum, Maastricht, Netherlands; [Al-Wosabi, Mohammed] Sanaa Univ, Dept Geol, Sanaa, Yemen; [Stevens, Nancy J.] Ohio Univ, Coll Osteopath Med, Dept Biomed Sci, Athens, OH USA	University System of Ohio; Ohio University	Schulp, AS (corresponding author), Nat Hist Museum, Maastricht, Netherlands.	stevensn@ohio.edu	Schulp, Anne/AAM-9015-2020; Stevens, Nancy J/E-6928-2013	Schulp, Anne/0000-0001-9389-1540; 	Yemen Geological Survey; Ohio University	Yemen Geological Survey; Ohio University	Partial funding for this work provided by the Yemen Geological Survey, Mr. T. Saleh, and Ohio University.	Ahmed AAK, 2004, LETHAIA, V37, P467, DOI 10.1080/00241160410002162; ALEXANDER RM, 1976, NATURE, V261, P129, DOI 10.1038/261129a0; ALWOSABI MA, 2001, THESIS SANAS U; AVNIMELECH M, 1962, NATURE, V196, P264, DOI 10.1038/196264a0; Avnimelech M., 1962, CRAS GEOL, V8, P233; AVNIMELECH MA, 1966, ISR ACAD SCI HUM P S, V1; BEYDOUN ZR, 1998, IUGS PUB, V34; Buffetaut E, 2006, NATURWISSENSCHAFTEN, V93, P440, DOI 10.1007/s00114-006-0124-z; Carrano MT, 2001, PALEOBIOLOGY, V27, P564, DOI 10.1666/0094-8373(2001)027<0564:TDATTT>2.0.CO;2; CROMPTON AW, 1962, NATURE, V196, P1074, DOI 10.1038/1961074a0; DUTUIT JM, 1980, MEM SOC GEOL FRANCE, V139, P95; Farlow James O., 1997, P519; GINSBURG L, 1966, CR ACAD SCI D NAT, V263, P28; Goodwin MB, 1999, J VERTEBR PALEONTOL, V19, P728, DOI 10.1080/02724634.1999.10011185; GOODWIN MB, 1996, J VERT PALEONT S, V16, pA38; GOW CE, 1975, ZOOL J LINN SOC-LOND, V57, P335, DOI 10.1111/j.1096-3642.1975.tb01895.x; Henderson DM, 2006, J VERTEBR PALEONTOL, V26, P907, DOI 10.1671/0272-4634(2006)26[907:BGCOMS]2.0.CO;2; HOOIJER DA, 1968, PROC K NED AKAD B-PH, V71, P150; Howarth Michael K., 1998, Bulletin of the Natural History Museum Geology Series, V54, P1; Ishigaki S., 1989, P83; Jacobs L.L., 1989, P349; JACOBS LL, 1990, NATL GEOGR RES, V6, P196; Jacobs LL, 1999, FOSSIL VERTEBRATES OF ARABIA, P454; Lamare P, 1930, MEMOIRS SOC GEOLOGIQ, V14, P49; MARTILL DM, 1996, NEUES JB GEOLOGIE PA, V199, P147; Moreno K, 2005, J S AM EARTH SCI, V20, P253, DOI 10.1016/j.jsames.2005.05.012; NOLAN SC, 1990, GEOL SOC LOND SPEC P, V49, P495; Schulp Anne S., 1999, Ichnos, V6, P239; Schulp AS, 2000, CRETACEOUS RES, V21, P851, DOI 10.1006/cres.2000.0235; Thulborn T., 1990, DINOSAUR TRACKS; Weishampel DB, 2004, DINOSAURIA, 2ND EDITION, P517; Wilson JA, 2005, PALEOBIOLOGY, V31, P400, DOI 10.1666/0094-8373(2005)031[0400:IIABFR]2.0.CO;2; Wilson JA, 1999, PALEOBIOLOGY, V25, P252, DOI 10.1017/S0094837300026543; Yates AM, 2003, P ROY SOC B-BIOL SCI, V270, P1753, DOI 10.1098/rspb.2003.2417	34	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2243	10.1371/journal.pone.0002243	http://dx.doi.org/10.1371/journal.pone.0002243			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493306	Green Published, Green Submitted, gold			2022-12-25	WOS:000262258700051
J	Zuena, AR; Mairesse, J; Casolini, P; Cinque, C; Alema, GS; Morley-Fletcher, S; Chiodi, V; Spagnoli, LG; Gradini, R; Catalani, A; Nicoletti, F; Maccari, S				Zuena, Anna Rita; Mairesse, Jerome; Casolini, Paola; Cinque, Carlo; Alema, Giovanni Sebastiano; Morley-Fletcher, Sara; Chiodi, Valentina; Spagnoli, Luigi Giusto; Gradini, Roberto; Catalani, Assia; Nicoletti, Ferdinando; Maccari, Stefania			Prenatal Restraint Stress Generates Two Distinct Behavioral and Neurochemical Profiles in Male and Female Rats	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; LONG-TERM POTENTIATION; MESSENGER-RNA EXPRESSION; ELEVATED PLUS-MAZE; ADULT HIPPOCAMPAL NEUROGENESIS; ANXIETY-RELATED BEHAVIOR; NEUROTROPHIC FACTOR; SPATIAL MEMORY; DENTATE GYRUS; VENTRAL HIPPOCAMPUS	Prenatal Restraint Stress (PRS) in rats is a validated model of early stress resulting in permanent behavioral and neurobiological outcomes. Although sexual dimorphism in the effects of PRS has been hypothesized for more than 30 years, few studies in this long period have directly addressed the issue. Our group has uncovered a pronounced gender difference in the effects of PRS (stress delivered to the mothers 3 times per day during the last 10 days of pregnancy) on anxiety, spatial learning, and a series of neurobiological parameters classically associated with hippocampus-dependent behaviors. Adult male rats subjected to PRS ("PRS rats'') showed increased anxiety-like behavior in the elevated plus maze (EPM), a reduction in the survival of newborn cells in the dentate gyrus, a reduction in the activity of mGlu1/5 metabotropic glutamate receptors in the ventral hippocampus, and an increase in the levels of brain-derived neurotrophic factor (BDNF) and pro-BDNF in the hippocampus. In contrast, female PRS rats displayed reduced anxiety in the EPM, improved learning in the Morris water maze, an increase in the activity of mGlu1/5 receptors in the ventral and dorsal hippocampus, and no changes in hippocampal neurogenesis or BDNF levels. The direction of the changes in neurogenesis, BDNF levels and mGlu receptor function in PRS animals was not consistent with the behavioral changes, suggesting that PRS perturbs the interdependency of these particular parameters and their relation to hippocampus-dependent behavior. Our data suggest that the epigenetic changes in hippocampal neuroplasticity induced by early environmental challenges are critically sex-dependent and that the behavioral outcome may diverge in males and females.	[Zuena, Anna Rita; Mairesse, Jerome; Morley-Fletcher, Sara; Maccari, Stefania] Univ Lille 1, Perinatal Stress Lab, F-59655 Villeneuve Dascq, France; [Zuena, Anna Rita; Mairesse, Jerome; Casolini, Paola; Cinque, Carlo; Alema, Giovanni Sebastiano; Chiodi, Valentina; Catalani, Assia; Nicoletti, Ferdinando; Maccari, Stefania] Univ Roma La Sapienza, Dept Human Physiol & Pharmacol, Rome, Italy; [Gradini, Roberto; Nicoletti, Ferdinando] Ist Neurol Mediterraneo Neuromed, Pozzilli, Italy; [Spagnoli, Luigi Giusto] Tor Vergata Univ, Inst Anatom Pathol, Rome, Italy; [Gradini, Roberto] Univ Roma La Sapienza, Dept Expt Med, Rome, Italy	Universite de Lille - ISITE; Universite de Lille; Sapienza University Rome; IRCCS Neuromed; University of Rome Tor Vergata; Sapienza University Rome	Zuena, AR (corresponding author), Univ Lille 1, Perinatal Stress Lab, F-59655 Villeneuve Dascq, France.	stefania.maccari@univ-lille1.fr	Maccari, Stefania/P-1641-2019; Nicoletti, Ferdinando/T-4898-2019; Nicoletti, Ferdinando/K-4410-2016; Alemà, Giovanni Sebastiano/D-2672-2009; Cinque, Carlo/AAD-6216-2019; Nicoletti, Ferdinando/A-2446-2010	Maccari, Stefania/0000-0002-8336-5990; Alemà, Giovanni Sebastiano/0000-0003-2350-6365; NICOLETTI, Ferdinando/0000-0003-3366-7269; Morley-Fletcher, Sara/0000-0003-0423-5563; CHIODI, VALENTINA/0000-0002-9783-0005; Spagnoli, Luigi Giusto/0000-0002-0684-5501; Nicoletti, Ferdinando/0000-0003-0917-443X	University of Lille 1; Sapienza University of Rome; Ministere des Affaires Etrangers; Lavoisier, EGIDE	University of Lille 1; Sapienza University of Rome; Ministere des Affaires Etrangers; Lavoisier, EGIDE	This research was supported by the University of Lille 1 and the Sapienza University of Rome (under the framework of an agreement signed between the 2 universities on 15/02/2007). Anna Rita Zuena was funded by the Ministere des Affaires Etrangers. Jerome Mairesse was funded by the Lavoisier, EGIDE.	Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; Alves SH, 2004, BEHAV PHARMACOL, V15, P37, DOI 10.1097/00008877-200402000-00005; Ballard TM, 2005, PSYCHOPHARMACOLOGY, V179, P218, DOI 10.1007/s00213-005-2211-9; Balschun D, 2002, PHARMACOL BIOCHEM BE, V73, P375, DOI 10.1016/S0091-3057(02)00847-X; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Becker S, 2007, TRENDS COGN SCI, V11, P70, DOI 10.1016/j.tics.2006.10.013; Bendel O, 2005, J CEREBR BLOOD F MET, V25, P1586, DOI 10.1038/sj.jcbfm.9600153; Bertoglio LJ, 2006, BEHAV BRAIN RES, V175, P183, DOI 10.1016/j.bbr.2006.08.021; Bortolotto ZA, 2005, NEUROPHARMACOLOGY, V49, P13, DOI 10.1016/j.neuropharm.2005.05.020; Bowman RE, 2005, J NEUROENDOCRINOL, V17, P526, DOI 10.1111/j.1365-2826.2005.01335.x; Bowman RE, 2004, ENDOCRINOLOGY, V145, P3778, DOI 10.1210/en.2003-1759; Brazel CY, 2005, NEUROSCIENCE, V131, P55, DOI 10.1016/j.neuroscience.2004.10.038; Brodkin J, 2002, PHARMACOL BIOCHEM BE, V73, P359, DOI 10.1016/S0091-3057(02)00828-6; Bruel-Jungerman E, 2007, REV NEUROSCIENCE, V18, P93; Canossa M, 2001, EMBO J, V20, P1640, DOI 10.1093/emboj/20.7.1640; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Darnaudery M, 2006, NEUROBIOL AGING, V27, P119, DOI 10.1016/j.neurobiolaging.2005.01.008; Darnaudery M, 2008, BRAIN RES REV, V57, P571, DOI 10.1016/j.brainresrev.2007.11.004; De Blasi A, 2001, TRENDS PHARMACOL SCI, V22, P114, DOI 10.1016/S0165-6147(00)01635-7; Degroot A, 2002, BRAIN RES, V949, P60, DOI 10.1016/S0006-8993(02)02965-7; Di Giorgi-Gerevini V, 2005, CELL DEATH DIFFER, V12, P1124, DOI 10.1038/sj.cdd.4401639; Dranovsky A, 2006, BIOL PSYCHIAT, V59, P1136, DOI 10.1016/j.biopsych.2006.03.082; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Dringenberg HC, 2008, BEHAV BRAIN RES, V186, P143, DOI 10.1016/j.bbr.2007.07.030; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Earnheart JC, 2007, J NEUROSCI, V27, P3845, DOI 10.1523/JNEUROSCI.3609-06.2007; FALKENBERG T, 1992, NEUROSCI LETT, V138, P153, DOI 10.1016/0304-3940(92)90494-R; File SE, 1996, PHARMACOL BIOCHEM BE, V54, P123, DOI 10.1016/0091-3057(95)02108-6; Francesconi W, 2004, BRAIN RES, V1022, P12, DOI 10.1016/j.brainres.2004.06.060; Furutani K, 2006, P NATL ACAD SCI USA, V103, P8528, DOI 10.1073/pnas.0600497103; GENAZZANI AA, 1994, BRAIN RES, V659, P10, DOI 10.1016/0006-8993(94)90857-5; Gomez-Pinilla F, 2005, EXP NEUROL, V192, P235, DOI 10.1016/j.expneurol.2004.12.001; Gomez-Pinilla F, 2001, BRAIN RES, V904, P13, DOI 10.1016/S0006-8993(01)02394-0; Gooney M, 2002, BEHAV NEUROSCI, V116, P455, DOI 10.1037//0735-7044.116.3.455; Gorski JA, 2003, NEUROSCIENCE, V121, P341, DOI 10.1016/S0306-4522(03)00426-3; Heldt SA, 2007, MOL PSYCHIATR, V12, P656, DOI 10.1038/sj.mp.4001957; Hogg S, 1996, PHARMACOL BIOCHEM BE, V54, P21, DOI 10.1016/0091-3057(95)02126-4; Jaako-Movits K, 2005, INT J DEV NEUROSCI, V23, P627, DOI 10.1016/j.ijdevneu.2005.07.005; Jia ZP, 1998, LEARN MEMORY, V5, P331; Jiang W, 2005, J CLIN INVEST, V115, P3104, DOI 10.1172/JCI25509; Katoh-Semba R, 2002, FASEB J, V16, P1328, DOI 10.1096/fj.02-0143fje; Kesslak JP, 2003, NEUROSCI LETT, V353, P95, DOI 10.1016/j.neulet.2003.08.078; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; Lante F, 2006, HIPPOCAMPUS, V16, P345, DOI 10.1002/hipo.20146; Leal-Galicia P, 2007, DEV NEUROBIOL, V67, P395, DOI 10.1002/dneu.20322; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Lee J, 2000, J MOL NEUROSCI, V15, P99, DOI 10.1385/JMN:15:2:99; Lee Y, 2006, NEUROSCI LETT, V398, P328, DOI 10.1016/j.neulet.2006.01.021; Lemaire V, 2006, EUR J NEUROSCI, V23, P3368, DOI 10.1111/j.1460-9568.2006.04870.x; Lemaire V, 2000, P NATL ACAD SCI USA, V97, P11032, DOI 10.1073/pnas.97.20.11032; Li XH, 2007, CHINESE MED J-PEKING, V120, P669, DOI 10.1097/00029330-200704020-00011; Linnarsson S, 1997, EUR J NEUROSCI, V9, P2581, DOI 10.1111/j.1460-9568.1997.tb01687.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Lu YM, 1997, J NEUROSCI, V17, P5196; Luo CX, 2007, J NEUROSCI RES, V85, P1637, DOI 10.1002/jnr.21317; MACCARI S, 1995, J NEUROSCI, V15, P110; Maccari S, 2007, PSYCHONEUROENDOCRINO, V32, pS10, DOI 10.1016/j.psyneuen.2007.06.005; Mairesse J, 2007, PSYCHONEUROENDOCRINO, V32, P765, DOI 10.1016/j.psyneuen.2007.03.013; Manahan-Vaughan D, 2005, CEREB CORTEX, V15, P1703, DOI 10.1093/cercor/bhi047; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Matarredona ER, 2001, J NEUROCHEM, V76, P351, DOI 10.1046/j.1471-4159.2001.00056.x; MCCORMICK CM, 1995, DEV BRAIN RES, V84, P55, DOI 10.1016/0165-3806(94)00153-Q; McHugh SB, 2004, BEHAV NEUROSCI, V118, P63, DOI 10.1037/0735-7044.118.1.63; Montaron ME, 2004, NEUROTOX RES, V6, P571, DOI 10.1007/BF03033453; Naie K, 2004, CEREB CORTEX, V14, P189, DOI 10.1093/cercor/bhg118; NICOLETTI F, 1986, J NEUROCHEM, V46, P40, DOI 10.1111/j.1471-4159.1986.tb12922.x; NICOLETTI F, 1993, EUR J PHARM-MOLEC PH, V245, P297, DOI 10.1016/0922-4106(93)90111-L; Nilsson M, 1999, J NEUROBIOL, V39, P569, DOI 10.1002/(SICI)1097-4695(19990615)39:4<569::AID-NEU10>3.0.CO;2-F; Palucha A, 2007, PHARMACOL THERAPEUT, V115, P116, DOI 10.1016/j.pharmthera.2007.04.007; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Pietraszek M, 2005, EUR J PHARMACOL, V514, P25, DOI 10.1016/j.ejphar.2005.03.028; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; Porter RHP, 2005, J PHARMACOL EXP THER, V315, P711, DOI 10.1124/jpet.105.089839; Rex A, 2005, EUR J NEUROSCI, V22, P1185, DOI 10.1111/j.1460-9568.2005.04251.x; Riedel G, 2003, BEHAV BRAIN RES, V140, P1, DOI 10.1016/S0166-4328(02)00272-3; Robertson DAF, 2005, EUR J NEUROSCI, V21, P1511, DOI 10.1111/j.1460-9568.2005.03990.x; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Rossi C, 2006, EUR J NEUROSCI, V24, P1850, DOI 10.1111/j.1460-9568.2006.05059.x; Rubino T, 2008, NEUROPHARMACOLOGY, V54, P151, DOI 10.1016/j.neuropharm.2007.06.024; Sairanen M, 2005, J NEUROSCI, V25, P1089, DOI 10.1523/JNEUROSCI.3741-04.2005; Scerri C, 2006, PSYCHOPHARMACOLOGY, V184, P540, DOI 10.1007/s00213-005-0086-4; Schaaf MJM, 2001, BRAIN RES, V915, P227, DOI 10.1016/S0006-8993(01)02855-4; Scharfman H, 2005, EXP NEUROL, V192, P348, DOI 10.1016/j.expneurol.2004.11.016; Schoepp DD, 1996, NEUROPHARMACOLOGY, V35, P1661, DOI 10.1016/S0028-3908(96)00121-9; Schoepp DD, 1999, NEUROPHARMACOLOGY, V38, P1431, DOI 10.1016/S0028-3908(99)00092-1; SHU SY, 1988, NEUROSCI LETT, V85, P169, DOI 10.1016/0304-3940(88)90346-1; Silhol M, 2007, NEUROSCIENCE, V146, P962, DOI 10.1016/j.neuroscience.2007.02.013; Simonyi A, 2005, DRUG NEWS PERSPECT, V18, P353, DOI 10.1358/dnp.2005.18.6.927927; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Spooren W, 2004, DRUG NEWS PERSPECT, V17, P251, DOI 10.1358/dnp.2004.17.4.829052; Steckler T, 2005, PSYCHOPHARMACOLOGY, V179, P198, DOI 10.1007/s00213-004-2056-7; Swanson CJ, 2005, NAT REV DRUG DISCOV, V4, P131, DOI 10.1038/nrd1630; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Takahashi LK, 1998, INT J DEV NEUROSCI, V16, P199, DOI 10.1016/S0736-5748(98)00020-3; Tatarczynska E, 2001, PSYCHOPHARMACOLOGY, V158, P94, DOI 10.1007/s002130100798; Tatarczynska E, 2001, BRIT J PHARMACOL, V132, P1423, DOI 10.1038/sj.bjp.0703923; Topolnik L, 2006, J PHYSIOL-LONDON, V575, P115, DOI 10.1113/jphysiol.2006.112896; Trejo JL, 2008, MOL CELL NEUROSCI, V37, P402, DOI 10.1016/j.mcn.2007.10.016; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Ueda S, 2005, NEUROSCIENCE, V135, P395, DOI 10.1016/j.neuroscience.2005.06.065; Vallee M, 1999, EUR J NEUROSCI, V11, P2906, DOI 10.1046/j.1460-9568.1999.00705.x; Vallee M, 1997, J NEUROSCI, V17, P2626; Van den Hove DLA, 2005, DEV NEUROSCI-BASEL, V27, P313, DOI 10.1159/000086711; van Praag H, 1998, BEHAV BRAIN RES, V92, P21, DOI 10.1016/S0166-4328(97)00117-4; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Venero JL, 2002, NEUROSCIENCE, V113, P857, DOI 10.1016/S0306-4522(02)00232-4; Viltart O, 2006, PSYCHONEUROENDOCRINO, V31, P769, DOI 10.1016/j.psyneuen.2006.02.007; Viveros MP, 2007, BEHAV PHARMACOL, V18, P375, DOI 10.1097/FBP.0b013e3282d28fb4; WARD IL, 1972, SCIENCE, V175, P82, DOI 10.1126/science.175.4017.82; Wati H, 2006, NEUROSCI LETT, V399, P171, DOI 10.1016/j.neulet.2006.01.056; Weinstock M, 2007, NEUROCHEM RES, V32, P1730, DOI 10.1007/s11064-007-9339-4; Yamada K, 2003, J PHARMACOL SCI, V91, P267; Yan XB, 2007, NEUROPHARMACOLOGY, V53, P487, DOI 10.1016/j.neuropharm.2007.06.020; Zagron G, 2006, BEHAV BRAIN RES, V175, P323, DOI 10.1016/j.bbr.2006.09.003; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629	116	244	260	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2170	10.1371/journal.pone.0002170	http://dx.doi.org/10.1371/journal.pone.0002170			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478112	Green Submitted, Green Published, gold			2022-12-25	WOS:000262172800035
J	Garcia-Dominguez, M; March-Diaz, R; Reyes, JC				Garcia-Dominguez, Mario; March-Diaz, Rosana; Reyes, Jose C.			The PHD domain of plant PIAS proteins mediates sumoylation of bromodomain GTE proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUMO E3 LIGASE; UBIQUITIN LIGASE; ARABIDOPSIS; NUCLEAR; UBC9; IDENTIFICATION; RECOGNITION; BINDING; ADAPTER	Covalent attachment of small ubiquitin-like modifier ( SUMO) to proteins regulates multiple processes in the eukaryotic cell. In numerous cases sumoylation is facilitated by protein inhibitor of activated STAT(PIAS) proteins, characterized by the presence of a SP-RING domain related to the RING finger of many ubiquitin E3 ligases. The importance of SP-RING relies on its capacity to bind the E2 enzyme of the pathway. Additional domains may participate in SUMO ligase function and target selection. We have studied the Arabidopsis SUMO ligase AtSIZ1, belonging to the PIAS family, and describe self-sumoylation and AtSIZ1-mediated sumoylation of the E2 enzyme AtSCE1 and GTE3, a bromodomain protein interacting with AtSIZ1. Modification of GTE3 modulates its capacity to bind acetyl-histone H3 in vitro. Interestingly, AtSIZ1, as other plant PIAS proteins, also includes a PHD domain. We found that the PHD domain binds AtSCE1 and contributes to the SUMO ligase function, being partially and absolutely required for AtSCE1 and GTE3 sumoylation, respectively. Based on the capacity of AtSCE1 and GTE3 to associate with both the PHD and SP-RING domains, we propose a model of interactions to explain AtSIZ1-mediated sumoylation of GTE3 and ligase function of the PHD domain.	[March-Diaz, Rosana] Consejo Super Invest Cient Univ Sevilla, Inst Bioquim Vegetal & Fotosintesis, Seville 41092, Spain; [Garcia-Dominguez, Mario; Reyes, Jose C.] Consejo Super Invest Cient Univ Sevilla, Ctr Andaluz Biol Mol & Med Regenerat, Seville 41092, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC - Instituto de Bioquimica Vegetal y Fotosintesis (IBVF); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER)	Garcia-Dominguez, M (corresponding author), CABIMER, Av Amer Vespucio, Seville 41092, Spain.	mario.garcia@cabimer.es	Reyes, Jose C/K-3699-2014; IBIS, NEURONAL/O-9910-2015; Garcia-Dominguez, Mario/K-3674-2014	Reyes, Jose C/0000-0002-8042-5142; Garcia-Dominguez, Mario/0000-0003-2211-8731				Aravind L, 2003, CELL CYCLE, V2, P123, DOI 10.4161/cc.2.2.335; Bencsath KP, 2002, J BIOL CHEM, V277, P47938, DOI 10.1074/jbc.M207442200; Chua YL, 2005, GENE DEV, V19, P2245, DOI 10.1101/gad.352005; Chung TL, 2004, J BIOL CHEM, V279, P39653, DOI 10.1074/jbc.M405637200; Colby T, 2006, PLANT PHYSIOL, V142, P318, DOI 10.1104/pp.106.085415; Dul BE, 2007, J BIOL CHEM, V282, P18397, DOI 10.1074/jbc.M700729200; Duque P, 2003, PLANT J, V35, P787, DOI 10.1046/j.1365-313X.2003.01848.x; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Florence B, 2001, FRONT BIOSCI-LANDMRK, V6, pD1008, DOI 10.2741/Florence; Hardeland U, 2002, EMBO J, V21, P1456, DOI 10.1093/emboj/21.6.1456; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hochstrasser M, 2001, CELL, V107, P5, DOI 10.1016/S0092-8674(01)00519-0; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Jin JB, 2008, PLANT J, V53, P530, DOI 10.1111/j.1365-313X.2007.03359.x; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Kanno T, 2004, MOL CELL, V13, P33, DOI 10.1016/S1097-2765(03)00482-9; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Knipscheer P, 2007, EMBO J, V26, P2797, DOI 10.1038/sj.emboj.7601711; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Kurepa J, 2003, J BIOL CHEM, V278, P6862, DOI 10.1074/jbc.M209694200; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Miura K, 2005, P NATL ACAD SCI USA, V102, P7760, DOI 10.1073/pnas.0500778102; Miura K, 2007, CURR OPIN PLANT BIOL, V10, P495, DOI 10.1016/j.pbi.2007.07.002; Miura K, 2007, PLANT CELL, V19, P1403, DOI 10.1105/tpc.106.048397; Mujtaba S, 2007, ONCOGENE, V26, P5521, DOI 10.1038/sj.onc.1210618; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Reindle A, 2006, J CELL SCI, V119, P4749, DOI 10.1242/jcs.03243; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Saracco SA, 2007, PLANT PHYSIOL, V145, P119, DOI 10.1104/pp.107.102285; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Sharrocks AD, 2006, GENE DEV, V20, P754, DOI 10.1101/gad.1421006; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Takahashi Y, 2001, J BIOL CHEM, V276, P48973, DOI 10.1074/jbc.M109295200; Uchimura Y, 2004, FEBS LETT, V564, P85, DOI 10.1016/S0014-5793(04)00321-7; van Waardenburg RCAM, 2006, MOL CELL BIOL, V26, P4958, DOI 10.1128/MCB.00160-06; vanDrunen CM, 1997, NUCLEIC ACIDS RES, V25, P3904, DOI 10.1093/nar/25.19.3904; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; Yang SH, 2006, EMBO J, V25, P5083, DOI 10.1038/sj.emboj.7601383	41	55	62	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21469	21477		10.1074/jbc.M708176200	http://dx.doi.org/10.1074/jbc.M708176200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18502747	hybrid			2022-12-25	WOS:000257898800019
J	Wang, X; Hammer, ND; Chapman, MR				Wang, Xuan; Hammer, Neal D.; Chapman, Matthew R.			The molecular basis of functional bacterial amyloid polymerization and nucleation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; AGGREGATIVE FIMBRIAE; ALZHEIMERS-DISEASE; PROTEIN; PRION; MECHANISM; TOXICITY; SCRAPIE; FIBERS	Amyloid fibers are filamentous proteinaceous structures commonly associated with mammalian neurodegenerative diseases. Nucleation is the rate-limiting step of amyloid propagation, and its nature remains poorly understood. Escherichia coli assembles functional amyloid fibers called curli on the cell surface using an evolved biogenesis machine. In vivo, amyloidogenesis of the major curli subunit protein, CsgA, is dependent on the minor curli subunit protein, CsgB. Here, we directly demonstrated that CsgB(+) cells efficiently nucleated purified soluble CsgA into amyloid fibers on the cell surface. CsgA contains five imperfect repeating units that fulfill specific roles in directing amyloid formation. Deletion analysis revealed that the N- and C-terminal most repeating units were required for in vivo amyloid formation. We found that CsgA nucleation specificity is encoded by the N- and C-terminal most repeating units using a blend of genetic, biochemical, and electron microscopic analyses. In addition, we found that the C-terminal most repeat was most aggregation-prone and dramatically contributed to CsgA polymerization in vitro. This work defines the elegant molecular signatures of bacterial amyloid nucleation and polymerization, thereby revealing how nature directs amyloid formation to occur at the correct time and location.	[Wang, Xuan; Chapman, Matthew R.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Hammer, Neal D.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chapman, MR (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, 830 N, Ann Arbor, MI 48109 USA.	chapmanm@umich.edu		Wang, Xuan/0000-0002-2910-8598; Chapman, Matthew/0000-0002-2645-1294; Hammer, Neal/0000-0001-6148-7850	NIAID NIH HHS [R01 AI073847, AI 073847-01, R01 AI073847-02] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073847] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; COLLINSON SK, 1991, J BACTERIOL, V173, P4773, DOI 10.1128/jb.173.15.4773-4781.1991; Collinson SK, 1999, J MOL BIOL, V290, P741, DOI 10.1006/jmbi.1999.2882; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Gerstel U, 2003, RES MICROBIOL, V154, P659, DOI 10.1016/j.resmic.2003.08.005; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Hammar M, 1996, P NATL ACAD SCI USA, V93, P6562, DOI 10.1073/pnas.93.13.6562; HAMMER ND, 2007, P NATL ACAD SCI US; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Robinson LS, 2006, MOL MICROBIOL, V59, P870, DOI 10.1111/j.1365-2958.2005.04997.x; Roher AE, 1996, J BIOL CHEM, V271, P20631, DOI 10.1074/jbc.271.34.20631; Romling U, 1998, J BACTERIOL, V180, P722; Sauer FG, 2004, BBA-MOL CELL RES, V1694, P259, DOI 10.1016/j.bbamcr.2004.02.010; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Tessier PM, 2007, NATURE, V447, P556, DOI 10.1038/nature05848; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang X, 2007, J BIOL CHEM, V282, P3713, DOI 10.1074/jbc.M609228200; Yonekura K, 2002, RES MICROBIOL, V153, P191, DOI 10.1016/S0923-2508(02)01308-6	27	98	103	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21530	21539		10.1074/jbc.M800466200	http://dx.doi.org/10.1074/jbc.M800466200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18508760	Green Published, hybrid			2022-12-25	WOS:000257898800026
J	Zhang, Y; Teoh, KH; Reed, DW; Maes, L; Goossens, A; Olson, DJH; Ross, ARS; Covello, PS				Zhang, Yansheng; Teoh, Keat H.; Reed, Darwin W.; Maes, Lies; Goossens, Alain; Olson, Douglas J. H.; Ross, Andrew R. S.; Covello, Patrick S.			The molecular cloning of artemisinic aldehyde Delta 11(13) reductase and its role in glandular trichome-dependent biosynthesis of artemisinin in Artemisia annua	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIHYDROARTEMISINIC ACID; OLD; EXPRESSION; PLANTS	At some point during biosynthesis of the antimalarial artemisinin in glandular trichomes of Artemisia annua, the Delta 11(13) double bond originating in amorpha-4,11-diene is reduced. This is thought to occur in artemisinic aldehyde, but other intermediates have been suggested. In an effort to understand double bond reduction in artemisinin biosynthesis, extracts of A. annua flower buds were investigated and found to contain artemisinic aldehyde Delta 11(13) double bond reductase activity. Through a combination of partial protein purification, mass spectrometry, and expressed sequence tag analysis, a cDNA clone corresponding to the enzyme was isolated. The corresponding gene Dbr2, encoding a member of the enoate reductase family with similarity to plant 12-oxophytodienoate reductases, was found to be highly expressed in glandular trichomes. Recombinant Dbr2 was subsequently characterized and shown to be relatively specific for artemisinic aldehyde and to have some activity on small alpha,beta-unsaturated carbonyl compounds. Expression in yeast of Dbr2 and genes encoding four other enzymes in the artemisinin pathway resulted in the accumulation of dihydroartemsinic acid. The relevance of Dbr2 to trichome-specific artemisinin biosynthesis is discussed.	[Zhang, Yansheng; Teoh, Keat H.; Reed, Darwin W.; Olson, Douglas J. H.; Ross, Andrew R. S.; Covello, Patrick S.] Natl Res Council Canada, Inst Plant Biotechnol, Saskatoon, SK S7N 0W9, Canada; [Maes, Lies; Goossens, Alain] Univ Ghent, Dept Mol Genet, B-9052 Ghent, Belgium; [Maes, Lies; Goossens, Alain] Univ Ghent, Flanders Inst Biotechnol, Dept Plant Syst Biol, B-9052 Ghent, Belgium	National Research Council Canada; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University	Covello, PS (corresponding author), Natl Res Council Canada, Inst Plant Biotechnol, 110 Gymnasium Pl, Saskatoon, SK S7N 0W9, Canada.	patrick.covello@nrc-cnrc.gc.ca		Goossens, Alain/0000-0002-1599-551X; Reed, Darwin/0000-0001-8038-8647				[Anonymous], MED CHEM BIOACTIVE N; Bertea CM, 2005, PLANTA MED, V71, P40, DOI 10.1055/s-2005-837749; Breithaupt C, 2006, P NATL ACAD SCI USA, V103, P14337, DOI 10.1073/pnas.0606603103; Brown GD, 2004, TETRAHEDRON, V60, P1139, DOI 10.1016/j.tet.2003.11.070; Chang YJ, 2000, ARCH BIOCHEM BIOPHYS, V383, P178, DOI 10.1006/abbi.2000.2061; COREY EJ, 1975, TETRAHEDRON LETT, V16, P2647; Covello PS, 2007, PHYTOCHEMISTRY, V68, P1864, DOI 10.1016/j.phytochem.2007.02.016; DUKE MV, 1994, INT J PLANT SCI, V155, P365, DOI 10.1086/297173; DUKE SO, 1993, INT J PLANT SCI, V154, P107, DOI 10.1086/297096; Ferreira J. F. S., 1997, Horticultural Reviews, V19, P319; FOX BG, 1994, BIOCHEMISTRY-US, V33, P12776, DOI 10.1021/bi00209a008; Haynes RK, 2006, CURR TOP MED CHEM, V6, P509, DOI 10.2174/156802606776743129; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kindermans JM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-125; Liu J., 1979, ACTA CHIM SINICA, V37, P129; Malone TE, 2005, PROTEINS, V58, P243, DOI 10.1002/prot.20162; Meesapyodsuk D, 2007, J BIOL CHEM, V282, P20191, DOI 10.1074/jbc.M702196200; Mutabingwa TK, 2005, ACTA TROP, V95, P305, DOI 10.1016/j.actatropica.2005.06.009; Olsen LJ, 1998, PLANT MOL BIOL, V38, P163, DOI 10.1023/A:1006092830670; Rathore D, 2005, EXPERT OPIN INV DRUG, V14, P871, DOI 10.1517/13543784.14.7.871; Ringer KL, 2003, ARCH BIOCHEM BIOPHYS, V418, P80, DOI 10.1016/S0003-9861(03)00390-4; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Strassner J, 2002, PLANT J, V32, P585, DOI 10.1046/j.1365-313X.2002.01449.x; Sy LK, 2002, TETRAHEDRON, V58, P897, DOI 10.1016/S0040-4020(01)01193-0; Teoh KH, 2006, FEBS LETT, V580, P1411, DOI 10.1016/j.febslet.2006.01.065; VON RUDLOFF E., 1963, CANADIAN JOUR CHEM, V41, P2876; Wagner GJ, 2004, ANN BOT-LONDON, V93, P3, DOI 10.1093/aob/mch011; Wallaart TE, 2000, PLANTA MED, V66, P57, DOI 10.1055/s-2000-11115; Williams RE, 2002, MICROBIOL-SGM, V148, P1607, DOI 10.1099/00221287-148-6-1607; Zeng QP, 2008, BIOTECHNOL LETT, V30, P581, DOI 10.1007/s10529-007-9596-y	30	222	258	2	60	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21501	21508		10.1074/jbc.M803090200	http://dx.doi.org/10.1074/jbc.M803090200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18495659	hybrid			2022-12-25	WOS:000257898800023
J	Mantuano, E; Mukandala, G; Li, XQ; Campana, WM; Gonias, SL				Mantuano, Elisabetta; Mukandala, Gatambwa; Li, Xiaoqing; Campana, W. Marie; Gonias, Steven L.			Molecular dissection of the human alpha(2)-macroglobulin subunit reveals domains with antagonistic activities in cell signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; RECEPTOR-RELATED PROTEIN; APPARENT EQUILIBRIUM CONDITIONS; PROMOTED NEURITE OUTGROWTH; SMOOTH-MUSCLE-CELLS; HUMAN ALPHA-2-MACROGLOBULIN; TRANSFORMING GROWTH-FACTOR-BETA-1; ALPHA-MACROGLOBULIN; SCHWANN-CELLS; DEPENDENT MECHANISM	alpha(2)-Macroglobulin (alpha M-2) is a plasma protease inhibitor, which reversibly binds growth factors and, in its activated form, binds to low density lipoprotein receptor-related protein (LRP-1), an endocytic receptor with cell signaling activity. Because distinct domains in alpha M-2 are responsible for its various functions, we hypothesized that the overall effects of alpha M-2 on cell physiology reflect the integrated activities of multiple domains, some of which may be antagonistic. To test this hypothesis, we expressed the growth factor carrier site and the LRP-1 recognition domain (RBD) as separate GST fusion proteins (FP3 and FP6, respectively). FP6 rapidly and robustly activated Akt and ERK/MAP kinase in Schwann cells and PC12 cells. This response was blocked by LRP-1 gene silencing or by co-incubation with the LRP-1 antagonist, receptor-associated protein. The activity of FP6 also was blocked by mutating Lys(1370) and Lys(1374), which precludes LRP-1 binding. FP3 blocked activation of Akt and ERK/MAP kinase in response to nerve growth factor-beta (NGF-beta) but not FP6. In PC12 cells, FP6 promoted neurite outgrowth and expression of growth-associated protein-43, whereas FP3 antagonized the same responses when NGF-beta was added. The ability of FP6 to trigger LRP-1-dependent cell signaling in PC12 cells was reproduced by the 18-kDa RBD, isolated from plasma-purified alpha M-2 by proteolysis and chromatography. We propose that the effects of intact alpha M-2 on cell physiology reflect the degree of penetration of activities associated with different domains, such as FP3 and FP6, which may be regulated asynchronously by conformational change and by other regulatory proteins in the cellular microenvironment.	[Gonias, Steven L.] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Gonias, SL (corresponding author), Univ Calif San Diego, Sch Med, Dept Pathol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	sgonias@ucsd.edu	Mantuano, Elisabetta/C-1769-2015; Mukandala, Gatambwa D/K-7278-2018	Mantuano, Elisabetta/0000-0001-5728-9261; Mukandala, Gatambwa D/0000-0003-4804-956X	NHLBI NIH HHS [R01 HL 60551] Funding Source: Medline; NINDS NIH HHS [R01 NS 054671] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054671] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arandjelovic S, 2005, ARCH BIOCHEM BIOPHYS, V438, P29, DOI 10.1016/j.abb.2005.03.019; Arandjelovic S, 2006, J BIOL CHEM, V281, P17061, DOI 10.1074/jbc.M602217200; Bacskai BJ, 2000, P NATL ACAD SCI USA, V97, P11551, DOI 10.1073/pnas.200238297; BARRETT AJ, 1979, BIOCHEM J, V181, P401, DOI 10.1042/bj1810401; Bonacci GR, 2007, ARCH BIOCHEM BIOPHYS, V460, P100, DOI 10.1016/j.abb.2007.01.004; Cai ML, 1998, PROTEIN SCI, V7, P2669, DOI 10.1002/pro.5560071221; Campana WM, 2006, J NEUROSCI, V26, P11197, DOI 10.1523/JNEUROSCI.2709-06.2006; Campana WM, 2007, BRAIN BEHAV IMMUN, V21, P522, DOI 10.1016/j.bbi.2006.12.008; Campana WM, 1998, FASEB J, V12, P307, DOI 10.1096/fasebj.12.3.307; Chiabrando GA, 2002, J NEUROSCI RES, V70, P57, DOI 10.1002/jnr.10369; CROOKSTON KP, 1994, J BIOL CHEM, V269, P1533; Doan N, 2007, BIOCHEM J, V407, P23, DOI 10.1042/BJ20070764; Eriksson M, 2007, J CELL PHYSIOL, V210, P538, DOI 10.1002/jcp.20907; Esadeg S, 2003, PLACENTA, V24, P912, DOI 10.1016/S0143-4004(03)00148-6; GONIAS SL, 1983, ANN NY ACAD SCI, V421, P457, DOI 10.1111/j.1749-6632.1983.tb18139.x; GONIAS SL, 1982, BIOCHIM BIOPHYS ACTA, V705, P306, DOI 10.1016/0167-4838(82)90252-7; Gonias SL, 2000, J BIOL CHEM, V275, P5826, DOI 10.1074/jbc.275.8.5826; Gourine AV, 2002, AM J PHYSIOL-REG I, V283, pR218, DOI 10.1152/ajpregu.00746.2001; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Hayashi H, 2007, J NEUROSCI, V27, P1933, DOI 10.1523/JNEUROSCI.5471-06.2007; Hochepied T, 2002, EUR CYTOKINE NETW, V13, P86; Howard GC, 1996, J BIOL CHEM, V271, P14105, DOI 10.1074/jbc.271.24.14105; Hu KB, 2006, J BIOL CHEM, V281, P2120, DOI 10.1074/jbc.M504988200; IMBER MJ, 1981, J BIOL CHEM, V256, P8134; KARNS LR, 1987, SCIENCE, V236, P597, DOI 10.1126/science.2437653; Kim Y, 2004, MOL CELLS, V18, P353; LAMARRE J, 1991, BIOCHIM BIOPHYS ACTA, V1091, P197, DOI 10.1016/0167-4889(91)90062-3; LAMARRE J, 1991, J CLIN INVEST, V87, P39, DOI 10.1172/JCI114998; Lee PG, 2000, J NEUROCHEM, V74, P81, DOI 10.1046/j.1471-4159.2000.0740081.x; Leppa S, 1998, EMBO J, V17, P4404, DOI 10.1093/emboj/17.15.4404; LYSIAK JJ, 1995, J BIOL CHEM, V270, P21919, DOI 10.1074/jbc.270.37.21919; Mettenburg JM, 2002, J BIOL CHEM, V277, P13338, DOI 10.1074/jbc.M106792200; MISAR UK, 2002, J BIOL CHEM, V44, P42082; Misra UK, 2006, J BIOL CHEM, V281, P13694, DOI 10.1074/jbc.M511694200; NELLES LP, 1980, BIOCHIM BIOPHYS ACTA, V623, P46, DOI 10.1016/0005-2795(80)90006-9; Nielsen KL, 1996, J BIOL CHEM, V271, P12909, DOI 10.1074/jbc.271.22.12909; OCONNORMCCOURT MD, 1987, J BIOL CHEM, V262, P14090; Padmasekar M, 2007, CARDIOVASC RES, V75, P118, DOI 10.1016/j.cardiores.2007.03.003; PHILIP A, 1991, J BIOL CHEM, V266, P22290; Qiu ZH, 2004, J BIOL CHEM, V279, P34948, DOI 10.1074/jbc.M401055200; Robinson MJ, 1998, CURR BIOL, V8, P1141, DOI 10.1016/S0960-9822(07)00485-X; Rufer AC, 2005, ACTA CRYSTALLOGR F, V61, P263, DOI 10.1107/S1744309105004823; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P15781; SOTTRUPJENSEN L, 1986, FEBS LETT, V205, P20, DOI 10.1016/0014-5793(86)80857-2; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; Tyson DR, 2003, INT J DEV NEUROSCI, V21, P63, DOI 10.1016/S0736-5748(02)00139-9; UMANS L, 1995, J BIOL CHEM, V270, P19778, DOI 10.1074/jbc.270.34.19778; Waghabi MC, 2002, INFECT IMMUN, V70, P5115, DOI 10.1128/IAI.70.9.5115-5123.2002; Weaver AM, 1995, J BIOL CHEM, V270, P30741, DOI 10.1074/jbc.270.51.30741; Webb DJ, 1995, EUR J BIOCHEM, V234, P714, DOI 10.1111/j.1432-1033.1995.714_a.x; Webb DJ, 1998, LAB INVEST, V78, P939; Webb DJ, 1998, J BIOL CHEM, V273, P13339, DOI 10.1074/jbc.273.21.13339; Webb DJ, 1997, FEBS LETT, V410, P249, DOI 10.1016/S0014-5793(97)00598-X; WILLNOW TE, 1994, J CELL SCI, V107, P719; WOLF BB, 1994, BIOCHEMISTRY-US, V33, P11270, DOI 10.1021/bi00203a024	55	41	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					19904	19911		10.1074/jbc.M801762200	http://dx.doi.org/10.1074/jbc.M801762200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18499670	Green Published, hybrid			2022-12-25	WOS:000257565300005
J	Lee, JH; Jeong, MW; Kim, W; Choi, YH; Kim, KT				Lee, Jong-Hee; Jeong, Min-Woo; Kim, Wanil; Choi, Yoon Ha; Kim, Kyong-Tai			Cooperative roles of c-Abl and Cdk5 in regulation of p53 in response to oxidative stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASE-5; DNA-DAMAGE; TYROSINE PHOSPHORYLATION; ACTIVATION; MDM2; BINDING; PATHWAYS; P35; STABILIZATION; DEGRADATION	The p53 tumor suppressor protein, a critical modulator of cellular stress responses, is activated through diverse mechanisms that result in its stabilization and transcriptional activation. p53 activity is controlled by transcriptional, translational, and post-translational regulation. The major mechanisms of p53 regulation occur primarily through interactions with HDM2, an E3 ubiquitin ligase that leads to p53 nuclear export and degradation. Here, we demonstrate that hydrogen peroxide-induced oxidative stress elicits down-regulation of HDM2. c-Abl mediates down-regulation of HDM2, leading to an increase of p53 level. Moreover, Cdk5 (cyclin-dependent kinase 5), a proline-directed Ser/Thr kinase, additionally increases p53 stability via post-translational modification of p53 in response to hydrogen peroxide. The p53 protein stabilized by c-Abl and Cdk5 is transcriptionally active; however, transcription of its target gene is differentially regulated with selective binding of p53 on promoter regions of its target genes by c-Abl. In addition, c-Abl modulates Cdk5 activity via phosphorylation of tyrosine 15 in cooperation with cleavage of p35 to p25. Our results show that c-Abl and Cdk5 cooperatively regulate maximal activation of p53, resulting in neuronal death in response to oxidative stress by hydrogen peroxide. These findings aid in clarifying the mechanism underlying the occurrence of neuronal apoptosis as a result of c-Abl and Cdk5-mediated p53 stabilization and transcriptional activation.	[Lee, Jong-Hee; Jeong, Min-Woo; Kim, Wanil; Choi, Yoon Ha; Kim, Kyong-Tai] Pohang Univ Sci & Technol, Dept Life Sci, Div Mol & Life Sci, Syst Biodynam Natl Care Res Ctr, Pohang 790784, South Korea	Pohang University of Science & Technology (POSTECH)	Kim, KT (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Div Mol & Life Sci, Syst Biodynam Natl Care Res Ctr, San 31, Pohang 790784, South Korea.	ktk@postech.ac.kr		KIM, KYONG-TAI/0000-0001-7292-2627				Ashcroft M, 2000, MOL CELL BIOL, V20, P3224, DOI 10.1128/MCB.20.9.3224-3233.2000; Barclay JW, 2004, J BIOL CHEM, V279, P41495, DOI 10.1074/jbc.M406670200; Ben-Yehoyada M, 2003, J BIOL CHEM, V278, P34475, DOI 10.1074/jbc.M301051200; Bernardi R, 2004, NAT CELL BIOL, V6, P665, DOI 10.1038/ncb1147; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Buschmann T, 2001, MOL CELL BIOL, V21, P2743, DOI 10.1128/MCB.21.8.2743-2754.2001; Cheung ZH, 2006, NEURON, V50, P13, DOI 10.1016/j.neuron.2006.02.024; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Cruz JC, 2004, TRENDS MOL MED, V10, P452, DOI 10.1016/j.molmed.2004.07.001; Culmsee C, 2005, BIOCHEM BIOPH RES CO, V331, P761, DOI 10.1016/j.bbrc.2005.03.149; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Dias SS, 2006, ONCOGENE, V25, P6666, DOI 10.1038/sj.onc.1209671; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Goldberg Z, 2002, EMBO J, V21, P3715, DOI 10.1093/emboj/cdf384; GUO Q, 2003, SCI AGING KNOWLEDGE, V50, pPE36; Harada T, 2001, NAT CELL BIOL, V3, P453, DOI 10.1038/35074516; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hsieh JK, 1999, MOL CELL, V3, P181, DOI 10.1016/S1097-2765(00)80309-3; Isaacs JS, 2001, J BIOL CHEM, V276, P18497, DOI 10.1074/jbc.M100638200; Jackson MW, 2000, MOL CELL BIOL, V20, P1001, DOI 10.1128/MCB.20.3.1001-1007.2000; Jones SB, 2004, J NEUROSCI, V24, P8510, DOI 10.1523/JNEUROSCI.1264-04.2004; Kubo T, 1996, BRAIN RES, V733, P175, DOI 10.1016/0006-8993(96)00542-2; Kulikov R, 2005, MOL CELL BIOL, V25, P7170, DOI 10.1128/MCB.25.16.7170-7180.2005; Lee JH, 2004, J NEUROCHEM, V91, P634, DOI 10.1111/j.1471-4159.2004.02770.x; Lee JH, 2007, J CELL SCI, V120, P2259, DOI 10.1242/jcs.03468; Lee JH, 2007, J CELL PHYSIOL, V210, P784, DOI 10.1002/jcp.20899; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Levav-Cohen Y, 2005, BIOCHEM BIOPH RES CO, V331, P737, DOI 10.1016/j.bbrc.2005.03.152; Lin H, 2007, CELL DEATH DIFFER, V14, P607, DOI 10.1038/sj.cdd.4402033; Meulmeester E, 2005, MOL CELL, V18, P565, DOI 10.1016/j.molcel.2005.04.024; Monaco EA, 2004, CURR ALZHEIMER RES, V1, P33, DOI 10.2174/1567205043480519; Moresco EMY, 2003, CURR OPIN NEUROBIOL, V13, P535, DOI 10.1016/j.conb.2003.08.002; Morrison RS, 2000, CELL DEATH DIFFER, V7, P868, DOI 10.1038/sj.cdd.4400741; Nie Y, 2000, MOL CELL BIOL, V20, P741, DOI 10.1128/MCB.20.3.741-748.2000; O'Hare MJ, 2005, J NEUROSCI, V25, P8954, DOI 10.1523/JNEUROSCI.2899-05.2005; Pluquet O, 2001, CANCER LETT, V174, P1, DOI 10.1016/S0304-3835(01)00698-X; Ross S, 2002, J BIOL CHEM, V277, P4455, DOI 10.1074/jbc.M110771200; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; Shelton SB, 2004, J NEUROCHEM, V88, P1313, DOI 10.1111/j.1471-4159.2003.02328.x; Shieh SY, 1999, EMBO J, V18, P1815, DOI 10.1093/emboj/18.7.1815; Smith DS, 2001, CELL GROWTH DIFFER, V12, P277; Stommel JM, 2004, EMBO J, V23, P1547, DOI 10.1038/sj.emboj.7600145; Stuart JR, 2005, ONCOGENE, V24, P8085, DOI 10.1038/sj.onc.1208953; Takahashi Y, 2000, GENE DEV, V14, P804; Wang XJ, 2002, J BIOL CHEM, V277, P15697, DOI 10.1074/jbc.M112068200; Wei G, 2005, J BIOL CHEM, V280, P12271, DOI 10.1074/jbc.M409522200; Xu Y, 2003, CELL DEATH DIFFER, V10, P1213, DOI 10.1038/sj.cdd.4401292; Yang A, 2002, TRENDS GENET, V18, P90, DOI 10.1016/S0168-9525(02)02595-7; Yang YL, 2004, ONCOGENE, V23, P2096, DOI 10.1038/sj.onc.1207411; Zukerberg LR, 2000, NEURON, V26, P633, DOI 10.1016/S0896-6273(00)81200-3	53	38	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19826	19835		10.1074/jbc.M706201200	http://dx.doi.org/10.1074/jbc.M706201200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18490454	hybrid			2022-12-25	WOS:000257387600066
J	Michalski, C; Mohagheghi, H; Nimtz, M; Pasteels, J; Ober, D				Michalski, Carmen; Mohagheghi, Hoda; Nimtz, Manfred; Pasteels, Jacques; Ober, Dietrich			Salicyl alcohol oxidase of the chemical defense secretion of two chrysomelid leaf beetles - Molecular and functional characterization of two new members of the glucose-methanol-choline oxidoreductase gene family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTROPHYSA-VIRIDULA COLEOPTERA; CRYSTAL-STRUCTURE; IRIDOID MONOTERPENES; CHOLESTEROL OXIDASE; GMC OXIDOREDUCTASES; DEHYDROGENASE GENE; HOST PLANT; BIOSYNTHESIS; LARVAE; EXPRESSION	Salicyl alcohol oxidase is an extracellular enzyme that occurs in glandular reservoirs of chrysomelid leaf beetle larvae and catalyzes the formation of salicylaldehyde, a volatile deterrent used by the larvae against predators. Salicyl alcohol is the hydrolysis product of salicin, a plant-derived precursor taken up by the beetle larvae from the leaves of willow and poplar trees. The cDNA encoding salicyl alcohol oxidase from two related species Chrysomela tremulae and Chrysomela populi has been identified, cloned, and expressed in an active form in Escherichia coli. The open reading frame of 623 amino acids begins in both enzymes with an N-terminal signal peptide of 21 amino acids. Sequence comparison has revealed that salicyl alcohol oxidase belongs to the family of glucose-methanol-choline oxidoreductase-like sequences with mostly unknown function. Enzymes of this family share similar overall structure with an essentially identical FAD-binding site but possess different catalytic activities. The data suggest that salicyl alcohol oxidase, essential for the activation of the plant-derived precursor salicin, was originally recruited from an oxidase involved in the autogenous biosynthesis of iridoid monoterpenes and found in related chrysomelid leaf beetle species.	[Michalski, Carmen; Ober, Dietrich] Univ Kiel, Inst Bot, D-24098 Kiel, Germany; Univ Kiel, Bot Gardens, D-24098 Kiel, Germany; [Mohagheghi, Hoda] Tech Univ Carolo Wilhelmina Braunschweig, Inst Pharmazeut Biol, D-38106 Braunschweig, Germany; [Nimtz, Manfred] Helmholtz Zentrum Infektionsforchung, D-38124 Braunschweig, Germany; [Pasteels, Jacques] Univ Libre Bruxelles, Lab Biol Anim & Celluaire, B-1050 Brussels, Belgium	University of Kiel; University of Kiel; Braunschweig University of Technology; Helmholtz Association; Helmholtz-Center for Infection Research; Universite Libre de Bruxelles	Ober, D (corresponding author), Univ Kiel, Inst Bot, Olshausenstr 40, D-24098 Kiel, Germany.	dober@bot.uni-kiel.de						Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bruckmann M, 2002, INSECT BIOCHEM MOLEC, V32, P1517, DOI 10.1016/S0965-1748(02)00072-3; Burse A, 2007, INSECT BIOCHEM MOLEC, V37, P255, DOI 10.1016/j.ibmb.2006.11.011; CASPERS P, 1994, CELL MOL BIOL, V40, P635; CAVENER DR, 1992, J MOL BIOL, V223, P811, DOI 10.1016/0022-2836(92)90992-S; CAVENER DR, 1983, P NATL ACAD SCI-BIOL, V80, P6286, DOI 10.1073/pnas.80.20.6286; COXFOSTER DL, 1990, GENETICS, V124, P873; COXFOSTER DL, 1994, J INSECT PHYSIOL, V40, P235, DOI 10.1016/0022-1910(94)90047-7; DALOZE D, 1994, J CHEM ECOL, V20, P2089, DOI 10.1007/BF02066245; Dreveny I, 2001, STRUCTURE, V9, P803, DOI 10.1016/S0969-2126(01)00639-6; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Feld BK, 2001, CHEMOECOLOGY, V11, P191, DOI 10.1007/PL00001851; FELSENSTEIN J, 2001, PHYLIP PHYLOGENY INT; FUTUYMA DJ, 2004, NEW DEV BIOL CHRYSOM, P17; Gross J, 2002, J CHEM ECOL, V28, P317, DOI 10.1023/A:1017934124650; Gross J, 2008, J CHEM ECOL, V34, P179, DOI 10.1007/s10886-007-9416-9; Hallberg BM, 2002, J MOL BIOL, V315, P421, DOI 10.1006/jmbi.2001.5246; HECHT HJ, 1993, J MOL BIOL, V229, P153, DOI 10.1006/jmbi.1993.1015; Horton P, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P147; Iida K, 2004, J EXP BIOL, V207, P675, DOI 10.1242/jeb.00816; Iida K, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-75; Jolivet, 1988, BIOL CHRYSOMELIDAE, P233, DOI DOI 10.1007/978-94-009-3105-3_14; Kiess M, 1998, EUR J BIOCHEM, V252, P90, DOI 10.1046/j.1432-1327.1998.2520090.x; KRASNEY PA, 1990, MOL BIOL EVOL, V7, P155; Laurent P, 2003, EUR J ORG CHEM, V2003, P2733, DOI 10.1002/ejoc.200300008; LI JY, 1993, BIOCHEMISTRY-US, V32, P11507, DOI 10.1021/bi00094a006; Lindigkeit R, 1997, EUR J BIOCHEM, V245, P626, DOI 10.1111/j.1432-1033.1997.00626.x; LORENZ M, 1993, ANGEW CHEM INT EDIT, V32, P912, DOI 10.1002/anie.199309121; Mattevi A, 1998, BIOPHYS CHEM, V70, P217, DOI 10.1016/S0301-4622(97)00126-9; Naumann C, 2002, P NATL ACAD SCI USA, V99, P6085, DOI 10.1073/pnas.082674499; Ohashi K, 1999, EUR J BIOCHEM, V265, P127, DOI 10.1046/j.1432-1327.1999.00696.x; PASTEELS JM, 1990, J CHEM ECOL, V16, P211, DOI 10.1007/BF01021280; PASTEELS JM, 1983, PHYSIOL ENTOMOL, V8, P307, DOI 10.1111/j.1365-3032.1983.tb00362.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sarfare S, 2005, J BIOL CHEM, V280, P11895, DOI 10.1074/jbc.M412236200; Schulz S, 1997, TETRAHEDRON, V53, P9203, DOI 10.1016/S0040-4020(97)00618-2; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Takeuchi H, 2005, BIOCHEM J, V389, P637, DOI 10.1042/BJ20050498; Termonia A, 2001, P NATL ACAD SCI USA, V98, P3909, DOI 10.1073/pnas.061034598; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VEITH M, 1994, TETRAHEDRON, V50, P6859, DOI 10.1016/S0040-4020(01)81338-7; Veith M, 1997, J CHEM ECOL, V23, P429, DOI 10.1023/B:JOEC.0000006369.26490.c6; Veith M, 1996, TETRAHEDRON, V52, P6601, DOI 10.1016/0040-4020(96)00298-0; VRIELINK A, 1991, J MOL BIOL, V219, P533, DOI 10.1016/0022-2836(91)90192-9; WALLACE JB, 1969, ANN ENTOMOL SOC AM, V62, P503, DOI 10.1093/aesa/62.3.503; Webb E. C., 1992, ENZYME NOMENCLATURE; Zamocky M, 2004, GENE, V338, P1, DOI 10.1016/j.gene.2004.04.025; Zorn H, 2005, PROTEOMICS, V5, P4832, DOI 10.1002/pmic.200500015	49	24	26	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19219	19228		10.1074/jbc.M802236200	http://dx.doi.org/10.1074/jbc.M802236200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18482980	hybrid			2022-12-25	WOS:000257387600007
J	Baez, S; Collins, SL				Baez, Selene; Collins, Scott L.			Shrub Invasion Decreases Diversity and Alters Community Stability in Northern Chihuahuan Desert Plant Communities	PLOS ONE			English	Article							NET PRIMARY PRODUCTION; SPECIES-DIVERSITY; BIODIVERSITY; FACILITATION; GRASSLAND; ECOSYSTEM; DYNAMICS; PATTERNS; CARBON; INTERFERENCE	Background: Global climate change is rapidly altering species range distributions and interactions within communities. As ranges expand, invading species change interactions in communities which may reduce stability, a mechanism known to affect biodiversity. In aridland ecosystems worldwide, the range of native shrubs is expanding as they invade and replace native grassland vegetation with significant consequences for biodiversity and ecosystem functioning. Methodology: We used two long-term data sets to determine the effects of shrub encroachment by Larrea tridentata on subdominant community composition and stability in formerly native perennial grassland dominated by Bouteloua eriopoda in New Mexico, USA. Principal Findings: Our results indicated that Larrea invasion decreased species richness during the last 100 years. We also found that over shorter temporal scales species-poor subdominant communities in areas invaded by Larrea were less stable (more variable in time) compared to species rich communities in grass-dominated vegetation. Compositional stability increased as cover of Bouteloua increased and decreased as cover of Larrea increased. Significance: Changes in community stability due to altered interspecific interactions may be one mechanism by which biodiversity declines in grasslands following shrub invasion. As global warming increases, shrub encroachment into native grasslands worldwide will continue to alter species interactions and community stability both of which may lead to a decline in biodiversity.	[Baez, Selene; Collins, Scott L.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA	University of New Mexico	Baez, S (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	sbaez@zoo.ufl.edu	Collins, Scott L/P-7742-2014	Collins, Scott L/0000-0002-0193-2892	National Science Foundation	National Science Foundation(National Science Foundation (NSF))	National Science Foundation	AGUIAR MR, 1994, OIKOS, V70, P26, DOI 10.2307/3545695; ARCHER S, 1995, CLIMATIC CHANGE, V29, P91, DOI 10.1007/BF01091640; Baez S, 2006, ECOLOGY, V87, P2746, DOI 10.1890/0012-9658(2006)87[2746:BROPCS]2.0.CO;2; BAGGS JE, 1997, ROLE BOUTELOUA ERIOP; Bhark EW, 2003, ECOSYSTEMS, V6, P185, DOI 10.1007/s10021-002-0210-9; Buonopane M, 2005, OIKOS, V110, P67, DOI 10.1111/j.0030-1299.2005.13949.x; Callaway R. M., 2007, POSITIVE INTERACTION; Callaway RM, 2006, TRENDS ECOL EVOL, V21, P369, DOI 10.1016/j.tree.2006.04.008; CLARK CW, 1994, AM NAT, V143, P583, DOI 10.1086/285621; Collins SL, 2000, AM NAT, V155, P311, DOI 10.1086/303326; Cottingham KL, 2001, ECOL LETT, V4, P72, DOI 10.1046/j.1461-0248.2001.00189.x; Cross AF, 1999, PLANT ECOL, V145, P11, DOI 10.1023/A:1009865020145; DERUITER PC, 1995, SCIENCE, V269, P1257, DOI 10.1126/science.269.5228.1257; Fowler MS, 2002, OIKOS, V99, P511, DOI 10.1034/j.1600-0706.2002.11757.x; Harpole WS, 2007, NATURE, V446, P791, DOI 10.1038/nature05684; Hochstrasser T, 2004, J VEG SCI, V15, P615, DOI 10.1111/j.1654-1103.2004.tb02303.x; Holmgren Milena, 1997, Ecology (Washington D C), V78, P1966, DOI 10.1890/0012-9658(1997)078[1966:TIOFAC]2.0.CO;2; Holzapfel C, 1999, ECOLOGY, V80, P1747, DOI 10.2307/176564; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Houlahan JE, 2007, P NATL ACAD SCI USA, V104, P3273, DOI 10.1073/pnas.0603798104; Hubbell Stephen P., 2001, V32, pi; Huenneke LF, 2002, GLOBAL CHANGE BIOL, V8, P247, DOI 10.1046/j.1365-2486.2002.00473.x; Hughes JB, 2000, AM NAT, V155, P618, DOI 10.1086/303348; Hughes RF, 2006, GLOBAL CHANGE BIOL, V12, P1733, DOI [10.1111/j.1365-2486.2006.01210.x, 10.1111/J.1365-2486.2006.01210.x]; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; Ives AR, 2002, AM NAT, V159, P388, DOI 10.1086/338994; Jackson RB, 2002, NATURE, V418, P623, DOI 10.1038/nature00910; Jansen VAA, 2003, ECOL LETT, V6, P498, DOI 10.1046/j.1461-0248.2003.00464.x; Kieft TL, 1998, ECOLOGY, V79, P671, DOI 10.2307/176962; KNAPP AK, 2008, GLOBAL CHANGE BIOL; Kokkoris GD, 2002, J ANIM ECOL, V71, P362, DOI 10.1046/j.1365-2656.2002.00604.x; Kroel-Dulay G, 2004, J VEG SCI, V15, P531, DOI 10.1111/j.1654-1103.2004.tb02292.x; Lehman CL, 2000, AM NAT, V156, P534, DOI 10.1086/303402; Lundberg P, 2000, ECOL LETT, V3, P465, DOI 10.1046/j.1461-0248.2000.00170.x; May R. M., 1973, STABILITY COMPLEXITY; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Mitchell CE, 2006, ECOL LETT, V9, P726, DOI 10.1111/j.1461-0248.2006.00908.x; Muldavin EH, 2008, OECOLOGIA, V155, P123, DOI 10.1007/s00442-007-0880-2; Peters DPC, 2006, BIOSCIENCE, V56, P491, DOI 10.1641/0006-3568(2006)56[491:DCLNII]2.0.CO;2; Peters DPC, 2004, P NATL ACAD SCI USA, V101, P15130, DOI 10.1073/pnas.0403822101; Pockman WT, 1997, OECOLOGIA, V109, P19, DOI 10.1007/s004420050053; Pugnaire FI, 1996, ECOLOGY, V77, P1420, DOI 10.2307/2265539; Ravi S, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2007JG000474; Reinhart KO, 2006, BIOL INVASIONS, V8, P231, DOI 10.1007/s10530-004-5163-9; Sankaran M, 1999, NATURE, V401, P691, DOI 10.1038/44368; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; SHMIDA A, 1981, ECOLOGY, V62, P234, DOI 10.2307/1936684; Suttle KB, 2007, SCIENCE, V315, P640, DOI 10.1126/science.1136401; Tielborger K, 1997, PLANT ECOL, V130, P191, DOI 10.1023/A:1009766824033; Tielborger K, 2000, ECOLOGY, V81, P1544, DOI 10.2307/177305; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Tilman D, 1996, ECOLOGY, V77, P350, DOI 10.2307/2265614; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; Valone TJ, 2007, ECOLOGY, V88, P26, DOI 10.1890/0012-9658(2007)88[26:RRBDPP]2.0.CO;2; Van Auken OW, 2000, ANNU REV ECOL SYST, V31, P197, DOI 10.1146/annurev.ecolsys.31.1.197; Whitford WG, 2020, ECOLOGY OF DESERT SYSTEMS, 2ND EDITION, P1, DOI 10.1016/B978-0-12-815055-9.00001-1; Wilby A, 2004, OIKOS, V106, P209, DOI 10.1111/j.0030-1299.2004.13085.x; Yao J, 2006, LANDSCAPE ECOL, V21, P1217, DOI 10.1007/s10980-006-0025-8; YODZIS P, 1981, NATURE, V289, P674, DOI 10.1038/289674a0	62	95	100	5	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2332	10.1371/journal.pone.0002332	http://dx.doi.org/10.1371/journal.pone.0002332			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523686	gold, Green Published, Green Submitted			2022-12-25	WOS:000262614300027
J	Chen, HY; Liu, B; Lukas, TJ; Neufeld, AH				Chen, Huiyi; Liu, Bin; Lukas, Thomas J.; Neufeld, Arthur H.			The Aged Retinal Pigment Epithelium/Choroid: A Potential Substratum for the Pathogenesis of Age-Related Macular Degeneration	PLOS ONE			English	Article							COMPLEMENT FACTOR-H; GENOME SCAN; SUSCEPTIBILITY; GENE; DRUSEN; POLYMORPHISM; EXPRESSION; COMMON; MODEL; CFH	Background: Although the statement that age is the greatest risk factor for Age-related macular degeneration (AMD) is widely accepted, the cellular and molecular explanations for that clinical statement are not generally known. A major focus of AMD research is the retinal pigment epithelium (RPE)/choroid. The purpose of this study was to characterize the changes in the RPE/choroid with age that may provide a background for the development of AMD. Methodology/Principal Findings: We compared the transcriptional profiles, key protein levels and histology of the RPE/choroid from young and old mice. Using three statistical methods, microarray data demonstrated marked changes in the old mouse. There were 315 genes differentially expressed with age; most of these genes were related to immune responses and inflammatory activity. Canonical pathways having significant numbers of upregulated genes in aged RPE/choroid included leukocyte extravasation, complement cascades, natural killer cell signaling and IL-10 signaling. By contrast, the adjacent neural retina showed completely different age-related changes. The levels of proteins that participate in leukocyte extravasation and complement pathways were consistently increased in the normal, aged RPE/choroid. Furthermore, there was increased gene expression and protein levels of leukocyte attracting signal, chemokine ligand 2 (Ccl2) in aged RPE/choroid. In old animals, there was marked extravasation and accumulation of leukocytes from the choroidal circulation onto Bruch's membrane and into the RPE. Conclusions/Significance: These phenotypic changes indicate that the RPE/choroid in the normal, old mouse has become an immunologically active tissue. There are signals from the normal, aged RPE/choroid which recruit leukocytes from the circulation and activate the complement cascade. These age-related changes that occur in the RPE/choroid with age, to the extent that they occur in the human retina, may provide the background for an error in regulation of immunological activity to cause AMD to appear in an elderly individual.	[Chen, Huiyi; Liu, Bin; Lukas, Thomas J.; Neufeld, Arthur H.] Northwestern Univ, Sch Med, Dept Ophthalmol, Lab Invest Aging Retina, Chicago, IL 60611 USA	Northwestern University	Chen, HY (corresponding author), Northwestern Univ, Sch Med, Dept Ophthalmol, Lab Invest Aging Retina, Chicago, IL 60611 USA.	a-neufeld@northwestern.edu			NIH [EY12017]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY012017] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH grant EY12017, a generous gift from the Forsythe Foundation and an unrestricted grant from Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2004, AM J HUM GENET, V74, P482, DOI 10.1086/382786; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Apte RS, 2006, PLOS MED, V3, P1371, DOI 10.1371/journal.pmed.0030310; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Burke D, 2007, BRIT J PSYCHIAT, V190, P371, DOI 10.1192/bjp.bp.106.033407; Coffey PJ, 2007, P NATL ACAD SCI USA, V104, P16651, DOI 10.1073/pnas.0705079104; Conley YP, 2005, HUM MOL GENET, V14, P1991, DOI 10.1093/hmg/ddi204; Conley YP, 2006, HUM MOL GENET, V15, P3206, DOI 10.1093/hmg/ddl396; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Drachman DA, 2006, NEUROLOGY, V67, P1340, DOI 10.1212/01.wnl.0000240127.89601.83; Dreier R, 2004, EXP CELL RES, V297, P303, DOI 10.1016/j.yexcr.2004.02.027; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fiotti N, 2005, GENET MED, V7, P272, DOI 10.1097/01.GIM.0000159903.69597.73; Frick C, 2005, EUR J IMMUNOL, V35, P3610, DOI 10.1002/eji.200425914; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Haddad S, 2006, SURV OPHTHALMOL, V51, P316, DOI 10.1016/j.survophthal.2006.05.001; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Ida H, 2003, PHYSIOL GENOMICS, V15, P258, DOI 10.1152/physiolgenomics.00126.2003; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lanier LL, 2003, CURR OPIN IMMUNOL, V15, P308, DOI 10.1016/S0952-7915(03)00039-6; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Liu WM, 2002, BIOINFORMATICS, V18, P1593, DOI 10.1093/bioinformatics/18.12.1593; Luckow B, 2004, EUR J IMMUNOL, V34, P2568, DOI 10.1002/eji.200324776; Magnusson KP, 2006, PLOS MED, V3, P109, DOI 10.1371/journal.pmed.0030005; Majewski J, 2003, AM J HUM GENET, V73, P540, DOI 10.1086/377701; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Murray J, 2006, J AAPOS, V10, P6, DOI 10.1016/j.jaapos.2006.01.010; Radeke MJ, 2007, EXP EYE RES, V85, P366, DOI 10.1016/j.exer.2007.05.006; Rattner A, 2006, NAT REV NEUROSCI, V7, P860, DOI 10.1038/nrn2007; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Schmidt Silke, 2002, Ophthalmic Genet, V23, P209, DOI 10.1076/opge.23.4.209.13883; Scholl HPN, 2007, MOL VIS, V13, P196; Seddon JM, 2005, ARCH OPHTHALMOL-CHIC, V123, P774, DOI 10.1001/archopht.123.6.774; Seth A, 2008, INVEST OPHTH VIS SCI, V49, P743, DOI 10.1167/iovs.07-1072; Simonelli F, 2001, OPHTHALMIC RES, V33, P325, DOI 10.1159/000055688; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Tou JS, 2004, FASEB J, V18, P1297, DOI 10.1096/fj.04-1862fje; Tsai YY, 2008, INVEST OPHTH VIS SCI, V49, P693, DOI 10.1167/iovs.07-0125; Turner M, 2000, IMMUNOL TODAY, V21, P148, DOI 10.1016/S0167-5699(99)01574-1; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Van Coillie E, 1999, CYTOKINE GROWTH F R, V10, P61, DOI 10.1016/S1359-6101(99)00005-2; Zen K, 2003, CURR OPIN CELL BIOL, V15, P557, DOI 10.1016/S0955-0674(03)00103-0; Zen K, 2004, J BIOL CHEM, V279, P44924, DOI 10.1074/jbc.M402115200; Zen K, 2005, MOL BIOL CELL, V16, P2694, DOI 10.1091/mbc.E05-01-0036	50	93	97	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2339	10.1371/journal.pone.0002339	http://dx.doi.org/10.1371/journal.pone.0002339			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523633	Green Published, gold, Green Submitted			2022-12-25	WOS:000262614300032
J	Cohen, T; Colijn, C; Finklea, B; Wright, A; Zignol, M; Pym, A; Murray, M				Cohen, Ted; Colijn, Caroline; Finklea, Bryson; Wright, Abigail; Zignol, Matteo; Pym, Alexander; Murray, Megan			Are Survey-Based Estimates of the Burden of Drug Resistant TB Too Low? Insight from a Simulation Study	PLOS ONE			English	Article								Background: The emergence of tuberculosis resistant to multiple first- and second-line antibiotics poses challenges to a global control strategy that relies on standard drug treatment regimens. Highly drug-resistant strains of Mycobacterium tuberculosis have been implicated in outbreaks and have been found throughout the world; a comprehensive understanding the magnitude of this threat requires an accurate assessment of the worldwide burden of resistance. Unfortunately, in many settings where resistance is emerging, laboratory capacity is limited and estimates of the burden of resistance are obtained by performing drug sensitivity testing on a sample of incident cases rather than through the use of routine surveillance. Methodology/Principal Findings: Using an individual-based dynamic tuberculosis model to simulate surveillance strategies for drug resistance, we found that current surveys may underestimate the total burden of resistant tuberculosis because cases of acquired resistance are undercounted and resistance among prevalent cases is not assessed. We explored how this bias is affected by the maturity of the epidemic and by the introduction of interventions that target the emergence and spread of resistant tuberculosis. Conclusions: Estimates of drug resistant tuberculosis based on samples of incident cases should be viewed as a lower bound of the total burden of resistance.	[Cohen, Ted; Murray, Megan] Brigham & Womens Hosp, Div Social Med & Hlth Inequal, Boston, MA 02115 USA; [Cohen, Ted; Colijn, Caroline; Finklea, Bryson; Murray, Megan] Harvard Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Wright, Abigail; Zignol, Matteo] WHO, STOP TB Dept, Geneva, Switzerland; [Pym, Alexander] S African MRC, Clin & Biomed TB Res Unit, Durban, South Africa; [Murray, Megan] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; World Health Organization; South African Medical Research Council; Harvard University; Massachusetts General Hospital	Cohen, T (corresponding author), Brigham & Womens Hosp, Div Social Med & Hlth Inequal, 75 Francis St, Boston, MA 02115 USA.	tcohen@hsph.harvard.edu	Cohen, Ted/G-8101-2011	Cohen, Ted/0000-0002-8091-7198; Pym, Alexander/0000-0002-6260-8180	NIH [5K08AI055985-05]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI055985] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	TC is supported by an NIH grant (5K08AI055985-05). The funding source had no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	Aziz MA, 2006, LANCET, V368, P2142, DOI 10.1016/S0140-6736(06)69863-2; Becerra MC, 2000, INT J TUBERC LUNG D, V4, P387; Bjorkman J, 2000, SCIENCE, V287, P1479, DOI 10.1126/science.287.5457.1479; Blower SM, 1998, J MOL MED, V76, P624, DOI 10.1007/s001090050260; Bottger EC, 1998, NAT MED, V4, P1343, DOI 10.1038/3906; Braden CR, 2001, CLIN INFECT DIS, V33, pE42, DOI 10.1086/322635; Cohen T, 2004, NAT MED, V10, P1117, DOI 10.1038/nm1110; COHEN T, 2008, AM J RESP C IN PRESS; Cohen T, 2007, J R SOC INTERFACE, V4, P523, DOI 10.1098/rsif.2006.0193; de Boer AS, 2000, J CLIN MICROBIOL, V38, P4478, DOI 10.1128/JCM.38.12.4478-4484.2000; Dye C, 2000, P NATL ACAD SCI USA, V97, P8180, DOI 10.1073/pnas.140102797; Dye C, 2001, P ROY SOC B-BIOL SCI, V268, P45, DOI 10.1098/rspb.2000.1328; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Farmer P, 1998, INT J TUBERC LUNG D, V2, P869; Gagneux S, 2006, PLOS PATHOG, V2, P603, DOI 10.1371/journal.ppat.0020061; Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410; HOLM J, 1969, DEV TUBERCULOSIS INF; Niemann S, 2000, EMERG INFECT DIS, V6, P548, DOI 10.3201/eid0605.000518; ORDWAY DJ, 1995, INFECT IMMUN, V63, P741, DOI 10.1128/IAI.63.2.741-743.1995; Portaels F, 1999, INT J TUBERC LUNG D, V3, P582; Raviglione MC, 2007, NEW ENGL J MED, V356, P656, DOI 10.1056/NEJMp068273; Read JM, 2003, P ROY SOC B-BIOL SCI, V270, P699, DOI 10.1098/rspb.2002.2305; Richardson M, 2002, J CLIN MICROBIOL, V40, P2750, DOI 10.1128/JCM.40.8.2750-2754.2002; RIGOUTS L, 1994, TUBERCLE LUNG DIS, V75, P160, DOI 10.1016/0962-8479(94)90051-5; Sander P, 2002, ANTIMICROB AGENTS CH, V46, P1204, DOI 10.1128/AAC.46.5.1204-1211.2002; Schrag SJ, 1996, NATURE, V381, P120, DOI 10.1038/381120b0; Schrag SJ, 1997, P ROY SOC B-BIOL SCI, V264, P1287, DOI 10.1098/rspb.1997.0178; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Shamputa IC, 2004, J CLIN MICROBIOL, V42, P5528, DOI 10.1128/JCM.42.12.5528-5536.2004; van Rie A, 2005, AM J RESP CRIT CARE, V172, P636, DOI 10.1164/rccm.200503-449OC; Vynnycky E, 1997, EPIDEMIOL INFECT, V119, P183, DOI 10.1017/S0950268897007917; Warren RM, 2004, AM J RESP CRIT CARE, V169, P610, DOI 10.1164/rccm.200305-714OC; *WHO, 2003, WHOTB2003320; *WHO, 2005, WHOHTMTB2005349; Zager EM, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-10; [No title captured]	36	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2363	10.1371/journal.pone.0002363	http://dx.doi.org/10.1371/journal.pone.0002363			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523659	Green Published, Green Submitted, gold			2022-12-25	WOS:000262614300050
J	Ngumbela, KC; Ryan, KP; Sivamurthy, R; Brockman, MA; Gandhi, RT; Bhardwaj, N; Kavanagh, DG				Ngumbela, Kholiswa C.; Ryan, Kieran P.; Sivamurthy, Rohini; Brockman, Mark A.; Gandhi, Rajesh T.; Bhardwaj, Nina; Kavanagh, Daniel G.			Quantitative Effect of Suboptimal Codon Usage on Translational Efficiency of mRNA Encoding HIV-1 gag in Intact T Cells	PLOS ONE			English	Article								Background: The sequences of wild-isolate strains of Human Immunodeficiency Virus-1 (HIV-1) are characterized by low GC content and suboptimal codon usage. Codon optimization of DNA vectors can enhance protein expression both by enhancing translational efficiency, and by altering RNA stability and export. Although gag codon optimization is widely used in DNA vectors and experimental vaccines, the actual effect of altered codon usage on gag translational efficiency has not been quantified. Methodology and Principal Findings: To quantify translational efficiency of gag mRNA in live T cells, we transfected Jurkat cells with increasing doses of capped, polyadenylated synthetic mRNA corresponding to wildtype or codon-optimized gag sequences, measured Gag production by quantitative ELISA and flow cytometry, and estimated the translational efficiency of each transcript as mu g of Gag antigen produced per mg of input mRNA. We found that codon optimization yielded a small increase in gag translational efficiency (approximately 1.6 fold). In contrast when cells were transfected with DNA vectors requiring nuclear transcription and processing of gag mRNA, codon optimization resulted in a very large enhancement of Gag production. Conclusions: We conclude that suboptimal codon usage by HIV-1 results in only a slight loss of gag translational efficiency per se, with the vast majority of enhancement in protein expression from DNA vectors due to altered processing and export of nuclear RNA.	[Ngumbela, Kholiswa C.] Univ KwaZulu Natal, Doris Duke Med Res Inst, HIV Pathogenesis Programme, Durban, South Africa; [Ryan, Kieran P.; Sivamurthy, Rohini; Brockman, Mark A.; Gandhi, Rajesh T.; Bhardwaj, Nina; Kavanagh, Daniel G.] Harvard Med Sch, Massachusetts Gen Hosp, Partners AIDS Res Ctr, Div AIDS, Boston, MA USA; [Bhardwaj, Nina] NYU, Sch Med, New York, NY USA	University of Kwazulu Natal; Harvard University; Harvard Medical School; Massachusetts General Hospital; New York University	Ngumbela, KC (corresponding author), Univ KwaZulu Natal, Doris Duke Med Res Inst, HIV Pathogenesis Programme, Durban, South Africa.	dkavanagh@partners.org	; Brockman, Mark/D-1669-2016	Bhardwaj, Nina/0000-0003-1865-4187; Brockman, Mark/0000-0001-6432-1426	Emerald Foundation, NY; NIH [R01AI0571278-03, R01AI066992];  [R37AI044628-08];  [F32AI058457]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI044628, F32AI058457, R01AI066992] Funding Source: NIH RePORTER	Emerald Foundation, NY; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Emerald Foundation, NY and NIH grants R37AI044628-08 (NB), R01AI0571278-03 (NB), and by R01AI066992 (RTG) and F32AI058457 (DGK). The funders did not particiapate in collection, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.	Deml L, 2001, J VIROL, V75, P10991, DOI 10.1128/JVI.75.22.10991-11001.2001; Freed E. O., 2001, FIELDS VIROLOGY, P1971; Gao F, 2003, AIDS RES HUM RETROV, V19, P817, DOI 10.1089/088922203769232610; Gilboa E, 2004, IMMUNOL REV, V199, P251, DOI 10.1111/j.0105-2896.2004.00139.x; Haas J, 1996, CURR BIOL, V6, P315, DOI 10.1016/S0960-9822(02)00482-7; Kavanagh DG, 2006, BLOOD, V107, P1963, DOI 10.1182/blood-2005-04-1513; Kofman Alexander, 2003, Tsitologiia, V45, P86; Kofman Alexander, 2003, Tsitologiia, V45, P94; Kong W, 2002, J VIROL, V76, P11434, DOI 10.1128/JVI.76.22.11434-11439.2002; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Nguyen KL, 2004, VIROLOGY, V319, P163, DOI 10.1016/j.virol.2003.11.021; Pasquinelli AE, 1995, RNA, V1, P957; Pollard VW, 1998, ANNU REV MICROBIOL, V52, P491, DOI 10.1146/annurev.micro.52.1.491; Schneider R, 1997, J VIROL, V71, P4892, DOI 10.1128/JVI.71.7.4892-4903.1997; Shindo K, 2003, J BIOL CHEM, V278, P44412, DOI 10.1074/jbc.C300376200; Smith JM, 2004, AIDS RES HUM RETROV, V20, P1335, DOI 10.1089/aid.2004.20.1335; Stepinski J, 2001, RNA, V7, P1486; Tang HL, 1999, ANNU REV GENET, V33, P133, DOI 10.1146/annurev.genet.33.1.133; Van Gulck ERA, 2006, BLOOD, V107, P1818, DOI 10.1182/blood-2005-01-0339; Vartanian JP, 2003, TRENDS MOL MED, V9, P409, DOI 10.1016/j.molmed.2003.08.008; Weissman D, 2000, J IMMUNOL, V165, P4710, DOI 10.4049/jimmunol.165.8.4710; Williamson C, 2003, AIDS RES HUM RETROV, V19, P133, DOI 10.1089/088922203762688649	22	38	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2356	10.1371/journal.pone.0002356	http://dx.doi.org/10.1371/journal.pone.0002356			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523584	Green Published, gold, Green Submitted			2022-12-25	WOS:000262614300043
J	Prudhomme, J; McDaniel, E; Ponts, N; Bertani, S; Fenical, W; Jensen, P; Le Roch, K				Prudhomme, Jacques; McDaniel, Eric; Ponts, Nadia; Bertani, Stephane; Fenical, William; Jensen, Paul; Le Roch, Karine			Marine Actinomycetes: A New Source of Compounds against the Human Malaria Parasite	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; PROTEASOME INHIBITOR; SALINOSPORAMIDE-A; RESISTANCE; KINASE; IDENTIFICATION; MECHANISMS; DIVERSITY	Background: Malaria continues to be a devastating parasitic disease that causes the death of 2 million individuals annually. The increase in multi-drug resistance together with the absence of an efficient vaccine hastens the need for speedy and comprehensive antimalarial drug discovery and development. Throughout history, traditional herbal remedies or natural products have been a reliable source of antimalarial agents, e. g. quinine and artemisinin. Today, one emerging source of small molecule drug leads is the world's oceans. Included among the source of marine natural products are marine microorganisms such as the recently described actinomycete. Members of the genus Salinispora have yielded a wealth of new secondary metabolites including salinosporamide A, a molecule currently advancing through clinical trials as an anticancer agent. Because of the biological activity of metabolites being isolated from marine microorganisms, our group became interested in exploring the potential efficacy of these compounds against the malaria parasite. Methods: We screened 80 bacterial crude extracts for their activity against malaria growth. We established that the pure compound, salinosporamide A, produced by the marine actinomycete, Salinispora tropica, shows strong inhibitory activity against the erythrocytic stages of the parasite cycle. Biochemical experiments support the likely inhibition of the parasite 20S proteasome. Crystal structure modeling of salinosporamide A and the parasite catalytic 20S subunit further confirm this hypothesis. Ultimately we showed that salinosporamide A protected mice against deadly malaria infection when administered at an extremely low dosage. Conclusion: These findings underline the potential of secondary metabolites, derived from marine microorganisms, to inhibit Plasmodium growth. More specifically, we highlight the effect of proteasome inhibitors such as salinosporamide A on in vitro and in vivo parasite development. Salinosporamide A (NPI-0052) now being advanced to phase I trials for the treatment of refractory multiple myeloma will need to be further explored to evaluate the safety profile for its use against malaria.	[Prudhomme, Jacques; McDaniel, Eric; Ponts, Nadia; Le Roch, Karine] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA; [Bertani, Stephane] Univ Calif Riverside, Dept Biochem, Riverside, CA USA; [Fenical, William; Jensen, Paul] Univ Calif San Diego, Ctr Marine Biotechnol & Biomed, Scripps Inst Oceanography, San Diego, CA USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California San Diego; Scripps Institution of Oceanography	Prudhomme, J (corresponding author), Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA.	karine.leroch@ucr.edu	Bertani, Stephane/B-1250-2013	Bertani, Stephane/0000-0002-0398-9745; Fenical, William/0000-0002-8955-1735; jensen, paul/0000-0003-2349-1888; McDaniel, Eric/0000-0002-5985-3919	National Institutes of Health [TW007401]; Fogarty International Center [TW007401]; FOGARTY INTERNATIONAL CENTER [U01TW007401] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	WF and PRJ thank the National Institutes of Health, Fogarty International Center, for funding under ICBG Grant #TW007401. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Adams J, 2004, CANCER CELL, V5, P417, DOI 10.1016/S1535-6108(04)00120-5; Alker AP, 2007, AM J TROP MED HYG, V76, P641, DOI 10.4269/ajtmh.2007.76.641; Bennett TN, 2004, ANTIMICROB AGENTS CH, V48, P1807, DOI 10.1128/AAC.48.5.1807-1810.2004; Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1; Blunt JW, 2007, NAT PROD REP, V24, P31, DOI 10.1039/b603047p; Buchanan GN, 2005, DIS COLON RECTUM, V48, P141, DOI 10.1007/s10350-004-0752-3; Buchanan GO, 2005, ORG LETT, V7, P2731, DOI 10.1021/ol050901i; Chauhan D, 2005, CANCER CELL, V8, P407, DOI 10.1016/j.ccr.2005.10.013; Chauhan D, 2005, MOL CANCER THER, V4, P686, DOI 10.1158/1535-7163.MCT-04-0338; Ciechanover A, 1998, P NATL ACAD SCI USA, V95, P2727, DOI 10.1073/pnas.95.6.2727; Corey EJ, 1999, CHEM PHARM BULL, V47, P1; Dorin D, 2005, MOL MICROBIOL, V55, P184, DOI 10.1111/j.1365-2958.2004.04393.x; Dorin D, 2001, EUR J BIOCHEM, V268, P2600, DOI 10.1046/j.1432-1327.2001.02151.x; Feling RH, 2003, ANGEW CHEM INT EDIT, V42, P355, DOI 10.1002/anie.200390115; Ferrer-Rodriguez I, 2004, J PARASITOL, V90, P152, DOI 10.1645/GE-3225; Gantt SM, 1998, ANTIMICROB AGENTS CH, V42, P2731, DOI 10.1128/AAC.42.10.2731; Gontang EA, 2007, APPL ENVIRON MICROB, V73, P3272, DOI 10.1128/AEM.02811-06; Gonzalez J, 1996, J EXP MED, V184, P1909, DOI 10.1084/jem.184.5.1909; Gonzalez J, 1997, Arch Med Res, V28 Spec No, P139; Gonzalez J, 1999, EUR J BIOCHEM, V264, P897, DOI 10.1046/j.1432-1327.1999.00682.x; Groll M, 2006, J AM CHEM SOC, V128, P5136, DOI 10.1021/ja058320b; Groll M, 2005, METHOD ENZYMOL, V398, P329, DOI 10.1016/S0076-6879(05)98027-0; Jambou R, 2005, LANCET, V366, P1960, DOI 10.1016/S0140-6736(05)67787-2; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Laurent D, 2006, MAR BIOTECHNOL, V8, P433, DOI 10.1007/s10126-006-6100-y; Le Roch K, 2000, J BIOL CHEM, V275, P8952, DOI 10.1074/jbc.275.12.8952; LEROCH KG, 2003, DISCOVERY GENE FUNCT; Lindenthal C, 2005, PARASITOLOGY, V131, P37, DOI 10.1017/S003118200500747X; Maldonado LA, 2005, ANTON LEEUW INT J G, V87, P11, DOI 10.1007/s10482-004-6525-0; Rao KV, 2004, J NAT PROD, V67, P1314, DOI 10.1021/np0400095; Schwartsmann G, 2003, EXPERT OPIN INV DRUG, V12, P1367, DOI 10.1517/13543784.12.8.1367; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; Walker DJ, 2000, ANTIMICROB AGENTS CH, V44, P344, DOI 10.1128/AAC.44.2.344-347.2000; Wan YQ, 2004, CHEM BIOL, V11, P247, DOI 10.1016/j.chembiol.2004.01.015; Williams PG, 2005, J ORG CHEM, V70, P6196, DOI 10.1021/jo050511+	36	122	131	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2335	10.1371/journal.pone.0002335	http://dx.doi.org/10.1371/journal.pone.0002335			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523554	Green Published, gold, Green Submitted			2022-12-25	WOS:000262614300030
J	Xing, GQ; Qualls, C; Huicho, L; River-Ch, M; Stobdan, T; Slessarev, M; Prisman, E; Ito, S; Wu, H; Norboo, A; Dolma, D; Kunzang, M; Norboo, T; Gamboa, JL; Claydon, VE; Fisher, J; Zenebe, G; Gebremedhin, A; Hainsworth, R; Verma, A; Appenzeller, O				Xing, Guoqiang; Qualls, Clifford; Huicho, Luis; River-Ch, Maria; Stobdan, Tsering; Slessarev, Marat; Prisman, Eitan; Ito, Soji; Wu, Hong; Norboo, Angchuk; Dolma, Diskit; Kunzang, Moses; Norboo, Tsering; Gamboa, Jorge L.; Claydon, Victoria E.; Fisher, Joseph; Zenebe, Guta; Gebremedhin, Amha; Hainsworth, Roger; Verma, Ajay; Appenzeller, Otto			Adaptation and Mal-Adaptation to Ambient Hypoxia; Andean, Ethiopian and Himalayan Patterns	PLOS ONE			English	Article							CHRONIC MOUNTAIN-SICKNESS; HIGH-ALTITUDE; GENE-EXPRESSION; FITNESS; LIFE	The study of the biology of evolution has been confined to laboratories and model organisms. However, controlled laboratory conditions are unlikely to model variations in environments that influence selection in wild populations. Thus, the study of "fitness'' for survival and the genetics that influence this are best carried out in the field and in matching environments. Therefore, we studied highland populations in their native environments, to learn how they cope with ambient hypoxia. The Andeans, African highlanders and Himalayans have adapted differently to their hostile environment. Chronic mountain sickness (CMS), a loss of adaptation to altitude, is common in the Andes, occasionally found in the Himalayas; and absent from the East African altitude plateau. We compared molecular signatures (distinct patterns of gene expression) of hypoxia-related genes, in white blood cells (WBC) from Andeans with (n = 10), without CMS (n = 10) and sea-level controls from Lima (n = 20) with those obtained from CMS (n = 8) and controls (n = 5) Ladakhi subjects from the Tibetan altitude plateau. We further analyzed the expression of a subset of these genes in Ethiopian highlanders (n = 8). In all subjects, we performed the studies at their native altitude and after they were rendered normoxic. We identified a gene that predicted CMS in Andeans and Himalayans (PDP2). After achieving normoxia, WBC gene expression still distinguished Andean and Himalayan CMS subjects. Remarkably, analysis of the small subset of genes (n = 8) studied in all 3 highland populations showed normoxia induced gene expression changes in Andeans, but not in Ethiopians nor Himalayan controls. This is consistent with physiologic studies in which Ethiopians and Himalayans show a lack of responsiveness to hypoxia of the cerebral circulation and of the hypoxic ventilatory drive, and with the absence of CMS on the East African altitude plateau.	[Xing, Guoqiang] Uniformed Serv Univ Hlth Sci, Dept Psychiat, Bethesda, MD 20814 USA; [Qualls, Clifford] University of New Mexico, Dept Math & Statist, Albuquerque, NM USA; [Huicho, Luis] Univ Nacl Mayor San Marcos, Dept Acad Pediat, Lima, Peru; [River-Ch, Maria] Univ Peruana Cayetano Heredia, Inst Invest Altura, Fac Cienc Filos, Dept Cienc Biol, Lima, Peru; [Stobdan, Tsering; Norboo, Tsering] Ladakh Heart Fdn, Ladakh Inst Prevent, Leh, India; [Slessarev, Marat; Prisman, Eitan; Fisher, Joseph] Univ Toronto, Dept Anesthesiol, Toronto, ON, Canada; [Slessarev, Marat; Fisher, Joseph] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Ito, Soji] Nagoya City Univ, Grad Sch Med Sci, Dept Anesthesiol, Nagoya, Aichi, Japan; [Ito, Soji] Nagoya City Univ, Grad Sch Med Sc, Dept Med Crisis Management, Nagoya, Aichi, Japan; [Wu, Hong] Uniformed Serv Univ Hlth Sci, Dept Pharmacol, Bethesda, MD USA; [Norboo, Angchuk; Dolma, Diskit] Sonam Norboo Memorial Hosp Leh, Leh, India; [Gamboa, Jorge L.] Univ Kentucky, Dept Physiol, Louisville, KY USA; [Gamboa, Jorge L.] Univ Kentucky, Dept Neurol, Louisville, KY USA; [Claydon, Victoria E.] Simon Fraser Univ, Sch Kinesiol, Burnaby, BC, Canada; [Zenebe, Guta] Univ Addis Ababa, Yehuleshet Higher Clin, Dept Neurol, Addis Ababa, Ethiopia; [Gebremedhin, Amha] Univ Addis Ababa, Dept Med, Addis Ababa, Ethiopia; [Hainsworth, Roger] Univ Leeds, Inst Cardiovascul Res, Leeds, W Yorkshire, England; [Verma, Ajay] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD USA; [Appenzeller, Otto] New Mexico Hlth Enhancement, Marathon Clin Res Fdn, Dept Neurol, Albuquerque, NM USA	Uniformed Services University of the Health Sciences - USA; Universidad Nacional Mayor de San Marcos; Universidad Peruana Cayetano Heredia; University of Toronto; University of Toronto; Nagoya City University; Nagoya City University; Uniformed Services University of the Health Sciences - USA; University of Kentucky; University of Kentucky; Simon Fraser University; Addis Ababa University; Addis Ababa University; University of Leeds; Uniformed Services University of the Health Sciences - USA	Xing, GQ (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Psychiat, Bethesda, MD 20814 USA.	oarun@unm.edu	Gamboa, Jorge/AFM-0631-2022; Xing, Guoqiang/ABA-8450-2020; Gamboa, Jorge/AAH-3052-2022; Huicho, Luis/AAD-7353-2019; Slessarev, Marat/G-2505-2018; Gamboa, Jorge/E-5879-2010; Slessarev, Marat/I-7482-2017	Gamboa, Jorge/0000-0002-4204-7670; Gamboa, Jorge/0000-0002-4204-7670; Gamboa, Jorge/0000-0002-4204-7670; Slessarev, Marat/0000-0003-1181-0706; Claydon, Victoria/0000-0002-2720-8042; Prisman, Eitan/0000-0001-7201-6181; Rivera-Chira, Maria/0000-0001-9470-6642; Huicho, Luis/0000-0002-5272-5885; Verma, Ajay/0000-0001-7715-0443	New Mexico Health Enhancement and Marathon Clinics Research Foundation Albuquerque NM USA; Thornhill Research Inc. Toronto, Canada; NIH [Ro1 NS37814]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037814] Funding Source: NIH RePORTER	New Mexico Health Enhancement and Marathon Clinics Research Foundation Albuquerque NM USA; Thornhill Research Inc. Toronto, Canada; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	New Mexico Health Enhancement and Marathon Clinics Research Foundation Albuquerque NM USA; Thornhill Research Inc. Toronto, Canada, NIH Ro1 NS37814 to A.V.	Appenzeller O, 2003, J NEUROL SCI, V207, P37, DOI 10.1016/S0022-510X(02)00356-8; Appenzeller O, 2006, STROKE, V37, P1754, DOI 10.1161/01.STR.0000226973.97858.0b; Appenzeller O, 2006, CLIN AUTON RES, V16, P217, DOI 10.1007/s10286-006-0338-3; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Bakonyi T, 2004, J SPORT SCI MED, V3, P64; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Beall CM, 2002, P NATL ACAD SCI USA, V99, P17215, DOI 10.1073/pnas.252649199; Beall CA, 2007, RESP PHYSIOL NEUROBI, V158, P161, DOI 10.1016/j.resp.2007.05.013; Beall CM, 2007, P NATL ACAD SCI USA, V104, P8655, DOI 10.1073/pnas.0701985104; Burgoyne JR, 2007, SCIENCE, V317, P1393, DOI 10.1126/science.1144318; Busch T, 2001, AM J RESP CRIT CARE, V163, P368, DOI 10.1164/ajrccm.163.2.2001134; Claydon VE, 2008, STROKE, V39, P336, DOI 10.1161/STROKEAHA.107.491498; Cohen J, 2007, SCIENCE, V317, P1315, DOI 10.1126/science.317.5843.1315; Ellegren H, 2008, NATURE, V452, P169, DOI 10.1038/nature06737; GILBERT DL, 1983, RESP PHYSIOL, V52, P327, DOI 10.1016/0034-5687(83)90089-0; GILBERT DL, 1983, RESP PHYSIOL, V52, P315, DOI 10.1016/0034-5687(83)90088-9; GOEBEL T, 2008, LATE PLEISTOCENE DIS, V319, P1497; Hartzell HC, 2007, SCIENCE, V317, P1331, DOI 10.1126/science.1148142; Hurtado A, 1942, J AMER MED ASSOC, V120, P1278, DOI 10.1001/jama.1942.02830510016004; Leon-Velarde F, 2003, ADV EXP MED BIOL, V543, P339; MONGE CC, 2003, RETO FISIOLOGICO VIV, V177, P435; MONGE MC, 1928, ANALES FACULTAD MED, V11, P76; Niermeyer S, 2001, LUNG BIOL HEALTH DIS, V161, P43; Pennisi E, 2008, SCIENCE, V319, P1177, DOI 10.1126/science.319.5867.1177; Sartori C, 2003, ADV EXP MED BIOL, V543, P263; SEMENIUK C, 2007, WETLANDS ECOL CONSER, V1, P1; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; Shen HY, 2005, J BIOL CHEM, V280, P39962, DOI 10.1074/jbc.M505524200; SIME F, 1975, INT J BIOMETEOROL, V19, P93, DOI 10.1007/BF01463864; Singel DJ, 2004, NATURE, V430, P297, DOI 10.1038/430297a; Slessarev M, 2006, CRIT CARE MED, V34, P829, DOI 10.1097/01.CCM.0000201877.82049.C3; SLESSAREV M, 2007, ADV EXPT MED BIOL, V618, P326; SLESSAREV M, 2006, ISR J EMERG MED, V6, P10; SLESSAREV M, 2007, ADV EXPT MED BIOL, V618, P328; SUTTON JR, 1983, SEMIN RESPIR MED, V5, P129, DOI 10.1055/s-2007-1011442; Thomas PK, 2000, J NEUROL NEUROSUR PS, V69, P447, DOI 10.1136/jnnp.69.4.447	36	57	60	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2342	10.1371/journal.pone.0002342	http://dx.doi.org/10.1371/journal.pone.0002342			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523639	Green Published, gold			2022-12-25	WOS:000262614300035
J	Bourke, J; Wroe, S; Moreno, K; McHenry, C; Clausen, P				Bourke, Jason; Wroe, Stephen; Moreno, Karen; McHenry, Colin; Clausen, Philip			Effects of Gape and Tooth Position on Bite Force and Skull Stress in the Dingo (Canis lupus dingo) Using a 3-Dimensional Finite Element Approach	PLOS ONE			English	Article								Models of the mammalian jaw have predicted that bite force is intimately linked to jaw gape and to tooth position. Despite widespread use, few empirical studies have provided evidence to validate these models in non-human mammals and none have considered the influence of gape angle on the distribution of stress. Here using a multi-property finite element (FE) model of Canis lupus dingo, we examined the influence of gape angle and bite point on both bite force and cranial stress. Bite force data in relation to jaw gape and along the tooth row, are in broad agreement with previously reported results. However stress data showed that the skull of C. l. dingo is mechanically suited to withstand stresses at wide gapes; a result that agreed well with previously held views regarding carnivoran evolution. Stress data, combined with bite force information, suggested that there is an optimal bite angle of between 25 degrees and 35 degrees in C. l. dingo. The function of these rather small bite angles remains unclear.	[Bourke, Jason; Wroe, Stephen; Moreno, Karen; McHenry, Colin] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [McHenry, Colin] Univ Newcastle, Sch Env & Life Sci, Callaghan, NSW, Australia; [McHenry, Colin; Clausen, Philip] Univ Newcastle, Sch Engn, Callaghan, NSW, Australia	University of New South Wales Sydney; University of Newcastle; University of Newcastle	Bourke, J (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia.	archosaur@gmail.com	Wroe, Stephen/A-4462-2010; Moreno, Karen/B-6127-2009; Clausen, Philip/G-7337-2013	Wroe, Stephen/0000-0002-5813-9182; Moreno, Karen/0000-0002-5949-133X; Clausen, Philip/0000-0003-1186-6419; Wroe, Stephen/0000-0002-6365-5915	ARC Discovery; ARC QE2 Research Fellowship; UNSW Strategic Research Initiatives; University of Newcastle	ARC Discovery(Australian Research Council); ARC QE2 Research Fellowship(Australian Research Council); UNSW Strategic Research Initiatives; University of Newcastle	This work was funded by ARC Discovery, ARC QE2 Research Fellowship and UNSW Strategic Research Initiatives grants to S.W., and an Internal Grant (University of Newcastle) to P.C.	Aguirre LF, 2002, P ROY SOC B-BIOL SCI, V269, P1271, DOI 10.1098/rspb.2002.2011; Binder WJ, 2000, J ZOOL, V252, P273, DOI 10.1111/j.1469-7998.2000.tb00622.x; Christiansen P, 2007, ECOLOGY, V88, P347, DOI 10.1890/0012-9658(2007)88[347:BFAEAT]2.0.CO;2; DECHOW PC, 1983, J BIOMECH, V16, P797, DOI 10.1016/0021-9290(83)90003-9; Dumont ER, 2003, J EXP BIOL, V206, P2117, DOI 10.1242/jeb.00375; Dumont ER, 2005, ANAT REC PART A, V283A, P319, DOI 10.1002/ar.a.20165; EMERSON SB, 1980, PALEOBIOLOGY, V6, P295, DOI 10.1017/S0094837300006813; FIELDS HW, 1986, J DENT RES, V65, P135, DOI 10.1177/00220345860650020901; GREAVES WS, 1982, J MAMMAL, V63, P261, DOI 10.2307/1380635; HERRING SW, 1974, AM NAT, V108, P561, DOI 10.1086/282934; Husak JF, 2006, COPEIA, P301, DOI 10.1643/0045-8511(2006)6[301:BPPDIM]2.0.CO;2; HYLANDER WL, 1979, J MORPHOL, V159, P253, DOI 10.1002/jmor.1051590208; HYLANDER WL, 1977, AM J PHYS ANTHROPOL, V46, P309, DOI 10.1002/ajpa.1330460212; LINDAUER SJ, 1993, J DENT RES, V72, P51, DOI 10.1177/00220345930720010701; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; PRUIM GJ, 1980, J BIOMECH, V13, P755, DOI 10.1016/0021-9290(80)90237-7; Rayfield EJ, 2007, ANNU REV EARTH PL SC, V35, P541, DOI 10.1146/annurev.earth.35.031306.140104; Ross CF, 2005, ANAT REC PART A, V283A, P288, DOI 10.1002/ar.a.20170; Strait DS, 2005, ANAT REC PART A, V283A, P275, DOI 10.1002/ar.a.20172; Thomason JJ, 2005, ANAT REC PART A, V283A, P366, DOI 10.1002/ar.a.20173; Thompson EN, 2003, J EXP BIOL, V206, P923, DOI 10.1242/jeb.00181; Wroe S, 2005, P ROY SOC B-BIOL SCI, V272, P619, DOI 10.1098/rspb.2004.2986; WROE S, J ZOOLOGY L IN PRESS; Wroe S, 2007, P ROY SOC B-BIOL SCI, V274, P2819, DOI 10.1098/rspb.2007.0906; Wroe S, 2007, ANAT REC, V290, P1248, DOI 10.1002/ar.20594	25	60	60	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2200	10.1371/journal.pone.0002200	http://dx.doi.org/10.1371/journal.pone.0002200			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493603	Green Published, Green Submitted, gold			2022-12-25	WOS:000262258700009
J	Djogbenou, L; Chandre, F; Berthomieu, A; Dabire, R; Koffi, A; Alout, H; Weill, M				Djogbenou, Luc; Chandre, Fabrice; Berthomieu, Arnaud; Dabire, Roch; Koffi, Alphonsine; Alout, Haoues; Weill, Mylene			Evidence of Introgression of the ace-1(R) Mutation and of the ace-1 Duplication in West African Anopheles gambiae s. s.	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; HIGH WOLBACHIA DENSITY; INSECTICIDE RESISTANCE; INCIPIENT SPECIATION; DNA ANALYSIS; GENE FLOW; MOSQUITOS; ACETYLCHOLINESTERASE; POPULATIONS; COST	Background: The role of inter-specific hybridisation is of particular importance in mosquito disease vectors for predicting the evolution of insecticide resistance. Two molecular forms of Anopheles gambiae s.s., currently recognized as S and M taxa, are considered to be incipient sibling species. Hybrid scarcity in the field was suggested that differentiation of M and S taxa is maintained by limited or absent gene flow. However, recent studies have revealed shared polymorphisms within the M and S forms, and a better understanding of the occurrence of gene flow is needed. One such shared polymorphism is the G119S mutation in the ace-1 gene (which is responsible for insecticide resistance); this mutation has been described in both the M and S forms of A. gambiae s.s. Methods and Results: To establish whether the G119S mutation has arisen independently in each form or by genetic introgression, we analysed coding and non-coding sequences of ace-1 alleles in M and S mosquitoes from representative field populations. Our data revealed many polymorphic sites shared by S and M forms, but no diversity was associated with the G119S mutation. These results indicate that the G119S mutation was a unique event and that genetic introgression explains the observed distribution of the G119S mutation within the two forms. However, it was impossible to determine from our data whether the mutation occurred first in the S form or in the M form. Unexpectedly, sequence analysis of some resistant individuals revealed a duplication of the ace-1 gene that was observed in both A. gambiae s.s. M and S forms. Again, the distribution of this duplication in the two forms most likely occurred through introgression. Conclusions: These results highlight the need for more research to understand the forces driving the evolution of insecticide resistance in malaria vectors and to regularly monitor resistance in mosquito populations of Africa.	[Djogbenou, Luc; Chandre, Fabrice] Inst Rech Dev, Cotonou, Benin; [Djogbenou, Luc] Ctr Rech Entomol Cotonou CREC, Cotonou, Benin; [Berthomieu, Arnaud; Alout, Haoues; Weill, Mylene] Univ Montpellier 2, Montpellier, France; [Berthomieu, Arnaud; Alout, Haoues; Weill, Mylene] Inst Sci Evolut, Equipe Genet Adapt, CNRS, Montpellier, France; [Dabire, Roch] Inst Region Sci Sante, Lab Entomol Parasitol, Bobo Dioulasso, Burkina Faso; [Koffi, Alphonsine] Inst Natl Sante Publ, Inst Pierre Richet IPR, Abidjan, Cote Ivoire	Institut de Recherche pour le Developpement (IRD); Entomological Research Center of Cotonou (CREC); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Djogbenou, L (corresponding author), Inst Rech Dev, Cotonou, Benin.	mylene.weill@univ-montp2.fr	Chandre, Fabrice/Q-3429-2019; Dabire, Roch Kounbobr/ABF-3525-2020; Alout, Haoues/N-9556-2016	Chandre, Fabrice/0000-0002-1994-9705; Alout, Haoues/0000-0001-7917-2697; DJOGBENOU, Salako Luc/0000-0002-7381-6321; Weill, Mylene/0000-0002-4043-1601	PAL+Programme, Ministere delegue a la Recherche [2002-45]; Institut de Recherche Pour le Developpement; ANR Morevol Sante-Environnement, Ministere delegue a la Recherche; Institut des Sciences de L'Evolution de Montpellier [2008-024, UMR CNRS-UM2 5554]	PAL+Programme, Ministere delegue a la Recherche; Institut de Recherche Pour le Developpement; ANR Morevol Sante-Environnement, Ministere delegue a la Recherche(French National Research Agency (ANR)); Institut des Sciences de L'Evolution de Montpellier	This work received financial support in part by the PAL+Programme, no. 2002-45 (Ministere delegue a la Recherche) and Institut de Recherche Pour le Developpement. It was also financed by the ANR Morevol Sante-Environnement (Ministere delegue a la Recherche) and Contribution 2008-024 of the Institut des Sciences de L'Evolution de Montpellier (UMR CNRS-UM2 5554).	ALOUT H, 2008, COMP BIOCH IN PRESS; Alout H, 2007, J MED ENTOMOL, V44, P463, DOI 10.1603/0022-2585(2007)44[463:DASCIR]2.0.CO;2; Arbogast BS, 2002, ANNU REV ECOL SYST, V33, P707, DOI 10.1146/annurev.ecolsys.33.010802.150500; Berticat C, 2004, GENET RES, V83, P189, DOI 10.1017/S0016672304006792; Berticat C, 2002, P ROY SOC B-BIOL SCI, V269, P1413, DOI 10.1098/rspb.2002.2022; Berticat C, 2002, GENET RES, V79, P41, DOI 10.1017/S001667230100547X; Bourguet D, 1996, PESTIC BIOCHEM PHYS, V55, P122, DOI 10.1006/pest.1996.0041; Bourguet D, 1996, BIOCHEM GENET, V34, P351, DOI 10.1007/BF00554410; COLLINS FH, 1987, AM J TROP MED HYG, V37, P37, DOI 10.4269/ajtmh.1987.37.37; COLUZZI M, 1985, B ZOOL, V52, P45, DOI 10.1080/11250008509440343; Coluzzi M, 2002, SCIENCE, V298, P1415, DOI 10.1126/science.1077769; COLUZZI M, 1964, Riv Malariol, V43, P197; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Cui F, 2006, J MED ENTOMOL, V43, P878, DOI 10.1603/0022-2585(2006)43[878:REOIAI]2.0.CO;2; della Torre A, 2001, INSECT MOL BIOL, V10, P9, DOI 10.1046/j.1365-2583.2001.00235.x; della Torre A, 2005, INSECT BIOCHEM MOLEC, V35, P755, DOI 10.1016/j.ibmb.2005.02.006; Djogbenou L, 2008, AM J TROP MED HYG, V78, P298, DOI 10.4269/ajtmh.2008.78.298; Donnelly MJ, 2004, HEREDITY, V92, P61, DOI 10.1038/sj.hdy.6800377; Duron O, 2006, EVOLUTION, V60, P303, DOI 10.1111/j.0014-3820.2006.tb01108.x; Edillo FE, 2002, J MED ENTOMOL, V39, P70, DOI 10.1603/0022-2585-39.1.70; Elissa N, 1994, Sante, V4, P95; Favia G, 2001, INSECT MOL BIOL, V10, P19, DOI 10.1046/j.1365-2583.2001.00236.x; Fehrer J, 1996, MOL BIOL EVOL, V13, P7, DOI 10.1093/oxfordjournals.molbev.a025572; Gentile G, 2001, INSECT MOL BIOL, V10, P25, DOI 10.1046/j.1365-2583.2001.00237.x; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HELMBYCHOWSKI K, 1993, MOL BIOL EVOL, V10, P1196; Labbe P, 2007, MOL BIOL EVOL, V24, P1056, DOI 10.1093/molbev/msm025; Lehmann T, 2003, J HERED, V94, P133, DOI 10.1093/jhered/esg024; Lenormand T, 1998, EVOLUTION, V52, P1705, DOI 10.1111/j.1558-5646.1998.tb02250.x; MASSOULIE J, 1992, MULTIDISCIPLINARY APPROACHES TO CHOLINESTERASE FUNCTIONS, P285; N'Guessan R, 2003, MED VET ENTOMOL, V17, P19, DOI 10.1046/j.1365-2915.2003.00406.x; NEI M, 1990, GENETICS, V125, P873; Nei M., 1987, MOL EVOLUTIONARY GEN; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SCHNEIDER S, 1997, ARLEQUIN VERSION 1 1; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Stump AD, 2005, P NATL ACAD SCI USA, V102, P15930, DOI 10.1073/pnas.0508161102; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; Taylor C, 2001, GENETICS, V157, P743; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tripet F, 2001, MOL ECOL, V10, P1725, DOI 10.1046/j.0962-1083.2001.01301.x; Tripet F, 2003, AM J TROP MED HYG, V68, P1; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; Weill M., 2005, P397, DOI 10.1079/9780851998121.0397; Weill M, 2004, INSECT MOL BIOL, V13, P1, DOI 10.1111/j.1365-2583.2004.00452.x; Weill M, 2003, NATURE, V423, P136, DOI 10.1038/423136b; Weill M, 2002, P ROY SOC B-BIOL SCI, V269, P2007, DOI 10.1098/rspb.2002.2122	47	99	103	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2172	10.1371/journal.pone.0002172	http://dx.doi.org/10.1371/journal.pone.0002172			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478097	Green Submitted, Green Published, gold			2022-12-25	WOS:000262172800037
J	Galan, RF				Galan, Roberto F.			On How Network Architecture Determines the Dominant Patterns of Spontaneous Neural Activity	PLOS ONE			English	Article								In the absence of sensory stimulation, neocortical circuits display complex patterns of neural activity. These patterns are thought to reflect relevant properties of the network, including anatomical features like its modularity. It is also assumed that the synaptic connections of the network constrain the repertoire of emergent, spontaneous patterns. Although the link between network architecture and network activity has been extensively investigated in the last few years from different perspectives, our understanding of the relationship between the network connectivity and the structure of its spontaneous activity is still incomplete. Using a general mathematical model of neural dynamics we have studied the link between spontaneous activity and the underlying network architecture. In particular, here we show mathematically how the synaptic connections between neurons determine the repertoire of spatial patterns displayed in the spontaneous activity. To test our theoretical result, we have also used the model to simulate spontaneous activity of a neural network, whose architecture is inspired by the patchy organization of horizontal connections between cortical columns in the neocortex of primates and other mammals. The dominant spatial patterns of the spontaneous activity, calculated as its principal components, coincide remarkably well with those patterns predicted from the network connectivity using our theory. The equivalence between the concept of dominant pattern and the concept of attractor of the network dynamics is also demonstrated. This in turn suggests new ways of investigating encoding and storage capabilities of neural networks.	[Galan, Roberto F.] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA	Case Western Reserve University	Galan, RF (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA.	rfgalan@case.edu		Fernandez Galan, Roberto/0000-0003-1426-1917	Mount Sinai Health Care Foundation	Mount Sinai Health Care Foundation	The author is grateful to the Mount Sinai Health Care Foundation for financial support.	Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; Cossart R, 2005, CELL CALCIUM, V37, P451, DOI 10.1016/j.ceca.2005.01.013; Froemke RC, 2002, TRENDS CARDIOVAS MED, V12, P247, DOI 10.1016/S1050-1738(02)00169-X; Galan RF, 2006, NEURAL COMPUT, V18, P10, DOI 10.1162/089976606774841558; Galan RF, 2004, NEURAL COMPUT, V16, P999, DOI 10.1162/089976604773135078; Haken H., 1991, SYNERGETIC COMPUTERS; Haken H., 1983, ADV SYNERGETICS INST; Hertz JA, 2018, INTRO THEORY NEURAL; HONERKAMP J, 1998, STOCHASTISCHE DYNAMI; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; HOPPENSTEADT F, 1997, WEAKLY CONNECTED NEU; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Laing CR, 2002, SIAM J APPL MATH, V63, P62, DOI 10.1137/S0036139901389495; Lennie P, 2003, CURR BIOL, V13, P493, DOI 10.1016/S0960-9822(03)00135-0; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; LUND JS, 1993, CEREB CORTEX, V3, P148, DOI 10.1093/cercor/3.2.148; Mao BQ, 2001, NEURON, V32, P883, DOI 10.1016/S0896-6273(01)00518-9; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; MIYASHITA Y, 1988, NATURE, V331, P68, DOI 10.1038/331068a0; MIYASHITA Y, 1988, NATURE, V335, P817, DOI 10.1038/335817a0; Mokeichev A, 2007, NEURON, V53, P413, DOI 10.1016/j.neuron.2007.01.017; Neumaier A, 2001, ACM T MATH SOFTWARE, V27, P27, DOI 10.1145/382043.382304; PRIESTLEY MB, 2001, SPECTRAL ANAL TIME S; RUMMELHART DE, 1987, EXPLORATIONS MICROST, V2; Rummelhart DE, 1986, EXPLORATIONS MICROST, V1; Schiff SJ, 2005, NEUROIMAGE, V28, P1043, DOI 10.1016/j.neuroimage.2005.06.059; Schiff SJ, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.178102; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Sporns O, 2000, NEURAL NETWORKS, V13, P909, DOI 10.1016/S0893-6080(00)00053-8; Steuer R, 2003, BIOCHEM SOC T, V31, P1476; Steuer R, 2003, BIOINFORMATICS, V19, P1019, DOI 10.1093/bioinformatics/btg120; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; White LE, 2001, NATURE, V411, P1049, DOI 10.1038/35082568; WILSON HR, 1973, KYBERNETIK, V13, P55, DOI 10.1007/BF00288786; Zemanova L, 2006, PHYSICA D, V224, P202, DOI 10.1016/j.physd.2006.09.008; Zhou CS, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.238103	39	131	132	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2148	10.1371/journal.pone.0002148	http://dx.doi.org/10.1371/journal.pone.0002148			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478091	gold, Green Published			2022-12-25	WOS:000262172800013
J	Rojas-Galeano, S; Hsieh, E; Agranoff, D; Krishna, S; Fernandez-Reyes, D				Rojas-Galeano, Sergio; Hsieh, Emily; Agranoff, Dan; Krishna, Sanjeev; Fernandez-Reyes, Delmiro			Estimation of Relevant Variables on High-Dimensional Biological Patterns Using Iterated Weighted Kernel Functions	PLOS ONE			English	Article							CANCER CLASSIFICATION; VECTOR; PERCEPTRON	Background: The analysis of complex proteomic and genomic profiles involves the identification of significant markers within a set of hundreds or even thousands of variables that represent a high-dimensional problem space. The occurrence of noise, redundancy or combinatorial interactions in the profile makes the selection of relevant variables harder. Methodology/Principal Findings: Here we propose a method to select variables based on estimated relevance to hidden patterns. Our method combines a weighted-kernel discriminant with an iterative stochastic probability estimation algorithm to discover the relevance distribution over the set of variables. We verified the ability of our method to select predefined relevant variables in synthetic proteome-like data and then assessed its performance on biological high-dimensional problems. Experiments were run on serum proteomic datasets of infectious diseases. The resulting variable subsets achieved classification accuracies of 99% on Human African Trypanosomiasis, 91% on Tuberculosis, and 91% on Malaria serum proteomic profiles with fewer than 20% of variables selected. Our method scaled-up to dimensionalities of much higher orders of magnitude as shown with gene expression microarray datasets in which we obtained classification accuracies close to 90% with fewer than 1% of the total number of variables. Conclusions: Our method consistently found relevant variables attaining high classification accuracies across synthetic and biological datasets. Notably, it yielded very compact subsets compared to the original number of variables, which should simplify downstream biological experimentation.	[Rojas-Galeano, Sergio; Fernandez-Reyes, Delmiro] Natl Inst Med Res, Div Parasitol, London NW7 1AA, England; [Rojas-Galeano, Sergio; Fernandez-Reyes, Delmiro] UCL, Dept Comp Sci, London, England; [Agranoff, Dan] Imperial Coll London, Fac Med, Dept Infect Dis & Immun, London, England; [Hsieh, Emily; Krishna, Sanjeev] St Georges Univ London, Ctr Infection, Div Cell & Mol Med, London, England	MRC National Institute for Medical Research; University of London; University College London; Imperial College London; St Georges University London	Rojas-Galeano, S (corresponding author), Natl Inst Med Res, Div Parasitol, London NW7 1AA, England.	dfernan@nimr.mrc.ac.uk		Fernandez-Reyes, Delmiro/0000-0001-5070-9198; Krishna, Sanjeev/0000-0003-0066-0634	Medical Research Council, United Kingdom; MRC [MC_U117585869] Funding Source: UKRI; Medical Research Council [MC_U117585869] Funding Source: researchfish	Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by The Medical Research Council, United Kingdom. The sponsor of the study had no direct role in study design, data collection, data analysis, data interpretation, or writing of the report.	Agranoff D, 2006, LANCET, V368, P1012, DOI 10.1016/S0140-6736(06)69342-2; Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Baldi P, 2002, DNA MICROARRAYS GENE; BEDO J, 2006, EFFICIENT ALTERNATIV; Briggs T, 2005, MATLAB MEX INTERFACE; Chapelle O, 2002, MACH LEARN, V46, P131, DOI 10.1023/A:1012450327387; CONRADS T, 2004, ENDOCR RELAT CANCER, P163; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cristianini N, 2000, INTRO SUPPORT VECTOR; DAVIES L, 1991, HDB GENETIC ALGORTIH; DAVIES S, 1994, NP COMPLETENESS SEAR; Ding YY, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S2-S12; Freund Y, 1999, MACH LEARN, V37, P277, DOI 10.1023/A:1007662407062; Friedrichs F, 2005, NEUROCOMPUTING, V64, P107, DOI 10.1016/j.neucom.2004.11.022; Frohlich H., 2003, FEATURE SELECTION SU; FROHLICH H, 2004, FEATURE SUBSET SELEC, P2041; GALEANO SR, 2005, ADAPTING MULTIPLE KE; Garey M.R., 1979, COMPUTERS INTRACTABI; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Guyon Isabelle, 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; HERBSTER M, 2001, LEARNING ADDITIVE MO, P444; Issaq HJ, 2002, BIOCHEM BIOPH RES CO, V292, P587, DOI 10.1006/bbrc.2002.6678; Joachims T., 1999, ADV KERNEL METHODS S; Li LB, 2005, GENOMICS, V85, P16, DOI 10.1016/j.ygeno.2004.09.007; Liu JJ, 2005, BIOINFORMATICS, V21, P2691, DOI 10.1093/bioinformatics/bti419; MERCER J, 1909, PHILOS T ROY SOC LON; Minsky M., 1969, PERCEPTRONS; NOVIKOV ABJ, 1962, P S MATH THEOR AUT, V12, P615; NUTT C, 2003, CANCER RES, P1602; Papadopoulos MC, 2004, LANCET, V363, P1358, DOI 10.1016/S0140-6736(04)16046-7; PELIKAN P, 2006, SCALABLE OPTIMIZATIO; ROSENBLATT F, 1958, PSYCHOL REV, V65, P386, DOI 10.1037/h0042519; Shawe-Taylor J., 2004, KERNEL METHODS PATTE; Tipping ME, 2001, J MACH LEARN RES, V1, P211, DOI 10.1162/15324430152748236; VANGESTEL T, 2001, AUTOMATIC RELEVANCE; Wagner M, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-26; Wagner M, 2003, PROTEOMICS, V3, P1692, DOI 10.1002/pmic.200300519; Weston Jason, 2000, FEATURE SELECTION SV; WHITLEY D, 1994, STAT COMPUT, V4, P65, DOI 10.1007/BF00175354; Zhang XG, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-197	40	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2008	3	3							e1806	10.1371/journal.pone.0001806	http://dx.doi.org/10.1371/journal.pone.0001806			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KZ	18509521	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000260762400001
J	Friedrich, O; von Wegner, F; Chamberlain, JS; Fink, RHA; Rohrbach, P				Friedrich, Oliver; von Wegner, Frederic; Chamberlain, Jeffrey S.; Fink, Rainer H. A.; Rohrbach, Petra			L-Type Ca2+ Channel Function Is Linked to Dystrophin Expression in Mammalian Muscle	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; CALCIUM LEAK CHANNELS; TRANSVERSE TUBULAR SYSTEM; SKELETAL-MUSCLE; SARCOPLASMIC-RETICULUM; GENE-THERAPY; MDX MICE; INTRACELLULAR CA2+; CHARGE MOVEMENT; FULL-LENGTH	Background: In dystrophic mdx skeletal muscle, aberrant Ca2+ homeostasis and fibre degeneration are found. The absence of dystrophin in models of Duchenne muscular dystrophy (DMD) has been connected to altered ion channel properties e. g. impaired L-type Ca2+ currents. In regenerating mdx muscle, 'revertant' fibres restore dystrophin expression. Their functionality involving DHPR-Ca2+- channels is elusive. Methods and Results: We developed a novel 'in-situ' confocal immuno-fluorescence and imaging technique that allows, for the first time, quantitative subcellular dystrophin-DHPR colocalization in individual, non-fixed, muscle fibres. Tubular DHPR signals alternated with second harmonic generation signals originating from myosin. Dystrophin-DHPR colocalization was substantial in wt fibres, but diminished in most mdx fibres. Mini-dystrophin (MinD) expressing fibres successfully restored colocalization. Interestingly, in some aged mdx fibres, colocalization was similar to wt fibres. Most mdx fibres showed very weak membrane dystrophin staining and were classified 'mdx-like'. Some mdx fibres, however, had strong 'wt-like' dystrophin signals and were identified as 'revertants'. Split mdx fibres were mostly 'mdx-like' and are not generally 'revertants'. Correlations between membrane dystrophin and DHPR colocalization suggest a restored putative link in 'revertants'. Using the two-micro-electrode-voltage clamp technique, Ca2+- current amplitudes (imax) showed very similar behaviours: reduced amplitudes in most aged mdx fibres (as seen exclusively in young mdx mice) and a few mdx fibres, most likely 'revertants', with amplitudes similar to wt or MinD fibres. Ca2+ current activation curves were similar in 'wt-like' and 'mdx-like' aged mdx fibres and are not the cause for the differences in current amplitudes. imax amplitudes were fully restored in MinD fibres. Conclusions: We present evidence for a direct/indirect DHPR-dystrophin interaction present in wt, MinD and 'revertant' mdx fibres but absent in remaining mdx fibres. Our imaging technique reliably detects single isolated 'revertant' fibres that could be used for subsequent physiological experiments to study mechanisms and therapy concepts in DMD.	[Friedrich, Oliver; von Wegner, Frederic; Fink, Rainer H. A.] Heidelberg Univ, Inst Physiol & Pathophysiol, Dept Syst Physiol, Heidelberg, Germany; [Chamberlain, Jeffrey S.] Univ Washington, Dept Neurol, Seattle, WA USA; [Rohrbach, Petra] Heidelberg Univ, Hyg Inst, Dept Parasitol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; University of Washington; University of Washington Seattle; Ruprecht Karls University Heidelberg	Friedrich, O (corresponding author), Heidelberg Univ, Inst Physiol & Pathophysiol, Dept Syst Physiol, Heidelberg, Germany.	oliver.friedrich@physiologie.uni-heidelberg.de	Rohrbach, Petra/F-3201-2011	Chamberlain, Jeffrey/0000-0001-5299-0059; Friedrich, Oliver/0000-0003-2238-2049				Alderton JM, 2000, J BIOL CHEM, V275, P9452, DOI 10.1074/jbc.275.13.9452; Allard B, 2006, J PHYSL, V575, P68; Allard B, 2006, J MUSCLE RES CELL M, V27, P367, DOI 10.1007/s10974-006-9083-4; ALMERS W, 1981, J PHYSIOL-LONDON, V312, P177, DOI 10.1113/jphysiol.1981.sp013623; BANGHAM AD, 1962, NATURE, V196, P952, DOI 10.1038/196952a0; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; Boland BJ, 1996, PEDIATR NEUROL, V14, P7, DOI 10.1016/0887-8994(95)00251-0; Both M, 2004, J BIOMED OPT, V9, P882, DOI 10.1117/1.1783354; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Chakkalakal JV, 2006, HUM MOL GENET, V15, P1423, DOI 10.1093/hmg/ddl065; Chamberlain JS, 2002, HUM MOL GENET, V11, P2355, DOI 10.1093/hmg/11.20.2355; Coirault C, 2002, AM J RESP CRIT CARE, V165, P250, DOI 10.1164/ajrccm.165.2.2105088; Collet C, 2003, BIOPHYS J, V84, P251, DOI 10.1016/S0006-3495(03)74846-2; Constantin B, 2006, J MUSCLE RES CELL M, V27, P375, DOI 10.1007/s10974-006-9085-2; CULLEN MJ, 1990, PROC R SOC SER B-BIO, V240, P197, DOI 10.1098/rspb.1990.0034; De Backer F, 2002, J PHYSIOL-LONDON, V542, P855, DOI 10.1113/jphysiol.2002.020487; Decrouy A, 1997, GENE THER, V4, P401, DOI 10.1038/sj.gt.3300407; Denti MA, 2006, P NATL ACAD SCI USA, V103, P3758, DOI 10.1073/pnas.0508917103; Divet A, 2005, ACTA PHYSIOL SCAND, V184, P173, DOI 10.1111/j.1365-201X.2005.01450.x; DULHUNTY AF, 1984, J MUSCLE RES CELL M, V5, P333, DOI 10.1007/BF00713111; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; FINK RHA, 1990, J PHYSIOL-LONDON, V420, P337, DOI 10.1113/jphysiol.1990.sp017916; FONG P, 1990, SCIENCE, V250, P673, DOI 10.1126/science.2173137; Francini F, 1996, J PHYSIOL-LONDON, V494, P121, DOI 10.1113/jphysiol.1996.sp021480; FRANK JS, 1994, AM J PHYSIOL-CELL PH, V267, pC1707, DOI 10.1152/ajpcell.1994.267.6.C1707; Friedrich O, 2004, J PHYSIOL-LONDON, V555, P251, DOI 10.1113/jphysiol.2003.054213; Friedrich O, 1999, J PHYSIOL-LONDON, V517, P757, DOI 10.1111/j.1469-7793.1999.0757s.x; Friedrich O, 2001, BIOPHYS J, V80, P2046, DOI 10.1016/S0006-3495(01)76178-4; GAILLY P, 1993, CELL CALCIUM, V14, P473, DOI 10.1016/0143-4160(93)90006-R; Ge Y, 2004, ELECTROPHORESIS, V25, P2576, DOI 10.1002/elps.200406013; GONZALEZSERRATOS H, 1982, NATURE, V298, P292, DOI 10.1038/298292a0; Gregorevic P, 2004, NAT MED, V10, P828, DOI 10.1038/nm1085; Harper SQ, 2002, NAT MED, V8, P253, DOI 10.1038/nm0302-253; HEAD SI, 1992, P ROY SOC B-BIOL SCI, V248, P163, DOI 10.1098/rspb.1992.0058; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HOFFMAN EP, 1990, J NEUROL SCI, V99, P9, DOI 10.1016/0022-510X(90)90195-S; HOFFMAN EP, 1987, NATURE, V330, P754, DOI 10.1038/330754a0; Imbert N, 2001, J PHYSIOL-LONDON, V534, P343, DOI 10.1111/j.1469-7793.2001.00343.x; Johnson BD, 2005, P NATL ACAD SCI USA, V102, P4191, DOI 10.1073/pnas.0409695102; Kumar A, 2004, FASEB J, V18, P102, DOI 10.1096/fj.03-0453com; Kurebayashi N, 2001, J PHYSIOL-LONDON, V533, P185, DOI 10.1111/j.1469-7793.2001.0185b.x; Launikonis BS, 1997, J PHYSIOL-LONDON, V504, P425, DOI 10.1111/j.1469-7793.1997.425be.x; Launikonis BS, 2002, J PHYSIOL-LONDON, V538, P607, DOI 10.1113/jphysiol.2001.012920; Liu MJ, 2005, MOL THER, V11, P245, DOI 10.1016/j.ymthe.2004.09.013; Lyfenko AD, 2004, BIOCHEM BIOPH RES CO, V322, P1256, DOI 10.1016/j.bbrc.2004.08.031; MacLennan DH, 2000, EUR J BIOCHEM, V267, P5291, DOI 10.1046/j.1432-1327.2000.01566.x; Mallouk N, 2002, BIOPHYS J, V82, P3012, DOI 10.1016/S0006-3495(02)75642-7; Marchand E, 2004, EXP CELL RES, V297, P363, DOI 10.1016/j.yexcr.2004.02.032; MATSUMURA K, 1994, NEUROMUSCULAR DISORD, V4, P115, DOI 10.1016/0960-8966(94)90002-7; McCarter GC, 2000, J MEMBRANE BIOL, V176, P169, DOI 10.1007/s002320001086; Melacini P, 1996, NEUROMUSCULAR DISORD, V6, P367, DOI 10.1016/0960-8966(96)00357-4; MELZER W, 1995, BBA-REV BIOMEMBRANES, V1241, P59, DOI 10.1016/0304-4157(94)00014-5; Messina S, 2006, EXP NEUROL, V198, P234, DOI 10.1016/j.expneurol.2005.11.021; Messina S, 2006, AM J PATHOL, V168, P918, DOI 10.2353/ajpath.2006.050673; MOENS P, 1993, J MUSCLE RES CELL M, V14, P446, DOI 10.1007/BF00121296; PASTORET C, 1995, J NEUROL SCI, V129, P97, DOI 10.1016/0022-510X(94)00276-T; PASTORET C, 1995, MUSCLE NERVE, V18, P1147, DOI 10.1002/mus.880181011; Pereon Y, 1997, BBA-MOL BASIS DIS, V1362, P201, DOI 10.1016/S0925-4439(97)00079-3; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; PHELPS SF, 1995, HUM MOL GENET, V4, P1251, DOI 10.1093/hmg/4.8.1251; Sadeghi A, 2002, AM J PHYSIOL-CELL PH, V282, pC1502, DOI 10.1152/ajpcell.00435.2001; SCHWARTZ LM, 1985, NATURE, V314, P747, DOI 10.1038/314747a0; SENTER L, 1995, BIOCHEM BIOPH RES CO, V206, P57, DOI 10.1006/bbrc.1995.1009; STRAUB V, 1992, J CELL BIOL, V119, P1183, DOI 10.1083/jcb.119.5.1183; TURNER PR, 1991, J CELL BIOL, V115, P1701, DOI 10.1083/jcb.115.6.1701; Tutdibi O, 1999, J PHYSIOL-LONDON, V515, P859, DOI 10.1111/j.1469-7793.1999.859ab.x; Vandebrouck A, 2005, FASEB J, V19, P136, DOI 10.1096/fj.04-3633fje; Vandebrouck C, 2002, J CELL BIOL, V158, P1089, DOI 10.1083/jcb.200203091; Wang X, 2005, NAT CELL BIOL, V7, P525, DOI 10.1038/ncb1254; Wang ZM, 2000, BIOPHYS J, V78, P1947, DOI 10.1016/S0006-3495(00)76742-7; Weisleder N, 2006, J CELL BIOL, V174, P639, DOI 10.1083/jcb.200604166; Woods CE, 2005, J PHYSIOL-LONDON, V568, P867, DOI 10.1113/jphysiol.2005.089318; Woods CE, 2004, J PHYSIOL-LONDON, V557, P59, DOI 10.1113/jphysiol.2004.061291; Woolf PJ, 2006, AM J PHYSIOL-HEART C, V290, pH2439, DOI 10.1152/ajpheart.00844.2005; Yeung EW, 2005, J PHYSIOL-LONDON, V562, P367, DOI 10.1113/jphysiol.2004.075275; Yokota T, 2006, J CELL SCI, V119, P2679, DOI 10.1242/jcs.03000	76	33	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1762	10.1371/journal.pone.0001762	http://dx.doi.org/10.1371/journal.pone.0001762			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18516256	Green Published, gold, Green Submitted			2022-12-25	WOS:000260723000016
J	Burgess, A; Labbe, JC; Vigneron, S; Bonneaud, N; Strub, JM; Van Dorsselaer, A; Lorca, T; Castro, A				Burgess, A.; Labbe, J. -C; Vigneron, S.; Bonneaud, N.; Strub, J. M.; Van Dorsselaer, A.; Lorca, T.; Castro, A.			Chfr interacts and colocalizes with TCTP to the mitotic spindle	ONCOGENE			English	Article						checkpoint; cancer; Chfr; prophase; spindle; TCTP	CONTROLLED TUMOR PROTEIN; CHECKPOINT PROTEIN; STRESS CHECKPOINT; CELL-CYCLE; GENE; HYPERMETHYLATION; MITOSIS; DELAYS; LIGASE; GROWTH	Chfr is a checkpoint protein that plays an important function in cell cycle progression and tumor suppression, although its exact role and regulation are unclear. Previous studies have utilized overexpression of Chfr to determine the signaling pathway of this protein in vivo. In this study, we demonstrate, by using three different antibodies against Chfr, that the endogenous and highly overexpressed ectopic Chfr protein is localized and regulated differently in cells. Endogenous and lowly expressed ectopic Chfr are cytoplasmic and localize to the spindle during mitosis. Higher expression of ectopic Chfr correlates with a shift in the localization of this protein to the nucleus/PML bodies, and with a block of cell proliferation. In addition, endogenous and lowly expressed ectopic Chfr is stable throughout the cell cycle, whereas when highly expressed, ectopic Chfr is actively degraded during S-G2/M phases in an autoubiquitination and proteasome-dependent manner. A two-hybrid screen identified TCTP as a possible Chfr-interacting partner. Biochemical analysis with the endogenous proteins confirmed this interaction and identified beta-tubulin as an additional partner for Chfr, supporting the mitotic spindle localization of Chfr. The Chfr-TCTP interaction was stable throughout the cell cycle, but it could be diminished by the complete depolymerization of the microtubules, providing a possible mechanism where Chfr could be the sensor that detects microtubule disruption and then activates the prophase checkpoint.	[Burgess, A.; Labbe, J. -C; Lorca, T.; Castro, A.] Univ Montpellier 2, Ctr Rech Biochim Macromol, CNRS, UMR Labellisee Ligue Natl Canc 5237,IFR 122, Montpellier, France; [Burgess, A.; Labbe, J. -C; Vigneron, S.; Lorca, T.; Castro, A.] Univ Montpellier I, Ctr Rech Biochim Macromol, CNRS, UMR Labellisee Ligue Natl Canc 5237,IFR 122, Montpellier, France; [Bonneaud, N.] CNRS, IGH, UPR14142, Montpellier, France; [Strub, J. M.] Inst Pluridisciplinaire Hubert Curien, UMR7178, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3)	Lorca, T (corresponding author), Univ Montpellier, Ctr Rech Biochim Macromol, CNRS, 1919 Route Mende, F-34293 Montpellier, France.	thierry.lorca@crbm.cnrs.fr; anna.castro@crbm.cnrs.fr	Burgess, Andrew/H-3339-2019; labbe, jean-claude/B-2277-2009; CASTRO, ANNA/F-4350-2010; Burgess, Andrew/C-7952-2009	Burgess, Andrew/0000-0003-4536-9226; CASTRO, ANNA/0000-0002-3655-1352; Burgess, Andrew/0000-0003-4536-9226; Lorca, Thierry/0000-0003-2007-8924; Strub, Jean-Marc/0000-0001-6224-3428	Ligue Nationale Contre le Cancer (Equipe Labellisee)	Ligue Nationale Contre le Cancer (Equipe Labellisee)(Ligue nationale contre le cancer)	We thank Julian Cau from the Montpellier RIO Imaging facility (CRBM). We also acknowledge J Casanova, JM Donnay and JC Mazur for their technical support. This work was supported by the Ligue Nationale Contre le Cancer (Equipe Labellisee). AB is a Ligue Nationale Contre le Cancer fellow.	Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; Bothos J, 2003, ONCOGENE, V22, P7101, DOI 10.1038/sj.onc.1206831; Burgess A, 2006, J BIOL CHEM, V281, P9987, DOI 10.1074/jbc.M512714200; Chaturvedi P, 2002, CANCER RES, V62, P1797; CHEUNG H, 2003, P NATL ACAD SCI USA, V100, P7818; Corn PG, 2003, CARCINOGENESIS, V24, P47, DOI 10.1093/carcin/24.1.47; Daniels MJ, 2004, NAT STRUCT MOL BIOL, V11, P1114, DOI 10.1038/nsmb837; Erson AE, 2004, MOL CARCINOGEN, V39, P26, DOI 10.1002/mc.10161; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Gabrielli BG, 1996, J CELL SCI, V109, P1081; Gachet Y, 1999, J CELL SCI, V112, P1257; Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528; Jung J, 2004, J BIOL CHEM, V279, P49868, DOI 10.1074/jbc.M400895200; Kang DM, 2002, J CELL BIOL, V156, P249, DOI 10.1083/jcb.200108016; Liu H, 2005, MOL CELL BIOL, V25, P3117, DOI 10.1128/MCB.25.8.3117-3126.2005; Loring GL, 2008, CELL CYCLE, V7, P96, DOI 10.4161/cc.7.1.5113; Mariatos G, 2003, CANCER RES, V63, P7185; Matsusaka T, 2004, J CELL BIOL, V166, P507, DOI 10.1083/jcb.200401139; Mikhailov A, 2005, CELL CYCLE, V4, P57, DOI 10.4161/cc.4.1.1357; Mizuno K, 2002, ONCOGENE, V21, P2328, DOI 10.1038/sj.onc.1205402; MURRAY AW, 1991, SCI AM, V264, P56, DOI 10.1038/scientificamerican0391-56; Privette LM, 2007, CANCER RES, V67, P6064, DOI 10.1158/0008-5472.CAN-06-4109; Rieder CL, 2000, CURR BIOL, V10, P1067, DOI 10.1016/S0960-9822(00)00678-3; Satoh A, 2003, CANCER RES, V63, P8606; Scolnick DM, 2000, NATURE, V406, P430, DOI 10.1038/35019108; Tuynder M, 2004, P NATL ACAD SCI USA, V101, P15364, DOI 10.1073/pnas.0406776101; Tuynder M, 2002, P NATL ACAD SCI USA, V99, P14976, DOI 10.1073/pnas.222470799; Uzbekov R, 1998, EXP CELL RES, V242, P60, DOI 10.1006/excr.1998.4097; Yang Y, 2005, ONCOGENE, V24, P4778, DOI 10.1038/sj.onc.1208666; Yarm FR, 2002, MOL CELL BIOL, V22, P6209, DOI 10.1128/MCB.22.17.6209-6221.2002; Yu XC, 2005, NAT GENET, V37, P401, DOI 10.1038/ng1538	31	37	41	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 18	2008	27	42					5554	5566		10.1038/onc.2008.167	http://dx.doi.org/10.1038/onc.2008.167			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	349KX	18504434	Green Submitted			2022-12-25	WOS:000259280800002
J	Maimets, T; Neganova, I; Armstrong, L; Lako, M				Maimets, T.; Neganova, I.; Armstrong, L.; Lako, M.			Activation of p53 by nutlin leads to rapid differentiation of human embryonic stem cells	ONCOGENE			English	Article						cell cycle; differentiation; human embryonic stem cells; p53-p21 pathway; tumour suppression	SELF-RENEWAL; TRANSCRIPTIONAL ACTIVATION; IN-VIVO; PROLIFERATION; CANCER; GENE; P21; ANTAGONISTS; QUIESCENCE; SITES	p53 is an important regulator of normal cell response to stress and frequently mutated in human tumours. Here, we studied the effects of activation of p53 and its target gene p21 in human embryonic stem cells. We show that activation of p53 with small-molecule activator nutlin leads to rapid differentiation of stem cells evidenced by changes in cell morphology and adhesion, expression of cell-specific markers for primitive endoderm and trophectoderm lineages and loss of pluripotency markers. p21 is quickly and dose-dependently activated by nutlin. It can also be activated independently from p53 by sodium butyrate, which leads to the differentiation events very similar to the ones induced by p53. During differentiation, the activating phosphorylation site of CDK2 Thr-160 becomes dephosphorylated and cyclins A and E become degraded. The target for CDK2 kinase in p53 molecule, Ser-315, also becomes dephosphorylated. We conclude that the main mechanism responsible for differentiation of human stem cells by p53 is abolition of S-phase entry and subsequent stop of cell cycle in G0/G1 phase accompanied by p21 activation.	[Maimets, T.] Univ Tartu, Inst Mol & Cell Biol, EE-51010 Tartu, Estonia; [Maimets, T.; Neganova, I.; Armstrong, L.; Lako, M.] Univ Newcastle Upon Tyne, Inst Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Neganova, I.; Armstrong, L.; Lako, M.] Univ Newcastle Upon Tyne, North East Stem Cell Inst, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Tartu; Newcastle University - UK; Newcastle University - UK	Maimets, T (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Riia 23, EE-51010 Tartu, Estonia.	toivo.maimets@ut.ee	Armstrong, Lyle/B-7812-2013; Lako, Majlinda/B-6297-2013; Maimets, Toivo/E-9268-2017	Maimets, Toivo/0000-0001-6461-3365; lako, majlinda/0000-0003-1327-8573; armstrong, lyle/0000-0002-7234-9362	Estonian Science Foundation [ETF6459]; Citrina Foundation (TM); One North East Regional Developmental Agency (ML); MRC [G0301182] Funding Source: UKRI	Estonian Science Foundation; Citrina Foundation (TM); One North East Regional Developmental Agency (ML); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Ian Dimmick for help in flow cytometry and Stuart Atkinson for assistance with Quantitative real-time-PCR. This work has been supported by grants from Estonian Science Foundation (ETF6459) and Citrina Foundation (TM) and One North East Regional Developmental Agency (ML).	Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Hainaut P, 2000, ADV CANCER RES, V77, P81; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hyslop L, 2005, STEM CELLS, V23, P1035, DOI 10.1634/stemcells.2005-0080; Hyslop Louise A., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405009804; Joers A, 1998, ONCOGENE, V17, P2351, DOI 10.1038/sj.onc.1202146; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; LANE DP, 1992, NATURE, V358, P16; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Liu M, 1996, GENE DEV, V10, P142, DOI 10.1101/gad.10.2.142; Liu M, 1996, J BIOL CHEM, V271, P31723, DOI 10.1074/jbc.271.49.31723; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Nakano K, 1997, J BIOL CHEM, V272, P22199, DOI 10.1074/jbc.272.35.22199; Qin H, 2007, J BIOL CHEM, V282, P5842, DOI 10.1074/jbc.M610464200; Stojkovic M, 2004, STEM CELLS, V22, P790, DOI 10.1634/stemcells.22-5-790; TANAKA M, 1990, CELL, V60, P75; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153	27	99	114	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP 11	2008	27	40					5277	5287		10.1038/onc.2008.166	http://dx.doi.org/10.1038/onc.2008.166			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	346UW	18521083				2022-12-25	WOS:000259096100001
J	Vanacore, RM; Ham, AJL; Cartailler, JP; Sundaramoorthy, M; Todd, P; Pedchenko, V; Sado, Y; Borza, DB; Hudson, BG				Vanacore, Roberto M.; Ham, Amy-Joan L.; Cartailler, Jean-Philippe; Sundaramoorthy, Munirathinam; Todd, Parvin; Pedchenko, Vadim; Sado, Yoshikazu; Borza, Dorin-Bogdan; Hudson, Billy G.			A role for collagen IV cross-links in conferring immune privilege to the Goodpasture autoantigen - Structural basis for the crypticity of B cell epitopes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASEMENT-MEMBRANE COLLAGEN; ALPHA-3(IV) COLLAGEN; CRYSTAL-STRUCTURE; GLOBULAR DOMAIN; MOLECULAR-BASIS; GRAVES-DISEASE; NC1 DOMAIN; FAS LIGAND; AUTOANTIBODIES; CHAIN	The detailed structural basis for the cryptic nature (crypticity) of a B cell epitope harbored by an autoantigen is unknown. Because the immune system may be ignorant of the existence of such " cryptic" epitopes, their exposure could be an important feature in autoimmunity. Here we investigated the structural basis for the crypticity of the epitopes of the Goodpasture autoantigen, the alpha 3 alpha 4 alpha 5 noncollagenous-1 (NC1) hexamer, a globular domain that connects two triple-helical molecules of the alpha 3 alpha 4 alpha 5 collagen IV network. The NC1 hexamer occurs in two isoforms as follows: the M-isoform composed of monomer subunits in which the epitopes are accessible to autoantibodies, and the D-isoform composed of both monomer and dimer subunits in which the epitopes are cryptic. The D-isoform was characterized with respect to quaternary structure, as revealed by mass spectrometry of dimer subunits, homology modeling, and molecular dynamics simulation. The results revealed that the D-isoform contains two kinds of cross-links as follows: S-hydroxylysylmethionine and S-lysyl-methionine cross-links, which stabilize the alpha 3 alpha 5 heterodimers and alpha 4 alpha 4-homodimers, respectively. Construction and analysis of a three-dimensional model of the D-isoform of the alpha 3 alpha 4 alpha 5 NC1 hexamer revealed that crypticity is a consequence of the following: (a) sequestration of key residues between neighboring subunits that are stabilized by domain-swapping interactions, and (b) by cross-linking of subunits at the trimer-trimer interface, which stabilizes the structural integrity of the NC1 hexamer and protects against binding of autoantibodies. The sequestrated epitopes and crosslinked subunits represent a novel structural mechanism for conferring immune privilege at the level of quaternary structure. Perturbation of the quaternary structure may be a key factor in the etiology of Goodpasture disease.	[Vanacore, Roberto M.; Cartailler, Jean-Philippe; Sundaramoorthy, Munirathinam; Todd, Parvin; Pedchenko, Vadim; Borza, Dorin-Bogdan; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol, Nashville, TN 37232 USA; [Vanacore, Roberto M.; Cartailler, Jean-Philippe; Sundaramoorthy, Munirathinam; Todd, Parvin; Pedchenko, Vadim; Borza, Dorin-Bogdan; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Ctr Matrix Biol, Nashville, TN 37232 USA; [Ham, Amy-Joan L.; Sundaramoorthy, Munirathinam; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN 37232 USA; [Borza, Dorin-Bogdan; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Ham, Amy-Joan L.] Vanderbilt Univ, Med Ctr, Mass Spectrometry Res Ctr, Nashville, TN 37232 USA; [Sado, Yoshikazu] Shigei Med Res Inst, Div Immunol, Okayama 701, Japan	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Hudson, BG (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol, B-3102 Med Ctr N,1161S 21st Ave S, Nashville, TN 37232 USA.	billy.hudson@vanderbilt.edu	Borza, Dorin-Bogdan/AAF-2156-2020; Pedchenko, Vadim/A-6873-2009; Vanacore, Roberto/C-9763-2012; Vanacore, Roberto/AAD-6399-2020; Cartailler, Jean-Philippe/D-2543-2010	Borza, Dorin-Bogdan/0000-0003-4568-279X; Vanacore, Roberto/0000-0002-2886-0606; Vanacore, Roberto/0000-0002-2886-0606; Cartailler, Jean-Philippe/0000-0002-0312-2391; Hudson, Billy/0000-0002-5420-4100	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI069874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018381, P01DK065123, R01DK062524, R37DK018381] Funding Source: NIH RePORTER; NIAID NIH HHS [AI69874, R21 AI069874] Funding Source: Medline; NIDDK NIH HHS [DK065123, P01 DK065123, DK18381, DK62524] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abbate M, 1998, KIDNEY INT, V54, P1550, DOI 10.1046/j.1523-1755.1998.00153.x; Borza DB, 2000, J BIOL CHEM, V275, P6030, DOI 10.1074/jbc.275.8.6030; Borza DB, 2005, J BIOL CHEM, V280, P27147, DOI 10.1074/jbc.M504050200; Borza DB, 2002, J BIOL CHEM, V277, P40075, DOI 10.1074/jbc.M207769200; Boutaud A, 2000, J BIOL CHEM, V275, P30716, DOI 10.1074/jbc.M004569200; Chazenbalk GD, 2002, J CLIN INVEST, V110, P209, DOI 10.1172/JCI200215745; Chen CR, 2003, J CLIN INVEST, V111, P1897, DOI 10.1172/JCI200317069; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; David M, 2001, J BIOL CHEM, V276, P6370, DOI 10.1074/jbc.M008956200; de Laat B, 2006, BLOOD, V107, P1916, DOI 10.1182/blood-2005-05-1943; DONAGHY M, 1983, LANCET, V2, P1390; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Ferguson TA, 2006, IMMUNOL REV, V213, P228, DOI 10.1111/j.1600-065X.2006.00430.x; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Giannakopoulos B, 2007, BLOOD, V109, P422, DOI 10.1182/blood-2006-04-001206; Goodnow CC, 2005, NATURE, V435, P590, DOI 10.1038/nature03724; GRIFFITH TS, 1995, SCIENCE, V270, P1189, DOI 10.1126/science.270.5239.1189; Hellmark T, 1999, J BIOL CHEM, V274, P25862, DOI 10.1074/jbc.274.36.25862; Hellmark T, 1999, KIDNEY INT, V55, P936, DOI 10.1046/j.1523-1755.1999.055003936.x; Hubbard SJ, 1993, NACCESS COMPUTER PRO; HUDSON BG, 1993, J BIOL CHEM, V268, P26033; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Kahsai TZ, 1997, J BIOL CHEM, V272, P17023, DOI 10.1074/jbc.272.27.17023; KALLURI R, 1994, P NATL ACAD SCI USA, V91, P6201, DOI 10.1073/pnas.91.13.6201; Kalluri R, 2000, J BIOL CHEM, V275, P20027, DOI 10.1074/jbc.M904549199; Khoshnoodi J, 2006, J BIOL CHEM, V281, P38117, DOI 10.1074/jbc.R600025200; Kivirikko KI, 1998, ADV ENZYMOL RAMB, V72, P325; KIVIRIKKO KI, 1984, EXTRACELLULAR MATRIX, P83; KLEPPEL MM, 1992, J BIOL CHEM, V267, P4137; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; MEDAWAR PB, 1948, BRIT J EXP PATHOL, V29, P58; Moudgil KD, 2005, TRENDS IMMUNOL, V26, P355, DOI 10.1016/j.it.2005.05.007; Netzer KO, 1999, J BIOL CHEM, V274, P11267, DOI 10.1074/jbc.274.16.11267; NINOMIYA Y, 1995, J CELL BIOL, V130, P1219, DOI 10.1083/jcb.130.5.1219; NOSSAL GJV, 1991, EUR J BIOCHEM, V202, P729, DOI 10.1111/j.1432-1033.1991.tb16427.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rautavuoma K, 2004, P NATL ACAD SCI USA, V101, P14120, DOI 10.1073/pnas.0404966101; ROBINS SP, 1975, BIOCHEM J, V149, P381, DOI 10.1042/bj1490381; Ruotsalainen H, 2006, J CELL SCI, V119, P625, DOI 10.1242/jcs.02780; Sado Y, 1998, KIDNEY INT, V53, P664, DOI 10.1046/j.1523-1755.1998.00795.x; Sercarz EE, 2002, NAT IMMUNOL, V3, P110, DOI 10.1038/ni0202-110; SIEBOLD B, 1988, EUR J BIOCHEM, V176, P617, DOI 10.1111/j.1432-1033.1988.tb14321.x; STEVENSON A, 1995, QJM-MON J ASSOC PHYS, V88, P23; Sundaramoorthy M, 2002, J BIOL CHEM, V277, P31142, DOI 10.1074/jbc.M201740200; Than ME, 2002, P NATL ACAD SCI USA, V99, P6607, DOI 10.1073/pnas.062183499; Vanacore RM, 2005, J BIOL CHEM, V280, P29300, DOI 10.1074/jbc.M502752200; Wang XP, 2005, J AM SOC NEPHROL, V16, P3563, DOI 10.1681/ASN.2005060670; WEBER S, 1984, EUR J BIOCHEM, V139, P401, DOI 10.1111/j.1432-1033.1984.tb08019.x; WIESLANDER J, 1985, J BIOL CHEM, V260, P8564; YATES JR, 1995, ANAL CHEM, V67, P3202, DOI 10.1021/ac00114a016	53	30	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22737	22748		10.1074/jbc.M803451200	http://dx.doi.org/10.1074/jbc.M803451200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18499662	Green Published, hybrid			2022-12-25	WOS:000258321000042
J	Qiu, HY; Dai, HC; Jain, K; Shah, R; Hong, C; Pain, J; Tian, B; Vatner, DE; Vatner, SF; Depre, C				Qiu, Hongyu; Dai, Huacheng; Jain, Komal; Shah, Rina; Hong, Chull; Pain, Jayashree; Tian, Bin; Vatner, Dorothy E.; Vatner, Stephen F.; Depre, Christophe			Characterization of a novel cardiac isoform of the cell cycle-related kinase that is regulated during heart failure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOCARDIAL-INFARCTION; ACTIVATING KINASE; GENE-EXPRESSION; H11 KINASE; APOPTOSIS; SURVIVAL; MECHANISMS; MYOCYTES; PROGRAM; COMPLEX	Myocardial infarction (MI) is often followed by heart failure (HF), but the mechanisms precipitating the transition to HF remain largely unknown. A genomic profile was performed in a monkey model of MI, from the myocardium adjacent to chronic (2-month) MI followed by 3 weeks of pacing to develop HF. The transcript of the gene encoding the cell cycle-related kinase (CCRK) was down-regulated by 50% in HF heart compared with control ( p < 0.05), which was confirmed by quantitative PCR. The CCRK sequence cloned from a heart library showed a conservation of the N-terminal kinase domain when compared with the "generic" isoform cloned previously but a different C-terminal half due to alternative splicing with frameshift. The homology of the cardiac sequence was 100% between mice and humans. Expression of the corresponding protein, measured upon generation of a monoclonal antibody, was limited to heart, liver, and kidney. Upon overexpression in cardiac myocytes, both isoforms promote cell growth and reduce apoptosis by chelerythrine (p < 0.05 versus control). Using a yeast two-hybrid screening, we found an interaction of the generic but not the cardiac CCRK with cyclin H and casein kinase 2. In addition, only the generic CCRK phosphorylates the cyclin-dependent kinase 2, which was accompanied by a doubling of myocytes in the S and G(2) phases of the cell cycle (p < 0.05 versus control). Therefore, the heart expresses a splice variant of CCRK, which promotes cardiac cell growth and survival; differs from the generic isoform in terms of protein-protein interactions, substrate specificity and regulation of the cell cycle; and is downregulated significantly in HF.	[Jain, Komal; Tian, Bin] Univ Med & Dent New Jersey, Sch Med, Dept Biochem, Newark, NJ 07103 USA; [Qiu, Hongyu; Dai, Huacheng; Shah, Rina; Hong, Chull; Pain, Jayashree; Vatner, Dorothy E.; Vatner, Stephen F.; Depre, Christophe] Univ Med & Dent New Jersey, Sch Med, Dept Cell Biol & Mol Med, Cardiovasc Res Inst, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Depre, C (corresponding author), Univ Med & Dent New Jersey, Sch Med, Dept Cell Biol & Mol Med, Cardiovasc Res Inst, MSB G609,185 S Orange Ave, Newark, NJ 07103 USA.	deprech@umdnj.edu		Tian, Bin/0000-0001-8903-8256	NHLBI NIH HHS [HL069752, HL033107, HL069020, HL059139] Funding Source: Medline; NIA NIH HHS [AG027211, AG014121, AG023137] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL069020, P01HL059139, R37HL033107, R01HL033107, T32HL069752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023137, R01AG014121, P01AG027211] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aikawa R, 1997, J CLIN INVEST, V100, P1813, DOI 10.1172/JCI119709; Anversa P, 2006, CIRCULATION, V113, P1451, DOI 10.1161/CIRCULATIONAHA.105.595181; Caligluri M, 2005, CHEM BIOL, V12, P1103, DOI 10.1016/j.chembiol.2005.08.008; Cheng RK, 2007, CIRC RES, V100, P1741, DOI 10.1161/CIRCRESAHA.107.153544; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Depre C, 2006, CIRC RES, V98, P280, DOI 10.1161/01.RES.0000201284.45482.e8; Depre C, 2004, CIRC RES, V95, P433, DOI 10.1161/01.RES.0000138301.42713.18; Depre C, 2005, TRENDS CARDIOVAS MED, V15, P101, DOI 10.1016/j.tcm.2005.04.006; Depre C, 2003, CARDIOVASC RES, V58, P126, DOI 10.1016/S0008-6363(02)00845-3; Depre C, 2002, CIRC RES, V91, P1007, DOI 10.1161/01.RES.0000044380.54893.4B; Depre C, 1998, NAT MED, V4, P1269, DOI 10.1038/3253; Depre C, 2001, P NATL ACAD SCI USA, V98, P9336, DOI 10.1073/pnas.171297498; Depre C, 2007, HEART FAIL REV, V12, P307, DOI 10.1007/s10741-007-9040-3; FISHER RP, 1995, CELL, V83, P47, DOI 10.1016/0092-8674(95)90233-3; FISHER RP, 1994, CELL, V78, P713, DOI 10.1016/0092-8674(94)90535-5; IWAKI K, 1990, J BIOL CHEM, V265, P13809; KENNAWAY NG, 1990, PEDIATR RES, V28, P529; Liao HS, 2001, CIRC RES, V88, P443; Liu Y, 2004, J BIOL CHEM, V279, P4507, DOI 10.1074/jbc.M309995200; Lu H, 1997, MOL CELL BIOL, V17, P5923, DOI 10.1128/MCB.17.10.5923; MAKELA TP, 1994, NATURE, V371, P254, DOI 10.1038/371254a0; Mori T, 2006, LIFE SCI, V79, P247, DOI 10.1016/j.lfs.2005.12.056; Narula J, 1996, NEW ENGL J MED, V335, P1182, DOI 10.1056/NEJM199610173351603; Ng SSM, 2007, J NATL CANCER I, V99, P936, DOI 10.1093/jnci/djm011; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; Palojoki E, 2001, AM J PHYSIOL-HEART C, V280, pH2726, DOI 10.1152/ajpheart.2001.280.6.H2726; Pasumarthi KBS, 2005, CIRC RES, V96, P110, DOI 10.1161/01.RES.0000152326.91223.4F; Qiu H, 2007, CIRCULATION, V116, P669, DOI 10.1161/CIRCULATIONAHA.107.689208; Qiu HY, 2007, PHYSIOL GENOMICS, V29, P169, DOI 10.1152/physiolgenomics.00229.2006; Reiss K, 1996, EXP CELL RES, V225, P44, DOI 10.1006/excr.1996.0155; ROY R, 1994, CELL, V79, P1093, DOI 10.1016/0092-8674(94)90039-6; SADOSHIMA J, 1992, J BIOL CHEM, V267, P10551; SERIZAWA H, 1995, NATURE, V374, P280, DOI 10.1038/374280a0; SHIEKHATTAR R, 1995, NATURE, V374, P283, DOI 10.1038/374283a0; Wang L, 2004, MOL CELL BIOCHEM, V265, P71, DOI 10.1023/B:MCBI.0000044311.58653.54; Woo YJ, 2006, CIRCULATION, V114, pI206, DOI 10.1161/CIRCULATIONAHA.105.000455	36	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22157	22165		10.1074/jbc.M710459200	http://dx.doi.org/10.1074/jbc.M710459200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18508765	Green Published, hybrid			2022-12-25	WOS:000258114700035
J	Hayashida, K; Chen, Y; Bartlett, AH; Park, PW				Hayashida, Kazutaka; Chen, Ye; Bartlett, Allison H.; Park, Pyong Woo			Syndecan-1 is an in vivo suppressor of Gram-positive toxic shock	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCAL-ENTEROTOXIN-B; HEPARAN-SULFATE PROTEOGLYCANS; TUMOR-NECROSIS-FACTOR; INDUCED LETHAL SHOCK; T-CELL-ACTIVATION; INTERFERON-GAMMA; PSEUDOMONAS-AERUGINOSA; SOLUBLE SYNDECAN-1; BINDING DOMAIN; GROWTH-FACTOR	Heparan sulfate proteoglycans bind to and regulate many inflammatory mediators in vitro, suggesting that they serve an important role in influencing inflammatory responses in vivo. Here we evaluated the role of syndecan-1, a major heparan sulfate proteoglycan, in modulating inflammatory responses in Gram-positive toxic shock, a systemic disease that is a significant cause of morbidity and mortality. Syndecan-1-null and wild-type mice were injected intraperitoneally with staphylococcal enterotoxin B, a pyrogenic superantigen, and their inflammatory responses were assessed. Syndecan-1-null mice showed significantly increased liver injury, vascular permeability, and death in response to staphylococcal enterotoxin B challenge compared with wild-type mice. Although serum levels of systemic IL-2 and IFN gamma were similar between the two backgrounds, those of TNF alpha and IL-6 were significantly increased in syndecan-1-null mice undergoing Gram-positive toxic shock. Furthermore, syndecan-1-null mice challenged with staphylococcal enterotoxin B showed enhanced T cell accumulation in tissues, whereas immunodepletion of T cells protected syndecan-1-null mice from the magnified systemic cytokine storm, inflammatory tissue injury, and death. Importantly, syndecan-1 shedding was induced in wild-type mice injected with staphylococcal enterotoxin B, and the administration of heparan sulfate, but not syndecan-1 core protein, rescued syndecan-1-null mice from lethal toxic shock by suppressing the production of TNF alpha and IL-6, and attenuating inflammatory tissue injury. Altogether, these data suggest that syndecan-1 shedding is a key endogenous mechanism that protects the host from Gram-positive toxic shock by inhibiting the dysregulation and amplification of the inflammatory response.	[Hayashida, Kazutaka; Park, Pyong Woo] Harvard Univ, Sch Med, Childrens Hosp, Div Resp Dis, Boston, MA 02115 USA; [Chen, Ye] So Med Univ, Nanfang Hosp, Dept Digest Dis, Guangzhou 510515, Guangdong, Peoples R China; [Bartlett, Allison H.] Baylor Coll Med, Div Pediat Infect Dis, Houston, TX 77030 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Southern Medical University - China; Baylor College of Medicine	Park, PW (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Div Resp Dis, 320 Longwood Ave,Enders-144, Boston, MA 02115 USA.	Pyong.Park@childrens.harvard.edu		Bartlett, Allison/0000-0002-4275-5642	NHLBI NIH HHS [HL 69050, R01 HL069050, HL 81474, R01 HL081474] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069050, R01HL081474] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alexander CM, 2000, NAT GENET, V25, P329, DOI 10.1038/77108; Anderson MR, 2001, CLIN IMMUNOL, V98, P85, DOI 10.1006/clim.2000.4960; Arad G, 2000, NAT MED, V6, P414, DOI 10.1038/74672; Bartlett AH, 2007, MOL CELLS, V24, P153; BEAN AGD, 1993, INFECT IMMUN, V61, P4937, DOI 10.1128/IAI.61.11.4937-4939.1993; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; Bode L, 2008, J CLIN INVEST, V118, P229, DOI 10.1172/JCI32335; Bohach GA, 2000, GRAM-POSITIVE PATHOGENS, P367; BOHACH GA, 1990, CRIT REV MICROBIOL, V17, P251, DOI 10.3109/10408419009105728; Brule S, 2006, GLYCOBIOLOGY, V16, P488, DOI 10.1093/glycob/cwj098; Charnaux N, 2005, GLYCOBIOLOGY, V15, P119, DOI 10.1093/glycob/cwh148; Chung MC, 2006, J BIOL CHEM, V281, P31408, DOI 10.1074/jbc.M605526200; Davidson BL, 2002, NEW ENGL J MED, V347, P1036, DOI 10.1056/NEJM200209263471316; Day R, 1999, LANCET, V354, P62, DOI 10.1016/S0140-6736(98)09267-8; Ding K, 2005, J CELL BIOL, V171, P729, DOI 10.1083/jcb.200508010; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; Farber JM, 1997, J LEUKOCYTE BIOL, V61, P246, DOI 10.1002/jlb.61.3.246; Faulkner L, 2005, J IMMUNOL, V175, P6870, DOI 10.4049/jimmunol.175.10.6870; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; FLORQUIN S, 1994, J IMMUNOL, V153, P2618; Fritchley SJ, 2000, CLIN EXP IMMUNOL, V120, P247, DOI 10.1046/j.1365-2249.2000.01178.x; GROSSMAN D, 1992, INFECT IMMUN, V60, P5190, DOI 10.1128/IAI.60.12.5190-5196.1992; Haynes A, 2005, INFECT IMMUN, V73, P7914, DOI 10.1128/IAI.73.12.7914-7921.2005; Henry-Stanley MJ, 2006, CYTOKINE, V34, P252, DOI 10.1016/j.cyto.2006.05.008; Joensuu H, 2002, CANCER RES, V62, P5210; Johnson GB, 2004, J IMMUNOL, V172, P20, DOI 10.4049/jimmunol.172.1.20; Kainulainen V, 1998, J BIOL CHEM, V273, P11563, DOI 10.1074/jbc.273.19.11563; Kato M, 1998, NAT MED, V4, P691, DOI 10.1038/nm0698-691; KOTB M, 1995, CLIN MICROBIOL REV, V8, P411, DOI 10.1128/CMR.8.3.411; LANTZ M, 1991, J CLIN INVEST, V88, P2026, DOI 10.1172/JCI115530; Li HM, 1999, ANNU REV IMMUNOL, V17, P435, DOI 10.1146/annurev.immunol.17.1.435; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Lopez-Boado YS, 2000, J CELL BIOL, V148, P1305, DOI 10.1083/jcb.148.6.1305; LORTAT-JACOB H, 1995, BIOCHEM J, V310, P497, DOI 10.1042/bj3100497; MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; McCormick JK, 2001, ANNU REV MICROBIOL, V55, P77, DOI 10.1146/annurev.micro.55.1.77; MCINTOSH JK, 1989, J IMMUNOL, V143, P162; McKallip RJ, 2005, INFECT IMMUN, V73, P50, DOI 10.1128/IAI.73.1.50-61.2005; MIETHKE T, 1992, J EXP MED, V175, P91, DOI 10.1084/jem.175.1.91; MOUNTZ JD, 1995, J IMMUNOL, V155, P4829; Mummery RS, 2000, J IMMUNOL, V165, P5671, DOI 10.4049/jimmunol.165.10.5671; Najjam S, 1998, GLYCOBIOLOGY, V8, P509, DOI 10.1093/glycob/8.5.509; Park PW, 2000, J BIOL CHEM, V275, P29923, DOI 10.1074/jbc.R000008200; Park PW, 2004, J BIOL CHEM, V279, P251, DOI 10.1074/jbc.M308537200; Park PW, 2001, NATURE, V411, P98, DOI 10.1038/35075100; Park PW, 2000, J BIOL CHEM, V275, P3057, DOI 10.1074/jbc.275.5.3057; PHILIP R, 1986, NATURE, V323, P86, DOI 10.1038/323086a0; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Saha B, 1996, J EXP MED, V183, P2675, DOI 10.1084/jem.183.6.2675; Sarrazin S, 2005, J BIOL CHEM, V280, P37558, DOI 10.1074/jbc.M507729200; Seidel C, 2003, TRANSPLANTATION, V76, P423, DOI 10.1097/01.TP.0000074316.76104.A5; Simpson KJ, 2003, CLIN SCI, V104, P47, DOI 10.1042/CS20020137; Simpson KJ, 1997, J HEPATOL, V27, P1120, DOI 10.1016/S0168-8278(97)80160-2; Stepp MA, 2002, J CELL SCI, V115, P4517, DOI 10.1242/jcs.00128; Tang QZ, 2003, J IMMUNOL, V170, P1510, DOI 10.4049/jimmunol.170.3.1510; Tyrrell DJ, 1999, ADV PHARMACOL, V46, P151, DOI 10.1016/S1054-3589(08)60471-8; Wang LC, 2002, J CLIN INVEST, V110, P127, DOI 10.1172/JCI200214996; Wrenshall LE, 2003, J IMMUNOL, V170, P5470, DOI 10.4049/jimmunol.170.11.5470; Xu J, 2005, J IMMUNOL, V174, P5758, DOI 10.4049/jimmunol.174.9.5758; Yang Y, 2002, BLOOD, V100, P610, DOI 10.1182/blood.V100.2.610; Yang Y, 2007, J BIOL CHEM, V282, P13326, DOI 10.1074/jbc.M611259200; Zhang WJ, 1996, J IMMUNOL, V157, P5049	63	30	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					19895	19903		10.1074/jbc.M801614200	http://dx.doi.org/10.1074/jbc.M801614200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18499671	Green Published, hybrid			2022-12-25	WOS:000257565300004
J	Barger, JL; Kayo, T; Vann, JM; Arias, EB; Wang, JL; Hacker, TA; Wang, Y; Raederstorff, D; Morrow, JD; Leeuwenburgh, C; Allison, DB; Saupe, KW; Cartee, GD; Weindruch, R; Prolla, TA				Barger, Jamie L.; Kayo, Tsuyoshi; Vann, James M.; Arias, Edward B.; Wang, Jelai; Hacker, Timothy A.; Wang, Ying; Raederstorff, Daniel; Morrow, Jason D.; Leeuwenburgh, Christiaan; Allison, David B.; Saupe, Kurt W.; Cartee, Gregory D.; Weindruch, Richard; Prolla, Tomas A.			A Low Dose of Dietary Resveratrol Partially Mimics Caloric Restriction and Retards Aging Parameters in Mice	PLOS ONE			English	Article								Resveratrol in high doses has been shown to extend lifespan in some studies in invertebrates and to prevent early mortality in mice fed a high-fat diet. We fed mice from middle age (14-months) to old age (30-months) either a control diet, a low dose of resveratrol (4.9 mg kg(-1) day(-1)), or a calorie restricted (CR) diet and examined genome-wide transcriptional profiles. We report a striking transcriptional overlap of CR and resveratrol in heart, skeletal muscle and brain. Both dietary interventions inhibit gene expression profiles associated with cardiac and skeletal muscle aging, and prevent age-related cardiac dysfunction. Dietary resveratrol also mimics the effects of CR in insulin mediated glucose uptake in muscle. Gene expression profiling suggests that both CR and resveratrol may retard some aspects of aging through alterations in chromatin structure and transcription. Resveratrol, at doses that can be readily achieved in humans, fulfills the definition of a dietary compound that mimics some aspects of CR.	[Barger, Jamie L.; Kayo, Tsuyoshi] LifeGen Technol LLC, Madison, WI USA; [Vann, James M.; Prolla, Tomas A.] Univ Wisconsin, Dept Med Genet, Madison, WI USA; [Vann, James M.; Prolla, Tomas A.] Univ Wisconsin, Dept Genet, Madison, WI USA; [Arias, Edward B.; Cartee, Gregory D.] Univ Michigan, Div Kinesiol, Ann Arbor, MI USA; [Wang, Jelai] Univ Alabama, Dept Biostat, Sect Stat Genet, Birmingham, AL USA; [Hacker, Timothy A.; Saupe, Kurt W.] Univ Wisconsin Madison, Dept Med, Madison, WI USA; [Wang, Ying; Raederstorff, Daniel] DSM Nutr Products Ltd, R&D Human Nutr & Hlth, Basel, Switzerland; [Morrow, Jason D.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN USA; [Morrow, Jason D.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN USA; [Leeuwenburgh, Christiaan] Univ Florida, Coll Med, Dept Aging & Geriat, Gainesville, FL USA; [Allison, David B.] Univ Alabama, Clin Nutr Res Ctr, Dept Biostat, Sect Stat Genet, Birmingham, AL USA; [Weindruch, Richard] Univ Wisconsin Madison, Vet Adm Hosp, Dept Med, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Michigan System; University of Michigan; University of Alabama System; University of Alabama Birmingham; University of Wisconsin System; University of Wisconsin Madison; DSM NV; Vanderbilt University; Vanderbilt University; State University System of Florida; University of Florida; University of Alabama System; University of Alabama Birmingham; University of Wisconsin System; University of Wisconsin Madison	Barger, JL (corresponding author), LifeGen Technol LLC, Madison, WI USA.	rhweindr@wisc.edu; taprolla@wisc.edu		Leeuwenburgh, Christiaan/0000-0003-0826-4257; Allison, David/0000-0003-3566-9399; Cartee, Gregory/0000-0001-5311-1722; Barger, Jamie/0000-0001-8694-0068	NIH [AG17994, AG21042, AG-000908, GM15431, DK48831, ES13125, AG020681]; NSF [EPSCoR 05026]; DSM Nutritional Products, Ltd.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES013125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM015431, P50GM015431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000908, R01AG021042, P30AG028740, R01AG020681, R01AG017994, K01AG000908] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); DSM Nutritional Products, Ltd.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	CL: NIH AG17994 and AG21042, DBA: NSF EPSCoR 05026, KAS: NIH AG-000908, JDM: NIH GM15431, DK48831 and ES13125, TAP: NIH AG020681 Portions of this research were funded by DSM Nutritional Products, Ltd.; however, DSM had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry WT, 2005, BIOINFORMATICS, V21, P1943, DOI 10.1093/bioinformatics/bti260; Bartke A, 2001, NATURE, V414, P412, DOI 10.1038/35106646; Bass TM, 2007, MECH AGEING DEV, V128, P546, DOI 10.1016/j.mad.2007.07.007; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Broberg CS, 2003, J AM SOC ECHOCARDIOG, V16, P814, DOI 10.1067/S0894-7317(03)00399-7; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Das DK, 2006, MOL INTERV, V6, P36, DOI 10.1124/mi.6.1.7; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Dhahbi JM, 2005, PHYSIOL GENOMICS, V23, P343, DOI 10.1152/physiolgenomics.00069.2005; Dunn SE, 1997, CANCER RES, V57, P4667; Flurkey K, 2002, MECH AGEING DEV, V123, P121, DOI 10.1016/S0047-6374(01)00339-6; Gazdag AC, 1999, DIABETES, V48, P1930, DOI 10.2337/diabetes.48.10.1930; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hansen M, 2007, AGING CELL, V6, P95, DOI 10.1111/j.1474-9726.2006.00267.x; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; HURSTING SD, 1993, CANCER RES, V53, P2750; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; KLINGE CM, 2008, FASEB J; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lakatta EG, 2002, COMP BIOCHEM PHYS A, V132, P699, DOI 10.1016/S1095-6433(02)00124-1; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lee CK, 2004, FREE RADICAL BIO MED, V36, P1043, DOI 10.1016/j.freeradbiomed.2004.01.015; Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991; McCurdy CE, 2005, DIABETES, V54, P1349, DOI 10.2337/diabetes.54.5.1349; Miller RA, 2002, MOL ENDOCRINOL, V16, P2657, DOI 10.1210/me.2002-0142; Morrow JD, 1999, METHOD ENZYMOL, V300, P3; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Osley MA, 2007, MUTAT RES-FUND MOL M, V618, P65, DOI 10.1016/j.mrfmmm.2006.07.011; PENUMATHSA SV, 2008, J CELL MOL MED; Pugh TD, 1999, NEUROBIOL AGING, V20, P157, DOI 10.1016/S0197-4580(99)00043-3; SELMAN C, 2007, FASEB J; Sengupta S, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-34; Thirunavukkarasu M, 2007, FREE RADICAL BIO MED, V43, P720, DOI 10.1016/j.freeradbiomed.2007.05.004; Weindruch R., 1988, RETARDATION AGING DI; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789	42	478	488	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2264	10.1371/journal.pone.0002264	http://dx.doi.org/10.1371/journal.pone.0002264			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523577	Green Published, Green Submitted, gold			2022-12-25	WOS:000262614300003
J	Di Segni, A; Farin, K; Pinkas-Kramarski, R				Di Segni, Ayelet; Farin, Keren; Pinkas-Kramarski, Ronit			Identification of Nucleolin as New ErbB Receptors-Interacting Protein	PLOS ONE			English	Article								Background: The ErbB receptor tyrosine kinases are major contributors to malignant transformation. These receptors are frequently overexpressed in a variety of human carcinomas. The role of the ErbB receptors and their ligands in carcinomas and the mechanism by which their overexpression leads to cancer development is still unclear. Ligand binding to specific ErbB receptor is followed by receptor dimerization, phosphorylation and recruitment of SH2 containing cytoplasmic proteins, which initiate the cascade of signaling events. Nevertheless, increasing data suggest that there are non-phosphorylated receptor-substrate interactions that may affect ErbB-mediated responses. Methodology/Principal Findings: In the present study, using GST-ErbB4 fusion protein pull down assay and mass spectroscopic analysis, we have found the ErbB receptors interact with nucleolin via their cytoplasmic tail. Nucleolin is a ubiquitous, nonhistone, nucleolar, multifunctional phosphoprotein that is also overexpressed in cancer cells. Our results demonstrate that overexpression of ErbB1 and nucleolin may lead to receptor dimerization, phosphorylation and to anchorage independent growth. Conclusions/Significance: The oncogenic potential of ErbB depends on receptor levels and activation. Our results suggest that nucleolin may affect ErbB dimerization and activation leading to enhanced cell growth.	[Di Segni, Ayelet; Farin, Keren; Pinkas-Kramarski, Ronit] Tel Aviv Univ, Dept Neurobiol, Ramat Aviv, Israel	Tel Aviv University	Di Segni, A (corresponding author), Tel Aviv Univ, Dept Neurobiol, Ramat Aviv, Israel.	lironit@post.tau.ac.il		Pinkas-Kramarski, Ronit/0000-0002-1000-369X	Cancer Biology Research Center of Tel Aviv University, Israel	Cancer Biology Research Center of Tel Aviv University, Israel	This work was supported by the Cancer Biology Research Center of Tel Aviv University, Israel.	Alete DE, 2006, FEBS J, V273, P4668, DOI 10.1111/j.1742-4658.2006.05471.x; Bacharach E, 2000, J VIROL, V74, P11027, DOI 10.1128/JVI.74.23.11027-11039.2000; BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; Birrane G, 2003, J BIOL CHEM, V278, P1399, DOI 10.1074/jbc.C200571200; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; BUGLER B, 1982, EUR J BIOCHEM, V128, P475; BUGLER B, 1987, J BIOL CHEM, V262, P10922; Carpenter G, 2003, EXP CELL RES, V284, P66, DOI 10.1016/S0014-4827(02)00100-3; Citri A, 2004, EMBO REP, V5, P1165, DOI 10.1038/sj.embor.7400300; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; Derenzini M, 2000, MICRON, V31, P117, DOI 10.1016/S0968-4328(99)00067-0; ERARD MS, 1988, EUR J BIOCHEM, V175, P525, DOI 10.1111/j.1432-1033.1988.tb14224.x; ESCANDEGERAUD ML, 1985, EXP CELL RES, V161, P353, DOI 10.1016/0014-4827(85)90092-8; FANG SH, 1993, EXP CELL RES, V208, P48, DOI 10.1006/excr.1993.1221; FAZIOLI F, 1993, EMBO J, V12, P3799, DOI 10.1002/j.1460-2075.1993.tb06058.x; GalchevaGargova Z, 1996, SCIENCE, V272, P1797, DOI 10.1126/science.272.5269.1797; Giri DK, 2005, MOL CELL BIOL, V25, P11005, DOI 10.1128/MCB.25.24.11005-11018.2005; Haklai R, 1998, BIOCHEMISTRY-US, V37, P1306, DOI 10.1021/bi972032d; Harms G, 2001, BIOCHEM J, V360, P531, DOI 10.1042/0264-6021:3600531; Holbro T, 2004, ANNU REV PHARMACOL, V44, P195, DOI 10.1146/annurev.pharmtox.44.101802.121440; Hovanessian AG, 2006, CELL RES, V16, P174, DOI 10.1038/sj.cr.7310024; Hovanessian AG, 2000, EXP CELL RES, V261, P312, DOI 10.1006/excr.2000.5071; Huang HJS, 1997, J BIOL CHEM, V272, P2927, DOI 10.1074/jbc.272.5.2927; Huang YZ, 2002, INT J DEV NEUROSCI, V20, P173, DOI 10.1016/S0736-5748(02)00011-4; Johnson HM, 2004, BIOESSAYS, V26, P993, DOI 10.1002/bies.20086; Koumakpayi IH, 2006, CLIN CANCER RES, V12, P2730, DOI 10.1158/1078-0432.CCR-05-2242; KRAUS MH, 1989, P NATL ACAD SCI USA, V86, P9193, DOI 10.1073/pnas.86.23.9193; LAPEYRE B, 1987, P NATL ACAD SCI USA, V84, P1472, DOI 10.1073/pnas.84.6.1472; Legrand D, 2004, EUR J BIOCHEM, V271, P303, DOI 10.1046/j.1432-1033.2003.03929.x; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Marmor MD, 2004, INT J RADIAT ONCOL, V58, P903, DOI 10.1016/j.ijrobp.2003.06.002; Pawson T, 2003, PHILOS T R SOC A, V361, P1251, DOI 10.1098/rsta.2003.1197; Pinkas-Kramarski R, 1997, J MAMMARY GLAND BIOL, V2, P97, DOI 10.1023/A:1026343528967; PLOWMAN GD, 1993, NATURE, V366, P473, DOI 10.1038/366473a0; PLOWMAN GD, 1990, P NATL ACAD SCI USA, V87, P4905, DOI 10.1073/pnas.87.13.4905; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SEMENKOVICH CF, 1990, BIOCHEMISTRY-US, V29, P9708, DOI 10.1021/bi00493a028; Shaw PJ, 1995, ANNU REV CELL DEV BI, V11, P93, DOI 10.1146/annurev.cb.11.110195.000521; SLAMON DJ, 1990, CANC INVEST, V8; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; STANCOVSKI I, 1994, REGULATORY MECH BREA, P161; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; Vaskovsky A, 2000, J NEUROCHEM, V74, P979, DOI 10.1046/j.1471-4159.2000.0740979.x; Williams CC, 2004, J CELL BIOL, V167, P469, DOI 10.1083/jcb.200403155; YAMAMOTO T, 1986, NATURE, V319, P230, DOI 10.1038/319230a0; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yoo JY, 2000, BRIT J CANCER, V82, P683	48	53	54	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2310	10.1371/journal.pone.0002310	http://dx.doi.org/10.1371/journal.pone.0002310			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523588	Green Submitted, gold, Green Published			2022-12-25	WOS:000262614300016
J	Bedhomme, S; Prasad, NG; Jiang, PP; Chippindale, AK				Bedhomme, Stephanie; Prasad, Nagaraj G.; Jiang, Pan-Pan; Chippindale, Adam K.			Reproductive Behaviour Evolves Rapidly When Intralocus Sexual Conflict Is Removed	PLOS ONE			English	Article								Background: Intralocus sexual conflict can inhibit the evolution of each sex towards its own fitness optimum. In a previous study, we confirmed this prediction through the experimental removal of female selection pressures in Drosophila melanogaster, achieved by limiting the expression of all major chromosomes to males. Compared to the control populations (C1-4) where the genomes are exposed to selection in both sexes, the populations with male-limited genomes (ML1-4) showed rapid increases in male fitness, whereas the fitness of females expressing ML-evolved chromosomes decreased [1]. Methodology/Principal Findings: Here we examine the behavioural phenotype underlying this sexual antagonism. We show that males expressing the ML genomes have a reduced courtship level but acquire the same number of matings. On the other hand, our data suggest that females expressing the ML genomes had reduced attractiveness, stimulating a lower rate of courtship from males. Moreover, females expressing ML genomes tend to display reduced yeast-feeding behaviour, which is probably linked to the reduction of their fecundity. Conclusion/Significance: These results suggest that reproductive behaviour is shaped by opposing selection on males and females, and that loci influencing attractiveness and foraging were polymorphic for alleles with sexually antagonistic expression patterns prior to ML selection. Hence, intralocus sexual conflict appears to play a role in the evolution of a wide range of fitness-related traits and may be a powerful mechanism for the maintenance of genetic variation in fitness.	[Bedhomme, Stephanie; Prasad, Nagaraj G.; Jiang, Pan-Pan; Chippindale, Adam K.] Queens Univ, Dept Biol, Kingston, ON, Canada	Queens University - Canada	Bedhomme, S (corresponding author), Queens Univ, Dept Biol, Kingston, ON, Canada.	sbedh_01@uni-muenster.de	bedhomme, stéphanie/C-8912-2014	Prasad, N G/0000-0002-0410-5518; Bedhomme, Stephanie/0000-0001-8075-0968	NSERC; Canada Research Chairs program; Canadian Foundation for Innovation; Ontario Innovation Trust; French government [Lavoisier Award]; Queen's University [ARC postdoctoral fellowship]	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs program(Canada Research Chairs); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Innovation Trust; French government; Queen's University	This work was supported by an NSERC Discovery grant, the Canada Research Chairs program, the Canadian Foundation for Innovation and the Ontario Innovation Trust to AKC. SB was supported in part by a Lavoisier Award from the French government and a Queen's University ARC postdoctoral fellowship.	Albert AYK, 2005, SCIENCE, V310, P119, DOI 10.1126/science.1115328; Arnqvist Goran, 2005, pUnpaginated; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Bedhomme Stephanie, 2007, P185; Blows MW, 2002, P ROY SOC B-BIOL SCI, V269, P1113, DOI 10.1098/rspb.2002.2002; Bourguet D, 2000, J EVOLUTION BIOL, V13, P515, DOI 10.1046/j.1420-9101.2000.00179.x; Byrne PG, 2006, P ROY SOC B-BIOL SCI, V273, P917, DOI 10.1098/rspb.2005.3372; Calsbeek R, 2004, J EVOLUTION BIOL, V17, P464, DOI 10.1046/j.1420-9101.2003.00665.x; Camperio-Ciani A, 2004, P ROY SOC B-BIOL SCI, V271, P2217, DOI 10.1098/rspb.2004.2872; CHAPMAN T, 1994, J EVOLUTION BIOL, V7, P51, DOI 10.1046/j.1420-9101.1994.7010051.x; Chapman T, 2003, TRENDS ECOL EVOL, V18, P41, DOI 10.1016/S0169-5347(02)00004-6; Chippindale AK, 2001, P NATL ACAD SCI USA, V98, P1671, DOI 10.1073/pnas.041378098; Chippindale AK, 2003, J GENET, V82, P133, DOI 10.1007/BF02715814; CHIPPINDALE AK, 1993, J EVOLUTION BIOL, V6, P171, DOI 10.1046/j.1420-9101.1993.6020171.x; Chippindale AK, 2001, P NATL ACAD SCI USA, V98, P5677, DOI 10.1073/pnas.101456898; Chippindale AK, 1997, J EVOLUTION BIOL, V10, P269, DOI 10.1007/s000360050023; Crompton B, 2003, P ROY SOC B-BIOL SCI, V270, P1991, DOI 10.1098/rspb.2003.2477; Day T, 2004, GENETICS, V167, P1537, DOI 10.1534/genetics.103.026211; Delph LF, 2004, EVOLUTION, V58, P1936, DOI 10.1111/j.0014-3820.2004.tb00481.x; Drapeau MD, 2006, GENETICS, V172, P1009, DOI 10.1534/genetics.105.045666; Fedorka KM, 2004, NATURE, V429, P65, DOI 10.1038/nature02492; Foerster K, 2007, NATURE, V447, P1107, DOI 10.1038/nature05912; Foley B, 2007, GENETICS, V175, P1465, DOI 10.1534/genetics.106.065771; FORSMAN A, 1995, J EVOLUTION BIOL, V8, P53, DOI 10.1046/j.1420-9101.1995.8010053.x; FOWLER K, 1989, NATURE, V338, P760, DOI 10.1038/338760a0; Friberg U, 2003, J EVOLUTION BIOL, V16, P797, DOI 10.1046/j.1420-9101.2003.00597.x; Gibson JR, 2002, P ROY SOC B-BIOL SCI, V269, P499, DOI 10.1098/rspb.2001.1863; Gleason JM, 2002, HEREDITY, V89, P1, DOI 10.1038/sj.hdy.6800099; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; Grillet M, 2006, P ROY SOC B-BIOL SCI, V273, P315, DOI 10.1098/rspb.2005.3332; Howard RW, 2003, J CHEM ECOL, V29, P961, DOI 10.1023/A:1022992002239; JALLON JM, 1987, EVOLUTION, V41, P294, DOI 10.1111/j.1558-5646.1987.tb05798.x; Jones AG, 2001, P ROY SOC B-BIOL SCI, V268, P2531, DOI 10.1098/rspb.2001.1841; Lew TA, 2006, EVOLUTION, V60, P97; Linder JE, 2005, J EVOLUTION BIOL, V18, P568, DOI 10.1111/j.1420-9101.2004.00872.x; Long TAF, 2007, P ROY SOC B-BIOL SCI, V274, P3105, DOI 10.1098/rspb.2007.1140; MARKOW TA, 1987, P NATL ACAD SCI USA, V84, P6200, DOI 10.1073/pnas.84.17.6200; Moehring AJ, 2004, GENETICS, V167, P1249, DOI 10.1534/genetics.103.024372; Moller AP, 1998, AM NAT, V151, P174, DOI 10.1086/286110; Parisi M, 2003, SCIENCE, V299, P697, DOI 10.1126/science.1079190; Parker G.A., 1979, P123; Pischedda A, 2006, PLOS BIOL, V4, P2099, DOI 10.1371/journal.pbio.0040356; Pitnick S, 2002, P ROY SOC B-BIOL SCI, V269, P1821, DOI 10.1098/rspb.2002.2090; Polak M, 2007, P ROY SOC B-BIOL SCI, V274, P3133, DOI 10.1098/rspb.2007.1272; Prasad NG, 2007, AM NAT, V169, P29, DOI 10.1086/509941; Raihani G, 2006, ANIM BEHAV, V71, P833, DOI 10.1016/j.anbehav.2005.06.013; RICE WR, 1994, SCIENCE, V263, P230, DOI 10.1126/science.8284674; Rice WR, 1998, P NATL ACAD SCI USA, V95, P6217, DOI 10.1073/pnas.95.11.6217; Rice WR, 1997, BEHAV ECOL SOCIOBIOL, V41, P1, DOI 10.1007/s002650050357; RICE WR, 1984, EVOLUTION, V38, P735, DOI 10.1111/j.1558-5646.1984.tb00346.x; RICE WR, 1987, GENETICS, V116, P161; Rice WR, 2001, J EVOLUTION BIOL, V14, P685, DOI 10.1046/j.1420-9101.2001.00319.x; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; Robinson MR, 2006, EVOLUTION, V60, P2168, DOI 10.1111/j.0014-3820.2006.tb01854.x; Rose MR, 2002, EVOLUTION, V56, P1982; Savarit F, 1999, P NATL ACAD SCI USA, V96, P9015, DOI 10.1073/pnas.96.16.9015; Shakarad M, 2001, J GENET, V80, P1, DOI 10.1007/BF02811412; STEELE RH, 1988, ANIM BEHAV, V36, P1190, DOI 10.1016/S0003-3472(88)80078-2; Stewart AD, 2005, P ROY SOC B-BIOL SCI, V272, P2029, DOI 10.1098/rspb.2005.3182; Svetec N, 2005, J EXP BIOL, V208, P891, DOI 10.1242/jeb.01454; Talyn BC, 2004, ANIM BEHAV, V68, P1165, DOI 10.1016/j.anbehav.2003.11.023; TOMPKINS L, 1980, J INSECT PHYSIOL, V26, P689, DOI 10.1016/0022-1910(80)90042-6; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Wigby S, 2005, CURR BIOL, V15, P316, DOI 10.1016/j.cub.2005.01.051	64	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2187	10.1371/journal.pone.0002187	http://dx.doi.org/10.1371/journal.pone.0002187			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478127	Green Submitted, gold, Green Published			2022-12-25	WOS:000262172800052
J	Moran, DM; Gawlak, G; Jayaprakash, MS; Mayar, S; Maki, CG				Moran, D. M.; Gawlak, G.; Jayaprakash, M. S.; Mayar, S.; Maki, C. G.			Geldanamycin promotes premature mitotic entry and micronucleation in irradiated p53/p21 deficient colon carcinoma cells	ONCOGENE			English	Article						HSP90; p53; micronuclei; radiation	INDUCED GENOMIC INSTABILITY; TUMOR-CELLS; CHROMOSOMAL INSTABILITY; IONIZING-RADIATION; G(2) CHECKPOINT; G1 CHECKPOINT; PHASE-I; S-PHASE; P53; INHIBITOR	P53 wild-type and p53-null or mutant cells undergo a G2-phase cell-cycle arrest in response to ionizing radiation (IR). In this study we examined the effect of heat-shock protein 90 (HSP90) inhibitor, geldanamycin (GA), on IR-induced G2 arrest in human colon adenocarcinoma cells with different p53 status. We show that GA treatment abrogates IR-induced G2-phase arrest in cells null or mutant for p53. Specifically, GA treatment pushed irradiated p53 signaling-defective cells into a premature mitosis characterized by aberrant mitotic figures, increased gamma H2AX expression and formation of micronucleated cells. Cells expressing wild-type p53 were resistant to GA-induced G2 checkpoint abrogation. Notably, GA treatment decreased levels of G2 regulatory proteins Wee1 and Chk1, and inhibitory phosphorylation of Cdc2, independent of p53 status. Further investigation identified p21 as the potential downstream effector of p53 that mediates resistance to G2 checkpoint abrogation. Clonogenic survival studies demonstrated higher sensitivity to GA alone or combination IR plus GA treatment in p53 and p21-null cells. Collectively, these data demonstrate potential mechanisms through which HSP90 inhibition can enhance the effects of ionizing radiation in p53compromised cancer cells. Combination IR plus HSP90 inhibitor therapies may be particularly useful in treating cancers that lack wild-type p53.	[Moran, D. M.; Gawlak, G.; Jayaprakash, M. S.; Mayar, S.; Maki, C. G.] Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA	University of Chicago	Maki, CG (corresponding author), Univ Chicago, Dept Radiat & Cellular Oncol, 5841 S Maryland Ave,MC1105,Room G-06, Chicago, IL 60637 USA.	cmaki@rover.uchicago.edu			National Institutes of Health [RO1 CA080918]; NATIONAL CANCER INSTITUTE [R01CA080918] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant RO1 CA080918.	Arlander SJH, 2003, J BIOL CHEM, V278, P52572, DOI 10.1074/jbc.M309054200; Banerji U, 2005, J CLIN ONCOL, V23, P4152, DOI 10.1200/JCO.2005.00.612; Bisht KS, 2003, CANCER RES, V63, P8984; Bull EEA, 2004, CLIN CANCER RES, V10, P8077, DOI 10.1158/1078-0432.CCR-04-1212; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Cohen-Jonathan E, 1999, CURR OPIN CHEM BIOL, V3, P77, DOI 10.1016/S1367-5931(99)80014-3; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Dixon H, 2002, CELL CYCLE, V1, P362, DOI 10.4161/cc.1.6.257; Dote H, 2006, CANCER RES, V66, P9211, DOI 10.1158/0008-5472.CAN-06-2181; Giono LE, 2006, J CELL PHYSIOL, V209, P13, DOI 10.1002/jcp.20689; Goes FS, 2001, EUR J BIOCHEM, V268, P2281, DOI 10.1046/j.1432-1327.2001.02105.x; Grem JL, 2005, J CLIN ONCOL, V23, P1885, DOI 10.1200/JCO.2005.12.085; Iliakis G, 2003, ONCOGENE, V22, P5834, DOI 10.1038/sj.onc.1206682; Inoue T, 2001, J BIOL CHEM, V276, P45255, DOI 10.1074/jbc.M107477200; Jackson JR, 2000, CANCER RES, V60, P566; Jascur T, 2005, MOL CELL, V17, P237, DOI 10.1016/j.molcel.2004.11.049; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Kawabe T, 2004, MOL CANCER THER, V3, P513; Limoli CL, 1997, CANCER RES, V57, P5557; MARDER BA, 1993, MOL CELL BIOL, V13, P6667, DOI 10.1128/MCB.13.11.6667; Morgan WF, 2003, RADIAT RES, V159, P567, DOI 10.1667/0033-7587(2003)159[0567:NADEOE]2.0.CO;2; Morgan WF, 2003, RADIAT RES, V159, P581, DOI 10.1667/0033-7587(2003)159[0581:NADEOE]2.0.CO;2; Noguchi M, 2006, BIOCHEM BIOPH RES CO, V351, P658, DOI 10.1016/j.bbrc.2006.10.094; NORBURY C, 1991, EMBO J, V10, P3321, DOI 10.1002/j.1460-2075.1991.tb04896.x; Pawlik TM, 2004, INT J RADIAT ONCOL, V59, P928, DOI 10.1016/j.ijrobp.2004.03.005; Rahmani M, 2003, CANCER RES, V63, P8420; RIEDER CL, 1992, J CELL SCI, V102, P387; Robles AI, 2006, CLIN CANCER RES, V12, P6547, DOI 10.1158/1078-0432.CCR-06-1178; Roninson IB, 2001, DRUG RESIST UPDATE, V4, P303, DOI 10.1054/drup.2001.0213; Russell KJ, 1996, INT J RADIAT ONCOL, V36, P1099, DOI 10.1016/S0360-3016(96)00432-4; Sarkaria JN, 1999, CANCER RES, V59, P4375; Sasaki M, 2007, J BIOL CHEM, V282, P14626, DOI 10.1074/jbc.M610514200; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Shintani S, 2006, INT J ONCOL, V29, P1111; SUGIMOTO K, 2007, ONCOGENE; Waldman T, 1996, NATURE, V381, P713, DOI 10.1038/381713a0; Wang YL, 2004, CANCER BIOL THER, V3, P305, DOI 10.4161/cbt.3.3.697; Wang YL, 2001, CANCER RES, V61, P8211; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716	42	22	22	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 18	2008	27	42					5567	5577		10.1038/onc.2008.172	http://dx.doi.org/10.1038/onc.2008.172			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	349KX	18504430	Green Accepted			2022-12-25	WOS:000259280800003
J	Madsen, L; Petersen, RK; Steffensen, KR; Pedersen, LM; Hallenborg, P; Ma, T; Froyland, L; Doskeland, SO; Gustafsson, JAA; Kristiansen, K				Madsen, Lise; Petersen, Rasmus K.; Steffensen, Knut R.; Pedersen, Lone M.; Hallenborg, Philip; Ma, Tao; Froyland, Livar; Doskeland, Stein Ove; Gustafsson, Jan-Ake; Kristiansen, Karsten			Activation of liver X receptors prevents statin-induced death of 3T3-L1 preadipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; COA REDUCTASE INHIBITORS; ORPHAN NUCLEAR RECEPTORS; ACUTE MYELOID LEUKEMIAS; TUMOR-NECROSIS-FACTOR; ADIPOCYTE DIFFERENTIATION; GENE-EXPRESSION; CELL-DEATH; LXR-ALPHA; P53-DEFICIENT CELLS	The biological functions of liver X receptors (LXRs) alpha and beta have primarily been linked to pathways involved in fatty acid and cholesterol homeostasis. Here we report a novel role of LXR activation in protecting cells from statin-induced death. When 3T3-L1 preadipocytes were induced to differentiate by standard isobutylmethylxanthine/ dexamethasone/ insulin treatment in the presence of statins, they failed to differentiate and underwent massive apoptosis. The simultaneous addition of selective LXR agonists prevented the statin-induced apoptosis. By using mouse embryo fibroblasts from wild-type (LXR alpha (+/+) /LXR beta (+/+)), LXR alpha knock-out mice (LXR alpha (-/-)/LXR beta(+/+)), LXR beta knock-out mice (LXR alpha(+/-)/ LXR beta (-/-)), and LXR double knock-out mice (LXR alpha(+/-)/LXR beta (+/+)) as well as 3T3-L1 cells transduced with retroviruses expressing either wild-type LXR alpha or a dominant negative version of LXR alpha, we demonstrate that the response to LXR agonists is LXR-dependent. Interestingly, LXR-mediated rescue of statin-induced apoptosis was not related to up-regulation of genes previously shown to be involved in the antiapoptotic action of LXR. Furthermore, forced expression of Bcl-2 did not prevent statin-induced apoptosis; nor did LXR action depend on protein kinase B, whose activation by insulin was impaired in statin-treated cells. Rather, LXR-dependent rescue of statin-induced apoptosis in 3T3-L1 preadipocytes required NF-kappa B activity, since expression of a dominant negative version of I kappa B alpha prevented LXR agonist-dependent rescue of statin-induced apoptosis. Thus, the results presented in this paper provide novel insight into the action of statins on and LXR-dependent inhibition of apoptosis.	[Madsen, Lise; Petersen, Rasmus K.; Pedersen, Lone M.; Hallenborg, Philip; Ma, Tao; Kristiansen, Karsten] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark; [Madsen, Lise; Froyland, Livar] Natl Inst Nutr & Seafood Res, N-5817 Bergen, Norway; [Petersen, Rasmus K.] BioLigands, DK-5230 Odense, Denmark; [Steffensen, Knut R.; Gustafsson, Jan-Ake] Karolinska Inst, Dept Biosci & Nutr, NOVUM, S-14157 Huddinge, Sweden; [Doskeland, Stein Ove] Univ Bergen, Fac Med, Dept Biomed, N-5097 Bergen, Norway	University of Southern Denmark; Karolinska Institutet; University of Bergen	Madsen, L (corresponding author), Univ So Denmark, Dept Biochem & Mol Biol, Campusvej 55, DK-5230 Odense M, Denmark.	lise.madsen@bmb.sdu.dk; kak@bmb.sdu.dk	Madsen, Lise/C-6246-2012; Kristiansen, Karsten/J-5148-2014	Madsen, Lise/0000-0003-4468-1947; Kristiansen, Karsten/0000-0002-6024-0917; Doskeland, Stein Ove/0000-0002-4009-4756; Steffensen, Knut/0000-0001-6093-2801				Agarwal B, 1999, CLIN CANCER RES, V5, P2223; Ahn KS, 2008, BIOCHEM PHARMACOL, V75, P907, DOI 10.1016/j.bcp.2007.10.010; Alberti S, 2001, J CLIN INVEST, V107, P565, DOI 10.1172/JCI9794; Andersson S, 2005, P NATL ACAD SCI USA, V102, P3857, DOI 10.1073/pnas.0500634102; Annis MG, 2004, BBA-MOL CELL RES, V1644, P115, DOI 10.1016/j.bbamcr.2003.07.001; Ballantyne CM, 2003, AM J CARDIOL, V92, p3K, DOI 10.1016/S0002-9149(03)00768-9; Bertin J, 2001, J BIOL CHEM, V276, P11877, DOI 10.1074/jbc.M010512200; Bian X, 2002, J BIOL CHEM, V277, P42144, DOI 10.1074/jbc.M203891200; Bian X, 2001, J BIOL CHEM, V276, P48921, DOI 10.1074/jbc.M108674200; Blanco-Colio LM, 2003, KIDNEY INT, V64, P181, DOI 10.1046/j.1523-1755.2003.00080.x; BUCHWALD H, 1992, LANCET, V339, P1154, DOI 10.1016/0140-6736(92)90744-N; Carel K, 1996, J BIOL CHEM, V271, P30625, DOI 10.1074/jbc.271.48.30625; Catz SD, 2001, ONCOGENE, V20, P7342, DOI 10.1038/sj.onc.1204926; Chamberlain LH, 2001, FEBS LETT, V507, P357, DOI 10.1016/S0014-5793(01)03007-1; Chang MY, 1998, BIOCHEM BIOPH RES CO, V248, P62, DOI 10.1006/bbrc.1998.8911; Corsini A, 2004, DRUGS, V64, P1305, DOI 10.2165/00003495-200464120-00004; Corsini A, 1999, PHARMACOL THERAPEUT, V84, P413, DOI 10.1016/S0163-7258(99)00045-5; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Dalen KT, 2003, J BIOL CHEM, V278, P48283, DOI 10.1074/jbc.M302287200; Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048; Dimitroulakos J, 1999, BLOOD, V93, P1308, DOI 10.1182/blood.V93.4.1308.404k08_1308_1318; Dimitroulakos J, 2000, LEUKEMIA LYMPHOMA, V40, P167, DOI 10.3109/10428190009054894; Elson CE, 1999, P SOC EXP BIOL MED, V221, P294, DOI 10.1046/j.1525-1373.1999.d01-87.x; Evans M, 2004, DRUGS, V64, P1181, DOI 10.2165/00003495-200464110-00003; Fajas L, 1999, MOL CELL BIOL, V19, P5495; FOLCH J, 1957, J BIOL CHEM, V226, P497; Furukawa N, 2005, CELL METAB, V2, P119, DOI 10.1016/j.cmet.2005.06.011; Garcia MJ, 2003, METHOD FIND EXP CLIN, V25, P457; Garcia-Roman N, 2001, MOL CELL NEUROSCI, V17, P329, DOI 10.1006/mcne.2000.0904; Giri DK, 1998, J BIOL CHEM, V273, P14008, DOI 10.1074/jbc.273.22.14008; Glasgow JN, 2000, J NEUROCHEM, V75, P1377, DOI 10.1046/j.1471-4159.2000.0751377.x; Goalstone ML, 1996, J BIOL CHEM, V271, P27585, DOI 10.1074/jbc.271.44.27585; Grilli M, 1996, SCIENCE, V274, P1383, DOI 10.1126/science.274.5291.1383; Hansen JB, 2002, J BIOL CHEM, V277, P26335, DOI 10.1074/jbc.M203870200; Heckman CA, 2002, ONCOGENE, V21, P3898, DOI 10.1038/sj.onc.1205483; Hindler K, 2006, ONCOLOGIST, V11, P306, DOI 10.1634/theoncologist.11-3-306; Jakobisiak M, 2003, INT J ONCOL, V23, P1055; Jang JH, 2004, J BIOL CHEM, V279, P38779, DOI 10.1074/jbc.M406371200; Johnson TE, 2004, TOXICOL APPL PHARM, V200, P237, DOI 10.1016/j.taap.2004.04.010; Jones SN, 1996, P NATL ACAD SCI USA, V93, P14106, DOI 10.1073/pnas.93.24.14106; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032; Juvet LK, 2003, MOL ENDOCRINOL, V17, P172, DOI 10.1210/me.2001-0210; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Kirkin V, 2004, BBA-MOL CELL RES, V1644, P229, DOI 10.1016/j.bbamcr.2003.08.009; Kleemann R, 2004, BLOOD, V103, P4188, DOI 10.1182/blood-2003-11-3791; Klemm DJ, 2001, J BIOL CHEM, V276, P28430, DOI 10.1074/jbc.M103382200; Kohro T, 2000, J Atheroscler Thromb, V7, P145; Kubota T, 2004, BIOCHEM PHARMACOL, V67, P2175, DOI 10.1016/j.bcp.2004.02.037; Kurland JF, 2001, J BIOL CHEM, V276, P45380, DOI 10.1074/jbc.M108294200; Larsson O, 1996, CRIT REV ONCOL HEMAT, V22, P197, DOI 10.1016/1040-8428(96)00193-X; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; LIN KI, 1995, J CELL BIOL, V131, P1149, DOI 10.1083/jcb.131.5.1149; Lu TT, 2001, J BIOL CHEM, V276, P37735, DOI 10.1074/jbc.R100035200; Mauser W, 2007, EUR J PHARMACOL, V564, P37, DOI 10.1016/j.ejphar.2007.02.024; Maxwell KN, 2003, J LIPID RES, V44, P2109, DOI 10.1194/jlr.M300203-JLR200; Meyers VE, 2005, J BONE MINER RES, V20, P1858, DOI 10.1359/JBMR.050611; Mistafa O, 2008, BIOCHEM BIOPH RES CO, V365, P131, DOI 10.1016/j.bbrc.2007.10.148; Morrison RS, 2003, NEUROCHEM RES, V28, P15, DOI 10.1023/A:1021687810103; Muck AO, 2004, INT J CLIN PHARM TH, V42, P695; Nakata M, 2006, DIABETOLOGIA, V49, P1881, DOI 10.1007/s00125-006-0269-5; Nakata S, 2007, ARTERIOSCL THROM VAS, V27, P92, DOI 10.1161/01.ATV.0000251615.61858.33; Newman A, 1997, LEUKEMIA LYMPHOMA, V24, P533, DOI 10.3109/10428199709055590; Nicholson AC, 2007, BRIT J PHARMACOL, V151, P807, DOI 10.1038/sj.bjp.0707250; Noguchi M, 2007, J BIOL CHEM, V282, P29574, DOI 10.1074/jbc.M705972200; Paumelle R, 2006, CIRC RES, V98, P361, DOI 10.1161/01.RES.0000202706.70992.95; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Poulaki V, 2002, AM J PATHOL, V161, P2229, DOI 10.1016/S0002-9440(10)64499-9; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Ross SE, 2002, MOL CELL BIOL, V22, P5989, DOI 10.1128/MCB.22.16.5989-5999.2002; Roudier E, 2006, MOL CANCER THER, V5, P2706, DOI 10.1158/1535-7163.MCT-06-0352; Ruan H, 2002, DIABETES, V51, P1319, DOI 10.2337/diabetes.51.5.1319; Sassano A, 2008, CANCER LETT, V260, P11, DOI 10.1016/j.canlet.2007.11.036; Schmidt F, 2001, ACTA NEUROPATHOL, V101, P217; Siddals KW, 2004, J BIOL CHEM, V279, P38353, DOI 10.1074/jbc.M404838200; Solomon CS, 2003, INT J OBESITY, V27, P40, DOI 10.1038/sj.ijo.0802189; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; Steffensen KR, 2004, DIABETES, V53, pS36, DOI 10.2337/diabetes.53.2007.S36; Steffensen KR, 2003, BIOCHEM BIOPH RES CO, V310, P589, DOI 10.1016/j.bbrc.2003.08.139; Steffensen KR, 2002, BIOCHEM BIOPH RES CO, V293, P1333, DOI 10.1016/S0006-291X(02)00390-X; Stulnig TM, 2002, MOL PHARMACOL, V62, P1299, DOI 10.1124/mol.62.6.1299; Tanaka T, 2000, J NEUROSCI, V20, P2852; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P44, DOI 10.1073/pnas.0137044100; Tomiyama K, 1999, JPN J PHARMACOL, V80, P375, DOI 10.1254/jjp.80.375; Valledor AF, 2004, P NATL ACAD SCI USA, V101, P17813, DOI 10.1073/pnas.0407749101; Wang Wei, 2005, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V30, P673; Wilt TJ, 2004, ARCH INTERN MED, V164, P1427, DOI 10.1001/archinte.164.13.1427; Wong WWL, 2002, LEUKEMIA, V16, P508, DOI 10.1038/sj.leu.2402476; Zhang HB, 2003, J BIOL CHEM, V278, P20906, DOI 10.1074/jbc.M300022200	91	5	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22723	22736		10.1074/jbc.M800720200	http://dx.doi.org/10.1074/jbc.M800720200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18487205	hybrid			2022-12-25	WOS:000258321000041
J	Chu, MLH; Chavas, LMG; Douglas, KT; Eyers, PA; Tabernero, L				Chu, Matthew L. H.; Chavas, Leonard M. G.; Douglas, Kenneth T.; Eyers, Patrick A.; Tabernero, Lydia			Crystal structure of the catalytic domain of the mitotic checkpoint kinase Mps1 in complex with SP600125	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE ASSEMBLY CHECKPOINT; SMALL-MOLECULE INHIBITORS; PROTEIN-KINASE; ACTIVATION; PHOSPHORYLATION; FAMILY	Chromosomal instability can result from defective control of checkpoints and is associated with malignant cell growth. Monopolar spindle 1 (Mps1) is a dual-specificity protein kinase that has important roles in the prevention of aneuploidy during the cell cycle and might therefore be a potential target for new therapeutic agents in the treatment of cancer. To gain insights into the molecular mechanism of Mps1 inhibition by small molecules, we determined the x-ray structure of Mps1, both alone and in complex with the ATP-competitive inhibitor SP600125. Mps1 adopts a classic protein kinase fold, with the inhibitor sitting in the ATP-binding site where it is stabilized by hydrophobic interactions. We identified a secondary pocket, not utilized by SP600125, which might be exploited for the rational design of specific Mps1 inhibitors. These structures provide important insights into the interaction of this protein kinase with small molecules and suggest potential mechanisms for Mps1 regulation.	[Chu, Matthew L. H.; Douglas, Kenneth T.] Univ Manchester, Sch Pharm & Pharmaceut Sci, Manchester M13 9PT, Lancs, England; [Chavas, Leonard M. G.; Eyers, Patrick A.; Tabernero, Lydia] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Chavas, Leonard M. G.; Eyers, Patrick A.; Tabernero, Lydia] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Chu, Matthew L. H.; Douglas, Kenneth T.] Univ Manchester, Sch Pharm & Pharmaceut Sci, Manchester M13 9PT, Lancs, England	University of Manchester; University of Manchester; University of Manchester; University of Manchester	Eyers, PA (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg, Manchester M13 9PT, Lancs, England.	Patrick.Eyers@manchester.ac.uk; Lydia.Tabernero@manchester.ac.uk	Chavas, Leonard M.G./AAZ-2286-2020; Tabernero, Lydia/F-3795-2018	Tabernero, Lydia/0000-0001-8867-455X	Medical Research Council [G120/1030] Funding Source: Medline; MRC [G120/1030] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Cheetham GMT, 2002, J BIOL CHEM, V277, P42419, DOI 10.1074/jbc.C200426200; de Carcer G, 2007, CURR MED CHEM, V14, P969, DOI 10.2174/092986707780362925; DeLano WL, 2005, DRUG DISCOV TODAY, V10, P213, DOI 10.1016/S1359-6446(04)03363-X; Dorer RK, 2005, CURR BIOL, V15, P1070, DOI 10.1016/j.cub.2005.05.020; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVANS PR, 1997, JOINT CCP4 ESF EACBM, V33; Eyers PA, 2003, CURR BIOL, V13, P691, DOI 10.1016/S0960-9822(03)00166-0; Fisk HA, 2004, CELL CYCLE, V3, P439; Fisk HA, 2003, P NATL ACAD SCI USA, V100, P14875, DOI 10.1073/pnas.2434156100; Heo JS, 2004, EMBO J, V23, P2185, DOI 10.1038/sj.emboj.7600212; Jelluma N, 2008, CELL, V132, P233, DOI 10.1016/j.cell.2007.11.046; Kang JS, 2007, P NATL ACAD SCI USA, V104, P20232, DOI 10.1073/pnas.0710519105; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Leng M, 2006, P NATL ACAD SCI USA, V103, P11485, DOI 10.1073/pnas.0601828103; Leslie A. G. W., 1992, JOINT CCP4 ESF EACBM, V26; LIU ST, 2003, MOL BIOL CELL, V14, P138; Mattison CP, 2007, J BIOL CHEM, V282, P30553, DOI 10.1074/jbc.M707063200; MILLS GB, 1992, J BIOL CHEM, V267, P16000; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagar B, 2002, CANCER RES, V62, P4236; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; OWEN DJ, 1995, STRUCTURE, V3, P467, DOI 10.1016/S0969-2126(01)00180-0; Scapin G, 2003, CHEM BIOL, V10, P705, DOI 10.1016/S1074-5521(03)00159-5; Schmidt M, 2005, EMBO REP, V6, P866, DOI 10.1038/sj.embor.7400483; Shimogawa MM, 2006, CURR BIOL, V16, P1489, DOI 10.1016/j.cub.2006.06.063; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780	30	45	48	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21495	21500		10.1074/jbc.M803026200	http://dx.doi.org/10.1074/jbc.M803026200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18480048	hybrid			2022-12-25	WOS:000257898800022
J	Galkin, A; Meyer, B; Wittig, I; Karas, M; Schagger, H; Vinogradov, A; Brandt, U				Galkin, Alexander; Meyer, Bjoern; Wittig, Ilka; Karas, Michael; Schaegger, Hermann; Vinogradov, Andrei; Brandt, Ulrich			Identification of the mitochondrial ND3 subunit as a structural component involved in the active/deactive enzyme transition of respiratory complex I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-INACTIVE TRANSITION; QUINONE OXIDOREDUCTASE; HYDROGEN-TRANSFER; PARACOCCUS-DENITRIFICANS; DNA MUTATION; NADH; PROTEINS; EPR; UBISEMIQUINONE; ELECTRON	Mitochondrial complex I (NADH: ubiquinone oxidoreductase) undergoes reversible deactivation upon incubation at 30-37 degrees C. The active/deactive transition could play an important role in the regulation of complex I activity. It has been suggested recently that complex I may become modified by S-nitrosation under pathological conditions during hypoxia or when the nitric oxide: oxygen ratio increases. Apparently, a specific cysteine becomes accessible to chemical modification only in the deactive form of the enzyme. By selective fluorescence labeling and proteomic analysis, we have identified this residue as cysteine-39 of the mitochondrially encoded ND3 subunit of bovine heart mitochondria. Cysteine-39 is located in a loop connecting the first and second transmembrane helix of this highly hydrophobic subunit. We propose that this loop connects the ND3 subunit of the membrane arm with the PSST subunit of the peripheral arm of complex I, placing it in a region that is known to be critical for the catalytic mechanism of complex I. In fact, mutations in three positions of the loop were previously reported to cause Leigh syndrome with and without dystonia or progressive mitochondrial disease.	[Galkin, Alexander; Wittig, Ilka; Schaegger, Hermann; Brandt, Ulrich] Goethe Univ Frankfurt, Cluster Excellence Frankfurt Macromol Complexes M, Mol Bioenerget Grp, D-60590 Frankfurt, Germany; [Meyer, Bjoern; Karas, Michael] Goethe Univ Frankfurt, Cluster Excellence Frankfurt Macromol Complexes M, Inst Pharmazeut Chem, D-60438 Frankfurt, Germany; [Vinogradov, Andrei] Moscow MV Lomonosov State Univ, Sch Biol, Dept Biochem, Moscow 119992, Russia	Goethe University Frankfurt; Goethe University Frankfurt; Lomonosov Moscow State University	Brandt, U (corresponding author), Goethe Univ Frankfurt, Cluster Excellence Frankfurt Macromol Complexes M, Mol Bioenerget Grp, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	brandt@zbc.kgu.de	Brandt, Ulrich/C-4406-2008; Brandt, Ulrich/GLV-1242-2022	Brandt, Ulrich/0000-0003-1869-6811; Brandt, Ulrich/0000-0003-1869-6811	FOGARTY INTERNATIONAL CENTER [R03TW007825] Funding Source: NIH RePORTER; FIC NIH HHS [R03 TW 07825] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Blow D. M., 1971, ENZYMES, VIII, P185, DOI DOI 10.1016/S1874-6047(08)60397-2; Brandt U, 1997, BBA-BIOENERGETICS, V1318, P79, DOI 10.1016/S0005-2728(96)00141-7; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; BURBAEV DS, 1989, FEBS LETT, V254, P47, DOI 10.1016/0014-5793(89)81007-5; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Chae JH, 2007, PEDIATR RES, V61, P622, DOI 10.1203/pdr.0b013e3180459f2d; Clason T, 2007, J STRUCT BIOL, V159, P433, DOI 10.1016/j.jsb.2007.05.002; Di Bernardo S, 2000, BIOCHEMISTRY-US, V39, P9411; DIVIRGILIO F, 1982, J BIOL CHEM, V257, P4106; Estabrook R.W., 1968, FLAVINS FLAVOPROTEIN, P268; Galkin A, 2007, J BIOL CHEM, V282, P37448, DOI 10.1074/jbc.M707543200; Galkin AS, 1999, FEBS LETT, V451, P157, DOI 10.1016/S0014-5793(99)00575-X; Gavrikova EV, 1999, FEBS LETT, V455, P36, DOI 10.1016/S0014-5793(99)00850-9; Gostimskaya IS, 2006, BBA-BIOENERGETICS, V1757, P1155, DOI 10.1016/j.bbabio.2006.04.016; Grivennikova VG, 2001, J BIOL CHEM, V276, P9038, DOI 10.1074/jbc.M009661200; KAMP RM, 1986, ADV METHODS PROTEIN, P8; Kao MC, 2004, BIOCHEMISTRY-US, V43, P3750, DOI 10.1021/bi049927s; KOTLYAR AB, 1990, BIOCHIM BIOPHYS ACTA, V1019, P151, DOI 10.1016/0005-2728(90)90137-S; KOTLYAR AB, 1992, BIOCHIM BIOPHYS ACTA, V1098, P144, DOI 10.1016/S0005-2728(05)80329-9; Magnitsky S, 2002, J BIOENERG BIOMEMBR, V34, P193, DOI 10.1023/A:1016083419979; Maklashina E, 2003, BBA-BIOENERGETICS, V1606, P95, DOI 10.1016/S0005-2728(03)00087-2; Maklashina E, 2002, BBA-BIOENERGETICS, V1556, P6, DOI 10.1016/S0005-2728(02)00280-3; Maklashina E. O., 1994, Biokhimiya, V59, P946; McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787; Meyer B, 2007, MOL CELL PROTEOMICS, V6, P1690, DOI 10.1074/mcp.M700097-MCP200; MINAKAMI S, 1964, J BIOL CHEM, V239, P2042; MINAKAMI S, 1964, J BIOL CHEM, V239, P2049; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Ohnishi T, 1998, BBA-BIOENERGETICS, V1364, P186, DOI 10.1016/S0005-2728(98)00027-9; Ohnishi T, 2005, FEBS LETT, V579, P500, DOI 10.1016/j.febslet.2004.11.107; Rais I, 2004, PROTEOMICS, V4, P2567, DOI 10.1002/pmic.200400829; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Sarzi E, 2007, AM J MED GENET A, V143A, P33, DOI 10.1002/ajmg.a.31565; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Schmidt F, 2006, RAPID COMMUN MASS SP, V20, P933, DOI 10.1002/rcm.2382; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Taylor RW, 2001, ANN NEUROL, V50, P104, DOI 10.1002/ana.1084; Vinogradov AD, 1998, BBA-BIOENERGETICS, V1364, P169, DOI 10.1016/S0005-2728(98)00026-7; WIKSTROM M, 1984, FEBS LETT, V169, P300, DOI 10.1016/0014-5793(84)80338-5; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yano T, 1999, J BIOL CHEM, V274, P28598, DOI 10.1074/jbc.274.40.28598	41	116	118	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20907	20913		10.1074/jbc.M803190200	http://dx.doi.org/10.1074/jbc.M803190200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18502755	Green Published, hybrid			2022-12-25	WOS:000257746100033
J	Costa, MDL; Reis, PAB; Valente, MAS; Irsigler, AST; Carvalho, CM; Loureiro, ME; Aragao, FJL; Boston, RS; Fietto, LG; Fontes, EPB				Costa, Maximiller D. L.; Reis, Pedro A. B.; Valente, Maria Anete S.; Irsigler, Andre S. T.; Carvalho, Claudine M.; Loureiro, Marcelo E.; Aragao, Francisco J. L.; Boston, Rebecca S.; Fietto, Luciano G.; Fontes, Elizabeth P. B.			A new branch of endoplasmic reticulum stress signaling and the osmotic signal converge on plant-specific asparagine-rich proteins to promote cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; SUPEROXIDE-DISMUTASE; LIPID-PEROXIDATION; LEAF SENESCENCE; GOLGI-APPARATUS; BREFELDIN-A; ARABIDOPSIS; EXPRESSION; BIP; HOMOLOG	NRPs (N-rich proteins) were identified as targets of a novel adaptive pathway that integrates endoplasmic reticulum (ER) and osmotic stress signals based on coordinate regulation and synergistic up-regulation by tunicamycin and polyethylene glycol treatments. This integrated pathway diverges from the molecular chaperone-inducing branch of the unfolded protein response (UPR) in several ways. While UPR-specific targets were inversely regulated by ER and osmotic stresses, NRPs required both signals for full activation. Furthermore, BiP (binding protein) overexpression in soybean prevented activation of the UPR by ER stress inducers, but did not affect activation of NRPs. We also found that this integrated pathway transduces a PCD signal generated by ER and osmotic stresses that result in the appearance of markers associated with leaf senescence. Overexpression of NRPs in soybean protoplasts induced caspase-3-like activity and promoted extensive DNA fragmentation. Furthermore, transient expression of NRPs in planta caused leaf yellowing, chlorophyll loss, malondialdehyde production, ethylene evolution, and induction of the senescence marker gene CP1. This phenotype was alleviated by the cytokinin zeatin, a potent senescence inhibitor. Collectively, these results indicate that ER stress induces leaf senescence through activation of plant-specific NRPs via a novel branch of the ER stress response.	[Costa, Maximiller D. L.; Reis, Pedro A. B.; Valente, Maria Anete S.; Irsigler, Andre S. T.; Carvalho, Claudine M.; Fietto, Luciano G.; Fontes, Elizabeth P. B.] Univ Fed Vicosa, Dept Bioquim & Biol Mol, BIOAGRO, BR-36571000 Vicosa, MG, Brazil; [Loureiro, Marcelo E.] Univ Fed Vicosa, Dept Biol Vegetal, BR-36571000 Vicosa, MG, Brazil; [Aragao, Francisco J. L.] Embrapa Recursos Genet & Biotecnol, BR-70770900 Brasilia, DF, Brazil; [Boston, Rebecca S.] N Carolina State Univ, Dept Plant Biol, Raleigh, NC 27695 USA	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); University of North Carolina; North Carolina State University	Fontes, EPB (corresponding author), Univ Fed Vicosa, Dept Bioquim & Biol Mol, BIOAGRO, BR-36571000 Vicosa, MG, Brazil.	bbfontes@ufv.br	Aragão, Francisco J.L./E-6962-2013; Costa, Maximiller/D-8804-2013; Fietto, Luciano G/F-9908-2012; Ding, Cheng-Qiang/B-6287-2011; Reis, Pedro Augusto Braga/U-4103-2019; Dal-Bianco, Maximiller/K-6377-2018; Carvalho, Claudine/J-6347-2014; Fontes, Elizabeth/K-3159-2012	Reis, Pedro Augusto Braga/0000-0003-2396-3662; Dal-Bianco, Maximiller/0000-0002-7001-4841; Fietto, Luciano/0000-0002-2674-6471; Irsigler, Andre/0000-0001-8943-8081; Fontes, Elizabeth/0000-0002-7986-1369				Alvim FC, 2001, PLANT PHYSIOL, V126, P1042, DOI 10.1104/pp.126.3.1042; Aragao FJL, 2000, THEOR APPL GENET, V101, P1, DOI 10.1007/s001220051441; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Batoko H, 2000, PLANT CELL, V12, P2201, DOI 10.1105/tpc.12.11.2201; Buzeli RAA, 2002, PLANT MOL BIOL, V50, P757, DOI 10.1023/A:1019994721545; CAKMAK I, 1991, PHYSIOL PLANTARUM, V83, P463, DOI 10.1111/j.1399-3054.1991.tb00121.x; CARVALHO CM, 2008, PLANT J IN PRESS; Cascardo JCM, 2001, PLANT SCI, V160, P273, DOI 10.1016/S0168-9452(00)00384-8; Cascardo JCM, 2000, J BIOL CHEM, V275, P14494, DOI 10.1074/jbc.275.19.14494; Crosti P, 2001, PROTOPLASMA, V216, P31, DOI 10.1007/BF02680128; Delu-Filho N, 2000, PLANT PHYSIOL BIOCH, V38, P353, DOI 10.1016/S0981-9428(00)00752-X; DENECKE J, 1995, PLANT CELL, V7, P391, DOI 10.1105/tpc.7.4.391; Denekamp M, 2003, PLANT PHYSIOL, V132, P1415, DOI 10.1104/pp.102.019273; DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; FONTES EPB, 1994, J BIOL CHEM, V269, P8459; Gan SS, 1997, PLANT PHYSIOL, V113, P313, DOI 10.1104/pp.113.2.313; Greenberg JT, 1996, P NATL ACAD SCI USA, V93, P12094, DOI 10.1073/pnas.93.22.12094; Irsigler AS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-431; Iwata Y, 2005, P NATL ACAD SCI USA, V102, P5280, DOI 10.1073/pnas.0408941102; Iwata Y, 2005, PLANTA, V220, P804, DOI 10.1007/s00425-004-1479-z; Kamauchi S, 2005, FEBS J, V272, P3461, DOI 10.1111/j.1742-4658.2005.04770.x; Kirst ME, 2005, PLANT PHYSIOL, V138, P218, DOI 10.1104/pp.105.060087; Koizumi N, 2001, PLANT PHYSIOL, V127, P949, DOI 10.1104/pp.010636; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Leborgne-Castel N, 1999, PLANT CELL, V11, P459, DOI 10.1105/tpc.11.3.459; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Liu JX, 2007, PLANT CELL, V19, P4111, DOI 10.1105/tpc.106.050021; Ludwig AA, 2001, EUR J PLANT PATHOL, V107, P323, DOI 10.1023/A:1011202225323; Ma YJ, 2004, J CHEM NEUROANAT, V28, P51, DOI 10.1016/j.jchemneu.2003.08.007; Malerba M, 2004, PROTOPLASMA, V224, P61, DOI 10.1007/s00709-004-0053-7; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Martinez IM, 2003, PLANT CELL, V15, P561, DOI 10.1105/tpc.007609; Pagny S, 2000, PLANT CELL, V12, P739, DOI 10.1105/tpc.12.5.739; Pirovani CP, 2002, EUR J BIOCHEM, V269, P3998, DOI 10.1046/j.1432-1033.2002.03089.x; QUIRINO BF, 2003, CURR OPIN PLANT BIOL, V6, P79; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; SINGH S, 1992, PHYSIOL PLANTARUM, V86, P388, DOI 10.1111/j.1399-3054.1992.tb01334.x; Tenhaken R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-169; Urade R, 2007, FEBS J, V274, P1152, DOI 10.1111/j.1742-4658.2007.05664.x; Wang SY, 2007, P NATL ACAD SCI USA, V104, P3817, DOI 10.1073/pnas.0611735104; Watanabe N, 2008, J BIOL CHEM, V283, P3200, DOI 10.1074/jbc.M706659200; Wertz IE, 1996, TRENDS BIOCHEM SCI, V21, P359, DOI 10.1016/0968-0004(96)40002-0; Woltering EJ, 2002, PLANT PHYSIOL, V130, P1764, DOI 10.1104/pp.006338; Zuppini A, 2004, J CELL SCI, V117, P2591, DOI 10.1242/jcs.01126	45	65	71	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20209	20219		10.1074/jbc.M802654200	http://dx.doi.org/10.1074/jbc.M802654200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18490446	Green Published, hybrid			2022-12-25	WOS:000257565300037
J	Iqbal, J; Rudel, LL; Hussain, MM				Iqbal, Jahangir; Rudel, Lawrence L.; Hussain, M. Mahmood			Microsomal triglyceride transfer protein enhances cellular cholesteryl esterification by relieving product inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATED CACO-2 CELLS; HAMSTER OVARY CELLS; MAMMALIAN ACYL-COA; ENDOPLASMIC-RETICULUM; APOLIPOPROTEIN-B; ACYLTRANSFERASE ACTIVITY; LIPOPROTEIN SECRETION; DIETARY-CHOLESTEROL; NONHUMAN-PRIMATES; MCA-RH7777 CELLS	Cholesteryl ester synthesis by the acyl-CoA: cholesterol acyltransferase enzymes ACAT1 and ACAT2 is, in part, a cellular homeostatic mechanism to avoid toxicity associated with high free cholesterol levels. In hepatocytes and enterocytes, cholesteryl esters are secreted as part of apoB lipoproteins, the assembly of which is critically dependent on microsomal triglyceride transfer protein (MTP). Conditional genetic ablation of MTP reduces cholesteryl esters and enhances free cholesterol in the liver and intestine without diminishing ACAT1 and ACAT2 mRNA levels. As expected, increases in hepatic free cholesterol are associated with decreases in 3-hydroxy-3-methylglutaryl-CoA reductase and increases in ATP-binding cassette transporter 1 mRNA levels. Chemical inhibition of MTP also decreases esterification of cholesterol in Caco-2 and HepG2 cells. Conversely, coexpression of MTP and apoB in AC29 cells stably transfected with ACAT1 and ACAT2 increases cholesteryl ester synthesis. Liver and enterocyte microsomes from MTP-deficient animals synthesize lesser amounts of cholesteryl esters in vitro, but addition of purified MTP and low density lipoprotein corrects this deficiency. Enrichment of microsomes with cholesteryl esters also inhibits cholesterol ester synthesis. Thus, MTP enhances cellular cholesterol esterification by removing cholesteryl esters from their site of synthesis and depositing them into nascent apoB lipoproteins. Therefore, MTP plays a novel role in regulating cholesteryl ester biosynthesis in cells that produce lipoproteins. We speculate that non-lipoprotein-producing cells may use different mechanisms to alleviate product inhibition and modulate cholesteryl ester biosynthesis.	[Iqbal, Jahangir; Hussain, M. Mahmood] Suny Downstate Med Ctr, Dept Anat & Cell Biol, Brooklyn, NY 11203 USA; [Iqbal, Jahangir; Hussain, M. Mahmood] Suny Downstate Med Ctr, Dept Pediat, Brooklyn, NY 11203 USA; [Rudel, Lawrence L.] Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol, Winston Salem, NC 27157 USA; [Rudel, Lawrence L.] Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Winston Salem, NC 27157 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Hussain, MM (corresponding author), Suny Downstate Med Ctr, Dept Anat & Cell Biol, Brooklyn, NY 11203 USA.	Mahmood.Hussain@downstate.edu	Iqbal, Jahangir/B-3903-2014	Iqbal, Jahangir/0000-0002-9021-2271	NHLBI NIH HHS [HL 49373] Funding Source: Medline; NIDDK NIH HHS [DK 46700] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL049373] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anderson RA, 1998, J BIOL CHEM, V273, P26747, DOI 10.1074/jbc.273.41.26747; Anwar K, 2006, J LIPID RES, V47, P1261, DOI 10.1194/jlr.M500523-JLR200; Athar H, 2004, J LIPID RES, V45, P764, DOI 10.1194/jlr.D300026-JLR200; Bakillah A, 1997, LIPIDS, V32, P1113, DOI 10.1007/s11745-997-0143-8; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brozovic S, 2004, NAT MED, V10, P535, DOI 10.1038/nm1043; Buhman KF, 2000, BBA-MOL CELL BIOL L, V1529, P142, DOI 10.1016/S1388-1981(00)00144-X; Burnett JR, 2007, EXPERT OPIN THER TAR, V11, P181, DOI 10.1517/14728222.11.2.181; CADIGAN KM, 1989, J CELL BIOL, V108, P2201, DOI 10.1083/jcb.108.6.2201; CADIGAN KM, 1988, J BIOL CHEM, V263, P274; Cases S, 1998, J BIOL CHEM, V273, P26755, DOI 10.1074/jbc.273.41.26755; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Chandler CE, 2003, J LIPID RES, V44, P1887, DOI 10.1194/jlr.M300094-JLR200; Chang CCY, 2000, J BIOL CHEM, V275, P28083; CHANG CCY, 1993, J BIOL CHEM, V268, P20747; Chang G, 2002, CURR OPIN DRUG DISC, V5, P562; Chang TY, 1997, ANNU REV BIOCHEM, V66, P613, DOI 10.1146/annurev.biochem.66.1.613; Chang TY, 2001, CURR OPIN LIPIDOL, V12, P289, DOI 10.1097/00041433-200106000-00008; Cheema SK, 1997, J LIPID RES, V38, P315; Cuchel M, 2007, NEW ENGL J MED, V356, P148, DOI 10.1056/NEJMoa061189; Dougan SK, 2005, J EXP MED, V202, P529, DOI 10.1084/jem.20050183; Dougan SK, 2007, J EXP MED, V204, P533, DOI 10.1084/jem.20062006; ERICKSON SK, 1980, J LIPID RES, V21, P930; Farese RV, 1998, CURR OPIN LIPIDOL, V9, P119, DOI 10.1097/00041433-199804000-00007; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Gordon DA, 2000, BBA-MOL CELL BIOL L, V1486, P72, DOI 10.1016/S1388-1981(00)00049-4; HAGAN DL, 1994, J BIOL CHEM, V269, P28737; Hui TY, 2002, J LIPID RES, V43, P785; Hussain MM, 2008, CURR OPIN LIPIDOL, V19, P277, DOI 10.1097/MOL.0b013e3282feea85; Hussain MM, 2003, J LIPID RES, V44, P22, DOI 10.1194/jlr.R200014-JLR200; Hussain MM, 2005, CURR OPIN LIPIDOL, V16, P281, DOI 10.1097/01.mol.0000169347.53568.5a; Hussain MM, 2003, FRONT BIOSCI, V8, pS500, DOI 10.2741/1071; HUSSAIN MM, 1995, ARTERIOSCL THROM VAS, V15, P485, DOI 10.1161/01.ATV.15.4.485; Iqbal J, 2005, J LIPID RES, V46, P1491, DOI 10.1194/jlr.M500023-JLR200; Iqbal J, 2003, J BIOL CHEM, V278, P31610, DOI 10.1074/jbc.M301177200; Iqbal J, 2008, CELL METAB, V7, P445, DOI 10.1016/j.cmet.2008.03.005; Joyce CW, 2000, MOL BIOL CELL, V11, P3675, DOI 10.1091/mbc.11.11.3675; Kadereit B, 2008, P NATL ACAD SCI USA, V105, P94, DOI 10.1073/pnas.0708579105; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kulinski A, 2002, J BIOL CHEM, V277, P31516, DOI 10.1074/jbc.M202015200; Lee RG, 2000, J LIPID RES, V41, P1991; Lieu HD, 2003, CIRCULATION, V107, P1315, DOI 10.1161/01.CIR.0000054781.50889.0C; Lin S, 1999, J BIOL CHEM, V274, P23276, DOI 10.1074/jbc.274.33.23276; Lin S, 2003, MOL BIOL CELL, V14, P2447, DOI 10.1091/mbc.E02-11-0725; Luchoomun J, 1999, J BIOL CHEM, V274, P19565, DOI 10.1074/jbc.274.28.19565; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Miyazaki A, 1998, ARTERIOSCL THROM VAS, V18, P1568, DOI 10.1161/01.ATV.18.10.1568; Nayak N, 2001, J LIPID RES, V42, P272; Oelkers P, 1998, J BIOL CHEM, V273, P26765, DOI 10.1074/jbc.273.41.26765; Pan XY, 2007, J BIOL CHEM, V282, P24707, DOI 10.1074/jbc.M701305200; Parini P, 2004, CIRCULATION, V110, P2017, DOI 10.1161/01.CIR.0000143163.76212.0B; Ploegh HL, 2007, NATURE, V448, P435, DOI 10.1038/nature06004; Raabe M, 1999, J CLIN INVEST, V103, P1287, DOI 10.1172/JCI6576; Raabe M, 1998, P NATL ACAD SCI USA, V95, P8686, DOI 10.1073/pnas.95.15.8686; Rava P, 2005, J LIPID RES, V46, P1779, DOI 10.1194/jlr.D400043-JLR200; Rudel LL, 2002, J BIOL CHEM, V277, P31401, DOI 10.1074/jbc.M204106200; Rudel LL, 2001, CURR OPIN LIPIDOL, V12, P121, DOI 10.1097/00041433-200104000-00005; Sakashita N, 2003, LAB INVEST, V83, P1569, DOI 10.1097/01.LAB.0000095687.17383.39; Sato R, 1999, J BIOL CHEM, V274, P24714, DOI 10.1074/jbc.274.35.24714; Seo T, 2001, BIOCHEMISTRY-US, V40, P4756, DOI 10.1021/bi0022947; Smith JL, 2004, J LIPID RES, V45, P686, DOI 10.1194/jlr.M300365-JLR200; SUCKLING KE, 1985, J LIPID RES, V26, P647; Tabas I, 2002, J CLIN INVEST, V110, P583, DOI 10.1172/JCI200216381; Wang S, 1996, J BIOL CHEM, V271, P14124, DOI 10.1074/jbc.271.24.14124; Wang YW, 1999, J BIOL CHEM, V274, P27793, DOI 10.1074/jbc.274.39.27793; WETTERAU JR, 1992, SCIENCE, V258, P999; Wetterau JR, 1997, BBA-LIPID LIPID MET, V1345, P136, DOI 10.1016/S0005-2760(96)00168-3; Xie Y, 2006, J BIOL CHEM, V281, P4075, DOI 10.1074/jbc.M510622200; Zhao B, 2007, J CLIN INVEST, V117, P2983, DOI 10.1172/JCI30485	69	40	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					19967	19980		10.1074/jbc.M800398200	http://dx.doi.org/10.1074/jbc.M800398200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18502767	hybrid, Green Published			2022-12-25	WOS:000257565300012
J	Kurihara, S; Oda, S; Tsuboi, Y; Kim, HG; Oshida, M; Kumagai, H; Suzuki, H				Kurihara, Shin; Oda, Shinpei; Tsuboi, Yuichi; Kim, Hyeon Guk; Oshida, Mayu; Kumagai, Hidehiko; Suzuki, Hideyuki			gamma-glutamylputrescine synthetase in the putrescine utilization pathway of Escherichia coli K-12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMINE-SYNTHETASE; POLYAMINES; PROTEIN; MUTANT; MICROORGANISMS; TRANSPEPTIDASE; ENZYMES; GROWTH; GENES; RANGE	Glutamate-putrescine ligase (gamma-glutamylputrescine synthetase, PuuA, EC 6.3.1.11) catalyzes the gamma-glutamylation of putrescine, the first step in a novel putrescine utilization pathway involving gamma-glutamylated intermediates, the Puu pathway, in Escherichia coli. In this report, the character and physiological importance of PuuA are described. Purified non-tagged PuuA catalyzed the ATP-dependent gamma-glutamylation of putrescine. The K-m values for glutamate, ATP, and putrescine are 2.07, 2.35, and 44.6 mM, respectively. There are two putrescine utilization pathways in E. coli: the Puu pathway and the pathway without gamma-glutamylation. Gene deletion experiments of puuA, however, indicated that the Puu pathway was more critical in utilizing putrescine as a sole carbon or nitrogen source. The transcription of puuA was induced by putrescine and in a puuR-deleted strain. The amino acid sequences of PuuA and glutamine synthetase (GS) show high similarity. The molecular weights of the monomers of the two enzymes are quite similar, and PuuA exists as a dodecamer as does GS. Moreover the two amino acid residues of E. coli GS that are important for the metal-catalyzed oxidation of the enzyme molecule involved in protein turnover are conserved in PuuA, and it was experimentally shown that the corresponding amino acid residues in PuuA were involved in the metal-catalyzed oxidation similarly to GS. It is suggested that the intracellular concentration of putrescine is optimized by PuuA transcriptionally and posttranslationally and that excess putrescine is converted to a nutrient source by the Puu pathway.	[Suzuki, Hideyuki] Kyoto Inst Technol, Grad Sch Sci & Technol, Div Appl Biol, Sakyo Ku, Kyoto 6068585, Japan; [Kurihara, Shin; Oda, Shinpei; Tsuboi, Yuichi; Kim, Hyeon Guk; Oshida, Mayu] Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Sakyo Ku, Kyoto 6068502, Japan; [Kumagai, Hidehiko] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa 9218836, Japan	Kyoto Institute of Technology; Kyoto University; Ishikawa Prefecture University	Suzuki, H (corresponding author), Kyoto Inst Technol, Grad Sch Sci & Technol, Div Appl Biol, Sakyo Ku, Goshokaido Cho Matsugasaki, Kyoto 6068585, Japan.	hideyuki@kit.ac.jp						BENSON JR, 1975, P NATL ACAD SCI USA, V72, P619, DOI 10.1073/pnas.72.2.619; Candela T, 2006, MOL MICROBIOL, V60, P1091, DOI 10.1111/j.1365-2958.2006.05179.x; CASADEI MA, 1984, J AM CHEM SOC, V106, P1051, DOI 10.1021/ja00316a039; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Eisenberg D, 2000, BBA-PROTEIN STRUCT M, V1477, P122, DOI 10.1016/S0167-4838(99)00270-8; FUKUCHI JI, 1995, J BIOL CHEM, V270, P18831, DOI 10.1074/jbc.270.32.18831; FULKS RM, 1985, BIOCHIM BIOPHYS ACTA, V843, P214, DOI 10.1016/0304-4165(85)90142-4; Igarashi K, 2006, J BIOCHEM, V139, P11, DOI 10.1093/jb/mvj020; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; KAKEGAWA T, 1991, J BIOCHEM, V109, P627, DOI 10.1093/oxfordjournals.jbchem.a123431; KINGDON HS, 1968, BIOCHEMISTRY-US, V7, P2136, DOI 10.1021/bi00846a016; KOHARA Y, 1987, CELL, V50, P495, DOI 10.1016/0092-8674(87)90503-4; Kurihara S, 2006, FEMS MICROBIOL LETT, V256, P318, DOI 10.1111/j.1574-6968.2006.00137.x; Kurihara S, 2005, J BIOL CHEM, V280, P4602, DOI 10.1074/jbc.M411114200; LARGE PJ, 1992, FEMS MICROBIOL LETT, V88, P249, DOI 10.1111/j.1574-6968.1992.tb04991.x; LIAW SH, 1993, BIOCHEMISTRY-US, V32, P7999, DOI 10.1021/bi00082a022; Linsalata M, 2002, ANTICANCER RES, V22, P2465; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MANNERVIK B, 1989, COENZYMES COFACTORS, V3, P475; Miller J. H., 1992, SHORT COURSE BACTERI, P263; PARK JT, 1996, ESCHERICHIA COLI SAL, P49; Partridge JD, 2006, J BIOL CHEM, V281, P27806, DOI 10.1074/jbc.M603450200; PEGG AE, 1986, BIOCHEM J, V234, P249, DOI 10.1042/bj2340249; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sambrook J, 2001, MOL CLONING LAB MANU; Samsonova NN, 2005, FEBS LETT, V579, P4107, DOI 10.1016/j.febslet.2005.06.038; Samsonova NN, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-2; SHAIBE E, 1985, J BACTERIOL, V163, P938, DOI 10.1128/JB.163.3.938-942.1985; SMITH GR, 1971, J BIOL CHEM, V246, P3320; Stadtman ER, 2001, J BIOL CHEM, V276, P44357, DOI 10.1074/jbc.R100055200; SUZUKI H, 1989, J BACTERIOL, V171, P5169, DOI 10.1128/jb.171.9.5169-5172.1989; Suzuki H, 2003, APPL ENVIRON MICROB, V69, P6399, DOI 10.1128/AEM.69.11.6399-6404.2003; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; Xaplanteri MA, 2005, NUCLEIC ACIDS RES, V33, P2792, DOI 10.1093/nar/gki557	34	66	89	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					19981	19990		10.1074/jbc.M800133200	http://dx.doi.org/10.1074/jbc.M800133200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18495664	hybrid			2022-12-25	WOS:000257565300013
J	Guo, XY; Oshima, H; Kitmura, T; Taketo, MM; Oshima, M				Guo, Xiaoying; Oshima, Hiroko; Kitmura, Takanori; Taketo, Makoto M.; Oshima, Masanobu			Stromal fibroblasts activated by tumor cells promote angiogenesis in mouse gastric cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; PROSTAGLANDIN-E SYNTHASE-1; BREAST-CANCER; INTESTINAL POLYPOSIS; EPITHELIAL-CELLS; TRANSGENIC MICE; KNOCKOUT MICE; MYOFIBROBLASTS; RECEPTOR; WNT	Myofibroblasts, also known as activated fibroblasts, constitute an important niche for tumor development through the promotion of angiogenesis. However, the mechanism of stromal fibroblast activation in tumor tissues has not been fully understood. A gastric cancer mouse model (Gan mice) was recently constructed by simultaneous activation of prostaglandin (PG) E-2 and Wnt signaling in the gastric mucosa. Because both the PGE(2) and Wnt pathways play a role in human gastric tumorigenesis, the Gan mouse model therefore recapitulates the molecular etiology of human gastric cancer. Microvessel density increased significantly in Gan mouse tumors. Moreover, the expression of vascular endothelial growth factorA(VEGFA) was predominantly induced in the stromal cells of gastric tumors. Immunohistochemistry suggested that VEGFA-expressing cells in the stroma were alpha-smooth muscle actin-positive myofibroblasts. Bone marrow transplantation experiments indicated that a subset of gastric myofibroblasts is derived from bone marrow. Importantly, the alpha-smooth muscle actin index in cultured fibroblasts increased significantly when stimulated with the conditioned medium of Gan mouse tumor cells, indicating that gastric tumor cells activate stromal fibroblasts. Furthermore, conditioned medium of Gan mouse tumor cells induced VEGFA expression both in embryonic and gastric fibroblasts, which further accelerated the tube formation of human umbilical vein endothelial cells in vitro. Notably, stimulation of fibroblasts with PGE2 and/or Wnt1 did not induce VEGFA expression, thus suggesting that factors secondarily induced by PGE2 and Wnt signaling in the tumor cells are responsible for activation of stromal fibroblasts. Such tumor cell-derived factors may therefore be an effective target for chemoprevention against gastric cancer.	[Guo, Xiaoying; Oshima, Hiroko; Oshima, Masanobu] Kanazawa Univ, Div Genet, Canc Res Inst, Kanazawa, Ishikawa 9200934, Japan; [Guo, Xiaoying] China Med Univ, Sch Publ Hlth, Dept Environm & Occupat Hlth, Shenyang 110001, Peoples R China; [Kitmura, Takanori; Taketo, Makoto M.] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto 6068501, Japan	Kanazawa University; China Medical University; Kyoto University	Oshima, M (corresponding author), Kanazawa Univ, Div Genet, Canc Res Inst, 13-1 Takara Machi, Kanazawa, Ishikawa 9200934, Japan.	oshimam@kenroku.kanazawa-u.ac.jp	Oshima, Masanobu/F-9958-2014	Oshima, Masanobu/0000-0002-3304-0004; Guo, Xiaoying/0000-0002-5337-2532; Kitamura, Takanori/0000-0003-2032-3918; Oshima, Hiroko/0000-0001-6855-4008				Adegboyega PA, 2002, ARCH PATHOL LAB MED, V126, P829; Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Barcellos-Hoff MH, 2000, CANCER RES, V60, P1254; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Brittan M, 2005, GASTROENTEROLOGY, V128, P1984, DOI 10.1053/j.gastro.2005.03.028; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Clements WM, 2002, CANCER RES, V62, P3503; Direkze NC, 2004, CANCER RES, V64, P8492, DOI 10.1158/0008-5472.CAN-04-1708; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Ishii G, 2003, BIOCHEM BIOPH RES CO, V309, P232, DOI 10.1016/S0006-291X(03)01544-4; Matsumoto K, 2005, BIOCHEM BIOPH RES CO, V333, P316, DOI 10.1016/j.bbrc.2005.05.131; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; Nakayama H, 2002, J CLIN PATHOL, V55, P741, DOI 10.1136/jcp.55.10.741; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Olumi AF, 1999, CANCER RES, V59, P5002; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Oshima H, 2004, EMBO J, V23, P1669, DOI 10.1038/sj.emboj.7600170; Oshima H, 2006, GASTROENTEROLOGY, V131, P1086, DOI 10.1053/j.gastro.2006.07.014; Oshima M, 2005, CANCER RES, V65, P9147, DOI 10.1158/0008-5472.CAN-05-1936; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; Roder David M, 2002, Gastric Cancer, V5 Suppl 1, P5, DOI 10.1007/s10120-002-0203-6; RONNOVJESSEN L, 1995, J CLIN INVEST, V95, P859, DOI 10.1172/JCI117736; SAPPINO AP, 1988, INT J CANCER, V41, P707, DOI 10.1002/ijc.2910410512; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Saukkonen K, 2003, APMIS, V111, P915, DOI 10.1034/j.1600-0463.2003.1111001.x; Seno H, 2002, CANCER RES, V62, P506; Serini G, 1999, EXP CELL RES, V250, P273, DOI 10.1006/excr.1999.4543; Shao JY, 2006, CANCER RES, V66, P846, DOI 10.1158/0008-5472.CAN-05-2606; Sonoshita M, 2001, NAT MED, V7, P1048, DOI 10.1038/nm0901-1048; Su JL, 2004, CANCER RES, V64, P554, DOI 10.1158/0008-5472.CAN-03-1301; Taketo MM, 2006, ONCOGENE, V25, P7522, DOI 10.1038/sj.onc.1210058; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; van Rees BP, 2003, INT J CANCER, V107, P551, DOI 10.1002/ijc.11422; Yoshida S, 1997, MOL CELL BIOL, V17, P4015, DOI 10.1128/MCB.17.7.4015; Zhang XB, 2001, CANCER RES, V61, P6050	37	138	143	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19864	19871		10.1074/jbc.M800798200	http://dx.doi.org/10.1074/jbc.M800798200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18495668	hybrid, Green Submitted			2022-12-25	WOS:000257387600070
J	Malmberg, SE; Adams, CM				Malmberg, Sharon E.; Adams, Christopher M.			Insulin signaling and the general amino acid control response - Two distinct pathways to amino acid synthesis and uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-III TRANSCRIPTION; GCN2 EIF2-ALPHA KINASE; ATF4; EXPRESSION; MICE; DEPRIVATION; PROTEIN; LIVER	ATF4 is a transcription factor that induces a genetic program for amino acid synthesis and amino acid uptake. Previous work demonstrated that ATF4 expression is increased either by insulin or by the general amino acid control (GAAC) response, an evolutionarily ancient pathway that is activated when eukaryotic cells are deprived of amino acids. It is not known whether insulin and the GAAC pathway increase ATF4 expression by the same or different mechanisms. In these studies, we demonstrate that insulin-mediated ATF4 expression occurs as part of a coordinated anabolic program that does not require an essential component of the GAAC pathway, the protein kinase GCN2. Moreover, insulin and the GAAC pathway have an additive effect on expression of ATF4 and downstream mRNAs for amino acid synthesis and uptake. These data suggest that the GAAC pathway may facilitate insulin-mediated anabolism when exogenous amino acids are limiting. We conclude that insulin signaling and the GAAC response comprise two distinct yet complimentary pathways to ATF4 expression, allowing anabolism to be finely tuned to amino acid availability.	[Malmberg, Sharon E.; Adams, Christopher M.] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa	Adams, CM (corresponding author), Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	christopher-adams@uiowa.edu		Adams, Christopher/0000-0002-5795-7212				Adams CM, 2007, J BIOL CHEM, V282, P16744, DOI 10.1074/jbc.M610510200; Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; BERDANIER CD, 1979, J NUTR, V109, P1766, DOI 10.1093/jn/109.10.1766; Daly NL, 2005, ONCOGENE, V24, P880, DOI 10.1038/sj.onc.1208031; Elefteriou F, 2006, CELL METAB, V4, P441, DOI 10.1016/j.cmet.2006.10.010; Foster DW, 1996, TXB ENDOCRINE PHYSL, P309; Guo FF, 2007, CELL METAB, V5, P103, DOI 10.1016/j.cmet.2007.01.001; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hettmann T, 2000, DEV BIOL, V222, P110, DOI 10.1006/dbio.2000.9699; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Jousse C, 2004, BIOCHEM BIOPH RES CO, V313, P447, DOI 10.1016/j.bbrc.2003.07.020; Kimball SR, 2005, SEMIN CELL DEV BIOL, V16, P21, DOI 10.1016/j.semcdb.2004.11.009; Lassot I, 2001, MOL CELL BIOL, V21, P2192, DOI 10.1128/MCB.21.6.2192-2202.2001; LEUNG K, 1975, ANNU REV PHYSIOL, V37, P245, DOI 10.1146/annurev.ph.37.030175.001333; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; LOBEL P, 1989, CELL, V57, P787, DOI 10.1016/0092-8674(89)90793-9; Lopez AB, 2007, BIOCHEM J, V402, P163, DOI 10.1042/BJ20060941; Masuoka HC, 2002, BLOOD, V99, P736, DOI 10.1182/blood.V99.3.736; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; PRATT WB, 1966, J BIOL CHEM, V241, P5244; Siu F, 2002, J BIOL CHEM, V277, P24120, DOI 10.1074/jbc.M201959200; Tanaka T, 1998, GENES CELLS, V3, P801, DOI 10.1046/j.1365-2443.1998.00230.x; TOWLE HC, 1995, J BIOL CHEM, V270, P23235, DOI 10.1074/jbc.270.40.23235; Winter AG, 2000, P NATL ACAD SCI USA, V97, P12619, DOI 10.1073/pnas.230224097; Yang J, 2001, P NATL ACAD SCI USA, V98, P13607, DOI 10.1073/pnas.201524598; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yang XL, 2004, J BIOL CHEM, V279, P47109, DOI 10.1074/jbc.M410010200; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002	29	34	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19229	19234		10.1074/jbc.M801331200	http://dx.doi.org/10.1074/jbc.M801331200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18480057	hybrid			2022-12-25	WOS:000257387600008
J	Vetter, I; Cheng, W; Peiris, M; Wyse, BD; Roberts-Thomson, SJ; Zheng, J; Monteith, GR; Cabot, PJ				Vetter, Irina; Cheng, Wei; Peiris, Madusha; Wyse, Bruce D.; Roberts-Thomson, Sarah J.; Zheng, Jie; Monteith, Gregory R.; Cabot, Peter J.			Rapid, opioid-sensitive mechanisms involved in transient receptor potential vanilloid 1 sensitization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; VANILLOID RECEPTOR TRPV1; ACTIVATED ION-CHANNEL; DORSAL-ROOT GANGLION; CAPSAICIN RECEPTOR; THERMAL HYPERALGESIA; NEUROPATHIC PAIN; CA2+ RELEASE; TISSUE TRANSGLUTAMINASE; ENDOPLASMIC-RETICULUM	TRPV1 is a nociceptive, Ca2+-selective ion channel involved in the development of several painful conditions. Sensitization of TRPV1 responses by cAMP-dependent PKA crucially contributes to the development of inflammatory hyperalgesia. However, the pathways involved in potentiation of TRPV1 responses by cAMP-dependent PKA remain largely unknown. Using HEK cells stably expressing TRPV1 and the mu opioid receptor, we demonstrated that treatment with the adenylate cyclase activator forskolin significantly increased the multimeric TRPV1 species. Pretreatment with the mu opioid receptor agonist morphine reversed this increased TRPV1 multimerization. FRET analysis revealed that treatment with forskolin did not cause multimerization of pre-existing TRPV1 monomers on the plasma membrane and that intracellular pools of TRPV1 exist mostly as monomers in this model. This suggests that increased TRPV1 multimerization occurred from an intracellular store of inactive TRPV1 monomers. Treatment with forskolin also caused an increase in TRPV1 expression on the plasma membrane not resulting from increased TRPV1 expression, and this rapid TRPV1 translocation was inhibited by treatment with morphine. Thus, potentiation of TRPV1 responses by cAMP-dependent PKA involves plasma membrane insertion of functional TRPV1 multimers formed from an intracellular store of inactive TRPV1 monomers. This potentiation occurs rapidly and can be dynamically modulated by activation of the mu opioid receptor under conditions where cAMP levels are raised, such as with inflammation. Increased translocation and multimerization of TRPV1 channels provide a cellular mechanism for fine-tuning of nociceptive responses that allow for rapid modulation of TRPV1 responses independent of transcriptional changes.	[Vetter, Irina; Peiris, Madusha; Wyse, Bruce D.; Roberts-Thomson, Sarah J.; Monteith, Gregory R.; Cabot, Peter J.] Univ Queensland, Sch Pharm, St Lucia, Qld 4072, Australia; [Cheng, Wei; Zheng, Jie] Univ Calif Davis, Sch Med, Dept Physiol & Membrane Biol, Davis, CA 95616 USA	University of Queensland; University of California System; University of California Davis	Cabot, PJ (corresponding author), Univ Queensland, Sch Pharm, St Lucia, Qld 4072, Australia.	p.cabot@uq.edu.au	Monteith, Gregory/B-1626-2008; Vetter, Irina/A-6035-2010; cheng, wei/F-2135-2011; Roberts-Thomson, Sarah/W-5676-2019; Cabot, Peter John/B-2424-2013; Roberts-Thomson, Sarah J/B-4282-2011	Monteith, Gregory/0000-0002-4345-530X; Vetter, Irina/0000-0002-3594-9588; Roberts-Thomson, Sarah/0000-0001-8202-5786; Cabot, Peter John/0000-0003-1778-3753; Roberts-Thomson, Sarah J/0000-0001-8202-5786	NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR012088] Funding Source: NIH RePORTER; NCRR NIH HHS [C06 RR012088, C06-RR-12088-01] Funding Source: Medline; PHS HHS [REY016754A] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Alebouyeh M, 2002, CYTOKINE, V19, P102, DOI 10.1006/cyto.2002.1947; Amaya F, 2003, BRAIN RES, V963, P190, DOI 10.1016/S0006-8993(02)03972-0; Ballet S, 1998, BRAIN RES, V796, P198, DOI 10.1016/S0006-8993(98)00350-3; Bhave G, 2002, NEURON, V35, P721, DOI 10.1016/S0896-6273(02)00802-4; Breese NM, 2005, PAIN, V115, P37, DOI 10.1016/j.pain.2005.02.010; Cabot PJ, 1997, J CLIN INVEST, V100, P142, DOI 10.1172/JCI119506; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cayouette S, 2007, CELL CALCIUM, V42, P225, DOI 10.1016/j.ceca.2007.01.014; Chang SY, 2002, J CELL SCI, V115, P783; CHAO CC, 1993, INT J IMMUNOPHARMACO, V15, P447, DOI 10.1016/0192-0561(93)90057-6; Cheng W, 2007, J GEN PHYSIOL, V129, P191, DOI 10.1085/jgp.200709731; Chheda MG, 2001, NAT CELL BIOL, V3, P331, DOI 10.1038/35070000; Clark JD, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-28; Csordas G, 2001, CELL CALCIUM, V29, P249, DOI 10.1054/ceca.2000.0191; Dutertre S, 2008, J BIOL CHEM, V283, P7100, DOI 10.1074/jbc.M706477200; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Eun SY, 2001, BIOCHEM BIOPH RES CO, V285, P1114, DOI 10.1006/bbrc.2001.5272; Hebert SS, 2000, J BIOL CHEM, V275, P32482, DOI 10.1074/jbc.M006528200; Hong SS, 2005, J BIOL CHEM, V280, P618, DOI 10.1074/jbc.M408500200; Hu HJ, 2002, J NEUROSCI, V22, P7444; Huang SM, 2002, P NATL ACAD SCI USA, V99, P8400, DOI 10.1073/pnas.122196999; Jung J, 1999, J NEUROSCI, V19, P529; Kedei N, 2001, J BIOL CHEM, V276, P28613, DOI 10.1074/jbc.M103272200; Kim JA, 2005, ARCH PHARM RES, V28, P73, DOI 10.1007/BF02975139; Kuzhikandathil EV, 2001, J NEUROSCI, V21, P8697, DOI 10.1523/JNEUROSCI.21-22-08697.2001; Lee SY, 2005, BIOCHEM BIOPH RES CO, V331, P1445, DOI 10.1016/j.bbrc.2005.04.066; Liu M, 2006, EUR J NEUROSCI, V24, P1, DOI 10.1111/j.1460-9568.2006.04889.x; Luo H, 2004, NEUROREPORT, V15, P655, DOI 10.1097/00001756-200403220-00016; Mahieu F, 2007, J BIOL CHEM, V282, P3325, DOI 10.1074/jbc.M605213200; Malmberg AB, 1997, J NEUROSCI, V17, P7462; Mammone T, 1998, SKIN PHARMACOL APPL, V11, P152, DOI 10.1159/000029821; Matsuura B, 2006, J BIOL CHEM, V281, P12390, DOI 10.1074/jbc.M511921200; Mohapatra DP, 2005, J BIOL CHEM, V280, P13424, DOI 10.1074/jbc.M410917200; Mohapatra DP, 2003, J BIOL CHEM, V278, P50080, DOI 10.1074/jbc.M306619200; Morenilla-Palao C, 2004, J BIOL CHEM, V279, P25665, DOI 10.1074/jbc.M311515200; MORRE DJ, 1989, BIOTECHNIQUES, V7, P946; MURTAUGH MP, 1986, J BIOL CHEM, V261, P614; Planells-Cases R, 2005, PFLUG ARCH EUR J PHY, V451, P151, DOI 10.1007/s00424-005-1423-5; Pomonis JD, 2003, J PHARMACOL EXP THER, V306, P387, DOI 10.1124/jpet.102.046268; Rathee PK, 2002, J NEUROSCI, V22, P4740, DOI 10.1523/JNEUROSCI.22-11-04740.2002; Rosenbaum T, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-4; Ross RA, 2001, BRIT J PHARMACOL, V132, P631, DOI 10.1038/sj.bjp.0703850; SCHAFER M, 1995, EUR J PHARMACOL, V279, P165, DOI 10.1016/0014-2999(95)00150-J; Stein A, 1999, PAIN, V83, P525, DOI 10.1016/S0304-3959(99)00156-6; TAIWO YO, 1989, NEUROSCIENCE, V32, P577, DOI 10.1016/0306-4522(89)90280-7; Takanishi CL, 2006, BRAIN RES, V1091, P132, DOI 10.1016/j.brainres.2006.01.119; Thomson LM, 2008, J PAIN, V9, P11, DOI 10.1016/j.jpain.2007.07.008; Tohda C, 2001, J NEUROCHEM, V76, P1628, DOI 10.1046/j.1471-4159.2001.00193.x; Vetter I, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-22; von Wronski MA, 2006, J BIOL CHEM, V281, P5702, DOI 10.1074/jbc.M511941200; Walker JS, 2003, ADV EXP MED BIOL, V521, P148; Walker KM, 2003, J PHARMACOL EXP THER, V304, P56, DOI 10.1124/jpet.102.042010; Wang CB, 2004, J BIOL CHEM, V279, P37423, DOI 10.1074/jbc.M407205200	54	39	40	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19540	19550		10.1074/jbc.M707865200	http://dx.doi.org/10.1074/jbc.M707865200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18482991	Green Published, hybrid			2022-12-25	WOS:000257387600040
J	Axe, DD; Dixon, BW; Lu, P				Axe, Douglas D.; Dixon, Brendan W.; Lu, Philip			Stylus: A System for Evolutionary Experimentation Based on a Protein/Proteome Model with Non-Arbitrary Functional Constraints	PLOS ONE			English	Article							PROTEIN EVOLUTION; SEQUENCE; SENSITIVITY; SELECTION; UNIVERSE; ORIGIN	The study of protein evolution is complicated by the vast size of protein sequence space, the huge number of possible protein folds, and the extraordinary complexity of the causal relationships between protein sequence, structure, and function. Much simpler model constructs may therefore provide an attractive complement to experimental studies in this area. Lattice models, which have long been useful in studies of protein folding, have found increasing use here. However, while these models incorporate actual sequences and structures ( albeit non-biological ones), they incorporate no actual functions-relying instead on largely arbitrary structural criteria as a proxy for function. In view of the central importance of function to evolution, and the impossibility of incorporating real functional constraints without real function, it is important that protein-like models be developed around real structure-function relationships. Here we describe such a model and introduce open-source software that implements it. The model is based on the structure-function relationship in written language, where structures are two-dimensional ink paths and functions are the meanings that result when these paths form legible characters. To capture something like the hierarchical complexity of protein structure, we use the traditional characters of Chinese origin. Twenty coplanar vectors, encoded by base triplets, act like amino acids in building the character forms. This vector-world model captures many aspects of real proteins, including life-size sequences, a life-size structural repertoire, a realistic genetic code, secondary, tertiary, and quaternary structure, structural domains and motifs, operon-like genetic structures, and layered functional complexity up to a level resembling bacterial genomes and proteomes. Stylus is a full-featured implementation of the vector world for Unix systems. To demonstrate the utility of Stylus, we generated a sample set of homologous vector proteins by evolving successive lines from a single starting gene. These homologues show sequence and structure divergence resembling those of natural homologues in many respects, suggesting that the system may be sufficiently life-like for informative comparison to biology.	[Axe, Douglas D.; Dixon, Brendan W.; Lu, Philip] Inst Biol, Redmond, WA USA		Axe, DD (corresponding author), Inst Biol, Redmond, WA USA.	daxe@biologicinstitute.org			Biologic Institute	Biologic Institute	The work was paid for by general research funds of Biologic Institute.	Axe DD, 1998, BIOCHEMISTRY-US, V37, P7157, DOI 10.1021/bi9804028; Axe DD, 2000, J MOL BIOL, V301, P585, DOI 10.1006/jmbi.2000.3997; Axe DD, 2004, J MOL BIOL, V341, P1295, DOI 10.1016/j.jmb.2004.06.058; Axe DD, 1996, P NATL ACAD SCI USA, V93, P5590, DOI 10.1073/pnas.93.11.5590; Blanco FJ, 1999, J MOL BIOL, V285, P741, DOI 10.1006/jmbi.1998.2333; Bloom JD, 2005, P NATL ACAD SCI USA, V102, P606, DOI 10.1073/pnas.0406744102; Brenner SE, 1998, P NATL ACAD SCI USA, V95, P6073, DOI 10.1073/pnas.95.11.6073; Brenner SE, 1996, METHOD ENZYMOL, V266, P635; CHAN HS, 1993, PHYS TODAY, V46, P24, DOI 10.1063/1.881371; Chan Hue Sun, 2002, Appl Bioinformatics, V1, P121; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Das S, 2000, ADV PROTEIN CHEM, V54, P159, DOI 10.1016/S0065-3233(00)54006-6; Deeds Eric J., 2007, V75, P133; Dill KA, 1999, PROTEIN SCI, V8, P1166, DOI 10.1110/ps.8.6.1166; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dokholyan NV, 2002, P NATL ACAD SCI USA, V99, P14132, DOI 10.1073/pnas.202497999; Drake JW, 1998, GENETICS, V148, P1667; EDEN M, 1967, MATH CHALLENGES NEO, P109; Freeland SJ, 2000, MOL BIOL EVOL, V17, P511, DOI 10.1093/oxfordjournals.molbev.a026331; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hirst JD, 1999, PROTEIN ENG, V12, P721, DOI 10.1093/protein/12.9.721; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Jordan IK, 2002, GENOME RES, V12, P962, DOI 10.1101/gr.87702; Kimura MA, 1985, NEUTRAL THEORY MOL E; Koonin EV, 2002, NATURE, V420, P218, DOI 10.1038/nature01256; Lenski RE, 2003, NATURE, V423, P139, DOI 10.1038/nature01568; LEVIN BR, 1981, GENETICS, V99, P1; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; Orengo CA, 2005, ANNU REV BIOCHEM, V74, P867, DOI 10.1146/annurev.biochem.74.082803.133029; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; SCHUTZENBERGER MP, 1967, MATH CHALLENGES NEO, P75; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Xia Y, 2004, CURR OPIN STRUC BIOL, V14, P202, DOI 10.1016/j.sbi.2004.03.001; Zeldovich KB, 2007, PLOS COMPUT BIOL, V3, P1224, DOI 10.1371/journal.pcbi.0030139	35	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2246	10.1371/journal.pone.0002246	http://dx.doi.org/10.1371/journal.pone.0002246			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523658	Green Published, gold, Green Submitted			2022-12-25	WOS:000262614300001
J	Hermine, O; Lortholary, O; Leventhal, PS; Catteau, A; Soppelsa, F; Baude, C; Cohen-Akenine, A; Palmerini, F; Hanssens, K; Yang, Y; Sobol, H; Fraytag, S; Ghez, D; Suarez, F; Barete, S; Casassus, P; Sans, B; Arock, M; Kinet, JP; Dubreuil, P; Moussy, A				Hermine, Olivier; Lortholary, Olivier; Leventhal, Phillip S.; Catteau, Adeline; Soppelsa, Frederique; Baude, Cedric; Cohen-Akenine, Annick; Palmerini, Fabienne; Hanssens, Katia; Yang, Ying; Sobol, Hagay; Fraytag, Sylvie; Ghez, David; Suarez, Felipe; Barete, Stephane; Casassus, Philippe; Sans, Beatrice; Arock, Michel; Kinet, Jean Pierre; Dubreuil, Patrice; Moussy, Alain			Case-Control Cohort Study of Patients' Perceptions of Disability in Mastocytosis	PLOS ONE			English	Article								Background: Indolent forms of mastocytosis account for more than 90% of all cases, but the types and type and severity of symptoms and their impact on the quality of life have not been well studied. We therefore performed a case-control cohort study to examine self-reported disability and impact of symptoms on the quality of life in patients with mastocytosis. Methodology/Principal Findings: In 2004, 363 mastocytosis patients and 90 controls in France were asked to rate to their overall disability (OPA score) and the severity of 38 individual symptoms. The latter was used to calculate a composite score (AFIRMM score). Of the 363 respondents, 262 were part of an ongoing pathophysiological study so that the following data were available: World Health Organization classification, standard measures of physical and psychological disability, existence of the D816V KIT mutation, and serum tryptase level. The mean OPA and AFIRMM scores and the standard measures of disability indicated that most mastocytosis patients suffer from disabilities due to the disease. Surprisingly, the patient's measurable and perceived disabilities did not differ according to disease classification or presence or absence of the D816V KIT mutation or an elevated (>= 20 ng/mL) serum tryptase level. Also, 32 of the 38 AFIRMM symptoms were more common in patients than controls, but there were not substantial differences according to disease classification, presence of the D816V mutation, or the serum tryptase level. Conclusions: On the basis of these results and for the purposes of treatment, we propose that mastocytosis be first classified as aggressive or indolent and that indolent mastocytosis then be categorized according to the severity of patients' perceived symptoms and their impact on the quality of life. In addition, it appears that mastocytosis patients suffer from more symptoms and greater disability than previously thought, that mastocytosis may therefore be under-diagnosed, and that the symptoms of the indolent forms of mastocytosis might be due more to systemic release of mediators than mast cell burden.	[Hermine, Olivier; Ghez, David; Barete, Stephane] Hop Necker Enfants Malad, Ctr Reference Mastocytose, Serv Dermatol, Paris, France; [Hermine, Olivier; Ghez, David; Suarez, Felipe] Hop Necker Enfants Malad, Ctr Reference Mastocytose, Serv Hematol Adulte, Paris, France; [Hermine, Olivier; Lortholary, Olivier; Leventhal, Phillip S.; Catteau, Adeline; Soppelsa, Frederique; Baude, Cedric; Cohen-Akenine, Annick; Palmerini, Fabienne; Hanssens, Katia; Sobol, Hagay; Casassus, Philippe; Kinet, Jean Pierre; Dubreuil, Patrice; Moussy, Alain] AFIRMM, Paris, France; [Lortholary, Olivier; Palmerini, Fabienne; Hanssens, Katia; Yang, Ying; Dubreuil, Patrice] Ctr Rech Cancerol Marseille, Lab Hematopoiese Mol Fonctionnelle, INSERM UMR599, Marseille, France; [Palmerini, Fabienne; Hanssens, Katia; Fraytag, Sylvie; Dubreuil, Patrice] Hop Necker Enfants Malad, Ctr Reference Mastocytose, Serv Anatomopathol, Paris, France; [Sobol, Hagay] Inst Paoli Calmettes, Ctr Reference Mastocytose, Dept Oncol Genet, Marseille, France; [Barete, Stephane] Univ Paris 06, Assistance Publ Hop Paris, Ctr Reference Mastocytose, Hop Tenon, Paris, France; [Casassus, Philippe] Univ Paris 13, CHU Bobigny, Hop Avicennes, Service Hematol, Paris, France; [Sans, Beatrice] Hop Purpan, Serv Dermatol, Venerol Allergol, Toulouse, France; [Arock, Michel] Hop Necker Enfants Malad, Assistance Publ Hop Paris, Ctr Reference Mastocytoses, Dept Infect & Trop Dis, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Institut Paoli-Calmette (IPC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; CHU de Toulouse; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Hermine, O (corresponding author), Hop Necker Enfants Malad, Ctr Reference Mastocytose, Serv Dermatol, Paris, France.	hermine@necker.fr	Dubreuil, Patrice/V-4816-2019; Hermine, Olivier/Q-7072-2018; dubreuil, patrice/F-5346-2011	Dubreuil, Patrice/0000-0003-1155-1150; dubreuil, patrice/0000-0003-1155-1150; Hermine, Olivier/0000-0003-2574-3874	Association Francaise pour les Initiatives et la Recherche sur le Mastocyte et les Mastocytoses (AFIRMM)	Association Francaise pour les Initiatives et la Recherche sur le Mastocyte et les Mastocytoses (AFIRMM)	Financial support for this study was provided by the Association Francaise pour les Initiatives et la Recherche sur le Mastocyte et les Mastocytoses (AFIRMM).	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Akin C, 2004, ANNU REV MED, V55, P419, DOI 10.1146/annurev.med.55.091902.103822; Akin C, 2007, CLIN IMMUNOL, V123, P268, DOI 10.1016/j.clim.2007.02.007; Boncoraglio GB, 2005, NEUROLOGY, V65, P332, DOI 10.1212/01.wnl.0000168897.35545.61; D'Inca M, 1996, Ann Ital Med Int, V11, P52; Escribano Luis, 2006, Inflammation & Allergy Drug Targets, V5, P61, DOI 10.2174/187152806775269303; Feger F, 2002, INT ARCH ALLERGY IMM, V127, P110, DOI 10.1159/000048179; Hedlund J.L., 1979, J OPER PSYCHIATR, V10, P149, DOI DOI 10.1192/BJP.BP.106.032532; Hogan DJ, EMEDICINE; Jensen RT, 2000, HEMATOL ONCOL CLIN N, V14, P579, DOI 10.1016/S0889-8588(05)70298-7; Proelss J, 2007, J AM ACAD DERMATOL, V56, P453, DOI 10.1016/j.jaad.2006.09.020; ROGERS MP, 1986, PSYCHOSOM MED, V48, P437, DOI 10.1097/00006842-198607000-00006; Schwartz LB, 2006, IMMUNOL ALLERGY CLIN, V26, P451, DOI 10.1016/j.iac.2006.05.010; SCHWARTZ LB, 1994, J CLIN IMMUNOL, V14, P190, DOI 10.1007/BF01533368; SOTER NA, 1979, NEW ENGL J MED, V301, P465, DOI 10.1056/NEJM197908303010903; Sperr WR, 2001, BLOOD, V98, P2200, DOI 10.1182/blood.V98.7.2200; Valent P, 2005, LEUKEMIA LYMPHOMA, V46, P35, DOI 10.1080/10428190400010775; Valent P, 2001, LEUKEMIA RES, V25, P603, DOI 10.1016/S0145-2126(01)00038-8; Zappulla JP, 2005, J EXP MED, V202, P1635, DOI 10.1084/jem.20050807	19	110	116	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2266	10.1371/journal.pone.0002266	http://dx.doi.org/10.1371/journal.pone.0002266			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509466	Green Published, gold, Green Submitted			2022-12-25	WOS:000262268500013
J	Perrin-Cocon, L; Agaugue, S; Diaz, O; Vanbervliet, B; Dollet, S; Guironnet-Paquet, A; Andre, P; Lotteau, V				Perrin-Cocon, Laure; Agaugue, Sophie; Diaz, Olivier; Vanbervliet, Beatrice; Dollet, Sandra; Guironnet-Paquet, Aurelie; Andre, Patrice; Lotteau, Vincent			Th1 Disabled Function in Response to TLR4 Stimulation of Monocyte-Derived DC from Patients Chronically-Infected by Hepatitis C Virus	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; PLASMACYTOID DENDRITIC CELLS; ACTIVATED PROTEIN-KINASE; TOLL-LIKE RECEPTOR-4; SIGNALING PATHWAY; MATURATION; LIPOPOLYSACCHARIDE; DYSFUNCTION; RECOGNITION; ASSOCIATION	Background: Lack of protective antibodies and inefficient cytotoxic responses are characteristics of chronic hepatitis C infection. A defect in dendritic cell (DC) function has thus been suspected, but this remains a controversial issue. Methods and Findings: Here we show that monocyte-derived DC (MoDC) from chronically-infected patients can mature in response to TLR1/2, TLR2/6 or TLR3 ligands. In contrast, when stimulated with the TLR4 ligand LPS, MoDC from patients show a profound defect in inducing IFN gamma secretion by allogeneic T cells. This defect is not due to defective phenotypic maturation or to the presence of HCV-RNA in DC or monocytes but is correlated to reduced IL-12 secretion by DC. Restoration of DC ability to stimulate IFN gamma secretion can be obtained by blocking MEK activation in DC, indicating that MEK/ERK pathway is involved in the Th1 defect of MoDC. Monocytes from HCV patients present increased spontaneous secretion of cytokines and chemokines, especially MIP-1 beta. Addition of MIP-1 beta on healthy monocytes during differentiation results in DC that have Th1 defect characteristic of MoDC from HCV patients, suggesting that MIP-1 beta secretion by HCV monocytes participates in the Th1 defect of DC. Conclusions: Our data indicate that monocytes from HCV patients are activated in vivo. This interferes with their differentiation into DC, leading to deficient TLR4 signaling in these cells that are enable to induce a Th1 response. This specific defect is linked to the activation of the MEK/ERK pathway.	[Perrin-Cocon, Laure; Agaugue, Sophie; Diaz, Olivier; Vanbervliet, Beatrice; Dollet, Sandra; Guironnet-Paquet, Aurelie; Andre, Patrice; Lotteau, Vincent] INSERM, U851, F-69008 Lyon, France; [Perrin-Cocon, Laure; Agaugue, Sophie; Diaz, Olivier; Vanbervliet, Beatrice; Dollet, Sandra; Guironnet-Paquet, Aurelie; Andre, Patrice; Lotteau, Vincent] Univ Lyon, IFR128 BioSci Lyon Gerland, Lyon, France; [Andre, Patrice; Lotteau, Vincent] Hop Croix Rousse, Lab Virol, Hospices Civils Lyon, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon	Perrin-Cocon, L (corresponding author), INSERM, U851, F-69008 Lyon, France.	laure.perrin@inserm.fr	André, Patrice/M-8139-2014; lotteau, vincent/M-8143-2014; Perrin-Cocon, Laure A/M-8099-2014; diaz, olivier/M-8112-2014; Carlet-Dollet, Sandra/X-8945-2019	André, Patrice/0000-0002-5834-7395; Perrin-Cocon, Laure A/0000-0003-0501-6733; diaz, olivier/0000-0002-3451-9914; Carlet-Dollet, Sandra/0000-0003-3908-6051; Lotteau, Vincent/0000-0003-0997-3282; Marteil, Gaelle/0000-0002-0064-571X	Agence Nationale de la Recherche sur le Sida et les hepatites (ANRS); Institut National de la Sante et de la Recherche Medicale (Inserm); les Hospices Civils de Lyon (HCL); Association pour la Recherche sur le Cancer [doctoral scholarship]	Agence Nationale de la Recherche sur le Sida et les hepatites (ANRS)(ANRSFrench National Research Agency (ANR)); Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); les Hospices Civils de Lyon (HCL); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was supported by the Agence Nationale de la Recherche sur le Sida et les hepatites (ANRS), Institut National de la Sante et de la Recherche Medicale (Inserm) and les Hospices Civils de Lyon (HCL). S.A was recipient of a doctoral scholarship from the Association pour la Recherche sur le Cancer.	Abe T, 2007, J VIROL, V81, P8953, DOI 10.1128/JVI.00649-07; Abreu MT, 2005, J IMMUNOL, V174, P4453, DOI 10.4049/jimmunol.174.8.4453; Agaugue S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000330; Agaugue S, 2006, J IMMUNOL, V177, P2061, DOI 10.4049/jimmunol.177.4.2061; Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Andre P, 2005, SEMIN LIVER DIS, V25, P93, DOI 10.1055/s-2005-864785; Ardeshna KM, 2000, BLOOD, V96, P1039, DOI 10.1182/blood.V96.3.1039.015k04_1039_1046; Arrighi JF, 2001, J IMMUNOL, V166, P3837, DOI 10.4049/jimmunol.166.6.3837; Auffermann-Gratzinger S, 2001, BLOOD, V97, P3171, DOI 10.1182/blood.V97.10.3171; Averill L, 2007, CLIN IMMUNOL, V123, P40, DOI 10.1016/j.clim.2006.12.001; Bain C, 2001, GASTROENTEROLOGY, V120, P512, DOI 10.1053/gast.2001.21212; BESNARD NC, 1994, J CLIN MICROBIOL, V32, P1887, DOI 10.1128/JCM.32.8.1887-1893.1994; Bieback K, 2002, J VIROL, V76, P8729, DOI 10.1128/JVI.76.17.8729-8736.2002; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Compton T, 2003, J VIROL, V77, P4588, DOI 10.1128/JVI.77.8.4588-4596.2003; Coutant F, 2004, J IMMUNOL, V172, P54, DOI 10.4049/jimmunol.172.1.54; Deforges S, 2004, J GEN VIROL, V85, P2515, DOI 10.1099/vir.0.80071-0; Della Bella S, 2007, IMMUNOLOGY, V121, P283, DOI 10.1111/j.1365-2567.2007.02577.x; Diaz O, 2008, J MED VIROL, V80, P242, DOI 10.1002/jmv.21037; Diaz O, 2006, J GEN VIROL, V87, P2983, DOI 10.1099/vir.0.82033-0; Haynes LM, 2001, J VIROL, V75, P10730, DOI 10.1128/JVI.75.22.10730-10737.2001; Hoofnagle JH, 1997, HEPATOLOGY, V26, pS15, DOI 10.1002/hep.510260703; Jude BA, 2003, NAT IMMUNOL, V4, P573, DOI 10.1038/ni926; Kanto T, 2005, INTERVIROLOGY, V49, P58, DOI 10.1159/000087264; Kanto T, 2004, J INFECT DIS, V190, P1919, DOI 10.1086/425425; Kanto T, 1999, J IMMUNOL, V162, P5584; Komurian-Pradel F, 2001, J VIROL METHODS, V95, P111, DOI 10.1016/S0166-0934(01)00300-7; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Lichterfeld M, 2002, J INFECT DIS, V185, P1803, DOI 10.1086/340829; Longman RS, 2005, J INFECT DIS, V192, P497, DOI 10.1086/431523; Longman RS, 2004, BLOOD, V103, P1026, DOI 10.1182/blood-2003-04-1339; Lupo G, 2005, BBA-MOL CELL BIOL L, V1735, P135, DOI 10.1016/j.bbalip.2005.05.008; MILLER RH, 1990, P NATL ACAD SCI USA, V87, P2057, DOI 10.1073/pnas.87.6.2057; Murakami H, 2004, CLIN EXP IMMUNOL, V137, P559, DOI 10.1111/j.1365-2249.2004.02550.x; Napolitano M, 2007, J MED VIROL, V79, P254, DOI 10.1002/jmv.20793; Nielsen SU, 2006, J VIROL, V80, P2418, DOI 10.1128/JVI.80.5.2418-2428.2006; Perrin-Cocon L, 2001, J IMMUNOL, V167, P3785, DOI 10.4049/jimmunol.167.7.3785; Piccioli D, 2005, J HEPATOL, V42, P61, DOI 10.1016/j.jhep.2004.09.014; Puig-Kroger A, 2001, BLOOD, V98, P2175, DOI 10.1182/blood.V98.7.2175; Rassa JC, 2002, P NATL ACAD SCI USA, V99, P2281, DOI 10.1073/pnas.042355399; Rodrigue-Gervais IG, 2007, J VIROL, V81, P5537, DOI 10.1128/JVI.01741-06; Rui LX, 2006, J IMMUNOL, V177, P5337, DOI 10.4049/jimmunol.177.8.5337; Sato A, 2006, P NATL ACAD SCI USA, V103, P17343, DOI 10.1073/pnas.0605102103; Tomkowicz B, 2006, BLOOD, V108, P1145, DOI 10.1182/blood-2005-12-012815; Tsubouchi E, 2004, J GASTROENTEROL, V39, P754, DOI 10.1007/s00535-003-1385-3; Tsubouchi E, 2004, CLIN EXP IMMUNOL, V137, P417, DOI 10.1111/j.1365-2249.2004.02544.x; Velarde V, 2001, J APPL PHYSIOL, V91, P1412, DOI 10.1152/jappl.2001.91.3.1412; Waggoner SN, 2007, J LEUKOCYTE BIOL, V82, P1407, DOI 10.1189/jlb.0507268; Walton KA, 2003, ARTERIOSCL THROM VAS, V23, P1197, DOI 10.1161/01.ATV.0000079340.80744.B8; Walton KA, 2006, J LIPID RES, V47, P1967, DOI 10.1194/jlr.M600060-JLR200; Zeyda M, 2005, J BIOL CHEM, V280, P14293, DOI 10.1074/jbc.M410000200; Zhao LJ, 2006, J LEUKOCYTE BIOL, V80, P424, DOI 10.1189/jlb.0106014	54	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2260	10.1371/journal.pone.0002260	http://dx.doi.org/10.1371/journal.pone.0002260			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509450	Green Submitted, gold, Green Published			2022-12-25	WOS:000262268500009
J	Giuliani, M; Giron-Michel, J; Negrini, S; Vacca, P; Durali, D; Caignard, A; Le Bousse-Kerdiles, MC; Chouaib, S; Devocelle, A; Bahri, R; Durrbach, A; Taoufik, Y; Ferrini, S; Croce, M; Mingari, MC; Moretta, L; Azzarone, B				Giuliani, Massimo; Giron-Michel, Julien; Negrini, Simone; Vacca, Paola; Durali, Deniz; Caignard, Anne; Le Bousse-Kerdiles, M. Caroline; Chouaib, Salem; Devocelle, Aurore; Bahri, Rajia; Durrbach, Antoine; Taoufik, Yassine; Ferrini, Silvano; Croce, Michela; Mingari, Maria Cristina; Moretta, Lorenzo; Azzarone, Bruno			Generation of a Novel Regulatory NK Cell Subset from Peripheral Blood CD34(+) Progenitors Promoted by Membrane-Bound IL-15	PLOS ONE			English	Article							NATURAL-KILLER-CELL; MESENCHYMAL STEM-CELLS; DENDRITIC CELLS; T-CELLS; HLA-G; GROWTH-FACTOR; CUTTING EDGE; BONE-MARROW; BETA-CHAIN; IFN-GAMMA	Background: NK cells have been long time considered as cytotoxic lymphocytes competent in killing virus-infected cells and tumors. However, NK cells may also play essential immuno-regulatory functions. In this context, the real existence of a defined NK subset with negative regulatory properties has been hypothesized but never clearly demonstrated. Methodology/Principal Findings: Herein, we show the in vitro generation from human peripheral blood haematopoietic progenitors (PB-HP), of a novel subset of non-cytolytic NK cells displaying a mature phenotype and remarkable immunoregulatory functions (NK-ireg). The main functional hallmark of these NK-ireg cells is represented by the surface expression/release of HLA-G, a major immunosuppressive molecule. In addition, NK-ireg cells secrete two powerful immuno-regulatory factors: IL-10 and IL-21. Through these factors, NK-ireg cells act as effectors of the down-regulation of the immune response: reconverting mature myeloid DC (mDC) into immature/tolerogenic DC, blocking cytolytic functions on conventional NK cells and inducing HLA-G membrane expression on PB-derived monocytes. The generation of "NK-ireg'' cells is obtained, by default, in culture conditions favouring cell-to-cell contacts, and it is strictly dependent on reciprocal trans-presentation of membrane-bound IL-15 forms constitutively and selectively expressed by human CD34(+) PB-HP. Finally, a small subset of NKp46(+) HLA-G(+) IL-10(+) is detected within freshly isolated decidual NK cells, suggesting that these cells could represent an in vivo counterpart of the NK-ireg cells. Conclusions/Significance: In conclusion, NK-ireg cells represent a novel truly differentiated non-cytolytic NK subset with a self-sustainable phenotype (CD56(+) CD16(+) NKp30(+) NKp44(+) NKp46(+) CD94(+) CD69(+) CCR7(+)) generated from specific pSTAT6(+) GATA3(+) precursors. NK-ireg cells could be employed to develop new immuno-suppressive strategies in autoimmune diseases, transplant rejection or graft versus host diseases. In addition, NK-ireg cells can be easily derived from peripheral blood of the patients and could constitute an autologous biotherapic tool to be used combined or in alternative to other immuno-regulatory cells.	[Giuliani, Massimo; Giron-Michel, Julien; Negrini, Simone; Durali, Deniz; Devocelle, Aurore; Bahri, Rajia; Durrbach, Antoine; Azzarone, Bruno] Univ Paris 11, Hop Paul Brousse, INSERM, UMR 542, Villejuif, France; [Giuliani, Massimo; Giron-Michel, Julien; Vacca, Paola; Moretta, Lorenzo] Ist Giannina Gaslini, Genoa, Italy; [Negrini, Simone] Univ Genoa, Dipartimento Med Interna, Genoa, Italy; [Vacca, Paola; Mingari, Maria Cristina] Univ Genoa, Ctr Eccelenza Ricerca Biomed, Genoa, Italy; [Vacca, Paola; Mingari, Maria Cristina] Ist Nazl Ricerca Canc, Genoa, Italy; [Durali, Deniz; Taoufik, Yassine] Univ Paris 11, Kremlin Bicetre, INSERM UMR 802, Villejuif, France; [Caignard, Anne; Chouaib, Salem] Univ Paris 11, IGR, INSERM UMR 753, Villejuif, France; [Le Bousse-Kerdiles, M. Caroline] Univ Paris 11, Hop Paul Brousse, INSERM UMR 602, Villejuif, France; [Ferrini, Silvano; Croce, Michela] Ist Nazl Ricerca Canc, Lab Immunotherapy, Genoa, Italy	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; University of Genoa; University of Genoa; IRCCS AOU San Martino IST; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Genoa; IRCCS AOU San Martino IST	Giuliani, M (corresponding author), Univ Paris 11, Hop Paul Brousse, INSERM, UMR 542, Villejuif, France.	bazzarone@hotmail.com	DURALI, Deniz/Y-6325-2019; Bahri, Rajia/ABE-1725-2021; Mingari, Maria Cristina/AAB-1315-2019; Giron-michel, Julien/GNP-7299-2022; Moretta, Lorenzo/AAA-7239-2020; NEGRINI, Simone/AAC-6823-2021; Caignard, Anne/F-8159-2013; Croce, Michela/AAA-8966-2020; Azzarone, Bruno/AAH-9251-2019; Chouaib, Salem/F-7939-2016; Giron-Michel, Julien/Q-4503-2018; Vacca, Paola/ABC-9416-2021; Le Bousse-Kerdiles, Marie-Caroline/Q-4029-2018	Giron-michel, Julien/0000-0001-6613-6099; Moretta, Lorenzo/0000-0003-4658-1747; NEGRINI, Simone/0000-0003-1267-4320; Caignard, Anne/0000-0001-9923-6045; Croce, Michela/0000-0003-4683-4951; Azzarone, Bruno/0000-0002-5962-3849; Giron-Michel, Julien/0000-0001-6613-6099; Vacca, Paola/0000-0002-0757-0108; Le Bousse-Kerdiles, Marie-Caroline/0000-0003-0863-5222; Ferrini, Silvano/0000-0001-7254-2616	Association pour la Recherche sur le Cancer [post-doctoral fellowship]; NRB-Vaincre le Cancer [post-doctoral fellowship]; Italian Association for Cancer Research (AIRC); Italian Ministry of health and CNR Functional Genomics; EMBO [post-doctoral fellowship]; Fondazione Italiana Neuroblastoma	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); NRB-Vaincre le Cancer; Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of health and CNR Functional Genomics; EMBO(European Molecular Biology Organization (EMBO)); Fondazione Italiana Neuroblastoma	This work was supported by grants from the Association pour la Recherche sur le Cancer (ARC, N 3690), NRB-Vaincre le Cancer, Italian Association for Cancer Research (AIRC), and the Italian Ministry of health and CNR Functional Genomics, M.G. and D.D. are recipient of post doctoral NRB-Vaincre le Cancer fellowships. S.N. is recipient of post-doctoral fellowships from EMBO and ARC. M.C. is recipient of a Fellowship from Fondazione Italiana Neuroblastoma. I declare, on behalf of all authors, that there are no financial, personal, or professional interests that could be construed to have influenced the paper.	Alvarado J, 2005, IMMUNOL LETT, V99, P109, DOI 10.1016/j.imlet.2005.02.005; Barton BE, 2006, EXPERT OPIN THER TAR, V10, P459, DOI 10.1517/14728222.10.3.459; Brady J, 2004, J IMMUNOL, V172, P2048, DOI 10.4049/jimmunol.172.4.2048; Brandt K, 2003, BLOOD, V102, P4090, DOI 10.1182/blood-2003-03-0669; Briard D, 2005, CLIN EXP IMMUNOL, V140, P265, DOI 10.1111/j.1365-2249.2005.02792.x; Briard D, 2002, J IMMUNOL, V168, P4326, DOI 10.4049/jimmunol.168.9.4326; Budagian V, 2004, J BIOL CHEM, V279, P42192, DOI 10.1074/jbc.M403182200; Burkett PR, 2004, J EXP MED, V200, P825, DOI 10.1084/jem.20041389; Burkett PR, 2003, P NATL ACAD SCI USA, V100, P4724, DOI 10.1073/pnas.0737048100; Cai GF, 1999, EUR J IMMUNOL, V29, P2658, DOI 10.1002/(SICI)1521-4141(199909)29:09<2658::AID-IMMU2658>3.3.CO;2-7; Capsoni F, 1998, CELL IMMUNOL, V189, P51, DOI 10.1006/cimm.1998.1349; Carayol G, 1998, EUR J IMMUNOL, V28, P1991, DOI 10.1002/(SICI)1521-4141(199806)28:06<1991::AID-IMMU1991>3.0.CO;2-7; CAVAILLON JM, 1994, BIOMED PHARMACOTHER, V48, P445, DOI 10.1016/0753-3322(94)90005-1; Chaouat G, 2002, J REPROD IMMUNOL, V53, P241, DOI 10.1016/S0165-0378(01)00119-X; Colucci F, 2003, NAT REV IMMUNOL, V3, P413, DOI 10.1038/nri1088; Cooper MA, 2004, TRENDS IMMUNOL, V25, P47, DOI 10.1016/j.it.2003.10.012; De Maria A, 2007, EUR J IMMUNOL, V37, P445, DOI 10.1002/eji.200635989; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Gandhi R, 2007, J IMMUNOL, V178, P4017, DOI 10.4049/jimmunol.178.7.4017; Ghiringhelli F, 2005, J EXP MED, V202, P1075, DOI 10.1084/jem.20051511; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; Giron-Michel J, 2005, BLOOD, V106, P2302, DOI 10.1182/blood-2005-01-0064; Giron-Michel J, 2003, BLOOD, V102, P109, DOI 10.1182/blood-2002-09-2760; GRABSTEIN KH, 1994, SCIENCE, V264, P965, DOI 10.1126/science.8178155; Harada M, 2006, J EXP MED, V203, P2929, DOI 10.1084/jem.20062206; Hunt JS, 2006, IMMUNOL REV, V213, P36, DOI 10.1111/j.1600-065X.2006.00436.x; Jiang XX, 2005, BLOOD, V105, P4120, DOI 10.1182/blood-2004-02-0586; Kaplan MH, 1998, J LEUKOCYTE BIOL, V64, P2, DOI 10.1002/jlb.64.1.2; Kennedy P, 2000, LAT TRADE, V8, P15; Kim DH, 2005, CYTOKINE, V31, P119, DOI 10.1016/j.cyto.2005.04.004; Kobayashi H, 2005, BLOOD, V105, P721, DOI 10.1182/blood-2003-12-4187; Koka R, 2003, J EXP MED, V197, P977, DOI 10.1084/jem.20021836; Kuwajima S, 2006, NAT IMMUNOL, V7, P740, DOI 10.1038/ni1348; Le Bouteiller P, 1999, HUM REPROD UPDATE, V5, P223, DOI 10.1093/humupd/5.3.223; Leichtman AB, 2007, NEW ENGL J MED, V357, P2625, DOI 10.1056/NEJMe078181; LeMaoult J, 2005, FASEB J, V19, P662, DOI 10.1096/fj.04-1617fje; LeMaoult J, 2005, AUTOIMMUN REV, V4, P503, DOI 10.1016/j.autrev.2005.04.006; Li ZQ, 2005, J IMMUNOL, V174, P5187, DOI 10.4049/jimmunol.174.9.5187; Lidstrom C, 2003, AM J REPROD IMMUNOL, V50, P444, DOI 10.1046/j.8755-8920.2003.00112.x; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Loza MJ, 2001, NAT IMMUNOL, V2, P917, DOI 10.1038/ni1001-917; Marcenaro E, 2006, TRANSPL IMMUNOL, V17, P16, DOI 10.1016/j.trim.2006.09.019; Ostroukhova M, 2004, J CLIN INVEST, V114, P28, DOI 10.1172/JC1200420509; Parrish-Novak J, 2002, J LEUKOCYTE BIOL, V72, P856; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Rebmann V, 2007, TISSUE ANTIGENS, V69, P143, DOI 10.1111/j.1399-0039.2006.763_5.x; Schluns KS, 2004, P NATL ACAD SCI USA, V101, P5616, DOI 10.1073/pnas.0307442101; Schwenger GTF, 2005, BIOCHEMISTRY-MOSCOW+, V70, P1065, DOI 10.1007/s10541-005-0225-x; Sivori S, 2003, EUR J IMMUNOL, V33, P3439, DOI 10.1002/eji.200324533; Sivori S, 2002, P NATL ACAD SCI USA, V99, P4526, DOI 10.1073/pnas.072065999; SPAGGIARI GM, 2007, BLOOD; Spits H, 2007, IMMUNITY, V26, P11, DOI 10.1016/j.immuni.2007.01.004; Trinder P, 1999, INT J ONCOL, V14, P23; Vacca P, 2006, BLOOD, V108, P4078, DOI 10.1182/blood-2006-04-017343; Walzer T, 2007, P NATL ACAD SCI USA, V104, P3384, DOI 10.1073/pnas.0609692104; Yang JS, 2000, IMMUNOLOGY, V101, P397, DOI 10.1046/j.1365-2567.2000.00115.x; Yu HX, 1998, BLOOD, V92, P3647, DOI 10.1182/blood.V92.10.3647.422k43_3647_3657; Zhang C, 2006, CELL MOL IMMUNOL, V3, P241; Zhou M, 2003, IMMUNOL RES, V28, P25, DOI 10.1385/IR:28:1:25; Zitvogel L, 2006, CURR TOP MICROBIOL, V298, P157	60	42	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2241	10.1371/journal.pone.0002241	http://dx.doi.org/10.1371/journal.pone.0002241			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493613	Green Published, gold, Green Submitted			2022-12-25	WOS:000262258700049
J	Redzynia, I; Ljunggren, A; Abrahamson, M; Mort, JS; Krupa, JC; Jaskolski, M; Bujacz, G				Redzynia, Izabela; Ljunggren, Anna; Abrahamson, Magnus; Mort, John S.; Krupa, Joanne C.; Jaskolski, Mariusz; Bujacz, Grzegorz			Displacement of the occluding loop by the parasite protein, chagasin, results in efficient inhibition of human cathepsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PROCATHEPSIN-B; CYSTEINE PROTEASE; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; STRUCTURAL BASIS; COMPLEX; MODEL; IDENTIFICATION; SPECIFICITY; PROGRAM	Cathepsin B is a papain-like cysteine protease showing both endo- and exopeptidase activity, the latter due to a unique occluding loop that restricts access to the active site cleft. To clarify the mode by which natural protein inhibitors manage to overcome this obstacle, we have analyzed the structure and function of cathepsin B in complexes with the Trypanosoma cruzi inhibitor, chagasin. Kinetic analysis revealed that substitution of His-110e, which anchors the loop in occluding position, results in 3-fold increased chagasin affinity (K-i for H110A cathepsin B, 0.35 nM) due to an improved association rate (kon, 5 x 105 M(-1)s(-1)). The structure of chagasin in complex with cathepsin B was solved in two crystal forms (1.8 and 2.67 A resolution), demonstrating that the occluding loop is displaced to allow chagasin binding with its three loops, L4, L2, and L6, spanning the entire active site cleft. The occluding loop is differently displaced in the two structures, indicating a large range of movement and adoption of conformations forced by the inhibitor. The area of contact is slightly larger than in chagasin complexes with the endopeptidase, cathepsin L. However, residues important for high affinity to both enzymes are mainly found in the outer loops L4 and L6 of chagasin. The chagasin- cathepsin B complex provides a structural framework for modeling and design of inhibitors for cruzipain, the parasite cysteine protease and a virulence factor in Chagas disease.	[Redzynia, Izabela; Bujacz, Grzegorz] Tech Univ Lodz, Fac Food Sci & Biotechnol, PL-90924 Lodz, Poland; [Ljunggren, Anna; Abrahamson, Magnus] Lund Univ, Div Clin Chem & Pharmacol, Dept Lab Med, SE-22185 Lund, Sweden; [Mort, John S.; Krupa, Joanne C.] Shriners Hosp Children, Joint Dis Lab, Montreal, PQ H3G 1A6, Canada; [Jaskolski, Mariusz] Adam Mickiewicz Univ, Fac Chem, Dept Crystallog, PL-60780 Poznan, Poland; [Jaskolski, Mariusz; Bujacz, Grzegorz] Polish Acad Sci, Inst Bioorgan Chem, Ctr Biocrystallog Res, PL-61704 Poznan, Poland; [Bujacz, Grzegorz] Tech Univ Lodz, Inst Tech Biochem, PL-90924 Lodz, Poland	Lodz University of Technology; Lund University; McGill University; Adam Mickiewicz University; Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; Lodz University of Technology	Abrahamson, M (corresponding author), Univ Hosp, S-22185 Lund, Sweden.	Magnus.Abrahamson@med.lu.se; gdbujacz@p.lodz.pl	Bujacz, Grzegorz/M-4446-2018; Szymczak, Izabela/N-3073-2018; Abrahamson, Magnus/CAG-9507-2022	Bujacz, Grzegorz/0000-0002-3787-7522; Szymczak, Izabela/0000-0002-0944-8237; Jaskolski, Mariusz/0000-0003-1587-6489				Abrahamson M, 2003, BIOCHEM SOC SYMP, V70, P179, DOI 10.1042/bss0700179; ABRAHAMSON M, 1994, METHOD ENZYMOL, V244, P685; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; BLUMBERG S, 1970, EUR J BIOCHEM, V15, P97, DOI 10.1111/j.1432-1033.1970.tb00981.x; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Cygler M, 1996, STRUCTURE, V4, P405, DOI 10.1016/S0969-2126(96)00046-9; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W, 2002, PYMOL 0 99; dos Reis FCG, 2008, FEBS LETT, V582, P485, DOI 10.1016/j.febslet.2008.01.008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; GASTEIGER E, 2005, PROTPARAM; Guncar G, 1998, STRUCTURE, V6, P51; HALL A, 1995, J BIOL CHEM, V270, P5115, DOI 10.1074/jbc.270.10.5115; HANADA K, 1978, AGR BIOL CHEM TOKYO, V42, P523, DOI 10.1080/00021369.1978.10863014; HASNAIN S, 1992, J BIOL CHEM, V267, P4713; HENDERSON PJ, 1972, BIOCHEM J, V127, P321, DOI 10.1042/bj1270321; Illy C, 1997, J BIOL CHEM, V272, P1197, DOI 10.1074/jbc.272.2.1197; JEPPSSON JO, 1979, CLIN CHEM, V25, P629; Krupa JC, 2002, BIOCHEM J, V361, P613, DOI 10.1042/0264-6021:3610613; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Ljunggren A, 2007, J MOL BIOL, V371, P137, DOI 10.1016/j.jmb.2007.05.005; MACH L, 1994, J BIOL CHEM, V269, P13030; Molgaard A, 2007, BIOCHEM J, V401, P645, DOI 10.1042/BJ20061389; Monteiro ACS, 2001, J CELL SCI, V114, P3933; MURATA M, 1991, FEBS LETT, V280, P307, DOI 10.1016/0014-5793(91)80318-W; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MUSIL D, 1991, EMBO J, V10, P2321, DOI 10.1002/j.1460-2075.1991.tb07771.x; Nagler DK, 1997, BIOCHEMISTRY-US, V36, P12608, DOI 10.1021/bi971264+; Nomura T, 2005, J MED INVESTIG, V52, P1, DOI 10.2152/jmi.52.1; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pavlova A, 2000, FEBS LETT, V487, P156, DOI 10.1016/S0014-5793(00)02337-1; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Saff EB, 1997, MATH INTELL, V19, P5, DOI 10.1007/BF03024331; Salmon D, 2006, J MOL BIOL, V357, P1511, DOI 10.1016/j.jmb.2006.01.064; Sivaraman J, 2000, J MOL BIOL, V295, P939, DOI 10.1006/jmbi.1999.3410; Turk D, 1996, FEBS LETT, V384, P211, DOI 10.1016/0014-5793(96)00309-2; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wang SX, 2007, STRUCTURE, V15, P535, DOI 10.1016/j.str.2007.03.012; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yasuda Y, 2005, ADV DRUG DELIVER REV, V57, P973, DOI 10.1016/j.addr.2004.12.013	43	32	33	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22815	22825		10.1074/jbc.M802064200	http://dx.doi.org/10.1074/jbc.M802064200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18515357	hybrid			2022-12-25	WOS:000258321000049
J	Urayama, S; Harada, Y; Nakagawa, Y; Ban, S; Akasaka, M; Kawasaki, N; Sawada, H				Urayama, Satoshi; Harada, Yoshito; Nakagawa, Yoko; Ban, Susumu; Akasaka, Mari; Kawasaki, Nana; Sawada, Hitoshi			Ascidian sperm glycosylphosphatidylinositol-anchored CRISP-like protein as a binding partner for an allorecognizable sperm receptor on the vitelline coat	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-STERILITY; PHYSIOLOGICAL PROBLEMS; LOW-DENSITY; FERTILIZATION; RECOGNITION; FRACTION; HRVC70; EGGS; SITE	Although ascidians are hermaphroditic, many species including Halocynthia roretzi are self-sterile. We previously reported that a vitelline coat polymorphic protein HrVC70, consisting of 12 EGF (epidermal growth factor)-like repeats, is a candidate allorecognition protein in H. roretzi, because the isolated HrVC70 shows higher affinity to nonself-sperm than to self-sperm. Here, we show that a sperm 35-kDa glycosylphosphatidylinositol-anchored CRISP (cysteine-rich secretory protein)-like protein HrUrabin in a low density detergent-insoluble membrane fraction is a physiological binding partner for HrVC70. We found that HrVC70 specifically interacts with HrUrabin, which had been separated by SDS-PAGE and transferred onto a nitrocellulose membrane. HrUrabin has an N-linked sugar chain, essential for binding to HrVC70. HrUrabin mRNA is expressed in the testis but not in the ovary, and the protein appears to be localized on the surface of sperm head and tail. Anti-HrUrabin antibody, which neutralizes the interaction between HrUrabin and HrVC70, potently inhibited fertilization and allorecognizable sperm-binding to HrVC70-agarose. However, no significant difference in the binding ability of HrUrabin to HrVC70 was observed in autologous and allogeneic combinations by Far Western analyses. These results indicate that sperm-egg binding in H. roretzi is mediated by the molecular interaction between HrUrabin on the sperm surface and HrVC70 on the vitelline coat, but that HrUrabin per se is unlikely to be a direct allorecognition protein.	[Urayama, Satoshi; Harada, Yoshito; Nakagawa, Yoko; Ban, Susumu; Akasaka, Mari; Sawada, Hitoshi] Nagoya Univ, Grad Sch Sci, Sugashima Marine Biol Lab, Toba 5170004, Japan; [Ban, Susumu] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Biochem, Sapporo, Hokkaido 0601206, Japan; [Kawasaki, Nana] Natl Inst Hlth Sci, Div Biol Chem & Biol, Setagaya Ku, Tokyo 1588501, Japan	Nagoya University; Hokkaido University; National Institute of Health Sciences - Japan	Sawada, H (corresponding author), Nagoya Univ, Grad Sch Sci, Sugashima Marine Biol Lab, Toba 5170004, Japan.	hsawada@bio.nagoya-u.ac.jp						ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Ellerman DA, 2006, DEV BIOL, V297, P228, DOI 10.1016/j.ydbio.2006.05.013; Fuke M, 1996, ROUX ARCH DEV BIOL, V205, P391, DOI 10.1007/BF00377219; Fuke M, 1999, MOL REPROD DEV, V52, P99, DOI 10.1002/(SICI)1098-2795(199901)52:1<99::AID-MRD12>3.0.CO;2-N; FUKE MT, 1983, ROUX ARCH DEV BIOL, V192, P347, DOI 10.1007/BF00848815; HARADA H, 2008, INT J DEV B IN PRESS, V52; Harada Y, 2008, SCIENCE, V320, P548, DOI 10.1126/science.1152488; Harada Y, 2007, MOL REPROD DEV, V74, P1178, DOI 10.1002/mrd.20616; Harazono A, 2005, GLYCOBIOLOGY, V15, P447, DOI 10.1093/glycob/cwi033; Hotta K, 1998, DEV GENES EVOL, V208, P164, DOI 10.1007/s004270050169; Jiang D, 2005, BIOL BULL-US, V209, P107, DOI 10.2307/3593128; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kodama E, 2002, EUR J BIOCHEM, V269, P657, DOI 10.1046/j.0014-2956.2001.02696.x; Kuern U, 2007, DEV COMP IMMUNOL, V31, P1242, DOI 10.1016/j.dci.2007.03.011; Matsumoto M, 2002, ZOOL SCI, V19, P43, DOI 10.2108/zsj.19.43; Milne TJ, 2003, J BIOL CHEM, V278, P31105, DOI 10.1074/jbc.M304843200; Morgan TH, 1942, J EXP ZOOL, V90, P199, DOI 10.1002/jez.1400900205; Morgan TH, 1944, J EXP ZOOL, V95, P37, DOI 10.1002/jez.1400950105; Morgan TH, 1923, P NATL ACAD SCI USA, V9, P170, DOI 10.1073/pnas.9.5.170; Morgan TH, 1939, J EXP ZOOL, V80, P19, DOI 10.1002/jez.1400800103; Ohta K, 1999, BIOCHEM BIOPH RES CO, V258, P616, DOI 10.1006/bbrc.1999.0686; Ohta K, 2000, GLYCOCONJUGATE J, V17, P205, DOI 10.1023/A:1026589223811; Roberts KP, 2006, MOL CELL ENDOCRINOL, V250, P122, DOI 10.1016/j.mce.2005.12.034; ROSATI F, 1978, EXP CELL RES, V112, P111, DOI 10.1016/0014-4827(78)90531-1; Sawada H, 2004, P NATL ACAD SCI USA, V101, P15615, DOI 10.1073/pnas.0401928101; Sawada H, 2002, ZOOL SCI, V19, P139, DOI 10.2108/zsj.19.139; Sawada H, 2002, P NATL ACAD SCI USA, V99, P1223, DOI 10.1073/pnas.032389499; SAWADA H, 1982, GAMETE RES, V5, P291, DOI 10.1002/mrd.1120050309; Takayama S, 2005, ANNU REV PLANT BIOL, V56, P467, DOI 10.1146/annurev.arplant.56.032604.144249; Yudin AI, 2002, MOL REPROD DEV, V63, P488, DOI 10.1002/mrd.10193	30	24	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21725	21733		10.1074/jbc.M802631200	http://dx.doi.org/10.1074/jbc.M802631200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18524765	hybrid			2022-12-25	WOS:000257898800046
J	Vincent, A; Ducourouble, MP; Van Seuningen, I				Vincent, Audrey; Ducourouble, Marie-Paule; Van Seuningen, Isabelle			Epigenetic regulation of the human mucin gene MUC4 in epithelial cancer cell lines involves both DNA methylation and histone modifications mediated by DNA methyltransferases and histone deacetylases	FASEB JOURNAL			English	Article						acetylation; chromatin; Sp1; pancreas; carcinogenesis; 5'-UTR	PANCREATIC-CANCER; TRANSCRIPTIONAL REPRESSION; ABERRANT EXPRESSION; TGF-BETA; PROMOTER; BINDING; INHIBITION; CARCINOMA; GROWTH; PROGRESSION	The human gene MUC4 encodes a transmembrane mucin, ligand of ErbB2, that is associated with pancreatic tumor progression. In the normal pancreas, MUC4 is not expressed, whereas activation of its expression is observed in the early steps of pancreatic carcinogenesis. The molecular mechanisms responsible for MUC4 gene activation are however still unknown. The MUC4 5'-flanking region being GC-rich and including two CpG islands, we hypothesized that epigenetic regulation may be involved and undertook to decipher the molecular phenomenons implied. By treating cancer cell lines with 5-aza-2'-deoxycytidine (5-aza) and trichostatin A (TSA), we were able to restore MUC4 expression in a cell-specific manner. We showed by bisulfite-treated genomic DNA sequencing and chromatin immunoprecipitation that methylation of five CpG sites and establishment of a repressive histone code at the 5'-untranslated region were associated with MUC4 silencing and impaired its activation by Sp1. Direct involvement of DNMT3A, DNMT3B, HDAC1, and HDAC3 was demonstrated by RNA interference and chromatin immunoprecipitation. Moreover, inhibition of histone deacetylation by TSA was associated with strong MUC4 repression in high-expressing cells. In conclusion, this work shows for the first time the importance of epigenetics in regulating MUC4 expression and may represent a new strategy to inhibit its expression in epithelial tumors.	[Vincent, Audrey; Ducourouble, Marie-Paule; Van Seuningen, Isabelle] INSERM, U837, Jean Pierre Aubert Res Ctr, F-59045 Lille, France	Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm)	Van Seuningen, I (corresponding author), INSERM, U837, Jean Pierre Aubert Res Ctr, Pl Verdun, F-59045 Lille, France.	isabelle.vanseuningen@inserm.fr	Vincent, Audrey/I-2934-2016; VAN SEUNINGEN, Isabelle/N-6176-2016	Vincent, Audrey/0000-0003-0058-2058; VAN SEUNINGEN, Isabelle/0000-0002-3131-2694				Augenlicht L, 2003, ONCOGENE, V22, P4983, DOI 10.1038/sj.onc.1206521; Belinsky SA, 2004, NAT REV CANCER, V4, P707, DOI 10.1038/nrc1432; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; CARRAWAY CA, 2007, SCI STKE, V381, pRE3; Carraway KL, 2007, CURR TOP DEV BIOL, V78, P1, DOI 10.1016/S0070-2153(06)78001-2; Carraway KL, 2003, BIOESSAYS, V25, P66, DOI 10.1002/bies.10201; Cervoni N, 2001, J BIOL CHEM, V276, P40778, DOI 10.1074/jbc.M103921200; Chaturvedi P, 2007, MOL CANCER RES, V5, P309, DOI 10.1158/1541-7786.MCR-06-0353; Clark SJ, 1997, GENE, V195, P67, DOI 10.1016/S0378-1119(97)00164-9; Donadelli M, 2007, BBA-MOL CELL RES, V1773, P1095, DOI 10.1016/j.bbamcr.2007.05.002; ESTELLER M, 2005, ANN REV PHARM TOXICO, V45, P9; Fauquette V, 2005, BIOCHEM J, V386, P35, DOI 10.1042/BJ20040706; Ferguson M, 2003, NUCLEIC ACIDS RES, V31, P3123, DOI 10.1093/nar/gkg403; GASTON K, 1995, GENE, V157, P257, DOI 10.1016/0378-1119(95)00120-U; Gaudier E, 2004, AM J PHYSIOL-GASTR L, V287, pG1168, DOI 10.1152/ajpgi.00219.2004; Ghoshal K, 2000, J BIOL CHEM, V275, P539, DOI 10.1074/jbc.275.1.539; Glasspool RM, 2006, BRIT J CANCER, V94, P1087, DOI 10.1038/sj.bjc.6603024; Grady WM, 2001, CANCER RES, V61, P900; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; HOLLER M, 1988, GENE DEV, V2, P1127, DOI 10.1101/gad.2.9.1127; Hruban RH, 2000, AM J PATHOL, V156, P1821, DOI 10.1016/S0002-9440(10)65054-7; Iacobuzio-Donahue CA, 2003, CANCER RES, V63, P8614; Jhala N, 2006, AM J CLIN PATHOL, V126, P572, DOI 10.1309/CEV30BE088CBDQD9; Jonckheere N, 2004, ONCOGENE, V23, P5729, DOI 10.1038/sj.onc.1207769; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Karagianni P, 2007, ONCOGENE, V26, P5439, DOI 10.1038/sj.onc.1210612; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Mariette C, 2004, BIOCHEM J, V377, P701, DOI 10.1042/BJ20031132; Matsubayashi H, 2006, CANCER RES, V66, P1208, DOI 10.1158/0008-5472.CAN-05-2664; Moniaux N, 2004, J HISTOCHEM CYTOCHEM, V52, P253, DOI 10.1177/002215540405200213; Perrais M, 2001, J BIOL CHEM, V276, P30923, DOI 10.1074/jbc.M104204200; Perrais M, 2001, J BIOL CHEM, V276, P15386, DOI 10.1074/jbc.M010534200; Piessen G, 2007, BIOCHEM J, V402, P81, DOI 10.1042/BJ20061461; Saitou M, 2005, J CLIN PATHOL, V58, P845, DOI 10.1136/jcp.2004.023572; Sansom OJ, 2007, NAT CLIN PRACT ONCOL, V4, P305, DOI 10.1038/ncponc0812; Santos-Rosa H, 2005, EUR J CANCER, V41, P2381, DOI 10.1016/j.ejca.2005.08.010; Scott GK, 2002, MOL CANCER THER, V1, P385; Shames DS, 2007, CANCER LETT, V251, P187, DOI 10.1016/j.canlet.2006.10.014; Singh AP, 2007, CANCER RES, V67, P433, DOI 10.1158/0008-5472.CAN-06-3114; Singh AP, 2006, PROSTATE, V66, P421, DOI 10.1002/pros.20372; Singh M, 2007, PANCREATOLOGY, V7, P9, DOI 10.1159/000101873; Swartz MJ, 2002, AM J CLIN PATHOL, V117, P791; Van Seuningen I, 2000, BIOCHEM J, V348, P675; Vincent A, 2007, ONCOGENE, V26, P6566, DOI 10.1038/sj.onc.1210479; Wilson AS, 2007, BBA-REV CANCER, V1775, P138, DOI 10.1016/j.bbcan.2006.08.007; Yamane K, 2005, J CELL PHYSIOL, V202, P822, DOI 10.1002/jcp.20205; Zhu WG, 2003, MOL CELL BIOL, V23, P4056, DOI 10.1128/MCB.23.12.4056-4065.2003	47	56	56	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2008	22	8					3035	3045		10.1096/fj.07-103390	http://dx.doi.org/10.1096/fj.07-103390			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	332NI	18492726	Green Submitted			2022-12-25	WOS:000258089300043
J	Shrimali, RK; Irons, RD; Carlson, BA; Sano, Y; Gladyshev, VN; Park, JM; Hatfield, DL				Shrimali, Rajeev K.; Irons, Robert D.; Carlson, Bradley A.; Sano, Yasuyo; Gladyshev, Vadim N.; Park, Jin Mo; Hatfield, Dolph L.			Selenoproteins mediate T cell immunity through an antioxidant mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR STIMULATION; HYDROGEN-PEROXIDE; SELENIUM; MICE; ACTIVATION; GENERATION; RESPONSES; HEALTH	Selenium is an essential dietary element with antioxidant roles in immune regulation, but there is little understanding of how this element acts at the molecular level in host defense and inflammatory disease. Selenium is incorporated into the amino acid selenocysteine (Sec), which in turn is inserted into selenoproteins in a manner dependent on Sec tRNA([Ser]Sec). To investigate the molecular mechanism that links selenium to T cell immunity, we generated mice with selenoprotein-less T cells by cell type-specific ablation of the Sec tRNA([Ser]Sec) gene (trsp). Herein, we show that these mutant mice exhibit decreased pools of mature T cells and a defect in T cell- dependent antibody responses. We also demonstrate that selenoprotein deficiency leads to oxidant hyperproduction in T cells and thereby suppresses T cell proliferation in response to T cell receptor stimulation. These findings offer novel insights into immune function of selenium and physiological antioxidants.	[Sano, Yasuyo; Park, Jin Mo] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Boston, MA 02129 USA; [Shrimali, Rajeev K.; Irons, Robert D.; Carlson, Bradley A.; Hatfield, Dolph L.] NCI, Mol Biol Selenium Sect, Lab Canc Prevent, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Gladyshev, Vadim N.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA	Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Nebraska System; University of Nebraska Lincoln	Park, JM (corresponding author), Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Boston, MA 02129 USA.	jmpark@cbrc2.mgh.harvard.edu; hatfield@mail.nih.gov	Gladyshev, Vadim N/J-6187-2013; Gladyshev, Vadim N/A-9894-2013	Gladyshev, Vadim/0000-0002-0372-7016	Intramural NIH HHS [Z01 BC005317-24] Funding Source: Medline; NCI NIH HHS [CA 080946] Funding Source: Medline; NIGMS NIH HHS [GM 065204] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA080946, ZIABC005317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM065204, R01GM065204] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beck MA, 2007, J NUTR, V137, P1338, DOI 10.1093/jn/137.5.1338; Copeland PR, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-221; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Devadas S, 2002, J EXP MED, V195, P59, DOI 10.1084/jem.20010659; Driscoll DM, 2003, ANNU REV NUTR, V23, P17, DOI 10.1146/annurev.nutr.23.011702.073318; Gladyshev VN, 1999, P NATL ACAD SCI USA, V96, P835, DOI 10.1073/pnas.96.3.835; HATFIELD DL, 2006, SELENIUM ITS MOL BIO, P1; Hatfield DL, 2006, PROG NUCLEIC ACID RE, V81, P97, DOI 10.1016/S0079-6603(06)81003-2; Hoffmann PR, 2007, ARCH IMMUNOL THER EX, V55, P289, DOI 10.1007/s00005-007-0036-4; Hoffmann PR, 2007, J IMMUNOL, V179, P3258, DOI 10.4049/jimmunol.179.5.3258; Hooven LA, 2006, BIOL TRACE ELEM RES, V109, P173, DOI 10.1385/BTER:109:2:173; Hurwitz BE, 2007, ARCH INTERN MED, V167, P148, DOI 10.1001/archinte.167.2.148; Jackson SH, 2004, NAT IMMUNOL, V5, P818, DOI 10.1038/ni1096; KIREMIDJIANSCHUMACHER L, 1992, BIOL TRACE ELEM RES, V33, P23, DOI 10.1007/BF02783989; Kumaraswamy E, 2003, MOL CELL BIOL, V23, P1477, DOI 10.1128/MCB.23.5.1477-1488.2003; Kwon J, 2003, FREE RADICAL BIO MED, V35, P406, DOI 10.1016/S0891-5849(03)00318-6; Mao XH, 1999, P NATL ACAD SCI USA, V96, P5037, DOI 10.1073/pnas.96.9.5037; ORBAN PC, 1992, P NATL ACAD SCI USA, V89, P6861, DOI 10.1073/pnas.89.15.6861; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Ueno H, 2008, J TRACE ELEM MED BIO, V22, P9, DOI 10.1016/j.jtemb.2007.10.002; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004	23	112	118	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20181	20185		10.1074/jbc.M802559200	http://dx.doi.org/10.1074/jbc.M802559200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18487203	hybrid, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000257565300034
J	FitzGerald, J; Luo, M; Chaudhury, A; Berger, F				FitzGerald, Jonathan; Luo, Ming; Chaudhury, Abed; Berger, Frederic			DNA Methylation Causes Predominant Maternal Controls of Plant Embryo Growth	PLOS ONE			English	Article							SEED DEVELOPMENT; CPG METHYLATION; ARABIDOPSIS; GENE; SIZE; ENDOSPERM; ORIGIN; FERTILIZATION; MAINTENANCE; DROSOPHILA	The parental conflict hypothesis predicts that the mother inhibits embryo growth counteracting growth enhancement by the father. In plants the DNA methyltransferase MET1 is a central regulator of parentally imprinted genes that affect seed growth. However the relation between the role of MET1 in imprinting and its control of seed size has remained unclear. Here we combine cytological, genetic and statistical analyses to study the effect of MET1 on seed growth. We show that the loss of MET1 during male gametogenesis causes a reduction of seed size, presumably linked to silencing of the paternal allele of growth enhancers in the endosperm, which nurtures the embryo. However, we find no evidence for a similar role of MET1 during female gametogenesis. Rather, the reduction of MET1 dosage in the maternal somatic tissues causes seed size increase. MET1 inhibits seed growth by restricting cell division and elongation in the maternal integuments that surround the seed. Our data demonstrate new controls of seed growth linked to the mode of reproduction typical of flowering plants. We conclude that the regulation of embryo growth by MET1 results from a combination of predominant maternal controls, and that DNA methylation maintained by MET1 does not orchestrate a parental conflict.	[FitzGerald, Jonathan; Berger, Frederic] Natl Univ Singapore, Dept Biol Sci, Temasek Life Sci Lab, Chromatin & Reprod Grp, Singapore, Singapore; [Luo, Ming; Chaudhury, Abed] Black Mountain Lab, Commonwealth Sci & Indust Res Org, Canberra, ACT, Australia	National University of Singapore; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	FitzGerald, J (corresponding author), Natl Univ Singapore, Dept Biol Sci, Temasek Life Sci Lab, Chromatin & Reprod Grp, Singapore, Singapore.	fred@tll.org.sg	Luo, Ming/F-4100-2010	Berger, Frederic/0000-0002-3609-8260	National University of Singapore, Temasek Life Science Laboratory; NSF [INT 0301886]; CSIRO	National University of Singapore, Temasek Life Science Laboratory(National University of Singapore); NSF(National Science Foundation (NSF)); CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	F.B. and J.F.G. were supported by the Temasek Life Science Laboratory affiliated to the National University of Singapore. J.F.G. is additionally supported by NSF International Research Fellowship Program grant INT 0301886. A.C. and M.L. were supported by the CSIRO.	Adams S, 2000, DEVELOPMENT, V127, P2493; Browning H, 1996, DEVELOPMENT, V122, P391; Canales C, 2002, CURR BIOL, V12, P1718, DOI 10.1016/S0960-9822(02)01151-X; Chaudhury AM, 1997, P NATL ACAD SCI USA, V94, P4223, DOI 10.1073/pnas.94.8.4223; Constancia M, 2005, P NATL ACAD SCI USA, V102, P19219, DOI 10.1073/pnas.0504468103; Feil R, 2007, TRENDS GENET, V23, P192, DOI 10.1016/j.tig.2007.02.004; Ferguson-Smith AC, 2006, PLACENTA, V27, pS122, DOI 10.1016/j.placenta.2006.01.015; Finnegan EJ, 1996, P NATL ACAD SCI USA, V93, P8449, DOI 10.1073/pnas.93.16.8449; Fitch KR, 1998, CURR TOP DEV BIOL, V38, P1; Garcia D, 2005, PLANT CELL, V17, P52, DOI 10.1105/tpc.104.027136; Garcia D, 2003, PLANT PHYSIOL, V131, P1661, DOI 10.1104/pp.102.018762; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Guitton AE, 2005, CURR BIOL, V15, P750, DOI 10.1016/j.cub.2005.02.066; Haig D, 2004, ANNU REV GENET, V38, P553, DOI 10.1146/annurev.genet.37.110801.142741; Jullien PE, 2006, PLANT CELL, V18, P1360, DOI 10.1105/tpc.106.041178; Jullien PE, 2006, CURR BIOL, V16, P486, DOI 10.1016/j.cub.2006.01.020; KERMICLE JL, 1990, DEVELOPMENT, P9; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Loppin B, 2005, CURR BIOL, V15, P87, DOI 10.1016/j.cub.2004.12.071; Luo M, 2000, P NATL ACAD SCI USA, V97, P10637, DOI 10.1073/pnas.170292997; Makarevich G, 2006, EMBO REP, V7, P947, DOI 10.1038/sj.embor.7400760; Mathieu O, 2007, CELL, V130, P851, DOI 10.1016/j.cell.2007.07.007; Nowack MK, 2006, NAT GENET, V38, P63, DOI 10.1038/ng1694; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Schruff MC, 2006, DEVELOPMENT, V133, P251, DOI 10.1242/dev.02194; Scott RJ, 1998, DEVELOPMENT, V125, P3329; Spielman M, 2001, TRENDS GENET, V17, P705, DOI 10.1016/S0168-9525(01)02519-7; Sundaresan V, 2005, P NATL ACAD SCI USA, V102, P17887, DOI 10.1073/pnas.0509021102; Tariq M, 2003, P NATL ACAD SCI USA, V100, P8823, DOI 10.1073/pnas.1432939100; Xiao WY, 2006, PLANT PHYSIOL, V142, P1160, DOI 10.1104/pp.106.088849	31	42	42	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2298	10.1371/journal.pone.0002298	http://dx.doi.org/10.1371/journal.pone.0002298			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509545	Green Published, Green Submitted, gold			2022-12-25	WOS:000262268500037
J	van Haperen, R; Samyn, H; Moerland, M; van Gent, T; Peeters, M; Grosveld, F; van Tol, A; de Crom, R				van Haperen, Rien; Samyn, Hannelore; Moerland, Matthijs; van Gent, Teus; Peeters, Marian; Grosveld, Frank; van Tol, Arie; de Crom, Rini			Elevated Expression of Phospholipid Transfer Protein in Bone Marrow Derived Cells Causes Atherosclerosis	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; ADENOVIRUS-MEDIATED OVEREXPRESSION; ANTIINFLAMMATORY PROPERTIES; APOLIPOPROTEIN-B; INSULIN-RESISTANCE; PLTP DEFICIENCY; HDL; MICE; CHOLESTEROL; INCREASES	Background: Phospholipid transfer protein (PLTP) is expressed by various cell types. In plasma, it is associated with high density lipoproteins (HDL). Elevated levels of PLTP in transgenic mice result in decreased HDL and increased atherosclerosis. PLTP is present in human atherosclerotic lesions, where it seems to be macrophage derived. The aim of the present study is to evaluate the atherogenic potential of macrophage derived PLTP. Methods and Findings: Here we show that macrophages from human PLTP transgenic mice secrete active PLTP. Subsequently, we performed bone marrow transplantations using either wild type mice (PLTPwt/wt), hemizygous PLTP transgenic mice (huPLTPtg/wt) or homozygous PLTP transgenic mice (huPLTPtg/tg) as donors and low density lipoprotein receptor deficient mice (LDLR-/-) as acceptors, in order to establish the role of PLTP expressed by bone marrow derived cells in diet-induced atherogenesis. Atherosclerosis was increased in the huPLTPtg/wt -> LDLR-/- mice (2.3-fold) and even further in the huPLTPtg/tg -> LDLR-/- mice (4.5-fold) compared with the control PLTPwt/wt -> LDLR-/- mice (both P<0.001). Plasma PLTP activity levels and non-HDL cholesterol were increased and HDL cholesterol decreased compared with controls (all P < 0.01). PLTP was present in atherosclerotic plaques in the mice as demonstrated by immunohistochemistry and appears to co-localize with macrophages. Isolated macrophages from PLTP transgenic mice do not show differences in cholesterol efflux or in cytokine production. Lipopolysaccharide activation of macrophages results in increased production of PLTP. This effect was strongly amplified in PLTP transgenic macrophages. Conclusions: We conclude that PLTP expression by bone marrow derived cells results in atherogenic effects on plasma lipids, increased PLTP activity, high local PLTP protein levels in the atherosclerotic lesions and increased atherosclerotic lesion size.	[van Haperen, Rien; Samyn, Hannelore; Moerland, Matthijs; van Gent, Teus; Peeters, Marian; Grosveld, Frank; van Tol, Arie; de Crom, Rini] Erasmus MC Univ, Med Ctr, Dept Cell Biol & Genet, Rotterdam, Netherlands; [de Crom, Rini] Erasmus MC Univ, Med Ctr, Dept Vascular Surg, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	van Haperen, R (corresponding author), Erasmus MC Univ, Med Ctr, Dept Cell Biol & Genet, Rotterdam, Netherlands.	m.decrom@erasmusmc.nl			Zorgonderzoek Nederland Medische Wetenschappen-the Netherlands Organisation for Health Research and Development [910-31-806]	Zorgonderzoek Nederland Medische Wetenschappen-the Netherlands Organisation for Health Research and Development	Part of this work was supported by Zorgonderzoek Nederland Medische Wetenschappen-the Netherlands Organisation for Health Research and Development (910-31-806).	Albers JJ, 2004, CURR OPIN LIPIDOL, V15, P255, DOI 10.1097/00041433-200406000-00004; ALBERS JJ, 1995, BBA-LIPID LIPID MET, V1258, P27, DOI 10.1016/0005-2760(95)00091-P; Ansell BJ, 2004, REV ENDOCR METAB DIS, V5, P351, DOI 10.1023/B:REMD.0000045107.71895.b2; Assmann G, 2004, CIRCULATION, V109, P8, DOI 10.1161/01.CIR.0000131512.50667.46; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; BASU SK, 1976, P NATL ACAD SCI USA, V73, P3178, DOI 10.1073/pnas.73.9.3178; Bouma G, 2005, EUR J IMMUNOL, V35, P225, DOI 10.1002/eji.200425513; Cheung MC, 2002, BBA-MOL BASIS DIS, V1587, P53, DOI 10.1016/S0925-4439(02)00054-6; CHEUNG MC, 2005, BIOCHIM BIOPHYS ACTA, V1762, P131; Colhoun HM, 2002, DIABETES, V51, P3300, DOI 10.2337/diabetes.51.11.3300; DAMEN J, 1982, BIOCHIM BIOPHYS ACTA, V712, P444, DOI 10.1016/0005-2760(82)90271-5; DAY JR, 1994, J BIOL CHEM, V269, P9388; de Vries R, 2006, DIABETOLOGIA, V49, P398, DOI 10.1007/s00125-005-0088-0; Desrumaux C, 1999, ARTERIOSCL THROM VAS, V19, P266, DOI 10.1161/01.ATV.19.2.266; Desrumaux CM, 2003, J LIPID RES, V44, P1453, DOI 10.1194/jlr.M200281-JLR200; DULLAART RPF, 1994, EUR J CLIN INVEST, V24, P188, DOI 10.1111/j.1365-2362.1994.tb00987.x; Ehnholm S, 1998, J LIPID RES, V39, P1248; Fielding CJ, 2001, BBA-MOL CELL BIOL L, V1533, P175, DOI 10.1016/S1388-1981(01)00162-7; Foger B, 1997, J BIOL CHEM, V272, P27393, DOI 10.1074/jbc.272.43.27393; Huuskonen J, 2001, ATHEROSCLEROSIS, V155, P269, DOI 10.1016/S0021-9150(01)00447-6; JAUHIAINEN M, 1993, J BIOL CHEM, V268, P4032; Jiang XC, 2002, J BIOL CHEM, V277, P31850, DOI 10.1074/jbc.M205077200; Jiang XC, 1999, J CLIN INVEST, V103, P907, DOI 10.1172/JCI5578; Jiang XC, 2001, NAT MED, V7, P847, DOI 10.1038/89977; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; Karkkainen M, 2002, J BIOL CHEM, V277, P15413, DOI 10.1074/jbc.M112247200; Kaser S, 2001, DIABETOLOGIA, V44, P1111, DOI 10.1007/s001250100630; KOSTNER GM, 1995, BIOCHEM J, V305, P659, DOI 10.1042/bj3050659; Laffitte BA, 2003, MOL CELL BIOL, V23, P2182, DOI 10.1128/MCB.23.6.2182-2191.2003; Lie J, 2004, J LIPID RES, V45, P805, DOI 10.1194/jlr.M300487-JLR200; Lie J, 2002, J LIPID RES, V43, P1875, DOI 10.1194/jlr.M200166-JLR200; Lie J, 2006, BBA-MOL CELL BIOL L, V1761, P1070, DOI 10.1016/j.bbalip.2006.06.013; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Murdoch SJ, 2003, J LIPID RES, V44, P1705, DOI 10.1194/jlr.M300073-JLR200; Murdoch SJ, 2000, J LIPID RES, V41, P237; OBRIEN KD, 2003, CIRCULATION; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Peeters M, 2005, HAEMATOLOGICA, V90, P734; Riemens SC, 1998, DIABETOLOGIA, V41, P929, DOI 10.1007/s001250051009; Rothblat G H, 1986, Methods Enzymol, V129, P628; Schlitt A, 2005, BBA-MOL CELL BIOL L, V1733, P187, DOI 10.1016/j.bbalip.2004.12.011; Stein O, 2005, ATHEROSCLEROSIS, V178, P217, DOI 10.1016/j.atherosclerosis.2004.10.008; TALL AR, 1980, J LIPID RES, V21, P354; TALL AR, 1983, J BIOL CHEM, V258, P2174; TU AY, 1993, J BIOL CHEM, V268, P23098; Valenta DT, 2008, J LIPID RES, V49, P24, DOI 10.1194/jlr.M700228-JLR200; VALENTA DT, 2006, ARTERIOSCLER THROMB; van Haperen R, 2000, ARTERIOSCL THROM VAS, V20, P1082, DOI 10.1161/01.ATV.20.4.1082; van Haperen R, 2002, J BIOL CHEM, V277, P48803, DOI 10.1074/jbc.M209477200; van Haperen R, 2002, J BIOL CHEM, V277, P48938, DOI 10.1074/jbc.M209128200; van Tol A, 2002, CURR OPIN LIPIDOL, V13, P135, DOI 10.1097/00041433-200204000-00004; Vikstedt R, 2007, ARTERIOSCL THROM VAS, V27, P578, DOI 10.1161/01.ATV.0000254815.49414.be; Yan DG, 2004, J LIPID RES, V45, P1852, DOI 10.1194/jlr.M400053-JLR200	53	23	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2255	10.1371/journal.pone.0002255	http://dx.doi.org/10.1371/journal.pone.0002255			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509527	Green Published, Green Submitted, gold			2022-12-25	WOS:000262268500007
J	Song, LZ; Nakaar, V; Kavita, U; Price, A; Huleatt, J; Tang, J; Jacobs, A; Liu, G; Huang, Y; Desai, P; Maksymiuk, G; Takahashi, V; Umlauf, S; Reiserova, L; Bell, R; Li, H; Zhang, Y; McDonald, WF; Powell, TJ; Tussey, L				Song, Langzhou; Nakaar, Valerian; Kavita, Uma; Price, Albert; Huleatt, Jim; Tang, Jie; Jacobs, Andrea; Liu, Ge; Huang, Yan; Desai, Priyanka; Maksymiuk, Gail; Takahashi, Virginia; Umlauf, Scott; Reiserova, Lucia; Bell, Rodney; Li, Hong; Zhang, Yi; McDonald, William F.; Powell, T. J.; Tussey, Lynda			Efficacious Recombinant Influenza Vaccines Produced by High Yield Bacterial Expression: A Solution to Global Pandemic and Seasonal Needs	PLOS ONE			English	Article								It is known that physical linkage of TLR ligands and vaccine antigens significantly enhances the immunopotency of the linked antigens. We have used this approach to generate novel influenza vaccines that fuse the globular head domain of the protective hemagglutinin (HA) antigen with the potent TLR5 ligand, flagellin. These fusion proteins are efficiently expressed in standard E. coli fermentation systems and the HA moiety can be faithfully refolded to take on the native conformation of the globular head. In mouse models of influenza infection, the vaccines elicit robust antibody responses that mitigate disease and protect mice from lethal challenge. These immunologically potent vaccines can be efficiently manufactured to support pandemic response, pre-pandemic and seasonal vaccines.	[Song, Langzhou; Kavita, Uma; Liu, Ge; Umlauf, Scott; Reiserova, Lucia; Bell, Rodney; Li, Hong; Zhang, Yi; Tussey, Lynda] VaxInnate Corp, Cranbury, NJ USA; [Nakaar, Valerian; Price, Albert; Huleatt, Jim; Tang, Jie; Jacobs, Andrea; Huang, Yan; Desai, Priyanka; Maksymiuk, Gail; Takahashi, Virginia; McDonald, William F.; Powell, T. J.] VaxInnate Corp, New Haven, CT USA		Song, LZ (corresponding author), VaxInnate Corp, Cranbury, NJ USA.	langzhou.song@vaxinnate.com			VaxInnate Corporation	VaxInnate Corporation	The work is supported by the VaxInnate Corporation	BIZEBARD T, 1995, NATURE, V376, P92, DOI 10.1038/376092a0; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Bright RA, 2003, VIROLOGY, V308, P270, DOI 10.1016/S0042-6822(03)00008-4; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Ha Y, 2002, EMBO J, V21, P865, DOI 10.1093/emboj/21.5.865; Hebert DN, 1997, J CELL BIOL, V139, P613, DOI 10.1083/jcb.139.3.613; Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062; Huleatt JW, 2007, VACCINE, V25, P763, DOI 10.1016/j.vaccine.2006.08.013; Jeon SH, 2002, VIRAL IMMUNOL, V15, P165, DOI 10.1089/088282402317340314; KILBOURNE ED, 1988, P NATL ACAD SCI USA, V85, P8098, DOI 10.1073/pnas.85.21.8098; McDonald WF, 2007, J INFECT DIS, V195, P1607, DOI 10.1086/517613; Rosenthal PB, 1998, NATURE, V396, P92, DOI 10.1038/23974; Russell RJ, 2004, VIROLOGY, V325, P287, DOI 10.1016/j.virol.2004.04.040; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0	18	92	112	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2257	10.1371/journal.pone.0002257	http://dx.doi.org/10.1371/journal.pone.0002257			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493310	Green Submitted, gold, Green Published			2022-12-25	WOS:000262258700057
J	Tribouillard-Tanvier, D; Dos Reis, S; Gug, F; Voisset, C; Beringue, V; Sabate, R; Kikovska, E; Talarek, N; Bach, S; Huang, CH; Desban, N; Saupe, SJ; Supattapone, S; Thuret, JY; Chedin, S; Vilette, D; Galons, H; Sanyal, S; Blondel, M				Tribouillard-Tanvier, Deborah; Dos Reis, Suzana; Gug, Fabienne; Voisset, Cecile; Beringue, Vincent; Sabate, Raimon; Kikovska, Ema; Talarek, Nicolas; Bach, Stephane; Huang, Chenhui; Desban, Nathalie; Saupe, Sven J.; Supattapone, Surachai; Thuret, Jean-Yves; Chedin, Stephane; Vilette, Didier; Galons, Herve; Sanyal, Suparna; Blondel, Marc			Protein Folding Activity of Ribosomal RNA Is a Selective Target of Two Unrelated Antiprion Drugs	PLOS ONE			English	Article							IN-VITRO; ESCHERICHIA-COLI; PRION PROTEIN; SCRAPIE AGENT; NUCLEIC-ACID; YEAST; GENERATION; ASSAY; SHEEP; URE3	Background: 6-Aminophenanthridine (6AP) and Guanabenz (GA, a drug currently in use for the treatment of hypertension) were isolated as antiprion drugs using a yeast-based assay. These structurally unrelated molecules are also active against mammalian prion in several cell-based assays and in vivo in a mouse model for prion-based diseases. Methodology/Principal Findings: Here we report the identification of cellular targets of these drugs. Using affinity chromatography matrices for both drugs, we demonstrate an RNA-dependent interaction of 6AP and GA with the ribosome. These specific interactions have no effect on the peptidyl transferase activity of the ribosome or on global translation. In contrast, 6AP and GA specifically inhibit the ribosomal RNA-mediated protein folding activity of the ribosome. Conclusion/Significance: 6AP and GA are therefore the first compounds to selectively inhibit the protein folding activity of the ribosome. They thus constitute precious tools to study the yet largely unexplored biological role of this protein folding activity.	[Tribouillard-Tanvier, Deborah; Voisset, Cecile; Blondel, Marc] INSERM, U613, Brest, France; [Tribouillard-Tanvier, Deborah; Voisset, Cecile; Blondel, Marc] Univ Brest, Fac Med Sci Sante, UMR S613, Brest, France; [Tribouillard-Tanvier, Deborah; Voisset, Cecile; Blondel, Marc] Etab Francais Sang EFS Bretagne, Brest, France; [Tribouillard-Tanvier, Deborah; Voisset, Cecile; Blondel, Marc] Lab Genet Mol, Hop Morvan, CHU Brest, Brest, France; [Tribouillard-Tanvier, Deborah; Bach, Stephane; Desban, Nathalie] Protein Phosphoryl & Dis Lab, Stn Biol, CNRS UPS2682, Roscoff, France; [Dos Reis, Suzana; Kikovska, Ema; Huang, Chenhui; Sanyal, Suparna] Uppsala Univ, Inst Cell & Mol Biol, Uppsala, Sweden; [Gug, Fabienne; Galons, Herve] Univ Paris 05, Lab Chim Organ 2, INSERM U648, Paris, France; [Beringue, Vincent; Vilette, Didier] INRA, UR892, Jouy En Josas, France; [Sabate, Raimon; Saupe, Sven J.] Univ Bordeaux 2, IBGC UMR CNRS 5095, Lab Genet Mol Champignons, Bordeaux, France; [Talarek, Nicolas] Univ Fribourg, Dept Med Biochem, Fribourg, Switzerland; [Supattapone, Surachai] Dartmouth Med Sch, Dept Med, Hanover, NH USA; [Supattapone, Surachai] Dartmouth Med Sch, Dept Biochem, Hanover, NH USA; [Thuret, Jean-Yves; Chedin, Stephane] iBiTec S, CEA, Gif Sur Yvette, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; Universite de Bretagne Occidentale; CHU Brest; Universite de Bretagne Occidentale; UDICE-French Research Universities; Sorbonne Universite; Uppsala University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite de Bordeaux; University of Fribourg; Dartmouth College; Dartmouth College; CEA; UDICE-French Research Universities; Universite Paris Saclay	Tribouillard-Tanvier, D (corresponding author), INSERM, U613, Brest, France.	marc.blondel@univ-brest.fr	Blondel, Marc/AAJ-9049-2020; Voisset, Cecile/AAK-1636-2020; Talarek, Nicolas/Q-4648-2019; BACH, Stéphane/ABD-5865-2020; Talarek, Nicolas/P-6870-2019; sabate, raimon/I-7849-2014	Blondel, Marc/0000-0003-4897-2995; Talarek, Nicolas/0000-0003-2804-7372; saupe, sven/0000-0002-5589-721X; Thuret, Jean-Yves/0000-0001-5385-7620; Voisset, Cecile/0000-0001-7505-1927; Dos Reis, Suzana/0000-0002-9117-7316; sabate, raimon/0000-0003-3894-2362; Tribouillard-Tanvier, Deborah/0000-0002-2290-5375	GIS Infections a prion; ACI Jeune Chercheur from the French government; CRITT Sante Bretagne; Ministere de la Recherche; FRM; CNRS [Ingenieur de valorisation fellowship]; French government; Swedish Research Council; Goran Gustafsson; EMBO [postdoctoral fellowship]; INSERM; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046478] Funding Source: NIH RePORTER	GIS Infections a prion; ACI Jeune Chercheur from the French government; CRITT Sante Bretagne; Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); FRM(Fondation pour la Recherche Medicale); CNRS(Centre National de la Recherche Scientifique (CNRS)); French government; Swedish Research Council(Swedish Research CouncilEuropean Commission); Goran Gustafsson; EMBO(European Molecular Biology Organization (EMBO)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the following grants: GIS Infections a prion, ACI Jeune Chercheur from the French government, CRITT Sante Bretagne to MB, Ministere de la Recherche and FRM grants (to DTT), Ingenieur de valorisation fellowship from the CNRS and ANR blanche from the French government to MB, SJS, HG and DV, Swedish Research Council (VR) and Goran Gustafsson grants to SS. SDR was supported by an EMBO postdoctoral fellowship and CV by a Junior Contract from INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoun A, 2006, EMBO J, V25, P2539, DOI 10.1038/sj.emboj.7601140; Archer F, 2004, J VIROL, V78, P482, DOI 10.1128/JVI.78.1.482-490.2004; Argent RH, 2000, J BIOL CHEM, V275, P9263, DOI 10.1074/jbc.275.13.9263; Bach S, 2003, NAT BIOTECHNOL, V21, P1075, DOI 10.1038/nbt855; BACH S, 2006, EVALUATION CDK INHIB, P103; Bach S, 2006, METHODS, V39, P72, DOI 10.1016/j.ymeth.2006.04.005; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Basu A, 2008, BIOCHEM BIOPH RES CO, V366, P598, DOI 10.1016/j.bbrc.2007.11.143; Basu A, 2008, BIOCHEM BIOPH RES CO, V366, P592, DOI 10.1016/j.bbrc.2007.11.142; BENKEMOUN L, 2006, FUNGAL GENET BIOL; Boye-Harnasch M, 2006, J BIOTECHNOL, V125, P222, DOI 10.1016/j.jbiotec.2006.03.006; Brachmann A, 2005, EMBO J, V24, P3082, DOI 10.1038/sj.emboj.7600772; Brachmann A, 2006, METHODS, V39, P35, DOI 10.1016/j.ymeth.2006.04.008; Brown JL, 1997, GENE DEV, V11, P2972, DOI 10.1101/gad.11.22.2972; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Caughey B, 2003, NATURE, V425, P673, DOI 10.1038/425673a; Chattopadhyay S, 1996, P NATL ACAD SCI USA, V93, P8284, DOI 10.1073/pnas.93.16.8284; Chattopadhyay S, 1999, BBA-PROTEIN STRUCT M, V1429, P293, DOI 10.1016/S0167-4838(98)00179-4; CHATTOPADHYAY S, 1994, BIOCHEM J, V300, P717, DOI 10.1042/bj3000717; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; COHEN FE, 1994, SCIENCE, V264, P530, DOI 10.1126/science.7909169; DAI H, 1986, Current Genetics, V11, P79, DOI 10.1007/BF00389429; Das B, 1996, EUR J BIOCHEM, V235, P613, DOI 10.1111/j.1432-1033.1996.00613.x; Das Gupta C, 1999, CURR SCI INDIA, V77, P568; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Doh-Ura K, 2000, J VIROL, V74, P4894, DOI 10.1128/JVI.74.10.4894-4897.2000; Gilch S, 2007, J MOL BIOL, V371, P362, DOI 10.1016/j.jmb.2007.05.052; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; HOLMES B, 1983, DRUGS, V26, P212, DOI 10.2165/00003495-198326030-00003; Jones GW, 2005, BIOESSAYS, V27, P823, DOI 10.1002/bies.20267; KERRIDGE D, 1958, J GEN MICROBIOL, V19, P497, DOI 10.1099/00221287-19-3-497; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Korth C, 2001, P NATL ACAD SCI USA, V98, P9836, DOI 10.1073/pnas.161274798; KOVALIC D, 1995, BIOCHEMISTRY-US, V34, P15838, DOI 10.1021/bi00048a029; Krasemann S, 1996, MOL MED, V2, P725, DOI 10.1007/BF03401656; Kudlicki W, 1997, FOLD DES, V2, P101, DOI 10.1016/S1359-0278(97)00014-X; Le Dur A, 2005, P NATL ACAD SCI USA, V102, P16031, DOI 10.1073/pnas.0502296102; LEE KM, 1986, PREP BIOCHEM, V16, P247, DOI 10.1080/00327488608062469; Maddelein ML, 2002, P NATL ACAD SCI USA, V99, P7402, DOI 10.1073/pnas.072199199; Patel BK, 2007, J MOL BIOL, V365, P773, DOI 10.1016/j.jmb.2006.10.069; Pavlov MY, 1996, ARCH BIOCHEM BIOPHYS, V328, P9, DOI 10.1006/abbi.1996.0136; Pavlov MY, 1997, J MOL BIOL, V273, P389, DOI 10.1006/jmbi.1997.1324; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; RODNINA MV, 1995, P NATL ACAD SCI USA, V92, P1945, DOI 10.1073/pnas.92.6.1945; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; SAMANTA D, 2008, J BACTERIOL; Sanyal SC, 2002, NUCLEIC ACIDS RES, V30, P2390, DOI 10.1093/nar/30.11.2390; Savvateeva-Popova E, 2007, CELL STRESS CHAPERON, V12, P9, DOI 10.1379/CSC-222R.1; Schlumpberger M, 2001, MOL CELL BIOL, V21, P7035, DOI 10.1128/MCB.21.20.7035-7046.2001; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Singh R, 2002, FEBS LETT, V527, P234, DOI 10.1016/S0014-5793(02)03243-X; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Trevitt CR, 2006, BRAIN, V129, P2241, DOI 10.1093/brain/awl150; Tribouillard Deborah, 2006, Biotechnology Journal, V1, P58, DOI 10.1002/biot.200500001; Tuite MF, 2004, MOL CELL, V14, P541, DOI 10.1016/j.molcel.2004.05.012; Udekwu KI, 2005, GENE DEV, V19, P2355, DOI 10.1101/gad.354405; Vido K, 2001, J BIOL CHEM, V276, P8469, DOI 10.1074/jbc.M008708200; Vilette D, 2001, P NATL ACAD SCI USA, V98, P4055, DOI 10.1073/pnas.061337998; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170	59	49	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2174	10.1371/journal.pone.0002174	http://dx.doi.org/10.1371/journal.pone.0002174			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478094	Green Published, Green Submitted, gold			2022-12-25	WOS:000262172800039
J	Fauquier, L; Duboe, C; Jore, C; Trouche, D; Vandel, L				Fauquier, Lucas; Duboe, Carine; Jore, Cecile; Trouche, Didier; Vandel, Laurence			Dual role of the arginine methyltransferase CARM1 in the regulation of c-Fos target genes	FASEB JOURNAL			English	Article						p160 proteins; MMPs; AP-1; transcription; mRNA stability; post-transcriptional regulation	AU-RICH ELEMENTS; TRANSCRIPTIONAL COACTIVATOR; MATRIX METALLOPROTEINASES; HISTONE H3; PROTEIN; METHYLATION; ACTIVATION; SRC-1; EXPRESSION; STABILITY	Fos proteins, the prototypic members of basic region-leucine zipper ( bZIP) transcription factors, bind to other bZIP proteins to form the activator protein-1 (AP-1) complex, which regulates the expression of a plethora of target genes. Notably, c-Fos target genes include members of the matrix metalloproteinase (MMP) gene family and c-fos is overexpressed in a number of metastatic cancers, suggesting its direct involvement in this process. Here, we reveal that c-Fos-mediated transcriptional activation is regulated by the protein arginine methyltransferase CARM1 and by all three members of the p160 protein family of coactivators. Carm1-deficient cells showed a dramatic reduction in the expression level of c-Fos target genes MMP-1b, -3, and -13, indicating a major role for CARM1 in regulating the expression of these genes. RNA interference combined with quantitative polymerase chain reaction demonstrated that CARM1 and p160 proteins synergize to activate expression of MMP-1b, -3, and -13 in vivo. Furthermore, we show that CARM1 also regulates MMP expression at the post-transcriptional level, either positively or negatively. Our data indicate that CARM1 can play a dual role in the expression of AP-1 target genes involved in cancer or other diseases by acting at the transcriptional as well as at the post-transcriptional levels.	[Fauquier, Lucas; Duboe, Carine; Jore, Cecile; Vandel, Laurence] Univ Toulouse 3, CNRS, Ctr Dev Biol, UMR 5547, F-31062 Toulouse, France; [Trouche, Didier] Lab Biol Cellulaire & Mol Controle Proliferat, UMR 5088, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Vandel, L (corresponding author), Univ Toulouse 3, CNRS, Ctr Dev Biol, UMR 5547, 118 Route Narbonne, F-31062 Toulouse, France.	vandel@cict.fr		Vandel, Laurence/0000-0002-3692-2942; Trouche, Didier/0000-0003-1398-6481	Centre National de la Recherche Scientifique; Fondation pour la Recherche Medicale; Universite Paul Sabatier Toulouse; Ministere de l'Education Nationale et de la Recherche; Association pour la Recherche contre le Cancer	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Universite Paul Sabatier Toulouse; Ministere de l'Education Nationale et de la Recherche; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer)	We are grateful to Drs. Lucas Waltzer and Julie Batut for critical reading of the manuscript and to Dr. Sandra Wenk for helpful discussions. We thank Dr. Mark Bedford (University of Texas, Smithville, TX, USA), Drs. Hinrich Gronemeyer and Claudine Gaudon (Institut de Genetique et de Biologie Moleculaire et Cellulaire, Illkirch, France), Dr. Marc Piechaczyk (Institut de Genetique Moleculaire, Montpellier, France), Dr. Michael Stallcup (University of Southern California, Los Angeles, CA, USA), Dr. Tony Kouzarides (University of Cambridge, Cambridge, UK), Dr. Rene Bernards ( The Netherlands Cancer Institute, Amsterdam, The Netherlands), and Jean-Marie Garnier and Cathie Erb (Institut de Genetique et de Biologie Moleculaire et Cellulaire, Illkirch, France) for reagents. This work was supported by an Action Thematique et Incitative sur Programme grant from the Centre National de la Recherche Scientifique and grants from the Fondation pour la Recherche Medicale and the Association pour la Recherche contre le Cancer and from Universite Paul Sabatier Toulouse to L. V. L. F. received a studentship from the Ministere de l'Education Nationale et de la Recherche and from the Association pour la Recherche contre le Cancer.	An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; BANNISTER AJ, 1995, EMBO J, V14, P4758, DOI 10.1002/j.1460-2075.1995.tb00157.x; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bauer UM, 2002, EMBO REP, V3, P39, DOI 10.1093/embo-reports/kvf013; Brook M, 2006, MOL CELL BIOL, V26, P2408, DOI 10.1128/MCB.26.6.2408-2418.2006; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Chevillard-Briet M, 2002, EMBO J, V21, P5457, DOI 10.1093/emboj/cdf548; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; Covic M, 2005, EMBO J, V24, P85, DOI 10.1038/sj.emboj.7600500; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Dixon DA, 2000, J BIOL CHEM, V275, P11750, DOI 10.1074/jbc.275.16.11750; Eberhardt W, 2007, PHARMACOL THERAPEUT, V114, P56, DOI 10.1016/j.pharmthera.2007.01.002; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; El Messaoudi S, 2006, P NATL ACAD SCI USA, V103, P13351, DOI 10.1073/pnas.0605692103; Feng Q, 2006, MOL CELL BIOL, V26, P7846, DOI 10.1128/MCB.00568-06; Fujiwara T, 2006, MOL CELL BIOL, V26, P2273, DOI 10.1128/MCB.26.6.2273-2285.2006; Gebhardt C, 2005, AM J PATHOL, V167, P243, DOI 10.1016/S0002-9440(10)62969-0; Gehin M, 2002, MOL CELL BIOL, V22, P5923, DOI 10.1128/MCB.22.16.5923-5937.2002; GRIGORIADIS AE, 1993, J CELL BIOL, V122, P685, DOI 10.1083/jcb.122.3.685; Hong H, 1996, P NATL ACAD SCI USA, V93, P4948, DOI 10.1073/pnas.93.10.4948; HU ED, 1994, EMBO J, V13, P3094, DOI 10.1002/j.1460-2075.1994.tb06608.x; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Koh SS, 2002, J BIOL CHEM, V277, P26031, DOI 10.1074/jbc.M110865200; Koh SS, 2001, J BIOL CHEM, V276, P1089, DOI 10.1074/jbc.M004228200; Lee SK, 1998, J BIOL CHEM, V273, P16651, DOI 10.1074/jbc.273.27.16651; Lee YH, 2005, P NATL ACAD SCI USA, V102, P3611, DOI 10.1073/pnas.0407159102; Lemaitre Vincent, 2006, Birth Defects Research, V78, P1, DOI 10.1002/bdrc.20065; Leo C, 2000, GENE, V245, P1, DOI 10.1016/S0378-1119(00)00024-X; Levy N, 2008, MOL ENDOCRINOL, V22, P287, DOI 10.1210/me.2007-0340; Li H, 1997, P NATL ACAD SCI USA, V94, P8479, DOI 10.1073/pnas.94.16.8479; Li HW, 2002, J BIOL CHEM, V277, P44623, DOI 10.1074/jbc.M206187200; Ma H, 2001, CURR BIOL, V11, P1981, DOI 10.1016/S0960-9822(01)00600-5; Naeem H, 2007, MOL CELL BIOL, V27, P120, DOI 10.1128/MCB.00815-06; Neininger A, 2002, J BIOL CHEM, V277, P3065, DOI 10.1074/jbc.C100685200; Nishihara E, 2003, J NEUROSCI, V23, P213; Onate SA, 1998, J BIOL CHEM, V273, P12101, DOI 10.1074/jbc.273.20.12101; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Pullmann R, 2005, J BIOL CHEM, V280, P22819, DOI 10.1074/jbc.M501106200; Rydziel S, 2004, J BIOL CHEM, V279, P5397, DOI 10.1074/jbc.M311984200; SAEZ E, 1995, CELL, V82, P721, DOI 10.1016/0092-8674(95)90469-7; Vandel L, 2001, MOL CELL BIOL, V21, P6484, DOI 10.1128/MCB.21.19.6484-6494.2001; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; Xu JM, 2000, P NATL ACAD SCI USA, V97, P6379, DOI 10.1073/pnas.120166297; Xu JM, 1998, SCIENCE, V279, P1922, DOI 10.1126/science.279.5358.1922; Xu W, 2001, SCIENCE, V294, P2507, DOI 10.1126/science.1065961; Yadav N, 2003, P NATL ACAD SCI USA, V100, P6464, DOI 10.1073/pnas.1232272100; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948; Zika E, 2005, P NATL ACAD SCI USA, V102, P16321, DOI 10.1073/pnas.0505045102	52	19	19	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2008	22	9					3337	3347		10.1096/fj.07-104604	http://dx.doi.org/10.1096/fj.07-104604			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	342CD	18511550				2022-12-25	WOS:000258761300026
J	Lin, SH; Cheng, CJ; Lee, YC; Ye, X; Tsai, WW; Kim, J; Pasqualini, R; Arap, W; Navone, NM; Tu, SM; Hu, M; Yu-Lee, LY; Logothetis, CJ				Lin, S-H; Cheng, C-J; Lee, Y-C; Ye, X.; Tsai, W-W; Kim, J.; Pasqualini, R.; Arap, W.; Navone, N. M.; Tu, S-M; Hu, M.; Yu-Lee, L-Y; Logothetis, C. J.			A 45-kDa ErbB3 secreted by prostate cancer cells promotes bone formation	ONCOGENE			English	Article						prostate cancer; bone metastasis; osteoblast; p45-sErbB3	EXPRESSION; OSTEOBLASTS; CARCINOMAS; METASTASIS; MDA-BF-1; ISOFORM; PROTEIN; GROWTH; TUMORS; MICE	ErbB3 is a transmembrane growth factor receptor that has been implicated in the pathogenesis of human cancer. After finding that a truncated form of ErbB3 was present and upregulated in metastatic prostate cancer cells in lymph nodes and bone, we explored the pathophysiological functions of this unusual form of ErbB3 in the context of mouse calvaria as well as osteoblasts in vitro and the femur microenvironment in vivo. Here we demonstrate that prostate cancer cells expressed an alternatively spliced transcript that encodes a 45-kDa glycosylated protein (p45-sErbB3). The recombinant p45-sErbB3 purified from conditioned medium stimulated calvarial bone formation and induced osteoblast differentiation. Overexpression of p45-sErbB3 in the osteolytic prostate cancer cell line PC-3 converted its phenotype from bone lysing to bone forming upon injection into the femurs of immunodeficient mice. Further, we detected sErbB3 in plasma samples from patients with castration-resistant prostate cancer with bone metastasis. These observations establish that p45- sErbB3 is a structurally and functionally unique gene product of ErbB3 and suggest that p45- sErbB3 is likely one ofthe factors involved in the osteoblastic bone metastases of prostate cancer.	[Lin, S-H; Lee, Y-C; Ye, X.; Tsai, W-W] Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA; [Lin, S-H; Kim, J.; Pasqualini, R.; Arap, W.; Navone, N. M.; Tu, S-M; Logothetis, C. J.] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Cheng, C-J] Taipei Med Univ, Dept Pathol, Taipei, Taiwan; [Hu, M.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Yu-Lee, L-Y] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Taipei Medical University; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine	Lin, SH (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	slin@mdanderson.org			National Institutes of Health [CA111479, P50-CA90270, DK53176]; Charlotte Geyer Foundation; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA111479, P50CA090270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053176] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charlotte Geyer Foundation; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Karen Earley, Weiping Luo, Matthew Gal. one for technical assistance, Dr Jian Kuang for critical reading of the manuscript and Christine Wogan for editing the manuscript. This work was supported by National Institutes of Health grants CA111479, P50-CA90270 and DK53176; the Charlotte Geyer Foundation and the Prostate Cancer Foundation.	ALIMANDI M, 1995, ONCOGENE, V10, P1813; Berruti A, 2000, J UROLOGY, V164, P1248, DOI 10.1016/S0022-5347(05)67149-2; BHARGAVA U, 1988, BONE, V9, P155, DOI 10.1016/8756-3282(88)90005-1; Chen NY, 2007, CANCER RES, V67, P6544, DOI 10.1158/0008-5472.CAN-07-1330; Choueiri MB, 2006, CANCER METAST REV, V25, P601, DOI 10.1007/s10555-006-9034-y; Corey E, 2002, PROSTATE, V52, P20, DOI 10.1002/pros.10091; Hellyer NJ, 2001, J BIOL CHEM, V276, P42153, DOI 10.1074/jbc.M102079200; KRAUS MH, 1989, P NATL ACAD SCI USA, V86, P9193, DOI 10.1073/pnas.86.23.9193; Liang AK, 2005, PROTEIN EXPRES PURIF, V44, P58, DOI 10.1016/j.pep.2005.03.025; LIN SH, 2008, CLIN CANC R IN PRESS; Logothetis CJ, 2005, NAT REV CANCER, V5, P21, DOI 10.1038/nrc1528; LOW SH, 1991, J BIOL CHEM, V266, P13391; Naidu R, 1998, BRIT J CANCER, V78, P1385, DOI 10.1038/bjc.1998.689; Shah RB, 2004, CANCER RES, V64, P9209, DOI 10.1158/0008-5472.CAN-04-2442; Soos G, 1996, INT J CANCER, V66, P280, DOI 10.1002/(SICI)1097-0215(19960410)66:2<280::AID-IJC24>3.0.CO;2-F; Vakar-Lopez F, 2004, J PATHOL, V203, P688, DOI 10.1002/path.1568; Wu TT, 1998, INT J CANCER, V77, P887, DOI 10.1002/(SICI)1097-0215(19980911)77:6<887::AID-IJC15>3.0.CO;2-Z; Yang J, 2001, CANCER RES, V61, P5652; Yi ES, 1997, MODERN PATHOL, V10, P142	19	21	24	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2008	27	39					5195	5203		10.1038/onc.2008.156	http://dx.doi.org/10.1038/onc.2008.156			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	344GO	18490922	Green Accepted			2022-12-25	WOS:000258915100003
J	Liu, F; Liang, ZH; Wegiel, J; Hwang, YW; Iqbal, K; Grundke-Iqbal, I; Ramakrishna, N; Gong, CX				Liu, Fei; Liang, Zhihou; Wegiel, Jerzy; Hwang, Yu-Wen; Iqbal, Khalid; Grundke-Iqbal, Inge; Ramakrishna, Narayan; Gong, Cheng-Xin			Overexpression of Dyrk1A contributes to neurofibrillary degeneration in Down syndrome	FASEB JOURNAL			English	Article						tau; hyperphosphorylation; GSK-3 beta; trisomy 21	PAIRED HELICAL FILAMENTS; SYNDROME CRITICAL REGION; ALZHEIMERS-DISEASE; PROTEIN-TAU; SUBCELLULAR-LOCALIZATION; PHOSPHORYLATES TAU; REGULATED KINASE; FUNCTIONAL-LINK; HUMAN HOMOLOG; BRAIN	Adults with Down syndrome (DS) develop Alzheimer neurofibrillary degeneration in the brain, but the underlying molecular mechanism is unknown. Here, we report that the presence of an extra copy of the dual-specificity tyrosine-phosphorylated and regulated kinase 1A (Dyrk1A) gene due to trisomy 21 resulted in overexpression of Dyrk1A and elevated kinase activity in DS brain. Dyrk1A phosphorylated tau at several sites, and these sites were hyperphosphorylated in adult DS brains. Phosphorylation of tau by Dyrk1A primed its further phosphorylation by glycogen synthase kinase-3 beta (GSK-3 beta). Dyrk1A-induced tau phosphorylation inhibited tau's biological activity and promoted its self-aggregation. In Ts65Dn mouse brain, an extra copy of the Dyrk1A gene caused increased expression and activity of Dyrk1A and resulted in increased tau phosphorylation. These findings strongly suggest a novel mechanism by which the overexpression of Dyrk1A in DS brain causes neurofibrillary degeneration via hyperphosphorylating tau.	[Liu, Fei; Liang, Zhihou; Iqbal, Khalid; Grundke-Iqbal, Inge; Gong, Cheng-Xin] New York State Inst Basic Res Dev Disabil, Dept Neurochem, Staten Isl, NY 10314 USA; [Wegiel, Jerzy] New York State Inst Basic Res Dev Disabil, Dept Dev Neurobiol, Staten Isl, NY 10314 USA; [Hwang, Yu-Wen; Ramakrishna, Narayan] New York State Inst Basic Res Dev Disabil, Dept Mol Biol, Staten Isl, NY 10314 USA	Institute for Basic Research in Developmental Disabilities; Institute for Basic Research in Developmental Disabilities; Institute for Basic Research in Developmental Disabilities	Gong, CX (corresponding author), New York State Inst Basic Res Dev Disabil, Dept Neurochem, 1050 Forest Hill Rd, Staten Isl, NY 10314 USA.	cxgong@mail.csi.cuny.edu			New York State Office of Mental Retardation and Developmental Disabilities; U. S. National Institutes of Health [AG027429, HD043960, HD038295, AG019158]; U. S. Alzheimer's Association [IIRG-05-13095]; Li Foundation, Inc.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038295, R01HD043960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027429, R01AG019158] Funding Source: NIH RePORTER	New York State Office of Mental Retardation and Developmental Disabilities; U. S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U. S. Alzheimer's Association(Alzheimer's Association); Li Foundation, Inc.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in part, by the New York State Office of Mental Retardation and Developmental Disabilities and by grants from the U. S. National Institutes of Health (AG027429 to C.-X. G., HD043960 to J.W., HD038295 to Y.-W. H., AG019158 to K. I.), the U. S. Alzheimer's Association (IIRG-05-13095 to C.-X. G.) and the Li Foundation, Inc. ( to C.-X. G.). We thank Dr. A. del C. Alonso for help with electron microscopy, Dr. D. Miller for support and advice, Dr. E. El-Akkad for preparation of recombinant tau<INF>441</INF>, Dr. J. Currie for critical reading of the manuscript and suggestions, Ms. M. Marlow for editorial suggestions, and Ms. J. Murphy for secretarial assistance.	Ahn KJ, 2006, NEUROBIOL DIS, V22, P463, DOI 10.1016/j.nbd.2005.12.006; ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Avila Jesus, 2007, Expert Rev Neurother, V7, P1527, DOI 10.1586/14737175.7.11.1527; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Becker W, 1998, J BIOL CHEM, V273, P25893, DOI 10.1074/jbc.273.40.25893; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; Chen-Hwang MC, 2002, J BIOL CHEM, V277, P17597, DOI 10.1074/jbc.M111101200; Cho JH, 2003, J BIOL CHEM, V278, P187, DOI 10.1074/jbc.M206236200; Davisson M T, 1993, Prog Clin Biol Res, V384, P117; de Graaf Katrin, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-7; Dowjat WK, 2007, NEUROSCI LETT, V413, P77, DOI 10.1016/j.neulet.2006.11.026; Ermak G, 2006, FEBS J, V273, P2100, DOI 10.1111/j.1742-4658.2006.05217.x; Ferrer I, 2005, NEUROBIOL DIS, V20, P392, DOI 10.1016/j.nbd.2005.03.020; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Godemann R, 1999, FEBS LETT, V454, P157, DOI 10.1016/S0014-5793(99)00741-3; Gong CX, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/31825; Gong CX, 2000, J BIOL CHEM, V275, P5535, DOI 10.1074/jbc.275.8.5535; GONG CX, 1994, J NEUROCHEM, V62, P803; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Guimera J, 1999, GENOMICS, V57, P407, DOI 10.1006/geno.1999.5775; Guimera J, 1996, HUM MOL GENET, V5, P1305, DOI 10.1093/hmg/5.9.1305; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Hammerle B, 2003, EUR J NEUROSCI, V17, P2277, DOI 10.1046/j.1460-9568.2003.02665.x; Hanger DP, 2007, J BIOL CHEM, V282, P23645, DOI 10.1074/jbc.M703269200; Harris CD, 2005, CELL MOL LIFE SCI, V62, P2477, DOI 10.1007/s00018-005-5085-4; Hashiguchi M, 2002, J BIOL CHEM, V277, P44525, DOI 10.1074/jbc.M207426200; Himpel S, 2000, J BIOL CHEM, V275, P2431, DOI 10.1074/jbc.275.4.2431; Holland AJ, 1998, BRIT J PSYCHIAT, V172, P493, DOI 10.1192/bjp.172.6.493; Huang Y, 2004, BIOCHEMISTRY-US, V43, P10173, DOI 10.1021/bi036060+; Kannanayakal TJ, 2008, NEUROSCI LETT, V431, P141, DOI 10.1016/j.neulet.2007.11.066; Kannanayakal TJ, 2006, ACTA NEUROPATHOL, V111, P413, DOI 10.1007/s00401-006-0049-9; KHATOON S, 1992, J NEUROCHEM, V59, P750, DOI 10.1111/j.1471-4159.1992.tb09432.x; Kim EJ, 2006, J BIOL CHEM, V281, P33250, DOI 10.1074/jbc.M606147200; Kimura R, 2007, HUM MOL GENET, V16, P15, DOI 10.1093/hmg/ddl437; Li GB, 2004, J BIOL CHEM, V279, P15938, DOI 10.1074/jbc.M314116200; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; Liu F, 2002, NEUROSCIENCE, V115, P829, DOI 10.1016/S0306-4522(02)00510-9; Liu F, 2007, EUR J NEUROSCI, V26, P3429, DOI 10.1111/j.1460-9568.2007.05955.x; Liu SJ, 2004, J BIOL CHEM, V279, P50078, DOI 10.1074/jbc.M406109200; Marti E, 2003, BRAIN RES, V964, P250, DOI 10.1016/S0006-8993(02)04069-6; Murakami N, 2006, J BIOL CHEM, V281, P23712, DOI 10.1074/jbc.M513497200; Olson LE, 2004, SCIENCE, V306, P687, DOI 10.1126/science.1098992; Park J, 2007, MOL CELL NEUROSCI, V36, P270, DOI 10.1016/j.mcn.2007.07.007; Perez M, 2002, EUR J BIOCHEM, V269, P1484, DOI 10.1046/j.1432-1033.2002.02794.x; QI Z, 1995, J BIOL CHEM, V270, P10847, DOI 10.1074/jbc.270.18.10847; Riley KP, 2002, ANN NEUROL, V51, P567, DOI 10.1002/ana.10161; Ryoo SR, 2008, J NEUROCHEM, V104, P1333, DOI 10.1111/j.1471-4159.2007.05075.x; Ryoo SR, 2007, J BIOL CHEM, V282, P34850, DOI 10.1074/jbc.M707358200; Shukkur EA, 2006, HUM MOL GENET, V15, P2752, DOI 10.1093/hmg/ddl211; Song WJ, 1996, GENOMICS, V38, P331, DOI 10.1006/geno.1996.0636; Takashima A, 2006, J ALZHEIMERS DIS, V9, P309; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tatebayashi Y, 1999, J NEUROSCI, V19, P5245; Wegiel J, 2004, BRAIN RES, V1010, P69, DOI 10.1016/j.brainres.2004.03.008; WISNIEWSKI KE, 1985, ANN NEUROL, V17, P278, DOI 10.1002/ana.410170310; Woods YL, 2001, BIOCHEM J, V355, P609, DOI 10.1042/bj3550609; YOSHIDA H, 1993, J NEUROCHEM, V61, P1183, DOI 10.1111/j.1471-4159.1993.tb03642.x	60	165	171	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2008	22	9					3224	3233		10.1096/fj.07-104539	http://dx.doi.org/10.1096/fj.07-104539			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	342CD	18509201	Green Published			2022-12-25	WOS:000258761300015
J	Veeramani, S; Yuan, TC; Lin, FF; Lin, MF				Veeramani, S.; Yuan, T-C; Lin, F-F; Lin, M-F			Mitochondrial redox signaling by p66Shc is involved in regulating androgenic growth stimulation of human prostate cancer cells	ONCOGENE			English	Article						p66Shc; prostate cancer; DHT; reactive oxygen species	66-KDA SHC ISOFORM; BREAST-CANCER; LIFE-SPAN; P66(SHC) PROTEIN; ACID-PHOSPHATASE; EXPRESSION; PATHWAY; LINES; PROLIFERATION; APOPTOSIS	p66Shc is shown to negatively regulate the life span in mice through reactive oxygen species (ROS) production. Recent reports, however, revealed that p66Shc protein level is significantly elevated in several human cancer tissues and growth-stimulated carcinoma cells, suggesting a mitogenic and carcinogenic role for p66Shc. In this communication, we demonstrate for the first time that p66Shc mediates androgenic growth signals in androgen-sensitive human prostate cancer cells through mitochondrial ROS production. Growth stimulation of prostate cancer cells with 5 alpha-dihydrotestosterone (DHT) is accompanied by increased p66Shc level and ROS production, which is abolished by antioxidant treatments. However, antioxidant treatments do not affect the transcriptional activity of androgen receptor (AR) as observed by its inability to block DHT-induced prostate-specific antigen expression, an AR-dependent correlate of prostate cancer progression. Elevated expression of p66Shc by cDNA transfection increases the basal cell proliferation and, thus, reduces additional DHT-induced cell proliferation. Furthermore, DHT increases the translocation of p66Shc into mitochondria and its interaction with cytochrome c. Conversely, both redox-negative p66Shc mutant (W134F), which is deficient in cytochrome c interaction, and p66Shc small interfering RNA decrease DHT-induced cell proliferation. These results collectively reveal a novel role for p66Shc-ROS pathway in androgen-induced prostate cancer cell proliferation and, thus, may play a role in early prostate carcinogenesis.	[Veeramani, S.; Yuan, T-C; Lin, F-F; Lin, M-F] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Coll Med, Omaha, NE 68198 USA; [Lin, M-F] Univ Nebraska Med Ctr, Eppley Inst Res Canc, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Lin, MF (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Coll Med, 985870 Nebraska Med Ctr, Omaha, NE 68198 USA.	mlin@unmc.edu	Veeramani, Suresh/P-7838-2019	Veeramani, Suresh/0000-0001-9217-0872	Department of Defense [W81XWH-04-1-0908, W81XWH-06-1-0070]; National Institutes of Health [R01 CA88184]; UNMC Graduate Student Fellowship; NATIONAL CANCER INSTITUTE [P30CA036727, R01CA088184] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNMC Graduate Student Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the technical supports from the Flow Cytometry core facility at UNMC and Eppley Cancer Center (P30CA036727). This study was supported in part by the Department of Defense Grants (W81XWH-04-1-0908 and W81XWH-06-1-0070), National Institutes of Health (R01 CA88184) and UNMC Graduate Student Fellowship. We thank Dr Ming-Shyue Lee for the initial study of DHT effect on serine-36 phosphorylation of p66Shc. We also acknowledge Dr Larry W Oberley at University of Iowa College of Medicine (Iowa City, IA, USA) and Dr Parmender P Mehta, University of Nebraska Medical Center (Omaha, NE, USA) for the plasmids Mn-SOD and pECFP-N1, respectively.	Bourdon JC, 2007, BRIT J CANCER, V97, P277, DOI 10.1038/sj.bjc.6603886; Davol PA, 2003, CANCER RES, V63, P6772; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Grossman SR, 2007, CLIN CANCER RES, V13, P5798, DOI 10.1158/1078-0432.CCR-07-0073; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Jackson JG, 2000, CLIN CANCER RES, V6, P1135; Khanday FA, 2006, J CELL BIOL, V172, P817, DOI 10.1083/jcb.200506001; Klein EA, 2001, J UROLOGY, V166, P1311, DOI 10.1016/S0022-5347(05)65759-X; Kuruma H, 2005, PROTEOMICS, V5, P1097, DOI 10.1002/pmic.200401115; Lee MS, 2004, ONCOGENE, V23, P3048, DOI 10.1038/sj.onc.1207451; Lee MS, 2004, INT J CANCER, V108, P672, DOI 10.1002/ijc.11621; Lim SD, 2005, PROSTATE, V62, P200, DOI 10.1002/pros.20137; Lin MF, 1998, J BIOL CHEM, V273, P5939, DOI 10.1074/jbc.273.10.5939; Lotti LV, 1996, MOL CELL BIOL, V16, P1946; Meng TC, 1998, J BIOL CHEM, V273, P22096, DOI 10.1074/jbc.273.34.22096; Migliaccio E, 1997, EMBO J, V16, P706, DOI 10.1093/emboj/16.4.706; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Navone NM, 1997, CLIN CANCER RES, V3, P2493; Nemoto S, 2006, J BIOL CHEM, V281, P10555, DOI 10.1074/jbc.M511626200; Okada S, 1997, J BIOL CHEM, V272, P28042, DOI 10.1074/jbc.272.44.28042; Orsini F, 2004, J BIOL CHEM, V279, P25689, DOI 10.1074/jbc.M401844200; Pacini S, 2004, MOL CELL BIOL, V24, P1747, DOI 10.1128/MCB.24.4.1747-1757.2004; Pandolfi S, 2005, MECH AGEING DEV, V126, P839, DOI 10.1016/j.mad.2005.03.004; Park YJ, 2005, ENDOCRINOLOGY, V146, P2473, DOI 10.1210/en.2004-1588; Pinton P, 2007, SCIENCE, V315, P659, DOI 10.1126/science.1135380; Ravichandran KS, 2001, ONCOGENE, V20, P6322, DOI 10.1038/sj.onc.1204776; Ripple MO, 1997, JNCI-J NATL CANCER I, V89, P40, DOI 10.1093/jnci/89.1.40; Stevenson LE, 1998, BREAST CANCER RES TR, V49, P119, DOI 10.1023/A:1006007227747; Trinei M, 2002, ONCOGENE, V21, P3872, DOI 10.1038/sj.onc.1205513; Veeramani S, 2005, ONCOGENE, V24, P7203, DOI 10.1038/sj.onc.1208852; Ventura A, 2004, J BIOL CHEM, V279, P2299, DOI 10.1074/jbc.M307655200; Xie YM, 1996, BIOCHEM BIOPH RES CO, V221, P140, DOI 10.1006/bbrc.1996.0559; Yang CPH, 2000, CANCER RES, V60, P5171	33	57	61	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG 28	2008	27	37					5057	5068		10.1038/onc.2008.143	http://dx.doi.org/10.1038/onc.2008.143			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	344GL	18504439	Green Accepted, Green Submitted, Bronze			2022-12-25	WOS:000258914800008
J	Archer, CT; Burdine, L; Liu, B; Ferdous, A; Johnston, SA; Kodadek, T				Archer, Chase T.; Burdine, Lyle; Liu, Bo; Ferdous, Anwarul; Johnston, Stephen Albert; Kodadek, Thomas			Physical and functional interactions of monoubiquitylated transactivators with the proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION DOMAIN; REGULATORY PARTICLE; 26S PROTEASOME; CROSS-LINKING; HISTONE H2B; PROTEIN; TRANSCRIPTION; ASSOCIATION; SUBUNIT; IDENTIFICATION	Destabilization of activator-DNA complexes by the proteasomal ATPases can inhibit transcription by limiting activator interaction with DNA. Modification of the activator by monou-biquitylation protects the activator from this destabilization activity. In this study, we probe the mechanism of this protective effect of monoubiquitylation. Using novel label transfer and chemical cross-linking techniques, we show that ubiquitin contacts the ATPase complex directly, apparently via Rpn1 and Rpt1. This interaction results in the dissociation of the activation domain-ATPase complex via an allosteric process. A model is proposed in which activator monoubiquitylation serves to limit the lifetime of the activator-ATPase complex interaction and thus the ability of the ATPases to unfold the activator and dissociate the protein-DNA complex.	[Archer, Chase T.; Burdine, Lyle; Liu, Bo; Kodadek, Thomas] Univ Texas SW Med Ctr Dallas, Div Translat Res, Dallas, TX 75390 USA; [Ferdous, Anwarul; Johnston, Stephen Albert; Kodadek, Thomas] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Kodadek, Thomas] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kodadek, T (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Thomas.Kodadek@utsouthwestern.edu	Burdine, Lyle/GLR-7495-2022	Kodadek, Thomas/0000-0003-1930-4795	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071833] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 71833] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; Archer CT, 2008, J BIOL CHEM, V283, P12614, DOI 10.1074/jbc.M801050200; Archer CT, 2005, MOL BIOSYST, V1, P366, DOI 10.1039/b510019d; Auld KL, 2006, MOL CELL, V21, P861, DOI 10.1016/j.molcel.2006.02.020; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Burdine L, 2004, J AM CHEM SOC, V126, P11442, DOI 10.1021/ja045982c; Chang C, 2001, J BIOL CHEM, V276, P30956, DOI 10.1074/jbc.M102254200; Denison C, 2004, J PROTEOME RES, V3, P417, DOI 10.1021/pr034071j; ELASSER S, 2002, NATURE CELL BIOL, V4, P725; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Ezhkova E, 2004, MOL CELL, V13, P435, DOI 10.1016/S1097-2765(04)00026-7; Ferdous A, 2002, BIOCHEMISTRY-US, V41, P12798, DOI 10.1021/bi020425t; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; Ferdous A, 2007, GENE DEV, V21, P112, DOI 10.1101/gad.1493207; Fu HY, 2001, EMBO J, V20, P7096, DOI 10.1093/emboj/20.24.7096; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; KREUZER KN, 1983, METHOD ENZYMOL, V100, P144; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Lassot I, 2007, MOL CELL, V25, P369, DOI 10.1016/j.molcel.2006.12.020; Lee DY, 2005, CELL, V123, P423, DOI 10.1016/j.cell.2005.08.015; LEE JW, 1995, NATURE, V374, P91, DOI 10.1038/374091a0; Liu B, 2007, J AM CHEM SOC, V129, P12348, DOI 10.1021/ja072904r; Liu B, 2006, J AM CHEM SOC, V128, P15228, DOI 10.1021/ja065794h; LOHR D, 1995, FASEB J, V9, P777, DOI 10.1096/fasebj.9.9.7601342; MATSUMOTO K, 1980, J BACTERIOL, V141, P508, DOI 10.1128/JB.141.2.508-527.1980; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Russell SJ, 2001, J BIOL CHEM, V276, P9825, DOI 10.1074/jbc.M010889200; Saeki Y, 2000, BIOCHEM BIOPH RES CO, V273, P509, DOI 10.1006/bbrc.2000.2980; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Sikder D, 2006, J BIOL CHEM, V281, P27346, DOI 10.1074/jbc.M604706200; Sun LP, 2002, BIOCHEM BIOPH RES CO, V296, P991, DOI 10.1016/S0006-291X(02)02026-0; SWAFFIELD JC, 1995, NATURE, V374, P88, DOI 10.1038/374088a0; SWAFFIELD JC, 1992, NATURE, V357, P698, DOI 10.1038/357698a0; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Yao J, 2006, NATURE, V442, P1050, DOI 10.1038/nature05025	38	34	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21789	21798		10.1074/jbc.M803075200	http://dx.doi.org/10.1074/jbc.M803075200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18515799	Green Published, hybrid			2022-12-25	WOS:000257898800052
J	Nievas, GAF; Barrantes, FJ; Antollini, SS				Nievas, Gaspar A. Fernandez; Barrantes, Francisco J.; Antollini, Silvia S.			Modulation of nicotinic acetylcholine receptor conformational state by free fatty acids and steroids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADRENAL CHROMAFFIN CELLS; PERMEABILITY CONTROL PROPERTIES; MEMBRANE-LIPID-COMPOSITION; ION-CHANNEL FUNCTION; TORPEDO-CALIFORNICA; TRANSMEMBRANE DOMAIN; LAURDAN FLUORESCENCE; GENERALIZED POLARIZATION; CATECHOLAMINE SECRETION; THALAMIC SYNAPTOSOMES	Steroids and free fatty acids (FFA) are noncompetitive antagonists of the nicotinic acetylcholine receptor (AChR). Their site of action is purportedly located at the lipid-AChR interface, but their exact mechanism of action is still unknown. Here we studied the effect of structurally different FFA and steroids on the conformational equilibrium of the AChR in Torpedo californica receptor-rich membranes. We took advantage of the higher affinity of the fluorescent AChR open channel blocker, crystal violet, for the desensitized state than for the resting state. Increasing concentrations of steroids and FFA decreased the K-D of crystal violet in the absence of agonist; however, only cis-unsaturated FFA caused an increase in K-D in the presence of agonist. This latter effect was also observed with treatments that caused the opposite effects on membrane polarity, such as phospholipase A(2) treatment or temperature increase (decreasing or increasing membrane polarity, respectively). Quenching by spin-labeled fatty acids of pyrene-labeled AChR reconstituted into model membranes, with the label located at the gamma M4 transmembrane segment, disclosed the occurrence of conformational changes induced by steroids and cis-unsaturated FFA. The present work is a step forward in understanding the mechanism of action of this type of molecules, suggesting that the direct contact between exogenous lipids and the AChR transmembrane segments removes the AChR from its resting state and that membrane polarity modulates the AChR activation equilibrium by an independent mechanism.	Univ Nacl Sur, CONICET, Inst Invest Bioquim, RA-8000 Bahia Blanca, Buenos Aires, Argentina; UNESCO, Chair Biophys & Mol Neurobiol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the South	Antollini, SS (corresponding author), Univ Nacl Sur, CONICET, Inst Invest Bioquim, CC 857,B8000FWB, RA-8000 Bahia Blanca, Buenos Aires, Argentina.	silviant@criba.edu.ar	Barrantes, Francisco J./HCH-0258-2022	Barrantes, Francisco J./0000-0002-4745-681X				ANDREASEN TJ, 1979, ARCH BIOCHEM BIOPHYS, V194, P468, DOI 10.1016/0003-9861(79)90641-6; ANDREASEN TJ, 1980, BIOCHEMISTRY-US, V19, P4719, DOI 10.1021/bi00561a027; Andreeva IE, 2006, BIOCHEMISTRY-US, V45, P195, DOI 10.1021/bi0516024; Antollini SS, 2002, J BIOL CHEM, V277, P1249, DOI 10.1074/jbc.M106618200; Antollini SS, 1996, BIOPHYS J, V70, P1275, DOI 10.1016/S0006-3495(96)79684-4; Antollini SS, 1998, BIOCHEMISTRY-US, V37, P16653, DOI 10.1021/bi9808215; Auerbach A, 2005, P NATL ACAD SCI USA, V102, P1408, DOI 10.1073/pnas.0406787102; Baenziger JE, 2000, J BIOL CHEM, V275, P777, DOI 10.1074/jbc.275.2.777; Barrantes FJ, 2004, BRAIN RES REV, V47, P71, DOI 10.1016/j.brainresrev.2004.06.008; Barrantes FJ, 2003, CURR OPIN DRUG DISC, V6, P620; BARRANTES FJ, 1978, J MOL BIOL, V124, P1, DOI 10.1016/0022-2836(78)90144-4; BARRANTES FJ, 1982, NEURORECEPTORS, P315; Blanton MP, 1999, MOL PHARMACOL, V55, P269, DOI 10.1124/mol.55.2.269; BLANTON MP, 1994, BIOCHEMISTRY-US, V33, P2859, DOI 10.1021/bi00176a016; BLANTON MP, 1992, BIOCHEMISTRY-US, V31, P3738, DOI 10.1021/bi00130a003; Bouzat C, 1996, J BIOL CHEM, V271, P25835, DOI 10.1074/jbc.271.42.25835; Bouzat C, 2000, J GEN PHYSIOL, V115, P663, DOI 10.1085/jgp.115.5.663; BOUZAT C, 1993, NEUROREPORT, V4, P143, DOI 10.1097/00001756-199302000-00007; BOUZAT CB, 1993, RECEPTOR CHANNEL, V1, P251; Bullock AE, 1997, J NEUROCHEM, V68, P2412; Butt CM, 2002, J NEUROCHEM, V83, P48, DOI 10.1046/j.1471-4159.2002.01135.x; COLQUHOUN D, 1985, J PHYSIOL-LONDON, V369, P501, DOI 10.1113/jphysiol.1985.sp015912; CRIADO M, 1982, BIOCHEMISTRY-US, V21, P5750, DOI 10.1021/bi00266a004; CRIADO M, 1984, J BIOL CHEM, V259, P9188; daCosta CJB, 2004, J BIOL CHEM, V279, P14967, DOI 10.1074/jbc.M310037200; daCosta CJB, 2002, J BIOL CHEM, V277, P201, DOI 10.1074/jbc.M108341200; DILGER JP, 1992, PFLUG ARCH EUR J PHY, V420, P479, DOI 10.1007/BF00374622; Nievas GAF, 2007, BIOCHEMISTRY-US, V46, P3503, DOI 10.1021/bi061388z; Garbus I, 2002, NEUROPHARMACOLOGY, V43, P65, DOI 10.1016/S0028-3908(02)00068-0; Garbus I, 2001, NEUROREPORT, V12, P227, DOI 10.1097/00001756-200102120-00010; GORNETSCHELNOKOW U, 1994, EMBO J, V13, P338, DOI 10.1002/j.1460-2075.1994.tb06266.x; GUTIERREZMERINO C, 1995, BIOCHEMISTRY-US, V34, P4846, DOI 10.1021/bi00014a042; Hansen SB, 2007, J MOL BIOL, V369, P895, DOI 10.1016/j.jmb.2007.03.067; Harris FM, 2002, BBA-BIOMEMBRANES, V1565, P123, DOI 10.1016/S0005-2736(02)00514-X; HARTIG PR, 1979, BIOCHEMISTRY-US, V18, P1146, DOI 10.1021/bi00574a004; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Ke L, 1996, J NEUROCHEM, V67, P1100; Kudo K, 2002, EUR J PHARMACOL, V456, P19, DOI 10.1016/S0014-2999(02)02623-7; LAKOWICZ RL, 1999, PRINCIPLES FLUORESCE, P239; LEE YH, 1994, BIOPHYS J, V66, P646, DOI 10.1016/S0006-3495(94)80838-0; Levi M, 1997, MECH AGEING DEV, V97, P109, DOI 10.1016/S0047-6374(97)00047-X; LI L, 1990, BIOCHEMISTRY-US, V29, P5428, DOI 10.1021/bi00475a003; Liu PS, 2004, J BIOMED SCI, V11, P200, DOI 10.1159/000076032; Liu PS, 1996, NEUROSCI LETT, V204, P181, DOI 10.1016/0304-3940(96)12350-8; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lurtz MM, 1999, MOL PHARMACOL, V55, P159, DOI 10.1124/mol.55.1.159; MARSH D, 1978, P NATL ACAD SCI USA, V75, P4329, DOI 10.1073/pnas.75.9.4329; MCCARTHY MP, 1992, J BIOL CHEM, V267, P7655; Minota S, 1997, J NEUROPHYSIOL, V78, P2396, DOI 10.1152/jn.1997.78.5.2396; Mitra A, 2004, STRUCTURE, V12, P1909, DOI 10.1016/j.str.2004.08.004; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; NARAYANASWAMI V, 1993, BIOCHEMISTRY-US, V32, P12413, DOI 10.1021/bi00097a020; Nurowska E, 1996, NEUROREPORT, V8, P77, DOI 10.1097/00001756-199612200-00016; Nurowska E, 2002, BBA-BIOMEMBRANES, V1564, P14, DOI 10.1016/S0005-2736(02)00356-5; OrtizMiranda SI, 1997, J MEMBRANE BIOL, V158, P17, DOI 10.1007/s002329900240; PARASASSI T, 1991, BIOPHYS J, V60, P179, DOI 10.1016/S0006-3495(91)82041-0; PARASASSI T, 1990, BIOPHYS J, V57, P1179, DOI 10.1016/S0006-3495(90)82637-0; PRASAD R, 1996, MANUAL MEMBRANE LIPI, P1; Purohit Y, 2006, J GEN PHYSIOL, V127, P719, DOI 10.1085/jgp.200509438; Ravichandra B, 1999, BIOPHYS CHEM, V76, P117, DOI 10.1016/S0301-4622(98)00222-1; Ryan SE, 2001, J BIOL CHEM, V276, P4796, DOI 10.1074/jbc.M007063200; Shi LJ, 2002, ACTA PHARMACOL SIN, V23, P237; Shi LJ, 2001, ARCH BIOCHEM BIOPHYS, V394, P145, DOI 10.1006/abbi.2001.2519; Shiraishi M, 2002, ANESTH ANALG, V95, P900, DOI 10.1097/00000539-200210000-00020; SINE SM, 1987, J PHYSIOL-LONDON, V385, P325, DOI 10.1113/jphysiol.1987.sp016496; SINE SM, 1990, J GEN PHYSIOL, V96, P395, DOI 10.1085/jgp.96.2.395; SUNSHINE C, 1992, BIOCHIM BIOPHYS ACTA, V1108, P240, DOI 10.1016/0005-2736(92)90031-G; SUNSHINE C, 1994, BBA-BIOMEMBRANES, V1191, P59, DOI 10.1016/0005-2736(94)90233-X; Tamamizu S, 1999, J MEMBRANE BIOL, V170, P157, DOI 10.1007/s002329900545; Trisciuoglio D, 2002, TOXICOL IN VITRO, V16, P449, DOI 10.1016/S0887-2333(02)00029-2; VALERA S, 1992, P NATL ACAD SCI USA, V89, P9949, DOI 10.1073/pnas.89.20.9949; Vest R, 2006, J MEMBRANE BIOL, V211, P15, DOI 10.1007/s00232-005-7008-6; VIJAYARAGHAVAN S, 1995, J NEUROSCI, V15, P3679; VILLAR MT, 1988, BIOCHIM BIOPHYS ACTA, V938, P35, DOI 10.1016/0005-2736(88)90119-8; Yonekubo K, 2003, NEUROSCI LETT, V337, P89, DOI 10.1016/S0304-3940(02)01313-7; Yu WM, 1996, BIOPHYS J, V70, P626, DOI 10.1016/S0006-3495(96)79646-7; Zanello LP, 1996, BIOPHYS J, V70, P2155, DOI 10.1016/S0006-3495(96)79781-3	77	31	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21478	21486		10.1074/jbc.M800345200	http://dx.doi.org/10.1074/jbc.M800345200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18511419	hybrid			2022-12-25	WOS:000257898800020
J	Chen, N; Onisko, B; Napoli, JL				Chen, Na; Onisko, Bruce; Napoli, Joseph L.			The nuclear transcription factor RAR alpha associates with neuronal RNA granules and suppresses translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENDRITIC PROTEIN-SYNTHESIS; RELATIONAL MEMORY DEFICIT; TERM SYNAPTIC PLASTICITY; VITAMIN-A-DEFICIENCY; RETINOIC ACID; RECEPTORS; BRAIN; TRAFFICKING; INHIBITION; INITIATION	All-trans-retinoic acid stimulates dendritic growth in hippocampal neurons within minutes by activating mitogen-activated protein kinase and mTOR and increasing dendritic translation of calcium calmodulin-dependent protein kinase II alpha and the alpha-amino-3-hydroxyl-5-methyl-4-isoxazole propionate receptor subunit GluR1. Hippocampal neurons express RAR alpha in dendrites, and knocking down RAR alpha prevents all-trans-retinoic acid effects on dendritic growth. Here we show, by liquid chromatography/mass spectrometry analysis of immunoaffinity isolates of hippocampal neurons, that RAR alpha partners with many RNA-binding proteins and translation factors conveyed in dendritic RNA transport granules, including the purine-rich element-binding protein, Pur alpha. The interaction of RAR alpha with Pur alpha, an RNA-binding protein required for dendritic RNA transport, and other RNA-binding proteins was confirmed by tandem affinity purification. Confocal microscopy confirmed localization of neuronal RAR alpha in dendritic RNA granules with Pur alpha and FMRP (the fragile x mental retardation protein). Hippocampal RAR alpha also associates with mRNA, e. g. encoding GluR1 and calcium calmodulin-dependent protein kinase II alpha. Consistent with a granule function of conveying translationally silenced mRNA, RAR alpha inhibits translation initiation, independent of 7-methylguanylate cap or poly(A) tail, and prompts mRNA redistribution to silencing ribonucleoprotein particles. These data afford a mechanism for rapid stimulation of dendritic growth by all-trans-retinoic acid and reveal that the ligand-dependent transcription factor RAR alpha also regulates translation.	[Chen, Na; Napoli, Joseph L.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Onisko, Bruce] Western Reg Res Ctr, USDA, Albany, CA 94710 USA	University of California System; University of California Berkeley; United States Department of Agriculture (USDA)	Napoli, JL (corresponding author), Univ Calif Berkeley, Dept Nutr Sci & Toxicol, 119 Morgan Hall,MC 3104, Berkeley, CA 94720 USA.	jna@berkeley.edu	Cabrera, Mariel/GMX-2706-2022	Onisko, Bruce/0000-0003-4657-8257	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036870, R01DK090522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013566] Funding Source: NIH RePORTER; NIA NIH HHS [AG 13566] Funding Source: Medline; NIDDK NIH HHS [DK 36870, R01 DK090522] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Barbee SA, 2006, NEURON, V52, P997, DOI 10.1016/j.neuron.2006.10.028; BEACH ME, 1995, CELL, V81, P905, DOI 10.1016/0092-8674(95)90010-1; Borman AM, 2000, NUCLEIC ACIDS RES, V28, P4068, DOI 10.1093/nar/28.21.4068; Bour G, 2007, TRENDS CELL BIOL, V17, P302, DOI 10.1016/j.tcb.2007.04.003; Chen N, 2008, FASEB J, V22, P236, DOI 10.1096/fj.07-8739com; Chiang MY, 1998, NEURON, V21, P1353, DOI 10.1016/S0896-6273(00)80654-6; Cocco S, 2002, NEUROSCIENCE, V115, P475, DOI 10.1016/S0306-4522(02)00423-2; DAMM K, 1993, P NATL ACAD SCI USA, V90, P2989, DOI 10.1073/pnas.90.7.2989; Dilworth FJ, 2001, ONCOGENE, V20, P3047, DOI 10.1038/sj.onc.1204329; Elvira G, 2006, MOL CELL PROTEOMICS, V5, P635, DOI 10.1074/mcp.M500255-MCP200; Etchamendy N, 2003, BEHAV BRAIN RES, V145, P37, DOI 10.1016/S0166-4328(03)00099-8; Etchamendy N, 2001, J NEUROSCI, V21, P6423, DOI 10.1523/JNEUROSCI.21-16-06423.2001; FORMAN BM, 1995, CELL, V81, P541, DOI 10.1016/0092-8674(95)90075-6; Gray NK, 2000, EMBO J, V19, P4723, DOI 10.1093/emboj/19.17.4723; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; KOSIK KS, 2002, SCI STKE, pPE16; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Martin KC, 2006, J NEUROSCI, V26, P7131, DOI 10.1523/JNEUROSCI.1801-06.2006; McCaffery P, 2006, J NEUROBIOL, V66, P780, DOI 10.1002/neu.20237; Minshall N, 2001, RNA, V7, P1728, DOI 10.1017/S135583820101158X; Misner DL, 2001, P NATL ACAD SCI USA, V98, P11714, DOI 10.1073/pnas.191369798; Nott A, 2004, GENE DEV, V18, P210, DOI 10.1101/gad.1163204; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Sutton MA, 2005, J NEUROBIOL, V64, P116, DOI 10.1002/neu.20152; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Svitkin YV, 1996, EMBO J, V15, P7147, DOI 10.1002/j.1460-2075.1996.tb01106.x; Yang Z, 2004, J CELL SCI, V117, P5567, DOI 10.1242/jcs.01477; Zalfa F, 2006, CURR OPIN NEUROBIOL, V16, P265, DOI 10.1016/j.conb.2006.05.010	32	69	72	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20841	20847		10.1074/jbc.M802314200	http://dx.doi.org/10.1074/jbc.M802314200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18495661	Green Published, hybrid			2022-12-25	WOS:000257746100026
J	Wan, ZL; Huang, K; Hu, SQ; Whittaker, J; Weiss, MA				Wan, Zhu-li; Huang, Kun; Hu, Shi-Quan; Whittaker, Jonathan; Weiss, Michael A.			The structure of a mutant insulin uncouples receptor binding from protein allostery - An electrostatic block to the TR transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLTEN-GLOBULE HYPOTHESIS; DES-PENTAPEPTIDE-INSULIN; <BETA-143 H21 HIS->ARG>; B-CHAIN; A-CHAIN; METABOLIC-CLEARANCE; CHIRAL MUTAGENESIS; HUMAN PROINSULIN; LOW-PH; HEMOGLOBIN	The zinc insulin hexamer undergoes allosteric reorganization among three conformational states, designated T-6, T3R3f, and R-6. Although the free monomer in solution (the active species) resembles the classical T-state, an R-like conformational change is proposed to occur upon receptor binding. Here, we distinguish between the conformational requirements of receptor binding and the crystallographic TR transition by design of an active variant refractory to such reorganization. Our strategy exploits the contrasting environments of His(B5) in wild-type structures: on the T-6 surface but within an intersubunit crevice in R-containing hexamers. The TR transition is associated with a marked reduction in His(B5) pK(a), in turn predicting that a positive charge at this site would destabilize the R-specific crevice. Remarkably, substitution of His(B5) (conserved among eutherian mammals) by Arg (occasionally observed among other vertebrates) blocks the TR transition, as probed in solution by optical spectroscopy. Similarly, crystallization of Arg(B5)-insulin in the presence of phenol (ordinarily a potent inducer of the TR transition) yields T-6 hexamers rather than R-6 as obtained in control studies of wild- type insulin. The variant structure, determined at a resolution of 1.3 angstrom, closely resembles the wild- type T-6 hexamer. Whereas Arg(B5) is exposed on the protein surface, its side chain participates in a solvent-stabilized network of contacts similar to those involving His(B5) in wild-type T-states. The substantial receptor-binding activity of Arg(B5)-insulin (40% relative to wild type) demonstrates that the function of an insulin monomer can be uncoupled from its allosteric reorganization within zinc-stabilized hexamers.	[Wan, Zhu-li; Huang, Kun; Hu, Shi-Quan; Weiss, Michael A.] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Whittaker, Jonathan] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Weiss, MA (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA.	michael.weiss@case.edu	Huang, Kun/H-4427-2012		NIDDK NIH HHS [R01 DK040949, DK 040949] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040949] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAJAJ M, 1986, BIOCHEM J, V238, P345, DOI 10.1042/bj2380345; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Becker RHA, 2007, DIABETES TECHNOL THE, V9, P109, DOI 10.1089/dia.2006.0035; BENTLEY G, 1976, NATURE, V261, P166, DOI 10.1038/261166a0; BI RC, 1983, ACTA CRYSTALLOGR B, V39, P90; BLUNDELL TL, 1971, NATURE, V231, P506, DOI 10.1038/231506a0; BONAVENTURA C, 1975, J BIOL CHEM, V250, P6273; BONAVENTURA J, 1975, J BIOL CHEM, V250, P9250; BONAVENTURA J, 1975, J BIOL CHEM, V250, P6278; BRADER ML, 1991, TRENDS BIOCHEM SCI, V16, P341; Brange J, 1997, J PHARM SCI, V86, P517, DOI 10.1021/js960297s; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURLEY SK, 1988, ADV PROTEIN CHEM, V39, P125; CHOTHIA C, 1983, NATURE, V302, P500, DOI 10.1038/302500a0; CISZAK E, 1994, BIOCHEMISTRY-US, V33, P1512, DOI 10.1021/bi00172a030; CISZAK E, 1995, STRUCTURE, V3, P615, DOI 10.1016/S0969-2126(01)00195-2; Conlon JM, 2001, PEPTIDES, V22, P1183, DOI 10.1016/S0196-9781(01)00423-5; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; DEREWENDA U, 1989, NATURE, V338, P594, DOI 10.1038/338594a0; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Edghill EL, 2008, DIABETES, V57, P1034, DOI 10.2337/db07-1405; Gow AJ, 1998, NATURE, V391, P169, DOI 10.1038/34402; HEINEMANN L, 1993, DIABETIC MED, V10, P535, DOI 10.1111/j.1464-5491.1993.tb00116.x; HELLMAN U, 1990, BIOCHEM BIOPH RES CO, V169, P571, DOI 10.1016/0006-291X(90)90369-X; HU SQ, 1993, BIOCHEMISTRY-US, V32, P2631, DOI 10.1021/bi00061a022; Hua QX, 2006, J BIOL CHEM, V281, P24900, DOI 10.1074/jbc.M602691200; Hua QX, 2006, J BIOL CHEM, V281, P24889, DOI 10.1074/jbc.M602617200; HUA QX, 1993, BIOCHEMISTRY-US, V32, P1433, DOI 10.1021/bi00057a006; HUA QX, 1991, BIOCHIM BIOPHYS ACTA, V1078, P101, DOI 10.1016/0167-4838(91)90098-K; HUA QX, 1991, BIOCHEMISTRY-US, V30, P5505, DOI 10.1021/bi00236a025; Hua QX, 2002, J BIOL CHEM, V277, P43443, DOI 10.1074/jbc.M206107200; Hua QX, 1996, J MOL BIOL, V264, P390, DOI 10.1006/jmbi.1996.0648; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; HUA QX, 1992, P NATL ACAD SCI USA, V89, P2379, DOI 10.1073/pnas.89.6.2379; Huang K, 2005, J BIOL CHEM, V280, P42345, DOI 10.1074/jbc.M507110200; Huang K, 2004, J MOL BIOL, V341, P529, DOI 10.1016/j.jmb.2004.05.023; Huang K, 2007, J BIOL CHEM, V282, P35337, DOI 10.1074/jbc.M705996200; Jacoby E, 1996, J MOL BIOL, V258, P136, DOI 10.1006/jmbi.1996.0239; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JORGENSEN AMM, 1992, J MOL BIOL, V227, P1146, DOI 10.1016/0022-2836(92)90527-Q; KARATAS Y, 1991, BIOL CHEM H-S, V372, P1035, DOI 10.1515/bchm3.1991.372.2.1035; KATSOYAN.PG, 1966, P NATL ACAD SCI USA, V55, P1554, DOI 10.1073/pnas.55.6.1554; Krezel A, 2004, J INORG BIOCHEM, V98, P161, DOI 10.1016/j.jinorgbio.2003.10.001; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LIANG DC, 1994, BIOPHYS CHEM, V50, P63, DOI 10.1016/0301-4622(94)85020-8; Liu M, 2005, J BIOL CHEM, V280, P13209, DOI 10.1074/jbc.C400475200; MIRMIRA RG, 1991, J BIOL CHEM, V266, P1428; Nakagawa SH, 2005, BIOCHEMISTRY-US, V44, P4984, DOI 10.1021/bi048025o; NAKAGAWA SH, 1992, BIOCHEMISTRY-US, V31, P3204, DOI 10.1021/bi00127a023; NAKAGAWA SH, 1991, J BIOL CHEM, V266, P11502; Nakagawa SH, 2000, BIOCHEMISTRY-US, V39, P15826, DOI 10.1021/bi001802+; NISHI M, 1990, MOL ENDOCRINOL, V4, P1192, DOI 10.1210/mend-4-8-1192; Olsen HB, 1996, BIOCHEMISTRY-US, V35, P8836, DOI 10.1021/bi960292+; Perutz MF, 1998, ANNU REV BIOPH BIOM, V27, P1, DOI 10.1146/annurev.biophys.27.1.1; PERUTZ MF, 1979, ANNU REV BIOCHEM, V48, P327, DOI 10.1146/annurev.bi.48.070179.001551; POYART C, 1980, J BIOL CHEM, V255, P9465; PULLEN RA, 1976, NATURE, V259, P369, DOI 10.1038/259369a0; ROY M, 1989, J BIOL CHEM, V264, P19081; SHOELSON SE, 1984, J CLIN INVEST, V73, P1351, DOI 10.1172/JCI111338; SORENSEN MD, 1994, BIOCHEMISTRY-US, V33, P13727; Sosnick TR, 2000, METHOD ENZYMOL, V317, P393; Stieglitz KA, 2005, J MOL BIOL, V349, P413, DOI 10.1016/j.jmb.2005.03.073; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; TILLIL H, 1990, ENDOCRINOLOGY, V127, P2418, DOI 10.1210/endo-127-5-2418; Wan ZL, 2003, BIOCHEMISTRY-US, V42, P12770, DOI 10.1021/bi034430o; Whittaker J, 2005, J BIOL CHEM, V280, P20932, DOI 10.1074/jbc.M411320200; Whittingham JL, 1998, BIOCHEMISTRY-US, V37, P11516, DOI 10.1021/bi980807s; Whittingham JL, 2002, J MOL BIOL, V318, P479, DOI 10.1016/S0022-2836(02)00021-9; WOLLMER A, 1994, BIOL CHEM H-S, V375, P219; Xu B, 2002, J MOL BIOL, V316, P435, DOI 10.1006/jmbi.2001.5377; Zhang YS, 2002, ACTA CRYSTALLOGR D, V58, P186, DOI 10.1107/S0907444901018455; Zoete V, 2004, J MOL BIOL, V342, P913, DOI 10.1016/j.jmb.2004.07.033	72	21	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21198	21210		10.1074/jbc.M800235200	http://dx.doi.org/10.1074/jbc.M800235200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18492668	Green Published, hybrid			2022-12-25	WOS:000257746100062
J	Wang, Y; Toei, M; Forgac, M				Wang, Yanru; Toei, Masashi; Forgac, Michael			Analysis of the membrane topology of transmembrane segments in the C-terminal hydrophobic domain of the yeast vacuolar ATPase subunit a (Vph1p) by chemical modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SCANNING MUTAGENESIS; MEDIATED CROSS-LINKING; V-ATPASE; H+-ATPASE; MUTATIONAL ANALYSIS; 100-KDA SUBUNIT; SYNTHASE; INTERACTS; ROTATION; SITE	The integral V-0 domain of the vacuolar (H+)-ATPases (V-ATPases) provides the pathway by which protons are transported across the membrane. Subunit a is a 100-kDa integral subunit of V-0 that plays an essential role in proton translocation. To better define the membrane topology of subunit a, unique cysteine residues were introduced into a Cys-less form of the yeast subunit a (Vph1p) and the accessibility of these cysteine residues to modification by the membrane permeant reagent N-ethylmaleimide (NEM) and the membrane impermeant reagent polyethyleneglycol maleimide (PEG-mal) in the presence and absence of the protein denaturant SDS was assessed. Thirty Vph1p mutants containing unique cysteine residues were constructed and analyzed. Cysteines introduced between residues 670 and 710 and between 807 and 840 were modified by PEG-mal in the absence of SDS, indicating a cytoplasmic orientation. Cysteines introduced between residues 602 and 620 and between residues 744 and 761 were modified by NEM but not PEG-mal in the absence of SDS, suggesting a lumenal orientation. Finally, cysteines introduced at residues 638, 645, 648, 723, 726, 734, and at nine positions between residue 766 and 804 were modified by NEM and PEG-mal only in the presence of SDS, consistent with their presence within the membrane or at a protein-protein interface. The results support an eight transmembrane helix (TM) model of subunit a in which the C terminus is located on the cytoplasmic side of the membrane and provide information on the location of hydrophilic loops separating TM6, 7, and 8.	[Wang, Yanru; Toei, Masashi; Forgac, Michael] Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA	Tufts University	Forgac, M (corresponding author), Tufts Univ, Sch Med, Dept Physiol, 136 Harrison Ave, Boston, MA 02111 USA.	michael.forgac@tufts.edu			NIDDK NIH HHS [DK 34928] Funding Source: Medline; NIGMS NIH HHS [R01 GM034478, GM 34478, R37 GM034478] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034478, R37GM034478] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Angevine CM, 2007, J BIOL CHEM, V282, P9001, DOI 10.1074/jbc.M610848200; Arata Y, 2002, BIOCHEMISTRY-US, V41, P11301, DOI 10.1021/bi0262449; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Cain BD, 2000, J BIOENERG BIOMEMBR, V32, P365, DOI 10.1023/A:1005575919638; Clarke M, 2002, J CELL SCI, V115, P2893; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; Fillingame RH, 2002, BBA-BIOENERGETICS, V1555, P29, DOI 10.1016/S0005-2728(02)00250-5; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gruenberg J, 2006, NAT REV MOL CELL BIO, V7, P495, DOI 10.1038/nrm1959; Hirata R, 1997, J BIOL CHEM, V272, P4795, DOI 10.1074/jbc.272.8.4795; Hirata T, 2003, J BIOL CHEM, V278, P23714, DOI 10.1074/jbc.M302756200; Imamizu H, 2003, P NATL ACAD SCI USA, V100, P5461, DOI 10.1073/pnas.0835746100; Inoue T, 2005, J BIOL CHEM, V280, P27896, DOI 10.1074/jbc.M504890200; Junge W, 1996, BER BUNSEN PHYS CHEM, V100, P2014, DOI 10.1002/bbpc.19961001215; KAKINUMA Y, 1981, J BIOL CHEM, V256, P859; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kawasaki-Nishi S, 2003, J BIOL CHEM, V278, P41908, DOI 10.1074/jbc.M308026200; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Kawasaki-Nishi S, 2001, P NATL ACAD SCI USA, V98, P12397, DOI 10.1073/pnas.221291798; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landolt-Marticorena C, 2000, J BIOL CHEM, V275, P15449, DOI 10.1074/jbc.M000207200; Leng XH, 1996, J BIOL CHEM, V271, P22487, DOI 10.1074/jbc.271.37.22487; Leng XH, 1998, J BIOL CHEM, V273, P6717, DOI 10.1074/jbc.273.12.6717; Leng XH, 1999, J BIOL CHEM, V274, P14655, DOI 10.1074/jbc.274.21.14655; Liu JZ, 1996, BIOCHEMISTRY-US, V35, P10938, DOI 10.1021/bi9608065; Long JC, 1998, J BIOL CHEM, V273, P16235, DOI 10.1074/jbc.273.26.16235; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu JL, 2001, BIOCHEMISTRY-US, V40, P13288, DOI 10.1021/bi0107647; MacLeod KJ, 1998, J BIOL CHEM, V273, P150, DOI 10.1074/jbc.273.1.150; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Nanda A, 1996, J BIOL CHEM, V271, P15963, DOI 10.1074/jbc.271.27.15963; Nelson N, 2003, J BIOENERG BIOMEMBR, V35, P281, DOI 10.1023/A:1025768529677; Pietrement C, 2006, BIOL REPROD, V74, P185, DOI 10.1095/biolreprod.105.043752; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Su Y, 2003, J BIOL CHEM, V278, P20013, DOI 10.1074/jbc.M210077200; Tamura N, 2001, J BIOL CHEM, V276, P20330, DOI 10.1074/jbc.M007993200; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; UCHIDA E, 1985, J BIOL CHEM, V260, P1090; Vasilyeva E, 2000, J BIOL CHEM, V275, P255, DOI 10.1074/jbc.275.1.255; Vik SB, 2000, BBA-BIOENERGETICS, V1458, P457, DOI 10.1016/S0005-2728(00)00094-3; Vik SB, 2005, J BIOENERG BIOMEMBR, V37, P445, DOI 10.1007/s10863-005-9488-6; VIK SB, 1994, J BIOL CHEM, V269, P30364; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003; Wang YR, 2004, J BIOL CHEM, V279, P44628, DOI 10.1074/jbc.M407345200; Wilkens S, 2001, J BIOL CHEM, V276, P44064, DOI 10.1074/jbc.M106579200	47	40	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20696	20702		10.1074/jbc.M803258200	http://dx.doi.org/10.1074/jbc.M803258200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18508769	hybrid, Green Published			2022-12-25	WOS:000257746100010
J	Jung, HY; Seong, HA; Ha, HJ				Jung, Haiyoung; Seong, Hyun-A; Ha, Hyunjung			Critical role of cysteine residue 81 of macrophage migration inhibitory factor (MIF) in MIF-induced inhibition of p53 activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-ASSOCIATED PROTEIN; TUMOR-SUPPRESSOR; CANCER-CELLS; PHYSICAL INTERACTION; GROWTH; MDM2; STABILITY; DEGRADATION; ADENOCARCINOMA; RESPONSES	Macrophage migration inhibitory factor (MIF) is a potent modulator of the p53 signaling pathway, but the molecular mechanisms of the effect of MIF on p53 function have so far remained unclear. Here we show that MIF physically interacts with the p53 tumor suppressor in vitro and in vivo. This association was significantly reduced by a C81S mutation but not C57S or C60S mutations, suggesting that Cys(81) is essential for the in vivo association between MIF and p53. This association also depended on Cys(242) (and, to some extent, on Cys(238)) within the central DNA binding domain of p53. Ectopic expression of MIF, but not MIF(C81S), inhibited p53-mediated transcriptional activation in a dose-dependent manner. Conversely, knockdown of endogenous MIF stimulated p53-mediated transcription. MIF inhibited p53-induced apoptosis and cell cycle arrest, whereas the MIF(C81S) mutant, which is unable to physically associate with p53, had no effect. Consistent with these findings, confocal microscopy showed that MIF prevented p53 translocation from the cytoplasm to the nucleus. We also demonstrated that MIF suppresses p53 activity by stabilizing the physical association between p53 and Mdm2. These results suggest that MIF physically associates with p53 and negatively regulates p53 function.	[Jung, Haiyoung; Seong, Hyun-A; Ha, Hyunjung] Chungbuk Natl Univ, Sch Life Sci, Biotechnol Res Inst, Dept Biochem, Cheongju 361763, South Korea	Chungbuk National University	Ha, HJ (corresponding author), Chungbuk Natl Univ, Sch Life Sci, Biotechnol Res Inst, Dept Biochem, Cheongju 361763, South Korea.	hyunha@chungbuk.ac.kr						Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Bech-Otschir D, 2001, EMBO J, V20, P1630, DOI 10.1093/emboj/20.7.1630; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; del Vecchio MT, 2000, PROSTATE, V45, P51, DOI 10.1002/1097-0045(20000915)45:1<51::AID-PROS6>3.0.CO;2-9; Fingerle-Rowson G, 2003, P NATL ACAD SCI USA, V100, P9354, DOI 10.1073/pnas.1533295100; Grossman SR, 1998, MOL CELL, V2, P405, DOI 10.1016/S1097-2765(00)80140-9; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hsieh JK, 1999, MOL CELL, V3, P181, DOI 10.1016/S1097-2765(00)80309-3; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Jung H, 2001, J BIOL CHEM, V276, P15504, DOI 10.1074/jbc.M009620200; Kaeser MD, 2004, J BIOL CHEM, V279, P7598, DOI 10.1074/jbc.M311732200; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Kleemann R, 1998, J MOL BIOL, V280, P85, DOI 10.1006/jmbi.1998.1864; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Leung KM, 2002, CANCER RES, V62, P4890; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Metz CN, 1997, ADV IMMUNOL, V66, P197, DOI 10.1016/S0065-2776(08)60598-2; Meyer-Siegler K, 2000, J INTERF CYTOK RES, V20, P769, DOI 10.1089/10799900050151030; MICHELL RA, 2002, P NATL ACAD SCI USA, V99, P345; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Ogawa H, 2000, CYTOKINE, V12, P309, DOI 10.1006/cyto.1999.0562; Petrenko O, 2005, MOL CELL, V17, P225, DOI 10.1016/j.molcel.2004.11.052; Petrenko O, 2003, J BIOL CHEM, V278, P11078, DOI 10.1074/jbc.M211985200; RAINWATER R, 1995, MOL CELL BIOL, V15, P3892; Rendon BE, 2007, J BIOL CHEM, V282, P29910, DOI 10.1074/jbc.M704898200; Seong HA, 2005, J BIOL CHEM, V280, P42897, DOI 10.1074/jbc.M507539200; Seong HA, 2007, J BIOL CHEM, V282, P12272, DOI 10.1074/jbc.M609279200; Seong HA, 2007, J BIOL CHEM, V282, P12075, DOI 10.1074/jbc.M609832200; Swope MD, 1998, J BIOL CHEM, V273, P14877, DOI 10.1074/jbc.273.24.14877; Winner M, 2007, CANCER RES, V67, P186, DOI 10.1158/0008-5472.CAN-06-3292; Yao KS, 2005, CLIN CANCER RES, V11, P7264, DOI 10.1158/1078-0432.CCR-05-0135	33	73	78	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20383	20396		10.1074/jbc.M800050200	http://dx.doi.org/10.1074/jbc.M800050200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18502749	hybrid			2022-12-25	WOS:000257565300054
J	Martinez-Munoz, GA; Kane, P				Martinez-Munoz, Gloria A.; Kane, Patricia			Vacuolar and plasma membrane proton pumps collaborate to achieve cytosolic pH homeostasis in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE LACKING; H+-ATPASE; NEUROSPORA-CRASSA; CYTOPLASMIC PH; GENE; ACIDIFICATION; GROWTH; IDENTIFICATION; ACTIVATION; TRANSPORT	Vacuolar proton-translocating ATPases (V-ATPases) play a central role in organelle acidification in all eukaryotic cells. To address the role of the yeast V-ATPase in vacuolar and cytosolic pH homeostasis, ratiometric pH-sensitive fluorophores specific for the vacuole or cytosol were introduced into wild-type cells and vma mutants, which lack V-ATPase subunits. Transiently glucose-deprived wild-type cells respond to glucose addition with vacuolar acidification and cytosolic alkalinization, and subsequent addition of K+ ion increases the pH of both the vacuole and cytosol. In contrast, glucose addition results in an increase in vacuolar pH in both vma mutants and wild-type cells treated with the V-ATPase inhibitor concanamycin A. Cytosolic pH homeostasis is also significantly perturbed in the vma mutants. Even at extracellular pH5, conditions optimal for their growth, cytosolic pH was much lower, and response to glucose was smaller in the mutants. In plasma membrane fractions from the vma mutants, activity of the plasma membrane proton pump, Pma1p, was 65-75% lower than in fractions from wildtype cells. Immunofluorescence microscopy confirmed decreased levels of plasma membrane Pma1p and increased Pma1p at the vacuole and other compartments in the mutants. Pma1p was not mislocalized in concanamycin-treated cells, but a significant reduction in cytosolic pH under all conditions was still observed. We propose that short-term, V-ATPase activity is essential for both vacuolar acidification in response to glucose metabolism and for efficient cytosolic pH homeostasis, and long-term, V-ATPases are important for stable localization of Pma1p at the plasma membrane.	[Martinez-Munoz, Gloria A.; Kane, Patricia] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Kane, P (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, 750 E Adams St, Syracuse, NY 13210 USA.	gloria_martinez2006@yahoo.com.mx; kanepm@upstate.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050322] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 50322, R01 GM050322] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ali R, 2004, J BIOL CHEM, V279, P4498, DOI 10.1074/jbc.M307446200; AMMERER G, 1986, MOL CELL BIOL, V6, P2490, DOI 10.1128/MCB.6.7.2490; Bagnat M, 2001, MOL BIOL CELL, V12, P4129, DOI 10.1091/mbc.12.12.4129; Banuelos MA, 1998, MICROBIOL-UK, V144, P2749, DOI 10.1099/00221287-144-10-2749; BEAUVOIT B, 1991, BIOCHEMISTRY-US, V30, P11212, DOI 10.1021/bi00111a004; BENITO B, 1991, BIOCHIM BIOPHYS ACTA, V1063, P265, DOI 10.1016/0005-2736(91)90381-H; Bowman EJ, 2000, J BIOL CHEM, V275, P167, DOI 10.1074/jbc.275.1.167; Bowman EJ, 1997, J BIOL CHEM, V272, P14776, DOI 10.1074/jbc.272.23.14776; Bowman EJ, 2000, J EXP BIOL, V203, P97; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Brett CL, 2006, FEBS LETT, V580, P717, DOI 10.1016/j.febslet.2005.12.103; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Cagnac O, 2007, J BIOL CHEM, V282, P24284, DOI 10.1074/jbc.M703116200; Calahorra M, 1998, YEAST, V14, P501, DOI 10.1002/(SICI)1097-0061(19980430)14:6<501::AID-YEA249>3.0.CO;2-6; CONWAY EJ, 1950, BIOCHEM J, V47, P360, DOI 10.1042/bj0470360; Davies SA, 1996, J BIOL CHEM, V271, P30677, DOI 10.1074/jbc.271.48.30677; Davis-Kaplan SR, 2004, J BIOL CHEM, V279, P4322, DOI 10.1074/jbc.M310680200; ERASO P, 1987, FEBS LETT, V224, P187, DOI 10.1016/0014-5793(87)80445-3; Eraso P, 2006, BBA-BIOMEMBRANES, V1758, P164, DOI 10.1016/j.bbamem.2006.01.010; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Freimoser FM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r109; Gerrard SR, 2000, TRAFFIC, V1, P259, DOI 10.1034/j.1600-0854.2000.010308.x; GORDON JA, 1991, METHOD ENZYMOL, V201, P477; Grabe M, 2001, J GEN PHYSIOL, V117, P329, DOI 10.1085/jgp.117.4.329; HAWORTH RS, 1993, MOL CELL BIOCHEM, V124, P131, DOI 10.1007/BF00929205; Hirata R., 2001, RIKEN REV, V41, P90; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kane PM, 2007, J BIOENERG BIOMEMBR, V39, P415, DOI 10.1007/s10863-007-9112-z; Kane PM, 2000, FEBS LETT, V469, P137, DOI 10.1016/S0014-5793(00)01265-5; KANE PM, 1995, J BIOL CHEM, V270, P17025; KANE PM, 1992, J BIOL CHEM, V267, P447; KLIONSKY DJ, 1990, MICROBIOL REV, V54, P266, DOI 10.1128/MMBR.54.3.266-292.1990; Lecchi S, 2007, J BIOL CHEM, V282, P35471, DOI 10.1074/jbc.M706094200; Liu Y, 2006, J CELL SCI, V119, P360, DOI 10.1242/jcs.02749; LOTSCHER HR, 1984, BIOCHEMISTRY-US, V23, P4140, DOI 10.1021/bi00313a020; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Madrid R, 1998, J BIOL CHEM, V273, P14838, DOI 10.1074/jbc.273.24.14838; Martinez-Munoz GA, 2005, YEAST, V22, P689, DOI 10.1002/yea.1238; Milgrom E, 2007, J BIOL CHEM, V282, P7125, DOI 10.1074/jbc.M608293200; MUNN AL, 1994, J CELL BIOL, V127, P373, DOI 10.1083/jcb.127.2.373; Nass R, 1998, J BIOL CHEM, V273, P21054, DOI 10.1074/jbc.273.33.21054; NELSON H, 1990, P NATL ACAD SCI USA, V87, P3503, DOI 10.1073/pnas.87.9.3503; Orlowski J, 1997, J BIOL CHEM, V272, P22373, DOI 10.1074/jbc.272.36.22373; Padilla-Lopez S, 2006, J BIOL CHEM, V281, P10273, DOI 10.1074/jbc.M510625200; Panaretou Barry, 2006, Methods Mol Biol, V313, P27; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; PENA A, 1972, ARCH BIOCHEM BIOPHYS, V153, P413, DOI 10.1016/0003-9861(72)90359-1; PENA A, 1969, BIOCHIM BIOPHYS ACTA, V180, P1, DOI 10.1016/0005-2728(69)90187-X; PENA A, 1975, ARCH BIOCHEM BIOPHYS, V167, P397, DOI 10.1016/0003-9861(75)90480-4; PENA A, 1995, J BACTERIOL, V177, P1017, DOI 10.1128/jb.177.4.1017-1022.1995; Perzov N, 2000, J BIOL CHEM, V275, P40088, DOI 10.1074/jbc.M007011200; PICK U, 1990, FEBS LETT, V274, P15, DOI 10.1016/0014-5793(90)81318-I; Plant PJ, 1999, J BIOL CHEM, V274, P37270, DOI 10.1074/jbc.274.52.37270; PORTILLO F, 1991, FEBS LETT, V287, P71, DOI 10.1016/0014-5793(91)80018-X; PRESTON RA, 1989, P NATL ACAD SCI USA, V86, P7027, DOI 10.1073/pnas.86.18.7027; ROBERTS CJ, 1991, METHOD ENZYMOL, V194, P644; SERRANO R, 1983, FEBS LETT, V156, P11, DOI 10.1016/0014-5793(83)80237-3; SERRANO R, 1986, NATURE, V319, P689, DOI 10.1038/319689a0; Serrano R, 2004, J BIOL CHEM, V279, P19698, DOI 10.1074/jbc.M313746200; SERRANO R, 1991, MOL CELLULAR BIOL YE, V1, P523; SETOYOUNG D, 1991, J BIOL CHEM, V266, P1383; Sun-Wada GH, 2000, DEV BIOL, V228, P315, DOI 10.1006/dbio.2000.9963; SWALLOW CJ, 1990, J BIOL CHEM, V265, P7645; SWALLOW CJ, 1993, J CELL PHYSIOL, V157, P453, DOI 10.1002/jcp.1041570304; TANIDA I, 1995, J BIOL CHEM, V270, P10113, DOI 10.1074/jbc.270.17.10113; UMEMOTO N, 1990, J BIOL CHEM, V265, P18447; Wang QQ, 2002, P NATL ACAD SCI USA, V99, P12853, DOI 10.1073/pnas.202115499; Withee JL, 1998, GENETICS, V149, P865; YAMASHIRO CT, 1990, MOL CELL BIOL, V10, P3737, DOI 10.1128/MCB.10.7.3737; Yenush L, 2005, MOL CELL BIOL, V25, P8683, DOI 10.1128/MCB.25.19.8683-8692.2005	70	186	190	1	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20309	20319		10.1074/jbc.M710470200	http://dx.doi.org/10.1074/jbc.M710470200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18502746	Green Published, hybrid			2022-12-25	WOS:000257565300047
J	Boshoff, HIM; Xu, X; Tahlan, K; Dowd, CS; Pethe, K; Camacho, LR; Park, TH; Yun, CS; Schnappinger, D; Ehrt, S; Williams, KJ; Barry, CE				Boshoff, Helena I. M.; Xu, Xia; Tahlan, Kapil; Dowd, Cynthia S.; Pethe, Kevin; Camacho, Luis R.; Park, Tae-Ho; Yun, Chang-Soo; Schnappinger, Dirk; Ehrt, Sabine; Williams, Kerstin J.; Barry, Clifton E., III			Biosynthesis and recycling of nicotinamide cofactors in Mycobacterium tuberculosis - An essential role for NAD in nonreplicating bacilli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRIDINE-NUCLEOTIDE CYCLE; ADENINE-DINUCLEOTIDE; CRYSTAL-STRUCTURE; TUBERCLE-BACILLI; ACID PHOSPHORIBOSYLTRANSFERASE; METABOLISM; PROTEIN; KINASE; PERSISTENCE; EXPRESSION	Despite the presence of genes that apparently encode NAD salvage-specific enzymes in its genome, it has been previously thought that Mycobacterium tuberculosis can only synthesize NAD de novo. Transcriptional analysis of the de novo synthesis and putative salvage pathway genes revealed an up-regulation of the salvage pathway genes in vivo and in vitro under conditions of hypoxia. [C-14] Nicotinamide incorporation assays in M. tuberculosis isolated directly from the lungs of infected mice or from infected macrophages revealed that incorporation of exogenous nicotinamide was very efficient in in vivo-adapted cells, in contrast to cells grown aerobically in vitro. Two putative nicotinic acid phosphoribosyltransferases, PncB1 (Rv1330c) and PncB2 (Rv0573c), were examined by a combination of in vitro enzymatic activity assays and allelic exchange studies. These studies revealed that both play a role in cofactor salvage. Mutants in the de novo pathway died upon removal of exogenous nicotinamide during active replication in vitro. Cell death is induced by both cofactor starvation and disruption of cellular redox homeostasis as electron transport is impaired by limiting NAD. Inhibitors of NAD synthetase, an essential enzyme common to both recycling and de novo synthesis pathways, displayed the same bactericidal effect as sudden NAD starvation of the de novo pathway mutant in both actively growing and nonreplicating M. tuberculosis. These studies demonstrate the plasticity of the organism in maintaining NAD levels and establish that the two enzymes of the universal pathway are attractive chemotherapeutic targets for active as well as latent tuberculosis.	[Boshoff, Helena I. M.; Xu, Xia; Tahlan, Kapil; Barry, Clifton E., III] NIAID, Tuberculosis Res Sect, Lab Clin Infect Dis, Natl Inst Hlth, Bethesda, MD 20892 USA; [Pethe, Kevin; Camacho, Luis R.] Novartis Inst Trop Dis, Singapore 138670, Singapore; [Park, Tae-Ho; Yun, Chang-Soo] Korea Res Inst Chem Technol, Ctr Anti Infect Agents Res, Drug Discovery Div, Taejon 305600, South Korea; [Schnappinger, Dirk; Ehrt, Sabine] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA; [Williams, Kerstin J.] Univ London Imperial Coll Sci Technol & Med, Dept Microbiol, Ctr Mol Microbiol & Infect, London SW7 2AZ, England	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Novartis; Korea Research Institute of Chemical Technology (KRICT); Cornell University; Imperial College London	Boshoff, HIM (corresponding author), 33 N Dr,Bldg 33 Rm, Bethesda, MD 20892 USA.	HBOSHOFF@niaid.nih.gov	Pethe, Kevin/F-9495-2015; Pethe, Kevin/D-4505-2011; Ehrt, Sabine/AAU-6449-2020; Barry, III, Clifton/H-3839-2012; Pethe, Kevin/L-1199-2013; Barry, Clifton E/ABE-7992-2020	Barry, III, Clifton/0000-0002-2927-270X; Pethe, Kevin/0000-0003-0297-0150; Barry, Clifton E/0000-0002-2927-270X; Pethe, Kevin/0000-0003-0916-8873	Intramural NIH HHS Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000783, ZIAAI000783] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Begley TP, 2001, VITAM HORM, V61, P103; Bellinzoni M, 2002, PROTEIN EXPRES PURIF, V25, P547, DOI 10.1016/S1046-5928(02)00041-4; Bembenek ME, 2005, ASSAY DRUG DEV TECHN, V3, P533, DOI 10.1089/adt.2005.3.533; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; Boshoff HIM, 2004, J BIOL CHEM, V279, P40174, DOI 10.1074/jbc.M406796200; Boshoff HIM, 2003, CELL, V113, P183, DOI 10.1016/S0092-8674(03)00270-8; Chappie JS, 2005, STRUCTURE, V13, P1385, DOI 10.1016/j.str.2005.05.016; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Dahl JL, 2003, P NATL ACAD SCI USA, V100, P10026, DOI 10.1073/pnas.1631248100; Dawes SS, 2003, INFECT IMMUN, V71, P6124, DOI 10.1128/IAI.71.11.6124-6131.2003; Denu JM, 2005, CURR OPIN CHEM BIOL, V9, P431, DOI 10.1016/j.cbpa.2005.08.010; Dolan KM, 2000, BIOCHEMISTRY-US, V39, P8266, DOI 10.1021/bi992856q; Domenech P, 2005, INFECT IMMUN, V73, P3492, DOI 10.1128/IAI.73.6.3492-3501.2005; Duncan K, 2004, CURR OPIN MICROBIOL, V7, P460, DOI 10.1016/j.mib.2004.08.011; FOSTER JW, 1980, MICROBIOL REV, V44, P83, DOI 10.1128/MMBR.44.1.83-105.1980; Garavaglia S, 2004, J BIOL CHEM, V279, P40980, DOI 10.1074/jbc.M406586200; Gerdes SY, 2002, J BACTERIOL, V184, P4555, DOI 10.1128/JB.184.16.4555-4572.2002; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; GOPINATH.KP, 1966, ARCH BIOCHEM BIOPHYS, V113, P376, DOI 10.1016/0003-9861(66)90201-3; Haferkamp I, 2004, NATURE, V432, P622, DOI 10.1038/nature03131; HILLYARD D, 1981, J BIOL CHEM, V256, P8491; KASAROV LB, 1972, J BACTERIOL, V110, P600; Katoh A, 2004, FRONT BIOSCI-LANDMRK, V9, P1577, DOI 10.2741/1350; KILBURN JO, 1968, AM J CLIN PATHOL, V50, P582; KONNO K, 1958, AM REV TUBERC PULM, V77, P669; KONNO K, 1957, AM REV TUBERC PULM, V75, P529; Kurnasov O, 2003, CHEM BIOL, V10, P1195, DOI 10.1016/j.chembiol.2003.11.011; Leder L, 2007, CURR OPIN DRUG DISC, V10, P193; Maggio-Hall LA, 2003, MICROBIOL-SGM, V149, P983, DOI 10.1099/mic.0.26040-0; Mdluli K, 1996, J INFECT DIS, V174, P1085, DOI 10.1093/infdis/174.5.1085; Merdanovic M, 2005, J BACTERIOL, V187, P4410, DOI 10.1128/JB.187.13.4410-4420.2005; O'Sullivan DM, 2005, J ANTIMICROB CHEMOTH, V55, P674, DOI 10.1093/jac/dki069; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; PREISS J, 1958, J BIOL CHEM, V233, P488; Raffaelli N, 2004, BIOCHEMISTRY-US, V43, P7610, DOI 10.1021/bi049650w; San KY, 2002, METAB ENG, V4, P182, DOI 10.1006/mben.2001.0220; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Scorpio A, 1996, NAT MED, V2, P662, DOI 10.1038/nm0696-662; Scott HM, 2002, INFECT IMMUN, V70, P5946, DOI 10.1128/IAI.70.11.5946-5954.2002; Sharma V, 1998, STRUCTURE, V6, P1587, DOI 10.1016/S0969-2126(98)00156-7; Shin DH, 2005, J BIOL CHEM, V280, P18326, DOI 10.1074/jbc.M501622200; Singh SK, 2002, J BIOL CHEM, V277, P33291, DOI 10.1074/jbc.M204368200; Velu SE, 2003, J MED CHEM, V46, P3371, DOI 10.1021/jm030003x; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; VINITSKY A, 1993, J BIOL CHEM, V268, P26004; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Vu CQ, 1997, ADV EXP MED BIOL, V419, P381; Wayne L G, 2001, Methods Mol Med, V54, P247, DOI 10.1385/1-59259-147-7:247; Wilkinson A, 2001, MOL MICROBIOL, V40, P1241, DOI 10.1046/j.1365-2958.2001.02479.x; YOU KS, 1985, CRC CR REV BIOCH MOL, V17, P313, DOI 10.3109/10409238509113625; Zhang Y, 1999, J BACTERIOL, V181, P2044, DOI 10.1128/JB.181.7.2044-2049.1999; Ziegler M, 2001, BIOESSAYS, V23, P543, DOI 10.1002/bies.1074	55	116	127	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19329	19341		10.1074/jbc.M800694200	http://dx.doi.org/10.1074/jbc.M800694200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18490451	Green Published, hybrid			2022-12-25	WOS:000257387600019
J	Coppin, JF; Qu, W; Waalkes, MP				Coppin, Jean-Francois; Qu, Wei; Waalkes, Michael P.			Interplay between cellular methyl metabolism and adaptive efflux during oncogenic transformation from chronic arsenic exposure in human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED MALIGNANT-TRANSFORMATION; S-ADENOSYLHOMOCYSTEINE-HYDROLASE; PROSTATIC EPITHELIAL-CELLS; DNA METHYLATION; GENE-EXPRESSION; SODIUM ARSENITE; GENOMIC DNA; GLUTATHIONE; HOMOCYSTEINE; HYPOMETHYLATION	After protracted low level arsenic exposure, the normal human prostate epithelial cell line RWPE-1 acquires a malignant phenotype with DNA hypomethylation, indicative of disrupted methyl metabolism, and shows arsenic adaptation involving glutathione overproduction and enhanced arsenic efflux. Thus, the interplay between methyl and glutathione metabolism during this progressive arsenic adaptation was studied. Arsenic-treated cells showed a time-dependent increase in LC50 and a marked increase in homocysteine (Hcy) levels. A marked suppression of S-adenosylmethionine (SAM) levels occurred with decreased methionine adenosyltransferase 2A (converts methionine to SAM) expression and increased negative regulator methionine adenosyltransferase B, suggesting reduced conversion of Hcy to SAM. Consistent with Hcy overproduction, activity and expression of S-adenosylhomocysteine hydrolase (converts S-adenosylhomocysteine to Hcy) were both increased. Expression of cystathionine beta-synthase, a key gene in the transsulfuration pathway, and various glutathione production genes were increased, resulting in a 5-fold increase in glutathione. Arsenic efflux increased along with expression of ATP-binding cassette protein C1, which effluxes arsenic as a glutathione conjugate. Evidence of genomic DNA hypomethylation was observed during early arsenic exposure, indicating that the disruption in methyl metabolism had a potential impact related to oncogenesis. Thus, cellular arsenic adaptation is a dynamic, progressive process that involves decreased SAM recycling and concurrent accumulation of Hcy, which is channeled via transsulfuration to increase glutathione and enhance arsenic efflux but may also impact the carcinogenic process.	[Coppin, Jean-Francois; Qu, Wei; Waalkes, Michael P.] NCI, Inorgan Carcinogenesis Sect, Comparat Carcinogenesis Lab, Natl Inst Hlth, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Waalkes, MP (corresponding author), NIEHS, NCI, POB 12233,Mail Drop F0-09,111 Alexander Dr, Res Triangle Pk, NC 27709 USA.	waalkes@niehs.nih.gov			NATIONAL CANCER INSTITUTE [ZIABC005488, Z01BC005488] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Achanzar WE, 2002, JNCI-J NATL CANCER I, V94, P1888, DOI 10.1093/jnci/94.24.1888; Bello D, 1997, CARCINOGENESIS, V18, P1215, DOI 10.1093/carcin/18.6.1215; Benbrahim-Tallaa L, 2005, TOXICOL APPL PHARM, V206, P288, DOI 10.1016/j.taap.2004.11.017; Benbrahim-Tallaa L, 2008, ENVIRON HEALTH PERSP, V116, P158, DOI 10.1289/ehp.10423; Brambila EM, 2002, TOXICOL APPL PHARM, V183, P99, DOI 10.1006/taap.2002.9468; BRODIE AE, 1985, ARCH BIOCHEM BIOPHYS, V240, P621, DOI 10.1016/0003-9861(85)90069-4; Brosnan JT, 2004, ACTA BIOCHIM POL, V51, P405; Chen H, 2004, CARCINOGENESIS, V25, P1779, DOI 10.1093/carcin/bgh161; CROOKS PA, 1984, J PHARM PHARMACOL, V36, P85, DOI 10.1111/j.2042-7158.1984.tb02999.x; Das PM, 2004, J CLIN ONCOL, V22, P4632, DOI 10.1200/JCO.2004.07.151; Davison K, 2003, LEUKEMIA, V17, P931, DOI 10.1038/sj.leu.2402876; GLICK JM, 1975, NUCLEIC ACIDS RES, V2, P1639, DOI 10.1093/nar/2.10.1639; Gonzalgo ML, 1997, CANCER RES, V57, P594; Guerra-Shinohara EM, 2004, AM J CLIN NUTR, V80, P1312, DOI 10.1093/ajcn/80.5.1312; *IARC, 2004, IARC MON EV CARC RIK; James SJ, 2002, J NUTR, V132, p2361S, DOI 10.1093/jn/132.8.2361S; Jiang YD, 2007, DNA CELL BIOL, V26, P603, DOI 10.1089/dna.2007.0584; Kligerman AD, 2003, ENVIRON MOL MUTAGEN, V42, P192, DOI 10.1002/em.10192; Kloor D, 1996, KIDNEY BLOOD PRESS R, V19, P100, DOI 10.1159/000174051; Kojima C, 2006, TOXICOL SCI, V91, P70, DOI 10.1093/toxsci/kfj117; Lertratanangkoon K, 1997, CANCER LETT, V120, P149, DOI 10.1016/S0304-3835(97)00300-5; Lertratanangkoon K, 1996, CANCER RES, V56, P995; Leslie EM, 2004, J BIOL CHEM, V279, P32700, DOI 10.1074/jbc.M404912200; Liu J, 2001, MOL PHARMACOL, V60, P302, DOI 10.1124/mol.60.2.302; Loenen WAM, 2006, BIOCHEM SOC T, V34, P330, DOI 10.1042/BST0340330; Lu SC, 2000, INT J BIOCHEM CELL B, V32, P391, DOI 10.1016/S1357-2725(99)00139-9; Martinov MV, 2000, J THEOR BIOL, V204, P521, DOI 10.1006/jtbi.2000.2035; Mass MJ, 2001, CHEM RES TOXICOL, V14, P355, DOI 10.1021/tx000251l; *NAT TOX PROGR, 2004, NAT TOX PROGR REP CA; National Research Council, 1999, ARS DRINK WAT, P83; Okoji RS, 2002, CARCINOGENESIS, V23, P777, DOI 10.1093/carcin/23.5.777; Park EI, 1999, J BIOL CHEM, V274, P7816, DOI 10.1074/jbc.274.12.7816; Pastore A, 2003, CLIN CHIM ACTA, V333, P19, DOI 10.1016/S0009-8981(03)00200-6; PEINADO MA, 1992, P NATL ACAD SCI USA, V89, P10065, DOI 10.1073/pnas.89.21.10065; Ramirez T, 2003, MUTAT RES-FUND MOL M, V528, P61, DOI 10.1016/S0027-5107(03)00099-X; Razin A, 2005, PROG MOLEC, V38, P151; Reichard JF, 2007, BIOCHEM BIOPH RES CO, V352, P188, DOI 10.1016/j.bbrc.2006.11.001; Romach EH, 2000, TOXICOL SCI, V54, P500, DOI 10.1093/toxsci/54.2.500; Savic-Radojevic A, 2007, EUR UROL, V52, P470, DOI 10.1016/j.eururo.2007.01.046; Serman A, 2006, COLLEGIUM ANTROPOL, V30, P665; Thomas DJ, 2001, TOXICOL APPL PHARM, V176, P127, DOI 10.1006/taap.2001.9258; Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X; UELAND PM, 1982, PHARMACOL REV, V34, P223; Waalkes MP, 2004, JNCI-J NATL CANCER I, V96, P466, DOI 10.1093/jnci/djh070; WAINFAN E, 1992, CANCER RES, V52, pS2071; Webber MM, 1997, CARCINOGENESIS, V18, P1225, DOI 10.1093/carcin/18.6.1225; WELSH J, 1990, NUCLEIC ACIDS RES, V18, P7213, DOI 10.1093/nar/18.24.7213; Xie YX, 2007, TOXICOLOGY, V236, P7, DOI 10.1016/j.tox.2007.03.021; Xie YX, 2004, ENVIRON HEALTH PERSP, V112, P1255, DOI 10.1289/txg.7152; Zhao CQ, 1997, P NATL ACAD SCI USA, V94, P10907, DOI 10.1073/pnas.94.20.10907; Zhao W, 2006, BIRTH DEFECTS RES A, V76, P230, DOI 10.1002/bdra.20240	51	58	63	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19342	19350		10.1074/jbc.M802942200	http://dx.doi.org/10.1074/jbc.M802942200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18487201	Green Published, hybrid			2022-12-25	WOS:000257387600020
J	Houston, SI; McManus, KJ; Adams, MM; Sims, JK; Carpenter, PB; Hendzel, MJ; Rice, JC				Houston, Sabrina I.; McManus, Kirk J.; Adams, Melissa M.; Sims, Jennifer K.; Carpenter, Phillip B.; Hendzel, Michael J.; Rice, Judd C.			Catalytic function of the PR-Set7 histone H4 lysine 20 monomethyltransferase is essential for mitotic entry and genomic stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE LYSINE METHYLATION; NEWLY REPLICATED CHROMATIN; CELL-CYCLE; DNA-DAMAGE; H4 LYS-20; MAMMALIAN CHROMATIN; SILENT CHROMATIN; S-PHASE; METHYLTRANSFERASE; H3	Histone-modifying enzymes play a critical role in modulating chromatin dynamics. In this report we demonstrate that one of these enzymes, PR-Set7, and its corresponding histone modification, the monomethylation of histone H4 lysine 20 (H4K20), display a distinct cell cycle profile in mammalian cells: low at G(1), increased during late S phase and G(2), and maximal from prometaphase to anaphase. The lack of PR-Set7 and monomethylated H4K20 resulted in a number of aberrant phenotypes in several different mammalian cell types. These include the inability of cells to progress past G(2), global chromosome condensation failure, aberrant centrosome amplification, and substantial DNA damage. By employing a catalytically dead dominant negative PR-Set7 mutant, we discovered that its mono-methyltransferase activity was required to prevent these phenotypes. Importantly, we demonstrate that all of the aberrant phenotypes associated with the loss of PR-Set7 enzymatic function occur independently of p53. Collectively, our findings demonstrate that PR-Set7 enzymatic activity is essential for mammalian cell cycle progression and for the maintenance of genomic stability, most likely by monomethylating histone H4K20. Our results predict that alterations of this pathway could result in gross chromosomal aberrations and aneuploidy.	[Houston, Sabrina I.; Sims, Jennifer K.; Rice, Judd C.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [McManus, Kirk J.; Hendzel, Michael J.] Univ Alberta, Cross Canc Inst, Dept Oncol, Edmonton, AB T6G 1Z2, Canada; [Adams, Melissa M.; Carpenter, Phillip B.] Univ Texas Houston, Hlth Sci Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	University of Southern California; University of Alberta; University of Texas System; University of Texas Health Science Center Houston	Rice, JC (corresponding author), Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, 1450 Biggy St,NRT 6506, Los Angeles, CA 90033 USA.	juddrice@usc.edu	Hendzel, Michael/C-3391-2009; McManus, Kirk J./AAE-3521-2020; Rice, Judd C/B-7806-2009	Hendzel, Michael/0000-0002-9603-7945; McManus, Kirk J./0000-0003-0081-8737; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM065812, R01GM075094] Funding Source: NIH RePORTER; NIGMS NIH HHS [R56 GM065812, GM075094, R01 GM075094] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANNUNZIATO AT, 1995, BIOCHEMISTRY-US, V34, P2916, DOI 10.1021/bi00009a023; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BORUN TW, 1972, J BIOL CHEM, V247, P4288; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; CAMATO R, 1982, EMBO J, V1, P1529, DOI 10.1002/j.1460-2075.1982.tb01350.x; Cheng AY, 1998, CANCER RES, V58, P3611; Couture JF, 2005, GENE DEV, V19, P1455, DOI 10.1101/gad.1318405; D'Assoro AB, 2004, ONCOGENE, V23, P4068, DOI 10.1038/sj.onc.1207568; Delaval K, 2007, EMBO J, V26, P720, DOI 10.1038/sj.emboj.7601513; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; Goto H, 1999, J BIOL CHEM, V274, P25543, DOI 10.1074/jbc.274.36.25543; HENDZEL MJ, 1989, J BIOL CHEM, V264, P19208; HENDZEL MJ, 1991, BIOCHEM J, V273, P753, DOI 10.1042/bj2730753; Huang J, 2008, CURR OPIN GENET DEV, V18, P152, DOI 10.1016/j.gde.2008.01.012; Huen MSY, 2008, J BIOL CHEM, V283, P11073, DOI 10.1074/jbc.C700242200; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jorgensen S, 2007, J CELL BIOL, V179, P1337, DOI 10.1083/jcb.200706150; Karachentsev D, 2005, GENE DEV, V19, P431, DOI 10.1101/gad.1263005; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; LEE NM, 1977, J NEUROCHEM, V29, P547, DOI 10.1111/j.1471-4159.1977.tb10704.x; Linger J, 2006, EUKARYOT CELL, V5, P1780, DOI 10.1128/EC.00202-06; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; McManus KJ, 2006, J BIOL CHEM, V281, P8888, DOI 10.1074/jbc.M505323200; McManus KJ, 2005, METHODS, V36, P351, DOI 10.1016/j.ymeth.2005.03.010; Morgan SE, 1997, ADV CANCER RES, V71, P1, DOI 10.1016/S0065-230X(08)60095-0; MURRAY K, 1964, BIOCHEMISTRY-US, V3, P10, DOI 10.1021/bi00889a003; Nelson JD, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj004; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Pesavento JJ, 2008, MOL CELL BIOL, V28, P468, DOI 10.1128/MCB.01517-07; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Rice JC, 2002, GENE DEV, V16, P2225, DOI 10.1101/gad.1014902; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Sakaguchi A, 2007, J CELL BIOL, V176, P155, DOI 10.1083/jcb.200607178; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Sautel CF, 2007, MOL CELL BIOL, V27, P5711, DOI 10.1128/MCB.00482-07; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Shinkai Yoichi, 2007, Subcell Biochem, V41, P337; Sims JK, 2006, J BIOL CHEM, V281, P12760, DOI 10.1074/jbc.M513462200; SMITH PA, 1984, BIOCHEMISTRY-US, V23, P1576, DOI 10.1021/bi00302a036; Tardat M, 2007, J CELL BIOL, V179, P1413, DOI 10.1083/jcb.200706179; THOMAS G, 1975, EUR J BIOCHEM, V51, P609, DOI 10.1111/j.1432-1033.1975.tb03963.x; TIDWELL T, 1968, J BIOL CHEM, V243, P707; Trievel RC, 2004, CRIT REV EUKAR GENE, V14, P147, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i3.10; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; Wolffe AP, 2000, J STRUCT BIOL, V129, P102, DOI 10.1006/jsbi.2000.4217; WORCEL A, 1978, CELL, V15, P969, DOI 10.1016/0092-8674(78)90280-5; Wu SM, 2007, FEBS LETT, V581, P3289, DOI 10.1016/j.febslet.2007.06.025; Xiao B, 2005, GENE DEV, V19, P1444, DOI 10.1101/gad.1315905; Yang HB, 2008, J BIOL CHEM, V283, P12085, DOI 10.1074/jbc.M707974200	55	120	123	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19478	19488		10.1074/jbc.M710579200	http://dx.doi.org/10.1074/jbc.M710579200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18480059	Green Published, hybrid			2022-12-25	WOS:000257387600034
J	Boutsma, E; Noback, S; van Lohuizen, M				Boutsma, Erwin; Noback, Sonja; van Lohuizen, Maarten			The Polycomb Protein and E3 Ubiquitin Ligase Ring1B Harbors an IRES in its Highly Conserved 5 ' UTR	PLOS ONE			English	Article								Ring1B is an essential member of the highly conserved Polycomb group proteins, which orchestrate developmental processes, cell growth and stem cell fate by modifying local chromatin structure. Ring1B was found to be the E3 ligase that monoubiquitinates histone H2A, which adds a new level of chromatin modification to Polycomb group proteins. Here we report that Ring1B belongs to the exclusive group of proteins that for their translation depend on a stable 5' UTR sequence in their mRNA known as an Internal Ribosome Entry Site (IRES). In cell transfection assays the Ring1B IRES confers significantly higher expression levels of Ring1B than a Ring1B cDNA without the IRES. Also, dual luciferase assays show strong activity of the Ring1B IRES. Although our findings indicate Ring1B can be translated under conditions where cap-dependent translation is impaired, we found the Ring1B IRES to be cap-dependent. This raises the possibility that translational control of Ring1B is a multi-layered process and that translation of Ring1B needs to be maintained under varying conditions, which is in line with its essential role as an E3 ligase for monoubiquitination of histone H2A in the PRC1 Polycomb protein complex.	[Boutsma, Erwin; Noback, Sonja; van Lohuizen, Maarten] Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	Boutsma, E (corresponding author), Netherlands Canc Inst, Div Mol Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	m.v.lohuizen@nki.nl			KWF	KWF	This research was supported by grants from the Dutch cancer foundation KWF.	Akasaka T, 1996, DEVELOPMENT, V122, P1513; Bert AG, 2006, RNA, V12, P1074, DOI 10.1261/rna.2320506; BONNAL S, 2004, J BIOL CHEM; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Byrd MP, 2005, J BIOL CHEM, V280, P18610, DOI 10.1074/jbc.M414014200; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Chadwick BP, 2003, DEV CELL, V4, P445, DOI 10.1016/S1534-5807(03)00097-2; Core N, 1997, DEVELOPMENT, V124, P721; De Quinto SL, 2001, RNA, V7, P1213, DOI 10.1017/S1355838201010433; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Fang J, 2004, J BIOL CHEM, V279, P52812, DOI 10.1074/jbc.C400493200; Fernandez J, 2001, J BIOL CHEM, V276, P12285, DOI 10.1074/jbc.M009714200; Gerlitz G, 2002, EUR J BIOCHEM, V269, P2810, DOI 10.1046/j.1432-1033.2002.02974.x; Goldstaub D, 2000, MOL CELL BIOL, V20, P1271, DOI 10.1128/MCB.20.4.1271-1277.2000; HAMBIDGE SJ, 1992, P NATL ACAD SCI USA, V89, P10272, DOI 10.1073/pnas.89.21.10272; Hernadez-Munoz I, 2005, P NATL ACAD SCI USA, V102, P7635, DOI 10.1073/pnas.0408918102; Hernandez-Munoz I, 2003, CANCER RES, V63, P4188; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Kalantry S, 2006, NAT CELL BIOL, V8, P195, DOI 10.1038/ncb1351; Kalantry S, 2006, PLOS GENET, V2, P656, DOI 10.1371/journal.pgen.0020066; Kim JH, 2003, MOL CELL BIOL, V23, P708, DOI 10.1128/MCB.23.2.708-720.2003; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lang KJD, 2002, MOL BIOL CELL, V13, P1792, DOI 10.1091/mbc.02-02-0017; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; LI Z, 2006, J BIOL CHEM; Lorente MD, 2000, DEVELOPMENT, V127, P5093; Mak W, 2002, CURR BIOL, V12, P1016, DOI 10.1016/S0960-9822(02)00892-8; MARUSHIGE Y, 1995, ANTICANCER RES, V15, P267; Matzura O, 1996, COMPUT APPL BIOSCI, V12, P247; Mimnaugh EG, 2001, CELL DEATH DIFFER, V8, P1182, DOI 10.1038/sj.cdd.4400924; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Perales C, 2003, FEBS LETT, V533, P89, DOI 10.1016/S0014-5793(02)03764-X; Pesole G, 1999, TRENDS GENET, V15, P378, DOI 10.1016/S0168-9525(99)01795-3; Pickering BM, 2003, NUCLEIC ACIDS RES, V31, P639, DOI 10.1093/nar/gkg146; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Sewalt RGAB, 1998, MOL CELL BIOL, V18, P3586, DOI 10.1128/MCB.18.6.3586; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Stein I, 1998, MOL CELL BIOL, V18, P3112, DOI 10.1128/MCB.18.6.3112; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Stoneley M, 2000, MOL CELL BIOL, V20, P1162, DOI 10.1128/MCB.20.4.1162-1169.2000; Suay L, 2005, NUCLEIC ACIDS RES, V33, P4754, DOI 10.1093/nar/gki760; Subkhankulova T, 2001, BIOCHEM J, V359, P183, DOI 10.1042/0264-6021:3590183; Takihara Y, 1997, DEVELOPMENT, V124, P3673; Tie F, 2001, DEVELOPMENT, V128, P275; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; Trimarchi JM, 2001, P NATL ACAD SCI USA, V98, P1519, DOI 10.1073/pnas.041597698; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; Van Eden ME, 2004, RNA, V10, P720, DOI 10.1261/rna.5225204; van Lohuizen M, 1998, MOL CELL BIOL, V18, P3572, DOI 10.1128/MCB.18.6.3572; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Voncken JW, 1999, J CELL SCI, V112, P4627; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Xia ZB, 2003, P NATL ACAD SCI USA, V100, P8342, DOI 10.1073/pnas.1436338100	63	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2322	10.1371/journal.pone.0002322	http://dx.doi.org/10.1371/journal.pone.0002322			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523580	gold, Green Published, Green Submitted			2022-12-25	WOS:000262614300018
J	Chen, SY; Wang, YL; Telen, MJ; Chi, JT				Chen, Shao-Yin; Wang, Yulei; Telen, Marilyn J.; Chi, Jen-Tsan			The Genomic Analysis of Erythrocyte microRNA Expression in Sickle Cell Diseases	PLOS ONE			English	Article								Background: Since mature erythrocytes are terminally differentiated cells without nuclei and organelles, it is commonly thought that they do not contain nucleic acids. In this study, we have re-examined this issue by analyzing the transcriptome of a purified population of human mature erythrocytes from individuals with normal hemoglobin (HbAA) and homozygous sickle cell disease (HbSS). Methods and Findings: Using a combination of microarray analysis, real-time RT-PCR and Northern blots, we found that mature erythrocytes, while lacking ribosomal and large-sized RNAs, contain abundant and diverse microRNAs. MicroRNA expression of erythrocytes was different from that of reticulocytes and leukocytes, and contributed the majority of the microRNA expression in whole blood. When we used microRNA microarrays to analyze erythrocytes from HbAA and HbSS individuals, we noted a dramatic difference in their microRNA expression pattern. We found that miR-320 played an important role for the down-regulation of its target gene, CD71 during reticulocyte terminal differentiation. Further investigation revealed that poor expression of miR-320 in HbSS cells was associated with their defective downregulation CD71 during terminal differentiation. Conclusions: In summary, we have discovered significant microRNA expression in human mature erythrocytes, which is dramatically altered in HbSS erythrocytes and their defect in terminal differentiation. Thus, the global analysis of microRNA expression in circulating erythrocytes can provide mechanistic insights into the disease phenotypes of erythrocyte diseases.	[Chen, Shao-Yin; Chi, Jen-Tsan] Duke Univ, Sch Med, Inst Genome Sci & Policy, Durham, NC 27710 USA; [Chen, Shao-Yin; Chi, Jen-Tsan] Duke Univ, Sch Med, Dept Mol Genet & Microbiol, Durham, NC USA; [Wang, Yulei] Appl Biosyst Inc, Foster City, CA USA; [Telen, Marilyn J.] Duke Univ, Sch Med, Dept Med, Div Hematol, Durham, NC USA	Duke University; Duke University; Thermo Fisher Scientific; Applied Biosystems; Duke University	Chen, SY (corresponding author), Duke Univ, Sch Med, Inst Genome Sci & Policy, Durham, NC 27710 USA.	chi00002@mc.duke.edu	Chi, Jen-Tsan/AAI-4125-2020	Chi, Jen-Tsan/0000-0003-3433-903X; Wang, Yulei/0000-0002-9057-9786; Telen, Marilyn/0000-0003-3809-1780				Bahou WF, 2004, SEMIN THROMB HEMOST, V30, P473, DOI 10.1055/s-2004-833482; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Birney E, 2004, NUCLEIC ACIDS RES, V32, pD468, DOI 10.1093/nar/gkh038; Browne EP, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-238; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Choong ML, 2007, EXP HEMATOL, V35, P551, DOI 10.1016/j.exphem.2006.12.002; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eisenstein RS, 2000, ANNU REV NUTR, V20, P627, DOI 10.1146/annurev.nutr.20.1.627; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; FRIEDMAN MJ, 1978, P NATL ACAD SCI USA, V75, P1994, DOI 10.1073/pnas.75.4.1994; Georgantas RW, 2007, P NATL ACAD SCI USA, V104, P2750, DOI 10.1073/pnas.0610983104; GIRALDEZ AJ, 2006, SCIENCE; Gnatenko DV, 2003, BLOOD, V101, P2285, DOI 10.1182/blood-2002-09-2797; Goh SH, 2004, NUCLEIC ACIDS RES, V32, pD572, DOI 10.1093/nar/gkh129; Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992; Harrison T, 2003, SCIENCE, V301, P1734, DOI 10.1126/science.1089324; Hoffman R, 2004, HEMATOLOGY BASIC PRI, V4th; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; JOHNSTONE RM, 1989, BLOOD, V74, P1844; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lao KQ, 2006, BIOCHEM BIOPH RES CO, V343, P85, DOI 10.1016/j.bbrc.2006.02.106; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Leung AKL, 2007, CELL, V130, P581, DOI 10.1016/j.cell.2007.08.010; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; LINDA G, 1986, CYTOMETRY, V7, P508; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Miller JL, 2004, BLOOD CELL MOL DIS, V32, P341, DOI 10.1016/j.bcmd.2004.01.003; PASVOL G, 1978, NATURE, V274, P701, DOI 10.1038/274701a0; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Rainen L, 2002, CLIN CHEM, V48, P1883; Rathjen T, 2006, FEBS LETT, V580, P5185, DOI 10.1016/j.febslet.2006.08.063; Shingara J, 2005, RNA, V11, P1461, DOI 10.1261/rna.2610405; Skadberg Oyvind, 2003, Lab Hematol, V9, P198; Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Waggoner SA, 2003, EXP BIOL MED, V228, P387, DOI 10.1177/153537020322800409; Wang BB, 2006, MOL CELL, V22, P553, DOI 10.1016/j.molcel.2006.03.034; WANG Q, 2007, BLOOD; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Zen Q, 2004, AM J HEMATOL, V75, P63, DOI 10.1002/ajh.10442; Zennadi R, 2004, BLOOD, V104, P3774, DOI 10.1182/blood-2004-01-0042; Zhan M, 2007, EXP HEMATOL, V35, P1015, DOI 10.1016/j.exphem.2007.03.014; Zhang BH, 2008, J CELL MOL MED, V12, P3, DOI 10.1111/j.1582-4934.2007.00196.x	46	125	134	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2360	10.1371/journal.pone.0002360	http://dx.doi.org/10.1371/journal.pone.0002360			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523662	Green Published, Green Submitted, gold			2022-12-25	WOS:000262614300047
J	Zeng, L; Wu, GZ; Goh, KJ; Lee, YM; Ng, CC; Ben You, A; Wang, JH; Jia, DY; Hao, AJ; Yu, Q; Li, BJ				Zeng, Li; Wu, Guang-Zhi; Goh, Kim Jee; Lee, Yew Mun; Ng, Chuo Chung; Ben You, Ang; Wang, Jianhe; Jia, Deyong; Hao, Aijun; Yu, Qiang; Li, Baojie			Saturated Fatty Acids Modulate Cell Response to DNA Damage: Implication for Their Role in Tumorigenesis	PLOS ONE			English	Article								DNA damage triggers a network of signaling events that leads to cell cycle arrest or apoptosis. This DNA damage response acts as a mechanism to prevent cancer development. It has been reported that fatty acids (FAs) synthesis is increased in many human tumors while inhibition of fatty acid synthase (FASN) could suppress tumor growth. Here we report that saturated fatty acids (SFAs) play a negative role in DNA damage response. Palmitic acid, as well as stearic acid and myristic acid, compromised the induction of p21 and Bax expression in response to double stranded breaks and ssDNA, while inhibition or knockdown of FASN enhanced these cellular events. SFAs appeared to regulate p21 and Bax expression via Atr-p53 dependent and independent pathways. These effects were only observed in primary mouse embryonic fibroblasts and osteoblasts, but not in immortalized murine NIH3T3, or transformed HCT116 and MCF-7 cell lines. Accordingly, SFAs showed some positive effects on proliferation of MEFs in response to DNA damage. These results suggest that SFAs, by negatively regulating the DNA damage response pathway, might promote cell transformation, and that increased synthesis of SFAs in precancer/cancer cells might contribute to tumor progression and drug resistance.	[Zeng, Li; Wu, Guang-Zhi; Goh, Kim Jee; Lee, Yew Mun; Ng, Chuo Chung; Ben You, Ang; Wang, Jianhe; Li, Baojie] Natl Univ Singapore, Inst Mol & Cell Biol, Canc & Dev Biol Div, Singapore 117548, Singapore; [Wu, Guang-Zhi] Jilin Univ, China Japan Union Hosp, Changchun, Peoples R China; [Jia, Deyong; Hao, Aijun] Shandong Univ, Fac Med, Key Lab Expt Teratol, Minist Educ, Jinan, Peoples R China; [Yu, Qiang] Genome Inst Singapore, Lab Mol Pharmacol, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; Jilin University; Shandong University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Zeng, L (corresponding author), Natl Univ Singapore, Inst Mol & Cell Biol, Canc & Dev Biol Div, 10 Kent Ridge Crescent, Singapore 117548, Singapore.	libj@imcb.a-star.edu.sg	Jia, Deyong/GSJ-0327-2022; Jia, Deyong/GQP-9611-2022; Lee, Yew Mun/G-8891-2017	Jia, Deyong/0000-0003-2034-0363; Lee, Yew Mun/0000-0002-8360-7689; Yu, Qiang/0000-0003-2132-8278	Agency for Science, Technology, and Research, Signapore; Ministry of Education, China [NCET-04-0624]	Agency for Science, Technology, and Research, Signapore; Ministry of Education, China(Ministry of Education, China)	The study was supported by Agency for Science, Technology, and Research, Signapore (BL) and New Century Excellent Talents Program in University (NCET-04-0624), Ministry of Education, China (AH).	Aja S, 2008, AM J PHYSIOL-REG I, V294, pR352, DOI 10.1152/ajpregu.00862.2006; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Beeharry N, 2003, MUTAT RES-FUND MOL M, V530, P27, DOI 10.1016/S0027-5107(03)00134-9; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Chajes V, 2006, CANCER RES, V66, P5287, DOI 10.1158/0008-5472.CAN-05-1489; CHALBOS D, 1987, J BIOL CHEM, V262, P9923; Dowell P, 2005, ANNU REV BIOCHEM, V74, P515, DOI 10.1146/annurev.biochem.73.011303.074027; Fraser DA, 1999, RHEUMATOLOGY, V38, P948, DOI 10.1093/rheumatology/38.10.948; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Greaves J, 2007, J CELL BIOL, V176, P249, DOI 10.1083/jcb.200610151; Grishko V, 2005, FREE RADICAL BIO MED, V38, P755, DOI 10.1016/j.freeradbiomed.2004.11.023; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Key T, 2007, BRIT MED J, V335, P897, DOI 10.1136/bmj.39373.676204.BE; Kiffmeyer T, 2007, Cancer Treat Res, V134, P275; KLEIN S, 1992, AM J PHYSIOL, V262, pE631, DOI 10.1152/ajpendo.1992.262.5.E631; Kuhajda FP, 2006, CANCER RES, V66, P5977, DOI 10.1158/0008-5472.CAN-05-4673; KUHAJDA FP, 1994, P NATL ACAD SCI USA, V91, P6379, DOI 10.1073/pnas.91.14.6379; Kuhajda FP, 2000, P NATL ACAD SCI USA, V97, P3450, DOI 10.1073/pnas.050582897; Li BJ, 2004, GENE DEV, V18, P1824, DOI 10.1101/gad.1223504; Li JN, 2001, CANCER RES, V61, P1493; Malhotra V, 2003, CANCER BIOL THER, V2, pS2; MEDES G, 1953, CANCER RES, V13, P27; Menendez JA, 2004, MOL CARCINOGEN, V41, P164, DOI 10.1002/mc.20054; Menendez JA, 2004, INT J ONCOL, V24, P591; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Ogino S, 2007, HUM PATHOL, V38, P842, DOI 10.1016/j.humpath.2006.11.018; Pandian SS, 1999, J ROY COLL SURG EDIN, V44, P352; Peterson CL, 2004, GENE DEV, V18, P602, DOI 10.1101/gad.1182704; Pizer ES, 1996, CANCER RES, V56, P745; Prentice RL, 2007, JNCI-J NATL CANCER I, V99, P1534, DOI 10.1093/jnci/djm159; Rotman G, 1998, HUM MOL GENET, V7, P1555, DOI 10.1093/hmg/7.10.1555; Schmid B, 2005, BIOCHEM BIOPH RES CO, V328, P1073, DOI 10.1016/j.bbrc.2005.01.067; Slade RF, 2003, ANTICANCER RES, V23, P1235; Van de Sande T, 2002, CANCER RES, V62, P642; vantHof W, 1997, J CELL BIOL, V136, P1023, DOI 10.1083/jcb.136.5.1023; Walley AJ, 2006, HUM MOL GENET, V15, pR124, DOI 10.1093/hmg/ddl215; Yan CH, 2005, EMBO J, V24, P2425, DOI 10.1038/sj.emboj.7600712; Yang YA, 2002, EXP CELL RES, V279, P80, DOI 10.1006/excr.2002.5600; Zeng L, 2005, J BIOL CHEM, V280, P29374, DOI 10.1074/jbc.M503016200; Zhang XH, 2007, J CELL SCI, V120, P4134, DOI 10.1242/jcs.015834; Zhou WB, 2003, CANCER RES, V63, P7330	43	48	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2329	10.1371/journal.pone.0002329	http://dx.doi.org/10.1371/journal.pone.0002329			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523653	gold, Green Published, Green Submitted			2022-12-25	WOS:000262614300024
J	Takeuchi, T; Ohtsuki, G; Yoshida, T; Fukaya, M; Wainai, T; Yamashita, M; Yamazaki, Y; Mori, H; Sakimura, K; Kawamoto, S; Watanabe, M; Hirano, T; Mishina, M				Takeuchi, Tomonori; Ohtsuki, Gen; Yoshida, Takashi; Fukaya, Masahiro; Wainai, Tasuku; Yamashita, Manami; Yamazaki, Yoshito; Mori, Hisashi; Sakimura, Kenji; Kawamoto, Susumu; Watanabe, Masahiko; Hirano, Tomoo; Mishina, Masayoshi			Enhancement of Both Long-Term Depression Induction and Optokinetic Response Adaptation in Mice Lacking Delphilin	PLOS ONE			English	Article								In the cerebellum, Delphilin is expressed selectively in Purkinje cells (PCs) and is localized exclusively at parallel fiber (PF) synapses, where it interacts with glutamate receptor (GluR) delta 2 that is essential for long-term depression (LTD), motor learning and cerebellar wiring. Delphilin ablation exerted little effect on the synaptic localization of GluR delta 2. There were no detectable abnormalities in cerebellar histology, PC cytology and PC synapse formation in contrast to GluR delta 2 mutant mice. However, LTD induction was facilitated at PF-PC synapses in Delphilin mutant mice. Intracellular Ca(2+) required for the induction of LTD appeared to be reduced in the mutant mice, while Ca(2+) influx through voltage-gated Ca(2+) channels and metabotropic GluR1-mediated slow synaptic response were similar between wild-type and mutant mice. We further showed that the gain-increase adaptation of the optokinetic response (OKR) was enhanced in the mutant mice. These findings are compatible with the idea that LTD induction at PF-PC synapses is a crucial rate-limiting step in OKR gain-increase adaptation, a simple form of motor learning. As exemplified in this study, enhancing synaptic plasticity at a specific synaptic site of a neural network is a useful approach to understanding the roles of multiple plasticity mechanisms at various cerebellar synapses in motor control and learning.	[Takeuchi, Tomonori; Wainai, Tasuku; Mori, Hisashi; Mishina, Masayoshi] Univ Tokyo, Grad Sch Med, Dept Mol Neurobiol & Pharmacol, Tokyo, Japan; [Ohtsuki, Gen; Yoshida, Takashi; Yamashita, Manami; Yamazaki, Yoshito; Hirano, Tomoo] Kyoto Univ, CREST, Grad Sch Sci, Japan Sci & Technol Agcy, Kyoto, Japan; [Fukaya, Masahiro; Watanabe, Masahiko] Hokkaido Univ, Sch Med, Dept Anat, Sapporo, Hokkaido, Japan; [Sakimura, Kenji] Niigata Univ, Brain Res Inst, Dept Cellular Neurobiol, Niigata, Japan; [Kawamoto, Susumu] Chiba Univ, Res Ctr Pathogen Fungi & Microbial Toxicoses, Dept Mol Funct, Chiba, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Kyoto University; Hokkaido University; Niigata University; Chiba University	Takeuchi, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Mol Neurobiol & Pharmacol, Tokyo, Japan.	thirano@neurosci.biophys.kyoto-u.ac.jp; mishina@m.u-tokyo.ac.jp	WATANABE, Masahiko/A-4055-2012; Takeuchi, Tomonori/P-5988-2016; Yoshida, Takashi/GPX-3941-2022; Watanabe, Masahiko/S-3614-2019; Ohtsuki/AAB-4570-2019	WATANABE, Masahiko/0000-0001-5037-7138; Takeuchi, Tomonori/0000-0002-9981-4260; Yoshida, Takashi/0000-0002-7089-4009; Watanabe, Masahiko/0000-0001-5037-7138; Ohtsuki/0000-0003-3004-5886	Ministry of Education, Culture, Sports, Science and Technology of Japan [Grant-in-Aid]; Japan Science and Technology Agency; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for Scientific Research on Priority Areas-Molecular Brain Science from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the Japan Science and Technology Agency. G.O. and T.Y. were supported by Japan Society for the Promotion of Science.	ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Altman J, 1997, DEV CEREBELLAR SYSTE; ARAKI K, 1993, BIOCHEM BIOPH RES CO, V197, P1267, DOI 10.1006/bbrc.1993.2614; Boyden ES, 2006, NEURON, V51, P823, DOI 10.1016/j.neuron.2006.08.026; Boyden ES, 2004, ANNU REV NEUROSCI, V27, P581, DOI 10.1146/annurev.neuro.27.070203.144238; Cesa R, 2003, J NEUROSCI, V23, P2363; Christian KM, 2003, LEARN MEMORY, V10, P427, DOI 10.1101/lm.59603; Cuthbert PC, 2007, J NEUROSCI, V27, P2673, DOI 10.1523/JNEUROSCI.4457-06.2007; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; Faulstich M, 2006, J NEUROPHYSIOL, V96, P1187, DOI 10.1152/jn.00045.2006; Feil R, 2003, J CELL BIOL, V163, P295, DOI 10.1083/jcb.200306148; Fukaya M, 2003, P NATL ACAD SCI USA, V100, P4855, DOI 10.1073/PNAS.0830996100; Fukaya M, 2000, J COMP NEUROL, V426, P572; Funabiki K, 1995, NEUROREPORT, V7, P189, DOI 10.1097/00001756-199512000-00045; Fuse T, 2004, BIOCHEM BIOPH RES CO, V318, P665, DOI 10.1016/j.bbrc.2004.04.076; Hansel C, 2001, NAT NEUROSCI, V4, P467, DOI 10.1038/87419; Hansel C, 2006, NEURON, V51, P835, DOI 10.1016/j.neuron.2006.08.013; Hashimoto K, 2001, J NEUROSCI, V21, P9701, DOI 10.1523/JNEUROSCI.21-24-09701.2001; HIRANO T, 1995, NEUROREPORT, V6, P524, DOI 10.1097/00001756-199502000-00029; HIRANO T, 1994, NEUROSCI LETT, V182, P172, DOI 10.1016/0304-3940(94)90790-0; Hironaka K, 2000, J BIOL CHEM, V275, P16167, DOI 10.1074/jbc.M909302199; Ichikawa R, 2002, J NEUROSCI, V22, P8487; ITO M, 1982, ANNU REV NEUROSCI, V5, P275, DOI 10.1146/annurev.ne.05.030182.001423; Ito M, 2002, NAT REV NEUROSCI, V3, P896, DOI 10.1038/nrn962; Ito M, 1984, CEREBELLUM NEURAL CO; Iwashita M, 2001, NEUROSCI RES, V39, P299, DOI 10.1016/S0168-0102(00)00228-5; Jorntell H, 2006, NEURON, V52, P227, DOI 10.1016/j.neuron.2006.09.032; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; Katoh A, 2000, LEARN MEMORY, V7, P220, DOI 10.1101/lm.7.4.220; Katoh A, 2005, EUR J NEUROSCI, V21, P1315, DOI 10.1111/j.1460-9568.2005.03946.x; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Kim SJ, 2003, NATURE, V426, P285, DOI 10.1038/nature02162; Kina S, 2007, EUR J NEUROSCI, V26, P2269, DOI 10.1111/j.1460-9568.2007.05829.x; Kishimoto Y, 2001, EUR J NEUROSCI, V13, P1249, DOI 10.1046/j.0953-816x.2001.01488.x; Koekkoek SKE, 2005, NEURON, V47, P339, DOI 10.1016/j.neuron.2005.07.005; Koekkoek SKE, 2003, SCIENCE, V301, P1736, DOI 10.1126/science.1088383; Komiyama NH, 2002, J NEUROSCI, V22, P9721; Kurihara H, 1997, J NEUROSCI, V17, P9613; Landsend AS, 1997, J NEUROSCI, V17, P834, DOI 10.1523/jneurosci.17-02-00834.1997; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; LOMELI H, 1993, FEBS LETT, V315, P318, DOI 10.1016/0014-5793(93)81186-4; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Mishina M, 2003, INT CONGR SER, V1250, P473, DOI 10.1016/S0531-5131(03)00186-9; Miyagi Y, 2002, J NEUROSCI, V22, P803, DOI 10.1523/JNEUROSCI.22-03-00803.2002; Miyazaki T, 2003, EUR J NEUROSCI, V17, P2563, DOI 10.1046/j.1460-9568.2003.02698.x; NAGAO S, 1988, EXP BRAIN RES, V73, P489, DOI 10.1007/BF00406606; Nakagama S, 1998, J COMP NEUROL, V395, P112, DOI 10.1002/(SICI)1096-9861(19980525)395:1<112::AID-CNE8>3.0.CO;2-3; Nakamura K, 2001, EUR J NEUROSCI, V13, P179, DOI 10.1046/j.0953-816X.2000.01366.x; Pugh JR, 2006, NEURON, V51, P113, DOI 10.1016/j.neuron.2006.05.021; Roche KW, 1999, J NEUROSCI, V19, P3926; SAKIMURA K, 1980, J NEUROCHEM, V34, P687, DOI 10.1111/j.1471-4159.1980.tb11198.x; Shimuta M, 2001, MOL CELL NEUROSCI, V17, P921, DOI 10.1006/mcne.2001.0981; Takahashi T, 1996, J NEUROSCI, V16, P4376; Takayama C, 1996, DEV BRAIN RES, V92, P147, DOI 10.1016/0165-3806(95)00212-X; Takeuchi T, 2005, J NEUROSCI, V25, P2146, DOI 10.1523/JNEUROSCI.4740-04.2005; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; Uemura T, 2007, J NEUROSCI, V27, P12096, DOI 10.1523/JNEUROSCI.2680-07.2007; Welsh JP, 2005, P NATL ACAD SCI USA, V102, P17166, DOI 10.1073/pnas.0508191102; YAMAZAKI M, 1992, BIOCHEM BIOPH RES CO, V183, P886, DOI 10.1016/0006-291X(92)90566-4; Yap CC, 2003, BIOCHEM BIOPH RES CO, V301, P1122, DOI 10.1016/S0006-291X(03)00070-6; Yasumura M, 2008, NEUROSCI LETT, V433, P146, DOI 10.1016/j.neulet.2008.01.009; Yawata S, 2006, J NEUROSCI, V26, P3626, DOI 10.1523/JNEUROSCI.4183-05.2006; Yue ZY, 2002, NEURON, V35, P921, DOI 10.1016/S0896-6273(02)00861-9; Zhang W, 2006, J NEUROSCI, V26, P6935, DOI 10.1523/JNEUROSCI.0784-06.2006; Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009	67	41	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2297	10.1371/journal.pone.0002297	http://dx.doi.org/10.1371/journal.pone.0002297			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509461	Green Published, Green Submitted, gold			2022-12-25	WOS:000262268500036
J	Tao, R; Hancock, WW				Tao, Ran; Hancock, Wayne W.			Resistance of Foxp3+Regulatory T Cells to Nur77-Induced Apoptosis Promotes Allograft Survival	PLOS ONE			English	Article								The NR4A nuclear receptor family member Nur77 (NR4A1) promotes thymocyte apoptosis during negative selection of autoreactive thymocytes, but may also function in mature extrathymic T cells. We studied the effects of over-expression of Nur77 on the apoptosis of murine peripheral T cells, including thymic-derived Foxp3+ regulatory (Treg) cells. Overexpression of Nur77 in the T cell lineage decreased numbers of peripheral CD4 and CD8 T cells by similar to 80% compared to wild-type (WT) mice. However, the proportions of Treg cells were markedly increased in the thymus (61% of CD4+Foxp3+ singly positive thymocytes vs. 8% in WT) and secondary lymphoid organs (40-50% of CD4+ Foxp3+ T cells vs. 7-8% in WT) of Nur77 transgenic (Nur77Tg) mice, and immunoprecipitation studies showed Nur77 was associated with a recently identified HDAC7/Foxp3 transcriptional complex. Upon activation through the T cell receptor in vitro or in vivo, Nur77Tg T cells showed only marginally decreased proliferation but significantly increased apoptosis. Fully allogeneic cardiac grafts transplanted to Nur77Tg mice survived long-term with well-preserved structure, and recipient splenocytes showed markedly enhanced apoptosis and greatly reduced anti-donor recall responses. Allografts in Nur77Tg recipients had significantly increased expression of multiple Treg-associated genes, including Foxp3, Foxp1, Tip60 and HDAC9. Allograft rejection was restored by CD25 monoclonal antibody therapy, indicating that allograft acceptance was dependent upon Treg function in Nur77Tg recipients. These data show that compared to conventional CD4 and CD8 T cells, Foxp3+ Tregs are relatively resistant to Nur77-mediated apoptosis, and that tipping the balance between the numbers of Tregs and responder T cells in the early period post-transplantation can determine the fate of the allograft. Hence, induced expression of Nur77 might be a novel means to achieve long-term allograft survival.	[Tao, Ran; Hancock, Wayne W.] Childrens Hosp Philadelphia, Stokes Res Inst, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Tao, R (corresponding author), Childrens Hosp Philadelphia, Stokes Res Inst, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	whancock@mail.med.upenn.edu			National Institutes of Health [1R01AI54720, 1R01AI 073938]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073938, R01AI054720] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grants from the National Institutes of Health (1R01AI54720 and 1R01AI 073938) to WWH. There are no financial, personal, or professional interests that could be construed to have influenced the paper.	CALNAN BJ, 1995, IMMUNITY, V3, P273; CORRY RJ, 1973, TRANSPLANTATION, V16, P343, DOI 10.1097/00007890-197310000-00010; Dawson MI, 2001, CANCER RES, V61, P4723; De Silva S, 2005, ARTHRITIS RHEUM-US, V52, P333, DOI 10.1002/art.20736; Dequiedt F, 2003, IMMUNITY, V18, P687, DOI 10.1016/S1074-7613(03)00109-2; Dequiedt F, 2005, J EXP MED, V201, P793, DOI 10.1084/jem.20042034; DeYoung AL, 2000, J IMMUNOL, V165, P6170, DOI 10.4049/jimmunol.165.11.6170; Fritzsching B, 2005, J IMMUNOL, V175, P32, DOI 10.4049/jimmunol.175.1.32; Fritzsching B, 2006, BLOOD, V108, P3371, DOI 10.1182/blood-2006-02-005660; Gennari A, 2002, TOXICOL APPL PHARM, V181, P27, DOI 10.1006/taap.2002.9357; Hancock WW, 2003, CURR OPIN IMMUNOL, V15, P479, DOI 10.1016/S0952-7915(03)00103-1; Kang HJ, 2000, EXP CELL RES, V256, P545, DOI 10.1006/excr.2000.4832; Kao HY, 2001, J BIOL CHEM, V276, P47496, DOI 10.1074/jbc.M107631200; Kasprowicz DJ, 2005, EUR J IMMUNOL, V35, P3424, DOI 10.1002/eji.200526339; Kim H, 2006, BIOCHEM BIOPH RES CO, V348, P950, DOI 10.1016/j.bbrc.2006.07.167; Lee I, 2005, J EXP MED, V201, P1037, DOI 10.1084/jem.20041709; LEE SL, 1995, SCIENCE, V269, P532, DOI 10.1126/science.7624775; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Li Y, 1998, MOL CELL BIOL, V18, P4719, DOI 10.1128/MCB.18.8.4719; Liu WF, 2001, EUR J IMMUNOL, V31, P1757, DOI 10.1002/1521-4141(200106)31:6<1757::AID-IMMU1757>3.0.CO;2-J; LIU ZG, 1994, NATURE, V367, P281, DOI 10.1038/367281a0; Mohamood AS, 2006, INT IMMUNOL, V18, P1265, DOI 10.1093/intimm/dxl057; Parra M, 2005, J BIOL CHEM, V280, P13762, DOI 10.1074/jbc.M413396200; Rajpal A, 2003, EMBO J, V22, P6526, DOI 10.1093/emboj/cdg620; SINGER GG, 1994, IMMUNITY, V1, P365, DOI 10.1016/1074-7613(94)90067-1; Suchin EJ, 2001, J IMMUNOL, V166, P973, DOI 10.4049/jimmunol.166.2.973; Tao R, 2005, J IMMUNOL, V175, P5774, DOI 10.4049/jimmunol.175.9.5774; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Toth R, 2001, EUR J IMMUNOL, V31, P1382, DOI 10.1002/1521-4141(200105)31:5<1382::AID-IMMU1382>3.0.CO;2-Y; Weih F, 1996, P NATL ACAD SCI USA, V93, P5533, DOI 10.1073/pnas.93.11.5533; WORONICZ JD, 1994, NATURE, V367, P277, DOI 10.1038/367277a0; YAZDANBAKHSH K, 1995, P NATL ACAD SCI USA, V92, P437, DOI 10.1073/pnas.92.2.437; Zhang J, 1999, COLD SPRING HARB SYM, V64, P363, DOI 10.1101/sqb.1999.64.363; Zhou T, 1996, J EXP MED, V183, P1879, DOI 10.1084/jem.183.4.1879	36	26	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2321	10.1371/journal.pone.0002321	http://dx.doi.org/10.1371/journal.pone.0002321			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509529	Green Published, Green Submitted, gold			2022-12-25	WOS:000262268500048
J	Abu-Raddad, LJ; Magaret, AS; Celum, C; Wald, A; Longini, IM; Self, SG; Corey, L				Abu-Raddad, Laith J.; Magaret, Amalia S.; Celum, Connie; Wald, Anna; Longini, Ira M., Jr.; Self, Steven G.; Corey, Lawrence			Genital Herpes Has Played a More Important Role than Any Other Sexually Transmitted Infection in Driving HIV Prevalence in Africa	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SUB-SAHARAN AFRICA; EMPIRICAL OBSERVATIONS UNDERESTIMATE; SIMPLEX-VIRUS; MALE CIRCUMCISION; TYPE-2 INFECTION; BEHAVIOR-CHANGE; ULCER DISEASE; DEVELOPING-COUNTRIES; TREATMENT TRIALS	Background: Extensive evidence from observational studies suggests a role for genital herpes in the HIV epidemic. A number of herpes vaccines are under development and several trials of the efficacy of HSV-2 treatment with acyclovir in reducing HIV acquisition, transmission, and disease progression have just reported their results or will report their results in the next year. The potential impact of these interventions requires a quantitative assessment of the magnitude of the synergy between HIV and HSV-2 at the population level. Methods and Findings: A deterministic compartmental model of HIV and HSV-2 dynamics and interactions was constructed. The nature of the epidemiologic synergy was explored qualitatively and quantitatively and compared to other sexually transmitted infections (STIs). The results suggest a more substantial role for HSV-2 in fueling HIV spread in sub-Saharan Africa than other STIs. We estimate that in settings of high HSV-2 prevalence, such as Kisumu, Kenya, more than a quarter of incident HIV infections may have been attributed directly to HSV-2. HSV-2 has also contributed considerably to the onward transmission of HIV by increasing the pool of HIV positive persons in the population and may explain one-third of the differential HIV prevalence among the cities of the Four City study. Conversely, we estimate that HIV had only a small net impact on HSV-2 prevalence. Conclusions: HSV-2 role as a biological cofactor in HIV acquisition and transmission may have contributed substantially to HIV particularly by facilitating HIV spread among the low-risk population with stable long-term sexual partnerships. This finding suggests that prevention of HSV-2 infection through a prophylactic vaccine may be an effective intervention both in nascent epidemics with high HIV incidence in the high risk groups, and in established epidemics where a large portion of HIV transmission occurs in stable partnerships.	[Abu-Raddad, Laith J.; Self, Steven G.] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98104 USA; [Abu-Raddad, Laith J.] Univ Washington, Ctr Stud Demography & Ecol, Seattle, WA USA; [Magaret, Amalia S.] Fred Hutchinson Canc Res Ctr, Program Biostat, Seattle, WA USA; [Celum, Connie; Wald, Anna] Univ Washington, Dept Med, Seattle, WA USA; [Celum, Connie; Wald, Anna] Univ Washington, Dept Epidemiol, Seattle, WA USA; [Wald, Anna] Univ Washington, Virol Res Clin, Seattle, WA USA; [Wald, Anna] Univ Washington, Dept Lab Med, Seattle, WA USA; [Longini, Ira M., Jr.] Fred Hutchinson Canc Res Ctr, Program Biostat & Biomath, Seattle, WA USA; [Longini, Ira M., Jr.; Self, Steven G.] Univ Washington, Dept Biostat, Seattle, WA USA; [Corey, Lawrence] Fred Hutchinson Canc Res Ctr, Clin Res Div, Seattle, WA USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Abu-Raddad, LJ (corresponding author), Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, 1124 Columbia St, Seattle, WA 98104 USA.	laith@scharp.org	Abu-Raddad, Laith J/AAY-1441-2020; Corey, Lawrence/AAE-1796-2020; Wald, Anna/B-6272-2012	Abu-Raddad, Laith J/0000-0003-0790-0506; Corey, Lawrence/0000-0002-2179-2436; Wald, Anna/0000-0003-3486-6438	University of Washington Center for AIDS Research (CFAR); NIH [P30 AI 27757, PO1 AI031448, K24 AI071113, PO1 AI-30731]; Fred Hutchinson Cancer Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI031448, P30AI027757, P01AI030731, U01AI031448, K24AI071113] Funding Source: NIH RePORTER	University of Washington Center for AIDS Research (CFAR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fred Hutchinson Cancer Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This publication resulted from research supported by the University of Washington Center for AIDS Research (CFAR), an NIH funded program (P30 AI 27757). Additional funding was provided by the Fred Hutchinson Cancer Research Center, NIH grants PO1 AI031448, K24 AI071113, and PO1 AI-30731. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2006, SCIENCE, V314, P1603, DOI 10.1126/science.1132338; ALBRECHT MA, 1989, J VIROL, V63, P1861, DOI 10.1128/JVI.63.5.1861-1868.1989; [Anonymous], INFECT DIS HUMANS DY; Artzrouni M, 2002, AIDS, V16, pW1; AUGENBRAUN M, 1995, ANN INTERN MED, V123, P845, DOI 10.7326/0003-4819-123-11-199512010-00006; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2001, AIDS, V15, pS31, DOI 10.1097/00002030-200108004-00004; Bailey R, 2007, SCALING CIRCUMCISION; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; BENEDETTI J, 1994, ANN INTERN MED, V121, P847, DOI 10.7326/0003-4819-121-11-199412010-00004; Blower S, 2004, CLIN INFECT DIS, V39, pS240, DOI 10.1086/422361; Boily MC, 1997, CAN J PUBLIC HEALTH, V88, P255, DOI 10.1007/BF03404793; Boily MC, 1996, SEX TRANSM DIS, V23, P312, DOI 10.1097/00007435-199607000-00012; BRUNHAM RC, 1990, MED CLIN N AM, V74, P1339, DOI 10.1016/S0025-7125(16)30484-9; Buve A, 2001, AIDS, V15, pS127, DOI 10.1097/00002030-200108004-00014; Buve A, 2001, AIDS, V15, pS5, DOI 10.1097/00002030-200108004-00002; Celum C, 2004, B WORLD HEALTH ORGAN, V82, P447; CELUM C, 2008, 15 C RETR OPP INF BO; Celum Connie L, 2004, Herpes, V11 Suppl 1, p36A; Cohen MS, 1998, LANCET, V351, P5, DOI 10.1016/S0140-6736(98)90002-2; Corey L, 2004, JAIDS-J ACQ IMM DEF, V35, P435, DOI 10.1097/00126334-200404150-00001; Corey L, 2004, NEW ENGL J MED, V350, P11, DOI 10.1056/NEJMoa035144; Corey L, 2000, JAMA-J AM MED ASSOC, V283, P791, DOI 10.1001/jama.283.6.791; COWAN FM, 1994, BRIT MED J, V309, P1325, DOI 10.1136/bmj.309.6965.1325; CUNNINGHAM AL, 1985, J CLIN INVEST, V75, P226, DOI 10.1172/JCI111678; DeJesus E, 2003, J INFECT DIS, V188, P1009, DOI 10.1086/378416; Dickerson MC, 1996, SEX TRANSM DIS, V23, P429, DOI 10.1097/00007435-199609000-00015; Ferry B, 2001, AIDS, V15, pS41, DOI 10.1097/00002030-200108004-00005; FIFE KH, 1994, J INFECT DIS, V169, P1338, DOI 10.1093/infdis/169.6.1338; Fleming DT, 1997, NEW ENGL J MED, V337, P1105, DOI 10.1056/NEJM199710163371601; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Freeman EE, 2007, SEX TRANSM INFECT; GOLDEN MP, 1992, J INFECT DIS, V166, P494, DOI 10.1093/infdis/166.3.494; Gray RH, 1999, AIDS, V13, P2113, DOI 10.1097/00002030-199910220-00015; Gray RH, 2004, J INFECT DIS, V189, P1209, DOI 10.1086/382750; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gray RH, 2007, SEX TRANSM DIS, V34, P61, DOI 10.1097/01.olq.0000253172.20985.9b; GREENLAND S, 1998, MODERN EPIDEMIOLOGY, P00281; Grosskurth H, 2000, LANCET, V355, P1981, DOI 10.1016/S0140-6736(00)02336-9; Gupta R, 2004, J INFECT DIS, V190, P1374, DOI 10.1086/424519; Halioua B, 1999, EUR J DERMATOL, V9, P177; Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042; HENG MCY, 1994, LANCET, V343, P255, DOI 10.1016/S0140-6736(94)91110-X; Hethcote H., 1984, LECT NOTES BIOMATH, V56, P18; Hitti J, 1997, AM J OBSTET GYNECOL, V177, P450, DOI 10.1016/S0002-9378(97)70214-X; Kamali A, 2003, LANCET, V361, P645, DOI 10.1016/S0140-6736(03)12598-6; Kamali A, 1999, SEX TRANSM INFECT, V75, P98, DOI 10.1136/sti.75.2.98; Kaul R, 2004, JAMA-J AM MED ASSOC, V291, P2555, DOI 10.1001/jama.291.21.2555; Keou FXM, 1999, AIDS, V13, P536, DOI 10.1097/00002030-199903110-00021; KOOPMAN JS, 1991, AM J EPIDEMIOL, V133, P1199, DOI 10.1093/oxfordjournals.aje.a115832; Korenromp EL, 2000, AIDS, V14, P573, DOI 10.1097/00002030-200003310-00013; Korenromp EL, 2002, SEX TRANSM DIS, V29, P228, DOI 10.1097/00007435-200204000-00008; Korenromp EL, 2002, AIDS, V16, P2209, DOI 10.1097/00002030-200211080-00014; Korenromp EL, 2001, SEX TRANSM DIS, V28, P613, DOI 10.1097/00007435-200111000-00001; Lagarde E, 2001, AIDS, V15, P877, DOI 10.1097/00002030-200105040-00008; LATIF AS, 1989, AIDS, V3, P519, DOI 10.1097/00002030-198908000-00006; Law G., 1999, ADM SUBDIVISIONS COU; LEVIN M L, 1953, Acta Unio Int Contra Cancrum, V9, P531; LYCKE E, 1980, SEX TRANSM DIS, V7, P6, DOI 10.1097/00007435-198001000-00002; Mbopi-Keou FX, 2003, CLIN MICROBIOL INFEC, V9, P161, DOI 10.1046/j.1469-0691.2003.00550.x; McFarland W, 1999, J INFECT DIS, V180, P1459, DOI 10.1086/315076; Mole L, 1997, J INFECT DIS, V176, P766, DOI 10.1086/517297; Morgan D, 2002, AIDS, V16, P597, DOI 10.1097/00002030-200203080-00011; Morgan D, 2001, NAT MED, V7, P143, DOI 10.1038/84564; Morison L, 2001, AIDS, V15, pS61, DOI 10.1097/00002030-200108004-00007; MOSCA JD, 1987, NATURE, V325, P67, DOI 10.1038/325067a0; MOSCA JD, 1987, P NATL ACAD SCI USA, V84, P7408, DOI 10.1073/pnas.84.21.7408; Mostad SB, 2000, AM J OBSTET GYNECOL, V183, P948, DOI 10.1067/mob.2000.106589; Mostad SB, 2000, J INFECT DIS, V181, P58, DOI 10.1086/315188; Nagot N, 2007, NEW ENGL J MED, V356, P790, DOI 10.1056/NEJMoa062607; Nahmias A J, 1990, Scand J Infect Dis Suppl, V69, P19; O'Farrell N, 1999, SEX TRANSM INFECT, V75, P377, DOI 10.1136/sti.75.6.377; Orroth KK, 2006, SEX TRANSM DIS, V33, P536, DOI 10.1097/01.olq.0000204667.11192.71; Orroth KK, 2003, SEX TRANSM INFECT, V79, P98, DOI 10.1136/sti.79.2.98; PLUMMER FA, 1983, LANCET, V2, P1293; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rebbapragada A, 2007, AIDS, V21, P589, DOI 10.1097/QAD.0b013e328012b896; Robinson NJ, 1997, INT J EPIDEMIOL, V26, P180, DOI 10.1093/ije/26.1.180; Rodriguez MDM, 2002, AIDS, V16, P451; Schacker T, 1998, J INFECT DIS, V178, P1616, DOI 10.1086/314486; Schacker T, 2002, J INFECT DIS, V186, P1718, DOI 10.1086/345771; Schacker T, 1998, ANN INTERN MED, V128, P21, DOI 10.7326/0003-4819-128-1-199801010-00004; Schacker T, 1998, JAMA-J AM MED ASSOC, V280, P61, DOI 10.1001/jama.280.1.61; SCHROETER AL, 1971, J AMER MED ASSOC, V218, P711, DOI 10.1001/jama.218.5.711; Serwadda D, 2003, J INFECT DIS, V188, P1492, DOI 10.1086/379333; Smith JS, 2002, J INFECT DIS, V186, pS3, DOI 10.1086/343739; STAMM WE, 1988, JAMA-J AM MED ASSOC, V260, P1429, DOI 10.1001/jama.260.10.1429; Suligoi B, 2002, ANTIVIR THER, V7, P289; *UNAIDS WHO, AIDS EP UPD 2007; Wald A, 2000, NEW ENGL J MED, V342, P844, DOI 10.1056/NEJM200003233421203; Wald A, 2006, J INFECT DIS, V194, P42, DOI 10.1086/504717; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; Wald A, 1997, J CLIN INVEST, V99, P1092, DOI 10.1172/JCI119237; Wald A, 2001, JAMA-J AM MED ASSOC, V285, P3100, DOI 10.1001/jama.285.24.3100; Wald Anna, 2004, Herpes, V11, P70; WASSERHEIT JN, 1992, SEX TRANSM DIS, V19, P61, DOI 10.1097/00007435-199219020-00001; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Wawer MJ, 1999, LANCET, V353, P525, DOI 10.1016/S0140-6736(98)06439-3; Weiss HA, 2001, AIDS, V15, pS97, DOI 10.1097/00002030-200108004-00011; Weiss HA, 2000, AIDS, V14, P2361, DOI 10.1097/00002030-200010200-00018; Weiss HA, 2006, SEX TRANSM INFECT, V82, P101, DOI 10.1136/sti.2005.017442; Weiss Helen, 2004, Herpes, V11 Suppl 1, p24A; YORKE JA, 1978, SEX TRANSM DIS, V5, P51, DOI 10.1097/00007435-197804000-00003; Zhu J, 2007, J EXP MED, V204, P595, DOI 10.1084/jem.20061792; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	125	192	197	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2230	10.1371/journal.pone.0002230	http://dx.doi.org/10.1371/journal.pone.0002230			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493617	Green Submitted, Green Published, gold			2022-12-25	WOS:000262258700038
J	Giretti, MS; Fu, XD; De Rosa, G; Sarotto, I; Baldacci, C; Garibaldi, S; Mannella, P; Biglia, N; Sismondi, P; Genazzani, AR; Simoncini, T				Giretti, Maria Silvia; Fu, Xiao-Dong; De Rosa, Giovanni; Sarotto, Ivana; Baldacci, Chiara; Garibaldi, Silvia; Mannella, Paolo; Biglia, Nicoletta; Sismondi, Piero; Genazzani, Andrea Riccardo; Simoncini, Tommaso			Extra-Nuclear Signalling of Estrogen Receptor to Breast Cancer Cytoskeletal Remodelling, Migration and Invasion	PLOS ONE			English	Article								Background: Estrogen is an established enhancer of breast cancer development, but less is known on its effect on local progression or metastasis. We studied the effect of estrogen receptor recruitment on actin cytoskeleton remodeling and breast cancer cell movement and invasion. Moreover, we characterized the signaling steps through which these actions are enacted. Methodology/Principal Findings: In estrogen receptor (ER) positive T47-D breast cancer cells ER activation with 17 beta-estradiol induces rapid and dynamic actin cytoskeleton remodeling with the formation of specialized cell membrane structures like ruffles and pseudopodia. These effects depend on the rapid recruitment of the actin-binding protein moesin. Moesin activation by estradiol depends on the interaction of ER alpha with the G protein G alpha(13), which results in the recruitment of the small GTPase RhoA and in the subsequent activation of its downstream effector Rho-associated kinase-2 (ROCK-2). ROCK-2 is responsible for moesin phosphorylation. The G alpha(13)/RhoA/ROCK/moesin cascade is necessary for the cytoskeletal remodeling and for the enhancement of breast cancer cell horizontal migration and invasion of three-dimensional matrices induced by estrogen. In addition, human samples of normal breast tissue, fibroadenomas and invasive ductal carcinomas show that the expression of wild-type moesin as well as of its active form is deranged in cancers, with increased protein amounts and a loss of association with the cell membrane. Conclusions/Significance: These results provide an original mechanism through which estrogen can facilitate breast cancer local and distant progression, identifying the extra-nuclear G alpha(13)/RhoA/ROCK/moes in signaling cascade as a target of ERa in breast cancer cells. This information helps to understand the effects of estrogen on breast cancer metastasis and may provide new targets for therapeutic interventions.	[Giretti, Maria Silvia; Fu, Xiao-Dong; Baldacci, Chiara; Garibaldi, Silvia; Mannella, Paolo; Genazzani, Andrea Riccardo; Simoncini, Tommaso] Univ Pisa, Dept Reprod Med & Child Dev, Pisa, Italy; [De Rosa, Giovanni; Sarotto, Ivana] Univ Turin, Inst Canc Res & Treatment Candiolo, Mauriziano Umberto I Hosp, Pathol Unit, Turin, Italy; [Biglia, Nicoletta; Sismondi, Piero] Univ Turin, Inst Canc Res & Treatment Candiolo, Mauriziano Umberto I Hosp, Dept Gynecol Oncol, Turin, Italy	University of Pisa; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; IRCCS Fondazione del Piemonte per l'Oncologia; Mauritian Umberto I Hospital; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; IRCCS Fondazione del Piemonte per l'Oncologia; Mauritian Umberto I Hospital; University of Turin	Giretti, MS (corresponding author), Univ Pisa, Dept Reprod Med & Child Dev, Pisa, Italy.	t.simoncini@obgyn.med.unipi.it	sarotto, ivana/AAB-7797-2020; Mannella, Paolo/AAB-2045-2019; Simoncini, Tommaso/AAC-1879-2019; Biglia, Nicoletta/F-8801-2013	Mannella, Paolo/0000-0001-8146-6731; Simoncini, Tommaso/0000-0002-2971-0079; Biglia, Nicoletta/0000-0003-1009-5309; Sismondi, Piero/0000-0002-2505-5716	Italian University and Scientific Research Ministry (MIUR) [2004057090_007]	Italian University and Scientific Research Ministry (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work has been supported by the PRIN grant 2004057090_007 by the Italian University and Scientific Research Ministry (MIUR) to TS.	Acconcia F, 2006, ENDOCRINOLOGY, V147, P1203, DOI 10.1210/en.2005-1293; Bretscher A, 1997, J CELL SCI, V110, P3011; Carmeci C, 1998, SURGERY, V124, P211, DOI 10.1016/S0039-6060(98)70122-9; Chen ZC, 2001, CANCER-AM CANCER SOC, V92, P3068, DOI 10.1002/1097-0142(20011215)92:12<3068::AID-CNCR10149>3.0.CO;2-5; Elliott BE, 2005, BREAST CANCER RES, V7, pR365, DOI 10.1186/bcr1006; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Iontcheva I, 2004, INFECT IMMUN, V72, P2312, DOI 10.1128/IAI.72.4.2312-2320.2004; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jeon S, 2002, J BIOL CHEM, V277, P16576, DOI 10.1074/jbc.M110380200; KELSEY JL, 1993, EPIDEMIOL REV, V15, P36, DOI 10.1093/oxfordjournals.epirev.a036115; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Kraichely DM, 2000, ENDOCRINOLOGY, V141, P3534, DOI 10.1210/en.141.10.3534; Long XH, 2006, J BIOL CHEM, V281, P9607, DOI 10.1074/jbc.M510809200; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Meyers MJ, 2001, J MED CHEM, V44, P4230, DOI 10.1021/jm010254a; Oshiro N, 1998, J BIOL CHEM, V273, P34663, DOI 10.1074/jbc.273.52.34663; Pawlak G, 2001, CURR OPIN GENET DEV, V11, P41, DOI 10.1016/S0959-437X(00)00154-4; Platet N, 2004, CRIT REV ONCOL HEMAT, V51, P55, DOI 10.1016/j.critrevonc.2004.02.001; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; RICKETTS D, 1991, CANCER RES, V51, P1817; SARRIO D, 2006, BREAST CANC RES TREA; Simoncini T, 2003, EUR J ENDOCRINOL, V148, P281, DOI 10.1530/eje.0.1480281; Simoncini T, 2006, MOL ENDOCRINOL, V20, P1756, DOI 10.1210/me.2005-0259; Song J, 2005, CANCER LETT, V220, P57, DOI 10.1016/j.canlet.2004.04.024; Song RXD, 2002, MOL ENDOCRINOL, V16, P116, DOI 10.1210/me.16.1.116; Tsukita S, 1999, J BIOL CHEM, V274, P34507, DOI 10.1074/jbc.274.49.34507; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966	28	93	96	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2238	10.1371/journal.pone.0002238	http://dx.doi.org/10.1371/journal.pone.0002238			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493596	Green Submitted, Green Published, gold			2022-12-25	WOS:000262258700046
J	Peters, JH; Hilbrands, LB; Koenen, HJPM; Joosten, I				Peters, Jorieke H.; Hilbrands, Luuk B.; Koenen, Hans J. P. M.; Joosten, Irma			Ex Vivo Generation of Human Alloantigen-Specific Regulatory T Cells from CD4(pos)CD25(high) T Cells for Immunotherapy	PLOS ONE			English	Article								Background: Regulatory T cell (Treg) based immunotherapy is a potential treatment for several immune disorders. By now, this approach proved successful in preclinical animal transplantation and auto-immunity models. In these models the success of Treg based immunotherapy crucially depends on the antigen-specificity of the infused Treg population. For the human setting, information is lacking on how to generate Treg with direct antigen-specificity ex vivo to be used for immunotherapy. Methodology/Principal Findings: Here, we demonstrate that in as little as two stimulation cycles with HLA mismatched allogeneic stimulator cells and T cell growth factors a very high degree of alloantigen-specificity was reached in magnetic bead isolated human CD4(pos)CD25(high) Treg. Efficient increases in cell numbers were obtained. Primary allogeneic stimulation appeared a prerequisite in the generation of alloantigen-specific Treg, while secondary allogeneic or polyclonal stimulation with anti-CD3 plus anti-CD28 monoclonal antibodies enriched alloantigen-specificity and cell yield to a similar extent. Conclusions/Significance: The ex vivo expansion protocol that we describe will very likely increase the success of clinical Treg-based immunotherapy, and will help to induce tolerance to selected antigens, while minimizing general immune suppression. This approach is of particular interest for recipients of HLA mismatched transplants.	[Peters, Jorieke H.; Koenen, Hans J. P. M.; Joosten, Irma] Radboud Univ Nijmegen, Med Ctr, Dept Bloodtransfus & Transplantat Immunol, NL-6525 ED Nijmegen, Netherlands; [Hilbrands, Luuk B.] Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Nephrol, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Peters, JH (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Bloodtransfus & Transplantat Immunol, NL-6525 ED Nijmegen, Netherlands.	I.Joosten@abti.umcn.nl	Koenen, Hans J.P.M./A-2852-2014; Hilbrands, Luuk/B-4921-2011; Joosten, Irma/N-4418-2013	Hilbrands, Luuk/0000-0002-4935-9765; Joosten, Irma/0000-0003-2950-4977	Dutch Kidney Foundation [C05-2106]	Dutch Kidney Foundation	This study was supported by a grant of the Dutch Kidney Foundation (C05-2106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzali B, 2007, TISSUE ANTIGENS, V69, P545, DOI 10.1111/j.1399-0039.2007.00834.x; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Bushell A, 2005, J IMMUNOL, V174, P3290, DOI 10.4049/jimmunol.174.6.3290; Coenen JJA, 2007, TRANSPL IMMUNOL, V17, P237, DOI 10.1016/j.trim.2007.01.004; Cohen JL, 2002, J EXP MED, V196, P401, DOI 10.1084/jem.20020090; Earle KE, 2005, CLIN IMMUNOL, V115, P3, DOI 10.1016/j.clim.2005.02.017; Edinger M, 2003, NAT MED, V9, P1144, DOI 10.1038/nm915; Fu S, 2004, AM J TRANSPLANT, V4, P65, DOI 10.1046/j.1600-6143.2003.00293.x; Godfrey WR, 2004, BLOOD, V104, P453, DOI 10.1182/blood-2004-01-0151; GOLSHAYAN D, 2006, BLOOD; Hoffmann P, 2002, J EXP MED, V196, P389, DOI 10.1084/jem.20020399; Hoffmann P, 2006, BIOL BLOOD MARROW TR, V12, P267, DOI 10.1016/j.bbmt.2006.01.005; Hoffmann P, 2004, BLOOD, V104, P895, DOI 10.1182/blood-2004-01-0086; Jiang SP, 2003, BLOOD, V102, P2180, DOI 10.1182/blood-2003-04-1164; Jin LP, 2004, J IMMUNOL, V173, P3612, DOI 10.4049/jimmunol.173.6.3612; Joffre O, 2004, BLOOD, V103, P4216, DOI 10.1182/blood-2004-01-0005; Jones SC, 2003, BIOL BLOOD MARROW TR, V9, P243, DOI 10.1053/bbmt.2003.50027; Karakhanova S, 2006, J IMMUNOTHER, V29, P336, DOI 10.1097/01.cji.0000203080.43235.9e; Koenen HJPM, 2005, J IMMUNOL, V174, P7573, DOI 10.4049/jimmunol.174.12.7573; Koenen HJPM, 2003, J IMMUNOL, V171, P6431, DOI 10.4049/jimmunol.171.12.6431; Koh LP, 2007, BIOL BLOOD MARROW TR, V13, P1249, DOI 10.1016/j.bbmt.2007.08.003; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; KREIJVELD E, 2006, J IMMUNOL METHODS; Levings MK, 2001, J EXP MED, V193, P1295, DOI 10.1084/jem.193.11.1295; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Masteller EL, 2005, J IMMUNOL, V175, P3053, DOI 10.4049/jimmunol.175.5.3053; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Nishimura E, 2004, INT IMMUNOL, V16, P1189, DOI 10.1093/intimm/dxh122; Roncarolo MG, 2007, NAT REV IMMUNOL, V7, P585, DOI 10.1038/nri2138; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Shlomchik WD, 1999, SCIENCE, V285, P412, DOI 10.1126/science.285.5426.412; Taams LS, 2002, EUR J IMMUNOL, V32, P1621, DOI 10.1002/1521-4141(200206)32:6<1621::AID-IMMU1621>3.0.CO;2-Q; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Tarbell KV, 2004, J EXP MED, V199, P1467, DOI 10.1084/jem.20040180; Trenado A, 2003, J CLIN INVEST, V112, P1688, DOI 10.1172/JCI17702; WICHLAN DG, 2006, J IMMUNOL METHODS; Yamazaki S, 2006, P NATL ACAD SCI USA, V103, P2758, DOI 10.1073/pnas.0510606103	37	71	78	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2233	10.1371/journal.pone.0002233	http://dx.doi.org/10.1371/journal.pone.0002233			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493605	Green Submitted, gold, Green Published			2022-12-25	WOS:000262258700041
J	Dumon, C; Varvak, A; Wall, MA; Flint, JE; Lewis, RJ; Lakey, JH; Morland, C; Luginbuhl, P; Healey, S; Todaro, T; DeSantis, G; Sun, M; Parra-Gessert, L; Tan, XQ; Weiner, DP; Gilbert, HJ				Dumon, Claire; Varvak, Alexander; Wall, Mark A.; Flint, James E.; Lewis, Richard J.; Lakey, Jeremy H.; Morland, Carl; Luginbuhl, Peter; Healey, Shaun; Todaro, Thomas; DeSantis, Grace; Sun, May; Parra-Gessert, Lilian; Tan, Xuqiu; Weiner, David P.; Gilbert, Harry J.			Engineering hyperthermostability into a GH11 xylanase is mediated by subtle changes to protein structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRICHODERMA-REESEI; THERMOSTABILITY; STABILITY; EVOLUTION; ENDO-1,4-BETA-XYLANASE-II; STABILIZATION; RESIDUES; PHYTASE	Understanding the structural basis for protein thermostability is of considerable biological and biotechnological importance as exemplified by the industrial use of xylanases at elevated temperatures in the paper pulp and animal feed sectors. Here we have used directed protein evolution to generate hyperthermostable variants of a thermophilic GH11 xylanase, EvXyn11. The Gene Site Saturation Mutagenesis (TM) (GSSM) methodology employed assesses the influence on thermostability of all possible amino acid substitutions at each position in the primary structure of the target protein. The 15 most thermostable mutants, which generally clustered in the N-terminal region of the enzyme, had melting temperatures (T-m) 1-8 degrees C higher than the parent protein. Screening of a combinatorial library of the single mutants identified a hyperthermostable variant, EvXyn11(TS), containing seven mutations. EvXyn11TS had a T-m similar to 25 degrees C higher than the parent enzyme while displaying catalytic properties that were similar to EvXyn11. The crystal structures of EvXyn11 and EvXyn11TS revealed an absence of substantial changes to identifiable intramolecular interactions. The only explicable mutations are T13F, which increases hydrophobic interactions, and S9P that apparently locks the conformation of a surface loop. This report shows that the molecular basis for the increased thermostability is extraordinarily subtle and points to the requirement for new tools to interrogate protein folding at non-ambient temperatures.	[Varvak, Alexander; Wall, Mark A.; Luginbuhl, Peter; Healey, Shaun; Todaro, Thomas; DeSantis, Grace; Sun, May; Parra-Gessert, Lilian; Tan, Xuqiu; Weiner, David P.] Verenium Corp, San Diego, CA 92121 USA; [Dumon, Claire; Flint, James E.; Lewis, Richard J.; Lakey, Jeremy H.; Morland, Carl] Univ Newcastle, Inst Cell & Mol Biosci, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Weiner, DP (corresponding author), Verenium Corp, San Diego, CA 92121 USA.	david.weiner@verenium.com; h.j.gilbert@ncl.ac.uk	Claire, Dumon/AAI-2553-2021; Lewis, Richard J./E-8674-2013	Claire, Dumon/0000-0003-4925-7336; Flint, James/0000-0003-2923-7813; Lakey, Jeremy/0000-0003-4646-9085; lewis, richard/0000-0003-2641-8643; Lewis, Richard J./0000-0003-3470-923X				Adams MWW, 1998, TRENDS BIOTECHNOL, V16, P329, DOI 10.1016/S0167-7799(98)01193-7; Andrews SR, 2004, J BIOL CHEM, V279, P54369, DOI 10.1074/jbc.M409044200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beg QK, 2001, APPL MICROBIOL BIOT, V56, P326, DOI 10.1007/s002530100704; Charnock SJ, 1997, J BIOL CHEM, V272, P2942, DOI 10.1074/jbc.272.5.2942; Clarke JH, 2000, APPL MICROBIOL BIOT, V53, P661, DOI 10.1007/s002530000344; Demarest SJ, 2006, PROTEIN ENG DES SEL, V19, P325, DOI 10.1093/protein/gzl016; Eisenthal R, 2006, TRENDS BIOTECHNOL, V24, P289, DOI 10.1016/j.tibtech.2006.05.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVANS P, 1993, CCP4 DARESBURY STUDY, P114; Garrett JB, 2004, APPL ENVIRON MICROB, V70, P3041, DOI 10.1128/AEM.70.5.3041-3046.2004; Gray KA, 2001, ADV SYNTH CATAL, V343, P607, DOI 10.1002/1615-4169(200108)343:6/7<607::AID-ADSC607>3.3.CO;2-D; Hennig M, 1995, STRUCTURE, V3, P1295, DOI 10.1016/S0969-2126(01)00267-2; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Jaenicke R, 1998, CURR OPIN STRUC BIOL, V8, P738, DOI 10.1016/S0959-440X(98)80094-8; Jahn TR, 2006, NAT STRUCT MOL BIOL, V13, P195, DOI 10.1038/nsmb1058; Karshikoff A, 1998, PROTEIN ENG, V11, P867, DOI 10.1093/protein/11.10.867; Kawamura S, 1998, J BIOL CHEM, V273, P19982, DOI 10.1074/jbc.273.32.19982; Kretz KA, 2004, METHOD ENZYMOL, V388, P3; Kulkarni N, 1999, BIOCHEM BIOPH RES CO, V255, P274, DOI 10.1006/bbrc.1998.9912; Leslie A, 1992, NEWSLETTER PROTEIN C; Liu ZR, 2005, PHYS BIOL, V2, pS75, DOI 10.1088/1478-3975/2/4/S01; Miyazaki K, 2006, J BIOL CHEM, V281, P10236, DOI 10.1074/jbc.M511948200; Mozo-Villiarias A, 2006, CURR BIOINFORM, V1, P25, DOI 10.2174/157489306775330561; Mueller U, 2000, J MOL BIOL, V297, P975, DOI 10.1006/jmbi.2000.3602; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Palackal N, 2004, PROTEIN SCI, V13, P494, DOI 10.1110/ps.03333504; Perl D, 2000, NAT STRUCT BIOL, V7, P380; PFEIL W, 1976, BIOPHYS CHEM, V4, P41, DOI 10.1016/0301-4622(76)80005-1; PRIVALOV PL, 1974, J MOL BIOL, V86, P665, DOI 10.1016/0022-2836(74)90188-0; Razvi A, 2006, PROTEIN SCI, V15, P1569, DOI 10.1110/ps.062130306; Schiraldi C, 2002, TRENDS BIOTECHNOL, V20, P515, DOI 10.1016/S0167-7799(02)02073-5; SHORT JM, 2001, Patent No. 6280926; SHORT JM, 2003, Patent No. 6537776; Solbak AI, 2005, J BIOL CHEM, V280, P9431, DOI 10.1074/jbc.M411838200; SPASSOV VZ, 1994, PROTEIN SCI, V3, P1556, DOI 10.1002/pro.5560030921; Spurway TD, 1997, J BIOL CHEM, V272, P17523, DOI 10.1074/jbc.272.28.17523; TORRONEN A, 1994, EMBO J, V13, P2493, DOI 10.1002/j.1460-2075.1994.tb06536.x; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Xiao L, 1999, J MOL BIOL, V289, P1435, DOI 10.1006/jmbi.1999.2810; Xie HF, 2006, J MOL BIOL, V360, P157, DOI 10.1016/j.jmb.2006.05.002; Xiong HR, 2004, EXTREMOPHILES, V8, P393, DOI 10.1007/s00792-004-0400-9; Yang HM, 2007, J IND MICROBIOL BIOT, V34, P213, DOI 10.1007/s10295-006-0188-y; Zhang WM, 2007, APPL ENVIRON MICROB, V73, P3069, DOI 10.1128/AEM.02970-06	44	99	115	0	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22557	22564		10.1074/jbc.M800936200	http://dx.doi.org/10.1074/jbc.M800936200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18515360	hybrid			2022-12-25	WOS:000258321000024
J	Vanhoose, AM; Samaras, S; Artner, I; Henderson, E; Hang, Y; Stein, R				Vanhoose, Amanda M.; Samaras, Susan; Artner, Isabella; Henderson, Eva; Hang, Yan; Stein, Roland			MafA and MafB regulate Pdx1 transcription through the Area II control region in pancreatic beta cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN GENE-TRANSCRIPTION; NUCLEAR FACTOR 3-BETA; TISSUE-SPECIFIC EXPRESSION; SEGMENTATION GENE; ALPHA-CELLS; DIFFERENTIATION; GLUCOSE; SITES; PAX6; PHOSPHORYLATION	Pancreatic-duodenal homeobox factor-1 (Pdx1) is highly enriched in islet beta cells and integral to proper cell development and adult function. Of the four conserved 5'-flanking sequence blocks that contribute to transcription in vivo, Area II (mouse base pairs -2153/-1923) represents the only mammalian specific control domain. Here we demonstrate that regulation of beta-cell-enriched Pdx1 expression by the MafA and MafB transcription factors is exclusively through Area II. Thus, these factors were found to specifically activate through Area II in cell line transfection-based assays, and MafA, which is uniquely expressed in adult islet beta cells was only bound to this region in quantitative chromatin immuno-precipitation studies. MafA and MafB are produced in beta cells during development and were both bound to Area II at embryonic day 18.5. Expression of a transgene driven by Pdx1 Areas I and II was also severely compromised during insulin (+) cell formation in MafB (-)/(-)mice, consistent with the importance of this large Maf in beta-cell production and Pdx1 expression. These findings illustrate the significance of large Maf proteins to Pdx1 expression in beta cells, and in particular MafB during pancreatic development.	[Vanhoose, Amanda M.; Samaras, Susan; Artner, Isabella; Henderson, Eva; Hang, Yan; Stein, Roland] Vanderbilt Univ Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University	Stein, R (corresponding author), Vanderbilt Univ Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA.	Roland.Stein@Vanderbilt.edu		Artner, Isabella/0000-0002-2895-5664	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK042502, R56DK050203, R01DK050203, T32DK007563, P60DK020593] Funding Source: NIH RePORTER; NIDDK NIH HHS [5T32 DK07563-20, P60 DK20593, P01 DK42502, DK50203] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Artner I, 2006, DIABETES, V55, P297, DOI 10.2337/diabetes.55.02.06.db05-0946; Artner I, 2007, P NATL ACAD SCI USA, V104, P3853, DOI 10.1073/pnas.0700013104; Ashery-Padan R, 2004, DEV BIOL, V269, P479, DOI 10.1016/j.ydbio.2004.01.040; Blanchi B, 2003, NAT NEUROSCI, V6, P1091, DOI 10.1038/nn1129; CORDES SP, 1994, CELL, V79, P1025, DOI 10.1016/0092-8674(94)90033-7; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; Fujitani Y, 2006, GENE DEV, V20, P253, DOI 10.1101/gad.1360106; Gannon M, 2001, DEV BIOL, V238, P185, DOI 10.1006/dbio.2001.0359; Gannon M, 2008, DEV BIOL, V314, P406, DOI 10.1016/j.ydbio.2007.10.038; Gerrish K, 2004, MOL ENDOCRINOL, V18, P533, DOI 10.1210/me.2003-0371; Gerrish K, 2000, J BIOL CHEM, V275, P3485, DOI 10.1074/jbc.275.5.3485; Gerrish K, 2001, J BIOL CHEM, V276, P47775, DOI 10.1074/jbc.M109244200; GUZ Y, 1995, DEVELOPMENT, V121, P11; Han S, 2007, MOL CELL BIOL, V27, P6593, DOI 10.1128/MCB.01573-06; JACOBY DB, 1989, J BIOL CHEM, V264, P17623; Johnson JD, 2006, P NATL ACAD SCI USA, V103, P19575, DOI 10.1073/pnas.0604208103; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Keller DM, 2007, J BIOL CHEM, V282, P32084, DOI 10.1074/jbc.M700899200; KERPPOLA TK, 1994, ONCOGENE, V9, P675; Kim JI, 1999, P NATL ACAD SCI USA, V96, P3781, DOI 10.1073/pnas.96.7.3781; MacLean HE, 2003, DEV BIOL, V262, P51, DOI 10.1016/S0012-1606(03)00324-5; Matsuoka T, 2003, MOL CELL BIOL, V23, P6049, DOI 10.1128/MCB.23.17.6049-6062.2003; Matsuoka T, 2004, P NATL ACAD SCI USA, V101, P2930, DOI 10.1073/pnas.0306233101; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Megason SG, 2002, DEVELOPMENT, V129, P2087; Nishimura W, 2006, DEV BIOL, V293, P526, DOI 10.1016/j.ydbio.2006.02.028; NORDEEN SK, 1987, DNA-J MOLEC CELL BIO, V6, P173, DOI 10.1089/dna.1987.6.173; Offield MF, 1996, DEVELOPMENT, V122, P983; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; Olbrot M, 2002, P NATL ACAD SCI USA, V99, P6737, DOI 10.1073/pnas.102168499; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rawdon BB, 1998, MICROSC RES TECHNIQ, V43, P292, DOI 10.1002/(SICI)1097-0029(19981115)43:4<292::AID-JEMT3>3.0.CO;2-X; Ring BZ, 2000, DEVELOPMENT, V127, P307; Rocques N, 2007, MOL CELL, V28, P584, DOI 10.1016/j.molcel.2007.11.009; Sadl VS, 2003, DEV DYNAM, V227, P134, DOI 10.1002/dvdy.10279; Sadl VS, 2002, DEV BIOL, V249, P16, DOI 10.1006/dbio.2002.0751; Samaras SE, 2003, J BIOL CHEM, V278, P12263, DOI 10.1074/jbc.M210801200; Samaras SE, 2002, MOL CELL BIOL, V22, P4702, DOI 10.1128/MCB.22.13.4702-4713.2002; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; Van Velkinburgh JC, 2005, J BIOL CHEM, V280, P38438, DOI 10.1074/jbc.M508594200; Wiebe PO, 2007, MOL CELL BIOL, V27, P4093, DOI 10.1128/MCB.01978-06; Wu KL, 1997, MOL CELL BIOL, V17, P6002, DOI 10.1128/MCB.17.10.6002; Yoshida T, 2005, NUCLEIC ACIDS RES, V33, P3465, DOI 10.1093/nar/gki653; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005; Zhao L, 2000, J BIOL CHEM, V275, P10532, DOI 10.1074/jbc.275.14.10532	47	30	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22612	22619		10.1074/jbc.M802902200	http://dx.doi.org/10.1074/jbc.M802902200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18522939	hybrid, Green Published			2022-12-25	WOS:000258321000030
J	Gembardt, F; Heringer-Walther, S; van Esch, JHM; Sterner-Kock, A; van Veghel, R; Le, TH; Garrelds, IM; Coffman, TM; Danser, AHJ; Schultheiss, HP; Walther, T				Gembardt, Florian; Heringer-Walther, Silvia; van Esch, Joep H. M.; Sterner-Kock, Anja; van Veghel, Richard; Le, Thu H.; Garrelds, Ingrid M.; Coffman, Thomas M.; Danser, A. H. Jan; Schultheiss, Heinz-Peter; Walther, Thomas			Cardiovascular phenotype of mice lacking all three subtypes of angiotensin II receptors	FASEB JOURNAL			English	Article						hemodynamics; receptor genes; transgenic mice; transmembrane-spanning receptors	BLOOD-PRESSURE; AT(2) RECEPTOR; MESSENGER-RNA; AT(1) RECEPTORS; TYPE-2 RECEPTOR; DEFICIENT MICE; URINARY-TRACT; AT2 RECEPTOR; KIDNEY; EXPRESSION	Angiotensin II activates two distinct receptors, the angiotensin II receptors type 1 (AT1) and type 2 (AT2). In rodents, two AT1 subtypes were identified (AT1a and AT1b). To determine receptor-specific functions and possible angiotensin II effects independent of its three known receptors we generated mice deficient in either one of the angiotensin II receptors, in two, or in all three (triple knockouts). Triple knockouts were vital and fertile, but survival was impaired. Hypotension and renal histological abnormalities in triple knockouts were comparable to those in mice lacking both AT1 subtypes. All combinations lacking AT1a were distinguished by reduced heart rate. AT1a deletion impaired the in vivo pressor response to angiotensin II bolus injection, whereas deficiency for AT1b and/or AT2 had no effect. However, the additional lack of AT1b in AT1a-deficient mice further impaired the vasoconstrictive capacity of angiotensin II. Although general vasoconstrictor properties were not changed, angiotensin II failed to alter blood pressure in triple knockouts, indicating that there are no other receptors involved in direct angiotensin II pressor effects. Our data identify mice deficient in all three angiotensin II receptors as an ideal tool to better understand the structure and function of the renin-angiotensin system and to search for angiotensin II effects independent of AT1 and AT2.	[Gembardt, Florian; Heringer-Walther, Silvia; van Esch, Joep H. M.; van Veghel, Richard; Garrelds, Ingrid M.; Danser, A. H. Jan; Schultheiss, Heinz-Peter; Walther, Thomas] Charite, Dept Cardiol, Berlin, Germany; [Gembardt, Florian; Heringer-Walther, Silvia; van Esch, Joep H. M.; van Veghel, Richard; Garrelds, Ingrid M.; Danser, A. H. Jan; Schultheiss, Heinz-Peter; Walther, Thomas] Erasmus MC, Dept Pharmacol, Rotterdam, Netherlands; [Sterner-Kock, Anja] Free Univ Berlin, Inst Vet Pathol, D-1000 Berlin, Germany; [Le, Thu H.; Coffman, Thomas M.] Durham VA Med Ctr, Durham, NC USA; [Le, Thu H.; Coffman, Thomas M.] Duke Univ, Dept Med, Durham, NC USA; [Gembardt, Florian; Heringer-Walther, Silvia; Schultheiss, Heinz-Peter; Walther, Thomas] Univ Hull, Hull York Med Sch, Dept Biomed Sci, Kingston Upon Hull HU6 7RX, N Humberside, England	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Erasmus University Rotterdam; Erasmus MC; Free University of Berlin; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; University of Hull; University of York - UK	Walther, T (corresponding author), Univ Hull, Hull York Med Sch, Dept Biomed Sci, Wolfson Bldg,Cottingham Rd, Kingston Upon Hull HU6 7RX, N Humberside, England.	thomas.walther@hyms.ac.uk	Danser, Jan/GLR-1479-2022; Gembardt, Florian/H-2360-2011	Gembardt, Florian/0000-0003-2739-345X				AbdAlla S, 2001, J BIOL CHEM, V276, P39721, DOI 10.1074/jbc.M105253200; Alexiou T, 2005, J HYPERTENS, V23, P945, DOI 10.1097/01.hjh.0000166834.32817.41; Andresen BT, 2005, AM J PHYSIOL-RENAL, V288, pF763, DOI 10.1152/ajprenal.00323.2004; Batenburg WW, 2006, J HYPERTENS, V24, P1355, DOI 10.1097/01.hjh.0000234116.17778.63; BURSON JM, 1994, AM J PHYSIOL, V267, pE260, DOI 10.1152/ajpendo.1994.267.2.E260; Crowley SD, 2007, TRENDS CARDIOVAS MED, V17, P30, DOI 10.1016/j.tcm.2006.11.002; DANSER AHJ, 1994, HYPERTENSION, V24, P37, DOI 10.1161/01.HYP.24.1.37; Dendorfer A, 2005, HANDB EXP PHARM, V170, P407; Dendorfer A, 1998, BASIC RES CARDIOL, V93, P24; GASC JM, 1994, HYPERTENSION, V24, P531, DOI 10.1161/01.HYP.24.5.531; Gembardt F, 2005, PEPTIDES, V26, P1270, DOI 10.1016/j.peptides.2005.01.009; GRADY EF, 1991, J CLIN INVEST, V88, P921, DOI 10.1172/JCI115395; Gross V, 2000, KIDNEY INT, V57, P191, DOI 10.1046/j.1523-1755.2000.00820.x; ICHIKI T, 1995, NATURE, V377, P748, DOI 10.1038/377748a0; ITO M, 1995, P NATL ACAD SCI USA, V92, P3521, DOI 10.1073/pnas.92.8.3521; IWAI N, 1992, BIOCHEM BIOPH RES CO, V188, P298, DOI 10.1016/0006-291X(92)92384-A; Kihara M, 1998, KIDNEY INT, V53, P548, DOI 10.1046/j.1523-1755.1998.00801.x; Konstam MA, 2005, AM HEART J, V150, P123, DOI 10.1016/j.ahj.2004.10.035; KREGE JH, 1995, NATURE, V375, P146, DOI 10.1038/375146a0; Li Q, 1996, BRIT J PHARMACOL, V118, P1653, DOI 10.1111/j.1476-5381.1996.tb15588.x; McEwan PE, 2000, J CARDIOVASC PHARM, V36, pS144, DOI 10.1097/00005344-200036051-00045; Miyazaki Y, 2001, COMP BIOCHEM PHYS A, V128, P89, DOI 10.1016/S1095-6433(00)00299-3; Niimura F, 1995, J CLIN INVEST, V96, P2947, DOI 10.1172/JCI118366; Nishimura H, 1999, MOL CELL, V3, P1, DOI 10.1016/S1097-2765(00)80169-0; Oliverio MI, 1998, P NATL ACAD SCI USA, V95, P15496, DOI 10.1073/pnas.95.26.15496; Ouyang X, 2005, AM J PHYSIOL-RENAL, V289, pF902, DOI 10.1152/ajprenal.00141.2005; Reid JL, 2005, J RENIN-ANGIO-ALDO S, V6, P15, DOI 10.3317/jraas.2005.002; Schmieder RE, 2007, LANCET, V369, P1208, DOI 10.1016/S0140-6736(07)60242-6; SHANMUGAM S, 1995, KIDNEY INT, V47, P1095, DOI 10.1038/ki.1995.156; Siragy HM, 1999, P NATL ACAD SCI USA, V96, P6506, DOI 10.1073/pnas.96.11.6506; Steckelings UM, 2005, PEPTIDES, V26, P1401, DOI 10.1016/j.peptides.2005.03.010; TANIMOTO K, 1994, J BIOL CHEM, V269, P31334; TIMMERMANS PBMWM, 1993, PHARMACOL REV, V45, P205; Tokuyama H, 2007, NEPHRON PHYSIOL, V106, P54, DOI 10.1159/000103910; van Esch JHM, 2006, BRIT J PHARMACOL, V148, P452, DOI 10.1038/sj.bjp.0706762; von Bohlen und Halbach O, 2001, REGUL PEPTIDES, V99, P209, DOI 10.1016/S0167-0115(01)00258-0; Walther T, 2004, EUR J PHARMACOL, V493, P161, DOI 10.1016/j.ejphar.2004.04.032; Walther T, 2007, CIRCULATION, V115, P333, DOI 10.1161/CIRCULATIONAHA.106.643296; Zhai PY, 2005, J CLIN INVEST, V115, P3045, DOI 10.1172/JCI25330	39	37	38	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2008	22	8					3068	3077		10.1096/fj.08-108316	http://dx.doi.org/10.1096/fj.08-108316			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	332NI	18497303				2022-12-25	WOS:000258089300046
J	Piessevaux, J; De Ceuninck, L; Catteeuw, D; Peelman, F; Tavernier, J				Piessevaux, Julie; De Ceuninck, Leentje; Catteeuw, Dominiek; Peelman, Frank; Tavernier, Jan			Elongin B/C recruitment regulates substrate binding by CIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; TUMOR-SUPPRESSOR PROTEIN; GROWTH-HORMONE RECEPTOR; CHRONIC MYELOID-LEUKEMIA; INDUCIBLE SH2 PROTEIN; RNA-POLYMERASE-II; SOCS-BOX MOTIF; LEPTIN RECEPTOR; STAT5 ACTIVATION; ERYTHROPOIETIN RECEPTOR	SOCS proteins play a major role in the regulation of cytokine signaling. They are recruited to activated receptors and can suppress signaling by different mechanisms including targeting of the receptor complex for proteasomal degradation. The activity of SOCS proteins is regulated at different levels including transcriptional control and posttranslational modification. We describe here a novel regulatory mechanism for CIS, one of the members of this protein family. A CIS mutant deficient in recruitment of the Elongin B/C complex completely failed to suppress STAT5 activation. This deficiency was not caused by altered turnover of CIS but by loss of cytokine receptor interaction. Intriguingly, no such effect was seen for binding to MyD88. The interaction between CIS and the Elongin B/C complex, which depends on the levels of uncomplexed Elongin B/C, was easily disrupted. This regulatory mechanism may be unique for CIS, as similar mutations in SOCS1, -2, -3, -6, and -7 had no functional impact. Our findings indicate that the SOCS box not only plays a role in the formation of E3 ligase complexes but, at least for CIS, can also regulate the binding modus of SOCS box-containing proteins.	VIB, Flanders Inst Biotechnol, Dept Med Prot Res, B-9000 Ghent, Belgium; Univ Ghent, Fac Med & Hlth Sci, Dept Biochem, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University	Tavernier, J (corresponding author), VIB, Flanders Inst Biotechnol, Dept Med Prot Res, A Baertsoenkaai 3, B-9000 Ghent, Belgium.	Jan.Tavernier@Ugent.be	Tavernier, Jan/AAG-3636-2019					Aman MJ, 1999, J BIOL CHEM, V274, P30266, DOI 10.1074/jbc.274.42.30266; Aso T, 1996, EMBO J, V15, P5557, DOI 10.1002/j.1460-2075.1996.tb00940.x; ASO T, 1995, SCIENCE, V269, P1439, DOI 10.1126/science.7660129; Bjorbaek C, 2000, J BIOL CHEM, V275, P40649, DOI 10.1074/jbc.M007577200; Botuyan MV, 1999, P NATL ACAD SCI USA, V96, P9033, DOI 10.1073/pnas.96.16.9033; Bradshaw JM, 1999, J MOL BIOL, V293, P971, DOI 10.1006/jmbi.1999.3190; BRADSHER JN, 1993, J BIOL CHEM, V268, P25587; Bullock AN, 2007, STRUCTURE, V15, P1493, DOI 10.1016/j.str.2007.09.016; Bullock AN, 2006, P NATL ACAD SCI USA, V103, P7637, DOI 10.1073/pnas.0601638103; Chen XP, 2002, P NATL ACAD SCI USA, V99, P2175, DOI 10.1073/pnas.042035699; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; DUAN DR, 1995, SCIENCE, V269, P1402, DOI 10.1126/science.7660122; DUAN DR, 1995, P NATL ACAD SCI USA, V92, P6459, DOI 10.1073/pnas.92.14.6459; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Evans MK, 2007, ONCOGENE, V26, P1941, DOI 10.1038/sj.onc.1209993; Eyckerman S, 2001, NAT CELL BIOL, V3, P1114, DOI 10.1038/ncb1201-1114; Eyckerman S, 2000, FEBS LETT, V486, P33, DOI 10.1016/S0014-5793(00)02205-5; Eyckerman S, 1999, EUR CYTOKINE NETW, V10, P549; Feldman DE, 1999, MOL CELL, V4, P1051, DOI 10.1016/S1097-2765(00)80233-6; Haan S, 2003, J BIOL CHEM, V278, P31972, DOI 10.1074/jbc.M303170200; Hanada T, 2001, J BIOL CHEM, V276, P40746, DOI 10.1074/jbc.M106139200; Hansen LH, 1996, J BIOL CHEM, V271, P12669, DOI 10.1074/jbc.271.21.12669; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; Hookham MB, 2007, BLOOD, V109, P4924, DOI 10.1182/blood-2006-08-039735; Johnston JA, 2004, J LEUKOCYTE BIOL, V75, P743, DOI 10.1189/jlb.1003507; Kamizono S, 2001, J BIOL CHEM, V276, P12530, DOI 10.1074/jbc.M010074200; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kamura T, 1998, GENE DEV, V12, P3872, DOI 10.1101/gad.12.24.3872; Kamura T, 2001, J BIOL CHEM, V276, P29748, DOI 10.1074/jbc.M103093200; Ketteler R, 2003, J BIOL CHEM, V278, P2654, DOI 10.1074/jbc.M211236200; KIBEL A, 1995, SCIENCE, V269, P1444, DOI 10.1126/science.7660130; Kile BT, 2002, TRENDS BIOCHEM SCI, V27, P235, DOI 10.1016/S0968-0004(02)02085-6; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; Landsman T, 2005, J BIOL CHEM, V280, P37471, DOI 10.1074/jbc.M504125200; Lavens D, 2007, BIOCHEM J, V401, P257, DOI 10.1042/BJ20060242; Lavens D, 2006, J CELL SCI, V119, P2214, DOI 10.1242/jcs.02947; Li SL, 2000, J EXP MED, V191, P985, DOI 10.1084/jem.191.6.985; Li Z, 2004, J INVEST DERMATOL, V123, P737, DOI 10.1111/j.0022-202X.2004.23408.x; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; Lonergan KM, 1998, MOL CELL BIOL, V18, P732, DOI 10.1128/MCB.18.2.732; LORENZEN JA, 1995, J CELL BIOL, V131, P631, DOI 10.1083/jcb.131.3.631; Lund IK, 2005, J MOL ENDOCRINOL, V34, P339, DOI 10.1677/jme.1.01694; Matsumoto A, 1999, MOL CELL BIOL, V19, P6396; Matsumoto A, 1997, BLOOD, V89, P3148, DOI 10.1182/blood.V89.9.3148; Melville MW, 2003, MOL CELL BIOL, V23, P3141, DOI 10.1128/MCB.23.9.3141-3151.2003; Montoye T, 2005, BLOOD, V105, P4264, DOI 10.1182/blood-2004-07-2733; Myers MP, 2001, J BIOL CHEM, V276, P47771, DOI 10.1074/jbc.C100583200; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Narazaki M, 1998, P NATL ACAD SCI USA, V95, P13130, DOI 10.1073/pnas.95.22.13130; Nicholson SE, 1999, EMBO J, V18, P375, DOI 10.1093/emboj/18.2.375; Piessevaux J, 2006, J BIOL CHEM, V281, P32953, DOI 10.1074/jbc.M600776200; Porkka K, 2002, LAB INVEST, V82, P629, DOI 10.1038/labinvest.3780457; Raccurt M, 2003, BRIT J CANCER, V89, P524, DOI 10.1038/sj.bjc.6601115; Rakesh K, 2005, BIOCHEM PHARMACOL, V70, P649, DOI 10.1016/j.bcp.2005.04.042; Ram PA, 1999, J BIOL CHEM, V274, P35553, DOI 10.1074/jbc.274.50.35553; Ram PK, 2000, J BIOL CHEM, V275, P39487, DOI 10.1074/jbc.M004755200; Rose KM, 2004, TRENDS MOL MED, V10, P291, DOI 10.1016/j.molmed.2004.04.008; Schultheis B, 2002, BLOOD, V99, P1766, DOI 10.1182/blood.V99.5.1766; Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Tannahill GM, 2005, MOL CELL BIOL, V25, P9115, DOI 10.1128/MCB.25.20.9115-9126.2005; Tavernier J, 2002, CLIN EXP ALLERGY, V32, P1397, DOI 10.1046/j.1365-2745.2002.01520.x; ten Hoeve J, 2002, MOL CELL BIOL, V22, P5662, DOI 10.1128/MCB.22.16.5662-5668.2002; Uyttendaele I, 2007, MOL ENDOCRINOL, V21, P2821, DOI 10.1210/me.2006-0541; van de Geijn GJM, 2004, BLOOD, V104, P667, DOI 10.1182/blood-2003-08-2913; Verdier F, 1998, J BIOL CHEM, V273, P28185, DOI 10.1074/jbc.273.43.28185; Wood TJJ, 1997, MOL CELL ENDOCRINOL, V130, P69, DOI 10.1016/S0303-7207(97)00075-0; Wu KL, 2007, AM J PHYSIOL-RENAL, V293, pF1836, DOI 10.1152/ajprenal.00096.2007; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; YOSHIMURA A, 1995, EMBO J, V14, P2816, DOI 10.1002/j.1460-2075.1995.tb07281.x; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071; Zheng C, 2006, LEUKEMIA, V20, P1028, DOI 10.1038/sj.leu.2404227	74	18	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21334	21346		10.1074/jbc.M803742200	http://dx.doi.org/10.1074/jbc.M803742200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18508766	hybrid			2022-12-25	WOS:000257898800005
J	Daniel, CJ; Conti, B; Johnson, AE; Skach, WR				Daniel, Colin J.; Conti, Brian; Johnson, Arthur E.; Skach, William R.			Control of translocation through the Sec61 translocon by nascent polypeptide structure within the ribosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; SIGNAL RECOGNITION PARTICLE; PREPRO-ALPHA-FACTOR; ER MEMBRANE; PROTEIN INTEGRATION; SECRETORY PROTEINS; EXIT TUNNEL; COTRANSLATIONAL INTEGRATION; TRANSMEMBRANE SEGMENTS; MOLECULAR-MECHANISMS	During polytopic protein biogenesis, multiple transmembrane segments (TMs) must pass through the ribosome exit tunnel and into the Sec61 translocon prior to insertion into the endoplasmic reticulum membrane. To investigate how movement of a newly synthesized TM along this integration pathway might be influenced by synthesis of a second TM, we used photocross-linking probes to detect the proximity of ribosome-bound nascent polypeptides to Sec61 alpha. Probes were inserted at sequential sites within TM2 of the aquaporin-1 water channel by in vitro translation of truncated mRNAs. TM2 first contacted Sec61 alpha when the probe was positioned similar to 38 residues from the ribosome peptidyltransferase center, and TM2-Sec61 alpha photo-adducts decreased markedly when the probe was > 80 residues from the peptidyltransferase center. Unexpectedly, as nascent chain length was gradually extended, photocross-linking at multiple sites within TM2 abruptly and transiently decreased, indicating that TM2 initially entered, withdrew, and then re-entered Sec61 alpha. This brief reduction in TM2 photocross-linking coincided with TM3 synthesis. Replacement of TM3 with a secretory reporter domain or introduction of proline residues into TM3 changed the TM2 cross-linking profile and this biphasic behavior. These findings demonstrate that the primary and likely secondary structure of the nascent polypeptide within the ribosome exit tunnel can influence the timing with which topogenic determinants contact, enter, and pass through the translocon.	[Daniel, Colin J.; Conti, Brian; Skach, William R.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Johnson, Arthur E.] Texas A&M Univ, Syst Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77843 USA; [Johnson, Arthur E.] Texas A&M Univ, Syst Hlth Sci Ctr, Dept Chem, College Stn, TX 77843 USA; [Johnson, Arthur E.] Texas A&M Univ, Syst Hlth Sci Ctr, Dept Biochem & Biophys, College Stn, TX 77843 USA	Oregon Health & Science University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Skach, WR (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, L-224,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	skachw@ohsu.edu	Johnson, Arthur E/G-3457-2012		NHLBI NIH HHS [T32 HL083808] Funding Source: Medline; NIDDK NIH HHS [DK 51818] Funding Source: Medline; NIGMS NIH HHS [GM 26494, GM 53457] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053457, R01GM026494] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agre P, 2002, J PHYSIOL-LONDON, V542, P3, DOI 10.1113/jphysiol.2002.020818; Alder NN, 2005, J CELL BIOL, V168, P389, DOI 10.1083/jcb.200409174; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; Belin D, 1996, EMBO J, V15, P468, DOI 10.1002/j.1460-2075.1996.tb00379.x; Buck TM, 2007, NAT STRUCT MOL BIOL, V14, P762, DOI 10.1038/nsmb1275; Buck TM, 2005, J BIOL CHEM, V280, P261, DOI 10.1074/jbc.M409920200; Cannon KS, 2005, J CELL BIOL, V169, P219, DOI 10.1083/jcb.200412019; CROWLEY KS, 1993, CELL, V73, P1101, DOI 10.1016/0092-8674(93)90640-C; CROWLEY KS, 1994, CELL, V78, P461, DOI 10.1016/0092-8674(94)90424-3; Denzer AJ, 1995, EMBO J, V14, P6311, DOI 10.1002/j.1460-2075.1995.tb00321.x; Do H, 1996, CELL, V85, P369, DOI 10.1016/S0092-8674(00)81115-0; Foster W, 2000, J BIOL CHEM, V275, P34157, DOI 10.1074/jbc.M000165200; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Goder V, 1999, J CELL BIOL, V147, P257, DOI 10.1083/jcb.147.2.257; Haigh NG, 2002, J CELL BIOL, V156, P261, DOI 10.1083/jcb.200110074; Hamman BD, 1998, CELL, V92, P747, DOI 10.1016/S0092-8674(00)81403-8; Heinrich SU, 2003, EMBO J, V22, P3654, DOI 10.1093/emboj/cdg346; Helenius Ari, 1992, Trends in Cell Biology, V2, P227, DOI 10.1016/0962-8924(92)90309-B; HO NS, 1989, GENE, V77, P51; HOFFMAN KE, 1988, J BIOL CHEM, V263, P4381; Ismail N, 2006, J CELL SCI, V119, P2826, DOI 10.1242/jcs.03018; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; KOWARIK M, 2003, MOL CELL, V10, P735; Kramer G, 2001, INT J BIOCHEM CELL B, V33, P541, DOI 10.1016/S1357-2725(01)00044-9; KRIEG UC, 1986, P NATL ACAD SCI USA, V83, P8604, DOI 10.1073/pnas.83.22.8604; KRIEG UC, 1989, J CELL BIOL, V109, P2033, DOI 10.1083/jcb.109.5.2033; Liao SR, 1997, CELL, V90, P31, DOI 10.1016/S0092-8674(00)80311-6; Lu JL, 2005, NAT STRUCT MOL BIOL, V12, P1123, DOI 10.1038/nsmb1021; Lu JL, 2005, BIOCHEMISTRY-US, V44, P8230, DOI 10.1021/bi050372q; Lu Y, 2000, MOL BIOL CELL, V11, P2973, DOI 10.1091/mbc.11.9.2973; Lu Y, 1998, J BIOL CHEM, V273, P568, DOI 10.1074/jbc.273.1.568; MATLACK KES, 1995, J BIOL CHEM, V270, P6170, DOI 10.1074/jbc.270.11.6170; Matlack KES, 1999, CELL, V97, P553, DOI 10.1016/S0092-8674(00)80767-9; McCormick PJ, 2003, MOL CELL, V12, P329, DOI 10.1016/S1097-2765(03)00304-6; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Menetret JF, 2005, J MOL BIOL, V348, P445, DOI 10.1016/j.jmb.2005.02.053; Mingarro I, 2000, BMC Cell Biol, V1, P3, DOI 10.1186/1471-2121-1-3; Morgan DG, 2002, J MOL BIOL, V324, P871, DOI 10.1016/S0022-2836(02)01111-7; MOTHES W, 1994, EMBO J, V13, P3973, DOI 10.1002/j.1460-2075.1994.tb06713.x; OBERDORF J, 2002, METHODS MOL MED CYST, P70; OOI CE, 1992, CELL, V71, P87, DOI 10.1016/0092-8674(92)90268-H; PERARA E, 1986, SCIENCE, V232, P348, DOI 10.1126/science.3961485; PICKING W, 1992, BIOCHEMISTRY-US, V331, P2368; Pitonzo D, 2006, BBA-BIOMEMBRANES, V1758, P976, DOI 10.1016/j.bbamem.2006.04.021; Plath K, 2004, MOL BIOL CELL, V15, P1, DOI 10.1091/mbc.E03-06-0390; Rapoport TA, 2004, TRENDS CELL BIOL, V14, P568, DOI 10.1016/j.tcb.2004.09.002; Sadlish H, 2005, NAT STRUCT MOL BIOL, V12, P870, DOI 10.1038/nsmb994; Saksena S, 2004, P NATL ACAD SCI USA, V101, P12537, DOI 10.1073/pnas.0404934101; Schnell DJ, 2003, CELL, V112, P491, DOI 10.1016/S0092-8674(03)00110-7; SIMON SM, 1992, P NATL ACAD SCI USA, V89, P3770, DOI 10.1073/pnas.89.9.3770; SKACH WR, 1994, J CELL BIOL, V125, P803, DOI 10.1083/jcb.125.4.803; Song WQ, 2000, CELL, V100, P333, DOI 10.1016/S0092-8674(00)80669-8; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Tsalkova T, 1998, J MOL BIOL, V278, P713, DOI 10.1006/jmbi.1998.1721; Voss NR, 2006, J MOL BIOL, V360, P893, DOI 10.1016/j.jmb.2006.05.023; Whitley P, 1996, J BIOL CHEM, V271, P6241, DOI 10.1074/jbc.271.11.6241; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; Woolhead CA, 2006, MOL CELL, V22, P587, DOI 10.1016/j.molcel.2006.05.021; Ziv G, 2005, P NATL ACAD SCI USA, V102, P18956, DOI 10.1073/pnas.0508234102	62	28	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20864	20873		10.1074/jbc.M803517200	http://dx.doi.org/10.1074/jbc.M803517200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18480044	Green Published, hybrid			2022-12-25	WOS:000257746100029
J	Mauri, F; McNamee, LM; Lunardi, A; Chiacchiera, F; Del Sal, G; Brodsky, MH; Collavin, L				Mauri, Federico; McNamee, Laura M.; Lunardi, Andrea; Chiacchiera, Fulvio; Del Sal, Giannino; Brodsky, Michael H.; Collavin, Licio			Modification of Drosophila p53 by SUMO modulates its transactivation and pro-apoptotic functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COVALENT MODIFICATION; NUCLEAR-BODIES; DNA-DAMAGE; C-JUN; PROTEIN; STABILITY; UBIQUITIN; MELANOGASTER; CONJUGATION; DAXX	Conjugation to SUMO is a reversible post-translational modification that regulates several transcription factors involved in cell proliferation, differentiation, and disease. The p53 tumor suppressor can be modified by SUMO-1 in mammalian cells, but the functional consequences of this modification are unclear. Here, we demonstrate that the Drosophila homolog of human p53 can be efficiently sumoylated in insect cells. We identify two lysine residues involved in SUMO attachment, one at the C terminus, between the DNA binding and oligomerization domains, and one at the N terminus of the protein. We find that sumoylation helps recruit Drosophila p53 to nuclear dot-like structures that can be marked by human PML and the Drosophila homologue of Daxx. We demonstrate that mutation of both sumoylation sites dramatically reduces the transcriptional activity of p53 and its ability to induce apoptosis in transgenic flies, providing in vivo evidence that sumoylation is critical for Drosophila p53 function.	[Mauri, Federico; Lunardi, Andrea; Chiacchiera, Fulvio; Del Sal, Giannino; Collavin, Licio] LNCIB, AREA Sci Pk, I-34012 Trieste, Italy; [Lunardi, Andrea; Chiacchiera, Fulvio; Del Sal, Giannino; Collavin, Licio] Univ Trieste, Dipartimento Biochim Biofis & Chim Macromol, I-34129 Trieste, Italy; [McNamee, Laura M.; Brodsky, Michael H.] Univ Massachusetts, Sch Med, Program Gene Funct, Worcester, MA 01605 USA; [McNamee, Laura M.; Brodsky, Michael H.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Trieste; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Collavin, L (corresponding author), LNCIB, AREA Sci Pk, Padriciano 99, I-34012 Trieste, Italy.	collavin@lncib.it	Collavin, Licio/A-5312-2010; Chiacchiera, Fulvio/ABD-6137-2020; Chiacchiera, Fulvio/K-6740-2016	Collavin, Licio/0000-0001-6815-5381; Chiacchiera, Fulvio/0000-0003-3830-2090; DEL SAL, GIANNINO/0000-0003-2185-6003	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Akdemir F, 2007, ONCOGENE, V26, P5184, DOI 10.1038/sj.onc.1210328; Bodai L, 2007, J BIOL CHEM, V282, P36386, DOI 10.1074/jbc.M705547200; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Brodsky MH, 2004, MOL CELL BIOL, V24, P1219, DOI 10.1128/MCB.24.3.1219-1231.2004; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; Feng LJ, 2005, MOL CELL BIOL, V25, P5389, DOI 10.1128/MCB.25.13.5389-5395.2005; Fogal V, 2000, EMBO J, V19, P6185, DOI 10.1093/emboj/19.22.6185; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Ghioni P, 2005, CELL CYCLE, V4, P183, DOI 10.4161/cc.4.1.1359; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Gostissa M, 2003, CURR OPIN CELL BIOL, V15, P351, DOI 10.1016/S0955-0674(03)00038-3; Gostissa M, 1999, EMBO J, V18, P6462, DOI 10.1093/emboj/18.22.6462; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; Huang YP, 2004, CELL CYCLE, V3, P1587, DOI 10.4161/cc.3.12.1290; Jakobs A, 2007, NAT METHODS, V4, P245, DOI 10.1038/NMETH1006; Jin SK, 2000, P NATL ACAD SCI USA, V97, P7301, DOI 10.1073/pnas.97.13.7301; Krummel KA, 2005, P NATL ACAD SCI USA, V102, P10188, DOI 10.1073/pnas.0503068102; Kwek SSS, 2001, ONCOGENE, V20, P2587, DOI 10.1038/sj.onc.1204362; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Lee JH, 2003, FEBS LETT, V550, P5, DOI 10.1016/S0014-5793(03)00771-3; Lehembre F, 2000, MOL CELL BIOL, V20, P1072, DOI 10.1128/MCB.20.3.1072-1082.2000; Li TW, 2006, J BIOL CHEM, V281, P36221, DOI 10.1074/jbc.M608236200; Long XM, 2000, J BIOL CHEM, V275, P40765, DOI 10.1074/jbc.M003949200; Megidish T, 2002, J BIOL CHEM, V277, P8255, DOI 10.1074/jbc.C200001200; Melchior F, 2002, CELL CYCLE, V1, P243, DOI 10.4161/cc.1.4.131; Michaelson JS, 2000, APOPTOSIS, V5, P217, DOI 10.1023/A:1009696227420; Minty A, 2000, J BIOL CHEM, V275, P36316, DOI 10.1074/jbc.M004293200; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Muller S, 2004, ONCOGENE, V23, P1998, DOI 10.1038/sj.onc.1207415; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Oikemus SR, 2004, GENE DEV, V18, P1850, DOI 10.1101/gad.1202504; Ollmann M, 2000, CELL, V101, P91, DOI 10.1016/S0092-8674(00)80626-1; Ou HD, 2007, EMBO J, V26, P3463, DOI 10.1038/sj.emboj.7601764; Peters M, 2002, P NATL ACAD SCI USA, V99, P11305, DOI 10.1073/pnas.172382899; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Salomoni P, 2006, TRENDS CELL BIOL, V16, P97, DOI 10.1016/j.tcb.2005.12.002; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Sogame N, 2003, P NATL ACAD SCI USA, V100, P4696, DOI 10.1073/pnas.0736384100; Stanyon CA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r96; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Watson IR, 2006, NEOPLASIA, V8, P655, DOI 10.1593/neo.06439	46	32	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20848	20856		10.1074/jbc.M710186200	http://dx.doi.org/10.1074/jbc.M710186200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18492669	Green Published, hybrid			2022-12-25	WOS:000257746100027
J	DeHaven, WI; Smyth, JT; Boyles, RR; Bird, GS; Putney, JW				DeHaven, Wayne I.; Smyth, Jeremy T.; Boyles, Rebecca R.; Bird, Gary S.; Putney, James W., Jr.			Complex actions of 2-aminoethyldiphenyl borate on store-operated calcium entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL TRISPHOSPHATE RECEPTOR; ACTIVATED CA2+ CHANNELS; EMBRYONIC KIDNEY-CELLS; PLASMA-MEMBRANE; CRAC CHANNEL; 2-AMINOETHOXYDIPHENYL BORATE; PHOSPHOLIPASE-C; STIM1; ORAI1; SENSOR	Store-operated Ca2+ entry (SOCE) is likely the most common mode of regulated influx of Ca2+ into cells. However, only a limited number of pharmacological agents have been shown to modulate this process. 2-Aminoethyldiphenyl borate (2-APB) is a widely used experimental tool that activates and then inhibits SOCE and the underlying calcium release-activated Ca2+ current (I-CRAC). The mechanism by which depleted stores activates SOCE involves complex cellular movements of an endoplasmic reticulum Ca2+ sensor, STIM1, which redistributes to puncta near the plasma membrane and, in some manner, activates plasma membrane channels comprising Orai1, -2, and -3 subunits. We show here that 2-APB blocks puncta formation of fluorescently tagged STIM1 in HEK293 cells. Accordingly, 2-APB also inhibited SOCE and I-CRAC-like currents in cells co-expressing STIM1 with the CRAC channel subunit, Orai1, with similar potency. However, 2-APB inhibited STIM1 puncta formation less well in cells co-expressing Orai1, indicating that the inhibitory effects of 2-APB are not solely dependent upon STIM1 reversal. Further, 2-APB only partially inhibited SOCE and current in cells co-expressing STIM1 and Orai2 and activated sustained currents in HEK293 cells expressing Orai3 and STIM1. Interestingly, the Orai3-dependent currents activated by 2-APB showed large outward currents at potentials greater than +50 mV. Finally, Orai3, and to a lesser extent Orai1, could be directly activated by 2-APB, independently of internal Ca2+ stores and STIM1. These data reveal novel and complex actions of 2-APB effects on SOCE that can be attributed to effects on both STIM1 as well as Orai channel subunits.	[DeHaven, Wayne I.; Smyth, Jeremy T.; Boyles, Rebecca R.; Bird, Gary S.; Putney, James W., Jr.] NIEHS, Lab Signal Transduct, Natl Inst Hlth, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Putney, JW (corresponding author), NIEHS, Lab Signal Transduct, Natl Inst Hlth, Dept Hlth & Human Serv, POB 12233, Res Triangle Pk, NC 27709 USA.	putney@niehs.nih.gov	Putney, James W/F-7247-2019; Bird, Gary/AAI-8186-2021	Putney, James W/0000-0002-3379-4789; Bird, Gary/0000-0003-1389-8748; Boyles, Rebecca/0000-0003-0073-6854	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES090087, Z01ES102485, ZIAES090087, ZIAES102485] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Bakowski D, 2001, J PHYSIOL-LONDON, V532, P55, DOI 10.1111/j.1469-7793.2001.0055g.x; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Bird GS, 2005, J PHYSIOL-LONDON, V562, P697, DOI 10.1113/jphysiol.2004.077289; Braun FJ, 2001, J BIOL CHEM, V276, P1063, DOI 10.1074/jbc.M008348200; Broad LM, 1999, J PHYSIOL-LONDON, V517, P121, DOI 10.1111/j.1469-7793.1999.0121z.x; Broad LM, 2001, J BIOL CHEM, V276, P15945, DOI 10.1074/jbc.M011571200; DeHaven WI, 2007, J BIOL CHEM, V282, P17548, DOI 10.1074/jbc.M611374200; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Iwasaki H, 2001, RECEPTOR CHANNEL, V7, P429; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; Ma HT, 2002, J BIOL CHEM, V277, P6915, DOI 10.1074/jbc.M107755200; Ma HT, 2001, J BIOL CHEM, V276, P18888, DOI 10.1074/jbc.M100944200; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; PEINELT C, 2008, J PHYSL IN PRESS; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Putney JW, 2007, J CELL SCI, V120, P1959, DOI 10.1242/jcs.03462; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Smyth JT, 2008, J CELL SCI, V121, P762, DOI 10.1242/jcs.023903; Smyth JT, 2007, J CELL SCI, V120, P3762, DOI 10.1242/jcs.015735; Smyth JT, 2006, BBA-MOL CELL RES, V1763, P1147, DOI 10.1016/j.bbamcr.2006.08.050; Smyth JT, 2006, J BIOL CHEM, V281, P11712, DOI 10.1074/jbc.M510541200; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Wedel B, 2007, J PHYSIOL-LONDON, V579, P679, DOI 10.1113/jphysiol.2006.125641; Xu PY, 2006, BIOCHEM BIOPH RES CO, V350, P969, DOI 10.1016/j.bbrc.2006.09.134; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	38	202	204	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19265	19273		10.1074/jbc.M801535200	http://dx.doi.org/10.1074/jbc.M801535200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18487204	Green Published, hybrid			2022-12-25	WOS:000257387600012
J	Grenegard, M; Vretenbrant-Oberg, K; Nylander, M; Desilets, S; Lindstrom, EG; Larsson, A; Ramstrom, I; Ramstrom, S; Lindahl, TL				Grenegard, Magnus; Vretenbrant-Oberg, Karin; Nylander, Martina; Desilets, Stephanie; Lindstrom, Eva G.; Larsson, Anders; Ramstrom, Ida; Ramstrom, Sofia; Lindahl, Tomas L.			The ATP-gated P2X(1) receptor plays a pivotal role in activation of aspirin-treated platelets by thrombin and epinephrine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AKT ACTIVATION; AGGREGATION; PAR4; STIMULATION; ADRENALINE; GENERATION; FIBRINOGEN; SECRETION; KINETICS; PROTEIN	Human platelets express protease-activated receptor 1 (PAR1) and PAR4 but limited data indicate for differences in signal transduction. We studied the involvement of PAR1 and PAR4 in the cross-talk between thrombin and epinephrine. The results show that epinephrine acted via alpha(2A)-adrenergic receptors to provoke aggregation, secretion, and Ca2+ mobilization in aspirin-treated platelets pre-stimulated with subthreshold concentrations of thrombin. Incubating platelets with antibodies against PAR4 or the PAR4-specific inhibitor pepducin P4pal-i1 abolished the aggregation. Furthermore, platelets pre-exposed to the PAR4-activating peptide AYPGKF, but not to the PAR1-activating peptide SFLLRN, were aggregated by epinephrine, whereas both AYPGKF and SFLLRN synergized with epinephrine in the absence of aspirin. The roles of released ATP and ADP were elucidated by using antagonists of the purinergic receptors P2X(1), P2Y(1), and P2Y(12) (i.e. NF449, MRS2159, MRS2179, and cangrelor). Intriguingly, ATP, but not ADP, was required for the epinephrine/thrombin-induced aggregation. In Western blot analysis, a low concentration of AYPGKF, but not SFLLRN, stimulated phosphorylation of Akt on serine 473. Moreover, the phosphatidyl inositide 3-kinase inhibitor LY294002 antagonized the effect of epinephrine combined with thrombin or AYPGKF. Thus, in aspirin-treated platelets, PAR4, but not PAR1, interacts synergistically with alpha(2A)-adrenergic receptors, and the PI3-kinase/Akt pathway is involved in this cross-talk. Furthermore, in PAR4-pretreated platelets, epinephrine caused dense granule secretion, and subsequent signaling from the ATP-gated P2X(1)-receptor and the alpha(2A)-adrenergic receptor induced aggregation. These results suggest a new mechanism that has ATP as a key element and circumvents the action of aspirin on epinephrine-facilitated PAR4-mediated platelet activation.	[Grenegard, Magnus; Desilets, Stephanie; Lindstrom, Eva G.; Ramstrom, Ida] Cardiovasc Inflammat Res Ctr, Div Drug Res, Dept Med & Hlth, SE-58185 Linkoping, Sweden; [Vretenbrant-Oberg, Karin; Nylander, Martina; Ramstrom, Sofia; Lindahl, Tomas L.] Cardiovasc Inflammat Res Ctr, Div Clin Chem, Dept Clin & Expt Med, SE-58185 Linkoping, Sweden; [Larsson, Anders] Univ Uppsala Hosp, Dept Med Sci, SE-75105 Uppsala, Sweden	Uppsala University; Uppsala University Hospital	Grenegard, M (corresponding author), Cardiovasc Inflammat Res Ctr, Div Drug Res, Dept Med & Hlth, SE-58185 Linkoping, Sweden.	Magnus.Grenegard@imv.liu.se	Lindahl, Tomas L/H-5150-2012; Ramström, Sofia/F-9798-2011	Lindahl, Tomas L/0000-0003-0174-8152; Ramström, Sofia/0000-0002-1920-3962				AKITA EM, 1993, J IMMUNOL METHODS, V160, P207, DOI 10.1016/0022-1759(93)90179-B; Covic L, 2000, BIOCHEMISTRY-US, V39, P5458, DOI 10.1021/bi9927078; Covic L, 2002, THROMB HAEMOSTASIS, V87, P722, DOI 10.1055/s-0037-1613071; CROUCH MF, 1989, J BIOL CHEM, V264, P584; Daniel JL, 1998, J BIOL CHEM, V273, P2024, DOI 10.1074/jbc.273.4.2024; Dorsam RT, 2002, J BIOL CHEM, V277, P47588, DOI 10.1074/jbc.M208778200; Erhardt JA, 2003, J THROMB HAEMOST, V1, P2626, DOI 10.1046/j.1538-7836.2003.00453.x; Fung CYE, 2007, J THROMB HAEMOST, V5, P910, DOI 10.1111/j.1538-7836.2007.02525.x; Fung CYE, 2005, THROMB HAEMOSTASIS, V94, P37, DOI 10.1160/TH04-11-0732; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hardy AR, 2005, BLOOD, V105, P3552, DOI 10.1182/blood-2004-07-2893; Harper MT, 2006, PLATELETS, V17, P134, DOI 10.1080/09537100500441218; Holinstat M, 2007, MOL PHARMACOL, V71, P686, DOI 10.1124/mol.106.029371; Holinstat M, 2006, J BIOL CHEM, V281, P26665, DOI 10.1074/jbc.M602174200; JAKOBS KH, 1989, EUR J BIOCHEM, V183, P115, DOI 10.1111/j.1432-1033.1989.tb14903.x; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Keularts IMLW, 2000, J BIOL CHEM, V275, P1763, DOI 10.1074/jbc.275.3.1763; Kim S, 2004, J BIOL CHEM, V279, P4186, DOI 10.1074/jbc.M306162200; LANZA F, 1988, AM J PHYSIOL, V255, pH1276, DOI 10.1152/ajpheart.1988.255.6.H1276; Leger AJ, 2006, CIRCULATION, V113, P1244, DOI 10.1161/CIRCULATIONAHA.105.587758; Lian LR, 2005, BLOOD, V106, P110, DOI 10.1182/blood-2004-05-2005; LINDAHL TL, 1992, THROMB HAEMOSTASIS, V68, P221; Mazharian A, 2007, J BIOL CHEM, V282, P5478, DOI 10.1074/jbc.M609881200; Molino M, 1997, J BIOL CHEM, V272, P6011, DOI 10.1074/jbc.272.9.6011; Nylander S, 2003, BLOOD COAGUL FIBRIN, V14, P159, DOI 10.1097/00001721-200302000-00007; OFFERMANNS S, 1994, P NATL ACAD SCI USA, V91, P504, DOI 10.1073/pnas.91.2.504; Oury C, 2002, BLOOD, V100, P2499, DOI 10.1182/blood-2002-03-0812; Resendiz JC, 2007, J THROMB HAEMOST, V5, P2484, DOI 10.1111/j.1538-7836.2007.02769.x; Roger S, 2004, FEBS LETT, V556, P227, DOI 10.1016/S0014-5793(03)01430-3; Shapiro MJ, 2000, J BIOL CHEM, V275, P25216, DOI 10.1074/jbc.M004589200; STEEN VM, 1993, THROMB HAEMOSTASIS, V70, P506; Vretenbrant K, 2007, THROMB HAEMOSTASIS, V97, P417, DOI 10.1160/TH06-07-0397; Wallen NH, 1999, CLIN SCI, V97, P27, DOI 10.1042/CS19990013; Wang XY, 1997, J BIOCHEM-TOKYO, V121, P325; Woulfe D, 2004, J CLIN INVEST, V113, P441, DOI 10.1172/JCI200420267	35	31	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 4	2008	283	27					18493	18504		10.1074/jbc.M800358200	http://dx.doi.org/10.1074/jbc.M800358200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	319LR	18480058	hybrid			2022-12-25	WOS:000257165600004
J	Pogson, M; Holcombe, M; Smallwood, R; Qwarnstrom, E				Pogson, Mark; Holcombe, Mike; Smallwood, Rod; Qwarnstrom, Eva			Introducing Spatial Information into Predictive NF-kappa B Modelling - An Agent-Based Approach	PLOS ONE			English	Article							REL PROTEINS; SIMULATION	Nature is governed by local interactions among lower-level sub-units, whether at the cell, organ, organism, or colony level. Adaptive system behaviour emerges via these interactions, which integrate the activity of the sub-units. To understand the system level it is necessary to understand the underlying local interactions. Successful models of local interactions at different levels of biological organisation, including epithelial tissue and ant colonies, have demonstrated the benefits of such 'agent-based' modelling [1-4]. Here we present an agent-based approach to modelling a crucial biological system the intracellular NF-kappa B signalling pathway. The pathway is vital to immune response regulation, and is fundamental to basic survival in a range of species [5-7]. Alterations in pathway regulation underlie a variety of diseases, including atherosclerosis and arthritis. Our modelling of individual molecules, receptors and genes provides a more comprehensive outline of regulatory network mechanisms than previously possible with equation-based approaches [8]. The method also permits consideration of structural parameters in pathway regulation; here we predict that inhibition of NF-kappa B is directly affected by actin filaments of the cytoskeleton sequestering excess inhibitors, therefore regulating steady-state and feedback behaviour.	[Pogson, Mark; Holcombe, Mike; Smallwood, Rod] Univ Sheffield, Dept Comp Sci, Sheffield S10 2TN, S Yorkshire, England; [Qwarnstrom, Eva] Univ Sheffield, Sect Infect Immun & Inflammat, Unit Cell Biol, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield	Pogson, M (corresponding author), Univ Sheffield, Dept Comp Sci, Sheffield S10 2TN, S Yorkshire, England.	m.holcombe@dcs.shef.ac.uk	Smallwood, Rod/C-5583-2011; Pogson, Mark/D-9558-2016	Pogson, Mark/0000-0002-2116-7200; Smallwood, Rod/0000-0003-0134-0632	EPSRC research studentship; BBSRC [BB/C515798/1]; Biotechnology and Biological Sciences Research Council [BB/C515798/1, BBS/B/04056] Funding Source: researchfish	EPSRC research studentship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was supported by an EPSRC research studentship and by BBSRC Grant BB/C515798/1.	Andrews SS, 2004, PHYS BIOL, V1, P137, DOI 10.1088/1478-3967/1/3/001; Are AF, 2000, EXP CELL RES, V256, P533, DOI 10.1006/excr.2000.4830; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Balanescu T., 1999, J UNIVERS COMPUT SCI, V5, P494; BEG AA, 1992, GENE DEV, V6, P2664; BURRAGE K, 2003, P HONG KONG C SCI CO; Carlotti F, 1999, J BIOL CHEM, V274, P37941, DOI 10.1074/jbc.274.53.37941; Carlotti F, 2000, J BIOL CHEM, V275, P41028, DOI 10.1074/jbc.M006179200; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Holcombe M, 2003, BIOSYSTEMS, V68, P223, DOI 10.1016/S0303-2647(02)00098-9; Jackson D, 2004, BIOSYSTEMS, V76, P101, DOI 10.1016/j.biosystems.2004.05.028; Jackson DE, 2004, NATURE, V432, P907, DOI 10.1038/nature03105; KOPP EB, 1995, ADV IMMUNOL, V58, P1, DOI 10.1016/S0065-2776(08)60618-5; McMinn P, 2004, SOFTW TEST VERIF REL, V14, P105, DOI 10.1002/stvr.294; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Pogson M, 2006, BIOSYSTEMS, V85, P37, DOI 10.1016/j.biosystems.2006.02.004; ROSETTE C, 1995, J CELL BIOL, V128, P1111, DOI 10.1083/jcb.128.6.1111; TAUSSIG R, 2002, NATURE, V420, P703; Walker DC, 2004, BIOSYSTEMS, V76, P89, DOI 10.1016/j.biosystems.2004.05.025; Walker DC, 2004, IEEE T NANOBIOSCI, V3, P153, DOI 10.1109/TNB.2004.833680; Yang L, 2003, J BIOL CHEM, V278, P30881, DOI 10.1074/jbc.M212216200	22	45	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2367	10.1371/journal.pone.0002367	http://dx.doi.org/10.1371/journal.pone.0002367			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523553	Green Published, Green Accepted, gold			2022-12-25	WOS:000262614300053
J	Rentero, C; Zech, T; Quinn, CM; Engelhardt, K; Williamson, D; Grewal, T; Jessup, W; Harder, T; Gaus, K				Rentero, Carles; Zech, Tobias; Quinn, Carmel M.; Engelhardt, Karin; Williamson, David; Grewal, Thomas; Jessup, Wendy; Harder, Thomas; Gaus, Katharina			Functional Implications of Plasma Membrane Condensation for T Cell Activation	PLOS ONE			English	Article								The T lymphocyte plasma membrane condenses at the site of activation but the functional significance of this receptor-mediated membrane reorganization is not yet known. Here we demonstrate that membrane condensation at the T cell activation sites can be inhibited by incorporation of the oxysterol 7-ketocholesterol (7KC), which is known to prevent the formation of raft-like liquid-ordered domains in model membranes. We enriched T cells with 7KC, or cholesterol as control, to assess the importance of membrane condensation for T cell activation. Upon 7KC treatment, T cell antigen receptor (TCR) triggered calcium fluxes and early tyrosine phosphorylation events appear unaltered. However, signaling complexes form less efficiently on the cell surface, fewer phosphorylated signaling proteins are retained in the plasma membrane and actin restructuring at activation sites is impaired in 7KC-enriched cells resulting in compromised downstream activation responses. Our data emphasizes lipids as an important medium for the organization at T cell activation sites and strongly indicates that membrane condensation is an important element of the T cell activation process.	[Rentero, Carles; Quinn, Carmel M.; Williamson, David; Jessup, Wendy; Gaus, Katharina] Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia; [Zech, Tobias; Engelhardt, Karin; Harder, Thomas] Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England; [Grewal, Thomas] Univ Sydney, Fac Pharm, Sydney, NSW, Australia	University of New South Wales Sydney; University of Oxford; University of Sydney	Rentero, C (corresponding author), Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia.	thomas.harder@path.ox.ac.uk; k.gaus@unsw.edu.au	Rentero Alfonso, Carles/L-4430-2017; Williamson, David J/G-2265-2012	Rentero Alfonso, Carles/0000-0003-4684-0278; Williamson, David J/0000-0002-6222-6297; Grewal, Thomas/0000-0002-7937-8887; Gaus, Katharina/0000-0002-8009-9658; Zech, Tobias/0000-0001-8394-088X	EPA [studentship, senior fellow]; Wellcome Trust [082782/2/07/2]; Australian Research Council; National Health & Medical Research Council of Australia	EPA(United States Environmental Protection Agency); Wellcome Trust(Wellcome TrustEuropean Commission); Australian Research Council(Australian Research Council); National Health & Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	TZ is recipient of an EPA studentship, TH is an EPA senior fellow. The work in T.H. laboratory was supported by the Wellcome trust project grant 082782/2/07/2. KG acknowledges funding from the Australian Research Council and the National Health & Medical Research Council of Australia.	Antollini SS, 1996, BIOPHYS J, V70, P1275, DOI 10.1016/S0006-3495(96)79684-4; Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; Berthier A, 2005, FEBS J, V272, P3093, DOI 10.1111/j.1742-4658.2005.04723.x; Blery M, 2006, J EXP MED, V203, P1773, DOI 10.1084/jem.20060552; Brown DA, 1997, BIOCHEM BIOPH RES CO, V240, P1, DOI 10.1006/bbrc.1997.7575; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Drevot P, 2002, EMBO J, V21, P1899, DOI 10.1093/emboj/21.8.1899; Dykstra M, 2003, ANNU REV IMMUNOL, V21, P457, DOI 10.1146/annurev.immunol.21.120601.141021; Flores-Borja F, 2005, ARTHRITIS RHEUM-US, V52, P3955, DOI 10.1002/art.21416; Gaus K, 2006, MOL MEMBR BIOL, V23, P41, DOI 10.1080/09687860500466857; Gaus K, 2005, J CELL BIOL, V171, P121, DOI 10.1083/jcb.200505047; Gaus K, 2004, FASEB J, V18, P574, DOI 10.1096/fj.03-0486fje; Gaus K, 2003, P NATL ACAD SCI USA, V100, P15554, DOI 10.1073/pnas.2534386100; Glebov OO, 2004, NAT CELL BIOL, V6, P238, DOI 10.1038/ncb1103; Harder T, 2000, J CELL BIOL, V151, P199, DOI 10.1083/jcb.151.2.199; Harder T, 2004, CURR OPIN IMMUNOL, V16, P353, DOI 10.1016/j.coi.2004.03.013; Hartgroves LC, 2003, J BIOL CHEM, V278, P20389, DOI 10.1074/jbc.M301212200; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Houtman JCD, 2006, NAT STRUCT MOL BIOL, V13, P798, DOI 10.1038/nsmb1133; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; Jury EC, 2004, J CLIN INVEST, V113, P1176, DOI 10.1172/JCI200420345; Kabouridis PS, 2000, EUR J IMMUNOL, V30, P954, DOI 10.1002/1521-4141(200003)30:3<954::AID-IMMU954>3.3.CO;2-P; KLEIN U, 1995, BIOCHEMISTRY-US, V34, P13784, DOI 10.1021/bi00042a009; Krawczyk C, 2001, TRENDS CELL BIOL, V11, P212, DOI 10.1016/S0962-8924(01)01981-X; Leonarduzzi G, 2006, ANTIOXID REDOX SIGN, V8, P375, DOI 10.1089/ars.2006.8.375; Li XM, 2003, BIOPHYS J, V85, P3788, DOI 10.1016/S0006-3495(03)74794-8; London E, 2002, CURR OPIN STRUC BIOL, V12, P480, DOI 10.1016/S0959-440X(02)00351-2; Massey JB, 2005, BIOCHEMISTRY-US, V44, P10423, DOI 10.1021/bi0506425; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Neekhra A, 2007, INVEST OPHTH VIS SCI, V48, P1362, DOI 10.1167/iovs.06-0900; PATTEN PA, 1993, J IMMUNOL, V150, P2281; Pizzo P, 2002, EUR J IMMUNOL, V32, P3082, DOI 10.1002/1521-4141(200211)32:11<3082::AID-IMMU3082>3.0.CO;2-2; Prunet C, 2005, J BIOCHEM MOL TOXIC, V19, P311, DOI 10.1002/jbt.20096; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Stentz FB, 2006, BIOCHEM BIOPH RES CO, V346, P721, DOI 10.1016/j.bbrc.2006.05.159; van der Merwe PA, 2002, NAT IMMUNOL, V3, P1122, DOI 10.1038/ni1202-1122; Villalba M, 2001, J CELL BIOL, V155, P331, DOI 10.1083/jcb.200107080; Wilde JI, 2001, CELL SIGNAL, V13, P691, DOI 10.1016/S0898-6568(01)00191-7	44	88	90	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2262	10.1371/journal.pone.0002262	http://dx.doi.org/10.1371/journal.pone.0002262			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509459	Green Published, Green Submitted, gold			2022-12-25	WOS:000262268500010
J	Saenz, FE; Balu, B; Smith, J; Mendonca, SR; Adams, JH				Saenz, Fabian E.; Balu, Bharath; Smith, Jonah; Mendonca, Sarita R.; Adams, John H.			The Transmembrane Isoform of Plasmodium falciparum MAEBL Is Essential for the Invasion of Anopheles Salivary Glands	PLOS ONE			English	Article								Malaria transmission depends on infective stages in the mosquito salivary glands. Plasmodium sporozoites that mature in midgut oocysts must traverse the hemocoel and invade the mosquito salivary glands in a process thought to be mediated by parasite ligands. MAEBL, a homologue of the transmembrane EBP ligands essential in merozoite invasion, is expressed abundantly in midgut sporozoites. Alternative splicing generates different MAEBL isoforms and so it is unclear what form is functionally essential. To identify the MAEBL isoform required for P. falciparum (NF54) sporozoite invasion of salivary glands, we created knockout and allelic replacements each carrying CDS of a single MAEBL isoform. Only the transmembrane form of MAEBL is essential and is the first P. falciparum ligand validated as essential for invasion of Anopheles salivary glands. MAEBL is the first P. falciparum ligand experimentally determined to be essential for this important step in the life cycle where the vector becomes infectious for transmitting sporozoites to people. With an increasing emphasis on advancing vector-based transgenic methods for suppression of malaria, it is important that this type of study, using modern molecular genetic tools, is done with the agent of the human disease. Understanding what P. falciparum sporozoite ligands are critical for mosquito transmission will help validate targets for vector-based transmission-blocking strategies.	[Saenz, Fabian E.; Balu, Bharath; Mendonca, Sarita R.; Adams, John H.] Univ S Florida, Coll Publ Hlth, Dept Global Hlth, Tampa, FL 33620 USA; [Saenz, Fabian E.; Smith, Jonah; Mendonca, Sarita R.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN USA	State University System of Florida; University of South Florida; University of Notre Dame	Saenz, FE (corresponding author), Univ S Florida, Coll Publ Hlth, Dept Global Hlth, Tampa, FL 33620 USA.	jadams3@health.usf.edu	Adams, John H./ABB-8458-2020; Adams, John/G-1800-2015; Saenz, Fabian E/X-8481-2018	Adams, John H./0000-0003-3707-7979; Adams, John/0000-0003-3707-7979; Saenz, Fabian E/0000-0001-6460-5373	National Institutes of Health [R01 AI33656]; University of Notre Dame [Kellogg fellowships]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033656] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Notre Dame; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by a grant from the National Institutes of Health R01 AI33656 to JHA and Kellogg fellowships for University of Notre Dame graduate students to FES.	Blair PL, 2002, MOL BIOCHEM PARASIT, V122, P35, DOI 10.1016/S0166-6851(02)00067-1; Bosch J, 2007, P NATL ACAD SCI USA, V104, P7015, DOI 10.1073/pnas.0605301104; Buscaglia CA, 2003, MOL BIOL CELL, V14, P4947, DOI 10.1091/mbc.E03-06-0355; Chesne-Seck ML, 2005, MOL BIOCHEM PARASIT, V144, P55, DOI 10.1016/j.molbiopara.2005.07.007; Deitsch KW, 2001, NUCLEIC ACIDS RES, V29, P850, DOI 10.1093/nar/29.3.850; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Fu J, 2005, MOL BIOCHEM PARASIT, V141, P113, DOI 10.1016/j.molbiopara.2004.12.017; Ghai M, 2002, MOL BIOCHEM PARASIT, V123, P35, DOI 10.1016/S0166-6851(02)00123-8; Hillyer JF, 2007, INT J PARASITOL, V37, P673, DOI 10.1016/j.ijpara.2006.12.007; Ifediba T, 1981, NATURE, V294, P364, DOI 10.1038/294364a0; Jewett TJ, 2003, MOL CELL, V11, P885, DOI 10.1016/S1097-2765(03)00113-8; Kappe S, 1999, J CELL BIOL, V147, P937, DOI 10.1083/jcb.147.5.937; Kappe SHI, 2004, ANNU REV CELL DEV BI, V20, P29, DOI 10.1146/annurev.cellbio.20.011603.150935; Kappe SHI, 1998, P NATL ACAD SCI USA, V95, P1230, DOI 10.1073/pnas.95.3.1230; Kariu T, 2002, J EXP MED, V195, P1317, DOI 10.1084/jem.20011876; Krettli AU, 2001, CURR BIOL, V11, pR409, DOI 10.1016/S0960-9822(01)00221-4; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Menard R, 1997, NATURE, V385, P336, DOI 10.1038/385336a0; Mironov AA, 1999, GENOME RES, V9, P1288, DOI 10.1101/gr.9.12.1288; Mitchell GH, 2004, INFECT IMMUN, V72, P154, DOI 10.1128/IAI.72.1.154-158.2004; Muhia DK, 2003, J BIOL CHEM, V278, P22014, DOI 10.1074/jbc.M301639200; PIMENTA PF, 1994, J EUKARYOT MICROBIOL, V41, P608, DOI 10.1111/j.1550-7408.1994.tb01523.x; PONNUDURAI T, 1988, PARASITOL TODAY, V4, P319, DOI 10.1016/0169-4758(88)90114-7; Preiser P, 2004, INFECT IMMUN, V72, P3604, DOI 10.1128/IAI.72.6.3604-3608.2004; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; Sidjanski SP, 1997, MOL BIOCHEM PARASIT, V90, P33, DOI 10.1016/S0166-6851(97)00124-2; Silvie O, 2004, J BIOL CHEM, V279, P9490, DOI 10.1074/jbc.M311331200; Singh N, 2004, J MOL BIOL, V343, P589, DOI 10.1016/j.jmb.2004.08.047; Srinivasan P, 2004, J BIOL CHEM, V279, P5581, DOI 10.1074/jbc.M307587200; Sultan AA, 1997, CELL, V90, P511, DOI 10.1016/S0092-8674(00)80511-5; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; WALLIKER D, 1987, SCIENCE, V236, P1661, DOI 10.1126/science.3299700; Wollerton MC, 2004, MOL CELL, V13, P91, DOI 10.1016/S1097-2765(03)00502-1	33	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2287	10.1371/journal.pone.0002287	http://dx.doi.org/10.1371/journal.pone.0002287			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509478	Green Submitted, Green Published, gold			2022-12-25	WOS:000262268500029
J	Kawaguchi, M; Hager, HA; Wada, A; Koyama, T; Chang, MS; Bader, DM				Kawaguchi, Michiya; Hager, Hillary A.; Wada, Aya; Koyama, Tatsuki; Chang, Min S.; Bader, David M.			Identification of a Novel Intracellular Interaction Domain Essential for Bves Function	PLOS ONE			English	Article								While Blood vessel epicardial substance (Bves) confers adhesive properties, the molecular mechanism of regulating this activity is unknown. No predicted functional motifs in this highly conserved integral membrane protein, other than the transmembrane domain, have been identified. Here, we report for the first time that Bves interacts with itself through an intracellular interaction domain that is essential for its intercellular adhesion activity. Glutathion-S-transferase (GST) pulldown and SPOTs analyses mapped this domain to amino acids 268-274 in the intracellular C-terminus. Site-directed mutagenesis revealed that lysines 272 and 273 are essential for homodimerization and cell adhesion. Human corneal cells transfected with wild-type Bves trafficked the protein to the cell surface, assembled junction complexes and formed epithelial sheets. In contrast, cells expressing Bves mutated at these positions did not form continuous epithelial sheets or maintain junctional proteins such as ZO-1 and E-cadherin at the membrane. A dramatic reduction in transepithelial electrical resistance was also observed indicating a functional loss of tight junctions. Importantly, expression of mutated Bves in epithelial cells promoted the transformation of cells from an epithelial to a mesenchymal phenotype. This study is the first to demonstrate the essential nature of any domain within Bves for maintenance of epithelial phenotype and function.	[Kawaguchi, Michiya; Hager, Hillary A.; Wada, Aya; Koyama, Tatsuki; Bader, David M.] Vanderbilt Univ, Dept Med, Stahlman Cardiovasc Res Labs, Nashville, TN 37235 USA; [Chang, Min S.] Vanderbilt Univ, Dept Ophthalmol & Visual Sci, Nashville, TN USA	Vanderbilt University; Vanderbilt University	Kawaguchi, M (corresponding author), Vanderbilt Univ, Dept Med, Stahlman Cardiovasc Res Labs, Nashville, TN 37235 USA.	david.bader@Vanderbilt.edu			NIH [HL 79050, EY017185, HL 07411]; RPB-Robert E McCormick Scholar;  [Challenge Grant]; NATIONAL EYE INSTITUTE [R01EY017185] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079050] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RPB-Robert E McCormick Scholar; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	DB is supported by NIH HL 79050; MC is supported by NIH HL 79050, NIH EY017185, RPB-Robert E McCormick Scholar (MSC) and Challenge Grant (VEI); and HH is supported by NIH HL 79050 and NIH HL 07411.	Andree B, 2000, DEV BIOL, V223, P371, DOI 10.1006/dbio.2000.9751; Andree B, 2002, MOL CELL BIOL, V22, P1504, DOI 10.1128/MCB.22.5.1504-1512.2002; ARAKISASAKI K, 1995, INVEST OPHTH VIS SCI, V36, P614; Brand T, 2005, CELL BIOCHEM BIOPHYS, V43, P95, DOI 10.1385/CBB:43:1:095; Breher SS, 2004, DEV DYNAM, V229, P695, DOI 10.1002/dvdy.20015; DiAngelo JR, 2001, HYBRIDOMA HYBRIDOM, V20, P377, DOI 10.1089/15368590152740789; Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345; Hitz MP, 2002, MECH DEVELOP, V115, P123, DOI 10.1016/S0925-4773(02)00085-0; Hsu J., 1996, MULTIPLE COMP THEORY, DOI DOI 10.1007/978-1-4899-7180-7; Knight RF, 2003, J BIOL CHEM, V278, P32872, DOI 10.1074/jbc.M301961200; Lin S, 2007, INT J DEV BIOL, V51, P37, DOI 10.1387/ijdb.052108sl; NAGAFUCHI A, 1988, EMBO J, V7, P3679, DOI 10.1002/j.1460-2075.1988.tb03249.x; Nakada MT, 2000, J IMMUNOL, V164, P452, DOI 10.4049/jimmunol.164.1.452; Osler ME, 2006, DEV DYNAM, V235, P586, DOI 10.1002/dvdy.20688; Osler ME, 2005, J CELL SCI, V118, P4667, DOI 10.1242/jcs.02588; Osler ME, 2004, DEV DYNAM, V229, P658, DOI 10.1002/dvdy.10490; Ozawa M, 1998, J BIOL CHEM, V273, P6166, DOI 10.1074/jbc.273.11.6166; Ozawa M, 1998, J CELL BIOL, V142, P1605, DOI 10.1083/jcb.142.6.1605; Reese DE, 2002, CIRC RES, V91, P761, DOI 10.1161/01.RES.0000038961.53759.3C; Reese DE, 1999, MAMM GENOME, V10, P913, DOI 10.1007/s003359901113; Reese DE, 1999, DEV BIOL, V209, P159, DOI 10.1006/dbio.1999.9246; Ripley AN, 2006, P NATL ACAD SCI USA, V103, P614, DOI 10.1073/pnas.0506095103; Ripley AN, 2004, INVEST OPHTH VIS SCI, V45, P2475, DOI 10.1167/iovs.04-0013; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Vasavada TK, 2004, J HISTOCHEM CYTOCHEM, V52, P371, DOI 10.1177/002215540405200308; Wada AM, 2001, DEVELOPMENT, V128, P2085	26	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2261	10.1371/journal.pone.0002261	http://dx.doi.org/10.1371/journal.pone.0002261			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493308	gold, Green Published, Green Submitted			2022-12-25	WOS:000262258700060
J	Ryu, JJ; Borrmann, K; Chaudhuri, A				Ryu, Jae-Jin; Borrmann, Karen; Chaudhuri, Avi			Imagine Jane and Identify John: Face Identity Aftereffects Induced by Imagined Faces	PLOS ONE			English	Article							IMPAIRED VISUAL-PERCEPTION; NEURAL SYSTEMS; MENTAL-IMAGERY; HUMAN BRAIN; ADAPTATION; REPRESENTATION; CORTEX; LINES; CONTRAST; NEURONS	It is not known whether prolonged exposure to perceived and imagined complex visual images produces similar shifts in subsequent perception through selective adaptation. This question is important because a positive finding would suggest that perception and imagery of visual stimuli are mediated by shared neural networks. In this study, we used a selective adaptation procedure designed to induce high-level face-identity aftereffects - a phenomenon in which extended exposure to a particular face facilitates recognition of subsequent faces with opposite features while impairing recognition of all other faces. We report here that adaptation to either real or imagined faces produces a similar shift in perception and that identity boundaries represented in real and imagined faces are equivalent. Together, our results show that identity information contained in imagined and real faces produce similar behavioral outcomes. Our findings of high-level visual aftereffects induced by imagined stimuli can be taken as evidence for the involvement of shared neural networks that mediate perception and imagery of complex visual stimuli.	[Ryu, Jae-Jin; Borrmann, Karen; Chaudhuri, Avi] McGill Univ, Dept Psychol, Montreal, PQ, Canada	McGill University	Ryu, JJ (corresponding author), McGill Univ, Dept Psychol, 1205 Dr Penfield Ave, Montreal, PQ, Canada.	jjryu@ego.psych.mcgill.ca			Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was funded by operating grants from the Canadian Institutes of Health Research (CIHR) to AC.	Bartolomeo P, 1998, NEUROPSYCHOLOGIA, V36, P239, DOI 10.1016/S0028-3932(97)00103-6; BEHRMANN M, 1994, J EXP PSYCHOL HUMAN, V20, P1068, DOI 10.1037/0096-1523.20.5.1068; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BROERSE J, 1980, PERCEPT PSYCHOPHYS, V28, P560, DOI 10.3758/BF03198826; FARAH MJ, 1985, J EXP PSYCHOL GEN, V114, P91, DOI 10.1037/0096-3445.114.1.91; FINKE RA, 1977, J EXP PSYCHOL HUMAN, V3, P599, DOI 10.1037/0096-1523.3.4.599; FINKE RA, 1978, PERCEPT PSYCHOPHYS, V23, P515, DOI 10.3758/BF03199528; Frisby J. P., 1980, SEEING ILLUSION BRAI; Furl N, 2007, NEUROIMAGE, V37, P300, DOI 10.1016/j.neuroimage.2007.04.057; Gibson JJ, 1937, J EXP PSYCHOL, V20, P453, DOI 10.1037/h0059826; Gibson JJ, 1933, J EXP PSYCHOL, V16, P1, DOI 10.1037/h0074626; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; ISHAI A, 1995, SCIENCE, V268, P1772, DOI 10.1126/science.7792605; Ishai A, 2000, NEURON, V28, P979, DOI 10.1016/S0896-6273(00)00168-9; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Kanwisher N, 1997, J NEUROSCI, V17, P4302; KOEHLER W, 1944, P AM PHILOS SOC, V88, P269; Kosslyn SM, 1997, NEUROIMAGE, V6, P320, DOI 10.1006/nimg.1997.0295; Kreiman G, 2000, NATURE, V408, P357, DOI 10.1038/35042575; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; Michelon P, 2003, NEUROPSYCHOLOGIA, V41, P421, DOI 10.1016/S0028-3932(02)00176-8; Moradi F, 2005, NEURON, V45, P169, DOI 10.1016/j.neuron.2004.12.018; O'Craven KM, 2000, J COGNITIVE NEUROSCI, V12, P1013, DOI 10.1162/08989290051137549; OVER R, 1972, PSYCHON SCI, V29, P203; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; SINGER G, 1965, AM J PSYCHOL, V78, P96, DOI 10.2307/1421086; VALENTINE T, 1991, Q J EXP PSYCHOL-A, V43, P161, DOI 10.1080/14640749108400966; Watson TL, 2003, PERCEPTION, V32, P1109, DOI 10.1068/p5082; Webster MA, 2004, NATURE, V428, P557, DOI 10.1038/nature02420	29	18	18	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2195	10.1371/journal.pone.0002195	http://dx.doi.org/10.1371/journal.pone.0002195			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	391UK	18493304	gold, Green Published, Green Submitted			2022-12-25	WOS:000262258700004
J	Roeber, S; Grasbon-Frodl, EM; Windl, O; Krebs, B; Xiang, W; Vollmert, C; Illig, T; Schroeter, A; Arzberger, T; Weber, P; Zerr, I; Kretzschmar, HA				Roeber, Sigrun; Grasbon-Frodl, Eva-Maria; Windl, Otto; Krebs, Bjarne; Xiang, Wei; Vollmert, Caren; Illig, Thomas; Schroeter, Andreas; Arzberger, Thomas; Weber, Petra; Zerr, Inga; Kretzschmar, Hans A.			Evidence for a Pathogenic Role of Different Mutations at Codon 188 of PRNP	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; PRION PROTEIN GENE; MRI; CLASSIFICATION; DIAGNOSIS; FRAGMENT; KORA	Clinical and pathological changes in familial Creutzfeldt-Jakob disease (CJD) cases may be similar or indistinguishable from sporadic CJD. Therefore determination of novel mutations in PRNP remains of major importance. We identified two different rare mutations in codon 188 of the prion protein gene (PRNP) in four patients suffering from a disease clinically very similar to the major subtype of sporadic CJD. Both mutations result in an exchange of the amino acid residue threonine for a highly basic residue, either arginine (T188R) or lysine (T188K). The T188R mutation was found in one patient and the T188K mutation in three patients. The prevalence of mutations at codon 188 of PRNP was tested in 593 sporadic CJD cases and 735 healthy individuals. Neither mutation was found. The data presented here argue in favor of T188K being a pathogenic mutation causing genetic CJD. Since one individual with this mutation, who is the father of a clinically affected patient with T188K mutation, is now 79 years old and shows no signs of disease, this mutation is likely associated with a penetrance under 100%. Further observations will have to show whether T188R is a pathogenic mutation.	[Roeber, Sigrun; Grasbon-Frodl, Eva-Maria; Windl, Otto; Krebs, Bjarne; Xiang, Wei; Arzberger, Thomas; Weber, Petra; Kretzschmar, Hans A.] Ludwig Maximilians Univ Munchen, Ctr Neuropathol & Prion Res, Munich, Germany; [Vollmert, Caren; Illig, Thomas] Forschungszentrum Umwelt Gesundheit GSF, Inst Epidemiol, Munich, Germany; [Schroeter, Andreas; Zerr, Inga] Univ Gottingen, Dept Neurol, Gottingen, Germany	University of Munich; University of Gottingen	Roeber, S (corresponding author), Ludwig Maximilians Univ Munchen, Ctr Neuropathol & Prion Res, Munich, Germany.	Hans.Kretzschmar@med.uni-muenchen.de	Windl, Otto/C-6760-2011; Xiang, Wei/Y-3171-2019		Federal Ministry of Health; European Commission [TSELAB QLK 2- CT-2002-81523]; Federal Ministry of Education and Research (BMBF) [01GS0166]; German Federal Ministry of Education and Research; State of Bavaria	Federal Ministry of Health; European Commission(European CommissionEuropean Commission Joint Research Centre); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); State of Bavaria	This study was supported by a grant from the Federal Ministry of Health (Bundesgesundheitsministerium) and the European Commission (TSELAB QLK 2- CT-2002-81523). Genotyping in this study was partially supported within the German National Genomic Research Network (01GS0166) by the Federal Ministry of Education and Research (BMBF). The KORA research platform (KORA, Cooperative Research in the Region of Augsburg) was initiated and financed by the GSF-National Research Centre for Environment and Health, which is funded by the German Federal Ministry of Education and Research and of the State of Bavaria.	[Anonymous], 1998, Wkly Epidemiol Rec, V73, P361; Cambier DM, 2003, CLIN NEUROPHYSIOL, V114, P1724, DOI 10.1016/S1388-2457(03)00109-3; CHAPMAN J, 1994, NEUROLOGY, V44, P1683, DOI 10.1212/WNL.44.9.1683; Collins S, 2000, ARCH NEUROL-CHICAGO, V57, P1058, DOI 10.1001/archneur.57.7.1058; Finckh U, 2000, AM J HUM GENET, V66, P110, DOI 10.1086/302702; GOLDFARB LG, 1991, EUR J EPIDEMIOL, V7, P477, DOI 10.1007/BF00143125; GOLDFARB LG, 1994, MOL NEUROBIOL, V8, P89, DOI 10.1007/BF02780658; GOLDGABER D, 1989, EXP NEUROL, V106, P204, DOI 10.1016/0014-4886(89)90095-2; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; HSIAO K, 1989, NATURE, V338, P342, DOI 10.1038/338342a0; Jin K, 2004, NEUROLOGY, V62, P502, DOI 10.1212/01.WNL.0000106954.54011.80; Kahle PJ, 2000, J NEUROSCI, V20, P6365, DOI 10.1523/JNEUROSCI.20-17-06365.2000; Kovacs GG, 2005, HUM GENET, V118, P166, DOI 10.1007/s00439-005-0020-1; Kovacs GG, 2002, J NEUROL, V249, P1567, DOI 10.1007/s00415-002-0896-9; Krasnianski A, 2006, BRAIN, V129, P2288, DOI 10.1093/brain/awl123; Lorenz H, 2002, J BIOL CHEM, V277, P8508, DOI 10.1074/jbc.M110197200; MEDORI R, 1992, NEW ENGL J MED, V326, P444, DOI 10.1056/NEJM199202133260704; Meissner B, 2005, NEUROLOGY, V65, P1544, DOI 10.1212/01.wnl.0000184674.32924.c9; Mollenhauer B, 2002, DEUT MED WOCHENSCHR, V127, P312, DOI 10.1055/s-2002-20150; Nitrini R, 2001, J NEUROL SCI, V184, P163, DOI 10.1016/S0022-510X(01)00432-4; Notari S, 2004, J BIOL CHEM, V279, P16797, DOI 10.1074/jbc.M313220200; Palmer MS, 1996, HUM MUTAT, V7, P280, DOI 10.1002/(SICI)1098-1004(1996)7:3<280::AID-HUMU17>3.0.CO;2-Z; Parchi P, 1998, P NATL ACAD SCI USA, V95, P8322, DOI 10.1073/pnas.95.14.8322; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; POCCHIARI M, 1993, ANN NEUROL, V34, P802, DOI 10.1002/ana.410340608; Roeber S, 2005, ACTA NEUROPATHOL, V109, P443, DOI 10.1007/s00401-004-0978-0; Satoh K, 2003, J GEN VIROL, V84, P2885, DOI 10.1099/vir.0.19236-0; SCHATZL HM, 1995, J MOL BIOL, V245, P362, DOI 10.1006/jmbi.1994.0030; Schulz-Schaeffer WJ, 2000, AM J PATHOL, V156, P51, DOI 10.1016/S0002-9440(10)64705-0; Spiegal J, 2002, NERVENARZT, V73, P952, DOI 10.1007/s00115-002-1364-6; SPUDICH S, 1995, MOL MED, V1, P607, DOI 10.1007/BF03401601; Tagliavini F, 2001, J BIOL CHEM, V276, P6009, DOI 10.1074/jbc.M007062200; Tschampa HJ, 2005, BRAIN, V128, P2026, DOI 10.1093/brain/awh575; VOLLMERT C, 2006, J MED GENET, V59, P43; *WHO, 2003, WHO MAN SURV HUM TRA, P71; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Windl O, 1999, HUM GENET, V105, P244, DOI 10.1007/s004390051096; WINDL O, 1995, GENE, V159, P181, DOI 10.1016/0378-1119(95)00064-D; Windl O, 1996, HUM GENET, V98, P259, DOI 10.1007/s004390050204; WINDL O, 1999, CONT NEUROLOGY SERIE, P191; Young GS, 2005, AM J NEURORADIOL, V26, P1551; ZERR I, 1995, LANCET, V345, P1609, DOI 10.1016/S0140-6736(95)90118-3	42	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2147	10.1371/journal.pone.0002147	http://dx.doi.org/10.1371/journal.pone.0002147			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478114	Green Submitted, Green Published, gold			2022-12-25	WOS:000262172800012
J	Bhaumik, D; Scott, GK; Schokrpur, S; Patil, CK; Campisi, J; Benz, CC				Bhaumik, D.; Scott, G. K.; Schokrpur, S.; Patil, C. K.; Campisi, J.; Benz, C. C.			Expression of microRNA-146 suppresses NF-kappa B activity with reduction of metastatic potential in breast cancer cells	ONCOGENE			English	Article						NF-kappa B; miRNA-146; metastatic breast cancer	RECEPTOR; INTERLEUKIN-1; SECRETION; ACTIVATION; SURVIVAL; INVASION; IMMUNITY; PATHWAY; PLAYERS	Cancer cells often acquire a constitutively active nuclear factor-kappa B (NF-kappa B) program to promote survival, proliferation and metastatic potential by mechanisms that remain largely unknown. Extending observations from an immunologic setting, we demonstrate that microRNA-146a and microRNA-146b (miR-146a/b) when expressed in the highly metastatic human breast cancer cell line MDA-MB-231 function to negatively regulate NF-kappa B activity. Lentiviral-mediated expression of miR-146a/b significantly downregulated interleukin (IL)-1 receptor-associated kinase and TNF receptor-associated factor 6, two key adaptor/scaffold proteins in the IL-1 and Toll-like receptor signaling pathway, known to positively regulate NF-kappa B activity. Impaired NF-kappa B activity was evident from reduced phosphorylation of the NF-kappa B inhibitor I kappa B alpha, reduced NF-kappa B DNA-binding activity and suppressed expression of the NF-kappa B target genes IL-8, IL-6 and matrix metalloproteinase-9. Functionally, miR-146a/b-expressing MDA-MB-231 cells showed markedly impaired invasion and migration capacity relative to control cells. These findings implicate miR-146a/b as a negative regulator of constitutive NF-kappa B activity in a breast cancer setting and suggest that modulating miR-146a/b levels has therapeutic potential to suppress breast cancer metastases.	[Bhaumik, D.; Scott, G. K.; Schokrpur, S.; Campisi, J.; Benz, C. C.] Buck Inst Age Res, Novato, CA 94945 USA; [Patil, C. K.; Campisi, J.] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA	Buck Institute for Research on Aging; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Scott, GK (corresponding author), Buck Inst Age Res, 8001 Redwood Blvd, Novato, CA 94945 USA.	gscott@buckinstitute.org		Schokrpur, Shiruyeh/0000-0001-9441-9547	NIH [R01CA36773, P01-AG025901, P50-CA58207, R37-AG09909]; NATIONAL CANCER INSTITUTE [P50CA058207, R01CA036773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG025901, R37AG009909] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by NIH grants R01CA36773, P01-AG025901, P50-CA58207 and R37-AG09909 as well as Hazel P Munroe memorial funding to the Buck Institute.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benoy IH, 2004, CLIN CANCER RES, V10, P7157, DOI 10.1158/1078-0432.CCR-04-0812; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Cicek M, 2005, CANCER RES, V65, P3586, DOI 10.1158/0008-5472.CAN-04-3139; Coppe JP, 2006, J BIOL CHEM, V281, P29568, DOI 10.1074/jbc.M603307200; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Karres JS, 2007, CELL, V131, P136, DOI 10.1016/j.cell.2007.09.020; Lin SL, 2008, RNA, V14, P417, DOI 10.1261/rna.874808; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Merrell MA, 2006, MOL CANCER RES, V4, P437, DOI 10.1158/1541-7786.MCR-06-0007; Monks NR, 2006, J CELL BIOCHEM, V98, P221, DOI 10.1002/jcb.20789; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Sethi G, 2008, EXP BIOL MED, V233, P21, DOI 10.3181/0707-MR-196; Singer CF, 2003, CLIN CANCER RES, V9, P4877; Sliva D, 2002, J BIOL CHEM, V277, P3150, DOI 10.1074/jbc.M109579200; Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005; Taganov KD, 2007, IMMUNITY, V26, P133, DOI 10.1016/j.immuni.2007.02.005; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Van Waes C, 2007, CLIN CANCER RES, V13, P1076, DOI 10.1158/1078-0432.CCR-06-2221; Zheng Y, 2006, J BIOL CHEM, V281, P15862, DOI 10.1074/jbc.M600660200; Zhou Y, 2005, ENDOCR-RELAT CANCER, V12, pS37, DOI 10.1677/erc.1.00977	26	487	541	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP 18	2008	27	42					5643	5647		10.1038/onc.2008.171	http://dx.doi.org/10.1038/onc.2008.171			5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	349KX	18504431	Green Accepted			2022-12-25	WOS:000259280800010
J	Brooks, WS; Helton, ES; Banerjee, S; Venable, M; Johnson, L; Schoeb, TR; Kesterson, RA; Crawford, DF				Brooks, William S.; Helton, E. Scott; Banerjee, Sami; Venable, Melanie; Johnson, Larry; Schoeb, Trenton R.; Kesterson, Robert A.; Crawford, David F.			G2E3 is a dual function ubiquitin ligase required for early embryonic development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; PROMOTING COMPLEX; GENE-EXPRESSION; PROTEIN; MICE; DOMAIN; PROLIFERATION; INACTIVATION; DEGRADATION; DISRUPTION	G2E3 is a putative ubiquitin ligase (E3) identified in a microarray screen for mitotic regulatory proteins. It shuttles between the cytoplasm and nucleus, concentrating in nucleoli and relocalizing to the nucleoplasm in response to DNA damage. In this study, we demonstrate that G2E3 is an unusual ubiquitin ligase that is essential in early embryonic development to prevent apopotic death. This protein has a catalytically inactive HECT domain and two distinct RING-like ubiquitin ligase domains that catalyze lysine 48-linked polyubiquitination. To address in vivo function, we generated a knock-out mouse model of G2E3 deficiency that incorporates a beta-galactosidase reporter gene under control of the endogenous promoter. Animals heterozygous for G2E3 inactivation are phenotypically normal with no overt change in development, growth, longevity, or fertility, whereas G2E3 null embryos die prior to implantation. Although normal numbers of G2E3(-/-) blastocysts are present at embryonic day 3.5, these blastocysts involute in culture as a result of massive apoptosis. Using beta-galactosidase staining as a marker for protein expression, we demonstrate that G2E3 is predominantly expressed within the central nervous system and the early stages of limb bud formation of the developing embryo. In adult animals, the most intense staining is found in Purkinje cell bodies and cells lining the ductus deferens. In summary, G2E3 is a dual function ubiquitin ligase essential for prevention of apoptosis in early embryogenesis.	[Brooks, William S.; Helton, E. Scott; Crawford, David F.] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35233 USA; [Johnson, Larry; Schoeb, Trenton R.; Kesterson, Robert A.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35233 USA; [Banerjee, Sami; Crawford, David F.] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35233 USA; [Venable, Melanie] Univ Alabama Birmingham, Sch Med, Birmingham, AL 35233 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Crawford, DF (corresponding author), Univ Oklahoma, Hlth Sci Ctr, 940 Stanton L Young Blvd,BMSB 311, Oklahoma City, OK 73104 USA.	david-crawford@ouhsc.edu			NATIONAL CANCER INSTITUTE [K08CA086941, P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NCI NIH HHS [K08CA86941, P30 CA13148] Funding Source: Medline; NIAMS NIH HHS [P30 AR48311, P30 AR048311] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Allen RT, 1997, J PHARMACOL TOX MET, V37, P215, DOI 10.1016/S1056-8719(97)00033-6; Aravind L, 2000, CURR BIOL, V10, pR132, DOI 10.1016/S0960-9822(00)00398-5; Aravind L, 2003, CELL CYCLE, V2, P123, DOI 10.4161/cc.2.2.335; Artus J, 2008, MOL CELL ENDOCRINOL, V282, P78, DOI 10.1016/j.mce.2007.11.008; Ayad NG, 2003, CELL, V113, P101, DOI 10.1016/S0092-8674(03)00232-0; Banerjee S, 2007, ONCOGENE, V26, P6509, DOI 10.1038/sj.onc.1210471; Brandeis M, 1998, P NATL ACAD SCI USA, V95, P4344, DOI 10.1073/pnas.95.8.4344; Brooks WS, 2007, EXP CELL RES, V313, P665, DOI 10.1016/j.yexcr.2006.11.020; Brown EJ, 2000, GENE DEV, V14, P397; Chaudhry MA, 2002, ONCOGENE, V21, P1934, DOI 10.1038/sj.onc.1205264; Ciemerych MA, 2002, GENE DEV, V16, P3277, DOI 10.1101/gad.1023602; Coscoy L, 2003, TRENDS CELL BIOL, V13, P7, DOI 10.1016/S0962-8924(02)00005-3; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; Crawford DF, 2001, J BIOL CHEM, V276, P37166, DOI 10.1074/jbc.M103414200; D'Andrea AD, 2003, GENE DEV, V17, P1933, DOI 10.1101/gad.1128303; Dul BE, 2007, J BIOL CHEM, V282, P18397, DOI 10.1074/jbc.M700729200; Elson A, 1996, P NATL ACAD SCI USA, V93, P13084, DOI 10.1073/pnas.93.23.13084; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Figueroa J, 1998, CHROMOSOMA, V107, P397, DOI 10.1007/s004120050323; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; GOLSTEYN RM, 1994, J CELL SCI, V107, P1509; Goto E, 2003, J BIOL CHEM, V278, P14657, DOI 10.1074/jbc.M211285200; Honda Y, 2002, J BIOL CHEM, V277, P3599, DOI 10.1074/jbc.M104347200; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Jung CR, 2006, NAT MED, V12, P809, DOI 10.1038/nm1440; Kallio M, 1998, J CELL BIOL, V141, P1393, DOI 10.1083/jcb.141.6.1393; Kang DM, 2002, J CELL BIOL, V156, P249, DOI 10.1083/jcb.200108016; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Lavin MF, 1997, ANNU REV IMMUNOL, V15, P177, DOI 10.1146/annurev.immunol.15.1.177; Lee H, 2006, MOL CELL BIOL, V26, P5373, DOI 10.1128/MCB.00043-06; Li TY, 2004, MOL CELL BIOL, V24, P3188, DOI 10.1128/MCB.24.8.3188-3197.2004; Liu CY, 1996, GENE DEV, V10, P1835, DOI 10.1101/gad.10.14.1835; Liu QH, 2000, GENE DEV, V14, P1448; LIU Z, 1992, J BIOL CHEM, V267, P15829; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Ludwig T, 1997, GENE DEV, V11, P1226, DOI 10.1101/gad.11.10.1226; Murphy M, 1997, NAT GENET, V15, P83, DOI 10.1038/ng0197-83; Nabetani A, 2001, CHROMOSOMA, V110, P322, DOI 10.1007/s004120100153; PINES J, 1989, CELL, V58, P833, DOI 10.1016/0092-8674(89)90936-7; Salvat C, 2004, J BIOL CHEM, V279, P18935, DOI 10.1074/jbc.M312201200; Saunders DN, 2004, MOL CELL BIOL, V24, P7225, DOI 10.1128/MCB.24.16.7225-7234.2004; Scheel H, 2003, TRENDS CELL BIOL, V13, P285, DOI 10.1016/S0962-8924(03)00102-8; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; Shedden K, 2002, P NATL ACAD SCI USA, V99, P4379, DOI 10.1073/pnas.062569899; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Sherr CJ, 2000, CANCER RES, V60, P3689; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Shi W, 2003, GENETICS, V165, P1869; Suzuki A, 1997, GENE DEV, V11, P1242, DOI 10.1101/gad.11.10.1242; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Tischkowitz MD, 2003, J MED GENET, V40, P1, DOI 10.1136/jmg.40.1.1; Uchida D, 2004, J EXP MED, V199, P167, DOI 10.1084/jem.20031291; Wei JH, 2006, J BIOL CHEM, V281, P22537, DOI 10.1074/jbc.M600826200; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Xiao JH, 2002, BIOCHEM BIOPH RES CO, V291, P101, DOI 10.1006/bbrc.2002.6396; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	58	28	31	6	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22304	22315		10.1074/jbc.M803238200	http://dx.doi.org/10.1074/jbc.M803238200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18511420	Green Published, hybrid			2022-12-25	WOS:000258114700049
J	Teghanemt, A; Widstrom, RL; Gioannini, TL; Weiss, JP				Teghanemt, Athmane; Widstrom, Richard L.; Gioannini, Theresa L.; Weiss, Jerrold P.			Isolation of monomeric and dimeric secreted MD-2 - Endotoxin.sCD14 and Toll-like receptor 4 ectodomain selectively react with the monomeric form of secreted MD-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR-4; CRYSTAL-STRUCTURE; CELL ACTIVATION; LIPOPOLYSACCHARIDE RESPONSIVENESS; NEISSERIA-MENINGITIDIS; GM2-ACTIVATOR PROTEIN; BINDING PROTEIN; SOLUBLE MD-2; COMPLEXES; CD14	Potent cell activation by endotoxin requires sequential protein-endotoxin and protein-protein interactions involving lipopolysaccharide-binding protein, CD14, MD-2, and Toll-like receptor 4 (TLR4). MD-2 plays an essential role by bridging endotoxin (E) recognition initiated by lipopolysaccharide-binding protein and CD14 to TLR4 activation by presenting endotoxin as a monomeric E .MD-2 complex that directly and potently activates TLR4. Secreted MD-2 (sMD-2) exists as a mixture of monomers and multimers. Published data suggest that only MD-2 monomer can interact with endotoxin and TLR4 and support cell activation, but the apparent instability of MD-2 has thwarted efforts to more fully separate and characterize the individual species of sMD-2. We have taken advantage of the much greater stability of sMD-2 in insect culture medium to fully separate sMD-2 monomer from dimer by gel sieving chromatography. At low nanomolar concentrations, the sMD-2 monomer, but not dimer, reacted with a monomeric complex of E . sCD14 to form monomeric E . MD-2 and activate HEK293/TLR4 cells. The monomer, but not dimer, also reacted with the ectodomain of TLR4 with an affinity comparable with the picomolar affinity of E . MD-2. These findings demonstrate directly that the monomeric form of sMD-2 is the active species both for reaction with E . CD14 and TLR4, as needed for potent endotoxin-induced TLR4 activation.	[Teghanemt, Athmane; Widstrom, Richard L.; Gioannini, Theresa L.; Weiss, Jerrold P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Inflammat Program, Dept Internal Med, Iowa City, IA 52242 USA; [Weiss, Jerrold P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Inflammat Program, Dept Microbiol, Iowa City, IA 52242 USA; [Gioannini, Theresa L.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Inflammat Program, Dept Biochem, Iowa City, IA 52242 USA; [Gioannini, Theresa L.] Vet Affairs Med Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Weiss, JP (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, 2501 Crosspark Rd, Coralville, IA 52241 USA.	jerrold-weiss@uiowa.edu		Weiss, Jerrold/0000-0003-1476-4485	NIAID NIH HHS [AI59372, R01 AI059372, P01 AI044642] Funding Source: Medline; PHS HHS [P0144642] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059372, P01AI044642] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akashi S, 2000, BIOCHEM BIOPH RES CO, V268, P172, DOI 10.1006/bbrc.2000.2089; Akashi S, 2003, J EXP MED, V198, P1035, DOI 10.1084/jem.20031076; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Derewenda U, 2002, J MOL BIOL, V318, P189, DOI 10.1016/S0022-2836(02)00027-X; Friedland N, 2003, P NATL ACAD SCI USA, V100, P2512, DOI 10.1073/pnas.0437840100; Gangloff M, 2004, TRENDS BIOCHEM SCI, V29, P294, DOI 10.1016/j.tibs.2004.04.008; Giardina PC, 2001, J BIOL CHEM, V276, P5883, DOI 10.1074/jbc.M009273200; Gioannini TL, 2005, J ENDOTOXIN RES, V11, P117, DOI 10.1179/096805105X35198; Gioannini TL, 2002, J BIOL CHEM, V277, P47818, DOI 10.1074/jbc.M206404200; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Gruber A, 2004, J BIOL CHEM, V279, P28475, DOI 10.1074/jbc.M400993200; Inohara N, 2002, TRENDS BIOCHEM SCI, V27, P219, DOI 10.1016/S0968-0004(02)02084-4; Jia HP, 2004, AM J PHYSIOL-LUNG C, V287, pL428, DOI 10.1152/ajplung.00377.2003; Kennedy MN, 2004, J BIOL CHEM, V279, P34698, DOI 10.1074/jbc.M405444200; Miyake K, 2003, INT IMMUNOPHARMACOL, V3, P119, DOI 10.1016/S1567-5769(02)00258-8; Mullen GED, 2003, P NATL ACAD SCI USA, V100, P3919, DOI 10.1073/pnas.0630495100; Ohnishi T, 2003, CLIN DIAGN LAB IMMUN, V10, P405, DOI 10.1128/CDLI.10.3.405-410.2003; Ohnishi T, 2001, J IMMUNOL, V167, P3354, DOI 10.4049/jimmunol.167.6.3354; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Post DMB, 2005, J BIOL CHEM, V280, P38383, DOI 10.1074/jbc.M508063200; Prohinar P, 2007, J BIOL CHEM, V282, P1010, DOI 10.1074/jbc.M609400200; Re F, 2003, J IMMUNOL, V171, P5272, DOI 10.4049/jimmunol.171.10.5272; Re F, 2002, J BIOL CHEM, V277, P23427, DOI 10.1074/jbc.M202554200; Shi XZ, 2007, CURR DRUG TARGETS, V8, P1116, DOI 10.2174/138945007782151360; Teghanemt A, 2005, J IMMUNOL, V175, P4669, DOI 10.4049/jimmunol.175.7.4669; Teghanemt A, 2008, J BIOL CHEM, V283, P1257, DOI 10.1074/jbc.M705994200; Teghanemt A, 2007, J BIOL CHEM, V282, P36250, DOI 10.1074/jbc.M705995200; Ulevitch RJ, 1999, CURR OPIN IMMUNOL, V11, P19, DOI 10.1016/S0952-7915(99)80004-1; Viriyakosol S, 2006, J BIOL CHEM, V281, P11955, DOI 10.1074/jbc.M511627200; Viriyakosol S, 2001, J BIOL CHEM, V276, P38044; Viriyakosol S, 2006, HYBRIDOMA, V25, P349, DOI 10.1089/hyb.2006.25.349; Visintin A, 2005, J IMMUNOL, V175, P6465, DOI 10.4049/jimmunol.175.10.6465; Visintin A, 2001, P NATL ACAD SCI USA, V98, P12156, DOI 10.1073/pnas.211445098; Wright CS, 2003, J MOL BIOL, V331, P951, DOI 10.1016/S0022-2836(03)00794-0; Wright CS, 2000, J MOL BIOL, V304, P411, DOI 10.1006/jmbi.2000.4225; Wright CS, 2005, BIOCHEMISTRY-US, V44, P13510, DOI 10.1021/bi050668w; Yang H, 2000, J BIOL CHEM, V275, P20861, DOI 10.1074/jbc.M002896200	37	34	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					21881	21889		10.1074/jbc.M800672200	http://dx.doi.org/10.1074/jbc.M800672200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18519568	Green Published, hybrid			2022-12-25	WOS:000258114700007
J	Johnston, CA; Afshar, K; Snyder, JT; Tall, GG; Gonczy, P; Siderovski, DP; Willard, FS				Johnston, Christopher A.; Afshar, Katayoun; Snyder, Jason T.; Tall, Gregory G.; Goenczy, Pierre; Siderovski, David P.; Willard, Francis S.			Structural determinants underlying the temperature-sensitive nature of a G alpha mutant in asymmetric cell division of Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; DISSOCIATION INHIBITOR ACTIVITY; GTPASE-ACTIVATING PROTEINS; C-ELEGANS; GOLOCO MOTIF; CRYSTAL-STRUCTURE; 2.0 ANGSTROM; EMBRYOS; G(I-ALPHA-1); SUBUNITS	Heterotrimeric G-proteins are integral to a conserved regulatory module that influences metazoan asymmetric cell division (ACD). In the Caenorhabditis elegans zygote, GOA-1 (G alpha(o)) and GPA-16 (G alpha(i)) are involved in generating forces that pull on astral microtubules and position the spindle asymmetrically. GPA-16 function has been analyzed in vivo owing notably to a temperature-sensitive allele gpa-16(it143), which, at the restrictive temperature, results in spindle orientation defects in early embryos. Here we identify the structural basis of gpa-16(it143), which encodes a point mutation (G202D) in the switch II region of GPA-16. Using G alpha(i1)(G202D) as a model in biochemical analyses, we demonstrate that high temperature induces instability of the mutant G alpha. At the permissive temperature, the mutant G alpha was stable upon GTP binding, but switch II rearrangement was compromised, as were activation state-selective interactions with regulators involved in ACD, including GoLoco motifs, RGS proteins, and RIC-8. We solved the crystal structure of the mutant G alpha bound to GDP, which indicates a unique switch II conformation as well as steric constraints that suggest activated GPA-16(it143) is destabilized relative to wild type. Spindle severing in gpa-16(it143) embryos revealed that pulling forces are symmetric and markedly diminished at the restrictive temperature. Interestingly, pulling forces are asymmetric and generally similar in magnitude to wild type at the permissive temperature despite defects in the structure of GPA-16(it143). These normal pulling forces in gpa-16(it143) embryos at the permissive temperature were attributable to GOA-1 function, underscoring a complex interplay of G alpha subunit function in ACD.	[Johnston, Christopher A.; Snyder, Jason T.; Siderovski, David P.; Willard, Francis S.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Siderovski, David P.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Afshar, Katayoun; Goenczy, Pierre] Swiss Inst Expt Canc Res, CH-1066 Lausanne, Switzerland; [Goenczy, Pierre] Swiss Fed Inst Technol, Sch Life Sci, CH-1066 Lausanne, Switzerland; [Tall, Gregory G.] Univ Rochester, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Swiss Institute Experimental Cancer Research; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Rochester	Johnston, CA (corresponding author), 1106 M E Jones Bldg,CB 7365, Chapel Hill, NC 27599 USA.	dsiderov@med.unc.edu	Siderovski, David Peter/AAA-9603-2019	Siderovski, David Peter/0000-0002-0688-8210; Gonczy, Pierre/0000-0002-6305-6883	NIGMS NIH HHS [GM 076944, GM 074268] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM076944, R01GM074268] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Afshar K, 2005, DEVELOPMENT, V132, P4449, DOI 10.1242/dev.02039; Afshar K, 2004, CELL, V119, P219, DOI 10.1016/j.cell.2004.09.026; AKIMA H, 1970, J ACM, V17, P589, DOI 10.1145/321607.321609; Bellaiche Y, 2005, CURR OPIN CELL BIOL, V17, P658, DOI 10.1016/j.ceb.2005.10.002; Bergmann DC, 2003, DEVELOPMENT, V130, P5731, DOI 10.1242/dev.00839; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; BRENNER S, 1974, GENETICS, V77, P71; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chidiac P, 1999, BIOCHEM PHARMACOL, V58, P39, DOI 10.1016/S0006-2952(99)00080-5; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Colombo K, 2003, SCIENCE, V300, P1957, DOI 10.1126/science.1084146; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gonczy P, 1999, J CELL BIOL, V144, P927, DOI 10.1083/jcb.144.5.927; Gotta M, 2001, NAT CELL BIOL, V3, P297, DOI 10.1038/35060092; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; Hampoelz B, 2004, CELL, V119, P453, DOI 10.1016/j.cell.2004.10.025; Hepler JR, 1997, P NATL ACAD SCI USA, V94, P428, DOI 10.1073/pnas.94.2.428; Hess HA, 2004, CELL, V119, P209, DOI 10.1016/j.cell.2004.09.025; IIRI T, 1994, NATURE, V371, P164, DOI 10.1038/371164a0; Johnston CA, 2007, MOL PHARMACOL, V72, P219, DOI 10.1124/mol.107.034348; Johnston CA, 2006, BIOCHEMISTRY-US, V45, P11390, DOI 10.1021/bi0613832; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kimple RJ, 2003, COMB CHEM HIGH T SCR, V6, P399; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; LINDER ME, 1990, J BIOL CHEM, V265, P8243; McCudden CR, 2005, BBA-MOL CELL RES, V1745, P254, DOI 10.1016/j.bbamcr.2005.05.002; Mergny JL, 2003, OLIGONUCLEOTIDES, V13, P515, DOI 10.1089/154545703322860825; MIXON MB, 1995, SCIENCE, V270, P954, DOI 10.1126/science.270.5238.954; Nguyen-Ngoc T, 2007, NAT CELL BIOL, V9, P1294, DOI 10.1038/ncb1649; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pereira R, 2005, J BIOL CHEM, V280, P35696, DOI 10.1074/jbc.M504935200; Posner BA, 1998, J BIOL CHEM, V273, P21752, DOI 10.1074/jbc.273.34.21752; Sarvazyan NA, 2002, BIOCHEMISTRY-US, V41, P12858, DOI 10.1021/bi026212l; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; Snow BE, 2002, METHOD ENZYMOL, V344, P740; Snyder JT, 2003, J BIOL CHEM, V278, P21099, DOI 10.1074/jbc.M301418200; Spiegel AM, 2004, ANNU REV MED, V55, P27, DOI 10.1146/annurev.med.55.091902.103843; Srinivasan DG, 2003, GENE DEV, V17, P1225, DOI 10.1101/gad.1081203; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Streiff J, 2004, ANESTH ANALG, V98, P660, DOI 10.1213/01.ANE.0000099367.97415.5F; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Tall GG, 2005, P NATL ACAD SCI USA, V102, P16584, DOI 10.1073/pnas.0508306102; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Wall MA, 1998, STRUCTURE, V6, P1169, DOI 10.1016/S0969-2126(98)00117-8; Willard FS, 2007, CELL SIGNAL, V19, P428, DOI 10.1016/j.cellsig.2006.07.013; Willard FS, 2006, CELL SIGNAL, V18, P1226, DOI 10.1016/j.cellsig.2005.10.003; Willard FS, 2005, ANAL BIOCHEM, V340, P341, DOI 10.1016/j.ab.2005.02.015; Willard FS, 2004, METHOD ENZYMOL, V389, P320; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Zwaal RR, 1996, CELL, V86, P619, DOI 10.1016/S0092-8674(00)80135-X	55	12	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21550	21558		10.1074/jbc.M803023200	http://dx.doi.org/10.1074/jbc.M803023200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18519563	Green Published, hybrid			2022-12-25	WOS:000257898800028
J	Lee, CW; Bhatt, S; Shukla, A; Desnoyer, RW; Yadav, SP; Kim, M; Jang, SH; Karnik, SS				Lee, ChangWoo; Bhatt, Sumantha; Shukla, Anita; Desnoyer, Russell W.; Yadav, Satya P.; Kim, Mijin; Jang, Sei-Heon; Karnik, Sadashiva S.			Site-specific cleavage of G protein-coupled receptor-engaged beta-arrestin - Influence of the AT(1) receptor conformation on scissile site selection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASES; ANGIOTENSIN-II; BETA(2)-ADRENERGIC RECEPTOR; ADRENERGIC-RECEPTOR; ACTIVE-STATE; ACTIVATION; PHOSPHORYLATION; BETA-ARRESTIN-2; INTERNALIZATION; MECHANISM	The discovery of beta-arrestin-related similar to 46-kDa polypeptide in transfected cells and mouse hearts led us to examine angiotensin II type 1 receptor (AT(1)R)-dependent proteolytic cleavage of beta-arrestin(s). Receptor-ligand induced proteolysis of beta-arrestin(s) is novel, especially in the endocrine system, since proteolytic and/or splice variants of nonvisual arrestins are unknown. We used a strategy to retrieve AT(1)R-engaged isoforms of beta-arrestin 1 to confirm direct interaction of fragments with this G protein-coupled receptor and determine cleavage sites. Here we show that the angiotensin II-AT(1)R complex is associated with full-length and similar to 46-kDa beta-arrestin forms. Mass spectrometric analysis of the AT(1)R-associated short form suggested a scissile site located within the Arg(363)-Arg(393) region in the bovine beta-arrestin 1. Edman degradation analysis of a beta-arrestin 1 C-terminal fragment fused to enhanced green fluorescent protein confirmed the major cleavage to be after Phe(388) and a minor cleavage after Asn(375). Rather unexpectedly, the inverse agonist EXP3174-bound AT(1)R generated different fragmentation of bovine beta-arrestin 1, at Pro(276). The angiotensin II-induced cleavage is independent of inositol 1,4,5-trisphosphateand Ca2+-mediated signaling pathways. The proteolysis of beta-arrestin 2 occurs, but the pattern is more complex. Our findings suggest that beta-arrestin cleavage upon AT(1)R stimulation is a part of the unraveling beta-arrestin-mediated G protein-coupled receptor signaling diversity.	[Karnik, Sadashiva S.] Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Lee, ChangWoo; Kim, Mijin; Jang, Sei-Heon] Daegu Univ, Dept Genet Engn, Gyongsan 712714, South Korea	Cleveland Clinic Foundation; Daegu University	Karnik, SS (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Cardiol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	karniks@ccf.org	Karnik, Sadashiva/Y-2477-2019	Karnik, Sadashiva/0000-0003-0746-2753	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057470] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL083243, R01 HL 57470, R01 HL057470, R01 HL064845] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ahn S, 2004, J BIOL CHEM, V279, P7807, DOI 10.1074/jbc.C300443200; AZARIAN SM, 1995, J BIOL CHEM, V270, P24375, DOI 10.1074/jbc.270.41.24375; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Diez J, 2006, CLIN THER, V28, P832, DOI 10.1016/j.clinthera.2006.06.002; Feng YH, 2005, HYPERTENSION, V46, P419, DOI 10.1161/01.HYP.0000172621.68061.22; Goodman OB, 1997, J BIOL CHEM, V272, P15017, DOI 10.1074/jbc.272.23.15017; Groarke DA, 1999, J BIOL CHEM, V274, P23263, DOI 10.1074/jbc.274.33.23263; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Holloway AC, 2002, MOL PHARMACOL, V61, P768, DOI 10.1124/mol.61.4.768; Hudson CC, 2006, METHOD ENZYMOL, V414, P63, DOI 10.1016/S0076-6879(06)14005-7; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; Hupfeld CJ, 2005, J BIOL CHEM, V280, P1016, DOI 10.1074/jbc.M403674200; Ji TH, 1998, J BIOL CHEM, V273, P17299, DOI 10.1074/jbc.273.28.17299; Laporte SA, 2000, J BIOL CHEM, V275, P23120, DOI 10.1074/jbc.M002581200; Lee C, 2007, FEBS LETT, V581, P2517, DOI 10.1016/j.febslet.2007.04.069; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Lin FT, 1997, J BIOL CHEM, V272, P31051, DOI 10.1074/jbc.272.49.31051; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; MENDELSON C, 1975, J BIOL CHEM, V250, P8818; Noda K, 1996, BIOCHEMISTRY-US, V35, P16435, DOI 10.1021/bi961593m; PALCZEWSKI K, 1994, PROTEIN SCI, V3, P314; Paradis P, 2000, P NATL ACAD SCI USA, V97, P931, DOI 10.1073/pnas.97.2.931; Perez DM, 2005, PHARMACOL REV, V57, P147, DOI 10.1124/pr.57.2.2; Qian HW, 2001, MOL ENDOCRINOL, V15, P1706, DOI 10.1210/me.15.10.1706; Reid JL, 2005, J RENIN-ANGIO-ALDO S, V6, P15, DOI 10.3317/jraas.2005.002; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; SMITH WC, 1994, J BIOL CHEM, V269, P15407; STERNEMARR R, 1993, J BIOL CHEM, V268, P15640; Thomas WG, 2000, J BIOL CHEM, V275, P2893, DOI 10.1074/jbc.275.4.2893; TIMMERMANS PBMWM, 1991, HYPERTENSION, V18, pS136; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302	36	3	3	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21612	21620		10.1074/jbc.M803062200	http://dx.doi.org/10.1074/jbc.M803062200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18505723	Green Published, hybrid			2022-12-25	WOS:000257898800034
J	Shan, B; Yao, TP; Nguyen, HT; Zhuo, Y; Levy, DR; Klingsberg, RC; Tao, H; Palmer, ML; Holder, KN; Lasky, JA				Shan, Bin; Yao, Tso-Pang; Nguyen, Hong T.; Zhuo, Ying; Levy, Dawn R.; Klingsberg, Ross C.; Tao, Hui; Palmer, Michael L.; Holder, Kevin N.; Lasky, Joseph A.			Requirement of HDAC6 for transforming growth factor-beta(1)-induced epithelial-mesenchymal transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; HISTONE DEACETYLASES; PULMONARY-FIBROSIS; ACTIVATION; RECEPTOR; IDENTIFICATION; POLYUBIQUITIN; ACETYLATION; EXPRESSION; INHIBITOR	The aberrant expression of transforming growth factor (TGF)-beta 1 in the tumor microenvironment and fibrotic lesions plays a critical role in tumor progression and tissue fibrosis by inducing epithelial-mesenchymal transition (EMT). EMT promotes tumor cell motility and invasiveness. How EMT affects motility and invasion is not well understood. Here we report that HDAC6 is a novel modulator of TGF-beta 1-induced EMT. HDAC6 is a microtubule-associated deacetylase that predominantly deacetylates nonhistone proteins, including alpha-tubulin, and regulates cell motility. We showed that TGF-beta 1-induced EMT is accompanied by HDAC6-dependent deacetylation of alpha-tubulin. Importantly, inhibition of HDAC6 by small interfering RNA or the small molecule inhibitor tubacin attenuated the TGF-alpha 1-induced EMT markers, such as the aberrant expression of epithelial and mesenchymal peptides, as well as the formation of stress fibers. Reduced expression of HDAC6 also impaired the activation of SMAD3 in response to TGF-beta 1. Conversely, inhibition of SMAD3 activation substantially impaired HDAC6-dependent deacetylation of alpha-tubulin as well as the expression of EMT markers. These findings reveal a novel function of HDAC6 in EMT by intercepting the TGF-beta-SMAD3 signaling cascade. Our results identify HDAC6 as a critical regulator of EMT and a potential therapeutic target against pathological EMT, a key event for tumor progression and fibrogenesis.	[Shan, Bin; Nguyen, Hong T.; Zhuo, Ying; Levy, Dawn R.; Klingsberg, Ross C.; Tao, Hui; Palmer, Michael L.; Holder, Kevin N.; Lasky, Joseph A.] Tulane Univ, Hlth Sci Ctr, Dept Med, New Orleans, LA 70112 USA; [Shan, Bin; Lasky, Joseph A.] Tulane Univ, Hlth Sci Ctr, Tulane Canc Ctr, New Orleans, LA 70112 USA; [Yao, Tso-Pang] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Tulane University; Tulane University; Duke University	Shan, B (corresponding author), Tulane Univ, Hlth Sci Ctr, Dept Med, 1430 Tulane Ave, New Orleans, LA 70112 USA.	bshan@tulane.edu		Shan, Bin/0000-0002-6869-2678	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054022] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 007973, HL 083901] Funding Source: Medline; NINDS NIH HHS [R01 NS054022-03, R01 NS054022] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Birukova AA, 2005, FEBS LETT, V579, P4031, DOI 10.1016/j.febslet.2005.06.018; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; Dong CM, 2000, MOL CELL, V5, P27, DOI 10.1016/S1097-2765(00)80400-1; Frid MG, 2002, CIRC RES, V90, P1189, DOI 10.1161/01.RES.0000021432.70309.28; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hook SS, 2002, P NATL ACAD SCI USA, V99, P13425, DOI 10.1073/pnas.172511699; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Jian HY, 2006, GENE DEV, V20, P666, DOI 10.1101/gad.1388806; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Li Y, 2008, J BIOL CHEM, V283, P12686, DOI 10.1074/jbc.C700185200; Murphy PJM, 2005, J BIOL CHEM, V280, P33792, DOI 10.1074/jbc.M506997200; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Phan SH, 2002, CHEST, V122, p286S, DOI 10.1378/chest.122.6_suppl.286S; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Roberts AB, 2006, CYTOKINE GROWTH F R, V17, P19, DOI 10.1016/j.cytogfr.2005.09.008; Saji S, 2005, ONCOGENE, V24, P4531, DOI 10.1038/sj.onc.1208646; Seigneurin-Berny D, 2001, MOL CELL BIOL, V21, P8035, DOI 10.1128/MCB.21.23.8035-8044.2001; Shan B, 2005, J BIOL CHEM, V280, P1103, DOI 10.1074/jbc.M406293200; Shan B, 2005, EXP CELL RES, V305, P10, DOI 10.1016/j.yexcr.2004.09.033; Shan B, 2003, J BIOL CHEM, V278, P44009, DOI 10.1074/jbc.M302671200; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Verdel A, 1999, J BIOL CHEM, V274, P2440, DOI 10.1074/jbc.274.4.2440; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Wu Z, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-1; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhu SK, 2004, CIRC RES, V94, P617, DOI 10.1161/01.RES.0000118599.25944.D5; Zhu SC, 2007, J BIOL CHEM, V282, P18327, DOI 10.1074/jbc.M700636200	36	124	134	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21065	21073		10.1074/jbc.M802786200	http://dx.doi.org/10.1074/jbc.M802786200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18499657	hybrid, Green Published			2022-12-25	WOS:000257746100048
J	Kim, JW; Song, PI; Jeong, MH; An, JH; Lee, SY; Jang, SM; Song, KH; Armstrong, CA; Choi, KH				Kim, Jung-Woong; Song, Peter I.; Jeong, Mi-Hee; An, Joo-Hee; Lee, So-Youn; Jang, Sang-Min; Song, Ki-Hyun; Armstrong, Cheryl A.; Choi, Kyung-Hee			TIP60 represses transcriptional activity of p73 beta via an MDM2-bridged ternary complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE ACETYLTRANSFERASE; DNA-DAMAGE; RECEPTOR COACTIVATOR; P53-RELATED PROTEIN; VIRAL ONCOPROTEINS; ANDROGEN RECEPTOR; P73; P53; APOPTOSIS; ACETYLATION	TIP60, a histone acetyl transferase, acts as a p53 coactivator by interfering with MDM2-mediated degradation of p53. However, little is known about its functional regulation of p73, which has structural features similar to p53. In this study we found that TIP60 represses apoptosis, which is induced by exogenous and endogenous p73 beta. TIP60 also negatively regulated the expression of p73 beta downstream target genes such as p21 and Bax. Moreover, the specific repression of p73 beta-mediated transactivation by TIP60 was independent of p53 expression and not due to histone deacetylase recruiting transcriptional machinery. Transcriptional activities of both p73splicing variants, p73 alpha and p73 beta, were also repressed by TIP60. Furthermore, TIP60 markedly enhanced p73 beta binding affinity to MDM2 and physically associated with MDM2 through its zinc finger domain, which is specifically localized in the nucleus. Therefore, we demonstrate that TIP60 forms a ternary complex with p73 beta, which is directly bridged by MDM2. It is important to note that our findings contribute to a functional linkage between TIP60 and p73 beta through MDM2 in the transcriptional regulation of cellular apoptosis.	[Kim, Jung-Woong; Jeong, Mi-Hee; An, Joo-Hee; Lee, So-Youn; Jang, Sang-Min; Song, Ki-Hyun; Choi, Kyung-Hee] Chung Ang Univ, Dept Life Sci, Dongjak Ku, Seoul 156756, South Korea; [Song, Peter I.; Armstrong, Cheryl A.] Univ Colorado, Hlth Sci Ctr, Dept Dermatol, Aurora, CO 80045 USA	Chung Ang University; University of Colorado System; University of Colorado Anschutz Medical Campus	Choi, KH (corresponding author), Chung Ang Univ, Dept Life Sci, Dongjak Ku, 221 Heuksuk Dong, Seoul 156756, South Korea.	khchoi@cau.ac.kr						Ai W, 2007, NUCLEIC ACIDS RES, V35, P6137, DOI 10.1093/nar/gkm656; Brady ME, 1999, J BIOL CHEM, V274, P17599, DOI 10.1074/jbc.274.25.17599; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Coates PJ, 2006, J PATHOL, V210, P385, DOI 10.1002/path.2080; Gaughan L, 2002, J BIOL CHEM, V277, P25904, DOI 10.1074/jbc.M203423200; Gavaravarapu S, 2000, BIOCHEM BIOPH RES CO, V269, P758, DOI 10.1006/bbrc.2000.2358; Gonzalez S, 2003, MOL CELL BIOL, V23, P8161, DOI 10.1128/MCB.23.22.8161-8171.2003; Halkidou K, 2003, ONCOGENE, V22, P2466, DOI 10.1038/sj.onc.1206342; Hlubek F, 2001, J BIOCHEM-TOKYO, V129, P635, DOI 10.1093/oxfordjournals.jbchem.a002901; Jeong MH, 2006, J BIOL CHEM, V281, P8707, DOI 10.1074/jbc.M513853200; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Kamine J, 1996, VIROLOGY, V216, P357, DOI 10.1006/viro.1996.0071; Kang KH, 2002, FEBS LETT, V522, P161, DOI 10.1016/S0014-5793(02)02921-6; Kim KC, 2001, ONCOGENE, V20, P6689, DOI 10.1038/sj.onc.1204839; Legube G, 2004, J BIOL CHEM, V279, P44825, DOI 10.1074/jbc.M407478200; Legube G, 2002, EMBO J, V21, P1704, DOI 10.1093/emboj/21.7.1704; Liu L, 1999, MOL CELL BIOL, V19, P1202; Marin MC, 1998, MOL CELL BIOL, V18, P6316, DOI 10.1128/MCB.18.11.6316; Mirnezami AH, 2003, CURR BIOL, V13, P1234, DOI 10.1016/S0960-9822(03)00454-8; Munarriz E, 2004, MOL CELL BIOL, V24, P10593, DOI 10.1128/MCB.24.24.10593-10610.2004; Oberst A, 2005, BIOCHEM BIOPH RES CO, V331, P707, DOI 10.1016/j.bbrc.2005.03.158; Ongkeko WM, 1999, CURR BIOL, V9, P829, DOI 10.1016/S0960-9822(99)80367-4; Ou YH, 2005, MOL BIOL CELL, V16, P1684, DOI 10.1091/mbc.E04-08-0689; Pozniak CD, 2000, SCIENCE, V289, P304, DOI 10.1126/science.289.5477.304; Pozniak CD, 2002, J NEUROSCI, V22, P9800; Rossi M, 2005, EMBO J, V24, P836, DOI 10.1038/sj.emboj.7600444; Roth J, 1999, J GEN VIROL, V80, P3251, DOI 10.1099/0022-1317-80-12-3251; Sapountzi V, 2006, INT J BIOCHEM CELL B, V38, P1496, DOI 10.1016/j.biocel.2006.03.003; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Smith ER, 1998, P NATL ACAD SCI USA, V95, P3561, DOI 10.1073/pnas.95.7.3561; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Takechi S, 1999, BIOCHEM BIOPH RES CO, V266, P405, DOI 10.1006/bbrc.1999.1836; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Wang JD, 2008, BBA-MOL CELL RES, V1783, P224, DOI 10.1016/j.bbamcr.2007.09.004; Watson IR, 2006, J BIOL CHEM, V281, P34096, DOI 10.1074/jbc.M603654200; Xiao H, 2003, J BIOL CHEM, V278, P11197, DOI 10.1074/jbc.M210816200; Yamamoto T, 1997, J BIOL CHEM, V272, P30595, DOI 10.1074/jbc.272.49.30595; Yang XJ, 2004, NUCLEIC ACIDS RES, V32, P959, DOI 10.1093/nar/gkh252; Zeng XY, 2000, MOL CELL BIOL, V20, P1299, DOI 10.1128/MCB.20.4.1299-1310.2000; Zeng XY, 1999, MOL CELL BIOL, V19, P3257; Zhu JH, 1998, CANCER RES, V58, P5061	42	15	16	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20077	20086		10.1074/jbc.M800161200	http://dx.doi.org/10.1074/jbc.M800161200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18499675	hybrid			2022-12-25	WOS:000257565300024
J	Musiek, ES; Brooks, JD; Joo, M; Brunoldi, E; Porta, A; Zanoni, G; Vidari, G; Blackwell, TS; Montine, TJ; Milne, GL; McLaughlin, B; Morrow, JD				Musiek, Erik S.; Brooks, Joshua D.; Joo, Myungsoo; Brunoldi, Enrico; Porta, Alessio; Zanoni, Giuseppe; Vidari, Giovanni; Blackwell, Timothy S.; Montine, Thomas J.; Milne, Ginger L.; McLaughlin, BethAnn; Morrow, Jason D.			Electrophilic cyclopentenone neuroprostanes are anti-inflammatory mediators formed from the peroxidation of the omega-3 polyunsaturated fatty acid docosahexaenoic acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; LIPID-PEROXIDATION; ALZHEIMER-DISEASE; F-RING; EXPRESSION; GAMMA; FISH; INFLAMMATION; ISOPROSTANES; MOUSE	The omega-3 polyunsaturated fatty acid docosahexaenoic acid (DHA) possesses potent anti-inflammatory properties and has shown therapeutic benefit in numerous inflammatory diseases. However, the molecular mechanisms of these anti-inflammatory properties are poorly understood. DHA is highly susceptible to peroxidation, which yields an array of potentially bioactive lipid species. One class of compounds are cyclopentenone neuroprostanes (A(4)/J(4)-NPs), which are highly reactive and similar in structure to anti-inflammatory cyclopentenone prostaglandins. Here we show that a synthetic A(4)/J(4)-NP, 14-A(4)-NP (A(4)-NP), potently suppresses lipopolysaccharide-induced expression of inducible nitric-oxide synthase and cyclooxygenase-2 in macrophages. Furthermore, A(4)-NP blocks lipopolysaccharide-induced NF-kappa B activation via inhibition of I kappa kinase-mediated phosphorylation of I kappa B alpha. Mutation on I kappa kinase beta cysteine 179 markedly diminishes the effect of A(4)-NP, suggesting that A(4)-NP acts via thiol modification at this residue. Accordingly, the effects of A(4)-NP are independent of peroxisome proliferator-activated receptor-gamma and are dependent on an intact reactive cyclopentenone ring. Interestingly, free radical-mediated oxidation of DHA greatly enhances its anti-inflammatory potency, an effect that closely parallels the formation of A(4)/J(4)-NPs. Furthermore, chemical reduction or conjugation to glutathione, both of which eliminate the bioactivity of A(4)-NP, also abrogate the anti-inflammatory effects of oxidized DHA. Thus, we have demonstrated that A(4)/J(4)-NPs, formed via the oxidation of DHA, are potent inhibitors of NF-kappa B signaling and may contribute to the antiinflammatory actions of DHA. These findings have implications for understanding the anti-inflammatory properties of omega-3 fatty acids, and elucidate novel interactions between lipid peroxidation products and inflammation.	[Musiek, Erik S.; Brooks, Joshua D.; Milne, Ginger L.; Morrow, Jason D.] Vanderbilt Univ, Med Ctr, Div Clin Pharmacol, Nashville, TN 37232 USA; [Blackwell, Timothy S.] Vanderbilt Univ, Med Ctr, Div Pulm & Crit Care Med, Nashville, TN 37232 USA; [McLaughlin, BethAnn] Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN 37232 USA; [Joo, Myungsoo; Brunoldi, Enrico; Porta, Alessio; Zanoni, Giuseppe; Vidari, Giovanni] Univ Pavia, Dept Organ Chem, I-27100 Pavia, Italy; [Montine, Thomas J.] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98104 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Pavia; University of Washington; University of Washington Seattle	Morrow, JD (corresponding author), Vanderbilt Univ, Med Ctr, Div Clin Pharmacol, 536 RRB,2222 Pierce Ave, Nashville, TN 37232 USA.	jason.morrow@vanderbilt.edu	McLaughlin, BethAnn/D-9580-2012; Milne, Ginger/D-7648-2014	McLaughlin, BethAnn/0000-0003-0228-6500; Milne, Ginger/0000-0003-3890-151X; Musiek, Erik/0000-0002-8873-0360; PORTA, ALESSIO/0000-0002-2564-9696; Vidari, Giovanni/0000-0003-4606-2154	NCI NIH HHS [CA 77839] Funding Source: Medline; NIDDK NIH HHS [DK 48831] Funding Source: Medline; NIEHS NIH HHS [ES 13125] Funding Source: Medline; NIGMS NIH HHS [GM 15431] Funding Source: Medline; NINDS NIH HHS [R01 NS050396, R01 NS050396-04] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA077839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES013125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM015431, P01GM015431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050396] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ATSMON J, 1990, CANCER RES, V50, P1879; Belluzzi A, 1996, NEW ENGL J MED, V334, P1557, DOI 10.1056/NEJM199606133342401; Blackwell TS, 2000, AM J RESP CRIT CARE, V162, P1095, DOI 10.1164/ajrccm.162.3.9906129; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Calon F, 2004, NEURON, V43, P633, DOI 10.1016/j.neuron.2004.08.013; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Chun KS, 2004, BIOCHEM PHARMACOL, V68, P1089, DOI 10.1016/j.bcp.2004.05.031; DECATERINA R, 1994, ARTERIOSCLER THROMB, V14, P1829, DOI 10.1161/01.ATV.14.11.1829; Fam SS, 2002, J BIOL CHEM, V277, P36076, DOI 10.1074/jbc.M205638200; Fan YY, 2004, J IMMUNOL, V173, P6151, DOI 10.4049/jimmunol.173.10.6151; GONZALEZ MJ, 1992, J NUTR, V122, P2190, DOI 10.1093/jn/122.11.2190; Ji C, 2001, J BIOL CHEM, V276, P18223, DOI 10.1074/jbc.M101266200; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Komatsu W, 2003, FREE RADICAL BIO MED, V34, P1006, DOI 10.1016/S0891-5849(03)00027-3; Lee JY, 2003, J BIOL CHEM, V278, P37041, DOI 10.1074/jbc.M305213200; Li H, 2005, KIDNEY INT, V67, P867, DOI 10.1111/j.1523-1755.2005.00151.x; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; Massaro M, 2006, P NATL ACAD SCI USA, V103, P15184, DOI 10.1073/pnas.0510086103; McGeer EG, 1998, EXP GERONTOL, V33, P371, DOI 10.1016/S0531-5565(98)00013-8; Milne GL, 2004, CHEM RES TOXICOL, V17, P17, DOI 10.1021/tx034213o; Montine TJ, 2005, AM J PATHOL, V166, P1283, DOI 10.1016/S0002-9440(10)62347-4; Mori Trevor A, 2004, Curr Atheroscler Rep, V6, P461, DOI 10.1007/s11883-004-0087-5; Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P940, DOI 10.1001/archneur.60.7.940; MORROW JD, 1994, J BIOL CHEM, V269, P4317; Musiek ES, 2005, J BIOL CHEM, V280, P35562, DOI 10.1074/jbc.M504785200; Musiek ES, 2004, J CHROMATOGR B, V799, P95, DOI 10.1016/j.jchromb.2003.10.036; Nathan C, 2005, J EXP MED, V202, P1163, DOI 10.1084/jem.20051529; Perez-Sala D, 2002, ANN NY ACAD SCI, V973, P533, DOI 10.1111/j.1749-6632.2002.tb04695.x; PORTER NA, 1995, LIPIDS, V30, P277, DOI 10.1007/BF02536034; Reich EE, 2001, AM J PATHOL, V158, P293, DOI 10.1016/S0002-9440(10)63968-5; Reich EE, 2000, BIOCHEMISTRY-US, V39, P2376, DOI 10.1021/bi992000l; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Roberts LJ, 1998, J BIOL CHEM, V273, P13605, DOI 10.1074/jbc.273.22.13605; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Schaefer EJ, 2006, ARCH NEUROL-CHICAGO, V63, P1545, DOI 10.1001/archneur.63.11.1545; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Sun YP, 2007, J BIOL CHEM, V282, P9323, DOI 10.1074/jbc.M609212200; Volker D, 2000, J RHEUMATOL, V27, P2343; Weldon SM, 2007, J NUTR BIOCHEM, V18, P250, DOI 10.1016/j.jnutbio.2006.04.003; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; XIE QW, 1994, J BIOL CHEM, V269, P4705; Zanoni G, 2007, J ORG CHEM, V72, P9698, DOI 10.1021/jo701719f	43	111	121	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					19927	19935		10.1074/jbc.M803625200	http://dx.doi.org/10.1074/jbc.M803625200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18490445	hybrid, Green Published			2022-12-25	WOS:000257565300008
J	Swietach, P; Wigfield, S; Cobden, P; Supuran, CT; Harris, AL; Vaughan-Jones, RD				Swietach, Pawel; Wigfield, Simon; Cobden, Philip; Supuran, Claudiu T.; Harris, Adrian L.; Vaughan-Jones, Richard D.			Tumor-associated carbonic anhydrase 9 spatially coordinates intracellular pH in three-dimensional multicellular growths	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBONIC-ANHYDRASE-IX; CYTOPLASMIC PH; CA-IX; HYPOXIA; EXPRESSION; CARCINOMA; MARKER; OXYGEN; CELLS; PROLIFERATION	CA9 is a membrane-tethered, carbonic anhydrase (CA) enzyme, expressed mainly at the external surface of cells, that catalyzes reversible CO2 hydration. Expression is greatly enhanced in many tumors, particularly in aggressive carcinomas. The functional role of CA9 in tumors is not well established. Here we show that CA9, when expressed heterologously in cultured spheroids (0.5-mm diameter, similar to 25,000 cells) of RT112 cells (derived from bladder carcinoma), induces a near-uniform intracellular pH (pH(i)) throughout the structure. Dynamic pH(i) changes during displacements of superfusate CO2 concentration are also spatially coincident (within 2 s). In contrast, spheroids of wild-type RT112 cells lacking CA9 exhibit an acidic core (similar to 0.25 pH(i) reduction) and significant time delays (similar to 9 s) for pH(i) changes in core versus peripheral regions. pH(i) non-uniformity also occurs in CA9-expressing spheroids after selective pharmacological inhibition of the enzyme. In isolated RT112 cells, pH(i) regulation is unaffected by CA9 expression. The influence of CA9 on pH(i) is thus only evident in multicellular tissue. Diffusion-reaction modeling indicates that CA9 coordinates pH(i) spatially by facilitating CO2 diffusion in the unstirred extracellular space of the spheroid. We suggest that pH(i) coordination may favor survival and growth of a tumor. By disrupting spatial pH(i) control, inhibition of CA9 activity may offer a novel strategy for the clinical treatment of CA9-associated tumors.	[Swietach, Pawel; Cobden, Philip; Vaughan-Jones, Richard D.] Burdon Sanderson Cardiac Sci Ctr, Dept Physiol Anat & Genet, Oxford OX1 3PT, England; [Wigfield, Simon; Harris, Adrian L.] Weatherall Inst Mol Med, Oxford OX3 9DS, England; [Supuran, Claudiu T.] Univ Florence, Lab Chim Bioinorgan, I-50019 Florence, Italy	University of Oxford; University of Oxford; University of Florence	Vaughan-Jones, RD (corresponding author), Burdon Sanderson Cardiac Sci Ctr, Dept Physiol Anat & Genet, Oxford OX1 3PT, England.	richard.vaughan-jones@dpag.ox.ac.uk	Swietach, Pawel/AAK-4169-2020; Supuran, Claudiu T/A-5151-2008; Harris, Adrian L/ABA-3343-2020	Swietach, Pawel/0000-0002-9945-9473; Harris, Adrian L/0000-0003-1376-8409; Supuran, Claudiu/0000-0003-4262-0323	British Heart Foundation Funding Source: Medline; Cancer Research UK Funding Source: Medline; Medical Research Council [G0700698] Funding Source: Medline	British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Airley RE, 2003, INT J CANCER, V104, P85, DOI 10.1002/ijc.10904; Alvarez BV, 2003, BIOCHEMISTRY-US, V42, P12321, DOI 10.1021/bi0353124; Becker HM, 2007, J BIOL CHEM, V282, P13508, DOI 10.1074/jbc.M700066200; Boron WF, 2004, ADV PHYSIOL EDUC, V28, P160, DOI 10.1152/advan.00045.2004; BOYARSKY G, 1988, AM J PHYSIOL, V255, pC844, DOI 10.1152/ajpcell.1988.255.6.C844; CARLSSON J, 1988, INT J CANCER, V42, P715, DOI 10.1002/ijc.2910420515; Casey JR, 2004, J MED CHEM, V47, P2337, DOI 10.1021/jm031079w; Chia SK, 2001, J CLIN ONCOL, V19, P3660, DOI 10.1200/JCO.2001.19.16.3660; Gatenby RA, 2006, CANCER RES, V66, P5216, DOI 10.1158/0008-5472.CAN-05-4193; Geers C, 2000, PHYSIOL REV, V80, P681, DOI 10.1152/physrev.2000.80.2.681; Generali D, 2006, ENDOCR-RELAT CANCER, V13, P921, DOI 10.1677/erc.1.01216; Giatromanolaki A, 2001, CANCER RES, V61, P7992; GILLIES R J, 1992, Cellular Physiology and Biochemistry, V2, P159, DOI 10.1159/000154638; Griffiths J R, 2001, Novartis Found Symp, V240, P46; Helmlinger G, 2002, CLIN CANCER RES, V8, P1284; HEMING TA, 1994, J APPL PHYSIOL, V77, P697, DOI 10.1152/jappl.1994.77.2.697; HOCHACHKA PW, 1983, SCIENCE, V219, P1391, DOI 10.1126/science.6298937; HOLM E, 1995, CANCER RES, V55, P1373; ISFORT RJ, 1993, EUR J BIOCHEM, V213, P349, DOI 10.1111/j.1432-1033.1993.tb17768.x; Ivanov S, 2001, AM J PATHOL, V158, P905, DOI 10.1016/S0002-9440(10)64038-2; Ivanov SV, 1998, P NATL ACAD SCI USA, V95, P12596, DOI 10.1073/pnas.95.21.12596; Kivela AJ, 2001, DIGEST DIS SCI, V46, P2179, DOI 10.1023/A:1011910931210; Kunz-Schughart LA, 1998, INT J EXP PATHOL, V79, P1, DOI 10.1046/j.1365-2613.1998.00051.x; Lee AH, 1998, CANCER RES, V58, P1901; Leek RD, 2005, CANCER RES, V65, P4147, DOI 10.1158/0008-5472.CAN-04-2184; Leem CH, 1999, J PHYSIOL-LONDON, V517, P159, DOI 10.1111/j.1469-7793.1999.0159z.x; Leem CH, 1998, J PHYSIOL-LONDON, V509, P471, DOI 10.1111/j.1469-7793.1998.471bn.x; Lin TY, 2008, AM J PHYSIOL-CELL PH, V294, pC1250, DOI 10.1152/ajpcell.00021.2008; Loncaster JA, 2001, CANCER RES, V61, P6394; Lu J, 2006, J BIOL CHEM, V281, P19241, DOI 10.1074/jbc.M602181200; MAREN TH, 1967, PHYSIOL REV, V47, P595, DOI 10.1152/physrev.1967.47.4.595; Morgan PE, 2007, AM J PHYSIOL-CELL PH, V293, pC738, DOI 10.1152/ajpcell.00157.2007; MUSGROVE E, 1987, EXP CELL RES, V172, P65, DOI 10.1016/0014-4827(87)90093-0; Olive PL, 2001, CANCER RES, V61, P8924; Parkkila S, 2000, P NATL ACAD SCI USA, V97, P2220, DOI 10.1073/pnas.040554897; PASTOREKOVA S, 1992, VIROLOGY, V187, P620, DOI 10.1016/0042-6822(92)90464-Z; Robertson N, 2004, CANCER RES, V64, P6160, DOI 10.1158/0008-5472.CAN-03-2224; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sterling D, 2001, J BIOL CHEM, V276, P47886, DOI 10.1074/jbc.M105959200; Stewart AK, 1999, J PHYSIOL-LONDON, V516, P209, DOI 10.1111/j.1469-7793.1999.209aa.x; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Svastova E, 2004, FEBS LETT, V577, P439, DOI 10.1016/j.febslet.2004.10.043; Swietach P, 2007, CANCER METAST REV, V26, P299, DOI 10.1007/s10555-007-9064-0; TEICHER BA, 1993, ANTICANCER RES, V13, P1549; VAUPEL P, 1989, CANCER RES, V49, P6449; WARBURG O, 1930, METABOLISM TUMORS; Wingo T, 2001, BIOCHEM BIOPH RES CO, V288, P666, DOI 10.1006/bbrc.2001.5824; Wykoff CC, 2000, CANCER RES, V60, P7075	48	176	180	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20473	20483		10.1074/jbc.M801330200	http://dx.doi.org/10.1074/jbc.M801330200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18482982	hybrid			2022-12-25	WOS:000257565300061
J	Yao, HJ; Li, PX; Venters, BJ; Zheng, S; Thompson, PR; Pugh, BF; Wang, YM				Yao, Hongjie; Li, Pingxin; Venters, Bryan J.; Zheng, Suting; Thompson, Paul R.; Pugh, B. Franklin; Wang, Yanming			Histone Arg modifications and p53 regulate the expression of OKL38, a mediator of apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGININE METHYLATION; STRUCTURAL-CHARACTERIZATION; TRANSCRIPTIONAL ACTIVATION; GROWTH INHIBITOR; PROTEIN; GENE; DEIMINATION; DEATH; METHYLTRANSFERASE; NUCLEOPHOSMIN/B23	Protein Arg methyltransferases function as coactivators of the tumor suppressor p53 to regulate gene expression. Peptidylarginine deiminase 4 (PAD4/PADI4) counteracts the functions of protein Arg methyltransferases in gene regulation by deimination and demethylimination. Here we show that the expression of a tumor suppressor gene, OKL38, is activated by the inhibition of PAD4 or the activation of p53 following DNA damage. Chromatin immunoprecipitation assays showed a dynamic change of p53 and PAD4 occupancy and histone Arg modifications at the OKL38 promoter during DNA damage, suggesting a direct role of PAD4 and p53 in the expression of OKL38. Furthermore, we found that OKL38 induces apoptosis through localization to mitochondria and induction of cytochrome c release. Together, our studies identify OKL38 as a novel p53 target gene that is regulated by PAD4 and plays a role in apoptosis.	[Yao, Hongjie; Li, Pingxin; Venters, Bryan J.; Zheng, Suting; Pugh, B. Franklin; Wang, Yanming] Penn State Univ, Dept Biochem & Mol Biol, Ctr Gene Regulat, University Pk, PA 16802 USA; [Thompson, Paul R.] Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Wang, YM (corresponding author), 332 S Frear, University Pk, PA 16802 USA.	yuw12@psu.edu	Zheng, Suting/B-7382-2013	Wang, Yanming/0000-0002-0710-043X	NCI NIH HHS [R01 CA136856] Funding Source: Medline; NIGMS NIH HHS [R01 GM079357, R01 GM079357-02, GM 079357] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA136856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079357] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Balint BL, 2005, MOL CELL BIOL, V25, P5648, DOI 10.1128/MCB.25.13.5648-5663.2005; Bauer UM, 2002, EMBO REP, V3, P39, DOI 10.1093/embo-reports/kvf013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Brooks C, 2007, P NATL ACAD SCI USA, V104, P11649, DOI 10.1073/pnas.0703976104; Cereghetti GM, 2006, ONCOGENE, V25, P4717, DOI 10.1038/sj.onc.1209605; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; Esteller M, 2006, BRIT J CANCER, V94, P179, DOI 10.1038/sj.bjc.6602918; Hagiwara T, 2002, BIOCHEM BIOPH RES CO, V290, P979, DOI 10.1006/bbrc.2001.6303; HALAZONETIS TD, 1993, EMBO J, V12, P5057, DOI 10.1002/j.1460-2075.1993.tb06199.x; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Huang SM, 2005, GENE DEV, V19, P1885, DOI 10.1101/gad.1333905; Huynh H, 2001, ENDOCRINOLOGY, V142, P3607, DOI 10.1210/en.142.8.3607; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; LI P, 2008, MOL CELL BI IN PRESS; Li RS, 2007, J LIPID RES, V48, P709, DOI 10.1194/jlr.M600501-JLR200; Luo Y, 2006, BIOCHEMISTRY-US, V45, P11727, DOI 10.1021/bi061180d; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Mund C, 2006, EPIGENETICS-US, V1, P7; Nakashima K, 2002, J BIOL CHEM, V277, P49562, DOI 10.1074/jbc.M208795200; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Okada M, 2007, J BIOL CHEM, V282, P36744, DOI 10.1074/jbc.M706169200; Ong CK, 2007, ONCOGENE, V26, P1155, DOI 10.1038/sj.onc.1209896; Ong CK, 2004, ENDOCRINOLOGY, V145, P4763, DOI 10.1210/en.2004-0446; Ong CK, 2004, J BIOL CHEM, V279, P743, DOI 10.1074/jbc.M308668200; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; SELVAKUMARAN M, 1994, ONCOGENE, V9, P1791; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Wang T, 2005, J BIOL CHEM, V280, P4374, DOI 10.1074/jbc.M408708200; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697	43	108	111	4	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20060	20068		10.1074/jbc.M802940200	http://dx.doi.org/10.1074/jbc.M802940200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18499678	Green Published, hybrid			2022-12-25	WOS:000257565300022
J	Fouchet, D; Regoes, R				Fouchet, David; Regoes, Roland			A Population Dynamics Analysis of the Interaction between Adaptive Regulatory T Cells and Antigen Presenting Cells	PLOS ONE			English	Article								Background: Regulatory T cells are central actors in the maintenance of tolerance of self-antigens or allergens and in the regulation of the intensity of the immune response during infections by pathogens. An understanding of the network of the interaction between regulatory T cells, antigen presenting cells and effector T cells is starting to emerge. Dynamical systems analysis can help to understand the dynamical properties of an interaction network and can shed light on the different tasks that can be accomplished by a network. Methodology and Principal Findings: We used a mathematical model to describe a interaction network of adaptive regulatory T cells, in which mature precursor T cells may differentiate into either adaptive regulatory T cells or effector T cells, depending on the activation state of the cell by which the antigen was presented. Using an equilibrium analysis of the mathematical model we show that, for some parameters, the network has two stable equilibrium states: one in which effector T cells are strongly regulated by regulatory T cells and another in which effector T cells are not regulated because the regulatory T cell population is vanishingly small. We then simulate different types of perturbations, such as the introduction of an antigen into a virgin system, and look at the state into which the system falls. We find that whether or not the interaction network switches from the regulated (tolerant) state to the unregulated state depends on the strength of the antigenic stimulus and the state from which the network has been perturbed. Conclusion/Significance: Our findings suggest that the interaction network studied in this paper plays an essential part in generating and maintaining tolerance against allergens and self-antigens.	[Fouchet, David; Regoes, Roland] ETH, ETH Zentrum, Inst Integrat Biol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Fouchet, D (corresponding author), ETH, ETH Zentrum, Inst Integrat Biol, Zurich, Switzerland.	david.fouchet@env.ethz.ch	Regoes, Roland R/A-6538-2008	Regoes, Roland R/0000-0001-8319-5293	Swiss National Science Fundation	Swiss National Science Fundation(Swiss National Science Foundation (SNSF))	RRR greatfully acknowledges the financial support of the Swiss National Science Fundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar AN, 2003, IMMUNOLOGY, V109, P319, DOI 10.1046/j.1365-2567.2003.01678.x; Asseman C, 2003, J IMMUNOL, V171, P971, DOI 10.4049/jimmunol.171.2.971; Bacchetta R, 2002, EUR J IMMUNOL, V32, P2237, DOI 10.1002/1521-4141(200208)32:8<2237::AID-IMMU2237>3.0.CO;2-2; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Burroughs NJ, 2006, J THEOR BIOL, V241, P134, DOI 10.1016/j.jtbi.2005.11.010; Carneiro J, 2007, IMMUNOL REV, V216, P48; CAUX C, 1994, J EXP MED, V180, P1263, DOI 10.1084/jem.180.4.1263; Dhodapkar MV, 2001, J EXP MED, V193, P233, DOI 10.1084/jem.193.2.233; Dieckmann D, 2002, J EXP MED, V196, P247, DOI 10.1084/jem.20020642; Elston DM, 2006, J AM ACAD DERMATOL, V54, P172, DOI 10.1016/j.jaad.2005.09.020; Fairweather D, 2005, REV MED VIROL, V15, P17, DOI 10.1002/rmv.445; Garza KM, 2000, J IMMUNOL, V164, P3982, DOI 10.4049/jimmunol.164.8.3982; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Hawrylowicz CM, 2005, NAT REV IMMUNOL, V5, P271, DOI 10.1038/nri1589; HORAK I, 1995, CLIN IMMUNOL IMMUNOP, V76, P172; Jonuleit H, 2003, J IMMUNOL, V171, P6323, DOI 10.4049/jimmunol.171.12.6323; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; Jonuleit H, 2001, TRENDS IMMUNOL, V22, P394, DOI 10.1016/S1471-4906(01)01952-4; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Koya T, 2007, J ALLERGY CLIN IMMUN, V119, P1241, DOI 10.1016/j.jaci.2007.01.039; Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X; Leon K, 2000, J THEOR BIOL, V207, P231, DOI 10.1006/jtbi.2000.2169; Ling EM, 2004, LANCET, V363, P608, DOI 10.1016/S0140-6736(04)15592-X; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Malek TR, 2004, NAT REV IMMUNOL, V4, P665, DOI 10.1038/nri1435; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; MODIGLIANI Y, 1995, P NATL ACAD SCI USA, V92, P7555, DOI 10.1073/pnas.92.16.7555; MORRISSEY PJ, 1993, J EXP MED, V178, P237, DOI 10.1084/jem.178.1.237; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Penna G, 2005, MICROBES INFECT, V7, P1033, DOI 10.1016/j.micinf.2005.03.025; Powrie F, 2003, SCIENCE, V299, P1030, DOI 10.1126/science.1082031; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Rose NR, 2001, J CLIN INVEST, V107, P943, DOI 10.1172/JCI12673; Rovere-Querini P, 2005, AUTOIMMUN REV, V4, P555, DOI 10.1016/j.autrev.2005.04.013; SAKAGUCHI S, 1985, J EXP MED, V161, P72, DOI 10.1084/jem.161.1.72; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; SMITH H, 1992, J IMMUNOL, V149, P2212; Steinbrink K, 1997, J IMMUNOL, V159, P4772; Steinbrink K, 2002, BLOOD, V99, P2468, DOI 10.1182/blood.V99.7.2468; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Veldman C, 2006, INT ARCH ALLERGY IMM, V140, P174, DOI 10.1159/000092576; Wakkach A, 2003, IMMUNITY, V18, P605, DOI 10.1016/S1074-7613(03)00113-4; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490	46	22	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2306	10.1371/journal.pone.0002306	http://dx.doi.org/10.1371/journal.pone.0002306			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509463	Green Published, Green Submitted, gold			2022-12-25	WOS:000262268500041
J	Miller, RA; Christoforou, N; Pevsner, J; McCallion, AS; Gearhart, JD				Miller, Ronald A.; Christoforou, Nicolas; Pevsner, Jonathan; McCallion, Andrew S.; Gearhart, John D.			Efficient Array-Based Identification of Novel Cardiac Genes through Differentiation of Mouse ESCs	PLOS ONE			English	Article								Remarkably, although cardiac disease accounts for the largest proportion of adult mortality and morbidity in the industrialized world, the genetic programs controlling early cardiogenesis are largely incompletely understood. To better understand this process, we set out to identify genes whose expression is enriched within early cardiac fated populations, obtaining the transcriptional signatures of mouse embryonic stem cells (mESCs) at defined intervals during their differentiation along a cardiac path. We compared the RNA profiles of cardiac precursors cells (CPCs) with time-matched non-CPCs and undifferentiated mESCs, using a transgenic mESC line harboring an Nkx2-5 cardiac-specific regulatory sequence driving green fluorescent protein (GFP) to facilitate selection of CPCs. We identify 176 transcripts that are significantly elevated in their abundance within CPCs compared with other assayed populations, predicting that they will likely play a role in cardiogenesis. Of note, approximately 24% (43/176) of the cardiogenic candidate transcripts have known roles in cardiac function or development. Importantly, we evaluated the biological relevance of a significant subset 31/133 (23%) of the remaining candidate genes by in situ hybridization at multiple time points during development (embryonic day, E7.5-9.5) and report that all were expressed in key cardiac structures during cardiogenesis. Furthermore 9/31, of which many were previously uncharacterized, were detected as early as the formation of the cardiac crescent. These data demonstrate the potential power of integrating genomic approaches with mESC differentiation to illuminate developmental processes, and provides a valuable resource that may be mined to further elucidate the genetic programs underlying cardiogenesis.	[Miller, Ronald A.; Christoforou, Nicolas; Gearhart, John D.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21218 USA; [Miller, Ronald A.; Pevsner, Jonathan; McCallion, Andrew S.; Gearhart, John D.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Pevsner, Jonathan] Kennedy Krieger Inst, Baltimore, MD USA; [Gearhart, John D.] Johns Hopkins Univ, Sch Med, Dept Obstet & Gynecol, Baltimore, MD USA; [McCallion, Andrew S.] Johns Hopkins Univ, Sch Med, Dept Mol & Comparative Pathobiol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Kennedy Krieger Institute; Johns Hopkins University; Johns Hopkins University	Miller, RA (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21218 USA.	amccalli@jhmi.edu; gearhart@jhmi.edu			Institute for Cell Engineering of Johns Hopkins Medicine; Armstrong Fellow in Regenerative medicine; NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071648] Funding Source: NIH RePORTER	Institute for Cell Engineering of Johns Hopkins Medicine; Armstrong Fellow in Regenerative medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Institute for Cell Engineering of Johns Hopkins Medicine for provided the funding for this research (JDG). NC is an Armstrong Fellow in Regenerative medicine. ASM was additionally supported by grants from NIH.	Abu-Issa R, 2004, DEV BIOL, V272, P281, DOI 10.1016/j.ydbio.2004.05.016; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BODMER R, 1993, DEVELOPMENT, V118, P719; Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; CHRISTOFOROU N, 2008, J CLIN INVEST; Eppig JT, 2007, NUCLEIC ACIDS RES, V35, pD630, DOI 10.1093/nar/gkl940; Gibson-Brown JJ, 1998, DEVELOPMENT, V125, P2499; Harvey RP, 2002, NAT REV GENET, V3, P544, DOI 10.1038/nrg843; Hescheler J, 1997, CARDIOVASC RES, V36, P149, DOI 10.1016/S0008-6363(97)00193-4; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kasahara H, 1998, CIRC RES, V82, P936, DOI 10.1161/01.RES.82.9.936; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kelly RG, 2001, DEV CELL, V1, P435, DOI 10.1016/S1534-5807(01)00040-5; Lien CL, 1999, DEVELOPMENT, V126, P75; LYONS I, 1995, GENE DEV, V9, P1954; MALTSEV VA, 1993, MECH DEVELOP, V44, P41, DOI 10.1016/0925-4773(93)90015-P; Masino AM, 2004, CIRC RES, V95, P389, DOI 10.1161/01.RES.0000138302.02691.be; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Stennard FA, 2003, DEV BIOL, V262, P206, DOI 10.1016/S0012-1606(03)00385-3; Takahashi T, 2003, CIRCULATION, V107, P1912, DOI 10.1161/01.CIR.0000064899.53876.A3; Tam PPL, 1997, DEVELOPMENT, V124, P1631; Thomas T, 1998, DEV BIOL, V196, P228, DOI 10.1006/dbio.1998.8849; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028	26	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2176	10.1371/journal.pone.0002176	http://dx.doi.org/10.1371/journal.pone.0002176			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478100	Green Published, Green Submitted, gold			2022-12-25	WOS:000262172800041
J	Wang, BE; Wang, XD; Ernst, JA; Polakis, P; Gao, WQ				Wang, Bu-Er; Wang, Xi-De; Ernst, James A.; Polakis, Paul; Gao, Wei-Qiang			Regulation of Epithelial Branching Morphogenesis and Cancer Cell Growth of the Prostate by Wnt Signaling	PLOS ONE			English	Article								Although Wnt signaling has been shown to be important for embryonic morphogenesis and cancer pathogenesis of several tissues, its role in prostatic development and tumorigenesis is not well understood. Here we show that Wnt signaling regulated prostatic epithelial branching morphogenesis and luminal epithelial cell differentiation in developing rat prostate organ cultures. Specifically, Wnt signaling regulated the proliferation of prostate epithelial progenitor cells. Assessment of the expression levels of a Wnt pathway transcriptional target gene, Axin2, showed that the Wnt pathway was activated in the developing prostate, but was down-regulated in the adult. Castration resulted in an upregulation of Axin2 whereas androgen replacement resulted in a down regulation of Axin2. Such dynamic changes of Wnt activity was also confirmed in a BAT-gal transgenic mouse line in which beta-galactosidase reporter is expressed under the control of beta-catenin/T cell factor responsive elements. Furthermore, we evaluated the role of Wnt signaling in prostate tumorigenesis. Axin2 expression was found upregulated in the majority of human prostate cancer cell lines examined. Moreover, addition of a Wnt pathway inhibitor, Dickkopf 1 (DKK1), into the culture medium significantly inhibited prostate cancer cell growth and migration. These findings suggest that Wnt signaling regulates prostatic epithelial ductal branching morphogenesis by influencing cell proliferation, and highlights a role for Wnt pathway activation in prostatic cancer progression.	[Wang, Bu-Er; Wang, Xi-De; Gao, Wei-Qiang] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Ernst, James A.] Genentech Inc, Dept Protein Chem & Protein Engn, San Francisco, CA USA; [Polakis, Paul] Genentech Inc, Dept Canc Target & Pathways, San Francisco, CA USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Wang, BE (corresponding author), Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA.	gao@gene.com	Gao, Wei/GXH-0380-2022; Thomson, Axel/A-7893-2013					Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Bruxvoort KJ, 2007, CANCER RES, V67, P2490, DOI 10.1158/0008-5472.CAN-06-3028; Chen GP, 2004, CANCER-AM CANCER SOC, V101, P1345, DOI 10.1002/cncr.20518; COFFEY DS, 1968, ARCH BIOCHEM BIOPHYS, V124, P184, DOI 10.1016/0003-9861(68)90319-6; Corey E, 2003, PROSTATE, V55, P239, DOI 10.1002/pros.10198; FURUYA Y, 1993, ENDOCRINOLOGY, V133, P2660, DOI 10.1210/en.133.6.2660; Gao H, 2004, P NATL ACAD SCI USA, V101, P17204, DOI 10.1073/pnas.0407693101; Hayward SW, 1996, ACTA ANAT, V155, P81; HAYWARD SW, 1995, IN VITRO CELL DEV-AN, V31, P14; Ilyas M, 2005, J PATHOL, V205, P130, DOI 10.1002/path.1692; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Katoh M, 2001, INT J ONCOL, V19, P1003; Kawano Y, 2006, ONCOGENE, V25, P6528, DOI 10.1038/sj.onc.1209661; Li Y, 2005, J MAMMARY GLAND BIOL, V10, P17, DOI 10.1007/s10911-005-2537-2; Lipschutz JH, 1997, PROSTATE, V32, P35; Lipschutz JH, 1996, J UROLOGY, V155, P1762, DOI 10.1016/S0022-5347(01)66194-9; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Maddison LA, 2004, PROSTATE, V58, P335, DOI 10.1002/pros.10341; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Polakis P, 2000, GENE DEV, V14, P1837; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Robinson EJ, 1998, PROSTATE, V37, P149, DOI 10.1002/(SICI)1097-0045(19981101)37:3<149::AID-PROS4>3.0.CO;2-E; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Shidaifat F, 2004, ENDOCR RES, V30, P327, DOI 10.1081/ERC-200033196; Shoemaker AR, 1998, P NATL ACAD SCI USA, V95, P10826, DOI 10.1073/pnas.95.18.10826; Shou JY, 2002, P NATL ACAD SCI USA, V99, P2830, DOI 10.1073/pnas.052705299; Shou JY, 2001, CANCER RES, V61, P7291; Signoretti S, 2000, AM J PATHOL, V157, P1769, DOI 10.1016/S0002-9440(10)64814-6; SUGIMURA Y, 1986, BIOL REPROD, V34, P961, DOI 10.1095/biolreprod34.5.961; Thomson AA, 1999, DEVELOPMENT, V126, P3693; TIMMS BG, 1994, J UROLOGY, V151, P1427, DOI 10.1016/S0022-5347(17)35273-4; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; Verras M, 2004, CANCER RES, V64, P8860, DOI 10.1158/0008-5472.CAN-04-2370; Verras M, 2006, CANCER LETT, V237, P22, DOI 10.1016/j.canlet.2005.06.004; Wang BE, 2003, J BIOL CHEM, V278, P18506, DOI 10.1074/jbc.M300968200; Wang XD, 2006, DEV BIOL, V290, P66, DOI 10.1016/j.ydbio.2005.11.009; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wissmann C, 2003, J PATHOL, V201, P204, DOI 10.1002/path.1449; Wright AS, 1999, ENDOCRINOLOGY, V140, P4509, DOI 10.1210/en.140.10.4509; Xin L, 2005, P NATL ACAD SCI USA, V102, P6942, DOI 10.1073/pnas.0502320102; Zhu HN, 2004, CANCER RES, V64, P7918, DOI 10.1158/0008-5472.CAN-04-2704; Zi XL, 2005, CANCER RES, V65, P9762, DOI 10.1158/0008-5472.CAN-05-0103	45	51	53	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2186	10.1371/journal.pone.0002186	http://dx.doi.org/10.1371/journal.pone.0002186			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478098	Green Submitted, Green Published, gold			2022-12-25	WOS:000262172800051
J	Cavet, ME; Pang, JJ; Yin, GY; Berk, BC				Cavet, Megan E.; Pang, Jinjiang; Yin, Guoyong; Berk, Bradford C.			An epidermal growth factor (EGF)-dependent interaction between GIT1 and sorting nexin 6 promotes degradation of the EGF receptor	FASEB JOURNAL			English	Article						G-protein coupled receptor; tyrosine kinase; signal transduction; endosome; receptor trafficking	GTPASE-ACTIVATING PROTEINS; ANGIOTENSIN-II; CELL-SURFACE; FAMILY; TRAFFICKING; COMPLEX; PIX; PATHWAYS; LOCALIZATION; ENDOCYTOSIS	G-protein coupled receptor (GPCR) kinase-2 interacting protein 1 (GIT1) is a multifunctional scaffolding protein that regulates epidermal growth factor receptor (EGFR) signaling pathways. We demonstrate that GIT1 interacts with sorting nexin 6 (SNX6), a member of the SNX family that increases EGFR trafficking between endosomes and lysosomes, thereby enhancing EGFR degradation. The GIT1-SNX6 interaction is increased 3-fold after treatment with EGF for 60 min. The second coiled-coil domain (CC2; as 424-474) of GIT1 mediates binding to SNX6. Subcellular fractionation and confocal microscopy data indicate that GIT1 and SNX6 interact in endosomes. Knockdown of GIT1 expression by small interfering RNA decreased the rate of EGF-induced EGFR degradation. Expression of exogenous GIT1 or SNX6 alone did not alter EGFR degradation; however, coexpression of GIT1 and SNX6 decreased EGFR levels both basally and in response to EGF. In contrast, expression of GIT1(CC2 deleted) and SNX6 did not reduce EGFR levels, demonstrating that the interaction between GIT1 and SNX6 was required to regulate EGFR trafficking. Phosphorylation of the EGFR substrate phospholipase C-gamma was decreased by coexpression of GIT1 and SNX6. These data demonstrate an endosomal, EGF-regulated interaction between SNX6 and GIT1 that enhances degradation of the EGFR, and thereby alters EGFR signaling. Our findings suggest a new role for GIT1 in tyrosine kinase receptor trafficking.	Univ Rochester, Cardiovasc Res Inst, Sch Med, Dept Med, Rochester, NY 14642 USA; Univ Rochester, Aab Cardiovasc Res Inst, Sch Med, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Berk, BC (corresponding author), Univ Rochester, Cardiovasc Res Inst, Sch Med, Dept Med, Box 679,601 Elmwood Ave, Rochester, NY 14642 USA.	bradford_berk@urmc.rochester.edu		Berk, Bradford/0000-0002-2767-4115	U.S. National Institutes of Health [HL63462]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063462] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by U.S. National Institutes of Health grant HL63462 to B.C.B.	Amerongen GPV, 2004, CIRC RES, V94, P1041, DOI 10.1161/01.RES.0000125627.77235.0C; Anborgh PH, 2000, MOL ENDOCRINOL, V14, P2040, DOI 10.1210/me.14.12.2040; Chin LS, 2001, J BIOL CHEM, V276, P7069, DOI 10.1074/jbc.M004129200; Claing A, 2000, P NATL ACAD SCI USA, V97, P1119, DOI 10.1073/pnas.97.3.1119; Di Cesare A, 2000, NAT CELL BIOL, V2, P521, DOI 10.1038/35019561; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Feng QY, 2006, NAT CELL BIOL, V8, P945, DOI 10.1038/ncb1453; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Gullapalli A, 2004, MOL BIOL CELL, V15, P2143, DOI 10.1091/mbc.E03-09-0711; Haendeler J, 2003, J BIOL CHEM, V278, P49936, DOI 10.1074/jbc.M307317200; Haendeler J, 2000, CIRC RES, V86, P729, DOI 10.1161/01.RES.86.7.729; Haft CR, 2000, MOL BIOL CELL, V11, P4105, DOI 10.1091/mbc.11.12.4105; Haft CR, 1998, MOL CELL BIOL, V18, P7278, DOI 10.1128/MCB.18.12.7278; Hanson BJ, 2003, J BIOL CHEM, V278, P34617, DOI 10.1074/jbc.M300143200; Hein L, 1997, MOL ENDOCRINOL, V11, P1266, DOI 10.1210/me.11.9.1266; Kurten RC, 1996, SCIENCE, V272, P1008, DOI 10.1126/science.272.5264.1008; Kurten RC, 2001, J CELL SCI, V114, P1743; Lin Q, 2002, J BIOL CHEM, V277, P10134, DOI 10.1074/jbc.M110329200; Liu YF, 1997, J BIOL CHEM, V272, P8121, DOI 10.1074/jbc.272.13.8121; Manabe R, 2002, J CELL SCI, V115, P1497; Matafora V, 2001, J CELL SCI, V114, P4509; Paris S, 2003, BIOCHEM J, V372, P391, DOI 10.1042/BJ20030047; Paris S, 2002, INT J BIOCHEM CELL B, V34, P826, DOI 10.1016/S1357-2725(02)00008-0; Parks WT, 2001, J BIOL CHEM, V276, P19332, DOI 10.1074/jbc.M100606200; Pons V, 2003, J BIOL CHEM, V278, P21155, DOI 10.1074/jbc.M211008200; Premont RT, 2000, J BIOL CHEM, V275, P22373, DOI 10.1074/jbc.275.29.22373; Premont RT, 2004, CELL SIGNAL, V16, P1001, DOI 10.1016/j.cellsig.2004.02.002; Premont RT, 1998, P NATL ACAD SCI USA, V95, P14082, DOI 10.1073/pnas.95.24.14082; ROTHMAN A, 1992, CIRCULATION, V86, P1977, DOI 10.1161/01.CIR.86.6.1977; Stockinger W, 2002, EMBO J, V21, P4259, DOI 10.1093/emboj/cdf435; Teasdale RD, 2001, BIOCHEM J, V358, P7, DOI 10.1042/0264-6021:3580007; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; Wang Y, 2002, MOL CELL BIOL, V22, P7279, DOI 10.1128/MCB.22.20.7279-7290.2002; Wiley HS, 2003, EXP CELL RES, V284, P78, DOI 10.1016/S0014-4827(03)00002-8; Worby CA, 2002, NAT REV MOL CELL BIO, V3, P919, DOI 10.1038/nrm974; Wu WJ, 2003, CELL, V114, P715, DOI 10.1016/S0092-8674(03)00688-3; Yin GY, 2004, MOL CELL BIOL, V24, P875, DOI 10.1128/MCB.24.2.875-885.2004; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000; Zhong Q, 2002, P NATL ACAD SCI USA, V99, P6767, DOI 10.1073/pnas.092142699	39	25	27	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	OCT	2008	22	10					3607	3616		10.1096/fj.07-094086	http://dx.doi.org/10.1096/fj.07-094086			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	354MB	18523162	Green Published			2022-12-25	WOS:000259642600022
J	McArthur, JD; McKay, FC; Ramachandran, V; Shyam, P; Cork, AJ; Sanderson-Smith, ML; Cole, JN; Ringdahl, U; Sjobring, U; Ranson, M; Walker, MJ				McArthur, Jason D.; McKay, Fiona C.; Ramachandran, Vidiya; Shyam, Priya; Cork, Amanda J.; Sanderson-Smith, Martina L.; Cole, Jason N.; Ringdahl, Ulrika; Sjobring, Ulf; Ranson, Marie; Walker, Mark J.			Allelic variants of streptokinase from Streptococcus pyogenes display functional differences in plasminogen activation	FASEB JOURNAL			English	Article						bacterial pathogenesis; virulence; invasive disease	GROUP-A STREPTOCOCCI; M-PROTEIN; POSTSTREPTOCOCCAL GLOMERULONEPHRITIS; HISTIDINE-RESIDUES; VIRULENCE FACTORS; INVASIVE DISEASE; BINDING-PROTEIN; SURFACE PROTEIN; TISSUE TROPISM; FIBRINOGEN	A common mammalian defense mechanism employed to prevent systemic dissemination of invasive bacteria involves occlusion of local microvasculature and encapsulation of bacteria within fibrin networks. Acquisition of plasmin activity at the bacterial cell surface circumvents this defense mechanism, allowing invasive disease initiation. To facilitate this process, S. pyogenes secretes streptokinase, a plasminogen-activating protein. Streptokinase polymorphism exhibited by S. pyogenes isolates is well characterized. However, the functional differences displayed by these variants and the biological significance of this variation has not been elucidated. Phylogenetic analysis of ska sequences from 28 S. pyogenes isolates revealed 2 main sequence clusters (clusters 1 and 2). All strains secreted streptokinase, as determined by Western blotting, and were capable of acquiring cell surface plasmin activity after incubation in human plasma. Whereas culture supernatants from strains containing cluster 1 ska alleles also displayed soluble plasminogen activation activity, supernatants from strains containing cluster 2 ska alleles did not. Furthermore, plasminogen activation activity in culture supernatants from strains containing cluster 2 ska alleles could only be detected when plasminogen was prebound with fibrinogen. This study indicates that variant streptokinase proteins secreted by S. pyogenes isolates display differing plasminogen activation characteristics and may therefore play distinct roles in disease pathogenesis.	[McArthur, Jason D.; McKay, Fiona C.; Ramachandran, Vidiya; Shyam, Priya; Cork, Amanda J.; Sanderson-Smith, Martina L.; Cole, Jason N.; Ranson, Marie; Walker, Mark J.] Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia; [Ringdahl, Ulrika; Sjobring, Ulf] Lund Univ, Sect Microbiol Immunol & Glycobiol, Dept Lab Med, Lund, Sweden	University of Wollongong; Lund University	Walker, MJ (corresponding author), Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia.	mwalker@uow.edu.au	Ranson, Marie/GRO-5792-2022; Cork, Amanda/C-3830-2012; Sanderson-Smith, Martina/O-9387-2019; Walker, Mark J./F-6940-2011; Ranson, Marie/A-6324-2008; Sanderson-Smith, Martina L/H-9614-2013; Ranson, Marie/AAC-4468-2019	Ranson, Marie/0000-0002-5570-9645; Cork, Amanda/0000-0003-2207-6877; Ranson, Marie/0000-0002-5570-9645; Sanderson-Smith, Martina L/0000-0002-6366-4993; Ranson, Marie/0000-0002-5570-9645; Walker, Mark/0000-0001-7423-2769; McKay, Fiona Catherine/0000-0002-9610-0668	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the National Health and Medical Research Council of Australia and from the University Research Committee at the University of Wollongong. A. C. and M. S-S. were recipients of Australian postgraduate awards. F. C. M. was the recipient of a National Health and Medical Research Council biomedical postgraduate scholarship.	Aziz RK, 2004, MOL MICROBIOL, V51, P123, DOI 10.1046/j.1365-2958.2003.03797.x; BERGE A, 1993, J BIOL CHEM, V268, P25417; Bessen DE, 1999, J INFECT DIS, V179, P627, DOI 10.1086/314631; CHIBBER BAK, 1985, BIOCHEMISTRY-US, V24, P3429, DOI 10.1021/bi00335a006; Cole JN, 2006, FASEB J, V20, P1745, DOI 10.1096/fj.06-5804fje; Coleman JL, 1999, J LAB CLIN MED, V134, P567, DOI 10.1016/S0022-2143(99)90095-1; D'Costa SS, 1998, MICROB PATHOGENESIS, V24, P341, DOI 10.1006/mpat.1998.0207; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; Derbise A, 2004, INFECT IMMUN, V72, P94, DOI 10.1128/IAI.72.1.94-105.2004; Kalia A, 2004, J BACTERIOL, V186, P110, DOI 10.1128/JB.186.1.110-121.2004; KAPUR V, 1995, MOL MICROBIOL, V16, P509, DOI 10.1111/j.1365-2958.1995.tb02415.x; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kunamneni A, 2007, J THROMB THROMBOLYS, V23, P9, DOI 10.1007/s11239-006-9011-x; KUUSELA P, 1992, INFECT IMMUN, V60, P196, DOI 10.1128/IAI.60.1.196-201.1992; Levi M, 2004, CIRCULATION, V109, P2698, DOI 10.1161/01.CIR.0000131660.51520.9A; Lizano S, 2005, INFECT IMMUN, V73, P4451, DOI 10.1128/IAI.73.7.4451-4453.2005; Lottenberg Richard, 1994, Trends in Microbiology, V2, P20, DOI 10.1016/0966-842X(94)90340-9; MALKE H, 1993, ZBL BAKT-INT J MED M, V278, P246; McArthur JD, 2006, MOL MICROBIOL, V59, P1, DOI 10.1111/j.1365-2958.2005.04967.x; McKay FC, 2004, INFECT IMMUN, V72, P364, DOI 10.1128/IAI.72.1.364-370.2004; MUSSER JM, 1994, ARCH PATHOL LAB MED, V118, P128; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Pancholi V, 2003, INT J MED MICROBIOL, V293, P391, DOI 10.1078/1438-4221-00283; PANCHOLI V, 1992, J EXP MED, V176, P415, DOI 10.1084/jem.176.2.415; Parry MAA, 2000, TRENDS BIOCHEM SCI, V25, P53, DOI 10.1016/S0968-0004(99)01521-2; PEAKE PW, 1991, APMIS, V99, P460, DOI 10.1111/j.1699-0463.1991.tb05176.x; PONTING CP, 1992, BLOOD COAGUL FIBRIN, V3, P605, DOI 10.1097/00001721-199210000-00012; Ranson M, 2003, FRONT BIOSCI, V8, pS294, DOI 10.2741/1044; REDDY KNN, 1972, J BIOL CHEM, V247, P1683; Rezcallah MS, 2004, MICROBIOL-SGM, V150, P365, DOI 10.1099/mic.0.26826-0; Ringdahl U, 2000, MOL MICROBIOL, V37, P1318, DOI 10.1046/j.1365-2958.2000.02062.x; Sanderson-Smith M, 2006, J BIOL CHEM, V281, P3217, DOI 10.1074/jbc.M508758200; Sanderson-Smith ML, 2007, J BACTERIOL, V189, P1435, DOI 10.1128/JB.01218-06; Sanderson-Smith ML, 2006, J BIOL CHEM, V281, P25965, DOI 10.1074/jbc.M603846200; Svensson MD, 2000, MOL MICROBIOL, V38, P242, DOI 10.1046/j.1365-2958.2000.02144.x; Svensson MD, 2002, MICROBIOL-SGM, V148, P3933, DOI 10.1099/00221287-148-12-3933; TEWODROS W, 1995, MICROB PATHOGENESIS, V18, P53; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; Walker MJ, 2005, TRENDS MICROBIOL, V13, P308, DOI 10.1016/j.tim.2005.05.006; WANG H, 1995, J INFECT DIS, V171, P85, DOI 10.1093/infdis/171.1.85; WHITNACK E, 1982, J CLIN INVEST, V69, P1042, DOI 10.1172/JCI110508; Winram SB, 1998, MICROBIOL-SGM, V144, P2025, DOI 10.1099/00221287-144-8-2025; Wistedt AC, 1998, J BIOL CHEM, V273, P24420, DOI 10.1074/jbc.273.38.24420	43	47	49	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2008	22	9					3146	3153		10.1096/fj.08-109348	http://dx.doi.org/10.1096/fj.08-109348			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	342CD	18511548				2022-12-25	WOS:000258761300007
J	Ristorcelli, E; Beraud, E; Verrando, P; Villard, C; Lafitte, D; Sbarra, V; Lombardo, D; Verine, A				Ristorcelli, Elodie; Beraud, Evelyne; Verrando, Patrick; Villard, Claude; Lafitte, Daniel; Sbarra, Veronique; Lombardo, Dominique; Verine, Alain			Human tumor nanoparticles induce apoptosis of pancreatic cancer cells	FASEB JOURNAL			English	Article						exosomes; cell death; proliferation	LIPID RAFTS; BIOLOGICAL SIGNIFICANCE; LYMPHOCYTE-RESPONSES; EXOSOMES; PTEN; KINASE; PATHWAY; PHOSPHATASE; VESICLES; CERAMIDE	Exosomes are vesicles secreted by most hematopoietic cells on fusion of multivesicular endosomes with the plasma membrane. Many studies have reported that exosomes may also be released by tumor cells. Exosomes are believed to play an antitumor role through immune cells. We asked whether tumor exosomes have biological activities on tumor cells. We report that human pancreatic tumor nanoparticles, exosome-like as characterized by proteomic analyses and rich in lipid rafts, decreased tumor cell proliferation. Nanoparticles increased Bax and decreased Bcl-2 expressions. Caspase-3 and -9 but not caspase-8 inhibitors impaired apoptosis, which implicates the mitochondria apoptotic pathway. The ceramide-sphingomyelin apoptotic pathway was inoperative. Moreover, nanoparticles induced phosphatase and tensin homolog ( PTEN) and glycogen synthase kinase (GSK)-3 beta activation and decreased pyruvate dehydrogenase activity. In nanoparticle-treated cells, PTEN formed complexes with actin, beta-catenin, and GSK-3 beta. Thus, beta-catenin may no longer be available to activate the survival pathway. Nanoparticles triggered the down-regulation of cyclin D1 and poly(ADP-ribose) polymerase. Hence, nanoparticles counteracted the constitutively activated phosphatidylinositol 3-kinase/Akt survival pathway to drive tumor cells toward apoptosis. Our study provides the first evidence of an apoptotic function of tumor-derived nanoparticles on tumor cells. We propose a new role for nanoparticles, i.e., as signal carriers for interaction between cells, which may have implications in physiopathological situations.	[Ristorcelli, Elodie; Beraud, Evelyne; Verrando, Patrick; Villard, Claude; Lafitte, Daniel; Sbarra, Veronique; Lombardo, Dominique; Verine, Alain] Aix Marseille Univ, Fac Med, INSERM, UMR 911, F-13385 Marseille 05, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Lombardo, D (corresponding author), Aix Marseille Univ, Fac Med, INSERM, UMR 911, 27 Bld Jean Moulin, F-13385 Marseille 05, France.	dominique.lombardo@medecine.univ-mrs.fr	Verrando, Patrick/M-4163-2018	lafitte, daniel/0000-0001-9921-7522; Villard, claude/0000-0002-6600-0762	INSERM (Paris, France); Universite de la Mediterranee (Marseille, France)	INSERM (Paris, France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite de la Mediterranee (Marseille, France)	The authors are grateful to J. Courageot (electron microscopy core facility, School of Medicine, Marseille, France) and C. Franceschi [INSERM Unite Mixte de Recherche (UMR) 911] for microscopy experiments. J. Bertrand-Michel (INSERM UMR563, Toulouse, France) is gratefully acknowledged for lipid analyses. This work was supported by institutional funding from INSERM (Paris, France) and from Universite de la Mediterranee (Marseille, France).	Al-Khouri AM, 2005, J BIOL CHEM, V280, P35195, DOI 10.1074/jbc.M503045200; Andre F, 2004, J IMMUNOL, V172, P2126, DOI 10.4049/jimmunol.172.4.2126; Aubert-Jousset E, 2004, STRUCTURE, V12, P1437, DOI 10.1016/j.str.2004.05.016; Byrne RD, 2007, CELL SIGNAL, V19, P321, DOI 10.1016/j.cellsig.2006.07.004; Clayton A, 2007, CANCER RES, V67, P7458, DOI 10.1158/0008-5472.CAN-06-3456; de Gassart A, 2004, TRAFFIC, V5, P896, DOI 10.1111/j.1600-0854.2004.00223.x; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Domingos PM, 2007, CURR OPIN GENET DEV, V17, P294, DOI 10.1016/j.gde.2007.05.009; Fadeel B, 2005, J INTERN MED, V258, P479, DOI 10.1111/j.1365-2796.2005.01570.x; Fasano C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000612; Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Friess H, 1998, GUT, V43, P414, DOI 10.1136/gut.43.3.414; Gastpar R, 2005, CANCER RES, V65, P5238, DOI 10.1158/0008-5472.CAN-04-3804; Geminard C, 2001, J BIOL CHEM, V276, P9910, DOI 10.1074/jbc.M009641200; Gericke A, 2006, GENE, V374, P1, DOI 10.1016/j.gene.2006.02.024; Hao SG, 2007, IMMUNOLOGY, V120, P90, DOI 10.1111/j.1365-2567.2006.02483.x; Hoshi M, 1996, P NATL ACAD SCI USA, V93, P2719, DOI 10.1073/pnas.93.7.2719; Janowska-Wieczorek A, 2005, INT J CANCER, V113, P752, DOI 10.1002/ijc.20657; Johnstone RM, 2006, BLOOD CELL MOL DIS, V36, P315, DOI 10.1016/j.bcmd.2005.12.001; Koga K, 2005, ANTICANCER RES, V25, P3703; Lafitte D, 2002, CLIN BIOCHEM, V35, P581, DOI 10.1016/S0009-9120(02)00362-4; Lai JP, 2007, BRIT J PHARMACOL, V152, P1172, DOI 10.1038/sj.bjp.0707501; Laulagnier K, 2005, BLOOD CELL MOL DIS, V35, P116, DOI 10.1016/j.bcmd.2005.05.010; Laulagnier K, 2004, BIOCHEM J, V380, P161, DOI 10.1042/BJ20031594; Levade T, 2002, NEUROCHEM RES, V27, P601, DOI 10.1023/A:1020215815013; Li YC, 2006, AM J PATHOL, V168, P1107, DOI 10.2353/ajpath.2006.050959; Maceyka M, 2002, BBA-MOL CELL BIOL L, V1585, P193, DOI 10.1016/S1388-1981(02)00341-4; Maffucci T, 2005, CANCER RES, V65, P8339, DOI 10.1158/0008-5472.CAN-05-0121; Michel V, 2007, BIOL CELL, V99, P129, DOI 10.1042/BC20060051; Morelli AE, 2004, BLOOD, V104, P3257, DOI 10.1182/blood-2004-03-0824; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Perugini RA, 2000, J SURG RES, V90, P39, DOI 10.1006/jsre.2000.5833; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Pilzer D, 2005, SPRINGER SEMIN IMMUN, V27, P375, DOI 10.1007/s00281-005-0004-1; Radu A, 2003, MOL CELL BIOL, V23, P6139, DOI 10.1128/MCB.23.17.6139-6149.2003; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Rebai O, 2005, ARTERIOSCL THROM VAS, V25, P359, DOI 10.1161/01.ATV.0000151618.49109.bd; Salama-Cohen P, 2005, MOL BIOL CELL, V16, P339, DOI 10.1091/mbc.e04-05-0438; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Soldani C, 2002, APOPTOSIS, V7, P321, DOI 10.1023/A:1016119328968; Soo PC, 2007, J BACTERIOL, V189, P109, DOI 10.1128/JB.00710-06; Subra C, 2007, BIOCHIMIE, V89, P205, DOI 10.1016/j.biochi.2006.10.014; Taieb J, 2005, CRIT REV IMMUNOL, V25, P215, DOI 10.1615/CritRevImmunol.v25.i3.30; Tan J, 2005, CANCER RES, V65, P9012, DOI 10.1158/0008-5472.CAN-05-1226; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Villa I, 2001, IMMUNOLOGY, V102, P165, DOI 10.1046/j.1365-2567.2001.01178.x; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200; Zhu Y, 2006, APOPTOSIS, V11, P197, DOI 10.1007/s10495-006-3714-5; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	53	110	118	0	34	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2008	22	9					3358	3369		10.1096/fj.07-102855	http://dx.doi.org/10.1096/fj.07-102855			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	342CD	18511551				2022-12-25	WOS:000258761300028
J	Segers, K; Dahlback, B; Rosing, J; Nicolaes, GAF				Segers, Kenneth; Dahlback, Bjorn; Rosing, Jan; Nicolaes, Gerry A. F.			Identification of surface epitopes of human coagulation factor Va that are important for interaction with activated protein C and heparin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROPOSED STRUCTURAL MODELS; PEPTIDE-BOND CLEAVAGES; BINDING-SITE; FACTOR XA; STUART FACTOR; 3-DIMENSIONAL MODEL; FACTOR VA(R506Q); BASIC RESIDUES; ANTICOAGULANT; INACTIVATION	Inactivation of factor Va (FVa) by activated protein C (APC) is a key reaction in the down- regulation of thrombin formation. FVa inactivation by APC is correlated with a loss of FXa cofactor activity as a result of three proteolytic cleavages in the FVa heavy chain at Arg(306), Arg(506), and Arg(679). Recently, we have shown that heparin specifically inhibits the APC- mediated cleavage at Arg(506) and stimulates cleavage at Arg(306). Three- dimensional molecular models of APC docked at the Arg(306) and Arg(506) cleavage sites in FVa have identified several FVa amino acids that may be important for FVa inactivation by APC in the absence and presence of heparin. Mutagenesis of Lys(320), Arg(321), and Arg(400) to Ala resulted in an increased inactivation rate by APC at Arg(306), which indicates the importance of these residues in the FVa- APC interaction. No heparin- mediated stimulation of Arg(306) cleavage was observed for these mutants, and stimulation by protein S was similar to that of wild type FVa. With this, we have now demonstrated that a cluster of basic residues in FVa comprising Lys(320), Arg(321), and Arg(400) is required for the heparin-mediated stimulation of cleavage at Arg(306) by APC. Furthermore, mutations that were introduced near the Arg(506) cleavage site had a significant but modest effect on the rate of APC- catalyzed FVa inactivation, suggesting an extended interaction surface between the FVa Arg(506) site and APC.	[Segers, Kenneth; Rosing, Jan; Nicolaes, Gerry A. F.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Biochem, NL-6200 MD Maastricht, Netherlands; [Dahlback, Bjorn] Malmo Univ Hosp, Wallenberg Lab, SE-20502 Malmo, Sweden; [Dahlback, Bjorn] Lund Univ, Dept Lab Med, S-22100 Lund, Sweden	Maastricht University; Lund University; Skane University Hospital; Lund University	Nicolaes, GAF (corresponding author), Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Biochem, NL-6200 MD Maastricht, Netherlands.	G.Nicolaes@bioch.unimaas.nl	Nicolaes, Gerry A.F./A-8421-2016	Nicolaes, Gerry A.F./0000-0002-2482-0412; Dahlback, Bjorn/0000-0003-1546-0328				Adams TE, 2004, P NATL ACAD SCI USA, V101, P8918, DOI 10.1073/pnas.0403072101; Autin L, 2006, PROTEINS, V63, P440, DOI 10.1002/prot.20848; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Cornet AD, 2007, THROMB HAEMOSTASIS, V98, P579, DOI 10.1160/TH07-01-0006; DISCIPIO RG, 1977, BIOCHEMISTRY-US, V16, P698, DOI 10.1021/bi00623a022; Fernandez JA, 1999, THROMB HAEMOSTASIS, V82, P1462; Friedrich U, 2001, J BIOL CHEM, V276, P24122, DOI 10.1074/jbc.M011567200; FUJIKAWA K, 1972, BIOCHEMISTRY-US, V11, P4892, DOI 10.1021/bi00776a003; FUJIKAWA K, 1972, BIOCHEMISTRY-US, V11, P4882, DOI 10.1021/bi00776a002; Gale AJ, 2000, BLOOD, V96, P585; Gale AJ, 2002, PROTEIN SCI, V11, P2091, DOI 10.1110/ps.0210002; Gale AJ, 2002, J BIOL CHEM, V277, P28836, DOI 10.1074/jbc.M204363200; Glasscock LN, 2003, BBA-PROTEINS PROTEOM, V1649, P106, DOI 10.1016/S1570-9639(03)00164-X; Haas S, 2007, Hamostaseologie, V27, P41; Heeb MJ, 1996, PROTEIN SCI, V5, P1883, DOI 10.1002/pro.5560050914; Izaguirre G, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702462200; KALAFATIS M, 1994, J BIOL CHEM, V269, P31869; KAUFMAN RJ, 1990, METHOD ENZYMOL, V185, P487, DOI 10.1016/0076-6879(90)85041-L; Kojima Y, 1998, J BIOL CHEM, V273, P14900, DOI 10.1074/jbc.273.24.14900; Lee CJ, 2008, J THROMB HAEMOST, V6, P83; Nicolaes GAF, 2004, EUR J BIOCHEM, V271, P2724, DOI 10.1111/j.1432-1033.2004.04201.x; NICOLAES GAF, 1995, J BIOL CHEM, V270, P21158, DOI 10.1074/jbc.270.36.21158; Nicolaes GAF, 1999, BIOCHEMISTRY-US, V38, P13584, DOI 10.1021/bi991165r; Norstrom E, 2002, BLOOD, V100, P524, DOI 10.1182/blood-2002-02-0343; Orban T, 2005, BIOCHEMISTRY-US, V44, P13082, DOI 10.1021/bi050891t; Pellequer JL, 2000, THROMB HAEMOSTASIS, V84, P849, DOI 10.1055/s-0037-1614127; Pike RN, 2005, FEBS J, V272, P4842, DOI 10.1111/j.1742-4658.2005.04880.x; Rezaie AR, 2003, TRENDS CARDIOVAS MED, V13, P8, DOI 10.1016/S1050-1738(02)00191-3; ROSING J, 1995, J BIOL CHEM, V270, P27852, DOI 10.1074/jbc.270.46.27852; ROSING J, 1980, J BIOL CHEM, V255, P274; Segers K, 2007, J BIOL CHEM, V282, P33915, DOI 10.1074/jbc.M701123200; Shen L, 1999, THROMB HAEMOSTASIS, V82, P72, DOI 10.1055/s-0037-1614632; Shen L, 2000, BIOCHEMISTRY-US, V39, P2853, DOI 10.1021/bi992357p; SOBEL M, 1991, J CLIN INVEST, V87, P1787, DOI 10.1172/JCI115198; Steen M, 2002, J BIOL CHEM, V277, P50022, DOI 10.1074/jbc.M205609200; STENFLO J, 1984, SEMIN THROMB HEMOST, V10, P109, DOI 10.1055/s-2007-1004413; Stoilova-Mcphie S, 2008, J THROMB HAEMOST, V6, P76; TANS G, 1991, BLOOD, V77, P2641; TRACY PB, 1982, BLOOD, V60, P59; VANDERNEUT KM, 2004, J BIOL CHEM, V279, P6567; Yang LK, 2002, BIOCHEMISTRY-US, V41, P6149, DOI 10.1021/bi015899r; Yegneswaran S, 1997, J BIOL CHEM, V272, P25013, DOI 10.1074/jbc.272.40.25013; Yegneswaran S, 2007, J BIOL CHEM, V282, P28353, DOI 10.1074/jbc.M704316200	43	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22573	22581		10.1074/jbc.M801724200	http://dx.doi.org/10.1074/jbc.M801724200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18519572	hybrid			2022-12-25	WOS:000258321000026
J	Vandemeulebroucke, A; De Vos, S; Van Holsbeke, E; Steyaert, J; Versees, W				Vandemeulebroucke, An; De Vos, Stefan; Van Holsbeke, Els; Steyaert, Jan; Versees, Wim			A flexible loop as a functional element in the catalytic mechanism of nucleoside hydrolase from Trypanosoma vivax	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEAVING GROUP ACTIVATION; PRE-STEADY-STATE; CRITHIDIA-FASCICULATA; ENZYME CATALYSIS; CONFORMATIONAL-CHANGES; SUBSTRATE-BINDING; PRODUCT RELEASE; REACTIVITY; COMPLEX	The nucleoside hydrolase of Trypanosoma vivax hydrolyzes the N-glycosidic bond of purine nucleosides. Structural and kinetic studies on this enzyme have suggested a catalytic role for a flexible loop in the vicinity of the active sites. Here we present the analysis of the role of this flexible loop via the combination of a proline scan of the loop, loop deletion mutagenesis, steady state and pre-steady state analysis, and x-ray crystallography. Our analysis reveals that this loop has an important role in leaving group activation and product release. The catalytic role involves the entire loop and could only be perturbed by deletion of the entire loop and not by single site mutagenesis. We present evidence that the loop closes over the active site during catalysis, thereby ordering a water channel that is involved in leaving group activation. Once chemistry has taken place, the loop dynamics determine the rate of product release.	[Steyaert, Jan] Vrije Univ Brussel VIB, Dept Ultrastruct, B-1050 Brussels, Belgium; Vrije Univ Brussel VIB, Dept Mol & Cell Interact, B-1050 Brussels, Belgium	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel	Steyaert, J (corresponding author), Vrije Univ Brussel VIB, Dept Ultrastruct, Pl Laan 2, B-1050 Brussels, Belgium.	jan.steyaert@vub.ac.be	Steyaert, Jan/H-4662-2011; steyaert, jan/GQP-7811-2022; Versées, Wim/H-5518-2015	Steyaert, Jan/0000-0002-3825-874X; Versees, Wim/0000-0002-4695-696X				Barlow JN, 2007, BBA-PROTEINS PROTEOM, V1774, P1451, DOI 10.1016/j.bbapap.2007.08.027; Chu V, 1998, PROTEIN SCI, V7, P848; Degano M, 1998, BIOCHEMISTRY-US, V37, P6277, DOI 10.1021/bi973012e; Degano M, 1996, BIOCHEMISTRY-US, V35, P5971, DOI 10.1021/bi952999m; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DUNN DB, 1970, CRC HDB BIOCH; EIGEN M, 1963, ADV ENZYMOL REL S BI, V25, P1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Foloppe N, 2005, J PHYS CHEM B, V109, P9119, DOI 10.1021/jp044513u; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; GARRETT ER, 1972, J AM CHEM SOC, V94, P8532, DOI 10.1021/ja00779a040; Giabbai B, 2004, STRUCTURE, V12, P739, DOI 10.1016/S0969-2126(04)00122-4; Gopaul DN, 1996, BIOCHEMISTRY-US, V35, P5963, DOI 10.1021/bi952998u; Gutteridge A, 2004, FEBS LETT, V567, P67, DOI 10.1016/j.febslet.2004.03.067; Hammes GG, 2002, BIOCHEMISTRY-US, V41, P8221, DOI 10.1021/bi0260839; HORENSTEIN BA, 1991, BIOCHEMISTRY-US, V30, P10788, DOI 10.1021/bi00108a026; KEMPNER ES, 1993, FEBS LETT, V326, P4, DOI 10.1016/0014-5793(93)81749-P; KLINE PC, 1992, BIOCHEMISTRY-US, V31, P5964, DOI 10.1021/bi00141a003; Loverix S, 2005, J BIOL CHEM, V280, P14799, DOI 10.1074/jbc.M413231200; Mazumder-Shivakumar D, 2005, BIOCHEMISTRY-US, V44, P7805, DOI 10.1021/bi047394h; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARKIN DW, 1991, J BIOL CHEM, V266, P20658; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Schramm Vern L, 2003, Nucleic Acids Res Suppl, P107; Vandemeulebroucke A, 2003, BIOCHEMISTRY-US, V42, P12902, DOI 10.1021/bi0347914; Vandemeulebroucke A, 2006, BIOCHEMISTRY-US, V45, P9307, DOI 10.1021/bi060666r; Versees W, 2006, J MOL BIOL, V359, P331, DOI 10.1016/j.jmb.2006.03.026; Versees W, 2003, CURR OPIN STRUC BIOL, V13, P731, DOI 10.1016/j.sbi.2003.10.002; Versees W, 2004, J MOL BIOL, V338, P1, DOI 10.1016/j.jmb.2004.02.049; Versees W, 2002, J BIOL CHEM, V277, P15938, DOI 10.1074/jbc.M111735200; Versees W, 2001, J MOL BIOL, V307, P1363, DOI 10.1006/jmbi.2001.4548; WARSHEL A, 1978, P NATL ACAD SCI USA, V75, P5250, DOI 10.1073/pnas.75.11.5250; Warshel A, 2006, CHEM REV, V106, P3210, DOI 10.1021/cr0503106	35	17	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22272	22282		10.1074/jbc.M803705200	http://dx.doi.org/10.1074/jbc.M803705200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18519562	Green Published, hybrid			2022-12-25	WOS:000258114700046
J	Binz, SK; Wold, MS				Binz, Sara K.; Wold, Marc S.			Regulatory functions of the N-terminal domain of the 70-kDa subunit of replication protein A (RPA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; 70 KDA SUBUNIT; NUCLEOTIDE EXCISION-REPAIR; P53 TRANSACTIVATION DOMAIN; S-PHASE CHECKPOINT; SACCHAROMYCES-CEREVISIAE; BINDING-PROTEIN; IN-VITRO; CONFORMATIONAL-CHANGE; DAMAGE CHECKPOINTS	Replication protein A (RPA) is the major single-stranded DNA-binding protein in eukaryotes. RPA is composed of three subunits of 70, 32, and 14 kDa. The N-terminal domain of the 70-kDa subunit (RPA70) has weak DNA binding activity, interacts with proteins, and is involved in cellular DNA damage response. To define the mechanism by which this domain regulates RPA function, we analyzed the function of RPA forms containing a deletion of the N terminus of RPA70 and mutations in the phosphorylation domain of RPA(N-terminal 40 amino acids of the 32-kDa subunit). Although each individual mutation has only modest effects on RPA activity, a form combining both phosphorylation mimetic mutations and a deletion of the N-terminal domain of RPA70 was found to have dramatically altered activity. This combined mutant was defective in binding to short single-stranded DNA oligonucleotides and had altered interactions with proteins that bind to the DNA-binding core of RPA70. These results indicate that in the absence of the N-terminal domain of RPA70, a negatively charged phosphorylation domain disrupts the activity of the core DNA-binding domain of RPA. We conclude that the N-terminal domain of RPA70 functions by interacting with the phosphorylation domain of the 32-kDa subunit and blocking undesirable interactions with the core DNA-binding domain of RPA. These studies indicate that RPA conformation is important for regulating RPA-DNA and RPA-protein interactions.	[Binz, Sara K.; Wold, Marc S.] Univ Iowa, Carver Coll Med, Dept Biotechnol, Iowa City, IA 52242 USA	University of Iowa	Wold, MS (corresponding author), 3107 MERF, Iowa City, IA 52242 USA.	marc-wold@uiowa.edu	Wold, Marc/F-5806-2010	Wold, Marc/0000-0002-4580-1624	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044721] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM044721, GM 44721] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anantha RW, 2007, J BIOL CHEM, V282, P35910, DOI 10.1074/jbc.M704645200; Ariza RR, 1996, NUCLEIC ACIDS RES, V24, P433, DOI 10.1093/nar/24.3.433; Arunkumar AI, 2005, NAT STRUCT MOL BIOL, V12, P332, DOI 10.1038/nsmb916; Arunkumar AI, 2003, J BIOL CHEM, V278, P41077, DOI 10.1074/jbc.M305871200; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; Ball HL, 2007, MOL CELL BIOL, V27, P3367, DOI 10.1128/MCB.02238-06; Bartrand AJ, 2006, GENETICS, V172, P27, DOI 10.1534/genetics.105.047845; Bastin-Shanower SA, 2001, J BIOL CHEM, V276, P36446, DOI 10.1074/jbc.M104386200; Binz SK, 2006, METHOD ENZYMOL, V409, P11, DOI 10.1016/S0076-6879(05)09002-6; Binz SK, 2003, J BIOL CHEM, V278, P35584, DOI 10.1074/jbc.M305388200; Binz SK, 2004, DNA REPAIR, V3, P1015, DOI 10.1016/j.dnarep.2004.03.028; Blackwell LJ, 1996, MOL CELL BIOL, V16, P4798; Bochkarev A, 2004, CURR OPIN STRUC BIOL, V14, P36, DOI 10.1016/j.sbi.2004.01.001; Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; Bochkarev A, 1999, EMBO J, V18, P4498, DOI 10.1093/emboj/18.16.4498; Bochkareva E, 2001, EMBO J, V20, P612, DOI 10.1093/emboj/20.3.612; Bochkareva E, 2002, EMBO J, V21, P1855, DOI 10.1093/emboj/21.7.1855; Bochkareva E, 1998, J BIOL CHEM, V273, P3932, DOI 10.1074/jbc.273.7.3932; Bochkareva E, 2005, P NATL ACAD SCI USA, V102, P15412, DOI 10.1073/pnas.0504614102; BRAUN KA, 1998, THESIS U IOWA; Brill SJ, 1998, MOL CELL BIOL, V18, P7225, DOI 10.1128/MCB.18.12.7225; Brush GS, 1995, METHOD ENZYMOL, V262, P522; CARTY MP, 1994, EMBO J, V13, P2114, DOI 10.1002/j.1460-2075.1994.tb06487.x; CHEN LC, 1991, P NATL ACAD SCI USA, V88, P3847, DOI 10.1073/pnas.88.9.3847; COLES C, 1990, LANCET, V336, P761, DOI 10.1016/0140-6736(90)93236-I; Cruet-Hennequart S, 2008, DNA REPAIR, V7, P582, DOI 10.1016/j.dnarep.2007.12.012; Cuvier O, 2006, CURR BIOL, V16, P516, DOI 10.1016/j.cub.2006.01.059; Daughdrill GW, 2003, NUCLEIC ACIDS RES, V31, P4176, DOI 10.1093/nar/gkg451; Daughdrill GW, 2001, NUCLEIC ACIDS RES, V29, P3270, DOI 10.1093/nar/29.15.3270; Deng XY, 2007, J MOL BIOL, V374, P865, DOI 10.1016/j.jmb.2007.09.074; FANG F, 1993, J CELL SCI, V106, P983; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; FIRMENICH AA, 1995, MOL CELL BIOL, V15, P1620; FOTEDAR R, 1992, EMBO J, V11, P2177, DOI 10.1002/j.1460-2075.1992.tb05277.x; Gao H, 2007, NAT STRUCT MOL BIOL, V14, P208, DOI 10.1038/nsmb1205; Givalos N, 2007, MODERN PATHOL, V20, P159, DOI 10.1038/modpathol.3800719; Golub EI, 1998, NUCLEIC ACIDS RES, V26, P5388, DOI 10.1093/nar/26.23.5388; Gomes XV, 1996, BIOCHEMISTRY-US, V35, P5586, DOI 10.1021/bi9526995; Gomes XV, 1996, BIOCHEMISTRY-US, V35, P10558, DOI 10.1021/bi9607517; Guo SL, 2006, J BIOL CHEM, V281, P21607, DOI 10.1074/jbc.M603504200; Gupta RC, 1998, P NATL ACAD SCI USA, V95, P9843, DOI 10.1073/pnas.95.17.9843; Han YF, 1999, J VIROL, V73, P4899, DOI 10.1128/JVI.73.6.4899-4907.1999; Haring SJ, 2008, J BIOL CHEM, V283, P19095, DOI 10.1074/jbc.M800881200; HARLOW E, 1981, J VIROL, V39, P861, DOI 10.1128/JVI.39.3.861-869.1981; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Iftode C, 1999, CRIT REV BIOCHEM MOL, V34, P141, DOI 10.1080/10409239991209255; Iftode C, 1998, NUCLEIC ACIDS RES, V26, P5636, DOI 10.1093/nar/26.24.5636; Ishibashi T, 2006, J BIOCHEM, V139, P99, DOI 10.1093/jb/mvj014; Jacobs DM, 1999, J BIOMOL NMR, V14, P321, DOI 10.1023/A:1008373009786; Kantake N, 2003, J BIOL CHEM, V278, P23410, DOI 10.1074/jbc.M302995200; KIM CS, 1994, BIOCHEMISTRY-US, V33, P14197, DOI 10.1021/bi00251a031; KIM CS, 1992, MOL CELL BIOL, V12, P3050, DOI 10.1128/MCB.12.7.3050; Kim HS, 2003, DNA REPAIR, V2, P1321, DOI 10.1016/j.dnarep.2003.07.004; Kim HS, 2001, MOL CELL BIOL, V21, P3725, DOI 10.1128/MCB.21.11.3725-3737.2001; Lao Y, 1999, BIOCHEMISTRY-US, V38, P3974, DOI 10.1021/bi982371m; Lao Y, 2000, BIOCHEMISTRY-US, V39, P850, DOI 10.1021/bi991704s; Liu JS, 2006, J CELL BIOCHEM, V99, P1452, DOI 10.1002/jcb.21066; Liu JS, 2000, J BIOL CHEM, V275, P1391, DOI 10.1074/jbc.275.2.1391; Liu JS, 2006, DNA REPAIR, V5, P369, DOI 10.1016/j.dnarep.2005.11.007; Liu YY, 2005, J BIOL CHEM, V280, P32775, DOI 10.1074/jbc.M505705200; LONGHESE MP, 1994, MOL CELL BIOL, V14, P7884, DOI 10.1128/MCB.14.12.7884; Longhese MP, 1996, NUCLEIC ACIDS RES, V24, P3533, DOI 10.1093/nar/24.18.3533; Mallory JC, 2003, DNA REPAIR, V2, P1041, DOI 10.1016/S1568-7864(03)00115-0; Maniar HS, 1997, GENETICS, V145, P891; Mer G, 2000, CELL, V103, P449, DOI 10.1016/S0092-8674(00)00136-7; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; Niu HW, 1997, J BIOL CHEM, V272, P12634, DOI 10.1074/jbc.272.19.12634; Nuss JE, 2004, PROTEIN SCI, V13, P1365, DOI 10.1110/ps.04616304; Nuss JE, 2005, BIOCHEMISTRY-US, V44, P8428, DOI 10.1021/bi0480584; Oakley GG, 2003, BIOCHEMISTRY-US, V42, P3255, DOI 10.1021/bi026377u; Olson E, 2006, J BIOL CHEM, V281, P39517, DOI 10.1074/jbc.M605121200; Olson KE, 2005, J BIOMOL STRUCT DYN, V23, P113, DOI 10.1080/07391102.2005.10507052; PAN ZQ, 1995, P NATL ACAD SCI USA, V92, P4636, DOI 10.1073/pnas.92.10.4636; Pestryakov PE, 2003, J BIOL CHEM, V278, P17515, DOI 10.1074/jbc.M301265200; Pfuetzner RA, 1997, J BIOL CHEM, V272, P430; Robison JG, 2004, J BIOL CHEM, V279, P34802, DOI 10.1074/jbc.M404750200; SANTOCANALE C, 1995, J MOL BIOL, V254, P595, DOI 10.1006/jmbi.1995.0641; Soustelle C, 2002, GENETICS, V161, P535; Stauffer ME, 2004, J BIOL CHEM, V279, P25638, DOI 10.1074/jbc.M400029200; Teng YM, 1998, J MOL BIOL, V280, P355, DOI 10.1006/jmbi.1998.1872; Treuner K, 1999, J BIOL CHEM, V274, P15556, DOI 10.1074/jbc.274.22.15556; Umezu K, 1998, GENETICS, V148, P989; Vassin VM, 2004, MOL CELL BIOL, V24, P1930, DOI 10.1128/MCB.24.5.1930-1943.2004; Vise PD, 2005, NUCLEIC ACIDS RES, V33, P2061, DOI 10.1093/nar/gki336; Walther AP, 1999, BIOCHEMISTRY-US, V38, P3963, DOI 10.1021/bi982370u; Wang Y, 1999, J BIOL CHEM, V274, P22060, DOI 10.1074/jbc.274.31.22060; Wang YX, 2005, NAT GENET, V37, P750, DOI 10.1038/ng1587; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; WOLD MS, 1988, P NATL ACAD SCI USA, V85, P2523, DOI 10.1073/pnas.85.8.2523; Wu X, 2005, BIOCHEM J, V391, P473, DOI 10.1042/BJ20050379; Wu XM, 2005, ONCOGENE, V24, P4728, DOI 10.1038/sj.onc.1208674; Wyka IM, 2003, BIOCHEMISTRY-US, V42, P12909, DOI 10.1021/bi034930h; ZernikKobak M, 1997, J BIOL CHEM, V272, P23896, DOI 10.1074/jbc.272.38.23896; Zou L, 2003, P NATL ACAD SCI USA, V100, P13827, DOI 10.1073/pnas.2336100100; Zou Y, 2006, J CELL PHYSIOL, V208, P267, DOI 10.1002/jcp.20622	95	27	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21559	21570		10.1074/jbc.M802450200	http://dx.doi.org/10.1074/jbc.M802450200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18515800	Green Published, hybrid			2022-12-25	WOS:000257898800029
J	Gao, J; Zhao, N; Knutson, MD; Enns, CA				Gao, Junwei; Zhao, Ningning; Knutson, Mitchell D.; Enns, Caroline A.			The hereditary hemochromatosis protein, HFE, inhibits iron uptake via down-regulation of Zip14 in HepG2 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFERRIN RECEPTOR; RESPONSIVE ELEMENT; MOUSE MODEL; LIVER; GENE; IDENTIFICATION; MODIFIER; HEPATOCYTES; EXPRESSION; INCREASES	Lack of functional hereditary hemochromatosis protein, HFE, causes iron overload predominantly in hepatocytes, the major site of HFE expression in the liver. In this study, we investigated the role of HFE in the regulation of both transferrin-bound iron (TBI) and non-transferrin-bound iron (NTBI) uptake in HepG2 cells, a human hepatoma cell line. Expression of HFE decreased both TBI and NTBI uptake. It also resulted in a decrease in the protein levels of Zip14 with no evident change in the mRNA level of Zip14. Zip14 (Slc39a14) is a metal transporter that mediates NTBI into cells (Liuzzi, J. P., Aydemir, F., Nam, H., Knutson, M. D., and Cousins, R. J. (2006) Proc. Natl. Acad. Sci. U. S. A. 103, 13612-13617). Knockdown of Zip14 with siRNA abolished the effect of HFE on NTBI uptake. To determine if HFE had a similar effect on Zip14 in another cell line, HeLa cells expressing HFE under the tetracycline-repressible promoter were transfected with Zip14. As in HepG2 cells, HFE expression inhibited NTBI uptake by similar to 50% and decreased Zip14 protein levels. Further analysis of protein turnover indicated that the half-life of Zip14 is lower in cells that express HFE. These results suggest that HFE decreases the stability of Zip14 and therefore reduces the iron loading in HepG2 cells.	[Gao, Junwei; Enns, Caroline A.] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97239 USA; [Zhao, Ningning; Knutson, Mitchell D.] Univ Florida, Food Sci & Human Nutr Dept, Gainesville, FL 32611 USA	Oregon Health & Science University; State University System of Florida; University of Florida	Enns, CA (corresponding author), 3181 SW Sam Jackson Pk Rd,L215, Portland, OR 97239 USA.	ennsca@ohsu.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK065064, R01DK072166] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 065064, DK 072166] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andrews NC, 2007, ANNU REV PHYSIOL, V69, P69, DOI 10.1146/annurev.physiol.69.031905.164337; Bokhari M, 2007, J ANAT, V211, P567, DOI 10.1111/j.1469-7580.2007.00778.x; Carlson H, 2005, BLOOD, V105, P2564, DOI 10.1182/blood-2004-03-1204; Chua ACG, 2004, BLOOD, V104, P1519, DOI 10.1182/blood-2003-11-3872; Coppin H, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r221; Cruz E, 2006, BLOOD CELL MOL DIS, V37, P33, DOI 10.1016/j.bcmd.2006.04.004; Davies PS, 2004, J BIOL CHEM, V279, P25085, DOI 10.1074/jbc.M400537200; Eide DJ, 2004, PFLUG ARCH EUR J PHY, V447, P796, DOI 10.1007/s00424-003-1074-3; Enns CA, 2006, BIOL RES, V39, P105, DOI 10.4067/S0716-97602006000100013; Feder JN, 1998, P NATL ACAD SCI USA, V95, P1472, DOI 10.1073/pnas.95.4.1472; Feder JN, 1997, J BIOL CHEM, V272, P14025, DOI 10.1074/jbc.272.22.14025; Fletcher LM, 2002, J INTERN MED, V251, P181, DOI 10.1046/j.1365-2796.2002.00945.x; Garrick MD, 2006, BIOCHEM J, V398, P539, DOI 10.1042/BJ20051987; Giannetti AM, 2004, J BIOL CHEM, V279, P25866, DOI 10.1074/jbc.M401467200; Gouya L, 2007, GASTROENTEROLOGY, V132, P679, DOI 10.1053/j.gastro.2006.11.024; Graham RM, 2007, WORLD J GASTROENTERO, V13, P4725, DOI 10.3748/wjg.v13.i35.4725; Gross CN, 1998, J BIOL CHEM, V273, P22068, DOI 10.1074/jbc.273.34.22068; GRUENHEID S, 1995, GENOMICS, V25, P514, DOI 10.1016/0888-7543(95)80053-O; Gunshin H, 2005, J CLIN INVEST, V115, P1258, DOI [10.1172/JCI200524356, 10.1172/JCI24356]; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; HAILE DJ, 1992, P NATL ACAD SCI USA, V89, P11735, DOI 10.1073/pnas.89.24.11735; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; HENTZE MW, 1987, SCIENCE, V238, P1570, DOI 10.1126/science.3685996; Jacolot S, 2004, BLOOD, V103, P2835, DOI 10.1182/blood-2003-10-3366; Knutson MD, 2007, NUTR REV, V65, P335, DOI 10.1301/nr.2007.jul.335-340; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lebron JA, 1998, CELL, V93, P111, DOI 10.1016/S0092-8674(00)81151-4; LEIBOLD EA, 1988, P NATL ACAD SCI USA, V85, P2171, DOI 10.1073/pnas.85.7.2171; Liuzzi JP, 2005, P NATL ACAD SCI USA, V102, P6843, DOI 10.1073/pnas.0502257102; Liuzzi JP, 2006, P NATL ACAD SCI USA, V103, P13612, DOI 10.1073/pnas.0606424103; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; OWEN D, 1987, EMBO J, V6, P1287, DOI 10.1002/j.1460-2075.1987.tb02366.x; Roy CN, 1999, J BIOL CHEM, V274, P9022, DOI 10.1074/jbc.274.13.9022; SARKAR B, 1970, CAN J BIOCHEM CELL B, V48, P1339, DOI 10.1139/o70-208; Schmidt PJ, 2008, CELL METAB, V7, P205, DOI 10.1016/j.cmet.2007.11.016; Shindo M, 2006, HEPATOL RES, V35, P152, DOI 10.1016/j.hepres.2006.03.011; Spasic MV, 2008, CELL METAB, V7, P173, DOI 10.1016/j.cmet.2007.11.014; Taylor KM, 2005, FEBS LETT, V579, P427, DOI 10.1016/j.febslet.2004.12.006; Zhang AS, 2007, J BIOL CHEM, V282, P12547, DOI 10.1074/jbc.M608788200; Zhang AS, 2004, BLOOD, V103, P1509, DOI 10.1182/blood-2003-07-2378; Zhou XY, 1998, P NATL ACAD SCI USA, V95, P2492, DOI 10.1073/pnas.95.5.2492	41	62	63	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21462	21468		10.1074/jbc.M803150200	http://dx.doi.org/10.1074/jbc.M803150200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18524764	hybrid, Green Published			2022-12-25	WOS:000257898800018
J	Rajabi, M; de Leeuw, E; Pazgier, M; Li, J; Lubkowski, J; Lu, W				Rajabi, Mohsen; de Leeuw, Erik; Pazgier, Marzena; Li, Jing; Lubkowski, Jacek; Lu, Wuyuan			The conserved salt bridge in human alpha-defensin 5 is required for its precursor processing and proteolytic stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ALPHA-DEFENSINS; HUMAN BETA-DEFENSINS; ANTIMICROBIAL PEPTIDES; HOST-DEFENSE; MAMMALIAN DEFENSINS; NEUTROPHIL DEFENSIN; CHEMICAL LIGATION; MOUSE CRYPTDIN-4; PANETH CELLS; PROTEINS	Mammalian alpha-defensins, expressed primarily in leukocytes and epithelia, play important roles in innate and adaptive immune responses to microbial infection. Six invariant cysteine residues forming three indispensable disulfide bonds and one Gly residue required structurally for an atypical beta-bulge are totally conserved in the otherwise diverse sequences of all known mammalian alpha-defensins. In addition, a pair of oppositely charged residues (Arg/Glu), forming a salt bridge across a protruding loop in the molecule, is highly conserved. To investigate the structural and functional roles of the conserved Arg(6)-Glu(14) salt bridge in human alpha-defensin 5 (HD5), we chemically prepared HD5 and its precursor proHD5 as well as their corresponding salt bridge-destabilizing analogs E14Q-HD5 and E57Q-proHD5. The Glu-to-Gln mutation, whereas significantly reducing the oxidative folding efficiency of HD5, had no effect on the folding of proHD5. Bovine trypsin productively and correctly processed proHD5 in vitro but spontaneously degraded E57Q-proHD5. Significantly, HD5 was resistant to trypsin treatment, whereas E14Q-HD5 was highly susceptible. Further, degradation of E14Q-HD5 by trypsin was initiated by the cleavage of the Arg(13)-Gln(14) peptide bond in the loop region, a catastrophic proteolytic event resulting directly in quick digestion of the whole defensin molecule. The E14Q mutation did not alter the bactericidal activity of HD5 against Staphylococcus aureus but substantially enhanced the killing of Escherichia coli. By contrast, proHD5 and E57Q-proHD5 were largely inactive against both strains at the concentrations tested. Our results confirm that the primary function of the conserved salt bridge in HD5 is to ensure correct processing of proHD5 and subsequent stabilization of mature alpha-defensin in vivo.	[Rajabi, Mohsen; de Leeuw, Erik; Li, Jing; Lu, Wuyuan] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Rajabi, Mohsen; de Leeuw, Erik; Li, Jing; Lu, Wuyuan] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Pazgier, Marzena; Lubkowski, Jacek] NCI, Macromol Assembly Struct & Cell Signaling Sect, Natl Inst Hlth, Frederick, MD 21702 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lu, W (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, 725 W Lombard St, Baltimore, MD 21201 USA.	wlu@ihv.umaryland.edu	Lu, Wuyuan/B-2268-2010; Pazgier, Marzena/B-7295-2012; Lu, Wuyuan/J-8452-2017	Lu, Wuyuan/0000-0003-1318-9968	NATIONAL CANCER INSTITUTE [ZIASC010386, Z01SC010386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061482, R21AI056264] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 056264, AI 061482] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Dawson PE, 2000, ANNU REV BIOCHEM, V69, P923, DOI 10.1146/annurev.biochem.69.1.923; de Leeuw E, 2007, FEBS LETT, V581, P515, DOI 10.1016/j.febslet.2006.12.036; Dorin JR, 2007, SCIENCE, V318, P1395, DOI 10.1126/science.1151370; Ericksen B, 2005, ANTIMICROB AGENTS CH, V49, P269, DOI 10.1128/AAC.49.1.269-275.2005; GABAY JE, 1989, P NATL ACAD SCI USA, V86, P5610, DOI 10.1073/pnas.86.14.5610; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; Hancock REW, 1997, LANCET, V349, P418, DOI 10.1016/S0140-6736(97)80051-7; Jia HP, 2001, GENE, V263, P211; JONES DE, 1993, FEBS LETT, V315, P187, DOI 10.1016/0014-5793(93)81160-2; JONES DE, 1992, J BIOL CHEM, V267, P23216; KENT SBH, 1988, ANNU REV BIOCHEM, V57, P957, DOI 10.1146/annurev.bi.57.070188.004521; Kluver E, 2005, BIOCHEMISTRY-US, V44, P9804, DOI 10.1021/bi050272k; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; LIU L, 1995, BLOOD, V85, P1095, DOI 10.1182/blood.V85.4.1095.bloodjournal8541095; Lu WY, 2000, BIOCHEMISTRY-US, V39, P3575, DOI 10.1021/bi992292q; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Ouellette AJ, 2006, CURR TOP MICROBIOL, V306, P1; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Rosengren KJ, 2006, J BIOL CHEM, V281, P28068, DOI 10.1074/jbc.M604992200; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Satchell DP, 2003, PEPTIDES, V24, P1795, DOI 10.1016/j.peptides.2003.08.020; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Schutte BC, 2002, P NATL ACAD SCI USA, V99, P2129, DOI 10.1073/pnas.042692699; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; SELSTED ME, 1985, J CLIN INVEST, V76, P1436, DOI 10.1172/JCI112121; SELSTED ME, 1987, INFECT IMMUN, V55, P2281, DOI 10.1128/IAI.55.9.2281-2286.1987; SINGH A, 1988, BIOCHEM BIOPH RES CO, V155, P524, DOI 10.1016/S0006-291X(88)81118-5; Szyk A, 2006, PROTEIN SCI, V15, P2749, DOI 10.1110/ps.062336606; Tanabe H, 2004, J BIOL CHEM, V279, P11976, DOI 10.1074/jbc.M310251200; Tanabe H, 2007, BIOCHEM BIOPH RES CO, V358, P349, DOI 10.1016/j.bbrc.2007.04.132; Taylor K, 2008, J BIOL CHEM, V283, P6631, DOI 10.1074/jbc.M709238200; Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273; Valore EV, 1996, J CLIN INVEST, V97, P1624, DOI 10.1172/JCI118588; VALORE EV, 1992, BLOOD, V79, P1538; WILDE CG, 1989, J BIOL CHEM, V264, P11200; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Wu Z, 2004, J PEPT RES, V64, P118, DOI 10.1111/j.1399-3011.2004.00179.x; Wu Z, 2003, J PEPT RES, V62, P53, DOI 10.1034/j.1399-3011.2003.00068.x; Wu ZB, 2003, P NATL ACAD SCI USA, V100, P8880, DOI 10.1073/pnas.1533186100; Wu ZB, 2005, J BIOL CHEM, V280, P43039, DOI 10.1074/jbc.M510562200; Wu ZB, 2003, J AM CHEM SOC, V125, P2402, DOI 10.1021/ja0294257; Wu ZB, 2007, J MOL BIOL, V368, P537, DOI 10.1016/j.jmb.2007.02.040; Xie C, 2005, J BIOL CHEM, V280, P32921, DOI 10.1074/jbc.M503084200; Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603; Zasloff M, 2002, NAT IMMUNOL, V3, P508, DOI 10.1038/ni0602-508; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zou GZ, 2007, J BIOL CHEM, V282, P19653, DOI 10.1074/jbc.M611003200	53	49	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21509	21518		10.1074/jbc.M801851200	http://dx.doi.org/10.1074/jbc.M801851200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18499668	Green Published, hybrid			2022-12-25	WOS:000257898800024
J	Steen, M; Tran, S; Autin, L; Villoutreix, BO; Tholander, AL; Dahlback, B				Steen, Marten; Tran, Sinh; Autin, Ludovic; Villoutreix, Bruno O.; Tholander, Ann-Louise; Dahlback, Bjorn			Mapping of the factor Xa binding site on factor Va by site-directed mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-C; COAGULATION-FACTOR VA; AMINO-ACID-RESIDUES; FACTOR-VIIIA A2; BLOOD-COAGULATION; PROTHROMBINASE COMPLEX; COFACTOR FUNCTION; INTERACTIVE SITE; HEMOPHILIA-A; HEAVY-CHAIN	Activated coagulation factor V functions as a cofactor to factor Xa in the conversion of prothrombin to thrombin. Based on the introduction of extra carbohydrate side chains in recombinant factor V, we recently proposed several regions in factor Va to be important for factor Xa binding. To further define which residues are important for factor Xa binding, we prepared fifteen recombinant factor V variants in which clusters of charged amino acid residues were mutated, mainly to alanines. The factor V variants were expressed in COS-1 cells, and their functional properties evaluated in a prothrombinase-based assay, as well as in a direct binding test. Four of the factor V variants, 501A/510A/511D, 501A/510A/511D/513A, 513A/577A/578A, and 501A/510A/511D/513A/577A/578A exhibited markedly reduced factor Xa-cofactor activity tested in the prothrombinase assay, and reduced binding affinity as judged by the direct binding assay. These factor Va variants were normally cleaved at Arg-506 by activated protein C, and the interaction between the factor Xa-factor Va complex and prothrombin was unaffected by the introduced mutations. Based on the integration of all available data, we propose a key factor Xa binding surface to be centered on Arg-501, Arg-510, Ala-511, Asp-513, Asp-577, and Asp-578 in the factor Va A2 domain. These residues form an elongated charged factor Xa binding cluster on the factor Va surface.	[Steen, Marten; Tran, Sinh; Tholander, Ann-Louise; Dahlback, Bjorn] Lund Univ, Dept Lab Med, Div Clin Chem, Wallenberg Lab,MAS, SE-20502 Malmo, Sweden; [Autin, Ludovic; Villoutreix, Bruno O.] Univ Paris 05, INSERM, U648, F-75006 Paris, France	Lund University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Dahlback, B (corresponding author), Lund Univ, Dept Clin Chem, Div Lab Med, Wallenberg Lab,MAS, SE-20502 Malmo, Sweden.	bjorn.dahlback@med.lu.se	Villoutreix, Bruno/I-4565-2015	Villoutreix, Bruno/0000-0002-6456-7730; Autin, Ludovic/0000-0002-2197-191X; Dahlback, Bjorn/0000-0003-1546-0328				Adams TE, 2004, P NATL ACAD SCI USA, V101, P8918, DOI 10.1073/pnas.0403072101; Autin L, 2006, PROTEINS, V63, P440, DOI 10.1002/prot.20848; Camire RM, 1998, BIOCHEMISTRY-US, V37, P11896, DOI 10.1021/bi980520v; Celie PHN, 1999, BRIT J HAEMATOL, V106, P792, DOI 10.1046/j.1365-2141.1999.01590.x; Dahlback B, 2005, ARTERIOSCL THROM VAS, V25, P1311, DOI 10.1161/01.ATV.0000168421.13467.82; Dahlback B, 2005, J INTERN MED, V257, P209, DOI 10.1111/j.1365-2796.2004.01444.x; DAHLBACK B, 1978, BIOCHEMISTRY-US, V17, P4938, DOI 10.1021/bi00616a013; FAY PJ, 1994, J BIOL CHEM, V269, P20522; Gale AJ, 2002, PROTEIN SCI, V11, P2091, DOI 10.1110/ps.0210002; Gale AJ, 2007, J BIOL CHEM, V282, P21848, DOI 10.1074/jbc.M702192200; Heeb MJ, 1996, PROTEIN SCI, V5, P1883, DOI 10.1002/pro.5560050914; Jenkins PV, 2004, J THROMB HAEMOST, V2, P452, DOI 10.1111/j.1538-7933.2004.00625.x; Jenkins PV, 2004, BIOCHEMISTRY-US, V43, P5094, DOI 10.1021/bi036289p; Jenkins PV, 2002, BLOOD, V100, P501, DOI 10.1182/blood-2001-12-0361; Kalafatis M, 2002, BIOCHEMISTRY-US, V41, P12715, DOI 10.1021/bi026208+; KALAFATIS M, 1994, BIOCHEMISTRY-US, V33, P6538, DOI 10.1021/bi00187a022; KANE WH, 1988, BLOOD, V71, P539; Kojima Y, 1998, J BIOL CHEM, V273, P14900, DOI 10.1074/jbc.273.24.14900; KRISHNASWAMY S, 1990, J BIOL CHEM, V265, P3708; Lenting PJ, 1996, J BIOL CHEM, V271, P1935, DOI 10.1074/jbc.271.4.1935; LUNDBLAD RL, 1975, BIOCHEM BIOPH RES CO, V66, P482, DOI 10.1016/0006-291X(75)90536-7; Mann KG, 2003, BLOOD, V101, P20, DOI 10.1182/blood-2002-01-0290; Mann KG, 2003, ARTERIOSCL THROM VAS, V23, P17, DOI 10.1161/01.ATV.0000046238.23903.FC; Mertens K, 1999, THROMB HAEMOSTASIS, V82, P209; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; NICOLAES GAF, 1995, J BIOL CHEM, V270, P21158, DOI 10.1074/jbc.270.36.21158; Nicolaes GAF, 2000, BLOOD COAGUL FIBRIN, V11, P89, DOI 10.1097/00001721-200011010-00010; Nicolaes GAF, 2002, ARTERIOSCL THROM VAS, V22, P530, DOI 10.1161/01.ATV.0000012665.51263.B7; Norstrom E, 2002, BLOOD, V100, P524, DOI 10.1182/blood-2002-02-0343; Norstrom EA, 2006, J BIOL CHEM, V281, P31486, DOI 10.1074/jbc.M606441200; Pellequer JL, 2000, THROMB HAEMOSTASIS, V84, P849, DOI 10.1055/s-0037-1614127; ROSING J, 1980, J BIOL CHEM, V255, P274; Saleh M, 2004, THROMB HAEMOSTASIS, V91, P16, DOI 10.1160/TH03-04-0222; Singh LS, 2003, J BIOL CHEM, V278, P28335, DOI 10.1074/jbc.M300233200; Steen M, 2002, J BIOL CHEM, V277, P50022, DOI 10.1074/jbc.M205609200; Steen M, 2002, J BIOL CHEM, V277, P38424, DOI 10.1074/jbc.M204972200; Sun YH, 2004, J BIOL CHEM, V279, P47528, DOI 10.1074/jbc.M407366200; Thiec F, 2003, J BIOL CHEM, V278, P10393, DOI 10.1074/jbc.M212144200; Villoutreix BO, 1998, PROTEIN SCI, V7, P1317, DOI 10.1002/pro.5560070607	39	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20805	20812		10.1074/jbc.M802703200	http://dx.doi.org/10.1074/jbc.M802703200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18502757	hybrid, Green Published			2022-12-25	WOS:000257746100022
J	Dixon, DP; Lapthorn, A; Madesis, P; Mudd, EA; Day, A; Edwards, R				Dixon, David P.; Lapthorn, Adrian; Madesis, Panagiotis; Mudd, Elisabeth A.; Day, Anil; Edwards, Robert			Binding and glutathione conjugation of porphyrinogens by plant glutathione transferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM MASS-SPECTROMETRY; S-TRANSFERASE; ANTHOCYANIN SEQUESTRATION; ARABIDOPSIS-THALIANA; HEME-BIOSYNTHESIS; ESCHERICHIA-COLI; GENE FAMILY; PROTEIN; CHLOROPHYLL; LIGANDIN	Overexpression in Escherichia coli of a tau (U) class glutathione transferase (GST) from maize (Zea mays L.), termed ZmGSTU1, caused a reduction in heme levels and an accumulation of porphyrin precursors. This disruption was highly specific, with the expression of the closely related ZmGSTU2 or other maize GSTs having little effect. Expression in E. coli of a series of chimeric ZmGSTU1/ZmGSTU2 proteins identified domains responsible for disrupting porphyrin metabolism. In addition to known heme precursors, expression of ZmGSTU1 led to the accumulation of a novel glutathione conjugate of harderoporphyrin(ogen) (2,7,12,18-tetramethyl-3-vinylporphyrin8,13,17-tripropionic acid). Using the related protoporphyrinogen as a substrate, conjugation could be shown to occur on one vinyl group and was actively catalyzed by the ZmGSTU. In plant transgenesis studies, the ZmGSTUs did not perturb porphyrin metabolism when expressed in the cytosol of Arabidopsis or tobacco. However, expression of a ZmGSTU1-ZmGSTU2 chimera in the chloroplasts of tobacco resulted in the accumulation of the harderoporphyrin(ogen)-glutathione conjugate observed in the expression studies in bacteria. Our results show that the well known ability of GSTs to act as ligand binding(ligandin) proteins of porphyrins in vitro results in highly specific interactions with porphyrinogen intermediates, which can be demonstrated in both plants and bacteria in vivo.	[Dixon, David P.; Edwards, Robert] Univ Durham, Sch Biol & Biomed Sci, Ctr Bioact Chem, Durham DH1 3LE, England; [Lapthorn, Adrian] Univ Glasgow, Dept Chem, Glasgow G12 8QQ, Lanark, Scotland; [Madesis, Panagiotis; Mudd, Elisabeth A.; Day, Anil] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	Durham University; University of Glasgow; University of Manchester	Edwards, R (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Ctr Bioact Chem, Durham DH1 3LE, England.	Robert.Edwards@durham.ac.uk	Dixon, David P/B-5413-2008; Madesis, Panagiotis/AAL-5980-2020	Dixon, David P/0000-0003-4644-8399; Madesis, Panagiotis/0000-0003-1447-3514; Edwards, Robert/0000-0003-0809-5991; Day, Anil/0000-0001-7835-9572; Lapthorn, Adrian/0000-0002-2197-8134	BBSRC [BB/E020445/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBC51227X1, BB/E020445/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alfenito MR, 1998, PLANT CELL, V10, P1135, DOI 10.1105/tpc.10.7.1135; BILANG J, 1995, PLANT PHYSIOL, V109, P253, DOI 10.1104/pp.109.1.253; Danton M, 2006, BIOMED CHROMATOGR, V20, P612, DOI 10.1002/bmc.656; Dixon D. P., 1999, Plant Physiology, V119, P1568; Dixon DP, 2005, PLANT SCI, V168, P873, DOI 10.1016/j.plantsci.2004.11.009; Dixon DP, 2002, J BIOL CHEM, V277, P30859, DOI 10.1074/jbc.M202919200; Dixon DP, 2003, J BIOL CHEM, V278, P23930, DOI 10.1074/jbc.M303620200; Dixon DP, 1998, PLANT MOL BIOL, V36, P75, DOI 10.1023/A:1005958711207; Dixon DP, 2000, ARCH BIOCHEM BIOPHYS, V384, P407, DOI 10.1006/abbi.2000.2125; Dixon DP, 1999, PLANT MOL BIOL, V40, P997, DOI 10.1023/A:1006257305725; EDWARDS R, 2000, HERBICIDES THEIR MEC, P39; Frankenberg N, 2003, APPL MICROBIOL BIOT, V63, P115, DOI 10.1007/s00253-003-1432-2; Gonneau J, 1998, PHYSIOL PLANTARUM, V103, P114, DOI 10.1034/j.1399-3054.1998.1030114.x; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hortensteiner S, 2006, ANNU REV PLANT BIOL, V57, P55, DOI 10.1146/annurev.arplant.57.032905.105212; KARAGIANIS G, 1993, AUST J CHEM, V46, P1755, DOI 10.1071/CH9931755; Kode V, 2006, PLANT J, V46, P901, DOI 10.1111/j.1365-313X.2006.02736.x; Kwon SJ, 2003, APPL ENVIRON MICROB, V69, P4875, DOI 10.1128/AEM.69.8.4875-4883.2003; Lederer B, 2005, Z NATURFORSCH C, V60, P166; Lederer B, 2003, BBA-GEN SUBJECTS, V1621, P226, DOI 10.1016/S0304-4165(03)00073-4; Levsen K, 2005, J CHROMATOGR A, V1067, P55, DOI 10.1016/j.chroma.2004.08.165; LISTOWSKY I, 1988, DRUG METAB REV, V19, P305, DOI 10.3109/03602538808994138; LITWACK G, 1971, NATURE, V234, P466, DOI 10.1038/234466a0; Martens JH, 2002, APPL MICROBIOL BIOT, V58, P275, DOI 10.1007/s00253-001-0902-7; Mueller LA, 2000, PLANT PHYSIOL, V123, P1561, DOI 10.1104/pp.123.4.1561; Nakayashiki T, 1997, MOL GEN GENET, V255, P376, DOI 10.1007/s004380050509; Razzaque MA, 2002, RAPID COMMUN MASS SP, V16, P1675, DOI 10.1002/rcm.768; Rea PA, 1998, ANNU REV PLANT PHYS, V49, P727, DOI 10.1146/annurev.arplant.49.1.727; SANO S, 1964, BIOCHEM J, V93, P270, DOI 10.1042/bj0930270; SINGH BR, 1988, FEBS LETT, V234, P379, DOI 10.1016/0014-5793(88)80120-0; SLAMA JT, 1975, J AM CHEM SOC, V97, P6556, DOI 10.1021/ja00855a045; Soranzo N, 2004, MOL GENET GENOMICS, V271, P511, DOI 10.1007/s00438-004-1006-8; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; Tewari AK, 1998, PLANT PHYSIOL, V117, P851, DOI 10.1104/pp.117.3.851; TIPPING E, 1978, BIOCHEM J, V169, P509, DOI 10.1042/bj1690509; TIPPING E, 1976, BIOCHEM J, V157, P461, DOI 10.1042/bj1570461; Vargo MA, 2001, J BIOL CHEM, V276, P2031, DOI 10.1074/jbc.M008212200; Vavilin DV, 2002, PHYSIOL PLANTARUM, V115, P9, DOI 10.1034/j.1399-3054.2002.1150102.x; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Wagner U, 2002, PLANT MOL BIOL, V49, P515, DOI 10.1023/A:1015557300450; Wroblewski T, 2005, PLANT BIOTECHNOL J, V3, P259, DOI 10.1111/j.1467-7652.2005.00123.x; Zachariah VT, 2000, J PROTEIN CHEM, V19, P425, DOI 10.1023/A:1026513528654; Zubko MK, 2004, TRANSGENIC RES, V13, P523, DOI 10.1007/s11248-004-2374-x	44	41	44	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20268	20276		10.1074/jbc.M802026200	http://dx.doi.org/10.1074/jbc.M802026200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18492666	hybrid			2022-12-25	WOS:000257565300043
J	Linderholm, A; Malmstrom, H; Liden, K; Holmlund, G; Gotherstrom, A				Linderholm, Anna; Malmstrom, Helena; Liden, Kerstin; Holmlund, Gunilla; Gotherstrom, Anders			Cryptic Contamination and Phylogenetic Nonsense	PLOS ONE			English	Article							ANCIENT DNA; LACTASE-PERSISTENCE; BONES	Ancient human DNA has been treated cautiously ever since the problems related to this type of material were exposed in the early 1990s, but as sequential genetic data from ancient specimens have been key components in several evolutionary and ecological studies, interest in ancient human DNA is on the increase again. It is especially tempting to approach archaeological and anthropological questions through this type of material, but DNA from ancient human tissue is notoriously complicated to work with due to the risk of contamination with modern human DNA. Various ways of authenticating results based on ancient human DNA have been developed to circumvent the problems. One commonly used method is to predict what the contamination is expected to look like and then test whether the ancient human DNA fulfils this prediction. If it does, the results are rejected as contamination, while if it does not, they are often considered authentic. We show here that human contamination in ancient material may well deviate from local allele frequencies or the distributions to be found among the laboratory workers and archaeologists. We conclude that it is not reliable to authenticate ancient human DNA solely by showing that it is different from what would be expected from people who have handled the material.	[Linderholm, Anna; Liden, Kerstin] Stockholm Univ, Archaeol Res Lab, S-10691 Stockholm, Sweden; [Malmstrom, Helena; Gotherstrom, Anders] Uppsala Univ, Dept Evol Biol, Uppsala, Sweden; [Holmlund, Gunilla] Natl Board Forens Med, Dept Forens Genet & Forens Toxicol, Linkoping, Sweden	Stockholm University; Uppsala University; Swedish National Board of Forensic Medicine	Linderholm, A (corresponding author), Stockholm Univ, Archaeol Res Lab, S-10691 Stockholm, Sweden.	anna.linderholm@arklab.su.se	Linderholm, Anna/R-7516-2019; Malmström, Helena/C-2476-2017	Malmström, Helena/0000-0002-6456-8055; Gotherstrom, Anders/0000-0001-8579-1304; Liden, Kerstin/0000-0002-5911-9503; Linderholm, Anna/0000-0002-1613-9926				Abbott A, 2003, NATURE, V423, P468, DOI 10.1038/423468b; Adcock GJ, 2001, P NATL ACAD SCI USA, V98, P537, DOI 10.1073/pnas.98.2.537; Burger J, 2007, P NATL ACAD SCI USA, V104, P3736, DOI 10.1073/pnas.0607187104; Caramelli D, 2003, P NATL ACAD SCI USA, V100, P6593, DOI 10.1073/pnas.1130343100; Cooper A, 2000, SCIENCE, V289, P1139; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; Haak W, 2005, SCIENCE, V310, P1016, DOI 10.1126/science.1118725; HANDT O, 1994, SCIENCE, V264, P1775, DOI 10.1126/science.8209259; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Kuokkanen M, 2005, INT J CANCER, V117, P90, DOI 10.1002/ijc.21130; Leonard JA, 2007, J ARCHAEOL SCI, V34, P1361, DOI 10.1016/j.jas.2006.10.023; Malmstrom H, 2005, MOL BIOL EVOL, V22, P2040, DOI 10.1093/molbev/msi195; Malmstrom H, 2007, MOL BIOL EVOL, V24, P998, DOI 10.1093/molbev/msm015; PAABO S, 1985, NATURE, V314, P644, DOI 10.1038/314644a0; RICHARDS MB, 1995, J ARCHAEOL SCI, V22, P291, DOI 10.1006/jasc.1995.0031; Ronaghi M, 2001, GENOME RES, V11, P3, DOI 10.1101/gr.11.1.3; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Sampietro ML, 2006, MOL BIOL EVOL, V23, P1801, DOI 10.1093/molbev/msl047; Svensson EM, 2007, ANIM GENET, V38, P378, DOI 10.1111/j.1365-2052.2007.01620.x; Wall JD, 2007, PLOS GENET, V3, P1862, DOI 10.1371/journal.pgen.0030175; WOODWARD SR, 1994, SCIENCE, V266, P1229; Xie CZ, 2007, P R SOC B, V274, P1597, DOI 10.1098/rspb.2007.0219; Yang DY, 1998, AM J PHYS ANTHROPOL, V105, P539, DOI 10.1002/(SICI)1096-8644(199804)105:4<539::AID-AJPA10>3.3.CO;2-2; ZISCHLER H, 1995, SCIENCE, V268, P1192, DOI 10.1126/science.7605504	24	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2316	10.1371/journal.pone.0002316	http://dx.doi.org/10.1371/journal.pone.0002316			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	391XW	18509458	Green Published, Green Submitted, gold			2022-12-25	WOS:000262268500044
J	Torpey, KE; Kabaso, ME; Mutale, LN; Kamanga, MK; Mwango, AJ; Simpungwe, J; Suzuki, C; Mukadi, YD				Torpey, Kwasi E.; Kabaso, Mushota E.; Mutale, Liya N.; Kamanga, Mpuma K.; Mwango, Albert J.; Simpungwe, James; Suzuki, Chiho; Mukadi, Ya Diul			Adherence Support Workers: A Way to Address Human Resource Constraints in Antiretroviral Treatment Programs in the Public Health Setting in Zambia	PLOS ONE			English	Article							DIRECTLY OBSERVED THERAPY; POOR SETTINGS; HIV TREATMENT; VIRAL LOAD; FEASIBILITY; EFFICACY	Background: In order to address staff shortages and improve adherence counseling for people on antiretroviral therapy (ART), the Zambia Prevention, Care and Treatment Partnership (ZPCT) developed an innovative strategy of training community volunteers to provide adherence support at the health facility and community levels. The objective of this study was to assess the effectiveness of these 'adherence support workers' (ASWs) in adherence counseling, treatment retention and addressing inadequate human resources at health facilities. Methodology/Principal Findings: The study used quantitative and qualitative research techniques at five selected ART sites in four provinces in Zambia. Five hundred patients on ART were interviewed using a structured questionnaire to compare the quality of adherence counseling before and after the ASW scheme was introduced at the selected sites and between ASWs and HCWs after the introduction of ASWs. In addition, 3,903 and 4,972 electronic records of all new patients accessing antiretroviral therapy for the time period of 12 months before and 12 months after the introduction of ASWs respectively, were analyzed to assess loss to follow-up rates. Two focus group discussions with ASWs and health care workers ( HCWs) were conducted in each clinic. Key informant interviews in the ART clinics were also conducted. There was a marked shift of workload from HCWs to ASWs without any compromise in the quality of counseling. Quality of adherence counseling by ASWs was comparable to HCWs after their introduction. The findings suggest that the deployment of ASWs helped reduce waiting times for adherence counseling. Loss to follow-up rates of new clients declined from 15% to 0% after the deployment of ASWs. Conclusion: Adherence counseling tasks can be shifted to lay cadres like ASWs without compromising the quality of counseling. Follow-up of clients by ASWs within the community is necessary to improve retention of clients on ART.	[Torpey, Kwasi E.; Kabaso, Mushota E.; Mutale, Liya N.; Kamanga, Mpuma K.] Family Hlth Int Zambia Prevent Care & Treatment P, Lusaka, Zambia; [Mwango, Albert J.; Simpungwe, James] Ministry Hlth, Lusaka, Zambia; [Suzuki, Chiho; Mukadi, Ya Diul] Family Hlth Int, Arlington, VA USA		Torpey, KE (corresponding author), Family Hlth Int Zambia Prevent Care & Treatment P, Lusaka, Zambia.	KTorpey@zpct.org		Torpey, Kwasi/0000-0003-1628-2922	U.S. Agency for International Development (USAID) [690-A-00-04-00319-00]	U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID))	Support for this paper was provided by Family Health International (FHI)/Zambia Prevention Care and Treatment Partnership with funds from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through U.S. Agency for International Development (USAID) Cooperative Agreement No. 690-A-00-04-00319-00. The views expressed in this publication do not necessarily reflect those of FHI. The sponsor of the study had no role in the design, data collection, analysis, interpretation and writing of the report. The corresponding author had full access to data and had final responsibility to submit this article for publication.	Arnsten JH, 2001, CLIN INFECT DIS, V33, P1417, DOI 10.1086/323201; Bangsberg DR, 2006, CLIN INFECT DIS, V43, P939, DOI 10.1086/507526; Bangsberg DR, 2000, AIDS, V14, P357, DOI 10.1097/00002030-200003100-00008; BANGSBERG DR, 2002, J ACQ IMMUN DEF SYND, V15, P1181; Berg KM, 2006, JAIDS-J ACQ IMM DEF, V43, pS79, DOI 10.1097/01.qai.0000248337.97814.66; BROWN S, 2004, ASSESSMENT ADHERENCE; Coetzee D, 2004, AIDS, V18, pS27, DOI 10.1097/00002030-200406003-00006; de Olalla PG, 2002, J ACQ IMMUN DEF SYND, V30, P105, DOI 10.1097/00042560-200205010-00014; Farmer P, 2001, LANCET, V358, P404, DOI 10.1016/S0140-6736(01)05550-7; Farmer P, 2001, B WORLD HEALTH ORGAN, V79, P1145; *FHI, 2007, ADH SUPP WORK TRAIN; *GBOH, 2003, NAT HLTH STRAT PLAN; Gifford AL, 2000, J ACQ IMMUN DEF SYND, V23, P386; Gill CJ, 2005, AIDS, V19, P1243, DOI 10.1097/01.aids.0000180094.04652.3b; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; Kober K, 2004, LANCET, V364, P103, DOI 10.1016/S0140-6736(04)16597-5; Koenig SP, 2004, AIDS, V18, pS21, DOI 10.1097/00002030-200406003-00005; *MIN HLTH, 2006, HLTH SECT JOINT ANN; *MIN HLTH, 2005, ANN HLTH STAT B; *MIN HLTH, 2005, MIN HLTH STRAT PLAN; Mukherjee JS, 2006, JAIDS-J ACQ IMM DEF, V43, pS123, DOI 10.1097/01.qai.0000248348.25630.74; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, pS127, DOI 10.1097/01.qai.0000248349.25630.3d; Orrell C, 2003, AIDS, V17, P1369, DOI 10.1097/00002030-200306130-00011; Oyugi JH, 2004, JAIDS-J ACQ IMM DEF, V36, P1100, DOI 10.1097/00126334-200408150-00014; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Pearson CR, 2006, JAIDS-J ACQ IMM DEF, V43, pS134, DOI 10.1097/01.qai.0000248339.82567.17; Person Anna K, 2007, Curr HIV/AIDS Rep, V4, P73, DOI 10.1007/s11904-007-0011-z; ROSEN S, 2007, PLOS MED; Simoni JM, 2006, JAIDS-J ACQ IMM DEF, V43, pS23, DOI 10.1097/01.qai.0000248342.05438.52; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Wainberg MA, 1998, JAMA-J AM MED ASSOC, V279, P1977, DOI 10.1001/jama.279.24.1977; Wohl AR, 2004, CLIN INFECT DIS, V38, pS388, DOI 10.1086/421401	32	81	82	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2204	10.1371/journal.pone.0002204	http://dx.doi.org/10.1371/journal.pone.0002204			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493615	Green Published, gold, Green Accepted			2022-12-25	WOS:000262258700013
J	Abaraviciene, SM; Lundquist, I; Galvanovskis, J; Flodgren, E; Olde, B; Salehi, A				Abaraviciene, Sandra Meidute; Lundquist, Ingmar; Galvanovskis, Juris; Flodgren, Erik; Olde, Bjorn; Salehi, Albert			Palmitate-Induced beta-Cell Dysfunction Is Associated with Excessive NO Production and Is Reversed by Thiazolidinedione-Mediated Inhibition of GPR40 Transduction Mechanisms	PLOS ONE			English	Article								Background: Type 2 diabetes often displays hyperlipidemia. We examined palmitate effects on pancreatic islet function in relation to FFA receptor GPR40, NO generation, insulin release, and the PPAR gamma agonistic thiazolidinedione, rosiglitazone. Principal Findings: Rosiglitazone suppressed acute palmitate-stimulated GPR40-transduced PI hydrolysis in HEK293 cells and insulin release from MIN6c cells and mouse islets. Culturing islets 24 h with palmitate at 5 mmol/l glucose induced beta-cell iNOS expression as revealed by confocal microscopy and increased the activities of ncNOS and iNOS associated with suppression of glucose-stimulated insulin response. Rosiglitazone reversed these effects. The expression of iNOS after high-glucose culturing was unaffected by rosiglitazone. Downregulation of GPR40 by antisense treatment abrogated GPR40 expression and suppressed palmitate-induced iNOS activity and insulin release. Conclusion: We conclude that, in addition to mediating acute FFA-stimulated insulin release, GPR40 is an important regulator of iNOS expression and dysfunctional insulin release during long-term exposure to FFA. The adverse effects of palmitate were counteracted by rosiglitazone at GPR40, suggesting that thiazolidinediones are beneficial for beta-cell function in hyperlipidemic type 2 diabetes.	[Abaraviciene, Sandra Meidute; Galvanovskis, Juris; Flodgren, Erik; Salehi, Albert] UMAS, Malmo Univ Hosp, Div Endocrine Pharmacol, Dept Clin Sci, Malmo, Sweden; [Lundquist, Ingmar; Olde, Bjorn] Lund Univ, Dept Expt Med Sci, Lund, Sweden	Lund University; Skane University Hospital; Lund University	Abaraviciene, SM (corresponding author), UMAS, Malmo Univ Hosp, Div Endocrine Pharmacol, Dept Clin Sci, Malmo, Sweden.	S_Albert.Salehi@med.lu.se	Salehi, Albert/F-7768-2018	Salehi, Albert/0000-0001-6120-3539	Swedish Science Council [04X-20029]; Medical faculty (University of Lund); NOVO Nordic; Magnus Bergvall; Crafoord Founda-tions	Swedish Science Council; Medical faculty (University of Lund); NOVO Nordic; Magnus Bergvall; Crafoord Founda-tions	This study was supported by the Swedish Science Council (04X-20029), the Medical faculty (University of Lund), NOVO Nordic, Magnus Bergvall, Albert Pahlsson and Crafoord Founda-tions. The technical assistance of Britt-Marie Nilsson is gratefully acknowledged.	Akesson B, 1999, J ENDOCRINOL, V163, P39, DOI 10.1677/joe.0.1630039; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Brunham LR, 2007, NAT MED, V13, P340, DOI 10.1038/nm1546; Cnop M, 2001, DIABETES, V50, P1771, DOI 10.2337/diabetes.50.8.1771; Cnop M, 2002, BIOCHEM PHARMACOL, V63, P1281, DOI 10.1016/S0006-2952(02)00860-2; Gastaldelli A, 2007, AM J PHYSIOL-ENDOC M, V292, pE871, DOI 10.1152/ajpendo.00551.2006; GOTTLICHER M, 1992, P NATL ACAD SCI USA, V89, P4653, DOI 10.1073/pnas.89.10.4653; HEDING LG, 1966, SIMPLIFIED INSULIN R, P345; Henningsson R, 2002, AM J PHYSIOL-CELL PH, V283, pC296, DOI 10.1152/ajpcell.00537.2001; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jimenez-Feltstrom J, 2005, CELL TISSUE RES, V319, P221, DOI 10.1007/s00441-004-1013-4; Jimenez-Feltstrom J, 2004, REGUL PEPTIDES, V122, P109, DOI 10.1016/j.regpep.2004.06.004; Kang DS, 2002, MOL PHARMACOL, V62, P281, DOI 10.1124/mol.62.2.281; Kotarsky K, 2003, BIOCHEM BIOPH RES CO, V301, P406, DOI 10.1016/S0006-291X(02)03064-4; Lajoix AD, 2001, DIABETES, V50, P1311, DOI 10.2337/diabetes.50.6.1311; Latour MG, 2007, DIABETES, V56, P1087, DOI 10.2337/db06-1532; Lupi R, 2004, AM J PHYSIOL-ENDOC M, V286, pE560, DOI 10.1152/ajpendo.00561.2002; McGarry JD, 1999, DIABETOLOGIA, V42, P128, DOI 10.1007/s001250051130; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; Olofsson CS, 2004, J PHYSIOL-LONDON, V557, P935, DOI 10.1113/jphysiol.2004.066258; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Qader SS, 2007, AM J PHYSIOL-ENDOC M, V292, pE1447, DOI 10.1152/ajpendo.00172.2006; Salehi A, 1996, AM J PHYSIOL-CELL PH, V270, pC1634, DOI 10.1152/ajpcell.1996.270.6.C1634; Salehi A, 2005, CELL TISSUE RES, V322, P207, DOI 10.1007/s00441-005-0017-z; Salehi A, 2001, ENDOCRINE, V16, P97, DOI 10.1385/ENDO:16:2:097; Salehi A, 2003, HORM METAB RES, V35, P48, DOI 10.1055/s-2003-38391; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Shimabukuro M, 1998, J BIOL CHEM, V273, P3547, DOI 10.1074/jbc.273.6.3547; Steneberg R, 2005, CELL METAB, V1, P245, DOI 10.1016/j.cmet.2005.03.007; Takamura T, 1998, J BIOL CHEM, V273, P2493, DOI 10.1074/jbc.273.5.2493; Tsuura Y, 1998, BIOCHEM BIOPH RES CO, V252, P34, DOI 10.1006/bbrc.1998.9601; Wang X, 2007, LIFE SCI, V81, P160, DOI 10.1016/j.lfs.2007.04.034; Yaney GC, 2003, DIABETOLOGIA, V46, P1297, DOI 10.1007/s00125-003-1207-4; Yang C, 2001, DIABETES, V50, P2598, DOI 10.2337/diabetes.50.11.2598; Yoshikawa H, 2004, AM J PHYSIOL-ENDOC M, V287, pE1202, DOI 10.1152/ajpendo.00255.2004	39	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2182	10.1371/journal.pone.0002182	http://dx.doi.org/10.1371/journal.pone.0002182			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478115	gold, Green Published, Green Submitted			2022-12-25	WOS:000262172800047
J	Zhu, YN; Hou, HY; Nikolic, WV; Ehrhart, J; Rrapo, E; Bickford, P; Giunta, B; Tan, J				Zhu, Yuyan; Hou, Huayan; Nikolic, William V.; Ehrhart, Jared; Rrapo, Elona; Bickford, Paula; Giunta, Brian; Tan, Jun			CD45RB Is a Novel Molecular Therapeutic Target to Inhibit A beta Peptide-Induced Microglial MAPK Activation	PLOS ONE			English	Article								Background: Microglial activation, characterized by p38 MAPK or p44/42 MAPK pathway signal transduction, occurs in Alzheimer's disease (AD). Our previous studies demonstrated CD45, a membrane-bound protein tyrosine phosphatase (PTP), opposed beta-amyloid (A beta) peptide-induced microglial activation via inhibition of p44/42 MAPK. Additionally we have shown agonism of the RB isoform of CD45 (CD45RB) abrogates lipopolysaccharide (LPS)-induced microglial activation. Methodology and Results: In this study, CD45RB modulation of A beta peptide or LPS-activated primary cultured microglial cells was further investigated. Microglial cells were co-treated with "aged" FITC-A beta(1-42) and multiple CD45 isoform agonist antibodies. Data revealed cross-linking of CD45, particularly the CD45RB isoform, enhances microglial phagocytosis of A beta(1-42) peptide and inhibits LPS-induced activation of p44/42 and p38 pathways. Co-treatment of microglial cells with agonist CD45 antibodies results in significant inhibition of LPS-induced microglial TNF-alpha and IL-6 release through p44/42 and/or p38 pathways. Moreover, inhibition of either of these pathways augmented CD45RB cross-linking induced microglial phagocytosis of A beta(1-42) peptide. To investigate the mechanism(s) involved, microglial cells were co-treated with a PTP inhibitor (potassium bisperoxo [1,10-phenanthroline oxovanadate; Phen]) and A beta(1-42) peptides. Data showed synergistic induction of microglial activation as evidenced by TNF-alpha and IL-6 release; both of which are demonstrated to be dependent on increased p44/42 and/or p38 activation. Finally, it was observed that cross-linking of CD45RB in the presence of A beta(1-42) peptide, inhibits co-localization of microglial MHC class II and A beta peptide; suggesting CD45 activation inhibits the antigen presenting phenotype of microglial cells. Conclusion: In summary, p38 MAPK is another novel signaling pathway, besides p44/42, in which CD45RB cross-linking negatively regulates microglial A beta phagocytosis while increasing potentially neurotoxic inflammation. Therefore, agonism of CD45RB PTP activity may be an effective therapeutic target for novel agents to treat AD due to its A beta lowering, and inflammation reducing, properties that are particularly targeted at microglial cells. Such treatments may be more effective with less potential to produce systemic side-effects than therapeutics which induce non-specific, systemic down-regulation of inflammation.	[Zhu, Yuyan; Hou, Huayan; Nikolic, William V.; Ehrhart, Jared; Rrapo, Elona; Giunta, Brian; Tan, Jun] Univ S Florida, Coll Med, Dept Psychiat & Behav Med, Silver Child Dev Ctr,Rashid Lab Dev Neurobiol, Tampa, FL 33620 USA; [Bickford, Paula; Tan, Jun] Univ S Florida, Coll Med, Ctr Excellence Aging & Brain Repair, Dept Neurosurg, Tampa, FL USA; [Bickford, Paula] Univ S Florida, Coll Med, Veterans Adm Hosp, Res Serv, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Zhu, YN (corresponding author), Univ S Florida, Coll Med, Dept Psychiat & Behav Med, Silver Child Dev Ctr,Rashid Lab Dev Neurobiol, Tampa, FL 33620 USA.	jtan@hsc.usf.edu	Tan, Jun/I-5339-2012; Bickford, Paula C/J-5970-2012; Giunta, Brian/H-3817-2011; Nikolic, William/H-4672-2013	Bickford, Paula C/0000-0001-9657-7725; Nikolic, William/0000-0002-7670-6910	NIH/NIA [AG04418]; NIH/NINDS [NS048335]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH098737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG004418] Funding Source: NIH RePORTER	NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants to J.T. from the NIH/NIA (AG04418) and the NIH/NINDS (NS048335).	Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Bard F, 2003, P NATL ACAD SCI USA, V100, P2023, DOI 10.1073/pnas.0436286100; Bradt BM, 1998, J EXP MED, V188, P431, DOI 10.1084/jem.188.3.431; Breitner JCS, 1996, ANNU REV MED, V47, P401; Breitner JCS, 1996, NEUROBIOL AGING, V17, P789; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; Chung HY, 1999, J BIOL CHEM, V274, P32301, DOI 10.1074/jbc.274.45.32301; Combs CK, 2001, J NEUROSCI, V21, P1179; Combs CK, 1999, J NEUROSCI, V19, P928; Cornet A, 1998, REV NEUROL, V154, P586; Cosenza-Nashat MA, 2006, BRAIN PATHOL, V16, P256, DOI 10.1111/j.1750-3639.2006.00027.x; Dalpke AH, 2002, J IMMUNOL, V168, P4854, DOI 10.4049/jimmunol.168.10.4854; Dickson DW, 1997, NEUROBIOL AGING, V18, pS21, DOI 10.1016/S0197-4580(97)00065-1; Fiala M, 2007, J ALZHEIMERS DIS, V11, P457; Funamoto S, 2004, BIOCHEMISTRY-US, V43, P13532, DOI 10.1021/bi049399k; Giunta B, 2004, BRAIN RES BULL, V64, P165, DOI 10.1016/j.brainresbull.2004.06.008; Golde TE, 2000, BBA-MOL BASIS DIS, V1502, P172, DOI 10.1016/S0925-4439(00)00043-0; HAMBLETON J, 1995, J EXP MED, V182, P147, DOI 10.1084/jem.182.1.147; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Higgins J. A., 1994, Insect Molecular Biology, V3, P27, DOI 10.1111/j.1365-2583.1994.tb00147.x; HIGGINS MJ, 1995, ENVIRON MOL MUTAGEN, V26, P37, DOI 10.1002/em.2850260106; Irie-Sasaki J, 2003, CURR TOP MED CHEM, V3, P783, DOI 10.2174/1568026033452339; Irie-Sasaki J, 2001, NATURE, V409, P349, DOI 10.1038/35053086; Kaisho T, 2002, BBA-MOL CELL RES, V1589, P1, DOI 10.1016/S0167-4889(01)00182-3; KARP HL, 1994, GLIA, V11, P284, DOI 10.1002/glia.440110310; Kim BO, 2003, AM J PATHOL, V162, P1693, DOI 10.1016/S0002-9440(10)64304-0; Koistinaho M, 2002, GLIA, V40, P175, DOI 10.1002/glia.10151; Koistinaho M, 2001, P NATL ACAD SCI USA, V98, P14675, DOI 10.1073/pnas.261562998; Launer LJ, 2003, DRUGS, V63, P731, DOI 10.2165/00003495-200363080-00001; Licastro F, 1998, J NEUROIMMUNOL, V88, P105, DOI 10.1016/S0165-5728(98)00096-4; LIEW SCK, 1994, J NEUROPATH EXP NEUR, V53, P150, DOI 10.1097/00005072-199403000-00006; Mackenzie IRA, 1998, NEUROLOGY, V50, P986, DOI 10.1212/WNL.50.4.986; Marambaud P, 2005, J BIOL CHEM, V280, P37377, DOI 10.1074/jbc.M508246200; MASLIAH E, 1991, ACTA NEUROPATHOL, V83, P12, DOI 10.1007/BF00294425; MATSUSHIMA GK, 1994, CELL, V78, P645, DOI 10.1016/0092-8674(94)90529-0; McDonald DR, 1998, J NEUROSCI, V18, P4451; Minagar A, 2002, J NEUROL SCI, V202, P13, DOI 10.1016/S0022-510X(02)00207-1; Mitrasinovic OM, 2002, J BIOL CHEM, V277, P29889, DOI 10.1074/jbc.M200868200; OLSSON T, 1995, NEUROLOGY, V45, pS11, DOI 10.1212/WNL.45.6_Suppl_6.S11; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; PERLMUTTER LS, 1992, J NEUROSCI RES, V33, P549, DOI 10.1002/jnr.490330407; Pyo H, 1998, NEUROREPORT, V9, P871, DOI 10.1097/00001756-199803300-00020; QUON D, 1991, NATURE, V352, P239, DOI 10.1038/352239a0; Sasaki T, 2001, INT J BIOCHEM CELL B, V33, P1041, DOI 10.1016/S1357-2725(01)00075-9; Sastre M, 2006, INT J DEV NEUROSCI, V24, P167, DOI 10.1016/j.ijdevneu.2005.11.014; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Stein VM, 2007, J VET MED A, V54, P314, DOI 10.1111/j.1439-0442.2007.00926.x; STREULI M, 1987, J EXP MED, V166, P1548, DOI 10.1084/jem.166.5.1548; Suttles J, 1999, J BIOL CHEM, V274, P5835, DOI 10.1074/jbc.274.9.5835; SWANBORG RH, 1995, CLIN IMMUNOL IMMUNOP, V77, P4, DOI 10.1016/0090-1229(95)90130-2; Tan J, 1999, SCIENCE, V286, P2352, DOI 10.1126/science.286.5448.2352; Tan J, 2002, J NEUROIMMUNOL, V132, P164, DOI 10.1016/S0165-5728(02)00309-0; Tan J, 2002, CURR OPIN PHARMACOL, V2, P445, DOI 10.1016/S1471-4892(02)00180-7; Tan J, 2000, J BIOL CHEM, V275, P37224, DOI 10.1074/jbc.M002006200; Tan J, 1999, J IMMUNOL, V163, P6614; Tan J, 2000, J NEUROSCI, V20, P7587; Town T, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-24; Townsend KP, 2004, NEUROSCI LETT, V362, P26, DOI 10.1016/j.neulet.2004.01.082; Townsend KP, 2005, EUR J IMMUNOL, V35, P901, DOI 10.1002/eji.200425585; Van Eldik LJ, 2007, INT REV NEUROBIOL, V82, P277, DOI 10.1016/S0074-7742(07)82015-0; von Bernhardi R, 2007, NEUROBIOL DIS, V26, P153, DOI 10.1016/j.nbd.2006.12.006; Yang YP, 1996, SCIENCE, V273, P1862, DOI 10.1126/science.273.5283.1862; Zhang K, 2002, J ALLERGY CLIN IMMUN, V110, P421, DOI 10.1067/mai.2002.126382	63	17	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2135	10.1371/journal.pone.0002135	http://dx.doi.org/10.1371/journal.pone.0002135			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478117	Green Published, Green Submitted, gold			2022-12-25	WOS:000262172800001
J	Cuchillo-Ibanez, I; Seereeram, A; Byers, HL; Leung, KY; Ward, MA; Anderton, BH; Hanger, DP				Cuchillo-Ibanez, Inmaculada; Seereeram, Anjan; Byers, Helen L.; Leung, Kit-Yi; Ward, Malcolm A.; Anderton, Brian H.; Hanger, Diane P.			Phosphorylation of tau regulates its axonal transport by controlling its binding to kinesin	FASEB JOURNAL			English	Article						GSK-3; mass spectrometry; lithium	GLYCOGEN-SYNTHASE KINASE-3; CYCLIN-DEPENDENT KINASE-5; DISEASE-LIKE PHOSPHORYLATION; HELICAL FILAMENT-TAU; MASS-SPECTROMETRY; PROTEIN-TAU; SITES; LITHIUM; INHIBITION; NEURONS	Defective axonal transport has been proposed as an underlying mechanism that may give rise to neurodegeneration. We investigated the effect of phosphorylation on the axonal transport of tau, a neuronal protein that stabilizes microtubules and is hyperphosphorylated and mislocalized in Alzheimer's disease. We report here that specific inhibition of glycogen synthase kinase-3 (GSK-3) reduces tau phosphorylation and significantly decreases the overall rate of axonal transport of tau in rat cortical neurons. Tau mutants, with serine/threonine targets of GSK-3 mutated to glutamate to mimic a permanent state of phosphorylation, were transported at a significantly increased rate compared to wild-type tau. Conversely, tau mutants, in which alanine replaced serine/threonine to mimic permanent dephosphorylation, were transported at a decreased rate compared to wild-type tau. We also found that tau interacts with the light chain of kinesin-1 and that this is dependent on the phosphorylation state of tau. Tau phosphorylation by GSK-3 increased binding, and dephosphorylated tau exhibited a reduced association with kinesin-1. We conclude that GSK-3 phosphorylation of tau modulates its axonal transport by regulating binding to kinesin-1. Hyperphosphorylated tau in Alzheimer's disease appearing first in distal portions of axons may result from aberrant axonal transport of phosphorylated tau reported here.	[Cuchillo-Ibanez, Inmaculada; Seereeram, Anjan; Anderton, Brian H.; Hanger, Diane P.] Kings Coll London, Inst Psychiat, MRC Ctr Neurodegenerat Res, London SE5 8AF, England	University of London; King's College London	Cuchillo-Ibanez, I (corresponding author), Kings Coll London, Inst Psychiat P037, MRC Ctr Neurodegenerat Res, De Crespigny Pk, London SE5 8AF, England.	spneici@iop.kcl.ac.uk	cuchillo, inmaculada/P-2975-2019; Hanger, Diane/C-5697-2009	Hanger, Diane/0000-0002-3044-9816; Ward, Malcolm/0000-0003-2164-6938; /0000-0002-3689-5518	Wellcome Trust; Alzheimer's Society; UK Medical Research Council; MRC [G0300408] Funding Source: UKRI; Medical Research Council [G0300408] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Alzheimer's Society; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust, the Alzheimer's Society, and the UK Medical Research Council. Plasmids expressing 2N4R tau, E18tau, and E27tau were kind gifts from M. Goedert (Medical Research Council Laboratory of Molecular Biology, Cambridge, UK).	Ackerley S, 2003, J CELL BIOL, V161, P489, DOI 10.1083/jcb.200303138; Ali A, 2001, CHEM REV, V101, P2527, DOI 10.1021/cr000110o; Anderton BH, 2001, BIOCHEM SOC SYMP, V67, P73; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Crosby AH, 2003, LANCET NEUROL, V2, P311, DOI 10.1016/S1474-4422(03)00383-1; Cross DAE, 2001, J NEUROCHEM, V77, P94, DOI 10.1046/j.1471-4159.2001.00251.x; Culbert AA, 2001, FEBS LETT, V507, P288, DOI 10.1016/S0014-5793(01)02990-8; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Derkinderen P, 2005, J NEUROSCI, V25, P6584, DOI 10.1523/JNEUROSCI.1487-05.2005; Dubey M, 2008, CELL MOTIL CYTOSKEL, V65, P89, DOI 10.1002/cm.20243; Eidenmuller J, 2001, BIOCHEM J, V357, P759, DOI 10.1042/0264-6021:3570759; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; Gibb GM, 2000, FEBS LETT, V485, P99, DOI 10.1016/S0014-5793(00)02196-7; Godemann R, 1999, FEBS LETT, V454, P157, DOI 10.1016/S0014-5793(99)00741-3; Haase C, 2004, J NEUROCHEM, V88, P1509, DOI 10.1046/j.1471-4159.2003.02287.x; Hallows JL, 2003, J NEUROSCI, V23, P10633; Hanger DP, 2007, J BIOL CHEM, V282, P23645, DOI 10.1074/jbc.M703269200; Hanger DP, 1998, J NEUROCHEM, V71, P2465; HANGER DP, 1992, NEUROSCI LETT, V147, P58, DOI 10.1016/0304-3940(92)90774-2; Hong M, 1997, J BIOL CHEM, V272, P25326, DOI 10.1074/jbc.272.40.25326; ISHIGURO K, 1992, NEUROSCI LETT, V148, P202, DOI 10.1016/0304-3940(92)90839-Y; Jancsik V, 1996, Neurobiology (Bp), V4, P417; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; KOZACK S, 2007, J NEUROSCI, V12, P9916; Lazarov O, 2007, J NEUROSCI, V27, P7011, DOI 10.1523/JNEUROSCI.4272-06.2007; Leger J, 1997, J BIOL CHEM, V272, P8441, DOI 10.1074/jbc.272.13.8441; LOVESTONE S, 1994, CURR BIOL, V4, P1077, DOI 10.1016/S0960-9822(00)00246-3; Lovestone S, 1997, NEUROSCIENCE, V78, P309; Ma DL, 2000, J NEUROSCI, V20, P2112; MacAulay K, 2003, EUR J BIOCHEM, V270, P3829, DOI 10.1046/j.1432-1033.2003.03777.x; Moran CM, 2005, MOL BRAIN RES, V134, P338, DOI 10.1016/j.molbrainres.2004.10.035; Morfini G, 2002, EMBO J, V21, P281, DOI 10.1093/emboj/21.3.281; Morfini G, 2004, EMBO J, V23, P2235, DOI 10.1038/sj.emboj.7600237; MORISHIMAKAWASHIMA M, 1995, NEUROBIOL AGING, V16, P365, DOI 10.1016/0197-4580(95)00027-C; Motil J, 2006, CELL MOTIL CYTOSKEL, V63, P266, DOI 10.1002/cm.20122; Munoz-Montano Juan Ramon, 1999, J Alzheimers Dis, V1, P361; MunozMontano JR, 1997, FEBS LETT, V411, P183, DOI 10.1016/S0014-5793(97)00688-1; Owen R, 2003, MOL CELL NEUROSCI, V23, P626, DOI 10.1016/S1044-7431(03)00095-2; Pei JJ, 1999, J NEUROPATH EXP NEUR, V58, P1010, DOI 10.1097/00005072-199909000-00011; Phiel CJ, 2001, ANNU REV PHARMACOL, V41, P789, DOI 10.1146/annurev.pharmtox.41.1.789; Pigino G, 2003, J NEUROSCI, V23, P4499; Plattner F, 2006, J BIOL CHEM, V281, P25457, DOI 10.1074/jbc.M603469200; Reynolds CH, 2000, J NEUROCHEM, V74, P1587, DOI 10.1046/j.1471-4159.2000.0741587.x; Sang HC, 2001, NEUROSCI LETT, V312, P141, DOI 10.1016/S0304-3940(01)02206-6; Sengupta A, 2006, FEBS LETT, V580, P5925, DOI 10.1016/j.febslet.2006.09.060; Shea TB, 2000, J NEUROCYTOL, V29, P873, DOI 10.1023/A:1010951626090; Smith KDB, 2007, NEUROIMAGE, V35, P1401, DOI 10.1016/j.neuroimage.2007.01.046; Smith MJ, 2000, FEBS LETT, V484, P265, DOI 10.1016/S0014-5793(00)02169-4; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Takahashi M, 1999, J NEUROCHEM, V73, P2073; Terwel D, 2002, NEUROMOL MED, V2, P151, DOI 10.1385/NMM:2:2:151; Tesseur I, 2000, AM J PATHOL, V157, P1495, DOI 10.1016/S0002-9440(10)64788-8; Utton MA, 2005, J CELL SCI, V118, P4645, DOI 10.1242/jcs.02558; Utton MA, 2002, J NEUROSCI, V22, P6394; Utton MA, 1997, BIOCHEM J, V323, P741, DOI 10.1042/bj3230741; Williams DR, 2006, INTERN MED J, V36, P652, DOI 10.1111/j.1445-5994.2006.01153.x; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4	59	123	126	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2008	22	9					3186	3195		10.1096/fj.08-109181	http://dx.doi.org/10.1096/fj.08-109181			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	342CD	18511549				2022-12-25	WOS:000258761300011
J	Semenov, MV; Zhang, X; He, X				Semenov, Mikhail V.; Zhang, Xinjun; He, Xi			DKK1 antagonizes Wnt signaling without promotion of LRP6 internalization and degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MASS; DICKKOPF-1; RECEPTORS; MECHANISM; PROTEINS; GENE; LIGAND; INHIBITION; INDUCTION; PATHWAY	DKK1 is a secreted protein that antagonizes Wnt signaling and plays essential roles in vertebrate embryogenesis including head induction, skeletal development, and limb patterning. DKK1 is also implicated in osteoporosis, arthritis, and cancer and represents a potential therapeutic target for the treatment of these diseases. DKK1 is a high affinity antagonistic ligand for LRP6, which is a Wnt coreceptor that acts together with the Frizzled serpentine receptor to initiate Wnt signal transduction. Two different models have been proposed to account for the mechanism by which DKK1 antagonizes LRP6 function. One model suggests that DKK1 binding to LRP6 disrupts Wnt-induced Frizzled-LRP6 complex formation, whereas the other model proposes that DKK1 interaction with LRP6 promotes LRP6 internalization and degradation, thereby reducing the cell surface LRP6 level. To clarify the molecular basis of DKK1 action, we examined how DKK1 affects the endogenous LRP6 in several mammalian cell lines including mouse embryonic fibroblasts. Here we show that DKK1 inhibits Wnt signaling but induces neither LRP6 down-regulation from the cell surface nor reduction of total LRP6 protein level and that DKK1 has no effect on the rate of continuous internalization of LRP6 and the half-life ( about 4.7 h) of LRP6. We conclude that DKK1 inhibition of LRP6 is independent of LRP6 internalization and degradation.	Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Semenov, MV (corresponding author), Childrens Hosp, FM Kirby Neurobiol Ctr, 61 Binney St, Boston, MA 02115 USA.	mikhail.semenov@childrens.harvard.edu	Zhang, Xinjun/H-8034-2012		NIGMS NIH HHS [R01 GM 57603] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057603] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adamska M, 2004, DEV BIOL, V272, P134, DOI 10.1016/j.ydbio.2004.04.026; Aguilera O, 2006, ONCOGENE, V25, P4116, DOI 10.1038/sj.onc.1209439; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Brott BK, 2002, MOL CELL BIOL, V22, P6100, DOI 10.1128/MCB.22.17.6100-6110.2002; Brown SD, 1998, BIOCHEM BIOPH RES CO, V248, P879, DOI 10.1006/bbrc.1998.9061; CARPENTER G, 1987, ANNU REV BIOCHEM, V56, P881, DOI 10.1146/annurev.biochem.56.1.881; Carter M, 2005, P NATL ACAD SCI USA, V102, P12843, DOI 10.1073/pnas.0501963102; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; GRAEVE L, 1989, J CELL BIOL, V109, P2809, DOI 10.1083/jcb.109.6.2809; Hassler C, 2007, DEVELOPMENT, V134, P4255, DOI 10.1242/dev.005942; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Kelly OG, 2004, DEVELOPMENT, V131, P2803, DOI 10.1242/dev.01137; Khan Z, 2007, MOL CELL BIOL, V27, P7291, DOI 10.1128/MCB.00773-07; Krupnik VE, 1999, GENE, V238, P301, DOI 10.1016/S0378-1119(99)00365-0; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; Li L, 2002, J BIOL CHEM, V277, P5977, DOI 10.1074/jbc.M111131200; Liu GZ, 2005, MOL CELL BIOL, V25, P3475, DOI 10.1128/MCB.25.9.3475-3482.2005; MacDonald BT, 2007, BONE, V41, P331, DOI 10.1016/j.bone.2007.05.009; MacDonald BT, 2004, DEVELOPMENT, V131, P2543, DOI 10.1242/dev.01126; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Mikheev AM, 2004, CARCINOGENESIS, V25, P47, DOI 10.1093/carcin/bgg190; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Mukhopadhyay M, 2001, DEV CELL, V1, P423, DOI 10.1016/S1534-5807(01)00041-7; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Semenov MV, 2006, J BIOL CHEM, V281, P38276, DOI 10.1074/jbc.M609509200; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tolwinski NS, 2003, DEV CELL, V4, P407, DOI 10.1016/S1534-5807(03)00063-7; Wei Q, 2007, J BIOL CHEM, V282, P15903, DOI 10.1074/jbc.M701927200; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540	39	102	112	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21427	21432		10.1074/jbc.M800014200	http://dx.doi.org/10.1074/jbc.M800014200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18505732	Green Published, hybrid			2022-12-25	WOS:000257898800014
J	Skorupinska-Tudek, K; Poznanski, J; Wojcik, J; Bienkowski, T; Szostkiewicz, I; Zelman-Femiak, M; Bajda, A; Chojnacki, T; Olszowska, O; Grunler, J; Meyer, O; Rohmer, M; Danikiewicz, W; Swiezewska, E				Skorupinska-Tudek, Karolina; Poznanski, Jaroslaw; Wojcik, Jacek; Bienkowski, Tomasz; Szostkiewicz, Izabela; Zelman-Femiak, Monika; Bajda, Agnieszka; Chojnacki, Tadeusz; Olszowska, Olga; Grunler, Jacob; Meyer, Odile; Rohmer, Michel; Danikiewicz, Witold; Swiezewska, Ewa			Contribution of the mevalonate and methylerythritol phosphate pathways to the biosynthesis of dolichols in plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FARNESYL-DIPHOSPHATE SYNTHASE; METABOLIC CROSS-TALK; ISOPRENOID BIOSYNTHESIS; ARABIDOPSIS-THALIANA; ISOPENTENYL DIPHOSPHATE; MOLECULAR-CLONING; NONMEVALONATE PATHWAY; CYTOSOLIC MEVALONATE; CHLOROPLAST ENVELOPE; PLASTIDIAL PATHWAYS	Plant isoprenoids are derived from two biosynthetic pathways, the cytoplasmic mevalonate (MVA) and the plastidial methylerythritol phosphate (MEP) pathway. In this study their respective contributions toward formation of dolichols in Coluria geoides hairy root culture were estimated using in vivo labeling with C-13-labeled glucose as a general precursor. NMR and mass spectrometry showed that both the MVA and MEP pathways were the sources of isopentenyl diphosphate incorporated into polyisoprenoid chains. The involvement of the MEP pathway was found to be substantial at the initiation stage of dolichol chain synthesis, but it was virtually nil at the terminal steps; statistically, 6-8 isoprene units within the dolichol molecule (i.e. 40-50% of the total) were derived from the MEP pathway. These results were further verified by incorporation of [5-H-2] mevalonate or [5,5-H-2(2)] deoxyxylulose into dolichols as well as by the observed decreased accumulation of dolichols upon treatment with mevinolin or fosmidomycin, selective inhibitors of either pathway. The presented data indicate that the synthesis of dolichols in C. geoides roots involves a continuous exchange of intermediates between the MVA and MEP pathways. According to our model, oligoprenyl diphosphate chains of a length not exceeding 13 isoprene units are synthesized in plastids from isopentenyl diphosphate derived from both the MEP and MVA pathways, and then are completed in the cytoplasm with several units derived solely from the MVA pathway. This study also illustrates an innovative application of mass spectrometry for qualitative and quantitative evaluation of the contribution of individual metabolic pathways to the biosynthesis of natural products.	[Bienkowski, Tomasz; Danikiewicz, Witold] Polish Acad Sci, Inst Organ Chem, PL-01224 Warsaw, Poland; [Skorupinska-Tudek, Karolina; Poznanski, Jaroslaw; Wojcik, Jacek; Szostkiewicz, Izabela; Zelman-Femiak, Monika; Bajda, Agnieszka; Chojnacki, Tadeusz; Swiezewska, Ewa] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland; [Olszowska, Olga] Med Univ Warsaw, PL-02090 Warsaw, Poland; [Grunler, Jacob] Karolinska Inst, Rolf Luft Res Ctr Diabet & Endocrinol, S-17176 Stockholm, Sweden; [Meyer, Odile; Rohmer, Michel] Univ Strasbourg 1, CNRS, Inst Chim, F-6700 Strasbourg, France	Polish Academy of Sciences; Institute of Organic Chemistry of the Polish Academy of Sciences; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Medical University of Warsaw; Karolinska Institutet; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Danikiewicz, W (corresponding author), Polish Acad Sci, Inst Organ Chem, Kasprzaka 44-52, PL-01224 Warsaw, Poland.	witold@icho.edu.pl; ewas@ibb.waw.pl	Poznanski, Jaroslaw/F-7705-2014; poznanski, jarek/G-7064-2013; Danikiewicz, Witold/H-2257-2016	Poznanski, Jaroslaw/0000-0003-2684-1775; Skorupinska-Tudek, Karolina/0000-0002-3472-2517; Danikiewicz, Witold/0000-0003-0484-2689; Swiezewska, Ewa/0000-0002-3439-8948; Wojcik, Jacek/0000-0002-7685-3515				ADAIR WL, 1982, J BIOL CHEM, V257, P8990; ALBERTS AW, 1980, P NATL ACAD SCI-BIOL, V77, P3957, DOI 10.1073/pnas.77.7.3957; Asawatreratanakul K, 2003, EUR J BIOCHEM, V270, P4671, DOI 10.1046/j.1432-1033.2003.03863.x; BACH TJ, 1995, LIPIDS, V30, P191, DOI 10.1007/BF02537822; Barlow AJ, 2003, PHYTOCHEMISTRY, V63, P25, DOI 10.1016/S0031-9422(02)00725-2; Bick JA, 2003, ARCH BIOCHEM BIOPHYS, V415, P146, DOI 10.1016/S0003-9861(03)00233-9; Bouvier F, 2000, PLANT J, V24, P241, DOI 10.1046/j.1365-313x.2000.00875.x; BRANDT S, 1999, DATA ANAL STAT COMPU, P423; CANET D, 1976, J MAGN RESON, V23, P361, DOI 10.1016/0022-2364(76)90220-1; CHOJNACKI T, 1988, BIOCHEM J, V251, P1; Cunillera N, 1997, J BIOL CHEM, V272, P15381, DOI 10.1074/jbc.272.24.15381; Cunillera N, 2000, FEBS LETT, V477, P170, DOI 10.1016/S0014-5793(00)01798-1; Disch A, 1998, BIOCHEM J, V331, P615, DOI 10.1042/bj3310615; Dudareva N, 2005, P NATL ACAD SCI USA, V102, P933, DOI 10.1073/pnas.0407360102; Duvold T, 1997, TETRAHEDRON LETT, V38, P6181, DOI 10.1016/S0040-4039(97)01392-0; Eisenreich W, 2004, CELL MOL LIFE SCI, V61, P1401, DOI 10.1007/s00018-004-3381-z; ERICSSON J, 1993, J BIOL CHEM, V268, P832; Ferro M, 2002, P NATL ACAD SCI USA, V99, P11487, DOI 10.1073/pnas.172390399; FREEMAN R, 1972, J MAGN RESON, V7, P327, DOI 10.1016/0022-2364(72)90194-1; Fukusaki E, 2004, BIOSCI BIOTECH BIOCH, V68, P1988, DOI 10.1271/bbb.68.1988; Ge XC, 2005, PLANT SCI, V168, P487, DOI 10.1016/j.plantsci.2004.09.012; GOUGH DP, 1970, BIOCHEM J, V117, P309, DOI 10.1042/bj1170309; Hampel D, 2005, PHYTOCHEMISTRY, V66, P305, DOI 10.1016/j.phytochem.2004.12.010; Hemmerlin A, 2003, J BIOL CHEM, V278, P26666, DOI 10.1074/jbc.M302526200; HEMMING FW, 1983, BIOCHEM SOC T, V11, P497, DOI 10.1042/bst0110497; HEMMING FW, 1992, BIOCHEM CELL BIOL, V70, P377, DOI 10.1139/o92-058; Kasahara H, 2002, J BIOL CHEM, V277, P45188, DOI 10.1074/jbc.M208659200; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; KELLER RK, 1986, J BIOL CHEM, V261, P2053; Kharel Y, 2003, NAT PROD REP, V20, P111, DOI 10.1039/b108934j; KONTAXIS G, 1994, J MAGN RESON SER A, V111, P70, DOI 10.1006/jmra.1994.1227; KREUZ K, 1984, EUR J BIOCHEM, V141, P531, DOI 10.1111/j.1432-1033.1984.tb08225.x; Kurisaki A, 1997, PHYTOCHEMISTRY, V44, P45, DOI 10.1016/S0031-9422(96)00400-1; Kuzuyama T, 1998, TETRAHEDRON LETT, V39, P7913, DOI 10.1016/S0040-4039(98)01755-9; Lange BM, 2003, PLANT MOL BIOL, V51, P925, DOI 10.1023/A:1023005504702; Laule O, 2003, P NATL ACAD SCI USA, V100, P6866, DOI 10.1073/pnas.1031755100; Liang PH, 2002, EUR J BIOCHEM, V269, P3339, DOI 10.1046/j.1432-1033.2002.03014.x; Meyer O, 2004, TETRAHEDRON, V60, P12153, DOI 10.1016/j.tet.2004.10.016; Milborrow BV, 2001, J EXP BOT, V52, P1145, DOI 10.1093/jexbot/52.359.1145; Nagata N, 2002, PLANTA, V216, P345, DOI 10.1007/s00425-002-0871-9; Oh SK, 2000, J BIOL CHEM, V275, P18482, DOI 10.1074/jbc.M002000200; Okada K, 2000, PLANT PHYSIOL, V122, P1045, DOI 10.1104/pp.122.4.1045; Olszowska O, 1996, PLANT CELL TISS ORG, V45, P273, DOI 10.1007/BF00043642; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; Piel J, 1998, ANGEW CHEM INT EDIT, V37, P2478, DOI 10.1002/(SICI)1521-3773(19981002)37:18<2478::AID-ANIE2478>3.0.CO;2-Q; Rezanka T, 2001, J CHROMATOGR A, V936, P95, DOI 10.1016/S0021-9673(01)01152-9; Rodriguez-Concepcion M, 2004, PLANT CELL, V16, P144, DOI 10.1105/tpc.016204; Rodriguez-Concepcion Manuel, 2006, Phytochemistry Reviews, V5, P1, DOI 10.1007/s11101-005-3130-4; Rohmer M, 1999, NAT PROD REP, V16, P565, DOI 10.1039/a709175c; Sakaihara T, 2000, J BIOCHEM-TOKYO, V128, P1073, DOI 10.1093/oxfordjournals.jbchem.a022835; Sanmiya K, 1999, PLANT CELL PHYSIOL, V40, P348, DOI 10.1093/oxfordjournals.pcp.a029549; Schuhr Christoph A., 2003, Phytochemistry Reviews, V2, P3, DOI 10.1023/B:PHYT.0000004180.25066.62; Skorupinska-Tudek K, 2003, LIPIDS, V38, P981, DOI 10.1007/s11745-003-1152-3; SOLER E, 1993, PLANTA, V191, P324, DOI 10.1007/BF00195689; SWIEZEWSKA E, 1993, BIOCHEM BIOPH RES CO, V192, P161, DOI 10.1006/bbrc.1993.1395; Swiezewska E, 2005, PROG LIPID RES, V44, P235, DOI 10.1016/j.plipres.2005.05.002; SWIEZEWSKA E, 1993, J BIOL CHEM, V268, P1494; TANAKA Y, 1987, BIOCHEM J, V243, P481, DOI 10.1042/bj2430481; VOGELI U, 1991, ARCH BIOCHEM BIOPHYS, V288, P157, DOI 10.1016/0003-9861(91)90178-L; Yamazaki Y, 2004, PLANT PHYSIOL, V134, P161, DOI 10.1104/pp.103.029389	60	58	60	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21024	21035		10.1074/jbc.M706069200	http://dx.doi.org/10.1074/jbc.M706069200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18502754	Green Published, hybrid			2022-12-25	WOS:000257746100044
J	Steichen, JM; Petty, RV; Sharkey, TD				Steichen, Jon M.; Petty, Ryan V.; Sharkey, Thomas D.			Domain characterization of a 4-alpha-glucanotransferase essential for maltose metabolism in photosynthetic leaves	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STARCH DEGRADATION; TRANSITORY STARCH; ALPHA-AMYLASE; ARABIDOPSIS LEAVES; R1 PROTEIN; AMYLOMALTASE; PHOSPHORYLASE; CHLOROPLAST; IDENTIFICATION; INTERMEDIATE	Maltose metabolism during the conversion of transitory (leaf) starch to sucrose requires a 4-alpha-glucanotransferase (EC 2.4.1.25) in the cytosol of leaf cells. This enzyme is called DPE2 because of its similarity to the disproportionating enzyme in plastids (DPE1). DPE1 does not use maltose; it primarily transfers a maltosyl unit from one maltotriose to a second maltotriose to make glucose and maltopentaose. DPE2 is a modular protein consisting of a family 77 glycosyl hydrolase domain, similar to DPE1, but unlike DPE1 the domain is interrupted by an insertion of similar to 150 amino acids as well as an N-terminal extension that consists of two carbohydrate binding modules. Phylogenetic analysis shows that the DPE2-type enzyme is present in a limited but highly diverse group of organisms. Here we show that DPE2 transfers the non-reducing glucosyl unit from maltose to glycogen by a ping-pong mechanism. The forward reaction (consumption of maltose) is specific for the beta- anomer of maltose, while the reverse reaction (production of maltose) is not stereospecific for the acceptor glucose. Additionally, through deletion mutants we show that the glycosyl hydrolase domain alone provides disproportionating activity with a much higher affinity for short maltodextrins than the complete wild-type enzyme, while absence of the carbohydrate binding modules completely abolishes activity with large complex carbohydrates, reflecting the presumed function of DPE2 in vivo.	[Sharkey, Thomas D.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Steichen, Jon M.; Sharkey, Thomas D.] Univ Wisconsin, Dept Bot, Madison, WI 53706 USA; [Petty, Ryan V.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	Michigan State University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Sharkey, TD (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	tsharkey@msu.edu	Sharkey, Thomas D/B-4032-2009; Sharkey, Thomas/ABF-1317-2020	Sharkey, Thomas D/0000-0002-4423-3223; Sharkey, Thomas/0000-0002-4423-3223				Barends TRM, 2007, J BIOL CHEM, V282, P17242, DOI 10.1074/jbc.M701444200; Chia T, 2004, PLANT J, V37, P853, DOI 10.1111/j.1365-313X.2003.02012.x; Dumez S, 2006, PLANT CELL, V18, P2694, DOI 10.1105/tpc.105.037671; Fettke J, 2006, PLANT J, V46, P668, DOI 10.1111/j.1365-313X.2006.02732.x; KAKEFUDA G, 1989, PLANT PHYSIOL, V91, P136, DOI 10.1104/pp.91.1.136; Kaper T, 2005, APPL ENVIRON MICROB, V71, P5098, DOI 10.1128/AEM.71.9.5098-5106.2005; Kaper T, 2007, BIOCHEMISTRY-US, V46, P5261, DOI 10.1021/bi602408j; KEILIN D, 1952, BIOCHEM J, V50, P341, DOI 10.1042/bj0500341; Kotting O, 2005, PLANT PHYSIOL, V137, P242, DOI 10.1104/pp.104.055954; Lee SB, 2001, CARBOHYD RES, V336, P47, DOI 10.1016/S0008-6215(01)00247-6; Lloyd JR, 2004, PLANT PHYSIOL, V134, P1347, DOI 10.1104/pp.103.038026; Lu Y, 2006, PLANT CELL ENVIRON, V29, P353, DOI 10.1111/j.1365-3040.2005.01480.x; Lu Y, 2004, PLANTA, V218, P466, DOI 10.1007/s00425-003-1127-z; Lu Y, 2006, PLANT PHYSIOL, V142, P878, DOI 10.1104/pp.106.086850; Lu Y, 2006, PLANTA, V224, P935, DOI 10.1007/s00425-006-0263-7; Machovic M, 2005, FEBS J, V272, P5497, DOI 10.1111/j.1742-4658.2005.04942.x; Niittyla T, 2004, SCIENCE, V303, P87, DOI 10.1126/science.1091811; PALM D, 1990, BIOCHEMISTRY-US, V29, P1099, DOI 10.1021/bi00457a001; Reimann R, 2002, PHYSIOL PLANTARUM, V114, P2, DOI 10.1034/j.1399-3054.2002.1140102.x; Ritte G, 2004, PLANT PHYSIOL, V135, P2068, DOI 10.1104/pp.104.041301; Ritte G, 2002, P NATL ACAD SCI USA, V99, P7166, DOI 10.1073/pnas.062053099; Scheidig A, 2002, PLANT J, V30, P581, DOI 10.1046/j.1365-313X.2002.01317.x; Shirokane Y, 2000, CARBOHYD RES, V329, P699, DOI 10.1016/S0008-6215(00)00232-9; Smith AM, 2005, ANNU REV PLANT BIOL, V56, P73, DOI 10.1146/annurev.arplant.56.032604.144257; TAKAHA T, 1993, J BIOL CHEM, V268, P1391; Uitdehaag JCM, 1999, NAT STRUCT BIOL, V6, P432, DOI 10.1038/8235; Weise SE, 2005, PLANT PHYSIOL, V137, P756, DOI 10.1104/pp.104.055996; Weise SE, 2004, PLANTA, V218, P474, DOI 10.1007/s00425-003-1128-y; Worby CA, 2006, J BIOL CHEM, V281, P30412, DOI 10.1074/jbc.M606117200; YANG Y, 1990, PLANT PHYSIOL, V94, P960, DOI 10.1104/pp.94.3.960; Zeeman SC, 2007, FUNCT PLANT BIOL, V34, P465, DOI 10.1071/FP06313	31	31	31	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20797	20804		10.1074/jbc.M803051200	http://dx.doi.org/10.1074/jbc.M803051200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18499663	hybrid, Green Published			2022-12-25	WOS:000257746100021
J	Carlsson, P; Presto, J; Spillmann, D; Lindahl, U; Kjellen, L				Carlsson, Pernilla; Presto, Jenny; Spillmann, Dorothe; Lindahl, Ulf; Kjellen, Lena			Heparin/heparan sulfate biosynthesis - Processive formation of N-sulfated domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE; 5'-PHOSPHOSULFATE TRANSPORTER; MOLECULAR DIVERSITY; GOLGI LOCALIZATION; TUMOR SUPPRESSORS; ENZYME-ACTIVITY; MAST-CELLS; SULFOTRANSFERASE; EXPRESSION; CLONING	Heparan sulfate (HS) proteoglycans influence embryonic development as well as adult physiology through interactions with various proteins, including growth factors/morphogens and their receptors. The interactions depend on HS structure, which is largely determined during biosynthesis by Golgi enzymes. A key step is the initial generation of N-sulfated domains, primary sites for further polymer modification and ultimately for functional interactions with protein ligands. Such domains, generated through action of a bifunctional GlcNAc N-deacetylase/ N-sulfotransferase (NDST) on a [GlcUA-GlcNAc](n) substrate, are of variable size due to regulatory mechanisms that remain poorly understood. We have studied the action of recombinant NDSTs on the [GlcUA-GlcNAc] n precursor in the presence and absence of the sulfate donor, 3'-phosphoadenosine 5'-phosphosulfate (PAPS). In the absence of PAPS, NDST catalyzes limited and seemingly random N-deacetylation of GlcNAc residues. By contrast, access to PAPS shifts the NDST toward generation of extended N-sulfated domains that are formed through coupled N-deacetylation/N-sulfation in an apparent processive mode. Variations in N-substitution pattern could be obtained by varying PAPS concentration or by experimentally segregating the N-deacetylation and N-sulfation steps. We speculate that similar mechanisms may apply also to the regulation of HS biosynthesis in the living cell.	[Carlsson, Pernilla; Presto, Jenny; Spillmann, Dorothe; Lindahl, Ulf; Kjellen, Lena] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden	Uppsala University	Kjellen, L (corresponding author), Box 582, SE-75123 Uppsala, Sweden.	lena.kjellen@imbim.uu.se	Kjellen, Lena/F-1362-2011	Presto, Jenny/0000-0001-5102-6815				Aikawa J, 2001, J BIOL CHEM, V276, P5876, DOI 10.1074/jbc.M009606200; Bengtsson J, 2003, BIOCHEMISTRY-US, V42, P2110, DOI 10.1021/bi026928g; Bulow HE, 2006, ANNU REV CELL DEV BI, V22, P375, DOI 10.1146/annurev.cellbio.22.010605.093433; Casu B, 2001, ADV CARBOHYD CHEM BI, V57, P159, DOI 10.1016/S0065-2318(01)57017-1; Crawford BE, 2001, J BIOL CHEM, V276, P21538, DOI 10.1074/jbc.M100880200; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Galvis MLE, 2007, NAT CHEM BIOL, V3, P773, DOI 10.1038/nchembio.2007.41; Grobe K, 2002, BBA-GEN SUBJECTS, V1573, P209, DOI 10.1016/S0304-4165(02)00386-0; HOOK M, 1975, J BIOL CHEM, V250, P6065; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; Kamiyama S, 2006, J BIOL CHEM, V281, P10945, DOI 10.1074/jbc.M508991200; Kamiyama S, 2003, J BIOL CHEM, V278, P25958, DOI 10.1074/jbc.M302439200; KJELLEN L, 1992, ADV EXP MED BIOL, V313, P107; Kreuger J, 1999, GLYCOBIOLOGY, V9, P723, DOI 10.1093/glycob/9.7.723; Kreuger J, 2002, EMBO J, V21, P6303, DOI 10.1093/emboj/cdf638; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; Kusche-Gullberg M, 1998, J BIOL CHEM, V273, P11902, DOI 10.1074/jbc.273.19.11902; Lamanna WC, 2007, J BIOTECHNOL, V129, P290, DOI 10.1016/j.jbiotec.2007.01.022; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Ledin J, 2006, J BIOL CHEM, V281, P35727, DOI 10.1074/jbc.M604113200; LIDHOLT K, 1989, BIOCHEM J, V261, P999, DOI 10.1042/bj2610999; LINDAHL B, 1995, BIOCHEM J, V306, P177, DOI 10.1042/bj3060177; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; Murphy KJ, 2004, J BIOL CHEM, V279, P27239, DOI 10.1074/jbc.M401774200; Nagai N, 2004, J CELL SCI, V117, P3331, DOI 10.1242/jcs.01191; PETTERSSON I, 1991, J BIOL CHEM, V266, P8044; PINHAL MA, 2001, P NATL ACAD SCI USA, V30, P30; Presto J, 2008, P NATL ACAD SCI USA, V105, P4751, DOI 10.1073/pnas.0705807105; RIESENFELD J, 1982, J BIOL CHEM, V257, P421; RIESENFELD J, 1982, J BIOL CHEM, V257, P7050; Roman E, 2003, BIOCHEM J, V374, P767, DOI 10.1042/BJ20030365; Senay C, 2000, EMBO REP, V1, P282, DOI 10.1093/embo-reports/kvd045; SHAKLEE PN, 1984, BIOCHEM J, V217, P187, DOI 10.1042/bj2170187; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; WEI Z, 1993, P NATL ACAD SCI USA, V90, P3885, DOI 10.1073/pnas.90.9.3885	38	96	98	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20008	20014		10.1074/jbc.M801652200	http://dx.doi.org/10.1074/jbc.M801652200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18487608	hybrid			2022-12-25	WOS:000257565300016
J	Challen, GA; Goodell, MA				Challen, Grant A.; Goodell, Margaret A.			Promiscuous Expression of H2B-GFP Transgene in Hematopoietic Stem Cells	PLOS ONE			English	Article							FLUORESCENT PROTEIN; LOCATION; REVEAL; RESIDE; NICHE; GENE; H3	Background: The study of adult stem cells relies on the ability to isolate them using complex combinations of markers for flow cytometry. A recent study has used a tetracycline-regulatable H2B-GFP transgenic mouse model analogous to BrdU pulse-chase methods to fluorescently label quiescent skin stem cells in vivo. In this study, we sought to use these mice to fluorescently label hematopoietic stem cells to study niche interactions. Methods and Findings: We crossed the H2B-GFP mice to mice carrying a tetracycline-regulated transactivator protein. When these mice were administered doxycycline, we observed a gradual decrease in total bone marrow GFP(+) cells over 12 weeks but the hematopoietic stem cell population remained largely GFP(+) (> 85%). In histological bone sections, the long-term GFP label-retaining cells tended to concentrate at the endosteal surface and competitive transplantation assays showed that the majority of hematopoietic stem cell activity was contained in the GFP(+) cell fraction. However, in response to stimulation with 5-fluorouracil, the hematopoietic stem cells of the crossed mice still retained a high level of GFP expression when it was anticipated the label should be lost when the cells divide. Upon further review, it was determined that the founder H2B-GFP mice showed spurious expression of the transgene at high levels in the hematopoietic stem cell population, thus the observed response of hematopoietic stem cells in the double transgenic mice to doxycycline was due to aberrant expression of the transgene and not the correct tetracycline-regulatable system. Conclusions: We observed promiscuous expression of the H2B-GFP transgene in the hematopoietic stem cell compartment of the bone marrow. This leaky expression prohibits the use of this model to study hematopoietic stem cells in vivo and careful characterization for each organ must be done if this transgenic system is to be used to isolate other prospective tissue stem cells.	[Challen, Grant A.; Goodell, Margaret A.] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Challen, Grant A.] Monash Univ, Clayton, Vic, Australia	Baylor College of Medicine; Monash University	Challen, GA (corresponding author), Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA.	goodell@bcm.edu		Goodell, Margaret A./0000-0003-1111-2932	Australian National Health and Medical Research Council (NHMRC) [CJ Martin Fellowship]; Leukemia and Lymphoma Society [fellow]; NIH [HL081007, EB005173, DK58192]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL081007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058192] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	G.A.C. was supported by an Australian National Health and Medical Research Council (NHMRC) CJ Martin Fellowship. M. A. G. was a fellow of the Leukemia and Lymphoma Society. This work was also supported by NIH grants HL081007, EB005173, and DK58192.	Attema JL, 2007, P NATL ACAD SCI USA, V104, P12371, DOI 10.1073/pnas.0704468104; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Hanazono Y, 2002, J GENE MED, V4, P470, DOI 10.1002/jgm.307; Haylock DN, 2007, STEM CELLS, V25, P1062, DOI 10.1634/stemcells.2006-0528; Hosen N, 2007, STEM CELLS, V25, P1635, DOI 10.1634/stemcells.2006-0229; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kimura H, 2001, J CELL BIOL, V153, P1341, DOI 10.1083/jcb.153.7.1341; Klopotowska D, 2008, NEUROCHEM INT, V52, P221, DOI 10.1016/j.neuint.2007.05.014; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Oliver JA, 2004, J CLIN INVEST, V114, P795, DOI 10.1172/JCI200420921; Purton LE, 2007, CELL STEM CELL, V1, P263, DOI 10.1016/j.stem.2007.08.016; Rice KL, 2007, ONCOGENE, V26, P6697, DOI 10.1038/sj.onc.1210755; Rizo A, 2008, BLOOD, V111, P2621, DOI 10.1182/blood-2007-08-106666; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; Swenson ES, 2007, STEM CELLS, V25, P2593, DOI 10.1634/stemcells.2007-0241; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; Torbett BE, 2002, J GENE MED, V4, P478, DOI 10.1002/jgm.323; Tsujimura A, 2002, J CELL BIOL, V157, P1257, DOI 10.1083/jcb.200202067; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Venezia TA, 2004, PLOS BIOL, V2, P1640, DOI 10.1371/journal.pbio.0020301	24	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2357	10.1371/journal.pone.0002357	http://dx.doi.org/10.1371/journal.pone.0002357			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523660	gold, Green Published, Green Submitted			2022-12-25	WOS:000262614300044
J	Thaut, MH; Demartin, M; Sanes, JN				Thaut, Michael H.; Demartin, Martina; Sanes, Jerome N.			Brain Networks for Integrative Rhythm Formation	PLOS ONE			English	Article							SUPPLEMENTARY MOTOR AREA; SENSORIMOTOR SYNCHRONIZATION; FINGER MOVEMENTS; TEMPORAL INFORMATION; CEREBELLAR LESIONS; PARKINSONS-DISEASE; PREFRONTAL CORTEX; VISUAL-ATTENTION; PARIETAL CORTEX; TIME PERCEPTION	Background: Performance of externally paced rhythmic movements requires brain and behavioral integration of sensory stimuli with motor commands. The underlying brain mechanisms to elaborate beat-synchronized rhythm and polyrhythms that musicians readily perform may differ. Given known roles in perceiving time and repetitive movements, we hypothesized that basal ganglia and cerebellar structures would have greater activation for polyrhythms than for on-the-beat rhythms. Methodology/Principal Findings: Using functional MRI methods, we investigated brain networks for performing rhythmic movements paced by auditory cues. Musically trained participants performed rhythmic movements at 2 and 3 Hz either at a 1: 1 on-the-beat or with a 3: 2 or a 2: 3 stimulus-movement structure. Due to their prior musical experience, participants performed the 3: 2 or 2: 3 rhythmic movements automatically. Both the isorhythmic 1: 1 and the polyrhythmic 3: 2 or 2: 3 movements yielded the expected activation in contralateral primary motor cortex and related motor areas and ipsilateral cerebellum. Direct comparison of functional MRI signals obtained during 3: 2 or 2: 3 and on-the-beat rhythms indicated activation differences bilaterally in the supplementary motor area, ipsilaterally in the supramarginal gyrus and caudate-putamen and contralaterally in the cerebellum. Conclusions/Significance: The activated brain areas suggest the existence of an interconnected brain network specific for complex sensory-motor rhythmic integration that might have specificity for elaboration of musical abilities.	[Thaut, Michael H.] Colorado State Univ, Ctr Biomed Res Mus, Ft Collins, CO 80523 USA; [Thaut, Michael H.] Colorado State Univ, Mol, Cellular, & Integrat Neurosci Program, Ft Collins, CO USA; [Demartin, Martina] Inst Expt Med, Natl Res Council, Rome, Italy; [Sanes, Jerome N.] Brown Univ, Alpert Med Sch, Dept Neurosci, Providence, RI USA; [Sanes, Jerome N.] IRCCS, Fdn Santa Lucia, Lab Funct Neuroimag, Rome, Italy	Colorado State University; Colorado State University; Brown University; IRCCS Santa Lucia	Thaut, MH (corresponding author), Colorado State Univ, Ctr Biomed Res Mus, Ft Collins, CO 80523 USA.	Jerome_Sanes@Brown.edu			Colorado Commission on Higher Education [Center of Excellence Grant]; National Institutes of Health [R01-AG10684, K02-NS35376]; Italian Ministry of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG010684] Funding Source: NIH RePORTER	Colorado Commission on Higher Education; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Ministry of Health(Ministry of Health, Italy); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by funds granted from a Center of Excellence Grant by the Colorado Commission on Higher Education to Michael H. Thaut, the National Institutes of Health to Jerome N. Sanes (R01-AG10684, K02-NS35376), and the Italian Ministry of Health to Foundation Santa Lucia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASCHERSLEBEN G, 1995, PERCEPT PSYCHOPHYS, V57, P305, DOI 10.3758/BF03213056; Astafiev SV, 2003, J NEUROSCI, V23, P4689; Barch DM, 1997, NEUROPSYCHOLOGIA, V35, P1373, DOI 10.1016/S0028-3932(97)00072-9; BEAUVILLAIN C, 1984, MUSIC PERCEPT, V1, P485; Blacking John, 1973, MUSICAL IS MAN; BOECKER H, 1994, BRAIN, V117, P1231, DOI 10.1093/brain/117.6.1231; Bogacz S, 2005, J MOTOR BEHAV, V37, P21, DOI 10.3200/JMBR.37.1.21-34; BUONOMANO DV, 1995, SCIENCE, V267, P1028, DOI 10.1126/science.7863330; Buonomano DV, 2000, J NEUROSCI, V20, P1129, DOI 10.1523/JNEUROSCI.20-03-01129.2000; Cariani PA, 1996, J NEUROPHYSIOL, V76, P1717, DOI 10.1152/jn.1996.76.3.1717; Cariani PA, 1996, J NEUROPHYSIOL, V76, P1698, DOI 10.1152/jn.1996.76.3.1698; Chen R, 1997, ANN NEUROL, V41, P247, DOI 10.1002/ana.410410216; Clynes, 1982, MUSIC MIND BRAIN, P83, DOI [10.1007/978-1-4684-8917-0_5, DOI 10.1007/978-1-4684-8917-0_5]; Cooper G., 1960, RHYTHMIC STRUCTURE M; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; DEUTSCH D, 1983, PERCEPT PSYCHOPHYS, V34, P331, DOI 10.3758/BF03203045; Durstewitz D, 2003, J NEUROSCI, V23, P5342; Duvernoy H. M., 1991, HUMAN BRAIN SURFACE; EPSTEIN D, 1985, MUSIC THEOR SPECTRUM, V7, P34, DOI 10.1525/mts.1985.7.1.02a00030; Del Olmo MF, 2007, J NEUROPHYSIOL, V98, P145, DOI 10.1152/jn.01088.2006; Friston K.J., 1994, HUMAN BRAIN MAPPING, V1, P210; FRISTON KJ, 1991, J CEREBR BLOOD F MET, V11, P690, DOI 10.1038/jcbfm.1991.122; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; GRACCO VL, 1988, EXP BRAIN RES, V71, P515, DOI 10.1007/BF00248744; HALSBAND U, 1993, BRAIN, V116, P243, DOI 10.1093/brain/116.1.243; Harrington DL, 1998, NEUROPSYCHOLOGY, V12, P3, DOI 10.1037/0894-4105.12.1.3; Harrington DL, 1998, J NEUROSCI, V18, P1085; Indovina I, 2001, EXP BRAIN RES, V140, P265, DOI 10.1007/s002210100796; Ivry R B, 1989, J Cogn Neurosci, V1, P136, DOI 10.1162/jocn.1989.1.2.136; JAGACINSKI RJ, 1988, J MOTOR BEHAV, V20, P416; Janata P, 2003, NAT NEUROSCI, V6, P682, DOI 10.1038/nn1081; Jancke L, 1998, NEUROSCI LETT, V252, P37, DOI 10.1016/S0304-3940(98)00540-0; KELSO JAS, 1990, ATTENTION PERFORM, P139; Kelso JAS, 1998, NATURE, V392, P814, DOI 10.1038/33922; Kim JA, 2005, J NEUROPHYSIOL, V94, P2504, DOI 10.1152/jn.01047.2004; Kimpo RR, 2003, J NEUROSCI, V23, P5750; Klapp ST, 1998, J MOTOR BEHAV, V30, P301, DOI 10.1080/00222899809601346; Krampe RT, 2000, J EXP PSYCHOL HUMAN, V26, P206, DOI 10.1037/0096-1523.26.1.206; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Lashley KS, 1930, PSYCHOL REV, V37, P1, DOI 10.1037/h0074134; Lewis PA, 2004, NEUROPSYCHOLOGIA, V42, P1301, DOI 10.1016/j.neuropsychologia.2004.03.001; Macar F, 2002, EXP BRAIN RES, V142, P475, DOI 10.1007/s00221-001-0953-0; Mangels JA, 1998, COGNITIVE BRAIN RES, V7, P15, DOI 10.1016/S0926-6410(98)00005-6; MATES J, 1994, BIOL CYBERN, V70, P463, DOI 10.1007/BF00203239; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; McAdams CJ, 2000, J NEUROPHYSIOL, V83, P1751, DOI 10.1152/jn.2000.83.3.1751; Molinari M, 2005, BRAIN RES BULL, V67, P448, DOI 10.1016/j.brainresbull.2005.07.014; Muller K, 2000, J COGNITIVE NEUROSCI, V12, P546, DOI 10.1162/089892900562282; OBoyle DJ, 1996, BRAIN, V119, P51, DOI 10.1093/brain/119.1.51; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PALMER C, 1990, J EXP PSYCHOL HUMAN, V16, P728, DOI 10.1037/0096-1523.16.4.728; PARNCUTT R, 1994, MUSIC PERCEPT, V11, P409; Parsons L, 2001, NEUROIMAGE, V13, pS925; Penhune VB, 1998, J COGNITIVE NEUROSCI, V10, P752, DOI 10.1162/089892998563149; Platel H, 1997, BRAIN, V120, P229, DOI 10.1093/brain/120.2.229; POVEL DJ, 1985, MUSIC PERCEPT, V2, P411; Pressing J, 2002, MUSIC PERCEPT, V19, P285, DOI 10.1525/mp.2002.19.3.285; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; Repp BH, 2001, HUM MOVEMENT SCI, V20, P277, DOI 10.1016/S0167-9457(01)00049-5; Rijntjes M, 1999, J NEUROSCI, V19, P8043; Roberts S, 2000, PHYS REV E, V62, P2597, DOI 10.1103/PhysRevE.62.2597; Rounis E, 2007, J COGNITIVE NEUROSCI, V19, P513, DOI 10.1162/jocn.2007.19.3.513; Rushworth MFS, 2001, J NEUROSCI, V21, P5262, DOI 10.1523/JNEUROSCI.21-14-05262.2001; Rushworth MFS, 2001, NAT NEUROSCI, V4, P656, DOI 10.1038/88492; Rushworth MFS, 2001, J COGNITIVE NEUROSCI, V13, P698, DOI 10.1162/089892901750363244; Schlaug G, 1996, NEUROREPORT, V7, P879, DOI 10.1097/00001756-199603220-00009; Schmahmann JD, 1999, NEUROIMAGE, V10, P233, DOI 10.1006/nimg.1999.0459; Snyder B, 2000, MUSIC AND MEMORY; Spencer RMC, 2007, NEUROIMAGE, V36, P378, DOI 10.1016/j.neuroimage.2007.03.009; Spencer RMC, 2005, BRAIN COGNITION, V58, P84, DOI 10.1016/j.bandc.2004.09.010; Spencer RMC, 2003, SCIENCE, V300, P1437, DOI 10.1126/science.1083661; Stephan KM, 2002, NEUROIMAGE, V15, P345, DOI 10.1006/nimg.2001.0929; STEPHAN KM, 2002, CORTICOCEREBELLAR CI; Summers J, 2002, BRAIN COGNITION, V48, P166, DOI 10.1006/brcg.2001.1311; Tajima M, 1999, PERCEPT MOTOR SKILL, V88, P1160, DOI 10.2466/PMS.88.3.1160-1168; Talairach J., 1988, COPLANAR STEREOTAXIC; Tecchio F, 2000, EXP BRAIN RES, V135, P222, DOI 10.1007/s002210000507; Thaut MH, 2003, HUM MOVEMENT SCI, V22, P321, DOI 10.1016/S0167-9457(03)00048-4; Thaut MH, 1998, BIOL CYBERN, V79, P241, DOI 10.1007/s004220050474; Thaut MH, 1999, IEEE ENG MED BIOL, V18, P101, DOI 10.1109/51.752991; THAUT MH, 2008, CORTEX IN PRESS; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Ullen F, 2003, J NEUROPHYSIOL, V89, P1126, DOI 10.1152/jn.00775.2002; Vorberg D., 1996, HDB PERCEPT ACTION, P181, DOI [10.1016/S1874-5822(06)80007-1, DOI 10.1016/S1874-5822(06)80007-1, 10.1016/S1874-5822(06)80007-1.]; Vuust P, 2006, NEUROIMAGE, V31, P832, DOI 10.1016/j.neuroimage.2005.12.037; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127	87	40	41	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2312	10.1371/journal.pone.0002312	http://dx.doi.org/10.1371/journal.pone.0002312			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	391XW	18509462	gold, Green Submitted, Green Published			2022-12-25	WOS:000262268500042
J	van der Stoop, P; Boutsma, EA; Hulsman, D; Noback, S; Heimerikx, M; Kerkhoven, RM; Voncken, JW; Wessels, LFA; van Lohuizen, M				van der Stoop, Petra; Boutsma, Erwin A.; Hulsman, Danielle; Noback, Sonja; Heimerikx, Mike; Kerkhoven, Ron M.; Voncken, J. Willem; Wessels, Lodewyk F. A.; van Lohuizen, Maarten			Ubiquitin E3 Ligase Ring1b/Rnf2 of Polycomb Repressive Complex 1 Contributes to Stable Maintenance of Mouse Embryonic Stem Cells	PLOS ONE			English	Article							RNA-POLYMERASE-II; HISTONE H2A; DEVELOPMENTAL REGULATORS; POLYHOMEOTIC GENE; X-INACTIVATION; SELF-RENEWAL; TARGET GENES; DIFFERENTIATION; PROTEINS; PLURIPOTENCY	Background: Polycomb repressive complex 1 (PRC1) core member Ring1b/Rnf2, with ubiquitin E3 ligase activity towards histone H2A at lysine 119, is essential for early embryogenesis. To obtain more insight into the role of Ring1b in early development, we studied its function in mouse embryonic stem (ES) cells. Methodology/Principal Findings: We investigated the effects of Ring1b ablation on transcriptional regulation using Ring1b conditional knockout ES cells and large-scale gene expression analysis. The absence of Ring1b results in aberrant expression of key developmental genes and deregulation of specific differentiation-related pathways, including TGFbeta signaling, cell cycle regulation and cellular communication. Moreover, ES cell markers, including Zfp42/Rex-1 and Sox2, are downregulated. Importantly, retained expression of ES cell regulators Oct4, Nanog and alkaline phosphatase indicates that Ring1b-deficient ES cells retain important ES cell specific characteristics. Comparative analysis of our expression profiling data with previously published global binding studies shows that the genes that are bound by Ring1b in ES cells have bivalent histone marks, i.e. both active H3K4me3 and repressive H3K27me3, or the active H3K4me3 histone mark alone and are associated with CpG- rich' promoters. However, deletion of Ring1b results in deregulation, mainly derepression, of only a subset of these genes, suggesting that additional silencing mechanisms are involved in repression of the other Ring1b bound genes in ES cells. Conclusions: Ring1b is essential to stably maintain an undifferentiated state of mouse ES cells by repressing genes with important roles during differentiation and development. These genes are characterized by high CpG content promoters and bivalent histone marks or the active H3K4me3 histone mark alone.	[van der Stoop, Petra; Boutsma, Erwin A.; Hulsman, Danielle; Noback, Sonja; van Lohuizen, Maarten] Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; [Heimerikx, Mike; Kerkhoven, Ron M.] Netherlands Canc Inst, Ctr Biomed Genet, Amsterdam, Netherlands; [Wessels, Lodewyk F. A.] Netherlands Canc Inst, Div Mol Biol, Amsterdam, Netherlands; [Voncken, J. Willem] Maastricht Univ, Med Ctr, Dept Mol Genet, Maastricht, Netherlands; [van Lohuizen, Maarten] Univ Amsterdam, Acad Med Ctr, Dept Neurogenet, Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Maastricht University; University of Amsterdam; Academic Medical Center Amsterdam	van der Stoop, P (corresponding author), Netherlands Canc Inst, Div Mol Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	m.v.lohuizen@nki.nl			Dutch Cancer Foundation; Dutch organization for Scientific Research	Dutch Cancer Foundation(KWF Kankerbestrijding); Dutch organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by grants from the Dutch Cancer Foundation (KWF) and the Dutch organization for Scientific Research (NWO).	Akasaka T, 1996, DEVELOPMENT, V122, P1513; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Ben-Saadon R, 2006, MOL CELL, V24, P701, DOI 10.1016/j.molcel.2006.10.022; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Breiling A, 2004, EMBO REP, V5, P976, DOI 10.1038/sj.embor.7400260; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; DECAMILLIS M, 1992, GENE DEV, V6, P223, DOI 10.1101/gad.6.2.223; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FAUST C, 1995, DEVELOPMENT, V121, P273; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; Hernadez-Munoz I, 2005, P NATL ACAD SCI USA, V102, P7635, DOI 10.1073/pnas.0408918102; Hernandez-Munoz I, 2005, MOL CELL BIOL, V25, P11047, DOI 10.1128/MCB.25.24.11047-11058.2005; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kuzmichev A, 2005, P NATL ACAD SCI USA, V102, P1859, DOI 10.1073/pnas.0409875102; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Leeb M, 2007, J CELL BIOL, V178, P219, DOI 10.1083/jcb.200612127; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lorente MD, 2000, DEVELOPMENT, V127, P5093; Lund AH, 2004, CURR OPIN CELL BIOL, V16, P239, DOI 10.1016/j.ceb.2004.03.010; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Minucci S, 1996, EMBO J, V15, P888, DOI 10.1002/j.1460-2075.1996.tb00423.x; Mulholland NM, 2003, GENE DEV, V17, P2741, DOI 10.1101/gad.1143303; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; PEASE S, 1990, DEV BIOL, V141, P344, DOI 10.1016/0012-1606(90)90390-5; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Schenke-Layland K, 2007, STEM CELLS, V25, P1529, DOI 10.1634/stemcells.2006-0729; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Takihara Y, 1997, DEVELOPMENT, V124, P3673; Tanay A, 2007, P NATL ACAD SCI USA, V104, P5521, DOI 10.1073/pnas.0609746104; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; von der Hardt S, 2007, CURR BIOL, V17, P475, DOI 10.1016/j.cub.2007.02.013; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wei JH, 2006, J BIOL CHEM, V281, P22537, DOI 10.1074/jbc.M600826200; White J, 2005, MOL BIOL CELL, V16, P2018, DOI 10.1091/mbc.e04-12-1056; Wong RCB, 2004, STEM CELLS, V22, P883, DOI 10.1634/stemcells.22-6-883; Yamauchi M, 2007, CANCER SCI, V98, P1491, DOI 10.1111/j.1349-7006.2007.00534.x; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhou W, 2008, MOL CELL, V29, P69, DOI 10.1016/j.molcel.2007.11.002	68	84	84	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2235	10.1371/journal.pone.0002235	http://dx.doi.org/10.1371/journal.pone.0002235			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493325	Green Published, gold			2022-12-25	WOS:000262258700043
J	Boeckstaens, M; Andre, B; Marini, AM				Boeckstaens, Melanie; Andre, Bruno; Marini, Anna Maria			Distinct transport mechanisms in yeast ammonium transport/sensor proteins of the Mep/Amt/Rh family and impact on filamentation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; CHANNEL AMTB; PSEUDOHYPHAL DIFFERENTIATION; ARCHAEOGLOBUS-FULGIDUS; CRYSTAL-STRUCTURE; HYDROPHOBIC PORE; NPR1 KINASE; CROSS-TALK; PERMEASE	Ammonium transport proteins of the Mep/Amt/Rh family include microbial and plant Mep/Amt members, crucial for ammonium scavenging, and animal Rhesus factors likely involved in ammonium disposal. Recent structural information on two bacterial Mep/Amt proteins has revealed the presence, in the hydrophobic conducting pore, of a pair of preserved histidines proposed to play an important role in substrate conductance, by participating either in NH4+ deprotonation or in shaping the pore. Here we highlight the existence of two functional Mep/Amt subfamilies distinguishable according to whether the first of these histidines is conserved, as in yeast ScMep2, or replaced by glutamate, as in ScMep1. Replacement of the native histidine of ScMep2 with glutamate leads to conversion from ScMep2 to ScMep1-like properties. This includes a two-unit up-shift of the optimal pH for transport and an increase of the transport rate, consistent with alleviation of an energy-limiting step. Similar effects are observed when the same substitution is introduced into the Escherichia coli AmtB protein. In contrast to ScMep1, ScMep2 is proposed to play an additional signaling role in the induction of filamentous growth, a dimorphic change often associated with virulence in pathogenic fungi. We show here that the histidine to glutamate substitution in ScMep2 leads to uncoupling of the transport and sensor functions, suggesting that a ScMep2-specific transport mechanism might be responsible for filamentation. Our overall data suggest the existence of two functional groups of Mep/Amt-type proteins with different transport mechanisms and distinct impacts on cell physiology and signaling.	[Boeckstaens, Melanie; Andre, Bruno; Marini, Anna Maria] Univ Libre Bruxelles, IBMM, Lab Physiol Mol Cellule, B-6041 Gosselies, Belgium	Universite Libre de Bruxelles		ammarini@dbm.ulb.ac.be	André, Bruno/D-1725-2010	Boeckstaens, Melanie/0000-0003-1629-7403				Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Andrade SLA, 2005, ACTA CRYSTALLOGR F, V61, P861, DOI 10.1107/S1744309105027004; Andrade SLA, 2005, P NATL ACAD SCI USA, V102, P14994, DOI 10.1073/pnas.0506254102; Andrade SLA, 2007, MOL MEMBR BIOL, V24, P357, DOI 10.1080/09687680701388423; Bagnat M, 2001, MOL BIOL CELL, V12, P4129, DOI 10.1091/mbc.12.12.4129; BECHET J, 1970, EUR J BIOCHEM, V12, P31, DOI 10.1111/j.1432-1033.1970.tb00817.x; Biswas K, 2005, MOL MICROBIOL, V56, P649, DOI 10.1111/j.1365-2958.2005.04576.x; Boeckstaens M, 2007, MOL MICROBIOL, V64, P534, DOI 10.1111/j.1365-2958.2007.05681.x; BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609; Bostick DL, 2007, PLOS COMPUT BIOL, V3, P231, DOI 10.1371/journal.pcbi.0030022; Bostick DL, 2007, BIOPHYS J, V92, pL103, DOI 10.1529/biophysj.107.109165; Bowman EJ, 1997, J BIOL CHEM, V272, P14776, DOI 10.1074/jbc.272.23.14776; CIMPRICH P, 1995, FEMS MICROBIOL LETT, V130, P245; DAVIES L, 1993, CELL, V75, P321, DOI 10.1016/0092-8674(93)80073-N; De Craene JO, 2001, J BIOL CHEM, V276, P43939, DOI 10.1074/jbc.M102944200; DUBOIS E, 1979, MOL GEN GENET, V175, P67, DOI 10.1007/BF00267857; Fong RN, 2007, P NATL ACAD SCI USA, V104, P18706, DOI 10.1073/pnas.0709267104; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; GRENSON M, 1966, BIOCHIM BIOPHYS ACTA, V127, P325, DOI 10.1016/0304-4165(66)90387-4; Huang CH, 2005, P NATL ACAD SCI USA, V102, P15512, DOI 10.1073/pnas.0507886102; Ishikita H, 2007, J AM CHEM SOC, V129, P1210, DOI 10.1021/ja066208n; JACOBS P, 1980, J MOL BIOL, V139, P691, DOI 10.1016/0022-2836(80)90055-8; Javelle A, 2003, TRENDS MICROBIOL, V11, P53, DOI 10.1016/S0966-842X(02)00012-4; Javelle A, 2001, FEBS LETT, V505, P393, DOI 10.1016/S0014-5793(01)02802-2; Javelle A, 2005, BIOCHEM J, V390, P215, DOI 10.1042/BJ20042094; Javelle A, 2006, J BIOL CHEM, V281, P39492, DOI 10.1074/jbc.M608325200; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Lamoureux G, 2007, BIOPHYS J, V92, pL82, DOI 10.1529/biophysj.106.102756; Li X, 2007, P NATL ACAD SCI USA, V104, P19279, DOI 10.1073/pnas.0709710104; Lin YC, 2006, J AM CHEM SOC, V128, P10876, DOI 10.1021/ja0631549; Loque D, 2007, NATURE, V446, P195, DOI 10.1038/nature05579; Lorenz MC, 1998, GENETICS, V150, P1443; Lorenz MC, 1998, EMBO J, V17, P1236, DOI 10.1093/emboj/17.5.1236; Ludewig U, 2003, J BIOL CHEM, V278, P45603, DOI 10.1074/jbc.M307424200; Ludewig U, 2002, J BIOL CHEM, V277, P13548, DOI 10.1074/jbc.M200739200; Lupo D, 2007, P NATL ACAD SCI USA, V104, P19303, DOI 10.1073/pnas.0706563104; Marini AM, 2000, MOL MICROBIOL, V38, P552, DOI 10.1046/j.1365-2958.2000.02151.x; Marini AM, 2000, MOL MICROBIOL, V35, P378, DOI 10.1046/j.1365-2958.2000.01704.x; MARINI AM, 1994, EMBO J, V13, P3456, DOI 10.1002/j.1460-2075.1994.tb06651.x; Marini AM, 1997, TRENDS BIOCHEM SCI, V22, P460, DOI 10.1016/S0968-0004(97)01132-8; Marini AM, 2000, NAT GENET, V26, P341, DOI 10.1038/81656; Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282; Marini AM, 2006, CURR GENET, V49, P364, DOI 10.1007/s00294-006-0062-5; Mayer M, 2006, BIOCHEM J, V396, P431, DOI 10.1042/BJ20060051; Neuhauser B, 2007, PLANT PHYSIOL, V143, P1651, DOI 10.1104/pp.106.094243; NINNEMANN O, 1994, EMBO J, V13, P3464, DOI 10.1002/j.1460-2075.1994.tb06652.x; Nygaard TP, 2006, BIOPHYS J, V91, P4401, DOI 10.1529/biophysj.106.089714; Pau VPT, 2007, J BIOL CHEM, V282, P29163, DOI 10.1074/jbc.M703277200; Quentin F, 2003, J AM SOC NEPHROL, V14, P545, DOI 10.1097/01.ASN.0000050413.43662.55; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Soupene E, 1998, P NATL ACAD SCI USA, V95, P7030, DOI 10.1073/pnas.95.12.7030; Van Nuland A, 2006, MOL MICROBIOL, V59, P1485, DOI 10.1111/j.1365-2958.2005.05043.x; Verlander JW, 2003, AM J PHYSIOL-RENAL, V284, pF323, DOI 10.1152/ajprenal.00050.2002; von Wiren N, 2004, TOP CURR GENET, V9, P95; Weiner ID, 2003, GASTROENTEROLOGY, V124, P1432, DOI 10.1016/S0016-5085(03)00277-4; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Wood CC, 2006, FEBS LETT, V580, P3931, DOI 10.1016/j.febslet.2006.06.026; Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101	58	52	54	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21362	21370		10.1074/jbc.M801467200	http://dx.doi.org/10.1074/jbc.M801467200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18508774	hybrid			2022-12-25	WOS:000257898800007
J	Iwasa, M; Maeda, K; Narita, A; Maeda, Y; Oda, T				Iwasa, Mitsusada; Maeda, Kayo; Narita, Akihiro; Maeda, Yuichiro; Oda, Toshiro			Dual roles of Gln(137) of actin revealed by recombinant human cardiac muscle alpha-actin mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING CLEFT; P-I RELEASE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; MONOMERIC ACTIN; ATP HYDROLYSIS; RATE-CONSTANT; POLYMERIZATION; FILAMENT; DYNAMICS	The actin filament is quite dynamic in the cell. To determine the relationship between the structure and the dynamic properties of the actin filament, experiments using actin mutants are indispensable. We focused on Gln(137) to understand the relationships between two activities: the conformational changes relevant to the G- to F-actin transition and the activation of actin ATPase upon actin polymerization. To elucidate the function of Gln137 in these activities, we characterized Gln137 mutants of human cardiac muscle alpha-actin. Although all of the single mutants, Q137E, Q137K, Q137P, and Q137A, as well as the wild type were expressed by a baculovirus-based system, only Q137A and the wild type were purified to high homogeneity. The CD spectrum of Q137A was similar to that of the wild type, and Q137A showed the typical morphology of negatively stained Q137A F-actin images. However, Q137A had an extremely low critical concentration for polymerization. Furthermore, we found that Q137A polymerized 4-fold faster, cleaved the gamma-phosphate group of bound ATP 4-fold slower, and depolymerized 5-fold slower, as compared with the wild-type rates. These results suggest that Gln137 plays dual roles in actin polymerization, in both the conformational transition of the actin molecule and the mechanism of ATP hydrolysis.	[Iwasa, Mitsusada; Maeda, Kayo; Narita, Akihiro; Maeda, Yuichiro; Oda, Toshiro] Japan Sci & Technol Agcy, ERATO Actin Filament Dynam Project, RIKEN SPring Ctr 8, Sayo, Hyogo 6795148, Japan; [Narita, Akihiro; Maeda, Yuichiro] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648602, Japan; [Narita, Akihiro; Maeda, Yuichiro] Nagoya Univ, Struct Biol Res Ctr, Nagoya, Aichi 4648602, Japan; [Oda, Toshiro] RIKEN SPring 8 Ctr, Xray Struct Anal Team, Sayo, Hyogo 6795148, Japan	Japan Science & Technology Agency (JST); RIKEN; Nagoya University; Nagoya University; RIKEN	Oda, T (corresponding author), Japan Sci & Technol Agcy, ERATO Actin Filament Dynam Project, RIKEN SPring Ctr 8, Sayo, Hyogo 6795148, Japan.	toda@spring8.or.jp	Oda, Toshiro/F-6151-2011					Belmont LD, 1999, P NATL ACAD SCI USA, V96, P29, DOI 10.1073/pnas.96.1.29; Belmont LD, 1999, J CELL SCI, V112, P1325; Bookwalter CS, 2006, J BIOL CHEM, V281, P16777, DOI 10.1074/jbc.M512935200; Carlier MF, 2007, J BIOL CHEM, V282, P23005, DOI 10.1074/jbc.R700020200; CARLIER MF, 1984, J BIOL CHEM, V259, P9983; De la Cruz EM, 2000, J MOL BIOL, V295, P517, DOI 10.1006/jmbi.1999.3390; ESNOUF RM, 1997, J MOL GRAPH MODEL, V15, P112; GERSHMAN LC, 1984, BIOCHEMISTRY-US, V23, P2199, DOI 10.1021/bi00305a015; Graceffa P, 2003, J BIOL CHEM, V278, P34172, DOI 10.1074/jbc.M303689200; HOUK TW, 1974, ANAL BIOCHEM, V62, P66, DOI 10.1016/0003-2697(74)90367-4; Joel PB, 2004, BIOCHEMISTRY-US, V43, P11554, DOI 10.1021/bi048899a; KORN ED, 1987, SCIENCE, V238, P638, DOI 10.1126/science.3672117; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Matsuura Y, 2000, J MOL BIOL, V296, P579, DOI 10.1006/jmbi.1999.3467; Melki R, 1996, BIOCHEMISTRY-US, V35, P12038, DOI 10.1021/bi961325o; Moraczewska J, 1996, BIOCHEM J, V317, P605, DOI 10.1042/bj3170605; NISHIDA E, 1983, J BIOCHEM-TOKYO, V93, P1011, DOI 10.1093/oxfordjournals.jbchem.a134224; Oda T, 2007, ADV EXP MED BIOL, V592, P385; Oosawa F., 1975, THERMODYNAMICS POLYM; Orlova A, 1997, J MOL BIOL, V271, P235, DOI 10.1006/jmbi.1997.1163; ORLOVA A, 1993, J MOL BIOL, V232, P334, DOI 10.1006/jmbi.1993.1393; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; PINDER JC, 1995, ANAL BIOCHEM, V225, P291, DOI 10.1006/abio.1995.1157; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; POLLARD TD, 1984, FEBS LETT, V170, P94, DOI 10.1016/0014-5793(84)81376-9; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Rould MA, 2006, J BIOL CHEM, V281, P31909, DOI 10.1074/jbc.M601973200; Samizo K, 2001, ANAL BIOCHEM, V293, P212, DOI 10.1006/abio.2001.5146; Sano KI, 2002, FEBS LETT, V532, P143, DOI 10.1016/S0014-5793(02)03659-1; Schafer DA, 1998, CELL MOTIL CYTOSKEL, V39, P166, DOI 10.1002/(SICI)1097-0169(1998)39:2<166::AID-CM7>3.0.CO;2-4; SHEFF DR, 1992, J BIOL CHEM, V267, P20217; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; STRZELECKAGOLASZEWSKA H, 1993, EUR J BIOCHEM, V211, P731, DOI 10.1111/j.1432-1033.1993.tb17603.x; TOBACMAN LS, 1983, J BIOL CHEM, V258, P3207; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vogel M, 2006, MOL CELL, V21, P359, DOI 10.1016/j.molcel.2005.12.017; Vorobiev S, 2003, P NATL ACAD SCI USA, V100, P5760, DOI 10.1073/pnas.0832273100; Wang HW, 2005, NATURE, V435, P911, DOI 10.1038/nature03606; WEBER A, 1994, BIOCHEMISTRY-US, V33, P4780, DOI 10.1021/bi00182a005	40	31	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21045	21053		10.1074/jbc.M800570200	http://dx.doi.org/10.1074/jbc.M800570200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18515362	hybrid, Green Published			2022-12-25	WOS:000257746100046
J	Rodgers, L; Gamez, A; Riek, R; Ghosh, P				Rodgers, Loren; Gamez, Alicia; Riek, Roland; Ghosh, Partho			The type III secretion chaperone SycE promotes a localized disorder-to-order transition in the natively unfolded effector YopE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YERSINIA-ENTEROCOLITICA; CRYSTAL-STRUCTURE; SHIGELLA-FLEXNERI; LARGE PROTEINS; NMR; SYSTEM; PESTIS; ASSIGNMENTS; FRAGMENT; SIGNALS	Many virulence-related, bacterial effector proteins are translocated directly into the cytosol of host cells by the type III secretion (TTS) system. Translocation of most TTS effectors requires binding by specific chaperones in the bacterial cytosol, although how chaperones promote translocation is unclear. To provide insight into the action of such chaperones, we studied the consequences of binding by the Yersinia chaperone SycE to the effector YopE by NMR. These studies examined the intact form of the effector, whereas prior studies have been limited to well ordered fragments. We found that YopE had the characteristics of a natively unfolded protein, with its N-terminal 100 residues, including its chaperone-binding (Cb) region, flexible and disordered in the absence of SycE. SycE binding caused a pronounced disorder-to-order transition in the Cb region of YopE. The effect of SycE was strictly localized to the Cb region, with other portions of YopE being unperturbed. These results provide stringent limits on models of chaperone action and are consistent with the chaperone promoting formation of a three-dimensional targeting signal in the Cb region of the effector. The target of this putative signal is unknown but appears to be a bacterial component other than the TTS ATPase YscN.	[Rodgers, Loren; Ghosh, Partho] Univ Calif San Diego, Mol Biol Sect, La Jolla, CA 92093 USA; [Gamez, Alicia; Ghosh, Partho] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Riek, Roland] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Riek, Roland] ETH, Phys Chem Lab, CH-8093 Zurich, Switzerland	University of California System; University of California San Diego; University of California System; University of California San Diego; Salk Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich	Ghosh, P (corresponding author), Univ Calif San Diego, Dept Chem & Biochem 0375, 9500 Gilman Dr, La Jolla, CA 92093 USA.	pghosh@ucsd.edu		Riek, Roland/0000-0002-6333-066X	NIAID NIH HHS [R01 AI 061452, R01 AI061452] Funding Source: Medline; NIGMS NIH HHS [T32 GM 007240] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061452] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007240] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Birtalan S, 2001, NAT STRUCT BIOL, V8, P974, DOI 10.1038/nsb1101-974; Birtalan SC, 2002, MOL CELL, V9, P971, DOI 10.1016/S1097-2765(02)00529-4; Blaylock B, 2006, J BACTERIOL, V188, P3525, DOI 10.1128/JB.188.10.3525-3534.2006; Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x; Boyd AP, 2000, EUR J CELL BIOL, V79, P659, DOI 10.1078/0171-9335-00098; Buttner CR, 2005, PROTEIN SCI, V14, P1993, DOI 10.1110/ps.051474605; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Daughdrill GW, 1997, NAT STRUCT BIOL, V4, P285, DOI 10.1038/nsb0497-285; Evdokimov AG, 2002, PROTEIN SCI, V11, P401, DOI 10.1110/ps.34102; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Gauthier A, 2003, J BACTERIOL, V185, P6747, DOI 10.1128/JB.185.23.6747-6755.2003; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; Guntert P, 2000, J BIOMOL NMR, V18, P129, DOI 10.1023/A:1008318805889; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Keller R., 2004, COMPUTER AIDED RESON, V1; Krall R, 2004, J BIOL CHEM, V279, P2747, DOI 10.1074/jbc.M301963200; Letzelter M, 2006, EMBO J, V25, P3223, DOI 10.1038/sj.emboj.7601202; Lilic M, 2006, MOL CELL, V21, P653, DOI 10.1016/j.molcel.2006.01.026; Lloyd SA, 2001, MOL MICROBIOL, V39, P520, DOI 10.1046/j.1365-2958.2001.02271.x; Locher M, 2005, J BIOL CHEM, V280, P31149, DOI 10.1074/jbc.M500603200; Luo Y, 2001, NAT STRUCT BIOL, V8, P1031, DOI 10.1038/nsb717; Phan J, 2004, ACTA CRYSTALLOGR D, V60, P1591, DOI 10.1107/S0907444904017597; Ramamurthi KS, 2005, J BACTERIOL, V187, P707, DOI 10.1128/JB.187.2.707-715.2005; Salzmann M, 1999, J AM CHEM SOC, V121, P844, DOI 10.1021/ja9834226; Salzmann M, 1999, J BIOMOL NMR, V14, P85, DOI 10.1023/A:1008346931993; Schubot FD, 2005, J MOL BIOL, V346, P1147, DOI 10.1016/j.jmb.2004.12.036; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; Singer AU, 2004, STRUCTURE, V12, P1669, DOI 10.1016/j.str.2004.06.023; Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998; Stebbins CE, 2001, NATURE, V414, P77, DOI 10.1038/35102073; van Eerde A, 2004, EMBO REP, V5, P477, DOI 10.1038/sj.embor.7400144; von Pawel-Rammingen U, 2000, MOL MICROBIOL, V36, P737, DOI 10.1046/j.1365-2958.2000.01898.x; Wulff-Strobel CR, 2002, MOL MICROBIOL, V43, P411, DOI 10.1046/j.1365-2958.2002.02752.x; Xia YL, 2000, J BIOMOL NMR, V18, P261, DOI 10.1023/A:1026590201757	36	38	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20857	20863		10.1074/jbc.M802339200	http://dx.doi.org/10.1074/jbc.M802339200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18502763	Green Published, hybrid			2022-12-25	WOS:000257746100028
J	Mukhopadhyay, D; Howell, KS; Riezman, H; Capitani, G				Mukhopadhyay, Debdyuti; Howell, Kate S.; Riezman, Howard; Capitani, Guido			Identifying key residues of sphinganine-1-phosphate lyase for function in vivo and in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE KINASE LCB4; GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED PROTEINS; SPHINGOSINE-PHOSPHATE LYASE; SACCHAROMYCES-CEREVISIAE; SPHINGOSINE-1-PHOSPHATE LYASE; SUBCELLULAR-LOCALIZATION; SPHINGOLIPID METABOLISM; TRANSMEMBRANE TOPOLOGY; CERAMIDE SYNTHASE; HEAT-STRESS	Sphinganine-1-phosphate lyase (Dpl1p) is a highly conserved enzyme of sphingolipid metabolism that catalyzes the irreversible degradation of sphingoid base phosphates, which are potent signaling molecules. Sphingoid base phosphates play a vital role in cell survival, proliferation, migration, heat stress, and cell wall integrity pathways. Little is known about the structure and regulation of Dpl1p. In this study, we have undertaken a combined computational modeling and mutagenesis approach for structure-function analysis of Dpl1p to discover possible modes of regulation. Our results identify important residues for catalysis in Dpl1p and confirm it as an integral endoplasmic reticulum-resident protein. Results further indicate that Dpl1p is most likely not regulated spatially. Importantly, we demonstrate that Dpl1p exists as an oligomer and that polar residues in its transmembrane domain are required for its full function in vivo but not for its localization or for its catalytic activity in vitro.	[Mukhopadhyay, Debdyuti; Howell, Kate S.; Riezman, Howard] Univ Geneva, Dept Biochem, CH-1211 Geneva 4, Switzerland; [Capitani, Guido] Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland	University of Geneva; University of Zurich	Riezman, H (corresponding author), Univ Geneva, Dept Biochem, 30 Quai E Ansermet, CH-1211 Geneva 4, Switzerland.	howard.riezman@biochem.unige.ch	Howell, Kate/M-2370-2013	Howell, Kate/0000-0001-6498-0472; Riezman, Howard/0000-0003-4680-9422				Alvarez-Vasquez F, 2005, NATURE, V433, P425, DOI 10.1038/nature03232; Bandhuvula P, 2005, J BIOL CHEM, V280, P33697, DOI 10.1074/jbc.C500294200; Birchwood CJ, 2001, J BIOL CHEM, V276, P11712, DOI 10.1074/jbc.M010221200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burkhard P, 2001, NAT STRUCT BIOL, V8, P963, DOI 10.1038/nsb1101-963; Capitani G, 2003, FEBS LETT, V554, P41, DOI 10.1016/S0014-5793(03)01079-2; Capitani G, 2003, EMBO J, V22, P4027, DOI 10.1093/emboj/cdg403; Cocquerel L, 2000, J VIROL, V74, P3623, DOI 10.1128/JVI.74.8.3623-3633.2000; Doron-Faigenboim A, 2005, BIOINFORMATICS, V21, P2101, DOI 10.1093/bioinformatics/bti259; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fujita M, 2006, MOL BIOL CELL, V17, P834, DOI 10.1091/mbc.E05-05-0443; Funato K, 2003, J BIOL CHEM, V278, P7325, DOI 10.1074/jbc.M209925200; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Gottlieb D, 1999, Mol Cell Biol Res Commun, V1, P66, DOI 10.1006/mcbr.1999.0109; Grote E, 2000, MOL BIOL CELL, V11, P4051, DOI 10.1091/mbc.11.12.4051; Guan XL, 2006, YEAST, V23, P465, DOI 10.1002/yea.1362; Gut H, 2006, EMBO J, V25, P2643, DOI 10.1038/sj.emboj.7601107; Hait NC, 2002, FEBS LETT, V532, P97, DOI 10.1016/S0014-5793(02)03636-0; Hait NC, 2006, BBA-BIOMEMBRANES, V1758, P2016, DOI 10.1016/j.bbamem.2006.08.007; Heese-Peck A, 2002, MOL BIOL CELL, V13, P2664, DOI 10.1091/mbc.E02-04-0186; Herr DR, 2003, DEVELOPMENT, V130, P2443, DOI 10.1242/dev.00456; HERSCOVICS A, 1993, FASEB J, V7, P540, DOI 10.1096/fasebj.7.6.8472892; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ikeda M, 2004, BIOCHEM BIOPH RES CO, V325, P338, DOI 10.1016/j.bbrc.2004.10.036; Iwaki S, 2005, J BIOL CHEM, V280, P6520, DOI 10.1074/jbc.M410908200; Iwaki S, 2007, J BIOL CHEM, V282, P28485, DOI 10.1074/jbc.M701607200; Kageyama-Yahara N, 2006, BIOCHEM J, V398, P585, DOI 10.1042/BJ20060697; Kihara A, 2005, MOL CELL BIOL, V25, P9189, DOI 10.1128/MCB.25.21.9189-9197.2005; Kihara A, 2003, GENES CELLS, V8, P525, DOI 10.1046/j.1365-2443.2003.00653.x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Le Stunff H, 2004, J CELL BIOCHEM, V92, P882, DOI 10.1002/h=jcb.20097; Mao CG, 1999, BIOCHEM J, V342, P667, DOI 10.1042/0264-6021:3420667; Mendel J, 2003, J BIOL CHEM, V278, P22341, DOI 10.1074/jbc.M302857200; Oskouian B, 2006, P NATL ACAD SCI USA, V103, P17384, DOI 10.1073/pnas.0600050103; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; ROTHMAN JH, 1986, P NATL ACAD SCI USA, V83, P3248, DOI 10.1073/pnas.83.10.3248; SALI A, 1995, MOL MED TODAY, V1, P270, DOI 10.1016/s1357-4310(95)91170-7; Sato M, 1996, J CELL BIOL, V134, P279, DOI 10.1083/jcb.134.2.279; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Skrzypek MS, 1999, J BACTERIOL, V181, P1134, DOI 10.1128/JB.181.4.1134-1140.1999; Sullards M C, 2001, Sci STKE, V2001, ppl1; Vallee B, 2005, EMBO J, V24, P730, DOI 10.1038/sj.emboj.7600562; Van Veldhoven PP, 2000, BBA-MOL CELL BIOL L, V1487, P128, DOI 10.1016/S1388-1981(00)00079-2; VANVELDHOVEN PP, 1991, J BIOL CHEM, V266, P12502; VANVELDHOVEN PP, 1993, ADV LIPID RES, V26, P69; Watanabe R, 2002, J BIOL CHEM, V277, P49538, DOI 10.1074/jbc.M206209200; Zhang K, 2007, EMBO J, V26, P1094, DOI 10.1038/sj.emboj.7601565; Zhang XP, 2001, CURR GENET, V40, P221, DOI 10.1007/s00294-001-0259-6	49	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20159	20169		10.1074/jbc.M709753200	http://dx.doi.org/10.1074/jbc.M709753200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18487605	hybrid, Green Accepted			2022-12-25	WOS:000257565300032
J	Shen, WL; Hao, JJ; Tian, CA; Ren, JM; Yang, L; Li, XS; Luo, C; Cotma, CW; Liu, JK				Shen, Weili; Hao, Jiejie; Tian, Chuan; Ren, Jinmin; Yang, Lu; Li, Xuesen; Luo, Cheng; Cotma, Carl W.; Liu, Jiankang			A Combination of Nutriments Improves Mitochondrial Biogenesis and Function in Skeletal Muscle of Type 2 Diabetic Goto-Kakizaki Rats	PLOS ONE			English	Article							ALPHA-LIPOIC ACID; FREE FATTY-ACIDS; BETA-CELL MASS; INSULIN-SECRETION; METABOLIC ANTIOXIDANT; PPAR-GAMMA; GLUCOSE; DYSFUNCTION; CARNITINE; PIOGLITAZONE	Background: Recent evidence indicates that insulin resistance in skeletal muscle may be related to reduce mitochondrial number and oxidation capacity. However, it is not known whether increasing mitochondrial number and function improves insulin resistance. In the present study, we investigated the effects of a combination of nutrients on insulin resistance and mitochondrial biogenesis/function in skeletal muscle of type 2 diabetic Goto-Kakizaki rats. Methodology/Principal Findings: We demonstrated that defect of glucose and lipid metabolism is associated with low mitochondrial content and reduced mitochondrial enzyme activity in skeletal muscle of the diabetic Goto-Kakizaki rats. The treatment of combination of R-alpha-lipoic acid, acetyl-L-carnitine, nicotinamide, and biotin effectively improved glucose tolerance, decreased the basal insulin secretion and the level of circulating free fatty acid (FFA), and prevented the reduction of mitochondrial biogenesis in skeletal muscle. The nutrients treatment also significantly increased mRNA levels of genes involved in lipid metabolism, including peroxisome proliferator-activated receptor-alpha (Ppar alpha), peroxisome proliferator activated receptor-delta (Ppar delta), and carnitine palmitoyl transferase-1 (Mcpt-1) and activity of mitochondrial complex I and II in skeletal muscle. All of these effects of mitochondrial nutrients are comparable to that of the antidiabetic drug, pioglitazone. In addition, the treatment with nutrients, unlike pioglitazone, did not cause body weight gain. Conclusions/Significance: These data suggest that a combination of mitochondrial targeting nutrients may improve skeletal mitochondrial dysfunction and exert hypoglycemic effects, without causing weight gain.	[Shen, Weili; Hao, Jiejie; Tian, Chuan; Ren, Jinmin; Yang, Lu; Li, Xuesen; Luo, Cheng] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai, Peoples R China; [Hao, Jiejie; Tian, Chuan; Li, Xuesen] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Cotma, Carl W.; Liu, Jiankang] Univ Calif Irvine, Inst Brain Aging & Dementia, Irvine, CA USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of California System; University of California Irvine	Shen, WL (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai, Peoples R China.	j.liu@uci.edu	Luo, Cheng/C-2849-2013; Liu, Jiankang/A-1610-2011	Luo, Cheng/0000-0003-2193-3670; Shen, Weili/0000-0002-3088-8245	Pujiang Talent Award [05PJ14104]; Science and Technology Commission of Shanghai Municipality [04dz14007]; Chinese Academy of Sciences	Pujiang Talent Award; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by the Pujiang Talent Award (05PJ14104) and the Diabetes Research Grant from the Science and Technology Commission of Shanghai Municipality (04dz14007), and the grant by the Chinese Academy of Sciences. The sponsors has no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Ames BN, 2003, ALZ DIS ASSOC DIS, V17, pS54, DOI 10.1097/00002093-200304002-00007; AMES BN, 1995, BBA-MOL BASIS DIS, V1271, P165, DOI 10.1016/0925-4439(95)00024-X; AMES BN, 2006, NUTRIGENOMICS DISCOV, P277; ANSTALL HB, 1965, CLIN CHEM, V11, P741; BIRCHMACHIN MA, 1994, BIOCHEM MED METAB B, V51, P35, DOI 10.1006/bmmb.1994.1004; Bogacka I, 2005, J CLIN ENDOCR METAB, V90, P6650, DOI 10.1210/jc.2005-1024; Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392; BONNARD C, 2008, J CLIN INVEST; Dachicourt N, 1998, EUR J PHARMACOL, V361, P243, DOI 10.1016/S0014-2999(98)00718-3; Estrada DE, 1996, DIABETES, V45, P1798, DOI 10.2337/diabetes.45.12.1798; Ghosh S, 2007, MOL PHARMACOL, V71, P1695, DOI 10.1124/mol.106.033845; Giancaterini A, 2000, METABOLISM, V49, P704, DOI 10.1053/meta.2000.6250; Gilde AJ, 2003, CIRC RES, V92, P518, DOI 10.1161/01.RES.0000060700.55247.7C; Haramaki N, 1997, FREE RADICAL BIO MED, V22, P535, DOI 10.1016/S0891-5849(96)00400-5; Harrison WA, 2004, ACCIDENT ANAL PREV, V36, P885, DOI 10.1016/j.aap.2003.09.004; Humphries KM, 1998, BIOCHEMISTRY-US, V37, P552, DOI 10.1021/bi971958i; Janssen U, 2004, J NEPHROL, V17, P769; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kirsch M, 2001, FASEB J, V15, P1569, DOI 10.1096/fj.00-0823hyp; Lee WJ, 2005, BIOCHEM BIOPH RES CO, V332, P885, DOI 10.1016/j.bbrc.2005.05.035; Liu CC, 2005, BRIT J NUTR, V94, P595, DOI 10.1079/BJN20051541; LIU J, 2007, NEUROCHEM RES; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Luo C, 2006, J BIOCHEM BIOPH METH, V68, P101, DOI 10.1016/j.jbbm.2006.04.003; Maru S, 2005, DIABETES CARE, V28, P20, DOI 10.2337/diacare.28.1.20; MCCAMAN RE, 1966, J BIOL CHEM, V241, P930; McCarty MF, 2005, MED HYPOTHESES, V64, P399, DOI 10.1016/j.mehy.2004.03.034; MENSINK M, 2007, INT J OBES LOND; Mingrone G, 2004, ANN NY ACAD SCI, V1033, P99, DOI 10.1196/annals.1320.009; Moreira PI, 2007, J ALZHEIMERS DIS, V12, P195, DOI 10.3233/jad-2007-12210; Packer L, 1997, Adv Pharmacol, V38, P79; PACKER L, 1995, FREE RADICAL BIO MED, V19, P227, DOI 10.1016/0891-5849(95)00017-R; Packer L, 1997, FREE RADICAL BIO MED, V22, P359, DOI 10.1016/S0891-5849(96)00269-9; Palmeira CM, 1999, FEBS LETT, V458, P103, DOI 10.1016/S0014-5793(99)01144-8; Pankow JS, 2004, DIABETES CARE, V27, P77, DOI 10.2337/diacare.27.1.77; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; Produit-Zengaffinen N, 2007, DIABETOLOGIA, V50, P84, DOI 10.1007/s00125-006-0499-6; REAVEN GM, 1988, AM J PHYSIOL, V254, pE23, DOI 10.1152/ajpendo.1988.254.1.E23; REGOUW BJM, 1971, CLIN CHIM ACTA, V31, P187, DOI 10.1016/0009-8981(71)90377-9; Reznick RM, 2006, J PHYSIOL-LONDON, V574, P33, DOI 10.1113/jphysiol.2006.109512; Rosen P, 2006, DIABETES-METAB RES, V22, P323, DOI 10.1002/dmrr.623; Rong JX, 2007, DIABETES, V56, P1751, DOI 10.2337/db06-1135; Satoh K, 2005, BIOL PHARM BULL, V28, P2092, DOI 10.1248/bpb.28.2092; Shen W, 2008, DIABETOLOGIA, V51, P165, DOI 10.1007/s00125-007-0852-4; Shima K, 1998, DIABETES RES CLIN PR, V41, P1, DOI 10.1016/S0168-8227(98)00061-8; Soyal S, 2006, DIABETOLOGIA, V49, P1477, DOI 10.1007/s00125-006-0268-6; SUGIYAMA Y, 1990, ARZNEIMITTEL-FORSCH, V40-1, P263; Sun LJ, 2006, MITOCHONDRION, V6, P136, DOI 10.1016/j.mito.2006.04.003; TSUJI K, 1988, METABOLISM, V37, P1040, DOI 10.1016/0026-0495(88)90064-9; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; Velykyi M. M., 1996, Ukrainskii Biokhimicheskii Zhurnal, V68, P109; Walczak R, 2003, NAT MED, V9, P1348, DOI 10.1038/nm1103-1348; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Yamanaka M, 2007, DIABETES OBES METAB, V9, P879, DOI 10.1111/j.1463-1326.2006.00675.x; Zempleni J, 1997, J NUTR, V127, P1776, DOI 10.1093/jn/127.9.1776	57	55	57	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2328	10.1371/journal.pone.0002328	http://dx.doi.org/10.1371/journal.pone.0002328			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523557	Green Published, gold			2022-12-25	WOS:000262614300023
J	Moustafa, A; Reyes-Prieto, A; Bhattacharya, D				Moustafa, Ahmed; Reyes-Prieto, Adrian; Bhattacharya, Debashish			Chlamydiae Has Contributed at Least 55 Genes to Plantae with Predominantly Plastid Functions	PLOS ONE			English	Article								Background: The photosynthetic organelle (plastid) originated via primary endosymbiosis in which a phagotrophic protist captured and harnessed a cyanobacterium. The plastid was inherited by the common ancestor of the red, green (including land plants), and glaucophyte algae (together, the Plantae). Despite the critical importance of primary plastid endosymbiosis, its ancient derivation has left behind very few "footprints" of early key events in organelle genesis. Methodology/Principal Findings: To gain insights into this process, we conducted an in-depth phylogenomic analysis of genomic data (nuclear proteins) from 17 Plantae species to identify genes of a surprising provenance in these taxa, Chlamydiae bacteria. Previous studies show that Chlamydiae contributed many genes (at least 21 in one study) to Plantae that primarily have plastid functions and were postulated to have played a fundamental role in organelle evolution. Using our comprehensive approach, we identify at least 55 Chlamydiae-derived genes in algae and plants, of which 67% (37/55) are putatively plastid targeted and at least 3 have mitochondrial functions. The remainder of the proteins does not contain a bioinformatically predicted organelle import signal although one has an N-terminal extension in comparison to the Chlamydiae homolog. Our data suggest that environmental Chlamydiae were significant contributors to early Plantae genomes that extend beyond plastid metabolism. The chlamydial gene distribution and protein tree topologies provide evidence for both endosymbiotic gene transfer and a horizontal gene transfer ratchet driven by recurrent endoparasitism as explanations for gene origin. Conclusions/Significance: Our findings paint a more complex picture of gene origin than can easily be explained by endosymbiotic gene transfer from an organelle-like point source. These data significantly extend the genomic impact of Chlamydiae on Plantae and show that about one-half (30/55) of the transferred genes are most closely related to sequences emanating from the genome of the only environmental isolate that is currently available. This strain, Candidatus Protochlamydia amoebophila UWE25 is an endosymbiont of Acanthamoeba and likely represents the type of endoparasite that contributed the genes to Plantae.	[Moustafa, Ahmed; Bhattacharya, Debashish] Univ Iowa, Interdisciplinary Program Genet, Iowa City, IA 52242 USA; [Moustafa, Ahmed; Reyes-Prieto, Adrian; Bhattacharya, Debashish] Univ Iowa, Roy J Carver Ctr Comparative Genom, Dept Biol Sci, Iowa City, IA USA	University of Iowa; University of Iowa	Moustafa, A (corresponding author), Univ Iowa, Interdisciplinary Program Genet, Iowa City, IA 52242 USA.	debashi-bhattacharya@uiowa.edu	Moustafa, Ahmed/AAZ-3991-2020; Moustafa, Ahmed/C-5234-2009	Moustafa, Ahmed/0000-0002-0111-3555; Moustafa, Ahmed/0000-0002-0111-3555	National Aeronautics and Space Administration [NNG04GM17G]; National Science Foundation [EF 04-31117]; National Institutes of Health [R01ES013679]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008629] Funding Source: NIH RePORTER	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Aeronautics and Space Administration, the National Science Foundation, and the National Institutes of Health in grants awarded to DB (NNG04GM17G, EF 04-31117, R01ES013679, respectively).	Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Bhattacharya D, 2004, BIOESSAYS, V26, P50, DOI 10.1002/bies.10376; Bhattacharya D, 2007, BIOESSAYS, V29, P1239, DOI 10.1002/bies.20671; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; BRENNICKE A, 1993, FEBS LETT, V325, P140, DOI 10.1016/0014-5793(93)81430-8; Brinkman FSL, 2002, GENOME RES, V12, P1159, DOI 10.1101/gr.341802; Cavalier-Smith T, 2002, INT J SYST EVOL MICR, V52, P297, DOI 10.1099/00207713-52-2-297; CHANG JMM, 2008, PROTEINS; Christie PJ, 2000, TRENDS MICROBIOL, V8, P354, DOI 10.1016/S0966-842X(00)01792-3; Corsarol D, 2006, CLIN MICROBIOL REV, V19, P283, DOI 10.1128/CMR.19.2.283-297.2006; Delwiche CF, 1999, AM NAT, V154, pS164, DOI 10.1086/303291; Deusch O, 2008, MOL BIOL EVOL, V25, P748, DOI 10.1093/molbev/msn022; Doolittle WE, 1998, TRENDS GENET, V14, P307; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Everett KDE, 2005, INT J SYST EVOL MICR, V55, P1581, DOI 10.1099/ijs.0.63454-0; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Frickey T, 2004, NUCLEIC ACIDS RES, V32, P5231, DOI 10.1093/nar/gkh867; Greub G, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-48; Greub G, 2003, APPL ENVIRON MICROB, V69, P5530, DOI 10.1128/AEM.69.9.5530-5535.2003; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Hackett JD, 2007, MOL BIOL EVOL, V24, P1702, DOI 10.1093/molbev/msm089; Horn M, 2004, SCIENCE, V304, P728, DOI 10.1126/science.1096330; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Huang CY, 2005, PLANT PHYSIOL, V138, P1723, DOI 10.1104/pp.105.060327; Huang JL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r99; Leister D, 2005, TRENDS GENET, V21, P655, DOI 10.1016/j.tig.2005.09.004; Martin W, 1998, NATURE, V393, P162, DOI 10.1038/30234; Martin W, 1998, PLANT PHYSIOL, V118, P9, DOI 10.1104/pp.118.1.9; Matsuo M, 2005, PLANT CELL, V17, P665, DOI 10.1105/tpc.104.027706; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; McFadden GI, 2004, CURR BIOL, V14, pR514, DOI 10.1016/j.cub.2004.06.041; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Moustafa A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-6; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Nosenko T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-173; Nozaki H, 2007, MOL BIOL EVOL, V24, P1592, DOI 10.1093/molbev/msm091; O'Brien EA, 2007, NUCLEIC ACIDS RES, V35, pD445, DOI 10.1093/nar/gkl770; Parfrey LW, 2006, PLOS GENET, V2, P2062, DOI 10.1371/journal.pgen.0020220; Reyes-Prieto A, 2007, ANNU REV GENET, V41, P147, DOI 10.1146/annurev.genet.41.110306.130134; Reyes-Prieto A, 2006, CURR BIOL, V16, P2320, DOI 10.1016/j.cub.2006.09.063; Rodriguez-Ezpeleta N, 2005, CURR BIOL, V15, P1325, DOI 10.1016/j.cub.2005.06.040; Schmitz-Esser S, 2004, J BACTERIOL, V186, P683, DOI 10.1128/JB.186.3.683-691.2004; Simpson AGB, 2004, CURR BIOL, V14, pR693, DOI 10.1016/j.cub.2004.08.038; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stechmann A, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-101; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Thorsness PE, 1996, INT REV CYTOL, V165, P207, DOI 10.1016/S0074-7696(08)62223-8; Tokuhisa JG, 1998, PLANT CELL, V10, P699, DOI 10.1105/tpc.10.5.699; Tyra HM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r212; Watkins RF, 2006, J MOL EVOL, V63, P801, DOI 10.1007/s00239-006-0031-0	52	96	97	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2205	10.1371/journal.pone.0002205	http://dx.doi.org/10.1371/journal.pone.0002205			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493612	gold, Green Published, Green Submitted			2022-12-25	WOS:000262258700014
J	Mwangi, TW; Fegan, G; Williams, TN; Kinyanjui, SM; Snow, RW; Marsh, K				Mwangi, Tabitha Wanja; Fegan, Gregory; Williams, Thomas Neil; Kinyanjui, Sam Muchina; Snow, Robert William; Marsh, Kevin			Evidence for Over-Dispersion in the Distribution of Clinical Malaria Episodes in Children	PLOS ONE			English	Article							ENTOMOLOGICAL INOCULATION RATE; COMBATING MALARIA; CHILDHOOD MALARIA; TRANSMISSION; MORBIDITY; PREVALENCE; PROTECTION; INFECTION; MORTALITY; DISEASE	Background: It may be assumed that patterns of clinical malaria in children of similar age under the same level of exposure would follow a Poisson distribution with no over-dispersion. Longitudinal studies that have been conducted over many years suggest that some children may experience more episodes of clinical malaria than would be expected. The aim of this study was to identify this group of children and investigate possible causes for this increased susceptibility. Methodology and Principal Findings: Using Poisson regression, we chose a group of children whom we designated as 'more susceptible' to malaria from 373 children under 10 years of age who were followed up for between 3 to 5 years from 1998-2003. About 21% of the children were categorized as 'more susceptible' and although they contributed only 23% of the person-time of follow-up, they experienced 55% of total clinical malaria episodes. Children that were parasite negative at all cross-sectional survey were less likely to belong to this group [AOR = 0.09, (95% CI: 0.14-0.61), p = 0.001]. Conclusions and Significance: The pattern of clinical malaria episodes follows a negative binomial distribution. Use of lack of a clinical malaria episode in a certain time period as endpoints for intervention or immunological studies may not adequately distinguish groups who are more or less immune. It may be useful in such studies, in addition to the usual endpoint of the time to first episode, to include end points which take into account the total number of clinical episodes experienced per child.	[Mwangi, Tabitha Wanja; Fegan, Gregory; Williams, Thomas Neil; Kinyanjui, Sam Muchina; Marsh, Kevin] Coast Wellcome Trust Collaborat Program, Ctr Geog Med Res, Kenya Med Res Inst, Kilifi, Kenya; [Fegan, Gregory] London Sch Hyg & Trop Med, Dept Populat Hlth, Infect Dis Epidemiol Unit, London, England; [Williams, Thomas Neil; Kinyanjui, Sam Muchina; Snow, Robert William; Marsh, Kevin] John Radcliffe Hosp, Ctr Trop Med, Nuffield Dept Clin Med, Oxford, England; [Snow, Robert William] Kenya Govt Med Res Ctr, Wellcome Trust Collaborative Program, Nairobi, Kenya	Kenya Medical Research Institute; University of London; London School of Hygiene & Tropical Medicine; University of Oxford; Kenya Medical Research Institute	Mwangi, TW (corresponding author), Coast Wellcome Trust Collaborat Program, Ctr Geog Med Res, Kenya Med Res Inst, Kilifi, Kenya.	tmwangi@kilifi.kemri-wellcome.org	Fegan, Greg W/O-8079-2018; Snow, Robert William/AFR-1436-2022	Fegan, Greg W/0000-0002-2663-2765; Snow, Robert William/0000-0003-3725-6088	Wellcome Trust [631342, 076934, 079080]; European Network 6 BioMalpar Consortium	Wellcome Trust(Wellcome TrustEuropean Commission); European Network 6 BioMalpar Consortium	Kevin Marsh is supported by The Wellcome Trust as Senior Research Fellow (#631342), Thomas Williams is also supported by The Wellcome trust as Senior Research Fellow (#076934) and the European Network 6 BioMalpar Consortium. Robert W. Snow is supported by The Wellcome Trust as a Principal Fellow (#079080). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Berkley JA, 1999, QJM-INT J MED, V92, P151, DOI 10.1093/qjmed/92.3.151; Bonnet S, 2002, TROP MED INT HEALTH, V7, P249, DOI 10.1046/j.1365-3156.2002.00861.x; Contamin H, 1996, AM J TROP MED HYG, V54, P632, DOI 10.4269/ajtmh.1996.54.632; Creasey A, 2004, PARASITOLOGY, V129, P263, DOI 10.1017/S0031182004005724; Deloron P, 1999, AM J TROP MED HYG, V61, P99, DOI 10.4269/ajtmh.1999.61.99; Elissa N, 2003, ACTA TROP, V85, P355, DOI 10.1016/S0001-706X(02)00266-8; Gaudart J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-286; Kazembe LN, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-93; Lloyd-Smith JO, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000180; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; Marsh K, 2006, PARASITE IMMUNOL, V28, P51, DOI 10.1111/j.1365-3024.2006.00808.x; Mwangi TW, 2005, J INFECT DIS, V191, P1932, DOI 10.1086/430006; Mwangi TW, 2003, T ROY SOC TROP MED H, V97, P369, DOI 10.1016/S0035-9203(03)90056-3; ROGIER C, 1993, T ROY SOC TROP MED H, V87, P245, DOI 10.1016/0035-9203(93)90110-C; Rogier C, 2003, T ROY SOC TROP MED H, V97, P193, DOI 10.1016/S0035-9203(03)90116-7; Rogier C, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P255; Smith DL, 2005, NATURE, V438, P492, DOI 10.1038/nature04024; SNOW RW, 1993, T ROY SOC TROP MED H, V87, P386, DOI 10.1016/0035-9203(93)90007-D; Snow RW, 2000, TROP MED INT HEALTH, V5, P377, DOI 10.1046/j.1365-3156.2000.00568.x; Trape JF, 2002, TRENDS PARASITOL, V18, P224, DOI 10.1016/S1471-4922(02)02249-3; Trape JF, 1996, PARASITOL TODAY, V12, P236, DOI 10.1016/0169-4758(96)10015-6; Wambua S, 2006, PLOS MED, V3, P643, DOI 10.1371/journal.pmed.0030158; Williams TN, 2005, PLOS MED, V2, P441, DOI 10.1371/journal.pmed.0020128; Williams TN, 2005, J INFECT DIS, V192, P178, DOI 10.1086/430744; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338	26	44	44	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2196	10.1371/journal.pone.0002196	http://dx.doi.org/10.1371/journal.pone.0002196			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493319	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000262258700005
J	Oda, S; Oda, T; Nishi, K; Takabuchi, S; Wakamatsu, T; Tanaka, T; Adachi, T; Fukuda, K; Semenza, GL; Hirota, K				Oda, Seiko; Oda, Tomoyuki; Nishi, Kenichiro; Takabuchi, Satoshi; Wakamatsu, Takuhiko; Tanaka, Tomoharu; Adachi, Takehiko; Fukuda, Kazuhiko; Semenza, Gregg L.; Hirota, Kiichi			Macrophage Migration Inhibitory Factor Activates Hypoxia-Inducible Factor in a p53-Dependent Manner	PLOS ONE			English	Article								Background: Macrophage migration inhibitory factor (MIF) is not only a cytokine which has a critical role in several inflammatory conditions but also has endocrine and enzymatic functions. MIF is identified as an intracellular signaling molecule and is implicated in the process of tumor progression, and also strongly enhances neovascularization. Overexpression of MIF has been observed in tumors from various organs. MIF is one of the genes induced by hypoxia in an hypoxia-inducible factor 1 (HIF-1)-dependent manner. Methods/Principal Findings: The effect of MIF on HIF-1 activity was investigated in human breast cancer MCF-7 and MDA-MB-231 cells, and osteosarcoma Saos-2 cells. We demonstrate that intracellular overexpression or extracellular administration of MIF enhances activation of HIF-1 under hypoxic conditions in MCF-7 cells. Mutagenesis analysis of MIF and knockdown of 53 demonstrates that the activation is not dependent on redox activity of MIF but on wild-type p53. We also indicate that the MIF receptor CD74 is involved in HIF-1 activation by MIF at least when MIF is administrated extracellularly. Conclusion/Significance: MIF regulates HIF-1 activity in a p53-dependent manner. In addition to MIF's potent effects on the immune system, MIF is linked to fundamental processes conferring cell proliferation, cell survival, angiogenesis, and tumor invasiveness. This functional interdependence between MIF and HIF-1 alpha protein stabilization and transactivation activity provide a molecular mechanism for promotion of tumorigenesis by MIF.	[Oda, Seiko; Takabuchi, Satoshi; Wakamatsu, Takuhiko; Tanaka, Tomoharu; Fukuda, Kazuhiko; Hirota, Kiichi] Kyoto Univ, Kyoto Univ Hosp, Dept Anesthesia, Kyoto, Japan; [Oda, Seiko; Oda, Tomoyuki; Nishi, Kenichiro; Takabuchi, Satoshi; Adachi, Takehiko; Hirota, Kiichi] Kitano Hosp, Tazuke Kofukai Med Res Inst, Osaka, Japan; [Oda, Tomoyuki] Kyoto Univ, Grad Sch Med, Dept Cardiovascular Med, Kyoto, Japan; [Nishi, Kenichiro] Kansai Med Univ, Dept Anesthesiol, Osaka, Japan; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Vascular Biol Program, Baltimore, MD USA	Kyoto University; Kitano Hospital; Kyoto University; Kansai Medical University; Johns Hopkins University	Oda, S (corresponding author), Kyoto Univ, Kyoto Univ Hosp, Dept Anesthesia, Kyoto, Japan.	hif1@mac.com	Hirota, Kiichi/E-9181-2010	Hirota, Kiichi/0000-0003-1110-0827	Ministry of education, culture, sports, science and technology, JAPAN [grant-in-aids]	Ministry of education, culture, sports, science and technology, JAPAN(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aids for scientific research from Ministry of education, culture, sports, science and technology, JAPAN (to TA and KH).	Amin MA, 2003, CIRC RES, V93, P321, DOI 10.1161/01.RES.0000087641.56024.DA; Bae MK, 2002, J BIOL CHEM, V277, P9, DOI 10.1074/jbc.C100442200; Baugh JA, 2006, BIOCHEM BIOPH RES CO, V347, P895, DOI 10.1016/j.bbrc.2006.06.148; Bemis L, 2004, GENE DEV, V18, P739, DOI 10.1101/gad.1180104; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bucala R, 2007, IMMUNITY, V26, P281, DOI 10.1016/j.immuni.2007.03.005; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Chesney J, 1999, MOL MED, V5, P181, DOI 10.1007/BF03402061; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Ema M, 1999, EMBO J, V18, P1905, DOI 10.1093/emboj/18.7.1905; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fingerle-Rowson G, 2003, P NATL ACAD SCI USA, V100, P9354, DOI 10.1073/pnas.1533295100; Hardman MJ, 2005, AM J PATHOL, V167, P1561, DOI 10.1016/S0002-9440(10)61241-2; Hirota K, 2005, BIOCHEM BIOPH RES CO, V338, P610, DOI 10.1016/j.bbrc.2005.08.193; Hirota K, 1997, P NATL ACAD SCI USA, V94, P3633, DOI 10.1073/pnas.94.8.3633; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Kasuno K, 2004, J BIOL CHEM, V279, P2550, DOI 10.1074/jbc.M308197200; Kleemann R, 1999, EUR J BIOCHEM, V261, P753, DOI 10.1046/j.1432-1327.1999.00327.x; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Kleemann R, 1998, J MOL BIOL, V280, P85, DOI 10.1006/jmbi.1998.1864; Koong AC, 2000, CANCER RES, V60, P883; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Leng L, 2005, CRIT CARE MED, V33, pS475, DOI 10.1097/01.CCM.0000191278.04636.D8; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Lue HQ, 2006, CELL SIGNAL, V18, P688, DOI 10.1016/j.cellsig.2005.06.013; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mitchell RA, 1999, J BIOL CHEM, V274, P18100, DOI 10.1074/jbc.274.25.18100; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; Moriguchi T, 1996, J BIOL CHEM, V271, P13675, DOI 10.1074/jbc.271.23.13675; Nishihira J, 2000, J INTERF CYTOK RES, V20, P751, DOI 10.1089/10799900050151012; ODA T, 2006, AM J PHYSIOL-CELL PH, V204, pC113; Ravi R, 2000, GENE DEV, V14, P34; Sasada T, 1996, J CLIN INVEST, V97, P2268, DOI 10.1172/JCI118668; Sawano A, 2000, Nucleic Acids Res, V28, pE78, DOI 10.1093/nar/28.16.e78; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Semenza GL, 2000, CANCER METAST REV, V19, P59, DOI 10.1023/A:1026544214667; Semenza GL, 2002, TRENDS MOL MED, V8, pS62, DOI 10.1016/S1471-4914(02)02317-1; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shimizu T, 1999, BIOCHEM BIOPH RES CO, V264, P751, DOI 10.1006/bbrc.1999.1584; Thiele M, 2005, ANTIOXID REDOX SIGN, V7, P1234, DOI 10.1089/ars.2005.7.1234; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Welsh SJ, 2003, MOL CANCER THER, V2, P235; Welsh SJ, 2002, CANCER RES, V62, P5089; Winner M, 2007, CANCER RES, V67, P186, DOI 10.1158/0008-5472.CAN-06-3292	47	92	97	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2215	10.1371/journal.pone.0002215	http://dx.doi.org/10.1371/journal.pone.0002215			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493321	Green Submitted, Green Published, gold			2022-12-25	WOS:000262258700023
J	Yang, LM; Wang, JL; Kang, L; Gao, S; Liu, YH; Hu, TM				Yang, Li-Min; Wang, Jing-Lin; Kang, Lin; Gao, Shan; Liu, Yan-Hua; Hu, Ting-Mao			Construction and Analysis of High-Complexity Ribosome Display Random Peptide Libraries	PLOS ONE			English	Article								Random peptide libraries displayed on the ribosome are becoming a new tool for the in vitro selection of biologically relevant macromolecules, including epitopes, antagonists, enzymes, and cell-surface receptors. Ribosome display is a cell-free system of coupling individual nascent proteins (phenotypes) to their corresponding mRNA (genotypes) by the formation of stable protein-ribosome-mRNA complexes and permitting the selection of a functional nascent protein by iterative cycles of panning and reverse transcription-polymerase chain reaction (RT-PCR) amplification in vitro. The complexity of the random peptide library is critical for the success of a panning experiment; greater the diversity of sequences within the library, the more likely it is that the library comprises sequences that can bind a given target with specific affinity. Here, we have used the cell-free system Escherichia coli S30 lysate to construct high-complexity random peptide libraries (>10(14) independent members) by introducing strategies that are different from the methods described by Mattheakis et al. and Lamla et al. The key step in our method is to produce nanomole (nmol) amounts of DNA elements that are necessary for in vitro transcription/translation by using PCR but not plasmid DNA. Library design strategies and protocols that facilitate rapid identification are also presented.	[Yang, Li-Min; Hu, Ting-Mao] Chinese Acad Sci, Ctr Mol Virol, Inst Microbiol, Beijing, Peoples R China; [Wang, Jing-Lin; Kang, Lin; Gao, Shan; Liu, Yan-Hua] Acad Mil Med Sci, Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecurity, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Academy of Military Medical Sciences - China	Yang, LM (corresponding author), Chinese Acad Sci, Ctr Mol Virol, Inst Microbiol, Beijing, Peoples R China.	wangjlin@bmi.ac.cn			National Natural Sciences Foundation of China [30370081]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This research work was supported by a grant from the National Natural Sciences Foundation of China (No. 30370081). In addition, we thank Dr. Ming-Yue He (chief scientific officer, Discerna Limited, Cambridge,UK) and Dr. Xiang-Bin Wang (Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing) for their comments and suggestions during the preparation of this manuscript.	Amstutz P, 2002, J AM CHEM SOC, V124, P9396, DOI 10.1021/ja025870q; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; CULL MG, 1992, P NATL ACAD SCI USA, V89, P1865, DOI 10.1073/pnas.89.5.1865; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Forrer P, 1998, GENE, V224, P45, DOI 10.1016/S0378-1119(98)00538-1; FRANCISCO JA, 1992, P NATL ACAD SCI USA, V89, P2713, DOI 10.1073/pnas.89.7.2713; Hanes J, 1997, P NATL ACAD SCI USA, V94, P4937, DOI 10.1073/pnas.94.10.4937; Hanes J, 2000, NAT BIOTECHNOL, V18, P1287, DOI 10.1038/82407; Hanes J, 2000, METHOD ENZYMOL, V328, P404, DOI 10.1016/S0076-6879(00)28409-7; He M, 2007, BIOCHEM SOC T, V35, P962, DOI 10.1042/BST0350962; Kim JM, 2007, MOL BIOTECHNOL, V36, P32, DOI 10.1007/s12033-007-0017-1; Lamla T, 2003, J MOL BIOL, V329, P381, DOI 10.1016/S0022-2836(03)00432-7; LANCET D, 1993, P NATL ACAD SCI USA, V90, P3715, DOI 10.1073/pnas.90.8.3715; MATTHEAKIS LC, 1994, P NATL ACAD SCI USA, V91, P9022, DOI 10.1073/pnas.91.19.9022; Mondon P, 2008, FRONT BIOSCI-LANDMRK, V13, P1117, DOI 10.2741/2749; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Schaffitzel C, 1999, J IMMUNOL METHODS, V231, P119, DOI 10.1016/S0022-1759(99)00149-0; Smith GP, 1997, CHEM REV, V97, P391, DOI 10.1021/cr960065d; Yang F, 2000, NAT STRUCT BIOL, V7, P230	19	15	16	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2092	10.1371/journal.pone.0002092	http://dx.doi.org/10.1371/journal.pone.0002092			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493302	gold, Green Published, Green Submitted			2022-12-25	WOS:000262258700001
J	Britschgi, A; Trinh, E; Rizzi, M; Jenal, M; Ress, A; Tobler, A; Fey, MF; Helin, K; Tschan, MP				Britschgi, A.; Trinh, E.; Rizzi, M.; Jenal, M.; Ress, A.; Tobler, A.; Fey, M. F.; Helin, K.; Tschan, M. P.			DAPK2 is a novel E2F1/KLF6 target gene involved in their proapoptotic function	ONCOGENE			English	Article						DAPK2; E2F1; KLF6; Sp1; transcription; cell death	KRUPPEL-LIKE FACTOR-6; TRANSCRIPTION FACTORS; PROSTATE-CANCER; CPG ISLAND; APOPTOSIS; KLF6; PROMOTER; PROTEIN; FAMILY; E2F1	Death-associated protein kinase 2 (DAPK2) belongs to a family of proapoptotic Ca(2+)/calmodulin-regulated serine/threonine kinases. We recently identified DAPK2 as an enhancing factor during granulocytic differentiation. To identify transcriptional DAPK2 regulators, we cloned 2.7 kb ofthe 5'-flanking region ofthe DAPK2 gene. We found that E2F1 and Kruppel-like factor 6 (KLF6) strongly activate the DAPK2 promoter. We mapped the E2F1 and KLF6 responsive elements to a GC-rich region 50 of exon 1 containing several binding sites for KLF6 and Sp1 but not for E2F. Moreover, we showed that transcriptional activation of DAPK2 by E2F1 and KLF6 is dependent on Sp1 using Sp1/KLF6-deficient insect cells, mithramycin A treatment to block Sp1-binding or Sp1 knockdown cells. Chromatin immunoprecipitation revealed recruitment of Sp1 and to lesser extent that of E2F1 and KLF6 to the DAPK2 promoter. Activation of E2F1 in osteosarcoma cells led to an increase of endogenous DAPK2 paralleled by cell death. Inhibition of DAPK2 expression resulted in significantly reduced cell death upon E2F1 activation. Similarly, KLF6 expression in H1299 cells increased DAPK2 levels accompanied by cell death that is markedly decreased upon DAPK2 knockdown. Moreover, E2F1 and KLF6 show cooperation in activating the DAPK2 promoter. In summary, our findings establish DAPK2 as a novel Sp1-dependent target gene for E2F1 and KLF6 in cell death response.	[Britschgi, A.; Rizzi, M.; Jenal, M.; Ress, A.; Tobler, A.; Fey, M. F.; Tschan, M. P.] Univ Bern, Dept Clin Res, CH-3010 Bern, Switzerland; [Trinh, E.; Helin, K.] Univ Copenhagen, Ctr Epigenet, Biotech Res & Innovat Ctr, Copenhagen, Denmark; [Tobler, A.] Univ Hosp Bern, Inselspital, Dept Hematol, CH-3010 Bern, Switzerland; [Fey, M. F.] Univ Hosp Bern, Inselspital, Dept Med Oncol, CH-3010 Bern, Switzerland	University of Bern; University of Copenhagen; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Tschan, MP (corresponding author), Univ Bern, Dept Clin Res, Murtenstr 35, CH-3010 Bern, Switzerland.	mtschan@dkf.unibe.ch	Helin, Kristian/HDM-8306-2022; Rizzi, Mattia/AHE-4168-2022; Helin, Kristian/K-2526-2019; Rizzi, Mattia/ABE-3996-2021	Helin, Kristian/0000-0003-1975-6097; Tschan, Mario P./0000-0001-5897-3647; Rizzi, Mattia/0000-0001-6987-0678	Swiss National Foundation [3100-067213]; Marlies-Schwegler Foundation; Bernese Foundation of Cancer Research; Werner and Hedy Berger-Janser Foundation of Cancer Research; Bern University Research Foundation; Danish Cancer Society	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Marlies-Schwegler Foundation; Bernese Foundation of Cancer Research; Werner and Hedy Berger-Janser Foundation of Cancer Research; Bern University Research Foundation; Danish Cancer Society(Danish Cancer Society)	Expert technical assistance by D Shan and G Arvidsson is appreciated. We are grateful to Drs SL Friedmann, G Thiel and JJ Rossi for providing the KLF6, CBP/p300 and Sp1 expression plasmids as well as an U6 promoter constructs. We also thank Dr D Kojic for providing the Schneider SL2 cells. This work was supported by grants from the Swiss National Foundation 3100-067213 (to AT and MFF); the Marlies-Schwegler Foundation and the Bernese Foundation of Cancer Research (to MFF and AT); the Werner and Hedy Berger-Janser Foundation of Cancer Research (to MFF and MPT); the Bern University Research Foundation (to MPT); and the Danish Cancer Society (to KH).	ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Bell LA, 2004, CELL DEATH DIFFER, V11, P137, DOI 10.1038/sj.cdd.4401324; Bialik S, 2006, ANNU REV BIOCHEM, V75, P189, DOI 10.1146/annurev.biochem.75.103004.142615; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; BLAKE MC, 1990, MOL CELL BIOL, V10, P6632, DOI 10.1128/MCB.10.12.6632; Botella LM, 2002, BLOOD, V100, P4001, DOI 10.1182/blood.V100.12.4001; Britschgi C, 2006, ONCOGENE, V25, P2030, DOI 10.1038/sj.onc.1209240; Chen CS, 2003, AM J PATHOL, V162, P1349, DOI 10.1016/S0002-9440(10)63930-2; Christoph F, 2006, BRIT J CANCER, V95, P1701, DOI 10.1038/sj.bjc.6603482; DeGregori J, 2006, CURR MOL MED, V6, P739; Denchi EL, 2005, EMBO REP, V6, P661, DOI 10.1038/sj.embor.7400452; Difeo A, 2006, CLIN CANCER RES, V12, P3730, DOI 10.1158/1078-0432.CCR-06-0054; Esteller M, 2001, CANCER RES, V61, P3225; Geng Y, 1996, ONCOGENE, V12, P1173; Hershko T, 2004, J BIOL CHEM, V279, P8627, DOI 10.1074/jbc.M312866200; Inbal B, 2000, MOL CELL BIOL, V20, P1044, DOI 10.1128/MCB.20.3.1044-1054.2000; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; Ito G, 2004, CANCER RES, V64, P3838, DOI 10.1158/0008-5472.CAN-04-0185; Karlseder J, 1996, MOL CELL BIOL, V16, P1659; Katzenellenbogen RA, 1999, BLOOD, V93, P4347, DOI 10.1182/blood.V93.12.4347.412k31_4347_4353; Kim Y, 1998, J BIOL CHEM, V273, P33750, DOI 10.1074/jbc.273.50.33750; KOLLMAR R, 1994, J BIOL CHEM, V269, P2252; Koutsodontis G, 2004, ONCOGENE, V23, P9190, DOI 10.1038/sj.onc.1208141; Kramps C, 2004, J BIOL CHEM, V279, P5110, DOI 10.1074/jbc.M304758200; Li D, 2005, CANCER RES, V65, P9216, DOI 10.1158/0008-5472.CAN-05-1040; Lin SY, 1996, MOL CELL BIOL, V16, P1668; Maruyama R, 2001, CANCER RES, V61, P8659; MILLER DM, 1987, AM J MED SCI, V294, P388, DOI 10.1097/00000441-198711000-00015; Moroni MC, 2001, NAT CELL BIOL, V3, P552, DOI 10.1038/35078527; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Narla G, 2003, AM J PATHOL, V162, P1047, DOI 10.1016/S0002-9440(10)63901-6; Narla G, 2001, SCIENCE, V294, P2563, DOI 10.1126/science.1066326; Parisi T, 2002, BIOCHEM BIOPH RES CO, V291, P1138, DOI 10.1006/bbrc.2002.6591; Park KK, 2003, BIOCHEM BIOPH RES CO, V306, P239, DOI 10.1016/S0006-291X(03)00941-0; Putzer BM, 2007, J CELL MOL MED, V11, P239, DOI 10.1111/j.1582-4934.2007.00030.x; Radziwill G, 2003, MOL CELL BIOL, V23, P4663, DOI 10.1128/MCB.23.13.4663-4672.2003; Reeves HL, 2004, GASTROENTEROLOGY, V126, P1090, DOI 10.1053/j.gastro.2004.01.005; Rizzi M, 2007, J LEUKOCYTE BIOL, V81, P1599, DOI 10.1189/jlb.0606400; Robertson KD, 1998, MOL CELL BIOL, V18, P6457, DOI 10.1128/MCB.18.11.6457; Shohat G, 2002, BBA-PROTEINS PROTEOM, V1600, P45, DOI 10.1016/S1570-9639(02)00443-0; Slavin DA, 2004, ONCOGENE, V23, P8196, DOI 10.1038/sj.onc.1208020; Stanelle J, 2005, CELL DEATH DIFFER, V12, P347, DOI 10.1038/sj.cdd.4401532; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Suzuki T, 2005, ARTERIOSCL THROM VAS, V25, P1135, DOI 10.1161/01.ATV.0000165656.65359.23; Tschan MP, 2003, J BIOL CHEM, V278, P42750, DOI 10.1074/jbc.M307067200; Turner J, 1999, TRENDS BIOCHEM SCI, V24, P236, DOI 10.1016/S0968-0004(99)01406-1; Voso MT, 2004, BLOOD, V103, P698, DOI 10.1182/blood-2003-07-2249; Xie W, 2006, NUCLEIC ACIDS RES, V34, P2046, DOI 10.1093/nar/gkl150; Yin D, 2007, INT J ONCOL, V30, P65	50	29	32	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2008	27	43					5706	5716		10.1038/onc.2008.179	http://dx.doi.org/10.1038/onc.2008.179			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	352HM	18521079				2022-12-25	WOS:000259487100006
J	Niclou, SP; Danzeisen, C; Eikesdal, HP; Wiig, H; Brons, NHC; Poli, AMF; Svendsen, A; Torsvik, A; Enger, PO; Terzis, JA; Bjerkvig, R				Niclou, Simone P.; Danzeisen, Claude; Eikesdal, Hans P.; Wiig, Helge; Brons, Nicolaas H. C.; Poli, Aurelie M. F.; Svendsen, Agnete; Torsvik, Anja; Enger, Per Oyvind; Terzis, Jorge A.; Bjerkvig, Rolf			A novel eGFP-expressing immunodeficient mouse model to study tumor-host interactions	FASEB JOURNAL			English	Article						xenograft; in vivo imaging; vascular mimicry; cell fusion; tumor microenvironment; glioma	STEM-CELLS; CANCER; GLIOMAS; ANGIOGENESIS; MICE	A NOD/Scid mouse expressing enhanced green fluorescent protein (eGFP) is described, in which human and mouse tumors marked with red fluorescent protein can be established in vivo, both at subcutaneous and orthotopic locations. Using light microscopy as well as multiphoton confocal microscopy techniques, we visualized in detail the intricate colocalization of tumor and host cells in situ. Moreover, using fluorescence-activated cell sorting (FACS), we were able to completely separate the host cells from the tumor cells, thus providing a system for detailed cellular and molecular analysis of tumor-host cell interactions. The fact that tumor and host cells can be reliably identified also allowed us to detect double-positive cells, possibly arising from cell fusion events or horizontal gene transfer. Similarly, the model can be applied for the detection of circulating metastatic cells and for detailed studies on the vascular compartments within tumors, including vasculogenic mimicry. Thus, the model described should provide significant insight into how tumor cells communicate with their microenvironment.	[Niclou, Simone P.; Danzeisen, Claude; Terzis, Jorge A.; Bjerkvig, Rolf] CRP Sante, NorLux Neurooncol Lab, L-1526 Luxembourg, Luxembourg; [Brons, Nicolaas H. C.] CRP Sante, Core Facil Flowcytometry, L-1526 Luxembourg, Luxembourg; [Poli, Aurelie M. F.] CRP Sante, Lab Immunogenet & Allergol LIGA, L-1526 Luxembourg, Luxembourg; [Eikesdal, Hans P.; Wiig, Helge; Svendsen, Agnete; Torsvik, Anja; Enger, Per Oyvind; Bjerkvig, Rolf] Univ Bergen, Dept Biomed, Bergen, Norway	Luxembourg Institute of Health; Luxembourg Institute of Health; Luxembourg Institute of Health; University of Bergen	Niclou, SP (corresponding author), CRP Sante, NorLux Neurooncol Lab, 84 Val Fleuri, L-1526 Luxembourg, Luxembourg.	simone.niclou@crp-sante.lu	Engelsen, Agnete Svendsen Tenfjord/AAB-6652-2020; Eikesdal, Hans Petter/AAG-3228-2020; Niclou, Simone/P-2304-2018	Engelsen, Agnete Svendsen Tenfjord/0000-0003-0375-3406; Eikesdal, Hans Petter/0000-0003-4086-0147; Niclou, Simone/0000-0002-3417-9534; Torsvik, Anja/0000-0001-8638-8357; Wiig, Helge/0000-0002-7740-8210; Poli, Aurelie/0000-0002-7986-0761	Norwegian Cancer Society; Norwegian Research Council; Innovest AS; Western Norway Regional Health Authority; Haukeland University Hospital, Bergen, Norway; Bergen Translational Research Programme; Centre de Recherche Public de la Sante (CRP-Sante); European Commission 6th Framework Program [504743]	Norwegian Cancer Society(Norwegian Cancer Society); Norwegian Research Council(Research Council of NorwayEuropean Commission); Innovest AS; Western Norway Regional Health Authority; Haukeland University Hospital, Bergen, Norway; Bergen Translational Research Programme; Centre de Recherche Public de la Sante (CRP-Sante); European Commission 6th Framework Program(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Norwegian Cancer Society; the Norwegian Research Council; Innovest AS; the Western Norway Regional Health Authority; Haukeland University Hospital, Bergen, Norway; The Bergen Translational Research Programme; the Centre de Recherche Public de la Sante (CRP-Sante) through a grant from the Research Ministry in Luxembourg; and the European Commission 6th Framework Program (contract 504743). The technical assistance of Vanessa Barthelemy, Virginie Baus, and Lene Nybo is greatly appreciated.	Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Axelrod R, 2006, P NATL ACAD SCI USA, V103, P13474, DOI 10.1073/pnas.0606053103; Ben-Baruch A, 2006, CANCER METAST REV, V25, P357, DOI 10.1007/s10555-006-9003-5; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; BJERKVIG R, 1990, J NEUROSURG, V72, P463, DOI 10.3171/jns.1990.72.3.0463; Bjerkvig R, 2005, NAT REV CANCER, V5, P899, DOI 10.1038/nrc1740; Duelli D, 2007, NAT REV CANCER, V7, P968, DOI 10.1038/nrc2272; Glinsky GV, 2006, CELL CYCLE, V5, P191, DOI 10.4161/cc.5.2.2320; Greiner DL, 1998, STEM CELLS, V16, P166, DOI 10.1002/stem.160166; GREINER DL, 1992, IMMUNOL TODAY, V13, P116, DOI 10.1016/0167-5699(92)90104-F; Hendrix MJC, 2003, NAT REV CANCER, V3, P411, DOI 10.1038/nrc1092; Hillen F, 2007, CANCER METAST REV, V26, P489, DOI 10.1007/s10555-007-9094-7; Hoffman RM, 2006, NAT PROTOC, V1, P1429, DOI 10.1038/nprot.2006.223; Holmgren L, 2002, VOX SANG, V83, P305, DOI 10.1111/j.1423-0410.2002.tb05323.x; *JACKS LAB, 2006, JAX NOT, V501; *JACKS LAB, 1999, JAX NOT, V476; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Langley RR, 2007, ENDOCR REV, V28, P297, DOI 10.1210/er.2006-0027; Munshi HG, 2006, CANCER METAST REV, V25, P45, DOI 10.1007/s10555-006-7888-7; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Sakariassen PO, 2006, P NATL ACAD SCI USA, V103, P16466, DOI 10.1073/pnas.0607668103; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400; Tysnes BB, 2007, BBA-REV CANCER, V1775, P283, DOI 10.1016/j.bbcan.2007.01.001; Yang M, 2004, CANCER RES, V64, P8651, DOI 10.1158/0008-5472.CAN-04-3118; Yang M, 2003, P NATL ACAD SCI USA, V100, P14259, DOI 10.1073/pnas.2436101100	29	51	55	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2008	22	9					3120	3128		10.1096/fj.08-109611	http://dx.doi.org/10.1096/fj.08-109611			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	342CD	18495755	hybrid, Green Published			2022-12-25	WOS:000258761300004
J	Zhao, LJ; Subramanian, T; Chinnadurai, G				Zhao, L-J; Subramanian, T.; Chinnadurai, G.			Inhibition of transcriptional activation and cell proliferation activities of adenovirus E1A by the unique N-terminal domain of CtBP2	ONCOGENE			English	Article						E1A; CtBP; transcriptional repression; cell proliferation	NUCLEAR-LOCALIZATION; NEGATIVE MODULATION; MOLECULAR-CLONING; TRANSFORMATION; BINDING; PROTEIN; REGION; GENE; PHOSPHOPROTEIN; TUMORIGENESIS	The 243-residue E1A protein of adenovirus induces cellular proliferation, at least partly by regulating the transcription of cellular genes. This E1A function requires E1A N-terminal region and conserved regions 1 and 2 (CR1 and CR2), which interact with histone acetyl transferases, p400 chromatin-modifying complex and the Rb family proteins. A PLDLS motif at the E1A C-terminal (CR4) region, interacts with the C-terminal binding proteins (CtBP1 and CtBP2), and antagonizes some E1A functions. In this report, we discovered that the transcriptional activation function of E1A was specifically repressed by a short N-terminal domain unique to CtBP2. The CtBP2-mediated repression of E1A transcriptional activation activity is independent of histone deacetylases, which can be recruited by CtBP1/2 proteins to inhibit transcription. Fusion of the CtBP2 N-terminal 20 residues to the E1A C-terminal region rendered E1A to be inactive in transcriptional activation without interfering with E1A's ability to interact with major cofactors such as pRb, p400 and p300. Substitution of the N-terminal domain of CtBP1 for the CtBP2 domain in E1A-CtBP2 fusion partially restored the transactivation activity of E1A. In a cell-proliferation model utilizing primary baby rat kidney cells and retrovirally expressed E1A, the ability of E1A to induce cellular proliferation was strongly inhibited when the CtBP2 N-terminal region was fused to E1A. These results are consistent with a hypothesis that CtBP2 may inhibit E1A induced cell proliferation by antagonizing the transcriptional activation function controlled by the N-terminal region of E1A.	[Zhao, L-J; Subramanian, T.; Chinnadurai, G.] St Louis Univ, Sch Med, Doisy Res Ctr, Inst Mol Virol, St Louis, MO 63104 USA	Saint Louis University	Chinnadurai, G (corresponding author), St Louis Univ, Sch Med, Doisy Res Ctr, Inst Mol Virol, 1100 S Grand Blvd, St Louis, MO 63104 USA.	chinnag@slu.edu			 [CA-84941];  [CA-33616]; NATIONAL CANCER INSTITUTE [R01CA084941, R01CA033616] Funding Source: NIH RePORTER	; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank R Subramanian for technical assistance. This study was supported by research grants CA-84941 and CA-33616.	Bergman LM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-35; Berk AJ, 2005, ONCOGENE, V24, P7673, DOI 10.1038/sj.onc.1209040; BOYD JM, 1993, EMBO J, V12, P469, DOI 10.1002/j.1460-2075.1993.tb05679.x; Chinnadurai G, 2007, INT J BIOCHEM CELL B, V39, P1593, DOI 10.1016/j.biocel.2007.01.025; CHINNADURAI G, 2007, MOL BIOL INTELL UNIT, pR9; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Fuchs M, 2001, CELL, V106, P297, DOI 10.1016/S0092-8674(01)00450-0; GRAHAM FL, 1973, VIROLOGY, V54, P536, DOI 10.1016/0042-6822(73)90163-3; Grignani F, 1998, CANCER RES, V58, P14; Hildebrand JD, 2002, MOL CELL BIOL, V22, P5296, DOI 10.1128/MCB.22.15.5296-5307.2002; Kuppuswamy M, 2008, MOL CELL BIOL, V28, P269, DOI 10.1128/MCB.01077-07; Lang SE, 2003, ONCOGENE, V22, P2836, DOI 10.1038/sj.onc.1206376; Reid JL, 1998, EMBO J, V17, P4469, DOI 10.1093/emboj/17.15.4469; Samuelson AV, 2005, J BIOL CHEM, V280, P21915, DOI 10.1074/jbc.M414564200; SCHAEPER U, 1995, P NATL ACAD SCI USA, V92, P10467, DOI 10.1073/pnas.92.23.10467; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Sollerbrant K, 1996, NUCLEIC ACIDS RES, V24, P2578, DOI 10.1093/nar/24.13.2578; SUBRAMANIAN T, 1989, ONCOGENE, V4, P415; Verger A, 2006, MOL CELL BIOL, V26, P4882, DOI 10.1128/MCB.02402-05; WANG HGH, 1993, J VIROL, V67, P476, DOI 10.1128/JVI.67.1.476-488.1993; WHYTE P, 1989, CELL, V56, P67, DOI 10.1016/0092-8674(89)90984-7; ZERLER B, 1987, MOL CELL BIOL, V7, P821, DOI 10.1128/MCB.7.2.821; Zhao LJ, 2007, ONCOGENE, V26, P7544, DOI 10.1038/sj.onc.1210569; Zhao LJ, 2006, J BIOL CHEM, V281, P36613, DOI 10.1074/jbc.M603550200; Zhao LJ, 2006, J BIOL CHEM, V281, P4183, DOI 10.1074/jbc.M509051200	26	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2008	27	39					5214	5222		10.1038/onc.2008.162	http://dx.doi.org/10.1038/onc.2008.162			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	344GO	18490918	Green Accepted			2022-12-25	WOS:000258915100005
J	Wang, K; Zhang, YZ; Li, XF; Chen, LJ; Wang, H; Wu, JG; Zheng, J; Wu, DQ				Wang, Ke; Zhang, Yazhou; Li, Xiaofeng; Chen, Lijun; Wang, He; Wu, Jianguo; Zheng, Jie; Wu, Dianqing			Characterization of the Kremen-binding site on Dkk1 and elucidation of the role of Kremen in Dkk-mediated Wnt antagonism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAY; DICKKOPF-1; PROTEINS; MECHANISMS; RECEPTOR; FAMILY; LEF-1	Wnt signaling is involved in a wide range of developmental, physiological, and pathophysiological processes and is negatively regulated by Dickkopf1 (Dkk1). Dkk1 has been shown to bind to two transmembrane proteins, the low density lipoprotein receptor-related proteins (LRP) 5/6 and Kremen. Here, we show that Dkk1 residues Arg(197), Ser(198), and Lys(232) are specifically involved in its binding to Kremen rather than to LRP6. These residues are localized at a surface that is at the opposite side of the LRP6-binding surface based on a three-dimensional structure of Dkk1 deduced from that of Dkk2. We were surprised to find that the Dkk1 mutants carrying a mutation at Arg(197), Ser(198), or Lys(232), the key Kremen-binding residues, could antagonize Wnt signaling as well as the wild-type Dkk1. These mutations only affected their ability to antagonize Wnt signaling when both LRP6 and Kremen were coexpressed. These results suggest that Kremen may not be essential for Dkk1-mediated Wnt antagonism and that Kremen may only play a role when cells express a high level of LRP 5/6.	[Wang, Ke; Wu, Jianguo] Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Peoples R China; [Wang, Ke; Zhang, Yazhou; Li, Xiaofeng; Wang, He; Wu, Dianqing] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Chen, Lijun; Zheng, Jie] St Jude Hosp, Dept Biol Struct, Memphis, TN 38105 USA	Wuhan University; Yale University; St Jude Children's Research Hospital	Wu, JG (corresponding author), Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Peoples R China.	wu9988@vip.sina.com; jie.zheng@stjude.org; dan.wu@yale.edu		Zheng, Jie/0000-0001-6524-6800; Wu, Jianguo/0000-0002-8326-2895	NCI NIH HHS [R01 CA132317-01A2, R01 CA132317, R01 CA139395, CA132317] Funding Source: Medline; NIAMS NIH HHS [R01 AR051476-03, R01 AR051476, R01 AR051476-05, R01 AR051476-04, AR051476, R01 AR051476-02] Funding Source: Medline; NIGMS NIH HHS [R01 GM081492, R01 GM081492-02, GM081492] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA139395, R01CA132317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081492] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Brott BK, 2002, MOL CELL BIOL, V22, P6100, DOI 10.1128/MCB.22.17.6100-6110.2002; Chen LJ, 2008, J BIOL CHEM, V283, P23364, DOI 10.1074/jbc.M802375200; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hsu SC, 1998, MOL CELL BIOL, V18, P4807, DOI 10.1128/MCB.18.8.4807; Krupnik VE, 1999, GENE, V238, P301, DOI 10.1016/S0378-1119(99)00365-0; Li L, 2002, J BIOL CHEM, V277, P5977, DOI 10.1074/jbc.M111131200; Li L, 1999, J BIOL CHEM, V274, P129, DOI 10.1074/jbc.274.1.129; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Monaghan AP, 1999, MECH DEVELOP, V87, P45, DOI 10.1016/S0925-4773(99)00138-0; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Moon RT, 1998, BIOESSAYS, V20, P536, DOI 10.1002/(SICI)1521-1878(199807)20:7<536::AID-BIES4>3.3.CO;2-U; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Zhang YH, 2004, MOL CELL BIOL, V24, P4677, DOI 10.1128/MCB.24.11.4677-4684.2004	23	71	83	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23371	23375		10.1074/jbc.M802376200	http://dx.doi.org/10.1074/jbc.M802376200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18502762	Green Published, hybrid			2022-12-25	WOS:000258455400047
J	Weaver, MS; Workman, G; Sage, EH				Weaver, Matt S.; Workman, Gail; Sage, E. Helene			The copper binding domain of SPARC mediates cell survival in vitro via interaction with integrin beta 1 and activation of integrin-linked kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRICELLULAR PROTEIN SPARC; LENS EPITHELIAL-CELLS; NULL MICE EXHIBIT; EXTRACELLULAR-MATRIX; MURINE LENS; CATARACT FORMATION; BASEMENT-MEMBRANE; ENHANCED GROWTH; CYSTEINE SPARC; APOPTOSIS	Secreted protein acidic and rich in cysteine (SPARC) is important for the normal growth and maintenance of the murine lens. SPARC-null animals develop cataracts associated with a derangement of the lens capsule basement membrane and alterations in lens fiber morphology. Cellular stress and disregulation of apoptotic pathways within lens epithelial cells (LEC) are linked to cataract formation. To identify molecular targets of SPARC that are linked to this disorder, we stressed wild-type (WT) and SPARC-null LEC by serum deprivation or exposure to tunicamycin. SPARC enhanced signaling by integrin-linked kinase (ILK), a serine/ threonine kinase known to enhance cell survival in vitro. In response to stress, an ILK-dependent decrease in apoptosis was observed in WT relative to SPARC-null LEC. Co-immunoprecipitation and cross-linking of cell lysates revealed enhanced levels of a SPARC-integrin beta 1 complex during stress. Competition with monoclonal antibodies and peptides indicated that the copper binding domain of SPARC is required for SPARC-mediated response to stress. Inhibiting the binding and/ or activity of ILK, integrin beta 1, or SPARC resulted in increased apoptosis of stressed LEC. We conclude that SPARC protects cells from stress-induced apoptosis in vitro via an interaction with integrin beta 1 heterodimers that enhances ILK activation and pro-survival activity.	[Weaver, Matt S.; Workman, Gail; Sage, E. Helene] Benaroya Res Inst Virginia Mason, Hope Heart Program, Seattle, WA 98101 USA; [Sage, E. Helene] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA	Benaroya Research Institute; Virginia Mason Medical Center; University of Washington; University of Washington Seattle	Sage, EH (corresponding author), 1201 9th Ave, Seattle, WA 98101 USA.	hsage@benaroyaresearch.org			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040711] Funding Source: NIH RePORTER; NEI NIH HHS [EY07031] Funding Source: Medline; NIGMS NIH HHS [GM40711] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Attwell S, 2003, MOL BIOL CELL, V14, P4813, DOI 10.1091/mbc.E03-05-0308; Barker TH, 2005, J BIOL CHEM, V280, P36483, DOI 10.1074/jbc.M504663200; Bradshaw AD, 2003, P NATL ACAD SCI USA, V100, P6045, DOI 10.1073/pnas.1030790100; Bradshaw AD, 2002, J HISTOCHEM CYTOCHEM, V50, P1; Brekken RA, 2003, J CLIN INVEST, V111, P487, DOI 10.1172/JCI200316804; Emerson RO, 2006, J CELL BIOCHEM, V98, P701, DOI 10.1002/jcb.20867; FUNK SE, 1993, J CELL PHYSIOL, V154, P53, DOI 10.1002/jcp.1041540108; Gasiorowski K, 2001, CELL MOL BIOL LETT, V6, P141; Gilmour DT, 1998, EMBO J, V17, P1860, DOI 10.1093/emboj/17.7.1860; Hohenester E, 1997, EMBO J, V16, P3778, DOI 10.1093/emboj/16.13.3778; Ikesugi K, 2006, EXP EYE RES, V83, P508, DOI 10.1016/j.exer.2006.01.033; Kyriakides TR, 2003, THROMB HAEMOSTASIS, V90, P986, DOI 10.1160/TH03-06-0399; Kzhyshkowska J, 2006, J CELL MOL MED, V10, P635, DOI 10.1111/j.1582-4934.2006.tb00425.x; Kzhyshkowska J, 2006, J IMMUNOL, V176, P5825, DOI 10.4049/jimmunol.176.10.5825; LANE TF, 1994, J CELL BIOL, V125, P929, DOI 10.1083/jcb.125.4.929; LANE TF, 1990, J CELL BIOL, V111, P3065, DOI 10.1083/jcb.111.6.3065; Martinek N, 2007, J DENT RES, V86, P296, DOI 10.1177/154405910708600402; Mills J, 2003, J NEUROSCI, V23, P1638; Murphy-Ullrich JE, 2001, J CLIN INVEST, V107, P785, DOI 10.1172/JCI12609; NERI M, 1992, EUR J BIOCHEM, V205, P569, DOI 10.1111/j.1432-1033.1992.tb16814.x; Norose K, 2000, EXP EYE RES, V71, P295, DOI 10.1006/exer.2000.0884; Norose K, 1998, INVEST OPHTH VIS SCI, V39, P2674; Puolakkainen PA, 2005, J HISTOCHEM CYTOCHEM, V53, P571, DOI 10.1369/jhc.4A6425.2005; Puolakkainen PA, 2004, MOL CANCER RES, V2, P215; Ribble D, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-12; Sage EH, 2003, J BIOL CHEM, V278, P37849, DOI 10.1074/jbc.M302946200; SAGE H, 1986, J CELL PHYSIOL, V127, P373, DOI 10.1002/jcp.1041270305; Said N, 2005, AM J PATHOL, V167, P1739, DOI 10.1016/S0002-9440(10)61255-2; SAUK JJ, 1992, TOXICOL APPL PHARM, V116, P240, DOI 10.1016/0041-008X(92)90303-A; Shi Q, 2007, ONCOGENE, V26, P4084, DOI 10.1038/sj.onc.1210181; Shi Q, 2004, J BIOL CHEM, V279, P52200, DOI 10.1074/jbc.M409630200; Sweetwyne MT, 2004, J HISTOCHEM CYTOCHEM, V52, P723, DOI 10.1369/jhc.3A6153.2004; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tartare-Deckert S, 2001, J BIOL CHEM, V276, P22231, DOI 10.1074/jbc.M010634200; Weaver MS, 2007, MOL VIS, V13, P707; Weaver MS, 2006, J CELL BIOCHEM, V97, P423, DOI 10.1002/jcb.20654; Yan Q, 2005, J CELL PHYSIOL, V203, P286, DOI 10.1002/jcp.20226; Yan Q, 2003, J HISTOCHEM CYTOCHEM, V51, P503, DOI 10.1177/002215540305100412; Yan Q, 2002, J CELL SCI, V115, P2747; Yan Q, 2006, DIFFERENTIATION, V74, P195, DOI 10.1111/j.1432-0436.2006.00068.x	40	93	93	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22826	22837		10.1074/jbc.M706563200	http://dx.doi.org/10.1074/jbc.M706563200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18503049	Green Published, hybrid			2022-12-25	WOS:000258321000050
J	Belyaeva, OV; Johnson, MP; Kedishvili, NY				Belyaeva, Olga V.; Johnson, Mary P.; Kedishvili, Natalia Y.			Kinetic analysis of human enzyme RDH10 defines the characteristics of a physiologically relevant retinol dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHORT-CHAIN DEHYDROGENASES/REDUCTASES; ALL-TRANS-RETINOL; DELAYED DARK-ADAPTATION; BINDING PROTEIN-I; NULL MUTANT MICE; ALCOHOL-DEHYDROGENASE; VITAMIN-A; GENE-EXPRESSION; HUMAN TISSUES; VISUAL CYCLE	Human retinol dehydrogenase 10 (RDH10) was implicated in the oxidation of all-trans-retinol for biosynthesis of all-trans-retinoic acid, however, initial assays suggested that RDH10 prefers NADP(+) as a cofactor, undermining its role as an oxidative enzyme. Here, we present evidence that RDH10 is, in fact, a strictly NAD(+)-dependent enzyme with multisubstrate specificity that recognizes cis-retinols as well as all-trans-retinol as substrates. RDH10 has a relatively high apparent Km value for NAD(+) (similar to 100 mu M) but the lowest apparent Km value for all-trans-retinol (similar to 0.035 mu M) among all NAD(+) -dependent retinoid oxidoreductases. Due to its high affinity for all-trans-retinol, RDH10 exhibits a greater rate of retinol oxidation in the presence of cellular retinol-binding protein type I (CRBPI) than human microsomal RoDH4, but like RoDH4, RDH10 does not recognize retinol bound to CRBPI as a substrate. Consistent with its preference for NAD(+), RDH10 functions exclusively in the oxidative direction in the cells, increasing the levels of retinaldehyde and retinoic acid. Targeted small interfering RNAmediated silencing of endogenous RDH10 or RoDH4 expression in human cells results in a significant decrease in retinoic acid production from retinol, identifying both human enzymes as physiologically relevant retinol dehydrogenases. The dual cis/trans substrate specificity suggests a dual physiological role for RDH10: in the biosynthesis of 11-cis-retinaldehyde for vision as well as the biosynthesis of all-trans-retinoic acid for differentiation and development.	Univ Alabama, Sch Med, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; Univ Alabama, Sch Dent, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Kedishvili, NY (corresponding author), 720 20th St S,440B Kaul Genet Bldg, Birmingham, AL 35294 USA.	nkedishvili@uab.edu		Beliaeva, Olga/0000-0003-2512-925X; Kedishvili, Natalia/0000-0001-6917-4891	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012153] Funding Source: NIH RePORTER; NIAAA NIH HHS [R01 AA012153-07, R01 AA012153, AA 12153] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Adams James D. Jr., 2001, Current Topics in Medicinal Chemistry, V1, P473, DOI 10.2174/1568026013394778; Belyaeva OV, 2007, ENDOCRINOLOGY, V148, P2148, DOI 10.1210/en.2006-1491; Belyaeva OV, 2006, GENOMICS, V88, P820, DOI 10.1016/j.ygeno.2006.06.004; Belyaeva OV, 2005, BIOCHEMISTRY-US, V44, P7035, DOI 10.1021/bi050226k; Belyaeva OV, 2003, BIOCHEMISTRY-US, V42, P14838, DOI 10.1021/bi035288u; BLANER WS, 1986, J LIPID RES, V10, P1084; BOERMAN MHEM, 1995, BIOCHEMISTRY-US, V34, P7027, DOI 10.1021/bi00021a014; BOK D, 1984, INVEST OPHTH VIS SCI, V25, P877; Brereton P, 2001, MOL CELL ENDOCRINOL, V171, P111, DOI 10.1016/S0303-7207(00)00417-2; BUBLITZ C, 1987, BIOCHEM J, V245, P263, DOI 10.1042/bj2450263; Chen Y, 2003, MOL VIS, V9, P345; Chen YM, 2003, VISION RES, V43, P3037, DOI 10.1016/j.visres.2003.08.001; Chetyrkin SV, 2001, ARCH BIOCHEM BIOPHYS, V386, P1, DOI 10.1006/abbi.2000.2203; Deltour L, 1999, J BIOL CHEM, V274, P16796, DOI 10.1074/jbc.274.24.16796; Duester G, 1996, BIOCHEMISTRY-US, V35, P12221, DOI 10.1021/bi961176+; FISHER GJ, 1995, J INVEST DERMATOL, V105, P80, DOI 10.1111/1523-1747.ep12313352; Gallego O, 2006, BIOCHEM J, V399, P101, DOI 10.1042/BJ20051988; GIBLIN FJ, 1980, EXP EYE RES, V31, P601, DOI 10.1016/S0014-4835(80)80019-4; Gough WH, 1998, J BIOL CHEM, V273, P19778, DOI 10.1074/jbc.273.31.19778; Haeseleer F, 1998, J BIOL CHEM, V273, P21790, DOI 10.1074/jbc.273.34.21790; HARADA H, 1995, ENDOCRINOLOGY, V136, P5329, DOI 10.1210/en.136.12.5329; HERR FM, 1992, BIOCHEMISTRY-US, V31, P6748, DOI 10.1021/bi00144a014; Hu PR, 2007, BBA-GEN SUBJECTS, V1770, P694, DOI 10.1016/j.bbagen.2006.12.008; Kallberg Y, 2002, EUR J BIOCHEM, V269, P4409, DOI 10.1046/j.1432-1033.2002.03130.x; KATO M, 1985, J BIOL CHEM, V260, P4832; Kedishvili NY, 1998, BIOCHEM BIOPH RES CO, V249, P191, DOI 10.1006/bbrc.1998.9105; Kedishvili NY, 2002, CURR ORG CHEM, V6, P1247, DOI 10.2174/1385272023373400; Kim TS, 2005, J BIOL CHEM, V280, P8694, DOI 10.1074/jbc.M413172200; Lapshina EA, 2003, BIOCHEMISTRY-US, V42, P776, DOI 10.1021/bi026836r; Lee SA, 2007, J BIOL CHEM, V282, P35621, DOI 10.1074/jbc.M706372200; Liu S, 2007, ACTA BIOCHIM POL, V54, P213, DOI 10.18388/abp.2007_3289; Mangelsdorf David J., 1994, P319; MATSCHINSKY FM, 1968, J NEUROCHEM, V15, P643, DOI 10.1111/j.1471-4159.1968.tb08963.x; Matsuzaka Y, 2002, BIOCHEM BIOPH RES CO, V297, P1171, DOI 10.1016/S0006-291X(02)02344-6; Matt N, 2005, DEV DYNAM, V233, P167, DOI 10.1002/dvdy.20313; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Molotkov A, 2004, BIOCHEM J, V383, P295, DOI 10.1042/BJ20040621; Molotkov A, 2002, J BIOL CHEM, V277, P13804, DOI 10.1074/jbc.M112039200; Molotkov A, 2002, P NATL ACAD SCI USA, V99, P5337, DOI 10.1073/pnas.082093299; Napoli JL, 1999, BBA-MOL CELL BIOL L, V1440, P139, DOI 10.1016/S1388-1981(99)00117-1; Napoli JL, 1998, METH MOL B, V89, P29; OKUNO M, 1995, J LIPID RES, V36, P137; ONG DE, 1986, AM J CLIN NUTR, V44, P425, DOI 10.1093/ajcn/44.3.425; RAJAN N, 1990, J LIPID RES, V31, P821; Rossman M.G., 1975, ENZYMES, V11, P61, DOI 10.1016/S1874-6047(08)60210-3; Sandell LL, 2007, GENE DEV, V21, P1113, DOI 10.1101/gad.1533407; SIMON A, 1995, J BIOL CHEM, V270, P1107, DOI 10.1074/jbc.270.34.19979; SMITH WC, 1991, EMBO J, V10, P2223, DOI 10.1002/j.1460-2075.1991.tb07758.x; VEECH RL, 1969, BIOCHEM J, V115, P609, DOI 10.1042/bj1150609a; Wu BX, 2004, INVEST OPHTH VIS SCI, V45, P3857, DOI 10.1167/iovs.03-1302; Wu BX, 2002, INVEST OPHTH VIS SCI, V43, P3365; Yamamoto H, 1999, NAT GENET, V22, P188, DOI 10.1038/9707; Zhang M, 2007, FASEB J, V21, P2886, DOI 10.1096/fj.06-7964com	53	52	53	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20299	20308		10.1074/jbc.M800019200	http://dx.doi.org/10.1074/jbc.M800019200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18502750	Green Published, hybrid			2022-12-25	WOS:000257565300046
J	Ghosh, RP; Horowitz-Scherer, RA; Nikitina, T; Gierasch, LM; Woodcock, CL				Ghosh, Rajarshi P.; Horowitz-Scherer, Rachel A.; Nikitina, Tatiana; Gierasch, Lila M.; Woodcock, Christopher L.			Rett syndrome-causing mutations in human MeCP2 result in diverse structural changes that impact folding and DNA interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; CPG BINDING DOMAIN; TRANSCRIPTIONAL REPRESSOR; HISTONE DEACETYLASE; INTRINSIC DISORDER; METHYLATED DNA; P53; ASSOCIATION; SELECTIVITY; EXPRESSION	Most cases of Rett syndrome (RTT) are caused by mutations in the methylated DNA-binding protein, MeCP2. Here, we have shown that frequent RTT-causing missense mutations (R106W, R133C, F155S, T158M) located in the methylated DNA-binding domain (MBD) of MeCP2 have profound and diverse effects on its structure, stability, and DNA-binding properties. Fluorescence spectroscopy, which reports on the single tryptophan in the MBD, indicated that this residue is strongly protected from the aqueous environment in the wild type but is more exposed in the R133C and F155S mutations. In the mutant proteins R133C, F155S, and T158M, the thermal stability of the domain was strongly reduced. Thermal stability of the wild-type protein was increased in the presence of unmethylated DNA and was further enhanced by DNA methylation. DNA-induced thermal stability was also seen, but to a lesser extent, in each of the mutant proteins. Circular dichroism (CD) of the MBD revealed differences in the secondary structure of the four mutants. Upon binding to methylated DNA, the wild type showed a subtle but reproducible increase in alpha-helical structure, whereas the F155S and R106W did not acquire secondary structure with DNA. Each of the mutant proteins studied is unique in terms of the properties of the MBD and the structural changes induced by DNA binding. For each mutation, we examined the extent to which the magnitude of these differences correlated with the severity of RTT patient symptoms.	[Horowitz-Scherer, Rachel A.; Nikitina, Tatiana; Woodcock, Christopher L.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Ghosh, Rajarshi P.; Gierasch, Lila M.; Woodcock, Christopher L.] Univ Massachusetts, Program Mol & Cellular Biol, Amherst, MA 01003 USA; [Gierasch, Lila M.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Woodcock, CL (corresponding author), Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA.	chris@bio.umass.edu	Gierasch, Lila M/D-1494-2009	ghosh, rajarshi/0000-0002-0020-6194; ghosh, rajarshi/0000-0003-2348-6333	NIGMS NIH HHS [GM 070897, GM 027616] Funding Source: Medline; NIH HHS [DP1 OD000945, DP1 OD000945-02] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027616, R01GM070897] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000945] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Adams VH, 2007, J BIOL CHEM, V282, P15057, DOI 10.1074/jbc.M700855200; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ang HC, 2006, J BIOL CHEM, V281, P21934, DOI 10.1074/jbc.M604209200; Ballestar E, 2000, BIOCHEMISTRY-US, V39, P7100, DOI 10.1021/bi0001271; Bernard D, 2006, ONCOGENE, V25, P1358, DOI 10.1038/sj.onc.1209179; Bienvenu T, 2006, NAT REV GENET, V7, P415, DOI 10.1038/nrg1878; Carpenter Mark L., 1994, V30, P313; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chadwick LH, 2007, CURR OPIN GENET DEV, V17, P121, DOI 10.1016/j.gde.2007.02.003; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Del Vecchio P, 2002, BIOCHEM J, V367, P857, DOI 10.1042/BJ20020695; Dlakic M, 2001, EMBO J, V20, P828, DOI 10.1093/emboj/20.4.828; Fasman G D, 1996, CIRCULAR DICHROISM C, P69; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Free A, 2001, J BIOL CHEM, V276, P3353, DOI 10.1074/jbc.M007224200; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Georgel PT, 2003, J BIOL CHEM, V278, P32181, DOI 10.1074/jbc.M305308200; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Ho KL, 2008, MOL CELL, V29, P525, DOI 10.1016/j.molcel.2007.12.028; Joerger AC, 2007, ONCOGENE, V26, P2226, DOI 10.1038/sj.onc.1210291; Joerger AC, 2006, P NATL ACAD SCI USA, V103, P15056, DOI 10.1073/pnas.0607286103; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kelley LA, 1996, PROTEIN ENG, V9, P1063, DOI 10.1093/protein/9.11.1063; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Klose RJ, 2005, MOL CELL, V19, P667, DOI 10.1016/j.molcel.2005.07.021; Kudo S, 2001, BRAIN DEV-JPN, V23, pS165, DOI 10.1016/S0387-7604(01)00345-X; Kumar A, 2008, J CELL SCI, V121, P1128, DOI 10.1242/jcs.016865; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LaSalle JM, 2004, CURR TOP DEV BIOL, V59, P61, DOI 10.1016/S0070-2153(04)59003-8; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Marchi M, 2007, EPIGENETICS-US, V2, P187, DOI 10.4161/epi.2.3.5057; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Muller HM, 2003, BRIT J CANCER, V89, P1934, DOI 10.1038/sj.bjc.6601392; Nagarajan Raman P, 2006, Epigenetics, V1, pe1; NAN XS, 1993, NUCLEIC ACIDS RES, V21, P4886, DOI 10.1093/nar/21.21.4886; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nikitina T, 2007, J BIOL CHEM, V282, P28237, DOI 10.1074/jbc.M704304200; Nikitina T, 2007, MOL CELL BIOL, V27, P864, DOI 10.1128/MCB.01593-06; Ohki I, 2001, CELL, V105, P487, DOI 10.1016/S0092-8674(01)00324-5; PANCOSKA P, 1995, PROTEIN SCI, V4, P1384, DOI 10.1002/pro.5560040713; PATEL L, 1990, NATURE, V347, P572, DOI 10.1038/347572a0; PERCY AK, 2007, J CHILD NEUROL, V20, P1; PERCZEL A, 1992, ANAL BIOCHEM, V203, P83, DOI 10.1016/0003-2697(92)90046-A; Philippe C, 2006, EUR J MED GENET, V49, P9, DOI 10.1016/j.ejmg.2005.04.003; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Shahbazian MD, 2002, AM J HUM GENET, V71, P1259, DOI 10.1086/345360; Sharma D, 2005, MOL ENDOCRINOL, V19, P1740, DOI 10.1210/me.2004-0011; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; VENYAMINOV SY, 1993, ANAL BIOCHEM, V214, P17, DOI 10.1006/abio.1993.1450; Vila R, 2001, J BIOL CHEM, V276, P46429, DOI 10.1074/jbc.M106952200; Villard L, 2007, J MED GENET, V44, P417, DOI 10.1136/jmg.2007.049452; Wade PA, 2001, BIOESSAYS, V23, P1131, DOI 10.1002/bies.10008; Wakefield RID, 1999, J MOL BIOL, V291, P1055, DOI 10.1006/jmbi.1999.3023; Wang W, 2008, CURR OPIN ONCOL, V20, P90, DOI 10.1097/CCO.0b013e3282f31d6f; WEISS MA, 1990, NATURE, V347, P575, DOI 10.1038/347575a0; Wellman SE, 1996, BIOPOLYMERS, V39, P491, DOI 10.1002/(SICI)1097-0282(199610)39:4<491::AID-BIP2>3.3.CO;2-8; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Xie HB, 2007, J PROTEOME RES, V6, P1882, DOI 10.1021/pr060392u; Yasui DH, 2007, P NATL ACAD SCI USA, V104, P19416, DOI 10.1073/pnas.0707442104; Young JI, 2005, P NATL ACAD SCI USA, V102, P17551, DOI 10.1073/pnas.0507856102; Yusufzai TM, 2000, NUCLEIC ACIDS RES, V28, P4172, DOI 10.1093/nar/28.21.4172	64	47	48	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20523	20534		10.1074/jbc.M803021200	http://dx.doi.org/10.1074/jbc.M803021200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18499664	Green Published, hybrid			2022-12-25	WOS:000257565300065
J	Bu, S; Kapanadze, B; Hsu, T; Trojanowska, M				Bu, Shizhong; Kapanadze, Bagrat; Hsu, Tien; Trojanowska, Maria			Opposite effects of dihydrosphingosine 1-phosphate and sphingosine 1-phosphate on transforming growth factor-beta/Smad signaling are mediated through the PTEN/PPM1A-dependent pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; TUMOR-SUPPRESSOR PTEN; FACTOR-BETA; TGF-BETA; MYOFIBROBLAST DIFFERENTIATION; NUCLEAR-LOCALIZATION; PHOSPHATASE; EXPRESSION; KINASE; SPHINGOSINE-1-PHOSPHATE	Transforming growth factor-beta (TGF-beta) is an important regulator of physiological connective tissue biosynthesis and plays a central role in pathological tissue fibrosis. Previous studies have established that a biologically active lipid mediator, sphingosine 1-phosphate (S1P), mimics some of the profibrotic functions of TGF-beta through cross-activation of Smad signaling. Here we report that another product of sphingosine kinase, dihydrosphingosine 1-phosphate (dhS1P), has an opposite role in the regulation of TGF-beta signaling. In contrast to S1P, dhS1P inhibits TGF-beta-induced Smad2/3 phosphorylation and up-regulation of collagen synthesis. The effects of dhS1P require a lipid phosphatase, PTEN, a key modulator of cell growth and survival. dhS1P stimulates phosphorylation of the C-terminal domain of PTEN and its subsequent translocation into the nucleus. We demonstrate a novel function of nuclear PTEN as a co-factor of the Smad2/3 phosphatase, PPM1A. Complex formation of PTEN with PPM1A does not require the lipid phosphatase activity but depends on phosphorylation of the serine/threonine residues located in the C-terminal domain of PTEN. Upon complex formation with PTEN, PPM1A is protected from degradation induced by the TGF-beta signaling. Consequently, overexpression of PTEN abrogates TGF-beta-induced Smad2/3 phosphorylation. This study establishes a novel role for nuclear PTEN in the stabilization of PPM1A. PTEN-mediated cross-talk between the sphingolipid and TGF-beta signaling pathways may play an important role in physiological and pathological TGF-beta signaling.	[Bu, Shizhong; Kapanadze, Bagrat; Trojanowska, Maria] Med Univ S Carolina, Div Rheumatol & Immunol, Charleston, SC 29425 USA; [Hsu, Tien] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Trojanowska, M (corresponding author), Med Univ S Carolina, Div Rheumatol & Immunol, Charleston, SC 29425 USA.	trojanme@musc.edu		Trojanowska, Maria/0000-0001-9550-7178; Hsu, Tien/0000-0003-2308-4297	NCI NIH HHS [P01 CA78582, R01 CA109860] Funding Source: Medline; NIAMS NIH HHS [P60 AR049459, R01 AR44883] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA109860, P01CA078582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR049459, R01AR044883] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Berdyshev EV, 2006, CELL SIGNAL, V18, P1779, DOI 10.1016/j.cellsig.2006.01.018; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Bu Shizhong, 2006, FASEB J, V20, P184; Desmouliere A, 2004, INT J DEV BIOL, V48, P509, DOI 10.1387/ijdb.041802ad; El Alwani M, 2006, PHARMACOL THERAPEUT, V112, P171, DOI 10.1016/j.pharmthera.2006.04.004; Faler Byron J, 2006, Perspect Vasc Surg Endovasc Ther, V18, P55, DOI 10.1177/153100350601800123; French KJ, 2003, CANCER RES, V63, P5962; Gardell SE, 2006, TRENDS MOL MED, V12, P65, DOI 10.1016/j.molmed.2005.12.001; Gil A, 2006, MOL BIOL CELL, V17, P4002, DOI 10.1091/mbc.E06-05-0380; Guzeloglu-Kayisli O, 2003, J CLIN ENDOCR METAB, V88, P5017, DOI 10.1210/jc.2003-030414; Hjelmeland AB, 2005, CANCER RES, V65, P11276, DOI 10.1158/0008-5472.CAN-05-3016; Keller CD, 2007, AM J PATHOL, V170, P281, DOI 10.2353/ajpath.2007.060485; Kono Y, 2007, AM J RESP CELL MOL, V37, P395, DOI 10.1165/rcmb.2007-0065OC; Leslie NR, 2004, BIOCHEM J, V382, P1, DOI 10.1042/BJ20040825; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Liu FH, 2005, J CELL BIOCHEM, V96, P221, DOI 10.1002/jcb.20525; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; Mahimainathan L, 2006, DIABETES, V55, P2115, DOI 10.2337/db05-1326; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Maudsley S, 2005, J PHARMACOL EXP THER, V314, P485, DOI 10.1124/jpet.105.083121; Minaguchi T, 2006, CANCER RES, V66, P11677, DOI 10.1158/0008-5472.CAN-06-2240; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Okumura K, 2005, P NATL ACAD SCI USA, V102, P2703, DOI 10.1073/pnas.0409370102; Saba JD, 2004, CIRC RES, V94, P724, DOI 10.1161/01.RES.0000122383.60368.24; Sanchez T, 2005, P NATL ACAD SCI USA, V102, P4312, DOI 10.1073/pnas.0409784102; Sato W, 2006, HEPATOL RES, V34, P256, DOI 10.1016/j.hepres.2006.01.003; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Spiegel S, 2007, J BIOL CHEM, V282, P2125, DOI 10.1074/jbc.R600028200; Takekawa M, 1998, EMBO J, V17, P4744, DOI 10.1093/emboj/17.16.4744; Tang YF, 2006, CANCER RES, V66, P736, DOI 10.1158/0008-5472.CAN-05-1557; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Van Brocklyn JR, 1998, J CELL BIOL, V142, P229, DOI 10.1083/jcb.142.1.229; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Verrecchia F, 2007, WORLD J GASTROENTERO, V13, P3056, DOI 10.3748/wjg.v13.i22.3056; Visentin B, 2006, CANCER CELL, V9, P225, DOI 10.1016/j.ccr.2006.02.023; White ES, 2006, AM J RESP CRIT CARE, V173, P112, DOI 10.1164/rccm.200507-1058OC; Xia P, 2000, CURR BIOL, V10, P1527, DOI 10.1016/S0960-9822(00)00834-4; Xin CY, 2004, J BIOL CHEM, V279, P35255, DOI 10.1074/jbc.M312091200; Yamanaka M, 2004, J BIOL CHEM, V279, P53994, DOI 10.1074/jbc.M410144200	42	53	54	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19593	19602		10.1074/jbc.M802417200	http://dx.doi.org/10.1074/jbc.M802417200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18482992	Green Published, hybrid			2022-12-25	WOS:000257387600045
J	Chu, LR; Lai, YL; Xu, XP; Eddy, S; Yang, S; Song, L; Kolodrubetz, D				Chu, Lianrui; Lai, Yanlai; Xu, Xiaoping; Eddy, Scott; Yang, Shuang; Song, Li; Kolodrubetz, David			A 52-kDa leucyl aminopeptidase from Treponema denticola is a cysteinylglycinase that mediates the second step of glutathione metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-SULFIDE PRODUCTION; GAMMA-GLUTAMYL-TRANSFERASE; VOLATILE SULFUR-COMPOUNDS; L-CYSTEINE DESULFHYDRASE; METHYL MERCAPTAN; CYSTALYSIN; BINDING; PURIFICATION; HEMOLYSIN; CAPACITY	The metabolism of glutathione by the periodontal pathogen Treponema denticola produces hydrogen sulfide, which may play a role in the host tissue destruction seen in periodontitis. H2S production in this organism has been proposed to occur via a three enzyme pathway, gamma-glutamyltransferase, cysteinylglycinase (CGase), and cystalysin. In this study, we describe the purification and characterization of T. denticola CGase. Standard approaches were used to purify a 52-kDa CGase activity from T. denticola, and high pressure liquid chromatography electrospray ionization tandem mass spectrometry analysis of this molecule showed that it matches the amino acid sequence of a predicted 52-kDa protein in the T. denticola genome data base. A recombinant version of this protein was overexpressed in and purified from Escherichia coli and shown to catalyze the hydrolysis of cysteinylglycine (Cys-Gly) with the same kinetics as the native protein. Surprisingly, because sequence homology indicates that this protein is a member of a family of metalloproteases called M17 leucine aminopeptidases, the preferred substrate for the T. denticola protein is Cys-Gly (k(cat)/K-m of 8.2 mu M-1 min(-1)) not L-Leu-p-NA (k(cat)/K-m of 1.1 mu M-1 min(-1)). The activity of CGase for Cys-Gly is optimum at pH 7.3 and is enhanced by Mn2+, Co2+, or Mg2+ but not by Zn2+ or Ca2+. Importantly, in combination with the two other previously purified T. denticola enzymes, gamma-glutamyltransferase and cystalysin, CGase mediates the in vitro degradation of glutathione into the expected end products, including H2S. These results prove that T. denticola contains the entire three-step pathway to produce H2S from glutathione, which may be important for pathogenesis.	[Chu, Lianrui; Lai, Yanlai; Eddy, Scott; Yang, Shuang; Song, Li] Univ Texas Hlth Sci Ctr San Antonio, Dept Orthodont, San Antonio, TX 78229 USA; [Xu, Xiaoping] Univ Texas Hlth Sci Ctr San Antonio, Dept Periodont, San Antonio, TX 78229 USA; [Kolodrubetz, David] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Chu, LR (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Orthodont, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	chul@uthscsa.edu			NIDCR NIH HHS [R01 DE-13819] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013819] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Aimetti M, 2007, J PERIODONTOL, V78, P1718, DOI 10.1902/jop.2007.060473; [Anonymous], 2004, HDB PROTEOLYTIC ENZY; [Anonymous], CLIN LAB METHODS; BEAUCHAMP RO, 1984, CRC CR REV TOXICOL, V13, P25, DOI 10.3109/10408448409029321; Bertoldi M, 2002, BIOCHEMISTRY-US, V41, P9153, DOI 10.1021/bi025649q; BLAKEMORE RP, 1976, J BACTERIOL, V128, P616, DOI 10.1128/JB.128.2.616-622.1976; Cappiello M, 2006, BIOCHEMISTRY-US, V45, P3226, DOI 10.1021/bi052069v; Cappiello M, 2004, BIOCHEM J, V378, P35, DOI 10.1042/BJ20031336; CARLSSON J, 1994, ORAL MICROBIOL IMMUN, V9, P297, DOI 10.1111/j.1399-302X.1994.tb00074.x; CARLSSON J, 1993, ORAL MICROBIOL IMMUN, V8, P42, DOI 10.1111/j.1399-302X.1993.tb00541.x; Cellini B, 2004, J BIOL CHEM, V279, P36898, DOI 10.1074/jbc.M404449200; Cellini B, 2006, BIOCHEMISTRY-US, V45, P14140, DOI 10.1021/bi061496l; Cellini B, 2006, ARCH BIOCHEM BIOPHYS, V455, P31, DOI 10.1016/j.abb.2006.08.020; CHU L, 1994, MICROB PATHOGENESIS, V16, P197, DOI 10.1006/mpat.1994.1020; CHU L, 1995, INFECT IMMUN, V63, P4448, DOI 10.1128/IAI.63.11.4448-4455.1995; Chu L, 1997, INFECT IMMUN, V65, P3231, DOI 10.1128/IAI.65.8.3231-3238.1997; Chu L, 1999, ORAL MICROBIOL IMMUN, V14, P293, DOI 10.1034/j.1399-302X.1999.140505.x; CHU L, 1986, SHANGHAI J IMMUNOL, V6, P243; Chu LR, 2003, INFECT IMMUN, V71, P335, DOI 10.1128/IAI.71.1.335-342.2003; Chu LR, 2002, INFECT IMMUN, V70, P1113, DOI 10.1128/IAI.70.3.1113-1120.2002; Chu LR, 1999, CLIN INFECT DIS, V28, P442, DOI 10.1086/515164; CLAESSON R, 1990, ORAL MICROBIOL IMMUN, V5, P137, DOI 10.1111/j.1399-302X.1990.tb00411.x; Dong L, 2005, MICROBIOL-SGM, V151, P2017, DOI 10.1099/mic.0.27767-0; GAITONDE MK, 1967, BIOCHEM J, V104, P627, DOI 10.1042/bj1040627; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; HOROWITZ A, 1973, J PERIODONTOL, V44, P390, DOI 10.1902/jop.1973.44.7.390; Josch C, 2003, BIOL CHEM, V384, P213, DOI 10.1515/BC.2003.023; Krupka HI, 2000, EMBO J, V19, P3168, DOI 10.1093/emboj/19.13.3168; Kurzban GP, 1999, ORAL MICROBIOL IMMUN, V14, P153, DOI 10.1034/j.1399-302X.1999.140303.x; Makinen PL, 1997, INFECT IMMUN, V65, P685; MOORE WEC, 1987, J PERIODONTAL RES, V22, P335, DOI 10.1111/j.1600-0765.1987.tb01595.x; MORHART RE, 1970, J PERIODONTOL, V41, P644, DOI 10.1902/jop.1970.41.11.644; Morty RE, 2002, J BIOL CHEM, V277, P26057, DOI 10.1074/jbc.M202779200; PERSSON S, 1992, ORAL MICROBIOL IMMUN, V7, P378, DOI 10.1111/j.1399-302X.1992.tb00641.x; PERSSON S, 1990, ORAL MICROBIOL IMMUN, V5, P195, DOI 10.1111/j.1399-302X.1990.tb00645.x; PERSSON S, 1989, ORAL MICROBIOL IMMUN, V4, P169, DOI 10.1111/j.1399-302X.1989.tb00246.x; REIFFENSTEIN RJ, 1992, ANNU REV PHARMACOL, V32, P109, DOI 10.1146/annurev.pa.32.040192.000545; RIZZO AA, 1967, PERIODONTICS, V5, P233; Sela MN, 2001, CRIT REV ORAL BIOL M, V12, P399, DOI 10.1177/10454411010120050301; Seshadri G, 2004, P NATL ACAD SCI USA, V101, P5646, DOI 10.1073/pnas.0307639101; SIEGEL LM, 1965, ANAL BIOCHEM, V11, P126, DOI 10.1016/0003-2697(65)90051-5; SIMONSON LG, 1988, INFECT IMMUN, V56, P726, DOI 10.1128/IAI.56.4.726-728.1988; [Смирнова Г.В. Smirnova G.V.], 2005, [Биохимия, BIOCHEMISTRY (MOSCOW), Biokhimiya], V70, P1459; STRATER N, 2004, HDB PROTEOLYTIC ENZY, P896; Suzuki H, 2001, J BACTERIOL, V183, P1489, DOI 10.1128/JB.183.4.1489-1490.2001; Suzuki H, 2001, BIOSCI BIOTECH BIOCH, V65, P1549, DOI 10.1271/bbb.65.1549; TANGLARSEN J, 1995, J PERIODONTAL RES, V30, P390, DOI 10.1111/j.1600-0765.1995.tb01292.x; Thomas JA, 2007, VIROLOGY, V368, P405, DOI 10.1016/j.virol.2007.06.043; *US NAT RES COUNC, 1979, HYDR SULF, P1; WEINBERG A, 1990, INFECT IMMUN, V58, P1720, DOI 10.1128/IAI.58.6.1720-1729.1990; ZHENG LM, 1993, P NATL ACAD SCI USA, V90, P2754, DOI 10.1073/pnas.90.7.2754	51	37	37	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19351	19358		10.1074/jbc.M801034200	http://dx.doi.org/10.1074/jbc.M801034200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18482986	Green Published, hybrid			2022-12-25	WOS:000257387600021
J	Mesnage, S; Chau, F; Dubost, L; Arthur, M				Mesnage, Stephane; Chau, Francoise; Dubost, Lionel; Arthur, Michel			Role of N-acetylglucosaminidase and N-acetylmuramidase activities in Enterococcus faecalis peptidoglycan metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; LYTIC TRANSGLYCOSYLASE; STREPTOCOCCUS-FAECALIS; BACILLUS-SUBTILIS; MUREIN SACCULUS; PENICILLIN; HYDROLASES; RESISTANCE; FAECIUM; SYSTEM	Identification of the full complement of peptidoglycan hydrolases detected by zymogram in Enterococcus faecalis extracts led to the characterization of two novel hydrolases that we named AtlB and AtlC. Both enzymes have a similar modular organization comprising a central catalytic domain fused to two LysM peptidoglycan-binding modules. AtlB and AtlC displayed N-acetylmuramidase activity, as demonstrated by tandem mass spectrometry analyses of peptidoglycan fragments generated by the purified enzymes. The genes encoding AtlB and AtlC were deleted either alone or in combination with the gene encoding AtlA, a previously describedN-acetylglucosaminidase. No autolytic activity was detected in the triple mutant indicating that AtlA, AtlB, and AtlC account for the major hydrolytic activities in E. faecalis. Analysis of cell size distribution by flow cytometry showed that deletion of atlA resulted in the formation of long chains. Thus, AtlA digests the septum and is required for cell separation after cell division. We found that AtlB could act as a surrogate for AtlA, although the enzyme was less efficient at septum digestion. Deletion of atlC had no impact on cell morphology. Labeling of the peptidoglycan with N-[C-14] acetylglucosamine revealed an unusually slow turnover as compared with model organisms, almost completely dependent upon the combined activities of AtlA and AtlB. In contrast to atlA, the atlB and atlC genes are located in putative prophages. Because AtlB and AtlC were produced in the absence of cell lysis or production of phage progeny, these enzymes may have been hijacked by E. faecalis to contribute to peptidoglycan metabolism.	[Mesnage, Stephane; Arthur, Michel] Univ Paris 06, UMR S 872, Equipe 12, Ctr Rech Cordeliers,LRMA, F-75006 Paris, France; [Mesnage, Stephane; Arthur, Michel] Univ Paris 05, UMR S 872, F-75006 Paris, France; [Mesnage, Stephane; Arthur, Michel] INSERM, U872, F-75006 Paris, France; [Chau, Francoise] Univ Paris 07, Fac Med Xavier Bichat, EA3964, F-75018 Paris, France; [Dubost, Lionel] Museum Natl Hist Nat, USM0502, F-75005 Paris, France; [Dubost, Lionel] CNRS, UMR8041, Plateforme Spectrometrie Masse & Prote Museum, Dept Rech Dev & Diversite Mol, F-75005 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS)	Mesnage, S (corresponding author), Univ Paris 06, INSERM, U872, LRMA,Ctr Rech Cordeliers,Equipe 12, 15 Rue Ecole Med, F-75270 Paris 06, France.	stephane.mesnage@crc.jussieu.fr	MESNAGE, Stephane/H-7156-2019; Arthur, Michel/G-3680-2013	Arthur, Michel/0000-0003-1007-636X; MESNAGE, Stephane/0000-0003-1648-4890				Arbeloa A, 2004, J BIOL CHEM, V279, P41546, DOI 10.1074/jbc.M407149200; Archibald A. R., 1993, P381; Baptista M, 1999, MOL MICROBIOL, V32, P17, DOI 10.1046/j.1365-2958.1999.01308.x; Bisicchia P, 2007, MOL MICROBIOL, V65, P180, DOI 10.1111/j.1365-2958.2007.05782.x; Bouhss A, 2002, J BIOL CHEM, V277, P45935, DOI 10.1074/jbc.M207449200; Cencic A, 2002, EUR J BIOCHEM, V269, P2772, DOI 10.1046/j.1432-1033.2002.02950.x; CHU CP, 1992, J BACTERIOL, V174, P1619, DOI 10.1128/jb.174.5.1619-1625.1992; Da Costa B, 2002, J VIROL, V76, P2393, DOI 10.1128/JVI.76.5.2393-2402.2002; DOLINGER DL, 1989, J BACTERIOL, V171, P4355, DOI 10.1128/JB.171.8.4355-4361.1989; Eckert C, 2006, J BACTERIOL, V188, P8513, DOI 10.1128/JB.01145-06; Holtje JV, 1996, MICROBIOL-SGM, V142, P1911, DOI 10.1099/13500872-142-8-1911; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; JACOB AE, 1974, J BACTERIOL, V117, P360, DOI 10.1128/JB.117.2.360-372.1974; KAWAMURA T, 1983, J BIOL CHEM, V258, P9514; LECLERC D, 1989, CAN J MICROBIOL, V35, P749, DOI 10.1139/m89-125; Lepage E, 2006, J BACTERIOL, V188, P6858, DOI 10.1128/JB.00421-06; Meberg BM, 2004, J BACTERIOL, V186, P8326, DOI 10.1128/JB.186.24.8326-8336.2004; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; ROMEIS T, 1994, J BIOL CHEM, V269, P21603; RUSSOMARIE F, 1993, P NATL ACAD SCI USA, V90, P8194, DOI 10.1073/pnas.90.17.8194; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; SHOCKMAN GD, 1969, J BACTERIOL, V98, P1199, DOI 10.1128/JB.98.3.1199-1207.1969; Smith TJ, 2000, MICROBIOL-UK, V146, P249, DOI 10.1099/00221287-146-2-249; Vollmer W, 1999, J BIOL CHEM, V274, P6726, DOI 10.1074/jbc.274.10.6726; Vollmer W, 2001, CURR OPIN MICROBIOL, V4, P625, DOI 10.1016/S1369-5274(01)00261-2; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; vonRechenberg M, 1996, MICROB DRUG RESIST, V2, P155, DOI 10.1089/mdr.1996.2.155; WEIDEL W, 1964, ADV ENZYMOL REL S BI, V26, P193	29	51	51	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19845	19853		10.1074/jbc.M802323200	http://dx.doi.org/10.1074/jbc.M802323200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18490448	hybrid			2022-12-25	WOS:000257387600068
J	Mollenbeck, M; Zhou, Y; Cavalcanti, ARO; Jonsson, F; Higgins, BP; Chang, WJ; Juranek, S; Doak, TG; Rozenberg, G; Lipps, HJ; Landweber, LF				Moellenbeck, Matthias; Zhou, Yi; Cavalcanti, Andre R. O.; Joensson, Franziska; Higgins, Brian P.; Chang, Wei-Jen; Juranek, Stefan; Doak, Thomas G.; Rozenberg, Grzegorz; Lipps, Hans J.; Landweber, Laura F.			The Pathway to Detangle a Scrambled Gene	PLOS ONE			English	Article							DEVELOPMENTAL GENOME REARRANGEMENTS; MACRONUCLEAR DEVELOPMENT; DNA DELETION; SMALL RNAS; EVOLUTION; EXCISION; ELIMINATION; TETRAHYMENA; DIMINUTION; MECHANISM	Background: Programmed DNA elimination and reorganization frequently occur during cellular differentiation. Development of the somatic macronucleus in some ciliates presents an extreme case, involving excision of internal eliminated sequences (IESs) that interrupt coding DNA segments (macronuclear destined sequences, MDSs), as well as removal of transposon-like elements and extensive genome fragmentation, leading to 98% genome reduction in Stylonychia lemnae. Approximately 20-30% of the genes are estimated to be scrambled in the germline micronucleus, with coding segment order permuted and present in either orientation on micronuclear chromosomes. Massive genome rearrangements are therefore critical for development. Methodology/Principal Findings: To understand the process of DNA deletion and reorganization during macronuclear development, we examined the population of DNA molecules during assembly of different scrambled genes in two related organisms in a developmental time-course by PCR. The data suggest that removal of conventional IESs usually occurs first, accompanied by a surprising level of error at this step. The complex events of inversion and translocation seem to occur after repair and excision of all conventional IESs and via multiple pathways. Conclusions/Significance: This study reveals a temporal order of DNA rearrangements during the processing of a scrambled gene, with simpler events usually preceding more complex ones. The surprising observation of a hidden layer of errors, absent from the mature macronucleus but present during development, also underscores the need for repair or screening of incorrectly-assembled DNA molecules.	[Moellenbeck, Matthias; Joensson, Franziska; Juranek, Stefan; Lipps, Hans J.] Univ Witten Herdecke, Inst Cell Biol, Witten, Germany; [Zhou, Yi; Cavalcanti, Andre R. O.; Higgins, Brian P.; Chang, Wei-Jen; Doak, Thomas G.; Landweber, Laura F.] Princeton Univ, Princeton, NJ USA; [Rozenberg, Grzegorz] Leiden Univ, Inst Advanced Comp Sci, Leiden, Netherlands	Witten Herdecke University; Princeton University; Leiden University; Leiden University - Excl LUMC	Mollenbeck, M (corresponding author), Univ Witten Herdecke, Inst Cell Biol, Witten, Germany.	lfl@Princeton.edu	Cavalcanti, Andre RO/H-9777-2013; Chang, Wei-Jen/AAT-3303-2021	Cavalcanti, Andre RO/0000-0001-8708-6932; Chang, Wei-Jen/0000-0002-8065-2281; Doak, Thomas/0000-0001-5487-553X	NSF [0121422, 0622112]; NIH [GM59708]; DFG; Alfried Krupp von Bohlen und Halbach Foundations; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059708] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG(German Research Foundation (DFG)); Alfried Krupp von Bohlen und Halbach Foundations; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by awards from the NSF (0121422 and 0622112) and NIH (GM59708) to L.F.L. and the DFG and Alfried Krupp von Bohlen und Halbach Foundations to H.J.L.	AMMERMANN D, 1974, CHROMOSOMA, V45, P401, DOI 10.1007/BF00283386; Angeleska A, 2007, J THEOR BIOL, V248, P706, DOI 10.1016/j.jtbi.2007.06.007; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; BEERMANN S, 1977, CHROMOSOMA, V60, P297, DOI 10.1007/BF00292858; BORST P, 1991, IMMUNOPARASITOL TOD, pA29, DOI 10.1016/S0167-5699(05)80009-X; Cavalcanti ARO, 2006, NAT COMP SER, P349, DOI 10.1007/3-540-30296-4_22; Cavalcanti ARO, 2005, NUCLEIC ACIDS RES, V33, pD396, DOI 10.1093/nar/gki130; Cavalcanti ARO, 2004, PROTIST, V155, P311, DOI 10.1078/1434461041844196; Cavalcanti ARO, 2004, BIOINFORMATICS, V20, P800, DOI 10.1093/bioinformatics/bth003; Chalker DL, 2001, GENE DEV, V15, P1287, DOI 10.1101/gad.884601; Chang WJ, 2006, GENE, V368, P72, DOI 10.1016/j.gene.2005.10.008; Chang WJ, 2005, P NATL ACAD SCI USA, V102, P15149, DOI 10.1073/pnas.0507682102; Chen J, 2007, NUCLEIC ACIDS RES, V35, P1377, DOI 10.1093/nar/gkm010; Doak TG, 2003, TRENDS GENET, V19, P603, DOI 10.1016/j.tig.2003.09.013; DUHARCOURT S, 1995, GENE DEV, V9, P2065, DOI 10.1101/gad.9.16.2065; Ehrenfeucht A., 2002, Mathematical Structures in Computer Science, V12, P113, DOI 10.1017/S0960129501003516; Garnier O, 2004, MOL CELL BIOL, V24, P7370, DOI 10.1128/MCB.24.17.7370-7379.2004; Gerbi S.A., 1986, Results and Problems in Cell Differentiation, V13, P71; Haber JE, 1998, ANNU REV GENET, V32, P561, DOI 10.1146/annurev.genet.32.1.561; HARRIMAN W, 1993, ANNU REV IMMUNOL, V11, P361, DOI 10.1146/annurev.iy.11.040193.002045; HERSKOWITZ I, 1989, NATURE, V342, P749, DOI 10.1038/342749a0; Jahn CL, 2002, ANNU REV MICROBIOL, V56, P489, DOI 10.1146/annurev.micro.56.012302.160916; Juranek SA, 2005, EUKARYOT CELL, V4, P1934, DOI 10.1128/EC.4.11.1934-1941.2005; Juranek SA, 2007, INT REV CYTOL, V262, P219, DOI 10.1016/S0074-7696(07)62005-1; KLOBUTCHER LA, 1993, GENE DEV, V7, P84, DOI 10.1101/gad.7.1.84; KRAUT H, 1986, INT REV CYTOL, V99, P1; Kuo SY, 2006, MOL BIOL EVOL, V23, P4, DOI 10.1093/molbev/msj017; Landweber LF, 2000, P NATL ACAD SCI USA, V97, P3298, DOI 10.1073/pnas.040574697; LEWIS SM, 1994, ADV IMMUNOL, V56, P27, DOI 10.1016/S0065-2776(08)60450-2; Lieber M, 1996, CURR BIOL, V6, P134, DOI 10.1016/S0960-9822(02)00443-8; Madireddi MT, 1996, CELL, V87, P75, DOI 10.1016/S0092-8674(00)81324-0; Meyer E, 1996, CELL, V87, P9, DOI 10.1016/S0092-8674(00)81317-3; Meyer E, 2002, ADV GENET, V46, P305; MITCHAM JL, 1992, GENE DEV, V6, P788, DOI 10.1101/gad.6.5.788; Mochizuki K, 2004, CURR OPIN GENET DEV, V14, P181, DOI 10.1016/j.gde.2004.01.004; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Mollenbeck M, 2006, J MOL EVOL, V63, P69, DOI 10.1007/s00239-005-0166-4; Muller F, 2000, INT J PARASITOL, V30, P391, DOI 10.1016/S0020-7519(99)00199-X; Myrick KV, 2002, GENE, V284, P125, DOI 10.1016/S0378-1119(02)00384-0; Nowacki M, 2008, NATURE, V451, P153, DOI 10.1038/nature06452; Paschka AG, 2005, GENE, V359, P81, DOI 10.1016/j.gene.2005.06.024; Prescott DM, 2000, NAT REV GENET, V1, P191, DOI 10.1038/35042057; Prescott DM, 1996, J EUKARYOT MICROBIOL, V43, P432, DOI 10.1111/j.1550-7408.1996.tb04502.x; Prescott DM, 2003, J THEOR BIOL, V222, P323, DOI 10.1016/S0022-5193(03)00037-7; PRESCOTT DM, 1992, DEV GENET, V13, P66, DOI 10.1002/dvg.1020130111; PRESCOTT DM, 1994, MICROBIOL REV, V58, P233, DOI 10.1128/MMBR.58.2.233-267.1994; Tobler H., 1986, Results and Problems in Cell Differentiation, V13, P1; Vanhamme L, 2001, TRENDS PARASITOL, V17, P338, DOI 10.1016/S1471-4922(01)01922-5; Wen JP, 1996, NUCLEIC ACIDS RES, V24, P4415, DOI 10.1093/nar/24.22.4415; Wong LC, 2006, MOL BIOL EVOL, V23, P756, DOI 10.1093/molbev/msj089; Yao MC, 2003, SCIENCE, V300, P1581, DOI 10.1126/science.1084737; Yao MC, 1996, TRENDS GENET, V12, P26, DOI 10.1016/0168-9525(96)81385-0	52	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2330	10.1371/journal.pone.0002330	http://dx.doi.org/10.1371/journal.pone.0002330			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523559	Green Published, Green Submitted, gold			2022-12-25	WOS:000262614300025
J	Bryk, J; Hardouin, E; Pugach, I; Hughes, D; Strotmann, R; Stoneking, M; Myles, S				Bryk, Jaroslaw; Hardouin, Emilie; Pugach, Irina; Hughes, David; Strotmann, Rainer; Stoneking, Mark; Myles, Sean			Positive Selection in East Asians for an EDAR Allele that Enhances NF-kappa B Activation	PLOS ONE			English	Article							SKIN PIGMENTATION; POPULATION DIFFERENTIATION; LINKAGE DISEQUILIBRIUM; GENETIC-STRUCTURE; GENOMIC REGIONS; SIGNATURES; RECEPTOR; IDENTIFICATION; MUTATIONS; PATTERNS	Genome-wide scans for positive selection in humans provide a promising approach to establish links between genetic variants and adaptive phenotypes. From this approach, lists of hundreds of candidate genomic regions for positive selection have been assembled. These candidate regions are expected to contain variants that contribute to adaptive phenotypes, but few of these regions have been associated with phenotypic effects. Here we present evidence that a derived nonsynonymous substitution (370A) in EDAR, a gene involved in ectodermal development, was driven to high frequency in East Asia by positive selection prior to 10,000 years ago. With an in vitro transfection assay, we demonstrate that 370A enhances NF-kappa B activity. Our results suggest that 370A is a positively selected functional genetic variant that underlies an adaptive human phenotype.	[Bryk, Jaroslaw; Hardouin, Emilie; Pugach, Irina; Hughes, David; Stoneking, Mark; Myles, Sean] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany; [Strotmann, Rainer] Univ Leipzig, Med Fac, Inst Biochem, Leipzig, Germany	Max Planck Society; Leipzig University	Bryk, J (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany.	smm367@cornell.edu	Bryk, Jarosław/C-4883-2009; Hughes, David/E-7190-2015	Bryk, Jarosław/0000-0002-2791-9709; Hughes, David/0000-0002-9644-8998; Myles, Sean/0000-0001-9754-5987	German Bundesministerium fur Bildung und Forschung; Max Planck Society	German Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by the German Bundesministerium fur Bildung und Forschung (BMBF: NGFN2) and the Max Planck Society.	Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Botchkarev VA, 2005, J INVEST DERM SYMP P, V10, P247, DOI 10.1111/j.1087-0024.2005.10129.x; Cann HM, 2002, SCIENCE, V296, P261; Carlson CS, 2005, GENOME RES, V15, P1553, DOI 10.1101/gr.4326505; Chassaing N, 2006, HUM MUTAT, V27, P255, DOI 10.1002/humu.20295; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Fischer A, 2004, MOL BIOL EVOL, V21, P799, DOI 10.1093/molbev/msh083; Franbourg A, 2003, J AM ACAD DERMATOL, V48, pS115, DOI 10.1067/mjd.2003.277; Friedlaender JS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040019; Frisse L, 2001, AM J HUM GENET, V69, P831, DOI 10.1086/323612; Fujimoto A, 2008, HUM MOL GENET, V17, P835, DOI 10.1093/hmg/ddm355; Headon DJ, 2001, NATURE, V414, P913, DOI 10.1038/414913a; Hey J, 2005, PLOS BIOL, V3, P965, DOI 10.1371/journal.pbio.0030193; Izagirre N, 2006, MOL BIOL EVOL, V23, P1697, DOI 10.1093/molbev/msl030; Kelley JL, 2006, GENOME RES, V16, P980, DOI 10.1101/gr.5157306; Koppinen P, 2001, EXP CELL RES, V269, P180, DOI 10.1006/excr.2001.5331; Kumar A, 2001, J BIOL CHEM, V276, P2668, DOI 10.1074/jbc.M008356200; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Lao O, 2007, ANN HUM GENET, V71, P354, DOI 10.1111/j.1469-1809.2006.00341.x; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Myles S, 2008, ANN HUM GENET, V72, P99, DOI 10.1111/j.1469-1809.2007.00390.x; MYLES S, 2008, RECENT ADV MOL BIOL; Myles S, 2007, HUM GENET, V120, P613, DOI 10.1007/s00439-006-0256-4; Norton HL, 2007, MOL BIOL EVOL, V24, P710, DOI 10.1093/molbev/msl203; Pollinger JP, 2005, GENOME RES, V15, P1809, DOI 10.1101/gr.4374505; Przeworski M, 2003, GENETICS, V164, P1667; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; Rosenberg NA, 2005, PLOS GENET, V1, P660, DOI 10.1371/journal.pgen.0010070; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2006, ANN HUM GENET, V70, P841, DOI 10.1111/j.1469-1809.2006.00285.x; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Shimomura Y, 2004, J INVEST DERMATOL, V123, P649, DOI 10.1111/j.0022-202X.2004.23405.x; Soejima M, 2006, MOL BIOL EVOL, V23, P179, DOI 10.1093/molbev/msj018; Tang K, 2007, PLOS BIOL, V5, P1587, DOI 10.1371/journal.pbio.0050171; Thesleff Irma, 2002, Sci STKE, V2002, ppe22, DOI 10.1126/stke.2002.131.pe22; Thornton KR, 2007, GENETICS, V175, P737, DOI 10.1534/genetics.106.064642; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Voight BF, 2005, P NATL ACAD SCI USA, V102, P18508, DOI 10.1073/pnas.0507325102; Waters MR, 2007, SCIENCE, V315, P1122, DOI 10.1126/science.1137166; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Wright S., 1969, THEORY GENE FREQUENC; Yan MH, 2002, CURR BIOL, V12, P409, DOI 10.1016/S0960-9822(02)00687-5	49	72	75	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2209	10.1371/journal.pone.0002209	http://dx.doi.org/10.1371/journal.pone.0002209			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493316	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000262258700018
J	Jiang, LQ; Wang, MY; Zhang, J; Monticone, RE; Telljohann, R; Spinetti, G; Pintus, G; Lakatta, EG				Jiang, Liqun; Wang, Mingyi; Zhang, Jing; Monticone, Robert E.; Telljohann, Richard; Spinetti, Gaia; Pintus, Gianfranco; Lakatta, Edward G.			Increased Aortic Calpain-1 Activity Mediates Age-Associated Angiotensin II Signaling of Vascular Smooth Muscle Cells	PLOS ONE			English	Article								Background: Angiotensin II (Ang II) signaling, including matrix metalloproteinase type II (MMP2) activation, has been linked to an age-associated increase in migration capacity of vascular smooth muscle cells (VSMC), and to other proinflammatory features of arterial aging. Calpain-1 activation is required for MMP2 expression in fibroblasts and is induced in cardiomyocytes by Ang II. The consequences of engagement of calpain-1 with its substrates, however, in governing the age-associated proinflammatory status within the arterial wall, remains unknown. Methodology/Principal Findings: The present findings demonstrate that transcription, translation, and activity of calpain-1 are significantly up-regulated in rat aortae or early-passage aortic VSMC from old (30-mo) rats compared to young (8-mo). Dual immunolabeling of the arterial wall indicates that colocalization of calpain-1 and Ang II increases within the aged arterial wall. To further explore the relationship of calpain-1 to Ang II, we chronically infused Ang II into young rats, and treated cultured aortic rings or VSMC with Ang II. We also constructed adenoviruses harboring calpain-1 (CANP1) or its endogenous inhibitor calpastatin (CAST) and infected these into VSMC. Ang II induces calpain-1 expression in the aortic walls in vivo and ex vivo and VSMC in vitro. The Ang II mediated, age-associated increased MMP2 activity and migration in VSMC are both blocked by calpain inhibitor 1 or CAST. Over-expression of calpain-1 in young VSMC results in cleavage of intact vimentin, and an increased migratory capacity mimicking that of old VSMC, which is blocked by the MMP inhibitor, GM6001. Conclusions/Significance: Calpain-1 activation is a pivotal molecular event in the age-associated arterial Ang II/MMP2 signaling cascade that is linked to cytoskeleton protein restructuring, and VSMC migration. Therefore, targeting calpain-1 has the potential to delay or reverse the arterial remodeling that underlies age-associated diseases i.e. atherosclerosis.	[Jiang, Liqun; Wang, Mingyi; Zhang, Jing; Monticone, Robert E.; Telljohann, Richard; Spinetti, Gaia; Pintus, Gianfranco; Lakatta, Edward G.] NIA, Cardiovasc Sci Lab, Natl Inst Hlth, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Jiang, LQ (corresponding author), NIA, Cardiovasc Sci Lab, Natl Inst Hlth, Baltimore, MD 21224 USA.	mingyiw@grc.nia.nih.gov	Pintus, Gianfranco/C-2975-2009; Wang, Mingyi/L-8370-2017; Spinetti, Gaia/T-8245-2018; Lakatta, Edward G/AAL-1447-2020	Pintus, Gianfranco/0000-0002-3031-7733; Wang, Mingyi/0000-0001-6412-369X; Spinetti, Gaia/0000-0001-7996-6809; Lakatta, Edward/0000-0002-4772-0035	Intramural Research Program of the NIH, National Institute on Aging; NATIONAL INSTITUTE ON AGING [ZIAAG000236, Z01AG000236] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Intramural Research Program of the NIH, National Institute on Aging.	Abe M, 1998, J CELL PHYSIOL, V174, P186, DOI 10.1002/(SICI)1097-4652(199802)174:2<186::AID-JCP6>3.0.CO;2-K; Bennett BJ, 2006, ARTERIOSCL THROM VAS, V26, P2117, DOI 10.1161/01.ATV.0000236428.91125.e6; Bialkowska K, 2005, J CELL SCI, V118, P381, DOI 10.1242/jcs.01625; Burkard N, 2005, CIRCULATION, V111, P1045, DOI 10.1161/01.CIR.0000156458.80515.F7; Byun Y, 2001, CELL DEATH DIFFER, V8, P443, DOI 10.1038/sj.cdd.4400840; Croall DE, 2002, ANAL BIOCHEM, V304, P129, DOI 10.1006/abio.2001.5606; Csiszar A, 2002, CIRC RES, V90, P1159, DOI 10.1161/01.RES.0000020401.61826.EA; Droge W, 2007, AGING CELL, V6, P361, DOI 10.1111/j.1474-9726.2007.00294.x; EGGENA P, 1988, CLIN EXP HYPERTENS A, V10, P597, DOI 10.3109/10641968809033912; Escobales N, 1996, J HYPERTENS, V14, P115; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Harris F, 2006, ANN NY ACAD SCI, V1084, P452, DOI 10.1196/annals.1372.011; HATA A, 1992, FEBS LETT, V304, P241, DOI 10.1016/0014-5793(92)80628-T; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hood JL, 2006, BIOESSAYS, V28, P850, DOI 10.1002/bies.20440; Huang YH, 2001, TRENDS MOL MED, V7, P355, DOI 10.1016/S1471-4914(01)02049-4; Ishihata A, 2006, ANN NY ACAD SCI, V1067, P173, DOI 10.1196/annals.1354.021; ISHII H, 1992, BIOCHEM J, V284, P755, DOI 10.1042/bj2840755; Jiang LQ, 2002, HYPERTENS RES, V25, P647; KAPPRELL HP, 1989, J BIOL CHEM, V264, P17888; Kieffer P, 2000, LIFE SCI, V66, P2371, DOI 10.1016/S0024-3205(00)00567-1; Korzick DH, 2005, CARDIOVASC RES, V66, P384, DOI 10.1016/j.cardiores.2005.01.015; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; Lakatta EG, 2003, CIRCULATION, V107, P490, DOI 10.1161/01.CIR.0000048894.99865.02; Lebart MC, 2006, FEBS J, V273, P3415, DOI 10.1111/j.1742-4658.2006.05350.x; Li ZH, 1997, EXP MOL PATHOL, V64, P1, DOI 10.1006/exmp.1997.2204; Manya H, 2002, J BIOL CHEM, V277, P35503, DOI 10.1074/jbc.M206033200; Matsubara H, 2000, MOL CELL BIOCHEM, V212, P187, DOI 10.1023/A:1007189828584; MICHEL JB, 1994, AM J PHYSIOL, V267, pR214; Nagai Y, 1998, CIRCULATION, V98, P1504, DOI 10.1161/01.CIR.98.15.1504; Newcomb JK, 2000, METH MOL B, V144, P219; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; PAULY RR, 1994, CIRC RES, V75, P41, DOI 10.1161/01.RES.75.1.41; Popp O, 2003, BIOL CHEM, V384, P951, DOI 10.1515/BC.2003.107; Postovit LM, 2002, BIOCHEM BIOPH RES CO, V297, P294, DOI 10.1016/S0006-291X(02)02187-3; Sahar S, 2005, CIRC RES, V96, P1064, DOI 10.1161/01.RES.0000168210.10358.f4; Sandmann S, 2001, BRIT J PHARMACOL, V132, P767, DOI 10.1038/sj.bjp.0703860; Schaub FJ, 2003, CIRC RES, V93, P515, DOI 10.1161/01.RES.0000093205.42313.7C; Scherberich A, 2000, J CELL SCI, V113, P653; Spinetti G, 2004, ARTERIOSCL THROM VAS, V24, P1397, DOI 10.1161/01.ATV.0000134529.65173.08; STARY HC, 1990, EUR HEART J, V11, P3, DOI 10.1093/eurheartj/11.suppl_E.3; Tabet F, 2004, J CARDIOVASC PHARM, V44, P200, DOI 10.1097/00005344-200408000-00009; Takahashi M, 2006, J CARDIOVASC PHARM, V47, P413; van der Loo B, 2000, J EXP MED, V192, P1731, DOI 10.1084/jem.192.12.1731; Viedt C, 2004, J MOL MED, V82, P31, DOI 10.1007/s00109-003-0500-5; VIRMANI R, 1991, AM J PATHOL, V139, P1119; Wang M, 2002, HYPERTENSION, V39, P865, DOI 10.1161/01.HYP.0000014506.13322.66; Wang M, 2006, HDB HYPERTENSION ART, P137; Wang M, 2007, HYPERTENSION, V50, P219, DOI 10.1161/HYPERTENSIONAHA.107.089409; Wang M, 2006, CIRCULATION, V114, P335; Wang MY, 2006, ARTERIOSCL THROM VAS, V26, P1503, DOI 10.1161/01.ATV.0000225777.58488.f2; Wang MY, 2005, AM J PATHOL, V167, P1429, DOI 10.1016/S0002-9440(10)61229-1; Wang MY, 2003, HYPERTENSION, V41, P1308, DOI 10.1161/01.HYP.0000073843.56046.45; Yildiz G, 2007, ANN NY ACAD SCI, V1100, P353, DOI 10.1196/annals.1395.038; ZAWASKI K, 1993, BIOCHEM BIOPH RES CO, V197, P585, DOI 10.1006/bbrc.1993.2519; Zhan YM, 2005, J CLIN INVEST, V115, P2508, DOI 10.1172/JCI24403	56	78	81	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2231	10.1371/journal.pone.0002231	http://dx.doi.org/10.1371/journal.pone.0002231			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493299	gold, Green Published, Green Submitted			2022-12-25	WOS:000262258700039
J	Marchesi, C; Belicchi, M; Meregalli, M; Farini, A; Cattaneo, A; Parolini, D; Gavina, M; Porretti, L; D'Angelo, MG; Bresolin, N; Cossu, G; Torrente, Y				Marchesi, Chiara; Belicchi, Marzia; Meregalli, Mirella; Farini, Andrea; Cattaneo, Alessandra; Parolini, Daniele; Gavina, Manuela; Porretti, Laura; D'Angelo, Maria Grazia; Bresolin, Nereo; Cossu, Giulio; Torrente, Yvan			Correlation of Circulating CD133+Progenitor Subclasses with a Mild Phenotype in Duchenne Muscular Dystrophy Patients	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; STEM-CELLS; EXPRESSION; MARKER; BLOOD; GLUCOCORTICOIDS; PROGRESSION; THICKNESS; DISEASE; HEART	Background: Various prognostic serum and cellular markers have been identified for many diseases, such as cardiovascular diseases and tumor pathologies. Here we assessed whether the levels of certain stem cells may predict the progression of Duchenne muscular dystrophy (DMD). Methods and Findings: The levels of several subpopulations of circulating stem cells expressing the CD133 antigen were determined by flow cytometry in 70 DMD patients. The correlation between the levels and clinical status was assessed by statistical analysis. The median (+/- SD) age of the population was 10.66 +/- 3.81 (range 3 to 20 years). The levels of CD133+CXCR4+CD34- stem cells were significantly higher in DMD patients compared to healthy controls (mean +/- standard deviation: 17.38 +/- 1.38 vs. 11.0 +/- 1.70; P = 0.03) with a tendency towards decreased levels in older patients. Moreover, the levels of this subpopulation of cells correlated with the clinical condition. In a subgroup of 19 DMD patients after 24 months of follow-up, increased levels of CD133+CXCR4+CD34- cells was shown to be associated with a phenotype characterised by slower disease progression. The circulating CD133+CXCR4+CD34- cells in patients from different ages did not exhibit significant differences in their myogenic and endothelial in vitro differentiation capacity. Conclusions: Our results suggest that levels of CD133+CXCR4+CD34- could function as a new prognostic clinical marker for the progression of DMD.	[Marchesi, Chiara; Belicchi, Marzia; Meregalli, Mirella; Farini, Andrea; Parolini, Daniele; Gavina, Manuela; Bresolin, Nereo; Torrente, Yvan] Univ Milan, Ctr Dino Ferrari, IRCCS Osped Maggiore Policliln, Dept Neurol Sci,Stem Cell Lab, Milan, Italy; [Cattaneo, Alessandra; Porretti, Laura] Univ Milan, IRCCS Osped Maggiore Policlin, Centro Trasfusionale Immunol Trapianti, Milan, Italy; [D'Angelo, Maria Grazia] IRCCS E Medea, Bosisio Parini, Italy; [Cossu, Giulio] Osped San Raffaele, Stem Cell Res Inst, Milan, Italy	University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Eugenio Medea; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Marchesi, C (corresponding author), Univ Milan, Ctr Dino Ferrari, IRCCS Osped Maggiore Policliln, Dept Neurol Sci,Stem Cell Lab, Milan, Italy.	torrenteyvan@hotmail.com	Porretti, Laura/J-6748-2015; Cattaneo, Alessandra/K-5049-2012; D'Angelo, Maria Grazia/K-4685-2016; TORRENTE, YVAN/A-2964-2015	Porretti, Laura/0000-0001-8100-4262; Cattaneo, Alessandra/0000-0002-4500-6540; D'Angelo, Maria Grazia/0000-0003-1241-4350; Bresolin, Nereo/0000-0001-6694-3595; Meregalli, Mirella/0000-0002-5151-607X; Farini, Andrea/0000-0002-8514-4921; TORRENTE, YVAN/0000-0002-2705-3984	European Union [LSH-2005-037479]; Association Monegasque contre les Myopathies; Duchenne Parent Project de France; Associazione La Nostra Famiglia Fondo DMD Gli Amici di Emanuele; Ricerca Corrente and Progetto a Concorso 2006 Fondazione IRCCS Policlinico Hospital of Milan; Associazione Amici Centro Dino Ferrari, Department of Neurological Science, University of Milan, Italy	European Union(European Commission); Association Monegasque contre les Myopathies; Duchenne Parent Project de France; Associazione La Nostra Famiglia Fondo DMD Gli Amici di Emanuele; Ricerca Corrente and Progetto a Concorso 2006 Fondazione IRCCS Policlinico Hospital of Milan; Associazione Amici Centro Dino Ferrari, Department of Neurological Science, University of Milan, Italy	This work was founded by the European Union under the 6th Framework Programme (Contract no.: LSH-2005-037479; Project acronym: MYOAMP) and supported by the Association Monegasque contre les Myopathies (AMM; ICE project), the Duchenne Parent Project de France (DPP France), the Associazione La Nostra Famiglia Fondo DMD Gli Amici di Emanuele, the Ricerca Corrente and Progetto a Concorso 2006 Fondazione IRCCS Policlinico Hospital of Milan and by the Associazione Amici Centro Dino Ferrari, Department of Neurological Science, University of Milan, Italy.	Angelini C, 1996, J NEUROL SCI, V142, P70, DOI 10.1016/0022-510X(96)00144-X; BAUMBACH LL, 1989, NEUROLOGY, V39, P465, DOI 10.1212/WNL.39.4.465; Boos CJ, 2006, J AM COLL CARDIOL, V48, P1538, DOI 10.1016/j.jacc.2006.02.078; BROOKE MH, 1989, NEUROLOGY, V39, P475, DOI 10.1212/WNL.39.4.475; de Groot E, 2004, CIRCULATION, V109, P33, DOI 10.1161/01.CIR.0000131516.65699.ba; Del Papa N, 2004, ARTHRITIS RHEUM-US, V50, P1296, DOI 10.1002/art.20116; Derfoul A, 2006, STEM CELLS, V24, P1487, DOI 10.1634/stemcells.2005-0415; Dome B, 2006, CANCER RES, V66, P7341, DOI 10.1158/0008-5472.CAN-05-4654; Duda DG, 2006, J CLIN ONCOL, V24, P1449, DOI 10.1200/JCO.2005.04.2861; Eagle M, 2002, NEUROMUSCULAR DISORD, V12, P926, DOI 10.1016/S0960-8966(02)00140-2; Fadini GP, 2006, STEM CELLS, V24, P1806, DOI 10.1634/stemcells.2005-0440; Finsterer J, 2003, CARDIOLOGY, V99, P1, DOI 10.1159/000068446; Gallacher L, 2000, BLOOD, V95, P2813, DOI 10.1182/blood.V95.9.2813.009k20_2813_2820; Gavina M, 2006, BLOOD, V108, P2857, DOI 10.1182/blood-2006-04-018564; Grafte-Faure S, 1999, AM J HEMATOL, V62, P65, DOI 10.1002/(SICI)1096-8652(199910)62:2<65::AID-AJH1>3.0.CO;2-G; Guven H, 2006, J AM COLL CARDIOL, V48, P1579, DOI 10.1016/j.jacc.2006.04.101; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HOFFMAN EP, 1990, J NEUROL SCI, V99, P9, DOI 10.1016/0022-510X(90)90195-S; Hyde SA, 2001, NEUROMUSCULAR DISORD, V11, P165, DOI 10.1016/S0960-8966(00)00175-9; Infante JP, 1999, MOL CELL BIOCHEM, V195, P155, DOI 10.1023/A:1006972315739; Lorenz MW, 2006, STROKE, V37, P87, DOI 10.1161/01.STR.0000196964.24024.ea; Makita S, 2005, STROKE, V36, P2138, DOI 10.1161/01.STR.0000181740.74005.ee; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; Phillips MF, 2001, AM J RESP CRIT CARE, V164, P2191, DOI 10.1164/ajrccm.164.12.2103052; Sabolek M, 2006, NEUROREPORT, V17, P1719, DOI 10.1097/01.wnr.0000236862.08834.50; Scott E, 2006, DEV MED CHILD NEUROL, V48, P540, DOI 10.1017/S0012162206001137; SCOTT OM, 1982, MUSCLE NERVE, V5, P291, DOI 10.1002/mus.880050405; Torrente Y, 2004, J CLIN INVEST, V114, P182, DOI 10.1172/JCI200420325; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	31	5	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2218	10.1371/journal.pone.0002218	http://dx.doi.org/10.1371/journal.pone.0002218			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493616	Green Published, Green Submitted, gold			2022-12-25	WOS:000262258700026
J	Raymond, SB; Treat, LH; Dewey, JD; McDannold, NJ; Hynynen, K; Bacskai, BJ				Raymond, Scott B.; Treat, Lisa H.; Dewey, Jonathan D.; McDannold, Nathan J.; Hynynen, Kullervo; Bacskai, Brian J.			Ultrasound Enhanced Delivery of Molecular Imaging and Therapeutic Agents in Alzheimer's Disease Mouse Models	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; FOCUSED ULTRASOUND; TARGETED DELIVERY; NERVOUS-SYSTEM; ADULT-MOUSE; ANTIBODIES; PEPTIDE; IMMUNOTHERAPY; PERMEABILITY; DISRUPTION	Alzheimer's disease is a neurodegenerative disorder typified by the accumulation of a small protein, beta-amyloid, which aggregates and is the primary component of amyloid plaques. Many new therapeutic and diagnostic agents for reducing amyloid plaques have limited efficacy in vivo because of poor transport across the blood-brain barrier. Here we demonstrate that low-intensity focused ultrasound with a microbubble contrast agent may be used to transiently disrupt the blood-brain barrier, allowing non-invasive, localized delivery of imaging fluorophores and immunotherapeutics directly to amyloid plaques. We administered intravenous Trypan blue, an amyloid staining red fluorophore, and anti-amyloid antibodies, concurrently with focused ultrasound therapy in plaque-bearing, transgenic mouse models of Alzheimer's disease with amyloid pathology. MRI guidance permitted selective treatment and monitoring of plaque-heavy anatomical regions, such as the hippocampus. Treated brain regions exhibited 16.5 +/- 5.4-fold increase in Trypan blue fluorescence and 2.7 +/- 1.2-fold increase in anti-amyloid antibodies that localized to amyloid plaques. Ultrasound-enhanced delivery was consistently reproduced in two different transgenic strains (APPswe:PSEN1dE9, PDAPP), across a large age range (9-26 months), with and without MR guidance, and with little or no tissue damage. Ultrasound-mediated, transient blood-brain barrier disruption allows the delivery of both therapeutic and molecular imaging agents in Alzheimer's mouse models, which should aid pre-clinical drug screening and imaging probe development. Furthermore, this technique may be used to deliver a wide variety of small and large molecules to the brain for imaging and therapy in other neurodegenerative diseases.	[Raymond, Scott B.; Treat, Lisa H.] Harvard Univ, MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Raymond, Scott B.; Bacskai, Brian J.] Harvard Med Sch, Massachusetts General Hosp, Dept Neurol, Boston, MA USA; [Treat, Lisa H.; McDannold, Nathan J.] Harvard Med Sch, Brigham and Womens Hosp, Dept Radiol, Boston, MA USA; [Dewey, Jonathan D.] Duke Univ, Sch Med, Durham, NC USA; [Hynynen, Kullervo] Univ Toronto, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada	Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Duke University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Raymond, SB (corresponding author), Harvard Univ, MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA.	bbacskai@partners.org	Bacskai, Brian/AAE-9583-2021; Raymond, Scott/AGV-0585-2022	Raymond, Scott/0000-0001-7008-8974	NIH [EB000768, EB000705, AG026240, U41RR019703, T32 EB001680]; NDSEG [fellowship]; Harvard University [Ashford fellowship]; MIT Whitaker Health Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES [U41RR019703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R33EB000705, R01EB003268, T32EB001680, R01EB000768, R21EB000705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026240] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NDSEG; Harvard University; MIT Whitaker Health Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Our work was supported by NIH EB000768, EB000705, AG026240, and U41RR019703. S. B. Raymond is supported by T32 EB001680, an NDSEG fellowship, and a Harvard University Ashford fellowship. L. H. Treat is supported by the MIT Whitaker Health Sciences Fund.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Bard F, 2003, P NATL ACAD SCI USA, V100, P2023, DOI 10.1073/pnas.0436286100; Choi JJ, 2007, ULTRASOUND MED BIOL, V33, P95, DOI 10.1016/j.ultrasmedbio.2006.07.018; Dickstein DL, 2006, FASEB J, V20, P426, DOI 10.1096/fj.05-3956com; Fryer JD, 2003, J NEUROSCI, V23, P7889; Furumoto S, 2007, CURR TOP MED CHEM, V7, P1773, DOI 10.2174/156802607782507402; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; Gardberg AS, 2007, P NATL ACAD SCI USA, V104, P15659, DOI 10.1073/pnas.0705888104; Hawkes Cheryl A, 2007, Expert Rev Neurother, V7, P1535, DOI 10.1586/14737175.7.11.1535; Hull M, 2006, DRUGS, V66, P2075; Hynynen K, 2005, NEUROIMAGE, V24, P12, DOI 10.1016/j.neuroimage.2004.06.046; Hynynen K, 2004, MAGN RESON MED, V52, P100, DOI 10.1002/mrm.20118; Hynynen K, 2001, RADIOLOGY, V220, P640, DOI 10.1148/radiol.2202001804; Hynynen K, 2006, EUR J RADIOL, V59, P149, DOI 10.1016/j.ejrad.2006.04.007; Ingelsson M, 2002, ANN MED, V34, P259, DOI 10.1080/078538902320322529; Kinoshita M, 2006, BIOCHEM BIOPH RES CO, V340, P1085, DOI 10.1016/j.bbrc.2005.12.112; Kinoshita M, 2006, P NATL ACAD SCI USA, V103, P11719, DOI 10.1073/pnas.0604318103; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Macklin CC, 1920, ARCH NEURO PSYCHIATR, V3, P353, DOI 10.1001/archneurpsyc.1920.02180160002001; McDannold N, 2005, ULTRASOUND MED BIOL, V31, P1527, DOI 10.1016/j.ultrasmedbio.2005.07.010; McDannold N J, 2000, Top Magn Reson Imaging, V11, P191, DOI 10.1097/00002142-200006000-00005; Mintun MA, 2006, NEUROLOGY, V67, P446, DOI 10.1212/01.wnl.0000228230.26044.a4; Nikolic WV, 2007, P NATL ACAD SCI USA, V104, P2507, DOI 10.1073/pnas.0609377104; Pike KE, 2007, BRAIN, V130, P2837, DOI 10.1093/brain/awm238; Poduslo JF, 2001, NEUROBIOL DIS, V8, P555, DOI 10.1006/nbdi.2001.0402; Poduslo JF, 2007, J NEUROCHEM, V102, P420, DOI 10.1111/j.1471-4159.2007.04591.x; Raymond SB, 2007, J CEREBR BLOOD F MET, V27, P393, DOI 10.1038/sj.jcbfm.9600336; Senechal Y, 2007, J NEUROCHEM, V102, P1928, DOI 10.1111/j.1471-4159.2007.04672.x; Sheikov N, 2004, ULTRASOUND MED BIOL, V30, P979, DOI 10.1016/j.ultrasmedbio.2004.04.010; Sheikov N, 2006, ULTRASOUND MED BIOL, V32, P1399, DOI 10.1016/j.ultrasmedbio.2006.05.015; Shi NY, 2000, P NATL ACAD SCI USA, V97, P7567, DOI 10.1073/pnas.130187497; SIGURDSSON EM, 2007, NEUROBIOL AGING; Skowronek M, 2000, COMPUT CHEM, V24, P429, DOI 10.1016/S0097-8485(99)00089-3; Thakker DR, 2004, P NATL ACAD SCI USA, V101, P17270, DOI 10.1073/pnas.0406214101; Treat LH, 2007, INT J CANCER, V121, P901, DOI 10.1002/ijc.22732; Ujiie M, 2003, MICROCIRCULATION, V10, P463, DOI 10.1038/sj.mn.7800212; Wu DF, 1999, P NATL ACAD SCI USA, V96, P254, DOI 10.1073/pnas.96.1.254; Yang FY, 2007, ULTRASOUND MED BIOL, V33, P1421, DOI 10.1016/j.ultrasmedbio.2007.04.006	39	168	183	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2175	10.1371/journal.pone.0002175	http://dx.doi.org/10.1371/journal.pone.0002175			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478109	Green Published, gold, Green Submitted			2022-12-25	WOS:000262172800040
J	Umar, S; Sarkar, S; Cowey, S; Singh, P				Umar, S.; Sarkar, S.; Cowey, S.; Singh, P.			Activation of NF-kappa B is required for mediating proliferative and antiapoptotic effects of progastrin on proximal colonic crypts of mice, in vivo	ONCOGENE			English	Article						annexin II; progastrin; NF kappa B; ERKs; Fabp-PG mice; NEMO	INTESTINAL EPITHELIAL-CELLS; TISSUE-PLASMINOGEN ACTIVATOR; ANNEXIN-II; GENE-EXPRESSION; CANCER CELLS; TRANSGENIC MICE; GROWTH; APOPTOSIS; RECEPTOR; BINDING	Mice overexpressing progastrin (PG) in intestinal mucosa (fatty acid-binding protein (Fabp)-PG mice) are at an increased risk of proximal colon carcinogenesis in response to azoxymethane. Here, we report a significant increase in the length of proximal colonic crypts in Fabp-PG mice, associated with potent antiapoptotic effects of PG, which likely contributed to the previously reported increase in colon carcinogenesis in Fabp-PG mice. Phosphorylation of kinase of I kappa B alpha (IKK alpha/beta), inhibitor of kappa B (I kappa B) a and p65NF-kappa B was significantly elevated in proximal colonic crypts of Fabp-PG versus wild-type mice, which was associated with degradation of I kappa B alpha and nuclear translocation/activation of p65. Surprisingly, distal colonic crypt cells were not as responsive to elevated levels of PG in Fabp-PG mice. Annexin II, recently described as a high-affinity receptor for PG, strongly colocalized with PG intracellularly and on basolateral membranes of proximal crypt cells, providing evidence that annexin-II binds PG in situ in colonic crypt cells. Proliferative and antiapoptotic effects of PG on proximal crypts of Fabp-PG mice were attenuated to wild-type levels, on treatment with NEMO peptide (an inhibitor of nuclear factor-kappa B (NF-kappa B) activation), demonstrating for the first time a critical role of NF-kappa B in mediating hyperproliferative affects of PG on colonic crypts of Fabp-PG mice, in vivo. Thus, downregulation of NF-kappa B may significantly reduce the increased risk of colon carcinogenesis in response to PG.	[Sarkar, S.; Cowey, S.; Singh, P.] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Umar, S.] Univ Texas Med Branch, Dept Internal Med, Galveston, TX USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Singh, P (corresponding author), Univ Texas Med Branch, Dept Neurosci & Cell Biol, 301 Univ Blvd,Route 1043, Galveston, TX 77555 USA.	posingh@utmb.edu			NATIONAL CANCER INSTITUTE [R01CA114264, R03CA099121, R01CA097959] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA114264-04, R03 CA099121, R01 CA097959, R01 CA114264-05, CA97959, R01 CA097959-05, R03 CA099121-03, CA099121, R01 CA097959-06A2, R01 CA114264, CA114264] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahmed S, 2005, PEPTIDES, V26, P1207, DOI 10.1016/j.peptides.2005.02.001; Aly A, 2001, INT J CANCER, V94, P307, DOI 10.1002/ijc.1483; Baldwin GS, 2001, J BIOL CHEM, V276, P7791, DOI 10.1074/jbc.M009985200; CHICONE L, 1989, BIOCHEM BIOPH RES CO, V164, P512, DOI 10.1016/0006-291X(89)91749-X; CHUNG CY, 1994, J CELL BIOL, V126, P539, DOI 10.1083/jcb.126.2.539; Cobb S, 2004, CANCER-AM CANCER SOC, V100, P1311, DOI 10.1002/cncr.20094; Dasgupta S, 2004, J IMMUNOL, V173, P1344, DOI 10.4049/jimmunol.173.2.1344; Dockray GJ, 1996, PHYSIOL REV, V76, P767, DOI 10.1152/physrev.1996.76.3.767; Ferrand A, 2005, CANCER RES, V65, P2770, DOI 10.1158/0008-5472.CAN-04-0978; Forstner J., 1994, PHYSL GASTROINTESTIN; Fric P, 2000, EUR J CANCER PREV, V9, P265, DOI 10.1097/00008469-200008000-00006; Glebov OK, 2003, CANCER EPIDEM BIOMAR, V12, P755; HAJJAR KA, 1994, J BIOL CHEM, V269, P21191; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hong MY, 1999, CELL GROWTH DIFFER, V10, P749; Iacopetta B, 2002, INT J CANCER, V101, P403, DOI 10.1002/ijc.10635; Lifshitz S, 2001, CANCER LETT, V163, P229, DOI 10.1016/S0304-3835(00)00624-8; Liu LU, 1999, GUT, V45, P45, DOI 10.1136/gut.45.1.45; Marshman E, 2001, J PATHOL, V195, P285; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Mills SJ, 2001, GUT, V48, P41, DOI 10.1136/gut.48.1.41; Muerkoster S, 2005, GASTROENTEROLOGY, V129, P952, DOI 10.1053/j.gastro.2005.06.059; Ortiz-Zapater E, 2007, AM J PATHOL, V170, P1573, DOI 10.2353/ajpath.2007.060850; Ottewell PD, 2005, AM J PHYSIOL-GASTR L, V288, pG541, DOI 10.1152/ajpgi.00268.2004; Ottewell PD, 2003, GASTROENTEROLOGY, V124, P1348, DOI 10.1016/S0016-5085(03)00288-9; Rengifo-Cam W, 2004, CURR PHARM DESIGN, V10, P2345, DOI 10.2174/1381612043383999; Rengifo-Cam W, 2007, CANCER RES, V67, P7266, DOI 10.1158/0008-5472.CAN-07-1206; Sarkar S, 2007, GASTROENTEROLOGY, V132, pA540; SATO M, 1992, ANAT RECORD, V233, P409, DOI 10.1002/ar.1092330308; SEVA C, 1994, SCIENCE, V265, P410, DOI 10.1126/science.8023165; Singh P, 2007, ONCOGENE, V26, P425, DOI 10.1038/sj.onc.1209798; Singh P, 2000, GASTROENTEROLOGY, V119, P162, DOI 10.1053/gast.2000.8527; Singh P, 2000, AM J PHYSIOL-GASTR L, V278, pG390, DOI 10.1152/ajpgi.2000.278.3.G390; Singh P, 2003, AM J PHYSIOL-GASTR L, V284, pG328, DOI 10.1152/ajpgi.00351.2002; Singh P, 2007, CANCER LETT, V252, P19, DOI 10.1016/j.canlet.2006.11.012; Song DH, 2003, AM J PHYSIOL-GASTR L, V285, pG217, DOI 10.1152/ajpgi.00516.2002; Umar S, 2003, CELL PROLIFERAT, V36, P361, DOI 10.1046/j.1365-2184.2003.00291.x; Umar S, 2000, AM J PHYSIOL-GASTR L, V279, pG223, DOI 10.1152/ajpgi.2000.279.1.G223; Umar S, 2007, AM J PHYSIOL-GASTR L, V292, pG599, DOI 10.1152/ajpgi.00343.2006; Wang TC, 1996, J CLIN INVEST, V98, P1918, DOI 10.1172/JCI118993; Wang Y, 2006, BRIT J PHARMACOL, V148, P814, DOI 10.1038/sj.bjp.0706784; Watanabe T, 2006, CANCER RES, V66, P9804, DOI 10.1158/0008-5472.CAN-06-1163; Wu H, 2003, AM J PHYSIOL-GASTR L, V285, pG1097, DOI 10.1152/ajpgi.00216.2003; Zizzo MG, 2006, BRIT J PHARMACOL, V148, P956, DOI 10.1038/sj.bjp.0706808	44	27	32	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP 18	2008	27	42					5599	5611		10.1038/onc.2008.169	http://dx.doi.org/10.1038/onc.2008.169			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	349KX	18521082	Green Accepted			2022-12-25	WOS:000259280800006
J	Suzuki, K; Juelich, T; Lim, H; Ishida, T; Watanebe, T; Cooper, DA; Rao, S; Kelleher, AD				Suzuki, Kazuo; Juelich, Torsten; Lim, Heidi; Ishida, Takaomi; Watanebe, Toshiki; Cooper, David A.; Rao, Sudha; Kelleher, Anthony D.			Closed chromatin architecture is induced by an RNA duplex targeting the HIV-1 promoter region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; H3 LYSINE-9 METHYLATION; DOUBLE-STRANDED-RNA; GENE-EXPRESSION; HUMAN-CELLS; TRANSCRIPTIONAL ACTIVATION; DNA METHYLATION; IN-VITRO; HETEROCHROMATIN PROTEIN-1; HISTONE METHYLATION	In some mammalian systems small interfering RNAs (siRNA) targeting homologous sequences in promoter regions of genes induce transcriptional gene silencing (TGS). We have previously reported the induction of TGS by an siRNA (prom-A siRNA) targeting the tandem NF-kappa B-binding motifs with in the human immunodeficiency virus, type 1 (HIV-1), promoter region. Here we report that induction of TGS by prom-A siRNA is accompanied by immediate and sustained local recruitment of Argonaute-1(Ago1), histone deacetylase-1 (HDAC1), and induction of dimethylation of histone 3 at lysine 9 (H3K9me2), processes known to be associated with transcriptional silencing. Elevated levels of H3K9me2 and HDAC1 spread upstream of the target sequence, and elevated H3K9me2 levels also spread downstream into the coding region. Moreover, this siRNA induces an immediate change in DNA accessibility to restriction enzyme digestion in the region of the transcription initiation site of the HIV-1. This change in accessibility is because of the relocation of a nucleosome known to be associated with this region of the integrated pro-virus. Although there is a theoretical possibility that the observed viral suppression could be mediated by the PTGS mechanism with this siRNA acting at the 3'-long term repeat of the virus, we demonstrate that this siRNA, and three other U3 targeted siRNAs, are inefficient inducers of PTGS. These data strongly suggest that siRNA targeting the promoter region acts predominantly at a site within the 5'-long term repeat of HIV to induce transcriptional silencing and alterations to chromatin structure of the HIV promoter region that extend well beyond the immediate siRNA target site. These induced changes are consistent with those described in latent HIV-1 infection.	[Suzuki, Kazuo; Lim, Heidi; Cooper, David A.; Kelleher, Anthony D.] St Vincents Hosp, Ctr Immunol, Immunovirol Lab, Darlinghurst, NSW 2010, Australia; [Juelich, Torsten; Rao, Sudha] John Curtin Sch Med Res, Div Immunol & Genet, Canc Vasc Biol Grp, Canberra, ACT 2601, Australia; [Ishida, Takaomi; Watanebe, Toshiki] Univ Tokyo, Tumor Cell Biol Lab, Dept Med Genome Sci, Grad Sch Frontier Sci, Tokyo 1088639, Japan; [Lim, Heidi; Cooper, David A.; Kelleher, Anthony D.] Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Darlinghurst, NSW 2010, Australia	St Vincents Hospital Sydney; Australian National University; John Curtin School of Medical Research; University of Tokyo; University of New South Wales Sydney; Kirby Institute	Suzuki, K (corresponding author), St Vincents Hosp, Ctr Immunol, Immunovirol Lab, Darlinghurst, NSW 2010, Australia.	k.suzuki@cfi.unsw.edu.au	Rao, Sudha/AAW-5192-2020	Rao, Sudha/0000-0001-9547-947X; Suzuki, Kazuo/0000-0002-2531-794X				ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; ALDOVINI A, 1990, TECHNIQUES HIV RES H, P51; Bennasser Yamina, 2004, Retrovirology, V1, P43, DOI 10.1186/1742-4690-1-43; Buhler M, 2005, MOL CELL, V18, P307, DOI 10.1016/j.molcel.2005.03.030; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Castanotto D, 2005, MOL THER, V12, P179, DOI 10.1016/j.ymthe.2005.03.003; CLARKE MF, 1984, VIROLOGY, V135, P97, DOI 10.1016/0042-6822(84)90120-X; COFFIN JM, 1997, RETROVIRUSES, P205; Cryderman DE, 2005, DEV DYNAM, V232, P767, DOI 10.1002/dvdy.20310; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; du Chene I, 2007, EMBO J, V26, P424, DOI 10.1038/sj.emboj.7601517; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Greil F, 2003, GENE DEV, V17, P2825, DOI 10.1101/gad.281503; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Han J, 2007, P NATL ACAD SCI USA, V104, P12422, DOI 10.1073/pnas.0701635104; Han YF, 2007, NAT REV MICROBIOL, V5, P95, DOI 10.1038/nrmicro1580; HARBERS K, 1981, P NATL ACAD SCI-BIOL, V78, P7609, DOI 10.1073/pnas.78.12.7609; Haynes KA, 2006, CURR BIOL, V16, P2222, DOI 10.1016/j.cub.2006.09.035; HU WS, 1984, J VIROL, V49, P66, DOI 10.1128/JVI.49.1.66-71.1984; Hutvagner G, 2008, NAT REV MOL CELL BIO, V105, P512; Janowski BA, 2005, NAT CHEM BIOL, V1, P216, DOI 10.1038/nchembio725; Janowski BA, 2005, NAT CHEM BIOL, V1, P210, DOI 10.1038/nchembio724; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Kirn JW, 2007, BIOCHEM BIOPH RES CO, V359, P292, DOI 10.1016/j.bbrc.2007.05.080; Klase Z, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-63; Koiwa T, 2002, J VIROL, V76, P9389, DOI 10.1128/JVI.76.18.9389-9397.2002; Lassen K, 2004, TRENDS MOL MED, V10, P525, DOI 10.1016/j.molmed.2004.09.006; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Lim HG, 2008, MOL THER, V16, P565, DOI 10.1038/sj.mt.6300380; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; Lu BY, 2000, GENETICS, V155, P699; Marban C, 2007, EMBO J, V26, P412, DOI 10.1038/sj.emboj.7601516; Matzke M, 2001, SCIENCE, V293, P1080, DOI 10.1126/science.1063051; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Morris SA, 2007, J BIOL CHEM, V282, P7632, DOI 10.1074/jbc.M607909200; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pazin MJ, 1996, GENE DEV, V10, P37, DOI 10.1101/gad.10.1.37; Peters AHFM, 2002, NAT GENET, V30, P77, DOI 10.1038/ng789; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Piacentini L, 2003, J CELL BIOL, V161, P707, DOI 10.1083/jcb.200303012; Pulukuri SMK, 2007, CANCER RES, V67, P6637, DOI 10.1158/0008-5472.CAN-07-0751; Rao SH, 2001, J IMMUNOL, V167, P4494, DOI 10.4049/jimmunol.167.8.4494; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Smith AE, 2008, J BIOL CHEM, V283, P9878, DOI 10.1074/jbc.M710393200; Soifer HS, 2007, MOL THER, V15, P2070, DOI 10.1038/sj.mt.6300311; Sugiyama T, 2007, CELL, V128, P491, DOI 10.1016/j.cell.2006.12.035; SUZUKI K, 1993, J VIROL METHODS, V44, P189, DOI 10.1016/0166-0934(93)90054-U; Suzuki Kazuo, 2005, J RNAi Gene Silencing, V1, P66; Ting AH, 2005, NAT GENET, V37, P906, DOI 10.1038/ng1611; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; VERDIN E, 1993, EMBO J, V12, P3249, DOI 10.1002/j.1460-2075.1993.tb05994.x; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wang XL, 2007, MOL CELL BIOCHEM, V301, P259, DOI 10.1007/s11010-007-9427-4; Weiler KS, 1995, ANNU REV GENET, V29, P577, DOI 10.1146/annurev.ge.29.120195.003045; Weinberg MS, 2006, RNA, V12, P256, DOI 10.1261/rna.2235106; Weinberg MS, 2007, NUCLEIC ACIDS RES, V35, P1; Williams SA, 2006, EMBO J, V25, P139, DOI 10.1038/sj.emboj.7600900; Williams SA, 2004, J BIOL CHEM, V279, P42008, DOI 10.1074/jbc.M402124200; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yasuhara JC, 2006, TRENDS GENET, V22, P330, DOI 10.1016/j.tig.2006.04.008; Zhang MX, 2005, P NATL ACAD SCI USA, V102, P16967, DOI 10.1073/pnas.0503853102	79	80	82	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23353	23363		10.1074/jbc.M709651200	http://dx.doi.org/10.1074/jbc.M709651200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18519571	Green Published, hybrid			2022-12-25	WOS:000258455400045
J	Genest, O; Neumann, M; Seduk, F; Stocklein, W; Mejean, V; Leimkuhler, S; Iobbi-Nivol, C				Genest, Olivier; Neumann, Meina; Seduk, Farida; Stoecklein, Walter; Mejean, Vincent; Leimkuehler, Silke; Iobbi-Nivol, Chantal			Dedicated metallochaperone connects apoenzyme and molybdenum cofactor biosynthesis components	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIMETHYL-SULFOXIDE REDUCTASE; N-OXIDE REDUCTASE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; RHODOBACTER-CAPSULATUS; SHEWANELLA-MASSILIA; NITRATE REDUCTASE; MOLYBDOPTERIN SYNTHASE; ANGSTROM RESOLUTION; MOLYBDOENZYME TORA	The biogenesis of molybdenum-containing enzymes is a sophisticated process involving the insertion of a complex molybdenum cofactor into competent apoproteins. As for many molybdoenzymes, the maturation of trimethylamine-oxide reductase TorA requires a private chaperone. This chaperone (TorD) interacts with the signal peptide and the core of apo-TorA. Using random mutagenesis, we established that alpha-helix 5 of TorD plays a key role in the core binding and that this binding drives the maturation of TorA. In addition, we showed for the first time that TorD interacts with molybdenum cofactor biosynthesis components, including MobA, the last enzyme of cofactor synthesis, and Mo-molybdopterin, the precursor form of the cofactor. Finally we demonstrated that TorD also binds the mature molybdopterin-guanine dinucleotide form of the cofactor. Wethus propose that TorD acts as a platform connecting the last step of the synthesis of the molybdenum cofactor just before its insertion into the catalytic site of TorA.	[Genest, Olivier; Seduk, Farida; Mejean, Vincent; Iobbi-Nivol, Chantal] IBSM CNRS, Chim Bacterienne Lab, F-13402 Marseille 20, France; [Neumann, Meina; Stoecklein, Walter; Leimkuehler, Silke] Univ Potsdam, Inst Biochem & Biol, D-14476 Potsdam, Germany	Centre National de la Recherche Scientifique (CNRS); University of Potsdam	Iobbi-Nivol, C (corresponding author), IBSM CNRS, Chim Bacterienne Lab, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	iobbi@ibsm.cnrs-mrs.fr	Neumann-Schaal, Meina/AAM-6389-2021; Genest, Olivier/GQZ-3215-2022	Genest, Olivier/0000-0003-1240-2827; Leimkuhler, Silke/0000-0003-3238-2122; Mejean, Vincent/0000-0001-6533-5846				Baraquet C, 2006, J BIOL CHEM, V281, P38189, DOI 10.1074/jbc.M604321200; Battesti A, 2006, MOL MICROBIOL, V62, P1048, DOI 10.1111/j.1365-2958.2006.05442.x; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; Bertero MG, 2003, NAT STRUCT BIOL, V10, P681, DOI 10.1038/nsb969; Blasco F, 1998, MOL MICROBIOL, V28, P435, DOI 10.1046/j.1365-2958.1998.00795.x; Bordi C, 2003, MOL MICROBIOL, V48, P211, DOI 10.1046/j.1365-2958.2003.03428.x; CHUNG CT, 1988, NUCLEIC ACIDS RES, V16, P3580, DOI 10.1093/nar/16.8.3580; Czjzek M, 1998, J MOL BIOL, V284, P435, DOI 10.1006/jmbi.1998.2156; Genes O, 2005, J BIOL CHEM, V280, P15644, DOI 10.1074/jbc.M501119200; Genest O, 2006, BIOCHEM BIOPH RES CO, V339, P991, DOI 10.1016/j.bbrc.2005.11.107; Genest O, 2006, FEMS MICROBIOL LETT, V265, P51, DOI 10.1111/j.1574-6968.2006.00468.x; Gutzke G, 2001, J BIOL CHEM, V276, P36268, DOI 10.1074/jbc.M105321200; Hanzelmann P, 2006, P NATL ACAD SCI USA, V103, P6829, DOI 10.1073/pnas.0510711103; Hanzelmann P, 2004, P NATL ACAD SCI USA, V101, P12870, DOI 10.1073/pnas.0404624101; Hatzixanthis K, 2005, P NATL ACAD SCI USA, V102, P8460, DOI 10.1073/pnas.0500737102; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Ilbert M, 2004, MICROBIOL-SGM, V150, P935, DOI 10.1099/mic.0.26909-0; Ilbert M, 2003, J BIOL CHEM, V278, P28787, DOI 10.1074/jbc.M302730200; Jack RL, 2004, EMBO J, V23, P3962, DOI 10.1038/sj.emboj.7600409; JOHNSON JL, 1990, P NATL ACAD SCI USA, V87, P3190, DOI 10.1073/pnas.87.8.3190; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Leimkuhler S, 2005, HUM GENET, V117, P565, DOI 10.1007/s00439-005-1341-9; McAlpine AS, 1998, J MOL BIOL, V275, P613, DOI 10.1006/jmbi.1997.1513; MEJEAN V, 1994, MOL MICROBIOL, V11, P1169, DOI 10.1111/j.1365-2958.1994.tb00393.x; Miller J. H., 1972, EXPT MOL GENETICS, P72; Neumann M, 2007, J BIOL CHEM, V282, P28493, DOI 10.1074/jbc.M704020200; Neumann M, 2006, J BIOL CHEM, V281, P15701, DOI 10.1074/jbc.M601617200; Nichols JD, 2005, J BIOL CHEM, V280, P7817, DOI 10.1074/jbc.M413783200; Pommier J, 1998, J BIOL CHEM, V273, P16615, DOI 10.1074/jbc.273.26.16615; RAJAGOPALAN KV, 1992, J BIOL CHEM, V267, P10199; Schindelin H, 1996, SCIENCE, V272, P1615, DOI 10.1126/science.272.5268.1615; Schneider F, 1996, J MOL BIOL, V263, P53, DOI 10.1006/jmbi.1996.0555; Schwarz G, 2005, CELL MOL LIFE SCI, V62, P2792, DOI 10.1007/s00018-005-5269-y; Temple CA, 2000, ARCH BIOCHEM BIOPHYS, V383, P281, DOI 10.1006/abbi.2000.2089; Tranier S, 2003, STRUCTURE, V11, P165, DOI 10.1016/S0969-2126(03)00008-X; Tranier S, 2002, PROTEIN SCI, V11, P2148, DOI 10.1110/ps.0202902; Vergnes A, 2006, J BIOL CHEM, V281, P2170, DOI 10.1074/jbc.M505902200; Vergnes A, 2004, J BIOL CHEM, V279, P41398, DOI 10.1074/jbc.M407087200	38	44	45	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21433	21440		10.1074/jbc.M802954200	http://dx.doi.org/10.1074/jbc.M802954200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18522945	hybrid			2022-12-25	WOS:000257898800015
J	Oezguen, N; Kumar, S; Hindupur, A; Braun, W; Muralidhara, BK; Halpert, JR				Oezguen, Numan; Kumar, Santosh; Hindupur, Aditya; Braun, Werner; Muralidhara, B. K.; Halpert, James R.			Identification and analysis of conserved sequence motifs in cytochrome P450 family 2 - Functional and structural role of a motif (RFDYKD192)-R-187 in CYP2B enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-RESIDUES; DIRECTED EVOLUTION; ACTIVE-SITE; ALLELE FREQUENCIES; CATALYTIC-ACTIVITY; SUBSTRATE; P4502B4; BINDING; MUTAGENESIS; VARIABILITY	Using a multiple alignment of 175 cytochrome P450 ( CYP) family 2 sequences, 20 conserved sequence motifs (CSMs) were identified with the program PCPMer. Functional importance of the CSM in CYP2B enzymes was assessed from available data on site-directed mutants and genetic variants. These analyses suggested an important role of the CSM 8, which corresponds to (RFDYKD192)-R-187 in CYP2B4. Further analysis showed that residues 187, 188, 190, and 192 have a very high rank order of conservation compared with 189 and 191. Therefore, eight mutants (R187A, R187K, F188A, D189A, Y190A, K191A, D192A, and a negative control K186A) were made in an N-terminal truncated and modified form of CYP2B4 with an internal mutation, which is termed 2B4dH/H226Y. Function was examined with the substrates 7-methoxy-4-(trifluoromethyl) coumarin (7-MFC), 7-ethoxy-4-(trifluoromethyl) coumarin (7-EFC), 7-benzyloxy-4(trifluoromethyl) coumarin (7-BFC), and testosterone and with the inhibitors 4-(4-chlorophenyl) imidazole (4-CPI) and bifonazole (BIF). Compared with the template and K186A, the mutants R187A, R187K, F188A, Y190A, and D192A showed >= 2-fold altered substrate specificity, k(cat), K-m, and/or k(cat)/K-m for 7-MFC and 7-EFC and 3- to 6-fold decreases in differential inhibition (IC50, BIF/IC50,4-CPI). Subsequently, these mutants displayed 5-12 degrees C decreases in thermal stability (T-m) and 2-8 degrees C decreases in catalytic tolerance to temperature (T-50) compared with the template and K186A. Furthermore, when R187A and D192A were introduced in CYP2B1dH, the P450 expression and thermal stability were decreased. In addition, R187A showed increased activity with 7-EFC and decreased IC50,BIF/IC50,4-CPI compared with 2B1dH. Analysis of long range residue-residue interactions in the CYP2B4 crystal structures indicated strong hydrogen bonds involving Glu(149)-Asn(177)-Arg(187) -Tyr(190) and Asp(192)-Val(194), which were significantly reduced/abolished by the Arg(187) --> Ala and Asp(192) --> Ala substitutions, respectively.	[Kumar, Santosh; Halpert, James R.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Oezguen, Numan; Hindupur, Aditya; Braun, Werner] Univ Texas Galveston, Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Oezguen, Numan; Hindupur, Aditya; Braun, Werner] Univ Texas Galveston, Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA; [Muralidhara, B. K.] Pfizer Inc, PhRD Global Biol, Chesterfield, MO 63017 USA	University of California System; University of California San Diego; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Pfizer	Kumar, S (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, 9500 Gilman Dr,Rm 2231, La Jolla, CA 92093 USA.	s8kumar@ucsd.edu	Oezguen, Numan/C-9267-2009; Braun, Werner/A-6642-2012	Oezguen, Numan/0000-0002-3175-2382; 	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064913, R56AI064913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676, R01ES003619] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 064913] Funding Source: Medline; NIEHS NIH HHS [ES 03619, ES 06676] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Blobaum AL, 2005, BIOCHEMISTRY-US, V44, P3831, DOI 10.1021/bi0478953; Bracey MH, 2004, FEBS LETT, V567, P159, DOI 10.1016/j.febslet.2004.04.084; Bridges A, 1998, J BIOL CHEM, V273, P17036, DOI 10.1074/jbc.273.27.17036; Case D.A., 2006, AMBER, V9; Chen CD, 1996, J BIOL CHEM, V271, P28607, DOI 10.1074/jbc.271.45.28607; Cho JY, 2004, DRUG METAB DISPOS, V32, P1341, DOI 10.1124/dmd.104.001107; Davydov DR, 2004, BIOCHEMISTRY-US, V43, P6475, DOI 10.1021/bi036260l; DAVYDOV DR, 1995, ARCH BIOCHEM BIOPHYS, V320, P330, DOI 10.1016/0003-9861(95)90017-9; Domanski TL, 1999, J PHARMACOL EXP THER, V290, P1141; Domanski TL, 2001, CURR DRUG METAB, V2, P117, DOI 10.2174/1389200013338612; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; GOTOH O, 1992, J BIOL CHEM, V267, P83; Harlow GR, 1997, BBA-PROTEIN STRUCT M, V1338, P259, DOI 10.1016/S0167-4838(96)00209-9; Hernandez CE, 2006, ARCH BIOCHEM BIOPHYS, V455, P61, DOI 10.1016/j.abb.2006.08.024; Hesse LM, 2004, PHARMACOGENETICS, V14, P225, DOI 10.1097/00008571-200404000-00002; Hiraoka K, 2004, DYSPHAGIA, V19, P155, DOI 10.1007/s00455-004-0002-9; Honma W, 2005, ARCH BIOCHEM BIOPHYS, V435, P157, DOI 10.1016/j.abb.2004.12.014; Johnson EF, 2005, BIOCHEM BIOPH RES CO, V338, P331, DOI 10.1016/j.bbrc.2005.08.190; Kim D, 2004, BIOCHEMISTRY-US, V43, P981, DOI 10.1021/bi035593f; Kim D, 2004, ARCH BIOCHEM BIOPHYS, V432, P102, DOI 10.1016/j.abb.2004.09.001; Kirchheiner J, 2003, PHARMACOGENETICS, V13, P619, DOI 10.1097/00008571-200310000-00005; Klein K, 2005, PHARMACOGENET GENOM, V15, P861, DOI 10.1097/01213011-200512000-00004; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kumar S, 2003, J BIOL CHEM, V278, P17178, DOI 10.1074/jbc.M212515200; Kumar S, 2005, J BIOL CHEM, V280, P19569, DOI 10.1074/jbc.M500158200; Kumar S, 2005, BIOCHEM BIOPH RES CO, V338, P456, DOI 10.1016/j.bbrc.2005.08.080; Kumar S, 2007, MOL PHARMACOL, V72, P1191, DOI 10.1124/mol.107.039693; Kumar S, 2006, DRUG METAB DISPOS, V34, P1958, DOI 10.1124/dmd.106.012054; Kumar S, 2006, PROTEIN ENG DES SEL, V19, P547, DOI 10.1093/protein/gzl042; Lang T, 2004, J PHARMACOL EXP THER, V311, P34, DOI 10.1124/jpet.104.068973; Lang T, 2001, PHARMACOGENETICS, V11, P399, DOI 10.1097/00008571-200107000-00004; Lehnerer M, 2000, J BIOCHEM, V127, P163, DOI 10.1093/oxfordjournals.jbchem.a022578; Leys D, 2003, J BIOL CHEM, V278, P5141, DOI 10.1074/jbc.M209928200; Lin HL, 2005, CHEM RES TOXICOL, V18, P1203, DOI 10.1021/tx050100o; Muralidhara BK, 2007, DRUG METAB REV, V39, P539, DOI 10.1080/03602530701498182; Muralidhara BK, 2006, J BIOL CHEM, V281, P8051, DOI 10.1074/jbc.M509696200; Nakamura K, 2001, ARCH BIOCHEM BIOPHYS, V395, P25, DOI 10.1006/abbi.2001.2569; Negi SS, 2006, J MOL MODEL, V12, P921, DOI 10.1007/s00894-006-0101-7; Poulos TL, 2003, P NATL ACAD SCI USA, V100, P13121, DOI 10.1073/pnas.2336095100; Schein CH, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-40; Schein CH, 2005, PROTEINS, V58, P200, DOI 10.1002/prot.20253; Schein CH, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-37; Schenkman JB, 2003, PHARMACOL THERAPEUT, V97, P139, DOI 10.1016/S0163-7258(02)00327-3; Scott EE, 2002, CHEM RES TOXICOL, V15, P1407, DOI 10.1021/tx020057u; Scott EE, 2003, P NATL ACAD SCI USA, V100, P13196, DOI 10.1073/pnas.2133986100; Scott EE, 2004, J BIOL CHEM, V279, P27294, DOI 10.1074/jbc.M403349200; Stout CD, 2004, STRUCTURE, V12, P1921, DOI 10.1016/j.str.2004.10.002; Sun L, 2007, ARCH BIOCHEM BIOPHYS, V458, P167, DOI 10.1016/j.abb.2006.12.021; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Venkatarajan MS, 2001, J MOL MODEL, V7, P445, DOI 10.1007/s00894-001-0058-5; Venkatarajan SM, 2003, BIOINFORMATICS, V19, P1381; Waller SC, 1999, CHEM RES TOXICOL, V12, P690, DOI 10.1021/tx990030j; Ward BA, 2003, J PHARMACOL EXP THER, V306, P287, DOI 10.1124/jpet.103.049601; Williams PA, 2000, MOL CELL, V5, P121, DOI 10.1016/S1097-2765(00)80408-6; Wu ZL, 2005, J BIOL CHEM, V280, P41090, DOI 10.1074/jbc.M508182200; Yano JK, 2005, NAT STRUCT MOL BIOL, V12, P822, DOI 10.1038/nsmb971; Yun CH, 2000, BIOCHEMISTRY-US, V39, P11319, DOI 10.1021/bi000869u; Zhao YH, 2006, J BIOL CHEM, V281, P5973, DOI 10.1074/jbc.M511464200; Zhao YG, 2007, BIOCHEMISTRY-US, V46, P11559, DOI 10.1021/bi7011614; Zhao YH, 2007, BBA-GEN SUBJECTS, V1770, P402, DOI 10.1016/j.bbagen.2006.07.006	60	13	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21808	21816		10.1074/jbc.M708582200	http://dx.doi.org/10.1074/jbc.M708582200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18495666	Green Published, hybrid			2022-12-25	WOS:000257898800054
J	Brazier-Hicks, M; Evans, KM; Cunningham, OD; Hodgson, DRW; Steel, PG; Edwards, R				Brazier-Hicks, Melissa; Evans, Kathryn M.; Cunningham, Oliver D.; Hodgson, David R. W.; Steel, Patrick G.; Edwards, Robert			Catabolism of glutathione conjugates in Arabidopsis thaliana - Role in metabolic reactivation of the herbicide safener fenclorim	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-S LYASE; TANDEM MASS-SPECTROMETRY; PHYTOCHELATIN SYNTHASE; TRANSFERASES; PLANTS; IDENTIFICATION; DETOXIFICATION; DEGRADATION; GLUCOSYLTRANSFERASE; PURIFICATION	The safener fenclorim (4,6-dichloro-2-phenylpyrimidine) increases tolerance to chloroacetanilide herbicides in rice by enhancing the expression of detoxifying glutathione S-transferases (GSTs). Fenclorim also enhances GSTs in Arabidopsis thaliana, and while investigating the functional significance of this induction in suspension cultures, we determined that these enzymes glutathionylated the safener. The resulting S-(fenclorim)glutathione conjugate was sequentially processed to S-(fenclorim)-gamma-glutamyl-cysteine and S-(fenclorim)-cysteine (FC), the latter accumulating in both the cells and the medium. FC was then either catabolized to 4-chloro-6-(methylthio)-phenylpyrimidine (CMTP) or N-acylated with malonic acid. These cysteine derivatives had distinct fates, with the enzymes responsible for their formation being induced by fenclorim and FC. Fenclorim-N-malonylcysteine was formed from FC by the action of a malonyl-CoA-dependent N-malonyltransferase. A small proportion of the fenclorim-N-malonylcysteine then underwent decarboxylation to yield a putative S-fenclorim-Nacetylcysteine intermediate, which underwent a second round of GST-mediated S-glutathionylation and subsequent proteolytic processing. The formation of CMTP was catalyzed by the concerted action of a cysteine conjugate beta-lyase and an S-methyltransferase, with the two activities being coordinately regulated. Although the fenclorim conjugates tested showed little GST-inducing activity in Arabidopsis, the formation of CMTP resulted in metabolic reactivation, with the product showing good enhancing activity. In addition, CMTP induced GSTs and herbicide-safening activity in rice. The bioactivated CMTP was in turn glutathione-conjugated and processed to a malonyl cysteine derivative. These results reveal the surprisingly complex set of competing catabolic reactions acting on xenobiotics entering the S-glutathionylation pathway in plants, which can result in both detoxification and bioactivation.	[Brazier-Hicks, Melissa; Evans, Kathryn M.; Cunningham, Oliver D.; Hodgson, David R. W.; Steel, Patrick G.; Edwards, Robert] Univ Durham, Dept Chem, Ctr Bioact Chem, Durham DH1 3LE, England	Durham University	Edwards, R (corresponding author), Univ Durham, Dept Chem, Ctr Bioact Chem, South Rd, Durham DH1 3LE, England.		Steel, Patrick/G-3187-2012; Hodgson, David/F-7174-2011	Steel, Patrick/0000-0002-2493-5826; Hodgson, David/0000-0003-4517-9166; Edwards, Robert/0000-0003-0809-5991; Brazier-Hicks, Melissa/0000-0001-5993-1940; EVANS, KATE/0000-0002-2184-7433	BBSRC [BB/D005620/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D005620/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Baerson SR, 2005, J BIOL CHEM, V280, P21867, DOI 10.1074/jbc.M500694200; BENICHOU M, 1995, PHYSIOL PLANTARUM, V94, P629, DOI 10.1111/j.1399-3054.1995.tb00977.x; Blum R, 2007, PLANT J, V49, P740, DOI 10.1111/j.1365-313X.2006.02993.x; Brazier-Hicks M, 2007, P NATL ACAD SCI USA, V104, P20238, DOI 10.1073/pnas.0706421104; Coiner H, 2006, PLANT J, V46, P193, DOI 10.1111/J.1365-313X.2006.02680.x; Coleman JOD, 1997, TRENDS PLANT SCI, V2, P144, DOI 10.1016/S1360-1385(97)01019-4; Cummins I, 1997, PESTIC SCI, V51, P244, DOI 10.1002/(SICI)1096-9063(199711)51:3&lt;244::AID-PS643&gt;3.0.CO;2-2; D'Auria JC, 2006, CURR OPIN PLANT BIOL, V9, P331, DOI 10.1016/j.pbi.2006.03.016; Davies J, 1999, PESTIC SCI, V55, P1043, DOI 10.1002/(SICI)1096-9063(199911)55:11&lt;1043::AID-PS60&gt;3.0.CO;2-L; De Veylder L, 1997, PLANT CELL PHYSIOL, V38, P568, DOI 10.1093/oxfordjournals.pcp.a029206; Deng F, 2002, PESTIC BIOCHEM PHYS, V72, P10, DOI 10.1006/pest.2001.2580; DeRidder BP, 2002, PLANT PHYSIOL, V130, P1497, DOI 10.1104/pp.010066; Edwards R, 2005, Z NATURFORSCH C, V60, P307; Edwards R, 2005, ADV BOT RES, V42, P1, DOI 10.1016/S0065-2296(05)42001-7; Grzam A, 2007, FEBS LETT, V581, P3131, DOI 10.1016/j.febslet.2007.05.071; Grzam A, 2006, FEBS LETT, V580, P6384, DOI 10.1016/j.febslet.2006.10.050; HARDEN DB, 1988, J ORG CHEM, V53, P4137, DOI 10.1021/jo00252a057; Hatzios KK, 2003, PHYTOPARASITICA, V31, P3, DOI 10.1007/BF02979761; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Kiddle GA, 1999, PLANT CELL ENVIRON, V22, P433, DOI 10.1046/j.1365-3040.1999.00416.x; LAMOUREUX GL, 1993, PESTIC BIOCHEM PHYS, V47, P8, DOI 10.1006/pest.1993.1058; LAMOUREUX GL, 1980, PESTIC BIOCHEM PHYS, V14, P50, DOI 10.1016/0048-3575(80)90022-X; LAMOUREUX GL, 1993, SULFUR NUTRITION AND ASSIMILATION IN HIGHER PLANTS, P221; Levsen K, 2005, J CHROMATOGR A, V1067, P55, DOI 10.1016/j.chroma.2004.08.165; Liu GS, 2001, J BIOL CHEM, V276, P8648, DOI 10.1074/jbc.M009690200; Loutre C, 2003, PLANT J, V34, P485, DOI 10.1046/j.1365-313X.2003.01742.x; MCCARTHY RI, 1994, TOXICOL IND HEALTH, V10, P103, DOI 10.1177/074823379401000107; Miller KD, 1996, J AGR FOOD CHEM, V44, P3335, DOI 10.1021/jf9505436; Miller KD, 1996, J AGR FOOD CHEM, V44, P3326, DOI 10.1021/jf950542d; Ohkama-Ohtsu N, 2007, PLANT J, V49, P878, DOI 10.1111/j.1365-313X.2006.03005.x; ONISKO BC, 1994, BIOL MASS SPECTROM, V23, P626, DOI 10.1002/bms.1200231005; Smith AP, 2004, J BIOL CHEM, V279, P26098, DOI 10.1074/jbc.M402807200; Wolf AE, 1996, FEBS LETT, V384, P31, DOI 10.1016/0014-5793(96)00272-4	33	48	52	2	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21102	21112		10.1074/jbc.M801998200	http://dx.doi.org/10.1074/jbc.M801998200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18522943	Green Published, hybrid			2022-12-25	WOS:000257746100052
J	Chen, S; Hall, C; Barbieri, JT				Chen, Sheng; Hall, Cherisse; Barbieri, Joseph T.			Substrate recognition of VAMP-2 by botulinum neurotoxin B and tetanus neurotoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEROTYPE-A; ENDOPEPTIDASE ACTIVITY; ANGSTROM RESOLUTION; LIGHT-CHAIN; SNARE MOTIF; TOXIN; CLEAVAGE; SPECIFICITY; SYNAPTOBREVIN; MECHANISM	Botulinum neurotoxin (BoNT; serotypes A-G) and tetanus neurotoxin elicit flaccid and spastic paralysis, respectively. These neurotoxins are zinc proteases that cleave SNARE proteins to inhibit synaptic vesicle fusion to the plasma membrane. Although BoNT/B and tetanus neurotoxin ( TeNT) cleave VAMP-2 at the same scissile bond, their mechanism(s) of VAMP-2 recognition is not clear. Mapping experiments showed that residues 60 - 87 of VAMP-2 were sufficient for efficient cleavage by BoNT/B and that residues 40 - 87 of VAMP-2 were sufficient for efficient TeNT cleavage. Alanine-scanning mutagenesis and kinetic analysis identified three regions within VAMP-2 that were recognized by BoNT/B and TeNT: residues adjacent to the site of scissile bond cleavage ( cleavage region) and residues located within N-terminal and C-terminal regions relative to the cleavage region. Analysis of residues within the cleavage region showed that mutations at the P7, P4, P2, and P1' residues of VAMP-2 had the greatest inhibition of LC/B cleavage (>= 32-fold), whereas mutations at P7, P4, P1', and P2' residues of VAMP-2 had the greatest inhibition of LC/TeNT cleavage (>= 64-fold). Residues within the cleavage region influenced catalysis, whereas residues N-terminal and C-terminal to the cleavage region influenced binding affinity. Thus, BoNT/B and TeNT possess similar organization but have unique residues to recognize and cleave VAMP-2. These studies provide new insights into how the clostridial neurotoxins recognize their substrates.	[Chen, Sheng; Hall, Cherisse; Barbieri, Joseph T.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Barbieri, JT (corresponding author), Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA.	jtb01@mcw.edu		Chen, Sheng/0000-0003-3526-7808	NIAID NIH HHS [U54 AI 057153] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Bohnert S, 2005, J BIOL CHEM, V280, P42336, DOI 10.1074/jbc.M506750200; Brandt FS, 1998, DERMATOL SURG, V24, P1232, DOI 10.1111/j.1524-4725.1998.tb04103.x; Breidenbach MA, 2004, NATURE, V432, P925, DOI 10.1038/nature03123; Chen S, 2006, J BIOL CHEM, V281, P10906, DOI 10.1074/jbc.M513032200; Chen S, 2007, J BIOL CHEM, V282, P25540, DOI 10.1074/jbc.M701922200; Chen S, 2007, J BIOL CHEM, V282, P9621, DOI 10.1074/jbc.M611211200; Cornille F, 1997, J BIOL CHEM, V272, P3459, DOI 10.1074/jbc.272.6.3459; DASGUPTA BR, 1972, BIOCHIM BIOPHYS ACTA, V268, P719, DOI 10.1016/0005-2744(72)90276-8; Deinhardt K, 2005, BIOCHEM SOC SYMP, V72, P139, DOI 10.1042/bss0720139; Deinhardt K, 2006, J CELL BIOL, V174, P459, DOI 10.1083/jcb.200508170; Foran P, 1996, BIOCHEMISTRY-US, V35, P2630, DOI 10.1021/bi9519009; FORAN P, 1994, BIOCHEMISTRY-US, V33, P15365, DOI 10.1021/bi00255a017; Hanson MA, 2000, NAT STRUCT BIOL, V7, P687, DOI 10.1038/77997; Humeau Y, 2000, BIOCHIMIE, V82, P427, DOI 10.1016/S0300-9084(00)00216-9; Klein AW, 2004, DERMATOL CLIN, V22, P197, DOI 10.1016/S0733-8635(03)00122-0; MONTECUCCO C, 1994, MOL MICROBIOL, V13, P1, DOI 10.1111/j.1365-2958.1994.tb00396.x; Pellizzari R, 1996, J BIOL CHEM, V271, P20353, DOI 10.1074/jbc.271.34.20353; Perpetuo EA, 2002, BIOTECHNOL APPL BIOC, V36, P155, DOI 10.1042/BA20020011; Purcell AL, 2007, ANAL BIOCHEM, V366, P207, DOI 10.1016/j.ab.2007.04.048; ROSSETTO O, 1994, NATURE, V372, P415, DOI 10.1038/372415a0; Rupp B, 2001, NAT STRUCT BIOL, V8, P663, DOI 10.1038/90361; SCHIAVO G, 1994, ANN NY ACAD SCI, V710, P65, DOI 10.1111/j.1749-6632.1994.tb26614.x; Schiavo G, 1995, CURR TOP MICROBIOL, V195, P257; SCHIAVO G, 1994, J BIOL CHEM, V269, P20213; SHONE CC, 1994, EUR J BIOCHEM, V225, P263, DOI 10.1111/j.1432-1033.1994.00263.x; SIEGEL LS, 1979, APPL ENVIRON MICROB, V38, P606, DOI 10.1128/AEM.38.4.606-611.1979; Sikorra S, 2006, J MOL BIOL, V357, P574, DOI 10.1016/j.jmb.2005.12.075; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tonello F, 1996, ADV EXP MED BIOL, V389, P251; Vaidyanathan VV, 1999, J NEUROCHEM, V72, P327, DOI 10.1046/j.1471-4159.1999.0720327.x; Washbourne P, 1997, FEBS LETT, V418, P1, DOI 10.1016/S0014-5793(97)01328-8; Wictome M, 1996, FEBS LETT, V386, P133, DOI 10.1016/0014-5793(96)00431-0; YAMASAKI S, 1994, J BIOL CHEM, V269, P12764; ZUBER M, 1993, NEUROLOGY, V43, P1715, DOI 10.1212/WNL.43.9.1715	35	53	58	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21153	21159		10.1074/jbc.M800611200	http://dx.doi.org/10.1074/jbc.M800611200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18511417	Green Published, hybrid			2022-12-25	WOS:000257746100057
J	Ifergan, I; Jansen, G; Assaraf, YG				Ifergan, Ilan; Jansen, Gerrit; Assaraf, Yehuda G.			The reduced folate carrier (RFC) is cytotoxic to cells under conditions of severe folate deprivation - RFC as a double edged sword in folate homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESISTANCE PROTEIN BCRP/ABCG2; GAMMA-GLUTAMYL HYDROLASE; ONE-CARBON METABOLISM; ANTIFOLATE RESISTANCE; BINDING-PROTEIN; FOLYLPOLYGLUTAMATE SYNTHETASE; METHOTREXATE TRANSPORT; MEMBRANE-TRANSPORT; MAMMALIAN-CELLS; DNA METHYLATION	The reduced folate carrier (RFC), a bidirectional anion transporter, is the major uptake route of reduced folates essential for a spectrum of biochemical reactions and thus cellular proliferation. However, here we show that ectopic overexpression of the RFC, but not of folate receptor alpha, a high affinity unidirectional folate uptake route serving here as a negative control, resulted in an similar to 15-fold decline in cellular viability in medium lacking folates but not in folate-containing medium. Moreover to explore possible mechanisms of adaptation to folate deficiency in various cell lines that express the endogenous RFC, we first determined the gene expression status of the following genes: (a) RFC, (b) ATP-driven folate exporters (i. e. MRP1, MRP5, and breast cancer resistance protein), and (c) folylpoly-gamma-glutamate synthetase and gamma-glutamate hydrolase (GGH), enzymes catalyzing folate polyglutamylation and hydrolysis, respectively. Upon 3 -7 days of folate deprivation, semiquantitative reverse transcription-PCR analysis revealed a specific similar to 2.5-fold decrease in RFC mRNA levels in both breast cancer and T-cell leukemia cell lines that was accompanied by a consistent fall in methotrexate influx, serving here as an RFC transport activity assay. Likewise a 2.4-fold decrease in GGH mRNA levels and similar to 19% decreased GGH activity was documented for folate-deprived breast cancer cells. These results along with those of a novel mathematical biomodeling devised here suggest that upon severe short term (i. e. up to 7 days) folate deprivation RFC transport activity becomes detrimental as RFC, but not ATP-driven folate exporters, efficiently extrudes folate monoglutamates out of cells. Hence down-regulation of RFC and GGH may serve as a novel adaptive response to severe folate deficiency.	[Ifergan, Ilan; Assaraf, Yehuda G.] Technion Israel Inst Technol, Dept Biol, Fred Wyszkowski Canc Res Lab, IL-32000 Haifa, Israel; [Jansen, Gerrit] Vrije Univ Amsterdam, Med Ctr, Dept Rheumatol, NL-1081 Amsterdam, Netherlands	Technion Israel Institute of Technology; Vrije Universiteit Amsterdam	Assaraf, YG (corresponding author), Technion Israel Inst Technol, Dept Biol, Fred Wyszkowski Canc Res Lab, IL-32000 Haifa, Israel.	assaraf@tx.technion.ac.il		Jansen, Gerrit/0000-0001-8190-8368; Assaraf, Yehuda G./0000-0001-6692-8221				ANTONY AC, 1992, BLOOD, V79, P2807; Assantachai P, 2007, PUBLIC HEALTH NUTR, V10, P65, DOI 10.1017/S136898000720494X; Assaraf YG, 2007, CANCER METAST REV, V26, P153, DOI 10.1007/s10555-007-9049-z; Assaraf YG, 2006, J THEOR BIOL, V240, P637, DOI 10.1016/j.jtbi.2005.11.001; Assaraf YG, 2006, DRUG RESIST UPDATE, V9, P227, DOI 10.1016/j.drup.2006.09.001; Assaraf YG, 2003, J BIOL CHEM, V278, P6680, DOI 10.1074/jbc.M209186200; Assaraf YG, 1998, J BIOL CHEM, V273, P8106, DOI 10.1074/jbc.273.14.8106; Backus HHJ, 2000, INT J CANCER, V87, P771, DOI 10.1002/1097-0215(20000915)87:6<771::AID-IJC2>3.0.CO;2-V; BAILEY LB, 1982, AM J CLIN NUTR, V35, P1023, DOI 10.1093/ajcn/35.5.1023; Birn H, 2006, AM J PHYSIOL-RENAL, V291, pF22, DOI 10.1152/ajprenal.00385.2005; BRIGLE KE, 1994, BIOCHEM PHARMACOL, V47, P337, DOI 10.1016/0006-2952(94)90025-6; Carmel Ralph, 2003, Hematology Am Soc Hematol Educ Program, P62; Chen ZS, 2002, CANCER RES, V62, P3144; Chen ZS, 2003, CANCER RES, V63, P4048; Cole PD, 2001, CANCER RES, V61, P4599; Elnakat H, 2006, FRONT BIOSCI-LANDMRK, V11, P506, DOI 10.2741/1815; ELWOOD PC, 1989, J BIOL CHEM, V264, P14893; Gates SB, 1996, CLIN CANCER RES, V2, P1135; GOLDMAN ID, 1971, ANN NY ACAD SCI, V186, P400; Hooijberg JH, 2004, BIOCHEM PHARMACOL, V67, P1541, DOI 10.1016/j.bcp.2003.12.022; Ifergan I, 2005, MOL PHARMACOL, V67, P1349, DOI 10.1124/mol.104.008250; Ifergan I, 2004, J BIOL CHEM, V279, P25527, DOI 10.1074/jbc.M401725200; JANSEN G, 1990, J BIOL CHEM, V265, P18272; Jordheim LP, 2004, CLIN CANCER RES, V10, P5614, DOI 10.1158/1078-0432.CCR-04-0506; Kanzaki A, 2001, JPN J CANCER RES, V92, P452, DOI 10.1111/j.1349-7006.2001.tb01115.x; Kim YI, 2004, CANCER EPIDEM BIOMAR, V13, P511; Kim YI, 2005, J NUTR, V135, P2703, DOI 10.1093/jn/135.11.2703; LACEY SW, 1989, J CLIN INVEST, V84, P715, DOI 10.1172/JCI114220; Lamers Y, 2006, AM J CLIN NUTR, V84, P156, DOI 10.1093/ajcn/84.1.156; LIN BF, 1993, J BIOL CHEM, V268, P21674; Matherly LH, 2003, VITAM HORM, V66, P403, DOI 10.1016/S0083-6729(03)01012-4; McGuire JJ, 2000, J BIOL CHEM, V275, P13012, DOI 10.1074/jbc.275.17.13012; Michaelis L, 1913, BIOCHEM Z, V49, P333; OCONNOR BM, 1991, CANCER RES, V51, P3874; OSBORNE CB, 1993, J BIOL CHEM, V268, P21657; Pathak Priyali, 2004, Indian Journal of Pediatrics, V71, P1007; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; QURESHI AA, 1994, CRIT REV ONCOL HEMAT, V17, P133, DOI 10.1016/1040-8428(94)90022-1; RATNAM M, 1989, BIOCHEMISTRY-US, V28, P8249, DOI 10.1021/bi00446a042; Rothem L, 2005, MOL PHARMACOL, V68, P616, DOI 10.1124/mol.105.013540; Rothem L, 2004, MOL PHARMACOL, V66, P1536, DOI 10.1124/mol.104.004135; Rothem L, 2003, J BIOL CHEM, V278, P8935, DOI 10.1074/jbc.M209578200; Rothem L, 2002, BIOCHEM J, V367, P741, DOI 10.1042/BJ20020801; Rots MG, 1999, BLOOD, V93, P1677, DOI 10.1182/blood.V93.5.1677.405a16_1677_1683; RUBIN RC, 1967, CANCER RES, V27, P553; SADASIVAN E, 1989, J BIOL CHEM, V264, P5806; Scott JM, 1999, P NUTR SOC, V58, P441, DOI 10.1017/S0029665199000580; SHANE B, 1989, VITAM HORM, V45, P263; SHANE B, 1995, FOLATE HLTH DIS; SHEN F, 1995, BIOCHEMISTRY-US, V34, P5660, DOI 10.1021/bi00016a042; SHEN F, 1994, BIOCHEMISTRY-US, V33, P1209, DOI 10.1021/bi00171a021; Sierra EE, 1997, BIOCHEM PHARMACOL, V53, P223, DOI 10.1016/S0006-2952(96)00730-7; SIROTNAK F M, 1987, NCI (National Cancer Institute) Monographs, P27; SIROTNAK FM, 1985, CANCER RES, V45, P3992; Spiegelstein O, 2000, GENE, V258, P117, DOI 10.1016/S0378-1119(00)00418-2; Stokstad ELR, 1990, FOLIC ACID METABOLIS, P1; Volk EL, 2003, CANCER RES, V63, P5538; Walling J, 2006, INVEST NEW DRUG, V24, P37, DOI 10.1007/s10637-005-4541-1; WANG X, 1992, BIOCHEM PHARMACOL, V44, P1898; Wielinga P, 2005, CANCER RES, V65, P4425, DOI 10.1158/0008-5472.CAN-04-2810; Worm J, 2001, J BIOL CHEM, V276, P39990, DOI 10.1074/jbc.M103181200; Zeng H, 2001, CANCER RES, V61, P7225; Zhao RB, 2002, AM J PHYSIOL-CELL PH, V282, pC1512, DOI 10.1152/ajpcell.00547.2001; Zhao RB, 2001, J BIOL CHEM, V276, P10224, DOI 10.1074/jbc.C000905200; Zhao R, 2007, BLOOD, V110, P1147, DOI 10.1182/blood-2007-02-077099; Zhu Wei-Yong, 2002, J Exp Ther Oncol, V2, P264, DOI 10.1046/j.1359-4117.2002.01049.x	66	38	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20687	20695		10.1074/jbc.M802812200	http://dx.doi.org/10.1074/jbc.M802812200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18499665	Green Published, hybrid			2022-12-25	WOS:000257746100009
J	Cheng, SL; Shao, JS; Cai, J; Sierra, OL; Towler, DA				Cheng, Su-Li; Shao, Jian-Su; Cai, Jun; Sierra, Oscar L.; Towler, Dwight A.			Msx2 exerts bone anabolism via canonical Wnt signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOCALCIN GENE-EXPRESSION; RECEPTOR-DEFICIENT MICE; CRANIAL NEURAL CREST; HOMEODOMAIN PROTEINS; TRANSCRIPTION FACTOR; FUNCTIONAL ANTAGONISM; PROMOTES OSTEOGENESIS; OVARIECTOMIZED RATS; HOMEOBOX GENE; STEM-CELLS	Msx2 is a homeodomain transcription factor first identified in craniofacial bone and human femoral osteoblasts. We hypothesized that Msx2 might activate skeletal Wnt signaling. Therefore, we analyzed the effects of CMV-Msx2 transgene (Msx2Tg) expression on skeletal physiology and composition. Skeletal Msx2 expression was increased 2-3-fold by Msx2Tg, with expanded protein accumulation in marrow, secondary ossification centers, and periosteum. Microcomputed tomography established increased bone volume in Msx2Tg mice, with increased numbers of plate-like trabeculae. Histomorphometry revealed increased bone formation in Msx2Tg mice versus non-Tg siblings, arising from increased osteoblast numbers. While decreasing adipogenesis, Msx2Tg increased osteogenic differentiation via mechanisms inhibited by Dkk1, an antagonist of Wnt receptors LRP5 and LRP6. Bone from Msx2Tg mice elaborated higher levels of Wnt7 canonical agonists, with diminished Dkk1, changes that augment canonical signaling. Analysis of non-Tg and Msx2Tg siblings possessing the TOP-GAL reporter confirmed this; Msx2Tg up-regulated skeletal beta-galactosidase expression (p <= 0.01), along with Wnt7a and Wnt7b, and reduced circulating Dkk1. To better understand molecular mechanisms, we studied C3H10T1/2 osteoprogenitor cells. As in bone, Msx2 increased Wnt7 genes and down-regulated Dkk1, while inducing the osteoblast gene alkaline phosphatase. Msx2-directed RNA interference increased Dkk1 expression and promoter activity, while reducing Wnt7a, Wnt7b, and alkaline phosphatase. Moreover, Msx2 inhibited Dkk1 promoter activity and reduced RNA polymerase association with Dkk1 chromatin. RNA interference-mediated knockdown of Wnt7a, Wnt7b, and LRP6 significantly reduced Msx2-induced alkaline phosphatase. Msx2 exerts bone anabolism in part by reducing Dkk1 expression and enhancing Wnt signaling, thus promoting osteogenic differentiation of skeletal progenitors.	[Cheng, Su-Li; Shao, Jian-Su; Cai, Jun; Sierra, Oscar L.; Towler, Dwight A.] Washington Univ, Sch Med, Dept Med, Div Bone & Mineral Dis, St Louis, MO 63110 USA	Washington University (WUSTL)	Towler, DA (corresponding author), Washington Univ, Sch Med, Dept Med, Div Bone & Mineral Dis, Campus Box 8301,660 S Euclid Ave St, St Louis, MO 63110 USA.	dtowler@dom.wustl.edu		Towler, Dwight/0000-0003-2107-7923	NHLBI NIH HHS [R01 HL081138, HL 81138] Funding Source: Medline; NIAMS NIH HHS [AR 43731] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043731] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Adamska M, 2005, DEV DYNAM, V233, P368, DOI 10.1002/dvdy.20437; Adamska M, 2003, DEV BIOL, V255, P350, DOI 10.1016/S0012-1606(02)00114-8; Aioub M, 2007, BONE, V41, P851, DOI 10.1016/j.bone.2007.07.023; Al-Aly Z, 2007, ARTERIOSCL THROM VAS, V27, P2589, DOI 10.1161/ATVBAHA.107.153668; Ali MM, 2007, J CELL SCI, V120, P2565, DOI 10.1242/jcs.005090; Banerjee C, 2001, ENDOCRINOLOGY, V142, P4026, DOI 10.1210/en.142.9.4026; Barnes GL, 2003, CANCER RES, V63, P2631; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Bidder M, 1998, J BONE MINER RES, V13, P609, DOI 10.1359/jbmr.1998.13.4.609; Boudreaux JM, 1996, J BIOL CHEM, V271, P7508, DOI 10.1074/jbc.271.13.7508; Brazas RM, 2005, METHOD ENZYMOL, V392, P112, DOI 10.1016/S0076-6879(04)92007-1; Brodt MD, 1999, J BONE MINER RES, V14, P2159, DOI 10.1359/jbmr.1999.14.12.2159; Brunelli S, 2004, CIRC RES, V94, P1571, DOI 10.1161/01.RES.0000132747.12860.10; Caira FC, 2006, J AM COLL CARDIOL, V47, P1707, DOI 10.1016/j.jacc.2006.02.040; CAMACHO P, 2006, PRIMER METABOLIC BON, P127; Caricasole A, 2003, J BIOL CHEM, V278, P37024, DOI 10.1074/jbc.M300191200; Castro CHM, 2004, J CELL SCI, V117, P2853, DOI 10.1242/jcs.01133; Chai Y, 2000, DEVELOPMENT, V127, P1671; Cheng SL, 2001, CALCIFIED TISSUE INT, V68, P87, DOI 10.1007/BF02678146; Cheng SL, 2003, J BIOL CHEM, V278, P45969, DOI 10.1074/jbc.M306972200; Christiansen BA, 2006, ANN BIOMED ENG, V34, P1149, DOI 10.1007/s10439-006-9133-5; Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Donahue LR, 2003, J BONE MINER RES, V18, P1612, DOI 10.1359/jbmr.2003.18.9.1612; Eriksen EF., 1994, BONE HISTOMORPHOMETR; Eriksen EF, 2007, J BONE MINER RES, V22, P1, DOI 10.1359/JBMR.060910; Fu H, 2007, GENESIS, V45, P477, DOI 10.1002/dvg.20316; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Glass DA, 2006, ANN NY ACAD SCI, V1068, P117, DOI 10.1196/annals.1346.015; Gotoh M, 2002, EUR J PHARMACOL, V451, P19, DOI 10.1016/S0014-2999(02)02183-0; Gowen LC, 2003, J BIOL CHEM, V278, P1998, DOI 10.1074/jbc.M203250200; Han J, 2007, MECH DEVELOP, V124, P729, DOI 10.1016/j.mod.2007.06.006; Hassan MQ, 2006, J BIOL CHEM, V281, P40515, DOI 10.1074/jbc.M604508200; Hassan MQ, 2004, MOL CELL BIOL, V24, P9248, DOI 10.1128/MCB.24.20.9248-9261.2004; Hens JR, 2007, DEVELOPMENT, V134, P1221, DOI 10.1242/dev.000182; Hildebrand TOR, 1997, Comput Methods Biomech Biomed Engin, V1, P15, DOI 10.1080/01495739708936692; HODGKINSON JE, 1993, BIOCHIM BIOPHYS ACTA, V1174, P11, DOI 10.1016/0167-4781(93)90086-S; HOFFMANN HM, 1994, P NATL ACAD SCI USA, V91, P12887, DOI 10.1073/pnas.91.26.12887; Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907; Hoshino T, 2000, J BIOMED MATER RES, V51, P299, DOI 10.1002/1097-4636(20000905)51:3<299::AID-JBM2>3.3.CO;2-#; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Ichida F, 2004, J BIOL CHEM, V279, P34015, DOI 10.1074/jbc.M403621200; JABS EW, 1993, CELL, V75, P443, DOI 10.1016/0092-8674(93)90379-5; Jackson A, 2005, BONE, V36, P585, DOI 10.1016/j.bone.2005.01.007; Ke HZ, 2006, J BONE MINER RES, V21, P565, DOI 10.1359/JBMR.051110; Ke HZ, 2003, MOL ENDOCRINOL, V17, P1356, DOI 10.1210/me.2003-0021; Kishimoto K, 2006, HISTOCHEM CELL BIOL, V125, P593, DOI 10.1007/s00418-005-0103-z; KOEDOOD M, 1995, J VIROL, V69, P2194, DOI 10.1128/JVI.69.4.2194-2207.1995; Lee MH, 2005, J BIOL CHEM, V280, P35579, DOI 10.1074/jbc.M502267200; Li J, 2006, BONE, V39, P754, DOI 10.1016/j.bone.2006.03.017; Liu YH, 1999, DEV BIOL, V205, P260, DOI 10.1006/dbio.1998.9114; LIU YH, 1995, P NATL ACAD SCI USA, V92, P6137, DOI 10.1073/pnas.92.13.6137; Ma L, 1996, HUM MOL GENET, V5, P1915, DOI 10.1093/hmg/5.12.1915; MacDonald BT, 2007, BONE, V41, P331, DOI 10.1016/j.bone.2007.05.009; MACKENZIE A, 1992, DEVELOPMENT, V115, P403; Malbon CC, 2006, CURR TOP DEV BIOL, V72, P153, DOI 10.1016/S0070-2153(05)72002-0; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Minguell JJ, 2005, STEM CELLS DEV, V14, P408, DOI 10.1089/scd.2005.14.408; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Newberry EP, 1997, BIOCHEMISTRY-US, V36, P10451, DOI 10.1021/bi971008x; Newberry EP, 1998, BIOCHEMISTRY-US, V37, P16360, DOI 10.1021/bi981878u; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Rifas L, 1997, P NATL ACAD SCI USA, V94, P7549, DOI 10.1073/pnas.94.14.7549; Roemmich JN, 1999, ENDOCRIN METAB CLIN, V28, P749, DOI 10.1016/S0889-8529(05)70100-6; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Sasaki A, 2002, J BIOL CHEM, V277, P22541, DOI 10.1074/jbc.M109728200; Satokata I, 2000, NAT GENET, V24, P391, DOI 10.1038/74231; Schmidt C, 2003, J BONE MINER RES, V18, P1486, DOI 10.1359/jbmr.2003.18.8.1486; Shao JS, 2005, J CLIN INVEST, V115, P1210, DOI 10.1172/JCI200524140; Shao JS, 2003, J BIOL CHEM, V278, P50195, DOI 10.1074/jbc.M308825200; Shirakabe K, 2001, GENES CELLS, V6, P851, DOI 10.1046/j.1365-2443.2001.00466.x; Sierra OL, 2004, J BIOL CHEM, V279, P32913, DOI 10.1074/jbc.M314098200; Stratman JL, 2003, TRANSGENIC RES, V12, P521, DOI 10.1023/A:1024225408961; TOWLER DA, 1994, MOL ENDOCRINOL, V8, P1484, DOI 10.1210/me.8.11.1484; Towler DA, 1998, J BIOL CHEM, V273, P30427, DOI 10.1074/jbc.273.46.30427; Tu XL, 2007, DEV CELL, V12, P113, DOI 10.1016/j.devcel.2006.11.003; Tyson KL, 2003, ARTERIOSCL THROM VAS, V23, P489, DOI 10.1161/01.ATV.0000059406.92165.31; VanHouten JN, 2003, J CLIN INVEST, V112, P1429, DOI 10.1172/JCI200319504; Wang FS, 2007, BONE, V40, P485, DOI 10.1016/j.bone.2006.09.004; Wang JC, 2007, AM J MED GENET A, V143A, P2931, DOI 10.1002/ajmg.a.31946; Willis DM, 2002, J BIOL CHEM, V277, P37280, DOI 10.1074/jbc.M206482200; Wu L, 1997, MECH DEVELOP, V65, P3, DOI 10.1016/S0925-4773(97)00032-4; Wuyts W, 2000, HUM MOL GENET, V9, P1251, DOI 10.1093/hmg/9.8.1251; Ye L, 2005, J BIOL CHEM, V280, P6197, DOI 10.1074/jbc.M412911200; Zhang HL, 1997, MOL CELL BIOL, V17, P2920, DOI 10.1128/MCB.17.5.2920; Zhou YL, 2000, J BIOL CHEM, V275, P29066, DOI 10.1074/jbc.M002031200; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	91	76	82	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20505	20522		10.1074/jbc.M800851200	http://dx.doi.org/10.1074/jbc.M800851200			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18487199	Green Published, hybrid			2022-12-25	WOS:000257565300064
J	Zhong, MC; Veillette, A				Zhong, Ming-Chao; Veillette, Andre			Control of T lymphocyte signaling by Ly108, a signaling lymphocytic activation molecule family receptor implicated in autoimmunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED LYMPHOPROLIFERATIVE DISEASE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; PROTEIN-KINASE P56LCK; NATURAL-KILLER-CELLS; HUMAN NK CELLS; NTB-A; HOMOPHILIC INTERACTION; IMMUNE REGULATION; CUTTING EDGE; GENE-PRODUCT	The signaling lymphocytic activation molecule family of receptors has been implicated in the pathophysiology of autoimmunity in humans and mice. One member of the family, Ly108, was strongly linked to lupus susceptibility in mice. High expression of a Ly108 isoform, Ly108-1, was observed in lymphocytes of lupus-prone mice. Herein, we examined the molecular basis for the influence of Ly108 on lupus susceptibility by studying Ly108 signal transduction in T cells. We observed that Ly108 was able to mediate a tyrosine phosphorylation signal implicating Ly108, Vav-1, and c-Cbl in a manner strictly dependent on engagement of the extracellular domain of Ly108 and co-expression of the Src homology 2 (SH2) domain-containing adaptor signaling lymphocytic activation molecule (SLAM)-associated protein (SAP). Evaluation of T cells from mice carrying mutations in the SAP-FynT pathway indicated that Ly108-triggered protein tyrosine phosphorylation was due to the capacity of SAP to recruit FynT. Importantly, Ly108-1 was more apt at triggering tyrosine phosphorylation signals in T cells when compared with the predominant Ly108 isoform found in non-lupus-prone mice, Ly108-2. This difference was due in part to the presence in Ly108-1 of a unique intra-cytoplasmic tyrosine-based motif that promoted Ly108 signal transduction. Together these data provided a molecular explanation for the involvement of Ly108 in lupus susceptibility in mice.	[Zhong, Ming-Chao; Veillette, Andre] Inst Rech Clin Montreal, Mol Oncol Lab, Montreal, PQ H2W 1R7, Canada; [Veillette, Andre] Univ Montreal, Dept Med, Montreal, PQ H3T 1J4, Canada; [Veillette, Andre] McGill Univ, Dept Med, Montreal, PQ H3G 1Y6, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; McGill University	Veillette, A (corresponding author), Inst Rech Clin Montreal, Mol Oncol Lab, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	veillea@ircm.qc.ca			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		ABRAHAM N, 1991, NATURE, V350, P62, DOI 10.1038/350062a0; Bottino C, 2001, J EXP MED, V194, P235, DOI 10.1084/jem.194.3.235; Calpe S, 2006, IMMUNOGENETICS, V58, P15, DOI 10.1007/s00251-005-0056-3; Castro AG, 1999, J IMMUNOL, V163, P5860; Chan B, 2003, NAT CELL BIOL, V5, P155, DOI 10.1038/ncb920; Chen RY, 2004, MOL CELL BIOL, V24, P5144, DOI 10.1128/MCB.24.12.5144-5156.2004; DAVIDSON D, 1992, J EXP MED, V175, P1483, DOI 10.1084/jem.175.6.1483; Davidson D, 2004, IMMUNITY, V21, P707, DOI 10.1016/j.immuni.2004.10.005; Duan L, 2004, IMMUNITY, V21, P7, DOI 10.1016/j.immuni.2004.06.012; Falco M, 2004, EUR J IMMUNOL, V34, P1663, DOI 10.1002/eji.200424886; Fernandez NC, 2005, BLOOD, V105, P4416, DOI 10.1182/blood-2004-08-3156; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; Flaig RM, 2004, J IMMUNOL, V172, P6524, DOI 10.4049/jimmunol.172.11.6524; Fournel M, 1996, J EXP MED, V183, P301, DOI 10.1084/jem.183.1.301; Griewank K, 2007, IMMUNITY, V27, P751, DOI 10.1016/j.immuni.2007.08.020; Howie D, 2005, J IMMUNOL, V174, P5931, DOI 10.4049/jimmunol.174.10.5931; Kumar KR, 2006, SCIENCE, V312, P1665, DOI 10.1126/science.1125893; Latour S, 2003, NAT CELL BIOL, V5, P149, DOI 10.1038/ncb919; Latour S, 2001, NAT IMMUNOL, V2, P681, DOI 10.1038/90615; Moser KL, 1998, P NATL ACAD SCI USA, V95, P14869, DOI 10.1073/pnas.95.25.14869; Nichols KE, 2005, IMMUNOL REV, V203, P180, DOI 10.1111/j.0105-2896.2005.00230.x; Peck SR, 2000, IMMUNOGENETICS, V52, P63, DOI 10.1007/s002510000252; Roncagalli R, 2005, NAT IMMUNOL, V6, P1002, DOI 10.1038/ni1242; RUBIN LA, 1985, HYBRIDOMA, V4, P91, DOI 10.1089/hyb.1985.4.91; Shai R, 1999, HUM MOL GENET, V8, P639, DOI 10.1093/hmg/8.4.639; Simarro M, 2004, INT IMMUNOL, V16, P727, DOI 10.1093/intimm/dxh074; Stark S, 2006, INT IMMUNOL, V18, P241, DOI 10.1093/intimm/dxh358; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; Tsao BP, 1997, J CLIN INVEST, V99, P725, DOI 10.1172/JCI119217; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; Valdez PA, 2004, J BIOL CHEM, V279, P18662, DOI 10.1074/jbc.M312313200; Veillette A, 2006, NAT REV IMMUNOL, V6, P56, DOI 10.1038/nri1761; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; Veillette A, 2007, IMMUNITY, V27, P698, DOI 10.1016/j.immuni.2007.11.005; Wandstrat AE, 2004, IMMUNITY, V21, P769, DOI 10.1016/j.immuni.2004.10.009; Yin L, 2003, J MED VIROL, V71, P446, DOI 10.1002/jmv.10504	36	50	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19255	19264		10.1074/jbc.M800209200	http://dx.doi.org/10.1074/jbc.M800209200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18482989	hybrid			2022-12-25	WOS:000257387600011
J	Ross, EA; Freeman, S; Zhao, Y; Dhanjal, TS; Ross, EJ; Lax, S; Ahmed, Z; Hou, TZ; Kalia, N; Egginton, S; Nash, G; Watson, SP; Frampton, J; Buckley, CD				Ross, Ewan A.; Freeman, Sylvie; Zhao, Yan; Dhanjal, Tarvinder S.; Ross, Emma J.; Lax, Sian; Ahmed, Zubair; Hou, Tie Zheng; Kalia, Neena; Egginton, Stuart; Nash, Gerard; Watson, Steve P.; Frampton, Jon; Buckley, Christopher D.			A Novel Role for PECAM-1 (CD31) in Regulating Haematopoietic Progenitor Cell Compartmentalization between the Peripheral Blood and Bone Marrow	PLOS ONE			English	Article								Although the expression of PECAM-1 (CD31) on vascular and haematopoietic cells within the bone marrow microenvironment has been recognized for some time, its physiological role within this niche remains unexplored. In this study we show that PECAM-1 influences steady state hematopoietic stem cell (HSC) progenitor numbers in the peripheral blood but not the bone marrow compartment. PECAM-1(-/-) mice have higher levels of HSC progenitors in the blood compared to their littermate controls. We show that PECAM-1 is required on both progenitors and bone marrow vascular cells in order for efficient transition between the blood and bone marrow to occur. We have identified key roles for PECAM-1 in both the regulation of HSC migration to the chemokine CXCL12, as well as maintaining levels of the matrix degrading enzyme MMP-9 in the bone marrow vascular niche. Using intravital microscopy and adoptive transfer of either wild type (WT) or PECAM-1(-/-) bone marrow precursors, we demonstrate that the increase in HSC progenitors in the blood is due in part to a reduced ability to migrate from blood to the bone marrow vascular niche. These findings suggest a novel role for PECAM-1 as a regulator of resting homeostatic progenitor cell numbers in the blood	[Ross, Ewan A.; Ross, Emma J.; Lax, Sian; Hou, Tie Zheng; Buckley, Christopher D.] Univ Birmingham, MRC, Ctr Immune Regulat, Rheumatol Res Grp, Birmingham, W Midlands, England; [Freeman, Sylvie; Frampton, Jon] Univ Birmingham, MRC, Ctr Immune Regulat, Div Immun & Infect, Birmingham, W Midlands, England; [Zhao, Yan; Dhanjal, Tarvinder S.; Kalia, Neena; Nash, Gerard; Watson, Steve P.] Univ Birmingham, Ctr Cardiovascul Stud, Birmingham, W Midlands, England; [Ahmed, Zubair] Univ Birmingham, Mol Neurosci Grp, Birmingham, W Midlands, England; [Egginton, Stuart] Univ Birmingham, Dept Physiol, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham	Ross, EA (corresponding author), Univ Birmingham, MRC, Ctr Immune Regulat, Rheumatol Res Grp, Birmingham, W Midlands, England.	c.d.buckley@bham.ac.uk	Nash, Gerard B/E-4182-2010; Buckley, Christopher/AAN-6378-2021; Watson, Stephen P/Q-6292-2016; HOU, TIEZHENG/B-4848-2015	Nash, Gerard B/0000-0002-5935-2831; Buckley, Christopher/0000-0001-6924-6402; Watson, Stephen P/0000-0002-7846-7423; Lax, Sian/0000-0002-0248-8973; Ross, Ewan/0000-0001-5733-9361; Freeman, Sylvie/0000-0003-1869-180X; KALIA, NEENA/0000-0003-2960-7829; Egginton, Stuart/0000-0002-3084-9692	Leukaemia Research Fund; Arthritis Research Campaign; MRC [G0300102] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [C19491] Funding Source: researchfish; Medical Research Council [G0300102, G9818340B] Funding Source: researchfish	Leukaemia Research Fund; Arthritis Research Campaign(Versus Arthritis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by grants from the Leukaemia Research Fund and Arthritis Research Campaign.	Ahmed Z, 2005, MOL CELL NEUROSCI, V28, P64, DOI 10.1016/j.mcn.2004.08.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; BAZZONI G, 1995, J BIOL CHEM, V270, P25570, DOI 10.1074/jbc.270.43.25570; Bird IN, 1999, J CELL SCI, V112, P1989; BROXMEYER HE, 2007, ANN N Y ACAD SCI; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; de Haan G, 2002, BLOOD, V100, P2056, DOI 10.1182/blood-2002-03-0808; DEBRUIJN MFTR, 1994, EUR J IMMUNOL, V24, P2279, DOI 10.1002/eji.1830241003; Dhanjal TS, 2007, BLOOD, V109, P4237, DOI 10.1182/blood-2006-10-050740; Enciso JM, 2003, J CELL BIOL, V160, P605, DOI 10.1083/jcb.200209014; Ferrero E, 2003, BLOOD, V101, P186, DOI 10.1182/blood-2002-03-0768; Geiger H, 2001, BLOOD, V98, P2966, DOI 10.1182/blood.V98.10.2966; GLODEK AM, 2007, LEUKEMIA; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Graesser D, 2002, J CLIN INVEST, V109, P383, DOI 10.1172/JCI13595; Hattori K, 2003, LEUKEMIA LYMPHOMA, V44, P575, DOI 10.1080/1042819021000037985; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Ilan N, 2001, FASEB J, V15, P362, DOI 10.1096/fj.00-0372com; Ilan N, 2001, DEV BIOL, V232, P219, DOI 10.1006/dbio.2001.0186; Jackson DE, 1997, J BIOL CHEM, V272, P6986, DOI 10.1074/jbc.272.11.6986; Katayama Y, 2003, BLOOD, V102, P2060, DOI 10.1182/blood-2003-04-1212; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kopp HG, 2005, PHYSIOLOGY, V20, P349, DOI 10.1152/physiol.00025.2005; LEAVESLEY DI, 1994, J IMMUNOL, V153, P4673; Lee S, 2000, STEM CELLS, V18, P281, DOI 10.1634/stemcells.18-4-281; LENTER M, 1993, P NATL ACAD SCI USA, V90, P9051, DOI 10.1073/pnas.90.19.9051; Ling V, 1997, EUR J IMMUNOL, V27, P509, DOI 10.1002/eji.1830270223; Luu NT, 2003, J VASC RES, V40, P467, DOI 10.1159/000074296; Maas M, 2005, AM J PHYSIOL-HEART C, V288, pH159, DOI 10.1152/ajpheart.00500.2004; Mazo IB, 1999, J LEUKOCYTE BIOL, V66, P25, DOI 10.1002/jlb.66.1.25; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Nakamura Y, 2004, EXP HEMATOL, V32, P390, DOI 10.1016/j.exphem.2004.01.004; Nelissen I, 2002, J LEUKOCYTE BIOL, V71, P89; Newman PJ, 1997, J CLIN INVEST, V100, pS25; Newman PJ, 2003, ARTERIOSCL THROM VAS, V23, P953, DOI 10.1161/01.ATV.0000071347.69358.D9; Nilsson SK, 1998, J HISTOCHEM CYTOCHEM, V46, P371, DOI 10.1177/002215549804600311; Papayannopoulou T, 2004, BLOOD, V103, P1580, DOI 10.1182/blood-2003-05-1595; Peled A, 2000, BLOOD, V95, P3289, DOI 10.1182/blood.V95.11.3289.011k33_3289_3296; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Pumphrey NJ, 1999, FEBS LETT, V450, P77, DOI 10.1016/S0014-5793(99)00446-9; Rainger GE, 1997, CURR BIOL, V7, P316, DOI 10.1016/S0960-9822(06)00155-2; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; Sagawa K, 1997, J BIOL CHEM, V272, P31086, DOI 10.1074/jbc.272.49.31086; SLIEKER WAT, 1993, INT IMMUNOL, V5, P1093, DOI 10.1093/intimm/5.9.1093; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Voermans C, 2000, STEM CELLS, V18, P435, DOI 10.1634/stemcells.18-6-435; Wagers AJ, 2002, EXP HEMATOL, V30, P176, DOI 10.1016/S0301-472X(01)00777-9; WATT SM, 1993, BLOOD, V82, P2649; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; Wong MX, 2005, J CLIN IMMUNOL, V25, P19, DOI 10.1007/s10875-005-0354-7; Wright DE, 2002, J EXP MED, V195, P1145, DOI 10.1084/jem.20011284; WU Y, 2007, BLOOD; Yang FC, 2001, P NATL ACAD SCI USA, V98, P5614, DOI 10.1073/pnas.101546898; Yong KL, 1998, BLOOD, V91, P1196, DOI 10.1182/blood.V91.4.1196; ZICHA D, 1991, J CELL SCI, V99, P769; [No title captured]	57	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2338	10.1371/journal.pone.0002338	http://dx.doi.org/10.1371/journal.pone.0002338			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523558	Green Published, gold, Green Accepted			2022-12-25	WOS:000262614300031
J	Takayama, H; Chelikani, P; Reeves, PJ; Zhang, SG; Khorana, HG				Takayama, Hidehito; Chelikani, Prashen; Reeves, Philip J.; Zhang, Shuguang; Khorana, H. Gobind			High-Level Expression, Single-Step Immunoaffinity Purification and Characterization of Human Tetraspanin Membrane Protein CD81	PLOS ONE			English	Article								The study of membrane protein structure and function requires their high-level expression and purification in fully functional form. We previously used a tetracycline-inducible stable mammalian cell line, HEK293S-TetR, for regulated high-level expression of G-protein coupled receptors. We here report successfully using this method for high-level expression of de novo oligo-DNA assembled human CD81 gene. CD81 is a member of the vital tetraspanin membrane protein family. It has recently been identified as the putative receptor for the Hepatitis C Virus envelope E2 glycoprotein (HCV-E2). In this study we used a single-step rho-1D4-affinity purification method to obtain > 95% purity from HEK293S-TetR-inducible stable cell lines. Using ELISA assay we determined that the affinity of the purified CD81 receptor for HCV-E2 protein is 3.8 +/- 1.2 nM. Using fluorescent confocal microscopy we showed that the inducibly overexpressed CD81 receptor in HEK293S-TetR cells is correctly located on the plasma membrane. We demonstrated that the combination of high-level expression of CD81 with efficient single-step immunoaffinity purification is a useful method for obtaining large quantities of CD81 membrane receptor suitable for detailed structural analyses of this elusive tetraspanin protein. Furthermore, this simple single-step immunoaffinity purification to high purity of membrane protein could be useful broadly for other membrane protein purifications, thus accelerating the determination of structures for large numbers of difficult-to-obtain membrane proteins.	[Takayama, Hidehito; Zhang, Shuguang] MIT, Ctr Biomed Engn, Cambridge, MA 02139 USA; [Takayama, Hidehito] Mitsubishi Chem Corp, Yokohama, Kanagawa, Japan; [Chelikani, Prashen; Khorana, H. Gobind] MIT, Dept Biol, Cambridge, MA USA; [Chelikani, Prashen; Khorana, H. Gobind] MIT, Dept Chem, Cambridge, MA USA; [Reeves, Philip J.] Univ Essex, Dept Biol Sci, Colchester, Essex, England	Massachusetts Institute of Technology (MIT); Mitsubishi Chemical Holdings Corporation; Mitsubishi Chemical; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Essex	Takayama, H (corresponding author), MIT, Ctr Biomed Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	Shuguang@mit.edu; khorana@mit.edu		Chelikani, Prashen/0000-0003-1129-7957; Zhang, Shuguang/0000-0002-3856-3752	Mitsubishi Chemical Corporation, Japan [fellowship]; NIH [RO1-EY11716]; American Heart Association [Postdoctoral Fellowship]; University of Manitoba, Canada; John Simon Guggenheim [fellowship]; NATIONAL EYE INSTITUTE [R01EY011716] Funding Source: NIH RePORTER	Mitsubishi Chemical Corporation, Japan; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); University of Manitoba, Canada; John Simon Guggenheim; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Research reported here was supported by unrestricted grants from Mitsubishi Chemical Corporation, Japan to SZ; RO1-EY11716 (NIH) to HGK, and an American Heart Association Postdoctoral Fellowship to PC. HT was supported by a fellowship from Mitsubishi Chemical Corporation. PC acknowledges support from the University of Manitoba, Canada. SZ gratefully acknowledges the John Simon Guggenheim fellowship to provide freedom to pursue frontiers of research.	Andre M, 2006, PROTEOMICS, V6, P1437, DOI 10.1002/pmic.200500180; Chelikani P, 2006, PROTEIN SCI, V15, P1433, DOI 10.1110/ps.062080006; DUBUISSON J, 2008, CELL MICROBIOL  0103; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; GARCIAESPAFIA A, 2008, GENOMICS        0219; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Kitadokoro K, 2001, EMBO J, V20, P12, DOI 10.1093/emboj/20.1.12; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Kusnezow W, 2003, J MOL RECOGNIT, V16, P165, DOI 10.1002/jmr.625; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Loll PJ, 2003, J STRUCT BIOL, V142, P144, DOI 10.1016/S1047-8477(03)00045-5; Min GW, 2006, J CELL BIOL, V173, P975, DOI 10.1083/jcb.200602086; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Nilsson J, 2005, PROTEINS, V60, P606, DOI 10.1002/prot.20583; Petracca R, 2000, J VIROL, V74, P4824, DOI 10.1128/JVI.74.10.4824-4830.2000; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; Shoham T, 2006, MOL CELL BIOL, V26, P1373, DOI 10.1128/MCB.26.4.1373-1385.2006; Sia SK, 2003, ELECTROPHORESIS, V24, P3563, DOI 10.1002/elps.200305584; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335	22	22	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2314	10.1371/journal.pone.0002314	http://dx.doi.org/10.1371/journal.pone.0002314			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523555	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000262614300017
J	Li, ZY; Yi, YZ; Yin, XP; Zhang, ZF; Liu, JX				Li, Zhiyong; Yi, Yongzhu; Yin, Xiangping; Zhang, Zhifang; Liu, Jixing			Expression of Foot-and-Mouth Disease Virus Capsid Proteins in Silkworm-Baculovirus Expression System and Its Utilization as a Subunit Vaccine	PLOS ONE			English	Article								Background: Foot-and-mouth disease (FMD) is a highly contagious disease of livestock that causes severe economic loss in susceptible cloven-hoofed animals. Although the traditional inactivated vaccine has been proved effective, it may lead to a new outbreak of FMD because of either incomplete inactivation of FMDV or the escape of live virus from vaccine production workshop. Thus, it is urgent to develop a novel FMDV vaccine that is safer, more effective and more economical than traditional vaccines. Methodology and Principal Findings: A recombinant silkworm baculovirus Bm-P12A3C which contained the intact P1-2A and 3C protease coding regions of FMDV Asia 1/HNK/CHA/05 was developed. Indirect immunofluorescence test and sandwich-ELISA were used to verify that Bm-P12A3C could express the target cassette. Expression products from silkworm were diluted to 30 folds and used as antigen to immunize cattle. Specific antibody was induced in all vaccinated animals. After challenge with virulent homologous virus, four of the five animals were completely protected, and clinical symptoms were alleviated and delayed in the remaining one. Furthermore, a PD50 (50% bovine protective dose) test was performed to assess the bovine potency of the subunit vaccine. The result showed the subunit vaccine could achieve 6.34 PD50 per dose. Conclusion: The results suggest that this strategy might be used to develop the new subunit FMDV vaccine.	[Li, Zhiyong; Yin, Xiangping; Liu, Jixing] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Key Lab Anim Virol,Minist Agr, Lanzhou, Gansu, Peoples R China; [Yi, Yongzhu; Zhang, Zhifang] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Li, ZY (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Key Lab Anim Virol,Minist Agr, Lanzhou, Gansu, Peoples R China.	zhifangzhang@yahoo.com; liuxing@hotmail.com			National 863 Project of China [2006AA02Z440]; Chinese Funding for Social Public Interests [2005DIB4J041]	National 863 Project of China; Chinese Funding for Social Public Interests	This work was supported by grants from National 863 Project of China (No. 2006AA02Z440) and Chinese Funding for Social Public Interests (No. 2005DIB4J041). The funders had no role in the study design and conduct, data collection and analysis, decision to publish, or in the preparation of the manuscript.	ABRAMS CC, 1995, J GEN VIROL, V76, P3089, DOI 10.1099/0022-1317-76-12-3089; Balamurugan V, 2005, ARCH VIROL, V150, P967, DOI 10.1007/s00705-004-0460-2; Belliot G, 2001, J CLIN MICROBIOL, V39, P4288, DOI 10.1128/JCM.39.12.4288-4295.2001; BELSHAM GJ, 1991, J GEN VIROL, V72, P747, DOI 10.1099/0022-1317-72-3-747; Brown F, 2003, VIRUS RES, V91, P3, DOI 10.1016/S0168-1702(02)00268-X; CHOUDARY PV, 1995, BACULOVIRUS EXPRESSI, P243; Doel TR, 2003, VIRUS RES, V91, P81, DOI 10.1016/S0168-1702(02)00261-7; GRUBMAN MJ, 1993, VACCINE, V11, P825, DOI 10.1016/0264-410X(93)90357-4; Guo H., 2006, Journal of Veterinary Medicine. Series B, V53, P29, DOI 10.1111/j.1439-0450.2006.01018.x; Guo HC, 2005, VACCINE, V23, P3236, DOI 10.1016/j.vaccine.2004.03.074; KLEID DG, 1981, SCIENCE, V214, P1125, DOI 10.1126/science.6272395; KRAUSSLICH HG, 1990, J VIROL, V64, P2433; LAURENT S, 1994, J VIROL, V68, P6794, DOI 10.1128/JVI.68.10.6794-6798.1994; LEWIS SA, 1991, J VIROL, V65, P6572, DOI 10.1128/JVI.65.12.6572-6580.1991; Li D, 2007, VIRUS GENES, V35, P273, DOI 10.1007/s11262-006-0073-9; Lin XA, 2006, Z NATURFORSCH C, V61, P595; Maranga Luis, 2002, Adv Biochem Eng Biotechnol, V74, P183; Mayr GA, 2001, VACCINE, V19, P2152, DOI 10.1016/S0264-410X(00)00384-4; Mayr GA, 1999, VIROLOGY, V263, P496, DOI 10.1006/viro.1999.9940; Moraes MP, 2003, VACCINE, V22, P268, DOI 10.1016/S0264-410X(03)00560-7; Moraes MP, 2002, VACCINE, V20, P1631, DOI 10.1016/S0264-410X(01)00483-2; Mortola E, 2004, FEBS LETT, V576, P174, DOI 10.1016/j.febslet.2004.09.009; Noad R, 2003, TRENDS MICROBIOL, V11, P438, DOI 10.1016/S0966-842X(03)00208-7; Pacheco JM, 2005, VIROLOGY, V337, P205, DOI 10.1016/j.virol.2005.04.014; Perry BD, 2003, FOOT-AND-MOUTH DISEASE: CONTROL STRATEGIES, P23; Pluimers FH, 2002, REV SCI TECH OIE, V21, P711, DOI 10.20506/rst.21.3.1371; ROOSIEN J, 1990, J GEN VIROL, V71, P1703, DOI 10.1099/0022-1317-71-8-1703; Santos MJD, 2005, VACCINE, V23, P1838, DOI 10.1016/j.vaccine.2004.11.014; Thompson D, 2002, REV SCI TECH OIE, V21, P675, DOI 10.20506/rst.21.3.1353; Wu XF, 2001, GENE EXPRESSION TECH, P135	30	56	66	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2273	10.1371/journal.pone.0002273	http://dx.doi.org/10.1371/journal.pone.0002273			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509464	Green Submitted, gold, Green Published			2022-12-25	WOS:000262268500018
J	Leclerc, P; Biarc, J; St-Onge, M; Gilbert, C; Dussault, AA; Laflamme, C; Pouliot, M				Leclerc, Patrick; Biarc, Jordane; St-Onge, Mireille; Gilbert, Caroline; Dussault, Andree-Anne; Laflamme, Cynthia; Pouliot, Marc			Nucleobindin Co-Localizes and Associates with Cyclooxygenase (COX)-2 in Human Neutrophils	PLOS ONE			English	Article								The inducible cyclooxygenase isoform (COX-2) is associated with inflammation, tumorigenesis, as well as with physiological events. Despite efforts deployed in order to understand the biology of this multi-faceted enzyme, much remains to be understood. Nucleobindin (Nuc), a ubiquitous Ca2+-binding protein, possesses a putative COX-binding domain. In this study, we investigated its expression and subcellular localization in human neutrophils, its affinity for COX-2 as well as its possible impact on PGE(2) biosynthesis. Complementary subcellular localization approaches including nitrogen cavitation coupled to Percoll fractionation, immunofluorescence, confocal and electron microscopy collectively placed Nuc, COX-2, and all of the main enzymes involved in prostanoid synthesis, in the Golgi apparatus and endoplasmic reticulum of human neutrophils. Immunoprecipitation experiments indicated a high affinity between Nuc and COX-2. Addition of human recombinant (hr) Nuc to purified hrCOX-2 dose-dependently caused an increase in PGE(2) biosynthesis in response to arachidonic acid. Co-incubation of Nuc with COX-2-expressing neutrophil lysates also increased their capacity to produce PGE(2). Moreover, neutrophil transfection with hrNuc specifically enhanced PGE(2) biosynthesis. Together, these results identify a COX-2-associated protein which may have an impact in prostanoid biosynthesis.	[Leclerc, Patrick; Biarc, Jordane; St-Onge, Mireille; Gilbert, Caroline; Dussault, Andree-Anne; Laflamme, Cynthia; Pouliot, Marc] Univ Laval, Fac Med, Ctr Rech Rhumatol & Immunol, Quebec City, PQ G1K 7P4, Canada	Laval University	Leclerc, P (corresponding author), Univ Laval, Fac Med, Ctr Rech Rhumatol & Immunol, Quebec City, PQ G1K 7P4, Canada.	Marc.Pouliot@crchul.ulaval.ca	Biarc, Jordane/AAP-4958-2020; Pouliot, Marc/G-4103-2016	Pouliot, Marc/0000-0002-2466-5424; Gilbert, Caroline/0000-0003-2722-1180	Canadian Institutes of Health Research [MOP-64315]; The Arthritis Society [04/0079]; Fonds de la Recherche en Sante du Quebec (FRSQ) [Senior Investigator Scholarship]; Canadian Arthritis Network [fellowship, studentship]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); The Arthritis Society; Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Canadian Arthritis Network	This work is supported by grants from the Canadian Institutes of Health Research (CIHR, grant no. MOP-64315) and The Arthritis Society (TAS, grant no. 04/0079 to MP). MP is the recipient of a Senior Investigator Scholarship from the Fonds de la Recherche en Sante du Quebec (FRSQ). JB and MSO are respectively recipients of a fellowship and studentship from the Canadian Arthritis Network.	Ballif BA, 1996, P NATL ACAD SCI USA, V93, P5544, DOI 10.1073/pnas.93.11.5544; Bertagnolli M M, 1999, Curr Oncol Rep, V1, P173, DOI 10.1007/s11912-999-0030-6; Bornfeldt KE, 1997, J CLIN INVEST, V100, P875, DOI 10.1172/JCI119603; BORREGAARD N, 1983, J CELL BIOL, V97, P52, DOI 10.1083/jcb.97.1.52; Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P77; BREDEROO P, 1983, CELL TISSUE RES, V234, P469, DOI 10.1007/BF00218646; Cadieux JS, 2005, J CELL SCI, V118, P1437, DOI 10.1242/jcs.01737; CHANDRA S, 1991, J CELL SCI, V100, P747; Degousee N, 2002, J BIOL CHEM, V277, P5061, DOI 10.1074/jbc.M109083200; DINCHUK JE, 1995, NATURE, V378, P406, DOI 10.1038/378406a0; DuBois RN, 1996, CANCER RES, V56, P733; FANTONE JC, 1981, PROSTAG LEUKOTR ESS, V7, P195, DOI 10.1016/0161-4630(81)90062-8; FANTONE JC, 1983, J IMMUNOL, V130, P1495; Faurschou M, 2003, MICROBES INFECT, V5, P1317, DOI 10.1016/j.micinf.2003.09.008; HAM EA, 1983, P NATL ACAD SCI-BIOL, V80, P4349, DOI 10.1073/pnas.80.14.4349; Higashi Y, 2000, INT J CANCER, V86, P667, DOI 10.1002/(SICI)1097-0215(20000601)86:5<667::AID-IJC10>3.3.CO;2-P; Howe LR, 2001, ENDOCR-RELAT CANCER, V8, P97, DOI 10.1677/erc.0.0080097; KANAI Y, 1992, IMMUNOL LETT, V32, P43; Kjeldsen L, 1999, J IMMUNOL METHODS, V232, P131, DOI 10.1016/S0022-1759(99)00171-4; Lachance G, 2002, J BIOL CHEM, V277, P21537, DOI 10.1074/jbc.M201903200; Lavoie C, 2002, MOL ENDOCRINOL, V16, P2462, DOI 10.1210/me.2002-0079; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Lin P, 1999, J CELL BIOL, V145, P279, DOI 10.1083/jcb.145.2.279; Lin P, 1998, J CELL BIOL, V141, P1515, DOI 10.1083/jcb.141.7.1515; Lin P, 2000, P NATL ACAD SCI USA, V97, P674, DOI 10.1073/pnas.97.2.674; Maloney CG, 1998, J IMMUNOL, V160, P1402; Marshall J, 2000, J IMMUNOL, V164, P2084, DOI 10.4049/jimmunol.164.4.2084; MIURA K, 1992, BIOCHEM BIOPH RES CO, V187, P375, DOI 10.1016/S0006-291X(05)81503-7; Miura K, 1996, GENOMICS, V34, P181, DOI 10.1006/geno.1996.0263; MIURA K, 1994, BIOCHEM BIOPH RES CO, V199, P1388, DOI 10.1006/bbrc.1994.1384; MOCHIZUKI N, 1995, FEBS LETT, V373, P155, DOI 10.1016/0014-5793(95)01031-9; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; Murakami M, 2004, PROG LIPID RES, V43, P3, DOI 10.1016/S0163-7827(03)00037-7; PELHAM HRB, 1990, TRENDS BIOCHEM SCI, V15, P483, DOI 10.1016/0968-0004(90)90303-S; Petersson U, 2004, BONE, V34, P949, DOI 10.1016/j.bone.2004.01.019; Pouliot M, 2002, J IMMUNOL, V169, P5279, DOI 10.4049/jimmunol.169.9.5279; Pouliot M, 1998, FASEB J, V12, P1109, DOI 10.1096/fasebj.12.12.1109; Pouliot M, 1996, EUR J BIOCHEM, V238, P250, DOI 10.1111/j.1432-1033.1996.0250q.x; Pouliot M, 1997, J IMMUNOL, V158, P4930; RIVKIN I, 1975, J IMMUNOL, V115, P1126; Somogyi E, 2004, CALCIFIED TISSUE INT, V74, P366, DOI 10.1007/s00223-003-0146-x; St-Onge M, 2007, BBA-MOL CELL BIOL L, V1771, P1235, DOI 10.1016/j.bbalip.2007.06.002; WANG SN, 1994, PATHOL INT, V44, P844, DOI 10.1111/j.1440-1827.1994.tb01682.x; WENDEL M, 1995, J BIOL CHEM, V270, P6125, DOI 10.1074/jbc.270.11.6125; Zimmermann KC, 1999, CANCER RES, V59, P198; ZURIER RB, 1974, J CLIN INVEST, V53, P297, DOI 10.1172/JCI107550	47	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2229	10.1371/journal.pone.0002229	http://dx.doi.org/10.1371/journal.pone.0002229			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493301	Green Submitted, Green Published, gold			2022-12-25	WOS:000262258700037
J	McGuigan, AP; Bruzewicz, DA; Glavan, A; Butte, M; Whitesides, GM				McGuigan, Alison P.; Bruzewicz, Derek A.; Glavan, Ana; Butte, Manish; Whitesides, George M.			Cell Encapsulation in Sub-mm Sized Gel Modules Using Replica Molding	PLOS ONE			English	Article							3-DIMENSIONAL CULTURES; COLLAGEN GEL; HEPATOCYTES; FIBROBLASTS; CONTRACTION; FABRICATION; MICROARRAY; SPHEROIDS; PHENOTYPE; HYDROGEL	For many types of cells, behavior in two-dimensional (2D) culture differs from that in three-dimensional (3D) culture. Among biologists, 2D culture on treated plastic surfaces is currently the most popular method for cell culture. In 3D, no analogous standard method-one that is similarly convenient, flexible, and reproducible-exists. This paper describes a soft-lithographic method to encapsulate cells in 3D gel objects (modules) in a variety of simple shapes (cylinders, crosses, rectangular prisms) with lateral dimensions between 40 and 1000 mu m, cell densities of 10(5) - 10(8) cells/cm(3), and total volumes between 1x10(-7) and 8x10(-4) cm(3). By varying (i) the initial density of cells at seeding, and (ii) the dimensions of the modules, the number of cells per module ranged from 1 to 2500 cells. Modules were formed from a range of standard biopolymers, including collagen, Matrigel (TM), and agarose, without the complex equipment often used in encapsulation. The small dimensions of the modules allowed rapid transport of nutrients by diffusion to cells at any location in the module, and therefore allowed generation of modules with cell densities near to those of dense tissues (10(8) - 10(9) cells/cm(3)). This modular method is based on soft lithography and requires little special equipment; the method is therefore accessible, flexible, and well suited to (i) understanding the behavior of cells in 3D environments at high densities of cells, as in dense tissues, and (ii) developing applications in tissue engineering.	[McGuigan, Alison P.; Bruzewicz, Derek A.; Glavan, Ana; Butte, Manish; Whitesides, George M.] Harvard Univ, Cambridge, MA 02138 USA	Harvard University	McGuigan, AP (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.	gwhitesides@gmwgroup.harvard.edu	Butte, Manish/AAM-8604-2020; McGuigan, Alison/B-4744-2010; Butte, Manish/T-8860-2019	Butte, Manish/0000-0002-4490-5595; Butte, Manish/0000-0002-4490-5595; McGuigan, Alison/0000-0003-2803-0917	NIH EHS [GM 065364]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065364] Funding Source: NIH RePORTER	NIH EHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH EHS grant GM 065364	Abu-Absi SF, 2002, EXP CELL RES, V274, P56, DOI 10.1006/excr.2001.5467; AHMED SA, 1994, J IMMUNOL METHODS, V170, P211, DOI 10.1016/0022-1759(94)90396-4; Albrecht DR, 2005, LAB CHIP, V5, P111, DOI 10.1039/b406953f; [Anonymous], PRINCIPLES TISSUE EN; Barralet JE, 2005, J MATER SCI-MATER M, V16, P515, DOI 10.1007/s10856-005-0526-z; BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274; Berthiaume F, 1996, FASEB J, V10, P1471, DOI 10.1096/fasebj.10.13.8940293; Bhatia SN, 1999, FASEB J, V13, P1883, DOI 10.1096/fasebj.13.14.1883; Choi NW, 2007, NAT MATER, V6, P908, DOI 10.1038/nmat2022; Cygan ZT, 2005, LANGMUIR, V21, P3629, DOI 10.1021/la0471137; Ehrlich HP, 2000, J CELL PHYSIOL, V185, P432, DOI 10.1002/1097-4652(200012)185:3<432::AID-JCP14>3.0.CO;2-R; Feinberg AW, 2007, SCIENCE, V317, P1366, DOI 10.1126/science.1146885; FINESMITH TH, 1990, J CELL PHYSIOL, V144, P99, DOI 10.1002/jcp.1041440113; Fukuda J, 2006, BIOMATERIALS, V27, P5259, DOI 10.1016/j.biomaterials.2006.05.044; Hui EE, 2007, P NATL ACAD SCI USA, V104, P5722, DOI 10.1073/pnas.0608660104; Humphreys P, 1996, J NEUROSCI METH, V66, P23, DOI 10.1016/0165-0270(95)00142-5; Kamamoto F, 2003, ARTIF ORGANS, V27, P701, DOI 10.1046/j.1525-1594.2003.07277.x; Karp JM, 2007, LAB CHIP, V7, P786, DOI 10.1039/b705085m; Kono Y, 1996, BIOCHEM BIOPH RES CO, V220, P628, DOI 10.1006/bbrc.1996.0454; LAZAR A, 1995, IN VITRO CELL DEV-AN, V31, P340, DOI 10.1007/BF02634282; LAZAR A, 1995, CELL TRANSPLANT, V4, P259, DOI 10.1016/0963-6897(94)00058-R; Li GN, 2007, TISSUE ENG, V13, P1035, DOI 10.1089/ten.2006.0251; LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628; Liu H, 2005, TISSUE ENG, V11, P319, DOI 10.1089/ten.2005.11.319; McGuigan AP, 2006, NAT PROTOC, V1, P2963, DOI 10.1038/nprot.2006.443; Mcguigan AP, 2007, TISSUE ENG, V13, P1069, DOI 10.1089/ten.2006.0253; McGuigan AP, 2006, P NATL ACAD SCI USA, V103, P11461, DOI 10.1073/pnas.0602740103; MORRA M, 1990, Clinical Materials, V5, P147, DOI 10.1016/0267-6605(90)90014-M; Nomi M, 2002, MOL ASPECTS MED, V23, P463, DOI 10.1016/S0098-2997(02)00008-0; PHILLIPS HJ, 1957, EXP CELL RES, V13, P341, DOI 10.1016/0014-4827(57)90013-7; Powers MJ, 2002, TISSUE ENG, V8, P499, DOI 10.1089/107632702760184745; Puri S, 2007, DEV BIOL, V306, P82, DOI 10.1016/j.ydbio.2007.03.003; Radisic M, 2006, TISSUE ENG, V12, P2077, DOI 10.1089/ten.2006.12.2077; SORANZO C, 1986, TUMORI, V72, P459, DOI 10.1177/030089168607200502; Tan W, 2005, J BIOMED MATER RES A, V72A, P146, DOI 10.1002/jbm.a.30182; Tan W, 2004, BIOMATERIALS, V25, P1355, DOI 10.1016/j.biomaterials.2003.08.021; Tan W, 2003, BIOMED MICRODEVICES, V5, P235, DOI 10.1023/A:1025764310391; Tsang VL, 2007, FASEB J, V21, P790, DOI 10.1096/fj.06-7117com; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G; Yeh J, 2006, BIOMATERIALS, V27, P5391, DOI 10.1016/j.biomaterials.2006.06.005	41	75	76	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2258	10.1371/journal.pone.0002258	http://dx.doi.org/10.1371/journal.pone.0002258			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493609	Green Published, gold			2022-12-25	WOS:000262258700058
J	Nakashima, A; Maruki, Y; Imamura, Y; Kondo, C; Kawamata, T; Kawanishi, I; Takata, H; Matsuura, A; Lee, KS; Kikkawa, U; Ohsumi, Y; Yonezawa, K; Kamada, Y				Nakashima, Akio; Maruki, Yoshiko; Imamura, Yuko; Kondo, Chika; Kawamata, Tomoko; Kawanishi, Ippei; Takata, Hideki; Matsuura, Akira; Lee, Kyung S.; Kikkawa, Ushio; Ohsumi, Yoshinori; Yonezawa, Kazuyoshi; Kamada, Yoshiaki			The Yeast Tor Signaling Pathway Is Involved in G2/M Transition via Polo-Kinase	PLOS ONE			English	Article							CELL-CYCLE; NUCLEAR-LOCALIZATION; BINDING-PROTEIN; HIGH OSMOLARITY; MESSENGER-RNA; FISSION YEAST; RAPAMYCIN; GROWTH; TRANSCRIPTION; PHOSPHATASE	The target of rapamycin (Tor) protein plays central roles in cell growth. Rapamycin inhibits cell growth and promotes cell cycle arrest at G1 (G0). However, little is known about whether Tor is involved in other stages of the cell division cycle. Here we report that the rapamycin-sensitive Tor complex 1 (TORC1) is involved in G2/M transition in S. cerevisiae. Strains carrying a temperature-sensitive allele of KOG1 (kog1-105) encoding an essential component of TORC1, as well as yeast cell treated with rapamycin show mitotic delay with prolonged G2. Overexpression of Cdc5, the yeast polo-like kinase, rescues the growth defect of kog1-105, and in turn, Cdc5 activity is attenuated in kog1-105 cells. The TORC1-Type2A phosphatase pathway mediates nucleocytoplasmic transport of Cdc5, which is prerequisite for its proper localization and function. The C-terminal polo-box domain of Cdc5 has an inhibitory role in nuclear translocation. Taken together, our results indicate a novel function of Tor in the regulation of cell cycle and proliferation.	[Nakashima, Akio; Maruki, Yoshiko; Kawanishi, Ippei; Kikkawa, Ushio; Ohsumi, Yoshinori; Yonezawa, Kazuyoshi] Kobe Univ, Biosignal Res Ctr, Kobe, Hyogo, Japan; [Nakashima, Akio; Yonezawa, Kazuyoshi; Kamada, Yoshiaki] Japan Sci & Technol Agcy, CREST, Kawaguchi, Japan; [Imamura, Yuko; Kondo, Chika; Kawamata, Tomoko; Kamada, Yoshiaki] Natl Inst Basic Biol, Div Mol Cell Biol, Okazaki, Aichi, Japan; [Takata, Hideki; Matsuura, Akira] Natl Inst Longevity Sci, Dept Geriat Res, Obu Aichi, Japan; [Lee, Kyung S.] Natl Inst Hlth, Natl Canc Inst, Ctr Canc Res, Lab Metabolism, Bethesda, MD USA	Kobe University; Japan Science & Technology Agency (JST); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Nakashima, A (corresponding author), Kobe Univ, Biosignal Res Ctr, Kobe, Hyogo, Japan.	yoshikam@nibb.ac.jp	Ohsumi, Yoshinori/C-6449-2009; Kawamata-HORIE, Tomoko/B-1699-2017; Matsuura, Akira/AAO-1572-2021; Matsuura, Akira/J-3864-2017	Ohsumi, Yoshinori/0000-0003-2384-2166; Kawamata-HORIE, Tomoko/0000-0002-3990-1194; Matsuura, Akira/0000-0002-2300-7227; Matsuura, Akira/0000-0002-2300-7227; Kamada, Yoshiaki/0000-0001-7395-660X				Asano S, 2005, EMBO J, V24, P2194, DOI 10.1038/sj.emboj.7600683; Barbe E., 1996, MEDITERR POLIT, V1, P25; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; BRENNER C, 1988, MOL CELL BIOL, V8, P3556, DOI 10.1128/MCB.8.8.3556; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Burke D., 2000, METHODS YEAST GENETI, pxvii; Cheng L, 1998, MOL CELL BIOL, V18, P7360, DOI 10.1128/MCB.18.12.7360; Cherkasova VA, 2003, GENE DEV, V17, P859, DOI 10.1101/gad.1069003; Cid VJ, 2002, MICROBIOL-SGM, V148, P2647, DOI 10.1099/00221287-148-9-2647; Darieva Z, 2006, NATURE, V444, P494, DOI 10.1038/nature05339; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Harwood FC, 2008, J BIOL CHEM, V283, P2575, DOI 10.1074/jbc.M706173200; Honma Y, 2006, EMBO J, V25, P3832, DOI 10.1038/sj.emboj.7601262; Hosoi H, 1998, MOL PHARMACOL, V54, P815, DOI 10.1124/mol.54.5.815; Huang S, 2001, CANCER METAST REV, V20, P69, DOI 10.1023/A:1013167315885; IIDA H, 1984, J CELL BIOL, V98, P1185, DOI 10.1083/jcb.98.4.1185; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Jang YJ, 2002, J BIOL CHEM, V277, P44115, DOI 10.1074/jbc.M202172200; Jiang Y, 2006, MICROBIOL MOL BIOL R, V70, P440, DOI 10.1128/MMBR.00049-05; JOHNSTON GC, 1977, EXP CELL RES, V105, P79, DOI 10.1016/0014-4827(77)90154-9; Kamada Y, 2005, MOL CELL BIOL, V25, P7239, DOI 10.1128/MCB.25.16.7239-7248.2005; Kawai M, 2001, CURR GENET, V39, P166; Kelm O, 2002, J BIOL CHEM, V277, P25247, DOI 10.1074/jbc.M202855200; Komeili A, 2000, J CELL BIOL, V151, P863, DOI 10.1083/jcb.151.4.863; Kubota H, 2003, J BIOL CHEM, V278, P20457, DOI 10.1074/jbc.C300133200; Lee KS, 2005, CELL CYCLE, V4, P1346, DOI 10.4161/cc.4.10.2049; Leslie DM, 2002, MOL CELL BIOL, V22, P2544, DOI 10.1128/MCB.22.8.2544-2555.2002; Lew DJ, 2003, CURR OPIN CELL BIOL, V15, P648, DOI 10.1016/j.ceb.2003.09.001; LIN FC, 1995, EMBO J, V14, P2745, DOI 10.1002/j.1460-2075.1995.tb07275.x; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Martin DE, 2004, CELL, V119, P969, DOI 10.1016/j.cell.2004.11.047; MITSUZAWA H, 1989, GENETICS, V123, P739; MORENO S, 1989, CELL, V58, P361, DOI 10.1016/0092-8674(89)90850-7; Park JE, 2004, MOL CELL BIOL, V24, P9873, DOI 10.1128/MCB.24.22.9873-9886.2004; Petersen J, 2007, NAT CELL BIOL, V9, P1263, DOI 10.1038/ncb1646; Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987; Pyhtila B, 2003, J BIOL CHEM, V278, P42699, DOI 10.1074/jbc.M307135200; SACHS AB, 1989, CELL, V58, P857, DOI 10.1016/0092-8674(89)90938-0; Shitamukai A, 2004, J BIOL CHEM, V279, P3651, DOI 10.1074/jbc.M306098200; Song S, 2000, MOL CELL BIOL, V20, P286, DOI 10.1128/MCB.20.1.286-298.2000; Taniguchi E, 2002, J BIOL CHEM, V277, P48884, DOI 10.1074/jbc.M206307200; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Wang HM, 2003, MOL BIOL CELL, V14, P4342, DOI 10.1091/mbc.E03-02-0072; Weisman R, 2003, CURR TOP MICROBIOL, V279, P85; Weisman R, 1997, J BACTERIOL, V179, P6325, DOI 10.1128/jb.179.20.6325-6334.1997; Yang HF, 2000, MOL CELL BIOL, V20, P8143, DOI 10.1128/MCB.20.21.8143-8156.2000; Yoshida S, 2006, SCIENCE, V313, P108, DOI 10.1126/science.1126747; Zheng Y, 2005, MOL BIOL CELL, V16, P2119, DOI 10.1091/mbc.e04-09-0797	51	50	50	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2223	10.1371/journal.pone.0002223	http://dx.doi.org/10.1371/journal.pone.0002223			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493323	gold, Green Submitted, Green Published			2022-12-25	WOS:000262258700031
J	Rencus-Lazar, S; Amir, Y; Wu, JT; Chien, CT; Chamovitz, DA; Segal, D				Rencus-Lazar, Sigal; Amir, Yaniv; Wu, Junetai; Chien, Cheng-Ting; Chamovitz, Daniel A.; Segal, Daniel			The Proto-Oncogene Int6 Is Essential for Neddylation of Cul1 and Cul3 in Drosophila	PLOS ONE			English	Article								Int6 is a proto-oncogene implicated in various types of cancer, but the mechanisms underlying its activity are not clear. Int6 encodes a subunit of the eukaryotic translation initiation factor 3, and interacts with two related complexes, the proteasome, whose activity is regulated by Int6 in S. pombe, and the COP9 signalosome. The COP9 signalosome regulates the activity of Cullin-Ring Ubiquitin Ligases via deneddylation of their cullin subunit. We report here the generation and analysis of two Drosophila mutants in Int6. The mutants are lethal demonstrating that Int6 is an essential gene. The mutant larvae accumulate high levels of non-neddylated Cul1, suggesting that Int6 is a positive regulator of cullin neddylation. Overexpression in Int6 in cell culture leads to accumulation of neddylated cullins, further supporting a positive role for Int6 in regulating neddylation. Thus Int6 and the COP9 signalosome play opposing roles in regulation of cullin neddylation.	[Rencus-Lazar, Sigal; Amir, Yaniv; Segal, Daniel] Tel Aviv Univ, Dept Mol Microbiol, IL-69978 Tel Aviv, Israel; [Rencus-Lazar, Sigal; Amir, Yaniv; Segal, Daniel] Tel Aviv Univ, Dept Biotechnol, Tel Aviv, Israel; [Wu, Junetai; Chien, Cheng-Ting] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Chamovitz, Daniel A.] Tel Aviv Univ, Dept Plant Sci, Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Academia Sinica - Taiwan; Tel Aviv University	Rencus-Lazar, S (corresponding author), Tel Aviv Univ, Dept Mol Microbiol, IL-69978 Tel Aviv, Israel.	dannyc@ex.tau.ac.il; dsegal@post.tau.ac.il	Chien, Cheng-Ting/AAA-5200-2021; Chamovitz, Daniel/S-5021-2019	Chien, Cheng-Ting/0000-0002-7906-7173; Chamovitz, Daniel/0000-0002-2815-2909; Segal, Daniel/0000-0002-6777-505X; WU, JUNE-TAI/0000-0002-4023-7315; Rencus-Lazar, Sigal/0000-0001-5076-1949	Israel Academy of Sciences	Israel Academy of Sciences	This work was supported by a grant from the Israel Academy of Sciences (to DAC).	Akiyoshi Y, 2001, J BIOL CHEM, V276, P10056, DOI 10.1074/jbc.M010188200; Alves KH, 2002, FEBS LETT, V527, P15, DOI 10.1016/S0014-5793(02)03147-2; Asano K, 1997, J BIOL CHEM, V272, P23477, DOI 10.1074/jbc.272.38.23477; Bandyopadhyay A, 2000, MOL BIOL CELL, V11, P4005, DOI 10.1091/mbc.11.11.4005; Chou TB, 1996, GENETICS, V144, P1673; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Doronkin S, 2003, DEV CELL, V4, P699, DOI 10.1016/S1534-5807(03)00121-7; Freilich S, 1999, CURR BIOL, V9, P1187, DOI 10.1016/S0960-9822(00)80023-8; Grumbling G, 2006, NUCLEIC ACIDS RES, V34, pD484, DOI 10.1093/nar/gkj068; Gusmaroli G, 2007, PLANT CELL, V19, P564, DOI 10.1105/tpc.106.047571; He Q, 2005, GENE DEV, V19, P1518, DOI 10.1101/gad.1322205; Karniol B, 1999, PLANT CELL, V11, P839, DOI 10.1105/tpc.11.5.839; Mack DL, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1742; MARCHETTI A, 1995, J VIROL, V69, P1932, DOI 10.1128/JVI.69.3.1932-1938.1995; Masutani M, 2007, EMBO J, V26, P3373, DOI 10.1038/sj.emboj.7601765; Mayeur GL, 2002, FEBS LETT, V514, P49, DOI 10.1016/S0014-5793(02)02307-4; Mistry H, 2004, MECH DEVELOP, V121, P1495, DOI 10.1016/j.mod.2004.07.007; Miyazaki S, 1999, GENE, V233, P241, DOI 10.1016/S0378-1119(99)00130-4; Morimoto M, 2003, BIOCHEM BIOPH RES CO, V301, P392, DOI 10.1016/S0006-291X(02)03051-6; Morris C, 2005, ONCOGENE, V24, P1203, DOI 10.1038/sj.onc.1208268; Oron E, 2002, DEVELOPMENT, V129, P4399; Oron E, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100150; Ou CY, 2002, GENE DEV, V16, P2403, DOI 10.1101/gad.1011402; Rasmussen SB, 2001, ONCOGENE, V20, P5291, DOI 10.1038/sj.onc.1204624; REICHHART JM, 1998, DROS INFO SERV, V81, P201; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Szlanka T, 2003, J CELL SCI, V116, P1023, DOI 10.1242/jcs.00332; Wee S, 2005, NAT CELL BIOL, V7, P387, DOI 10.1038/ncb1241; WHITFIELD WGF, 1990, EMBO J, V9, P2563, DOI 10.1002/j.1460-2075.1990.tb07437.x; Wu JT, 2005, NAT CELL BIOL, V7, P1014, DOI 10.1038/ncb1301; Yahalom A, 2001, J BIOL CHEM, V276, P334, DOI 10.1074/jbc.M006721200; YAHALOM A, 2007, PLANT J IN PRESS; Yen HCS, 2003, CELL, V112, P207, DOI 10.1016/S0092-8674(03)00043-6	33	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2239	10.1371/journal.pone.0002239	http://dx.doi.org/10.1371/journal.pone.0002239			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493598	Green Submitted, Green Published, gold			2022-12-25	WOS:000262258700047
J	Xing, JH; Chen, J				Xing, Jianhua; Chen, Jing			The Goldbeter-Koshland Switch in the First-Order Region and Its Response to Dynamic Disorder	PLOS ONE			English	Article								In their classical work (Proc. Natl. Acad. Sci. USA, 1981, 78: 6840-6844), Goldbeter and Koshland mathematically analyzed a reversible covalent modification system which is highly sensitive to the concentration of effectors. Its signal-response curve appears sigmoidal, constituting a biochemical switch. However, the switch behavior only emerges in the 'zero-order region', i.e. when the signal molecule concentration is much lower than that of the substrate it modifies. In this work we showed that the switching behavior can also occur under comparable concentrations of signals and substrates, provided that the signal molecules catalyze the modification reaction in cooperation. We also studied the effect of dynamic disorders on the proposed biochemical switch, in which the enzymatic reaction rates, instead of constant, appear as stochastic functions of time. We showed that the system is robust to dynamic disorder at bulk concentration. But if the dynamic disorder is quasi-static, large fluctuations of the switch response behavior may be observed at low concentrations. Such fluctuation is relevant to many biological functions. It can be reduced by either increasing the conformation interconversion rate of the protein, or correlating the enzymatic reaction rates in the network.	[Xing, Jianhua] Lawrence Livermore Natl Lab, Chem Mat & Life Sci Directorate, Lawrence Livermore Natl Lab, Livermore, CA USA; [Xing, Jianhua] Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA USA; [Chen, Jing] Univ Calif, Biophys Grad Program, Berkeley, CA USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Virginia Polytechnic Institute & State University; University of California System; University of California Berkeley	Xing, JH (corresponding author), Lawrence Livermore Natl Lab, Chem Mat & Life Sci Directorate, Lawrence Livermore Natl Lab, Livermore, CA USA.	jxing@vt.edu	Xing, Jianhua/A-8101-2012; Chen, Jing/D-4845-2016	Xing, Jianhua/0000-0002-3700-8765; Chen, Jing/0000-0001-6321-0505	Lawrence Livermore National Laboratory; U.S. Department of Energy by the University of California, Lawrence Livermore National Laboratory [W-7405-Eng-48]	Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); U.S. Department of Energy by the University of California, Lawrence Livermore National Laboratory(United States Department of Energy (DOE))	JX is partly supported by a Lawrence Livermore National Laboratory Directed Research and Development grant. This work was performed under the auspices of the U.S. Department of Energy by the University of California, Lawrence Livermore National Laboratory under Contract No. W-7405-Eng-48.	ASTUMIAN RD, 1994, PHYS REV LETT, V72, P1766, DOI 10.1103/PhysRevLett.72.1766; AUSTIN RH, 1975, BIOCHEMISTRY-US, V14, P5355, DOI 10.1021/bi00695a021; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Bustamante C, 2001, ACCOUNTS CHEM RES, V34, P412, DOI 10.1021/ar0001719; CHOCK PB, 1977, P NATL ACAD SCI USA, V74, P2766, DOI 10.1073/pnas.74.7.2766; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; English BP, 2006, NAT CHEM BIOL, V2, P87, DOI 10.1038/nchembio759; FEINBERG M, 1998, CHEM REACTION NETWOR; Frauenfelder H, 1999, REV MOD PHYS, V71, pS419, DOI 10.1103/RevModPhys.71.S419; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; FRIEDEN C, 1979, ANNU REV BIOCHEM, V48, P471, DOI 10.1146/annurev.bi.48.070179.002351; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Karplus M, 2000, J PHYS CHEM B, V104, P11, DOI 10.1021/jp993555t; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kou SC, 2005, J PHYS CHEM B, V109, P19068, DOI 10.1021/jp051490q; Levine J, 2007, BIOPHYS J, V92, P4473, DOI 10.1529/biophysj.106.088856; Li GP, 2003, CELL BIOCHEM BIOPHYS, V39, P45, DOI 10.1385/CBB:39:1:45; MAGNASCO MO, 1993, PHYS REV LETT, V71, P1477, DOI 10.1103/PhysRevLett.71.1477; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Min W, 2005, ACCOUNTS CHEM RES, V38, P923, DOI 10.1021/ar040133f; Min W, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.198302; Min W, 2008, J PHYS CHEM B, V112, P454, DOI 10.1021/jp076533c; Morishita Y, 2006, BIOPHYS J, V91, P2072, DOI 10.1529/biophysj.105.070797; Paulsson J, 2000, P NATL ACAD SCI USA, V97, P7148, DOI 10.1073/pnas.110057697; PRESS WH, 1997, NUMERICAL RECIPES C, pR26; PRESS WH, 1997, NUMERICAL RECIPES C, P994; Qian H, 2002, J PHYS CHEM B, V106, P2065, DOI 10.1021/jp013143w; Qian H, 2008, BIOCHEMISTRY-US, V47, P2211, DOI 10.1021/bi702125s; Qian H, 2007, ANNU REV PHYS CHEM, V58, P113, DOI 10.1146/annurev.physchem.58.032806.104550; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Reimann P, 2002, PHYS REP, V361, P57, DOI 10.1016/S0370-1573(01)00081-3; RICARD J, 1987, EUR J BIOCHEM, V166, P255, DOI 10.1111/j.1432-1033.1987.tb13510.x; Sabouri-Ghomi M, 2008, J THEOR BIOL, V250, P209, DOI 10.1016/j.jtbi.2007.09.001; Samoilov M, 2005, P NATL ACAD SCI USA, V102, P2310, DOI 10.1073/pnas.0406841102; Samoilov MS, 2006, NAT BIOTECHNOL, V24, P1235, DOI 10.1038/nbt1253; Shibata T, 2005, P NATL ACAD SCI USA, V102, P331, DOI 10.1073/pnas.0403350102; STADTMAN ER, 1977, P NATL ACAD SCI USA, V74, P2761, DOI 10.1073/pnas.74.7.2761; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Tanase-Nicola S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.068102; Thattai M, 2002, BIOPHYS J, V82, P2943, DOI 10.1016/S0006-3495(02)75635-X; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Wang J, 2006, PLOS COMPUT BIOL, V2, P1385, DOI 10.1371/journal.pcbi.0020147; Xie XS, 1999, J BIOL CHEM, V274, P15967, DOI 10.1074/jbc.274.23.15967; Xing JH, 2005, BIOPHYS J, V89, P1551, DOI 10.1529/biophysj.104.055178; Xing JH, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.168103; Xing JH, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.061911; ZWANZIG R, 1992, J CHEM PHYS, V97, P3587, DOI 10.1063/1.462993; ZWANZIG R, 1990, ACCOUNTS CHEM RES, V23, P148, DOI 10.1021/ar00173a005	49	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2140	10.1371/journal.pone.0002140	http://dx.doi.org/10.1371/journal.pone.0002140			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478088	Green Published, gold, Green Submitted			2022-12-25	WOS:000262172800005
J	Lu, Z; Beck, MH; Wang, Y; Jiang, H; Strand, MR				Lu, Zhiqiang; Beck, Markus H.; Wang, Yang; Jiang, Haobo; Strand, Michael R.			The viral protein Egf1.0 is a dual activity inhibitor of prophenoloxidase-activating proteinases 1 and 3 from Manduca sexta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRO-PHENOL-OXIDASE; HOLOTRICHIA-DIOMPHALIA LARVAE; PSEUDOPLUSIA-INCLUDENS; MOLECULAR-CLONING; COLEOPTERAN INSECT; ANOPHELES-GAMBIAE; IMMUNE-RESPONSE; IN-VITRO; HEMOLYMPH; CELLS	Some pathogens are capable of suppressing the melanization response of host insects, but the virulence factors responsible are largely unknown. The insect pathogen Microplitis demolitor bracovirus encodes the Egf family of small serine proteinase inhibitors. One family member, Egf1.0, was recently shown to suppress melanization of hemolymph in Manduca sexta in part by inhibiting the enzymatic activity of prophenoloxidase activating proteinase 3 (PAP3). However, other experiments suggested this viral protein suppresses melanization by more than one mechanism. Here we report that Egf1.0 inhibited the amidolytic activity of PAP1 and dose-dependently blocked processing of pro-PAP1 and pro-PAP3. Consistent with its PAP inhibitory activity, Egf1.0 also prevented processing of pro-phenoloxidase, serine proteinase homolog (SPH) 1, and SPH2. Isolation of Egf1.0-protein complexes from plasma indicated that Egf1.0 binds PAPs through its C-terminal repeat domain. Egf1.0 also potentially interacts with SPH2 and two other proteins, ferritin and gloverin, not previously associated with the phenoloxidase cascade. Overall, our results indicate that Egf1.0 is a dual activity PAP inhibitor that strongly suppresses the insect melanization response.	[Lu, Zhiqiang; Beck, Markus H.; Strand, Michael R.] Univ Georgia, Dept Entomol, Athens, GA 30602 USA; [Wang, Yang; Jiang, Haobo] Oklahoma State Univ, Dept Entomol & Plant Pathol, Stillwater, OK 74078 USA	University System of Georgia; University of Georgia; Oklahoma State University System; Oklahoma State University - Stillwater	Strand, MR (corresponding author), Univ Georgia, Dept Entomol, 413 Biol Sci Bldg, Athens, GA 30602 USA.	mrstrand@uga.edu		Jiang, Haobo/0000-0003-1357-1315	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058634] Funding Source: NIH RePORTER; NCRR NIH HHS [P20 RR 016464, P20 RR016464] Funding Source: Medline; NIGMS NIH HHS [GM 58634] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altincicek B, 2008, DEV COMP IMMUNOL, V32, P585, DOI 10.1016/j.dci.2007.09.005; Beck M, 2003, VIROLOGY, V314, P521, DOI 10.1016/S0042-6822(03)00463-X; Beck M, 2005, J VIROL, V79, P1861, DOI 10.1128/JVI.79.3.1861-1870.2005; Beck MH, 2007, P NATL ACAD SCI USA, V104, P19267, DOI 10.1073/pnas.0708056104; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Eleftherianos I, 2007, P NATL ACAD SCI USA, V104, P2419, DOI 10.1073/pnas.0610525104; Goodrich-Blair H, 2007, MOL MICROBIOL, V64, P260, DOI 10.1111/j.1365-2958.2007.05671.x; Gorman MJ, 2007, J BIOL CHEM, V282, P11742, DOI 10.1074/jbc.M611243200; Gotz ME, 2004, ANN NY ACAD SCI, V1012, P193, DOI 10.1196/annals.1306.017; Gupta S, 2005, PROTEIN EXPRES PURIF, V39, P261, DOI 10.1016/j.pep.2004.10.011; HALL M, 1995, P NATL ACAD SCI USA, V92, P7764, DOI 10.1073/pnas.92.17.7764; Ji CY, 2003, PROTEIN EXPRES PURIF, V29, P235, DOI 10.1016/S1046-5928(03)00020-2; Jiang HB, 2003, INSECT BIOCHEM MOLEC, V33, P1049, DOI 10.1016/S0965-1748(03)00123-1; Jiang HB, 2003, J BIOL CHEM, V278, P3552, DOI 10.1074/jbc.M205743200; Jiang HB, 1997, INSECT BIOCHEM MOLEC, V27, P835, DOI 10.1016/S0965-1748(97)00066-0; Jiang HB, 1998, P NATL ACAD SCI USA, V95, P12220, DOI 10.1073/pnas.95.21.12220; Kanost MR, 2008, INSECT IMMUNOLOGY, P69, DOI 10.1016/B978-012373976-6.50006-9; Karlsson C, 2004, J BIOL CHEM, V279, P52033, DOI 10.1074/jbc.M408220200; Kwon TH, 2000, EUR J BIOCHEM, V267, P6188, DOI 10.1046/j.1432-1327.2000.01695.x; Lavine MD, 2005, INSECT BIOCHEM MOLEC, V35, P1335, DOI 10.1016/j.ibmb.2005.08.005; Leclerc V, 2006, EMBO REP, V7, P231, DOI 10.1038/sj.embor.7400592; Lee SY, 1998, EUR J BIOCHEM, V257, P615, DOI 10.1046/j.1432-1327.1998.2570615.x; Lu ZQ, 2008, INSECT BIOCHEM MOLEC, V38, P89, DOI 10.1016/j.ibmb.2007.09.011; Lundstrom A, 2002, INSECT BIOCHEM MOLEC, V32, P795, DOI 10.1016/S0965-1748(01)00162-X; Maresca V, 2006, J CELL PHYSIOL, V206, P843, DOI 10.1002/jcp.20543; Mortz E, 2001, PROTEOMICS, V1, P1359, DOI 10.1002/1615-9861(200111)1:11<1359::AID-PROT1359>3.0.CO;2-Q; Park DS, 2000, MOL CELLS, V10, P186, DOI 10.1007/s10059-000-0186-2; Paskewitz SM, 2005, INSECT BIOCHEM MOLEC, V35, P815, DOI 10.1016/j.ibmb.2005.03.002; Paskewitz SM, 2006, INSECT BIOCHEM MOLEC, V36, P701, DOI 10.1016/j.ibmb.2006.06.001; Pennacchio F, 2006, ANNU REV ENTOMOL, V51, P233, DOI 10.1146/annurev.ento.51.110104.151029; Pruijssers AJ, 2007, J VIROL, V81, P1209, DOI 10.1128/JVI.02189-06; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Satoh D, 1999, J BIOL CHEM, V274, P7441, DOI 10.1074/jbc.274.11.7441; Schmidt O, 2001, BIOESSAYS, V23, P344, DOI 10.1002/bies.1049; STRAND MR, 1995, ANNU REV ENTOMOL, V40, P31, DOI 10.1146/annurev.en.40.010195.000335; Strand MR, 1997, J VIROL, V71, P2146, DOI 10.1128/JVI.71.3.2146-2156.1997; Tang HP, 2006, J BIOL CHEM, V281, P28097, DOI 10.1074/jbc.M601642200; Thoetkiattikul H, 2005, P NATL ACAD SCI USA, V102, P11426, DOI 10.1073/pnas.0505240102; Tong YR, 2005, J BIOL CHEM, V280, P14932, DOI 10.1074/jbc.M500532200; Trudeau D, 2000, J GEN VIROL, V81, P3049, DOI 10.1099/0022-1317-81-12-3049; Volz J, 2006, CELL MICROBIOL, V8, P1392, DOI 10.1111/j.1462-5822.2006.00718.x; Wang Y, 2006, J BIOL CHEM, V281, P9271, DOI 10.1074/jbc.M513797200; Wang Y, 2004, INSECT BIOCHEM MOLEC, V34, P731, DOI 10.1016/j.ibmb.2004.03.008; Wang Y, 2007, INSECT BIOCHEM MOLEC, V37, P1015, DOI 10.1016/j.ibmb.2007.05.013; Webb BA, 2006, VIROLOGY, V347, P160, DOI 10.1016/j.virol.2005.11.010; Webb BA, 2005, COMPREHENSIVE MOL IN, V6, P323, DOI DOI 10.1016/B0-44-451924-6/00086-7; Yu XQ, 2003, INSECT BIOCHEM MOLEC, V33, P197, DOI 10.1016/S0965-1748(02)00191-1; Zang XX, 2001, TRENDS BIOCHEM SCI, V26, P191, DOI 10.1016/S0968-0004(00)01761-8; Zhang GM, 2004, INSECT BIOCHEM MOLEC, V34, P477, DOI 10.1016/j.ibmb.2004.02.009; Zhu YF, 2003, J BIOL CHEM, V278, P46556, DOI 10.1074/jbc.M309682200	50	62	67	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21325	21333		10.1074/jbc.M801593200	http://dx.doi.org/10.1074/jbc.M801593200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18519564	hybrid, Green Published			2022-12-25	WOS:000257898800004
J	Noureddine, H; Carvalho, S; Schmitt, C; Massoulie, J; Bon, S				Noureddine, Hiba; Carvalho, Stephanie; Schmitt, Claudine; Massoulie, Jean; Bon, Suzanne			Acetylcholinesterase associates differently with its anchoring proteins ColQ and PRiMA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL T-PEPTIDE; QUATERNARY ASSOCIATIONS; MEMBRANE ANCHOR; CAUDATE-NUCLEUS; COLLAGEN TAIL; FORMS; DEGRADATION; SECRETION; SUBUNIT; BOVINE	Acetylcholinesterase tetramers are inserted in the basal lamina of neuromuscular junctions or anchored in cell membranes through the interaction of four C-terminal t peptides with proline-rich attachment domains (PRADs) of cholinesterase-associated collagen Q (ColQ) or of the transmembrane protein PRiMA (proline-rich membrane anchor). ColQ and PRiMA differ in the length of their proline-rich motifs (10 and 15 residues, respectively). ColQ has two cysteines upstream of the PRAD, which are disulfide-linked to two AChE(T) subunits ("heavy" dimer), and the other two subunits are disulfide-linked together ("light" dimer). In contrast, PRiMA has four cysteines upstream of the PRAD. We examined whether these cysteines could be linked to AChET subunits in complexes formed with PRiMA in transfected COS cells and in the mammalian brain. For comparison, we studied complexes formed with N-terminal fragments of ColQ, N-terminal fragments of PRiMA, and chimeras in which the upstream regions containing the cysteines were exchanged. We also compared the effect of mutations in the t peptides on their association with the two PRADs. We report that the two PRADs differ in their interaction with AChET subunits; in complexes formed with the PRAD of PRiMA, we observed light dimers, but very few heavy dimers, even though such dimers were formed with the PQ chimera in which the N-terminal region of PRiMA was associated with the PRAD of ColQ. Complexes with PQ or with PRiMA contained heavy components, which migrated abnormally in SDS-PAGE but probably resulted from disulfide bonding of four AChE(T) subunits with the four upstream cysteines of the associated protein.	[Noureddine, Hiba; Carvalho, Stephanie; Schmitt, Claudine; Massoulie, Jean; Bon, Suzanne] Ecole Normale Super, CNRS UMR 8544, Neurobiol Lab, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Massoulie, J (corresponding author), Ecole Normale Super, CNRS UMR 8544, Neurobiol Lab, 46 Rue Ulm, F-75005 Paris, France.	jean.massoulie@biologie.ens.fr						Belbeoc'h S, 2004, EUR J BIOCHEM, V271, P1476, DOI 10.1111/j.1432-1033.2004.04052.x; BON S, 1979, P NATL ACAD SCI USA, V76, P2546, DOI 10.1073/pnas.76.6.2546; Bon S, 2004, EUR J BIOCHEM, V271, P33, DOI 10.1046/j.1432-1033.2003.03892.x; Bon S, 1997, J BIOL CHEM, V272, P3007, DOI 10.1074/jbc.272.5.3007; Bon S, 1997, J BIOL CHEM, V272, P3016, DOI 10.1074/jbc.272.5.3016; BON S, 1991, J NEUROCHEM, V57, P1100, DOI 10.1111/j.1471-4159.1991.tb08267.x; BRODBECK U, 1992, MULTIDISCIPLINARY APPROACHES TO CHOLINESTERASE FUNCTIONS, P33; DUVAL N, 1992, EMBO J, V11, P3255, DOI 10.1002/j.1460-2075.1992.tb05403.x; Dvir H, 2004, EMBO J, V23, P4394, DOI 10.1038/sj.emboj.7600425; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; GENNARI K, 1987, J NEUROCHEM, V49, P12, DOI 10.1111/j.1471-4159.1987.tb03386.x; INESTROSA NC, 1987, J BIOL CHEM, V262, P4441; KARNOVSKY MJ, 1964, J HISTOCHEM CYTOCHEM, V12, P219, DOI 10.1177/12.3.219; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LEGAY C, 1993, J NEUROCHEM, V60, P337, DOI 10.1111/j.1471-4159.1993.tb05856.x; LIAO J, 1993, EUR J BIOCHEM, V215, P333, DOI 10.1111/j.1432-1033.1993.tb18039.x; Massoulie J, 2005, CHEM-BIOL INTERACT, V157, P3, DOI 10.1016/j.cbi.2005.10.002; Massoulie J, 2006, J MOL NEUROSCI, V30, P233, DOI 10.1385/JMN:30:1:233; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Morel N, 2001, J BIOL CHEM, V276, P37379, DOI 10.1074/jbc.M103192200; Moussa CEH, 2004, NEUROSCI LETT, V371, P239, DOI 10.1016/j.neulet.2004.09.004; Noureddine H, 2007, J BIOL CHEM, V282, P3487, DOI 10.1074/jbc.M607221200; Perrier AL, 2000, J BIOL CHEM, V275, P34260, DOI 10.1074/jbc.M004289200; Perrier AL, 2002, NEURON, V33, P275, DOI 10.1016/S0896-6273(01)00584-0; ROBERTS WL, 1991, J BIOL CHEM, V266, P7481; Xie WH, 1999, CHEM-BIOL INTERACT, V119, P289, DOI 10.1016/S0009-2797(99)00039-3	26	22	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20722	20732		10.1074/jbc.M801364200	http://dx.doi.org/10.1074/jbc.M801364200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18511416	Green Published, hybrid			2022-12-25	WOS:000257746100013
J	Massaro, M; Starling-Windhof, A; Briskie, JV; Martin, TE				Massaro, Melanie; Starling-Windhof, Amanda; Briskie, James V.; Martin, Thomas E.			Introduced Mammalian Predators Induce Behavioural Changes in Parental Care in an Endemic New Zealand Bird	PLOS ONE			English	Article							LIFE-HISTORY EVOLUTION; POOR KNIGHTS ISLANDS; NEST PREDATION; CONTEMPORARY EVOLUTION; CONSERVATION BIOLOGY; AVIAN EXTINCTION; OCEANIC ISLANDS; CLUTCH SIZE; INCUBATION; TEMPERATURE	The introduction of predatory mammals to oceanic islands has led to the extinction of many endemic birds. Although introduced predators should favour changes that reduce predation risk in surviving bird species, the ability of island birds to respond to such novel changes remains unstudied. We tested whether novel predation risk imposed by introduced mammalian predators has altered the parental behaviour of the endemic New Zealand bellbird (Anthornis melanura). We examined parental behaviour of bellbirds at three woodland sites in New Zealand that differed in predation risk: 1) a mainland site with exotic predators present (high predation risk), 2) a mainland site with exotic predators experimentally removed (low risk recently) and, 3) an off-shore island where exotic predators were never introduced (low risk always). We also compared parental behaviour of bellbirds with two closely related Tasmanian honeyeaters (Phylidonyris spp.) that evolved with native nest predators (high risk always). Increased nest predation risk has been postulated to favour reduced parental activity, and we tested whether island bellbirds responded to variation in predation risk. We found that females spent more time on the nest per incubating bout with increased risk of predation, a strategy that minimised activity at the nest during incubation. Parental activity during the nestling period, measured as number of feeding visits/hr, also decreased with increasing nest predation risk across sites, and was lowest among the honeyeaters in Tasmania that evolved with native predators. These results demonstrate that some island birds are able to respond to increased risk of predation by novel predators in ways that appear adaptive. We suggest that conservation efforts may be more effective if they take advantage of the ability of island birds to respond to novel predators, especially when the elimination of exotic predators is not possible.	[Massaro, Melanie; Starling-Windhof, Amanda; Briskie, James V.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; [Martin, Thomas E.] Univ Montana, USGS Montana Cooperat Wildlife Res Unit, Missoula, MT USA	University of Canterbury; United States Department of the Interior; United States Geological Survey; University of Montana System; University of Montana	Massaro, M (corresponding author), Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand.	melanie.massaro@canterbury.ac.nz	Martin, Thomas E/F-6016-2011; Massaro, Melanie/P-4791-2017	Martin, Thomas E/0000-0002-4028-4867; , Amanda/0000-0003-2483-3886; Massaro, Melanie/0000-0001-9039-1268	Percy Sladen Fund; Brian Mason Trust; Association for the Study of Animal Behaviour; University of Canterbury [postdoctoral fellowships]; Foundation for Research, Science and Technology [UOCX0601]	Percy Sladen Fund; Brian Mason Trust; Association for the Study of Animal Behaviour; University of Canterbury; Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology)	This research was financially supported by grants from the Percy Sladen Fund, the Brian Mason Trust, the Association for the Study of Animal Behaviour and the University of Canterbury to J. Briskie, as well as postdoctoral fellowships from the University of Canterbury and the Foundation for Research, Science and Technology (UOCX0601) to M. Massaro.	Ashley MV, 2003, BIOL CONSERV, V111, P115, DOI 10.1016/S0006-3207(02)00279-3; BARTLE J A, 1987, Notornis, V34, P253; Blackburn TM, 2005, ECOLOGY, V86, P2916, DOI 10.1890/04-1847; Blackburn TM, 2004, SCIENCE, V305, P1955, DOI 10.1126/science.1101617; Briskie JV, 1999, P ROY SOC B-BIOL SCI, V266, P2153, DOI 10.1098/rspb.1999.0902; Carroll SP, 2007, FUNCT ECOL, V21, P387, DOI 10.1111/j.1365-2435.2007.01289.x; Clarke RH, 2000, EMU, V100, P115, DOI 10.1071/MU9843; CLARKE RH, 1999, AUSTR J ECOLOGY, V204, P604; Conway CJ, 2000, EVOLUTION, V54, P670; de Lange PJ, 1999, NEW ZEAL J BOT, V37, P433, DOI 10.1080/0028825X.1999.9512646; DIAMOND JM, 1981, SCIENCE, V211, P499, DOI 10.1126/science.211.4481.499; Didham RK, 2007, TRENDS ECOL EVOL, V22, P489, DOI 10.1016/j.tree.2007.07.001; Didham RK, 2005, SCIENCE, V307, P1412, DOI 10.1126/science.1107333; Doligez B, 2003, ECOLOGY, V84, P2582, DOI 10.1890/02-3116; Driskell AC, 2004, MOL PHYLOGENET EVOL, V31, P943, DOI 10.1016/j.ympev.2003.10.017; Duncan RP, 2004, GLOBAL ECOL BIOGEOGR, V13, P509, DOI 10.1111/j.1466-822X.2004.00132.x; Eggers S, 2006, P ROY SOC B-BIOL SCI, V273, P701, DOI 10.1098/rspb.2005.3373; Eggers S, 2005, BEHAV ECOL, V16, P309, DOI 10.1093/beheco/arh163; Ferretti V, 2005, P ROY SOC B-BIOL SCI, V272, P769, DOI 10.1098/rspb.2004.3039; Fontaine JJ, 2006, ECOL LETT, V9, P428, DOI 10.1111/j.1461-0248.2006.00892.x; Heather B., 2005, FIELD GUIDE BIRDS NZ; HENSLER GL, 1981, WILSON BULL, V93, P42; HIGGINS PJ, 2001, HDB AUSTR NZ ANTARTI, V5; Holdaway Richard N., 1999, P189; Kinnison MT, 2007, FUNCT ECOL, V21, P444, DOI 10.1111/j.1365-2435.2007.01278.x; Martin TE, 2000, P ROY SOC B-BIOL SCI, V267, P2287, DOI 10.1098/rspb.2000.1281; MARTIN TE, 1995, ECOL MONOGR, V65, P101, DOI 10.2307/2937160; Martin TE, 2000, SCIENCE, V287, P1482, DOI 10.1126/science.287.5457.1482; Martin TE, 1999, AM NAT, V153, P131, DOI 10.1086/303153; Martin TE, 2002, P ROY SOC B-BIOL SCI, V269, P309, DOI 10.1098/rspb.2001.1879; Martin TE, 2007, EVOLUTION, V61, P2558, DOI 10.1111/j.1558-5646.2007.00204.x; MAYFIELD HAROLD, 1961, WILSON BULL, V73, P255; MAYFIELD HF, 1975, WILSON BULL, V87, P456; MCFARLAND DC, 1986, EMU, V86, P161, DOI 10.1071/MU9860161; Muchai M, 2005, J AVIAN BIOL, V36, P110, DOI 10.1111/j.0908-8857.2005.03312.x; ODonnell CFJ, 1996, NEW ZEAL J ZOOL, V23, P279, DOI 10.1080/03014223.1996.9518086; OLSON SL, 1982, SCIENCE, V217, P633, DOI 10.1126/science.217.4560.633; Owens IPF, 2000, P NATL ACAD SCI USA, V97, P12144, DOI 10.1073/pnas.200223397; RECHER H F, 1977, Emu, V77, P136; Roff Derek A., 1992; SAGAR PM, 1985, NEW ZEAL J ZOOL, V12, P643, DOI 10.1080/03014223.1985.10428314; SAUER JR, 1989, J WILDLIFE MANAGE, V53, P137, DOI 10.2307/3801320; Saunders A, 2001, BIOL CONSERV, V99, P109, DOI 10.1016/S0006-3207(00)00192-0; SAVIDGE JA, 1987, ECOLOGY, V68, P660, DOI 10.2307/1938471; Schlaepfer MA, 2005, ECOL LETT, V8, P241, DOI 10.1111/j.1461-0248.2005.00730.x; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; SKUTCH AF, 1949, IBIS, V91, P430, DOI 10.1111/j.1474-919X.1949.tb02293.x; SMITH TB, 1995, CONSERV BIOL, V9, P107, DOI 10.1046/j.1523-1739.1995.09010107.x; STARLING A, THESIS U CANTERBURY; Stattersfield A J, 2000, THREATENED BIRDS WOR, P205; Stockwell CA, 2003, TRENDS ECOL EVOL, V18, P94, DOI 10.1016/S0169-5347(02)00044-7; Taylor SS, 2007, J EVOLUTION BIOL, V20, P2035, DOI 10.1111/j.1420-9101.2007.01362.x; Visser ME, 2001, P ROY SOC B-BIOL SCI, V268, P1271, DOI 10.1098/rspb.2001.1661; WEATHERS WW, 1989, CONDOR, V91, P628, DOI 10.2307/1368113; WORTHY TH, 2002, LOST WORLD MOA BLOOM	55	69	70	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2331	10.1371/journal.pone.0002331	http://dx.doi.org/10.1371/journal.pone.0002331			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523640	Green Published, gold, Green Submitted			2022-12-25	WOS:000262614300026
J	Kim, W; Yoo, TK; Shin, DJ; Rho, HW; Jin, HJ; Kim, ET; Bae, YS				Kim, Wook; Yoo, Tag-Keun; Shin, Dong-Jik; Rho, Hyun-Wook; Jin, Han-Jun; Kim, Eun-Tak; Bae, Yoon-Sun			Mitochondrial DNA Haplogroup Analysis Reveals no Association between the Common Genetic Lineages and Prostate Cancer in the Korean Population	PLOS ONE			English	Article								Mitochondrial DNA (mtDNA) variation has recently been suggested to have an association with various cancers, including prostate cancer risk, in human populations. Since mtDNA is haploid and lacks recombination, specific mutations in the mtDNA genome associated with human diseases arise and remain in particular genetic backgrounds referred to as haplogroups. To assess the possible contribution of mtDNA haplogroup-specific mutations to the occurrence of prostate cancer, we have therefore performed a population-based study of a prostate cancer cases and corresponding controls from the Korean population. No statistically significant difference in the distribution of mtDNA haplogroup frequencies was observed between the case and control groups of Koreans. Thus, our data imply that specific mtDNA mutations/lineages did not appear to have a significant effect on a predisposition to prostate cancer in the Korean population, although larger sample sizes are necessary to validate our results.	[Kim, Wook; Rho, Hyun-Wook; Jin, Han-Jun] Dankook Univ, Dept Biol Sci, Cheonan, South Korea; [Yoo, Tag-Keun] Eulji Univ, Sch Med, Eulji Med Ctr, Dept Urol, Seoul, South Korea; [Shin, Dong-Jik; Bae, Yoon-Sun] Yonsei Univ, Coll Med, Cardiovascular Genome Ctr, Seoul, South Korea; [Kim, Eun-Tak] Eulji Univ, Sch Med, Dept Urol, Seoul, South Korea	Dankook University; Eulji University; Yonsei University; Yonsei University Health System; Eulji University	Kim, W (corresponding author), Dankook Univ, Dept Biol Sci, Cheonan, South Korea.	wookkim@dankook.ac.kr	Yoo, Tag/M-8852-2019		Korean Science and Engineering Foundation;  [KOSEF R01-2005-000-10534-0]	Korean Science and Engineering Foundation(Korea Science and Engineering Foundation); 	WK is supported by grants from the Korean Science and Engineering Foundation (KOSEF R01-2005-000-10534-0), Republic of Korea.	Booker LM, 2006, J UROLOGY, V175, P468, DOI 10.1016/S0022-5347(05)00163-1; Bostwick DG, 2004, CANCER-AM CANCER SOC, V101, P2371, DOI 10.1002/cncr.20408; Brothman AR, 1999, PROSTATE, V38, P303; Dagnelie PC, 2004, BJU INT, V93, P1139, DOI 10.1111/j.1464-410X.2004.04795.x; Derenko M. V., 2004, Genetika, V40, P1562; Greenlee RT, 2001, CA-CANCER J CLIN, V51, P15, DOI 10.3322/canjclin.51.1.15; Hsing AW, 2000, CANCER EPIDEM BIOMAR, V9, P1335; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Jessie BC, 2001, EXP GERONTOL, V37, P169, DOI 10.1016/S0531-5565(01)00153-X; Jin HJ, 2003, HUM GENET, V114, P27, DOI 10.1007/s00439-003-1019-0; Kim W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000172; Kivisild T, 2002, MOL BIOL EVOL, V19, P1737, DOI 10.1093/oxfordjournals.molbev.a003996; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Pakendorf B, 2005, ANNU REV GENOM HUM G, V6, P165, DOI 10.1146/annurev.genom.6.080604.162249; Paracchini S, 2003, J MED GENET, V40, P815, DOI 10.1136/jmg.40.11.815; Parr RL, 2006, J MOL DIAGN, V8, P312, DOI 10.2353/jmoldx.2006.050112; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Salas A, 2005, PLOS MED, V2, P1158, DOI 10.1371/journal.pmed.0020296; Sambrook J., 2002, MOL CLONING LAB MANU; Schneider S., 2000, ARLEQUIN SOFTWARE PO, V2, P2496; Sim HG, 2005, EUR J CANCER, V41, P834, DOI 10.1016/j.ejca.2004.12.033; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Torroni A, 1996, GENETICS, V144, P1835; Umetsu K, 2005, ELECTROPHORESIS, V26, P91, DOI 10.1002/elps.200406129; van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751	26	24	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2211	10.1371/journal.pone.0002211	http://dx.doi.org/10.1371/journal.pone.0002211			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493608	Green Published, gold, Green Submitted			2022-12-25	WOS:000262258700020
J	Faivre, O; Juusola, M				Faivre, Olivier; Juusola, Mikko			Visual Coding in Locust Photoreceptors	PLOS ONE			English	Article							ADAPTING-BUMP MODEL; LIGHT ADAPTATION; SPECTRAL SENSITIVITY; FLY PHOTORECEPTORS; 2ND-ORDER NEURONS; RESPONSE DYNAMICS; PUPIL MECHANISM; COMPOUND EYE; SIGNAL; NOISE	Information capture by photoreceptors ultimately limits the quality of visual processing in the brain. Using conventional sharp microelectrodes, we studied how locust photoreceptors encode random (white-noise, WN) and naturalistic (1/f stimuli, NS) light patterns in vivo and how this coding changes with mean illumination and ambient temperature. We also examined the role of their plasma membrane in shaping voltage responses. We found that brightening or warming increase and accelerate voltage responses, but reduce noise, enabling photoreceptors to encode more information. For WN stimuli, this was accompanied by broadening of the linear frequency range. On the contrary, with NS the signaling took place within a constant bandwidth, possibly revealing a 'preference' for inputs with 1/f statistics. The faster signaling was caused by acceleration of the elementary phototransduction current - leading to bumps - and their distribution. The membrane linearly translated phototransduction currents into voltage responses without limiting the throughput of these messages. As the bumps reflected fast changes in membrane resistance, the data suggest that their shape is predominantly driven by fast changes in the light-gated conductance. On the other hand, the slower bump latency distribution is likely to represent slower enzymatic intracellular reactions. Furthermore, the Q(10)s of bump duration and latency distribution depended on light intensity. Altogether, this study suggests that biochemical constraints imposed upon signaling change continuously as locust photoreceptors adapt to environmental light and temperature conditions.	[Faivre, Olivier] Univ Cambridge, Dept Zool, Cambridge, England; [Juusola, Mikko] Univ Sheffield, Dept Biomed Sci, Sheffield, S Yorkshire, England	University of Cambridge; University of Sheffield	Faivre, O (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	m.juusola@sheffield.ac.uk	Juusola, Mikko/E-6948-2011	Juusola, Mikko/0000-0002-4428-5330	Royal Society; Gatsby Charitable Trust; BBSRC; Cambridge European trust; Isaac Newton Trust; Ecole Normale Superieure, Paris	Royal Society(Royal Society of London); Gatsby Charitable Trust; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cambridge European trust; Isaac Newton Trust; Ecole Normale Superieure, Paris	This work was supported by grants from the Royal Society (MJ), the Gatsby Charitable Trust (MJ) and the BBSRC (MJ). OF was supported by the Cambridge European trust, the Isaac Newton Trust and the Ecole Normale Superieure, Paris. These sponsors had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arganda S, 2007, NAT NEUROSCI, V10, P1467, DOI 10.1038/nn1982; ATICK JJ, 1992, COULD INFORM THEORY, P213; Atick JJ, 1990, NEURAL COMPUT, V2, P308, DOI 10.1162/neco.1990.2.3.308; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Baker R. R., 1978, EVOLUTIONARY ECOLOGY; Barlow H. B., 1961, P331; BARLOW HB, 1996, INTRANEURONAL INFORM, P251; BENDAT JS, 1971, RANDOM DATA ANAL MEA, P566; BENNETT RR, 1967, Z VERGL PHYSIOL, V55, P195, DOI 10.1007/BF00342254; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; BRAY D, 1995, NATURE, V376, P307, DOI 10.1038/376307a0; Burton BG, 2006, VISION RES, V46, P622, DOI 10.1016/j.visres.2005.09.020; Burton BG, 2001, J NEUROPHYSIOL, V86, P950, DOI 10.1152/jn.2001.86.2.950; CUTTLE MF, 1995, J COMP PHYSIOL A, V176, P307, DOI 10.1007/BF00219056; Dan Y, 1996, J NEUROSCI, V16, P3351; de Polavieja GG, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.061910; EVANS PD, 1984, J EXP BIOL, V110, P231; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; FRENCH AS, 1980, NATURE, V283, P200, DOI 10.1038/283200a0; Gu YC, 2005, CURR BIOL, V15, P1228, DOI 10.1016/j.cub.2005.05.058; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; HARRIS FJ, 1978, P IEEE, V66, P51, DOI 10.1109/PROC.1978.10837; HOWARD J, 1987, PROC R SOC SER B-BIO, V231, P415, DOI 10.1098/rspb.1987.0053; HOWARD J, 1981, J COMP PHYSIOL, V144, P61, DOI 10.1007/BF00612798; James AC, 1996, J COMP PHYSIOL A, V178, P183, DOI 10.1007/BF00188161; JARVILEHTO M, 1973, Z ZELLFORSCH MIK ANA, V136, P291, DOI 10.1007/BF00307446; JUUSOLA M, 1993, J COMP PHYSIOL A, V172, P511, DOI 10.1007/BF00213533; Juusola M, 1997, J NEUROPHYSIOL, V77, P1487, DOI 10.1152/jn.1997.77.3.1487; Juusola M, 2003, J NEUROPHYSIOL, V90, P2014, DOI 10.1152/jn.00395.2003; JUUSOLA M, 1994, J NEUROSCI METH, V53, P1, DOI 10.1016/0165-0270(94)90137-6; Juusola M, 2001, J GEN PHYSIOL, V117, P3, DOI 10.1085/jgp.117.1.3; JUUSOLA M, 1993, NEUROSCI LETT, V154, P84, DOI 10.1016/0304-3940(93)90177-M; JUUSOLA M, 1995, J GEN PHYSIOL, V105, P117, DOI 10.1085/jgp.105.1.117; Krapp HG, 2005, J NEUROPHYSIOL, V93, P2240, DOI 10.1152/jn.00965.2004; Laughlin SB, 1996, VISION RES, V36, P1529, DOI 10.1016/0042-6989(95)00242-1; LAUGHLIN SB, 1978, J COMP PHYSIOL, V128, P319, DOI 10.1007/BF00657606; LILLYWHITE PG, 1977, J COMP PHYSIOL, V122, P189, DOI 10.1007/BF00611889; LILLYWHITE PG, 1979, NATURE, V277, P569, DOI 10.1038/277569a0; MARR D, 1976, SCIENCE, V194, P283, DOI 10.1126/science.968482; MEINERTZHAGEN IA, 1976, PHILOS T ROY SOC B, V274, P555, DOI 10.1098/rstb.1976.0064; Oberwinkler J, 2000, J NEUROSCI, V20, P1701; PAYNE R, 1981, NATURE, V290, P415, DOI 10.1038/290415a0; PECE AEC, 1990, BIOPHYS J, V57, P733, DOI 10.1016/S0006-3495(90)82594-7; ROEBROEK JGH, 1990, J INSECT PHYSIOL, V36, P499, DOI 10.1016/0022-1910(90)90101-K; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; SHAPLEY RJ, 1984, PROG RETIN RES, V2, P263; Shaw S. R., 1968, Symposia of the Zoological Society of London, VNo. 23, P135; Simmons PJ, 2005, J NEUROSCI, V25, P7529, DOI 10.1523/JNEUROSCI.1119-05.2005; SNYDER AW, 1977, J COMP PHYSIOL, V116, P161, DOI 10.1007/BF00605401; Sourjik V, 2004, TRENDS MICROBIOL, V12, P569, DOI 10.1016/j.tim.2004.10.003; SPEKREIJ.H, 1970, KYBERNETIK, V7, P22, DOI 10.1007/BF00270331; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; SRINIVASAN MV, 1975, VISION RES, V15, P515, DOI 10.1016/0042-6989(75)90029-2; Stavenga DG, 2004, J EXP BIOL, V207, P1703, DOI 10.1242/jeb.00949; Stavenga DG, 2004, J COMP PHYSIOL A, V190, P115, DOI 10.1007/s00359-003-0477-0; VANHATEREN JH, 1992, NATURE, V360, P68, DOI 10.1038/360068a0; VanHateren JH, 1997, VISION RES, V37, P3407, DOI 10.1016/S0042-6989(97)00105-3; VanSteveninck RRD, 1996, INT J NEURAL SYST, V7, P437, DOI 10.1142/S0129065796000415; VANSTEVENNICK RD, 1996, RATE INFORM TRANSFER, P642; VOSS RF, 1975, NATURE, V258, P317, DOI 10.1038/258317a0; WARRANT EJ, 1993, PROG NEUROBIOL, V40, P413, DOI 10.1016/0301-0082(93)90017-M; Warrant EJ, 2006, ARTHROPOD STRUCT DEV, V35, P293, DOI 10.1016/j.asd.2006.08.012; WECKSTROM M, 1992, PFLUG ARCH EUR J PHY, V421, P469, DOI 10.1007/BF00370258; WECKSTROM M, 1991, J PHYSIOL-LONDON, V440, P635, DOI 10.1113/jphysiol.1991.sp018729; WECKSTROM M, 1994, J COMP PHYSIOL A, V174, P795, DOI 10.1007/BF00192729; WECKSTROM M, 1992, P R SOC B, P83; WILLIAMS DS, 1982, SCIENCE, V218, P898, DOI 10.1126/science.7134980; WILLIAMS DS, 1983, J COMP PHYSIOL, V150, P509, DOI 10.1007/BF00609577; Yu YG, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108103	79	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2173	10.1371/journal.pone.0002173	http://dx.doi.org/10.1371/journal.pone.0002173			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478123	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000262172800038
J	Konigshoff, M; Balsara, N; Pfaff, EM; Kramer, M; Chrobak, I; Seeger, W; Eickelberg, O				Koenigshoff, Melanie; Balsara, Nisha; Pfaff, Eva-Maria; Kramer, Monika; Chrobak, Izabella; Seeger, Werner; Eickelberg, Oliver			Functional Wnt Signaling Is Increased in Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							KEY REGULATOR; BETA-CATENIN; PATHWAY; PATHOGENESIS; DISEASE; CELLS	Background: Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease, characterized by distorted lung architecture and loss of respiratory function. Alveolar epithelial cell injury and hyperplasia, enhanced extracellular matrix deposition, and (myo) fibroblast activation are features of IPF. Wnt/beta-catenin signaling has been shown to determine epithelial cell fate during development. As aberrant reactivation of developmental signaling pathways has been suggested to contribute to IPF pathogenesis, we hypothesized that Wnt/beta-catenin signaling is activated in epithelial cells in IPF. Thus, we quantified and localized the expression and activity of the Wnt/beta-catenin pathway in IPF. Methodology/Principal Findings: The expression of Wnt1, 3a, 7b, and 10b, the Wnt receptors Fzd1-4, Lrp5-6, as well as the intracellular signal transducers Gsk-3 beta, beta-catenin, Tcf1, 3, 4, and Lef1 was analyzed in IPF and transplant donor lungs by quantitative real-time (q) RT-PCR. Wnt1, 7b and 10b, Fzd2 and 3, beta-catenin, and Lef1 expression was significantly increased in IPF. Immunohistochemical analysis localized Wnt1, Wnt3a, beta-catenin, and Gsk-3 beta expression largely to alveolar and bronchial epithelium. This was confirmed by qRT-PCR of primary alveolar epithelial type II (ATII) cells, demonstrating a significant increase of Wnt signaling in ATII cells derived from IPF patients. In addition, Western blot analysis of phospho-Gsk-3 beta, phospho-Lrp6, and beta-catenin, and qRT-PCR of the Wnt target genes cyclin D1, Mmp 7, or Fibronectin 1 demonstrated increased functional Wnt/beta-catenin signaling in IPF compared with controls. Functional in vitro studies further revealed that Wnt ligands induced lung epithelial cell proliferation and (myo) fibroblast activation and collagen synthesis. Conclusions/Significance: Our study demonstrates that the Wnt/beta-catenin pathway is expressed and operative in adult lung epithelium. Increased Wnt/beta-catenin signaling may be involved in epithelial cell injury and hyperplasia, as well as impaired epithelial-mesenchymal cross-talk in IPF. Thus, modification of Wnt signaling may represent a therapeutic option in IPF.	[Koenigshoff, Melanie; Balsara, Nisha; Pfaff, Eva-Maria; Kramer, Monika; Chrobak, Izabella; Seeger, Werner; Eickelberg, Oliver] Univ Giessen, Dept Med, Lung Ctr, Giessen, Germany	Justus Liebig University Giessen	Konigshoff, M (corresponding author), Univ Giessen, Dept Med, Lung Ctr, Giessen, Germany.	oliver.eickelberg@innere.med.uni-giessen.de	Eickelberg, Oliver/A-5461-2013	Eickelberg, Oliver/0000-0001-7170-0360; Seeger, Werner/0000-0003-1946-0894	The German Research Foundation's (DFG); Excellence Cluster Cardiopulmonary System (ECCPS); Clinical Research Group 118 Lung Fibrosis; Signalling Mechanisms of Lung Physiology and Disease (SMLPD) [IGRK1062]; Alexander von Humboldt-Foundation [Sofja Kovalevskaja Award]	The German Research Foundation's (DFG)(German Research Foundation (DFG)); Excellence Cluster Cardiopulmonary System (ECCPS)(German Research Foundation (DFG)); Clinical Research Group 118 Lung Fibrosis; Signalling Mechanisms of Lung Physiology and Disease (SMLPD); Alexander von Humboldt-Foundation(Alexander von Humboldt Foundation)	The German Research Foundation's (DFG) Excellence Cluster Cardiopulmonary System (ECCPS) (W.S., O.E.), Clinical Research Group 118 Lung Fibrosis (W.S., O.E.), the International Graduate Program IGRK1062 Signalling Mechanisms of Lung Physiology and Disease (SMLPD) (M.K., W.S., O.E.), and the Sofja Kovalevskaja Award by the Alexander von Humboldt-Foundation to O.E.	American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Cadigan KM, 2006, J CELL SCI, V119, P395, DOI 10.1242/jcs.02826; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; Chua F, 2005, AM J RESP CELL MOL, V33, P9, DOI 10.1165/rcmb.2005-0062TR; Fang XH, 2006, AM J PHYSIOL-LUNG C, V290, pL242, DOI 10.1152/ajplung.00178.2005; Forde JE, 2007, CELL MOL LIFE SCI, V64, P1930, DOI 10.1007/s00018-007-7045-7; Guo X, 2008, GENE DEV, V22, P106, DOI 10.1101/gad.1590908; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Johnson ML, 2006, REV ENDOCR METAB DIS, V7, P41, DOI 10.1007/s1154-006-9003-3; Kikuchi A, 2007, CELL SIGNAL, V19, P659, DOI 10.1016/j.cellsig.2006.11.001; Kim Dong Soon, 2006, Proc Am Thorac Soc, V3, P285, DOI 10.1513/pats.200601-005TK; King TE, 2001, AM J RESP CRIT CARE, V164, P1025, DOI 10.1164/ajrccm.164.6.2001056; Kitowska K, 2008, AM J PHYSIOL-LUNG C, V294, pL34, DOI 10.1152/ajplung.00007.2007; Konigshoff M, 2007, AM J RESP CELL MOL, V37, P640, DOI 10.1165/rcmb.2006-0379TR; Lewis CC, 2008, AM J RESP CRIT CARE, V177, P376, DOI 10.1164/rccm.200702-333OC; Li CG, 2002, DEV BIOL, V248, P68, DOI 10.1006/dbio.2002.0729; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; Martinez FJ, 2005, ANN INTERN MED, V142, P963, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00005; Mikels AJ, 2006, ONCOGENE, V25, P7461, DOI 10.1038/sj.onc.1210053; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morrisey EE, 2003, AM J PATHOL, V162, P1393, DOI 10.1016/S0002-9440(10)64271-X; Mucenski ML, 2005, AM J PHYSIOL-LUNG C, V289, pL971, DOI 10.1152/ajplung.00172.2005; Mucenski ML, 2003, J BIOL CHEM, V278, P40231, DOI 10.1074/jbc.M305892200; Muro AF, 2008, AM J RESP CRIT CARE, V177, P638, DOI 10.1164/rccm.200708-1291OC; Noble PW, 2005, AM J RESP CELL MOL, V33, P113, DOI 10.1165/rcmb.F301; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Perez-Moreno M, 2006, DEV CELL, V11, P601, DOI 10.1016/j.devcel.2006.10.010; Rulifson EJ, 2000, MOL CELL, V6, P117, DOI 10.1016/S1097-2765(00)00013-7; Scotton CJ, 2007, CHEST, V132, P1311, DOI 10.1378/chest.06-2568; Selman M, 2006, AM J RESP CRIT CARE, V173, P188, DOI 10.1164/rccm.200504-644OC; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Selman M, 2008, PLOS MED, V5, P373, DOI 10.1371/journal.pmed.0050062; Shu WG, 2002, DEVELOPMENT, V129, P4831; Szeto W, 2001, CANCER RES, V61, P4197; Taneyhill Lisa, 2004, BMC Developmental Biology, V4; Taskar Varsha S, 2006, Proc Am Thorac Soc, V3, P293, DOI 10.1513/pats.200512-131TK; Visscher Daniel W, 2006, Proc Am Thorac Soc, V3, P322, DOI 10.1513/pats.200602-019TK; Walter Nicholas, 2006, Proc Am Thorac Soc, V3, P330, DOI 10.1513/pats.200602-016TK; White ES, 2003, J PATHOL, V201, P343, DOI 10.1002/path.1446; Yang IV, 2007, AM J RESP CRIT CARE, V175, P45, DOI 10.1164/rccm.200601-062OC; Zuo FR, 2002, P NATL ACAD SCI USA, V99, P6292, DOI 10.1073/pnas.092134099; 1998, AM J RESP CRIT CARE, V157, P1301	45	351	381	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2142	10.1371/journal.pone.0002142	http://dx.doi.org/10.1371/journal.pone.0002142			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478089	Green Submitted, gold, Green Published			2022-12-25	WOS:000262172800007
J	Srikakulam, R; Liu, L; Winkelmann, DA				Srikakulam, Rajani; Liu, Li; Winkelmann, Donald A.			Unc45b Forms a Cytosolic Complex with Hsp90 and Targets the Unfolded Myosin Motor Domain	PLOS ONE			English	Article								Myosin folding and assembly in striated muscle is mediated by the general chaperones Hsc70 and Hsp90 and a myosin specific co-chaperone, UNC45. Two UNC45 genes are found in vertebrates, including a striated muscle specific form, Unc45b. We have investigated the role of Unc45b in myosin folding. Epitope tagged murine Unc45b (Unc45b(Flag)) was expressed in muscle and non-muscle cells and bacteria, isolated and characterized. The protein is a soluble monomer in solution with a compact folded rod-shaped structure of similar to 19 nm length by electron microscopy. When over-expressed in striated muscle cells, Unc45b(Flag) fractionates as a cytosolic protein and isolates as a stable complex with Hsp90. Purified Unc45b(Flag) re-binds Hsp90 and forms a stable complex in solution. The endogenous Unc45b in muscle cell lysates is also found associated with Hsp90. The Unc45b(Flag)/Hsp90 complex binds the partially folded myosin motor domain when incubated with myosin subfragments synthesized in a reticulocyte lysate. This binding is independent of the myosin rod or light chains. Unc45b(Flag) does not bind native myosin subfragments consistent with a chaperone function. More importantly, Unc45b(Flag) enhances myosin motor domain folding during de novo motor domain synthesis indicating that it has a direct role in myosin maturation. Thus, mammalian Unc45b is a cytosolic protein that forms a stable complex with Hsp90, selectively binds the unfolded conformation of the myosin motor domain, and promotes motor domain folding.	[Srikakulam, Rajani; Liu, Li; Winkelmann, Donald A.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pathol & Lab Med, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Srikakulam, R (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pathol & Lab Med, Piscataway, NJ 08854 USA.	daw@pleiad.umdnj.edu			NIAMS [AR38454]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR038454, R29AR038454] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by a grant number AR38454 from NIAMS to DAW. NIAMS had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao WY, 2000, J CELL BIOL, V148, P375, DOI 10.1083/jcb.148.2.375; Barral JM, 1998, J CELL BIOL, V143, P1215, DOI 10.1083/jcb.143.5.1215; Barral JM, 2002, SCIENCE, V295, P669, DOI 10.1126/science.1066648; Berteaux-Lecellier V, 1998, EMBO J, V17, P1248, DOI 10.1093/emboj/17.5.1248; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; Chow D, 2002, J BIOL CHEM, V277, P36799, DOI 10.1074/jbc.M204101200; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Du SJ, 2008, P NATL ACAD SCI USA, V105, P554, DOI 10.1073/pnas.0707330105; Hawkins TA, 2008, DEVELOPMENT, V135, P1147, DOI 10.1242/dev.018150; Hoppe T, 2004, CELL, V118, P337, DOI 10.1016/j.cell.2004.07.014; Kachur T, 2004, J CELL SCI, V117, P5313, DOI 10.1242/jcs.01389; Kinose F, 1996, J CELL BIOL, V134, P895, DOI 10.1083/jcb.134.4.895; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landsverk ML, 2007, J CELL BIOL, V177, P205, DOI 10.1083/jcb.200607084; LIU L, 2008, J BIOL CHEM IN PRESS; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Maruya M, 1999, J MOL BIOL, V285, P903, DOI 10.1006/jmbi.1998.2349; Murphy PJM, 2001, J BIOL CHEM, V276, P30092, DOI 10.1074/jbc.M103773200; Price MG, 2002, J CELL SCI, V115, P4013, DOI 10.1242/jcs.00108; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Shiau AK, 2006, CELL, V127, P329, DOI 10.1016/j.cell.2006.09.027; Srikakulam R, 2004, J CELL SCI, V117, P641, DOI 10.1242/jcs.00899; Srikakulam R, 1999, J BIOL CHEM, V274, P27265, DOI 10.1074/jbc.274.38.27265; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; VENOLIA L, 1990, GENETICS, V126, P345; Wang Q, 2003, J CELL SCI, V116, P4227, DOI 10.1242/jcs.00709; Wesche S, 2003, CURR BIOL, V13, P715, DOI 10.1016/S0960-9822(03)00264-1; WINKELMANN DA, 1986, J MOL BIOL, V188, P595, DOI 10.1016/S0022-2836(86)80009-2; Wohlgemuth SL, 2007, DEV BIOL, V303, P483, DOI 10.1016/j.ydbio.2006.11.027; Wong KCY, 2000, J CELL SCI, V113, P2421; Yu Q, 2003, CURR BIOL, V13, pR525, DOI 10.1016/S0960-9822(03)00447-0	32	61	64	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2137	10.1371/journal.pone.0002137	http://dx.doi.org/10.1371/journal.pone.0002137			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478096	Green Published, gold, Green Submitted			2022-12-25	WOS:000262172800002
J	Rankin, EB; Rha, J; Unger, TL; Wu, CH; Shutt, HP; Johnson, RS; Simon, MC; Keith, B; Haase, VH				Rankin, E. B.; Rha, J.; Unger, T. L.; Wu, C. H.; Shutt, H. P.; Johnson, R. S.; Simon, M. C.; Keith, B.; Haase, V. H.			Hypoxia-inducible factor-2 regulates vascular tumorigenesis in mice	ONCOGENE			English	Article						von Hippel-Lindau (VHL) tumor suppressor; hypoxia-inducible factor (HIF); hemangioma; liver angiogenesis; mouse model; Cre-loxP recombination	HIPPEL-LINDAU-DISEASE; TUMOR-SUPPRESSOR; TARGET GENES; CYCLIN D1; EXPRESSION; HEMANGIOBLASTOMAS; ERYTHROPOIETIN; IDENTIFICATION; INACTIVATION; HIF-2-ALPHA	The von Hippel-Lindau tumor suppressor pVHL regulates the stability of hypoxia-inducible factors (HIF)-1 and-2, oxygen-sensitive basic helix-loop-helix transcription factors, which mediate the hypoxic induction of angiogenic growth factors such as vascular endothelial growth factor. Loss of pVHL function results in constitutive activation of HIF-1 and HIF-2 and is associated with the development of highly vascularized tumors in multiple organs. We have used a conditional gene-targeting approach to investigate the relative contributions of HIF-1 and HIF-2 to VHL-associated vascular tumorigenesis in a mouse model of liver hemangiomas. Here we demonstrate genetically that conditional inactivation of HIF-2 alpha suppressed the development of VHL-associated liver hemangiomas and that angiogenic gene expression in hepatocytes is predominantly regulated by HIF-2 and not by HIF-1. These findings suggest that HIF-2 is the dominant HIF in the pathogenesis of VHL-associated vascular tumors and that pharmacologic targeting of HIF-2 may be an effective strategy for their treatment.	[Rankin, E. B.; Rha, J.; Unger, T. L.; Wu, C. H.; Shutt, H. P.; Haase, V. H.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Johnson, R. S.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Simon, M. C.; Keith, B.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Simon, M. C.; Keith, B.] Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; University of California System; University of California San Diego; University of Pennsylvania; Pennsylvania Medicine; Howard Hughes Medical Institute; University of Pennsylvania	Haase, VH (corresponding author), Univ Penn, Sch Med, Dept Med, 626 Clinical Res Bldg,415 Curie Blvd, Philadelphia, PA 19104 USA.	vhaase@mail.med.upenn.edu	Simon, Celeste/AAG-3941-2021; Haase, Volker Hans/AAJ-5061-2021; Haase, Volker Hans/A-6758-2013; Johnson, Randall/AAM-1189-2021	Haase, Volker Hans/0000-0002-7051-8994; Johnson, Randall/0000-0002-4084-6639; Rankin, Erinn/0000-0002-2045-2296; Rha, Jennifer/0000-0001-9653-4370	NIH [DK073467, CA100787]; Center for Molecular Studies in Digestive and Liver Disease [P30-DK50306]; Penn Diabetes and Endocrinology Research Center Functional Genomics Core [P30-DK19525]; American Heart Association; NATIONAL CANCER INSTITUTE [R01CA100787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK073467, P30DK050306, P30DK019525] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Molecular Studies in Digestive and Liver Disease; Penn Diabetes and Endocrinology Research Center Functional Genomics Core; American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grant DK073467 and CA100787 (both to VHH), the Center for Molecular Studies in Digestive and Liver Disease (P30-DK50306) and the Penn Diabetes and Endocrinology Research Center Functional Genomics Core (P30-DK19525). EBR was supported by a fellowship grant from the American Heart Association.	Biju MP, 2004, MOL CELL BIOL, V24, P9038, DOI 10.1128/MCB.24.20.9038-9047.2004; Bindra RS, 2002, CANCER RES, V62, P3014; Chavez JC, 2006, J NEUROSCI, V26, P9471, DOI 10.1523/JNEUROSCI.2838-06.2006; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; Flamme I, 1998, AM J PATHOL, V153, P25, DOI 10.1016/S0002-9440(10)65541-1; Gijtenbeek JMM, 2005, J NEURO-ONCOL, V74, P261, DOI 10.1007/s11060-004-7326-z; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Kapitsinou PP, 2008, CELL DEATH DIFFER, V15, P650, DOI 10.1038/sj.cdd.4402313; Maher ER, 1997, MEDICINE, V76, P381, DOI 10.1097/00005792-199711000-00001; MCGRATH FP, 1992, CLIN RADIOL, V45, P37, DOI 10.1016/S0009-9260(05)81467-9; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Rankin EB, 2005, MOL CELL BIOL, V25, P3163, DOI 10.1128/MCB.25.8.3163-3172.2005; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Rothhammer T, 2007, ONCOGENE, V26, P4158, DOI 10.1038/sj.onc.1210182; Vortmeyer AO, 1997, HUM PATHOL, V28, P540, DOI 10.1016/S0046-8177(97)90075-7; White P, 2005, J BIOL CHEM, V280, P3715, DOI 10.1074/jbc.M410844200; Zatyka M, 2002, CANCER RES, V62, P3803	21	118	124	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP 11	2008	27	40					5354	5358		10.1038/onc.2008.160	http://dx.doi.org/10.1038/onc.2008.160			5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	346UW	18490920	Green Accepted			2022-12-25	WOS:000259096100008
J	Narzi, D; Winkler, K; Saidowsky, J; Misselwitz, R; Ziegler, A; Bockmann, RA; Alexiev, U				Narzi, Daniele; Winkler, Kathrin; Saidowsky, Juergen; Misselwitz, Rolf; Ziegler, Andreas; Boeckmann, Rainer A.; Alexiev, Ulrike			Molecular determinants of major histocompatibility complex class I complex stability - Shaping antigenic features through short and long range electrostatic interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POISSON-BOLTZMANN EQUATION; CYTOTOXIC T-LYMPHOCYTES; ANKYLOSING-SPONDYLITIS; SELF-PEPTIDES; HLA-B27; DYNAMICS; IMMUNOGENICITY; SUSCEPTIBILITY; DISSOCIATION; PATHOGENESIS	A single amino acid exchange between the major histocompatibility complex molecules HLA-B* 2705 and HLA-B* 2709 (Asp116/His) is responsible for the emergence of distinct HLA-B27-restricted T cell repertoires in individuals harboring either of these two subtypes and could correlate with their differential association with the autoimmune disease ankylosing spondylitis. By using fluorescence depolarization and pK(a) calculations, we investigated to what extent electrostatic interactions contribute to shape antigenic differences between these HLA molecules complexed with viral, self, and non-natural peptide ligands. In addition to the established main anchor of peptides binding to HLA-B27, arginine at position 2 (pArg-2), and the secondary anchors at the peptide termini, at least two further determinants contribute to stable peptide accommodation. 1) The interaction of Asp-116 with arginine at peptide position 5, as found in pLMP2 (RRRWRRLTV; viral) and pVIPR (RRKWRRWHL; self), and with lysine in p Omega, as found in gag (KRWIILGLNK; viral), additionally stabilizes the B*2705 complexes by similar to 5 and similar to 27 kJ/mol, respectively, in comparison with B*2709. 2) The protonation state of the key residues Glu-45 and Glu-63 in the B-pocket, which accommodates pArg-2, affects peptide binding strength in a peptide- and subtype-dependent manner. In B*2705/pLMP2, protonation of Glu-45/Glu-63 reduces the interaction energy of pArg-2 by similar to 24 kJ/mol as compared with B*2705/pVIPR. B*2705/pVIPR is stabilized by a deprotonated Glu45/Glu-63 pair, evoked by allosteric interactions with pHis-8. The mutual electrostatic interactions of peptide and HLA molecule, including peptide- and subtype-dependent protonation of key residues, modulate complex stability and antigenic features of the respective HLA-B27 subtype.	[Narzi, Daniele; Boeckmann, Rainer A.] Univ Saarland, Ctr Bioinformat, D-66041 Saarbrucken, Germany; [Winkler, Kathrin; Saidowsky, Juergen; Alexiev, Ulrike] Free Univ Berlin, Dept Phys, D-14195 Berlin, Germany; [Misselwitz, Rolf; Ziegler, Andreas] Free Univ Berlin, Charite Univ Med Berlin, Inst Immungenet, D-14195 Berlin, Germany	Saarland University; Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Bockmann, RA (corresponding author), Univ Saarland, Ctr Bioinformat, POB 15 11 50, D-66041 Saarbrucken, Germany.	rainer@bioinformatik.uni-saarland.de; alexiev@physik.fu-berlin.de	Alexiev, Ulrike/L-8478-2016; Böckmann, Rainer A/G-7863-2015	Böckmann, Rainer A/0000-0002-9325-5162; Narzi, Daniele/0000-0003-2731-6286	VolkswagenStiftung [1/79 983]; Deutsche Forschungsgemeinschaf [Sfb 449 TPA5, BIZ 4/1]; European Union [EFRE 2000-2006 2u/2]	VolkswagenStiftung(Volkswagen); Deutsche Forschungsgemeinschaf(German Research Foundation (DFG)); European Union(European Commission)	This work was supported by VolkswagenStiftung Grant 1/79 983 ( to U. A., R. B., and A.Z.) and in part by Deutsche Forschungsgemeinschaft Grant Sfb 449 TPA5 ( to U. A.), Deutsche Forschungsgemeinschaft Grant BIZ 4/1 ( to R. A. B.), and European Union Grant EFRE 2000-2006 2u/2 ( to A.Z.).	Alexiev U, 2003, J MOL BIOL, V328, P705, DOI 10.1016/S0022-2836(03)00326-7; Allen RL, 1999, IMMUNOGENETICS, V50, P220, DOI 10.1007/s002510050596; Allen RL, 1999, J IMMUNOL, V162, P5045; BECKTEL WJ, 1987, BIOPOLYMERS, V26, P1859, DOI 10.1002/bip.360261104; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Binz AK, 2003, BIOCHEMISTRY-US, V42, P4954, DOI 10.1021/bi034077m; Borbulevych OY, 2005, J IMMUNOL, V174, P4812, DOI 10.4049/jimmunol.174.8.4812; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; BOWNESS P, 1993, EUR J IMMUNOL, V23, P1417, DOI 10.1002/eji.1830230702; BROOKS JM, 1993, J EXP MED, V178, P879, DOI 10.1084/jem.178.3.879; Cascino I, 2007, ARTHRITIS RHEUM-US, V56, P2640, DOI 10.1002/art.22820; Chen ZW, 2000, J IMMUNOL, V164, P6474, DOI 10.4049/jimmunol.164.12.6474; CHINEA G, 1995, PROTEINS, V23, P415, DOI 10.1002/prot.340230315; Colbert RA, 2000, MOL MED TODAY, V6, P224, DOI 10.1016/S1357-4310(00)01699-3; DAMATO M, 1995, EUR J IMMUNOL, V25, P3199, DOI 10.1002/eji.1830251133; Dangoria NS, 2002, J BIOL CHEM, V277, P23459, DOI 10.1074/jbc.M110336200; de Castro JAL, 2004, TISSUE ANTIGENS, V63, P424, DOI 10.1111/j.0001-2815.2004.00220.x; De Groot AS, 2004, METHODS, V34, P425, DOI 10.1016/j.ymeth.2004.06.004; Dedier S, 2001, J IMMUNOL METHODS, V255, P57, DOI 10.1016/S0022-1759(01)00423-9; Edwards JCW, 2000, IMMUNOL TODAY, V21, P256, DOI 10.1016/S0167-5699(00)01625-X; Fabian H, 2008, J MOL BIOL, V376, P798, DOI 10.1016/j.jmb.2007.12.009; Ferrara GB, 2001, BLOOD, V98, P3150, DOI 10.1182/blood.V98.10.3150; Fiorillo MT, 2000, J CLIN INVEST, V106, P47, DOI 10.1172/JCI9295; Fiorillo MT, 2005, J BIOL CHEM, V280, P2962, DOI 10.1074/jbc.M410807200; Gao XJ, 2001, NEW ENGL J MED, V344, P1668, DOI 10.1056/NEJM200105313442203; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Hillig RC, 2004, J BIOL CHEM, V279, P652, DOI 10.1074/jbc.M307457200; Hulsmeyer M, 2005, J MOL BIOL, V346, P1367, DOI 10.1016/j.jmb.2004.12.047; Hulsmeyer M, 2004, J EXP MED, V199, P271, DOI 10.1084/jem.20031690; Hulsmeyer M, 2002, J BIOL CHEM, V277, P47844, DOI 10.1074/jbc.M206392200; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Khan MA, 2007, AUTOIMMUN REV, V6, P183, DOI 10.1016/j.autrev.2006.11.003; Kim TH, 2005, CURR OPIN RHEUMATOL, V17, P400, DOI 10.1097/01.bor.0000163447.44037.c4; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; de Castro JAL, 2007, IMMUNOL LETT, V108, P27, DOI 10.1016/j.imlet.2006.10.004; MADDEN DR, 1991, NATURE, V353, P321, DOI 10.1038/353321a0; Marelius J, 1998, J COMPUT AID MOL DES, V12, P119, DOI 10.1023/A:1007929626986; Mear JP, 1999, J IMMUNOL, V163, P6665; Nielsen JE, 2001, PROTEINS, V43, P403, DOI 10.1002/prot.1053; Nielsen JE, 2003, PROTEIN SCI, V12, P1894, DOI 10.1110/ps.03114903; Nielsen JE, 2003, PROTEIN SCI, V12, P313, DOI 10.1110/ps.0229903; Pohlmann T, 2004, J BIOL CHEM, V279, P28197, DOI 10.1074/jbc.C400128200; Ramos M, 2002, J BIOL CHEM, V277, P28749, DOI 10.1074/jbc.M204155200; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; Ruckert C, 2006, J BIOL CHEM, V281, P2306, DOI 10.1074/jbc.M508528200; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Stewart-Jones GBE, 2005, EUR J IMMUNOL, V35, P341, DOI 10.1002/eji.200425724; Uchanska-Ziegler B, 2003, TRENDS IMMUNOL, V24, P73, DOI 10.1016/S1471-4906(02)00028-5; UCHANSKAZIEGLER B, 2006, IMMUNOBIOLOGY HUMAN, V1, P138; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wilson JDK, 2000, AIDS, V14, P225, DOI 10.1097/00002030-200002180-00003; Winkler K, 2007, BIOPHYS J, V93, P2743, DOI 10.1529/biophysj.106.096602; Yu ZY, 2004, J CLIN INVEST, V114, P551, DOI 10.1172/JCI200421695	55	18	18	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23093	23103		10.1074/jbc.M710234200	http://dx.doi.org/10.1074/jbc.M710234200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18505734	hybrid			2022-12-25	WOS:000258455400022
J	Gauguin, L; Delaine, C; Alvino, CL; McNeil, KA; Wallace, JC; Forbes, BE; De Meyts, P				Gauguin, Lisbeth; Delaine, Carlie; Alvino, Clair L.; McNeil, Kerrie A.; Wallace, John C.; Forbes, Briony E.; De Meyts, Pierre			Alanine scanning of a putative receptor binding surface of insulin-like growth factor-I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-AFFINITY BINDING; CHAIN ALPHA-HELIX; B-DOMAIN ANALOGS; LIGAND-BINDING; IGF-I; NEGATIVE COOPERATIVITY; FUSION PROTEINS; POSTNATAL-GROWTH; FACTOR (IGF)-I; TYPE-1 IGF	Current evidence supports a binding model in which the insulin molecule contains two binding surfaces, site 1 and site 2, which contact the two halves of the insulin receptor. The interaction of these two surfaces with the insulin receptor results in a high affinity cross-linking of the two receptor alpha subunits and leads to receptor activation. Evidence suggests that insulin-like growth factor-I (IGF-I) may activate the IGF-I receptor in a similar mode. So far IGF-I residues structurally corresponding to the residues of the insulin site 1 together with residues in the C-domain of IGF-I have been found to be important for binding of IGF-I to the IGF-I receptor (e. g. Phe(23), Tyr(24), Tyr(31), Arg(36), Arg(37), Val(44), Tyr(60), and Ala(62)). However, an IGF-I second binding surface similar to site 2 of insulin has not been identified yet. In this study, we have analyzed whether IGF-I residues corresponding to the six residues of the insulin site 2 have a role in high affinity binding of IGF-I to the IGF-I receptor. Six single-substituted IGF-I analogues were produced, each containing an alanine substitution in one of the following positions (corresponding insulin residues in parentheses): Glu(9) (His(B10)), Asp(12) (Glu(B13)), Phe(16) (Leu(B17)), Asp(53) (Ser(A12)), Leu(54) (Leu(A13)), and Glu(58) (Glu(A17)). In addition, two analogues with 2 and 3 combined alanine substitutions were also produced (E9A, D12A IGF-I and E9A, D12A, E58A IGF-I). The results show that introducing alanine in positions Glu9, Asp12, Phe16, Leu54, and Glu58 results in a significant reduction in IGF-I receptor binding affinity, whereas alanine substitution at position 53 had no effect on IGF-I receptor binding. The multiple substitutions resulted in a 33 -100-fold reduction in IGF-I receptor binding affinity. These data suggest that IGF-I, in addition to the C-domain, uses surfaces similar to those of insulin in contacting its cognate receptor, although the relative contribution of the side chains of homologous residues varies.	[Gauguin, Lisbeth; De Meyts, Pierre] Hagedorn Res Inst, Receptor Syst Biol Lab, Gentofte 2820, Denmark; [Delaine, Carlie; Alvino, Clair L.; McNeil, Kerrie A.; Wallace, John C.; Forbes, Briony E.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia	Novo Nordisk; Hagedorn Research Institute; University of Adelaide	Gauguin, L (corresponding author), Hagedorn Res Inst, Receptor Syst Biol Lab, Gentofte 2820, Denmark.	lgau@hagedorn.dk	, John/AAP-5150-2020; Forbes, Briony/R-1838-2019	De Meyts, Pierre/0000-0001-6214-0824; Forbes, Briony/0000-0003-4360-9927				Adams TE, 2000, CELL MOL LIFE SCI, V57, P1050, DOI 10.1007/PL00000744; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; BAYNE ML, 1989, J BIOL CHEM, V264, P11004; BAYNE ML, 1990, J BIOL CHEM, V265, P15648; Benyoucef S, 2007, BIOCHEM J, V403, P603, DOI 10.1042/BJ20061709; Brzozowski AM, 2002, BIOCHEMISTRY-US, V41, P9389, DOI 10.1021/bi020084j; CASCIERI MA, 2008, BIOCHEMISTRY-US, V27, P3229; Chakravarty A, 2005, BIOCHEM BIOPH RES CO, V331, P74, DOI 10.1016/j.bbrc.2005.03.122; Chan SJ, 2007, J BIOL CHEM, V282, P13754, DOI 10.1074/jbc.M700724200; CHRISTOFFERSEN CT, 1994, ENDOCRINOLOGY, V135, P472, DOI 10.1210/en.135.1.472; COOKE RM, 1991, BIOCHEMISTRY-US, V30, P5484, DOI 10.1021/bi00236a022; De Meyts P, 2004, BIOESSAYS, V26, P1351, DOI 10.1002/bies.20151; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; Delaine C, 2007, J BIOL CHEM, V282, P18886, DOI 10.1074/jbc.M700531200; DEMEYTS P, 1978, NATURE, V273, P504; DEMEYTS P, 1994, DIABETOLOGIA, V37, pS135, DOI 10.1007/BF00400837; Denley A, 2004, MOL ENDOCRINOL, V18, P2502, DOI 10.1210/me.2004-0183; Denley A, 2005, MOL ENDOCRINOL, V19, P711, DOI 10.1210/me.2004-0409; Denley A, 2005, CYTOKINE GROWTH F R, V16, P421, DOI 10.1016/j.cytogfr.2005.04.004; Epa VC, 2006, PROTEIN ENG DES SEL, V19, P377, DOI 10.1093/protein/gzl022; FABRY M, 1992, J BIOL CHEM, V267, P8950; FRANCIS GL, 1993, BIOCHEM J, V293, P713, DOI 10.1042/bj2930713; Gauguin L, 2008, J BIOL CHEM, V283, P2604, DOI 10.1074/jbc.M709220200; Gill R, 1999, PROTEIN ENG, V12, P297, DOI 10.1093/protein/12.4.297; Glendorf T, 2008, BIOCHEMISTRY-US, V47, P4743, DOI 10.1021/bi800054z; Hao CL, 2006, BIOCHEM BIOPH RES CO, V347, P334, DOI 10.1016/j.bbrc.2006.06.089; Huang K, 2004, J MOL BIOL, V341, P529, DOI 10.1016/j.jmb.2004.05.023; HUMBEL RE, 1990, EUR J BIOCHEM, V190, P445, DOI 10.1111/j.1432-1033.1990.tb15595.x; Jansson M, 1998, J BIOL CHEM, V273, P24701, DOI 10.1074/jbc.273.38.24701; Jansson M, 1997, FEBS LETT, V416, P259, DOI 10.1016/S0014-5793(97)01149-6; Jansson M, 1997, BIOCHEMISTRY-US, V36, P4108, DOI 10.1021/bi961553i; Keyhanfar M, 2007, BIOCHEM J, V401, P269, DOI 10.1042/BJ20060890; KING R, 1992, J MOL ENDOCRINOL, V8, P29, DOI 10.1677/jme.0.0080029; KJELDSEN T, 1991, P NATL ACAD SCI USA, V88, P4404, DOI 10.1073/pnas.88.10.4404; Kristensen C, 1997, J BIOL CHEM, V272, P12978, DOI 10.1074/jbc.272.20.12978; Kristensen C, 2002, J BIOL CHEM, V277, P18340, DOI 10.1074/jbc.M112249200; Lawrence MC, 2007, CURR OPIN STRUC BIOL, V17, P699, DOI 10.1016/j.sbi.2007.07.007; Lien S, 2001, BIOTECHNOL BIOENG, V74, P335, DOI 10.1002/bit.1124; Lou MZ, 2006, P NATL ACAD SCI USA, V103, P12429, DOI 10.1073/pnas.0605395103; Magee BA, 1999, BIOCHEMISTRY-US, V38, P15863, DOI 10.1021/bi9910070; Molina L, 2000, FEBS LETT, V467, P226, DOI 10.1016/S0014-5793(00)01161-3; Mynarcik DC, 1996, J BIOL CHEM, V271, P2439, DOI 10.1074/jbc.271.5.2439; Mynarcik DC, 1997, J BIOL CHEM, V272, P18650, DOI 10.1074/jbc.272.30.18650; PULLEN RA, 1976, NATURE, V259, P369, DOI 10.1038/259369a0; RINDERKNECHT E, 1978, J BIOL CHEM, V253, P2769; SATO A, 1993, INT J PEPT PROT RES, V41, P433; SCHAFFER L, 1994, EUR J BIOCHEM, V221, P1127, DOI 10.1111/j.1432-1033.1994.tb18833.x; Shooter GK, 1996, J MOL ENDOCRINOL, V17, P237, DOI 10.1677/jme.0.0170237; SOOS MA, 1992, J BIOL CHEM, V267, P12955; SOOS MA, 1993, BIOCHEM J, V290, P419, DOI 10.1042/bj2900419; Surinya HH, 2002, J BIOL CHEM, V277, P16718, DOI 10.1074/bjc.M112014200; Surinya KH, 2008, J BIOL CHEM, V283, P5355, DOI 10.1074/jbc.M707054200; SUSSENBACH JS, 1992, GROWTH REGULAT, V2, P1; WELLS JA, 1991, METHOD ENZYMOL, V202, P390; Whittaker J, 2001, J BIOL CHEM, V276, P43980, DOI 10.1074/jbc.M102863200; Woods KA, 1996, NEW ENGL J MED, V335, P1363, DOI 10.1056/NEJM199610313351805	56	45	46	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20821	20829		10.1074/jbc.M802620200	http://dx.doi.org/10.1074/jbc.M802620200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18502759	hybrid, Green Published			2022-12-25	WOS:000257746100024
J	Wang, XX; Fukuda, K; Byeon, IJ; Velyvis, A; Wu, CY; Gronenborn, A; Qin, J				Wang, Xiaoxia; Fukuda, Koichi; Byeon, In-Ja; Velyvis, Algirdas; Wu, Chuanyue; Gronenborn, Angela; Qin, Jun			The structure of alpha-parvin CH2-paxillin LD1 complex reveals a novel modular recognition for focal adhesion assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATES CELL-ADHESION; INTEGRIN-LINKED KINASE; TARGETING DOMAIN; BINDS PAXILLIN; PROTEIN; MOTIFS; ACTIN; ACTOPAXIN; INTERACTS; DYNAMICS	alpha-Parvin is an essential component of focal adhesions (FAs), which are large multiprotein complexes that link the plasma membrane and actin cytoskeleton. alpha-Parvin contains two calponin homology (CH) domains and its C-terminal CH2 domain binds multiple targets including paxillin LD motifs for regulating the FA network and signaling. Here we describe the solution structure of alpha-parvin CH2 bound to paxillin LD1. We show that although CH2 contains the canonical CH-fold, a previously defined N-terminal linker forms an alpha-helix that packs unexpectedly with the C-terminal helix of CH2, resulting in a novel variant of the CH domain. Importantly, such packing generates a hydrophobic surface that recognizes the Leu-rich face of paxillin-LD1, and the binding pattern differs drastically from the classical paxillin-LD binding to four-helix bundle proteins such as focal adhesion kinase. These results define a novel modular recognition mode and reveal how alpha-parvin associates with paxillin to mediate the FA assembly and signaling.	[Wang, Xiaoxia; Fukuda, Koichi; Velyvis, Algirdas; Qin, Jun] Cleveland Clin, Lerner Res Inst, Struct Biol Program, Cleveland, OH 44195 USA; [Wang, Xiaoxia; Qin, Jun] Cleveland State Univ, Dept Chem, Cleveland, OH 44195 USA; [Byeon, In-Ja; Gronenborn, Angela] Univ Pittsburgh, Dept Biol Struct, Pittsburgh, PA 15261 USA; [Wu, Chuanyue] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA	Cleveland Clinic Foundation; University System of Ohio; Cleveland State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Qin, J (corresponding author), Cleveland Clin, Lerner Res Inst, Struct Biol Program, NB20,9500 Euclid Ave, Cleveland, OH 44195 USA.	qinj@ccf.org	Qin, Jun/D-5559-2009	Gronenborn, Angela M/0000-0001-9072-3525; Qin, Jun/0000-0002-2647-9270	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL073311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065188] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL 073311, HL 58757] Funding Source: Medline; NIGMS NIH HHS [GM 65188] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Banuelos S, 1998, STRUCTURE, V6, P1419, DOI 10.1016/S0969-2126(98)00141-5; Bertolucci CM, 2005, PROTEIN SCI, V14, P644, DOI 10.1110/ps.041107205; Brown MC, 1998, NAT STRUCT BIOL, V5, P677, DOI 10.1038/1370; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; Carugo KD, 1997, NAT STRUCT BIOL, V4, P175, DOI 10.1038/nsb0397-175; Clore GM, 1998, CURR OPIN CHEM BIOL, V2, P564, DOI 10.1016/S1367-5931(98)80084-7; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; DEARRUDA MV, 1990, J CELL BIOL, V111, P1069, DOI 10.1083/jcb.111.3.1069; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Gao GH, 2004, J BIOL CHEM, V279, P8441, DOI 10.1074/jbc.M309808200; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Gimona M, 2002, FEBS LETT, V513, P98, DOI 10.1016/S0014-5793(01)03240-9; Hayashi I, 2002, NAT STRUCT BIOL, V9, P101, DOI 10.1038/nsb755; Hoellerer MK, 2003, STRUCTURE, V11, P1207, DOI 10.1016/j.str.2003.08.010; Jung EJ, 2006, MOL CELL BIOL, V26, P2175, DOI 10.1128/MCB.26.6.2175-2186.2006; LaLonde DP, 2005, J BIOL CHEM, V280, P21680, DOI 10.1074/jbc.m500752200; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Lo SH, 2006, DEV BIOL, V294, P280, DOI 10.1016/j.ydbio.2006.03.029; Martin KH, 2002, SCIENCE, V296, P1652, DOI 10.1126/science.296.5573.1652; Nikolopoulos SN, 2000, J CELL BIOL, V151, P1435, DOI 10.1083/jcb.151.7.1435; Nikolopoulos SN, 2001, J BIOL CHEM, V276, P23499, DOI 10.1074/jbc.M102163200; Olski TM, 2001, J CELL SCI, V114, P525; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sepulveda JL, 2006, CELL MOL LIFE SCI, V63, P25, DOI 10.1007/s00018-005-5355-1; Straube A, 2007, CURR BIOL, V17, P1318, DOI 10.1016/j.cub.2007.06.058; Tu YZ, 2001, J CELL BIOL, V153, P585, DOI 10.1083/jcb.153.3.585; Vaynberg J, 2005, MOL CELL, V17, P513, DOI 10.1016/j.molcel.2004.12.031; Velyvis A, 2003, NAT STRUCT BIOL, V10, P558, DOI 10.1038/nsb938; Wei RR, 2007, NAT STRUCT MOL BIOL, V14, P54, DOI 10.1038/nsmb1186; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858	33	25	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21113	21119		10.1074/jbc.M801270200	http://dx.doi.org/10.1074/jbc.M801270200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18508764	hybrid, Green Published			2022-12-25	WOS:000257746100053
J	Carlson, CB; Liu, YY; Keck, JL; Mosher, DF				Carlson, C. Britt; Liu, Yuanyuan; Keck, James L.; Mosher, Deane F.			Influences of the N700S thrombospondin-1 polymorphism on protein structure and stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGOMERIC MATRIX PROTEIN; SIGNATURE DOMAINS; CALCIUM-BINDING; PREMATURE; PSEUDOACHONDROPLASIA; MULTIPLE; MUTATION; MICE; REVEALS; DENSITY	Thrombospondins (THBSs) are multimodular, secreted proteins characterized by a signature domain comprising a unique set of 13 calcium-binding repeats flanked by epidermal growth factor (EGF)-like and lectin-like modules. A polymorphism that changes a conserved Asn to Ser at residue 700 in the most N-terminal calcium-binding repeat of THBS-1 (repeat 1C) is found in 8-10% of European populations and has been linked to increased risk of premature coronary artery disease. The Ser substitution leads to altered stability in the EGF-like and wire modules of the THBS-1 signature domain as assessed by differential scanning calorimetry carried out in 2 mM or 200 mu M calcium. Studies of the melting profiles of the THBS-2 signature domain proteins with Asn or Ser at position 702 (homologous to 700 in THBS-1) revealed that the impact of the Ser allele is similar in both THBS-1 and THBS-2. Structure determination of the Ser(702) THBS-2 variant in 2 mM calcium showed that repeat 1C contains two bound calcium ions as in the crystal of the Asn(702) protein, including the ion that is coordinated by Asn(702), and is associated with changes in conformation of repeat 1C and the adjacent EGF-like modules. The Ser substitution leads to the decreased ability of soluble THBS-2 signature domain protein to bind 4B6.13, a conformation-sensitive monoclonal antibody that recognizes an epitope in repeat 1C. These results indicate that although THBS harboring the Ser allele binds a full complement of calcium ions, repeat 1C is altered, leading to destabilization of surrounding structures.	[Mosher, Deane F.] Univ Wisconsin, Dept Med, Madison, WI 53706 USA; Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Mosher, DF (corresponding author), Univ Wisconsin, Dept Med, 4285 Med Sci Ctr,1300 Univ Ave, Madison, WI 53706 USA.	dfmosher@wisc.edu	Liu, Yuanyuan/E-9439-2013	Keck, James/0000-0002-5961-0220	NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR013790] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054462] Funding Source: NIH RePORTER; NCRR NIH HHS [S10 RR 13790] Funding Source: Medline; NHLBI NIH HHS [HL 07899, HL 54462] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams J, 2004, INT J BIOCHEM CELL B, V36, P960, DOI 10.1016/j.biocel.2004.02.009; ADAMS JC, 1995, THROMBOSPONDIN GENE, P11; Annis DS, 2007, J BIOL CHEM, V282, P27067, DOI 10.1074/jbc.M703804200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boekholdt SM, 2002, ARTERIOSCL THROM VAS, V22, pE24, DOI 10.1161/01.ATV.0000046235.22451.66; Breitwieser GE, 2008, INT J BIOCHEM CELL B, V40, P1467, DOI 10.1016/j.biocel.2008.01.019; CALZADA MJ, 2008, MATRIX BIOL IN PRESS; Carlson CB, 2005, NAT STRUCT MOL BIOL, V12, P910, DOI 10.1038/nsmb997; Chen H, 2000, J BIOL CHEM, V275, P26538, DOI 10.1074/jbc.M909780199; Deere M, 1999, AM J MED GENET, V85, P486, DOI 10.1002/(SICI)1096-8628(19990827)85:5<486::AID-AJMG10>3.0.CO;2-O; DeLano W, 2002, PYMOL 0 99; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hankenson KD, 2005, MOL CELL BIOL, V25, P5599, DOI 10.1128/MCB.25.13.5599-5606.2005; Hannah BLA, 2004, J BIOL CHEM, V279, P51915, DOI 10.1074/jbc.M409632200; Hannah BLA, 2003, J BIOL CHEM, V278, P8929, DOI 10.1074/jbc.M211185200; Hou J, 2000, CELL CALCIUM, V27, P309, DOI 10.1054/ceca.2000.0125; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karen LP, 2004, INT J BIOCHEM CELL B, V36, P1005, DOI 10.1016/j.biocel.2004.01.011; Kennedy J, 2005, EUR J HUM GENET, V13, P547, DOI 10.1038/sj.ejhg.5201374; Kleerekoper Q, 2002, J BIOL CHEM, V277, P10581, DOI 10.1074/jbc.M109944200; Kvansakul M, 2004, EMBO J, V23, P1223, DOI 10.1038/sj.emboj.7600166; Kyriakides TR, 1998, J CELL BIOL, V140, P419, DOI 10.1083/jcb.140.2.419; Lawler J, 1998, J CLIN INVEST, V101, P982, DOI 10.1172/JCI1684; MACH H, 1992, ANAL BIOCHEM, V200, P74, DOI 10.1016/0003-2697(92)90279-G; Maddox BK, 2000, J BIOL CHEM, V275, P11412, DOI 10.1074/jbc.275.15.11412; McKenzie P, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-33; Miao WM, 2001, CANCER RES, V61, P7830; Misenheimer TM, 2005, J BIOL CHEM, V280, P41229, DOI 10.1074/JBC.M504696200; Misenheimer TM, 2003, BIOCHEMISTRY-US, V42, P5125, DOI 10.1021/bi026983p; Mosher DF, 2002, METHOD CELL BIOL, V69, P69, DOI 10.1016/S0091-679X(02)69008-9; Narizhneva NV, 2004, J BIOL CHEM, V279, P21651, DOI 10.1074/jbc.M311090200; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Svensson L, 2002, MOL CELL BIOL, V22, P4366, DOI 10.1128/MCB.22.12.4366-4371.2002; Thur J, 2001, J BIOL CHEM, V276, P6083, DOI 10.1074/jbc.M009512200; Tooney PA, 1998, MATRIX BIOL, V17, P131, DOI 10.1016/S0945-053X(98)90026-9; Topol EJ, 2001, CIRCULATION, V104, P2641, DOI 10.1161/hc4701.100910; Zwicker JI, 2006, BLOOD, V108, P1280, DOI 10.1182/blood-2006-04-015701	39	18	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20069	20076		10.1074/jbc.M800223200	http://dx.doi.org/10.1074/jbc.M800223200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18499674	hybrid, Green Published			2022-12-25	WOS:000257565300023
J	Vargas, WA; Djonovic, S; Sukno, SA; Kenerley, CM				Vargas, Walter A.; Djonovic, Slavica; Sukno, Serenella A.; Kenerley, Charles M.			Dimerization controls the activity of fungal elicitors that trigger systemic resistance in plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE CROSS-LINKING; TRICHODERMA-VIRENS; ACQUIRED-RESISTANCE; SECRETED PROTEIN; INNATE IMMUNITY; DEFENSE; GLYCOSYLATION; HYDROPHOBINS; ARABIDOPSIS; PATHOGEN	The soilborne fungus Trichoderma virens secretes a small protein (Sm1) that induces local and systemic defenses in plants. This protein belongs to the ceratoplatanin protein family and is mainly present as a monomer in culture filtrates. However, Hypocrea atroviride (the telomorph form of Trichoderma atroviride) secretes an Sm1-homologous protein, Epl1, with high levels of dimerization. Nonetheless, the molecular mechanisms involved in recognition and the signaling pathways involved in the induction of systemic resistance in plants are still unclear. In this report, we demonstrate that Sm1 and Epl1 are mainly produced as monomer and a dimer, respectively, in the presence of maize seedlings. The results presented show that the ability to induce plant defenses reside only in the monomeric form of both Sm1 and Epl1, and we demonstrate for the first time that the monomeric form of Epl1, likewise Sm1, induces defenses in maize plants. Biochemical analyses indicate that monomeric Sm1 is produced as a glycoprotein, but the glycosyl moiety is missing from its dimeric form, and Epl1 is produced as a nonglycosylated protein. Moreover, for Sm1 homologues in various fungal strains, there is a negative correlation between the presence of the glycosylation site and their ability to aggregate. We propose a subdivision in the ceratoplatanin protein family according to the presence of the glycosylation site and the ability of the proteins to aggregate. The data presented suggest that the elicitor's aggregation may control the Trichoderma-plant molecular dialogue and block the activation of induced systemic resistance in plants.	[Vargas, Walter A.; Djonovic, Slavica; Kenerley, Charles M.] Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA; [Sukno, Serenella A.] Univ Salamanca, Dept Genet & Microbiol, Ctr Hispano Luso Invest Agr, Salamanca 37007, Spain	Texas A&M University System; Texas A&M University College Station; University of Salamanca	Kenerley, CM (corresponding author), Texas A&M Univ, Dept Plant Pathol & Microbiol, 413C LF Peterson, College Stn, TX 77843 USA.	c-kenerley@tamu.edu	Sukno, Serenella/T-5919-2019; Sukno, Serenella A/K-1449-2014	Sukno, Serenella/0000-0003-3248-6490; Sukno, Serenella A/0000-0003-3248-6490				Bais HP, 2004, TRENDS PLANT SCI, V9, P26, DOI 10.1016/j.tplants.2003.11.008; Benz I, 2002, MOL MICROBIOL, V45, P267, DOI 10.1046/j.1365-2958.2002.03030.x; BRADLEY DJ, 1992, CELL, V70, P21, DOI 10.1016/0092-8674(92)90530-P; BRISSON LF, 1994, PLANT CELL, V6, P1703, DOI 10.1105/tpc.6.12.1703; Brotman Y, 2008, PLANT PHYSIOL, V147, P779, DOI 10.1104/pp.108.116293; Brown I, 1998, PLANT J, V15, P333, DOI 10.1046/j.1365-313X.1998.00215.x; Brunner F, 2002, EMBO J, V21, P6681, DOI 10.1093/emboj/cdf667; COOK RJ, 1995, P NATL ACAD SCI USA, V92, P4197, DOI 10.1073/pnas.92.10.4197; Djonovic S, 2007, PLANT PHYSIOL, V145, P875, DOI 10.1104/pp.107.103689; Djonovic S, 2007, MOL PLANT PATHOL, V8, P469, DOI [10.1111/j.1364-3703.2007.00407.x, 10.1111/J.1364-3703.2007.00407.X]; Djonovic S, 2006, MOL PLANT MICROBE IN, V19, P838, DOI 10.1094/MPMI-19-0838.02006; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Ferrari S, 2007, PLANT PHYSIOL, V144, P367, DOI 10.1104/pp.107.095596; Fu XY, 2004, J BIOL CHEM, V279, P6209, DOI 10.1074/jbc.C300506200; Hall N, 1999, PHYSIOL MOL PLANT P, V55, P69, DOI 10.1006/pmpp.1999.0203; Harman GE, 2006, PHYTOPATHOLOGY, V96, P190, DOI 10.1094/PHYTO-96-0190; HEINECKE JW, 1993, J CLIN INVEST, V91, P2866, DOI 10.1172/JCI116531; Hemmann S, 1997, AM J RESP CRIT CARE, V156, P1956, DOI 10.1164/ajrccm.156.6.9702087; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Kullnig-Gradinger CM, 2002, MYCOL RES, V106, P757, DOI 10.1017/S0953756202006172; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larios JM, 2001, J BIOL CHEM, V276, P17437, DOI 10.1074/jbc.M100426200; Linder MB, 2005, FEMS MICROBIOL REV, V29, P877, DOI 10.1016/j.femsre.2005.01.004; Logan SM, 2006, MICROBIOL-SGM, V152, P1249, DOI 10.1099/mic.0.28735-0; Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006; Mattinen ML, 2008, J BIOTECHNOL, V133, P395, DOI 10.1016/j.jbiotec.2007.10.009; Mou Z, 2003, CELL, V113, P935, DOI 10.1016/S0092-8674(03)00429-X; Nimchuk Z, 2003, ANNU REV GENET, V37, P579, DOI 10.1146/annurev.genet.37.110801.142628; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; PAN SC, 1995, INFECT IMMUN, V63, P3994, DOI 10.1128/IAI.63.10.3994-4002.1995; Paul R, 2007, J BIOL CHEM, V282, P29170, DOI 10.1074/jbc.M704702200; Pazzagli L, 1999, J BIOL CHEM, V274, P24959, DOI 10.1074/jbc.274.35.24959; *PE APPL BIOS, 2001, SEQ DET US B, V2, P1; Penas MM, 1998, APPL ENVIRON MICROB, V64, P4028; Pozo MJ, 2004, J PLANT GROWTH REGUL, V23, P211, DOI 10.1007/s00344-004-003105; Ramonell KM, 2002, MOL PLANT PATHOL, V3, P301, DOI 10.1046/j.1364-3703.2002.00123.x; RENART J, 1984, METHOD ENZYMOL, V104, P455; REYMOND P, 1995, P NATL ACAD SCI USA, V92, P4145, DOI 10.1073/pnas.92.10.4145; Seidl V, 2006, FEBS J, V273, P4346, DOI 10.1111/j.1742-4658.2006.05435.x; Shoresh M, 2005, PHYTOPATHOLOGY, V95, P76, DOI 10.1094/PHYTO-95-0076; Sukno SA, 2008, APPL ENVIRON MICROB, V74, P823, DOI 10.1128/AEM.01165-07; Taguchi F, 2003, PLANT CELL PHYSIOL, V44, P342, DOI 10.1093/pcp/pcg042; Takeuchi K, 2003, J BACTERIOL, V185, P6658, DOI 10.1128/JB.185.22.6658-6665.2003; Takeuchi K, 2007, J BACTERIOL, V189, P6945, DOI 10.1128/JB.00500-07; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Torkkeli M, 2002, BIOPHYS J, V83, P2240, DOI 10.1016/S0006-3495(02)73984-2; Vallad GE, 2004, CROP SCI, V44, P1920, DOI 10.2135/cropsci2004.1920; Viterbo A, 2007, MOL PLANT PATHOL, V8, P737, DOI 10.1111/J.1364-3703.2007.00430.X; Vogel H.J., 1956, MICROBIAL GENET B, V13, P42; Wayne N, 2007, J BIOL CHEM, V282, P35386, DOI 10.1074/jbc.M703844200; Weaver M, 2005, BIOCONTROL SCI TECHN, V15, P847, DOI 10.1080/09583150500187108; WESSELS JGH, 1994, ANNU REV PHYTOPATHOL, V32, P413, DOI 10.1146/annurev.py.32.090194.002213; Wilson LM, 2002, MOL PLANT PATHOL, V3, P487, DOI 10.1046/j.1364-3703.2002.00144.x; Wosten HAB, 2001, ANNU REV MICROBIOL, V55, P625, DOI 10.1146/annurev.micro.55.1.625; Yedidia I, 2003, APPL ENVIRON MICROB, V69, P7343, DOI 10.1128/AEM.69.12.7343-7353.2003; Zhang H, 2003, J BIOL CHEM, V278, P24078, DOI 10.1074/jbc.M302051200; Ziouzenkova O, 1999, J BIOL CHEM, V274, P18916, DOI 10.1074/jbc.274.27.18916	59	83	87	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19804	19815		10.1074/jbc.M802724200	http://dx.doi.org/10.1074/jbc.M802724200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18487198	hybrid			2022-12-25	WOS:000257387600064
J	Yoda, A; Toyoshima, K; Watanabe, Y; Onishi, N; Hazaka, Y; Tsukuda, Y; Tsukada, J; Kondo, T; Tanaka, Y; Minami, Y				Yoda, Akinori; Toyoshima, Kyoko; Watanabe, Yasuhide; Onishi, Nobuyuki; Hazaka, Yuki; Tsukuda, Yusuke; Tsukada, Junichi; Kondo, Takeshi; Tanaka, Yoshiya; Minami, Yasuhiro			Arsenic trioxide augments Chk2/p53-mediated apoptosis by inhibiting oncogenic Wip1 phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE PATHWAY; DNA-DAMAGE-RESPONSE; CHK2 KINASE; IN-VITRO; HEMATOLOGIC MALIGNANCIES; GENOMIC INSTABILITY; SIGNALING PATHWAYS; DEPENDENT PATHWAY; DOWN-REGULATION; CELL APOPTOSIS	The oncogenic Wip1 phosphatase (PPM1D) is induced upon DNA damage in a p53-dependent manner and is required for inactivation or suppression of DNA damage-induced cell cycle checkpoint arrest and of apoptosis by dephosphorylating and inactivating phosphorylated Chk2, Chk1, and ATM kinases. It has been reported that arsenic trioxide (ATO), a potent cancer chemotherapeutic agent, in particular for acute promyelocytic leukemia, activates the Chk2/p53 pathway, leading to apoptosis. ATO is also known to activate the p38 MAPK/p53 pathway. Here we show that phosphatase activities of purified Wip1 toward phosphorylated Chk2 and p38 in vitro are inhibited by ATO in a dose-dependent manner. Furthermore, DNA damage-induced phosphorylation of Chk2 and p38 in cultured cells is suppressed by ectopic expression of Wip1, and this Wip1-mediated suppression can be restored by the presence of ATO. We also show that treatment of acute promyelocytic leukemia cells with ATO resulted in induction of phosphorylation and activation of Chk2 and p38 MAPK, which are required for ATO-induced apoptosis. Importantly, this ATO-induced activation of Chk2/p53 and p38 MAPK/p53 apoptotic pathways can be enhanced by siRNA-mediated suppression of Wip1 expression, further indicating that ATO inhibits Wip1 phosphatase in vivo. These results exemplify that Wip1 is a direct molecular target of ATO.	[Yoda, Akinori; Toyoshima, Kyoko; Watanabe, Yasuhide; Onishi, Nobuyuki; Hazaka, Yuki; Tsukuda, Yusuke; Minami, Yasuhiro] Kobe Univ, Grad Sch Med, Fac Med Sci, Dept Physiol & Cell Biol,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Tanaka, Yoshiya] Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 1, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan; [Tsukuda, Yusuke] Univ Occupat & Environm Hlth, Sch Med, Ctr Canc Chemotherapy, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan; [Kondo, Takeshi] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol & Hematol, Kita Ku, Sapporo, Hokkaido 0608638, Japan	Kobe University; University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan; Hokkaido University	Minami, Y (corresponding author), Kobe Univ, Grad Sch Med, Fac Med Sci, Dept Physiol & Cell Biol,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	minami@kobe-u.ac.jp	Kondo, Takeshi/G-2103-2012; ONISHI, Nobuyuki/L-6296-2013	Kondo, Takeshi/0000-0001-7455-5824; 				Abe Y, 2000, J BIOL CHEM, V275, P21525, DOI 10.1074/jbc.M909629199; Ahn J, 2004, DNA REPAIR, V3, P1039, DOI 10.1016/j.dnarep.2004.03.033; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Cavigelli M, 1996, EMBO J, V15, P6269, DOI 10.1002/j.1460-2075.1996.tb01017.x; Chen GQ, 1997, BLOOD, V89, P3345; Chen GQ, 1996, BLOOD, V88, P1052; Chen YC, 1998, J CELL PHYSIOL, V177, P324, DOI 10.1002/(SICI)1097-4652(199811)177:2<324::AID-JCP14>3.0.CO;2-9; Chen YH, 2004, DNA REPAIR, V3, P1025, DOI 10.1016/j.dnarep.2004.03.003; Cheng YH, 2006, ARCH TOXICOL, V80, P310, DOI 10.1007/s00204-005-0045-1; Choi J, 2002, MOL CELL BIOL, V22, P1094, DOI 10.1128/MCB.22.4.1094-1105.2002; Chouchane S, 2001, CHEM RES TOXICOL, V14, P517, DOI 10.1021/tx000123x; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; Dai J, 1999, BLOOD, V93, P268, DOI 10.1182/blood.V93.1.268.401a21_268_277; Dilda PJ, 2007, CANCER TREAT REV, V33, P542, DOI 10.1016/j.ctrv.2007.05.001; Douer D, 2005, J CLIN ONCOL, V23, P2396, DOI 10.1200/JCO.2005.10.217; Eyfjord JE, 2005, MUTAT RES-FUND MOL M, V592, P18, DOI 10.1016/j.mrfmmm.2005.05.010; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Fjeld CC, 1999, J BIOL CHEM, V274, P20336, DOI 10.1074/jbc.274.29.20336; Fujimoto H, 2006, CELL DEATH DIFFER, V13, P1170, DOI 10.1038/sj.cdd.4401801; Giafis N, 2006, CANCER RES, V66, P6763, DOI 10.1158/0008-5472.CAN-05-3699; Harrison M, 2004, TRENDS MOL MED, V10, P359, DOI 10.1016/j.molmed.2004.06.010; Hirasawa A, 2003, CLIN CANCER RES, V9, P1995; Iwama K, 2001, INT J CANCER, V92, P518, DOI 10.1002/ijc.1220; Jing YK, 1999, BLOOD, V94, P2102, DOI 10.1182/blood.V94.6.2102; Joe YS, 2006, J BIOL CHEM, V281, P28764, DOI 10.1074/jbc.M604392200; Kani S, 2007, GENES CELLS, V12, P919, DOI 10.1111/j.1365-2443.2007.01100.x; Kitamura K, 2000, LEUKEMIA, V14, P1743, DOI 10.1038/sj.leu.2401900; LEONARD A, 1980, MUTAT RES, V75, P49, DOI 10.1016/0165-1110(80)90027-5; Li J, 2002, NAT GENET, V31, P133, DOI 10.1038/ng888; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Lu J, 2007, P NATL ACAD SCI USA, V104, P12288, DOI 10.1073/pnas.0701549104; Lu XB, 2005, GENE DEV, V19, P1162, DOI 10.1101/gad.1291305; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; McGowan CH, 2004, CURR OPIN CELL BIOL, V16, P629, DOI 10.1016/j.ceb.2004.09.005; Miller WH, 2002, ONCOLOGIST, V7, P14; Miller WH, 2002, CANCER RES, V62, P3893; MINAMI Y, 1991, J BIOL CHEM, V266, P9222; Motoyama N, 2004, CURR OPIN GENET DEV, V14, P11, DOI 10.1016/j.gde.2003.12.003; Oishi I, 1998, MECH DEVELOP, V71, P49, DOI 10.1016/S0925-4773(97)00200-1; Oliva-Trastoy M, 2007, ONCOGENE, V26, P1449, DOI 10.1038/sj.onc.1209927; Platanias LC, 2003, BLOOD, V101, P4667, DOI 10.1182/blood-2002-12-3647; Saito-Ohara F, 2003, CANCER RES, V63, P1876; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Sanchez-Prieto R, 2000, CANCER RES, V60, P2464; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Shim MJ, 2002, J BIOCHEM MOL BIOL, V35, P377; Shreeram S, 2006, MOL CELL, V23, P757, DOI 10.1016/j.molcel.2006.07.010; Soignet SL, 2001, J CLIN ONCOL, V19, P3852, DOI 10.1200/JCO.2001.19.18.3852; Takekawa M, 1998, EMBO J, V17, P4744, DOI 10.1093/emboj/17.16.4744; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; Traven A, 2005, BIOESSAYS, V27, P397, DOI 10.1002/bies.20204; Tseng CH, 2004, TOXICOL APPL PHARM, V197, P67, DOI 10.1016/j.taap.2004.02.009; Verma A, 2002, J BIOL CHEM, V277, P44988, DOI 10.1074/jbc.M207176200; Ward IM, 2001, J BIOL CHEM, V276, P47755, DOI 10.1074/jbc.C100587200; Yih LH, 2000, CANCER RES, V60, P6346; Yoda A, 2006, J BIOL CHEM, V281, P24847, DOI 10.1074/jbc.M600403200; Zhang TD, 2001, ONCOGENE, V20, P7146, DOI 10.1038/sj.onc.1204762	60	47	54	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 4	2008	283	27					18969	18979		10.1074/jbc.M800560200	http://dx.doi.org/10.1074/jbc.M800560200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	319LR	18482988	hybrid			2022-12-25	WOS:000257165600053
J	Beck, IM; Ruckert, R; Brandt, K; Mueller, MS; Sadowski, T; Brauer, R; Schirmacher, P; Mentlein, R; Sedlacek, R				Beck, Inken M.; Rueckert, Rene; Brandt, Katja; Mueller, Markus S.; Sadowski, Thorsten; Brauer, Rena; Schirmacher, Peter; Mentlein, Rolf; Sedlacek, Radislav			MMP19 Is Essential for T Cell Development and T Cell-Mediated Cutaneous Immune Responses	PLOS ONE			English	Article								Matrix metalloproteinase-19 (MMP19) affects cell proliferation, adhesion, and migration in vitro but its physiological role in vivo is poorly understood. To determine the function of MMP19, we generated mice deficient for MMP19 by disrupting the catalytic domain of mmp19 gene. Although MMP19-deficient mice do not show overt developmental and morphological abnormalities they display a distinct physiological phenotype. In a model of contact hypersensitivity (CHS) MMP19-deficient mice showed impaired T cell-mediated immune reaction that was characterized by limited influx of inflammatory cells, low proliferation of keratinocytes, and reduced number of activated CD8(+) T cells in draining lymph nodes. In the inflamed tissue, the low number of CD8(+) T cells in MMP19-deficient mice correlated with low amounts of proinflammatory cytokines, especially lymphotactin and interferon-inducible T cell a chemoattractant (I-TAC). Further analyses showed that T cell populations in the blood of immature, unsensitized mice were diminished and that this alteration originated from an altered maturation of thymocytes. In the thymus, thymocytes exhibited low proliferation rates and the number of CD4(+) CD8(+) double-positive cells was remarkably augmented. Based on the phenotype of MMP19-deficient mice we propose that MMP19 is an important factor in cutaneous immune responses and influences the development of T cells.	[Beck, Inken M.] Inst Biotechnol, Prague, Czech Republic; [Beck, Inken M.; Sedlacek, Radislav] Inst Mol Genet, Prague, Czech Republic; [Rueckert, Rene; Brandt, Katja] Res Ctr Borstel, Dept Immunol & Cell Biol, Borstel, Germany; [Mueller, Markus S.] Swiss Trop Inst, Basel, Switzerland; [Sadowski, Thorsten] Sanofi Aventis Deutschland GmbH, Frankfurt, Germany; [Brauer, Rena; Sedlacek, Radislav] Univ Kiel, Dept Biochem, Kiel, Germany; [Schirmacher, Peter] Univ Hosp Heidelberg, Inst Pathol, Heidelberg, Germany; [Mentlein, Rolf] Univ Kiel, Dept Anat, Kiel, Germany	Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Forschungszentrum Borstel; University of Basel; Swiss Tropical & Public Health Institute; Sanofi-Aventis; University of Kiel; Ruprecht Karls University Heidelberg; University of Kiel	Beck, IM (corresponding author), Inst Biotechnol, Prague, Czech Republic.	radislav.sedlacek@img.cas.cz	Mentlein, Rolf/B-1613-2010; Sedlacek, Radislav/G-4408-2014; Beck, Inken/G-4416-2014	Mentlein, Rolf/0000-0002-6350-3911; Brauer, Rena/0000-0002-5900-4853	DFG [SE 878/2-1, SFB617-A8]	DFG(German Research Foundation (DFG))	This work was supported by grants SE 878/2-1 and SFB617-A8 (R.S.) from DFG. The findings and conclusions of this report are those of the authors and do not represent the views of DFG. The authors have no conflicting financial interests.	Akiba H, 2002, J IMMUNOL, V168, P3079, DOI 10.4049/jimmunol.168.6.3079; Aoudjit F, 1997, INT J CANCER, V71, P71, DOI 10.1002/(SICI)1097-0215(19970328)71:1<71::AID-IJC13>3.3.CO;2-O; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Behera AK, 2005, INFECT IMMUN, V73, P126, DOI 10.1128/IAI.73.1.126-134.2005; Blachere NE, 2006, J IMMUNOL, V176, P7288, DOI 10.4049/jimmunol.176.12.7288; Bouloc A, 1998, J INVEST DERMATOL, V111, P44, DOI 10.1046/j.1523-1747.1998.00236.x; BOUR H, 1995, EUR J IMMUNOL, V25, P3006, DOI 10.1002/eji.1830251103; Brandt K, 2003, J INVEST DERMATOL, V121, P1379, DOI 10.1046/j.1523-1747.2003.12603.x; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Caldelari R, 2000, J INVEST DERMATOL, V114, P1064, DOI 10.1046/j.1523-1747.2000.00960-4.x; Cavani A, 2001, TRENDS IMMUNOL, V22, P118, DOI 10.1016/S1471-4906(00)01815-9; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; Cossins J, 1996, BIOCHEM BIOPH RES CO, V228, P494, DOI 10.1006/bbrc.1996.1688; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dilulio NA, 1999, EUR J IMMUNOL, V29, P3485, DOI 10.1002/(SICI)1521-4141(199911)29:11<3485::AID-IMMU3485>3.0.CO;2-B; Djonov V, 2001, J PATHOL, V195, P147, DOI 10.1002/path.927; GOCINSKI BL, 1990, J IMMUNOL, V144, P4121; Goebeler M, 2001, AM J PATHOL, V158, P431, DOI 10.1016/S0002-9440(10)63986-7; Gorbachev AV, 2001, IMMUNOL RES, V24, P69, DOI 10.1385/IR:24:1:69; Grabbe S, 1998, IMMUNOL TODAY, V19, P37, DOI 10.1016/S0167-5699(97)01186-9; Haidl ID, 2006, SCAND J IMMUNOL, V64, P280, DOI 10.1111/j.1365-3083.2006.01820.x; Held-Feindt J, 2006, INT J CANCER, V118, P55, DOI 10.1002/ijc.21258; Hogan B, 1994, MANIPULATING MOUSE E; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Jost M, 2006, CANCER RES, V66, P5234, DOI 10.1158/0008-5472.CAN-05-4315; KELNER GS, 1994, SCIENCE, V266, P1395, DOI 10.1126/science.7973732; Kolb C, 1999, EXP CELL RES, V250, P122, DOI 10.1006/excr.1999.4493; Kolb C, 1997, IMMUNOL LETT, V57, P83, DOI 10.1016/S0165-2478(97)00057-6; Locati M, 2002, J IMMUNOL, V168, P3557, DOI 10.4049/jimmunol.168.7.3557; Lopez CB, 1998, INT ARCH ALLERGY IMM, V117, P194, DOI 10.1159/000024010; MACATONIA SE, 1986, IMMUNOLOGY, V59, P509; Masuda K, 2005, CLIN EXP IMMUNOL, V140, P213, DOI 10.1111/j.1365-2249.2005.02752.x; Mauch S, 2002, J IMMUNOL, V168, P1244, DOI 10.4049/jimmunol.168.3.1244; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Mizumoto N, 2001, IMMUNOBIOLOGY, V204, P477, DOI 10.1078/0171-2985-00057; Mohan K, 2005, EUR J IMMUNOL, V35, P1702, DOI 10.1002/eji.200425885; Moodycliffe AM, 2000, J EXP MED, V191, P2011, DOI 10.1084/jem.191.11.2011; Mueller MS, 2000, GENE, V252, P27, DOI 10.1016/S0378-1119(00)00236-5; Mueller MS, 2000, GENE, V256, P101, DOI 10.1016/S0378-1119(00)00369-3; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nakae S, 2003, INT IMMUNOL, V15, P251, DOI 10.1093/intimm/dxg028; Nakae S, 2001, INT IMMUNOL, V13, P1471, DOI 10.1093/intimm/13.12.1471; NAKAMURA K, 1995, J INVEST DERMATOL, V105, P635, DOI 10.1111/1523-1747.ep12324061; Odaka C, 2005, J IMMUNOL, V174, P846, DOI 10.4049/jimmunol.174.2.846; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Pendas AM, 2004, MOL CELL BIOL, V24, P5304, DOI 10.1128/MCB.24.12.5304-5313.2004; Pendas AM, 1997, J BIOL CHEM, V272, P4281, DOI 10.1074/jbc.272.7.4281; PIGUET PF, 1991, J EXP MED, V173, P673, DOI 10.1084/jem.173.3.673; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Ramanathan M, 2001, J NEUROIMMUNOL, V116, P213, DOI 10.1016/S0165-5728(01)00308-3; Sadowski T, 2005, CELL MOL LIFE SCI, V62, P870, DOI 10.1007/s00018-005-4478-8; Sadowski T, 2003, MOL BIOL CELL, V14, P4569, DOI 10.1091/mbc.E03-01-0009; Sadowski T, 2003, J INVEST DERMATOL, V121, P989, DOI 10.1046/j.1523-1747.2003.12526.x; Saint-Mezard P, 2005, J INVEST DERMATOL, V124, P562, DOI 10.1111/j.0022-202X.2005.23567.x; Saint-Mezard P, 2003, J INVEST DERMATOL, V120, P641, DOI 10.1046/j.1523-1747.2003.12093.x; Sauty A, 2001, J IMMUNOL, V167, P7084, DOI 10.4049/jimmunol.167.12.7084; Savino W, 2002, TRENDS IMMUNOL, V23, P305, DOI 10.1016/S1471-4906(02)02224-X; Schroen DJ, 1996, CELL IMMUNOL, V167, P141, DOI 10.1006/cimm.1996.0018; Sedlacek R, 1998, IMMUNOBIOLOGY, V198, P408, DOI 10.1016/S0171-2985(98)80049-1; Shimizu T, 2003, EUR J IMMUNOL, V33, P1478, DOI 10.1002/eji.200323751; Stracke JO, 2000, J BIOL CHEM, V275, P14809, DOI 10.1074/jbc.275.20.14809; Stracke JO, 2000, FEBS LETT, V478, P52, DOI 10.1016/S0014-5793(00)01819-6; Suto H, 2006, J IMMUNOL, V176, P4102, DOI 10.4049/jimmunol.176.7.4102; Takeshita K, 2004, INT IMMUNOL, V16, P685, DOI 10.1093/intimm/dxh073; Tensen CP, 1999, J INVEST DERMATOL, V112, P716, DOI 10.1046/j.1523-1747.1999.00581.x; Titz B, 2004, CELL MOL LIFE SCI, V61, P1826, DOI 10.1007/s00018-004-4105-0; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; van Horssen J, 2006, NEUROPATH APPL NEURO, V32, P585, DOI 10.1111/j.1365-2990.2006.00766.x; Van Lint P, 2007, J LEUKOCYTE BIOL, V82, P1375, DOI 10.1189/jlb.0607338; Vivinus-Nebot M, 2004, J IMMUNOL, V172, P1397, DOI 10.4049/jimmunol.172.3.1397; Wang BH, 2000, J IMMUNOL, V165, P6783, DOI 10.4049/jimmunol.165.12.6783; Warner RL, 2001, AM J PATHOL, V158, P2139, DOI 10.1016/S0002-9440(10)64685-8; Warner RL, 2001, AM J RESP CELL MOL, V24, P537, DOI 10.1165/ajrcmb.24.5.4160; Xu H, 1996, J EXP MED, V183, P1001, DOI 10.1084/jem.183.3.1001	75	36	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2343	10.1371/journal.pone.0002343	http://dx.doi.org/10.1371/journal.pone.0002343			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523579	Green Published, Green Submitted, gold			2022-12-25	WOS:000262614300036
J	Singh, LN; Hannenhalli, S				Singh, Larry N.; Hannenhalli, Sridhar			Functional Diversification of Paralogous Transcription Factors via Divergence in DNA Binding Site Motif and in Expression	PLOS ONE			English	Article							GENE-EXPRESSION; DUPLICATE GENES; EVOLUTION; MOUSE; SELECTION; PROFILES; DATABASE; PATTERN; FOXA2; RATES	Background: Gene duplication is a major driver of evolutionary innovation as it allows for an organism to elaborate its existing biological functions via specialization or diversification of initially redundant gene paralogs. Gene function can diversify in several ways. Transcription factor gene paralogs in particular, can diversify either by changes in their tissue-specific expression pattern or by changes in the DNA binding sitemotif recognized by their protein product, which in turn alters their gene targets. The relationship between these two modes of functional diversification of transcription factor paralogs has not been previously investigated, and is essential for understanding adaptive evolution of transcription factor gene families. Findings: Based on a large set of human paralogous transcription factor pairs, we show that when the DNA binding site motifs of transcription factor paralogs are similar, the expressions of the genes that encode the paralogs have diverged, so in general, at most one of the paralogs is highly expressed in a tissue. Moreover, paralogs with diverged DNA binding site motifs tend to be diverged in their function. Conversely, two paralogs that are highly expressed in a tissue tend to have dissimilar DNA binding site motifs. We have also found that in general, within a paralogous family, tissue-specific decrease in gene expression is more frequent than what is expected by chance. Conclusions: While previous investigations of paralogous gene diversification have only considered coding sequence divergence, by explicitly quantifying divergence in DNA binding site motif, our work presents a new paradigm for investigating functional diversification. Consistent with evolutionary expectation, our quantitative analysis suggests that paralogous transcription factors have survived extinction in part, either through diversification of their DNA binding site motifs or through alterations in their tissue-specific expression levels.	[Singh, Larry N.; Hannenhalli, Sridhar] Univ Penn, Dept Genet, Penn Ctr Bioinformat, Philadelphia, PA 19104 USA	University of Pennsylvania	Singh, LN (corresponding author), Univ Penn, Dept Genet, Penn Ctr Bioinformat, Philadelphia, PA 19104 USA.	sridharh@pcbi.upenn.edu	Singh, Larry N./AAG-6880-2021	Singh, Larry N./0000-0002-2478-5864	NIH [R21]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	NIH R21 (PI Hannenhalli)	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Bartolome C, 2005, GENETICS, V169, P1495, DOI 10.1534/genetics.104.033068; Bouchard M, 2002, GENE DEV, V16, P2958, DOI 10.1101/gad.240102; Castillo-Davis CI, 2004, GENOME RES, V14, P1530, DOI 10.1101/gr.2662504; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chi N, 2002, TRENDS GENET, V18, P41, DOI 10.1016/S0168-9525(01)02594-X; Conant GC, 2003, GENOME RES, V13, P2052, DOI 10.1101/gr.1252603; CONOVER W. J, 1980, PRACTICAL NONPARAMET; Gaut BS, 1997, P NATL ACAD SCI USA, V94, P6809, DOI 10.1073/pnas.94.13.6809; Gu X, 2007, P NATL ACAD SCI USA, V104, P2779, DOI 10.1073/pnas.0610797104; Gu ZL, 2002, TRENDS GENET, V18, P609, DOI 10.1016/S0168-9525(02)02837-8; Hannenhalli S, 2006, CIRCULATION, V114, P1269, DOI 10.1161/CIRCULATIONAHA.106.632430; Harrison AP, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-195; Hughes A.L., 1999, ADAPTIVE EVOLUTION G; HUGHES MK, 1993, MOL BIOL EVOL, V10, P1360; Irizarry RA, 2006, BIOINFORMATICS, V22, P789, DOI 10.1093/bioinformatics/btk046; Jordan IK, 2005, GENE, V345, P119, DOI 10.1016/j.gene.2004.11.034; Lantz KA, 2004, J CLIN INVEST, V114, P512, DOI 10.1172/JCI200421149; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Liao BY, 2006, MOL BIOL EVOL, V23, P2072, DOI 10.1093/molbev/msl076; Liao BY, 2006, MOL BIOL EVOL, V23, P530, DOI 10.1093/molbev/msj054; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Mahony S, 2007, PLOS COMPUT BIOL, V3, P578, DOI 10.1371/journal.pcbi.0030061; Makova KD, 2003, GENOME RES, V13, P1638, DOI 10.1101/gr.1133803; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Nadeau JH, 1997, GENETICS, V147, P1259; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Ohno S., 1970, EVOLUTION GENE DUPLI; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Shiu SH, 2005, PLANT PHYSIOL, V139, P18, DOI 10.1104/pp.105.065110; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Vavouri T, 2006, TRENDS GENET, V22, P5, DOI 10.1016/j.tig.2005.10.005; Wagner A, 2002, GENOME BIOL, V3; Wan HJ, 2005, J BIOL CHEM, V280, P13809, DOI 10.1074/jbc.M414122200; Wilcox RR, 2001, FUNDAMENTALS MODERN; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Yanai I, 2004, OMICS, V8, P15, DOI 10.1089/153623104773547462; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yu H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-194; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	43	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2345	10.1371/journal.pone.0002345	http://dx.doi.org/10.1371/journal.pone.0002345			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523562	gold, Green Published, Green Submitted			2022-12-25	WOS:000262614300038
J	Sordino, P; Andreakis, N; Brown, ER; Leccia, NI; Squarzoni, P; Tarallo, R; Alfano, C; Caputi, L; D'Ambrosio, P; Daniele, P; D'Aniello, E; D'Aniello, S; Maiella, S; Miraglia, V; Russo, MT; Sorrenti, G; Branno, M; Cariello, L; Cirino, P; Locascio, A; Spagnuolo, A; Zanetti, L; Ristoratore, F				Sordino, Paolo; Andreakis, Nikos; Brown, Euan R.; Leccia, Nicola I.; Squarzoni, Paola; Tarallo, Raffaella; Alfano, Christian; Caputi, Luigi; D'Ambrosio, Palmira; Daniele, Paola; D'Aniello, Enrico; D'Aniello, Salvatore; Maiella, Sylvie; Miraglia, Valentina; Russo, Monia Teresa; Sorrenti, Gerarda; Branno, Margherita; Cariello, Lucio; Cirino, Paola; Locascio, Annamaria; Spagnuolo, Antonietta; Zanetti, Laura; Ristoratore, Filomena			Natural Variation of Model Mutant Phenotypes in Ciona intestinalis	PLOS ONE			English	Article							NERVOUS-SYSTEM; GERMLINE TRANSGENESIS; MICROSATELLITE LOCI; ALLELIC FREQUENCIES; TRANSPOSON MINOS; SENSORY ORGANS; POPULATIONS; MUTATIONS; LARVA; TRANSMISSION	Background: The study of ascidians (Chordata, Tunicata) has made a considerable contribution to our understanding of the origin and evolution of basal chordates. To provide further information to support forward genetics in Ciona intestinalis, we used a combination of natural variation and neutral population genetics as an approach for the systematic identification of new mutations. In addition to the significance of developmental variation for phenotype-driven studies, this approach can encompass important implications in evolutionary and population biology. Methodology/Principal Findings: Here, we report a preliminary survey for naturally occurring mutations in three geographically interconnected populations of C. intestinalis. The influence of historical, geographical and environmental factors on the distribution of abnormal phenotypes was assessed by means of 12 microsatellites. We identified 37 possible mutant loci with stereotyped defects in embryonic development that segregate in a way typical of recessive alleles. Local populations were found to differ in genetic organization and frequency distribution of phenotypic classes. Conclusions/Significance: Natural genetic polymorphism of C. intestinalis constitutes a valuable source of phenotypes for studying embryonic development in ascidians. Correlating genetic structure and the occurrence of abnormal phenotypes is a crucial focus for understanding the selective forces that shape natural finite populations, and may provide insights of great importance into the evolutionary mechanisms that generate animal diversity.	[Sordino, Paolo; Andreakis, Nikos; Leccia, Nicola I.; Squarzoni, Paola; Tarallo, Raffaella; Alfano, Christian; Caputi, Luigi; D'Ambrosio, Palmira; Daniele, Paola; D'Aniello, Enrico; D'Aniello, Salvatore; Maiella, Sylvie; Miraglia, Valentina; Russo, Monia Teresa; Sorrenti, Gerarda; Branno, Margherita; Cariello, Lucio; Locascio, Annamaria; Spagnuolo, Antonietta; Zanetti, Laura; Ristoratore, Filomena] Staz Zool Anton Dohrn, Biochem & Mol Biol Lab, Naples, Italy; [Brown, Euan R.] Staz Zoolo Anton Dohrn, Lab Neurobiol, Naples, Italy; [Leccia, Nicola I.] G Rummo Hosp, Benevento, Italy; [Alfano, Christian] Tigem Telethon Inst Genet & Med, Naples, Italy; [D'Aniello, Salvatore] Univ Barcelona, Dept Genet, Barcelona, Spain; [Maiella, Sylvie] Inst Pasteur, Paris, France; [Sorrenti, Gerarda] CNR, Inst Marine Sci, Lesina, Italy; [Cirino, Paola] Staz Zool Anton Dohrn, Serv Marine Resources Res, Naples, Italy	Stazione Zoologica Anton Dohrn di Napoli; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Barcelona; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR); Stazione Zoologica Anton Dohrn di Napoli	Sordino, P (corresponding author), Staz Zool Anton Dohrn, Biochem & Mol Biol Lab, Naples, Italy.	sordino@szn.it	caputi, Luigi/H-9304-2012; Daniele, Paola/AAB-9604-2019; Andreakis, Nikos/A-4010-2010; Locascio, Annamaria/E-8714-2015; Russo, Monia Teresa/AGI-3134-2022; Brown, Euan R/A-5558-2008; Brown, Euan Robert/I-2389-2019; russo, monia t/Q-5774-2016; CNR, Ismar/P-1247-2014	Daniele, Paola/0000-0001-5640-4184; Andreakis, Nikos/0000-0001-7120-4279; Locascio, Annamaria/0000-0001-6956-2157; Brown, Euan R/0000-0002-5995-834X; Brown, Euan Robert/0000-0002-5995-834X; russo, monia t/0000-0003-2001-5384; Caputi, Luigi/0000-0002-5724-1943; Cirino, Paola/0000-0002-0688-4199; Spagnuolo, Antonietta/0000-0001-6660-071X; D'Aniello, Enrico/0000-0002-2627-0477; CNR, Ismar/0000-0001-5351-1486	European Union; Italian Ministry of University and Research [24/C08c]	European Union(European Commission); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants from the European Union (Network of Excellence, Marine Genomics Europe, WP36 The genetic identity of species) (PS, NA) and the Italian Ministry of University and Research (24/C08c) (PS, GS).	Andreakis N, 2007, MOL ECOL NOTES, V7, P610, DOI 10.1111/j.1471-8286.2006.01649.x; Awazu S, 2007, GENESIS, V45, P307, DOI 10.1002/dvg.20290; Berrill N. J., 1950, TUNICATA ACCOUNT BRI; Berrill NJ, 1931, PHILOS T R SOC LON B, V219, P281, DOI 10.1098/rstb.1931.0006; Beutler B, 2007, NAT IMMUNOL, V8, P659, DOI 10.1038/ni0707-659; Boffelli D, 2004, GENOME RES, V14, P2406, DOI 10.1101/gr.3199704; Brown ER, 2005, EUR J NEUROSCI, V22, P2541, DOI 10.1111/j.1460-9568.2005.04420.x; Caputi L, 2007, P NATL ACAD SCI USA, V104, P9364, DOI 10.1073/pnas.0610158104; Caputi L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-39; Charlesworth B, 1998, GENETICA, V102-3, P3, DOI 10.1023/A:1017066304739; CHARLESWORTH B, 1993, GENETICS, V134, P1289; CIRINO P, 2002, LAB CULTURE ASCIDIAN; Colson I, 2002, MOL ECOL, V11, P1311, DOI 10.1046/j.1365-294X.2002.01549.x; De Santis R, 2001, BIOLOGY OF ASCIDIANS, P14; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Deschet K, 2004, CURR BIOL, V14, pR408, DOI 10.1016/j.cub.2004.05.029; Deschet K, 2003, GENESIS, V35, P248, DOI 10.1002/gene.10195; Fields S, 2005, SCIENCE, V307, P1885, DOI 10.1126/science.1108872; Haffter P, 1996, DEVELOPMENT, V123, P1; Hendrickson C, 2004, METHOD CELL BIOL, V74, P143; Iannelli F, 2007, TRENDS GENET, V23, P419, DOI 10.1016/j.tig.2007.07.001; Ikuta T, 2007, DEV BIOL, V312, P631, DOI 10.1016/j.ydbio.2007.10.005; Imai JH, 2007, J COMP NEUROL, V501, P316, DOI 10.1002/cne.21246; Jeffery WR, 2004, EVOL DEV, V6, P170, DOI 10.1111/j.1525-142X.2004.04022.x; Jiang D, 2005, CURR BIOL, V15, P79; Jiang D, 2005, J EXP BIOL, V208, P433, DOI 10.1242/jeb.01420; Kano S, 2001, MAR BIOTECHNOL, V3, P58, DOI 10.1007/s101260000048; Kano S, 2006, ZOOL SCI, V23, P31, DOI 10.2108/zsj.23.31; KIMURA M, 1978, P NATL ACAD SCI USA, V75, P2868, DOI 10.1073/pnas.75.6.2868; KIMURA M, 1975, P NATL ACAD SCI USA, V72, P2761, DOI 10.1073/pnas.72.7.2761; Kowalewsky A., 1866, Mem. Acad. Imp. St. Petersbourg, Vtom. x, P1; Locascio A, 1999, DEVELOPMENT, V126, P4737; Matsumoto M., 1992, Zoological Science (Tokyo), V9, P1304; Matsuoka T, 2005, GENESIS, V41, P67, DOI 10.1002/gene.20096; Matsuoka T, 2004, DEV GROWTH DIFFER, V46, P249; McCune AR, 2002, SCIENCE, V296, P2398, DOI 10.1126/science.1071757; Meinertzhagen IA, 2004, ANNU REV NEUROSCI, V27, P453, DOI 10.1146/annurev.neuro.27.070203.144255; Moody R, 1999, MOL GEN GENET, V262, P199, DOI 10.1007/s004380051075; Nakatani Y, 1999, DEVELOPMENT, V126, P3293; Naranjo SA, 1996, MAR ECOL PROG SER, V144, P119, DOI 10.3354/meps144119; NEI M, 1978, GENETICS, V89, P583; Noramly S, 2005, MECH DEVELOP, V122, P273, DOI 10.1016/j.mod.2004.11.001; OHMORI H, 1977, J PHYSIOL-LONDON, V269, P221, DOI 10.1113/jphysiol.1977.sp011900; PAPADOPOULOU C, 1977, MAR POLLUT BULL, V8, P229, DOI 10.1016/0025-326X(77)90431-3; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; PETERSEN JK, 1995, J EXP MAR BIOL ECOL, V186, P89, DOI 10.1016/0022-0981(94)00157-9; Procaccini G, 2000, MOL ECOL, V9, P1924, DOI 10.1046/j.1365-294x.2000.01071-4.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Riisgard HU, 1998, OPHELIA, V49, P1; Sasakura Y, 2005, P NATL ACAD SCI USA, V102, P15134, DOI 10.1073/pnas.0503640102; Sasakura Y, 2003, P NATL ACAD SCI USA, V100, P7726, DOI 10.1073/pnas.1230736100; Satoh N, 2003, TRENDS GENET, V19, P376, DOI 10.1016/S0168-9525(03)00144-6; Satoh N., 1994, DEV BIOL ASCIDIANS; SCHMIDTKE J, 1980, BIOCHEM GENET, V18, P503, DOI 10.1007/BF00484397; Schultz ST, 1999, P NATL ACAD SCI USA, V96, P11393, DOI 10.1073/pnas.96.20.11393; Shimeld SM, 2006, DEV DYNAM, V235, P1543, DOI 10.1002/dvdy.20792; Small KS, 2007, P NATL ACAD SCI USA, V104, P5698, DOI 10.1073/pnas.0700890104; Sordino P, 2000, SARSIA, V85, P173, DOI 10.1080/00364827.2000.10414567; Sordino P, 2001, PHILOS T R SOC B, V356, P1573, DOI 10.1098/rstb.2001.0919; Stachowicz JJ, 1999, SCIENCE, V286, P1577, DOI 10.1126/science.286.5444.1577; Suzuki MM, 2005, J MOL EVOL, V61, P627, DOI 10.1007/s00239-005-0009-3; TAKAHATA N, 1979, P NATL ACAD SCI USA, V76, P5813, DOI 10.1073/pnas.76.11.5813; Theodorakis CW, 1997, ECOTOXICOLOGY, V6, P335, DOI 10.1023/A:1018695231565; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vinson JP, 2005, GENOME RES, V15, P1127, DOI 10.1101/gr.3722605; Whitehead A, 2003, MOL ECOL, V12, P2817, DOI 10.1046/j.1365-294X.2003.01933.x; Whittaker JR, 1997, AM ZOOL, V37, P237; Zega G, 2006, J EXP BIOL, V209, P3405, DOI 10.1242/jeb.02421	69	18	18	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2344	10.1371/journal.pone.0002344	http://dx.doi.org/10.1371/journal.pone.0002344			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523552	Green Submitted, Green Published, gold			2022-12-25	WOS:000262614300037
J	de Heering, A; Rossion, B				de Heering, Adelaide; Rossion, Bruno			Prolonged Visual Experience in Adulthood Modulates Holistic Face Perception	PLOS ONE			English	Article							OTHER-RACE FACES; OWN-RACE; RECOGNITION; INVERSION; AGE; MEMORY; BIAS	Background: Using the well-known composite illusion as a marker of the holistic perception of faces, we tested how prolonged visual experience with a specific population of faces (4- to 6-year-old children) modulates the face perception system in adulthood. Methodology/Principal Findings: We report a face composite effect that is larger for adult than children faces in a group of adults without experience with children faces ("children-face novices''), while it is of equal magnitude for adults and children faces in a population of preschool teachers ("children-face experts''). When considering preschool teachers only, we observed a significant correlation between the number of years of experience with children faces and the differential face composite effect between children and adults faces. Participants with at least 10 years of qualitative experience with children faces had a larger composite face effect for children than adult faces. Conclusions/Significance: Overall, these observations indicate that even in adulthood face processes can be reshaped qualitatively, presumably to facilitate efficient processing of the differential morphological features of the frequently encountered population of faces.	[de Heering, Adelaide; Rossion, Bruno] Catholic Univ Louvain, Unite Cognit & Dev, B-1348 Louvain, Ottignies, Belgium	Universite Catholique Louvain	de Heering, A (corresponding author), Catholic Univ Louvain, Unite Cognit & Dev, B-1348 Louvain, Ottignies, Belgium.	adelaide.deheering@uclouvain.be; bruno.rossion@uclouvain.be	de Heering, Adelaide/A-6482-2017	de Heering, Adelaide/0000-0001-5843-7406; Rossion, Bruno/0000-0002-1845-3935	Belgian National Fund for Scientific Research (FNRS)	Belgian National Fund for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS)	AH and BR are supported by the Belgian National Fund for Scientific Research (FNRS).	Anastasi JS, 2005, PSYCHON B REV, V12, P1043, DOI 10.3758/BF03206441; CAREY S, 1980, DEV PSYCHOL, V16, P257, DOI 10.1037/0012-1649.16.4.257; de Heering A, 2007, J EXP CHILD PSYCHOL, V96, P57, DOI 10.1016/j.jecp.2006.07.001; FARAH MJ, 1995, J EXP PSYCHOL HUMAN, V21, P628, DOI 10.1037/0096-1523.21.3.628; Goffaux V, 2006, J EXP PSYCHOL HUMAN, V32, P1023, DOI 10.1037/0096-1523.32.4.1023; HOLE GJ, 1994, PERCEPTION, V23, P65, DOI 10.1068/p230065; Kelly DJ, 2007, PSYCHOL SCI, V18, P1084, DOI 10.1111/j.1467-9280.2007.02029.x; KUEFNER D, J EXPT PSYC IN PRESS; Lamont AC, 2005, MEM COGNITION, V33, P1017, DOI 10.3758/BF03193209; Le Grand R, 2004, PSYCHOL SCI, V15, P762, DOI 10.1111/j.0956-7976.2004.00753.x; MALPASS RS, 1969, J PERS SOC PSYCHOL, V13, P330, DOI 10.1037/h0028434; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Michel C, 2006, PSYCHOL SCI, V17, P608, DOI 10.1111/j.1467-9280.2006.01752.x; Michel C, 2006, VIS COGN, V14, P55, DOI 10.1080/13506280500158761; POLK TA, 1995, NATURE, V376, P648, DOI 10.1038/376648a0; RHODES G, 1987, COGNITIVE PSYCHOL, V19, P473, DOI 10.1016/0010-0285(87)90016-8; RHODES G, 1989, BRIT J PSYCHOL, V80, P313, DOI 10.1111/j.2044-8295.1989.tb02323.x; Rossion B, 2008, J VISION, V8, DOI 10.1167/8.4.3; Sangrigoli S, 2004, J CHILD PSYCHOL PSYC, V45, P1219, DOI 10.1111/j.1469-7610.2004.00319.x; Sangrigoli S, 2004, DEVELOPMENTAL SCI, V7, P74, DOI 10.1111/j.1467-7687.2004.00324.x; Sangrigoli S, 2005, PSYCHOL SCI, V16, P440; Schiltz C, 2006, NEUROIMAGE, V32, P1385, DOI 10.1016/j.neuroimage.2006.05.037; Tanaka JW, 2004, COGNITION, V93, pB1, DOI 10.1016/j.cognition.2003.09.011; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; VALENTINE T, 1986, ACTA PSYCHOL, V61, P259, DOI 10.1016/0001-6918(86)90085-5; YOUNG AW, 1987, PERCEPTION, V16, P747, DOI 10.1068/p160747	27	54	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2317	10.1371/journal.pone.0002317	http://dx.doi.org/10.1371/journal.pone.0002317			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	391XW	18509528	Green Published, gold, Green Submitted			2022-12-25	WOS:000262268500045
J	Iwata, Y; Suzuki, K; Wakuda, T; Seki, N; Thanseem, I; Matsuzaki, H; Mamiya, T; Ueki, T; Mikawa, S; Sasaki, T; Suda, S; Yamamoto, S; Tsuchiya, KJ; Sugihara, G; Nakamura, K; Sato, K; Takei, N; Hashimoto, K; Mori, N				Iwata, Yasuhide; Suzuki, Katsuaki; Wakuda, Tomoyasu; Seki, Norihito; Thanseem, Ismail; Matsuzaki, Hideo; Mamiya, Takayoshi; Ueki, Takatoshi; Mikawa, Sumiko; Sasaki, Takeshi; Suda, Shiro; Yamamoto, Shigeyuki; Tsuchiya, Kenji J.; Sugihara, Genichi; Nakamura, Kazuhiko; Sato, Kohji; Takei, Nori; Hashimoto, Kenji; Mori, Norio			Irradiation in Adulthood as a New Model of Schizophrenia	PLOS ONE			English	Article							HIPPOCAMPAL NEUROGENESIS; CELL-PROLIFERATION; STEM-CELL; OBSTETRIC COMPLICATIONS; SPECTRUM DISORDERS; IONIZING-RADIATION; DENTATE GYRUS; BRAIN; MICE; METHAMPHETAMINE	Background: Epidemiological studies suggest that radiation exposure may be a potential risk factor for schizophrenia in adult humans. Here, we investigated whether adult irradiation in rats caused behavioral abnormalities relevant to schizophrenia. Methodology/Principal Findings: A total dose of 15-Gy irradiation in six fractionations during 3 weeks was exposed to the forebrain including the subventricular zone (SVZ) and subgranular zone (SGZ) with male rats in the prone position. Behavioral, immunohistochemical, and neurochemical studies were performed three months after fractionated ionizing irradiation. Three months after fractionated ionizing irradiation, the total numbers of BrdU-positive cells in both the SVZ and SGZ zones of irradiated rats were significantly lower than those of control (sham-irradiated) rats. Hyperactivity after administration of the dopaminergic agonist methamphetamine, but not the N-methyl-D-aspartate (NMDA) receptor antagonist dizocilpine, was significantly enhanced in the irradiated rats although spontaneous locomotion in the irradiated rats was significantly lower than that of controls. Behavioral abnormalities including auditory sensory gating deficits, social interaction deficits, and working memory deficits were observed in the irradiated rats. Conclusion/Significance: The present study suggests that irradiation in adulthood caused behavioral abnormalities relevant to schizophrenia, and that reduction of adult neurogenesis by irradiation may be associated with schizophrenia-like behaviors in rats.	[Iwata, Yasuhide; Suzuki, Katsuaki; Wakuda, Tomoyasu; Suda, Shiro; Nakamura, Kazuhiko; Mori, Norio] Hamamatsu Univ Sch Med, Dept Psychiat & Neurol, Shizuoka, Japan; [Ueki, Takatoshi; Mikawa, Sumiko; Sasaki, Takeshi; Sato, Kohji] Hamamatsu Univ Sch Med, Dept Anat, Shizuoka, Japan; [Seki, Norihito; Thanseem, Ismail; Yamamoto, Shigeyuki; Tsuchiya, Kenji J.; Sugihara, Genichi; Takei, Nori] Hamamatsu Univ Sch Med, Mental Dev Res Ctr, Shizuoka, Japan; [Matsuzaki, Hideo] Osaka Univ, Grad Sch Med, Mental Dev Res Ctr, Osaka, Japan; [Mamiya, Takayoshi] Meijo Univ, Fac Pharm Sci, Dept Chem Pharm, Nagoya, Aichi, Japan; [Hashimoto, Kenji] Chiba Univ, Ctr Forensic Mental Hlth, Div Clin Neurosci, Chiba, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Osaka University; Meijo University; Chiba University	Iwata, Y (corresponding author), Hamamatsu Univ Sch Med, Dept Psychiat & Neurol, Shizuoka, Japan.	iwata@hama-med.ac.jp; hashimoto@faculty.chiba-u.jp	MATSUZAKI, HIDEO/AAE-5246-2020; Takei, Nori/GWZ-7464-2022; Tsuchiya, Kenji J./I-9123-2019; Takei, Nori/AAC-8578-2019; Hashimoto, Kenji/I-5800-2015	MATSUZAKI, HIDEO/0000-0002-6869-1261; Tsuchiya, Kenji J./0000-0002-1314-4199; Hashimoto, Kenji/0000-0002-8892-0439; Wakuda, Tomoyasu/0000-0002-1924-8167; Suzuki, Katsuaki/0000-0003-0446-3355	Japan Society for the Promotion of Science [19209039, 15209036, 19390301]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for Scientific Research (#19209039 and #15209036; to N.M. and #19390301; to K.H.) from the Japan Society for the Promotion of Science. These fundings had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	Byrne TN, 2005, CURR OPIN NEUROL, V18, P662, DOI 10.1097/01.wco.0000191511.52745.99; Cannon M, 2002, AM J PSYCHIAT, V159, P1080, DOI 10.1176/appi.ajp.159.7.1080; Eriksson PS, 2006, EXP NEUROL, V199, P26, DOI 10.1016/j.expneurol.2005.10.017; GASBARRI A, 1994, BRAIN RES, V668, P71, DOI 10.1016/0006-8993(94)90512-6; Geddes JR, 1999, SCHIZOPHRENIA BULL, V25, P413, DOI 10.1093/oxfordjournals.schbul.a033389; Goff DC, 2001, AM J PSYCHIAT, V158, P1367, DOI 10.1176/appi.ajp.158.9.1367; Gould E, 1999, TRENDS COGN SCI, V3, P186, DOI 10.1016/S1364-6613(99)01310-8; Green MF, 2004, BIOL PSYCHIAT, V56, P301, DOI 10.1016/j.biopsych.2004.06.023; GUNDERSEN HJ, 1989, J MICROSC-OXFORD, V147, P229; HASHIMOTO K, 2008, EUR NEUROPS IN PRESS; Hashimoto K, 2005, CURR PSYCHIATRY REV, V1, P151, DOI 10.2174/1573400054065569; JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301; Kempermann G, 2004, CURR OPIN NEUROBIOL, V14, P186, DOI 10.1016/j.conb.2004.03.001; Juan L, 2006, SYNAPSE, V60, P56, DOI 10.1002/syn.20275; Loganovsky KN, 2005, WORLD J BIOL PSYCHIA, V6, P212, DOI 10.1080/15622970510029876; LOGANOVSKY KN, 2005, SCHIZOPHR B, V26, P751; Matsumoto H, 2001, PSYCHOL MED, V31, P907, DOI 10.1017/S0033291701003944; Miyakawa T, 1996, MOL BRAIN RES, V37, P145; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Mulhern RK, 2004, LANCET ONCOL, V5, P399, DOI 10.1016/S1470-2045(04)01507-4; Nacher J, 2003, NEUROBIOL AGING, V24, P273, DOI 10.1016/S0197-4580(02)00096-9; Nakane Y., 1986, PSYCHIATRIC CASE REG, P26; Panagiotakos G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000588; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Reif A, 2006, MOL PSYCHIATR, V11, P514, DOI 10.1038/sj.mp.4001791; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Tada E, 2000, NEUROSCIENCE, V99, P33, DOI 10.1016/S0306-4522(00)00151-2; Takei N, 1996, BIOL PSYCHIAT, V40, P817, DOI 10.1016/0006-3223(95)00592-7; Tani K, 2001, BRIT J PHARMACOL, V134, P1411, DOI 10.1038/sj.bjp.0704370; Toro CT, 2007, SCHIZOPHR RES, V90, P1, DOI 10.1016/j.schres.2006.09.030; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Wojtowicz JM, 2006, HIPPOCAMPUS, V16, P261, DOI 10.1002/hipo.20158; Zhang L, 2006, PROG NEURO-PSYCHOPH, V30, P1381, DOI 10.1016/j.pnpbp.2006.05.015	35	31	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2283	10.1371/journal.pone.0002283	http://dx.doi.org/10.1371/journal.pone.0002283			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	391XW	18509473	Green Submitted, Green Published, gold			2022-12-25	WOS:000262268500026
J	Berrebi, D; Leclerc, J; Schleiermacher, G; Zaccaria, I; Boccon-Gibod, L; Fabre, M; Jaubert, F; El Ghoneimi, A; Jeanpierre, C; Peuchmaur, M				Berrebi, Dominique; Leclerc, Julie; Schleiermacher, Gudrun; Zaccaria, Isabelle; Boccon-Gibod, Liliane; Fabre, Monique; Jaubert, Francis; El Ghoneimi, Alaa; Jeanpierre, Cecile; Peuchmaur, Michel			High Cyclin E Staining Index in Blastemal, Stromal or Epithelial Cells Is Correlated with Tumor Aggressiveness in Patients with Nephroblastoma	PLOS ONE			English	Article								Purpose: Identifying among nephroblastoma those with a high propensity for distant metastases using cell cycle markers: cyclin E as a regulator of progression through the cell cycle and Ki-67 as a tumor proliferation marker, since both are often deregulated in many human malignancies. Methodology/Principal Findings: A staining index (SI) was obtained by immunohistochemistry using anti-cyclin E and anti-Ki-67 antibodies in paraffin sections of 54 postchemotherapy nephroblastoma including 42 nephroblastoma without metastasis and 12 with metastases. Median cyclin E and Ki-67 SI were 46% and 33% in blastemal cells, 30% and 10% in stromal cells, 37% and 29.5% in epithelial cells. The highest values were found for anaplastic nephroblastoma. A correlation between cyclin E and Ki-67 SI was found for the blastemal component and for the epithelial component. Univariate analysis showed prognostic significance for metastases with cyclin E SI in stromal cells, epithelial cells and blastemal cells (p = 0.03, p = 0.01 and p = 0.002, respectively) as well as with Ki-67 SI in blastema (p, 10 24). The most striking data were that both cyclin E SI and blastemal Ki-67 SI discriminated between patients with metastases and patients without metastasis among intermediate-risk nephroblastoma. Conclusions: Our findings show that a high cyclin E SI in all components of nephroblastoma is correlated with tumor aggressiveness and metastases, and that assessment of its expression may have prognostic value in the categorization of nephroblastoma.	[Berrebi, Dominique; Peuchmaur, Michel] Hop Robert Debre, AP HP, Serv Anat & Cytol Pathol, F-75019 Paris, France; [Berrebi, Dominique; Leclerc, Julie; El Ghoneimi, Alaa; Peuchmaur, Michel] Univ Paris 07, UFR Med EA3102, Paris, France; [Leclerc, Julie; Jeanpierre, Cecile] Univ Paris 05, Fac Med, Hop Necker Enfants Malades, Inserm U574, Paris, France; [Schleiermacher, Gudrun] Inst Curie, Serv Oncol Pediat, Paris, France; [Zaccaria, Isabelle] Assistance Publ Hop Paris AP HP, Hop Robert Debre, Unite Epidemiol Clin, Paris, France; [Zaccaria, Isabelle] Hop Robert Debre, CIE5, Inserm, Paris, France; [Boccon-Gibod, Liliane] Assistance Publ Hop Paris AP HP, Hop Armand Trousseau, Serv Anatom Cytol Pathol, Paris, France; [Fabre, Monique] Assistance Publ Hop Paris AP HP, Hop Bicetre, Serv Anatom Cytol Pathol, Paris, France; [Jaubert, Francis] Assistance Publ Hop Paris AP HP, Hop Necker Enfants Malades, Serv Anatom Cytol Pathol, Paris, France; [El Ghoneimi, Alaa] Assistance Publ Hop Paris AP HP, Hop Robert Debre, Serv Chirurg Infantile, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Berrebi, D (corresponding author), Hop Robert Debre, AP HP, Serv Anat & Cytol Pathol, F-75019 Paris, France.	dominique.berrebi@rdb.ap-hop-paris.fr	Schleiermacher, Gudrun/AAN-4711-2021; berrebi, dominique/B-1419-2014; Jeanpierre, cecile/H-3770-2017	Schleiermacher, Gudrun/0000-0002-0133-5879; Jeanpierre, cecile/0000-0002-3463-5907; El Ghoneimi, Alaa/0000-0001-8133-2979				Dome JS, 2005, J CLIN ONCOL, V23, P9138, DOI 10.1200/JCO.2005.00.562; DUTTA A, 1995, P NATL ACAD SCI USA, V92, P5386, DOI 10.1073/pnas.92.12.5386; Eggert A, 2001, J CLIN ONCOL, V19, P689, DOI 10.1200/JCO.2001.19.3.689; FAUSSILLON M, 2005, CANC LETT, V67, pD2; GERDES J, 1983, INT J CANCER, V31, P13, DOI 10.1002/ijc.2910310104; Ghanem MA, 2005, UROLOGY, V65, P1047, DOI 10.1016/j.urology.2004.12.005; Ghanem MA, 2004, CLIN CANCER RES, V10, P591, DOI 10.1158/1078-0432.CCR-0884-02; Ghanem MA, 2003, J CLIN PATHOL, V56, P107, DOI 10.1136/jcp.56.2.107; Ghanem MA, 2001, CANCER-AM CANCER SOC, V92, P3120, DOI 10.1002/1097-0142(20011215)92:12<3120::AID-CNCR10173>3.0.CO;2-2; Ghanems MA, 2001, BRIT J CANCER, V85, P1557, DOI 10.1054/bjoc.2001.2146; Grundy PE, 2005, J CLIN ONCOL, V23, P7312, DOI 10.1200/JCO.2005.01.2799; Harwell RM, 2000, CANCER RES, V60, P481; Hunt KK, 2005, SEMIN CANCER BIOL, V15, P319, DOI 10.1016/j.semcancer.2005.04.007; Hwang HC, 2005, ONCOGENE, V24, P2776, DOI 10.1038/sj.onc.1208613; Juszkiewicz Piotr, 1997, Polish Journal of Pathology, V48, P113; Loeb DM, 2002, J BIOL CHEM, V277, P19627, DOI 10.1074/jbc.M201336200; Marshall RJ, 2001, J CLIN EPIDEMIOL, V54, P603, DOI 10.1016/S0895-4356(00)00344-9; NAGOSHI M, 1994, J SURG ONCOL, V55, P114, DOI 10.1002/jso.2930550211; Natrajan R, 2006, CLIN CANCER RES, V12, P7284, DOI 10.1158/1078-0432.CCR-06-1567; Natrajan R, 2006, CANCER RES, V66, P11148, DOI 10.1158/0008-5472.CAN-06-1931; Perlman E, 2004, ANN PATHOL, V24, P516, DOI 10.1016/S0242-6498(04)94016-3; Pollack A, 2004, J CLIN ONCOL, V22, P2133, DOI 10.1200/JCO.2004.09.150; Porter PL, 1997, NAT MED, V3, P222, DOI 10.1038/nm0297-222; Rosen DG, 2006, CANCER-AM CANCER SOC, V106, P1925, DOI 10.1002/cncr.21767; Singhal S, 2005, CLIN CANCER RES, V11, P3974, DOI 10.1158/1078-0432.CCR-04-2661; Takahashi M, 2002, CANCER RES, V62, P6598; Tissier F, 2004, EUR J ENDOCRINOL, V150, P809, DOI 10.1530/eje.0.1500809; Vujanic GM, 2002, MED PEDIATR ONCOL, V38, P79, DOI 10.1002/mpo.1276; Wingate H, 2005, J BIOL CHEM, V280, P15148, DOI 10.1074/jbc.M409789200; Wittmann S, 2008, GENE CHROMOSOME CANC, V47, P386, DOI 10.1002/gcc.20544	30	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2216	10.1371/journal.pone.0002216	http://dx.doi.org/10.1371/journal.pone.0002216			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493303	Green Submitted, Green Published, gold			2022-12-25	WOS:000262258700024
J	Colomb, S; Joly, W; Bonneaud, N; Maschat, F				Colomb, Sophie; Joly, Willy; Bonneaud, Nathalie; Maschat, Florence			A Concerted Action of Engrailed and Gooseberry-Neuro in Neuroblast 6-4 Is Triggering the Formation of Embryonic Posterior Commissure Bundles	PLOS ONE			English	Article								One challenging question in neurogenesis concerns the identification of cues that trigger axonal growth and pathfinding to form stereotypic neuronal networks during the construction of a nervous system. Here, we show that in Drosophila, Engrailed (EN) and Gooseberry-Neuro (GsbN) act together as cofactors to build the posterior commissures (PCs), which shapes the ventral nerve cord. Indeed, we show that these two proteins are acting together in axon growth and midline crossing, and that this concerted action occurs at early development, in neuroblasts. More precisely, we identified that their expressions in NB 6-4 are necessary and sufficient to trigger the formation of the PCs, demonstrating that segmentation genes such as EN and GsbN play a crucial role in the determination of NB 6-4 in a way that will later influence growth and guidance of all the axons that form the PCs. We also demonstrate a more specific function of GsbN in differentiated neurons, leading to fasciculations between axons, which might be required to obtain PC mature axon bundles.	[Colomb, Sophie; Joly, Willy; Bonneaud, Nathalie; Maschat, Florence] Inst Human Genet, Montpellier, France	Universite de Montpellier	Colomb, S (corresponding author), Inst Human Genet, Montpellier, France.	fmaschat@igh.cnrs.fr		Colomb, Sophie/0000-0001-6948-120X	CNRS [ACI-BCMS270]; ARC [3595]	CNRS(Centre National de la Recherche Scientifique (CNRS)); ARC(Australian Research Council)	Financial support for FM was CNRS, ACI-BCMS270 and ARC 3595.	Alexandre C, 2003, DEVELOPMENT, V130, P729, DOI 10.1242/dev.00286; BATE CM, 1976, NATURE, V260, P54, DOI 10.1038/260054a0; Baumgardt M, 2007, PLOS BIOL, V5, P295, DOI 10.1371/journal.pbio.0050037; BAUMGARTNER S, 1987, GENE DEV, V1, P1247, DOI 10.1101/gad.1.10.1247; Bhat KM, 1999, BIOESSAYS, V21, P472, DOI 10.1002/(SICI)1521-1878(199906)21:6<472::AID-BIES4>3.0.CO;2-W; Bhat KM, 1997, DEVELOPMENT, V124, P1675; Bossing T, 1996, DEV BIOL, V179, P41, DOI 10.1006/dbio.1996.0240; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROADUS J, 1995, MECH DEVELOP, V53, P393, DOI 10.1016/0925-4773(95)00454-8; Brunet I, 2007, TRENDS NEUROSCI, V30, P260, DOI 10.1016/j.tins.2007.03.010; Butler SJ, 2007, DEVELOPMENT, V134, P439, DOI 10.1242/dev.02762; Casso D, 2000, MECH DEVELOP, V91, P449; Chanas G, 2004, DEV BIOL, V272, P522, DOI 10.1016/j.ydbio.2004.05.020; Deshpande N, 2001, DEVELOPMENT, V128, P3253; Dittrich R, 1997, DEVELOPMENT, V124, P2515; DOE CQ, 1992, DEVELOPMENT, V116, P855; Dubois L, 2007, DEVELOPMENT, V134, P4347, DOI 10.1242/dev.008409; DumanScheel M, 1997, DEVELOPMENT, V124, P2855; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Garbe DS, 2007, J NEUROSCI, V27, P3584, DOI 10.1523/JNEUROSCI.0301-07.2007; Girard F, 2006, DEV BIOL, V299, P530, DOI 10.1016/j.ydbio.2006.08.014; Gustavson E, 1996, GENETICS, V142, P893; GUTJAHR T, 1993, DEVELOPMENT, V118, P21; Hidalgo A, 1997, DEVELOPMENT, V124, P3253; HIDALGO A, 1995, DEVELOPMENT, V121, P3703; Hidalgo A, 2000, DEVELOPMENT, V127, P393; Higashijima S, 1996, DEVELOPMENT, V122, P527; Hummel T, 1999, DEV BIOL, V209, P381, DOI 10.1006/dbio.1999.9235; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; JACOBS JR, 1989, J NEUROSCI, V9, P2412; Joly W, 2007, DEV BIOL, V301, P542, DOI 10.1016/j.ydbio.2006.10.019; KLAMBT C, 1991, CELL, V64, P801, DOI 10.1016/0092-8674(91)90509-W; Klein T, 1997, DEVELOPMENT, V124, P3123; Kuzin A, 2005, DEV BIOL, V277, P347, DOI 10.1016/j.ydbio.2004.09.027; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LI XL, 1994, NATURE, V367, P83, DOI 10.1038/367083a0; LIN DM, 1995, NEURON, V14, P707, DOI 10.1016/0896-6273(95)90215-5; Liu AM, 2001, DEVELOPMENT, V128, P181; Louvi A, 2000, DEVELOPMENT, V127, P4061; Lundell MJ, 1998, DEVELOPMENT, V125, P463; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Matsuzaki M, 1996, DEVELOPMENT, V122, P3567; Milan M, 2000, DEVELOPMENT, V127, P3069; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; Plachez C, 2005, CURR TOP DEV BIOL, V69, P267, DOI 10.1016/S0070-2153(05)69010-2; Ragone G, 2003, DEV BIOL, V255, P138, DOI 10.1016/S0012-1606(02)00081-7; SAENZROBLES MT, 1995, MECH DEVELOP, V53, P185, DOI 10.1016/0925-4773(95)00433-2; Sanchez-Soriano N, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-9; Schmid A, 1999, DEVELOPMENT, V126, P4653; Schmidt H, 1997, DEV BIOL, V189, P186, DOI 10.1006/dbio.1997.8660; SERRANO N, 1995, DEVELOPMENT, V121, P1691; Serrano N, 1997, DEVELOPMENT, V124, P2527; Simon HH, 2003, ANN NY ACAD SCI, V991, P36; Skeath JB, 2003, CURR OPIN NEUROBIOL, V13, P8, DOI 10.1016/S0959-4388(03)00007-2; Solano PJ, 2003, DEVELOPMENT, V130, P1243, DOI 10.1242/dev.00348; TABATA T, 1995, DEVELOPMENT, V121, P3359; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Yang XH, 1997, GENE DEV, V11, P1396, DOI 10.1101/gad.11.11.1396; ZHANG Y, 1994, DEVELOPMENT, V120, P1151	60	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2197	10.1371/journal.pone.0002197	http://dx.doi.org/10.1371/journal.pone.0002197			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493305	Green Published, Green Submitted, gold			2022-12-25	WOS:000262258700006
J	Fontana, L; Fiori, ME; Albini, S; Cifaldi, L; Giovinazzi, S; Forloni, M; Boldrini, R; Donfrancesco, A; Federici, V; Giacomini, P; Peschle, C; Fruci, D				Fontana, Laura; Fiori, Micol E.; Albini, Sonia; Cifaldi, Loredana; Giovinazzi, Serena; Forloni, Matteo; Boldrini, Renata; Donfrancesco, Alberto; Federici, Valentina; Giacomini, Patrizio; Peschle, Cesare; Fruci, Doriana			Antagomir-17-5p Abolishes the Growth of Therapy-Resistant Neuroblastoma through p21 and BIM	PLOS ONE			English	Article							N-MYC; MICRORNAS; EXPRESSION; APOPTOSIS; PROLIFERATION; SUPPRESSION; BIOGENESIS; INHIBITOR; MUTATIONS; INDUCTION	We identified a key oncogenic pathway underlying neuroblastoma progression: specifically, MYCN, expressed at elevated level, transactivates the miRNA 17-5p-92 cluster, which inhibits p21 and BIM translation by interaction with their mRNA 39 UTRs. Overexpression of miRNA 17-5p-92 cluster in MYCN-not-amplified neuroblastoma cells strongly augments their in vitro and in vivo tumorigenesis. In vitro or in vivo treatment with antagomir-17-5p abolishes the growth of MYCN-amplified and therapy-resistant neuroblastoma through p21 and BIM upmodulation, leading to cell cycling blockade and activation of apoptosis, respectively. In primary neuroblastoma, the majority of cases show a rise of miR-17-5p level leading to p21 downmodulation, which is particularly severe in patients with MYCN amplification and poor prognosis. Altogether, our studies demonstrate for the first time that antagomir treatment can abolish tumor growth in vivo, specifically in therapy-resistant neuroblastoma.	[Fontana, Laura; Fiori, Micol E.; Giovinazzi, Serena; Peschle, Cesare] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [Albini, Sonia; Cifaldi, Loredana; Forloni, Matteo; Fruci, Doriana] Osped Pediat Bambino Gesu, Res Ctr, Rome, Italy; [Boldrini, Renata] Osped Pediat Bambino Gesu, Div Pathol, Rome, Italy; [Donfrancesco, Alberto] Osped Pediat Bambino Gesu, Div Pediat Oncol, Rome, Italy; [Federici, Valentina] Regina Elena Inst Canc Res, Pathol Lab, Rome, Italy; [Giacomini, Patrizio] Regina Elena Inst Canc Res, Lab Immunol, Rome, Italy; [Peschle, Cesare] IRCCS MultiMedica, Milan, Italy	Istituto Superiore di Sanita (ISS); IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Multimedica	Fontana, L (corresponding author), Ist Super Sanita, Dept Hematol Oncol & Mol Med, Viale Regina Elena 299, I-00161 Rome, Italy.	lfontana@iss.it	Fiori, Micol E/J-4043-2014; Giacomini, Patrizio/K-5217-2016; Cifaldi, Loredana/AAI-1972-2019; Fiori, Micol Eleonora/J-7295-2016; Fruci, Doriana/AAA-8218-2019	Fiori, Micol E/0000-0002-1813-7035; Giacomini, Patrizio/0000-0001-6109-1709; Fiori, Micol Eleonora/0000-0002-1813-7035; Fruci, Doriana/0000-0003-3388-7296; Cifaldi, Loredana/0000-0001-5014-430X; Forloni, Matteo/0000-0003-4858-8491; albini, sonia/0000-0001-9502-1004	Italy-USA Oncology Program, Istituto Superiore di Sanita, Rome, Italy; AIRC, Milan, Italy	Italy-USA Oncology Program, Istituto Superiore di Sanita, Rome, Italy; AIRC, Milan, Italy(Fondazione AIRC per la ricerca sul cancro)	Supported by Italy-USA Oncology Program, Istituto Superiore di Sanita, Rome, Italy to CP and AIRC, Milan, Italy to DF.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Fontana L, 2007, NAT CELL BIOL, V9, P775, DOI 10.1038/ncb1613; Fulda S, 1999, ONCOGENE, V18, P1479, DOI 10.1038/sj.onc.1202435; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Goldschneider D, 2006, NUCLEIC ACIDS RES, V34, P5603, DOI 10.1093/nar/gkl619; HARPER JW, 1993, CELL, V75, P805; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; IVANOVSKA I, 2008, MOL CELL BIOL; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Laneve P, 2007, P NATL ACAD SCI USA, V104, P7957, DOI 10.1073/pnas.0700071104; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Leonetti C, 1999, CLIN CANCER RES, V5, P2588; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007; Lutz W, 1996, ONCOGENE, V13, P803; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Martin-Caballero J, 2001, CANCER RES, V61, P6234; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Santamaria D, 2006, FRONT BIOSCI-LANDMRK, V11, P1164, DOI 10.2741/1871; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; SHIOHARA M, 1994, BLOOD, V84, P3781, DOI 10.1182/blood.V84.11.3781.bloodjournal84113781; Tan TT, 2005, CANCER CELL, V7, P227, DOI 10.1016/j.ccr.2005.02.008; Tweddle DA, 2001, AM J PATHOL, V158, P2067, DOI 10.1016/S0002-9440(10)64678-0; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; van Golen CM, 2003, ONCOGENE, V22, P2664, DOI 10.1038/sj.onc.1206362; VOGAN K, 1993, CANCER RES, V53, P5269; Wang Q, 2003, CANCER RES, V63, P1631; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang WY, 2007, AM J PATHOL, V171, P728, DOI 10.2353/ajpath.2007.070070; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006	50	305	327	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2236	10.1371/journal.pone.0002236	http://dx.doi.org/10.1371/journal.pone.0002236			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493594	gold, Green Submitted, Green Published			2022-12-25	WOS:000262258700044
J	Souza, GR; Yonel-Gumruk, E; Fan, D; Easley, J; Rangel, R; Guzman-Rojas, L; Miller, JH; Arap, W; Pasqualini, R				Souza, Glauco R.; Yonel-Gumruk, Esra; Fan, Davin; Easley, Jeffrey; Rangel, Roberto; Guzman-Rojas, Liliana; Miller, J. Houston; Arap, Wadih; Pasqualini, Renata			Bottom-Up Assembly of Hydrogels from Bacteriophage and Au Nanoparticles: The Effect of Cis- and Trans-Acting Factors	PLOS ONE			English	Article								Hydrogels have become a promising research focus because of their potential for biomedical application. Here we explore the long-range, electrostatic interactions by following the effect of trans-acting (pH) and cis-acting factors (peptide mutation) on the formation of Au-phage hydrogels. These bioinorganic hydrogels can be generated from the bottom-up assembly of Au nanoparticles (Au NP) with either native or mutant bacteriophage (phage) through electrostatic interaction of the phage pVIII major capsid proteins (pVIII). The cis-acting factor consists of a peptide extension displayed on the pVIII that mutates the phage. Our results show that pH can dictate the direct-assembly and stability of Au-phage hydrogels in spite of the differences between the native and the mutant pVIII. The first step in characterizing the interactions of Au NP with phage was to generate a molecular model that identified the charge distribution and structure of the native and mutant pVIII. This model indicated that the mutant peptide extension carried a higher positive charge relative to the native pVIII at all pHs. Next, by monitoring the Au-phage interaction by means of optical microscopy, elastic light scattering, fractal dimension analysis as well as Uv-vis and surface plasmon resonance spectroscopy, we show that the positive charge of the mutant peptide extension favors the opposite charge affinity between the phage and Au NP as the pH is decreased. These results show the versatility of this assembly method, where the stability of these hydrogels can be achieved by either adjusting the pH or by changing the composition of the phage pVIII without the need of phage display libraries.	[Souza, Glauco R.; Rangel, Roberto; Guzman-Rojas, Liliana; Arap, Wadih; Pasqualini, Renata] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Souza, Glauco R.; Rangel, Roberto; Guzman-Rojas, Liliana; Arap, Wadih; Pasqualini, Renata] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX USA; [Fan, Davin; Easley, Jeffrey; Miller, J. Houston] Massachusetts Inst Technol, Dept Chem Engn, Boston, MA USA; [Yonel-Gumruk, Esra] George Washington Univ, Dept Chem, Washington, DC USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Massachusetts Institute of Technology (MIT); George Washington University	Souza, GR (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA.	rpasqual@mdanderson.org	Rangel, Roberto/AHE-6583-2022; Miller, John Houston/B-7324-2009	Rangel, Roberto/0000-0002-9088-7957; Miller, John Houston/0000-0002-6686-1976	Odyssey Program at The University of Texas M.D. Anderson Cancer Center; Department of Defense [Breast Cancer Concept Award]; Gillson-Longenbaugh Foundation	Odyssey Program at The University of Texas M.D. Anderson Cancer Center; Department of Defense(United States Department of Defense); Gillson-Longenbaugh Foundation	G.S. is a Scholar from the Odyssey Program at The University of Texas M.D. Anderson Cancer Center and a recipient of the Breast Cancer Concept Award from DOD. R.R. is also a Scholar from the Odyssey Program at The University of Texas M.D. Anderson Cancer Center. This work was supported by a grant from the Department of Defense and by an award from the Gillson-Longenbaugh Foundation (to W.A. and R.P.). Besides funding the work, the sponsors did not have any role in designing or conducting these studies.	Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Barbas C. F., 2001, PHAGE DISPLAY LAB MA; Chen C, 2006, NANO LETT, V6, P611, DOI 10.1021/nl0600878; Chen LM, 2004, CHEM BIOL, V11, P1081, DOI 10.1016/j.chembiol.2004.05.019; Hajitou A, 2006, CELL, V125, P385, DOI 10.1016/j.cell.2006.02.042; HANDLEY D A, 1989, P23; Huang Y, 2005, NANO LETT, V5, P1429, DOI 10.1021/nl050795d; LEITE ER, 2004, ENCY NANOSCIENCE NAN, P537; Lin Y, 2003, LANGMUIR, V19, P10000, DOI 10.1021/la0350251; Peterson AW, 2002, J AM CHEM SOC, V124, P14601, DOI 10.1021/ja0279996; Sarikaya M, 2003, NAT MATER, V2, P577, DOI 10.1038/nmat964; Shipway AN, 2000, LANGMUIR, V16, P8789, DOI [10.1021/la000316k, 10.1021/1a000316k]; Sigal GB, 1996, ANAL CHEM, V68, P490, DOI 10.1021/ac9504023; Souza GR, 2006, ANAL CHEM, V78, P6232, DOI 10.1021/ac060483a; Souza GR, 2006, P NATL ACAD SCI USA, V103, P1215, DOI 10.1073/pnas.0509739103; Souza GR, 2001, J AM CHEM SOC, V123, P6734, DOI 10.1021/ja005919x; SOUZA GR, 2006, ANN REV PLASMONICS; Weisbecker CS, 1996, LANGMUIR, V12, P3763, DOI 10.1021/la950776r; ZACHER AN, 1980, GENE, V9, P127, DOI 10.1016/0378-1119(80)90171-7; Zhong ZY, 2004, J PHYS CHEM B, V108, P4046, DOI 10.1021/jp037056a	20	39	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2242	10.1371/journal.pone.0002242	http://dx.doi.org/10.1371/journal.pone.0002242			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493583	Green Published, Green Submitted, gold			2022-12-25	WOS:000262258700050
J	Bettencourt, LMA; Ribeiro, RM				Bettencourt, Luis M. A.; Ribeiro, Ruy M.			Real Time Bayesian Estimation of the Epidemic Potential of Emerging Infectious Diseases	PLOS ONE			English	Article							TO-HUMAN TRANSMISSION; H5N1 INFLUENZA-VIRUS; PANDEMIC INFLUENZA; POPULATION; STRATEGIES; EVOLUTION; DYNAMICS; OUTBREAK; RISK	Background: Fast changes in human demographics worldwide, coupled with increased mobility, and modified land uses make the threat of emerging infectious diseases increasingly important. Currently there is worldwide alert for H5N1 avian influenza becoming as transmissible in humans as seasonal influenza, and potentially causing a pandemic of unprecedented proportions. Here we show how epidemiological surveillance data for emerging infectious diseases can be interpreted in real time to assess changes in transmissibility with quantified uncertainty, and to perform running time predictions of new cases and guide logistics allocations. Methodology/Principal Findings: We develop an extension of standard epidemiological models, appropriate for emerging infectious diseases, that describes the probabilistic progression of case numbers due to the concurrent effects of (incipient) human transmission and multiple introductions from a reservoir. The model is cast in terms of surveillance observables and immediately suggests a simple graphical estimation procedure for the effective reproductive number R (mean number of cases generated by an infectious individual) of standard epidemics. For emerging infectious diseases, which typically show large relative case number fluctuations over time, we develop a Bayesian scheme for real time estimation of the probability distribution of the effective reproduction number and show how to use such inferences to formulate significance tests on future epidemiological observations. Conclusions/Significance: Violations of these significance tests define statistical anomalies that may signal changes in the epidemiology of emerging diseases and should trigger further field investigation. We apply the methodology to case data from World Health Organization reports to place bounds on the current transmissibility of H5N1 influenza in humans and establish a statistical basis for monitoring its evolution in real time.	[Bettencourt, Luis M. A.; Ribeiro, Ruy M.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA; [Bettencourt, Luis M. A.] Santa Fe Inst, Santa Fe, NM USA	United States Department of Energy (DOE); Los Alamos National Laboratory; The Santa Fe Institute	Bettencourt, LMA (corresponding author), Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA.	lmbett@lanl.gov	Bettencourt, Luis/R-9861-2019	Ribeiro, Ruy/0000-0002-3988-8241	U.S. Department of Energy	U.S. Department of Energy(United States Department of Energy (DOE))	We gratefully acknowledge the support of the U.S. Department of Energy through the LANL/LDRD Program for this work.	Abbott A, 2004, NATURE, V427, P472, DOI 10.1038/427472a; ANDERSON RA, 1995, INFECT DIS HUMANS; Antia R, 2003, NATURE, V426, P658, DOI 10.1038/nature02104; Bettencourt LMA, 2007, LECT NOTES COMPUT SC, V4506, P79; Bjornstad ON, 2002, ECOL MONOGR, V72, P169, DOI 10.1890/0012-9615(2002)072[0169:DOMEES]2.0.CO;2; Brauer F., 2012, MATH MODELS POPULATI, V2; Cauchemez S, 2006, EMERG INFECT DIS, V12, P110; Cauchemez S, 2006, AM J EPIDEMIOL, V164, P591, DOI 10.1093/aje/kwj274; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Chowell G, 2007, J R SOC INTERFACE, V4, P155, DOI 10.1098/rsif.2006.0161; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Dushoff J, 2004, P NATL ACAD SCI USA, V101, P16915, DOI 10.1073/pnas.0407293101; Fauci AS, 2005, NATURE, V435, P423, DOI 10.1038/435423a; Ferguson NM, 2004, SCIENCE, V304, P968, DOI 10.1126/science.1096898; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Ferrari MJ, 2005, MATH BIOSCI, V198, P14, DOI 10.1016/j.mbs.2005.08.002; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Gog JR, 2003, P NATL ACAD SCI USA, V100, P11143, DOI 10.1073/pnas.1830296100; Jansen VAA, 2003, SCIENCE, V301, P804, DOI 10.1126/science.1086726; LAWSON AB, SPATIAL SYNDROMIC SU; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Matthews L, 2005, NAT REV MICROBIOL, V3, P529, DOI 10.1038/nrmicro1178; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Mills CE, 2006, PLOS MED, V3, P769, DOI 10.1371/journal.pmed.0030135; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Olsen SJ, 2005, EMERG INFECT DIS, V11, P1799; Ortiz JR, 2007, J INFECT DIS, V196, P1685, DOI 10.1086/522158; Osterholm MT, 2005, NEW ENGL J MED, V352, P1839, DOI 10.1056/NEJMp058068; Sedyaningsih ER, 2007, J INFECT DIS, V196, P522, DOI 10.1086/519692; SPICER CC, 1984, J HYG-CAMBRIDGE, V93, P105, DOI 10.1017/S0022172400060988; Tiensin T, 2007, J INFECT DIS, V196, P1679, DOI 10.1086/522007; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; van Boven M, 2007, PLOS COMPUT BIOL, V3, P1394, DOI 10.1371/journal.pcbi.0030145; Vong S, 2006, EMERG INFECT DIS, V12, P1542, DOI 10.3201/eid1210.060424; Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255; Webby RJ, 2003, SCIENCE, V302, P1519, DOI 10.1126/science.1090350; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775; Woolhouse MEJ, 2005, TRENDS ECOL EVOL, V20, P238, DOI 10.1016/j.tree.2005.02.009; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997; Yang Y, 2007, EMERG INFECT DIS, V13, P1348, DOI 10.3201/eid1309.070111; 2005, AVIAN INFLUENZA ASSE	44	135	140	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2185	10.1371/journal.pone.0002185	http://dx.doi.org/10.1371/journal.pone.0002185			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478118	Green Submitted, gold, Green Published			2022-12-25	WOS:000262172800050
J	Lanier, W; Moustafa, A; Bhattacharya, D; Comeron, JM				Lanier, William; Moustafa, Ahmed; Bhattacharya, Debashish; Comeron, Josep M.			EST Analysis of Ostreococcus lucimarinus, the Most Compact Eukaryotic Genome, Shows an Excess of Introns in Highly Expressed Genes	PLOS ONE			English	Article								Background: The genome of the pico-eukaryotic (bacterial-sized) prasinophyte green alga Ostreococcus lucimarinus has one of the highest gene densities known in eukaryotes, yet it contains many introns. Phylogenetic studies suggest this unusually compact genome (13.2 Mb) is an evolutionarily derived state among prasinophytes. The presence of introns in the highly reduced O. lucimarinus genome appears to be in opposition to simple explanations of genome evolution based on unidirectional tendencies, either neutral or selective. Therefore, patterns of intron retention in this species can potentially provide insights into the forces governing intron evolution. Methodology/Principal Findings: Here we studied intron features and levels of expression in O. lucimarinus using expressed sequence tags (ESTs) to annotate the current genome assembly. ESTs were assembled into unigene clusters that were mapped back to the O. lucimarinus Build 2.0 assembly using BLAST and the level of gene expression was inferred from the number of ESTs in each cluster. We find a positive correlation between expression levels and both intron number (R = +0.0893, p = <0.0005) and intron density (number of introns/kb of CDS; R = +0.0753, p = <0.005). Conclusions/Significance: In a species with a genome that has been recently subjected to a great reduction of non-coding DNA, these results imply the existence of selective/functional roles for introns that are principally detectable in highly expressed genes. In these cases, introns are likely maintained by balancing the selective forces favoring their maintenance with other mutational and/or selective forces acting on genome size.	[Lanier, William; Moustafa, Ahmed; Bhattacharya, Debashish; Comeron, Josep M.] Univ Iowa, Interdisciplinary Program Genet, Iowa City, IA 52242 USA; [Bhattacharya, Debashish; Comeron, Josep M.] Univ Iowa, Roy J Carver Ctr Comparative Genom, Dept Biol Sci, Iowa City, IA USA	University of Iowa; University of Iowa	Lanier, W (corresponding author), Univ Iowa, Interdisciplinary Program Genet, Iowa City, IA 52242 USA.	josep-comeron@uiowa.edu	Moustafa, Ahmed/C-5234-2009; Comeron, Josep/G-6630-2012; Moustafa, Ahmed/AAZ-3991-2020	Moustafa, Ahmed/0000-0002-0111-3555; Moustafa, Ahmed/0000-0002-0111-3555	National Science Foundation [DEB-03-44209, EF 04-31117, EF 06-25440]; National Institutes of Health [T 32 GM98629]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008629, R01GM098629] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Science Foundation awarded to JMC (DEB-03-44209) and to DB (EF 04-31117, EF 06-25440). WL was supported by an Institutional NRSA (T 32 GM98629) from the National Institutes of Health.	Ares M, 1999, RNA, V5, P1138, DOI 10.1017/S1355838299991379; Blumenstiel JP, 2002, MOL BIOL EVOL, V19, P2211, DOI 10.1093/oxfordjournals.molbev.a004045; Carvalho AB, 1999, NATURE, V401, P344, DOI 10.1038/43827; Castillo-Davis CI, 2002, NAT GENET, V31, P415, DOI 10.1038/ng940; CHRETIENNOTDINET MJ, 1995, PHYCOLOGIA, V34, P285, DOI 10.2216/i0031-8884-34-4-285.1; Comeron JM, 2004, GENETICS, V167, P1293, DOI 10.1534/genetics.104.026351; Comeron JM, 2002, GENETICS, V161, P389; Comeron JM, 2001, CURR OPIN GENET DEV, V11, P652, DOI 10.1016/S0959-437X(00)00249-5; Comeron JM, 2000, GENETICS, V156, P1175; COURTIES C, 1994, NATURE, V370, P255, DOI 10.1038/370255a0; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; Duret L, 1999, P NATL ACAD SCI USA, V96, P4482, DOI 10.1073/pnas.96.8.4482; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Fahey ME, 2007, J MOL EVOL, V65, P349, DOI 10.1007/s00239-007-9015-y; Fong YW, 2001, NATURE, V414, P929, DOI 10.1038/414929a; Gregory TR, 2004, GENE, V324, P15, DOI 10.1016/j.gene.2003.09.030; Gregory TR, 2005, ANN BOT-LONDON, V95, P133, DOI 10.1093/aob/mci009; Gregory TR, 2003, TRENDS GENET, V19, P485, DOI 10.1016/S0168-9525(03)00192-6; Henderson GP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000749; Kapraun DF, 2007, ANN BOT-LONDON, V99, P677, DOI 10.1093/aob/mcl294; Keeling Patrick J, 2007, Trends Genet, V23, P151, DOI 10.1016/j.tig.2007.02.008; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lynch M, 2003, MOL BIOL EVOL, V20, P563, DOI 10.1093/molbev/msg068; Munoz ET, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-30; Ophir R, 1997, GENE, V205, P191, DOI 10.1016/S0378-1119(97)00398-3; Palenik B, 2007, P NATL ACAD SCI USA, V104, P7705, DOI 10.1073/pnas.0611046104; Pendle AF, 2005, MOL BIOL CELL, V16, P260, DOI 10.1091/mbc.E04-09-0791; Petrov DA, 1997, GENE, V205, P279, DOI 10.1016/S0378-1119(97)00516-7; Petrov DA, 1996, NATURE, V384, P346, DOI 10.1038/384346a0; Petrov DA, 2002, THEOR POPUL BIOL, V61, P531, DOI 10.1006/tpbi.2002.1605; Petrov DA, 2001, TRENDS GENET, V17, P23, DOI 10.1016/S0168-9525(00)02157-0; Petrov DA, 2000, SCIENCE, V287, P1060, DOI 10.1126/science.287.5455.1060; Presgraves DC, 2006, MOL BIOL EVOL, V23, P2203, DOI 10.1093/molbev/msl094; Ren XY, 2006, TRENDS GENET, V22, P528, DOI 10.1016/j.tig.2006.08.008; Robbens S, 2007, MOL BIOL EVOL, V24, P956, DOI 10.1093/molbev/msm012; Scofield DG, 2007, MOL BIOL EVOL, V24, P896, DOI 10.1093/molbev/msm010; Spingola M, 1999, RNA, V5, P221, DOI 10.1017/S1355838299981682; STEINKOTTER J, 1994, J PHYCOL, V30, P340, DOI 10.1111/j.0022-3646.1994.00340.x; Urrutia AO, 2003, GENOME RES, V13, P2260, DOI 10.1101/gr.641103; Vinogradov AE, 1999, J MOL EVOL, V49, P376, DOI 10.1007/PL00006561; Williams BAP, 2005, P NATL ACAD SCI USA, V102, P10936, DOI 10.1073/pnas.0501321102; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	42	23	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2171	10.1371/journal.pone.0002171	http://dx.doi.org/10.1371/journal.pone.0002171			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478122	Green Published, gold			2022-12-25	WOS:000262172800036
J	Bleeker, FE; Felicioni, L; Buttitta, F; Lamba, S; Cardone, L; Rodolfo, M; Scarpa, A; Leenstra, S; Frattini, M; Barbareschi, M; Del Grammastro, M; Sciarrotta, MG; Zanon, C; Marchetti, A; Bardelli, A				Bleeker, F. E.; Felicioni, L.; Buttitta, F.; Lamba, S.; Cardone, L.; Rodolfo, M.; Scarpa, A.; Leenstra, S.; Frattini, M.; Barbareschi, M.; Del Grammastro, M.; Sciarrotta, M. G.; Zanon, C.; Marchetti, A.; Bardelli, A.			AKT1(E17K) in human solid tumours	ONCOGENE			English	Article						AKT1; PIK3CA; mutation; cancer	PIK3CA MUTATIONS; HUMAN BREAST; GENE; PTEN	The serine- threonine kinase AKT1 is a central player in the oncogenic pathway controlled by PI3K. Recently, a somatic mutation in AKT1 (E17K) has been detected in breast, colorectal, lung and ovarian cancers. The E17K change results in constitutive AKT1 activation and induces leukaemia in mice. We determined the occurrence of the E17K variant in a panel of 764 tumour samples. These included breast, lung, ovarian, colorectal and pancreatic carcinomas as well as melanomas and glioblastomas. Despite the fact that these tumours are known to bear alterations in genes involved in the PI3K signalling pathway, AKT1(E17K) was detected only in breast (16/273), colorectal (1/88) and lung(1/155) cancers. Within the neoplasms of breast origin, the AKT1(E17K) variant was mutually exclusive with respect to the PIK3CA(E454K) (or H1047R) alleles and was present only in ductal and lobular histotypes. Our results, showing that AKT1 mutations seem to occur in a tissue-specific fashion have basic and clinical implications. First, the activity of mutated AKT1 in oncogenic PI3K signalling could be strictly dependent on the cell and tissue milieu. Second, therapeutic efforts aimed at selective targeting the AKT1(E17K) variant could be effective mainly in specific cancer types.	[Bleeker, F. E.; Lamba, S.; Cardone, L.; Zanon, C.; Bardelli, A.] Univ Turin, Sch Med, Mol Genet Lab, Oncogenom Ctr,Inst Canc Res & Treatment, Candiolo, Italy; [Bleeker, F. E.] Locat Acad Med Ctr, Neurosurg Ctr Amsterdam, Amsterdam, Netherlands; [Felicioni, L.; Buttitta, F.; Del Grammastro, M.; Sciarrotta, M. G.; Marchetti, A.] Univ Fdn, Ctr Excellence Aging, Clin Res Ctr, Chieti, Italy; [Rodolfo, M.; Frattini, M.] Ist Nazl Tumori, Dept Expt Oncol, I-20133 Milan, Italy; [Scarpa, A.] Univ Verona, Dept Pathol, Sect Anat Pathol, I-37100 Verona, Italy; [Leenstra, S.] St Elizabeth Hosp, Dept Neurosurg, Tilburg, Netherlands; [Frattini, M.] Osped San Giovanni Bellinzona, Oncol Inst So Switzerland, Bellinzona, Switzerland; [Barbareschi, M.] Santa Chiara Hosp, Unit Surg Pathol, Trento, Italy; [Bardelli, A.] FIRC Inst Mol Oncol, Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Verona; Elisabeth-TweeSteden Ziekenhuis (ETZ); Institute of Oncology Research (IOR); Regional Hospital of Bellinzona & Valleys, San Giovanni; Santa Chiara Hospital; IFOM - FIRC Institute of Molecular Oncology	Bardelli, A (corresponding author), Univ Turin, Sch Med, Mol Genet Lab, Oncogenom Ctr,Inst Canc Res & Treatment, Str Prov 142 Km 3-95, I-10060 Turin, Italy.	a.bardelli@unito.it	rodolfo, monica/H-2671-2012; scarpa, aldo/K-6832-2016; Barbareschi, Mattia/AAF-2043-2020; BARDELLI, Alberto/J-9721-2018	rodolfo, monica/0000-0002-9196-0298; scarpa, aldo/0000-0003-1678-739X; Cardone, Luca/0000-0001-8184-2856; Zanon, Carlo/0000-0003-2539-7238; Lamba, Simona Elena/0000-0003-3207-1594; BARDELLI, Alberto/0000-0003-1647-5070	Italian Association for Cancer Research; Italian Ministry of Health; Regione Piemonte; Italian Ministry of University and Research and Association for International Cancer Research (AICR- UK, A Bardelli); EU FP6 [037297]; Netherlands Genomic Initiative Fellowship	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy); Regione Piemonte(Regione Piemonte); Italian Ministry of University and Research and Association for International Cancer Research (AICR- UK, A Bardelli); EU FP6(European Commission); Netherlands Genomic Initiative Fellowship	We thank Dr T Hulsebos and Professor Dr Troost for making glioblastoma tumour samples available. We thank Dr S Pilotti and Dr M Pierotti for providing the colorectal cancer samples. This work was supported by grants from Italian Association for Cancer Research (AIRC, A Bardelli), Italian Ministry of Health, Regione Piemonte (A Bardelli), Italian Ministry of University and Research and Association for International Cancer Research (AICR- UK, A Bardelli), EU FP6 contract 037297 (A Bardelli) and MolDiagPaca (AS). FB is supported by a Netherlands Genomic Initiative Fellowship.	Balakrishnan A, 2007, CANCER RES, V67, P3545, DOI 10.1158/0008-5472.CAN-07-0065; Barbareschi M, 2007, CLIN CANCER RES, V13, P6064, DOI 10.1158/1078-0432.CCR-07-0266; Benvenuti S, 2008, HUM MUTAT, V29, P284, DOI 10.1002/humu.20648; Brugge J, 2007, CANCER CELL, V12, P104, DOI 10.1016/j.ccr.2007.07.014; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Frattini M, 2005, CANCER RES, V65, P11227, DOI 10.1158/0008-5472.CAN-05-2780; Guldberg P, 1997, CANCER RES, V57, P3660; Karakas B, 2006, BRIT J CANCER, V94, P455, DOI 10.1038/sj.bjc.6602970; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Malanga D, 2008, CELL CYCLE, V7, P665, DOI 10.4161/cc.7.5.5485; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Schonleben F, 2006, CLIN CANCER RES, V12, P3851, DOI 10.1158/1078-0432.CCR-06-0292; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	14	155	156	2	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 18	2008	27	42					5648	5650		10.1038/onc.2008.170	http://dx.doi.org/10.1038/onc.2008.170			3	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	349KX	18504432				2022-12-25	WOS:000259280800011
J	Bessard, A; Fremin, C; Ezan, F; Fautrel, A; Gailhouste, L; Baffet, G				Bessard, A.; Fremin, C.; Ezan, F.; Fautrel, A.; Gailhouste, L.; Baffet, G.			RNAi-mediated ERK2 knockdown inhibits growth of tumor cells in vitro and in vivo	ONCOGENE			English	Article						MEK/ERK pathway; MEK inhibitor; U0126; RNAi; tumor growth; in vivo	HUMAN HEPATOCELLULAR-CARCINOMA; SMALL INTERFERING RNAS; MAP KINASE PATHWAY; S-PHASE ENTRY; PROTEIN-KINASES; MEK INHIBITOR; HUMAN LIVER; SUPPRESSES GROWTH; MAMMALIAN-CELLS; EXPRESSION	The MAPK MEK/ERK pathway is often upregulated in cancer cells and represents an attractive target for development of anticancer drugs. Only few data concerning the specific functions of ERK1 and 2 are reported in the literature. In this report, we investigated the specific role of ERK1 and 2 in liver tumor growth both in vitro and in vivo. DNA synthesis and cells in S phase analysed by flow cytometry, correlated with strong inhibition of Cdk1 and cyclin E levels, are strongly reduced after exposure to MEK inhibitor, U0126. We obtained a significant reduction of colony formation in soft agar assays and a reduction in the size of tumor xenografts in nude mice treated with U0126. Then, we could specifically abolished ERK1 or 2 expression by small-interfering RNA (siRNA) and demonstrated that ERK2 knockdown but not ERK1 interferes with the process of replication. Moreover, we found that colony formation and tumor growth in vivo were significantly inhibited by targeting ERK2 using stable chemically modified siRNA. Taken together, our results emphasize the importance of the MEK/ERK pathway in liver cancer cell growth in vitro and in vivo and argue for a crucial role of ERK2 in this regulation.	[Bessard, A.; Fremin, C.; Ezan, F.; Gailhouste, L.; Baffet, G.] Univ Rennes 1, Hop Pontchaillou, IFR 140, INSERM U522, F-35033 Rennes, France; [Fautrel, A.] Univ Rennes 1, CHU Rennes, IFR140, F-35033 Rennes, France	CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; CHU Rennes; Universite de Rennes	Baffet, G (corresponding author), Univ Rennes 1, Rue H Guillou, F-35033 Rennes, France.	georges.baffet@rennes.inserm.fr	Baffet, Georges/M-1583-2016; Bessard, Anne/K-2396-2015; Fautrel, Alain/AAL-7391-2020; Baffet, Georges/I-2574-2015	FAUTREL, Alain/0000-0002-3449-0779	Institut National de la Sante et de la Recherche Medicale; Association pour la Recherche sur le Cancer (ARC)	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer)	We thank Dr P Loyer for flow cytometry advices, Sigma-Aldrich and Dr Heike Lehrmann for giving us the LNA ERK2 oligonucleotides, and C Ribault for technical assistance. This research was supported by the Institut National de la Sante et de la Recherche Medicale and the Association pour la Recherche sur le Cancer (ARC). A Bessard and C Fremin are a recipient of fellowship from the Region Bretagne/INSERM and the Ministere de l'Education Nationale et de la Technologie, respectively, and the ARC.	Aharinejad S, 2004, CANCER RES, V64, P5378, DOI 10.1158/0008-5472.CAN-04-0961; ALBRECHT JH, 1995, BIOCHEM BIOPH RES CO, V209, P648, DOI 10.1006/bbrc.1995.1548; ALBRECHT JH, 1993, AM J PHYSIOL, V265, pG857, DOI 10.1152/ajpgi.1993.265.5.G857; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Andrieux LO, 2007, CANCER RES, V67, P2114, DOI 10.1158/0008-5472.CAN-06-3821; Arslan MA, 2006, CURR CANCER DRUG TAR, V6, P623, DOI 10.2174/156800906778742479; Behlke MA, 2006, MOL THER, V13, P644, DOI 10.1016/j.ymthe.2006.01.001; Bessard A, 2007, J CELL PHYSIOL, V212, P526, DOI 10.1002/jcp.21049; Braasch DA, 2003, BIOCHEMISTRY-US, V42, P7967, DOI 10.1021/bi0343774; BRONDELLO JM, 1995, ONCOGENE, V10, P1895; Dahlgren C, 2006, BIOCHEM BIOPH RES CO, V341, P1211, DOI 10.1016/j.bbrc.2006.01.085; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7689; Duesbery NS, 2001, P NATL ACAD SCI USA, V98, P4089, DOI 10.1073/pnas.061031898; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; Elmen J, 2005, NUCLEIC ACIDS RES, V33, P439, DOI 10.1093/nar/gki193; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Fremin C, 2007, HEPATOLOGY, V45, P1035, DOI 10.1002/hep.21551; Gysin S, 2005, CANCER RES, V65, P4870, DOI 10.1158/0008-5472.CAN-04-2848; Haass NK, 2008, CLIN CANCER RES, V14, P230, DOI 10.1158/1078-0432.CCR-07-1440; Hilger RA, 2002, ONKOLOGIE, V25, P511, DOI 10.1159/000068621; Huynh H, 2003, BMC GASTROENTEROL, V3, DOI 10.1186/1471-230X-3-19; Ito Y, 1998, HEPATOLOGY, V27, P951, DOI 10.1002/hep.510270409; Klein PJ, 2006, NEOPLASIA, V8, P1, DOI 10.1593/neo.05373; Lefloch R, 2008, MOL CELL BIOL, V28, P511, DOI 10.1128/MCB.00800-07; Leung RKM, 2005, PHARMACOL THERAPEUT, V107, P222, DOI 10.1016/j.pharmthera.2005.03.004; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; Liu X, 2004, ONCOGENE, V23, P763, DOI 10.1038/sj.onc.1207188; LoRusso PM, 2005, J CLIN ONCOL, V23, P5281, DOI 10.1200/JCO.2005.14.415; Loyer P, 1996, J BIOL CHEM, V271, P11484, DOI 10.1074/jbc.271.19.11484; Mook OR, 2007, MOL CANCER THER, V6, P833, DOI 10.1158/1535-7163.MCT-06-0195; MORELCHANY E, 1978, EUR J CANCER, V14, P1341, DOI 10.1016/0014-2964(78)90116-0; Normanno N, 2006, J CELL PHYSIOL, V207, P420, DOI 10.1002/jcp.20588; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; Rescan C, 2001, MOL BIOL CELL, V12, P725, DOI 10.1091/mbc.12.3.725; REUBER MD, 1961, J NATL CANCER I, V26, P891; Saba-El-Leil MK, 2003, EMBO REP, V4, P964, DOI 10.1038/sj.embor.embor939; Sanjo H, 2007, MOL CELL BIOL, V27, P1236, DOI 10.1128/MCB.01530-06; Schmidt CM, 1997, BIOCHEM BIOPH RES CO, V236, P54, DOI 10.1006/bbrc.1997.6840; Sebolt-Leopold JS, 1999, NAT MED, V5, P810, DOI 10.1038/10533; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Sebolt-Leopold JS, 2006, NATURE, V441, P457, DOI 10.1038/nature04874; Stennicke HR, 1997, J BIOL CHEM, V272, P25719, DOI 10.1074/jbc.272.41.25719; Takei Y, 2004, CANCER RES, V64, P3365, DOI 10.1158/0008-5472.CAN-03-2682; Talarmin H, 1999, MOL CELL BIOL, V19, P6003; Vantaggiato Chiara, 2006, J Biol, V5, P14, DOI 10.1186/jbiol38; Wabnitz PA, 2004, PHARM RES, V21, P1670, DOI 10.1023/B:PHAM.0000041464.27579.d0; Wang D, 2007, BBA-MOL CELL RES, V1773, P1248, DOI 10.1016/j.bbamcr.2006.11.009; Yeh TC, 2007, CLIN CANCER RES, V13, P1576, DOI 10.1158/1078-0432.CCR-06-1150	50	65	71	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP 11	2008	27	40					5315	5325		10.1038/onc.2008.163	http://dx.doi.org/10.1038/onc.2008.163			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	346UW	18521085				2022-12-25	WOS:000259096100004
J	Furze, RC; Rankin, SM				Furze, Rebecca C.; Rankin, Sara M.			The role of the bone marrow in neutrophil clearance under homeostatic conditions in the mouse	FASEB JOURNAL			English	Article						macrophage; apoptosis; chemokine	COLONY-STIMULATING FACTOR; APOPTOTIC CELLS; CYTOKINE PRODUCTION; B-LYMPHOPOIESIS; MACROPHAGES; GRANULOCYTE; PHAGOCYTOSIS; IL-17; MICE; GRANULOPOIESIS	In humans, 10(11) neutrophils are released from the bone marrow per day, and these cells have a half-life in the blood of only similar to 6.5 h. Although it is generally believed that neutrophils are cleared from the circulation via the liver and spleen, in this study using (111)In-labeled senescent neutrophils, we show that in mice, 32% of neutrophils are cleared from the circulation via the bone marrow. We have previously shown that senescent neutrophils home to the bone marrow in a CXCR4-dependent manner, and we show here that pretreatment of neutrophils with pertussis toxin significantly inhibits neutrophil clearance via the bone marrow (75%), consistent with a role for chemokines in this process. By labeling senescent neutrophils with inert fluorescent microspheres, we have tracked their fate and shown that in vivo, they are ultimately phagocytosed by bone marrow stromal macrophages. Finally, we show that under noninflammatory conditions, circulating levels of neutrophils are regulated by granulocyte-colony stimulating factor (G-CSF), but not interleukin-17. Interestingly, we report that the uptake of apoptotic neutrophils by bone marrow macrophages stimulates their production of G-CSF in vitro. Taken together, these data provide evidence that the bone marrow represents a major site of neutrophil clearance in mice.	[Furze, Rebecca C.; Rankin, Sara M.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Natl Heart & Lung Inst, Leukocyte Biol Sect, London SW7 2AZ, England	Imperial College London	Rankin, SM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Natl Heart & Lung Inst, Leukocyte Biol Sect, Sir Alexander Fleming Bldg, London SW7 2AZ, England.	s.rankin@imperial.ac.uk			Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	The authors thank C. A. Dewar for help with the TEM. The authors also thank R. Palframan and S. Rapecki (UCB Celltech, Slough, Berkshire, UK) for kindly providing the antimurine IL-17 and isotype control 101.4 used in this study. This work was funded by the Wellcome Trust. The authors declare no competing financial interests.	CHERVENICK PA, 1968, AM J PHYSIOL, V215, P353, DOI 10.1152/ajplegacy.1968.215.2.353; DEXTER TM, 1977, BIOMED EXPRESS, V27, P344; Dogusan Z, 2004, J IMMUNOL, V172, P4717, DOI 10.4049/jimmunol.172.8.4717; DRESCH C, 1980, J CLIN PATHOL, V33, P1110, DOI 10.1136/jcp.33.11.1110; FADOK VA, 1992, J IMMUNOL, V149, P4029; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fadok VA, 1998, BIOCHEM SOC T, V26, P653, DOI 10.1042/bst0260653; Forlow SB, 2001, BLOOD, V98, P3309, DOI 10.1182/blood.V98.12.3309; Hareng L, 2002, BIOL CHEM, V383, P1501, DOI 10.1515/BC.2002.172; KING AG, 1988, J IMMUNOL, V141, P2016; KITTLER ELW, 1992, BLOOD, V79, P3168; Laan M, 1999, J IMMUNOL, V162, P2347; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Lovas K, 1996, EUR J HAEMATOL, V56, P221; Lucas M, 2003, J IMMUNOL, V171, P2610, DOI 10.4049/jimmunol.171.5.2610; Martin C, 2003, IMMUNITY, V19, P583, DOI 10.1016/S1074-7613(03)00263-2; MAUER AM, 1960, J CLIN INVEST, V39, P1481, DOI 10.1172/JCI104167; Metcalf D, 1996, BLOOD, V88, P3755, DOI 10.1182/blood.V88.10.3755.bloodjournal88103755; Miyamoto M, 2003, J IMMUNOL, V170, P4665, DOI 10.4049/jimmunol.170.9.4665; Nagase H, 2002, J LEUKOCYTE BIOL, V71, P711; OSMOND DG, 1994, IMMUNOL REV, V142, P209, DOI 10.1111/j.1600-065X.1994.tb00891.x; Sadahira Y, 1999, PATHOL INT, V49, P841, DOI 10.1046/j.1440-1827.1999.00954.x; SAVERYMUTTU SH, 1985, BRIT J HAEMATOL, V61, P675, DOI 10.1111/j.1365-2141.1985.tb02882.x; SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970; Semerad CL, 2002, IMMUNITY, V17, P413, DOI 10.1016/S1074-7613(02)00424-7; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Suratt BT, 2001, AM J PHYSIOL-LUNG C, V281, pL913, DOI 10.1152/ajplung.2001.281.4.L913; TEMELES DS, 1993, EXP HEMATOL, V21, P388; THAKUR ML, 1977, J NUCL MED, V18, P1014; Witowski J, 2000, J IMMUNOL, V165, P5814, DOI 10.4049/jimmunol.165.10.5814; Witowski J, 2007, KIDNEY INT, V71, P514, DOI 10.1038/sj.ki.5002082; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Ye P, 2001, AM J RESP CELL MOL, V25, P335, DOI 10.1165/ajrcmb.25.3.4424	33	133	134	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2008	22	9					3111	3119		10.1096/fj.08-109876	http://dx.doi.org/10.1096/fj.08-109876			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	342CD	18509199	Green Published			2022-12-25	WOS:000258761300003
J	Pan, YH; Jing, RF; Pitre, A; Williams, BJ; Skalli, O				Pan, Yihang; Jing, Runfeng; Pitre, Aaron; Williams, Briana Jill; Skalli, Omar			Intermediate filament protein synemin contributes to the migratory properties of astrocytoma cells by influencing the dynamics of the actin cytoskeleton	FASEB JOURNAL			English	Article						glioma; invasion; alpha-actinin	ENDOTHELIAL-CELLS; COMPLEMENTARY-DNA; FOCAL ADHESIONS; ALPHA-ACTININ; CANCER-CELLS; VIMENTIN; EXPRESSION; MOTILITY; INVASION; FIBROBLASTS	We have shown previously that, in astrocytoma cells, synemin is present at the leading edge, an unusual localization for an intermediate filament (IF) protein. Here, we report that synemin down-regulation with specific small hairpin RNAs (shRNAs) sharply decreased the migration of astrocytoma cells. The presence of synemin at the leading edge also correlated with a high migratory potential, as shown by comparing astrocytoma cells to carcinoma cells without synemin at the leading edge. Synemin-silenced astrocytoma cells were smaller and spread more slowly than controls. In addition, synemin silencing reduced proliferation without increasing apoptosis. The adhesion to substratum and distribution of vinculin in focal contacts of synemin-silenced astrocytoma cells were similar to those of controls. Synemin-silenced cells, however, exhibited a reduction in the amount of filamentous (F) -actin and of alpha-actinin, but not of vinculin, associated with F-actin. Altogether, these results demonstrate that synemin is important for the malignant behavior of astrocytoma cells and that it contributes to the high motility of these cells by modulating the dynamics of alpha-actinin and actin.	[Pan, Yihang; Jing, Runfeng; Pitre, Aaron; Skalli, Omar] Louisiana State Univ, Hlth Sci Ctr, Dept Cellular Biol & Anat, Shreveport, LA 71130 USA; [Williams, Briana Jill] Louisiana State Univ, Hlth Sci Ctr, Dept Urol, Shreveport, LA 71130 USA; [Pan, Yihang; Jing, Runfeng; Pitre, Aaron; Williams, Briana Jill; Skalli, Omar] Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Shreveport, LA 71130 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Skalli, O (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Cellular Biol & Anat, 1501 Kings Hwy, Shreveport, LA 71130 USA.	oskall@lsuhsc.edu	Pitre, Aaron/C-3423-2016; Skalli, Omar/D-4980-2013	Pitre, Aaron/0000-0002-3017-2140; 	National Institutes of Health [NS-35317]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035317, R29NS035317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are thankful to Drs. Long Chen and Kathryn Llorens for assistance with the adhesion assays and confocal microscopy, respectively, and to Larry Smart for help with apoptosis assays. This work was supported by National Institutes of Health grant NS-35317 to O.S.	Beil M, 2003, NAT CELL BIOL, V5, P803, DOI 10.1038/ncb1037; Bellin RM, 1999, J BIOL CHEM, V274, P29493, DOI 10.1074/jbc.274.41.29493; Bellin RM, 2001, J BIOL CHEM, V276, P32330, DOI 10.1074/jbc.M104005200; CANO ML, 1992, J CELL BIOL, V116, P1123, DOI 10.1083/jcb.116.5.1123; Capetanaki Y, 2007, EXP CELL RES, V313, P2063, DOI 10.1016/j.yexcr.2007.03.033; Carlsson L, 2000, HISTOCHEM CELL BIOL, V114, P39; Chou YH, 2007, EXP CELL RES, V313, P2236, DOI 10.1016/j.yexcr.2007.04.008; CHU YW, 1993, P NATL ACAD SCI USA, V90, P4261, DOI 10.1073/pnas.90.9.4261; Chun J, 1997, J CELL PHYSIOL, V173, P361, DOI 10.1002/(SICI)1097-4652(199712)173:3<361::AID-JCP8>3.0.CO;2-L; Correia I, 1999, J CELL BIOL, V146, P831, DOI 10.1083/jcb.146.4.831; Eckes B, 1998, J CELL SCI, V111, P1897; Fukushima N, 2002, MOL BIOL CELL, V13, P2692, DOI 10.1091/mbc.01-09-0465; Gilles C, 1999, J CELL SCI, V112, P4615; Gonzales M, 2001, MOL BIOL CELL, V12, P85, DOI 10.1091/mbc.12.1.85; Green KJ, 1996, FASEB J, V10, P871, DOI 10.1096/fasebj.10.8.8666164; Hendrix MJC, 1997, AM J PATHOL, V150, P483; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Ivaska J, 2005, EMBO J, V24, P3834, DOI 10.1038/sj.emboj.7600847; Izmiryan A, 2006, GLIA, V54, P204, DOI 10.1002/glia.20378; Jing RF, 2005, GLIA, V50, P107, DOI 10.1002/glia.20158; Jing RF, 2007, J CELL SCI, V120, P1267, DOI 10.1242/jcs.03423; Kim S, 2007, GENE DEV, V21, P1581, DOI 10.1101/gad.1552107; Kleeberger W, 2007, CANCER RES, V67, P9199, DOI 10.1158/0008-5472.CAN-07-0806; Lee YJ, 2005, MOL BIOTECHNOL, V31, P1, DOI 10.1385/MB:31:1:001; Lepekhin EA, 2001, J NEUROCHEM, V79, P617, DOI 10.1046/j.1471-4159.2001.00595.x; Lohez OD, 2003, J CELL BIOL, V161, P67, DOI 10.1083/jcb.200208140; MANESS PF, 1982, CELL, V30, P253, DOI 10.1016/0092-8674(82)90031-9; MOONEY DJ, 1995, J CELL SCI, V108, P2311; MUGURUMA M, 1992, J BIOL CHEM, V267, P5621; Nakamura F, 2002, J BIOL CHEM, V277, P9148, DOI 10.1074/jbc.M111297200; Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355; Pitre A, 2007, ANAL BIOCHEM, V361, P305, DOI 10.1016/j.ab.2006.11.008; Rafelski SM, 2004, ANNU REV BIOCHEM, V73, P209, DOI 10.1146/annurev.biochem.73.011303.073844; Russell MA, 2006, ARCH BIOCHEM BIOPHYS, V456, P204, DOI 10.1016/j.abb.2006.06.010; RUTKA JT, 1993, CANCER RES, V53, P3624; RUTKA JT, 1994, CANCER RES, V54, P3267; Schmitt-Graeff A, 2006, HUM PATHOL, V37, P1200, DOI 10.1016/j.humpath.2006.04.017; Sultana S, 2000, GLIA, V30, P143, DOI 10.1002/(SICI)1098-1136(200004)30:2<143::AID-GLIA4>3.0.CO;2-Z; Sun N, 2008, BIOCHEM J, V409, P657, DOI 10.1042/BJ20071188; Titeux M, 2001, EUR J BIOCHEM, V268, P6435, DOI 10.1046/j.0014-2956.2001.02594.x; Tsuruta D, 2003, J CELL SCI, V116, P4977, DOI 10.1242/jcs.00823; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Uyama N, 2006, GUT, V55, P1276, DOI 10.1136/gut.2005.078865; Wakatsuki T, 2003, J CELL SCI, V116, P1617, DOI 10.1242/jcs.00340; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004	45	38	38	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2008	22	9					3196	3206		10.1096/fj.08-106187	http://dx.doi.org/10.1096/fj.08-106187			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	342CD	18509200	Green Published			2022-12-25	WOS:000258761300012
J	Sheridan, C; Brumatti, G; Martin, SJ				Sheridan, Clare; Brumatti, Gabriela; Martin, Seamus J.			Oncogenic B-Raf(V600E) inhibits apoptosis and promotes ERK-dependent inactivation of Bad and Bim	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAPK SIGNALING PATHWAY; BH3-ONLY PROTEINS; MITOCHONDRIAL-MEMBRANE; THERAPEUTIC TARGET; MELANOMA-CELLS; BH3 DOMAINS; B-RAF; DEATH; BRAF; SURVIVAL	Recent studies have revealed that B-Raf mutations are very common in malignant melanoma and are required for tumor growth and maintenance. The majority of melanoma-associated B-Raf mutations involve a single point mutation, V600E, which results in greatly elevated B-Raf kinase activity and constitutive activation of MAPK/ERK downstream. Here we show that B-Raf(V600E) increases resistance to apoptosis induced by chemotherapeutic drugs and promotes ERK-dependent phosphorylation of the BH3-only proteins Bim and Bad that are involved in setting thresholds for apoptosis. ERK-dependent phosphorylation of Bim resulted in degradation of this BH3-only protein, whereas phosphorylation of Bad has previously been shown to result in its sequestration by 14-3-3 proteins. Consistent with this, inhibition of ERK activity in a panel of melanoma cell lines resulted in stabilization of Bim and dephosphorylation of Bad. Furthermore, apoptosis induced through overexpression of Bad or Bim was efficiently blocked by coexpression of mutant B-Raf(V600E). However, small interfering RNA-mediated silencing of Bim and Bad expression conferred only modest protection against cytotoxic drugs, whereas oncogenic B-Raf strongly protected against the same stimuli. These observations suggest that B-Raf-initiated inactivation of Bad and Bim only partly contributes to the anti-apoptotic activities of this oncogene and that other points within the cell death machinery are also targeted by deregulated ERK signaling.	[Sheridan, Clare; Brumatti, Gabriela; Martin, Seamus J.] Trinity Coll Dublin, Smurfit Inst, Dept Genet, Mol Cell Biol Lab, Dublin 2, Ireland	Trinity College Dublin	Martin, SJ (corresponding author), Trinity Coll Dublin, Smurfit Inst, Dept Genet, Mol Cell Biol Lab, Dublin 2, Ireland.	martinsj@tcd.ie		Martin, Seamus/0000-0002-8539-3143				Adrain C, 2006, SCIENCE, V311, P785, DOI 10.1126/science.1124154; Adrain C, 2006, TRENDS BIOCHEM SCI, V31, P243, DOI 10.1016/j.tibs.2006.03.004; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Borner C, 2003, MOL IMMUNOL, V39, P615, DOI 10.1016/S0161-5890(02)00252-3; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Collisson EA, 2003, CANCER RES, V63, P5669; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Fernandez Y, 2005, CANCER RES, V65, P6294, DOI 10.1158/0008-5472.CAN-05-0686; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Harada H, 2004, P NATL ACAD SCI USA, V101, P15313, DOI 10.1073/pnas.0406837101; Hingorani SR, 2003, CANCER RES, V63, P5198; Hoeflich MP, 2006, CANCER RES, V66, P999, DOI 10.1158/0008-5472.CAN-05-2720; Houghton AN, 2002, CANCER CELL, V2, P275, DOI 10.1016/S1535-6108(02)00161-7; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Karasarides M, 2004, ONCOGENE, V23, P6292, DOI 10.1038/sj.onc.1207785; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Ley R, 2004, J BIOL CHEM, V279, P8837, DOI 10.1074/jbc.M311578200; Maldonado JL, 2003, J NATL CANCER I, V95, P1878, DOI 10.1093/jnci/djg123; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Perez D, 2000, MOL CELL, V6, P53, DOI 10.1016/S1097-2765(00)00007-1; Qin JZ, 2005, CANCER RES, V65, P6282, DOI 10.1158/0008-5472.CAN-05-0676; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; SHARMA A, 2005, CANCER RES, V24, P12; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Sumimoto H, 2006, J EXP MED, V203, P1651, DOI 10.1084/jem.20051848; Tan TT, 2005, CANCER CELL, V7, P227, DOI 10.1016/j.ccr.2005.02.008; Tuveson DA, 2003, CANCER CELL, V4, P95, DOI 10.1016/S1535-6108(03)00189-2; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Yang WT, 2006, DEV CELL, V10, P317, DOI 10.1016/j.devcel.2006.01.002; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3	36	57	60	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22128	22135		10.1074/jbc.M800271200	http://dx.doi.org/10.1074/jbc.M800271200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18508762	hybrid			2022-12-25	WOS:000258114700032
J	Bhalla, A; Chicka, MC; Chapman, ER				Bhalla, Akhil; Chicka, Michael C.; Chapman, Edwin R.			Analysis of the synaptotagmin family during reconstituted membrane fusion - Uncovering a class of inhibitory isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGGER NEUROTRANSMITTER RELEASE; CRACKED PC12 CELLS; TANDEM C2 DOMAINS; SNARE COMPLEX; T-SNARE; FAST EXOCYTOSIS; CA2+ SENSOR; BINDING; PROTEIN; CORE	Ca2+-triggered exocytosis in neurons and neuroendocrine cells is regulated by the Ca2+-binding protein synaptotagmin (syt) I. Sixteen additional isoforms of syt have been identified, but little is known concerning their biochemical or functional properties. Here, we assessed the abilities of fourteen syt isoforms to directly regulate SNARE ( soluble N-ethylmaleimide-sensitive factor (NSF) attachment protein receptor)-catalyzed membrane fusion. One group of isoforms stimulated neuronal SNARE-mediated fusion in response to Ca2+, while another set inhibited SNARE catalyzed fusion in both the absence and presence of Ca2+. Biochemical analysis revealed a strong correlation between the ability of syt isoforms to bind 1,2-dioleoyl phosphatidylserine ( PS) and t-SNAREs in a Ca2+-promoted manner with their abilities to enhance fusion, further establishing PS and SNAREs as critical effectors for syt action. The ability of syt I to efficiently stimulate fusion was specific for certain SNARE pairs, suggesting that syts might contribute to the specificity of intracellular membrane fusion reactions. Finally, a subset of inhibitory syts down-regulated the ability of syt I to activate fusion, demonstrating that syt isoforms can modulate the function of each other.	[Bhalla, Akhil; Chicka, Michael C.; Chapman, Edwin R.] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; [Bhalla, Akhil; Chicka, Michael C.; Chapman, Edwin R.] Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA; [Chicka, Michael C.; Chapman, Edwin R.] Univ Wisconsin, Dept Cellular & Mol Biol, Madison, WI 53706 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Chapman, ER (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, 1300 Univ Ave,SMI 129, Madison, WI 53706 USA.	chapman@physiology.wisc.edu		Chapman, Edwin/0000-0001-9787-8140	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061876] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Ahras M, 2006, J CELL BIOL, V173, P241, DOI 10.1083/jcb.200506163; Augustine GJ, 2001, CURR OPIN NEUROBIOL, V11, P320, DOI 10.1016/S0959-4388(00)00214-2; Babity JM, 1997, P NATL ACAD SCI USA, V94, P2638, DOI 10.1073/pnas.94.6.2638; Bai JH, 2004, NEURON, V41, P929, DOI 10.1016/S0896-6273(04)00117-5; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; Bhalla A, 2005, MOL BIOL CELL, V16, P4755, DOI 10.1091/mbc.E05-04-0277; Bhalla A, 2006, NAT STRUCT MOL BIOL, V13, P323, DOI 10.1038/nsmb1076; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Chapman ER, 1998, J BIOL CHEM, V273, P32966, DOI 10.1074/jbc.273.49.32966; Chapman ER, 2002, NAT REV MOL CELL BIO, V3, P498, DOI 10.1038/nrm855; Chapman ER, 1998, J BIOL CHEM, V273, P13995, DOI 10.1074/jbc.273.22.13995; Craxton M, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-43; Craxton M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-259; Davis AF, 1999, NEURON, V24, P363, DOI 10.1016/S0896-6273(00)80850-8; Earles CA, 2001, J CELL BIOL, V154, P1117, DOI 10.1083/jcb.200105020; Hui EF, 2005, P NATL ACAD SCI USA, V102, P5210, DOI 10.1073/pnas.0500941102; Hui EF, 2006, BIOPHYS J, V91, P1767, DOI 10.1529/biophysj.105.080325; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Koh TW, 2003, TRENDS NEUROSCI, V26, P413, DOI 10.1016/S0166-2236(03)00195-4; Machado HB, 2004, J NEUROSCI RES, V76, P334, DOI 10.1002/jnr.20072; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; MATTHEW WD, 1981, J CELL BIOL, V91, P257, DOI 10.1083/jcb.91.1.257; Maximov A, 2007, J CELL BIOL, V176, P113, DOI 10.1083/jcb.200607021; Nagy G, 2006, J NEUROSCI, V26, P632, DOI 10.1523/JNEUROSCI.2589-05.2006; Nalefski EA, 2001, BIOCHEMISTRY-US, V40, P3089, DOI 10.1021/bi001968a; Niemann Heiner, 1994, Trends in Cell Biology, V4, P179, DOI 10.1016/0962-8924(94)90203-8; Pang ZPP, 2006, J NEUROSCI, V26, P13493, DOI 10.1523/JNEUROSCI.3519-06.2006; Pang ZP, 2006, EMBO J, V25, P2039, DOI 10.1038/sj.emboj.7601103; Parlati F, 1999, P NATL ACAD SCI USA, V96, P12565, DOI 10.1073/pnas.96.22.12565; PERIN MS, 1991, J BIOL CHEM, V266, P623; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Rickman C, 2004, BIOCHEM J, V378, P681, DOI 10.1042/BJ20031407; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Schiavo G, 1997, P NATL ACAD SCI USA, V94, P997, DOI 10.1073/pnas.94.3.997; Shin OH, 2004, P NATL ACAD SCI USA, V101, P2554, DOI 10.1073/pnas.0308477100; Shin OH, 2003, NEURON, V37, P99, DOI 10.1016/S0896-6273(02)01145-5; Shin OH, 2002, NAT NEUROSCI, V5, P649, DOI 10.1038/nn869; Stein A, 2007, NAT STRUCT MOL BIOL, V14, P904, DOI 10.1038/nsmb1305; Sutton RB, 1999, J CELL BIOL, V147, P589, DOI 10.1083/jcb.147.3.589; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Tucker WC, 2003, J CELL BIOL, V162, P199, DOI 10.1083/jcb.200302060; VICIAN L, 1995, P NATL ACAD SCI USA, V92, P2164, DOI 10.1073/pnas.92.6.2164; Wang CT, 2003, NATURE, V424, P943, DOI 10.1038/nature01857; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Xu J, 2007, NEURON, V54, P567, DOI 10.1016/j.neuron.2007.05.004; Zhang Q, 2004, P NATL ACAD SCI USA, V101, P9441, DOI 10.1073/pnas.0401960101; Zhang XD, 2002, NEURON, V34, P599, DOI 10.1016/S0896-6273(02)00671-2	51	48	53	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21799	21807		10.1074/jbc.M709628200	http://dx.doi.org/10.1074/jbc.M709628200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18508778	Green Published, hybrid			2022-12-25	WOS:000257898800053
J	Mathew, LK; Sengupta, SS; Ladu, J; Andreasen, EA; Tanguay, RL				Mathew, Lijoy K.; Sengupta, Sumitra S.; Ladu, Jane; Andreasen, Eric A.; Tanguay, Robert L.			Crosstalk between AHR and Wnt signaling through R-Spondin1 impairs tissue regeneration in zebrafish	FASEB JOURNAL			English	Article						TCDD; dioxin; fin; differentiation; LRP6	ARYL-HYDROCARBON RECEPTOR; BETA-CATENIN ACTIVATION; HEMATOPOIETIC STEM-CELL; FIN REGENERATION; CHONDROCYTE DIFFERENTIATION; TRANSCRIPTION FACTOR; GENE-EXPRESSION; R-SPONDIN; GROWTH; PATHWAY	Exposure to dioxins, including 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), causes a wide array of toxicities in vertebrates, which are mostly considered to be mediated through the inappropriate activation of the aryl hydrocarbon receptor (AHR) signaling pathway. Although transcriptional regulation by AHR is widely studied, the molecular mechanisms responsible for the adverse outcomes after AHR activation are largely unknown. To identify the important downstream events of AHR activation, we employed the zebrafish caudal fin regeneration model, where AHR activation blocks the regenerative process. Comparative toxicogenomic analysis revealed that both adult and larval fins respond to TCDD during regeneration with misexpression of Wnt signaling pathway members and Wnt target genes. R-Spondin1, a novel ligand for the Wnt coreceptor, was highly induced, and we hypothesized that misexpression of R-Spondin1 is necessary for AHR activation to block regeneration. Partial antisense repression of R-Spondin1 reversed the inhibitory effect of TCDD, and tissue regeneration was restored. This finding demonstrates that inhibition of regeneration by TCDD is mediated by misinduction of R-Spondin1. Because R-Spondin1 signals through the Wnt coreceptor LRP6, we further demonstrated that the TCDD-mediated block in regeneration is also LRP6 dependent. Collectively, these results indicate that inappropriate regulation of R-Spondin/LRP6 is absolutely required for TCDD to inhibit fin regeneration.	[Mathew, Lijoy K.; Sengupta, Sumitra S.; Ladu, Jane; Andreasen, Eric A.; Tanguay, Robert L.] Oregon State Univ, Dept Environm & Mol Toxicol, Environm Hlth Sci Ctr, Corvallis, OR 97331 USA	Oregon State University	Tanguay, RL (corresponding author), Oregon State Univ, Dept Environm & Mol Toxicol, Environm Hlth Sci Ctr, 1007 ALS, Corvallis, OR 97331 USA.	robert.tanguay@oregonstate.edu	Sengupta, Sumitra/G-1814-2017	Sengupta, Sumitra/0000-0003-2861-5608	NIEHS NIH HHS [ES10820, ES03850, R01 ES010820, P30 ES000210, ES00210, P30 ES003850] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210, P50ES003850, R01ES010820, P30ES003850] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Akimenko MA, 2003, DEV DYNAM, V226, P190, DOI 10.1002/dvdy.10248; Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Andreasen EA, 2007, TOXICOL SCI, V95, P215, DOI 10.1093/toxsci/kfl119; Andreasen EA, 2006, TOXICOL SCI, V92, P254, DOI 10.1093/toxsci/kfj118; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; Blache P, 2004, J CELL BIOL, V166, P37, DOI 10.1083/jcb.200311021; Blaydon DC, 2006, NAT GENET, V38, P1245, DOI 10.1038/ng1883; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; BURBACH KM, 1992, P NATL ACAD SCI USA, V89, P8185, DOI 10.1073/pnas.89.17.8185; Chang XQ, 2007, MOL CELL BIOL, V27, P6127, DOI 10.1128/MCB.00323-07; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; HENRY EC, 1993, BIOCHEM J, V294, P95, DOI 10.1042/bj2940095; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Kamata T, 2004, BBA-GENE STRUCT EXPR, V1676, P51, DOI 10.1016/j.bbaexp.2003.10.009; Kawakami A, 2004, DEV DYNAM, V231, P693, DOI 10.1002/dvdy.20181; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kim KA, 2006, CELL CYCLE, V5, P23, DOI 10.4161/cc.5.1.2305; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Mathew LK, 2006, MOL PHARMACOL, V69, P257, DOI 10.1124/mol.105.018044; Mitchell KA, 2006, MOL PHARMACOL, V70, P163, DOI 10.1124/mol.106.023465; Nam JS, 2006, J BIOL CHEM, V281, P13247, DOI 10.1074/jbc.M508324200; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Poss KD, 2000, DEV DYNAM, V219, P282, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1045>3.3.CO;2-3; Puga A, 2005, BIOCHEM PHARMACOL, V69, P199, DOI 10.1016/j.bcp.2004.06.043; SANTAMARIA JA, 1991, J ANAT, V176, P9; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Schier AF, 1997, DEVELOPMENT, V124, P327; Schmidt JV, 1996, ANNU REV CELL DEV BI, V12, P55, DOI 10.1146/annurev.cellbio.12.1.55; Smith A, 2006, DEV BIOL, V299, P438, DOI 10.1016/j.ydbio.2006.08.016; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Thomae TL, 2005, J BIOL CHEM, V280, P12742, DOI 10.1074/jbc.M410780200; Wei Q, 2007, J BIOL CHEM, V282, P15903, DOI 10.1074/jbc.M701927200; Westerfield M, 1995, ZEBRAFISH BOOK; Yano F, 2005, BIOCHEM BIOPH RES CO, V333, P1300, DOI 10.1016/j.bbrc.2005.06.041; Zodrow JM, 2003, TOXICOL SCI, V76, P151, DOI 10.1093/toxsci/kfg205	39	65	72	1	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	AUG	2008	22	8					3087	3096		10.1096/fj.08-109009	http://dx.doi.org/10.1096/fj.08-109009			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	332NI	18495758	Green Published			2022-12-25	WOS:000258089300048
J	Moussaieff, A; Rimmerman, N; Bregman, T; Straiker, A; Felder, CC; Shoham, S; Kashman, Y; Huang, SM; Lee, H; Shohami, E; Mackie, K; Caterina, MJ; Walker, JM; Fride, E; Mechoulam, R				Moussaieff, Arieh; Rimmerman, Neta; Bregman, Tatiana; Straiker, Alex; Felder, Christian C.; Shoham, Shai; Kashman, Yoel; Huang, Susan M.; Lee, Hyosang; Shohami, Esther; Mackie, Ken; Caterina, Michael J.; Walker, J. Michael; Fride, Ester; Mechoulam, Raphael			Incensole acetate, an incense component, elicits psychoactivity by activating TRPV3 channels in the brain	FASEB JOURNAL			English	Article						Boswellia; frankincense; depression; anxiety	FORCED SWIMMING TEST; GATED ION-CHANNEL; SEXUAL DYSFUNCTION; RECEPTOR; HEAT; ANXIETY; MICE; ANTAGONISTS; AGONISTS; CURRENTS	Burning of Boswellia resin as incense has been part of religious and cultural ceremonies for millennia and is believed to contribute to the spiritual exaltation associated with such events. Transient receptor potential vanilloid (TRPV) 3 is an ion channel implicated in the perception of warmth in the skin. TRPV3 mRNA has also been found in neurons throughout the brain; however, the role of TRPV3 channels there remains unknown. Here we show that incensole acetate (IA), a Boswellia resin constituent, is a potent TRPV3 agonist that causes anxiolytic-like and antide-pressive-like behavioral effects in wild-type (WT) mice with concomitant changes in c-Fos activation in the brain. These behavioral effects were not noted in TRPV3(-/-) mice, suggesting that they are mediated via TRPV3 channels. IA activated TRPV3 channels stably expressed in HEK293 cells and in keratinocytes from TRPV3(-/-) mice. It had no effect on keratinocytes from TRPV3(-/-) mice and showed modest or no effect on TRPV1, TRPV2, and TRPV4, as well as on 24 other receptors, ion channels, and transport proteins. Our results imply that TRPV3 channels in the brain may play a role in emotional regulation. Furthermore, the biochemical and pharmacological effects of IA may provide a biological basis for deeply rooted cultural and religious traditions.	[Moussaieff, Arieh; Shohami, Esther; Mechoulam, Raphael] Hebrew Univ Jerusalem, Fac Med, Dept Med Chem & Nat Prod, IL-91120 Jerusalem, Israel; [Moussaieff, Arieh; Shohami, Esther] Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmacol, IL-91120 Jerusalem, Israel; [Rimmerman, Neta; Straiker, Alex; Mackie, Ken; Walker, J. Michael] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA; [Rimmerman, Neta; Straiker, Alex; Mackie, Ken; Walker, J. Michael] Indiana Univ, Gill Ctr Biomol Sci, Bloomington, IN USA; [Bregman, Tatiana; Fride, Ester] Ariel Univ Ctr Samaria, Dept Behav Sci, Ariel, Israel; [Bregman, Tatiana; Fride, Ester] Ariel Univ Ctr Samaria, Dept Mol Biol, Ariel, Israel; [Felder, Christian C.] Eli Lilly & Co, Div Neurosci, Indianapolis, IN 46285 USA; [Shoham, Shai] Herzog Mem Hosp, Res Dept, Jerusalem, Israel; [Kashman, Yoel] Tel Aviv Univ, Raymond & Beverly Sackler Fac Exact Sci, Sch Chem, Ramat Aviv, Israel; [Huang, Susan M.; Lee, Hyosang; Caterina, Michael J.] Johns Hopkins Sch Med, Dept Biol Chem, Baltimore, MD USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Ariel University; Ariel University; Eli Lilly; Hebrew University of Jerusalem; Herzog Medical Center; Tel Aviv University; Johns Hopkins University; Johns Hopkins Medicine	Moussaieff, A (corresponding author), Hebrew Univ Jerusalem, Fac Med, Dept Med Chem & Nat Prod, IL-91120 Jerusalem, Israel.	arieh@weizmann.ac.il; mechou@cc.huji.ac.il	Mackie, Ken/E-3715-2013; Rimmerman, Neta/F-1331-2010; Mackie, Kenneth P/B-7358-2011	Mackie, Ken/0000-0001-8501-6199; , Hyosang/0000-0002-3200-8678; Felder, Christian/0000-0003-1134-8881; Moussaieff, Arieh/0000-0003-1289-4737	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA009789, R01DA020402, K05DA021696, R01DA011322] Funding Source: NIH RePORTER; NIDA NIH HHS [R01 DA011322, DA020402, DA11322, P01 DA009789, R01 DA020402, K05 DA021696, DA21696, DA018244, DA9789] Funding Source: Medline; NINDS NIH HHS [R01 NS051551, NS051551] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANGEL I, 1991, FUNDAM CLIN PHARM, V5, P107, DOI 10.1111/j.1472-8206.1991.tb00704.x; Bandelow Borwin, 2007, Expert Rev Neurother, V7, P769, DOI 10.1586/14737175.7.7.769; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Chung MK, 2005, J BIOL CHEM, V280, P15928, DOI 10.1074/jbc.M500596200; Chung MK, 2004, J BIOL CHEM, V279, P21569, DOI 10.1074/jbc.M401872200; Chung MK, 2004, J NEUROSCI, V24, P5177, DOI 10.1523/JNEUROSCI.0934-04.2004; CHUNG MK, J BIOL CHEM, V279, P21569; CORSANO S, 1967, TETRAHEDRON, V23, P1977, DOI 10.1016/S0040-4020(01)82601-6; Crawley Jacqueline N., 2007, WHATS WRONG MY MOUSE; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; DRAGUNOW M, 1990, NEUROSCIENCE, V37, P287, DOI 10.1016/0306-4522(90)90399-O; ELFERINK JGR, 1983, J ETHNOPHARMACOL, V7, P111, DOI 10.1016/0378-8741(83)90084-3; Fride E, 2006, METH MOLEC MED, V123, P269; FRIDE E, 1993, EUR J PHARMACOL, V231, P313, DOI 10.1016/0014-2999(93)90468-W; Guler AD, 2002, J NEUROSCI, V22, P6408; Gunther R.T., 1959, GREEK HERBAL DIOSCOR; Haberfellner EM, 2007, PHARMACOPSYCHIATRY, V40, P173, DOI 10.1055/s-2007-985881; Hamm S, 2005, PHYTOCHEMISTRY, V66, P1499, DOI 10.1016/j.phytochem.2005.04.025; Harkin A, 2004, EUR NEUROPSYCHOPHARM, V14, P274; Henry B, 2006, J NEUROSCI, V26, P9142, DOI 10.1523/JNEUROSCI.1494-06.2006; Keller MB, 2003, JAMA-J AM MED ASSOC, V289, P3152, DOI 10.1001/jama.289.23.3152; MACCULLOCH JA, ENCY RELIG ETHICS, V7, P201; Marsch R, 2007, J NEUROSCI, V27, P832, DOI 10.1523/JNEUROSCI.3303-06.2007; MENON MK, 1971, PLANTA MED, V19, P333, DOI 10.1055/s-0028-1099651; Moore PD, 2006, NATURE, V444, P829, DOI 10.1038/444829a; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Moussaieff A, 2008, J CEREBR BLOOD F MET, V28, P1341, DOI 10.1038/jcbfm.2008.28; Moussaieff A, 2007, MOL PHARMACOL, V72, P1657, DOI 10.1124/mol.107.038810; Nurnberg HG, 2003, JAMA-J AM MED ASSOC, V289, P56, DOI 10.1001/jama.289.1.56; O'Connor KA, 2005, LIFE SCI, V78, P506, DOI 10.1016/j.lfs.2005.09.002; O'Dell DK, 2007, BIOORGAN MED CHEM, V15, P6164, DOI 10.1016/j.bmc.2007.06.032; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Petit-Demouliere B, 2005, PSYCHOPHARMACOLOGY, V177, P245, DOI 10.1007/s00213-004-2048-7; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; RICHARDS MH, 1990, BRIT J PHARMACOL, V99, P753, DOI 10.1111/j.1476-5381.1990.tb13002.x; Schultes R.E., 1980, BOT CHEM HALLUCINOGE; SHACHTER J, 1935, BABYLONIAN TALMUD, P43; Sheehan DV, 2007, PSYCHOPHARMACOL BULL, V40, P98; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; SMITH PL, 2006, J BIOL CHEM, V28; Thompson BL, 2006, NEUROPHARMACOLOGY, V50, P57, DOI 10.1016/j.neuropharm.2005.07.024; TREIT D, 1998, IN VIVO NEUROMETHODS, P89; Vogt-Eisele AK, 2007, BRIT J PHARMACOL, V151, P530, DOI 10.1038/sj.bjp.0707245; Werme M, 2000, BRAIN RES, V863, P112, DOI 10.1016/S0006-8993(00)02109-0; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; 1975, ENCY BRITANNICA, V5, P322; [No title captured]	48	111	124	2	34	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	AUG	2008	22	8					3024	3034		10.1096/fj.07-101865	http://dx.doi.org/10.1096/fj.07-101865			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	332NI	18492727	Green Published			2022-12-25	WOS:000258089300042
J	Giraudo, CG; Garcia-Diaz, A; Eng, WS; Yamamoto, A; Melia, TJ; Rothman, JE				Giraudo, Claudio G.; Garcia-Diaz, Alejandro; Eng, William S.; Yamamoto, Ai; Melia, Thomas J.; Rothman, James E.			Distinct domains of complexins bind SNARE complexes and clamp fusion in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTRANSMITTER RELEASE; SYNAPTOTAGMIN-I; MEMBRANE-FUSION; CA2+ SENSOR; HEMIFUSION; ABSENCE; SWITCH	In regulated exocytosis, the core membrane fusion machinery proteins, the SNARE proteins, are assisted by a group of regulatory factors in order to couple membrane fusion to an increase of intracellular calcium ion (Ca2(+)) concentration. Complexin-I and synaptotagmin-I have been shown to be key elements for this tightly regulated process. Many studies suggest that complexin-I can arrest the fusion reaction and that synaptotagmin-I can release the complexin-I blockage in a calcium-dependent manner. Although the actual molecular mechanism by which they exert their function is still unknown, recent in vivo experiments postulate that domains of complexin-I produce different effects on neurotransmitter release. Herein, by using an in vitro flipped SNARE cell fusion assay, we have identified and characterized the minimal functional domains of complexin-I necessary to couple calcium and synaptotagmin-I to membrane fusion. Moreover, we provide evidence that other isoforms of complexin, complexin-II, -III, and -IV, can also be functionally coupled to synaptotagmin-I and calcium. These correspond closely to results from in vivo experiments, providing further validation of the physiological relevance of the flipped SNARE system.	[Giraudo, Claudio G.; Garcia-Diaz, Alejandro; Eng, William S.; Melia, Thomas J.; Rothman, James E.] Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Yamamoto, Ai] Columbia Univ, Dept Neurol, New York, NY 10032 USA	Columbia University; Columbia University	Giraudo, CG (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, 1150 St Nicholas Ave,Russ Berrie Bldg,Rm 520, New York, NY 10032 USA.	cgg2103@columbia.edu; jr2269@columbia.edu	Yamamoto, Ai/D-1100-2011		NIGMS NIH HHS [R01 GM 071458] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071458] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARON U, 1995, NUCLEIC ACIDS RES, V23, P3605, DOI 10.1093/nar/23.17.3605; Bracher A, 2002, J BIOL CHEM, V277, P26517, DOI 10.1074/jbc.M203460200; BROADIE K, 1994, P NATL ACAD SCI USA, V91, P10727, DOI 10.1073/pnas.91.22.10727; Brunger AT, 2005, Q REV BIOPHYS, V38, P1, DOI 10.1017/S0033583505004051; Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Gallwitz D, 2003, TRENDS BIOCHEM SCI, V28, P113, DOI 10.1016/S0968-0004(03)00028-8; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Giraudo CG, 2005, J CELL BIOL, V170, P249, DOI 10.1083/jcb.200501093; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; Hu C, 2003, SCIENCE, V300, P1745, DOI 10.1126/science.1084909; Huntwork S, 2007, NAT NEUROSCI, V10, P1235, DOI 10.1038/nn1980; Jackson MB, 2006, ANNU REV BIOPH BIOM, V35, P135, DOI 10.1146/annurev.biophys.35.040405.101958; Koh TW, 2003, TRENDS NEUROSCI, V26, P413, DOI 10.1016/S0166-2236(03)00195-4; LITTLETON JT, 1994, P NATL ACAD SCI USA, V91, P10888, DOI 10.1073/pnas.91.23.10888; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; Melia TJ, 2007, FEBS LETT, V581, P2131, DOI 10.1016/j.febslet.2007.02.066; Mellman I, 2000, CELL, V100, P99, DOI 10.1016/S0092-8674(00)81687-6; Ono S, 1998, EUR J NEUROSCI, V10, P2143, DOI 10.1046/j.1460-9568.1998.00225.x; Pabst S, 2002, J BIOL CHEM, V277, P7838, DOI 10.1074/jbc.M109507200; Pabst S, 2000, J BIOL CHEM, V275, P19808, DOI 10.1074/jbc.M002571200; Pang ZPP, 2006, J NEUROSCI, V26, P13493, DOI 10.1523/JNEUROSCI.3519-06.2006; Peng RW, 2005, THESCIENTIFICWORLDJO, V5, P471, DOI 10.1100/tsw.2005.53; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Reim K, 2005, J CELL BIOL, V169, P669, DOI 10.1083/jcb.200502115; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; Schaub JR, 2006, NAT STRUCT MOL BIOL, V13, P748, DOI 10.1038/nsmb1124; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Tokumaru H, 2001, CELL, V104, P421, DOI 10.1016/S0092-8674(01)00229-X; Toonen RFG, 2003, TRENDS CELL BIOL, V13, P177, DOI 10.1016/S0962-8924(03)00031-X; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Wojcik SM, 2007, NEURON, V55, P11, DOI 10.1016/j.neuron.2007.06.013; Xue M, 2007, NAT STRUCT MOL BIOL, V14, P949, DOI 10.1038/nsmb1292	37	39	39	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21211	21219		10.1074/jbc.M803478200	http://dx.doi.org/10.1074/jbc.M803478200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18499660	Green Published, hybrid			2022-12-25	WOS:000257746100063
J	Kang, NJ; Lee, KW; Lee, DE; Rogozin, EA; Bode, AM; Lee, HJ; Dong, ZG				Kang, Nam Joo; Lee, Ki Won; Lee, Dong Eun; Rogozin, Evgeny A.; Bode, Ann M.; Lee, Hyong Joo; Dong, Zigang			Cocoa procyanidins suppress transformation by inhibiting mitogen-activated protein kinase kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CACAO LIQUOR PROANTHOCYANIDINS; NF-KAPPA-B; MAP KINASE; TEA POLYPHENOLS; IN-VIVO; NEOPLASTIC TRANSFORMATION; CANCER CHEMOPREVENTION; SIGNALING PATHWAY; PROSTAGLANDIN E-2; GREEN TEA	Cocoa was shown to inhibit chemically induced carcinogenesis in animals and exert antioxidant activity in humans. However, the molecular mechanisms of the chemopreventive potential of cocoa and its active ingredient(s) remain unknown. Here we report that cocoa procyanidins inhibit neoplastic cell transformation by suppressing the kinase activity of mitogen-activated protein kinase kinase (MEK). A cocoa procyanidin fraction (CPF) and procyanidin B2 at 5 mu g/ml and 40 mu M, respectively, inhibited 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced neoplastic transformation of JB6 P+ mouse epidermal (JB6 P+) cells by 47 and 93%, respectively. The TPA-induced promoter activity and expression of cyclooxygenase-2, which is involved in tumor promotion and inflammation, were dose-dependently inhibited by CPF or procyanidin B2. The activation of activator protein-1 and nuclear factor-kappa B induced by TPA was also attenuated by CPF or procyanidin B2. The TPA-induced phosphorylation of MEK, extracellular signal-regulated kinase, and p90 ribosomal s6 kinase was suppressed by CPF or procyanidin B2. In vitro and ex vivo kinase assay data demonstrated that CPF or procyanidin B2 inhibited the kinase activity of MEK1 and directly bound with MEK1. CPF or procyanidin B2 suppressed JB6 P+ cell transformation induced by epidermal growth factor or H-Ras, both of which are known to be involved in MEK/ERK signal activation. In contrast, theobromine (up to 80 mu M) had no effect on TPA-induced transformation, cyclooxygenase-2 expression, the transactivation of activator protein-1 or nuclear factor-kappa B, or MEK. Notably, procyanidin B2 exerted stronger inhibitory effects compared with PD098059 (a well known pharmacological inhibitor of MEK) on MEK1 activity and neoplastic cell transformation.	[Kang, Nam Joo; Lee, Ki Won; Rogozin, Evgeny A.; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Kang, Nam Joo; Lee, Dong Eun; Lee, Hyong Joo] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151742, South Korea; [Kang, Nam Joo; Lee, Dong Eun; Lee, Hyong Joo] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 151742, South Korea; [Lee, Ki Won] Konkuk Univ, Dept Biosci & Biotechnol, Seoul 143701, South Korea	University of Minnesota System; Seoul National University (SNU); Seoul National University (SNU); Konkuk University	Dong, ZG (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	zgdong@hi.umn.edu	Lee, Ki Won/M-4114-2018		NCI NIH HHS [CA 81064, CA 88961, CA 120388, CA 111536] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA111536, R37CA081064, R01CA081064, P01CA088961, R01CA120388] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bode A M, 2000, Lancet Oncol, V1, P181, DOI 10.1016/S1470-2045(00)00029-2; Bode AM, 2005, PROG NUCLEIC ACID RE, V79, P237, DOI 10.1016/S0079-6603(04)79005-4; Carnesecchi S, 2002, CANCER LETT, V175, P147, DOI 10.1016/S0304-3835(01)00731-5; Chan AT, 2007, NEW ENGL J MED, V356, P2131, DOI 10.1056/NEJMoa067208; Chung JY, 1999, CANCER RES, V59, P4610; Chung JY, 2001, FASEB J, V15, P2022, DOI 10.1096/fj.01-0031fje; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; DONG Z, 2002, SCI STKE, pPL7; Dong ZG, 1997, MOL CARCINOGEN, V19, P204, DOI 10.1002/(SICI)1098-2744(199707)19:3<204::AID-MC8>3.0.CO;2-D; DONG ZG, 1994, P NATL ACAD SCI USA, V91, P609, DOI 10.1073/pnas.91.2.609; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7689; Ermakova S, 2005, J BIOL CHEM, V280, P16882, DOI 10.1074/jbc.M414185200; Ermakova SP, 2006, CANCER RES, V66, P9260, DOI 10.1158/0008-5472.CAN-06-1586; He ZW, 2003, CANCER RES, V63, P4396; Hou DX, 2004, CARCINOGENESIS, V25, P29, DOI 10.1093/carcin/bgg184; Hsu TC, 2000, FREE RADICAL BIO MED, V28, P1338, DOI 10.1016/S0891-5849(00)00220-3; Huang CS, 1997, P NATL ACAD SCI USA, V94, P5826, DOI 10.1073/pnas.94.11.5826; Huang CS, 1998, P NATL ACAD SCI USA, V95, P156, DOI 10.1073/pnas.95.1.156; Kohno M, 2006, ANN MED, V38, P200, DOI 10.1080/07853890600551037; Lee KW, 2006, BIOFACTORS, V26, P105, DOI 10.1002/biof.5520260202; Lee KW, 2003, J AGR FOOD CHEM, V51, P7292, DOI 10.1021/jf0344385; Lee KW, 2006, J NUTR, V136, P1150, DOI 10.1093/jn/136.5.1150; Lee KW, 2005, J AGR FOOD CHEM, V53, P1990, DOI 10.1021/jf0486040; Li JJ, 1997, CANCER RES, V57, P3569; Liu GM, 2003, J BIOL CHEM, V278, P2124, DOI 10.1074/jbc.M202443200; Lu YP, 2002, P NATL ACAD SCI USA, V99, P12455, DOI 10.1073/pnas.182429899; Lu YP, 2001, CANCER RES, V61, P5002; Miller KB, 2006, J AGR FOOD CHEM, V54, P4062, DOI 10.1021/jf060290o; Pai R, 2002, NAT MED, V8, P289, DOI 10.1038/nm0302-289; Prosperi JR, 2004, PROSTAG OTH LIPID M, V73, P249, DOI 10.1016/j.prostaglandis.2004.03.004; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Sang SM, 2005, ANTIOXID REDOX SIGN, V7, P1704, DOI 10.1089/ars.2005.7.1704; Sebolt-Leopold JS, 1999, NAT MED, V5, P810, DOI 10.1038/10533; Shapiro P, 2002, CRIT REV CL LAB SCI, V39, P285, DOI 10.1080/10408360290795538; Sheng HM, 1998, CANCER RES, V58, P362; Smit HJ, 2004, PSYCHOPHARMACOLOGY, V176, P412, DOI 10.1007/s00213-004-1898-3; Steinberg FM, 2003, J AM DIET ASSOC, V103, P215, DOI 10.1053/jada.2003.50028; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Suzukawa K, 2002, ENVIRON HEALTH PERSP, V110, P865, DOI 10.1289/ehp.02110865; Weisburger JH, 2001, EXP BIOL MED, V226, P891, DOI 10.1177/153537020122601003; Wong BCY, 2004, GASTROENTEROLOGY, V126, P136, DOI 10.1053/j.gastro.2003.10.063; Yamagishi M, 2003, CANCER LETT, V191, P49, DOI 10.1016/S0304-3835(02)00629-8; Yamagishi M, 2002, CANCER LETT, V185, P123, DOI 10.1016/S0304-3835(02)00276-8; Yan Y, 2006, J CELL SCI, V119, P2985, DOI 10.1242/jcs.03014	47	62	62	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20664	20673		10.1074/jbc.M800263200	http://dx.doi.org/10.1074/jbc.M800263200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18519570	Green Published, hybrid			2022-12-25	WOS:000257746100007
J	Signorell, A; Jelk, J; Rauch, M; Butikofer, P				Signorell, Aita; Jelk, Jennifer; Rauch, Monika; Buetikofer, Peter			Phosphatidylethanolamine is the precursor of the ethanolamine phosphoglycerol moiety bound to eukaryotic elongation factor 1A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPANOSOMA-BRUCEI; FACTOR 1-ALPHA; GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHOR; H-3 ETHANOLAMINE; SURFACE PROTEIN; CULTURE FORMS; TRANSLATION; PHOSPHORYLATION; BIOSYNTHESIS; EF-1-ALPHA	In addition to its conventional role during protein synthesis, eukaryotic elongation factor 1A is involved in other cellular processes. Several regions of interaction between eukaryotic elongation factor 1A and the translational apparatus or the cytoskeleton have been identified, yet the roles of the different post-translational modifications of eukaryotic elongation factor 1A are completely unknown. One amino acid modification, which so far has only been found in eukaryotic elongation factor 1A, consists of ethanolamine-phosphoglycerol attached to two glutamate residues that are conserved between mammals and plants. We now report that ethanolamine-phosphoglycerol is also present in eukaryotic elongation factor 1A of the protozoan parasite Trypanosoma brucei, indicating that this unique protein modification is of ancient origin. In addition, using RNA-mediated gene silencing against enzymes of the Kennedy pathway, we demonstrate that phosphatidylethanolamine is a direct precursor of the ethanolamine-phosphoglycerol moiety. Down-regulation of the expression of ethanolamine kinase and ethanolamine-phosphate cytidylyltransferase results in inhibition of phosphatidylethanolamine synthesis in T. brucei procyclic forms and, concomitantly, in a block in glycosylphosphatidylinositol attachment to procyclins and ethanolamine-phosphoglycerol modification of eukaryotic elongation factor 1A.	[Signorell, Aita; Jelk, Jennifer; Rauch, Monika; Buetikofer, Peter] Univ Bern, Inst Biochem & Mol Med, CH-3012 Bern, Switzerland	University of Bern	Butikofer, P (corresponding author), Univ Bern, Inst Biochem & Mol Med, Buhlstr 28, CH-3012 Bern, Switzerland.	peter.buetikofer@mci.unibe.ch						Acosta-Serrano A, 2000, J MOL BIOL, V304, P633, DOI 10.1006/jmbi.2000.4246; Andersen GR, 2003, TRENDS BIOCHEM SCI, V28, P434, DOI 10.1016/S0968-0004(03)00162-2; Andersen GR, 2001, NAT STRUCT BIOL, V8, P531, DOI 10.1038/88598; Birner R, 2003, INT REV CYTOL, V225, P273, DOI 10.1016/S0074-7696(05)25007-6; Bochud-Allemann N, 2002, J BIOL CHEM, V277, P32849, DOI 10.1074/jbc.M205776200; Bouzaidi-Tiali N, 2007, EMBO J, V26, P4302, DOI 10.1038/sj.emboj.7601857; Browne GJ, 2002, EUR J BIOCHEM, V269, P5360, DOI 10.1046/j.1432-1033.2002.03290.x; Butikofer P, 1997, BIOCHEM J, V326, P415; Butikofer P, 1999, J CELL SCI, V112, P1785; Butikofer P, 1996, J BIOL CHEM, V271, P15533, DOI 10.1074/jbc.271.26.15533; CAVALLIUS J, 1993, BIOCHIM BIOPHYS ACTA, V1163, P75, DOI 10.1016/0167-4838(93)90281-U; Choi JY, 2005, ANAL BIOCHEM, V347, P165, DOI 10.1016/j.ab.2005.03.017; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; CONDEELIS J, 1995, TRENDS BIOCHEM SCI, V20, P169, DOI 10.1016/S0968-0004(00)88998-7; DIXON H, 1970, COMP BIOCHEM PHYSIOL, V33, P111, DOI 10.1016/0010-406X(70)90487-1; Eisenhaber B, 2003, BIOESSAYS, V25, P367, DOI 10.1002/bies.10254; Ferguson MAJ, 1999, J CELL SCI, V112, P2799; Field M. C., 1992, LIPID MODIFICATION P, P155; FIELD MC, 1991, EMBO J, V10, P2731, DOI 10.1002/j.1460-2075.1991.tb07821.x; Gross SR, 2005, NAT STRUCT MOL BIOL, V12, P772, DOI 10.1038/nsmb979; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; INGLIS AS, 1983, METHOD ENZYMOL, V91, P324; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kiel JAKW, 2007, FEMS YEAST RES, V7, P1114, DOI 10.1111/j.1567-1364.2007.00232.x; Kinoshita T, 2000, CURR OPIN CHEM BIOL, V4, P632, DOI 10.1016/S1367-5931(00)00151-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leclercq TM, 2008, J BIOL CHEM, V283, P9606, DOI 10.1074/jbc.M708782200; MENON AK, 1992, J BIOL CHEM, V267, P15277; MENON AK, 1993, EMBO J, V12, P1907, DOI 10.1002/j.1460-2075.1993.tb05839.x; Merrick WC, 2000, COLD SPRING HARBOR M, V39, P89; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Negrutskii BS, 1998, PROG NUCLEIC ACID RE, V60, P47, DOI 10.1016/S0079-6603(08)60889-2; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; Panasyuk G, 2008, INT J BIOCHEM CELL B, V40, P63, DOI 10.1016/j.biocel.2007.08.014; PATNAIK PK, 1993, MOL BIOCHEM PARASIT, V58, P97, DOI 10.1016/0166-6851(93)90094-E; Ransom WD, 1998, PLANT PHYSIOL, V117, P949, DOI 10.1104/pp.117.3.949; RIFKIN MR, 1995, J BIOL CHEM, V270, P16160, DOI 10.1074/jbc.270.27.16160; Roditi I, 2002, TRENDS MICROBIOL, V10, P128, DOI 10.1016/S0966-842X(02)02309-0; ROSENBERRY TL, 1989, J BIOL CHEM, V264, P7096; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Ruepp S, 1997, J CELL BIOL, V137, P1369, DOI 10.1083/jcb.137.6.1369; Stephens JL, 2007, J BIOL CHEM, V282, P4427, DOI 10.1074/jbc.M609037200; van Hellemond JJ, 2006, FEBS LETT, V580, P5552, DOI 10.1016/j.febslet.2006.07.056; Vance JE, 2005, PROG LIPID RES, V44, P207, DOI 10.1016/j.plipres.2005.05.001; Vance JE, 2003, PROG NUCLEIC ACID RE, V75, P69, DOI 10.1016/S0079-6603(03)75003-X; Vassella E, 2003, MOL BIOL CELL, V14, P1308, DOI 10.1091/mbc.E02-10-0694; Vial HJ, 2003, MOL BIOCHEM PARASIT, V126, P143, DOI 10.1016/S0166-6851(02)00281-5; WHITEHEART SW, 1994, ARCH BIOCHEM BIOPHYS, V309, P387, DOI 10.1006/abbi.1994.1128; WHITEHEART SW, 1989, J BIOL CHEM, V264, P14334; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	51	36	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20320	20329		10.1074/jbc.M802430200	http://dx.doi.org/10.1074/jbc.M802430200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18499667	hybrid			2022-12-25	WOS:000257565300048
J	Kwak, JH; Kim, SI; Kim, JK; Choi, ME				Kwak, Joon Hyeok; Kim, Sung Il; Kim, Jin Kuk; Choi, Mary E.			BAT3 interacts with transforming growth factor-beta (TGF-beta) receptors and enhances TGF-beta 1-induced type I collagen expression in mesangial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-ASSOCIATED TRANSCRIPT-3; SIGNAL-TRANSDUCTION; DOMAIN PROTEIN; SCYTHE; REAPER; ACTIVATION; APOPTOSIS; PATHWAY	Transforming growth factor-beta 1 (TGF-beta 1) plays essential roles in a wide array of cellular processes, such as in development and the pathogenesis of tissue fibrosis, including that associated with progressive kidney diseases. Tight regulation of its signaling pathways is critical, and proteins that associate with the TGF-beta receptors may exert positive or negative regulatory effects on TGF-beta signaling. In the present study we employed a yeast-based two-hybrid screening system to identify BAT3 (HLA-B-associated transcript 3) as a TGF-beta receptor-interacting protein. Analysis of endogenously expressed BAT3 in various tissues including the kidney reveals the existence of similar to 140kDa full-length protein as well as truncated forms of BAT3 whose expression is developmentally regulated. Endogenous BAT3 protein interacts with TGF-beta receptors type I and type II in renal mesangial cells. Functional assays show that expression of full-length BAT3 results in enhancement of TGF-beta 1-stimulated transcriptional activation of p3TP-Lux reporter, and these effects require the presence of functional TGF-beta signaling receptors as demonstrated in R-1B and DR-26 mutant cells. Moreover, expression of full-length BAT3, but not C-terminal truncated mutant of BAT3, enhanced TGF-beta 1-induced type I collagen expression in mesangial cells, whereas knock down of BAT3 protein expression by small interfering RNA suppressed the expression of type I collagen induced by TGF-beta 1. Our findings suggest that BAT3, a TGF-beta receptor-interacting protein, is capable of modulating TGF-beta signaling and acts as a positive regulator of TGF-beta 1 stimulation of type I collagen expression in mesangial cells.	[Kwak, Joon Hyeok; Kim, Sung Il; Kim, Jin Kuk; Choi, Mary E.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Renal Div, Boston, MA 02115 USA; [Kim, Jin Kuk] Soonchunhyang Univ, Bucheon Hosp, Dept Internal Med, Puchon 420767, South Korea	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Soonchunhyang University	Choi, ME (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Renal Div, 4 Blackfan Circle,HIM-5, Boston, MA 02115 USA.	mchoi@rics.bwh.harvard.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057661] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01DK57661] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ATTISANO L, 1994, BBA-MOL CELL RES, V1222, P71, DOI 10.1016/0167-4889(94)90026-4; BANERJI J, 1990, P NATL ACAD SCI USA, V87, P2374, DOI 10.1073/pnas.87.6.2374; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Charng MJ, 1998, J BIOL CHEM, V273, P9365, DOI 10.1074/jbc.273.16.9365; Cheng JF, 2002, EXP BIOL MED, V227, P943, DOI 10.1177/153537020222701102; Chin BY, 2001, AM J PHYSIOL-RENAL, V280, pF495, DOI 10.1152/ajprenal.2001.280.3.F495; Choi ME, 1999, AM J PHYSIOL-RENAL, V276, pF88, DOI 10.1152/ajprenal.1999.276.1.F88; Choi ME, 1997, AM J PHYSIOL-RENAL, V273, pF386, DOI 10.1152/ajprenal.1997.273.3.F386; Datta PK, 1998, J BIOL CHEM, V273, P34671, DOI 10.1074/jbc.273.52.34671; Desmots F, 2005, MOL CELL BIOL, V25, P10329, DOI 10.1128/MCB.25.23.10329-10337.2005; Desmots F, 2008, J BIOL CHEM, V283, P3264, DOI 10.1074/jbc.M706419200; Furuhashi M, 2001, MOL CELL BIOL, V21, P5132, DOI 10.1128/MCB.21.15.5132-5141.2001; He CH, 2001, J BIOL CHEM, V276, P20858, DOI 10.1074/jbc.M101198200; Kikukawa Y, 2005, FEBS J, V272, P6373, DOI 10.1111/j.1742-4658.2005.05032.x; Kim S. I., 2007, AM J PHYSIOL-RENAL, V292, P1471; Kim SI, 2008, J BIOL CHEM, V283, P10753, DOI 10.1074/jbc.M801263200; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Kumar R, 2004, BIOCHEM BIOPH RES CO, V323, P1293, DOI 10.1016/j.bbrc.2004.09.006; Manchen ST, 2001, BIOCHEM BIOPH RES CO, V287, P1075, DOI 10.1006/bbrc.2001.5701; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Miura S, 2000, MOL CELL BIOL, V20, P9346, DOI 10.1128/MCB.20.24.9346-9355.2000; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Moustakas A, 2001, J CELL SCI, V114, P4359; Ozaki T, 1999, DNA CELL BIOL, V18, P503, DOI 10.1089/104454999315222; Parks WT, 2001, J BIOL CHEM, V276, P19332, DOI 10.1074/jbc.M100606200; Sasaki T, 2007, GENE DEV, V21, P848, DOI 10.1101/gad.1534107; Song JW, 2001, NAT CELL BIOL, V3, P276, DOI 10.1038/35060068; Thress K, 1999, EMBO J, V18, P5486, DOI 10.1093/emboj/18.20.5486; Thress K, 1998, EMBO J, V17, P6135, DOI 10.1093/emboj/17.21.6135; Thress K, 2001, EMBO J, V20, P1033, DOI 10.1093/emboj/20.5.1033; von Strandmann EP, 2007, IMMUNITY, V27, P965, DOI 10.1016/j.immuni.2007.10.010; Wang L, 2004, J BIOL CHEM, V279, P33213, DOI 10.1074/jbc.M403758200; Wang L, 2002, J BIOL CHEM, V277, P47257, DOI 10.1074/jbc.M208573200; WeisGarcia F, 1996, EMBO J, V15, P276, DOI 10.1002/j.1460-2075.1996.tb00358.x; Winnefeld M, 2006, EXP CELL RES, V312, P2500, DOI 10.1016/j.yexcr.2006.04.020; Wu YH, 2004, J BIOL CHEM, V279, P19264, DOI 10.1074/jbc.M307049200; Yi JY, 2005, J BIOL CHEM, V280, P10870, DOI 10.1074/jbc.M413223200	37	38	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19816	19825		10.1074/jbc.M802285200	http://dx.doi.org/10.1074/jbc.M802285200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18487607	Green Published, hybrid			2022-12-25	WOS:000257387600065
J	Tolia, A; Horre, K; De Strooper, B				Tolia, Alexandra; Horre, Katrien; De Strooper, Bart			Transmembrane domain 9 of presenilin determines the dynamic conformation of the catalytic site of gamma-secretase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL PEPTIDE PEPTIDASE; AMYLOID PRECURSOR PROTEIN; INTRAMEMBRANE CLEAVAGE; MECHANISM; NICASTRIN; DOMAIN; APH-1; IDENTIFICATION; COMPLEX; ENDOPROTEOLYSIS	One of the most prominent drug targets for the treatment of Alzheimer disease is gamma-secretase, a multi-protein complex responsible for the generation of the amyloid-beta peptide. The catalytic core of the complex lies on presenilin, a multi-spanning membrane protease, the activity of which depends on two aspartate residues located in transmembrane domains 6 and 7. We have recently shown by cysteine-scanning mutagenesis that these aspartates are facing a water-filled cavity in the lipid bilayer, demonstrating how proteolytic cleavage of the substrates can be taking place within the membrane. Here, we demonstrate that transmembrane domain 9 and hydrophobic domain VII in the large cytoplasmic loop of presenilin are dynamic structural parts of this cavity. Hydrophobic domain VII is associated with transmembrane domain 7 in the membrane, probably facilitating the entrance of water molecules in the catalytic site. Transmembrane domain 9, on the other hand, exhibits a highly flexible structure, potentially involved in the transport of substrates to the catalytic site, as well as in the binding of gamma-secretase inhibitors. The conserved proline-alanine-leucine motif at the cytoplasmic part of this domain is extremely close to the catalytic Asp(257) and is crucial for conformational changes leading to the activation of the catalytic site. We, also, identify a unique mutant in this domain (I437C) that specifically blocks amyloid-beta peptide production without affecting the processing of the physiologically indispensable Notch substrate. Our data are finally combined to propose a model for the architectural organization and activation of the catalytic site of presenilin.	[Tolia, Alexandra; Horre, Katrien; De Strooper, Bart] Katholieke Univ Leuven, VIB, Dept Mol & Dev Genet, B-3000 Louvain, Belgium; [Tolia, Alexandra; Horre, Katrien; De Strooper, Bart] Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven	De Strooper, B (corresponding author), Herestr 49, B-3000 Louvain, Belgium.	Bart.destrooper@med.kuleuven.be	de+Strooper, Bart/Z-1638-2019; De Strooper, Bart/F-6507-2012	De Strooper, Bart/0000-0001-5455-5819; Horre, Katrien/0000-0002-6801-3137				Annaert WG, 2001, NEURON, V32, P579, DOI 10.1016/S0896-6273(01)00512-8; Baker RP, 2007, P NATL ACAD SCI USA, V104, P8257, DOI 10.1073/pnas.0700814104; Cordes FS, 2002, J MOL BIOL, V323, P951, DOI 10.1016/S0022-2836(02)01006-9; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; Iben LG, 2007, J BIOL CHEM, V282, P36829, DOI 10.1074/jbc.M707002200; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Kaback HR, 2001, NAT REV MOL CELL BIO, V2, P610, DOI 10.1038/35085077; Kaether C, 2002, J CELL BIOL, V158, P551, DOI 10.1083/jcb.200201123; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Knappenberger KS, 2004, BIOCHEMISTRY-US, V43, P6208, DOI 10.1021/bi036072v; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kornilova AY, 2005, P NATL ACAD SCI USA, V102, P3230, DOI 10.1073/pnas.0407640102; Laudon H, 2005, J BIOL CHEM, V280, P35352, DOI 10.1074/jbc.M507217200; Laudon H, 2004, J BIOL CHEM, V279, P23925, DOI 10.1074/jbc.M401277200; Loo TW, 2003, J BIOL CHEM, V278, P13603, DOI 10.1074/jbc.C300073200; Luo WJ, 2003, J BIOL CHEM, V278, P7850, DOI 10.1074/jbc.C200648200; Martoglio B, 2003, HUM MOL GENET, V12, pR201, DOI 10.1093/hmg/ddg303; Matthews EE, 2006, CELL, V127, P447, DOI 10.1016/j.cell.2006.10.016; Morohashi Y, 2006, J BIOL CHEM, V281, P14670, DOI 10.1074/jbc.M513012200; Niimura M, 2005, J BIOL CHEM, V280, P12967, DOI 10.1074/jbc.M409829200; Nyborg AC, 2004, J BIOL CHEM, V279, P43148, DOI 10.1074/jbc.M405879200; Pirch T, 2003, J BIOL CHEM, V278, P42942, DOI 10.1074/jbc.M308253200; Politzer P, 2003, J COMPUT CHEM, V24, P505, DOI 10.1002/jcc.10209; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Ray WJ, 1999, J BIOL CHEM, V274, P36801, DOI 10.1074/jbc.274.51.36801; Ruta V, 2005, CELL, V123, P463, DOI 10.1016/j.cell.2005.08.041; Sansom MSP, 2000, TRENDS PHARMACOL SCI, V21, P445; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Sato T, 2006, BIOCHEMISTRY-US, V45, P8649, DOI 10.1021/bi060597g; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Spasic D, 2006, J BIOL CHEM, V281, P26569, DOI 10.1074/jbc.M600592200; Tamura N, 2003, CURR OPIN CHEM BIOL, V7, P570, DOI 10.1016/j.cbpa.2003.08.014; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Wang J, 2006, J NEUROCHEM, V96, P218, DOI 10.1111/j.1471-4159.2005.03548.x; Wang J, 2004, NEUROBIOL DIS, V15, P654, DOI 10.1016/j.nbd.2003.12.008; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; Weihofen A, 2003, J BIOL CHEM, V278, P16528, DOI 10.1074/jbc.M301372200; Weihofen A, 2003, TRENDS CELL BIOL, V13, P71, DOI 10.1016/S0962-8924(02)00041-7; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wiita AP, 2006, P NATL ACAD SCI USA, V103, P7222, DOI 10.1073/pnas.0511035103; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wu ZR, 2006, NAT STRUCT MOL BIOL, V13, P1084, DOI 10.1038/nsmb1179; Yagishita S, 2006, BIOCHEMISTRY-US, V45, P3952, DOI 10.1021/bi0521846; Zhao B, 2008, J BIOL CHEM, V283, P2927, DOI 10.1074/jbc.M708870200; Zhao GJ, 2004, J BIOL CHEM, V279, P50647, DOI 10.1074/jbc.C400473200	52	61	64	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19793	19803		10.1074/jbc.M802461200	http://dx.doi.org/10.1074/jbc.M802461200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18482978	hybrid			2022-12-25	WOS:000257387600063
J	Grosman, AH; Janssen, A; de Brito, EF; Cordeiro, EG; Colares, F; Fonseca, JO; Lima, ER; Pallini, A; Sabelis, MW				Grosman, Amir H.; Janssen, Arne; de Brito, Elaine F.; Cordeiro, Eduardo G.; Colares, Felipe; Fonseca, Juliana Oliveira; Lima, Eraldo R.; Pallini, Angelo; Sabelis, Maurice W.			Parasitoid Increases Survival of Its Pupae by Inducing Hosts to Fight Predators	PLOS ONE			English	Article							HORNWORM MANDUCA-SEXTA; TOBACCO HORNWORM; ADAPTIVE-CHANGES; BEHAVIOR; MANIPULATION; WASP; TEMPERATURE; EVOLUTION; SELECTION	Many true parasites and parasitoids modify the behaviour of their host, and these changes are thought to be to the benefit of the parasites. However, field tests of this hypothesis are scarce, and it is often unclear whether the host or the parasite profits from the behavioural changes, or even if parasitism is a cause or consequence of the behaviour. We show that braconid parasitoids (Glyptapanteles sp.) induce their caterpillar host (Thyrinteina leucocerae) to behave as a bodyguard of the parasitoid pupae. After parasitoid larvae exit from the host to pupate, the host stops feeding, remains close to the pupae, knocks off predators with violent head-swings, and dies before reaching adulthood. Unparasitized caterpillars do not show these behaviours. In the field, the presence of bodyguard hosts resulted in a two-fold reduction in mortality of parasitoid pupae. Hence, the behaviour appears to be parasitoid-induced and confers benefits exclusively to the parasitoid.	[Grosman, Amir H.; Janssen, Arne; Sabelis, Maurice W.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Sect Populat Biol, Amsterdam, Netherlands; [de Brito, Elaine F.; Cordeiro, Eduardo G.; Colares, Felipe; Fonseca, Juliana Oliveira; Lima, Eraldo R.; Pallini, Angelo] Univ Fed Vicosa, Dept Animal Biol, Sect Agr Entomol, Vicosa, MG, Brazil	University of Amsterdam; Universidade Federal de Vicosa	Grosman, AH (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Sect Populat Biol, Amsterdam, Netherlands.	Janssen@science.uva.nl	Janssen, Arne/B-2657-2009; Pallini, Angelo/F-7791-2012; Lima, Eraldo R/S-9585-2018; Lima, Eraldo R/B-6675-2008	Janssen, Arne/0000-0001-5075-5303; Pallini, Angelo/0000-0003-3752-3545; Lima, Eraldo R/0000-0003-4446-5435	NWO-WOTRO [W 84-520]; CAPES [scholarship]; CNPq; FAPEMIG	NWO-WOTRO(Netherlands Organization for Scientific Research (NWO)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	A.H. Grosman was supported by NWO-WOTRO grant no. W 84-520, A.J. received a scholarship from CAPES (PVE), A.P. was supported by CNPq and FAPEMIG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo SA, 2000, CAN J ZOOL, V78, P1580, DOI 10.1139/cjz-78-9-1580; Adamo SA, 2005, ARCH INSECT BIOCHEM, V60, P185, DOI 10.1002/arch.20068; Adamo SA, 2002, BRAIN BEHAV EVOLUT, V60, P370, DOI 10.1159/000067790; Adamo SA, 1997, J EXP BIOL, V200, P117; BAUDOIN M, 1975, EVOLUTION, V29, P335, DOI [10.2307/2407221, 10.1111/j.1558-5646.1975.tb00213.x]; BECKAGE NE, 1978, ENTOMOL EXP APPL, V23, P139, DOI 10.1007/BF00290629; BRODEUR J, 1989, SCIENCE, V244, P226, DOI 10.1126/science.244.4901.226; Brodeur J, 2004, ANNU REV ENTOMOL, V49, P27, DOI 10.1146/annurev.ento.49.061703.153618; BRODEUR J, 1994, ANIM BEHAV, V48, P187, DOI 10.1006/anbe.1994.1225; CARNEY WP, 1969, AM MIDL NAT, V82, P605, DOI 10.2307/2423801; Castellan NJ, 1988, NONPARAMETRIC STAT B; Cezilly F., 2005, Behavioural Processes, V68, P185, DOI 10.1016/j.beproc.2004.06.010; Cezilly F, 2005, BEHAV PROCESS, V68, P223, DOI 10.1016/j.beproc.2004.08.013; COMBES C, 1991, AM NAT, V138, P866, DOI 10.1086/285257; Crawley MJ., 2007, R BOOK; Dawkins R., 1982, pi; Eberhard WG, 2000, NATURE, V406, P255, DOI 10.1038/35018636; Elliot SL, 2002, P ROY SOC B-BIOL SCI, V269, P1599, DOI 10.1098/rspb.2002.2067; Gelman DB, 1998, J INSECT PHYSIOL, V44, P833, DOI 10.1016/S0022-1910(98)00015-8; Gelman DB, 1999, ARCH INSECT BIOCHEM, V40, P17, DOI 10.1002/(SICI)1520-6327(1999)40:1&lt;17::AID-ARCH3&gt;3.0.CO;2-#; Godfray H. C. J., 1994, MONOGRAPHS BEHAV ECO; HOHORST W, 1961, NATURWISSENSCHAFTEN, V48, P229, DOI 10.1007/BF00597502; Miles CI, 2000, J EXP BIOL, V203, P1689; Moore J., 2002, OXFORD SERIES ECOLOG, P338; Mouritsen KN, 2003, INT J PARASITOL, V33, P1043, DOI 10.1016/S0020-7519(03)00178-4; MULLER CB, 1993, NATURE, V363, P65, DOI 10.1038/363065a0; MULLER CB, 1994, ANIM BEHAV, V48, P961, DOI 10.1006/anbe.1994.1321; Ponton F, 2006, NATURE, V440, P756, DOI 10.1038/440756a; Poulin R, 1999, PARASITOL TODAY, V15, P28, DOI 10.1016/S0169-4758(98)01357-X; Poulin R, 2005, BEHAV PROCESS, V68, P241, DOI 10.1016/j.beproc.2004.07.011; Poulin R, 1995, INT J PARASITOL, V25, P1371, DOI 10.1016/0020-7519(95)00100-X; Roy HE, 2006, ANNU REV ENTOMOL, V51, P331, DOI 10.1146/annurev.ento.51.110104.150941; SCHNEIDER G, 1971, NATURWISSENSCHAFTEN, V58, P327, DOI 10.1007/BF00624750; Thomas F, 1998, PARASITOLOGY, V116, P431, DOI 10.1017/S003118209800239X; Thomas F, 2002, J EVOLUTION BIOL, V15, P356, DOI 10.1046/j.1420-9101.2002.00410.x; Thomas F, 2005, BEHAV PROCESS, V68, P185, DOI 10.1016/j.beproc.2004.06.010; Vyas A, 2007, P NATL ACAD SCI USA, V104, P6442, DOI 10.1073/pnas.0608310104; WICKLER W, 1976, Z TIERPSYCHOL, V42, P206; [No title captured]	39	77	80	0	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2276	10.1371/journal.pone.0002276	http://dx.doi.org/10.1371/journal.pone.0002276			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	396TO	18523578	Green Published, Green Submitted, gold			2022-12-25	WOS:000262614300005
J	Moleon, M; Almaraz, P; Sanchez-Zapata, JA				Moleon, Marcos; Almaraz, Pablo; Sanchez-Zapata, Jose A.			An Emerging Infectious Disease Triggering Large-Scale Hyperpredation	PLOS ONE			English	Article							VIRAL HEMORRHAGIC-DISEASE; WILD RABBIT; POPULATION; PREDATION; EMERGENCE; DENSITY; DECLINE; BIRDS	Hyperpredation refers to an enhanced predation pressure on a secondary prey due to either an increase in the abundance of a predator population or a sudden drop in the abundance of the main prey. This scarcely documented mechanism has been previously studied in scenarios in which the introduction of a feral prey caused overexploitation of native prey. Here we provide evidence of a previously unreported link between Emergent Infectious Diseases (EIDs) and hyperpredation on a predator-prey community. We show how a viral outbreak caused the population collapse of a host prey at a large spatial scale, which subsequently promoted higher-than-normal predation intensity on a second prey from shared predators. Thus, the disease left a population dynamic fingerprint both in the primary host prey, through direct mortality from the disease, and indirectly in the secondary prey, through hyperpredation. This resulted in synchronized prey population dynamics at a large spatio-temporal scale. We therefore provide evidence for a novel mechanism by which EIDs can disrupt a predator-prey interaction from the individual behavior to the population dynamics. This mechanism can pose a further threat	[Moleon, Marcos] Univ Granada, Dept Biol Anim, Granada, Spain; [Almaraz, Pablo] Consejo Superior Investigac Cient, Estac Biol Donana, Seville, Spain; [Sanchez-Zapata, Jose A.] Univ Miguel Hernandez, Dept Biol Aplicada, Alicante, Spain	University of Granada; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Universidad Miguel Hernandez de Elche	Moleon, M (corresponding author), Univ Granada, Dept Biol Anim, Granada, Spain.	mmoleonpaiz@hotmail.com	Almaraz, Pablo/A-3683-2014; Moleón, Marcos/K-2875-2014; Sanchez-Zapata, Jose Antonio/H-1413-2015	Almaraz, Pablo/0000-0003-1416-2695; Moleón, Marcos/0000-0002-3126-619X; Sanchez-Zapata, Jose Antonio/0000-0001-8230-4953	Spanish Ministerio de Educacion y Ciencia;  [CGL-2006-10689/BOS]	Spanish Ministerio de Educacion y Ciencia(Spanish Government); 	MM and JASZ were partially supported by a project of the Spanish Ministerio de Educacion y Ciencia (reference CGL-2006-10689/BOS).	Almaraz P, 2004, ECOL LETT, V7, P547, DOI 10.1111/j.1461-0248.2004.00612.x; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; ANGELSTAM P, 1985, HOLARCTIC ECOL, V8, P285; [Anonymous], 1999, BIOL WILDLIFE MEDITE; BOSTFORD LW, 1983, CAN J FISH AQUAT SCI, V40, P337; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Burnham K. P., 1998, MODEL SELECTION INFE; Calvete C, 2002, VET REC, V150, P776, DOI 10.1136/vr.150.25.776; Calvete C, 2006, CONSERV BIOL, V20, P1232, DOI 10.1111/j.1523-1739.2006.00371.x; Cattadori IM, 2003, OIKOS, V100, P439, DOI 10.1034/j.1600-0706.2003.12072.x; Clark J. S, 2007, MODELS ECOLOGICAL DA; Courchamp F, 2000, J ANIM ECOL, V69, P154, DOI 10.1046/j.1365-2656.2000.00383.x; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Dennis B, 2006, ECOL MONOGR, V76, P323, DOI 10.1890/0012-9615(2006)76[323:EDDPNA]2.0.CO;2; DURBIN B, 2001, TIME SERIES ANAL STA; FERNANDEZ C, 1993, REV ECOL-TERRE VIE, V48, P323; Gelman A., 2004, BAYESIAN DATA ANAL; Hatcher MJ, 2006, ECOL LETT, V9, P1253, DOI 10.1111/j.1461-0248.2006.00964.x; Kristan WB, 2003, ECOLOGY, V84, P2432, DOI 10.1890/02-0448; LaDeau SL, 2007, NATURE, V447, P710, DOI 10.1038/nature05829; Madrono A., 2004, LIBRO ROJO AVES ESPA; MOLEON M., 2007, BIODIVERSIDAD CONSER, P743; MORSE SS, 1995, EMERG INFECT DIS, V1, P7, DOI 10.3201/eid0101.950102; Robert PC, 2004, MONTE CARLO STAT MET; Roemer GW, 2001, ANIM CONSERV, V4, P307, DOI 10.1017/S1367943001001366; Royama T., 1992, ANAL POPULATION ECOL; Sheppard SK, 2005, MOL ECOL, V14, P4461, DOI 10.1111/j.1365-294X.2005.02742.x; Smith AP, 1996, BIOL CONSERV, V77, P243, DOI 10.1016/0006-3207(96)00002-X; Tong H, 1990, NONLINEAR TIME SERIE; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; Villafuerte R, 1995, MAMMALIA, V59, P651, DOI 10.1515/mamm.1995.59.4.651; VIRGOS E, BIODIVERS C IN PRESS; Whelan CJ, 2003, EVOL ECOL RES, V5, P329	33	36	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2307	10.1371/journal.pone.0002307	http://dx.doi.org/10.1371/journal.pone.0002307			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523587	Green Published, Green Submitted, gold			2022-12-25	WOS:000262614300014
J	Zeeuwen, PLJM; de Jongh, GJ; Rodijk-Olthuis, D; Kamsteeg, M; Verhoosel, RM; van Rossum, MM; Hiemstra, PS; Schalkwijk, J				Zeeuwen, Patrick L. J. M.; de Jongh, Gys J.; Rodijk-Olthuis, Diana; Kamsteeg, Marijke; Verhoosel, Renate M.; van Rossum, Michelle M.; Hiemstra, Pieter S.; Schalkwijk, Joost			Genetically Programmed Differences in Epidermal Host Defense between Psoriasis and Atopic Dermatitis Patients	PLOS ONE			English	Article								In the past decades, chronic inflammatory diseases such as psoriasis, atopic dermatitis, asthma, Crohn's disease and celiac disease were generally regarded as immune-mediated conditions involving activated T-cells and proinflammatory cytokines produced by these cells. This paradigm has recently been challenged by the finding that mutations and polymorphisms in epithelium-expressed genes involved in physical barrier function or innate immunity, are risk factors of these conditions. We used a functional genomics approach to analyze cultured keratinocytes from patients with psoriasis or atopic dermatitis and healthy controls. First passage primary cells derived from non-lesional skin were stimulated with pro-inflammatory cytokines, and expression of a panel of 55 genes associated with epidermal differentiation and cutaneous inflammation was measured by quantitative PCR. A subset of these genes was analyzed at the protein level. Using cluster analysis and multivariate analysis of variance we identified groups of genes that were differentially expressed, and could, depending on the stimulus, provide a disease-specific gene expression signature. We found particularly large differences in expression levels of innate immunity genes between keratinocytes from psoriasis patients and atopic dermatitis patients. Our findings indicate that cell-autonomous differences exist between cultured keratinocytes of psoriasis and atopic dermatitis patients, which we interpret to be genetically determined. We hypothesize that polymorphisms of innate immunity genes both with signaling and effector functions are coadapted, each with balancing advantages and disadvantages. In the case of psoriasis, high expression levels of antimicrobial proteins genes putatively confer increased protection against microbial infection, but the biological cost could be a beneficial system gone awry, leading to overt inflammatory disease.	[Zeeuwen, Patrick L. J. M.; de Jongh, Gys J.; Rodijk-Olthuis, Diana; Kamsteeg, Marijke; van Rossum, Michelle M.; Schalkwijk, Joost] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Lab Skin Biol & Expt Dermatol, NL-6525 ED Nijmegen, Netherlands; [Verhoosel, Renate M.; Hiemstra, Pieter S.] Leiden Univ, Med Ctr, Dept Pulmonol, Leiden, Netherlands	Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Zeeuwen, PLJM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Lab Skin Biol & Expt Dermatol, NL-6525 ED Nijmegen, Netherlands.	P.Zeeuwen@ncmls.ru.nl; J.Schalkwijk@ncmls.ru.nl	Schalkwijk, Joost/R-7509-2019; Kamsteeg, M./L-4422-2015; Hiemstra, Pieter S/K-8587-2018; Zeeuwen, Patrick/N-1779-2013; /V-8478-2019; Schalkwijk, Joost/N-1774-2013; Rossum, M.M./L-4614-2015	Schalkwijk, Joost/0000-0002-1308-1319; Hiemstra, Pieter S/0000-0002-0238-5982; Zeeuwen, Patrick/0000-0002-6878-2438; 				Cookson W, 2004, NAT REV IMMUNOL, V4, P978, DOI 10.1038/nri1500; de Jongh GJ, 2005, J INVEST DERMATOL, V125, P1163, DOI 10.1111/j.0022-202X.2005.23935.x; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Franssen MEJ, 2005, J INVEST DERMATOL, V124, P373, DOI 10.1111/j.0022-202X.2004.23612.x; Fry L, 2007, CLIN DERMATOL, V25, P606, DOI 10.1016/j.clindermatol.2007.08.015; Giustizieri ML, 2001, J ALLERGY CLIN IMMUN, V107, P871, DOI 10.1067/mai.2001.114707; HENSELER T, 1995, J AM ACAD DERMATOL, V32, P982, DOI 10.1016/0190-9622(95)91336-X; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Howell MD, 2006, IMMUNITY, V24, P341, DOI 10.1016/j.immuni.2006.02.006; Howell MD, 2006, CLIN IMMUNOL, V121, P332, DOI 10.1016/j.clim.2006.08.008; Kamsteeg M, 2007, J INVEST DERMATOL, V127, P1786, DOI 10.1038/sj.jid.5700752; Liu AY, 2002, J INVEST DERMATOL, V118, P275, DOI 10.1046/j.0022-202x.2001.01651.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MUKAIDA N, 1990, J BIOL CHEM, V265, P21128; Nickoloff BJ, 2006, TRENDS MOL MED, V12, P102, DOI 10.1016/j.molmed.2006.01.001; NICKOLOFF BJ, 1989, BRIT J DERMATOL, V121, P161, DOI 10.1111/j.1365-2133.1989.tb01795.x; Nomura I, 2003, J IMMUNOL, V171, P3262, DOI 10.4049/jimmunol.171.6.3262; Nomura L, 2003, J ALLERGY CLIN IMMUN, V112, P1195, DOI 10.1016/j.jaci.2003.08.049; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; OLANIRAN AK, 1995, ARCH DERMATOL RES, V287, P231, DOI 10.1007/BF01105071; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Pfundt R, 2000, ARCH DERMATOL RES, V292, P180, DOI 10.1007/s004030050475; Pfundt R, 1996, J CLIN INVEST, V98, P1389, DOI 10.1172/JCI118926; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Vandermeeren M, 2001, ARCH DERMATOL RES, V293, P343, DOI 10.1007/s004030100238; vanRuissen F, 1996, J CELL PHYSIOL, V168, P442; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Wehkamp K, 2006, J INVEST DERMATOL, V126, P121, DOI 10.1038/sj.jid.5700020; Wingens M, 1998, J INVEST DERMATOL, V111, P996, DOI 10.1046/j.1523-1747.1998.00425.x; Zhou XH, 2003, PHYSIOL GENOMICS, V13, P69, DOI 10.1152/physiolgenomics.00157.2002	33	38	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2301	10.1371/journal.pone.0002301	http://dx.doi.org/10.1371/journal.pone.0002301			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523683	Green Submitted, Green Published, gold			2022-12-25	WOS:000262614300012
J	Lange, TS; Kim, KK; Singh, RK; Strongin, RM; McCourt, CK; Brard, L				Lange, Thilo S.; Kim, Kyu Kwang; Singh, Rakesh K.; Strongin, Robert M.; McCourt, Carolyn K.; Brard, Laurent			Iron(III)-Salophene: An Organometallic Compound with Selective Cytotoxic and Anti-Proliferative Properties in Platinum-Resistant Ovarian Cancer Cells	PLOS ONE			English	Article							DNA-BINDING; CLEAVING PROPERTIES; CYCLE CONTROL; MAP KINASE; COMPLEXES; APOPTOSIS; PROLIFERATION; COPPER(II); ACTIVATION; CARCINOMA	Background: In this pioneer study to the biological activity of organometallic compound Iron(III)-salophene (Fe-SP) the specific effects of Fe-SP on viability, morphology, proliferation, and cell-cycle progression on platinum-resistant ovarian cancer cell lines were investigated. Methodology/Principal Findings: Fe-SP displayed selective cytotoxicity against SKOV-3 and OVCAR-3 (ovarian epithelial adenocarcinoma) cell lines at concentrations between 100 nM and 1 mu M, while the viability of HeLa cells (epithelial cervix adenocarcinoma) or primary lung or skin fibroblasts was not affected. SKOV-3 cells in contrast to fibroblasts after treatment with Fe-SP revealed apparent hallmarks of apoptosis including densely stained nuclear granular bodies within fragmented nuclei, highly condensed chromatin and chromatin fragmentation. Fe-SP treatment led to the activation of markers of the extrinsic (Caspase-8) and intrinsic (Caspase-9) pathway of apoptosis as well as of executioner Caspase-3 while PARP-1 was deactivated. Fe-SP exerted effects as an anti-proliferative agent with an IC50 value of 300 nM and caused delayed progression of cells through S-phase phase of the cell cycle resulting in a complete S-phase arrest. When intra-peritoneally applied to rats Fe-SP did not show any systemic toxicity at concentrations that in preliminary trials were determined to be chemotherapeutic relevant doses in a rat ovarian cancer cell model. Conclusion/Significance: The present report suggests that Fe-SP is a potent growth-suppressing agent in vitro for cell lines derived from ovarian cancer and a potential therapeutic drug to treat such tumors in vivo.	[Lange, Thilo S.; Kim, Kyu Kwang; Singh, Rakesh K.; McCourt, Carolyn K.; Brard, Laurent] Brown Univ, Women & Infants Hosp RI, Warren Alpert Med Sch,Mol Therapeut Lab, Program Womens Oncol,Dept Obstet & Gynecol, Providence, RI 02912 USA; [Lange, Thilo S.] Brown Univ, Dept Biol & Med, Providence, RI USA; [Strongin, Robert M.] Portland State Univ, Dept Chem, Portland, OR USA	Brown University; Women & Infants Hospital Rhode Island; Brown University; Portland State University	Lange, TS (corresponding author), Brown Univ, Women & Infants Hosp RI, Warren Alpert Med Sch,Mol Therapeut Lab, Program Womens Oncol,Dept Obstet & Gynecol, Providence, RI 02912 USA.	lbrard@wihri.org	Strongin, Robert M./F-1026-2010	Brard, Laurent/0000-0003-0065-1826	Brown University [Seed Grant]; NICHD [K12 HD043447]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD043447] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018728] Funding Source: NIH RePORTER	Brown University; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a Brown University Seed Grant and a NICHD, K12 HD043447 BIRCWH Scholar Grant to Dr. Brard.	Aggarwal P, 2007, GENE DEV, V21, P2908, DOI 10.1101/gad.1586007; Alpturk O, 2006, P NATL ACAD SCI USA, V103, P9756, DOI 10.1073/pnas.0603758103; *AM CANC SOC, 2007, CANC FACTS FIG 2007; Bi CF, 2001, SYN REACT INORG MET, V31, P219, DOI 10.1081/SIM-100002041; Birkenkamp KU, 1999, LEUKEMIA, V13, P1037, DOI 10.1038/sj.leu.2401447; BURROWS CJ, 1994, ACCOUNTS CHEM RES, V27, P295, DOI 10.1021/ar00046a002; Cerchiaro G, 2005, J INORG BIOCHEM, V99, P1433, DOI 10.1016/j.jinorgbio.2005.03.013; CREASY LE, 1896, 256 EC TEMPL CHAMB, V9; Desoize B, 2002, CRIT REV ONCOL HEMAT, V42, P213, DOI 10.1016/S1040-8428(02)00039-2; Doctrow SR, 2002, J MED CHEM, V45, P4549, DOI 10.1021/jm020207y; DOLLWET HHA, 1985, TRACE ELEM MED, V2, P80; EARNSHAW WC, 1995, CURR OPIN CELL BIOL, V7, P337, DOI 10.1016/0955-0674(95)80088-3; Gladden AB, 2003, CANCER CELL, V4, P160, DOI 10.1016/S1535-6108(03)00217-4; Gust R, 2004, J MED CHEM, V47, P5837, DOI 10.1021/jm040763n; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Heintz APM, 2003, INT J GYNECOL OBSTET, V83, P135, DOI 10.1016/S0020-7292(03)90118-4; Huang RL, 2005, BIOCHEM PHARMACOL, V69, P1009, DOI 10.1016/j.bcp.2005.01.001; KOEHLAR CSW, 2001, CHEM CHRONICLES, V10, P61; KOPFMAIER P, 1994, EUR J CLIN PHARMACOL, V47, P1, DOI 10.1007/BF00193472; Lambert HE, 2004, INT J GYNECOL CANCER, V14, P772, DOI 10.1111/j.1048-891X.2004.014507.x; Lange TS, 2007, CHEM BIOL DRUG DES, V70, P302, DOI 10.1111/j.1747-0285.2007.00567.x; LIU ZX, 1994, ARCH BIOCHEM BIOPHYS, V315, P74, DOI 10.1006/abbi.1994.1473; Malich G, 1997, TOXICOLOGY, V124, P179, DOI 10.1016/S0300-483X(97)00151-0; Mandal SS, 1997, BIOCONJUGATE CHEM, V8, P798, DOI 10.1021/bc970121x; Mazumder S, 2004, CURR CANCER DRUG TAR, V4, P65, DOI 10.2174/1568009043481669; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Ott I, 2007, ARCH PHARM, V340, P117, DOI 10.1002/ardp.200600151; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; PINES J, 1999, NATL CELL BIOL, V1, P73; Putcha GV, 2002, J CELL BIOL, V157, P441, DOI 10.1083/jcb.200110108; Routier S, 1999, NUCLEIC ACIDS RES, V27, P4160, DOI 10.1093/nar/27.21.4160; Routier S, 1997, BIOCONJUGATE CHEM, V8, P789, DOI 10.1021/bc970131y; Routier S, 1996, BIOORGAN MED CHEM, V4, P1185, DOI 10.1016/0968-0896(96)00082-X; Salvesen GS, 2004, ONCOGENE, V23, P2774, DOI 10.1038/sj.onc.1207522; Shapiro GI, 1999, J CLIN INVEST, V104, P1645, DOI 10.1172/JCI9054; Shishodia S, 2007, BIOCHEM PHARMACOL, V74, P118, DOI 10.1016/j.bcp.2007.03.026; Shrivastava HY, 2005, FREE RADICAL BIO MED, V38, P58, DOI 10.1016/j.freeradbiomed.2004.09.029; Singh RK, 2008, LETT ORG CHEM, V5, P103; SINGH RK, 2008, GYN ONC IN PRESS; Stillman B, 1996, SCIENCE, V274, P1659, DOI 10.1126/science.274.5293.1659; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Woldemariam GA, 2008, J INORG BIOCHEM, V102, P740, DOI 10.1016/j.jinorgbio.2007.11.008; Zhong X, 2007, BIOORG MED CHEM LETT, V17, P3774, DOI 10.1016/j.bmcl.2007.04.006	43	46	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2303	10.1371/journal.pone.0002303	http://dx.doi.org/10.1371/journal.pone.0002303			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509533	Green Published, Green Submitted, gold			2022-12-25	WOS:000262268500038
J	Cameron, N; Del Corpo, A; Diorio, J; McAllister, K; Sharma, S; Meaney, MJ				Cameron, Nicole; Del Corpo, Adina; Diorio, Josie; McAllister, Kelli; Sharma, Shakti; Meaney, Michael J.			Maternal Programming of Sexual Behavior and Hypothalamic-Pituitary-Gonadal Function in the Female Rat	PLOS ONE			English	Article							HORMONE-RELEASING HORMONE; ESTROGEN-RECEPTOR-ALPHA; CENTRAL-NERVOUS-SYSTEM; MESSENGER-RNA LEVELS; INDIVIDUAL-DIFFERENCES; GENE-EXPRESSION; REPRODUCTIVE STRATEGIES; CHILDHOOD EXPERIENCE; PUBERTAL MATURATION; CARE	Variations in parental care predict the age of puberty, sexual activity in adolescence and the age at first pregnancy in humans. These findings parallel descriptions of maternal effects on phenotypic variation in reproductive function in other species. Despite the prevalence of such reports, little is known about potential biological mechanisms and this especially true for effects on female reproductive development. We examined the hypothesis that parental care might alter hypothalamic-pituitary-ovarian function and thus reproductive function in the female offspring of rat mothers that vary pup licking/grooming (LG) over the first week postpartum. As adults, the female offspring of Low LG mothers showed 1) increased sexual receptivity; 2) increased plasma levels of luteinizing hormone (LH) and progesterone at proestrus; 3) an increased positive-feedback effect of estradiol on both plasma LH levels and gonadotropin releasing-hormone (GnRH) expression in the medial preoptic region; and 4) increased estrogen receptor alpha (ER alpha) expression in the anterioventral paraventricular nucleus, a system that regulates GnRH. The results of a cross-fostering study provide evidence for a direct effect of postnatal maternal care as well as a possible prenatal influence. Indeed, we found evidence for increased fetal testosterone levels at embryonic day 20 in the female fetuses of High compared to Low LG mothers. Finally, the female offspring of Low LG mothers showed accelerated puberty compared to those of High LG mothers. These data suggest maternal effects in the rat on the development of neuroendocrine systems that regulate female sexual behaviour. Together with studies revealing a maternal effect on the maternal behavior of the female offspring, these findings suggest that maternal care can program alternative reproductive phenotypes in the rat through regionally-specific effects on ER alpha expression.	[Cameron, Nicole; Del Corpo, Adina; Diorio, Josie; McAllister, Kelli; Sharma, Shakti; Meaney, Michael J.] McGill Univ, Sackler Program Epigenet & Psychobiol, Montreal, PQ, Canada	McGill University	Cameron, N (corresponding author), McGill Univ, Sackler Program Epigenet & Psychobiol, Montreal, PQ, Canada.	michael.meaney@mcgill.ca	Meaney, Michael/N-5931-2019	Cameron, Nicole/0000-0002-5372-3902; Reis, AlessanRSS/0000-0001-8486-7469	Canadian Institutes for Health Research	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported by a grant from the Canadian Institutes for Health Research to MJM.	AnderssonEllstrom A, 1996, ACTA OBSTET GYN SCAN, V75, P484, DOI 10.3109/00016349609033359; [Anonymous], 1986, DEV ANTISOCIAL PROSO; Arnold AP, 2004, NAT REV NEUROSCI, V5, P701, DOI 10.1038/nrn1494; Belsky J, 1997, CHILD DEV, V68, P598, DOI 10.2307/1132110; BELSKY J, 1991, CHILD DEV, V62, P647, DOI 10.1111/j.1467-8624.1991.tb01558.x; Bingham C R, 1990, J Adolesc Res, V5, P18, DOI 10.1177/074355489051004; Blaustein J. D., 2002, HORMONES BRAIN BEHAV, P139; BREEDLOVE SM, 2002, BEHAV ENDOCRINOLOGY, P75; Caldji C, 1998, P NATL ACAD SCI USA, V95, P5335, DOI 10.1073/pnas.95.9.5335; CAMERON N, HORMONES BE IN PRESS; Cameron NM, 2005, NEUROSCI BIOBEHAV R, V29, P843, DOI 10.1016/j.neubiorev.2005.03.022; Champagne F, 2001, P NATL ACAD SCI USA, V98, P12736, DOI 10.1073/pnas.221224598; Champagne FA, 2003, PHYSIOL BEHAV, V79, P359, DOI 10.1016/S0031-9384(03)00149-5; Champagne FA, 2003, ENDOCRINOLOGY, V144, P4720, DOI 10.1210/en.2003-0564; Champagne FA, 2006, ENDOCRINOLOGY, V147, P2909, DOI 10.1210/en.2005-1119; Charnov Eric L., 1993, P1; CHISHOLM JS, 1993, CURR ANTHROPOL, V34, P1, DOI 10.1086/204131; Coall DA, 2003, SOC SCI MED, V57, P1771, DOI 10.1016/S0277-9536(03)00022-4; Ellis BJ, 1999, J PERS SOC PSYCHOL, V77, P387, DOI 10.1037/0022-3514.77.2.387; Ellis BJ, 2004, PSYCHOL BULL, V130, P920, DOI 10.1037/0033-2909.130.6.920; Ellis BJ, 2000, CHILD DEV, V71, P485, DOI 10.1111/1467-8624.00159; Erskine MS, 2004, BEHAV BRAIN RES, V153, P295, DOI 10.1016/j.bbr.2004.01.026; ERSKINE MS, 1989, HORM BEHAV, V23, P473, DOI 10.1016/0018-506X(89)90037-8; ERSKINE MS, 1992, BEHAV NEUROSCI, V106, P690, DOI 10.1037/0735-7044.106.4.690; Fairbanks LA., 1996, ADV STUDY BEHAV VOL, V25, P579, DOI [10.1016/S0065-3454(08)60343-5, DOI 10.1016/S0065-3454(08)60343-5]; Fleming AS, 1999, NEUROSCI BIOBEHAV R, V23, P673, DOI 10.1016/S0149-7634(99)00011-1; Foecking EM, 2005, BIOL REPROD, V72, P1475, DOI 10.1095/biolreprod.105.039800; Francis D, 1999, SCIENCE, V286, P1155, DOI 10.1126/science.286.5442.1155; Freeman Marc E., 1994, P613; Gangestad SW, 2000, BEHAV BRAIN SCI, V23, P573, DOI 10.1017/S0140525X0000337X; GANS SE, 1993, HORM BEHAV, V27, P403, DOI 10.1006/hbeh.1993.1030; Gomes CM, 2005, J ENDOCRINOL, V184, P435, DOI 10.1677/joe.1.05907; GOODMAN RL, 1978, ENDOCRINOLOGY, V102, P151, DOI 10.1210/endo-102-1-151; GORE AC, 1995, ENDOCRINOLOGY, V136, P889, DOI 10.1210/en.136.3.889; GOSDEN RG, 1976, ENDOCRINOLOGY, V99, P1046, DOI 10.1210/endo-99-4-1046; Goy R. W., 1980, SEXUAL DIFFERENTIATI; GRABER JA, 1995, CHILD DEV, V66, P346, DOI 10.1111/j.1467-8624.1995.tb00875.x; Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; Gu GB, 1997, J COMP NEUROL, V384, P142; HARDY DF, 1972, J COMP PHYSIOL PSYCH, V78, P400, DOI 10.1037/h0032536; HENNESSY MB, 1980, DEV PSYCHOBIOL, V13, P573, DOI 10.1002/dev.420130603; Herbison AE, 1998, ENDOCR REV, V19, P302, DOI 10.1210/edrv.19.3.0332; HERBISON AE, 1992, NEUROSCIENCE, V50, P283, DOI 10.1016/0306-4522(92)90423-Y; Herbison AE, 2008, ENDOCRINOLOGY, V149, P597, DOI 10.1210/en.2007-1139; HOFFMAN GE, 1993, FRONT NEUROENDOCRIN, V14, P173, DOI 10.1006/frne.1993.1006; KALRA PS, 1975, NEUROENDOCRINOLOGY, V19, P289, DOI 10.1159/000122450; Karsch FJ, 1997, BIOL REPROD, V56, P303, DOI 10.1095/biolreprod56.2.303; Kim K, 1997, EVOL HUM BEHAV, V18, P109, DOI 10.1016/S1090-5138(96)00114-6; Laflamme N, 1998, J NEUROBIOL, V36, P357, DOI 10.1002/(SICI)1097-4695(19980905)36:3<357::AID-NEU5>3.0.CO;2-V; Lannigan DA, 2003, STEROIDS, V68, P1, DOI 10.1016/S0039-128X(02)00110-1; LEE MHS, 1975, DEV PSYCHOBIOL, V8, P91, DOI 10.1002/dev.420080113; LEE WS, 1990, P NATL ACAD SCI USA, V87, P5163, DOI 10.1073/pnas.87.13.5163; LEVINE JE, 1991, RECENT PROG HORM RES, V47, P97; Liu D, 2000, NAT NEUROSCI, V3, P799, DOI 10.1038/77702; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Maestripieri D, 1999, NEUROSCI BIOBEHAV R, V23, P411, DOI 10.1016/S0149-7634(98)00042-6; MARLOWE FW, 2003, J COMP SOC SCI, V37, P282; MCCARTHY MM, 1994, PSYCHONEUROENDOCRINO, V19, P415, DOI 10.1016/0306-4530(94)90029-9; MCCLINTOCK MK, 1982, ANIM BEHAV, V30, P410, DOI 10.1016/S0003-3472(82)80052-3; MCLOYD VC, 1990, CHILD DEV, V61, P311, DOI 10.1111/j.1467-8624.1990.tb02781.x; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; Miller L, 1997, J AM ACAD CHILD PSY, V36, P1134, DOI 10.1097/00004583-199708000-00022; MOFFITT TE, 1992, CHILD DEV, V63, P47, DOI 10.1111/j.1467-8624.1992.tb03594.x; MYERS MM, 1989, DEV PSYCHOBIOL, V22, P55, DOI 10.1002/dev.420220105; Ojeda S.R., 1988, PHYSL REPROD, P1699; Padoin MJ, 2001, BEHAV NEUROSCI, V115, P1332, DOI 10.1037//0735-7044.115.6.1332; PETERSEN SL, 1989, BRAIN RES, V484, P279, DOI 10.1016/0006-8993(89)90371-5; PETERSEN SL, 1993, AM ZOOL, V33, P255; PETERSEN SL, 1989, J NEUROENDOCRINOL, V1, P279, DOI 10.1111/j.1365-2826.1989.tb00116.x; PFAFF D, 1973, J COMP NEUROL, V151, P121, DOI 10.1002/cne.901510204; Pfaff Donald W., 1994, P107; PHINNEY VG, 1990, ADOLESCENCE, V25, P321; Quinlan RJ, 2003, EVOL HUM BEHAV, V24, P376, DOI 10.1016/S1090-5138(03)00039-4; Qvarnstrom A, 2001, TRENDS ECOL EVOL, V16, P95, DOI 10.1016/S0169-5347(00)02063-2; Repetti RL, 2002, PSYCHOL BULL, V128, P330, DOI 10.1037/0033-2909.128.2.330; Rhen T, 2002, J NEUROENDOCRINOL, V14, P517, DOI 10.1046/j.1365-2826.2002.00820.x; Roff Derek A., 1992; Roosa MW, 1997, J MARRIAGE FAM, V59, P119, DOI 10.2307/353666; Rossiter M, 1998, MATERNAL EFFECTS AS ADAPTATIONS, P112; Ryder N. B., 1971, REPROD US 1965; SAAL FSV, 1983, SCIENCE, V220, P1306, DOI 10.1126/science.6857252; Shughrue PJ, 1997, J COMP NEUROL, V388, P507, DOI 10.1002/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6; Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745; SIMERLY RB, 1990, J COMP NEUROL, V294, P76, DOI 10.1002/cne.902940107; Stearns S.C., 1992, pi; STEINBERG L, 1988, DEV PSYCHOL, V24, P122, DOI 10.1037/0012-1649.24.1.122; Swanson LW., 2004, BRAIN MAPS STRUCTURE, V3rd edition; UDRY JR, 1982, DEMOGRAPHY, V19, P53, DOI 10.2307/2061128; VIAU V, 1991, ENDOCRINOLOGY, V129, P2503, DOI 10.1210/endo-129-5-2503; VOMACHKA AJ, 1986, HORM BEHAV, V20, P181, DOI 10.1016/0018-506X(86)90016-4; WATSON RE, 1986, PEPTIDES, V7, P155, DOI 10.1016/0196-9781(86)90076-8; WIEGAND SJ, 1982, NEUROENDOCRINOLOGY, V34, P395, DOI 10.1159/000123335; Wilson M, 1997, BRIT MED J, V314, P1271, DOI 10.1136/bmj.314.7089.1271; Worthman CM, 1999, EVOLUTIONARY MEDICI NE, P135	94	127	128	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2210	10.1371/journal.pone.0002210	http://dx.doi.org/10.1371/journal.pone.0002210			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	391UK	18493313	gold, Green Published, Green Submitted			2022-12-25	WOS:000262258700019
J	Josefsson, E; Higgins, J; Foster, TJ; Tarkowski, A				Josefsson, Elisabet; Higgins, Judy; Foster, Timothy J.; Tarkowski, Andrej			Fibrinogen Binding Sites P-336 and Y-338 of Clumping Factor A Are Crucial for Staphylococcus aureus Virulence	PLOS ONE			English	Article							FACTOR-A; ARTHRITIS; ROLES; IMMUNOGLOBULIN; PHAGOCYTOSIS; COMPLEMENT; SEPTICEMIA; ACTIVATION; PROTEINS; RECEPTOR	We have earlier shown that clumping factor A (ClfA), a fibrinogen binding surface protein of Staphylococcus aureus, is an important virulence factor in septic arthritis. When two amino acids in the ClfA molecule, P-336 and Y-338, were changed to serine and alanine, respectively, the fibrinogen binding property was lost. ClfAP(336)Y(338) mutants have been constructed in two virulent S. aureus strains Newman and LS-1. The aim of this study was to analyze if these two amino acids which are vital for the fibrinogen binding of ClfA are of importance for the ability of S. aureus to generate disease. Septic arthritis or sepsis were induced in mice by intravenous inoculation of bacteria. The clfAP(336)Y(338) mutant induced significantly less arthritis than the wild type strain, both with respect to severity and frequency. The mutant infected mice developed also a much milder systemic inflammation, measured as lower mortality, weight loss, bacterial growth in kidneys and lower IL-6 levels. The data were verified with a second mutant where clfAP(336) and Y-338 were changed to alanine and serine respectively. When sepsis was induced by a larger bacterial inoculum, the clfAP(336)Y(338) mutants induced significantly less septic death. Importantly, immunization with the recombinant A domain of ClfAP(336)SY(338)A mutant but not with recombinant ClfA, protected against septic death. Our data strongly suggest that the fibrinogen binding activity of ClfA is crucial for the ability of S. aureus to provoke disease manifestations, and that the vaccine potential of recombinant ClfA is improved by removing its ability to bind fibrinogen.	[Josefsson, Elisabet; Tarkowski, Andrej] Univ Gothenburg, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden; [Higgins, Judy; Foster, Timothy J.] Trinity Coll Dublin, Moyne Inst Prevent Med, Microbiol Dept, Dublin, Ireland	University of Gothenburg; Trinity College Dublin	Josefsson, E (corresponding author), Univ Gothenburg, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden.	elisabet.josefsson@rheuma.gu.se			Goteborg Medical Society; Goteborg Rheumatism Association; King Gustaf V's 80 Years Foundation; LUA/ALF; Rune and Ulla Amlovs Foundation; Swedish Medical Society; Swedish Research Council; Swedish Rheumatism Association; The Sigurd and Elsa Golje Memorial Foundation; The Family Tholens and Kristlers Foundation; Science Foundation Ireland	Goteborg Medical Society; Goteborg Rheumatism Association; King Gustaf V's 80 Years Foundation; LUA/ALF; Rune and Ulla Amlovs Foundation; Swedish Medical Society; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Rheumatism Association; The Sigurd and Elsa Golje Memorial Foundation; The Family Tholens and Kristlers Foundation; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by Goteborg Medical Society, Goteborg Rheumatism Association, King Gustaf V's 80 Years Foundation, LUA/ALF, Rune and Ulla Amlovs Foundation, Swedish Medical Society, Swedish Research Council, Swedish Rheumatism Association, The Sigurd and Elsa Golje Memorial Foundation, The Family Tholens and Kristlers Foundation and Science Foundation Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BREMELL T, 1991, INFECT IMMUN, V59, P2615, DOI 10.1128/IAI.59.8.2615-2623.1991; BREMELL T, 1992, INFECT IMMUN, V60, P2976, DOI 10.1128/IAI.60.7.2976-2985.1992; Deivanayagam CCS, 2002, EMBO J, V21, P6660, DOI 10.1093/emboj/cdf619; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; Foster TJ, 1998, METHOD MICROBIOL, V27, P433; Higgins J, 2006, FEMS MICROBIOL LETT, V258, P290, DOI 10.1111/j.1574-6968.2006.00229.x; Josefsson E, 2001, J INFECT DIS, V184, P1572, DOI 10.1086/324430; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Loughman A, 2005, MOL MICROBIOL, V57, P804, DOI 10.1111/j.1365-2958.2005.04731.x; Mancini G, 1965, Immunochemistry, V2, P235, DOI 10.1016/0019-2791(65)90004-2; McDevitt D, 1997, EUR J BIOCHEM, V247, P416, DOI 10.1111/j.1432-1033.1997.00416.x; MCDEVITT D, 1994, MOL MICROBIOL, V11, P237, DOI 10.1111/j.1365-2958.1994.tb00304.x; O'Connell DP, 1998, J BIOL CHEM, V273, P6821, DOI 10.1074/jbc.273.12.6821; OBrien L, 2002, MOL MICROBIOL, V44, P1033, DOI 10.1046/j.1365-2958.2002.02935.x; Palmqvist N, 2005, J INFECT DIS, V191, P791, DOI 10.1086/427663; Palmqvist N, 2004, MICROBES INFECT, V6, P188, DOI 10.1016/j.micinf.2003.11.005; Peacock SJ, 2002, INFECT IMMUN, V70, P4987, DOI 10.1128/IAI.70.9.4987-4996.2002; Sakiniene E, 1996, ARTHRITIS RHEUM, V39, P1596, DOI 10.1002/art.1780390921; Sakiniene E, 1999, CLIN EXP IMMUNOL, V115, P95; Sandin C, 2006, MOL MICROBIOL, V59, P20, DOI 10.1111/j.1365-2958.2005.04913.x; Verdrengh M, 1997, INFECT IMMUN, V65, P2517, DOI 10.1128/IAI.65.7.2517-2521.1997; Weineisen M, 2004, J IMMUNOL, V172, P3798, DOI 10.4049/jimmunol.172.6.3798	22	57	68	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2206	10.1371/journal.pone.0002206	http://dx.doi.org/10.1371/journal.pone.0002206			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493318	Green Published, gold, Green Submitted			2022-12-25	WOS:000262258700015
J	Ramot, D; Johnson, BE; Berry, TL; Carnell, L; Goodman, MB				Ramot, Daniel; Johnson, Brandon E.; Berry, Tommie L., Jr.; Carnell, Lucinda; Goodman, Miriam B.			The Parallel Worm Tracker: A Platform for Measuring Average Speed and Drug-Induced Paralysis in Nematodes	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; NEUROTRANSMITTER RELEASE; SYNAPTIC-TRANSMISSION; LOCOMOTORY BEHAVIOR; MACHINE VISION; MUTANTS; SEROTONIN; SYSTEM; SENSITIVITY	Background: Caenorhabditis elegans locomotion is a simple behavior that has been widely used to dissect genetic components of behavior, synaptic transmission, and muscle function. Many of the paradigms that have been created to study C. elegans locomotion rely on qualitative experimenter observation. Here we report the implementation of an automated tracking system developed to quantify the locomotion of multiple individual worms in parallel. Methodology/Principal Findings: Our tracking system generates a consistent measurement of locomotion that allows direct comparison of results across experiments and experimenters and provides a standard method to share data between laboratories. The tracker utilizes a video camera attached to a zoom lens and a software package implemented in MATLAB (R). We demonstrate several proof-of-principle applications for the tracker including measuring speed in the absence and presence of food and in the presence of serotonin. We further use the tracker to automatically quantify the time course of paralysis of worms exposed to aldicarb and levamisole and show that tracker performance compares favorably to data generated using a hand-scored metric. Conclusions/Signficance: Although this is not the first automated tracking system developed to measure C. elegans locomotion, our tracking software package is freely available and provides a simple interface that includes tools for rapid data collection and analysis. By contrast with other tools, it is not dependent on a specific set of hardware. We propose that the tracker may be used for a broad range of additional worm locomotion applications including genetic and chemical screening.	[Ramot, Daniel; Goodman, Miriam B.] Stanford Univ, Program Neurosci, Stanford, CA USA; [Johnson, Brandon E.; Berry, Tommie L., Jr.; Goodman, Miriam B.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA USA; [Carnell, Lucinda] Cent Washington Univ, Dept Biol Sci, Ellensburg, WA USA	Stanford University; Stanford University; Central Washington University	Ramot, D (corresponding author), Stanford Univ, Program Neurosci, Stanford, CA USA.	mbgoodman@stanford.edu	Goodman, Miriam B./H-3036-2019	Goodman, Miriam B./0000-0002-5810-1272	Muscular Dystrophy Association [MDA4206]; National Institutes of Health [RO1NS047715, R21NS061147]; National Science Foundation [NSF0725079]; A. P. Sloan Foundation; Klingenstein Fund; McKnight Endowment Fund for Neuroscience; Donald B. and Delia E. Baxter Foundation; Dan David Foundation; Albion Walter Hewlett Stanford Graduate Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS061147, R01NS047715] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); A. P. Sloan Foundation(Alfred P. Sloan Foundation); Klingenstein Fund(Klingenstein Philanthropies); McKnight Endowment Fund for Neuroscience; Donald B. and Delia E. Baxter Foundation; Dan David Foundation; Albion Walter Hewlett Stanford Graduate Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Work funded by grants to MBG from the Muscular Dystrophy Association (MDA4206), National Institutes of Health (RO1NS047715, R21NS061147) and the National Science Foundation (NSF0725079), fellowships to MBG from the A. P. Sloan Foundation, Klingenstein Fund, McKnight Endowment Fund for Neuroscience, and the Donald B. and Delia E. Baxter Foundation, a scholarship from the Dan David Foundation (DR), and an Albion Walter Hewlett Stanford Graduate Fellowship (DR). None of the sponsors or funders had a role in the design or conduct of the study, data collection, analysis, interpretation, or in the preparation, review or approval of the manuscript.	Artal-Sanz Marto, 2006, Biotechnology Journal, V1, P1405, DOI 10.1002/biot.200600176; Baek JH, 2002, J NEUROSCI METH, V118, P9, DOI 10.1016/S0165-0270(02)00117-6; BRENNER S, 1974, GENETICS, V77, P71; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Cheung BHH, 2005, CURR BIOL, V15, P905, DOI 10.1016/j.cub.2005.04.017; Cole RD, 2004, TOXICOL APPL PHARM, V194, P248, DOI 10.1016/j.taap.2003.09.013; Cronin CJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-5; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; Dernovici S, 2007, DEV NEUROBIOL, V67, P189, DOI 10.1002/dneu.20340; Doi M, 2002, NEURON, V33, P249, DOI 10.1016/S0896-6273(01)00587-6; DUSENBERY DB, 1985, COMPUT BIOL MED, V15, P169, DOI 10.1016/0010-4825(85)90058-7; Feng ZY, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-115; Fontaine Ebraheem, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P3716; Fujiwara M, 2002, NEURON, V36, P1091, DOI 10.1016/S0896-6273(02)01093-0; Geng W, 2003, GENETICS, V165, P1117; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Graves AL, 2005, ARCH ENVIRON CON TOX, V48, P490, DOI 10.1007/s00244-004-0031-2; Hardaker LA, 2001, J NEUROBIOL, V49, P303, DOI 10.1002/neu.10014; Hawasli AH, 2004, GENETICS, V168, P831, DOI 10.1534/genetics.104.030502; Hiley E, 2006, EMBO J, V25, P5884, DOI 10.1038/sj.emboj.7601458; HOSONO R, 1991, NEUROSCI LETT, V128, P243, DOI 10.1016/0304-3940(91)90270-4; HUANG KM, 2007, AUTOMATED TRACKING M, P1240; Huang KM, 2006, J NEUROSCI METH, V158, P323, DOI 10.1016/j.jneumeth.2006.06.007; Jacob TC, 2003, J NEUROSCI, V23, P2122; Karbowski J, 2006, J THEOR BIOL, V242, P652, DOI 10.1016/j.jtbi.2006.04.012; Lesa GM, 2003, J CELL SCI, V116, P4965, DOI 10.1242/jcs.00918; LEWIS JA, 1980, GENETICS, V95, P905; LEWIS JA, 1987, J NEUROSCI, V7, P3059; Loria PM, 2004, J NEUROSCI, V24, P2191, DOI 10.1523/JNEUROSCI.5462-03.2004; Mahoney TR, 2006, NAT PROTOC, V1, P1772, DOI 10.1038/nprot.2006.281; McMullan R, 2006, GENE DEV, V20, P65, DOI 10.1101/gad.359706; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; NGUYEN M, 1995, GENETICS, V140, P527; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; Pierce-Shimomura JT, 2005, J EXP BIOL, V208, P4727, DOI 10.1242/jeb.01933; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Reynolds NK, 2005, GENETICS, V169, P651, DOI 10.1534/genetics.104.031286; Richards J. P., 2005, SUPER PORPHYRY COPPE, V1, P7; Robatzek M, 2000, GENETICS, V156, P1069; Roussel N, 2007, IEEE T BIO-MED ENG, V54, P1786, DOI 10.1109/TBME.2007.894981; Ryu WS, 2002, J NEUROSCI, V22, P5727; Sambongi Y, 1999, NEUROREPORT, V10, P753, DOI 10.1097/00001756-199903170-00017; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Segalat L, 2007, ACS CHEM BIOL, V2, P231, DOI 10.1021/cb700009m; Shingai R, 2000, NEUROSCI RES, V38, P71, DOI 10.1016/S0168-0102(00)00148-6; Shtonda BB, 2006, J EXP BIOL, V209, P89, DOI 10.1242/jeb.01955; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Simonetta SH, 2007, J NEUROSCI METH, V161, P273, DOI 10.1016/j.jneumeth.2006.11.015; Stiernagle Theresa, 2006, WormBook, P1; Tsibidis GD, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-86; Van Buskirk C, 2007, NAT NEUROSCI, V10, P1300, DOI 10.1038/nn1981; van der Linden AM, 2001, GENETICS, V158, P221; Waggoner LE, 1998, NEURON, V21, P203, DOI 10.1016/S0896-6273(00)80527-9; Wang Q, 2002, J NEUROSCI, V22, P2274, DOI 10.1523/JNEUROSCI.22-06-02274.2002; WANG W, 2007, MICROPOSITIONING SYS, P243; Wang ZW, 2001, NEURON, V32, P867, DOI 10.1016/S0896-6273(01)00522-0; Wei G, 2004, IEEE T BIO-MED ENG, V51, P1811, DOI 10.1109/TBME.2004.831532; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1	59	194	196	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2208	10.1371/journal.pone.0002208	http://dx.doi.org/10.1371/journal.pone.0002208			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493300	Green Submitted, Green Published, gold			2022-12-25	WOS:000262258700017
J	Raymond, J; Thiberge, JM; Kalach, N; Bergeret, M; Dupont, C; Labigne, A; Dauga, C				Raymond, Josette; Thiberge, Jean-Michel; Kalach, Nicolas; Bergeret, Michel; Dupont, Christophe; Labigne, Agnes; Dauga, Catherine			Using Macro-Arrays to Study Routes of Infection of Helicobacter pylori in Three Families	PLOS ONE			English	Article								Background: Analysis of the evolutionary dynamics of Helicobacter pylori allowed tracing the spread of infection through populations on different continents but transmission pathways between individual humans have not been clearly described. Materials and Methods: To investigate person-to-person transmission, we studied three families each including one child with persistence of symptoms after antibiotic treatment. Ten isolates from the antrum and corpus of stomach of each family member were analyzed both by sequencing of two housekeeping genes and macroarray tests. Results: A total of 134 (8.4%) out of the 1590 coding sequences (CDSs) tested, including cag PAI and insertion sequences, were present in some but not all isolates (and are therefore defined as variable CDSs). Most of the variable CDSs encoded proteins of unknown function (76/134) or were selfish DNA including that encoding restriction/modification enzymes (13/134). Isolates colonizing the stomach of one individual can vary by point mutations, as seen in hspA, or by the gain or loss of one to five CDSs. They were considered as (genetic) variants. The phylogenetic clustering of gene profiles obtained on macro-arrays allowed identifying the different strains infecting families. Two to five strains circulated within a family. Identical strains were present in at least two members of all three families supporting the accepted model of intrafamilial transmission. Surprisingly, the mother was not implicated in the transmission of H. pylori in the two French families. Sibling-to-sibling transmission and acquisition of H. pylori from outside the family appeared to be probable in the transmission pathways. Conclusion: Macroarray analysis based on previously selected CDSs gives a comprehensive view of the genome diversity of a pathogen. This approach combined with information on the origin of the hspA and glmM alleles revealed that Helicobacter pylori infection may be acquired by more diverse routes than previously expected.	[Raymond, Josette; Bergeret, Michel] Univ Paris 05, Hop Cochin, Serv Bacteriol, Paris, France; [Thiberge, Jean-Michel; Labigne, Agnes] Dept Pathogen Microbienne, Unite Pathogen Bacterienne Muqueuses, Paris, France; [Kalach, Nicolas] Hop St Antoine, Serv Pediat, Lille, France; [Dupont, Christophe] Hop Cochin St Vincent Paul, Dept Pediat, Paris, France; [Dauga, Catherine] Inst Pasteur, Dept Genet Genom, Plateforme 4 Genopole, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Raymond, J (corresponding author), Univ Paris 05, Hop Cochin, Serv Bacteriol, Paris, France.	j.raymond@svp.aphp.fr	Catherine, Dauga/AAA-1379-2019					Achtman M, 1999, MOL MICROBIOL, V32, P459, DOI 10.1046/j.1365-2958.1999.01382.x; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Ando T, 2000, MOL MICROBIOL, V37, P1052, DOI 10.1046/j.1365-2958.2000.02049.x; Berg DE, 1997, CLIN INFECT DIS, V25, P996, DOI 10.1086/516081; BLASER MJ, 1995, CANCER RES, V55, P2111; Carroll IM, 2004, J MED MICROBIOL, V53, P669, DOI 10.1099/jmm.0.05440-0; DRUMM B, 1990, NEW ENGL J MED, V322, P359, DOI 10.1056/NEJM199002083220603; Ernst PB, 2000, ANNU REV MICROBIOL, V54, P615, DOI 10.1146/annurev.micro.54.1.615; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Georgopoulos SD, 1996, GUT, V39, P634, DOI 10.1136/gut.39.5.634; Ghose C, 2005, J CLIN MICROBIOL, V43, P2635, DOI 10.1128/JCM.43.6.2635-2641.2005; Goodman KJ, 2000, LANCET, V355, P358, DOI 10.1016/S0140-6736(99)05273-3; Gressmann H, 2005, PLOS GENET, V1, P419, DOI 10.1371/journal.pgen.0010043; Han SR, 2000, J CLIN MICROBIOL, V38, P3646, DOI 10.1128/JCM.38.10.3646-3651.2000; Hook-Nikanne J, 1998, HELICOBACTER, V3, P79, DOI 10.1111/j.1523-5378.1998.08011.x; Israel DA, 2001, P NATL ACAD SCI USA, V98, P14625, DOI 10.1073/pnas.251551698; Jorgensen M, 1996, J INFECT DIS, V174, P631, DOI 10.1093/infdis/174.3.631; Joyce EA, 2002, NAT REV GENET, V3, P462, DOI 10.1038/nrg820; Kauser F, 2004, J CLIN MICROBIOL, V42, P5302, DOI 10.1128/JCM.42.11.5302-5308.2004; Kim Jeong Wook, 2004, Korean Journal of Internal Medicine, V19, P1; Kivi M, 2003, J CLIN MICROBIOL, V41, P5604, DOI 10.1128/JCM.41.12.5604-5608.2003; Knippig C, 2002, Z GASTROENTEROL, V40, P383, DOI 10.1055/s-2002-32128; Kraft C, 2006, J BACTERIOL, V188, P249, DOI 10.1128/JB.188.1.249-254.2006; Marshall DG, 1998, MICROBIOL-SGM, V144, P2925, DOI 10.1099/00221287-144-11-2925; NWOKOLO CU, 1992, GUT, V33, P1323, DOI 10.1136/gut.33.10.1323; Owen RJ, 2003, J MED MICROBIOL, V52, P515, DOI 10.1099/jmm.0.04988-0; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; PARSONNET J, 1994, NEW ENGL J MED, V330, P1267, DOI 10.1056/NEJM199405053301803; Raymond J, 2004, EMERG INFECT DIS, V10, P1816, DOI 10.3201/eid1010.040042; Rothenbacher D, 2000, LANCET, V355, P1998, DOI 10.1016/S0140-6736(05)72939-1; Rothenbacher D, 1999, J INFECT DIS, V179, P398, DOI 10.1086/314595; Salama N, 2000, P NATL ACAD SCI USA, V97, P14668, DOI 10.1073/pnas.97.26.14668; Saunders NJ, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-9; Solca NM, 2001, MICROBIOL-SGM, V147, P1693, DOI 10.1099/00221287-147-6-1693; Suerbaum S, 1998, P NATL ACAD SCI USA, V95, P12619, DOI 10.1073/pnas.95.21.12619; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Tindberg Y, 2001, GASTROENTEROLOGY, V121, P310, DOI 10.1053/gast.2001.26282; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Vulic M, 1999, P NATL ACAD SCI USA, V96, P7348, DOI 10.1073/pnas.96.13.7348; Xu Q, 2000, P NATL ACAD SCI USA, V97, P9671, DOI 10.1073/pnas.97.17.9671	40	16	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2259	10.1371/journal.pone.0002259	http://dx.doi.org/10.1371/journal.pone.0002259			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493595	gold, Green Published, Green Submitted			2022-12-25	WOS:000262258700059
J	Reiss, AL; Hoeft, F; Tenforde, AS; Chen, W; Mobbs, D; Mignot, EJ				Reiss, Allan L.; Hoeft, Fumiko; Tenforde, Adam S.; Chen, Wynne; Mobbs, Dean; Mignot, Emmanuel J.			Anomalous Hypothalamic Responses to Humor in Cataplexy	PLOS ONE			English	Article								Background: Cataplexy is observed in a subset of patients with narcolepsy and affects approximately 1 in 2,000 persons. Cataplexy is most often triggered by strong emotions such as laughter, which can result in transient, yet debilitating, muscle atonia. The objective of this study was to examine the neural systems underlying humor processing in individuals with cataplexy. Methodology/Principal Findings: While undergoing functional Magnetic Resonance Imaging (fMRI), we showed ten narcolepsy-cataplexy patients and ten healthy controls humorous cartoons. In addition, we examined the brain activity of one subject while in a full-blown cataplectic attack. Behavioral results showed that participants with cataplexy rated significantly fewer humorous cartoons as funny compared to controls. Concurrent fMRI showed that patients, when compared to controls and in the absence of overt cataplexy symptoms, showed pronounced activity in the emotional network including the ventral striatum and hypothalamus while viewing humorous versus non-humorous cartoons. Increased activity was also observed in the right inferior frontal gyri -a core component of the inhibitory circuitry. In comparison, the one subject who experienced a cataplectic attack showed dramatic reductions in hypothalamic activity. Conclusions: These findings suggest an overdrive of the emotional circuitry and possible compensatory suppression by cortical inhibitory regions in cataplexy. Moreover, during cataplectic attacks, the hypothalamus is characterized by a marked decrease in activity similar to that observed during sleep. One possible explanation for these findings is an initial overdrive and compensatory shutdown of the hypothalamus resulting in full cataplectic symptoms.	[Reiss, Allan L.; Hoeft, Fumiko; Tenforde, Adam S.; Mobbs, Dean] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Ctr Interdisciplinary Brain Sci Res, Stanford, CA 94305 USA; [Chen, Wynne; Mignot, Emmanuel J.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Ctrr Narcolepsy, Stanford, CA USA; [Mobbs, Dean] MRC Cognition & Brain Sci Unit, Cambridge, England	Stanford University; Stanford University	Reiss, AL (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Ctr Interdisciplinary Brain Sci Res, Stanford, CA 94305 USA.	reiss@stanford.edu			NIH [23724]; Howard Hughes Medical Institute; Medical Research Council; Medical Research Council [MC_U105579215] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS023724] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funded by NIH 23724 and the Howard Hughes Medical Institute. DM is funded by the Medical Research Council.	*AASM, 2005, INT CLASS SLEEP DIS; Anic-Labat S, 1999, SLEEP, V22, P77; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Azim E, 2005, P NATL ACAD SCI USA, V102, P16496, DOI 10.1073/pnas.0408456102; Bartolo A, 2006, J COGNITIVE NEUROSCI, V18, P1789, DOI 10.1162/jocn.2006.18.11.1789; Chabas D, 2007, SLEEP, V30, P153, DOI 10.1093/sleep/30.2.153; Depue BE, 2007, SCIENCE, V317, P215, DOI 10.1126/science.1139560; Duvernoy H. M., 1991, HUMAN BRAIN SURFACE; GELB M, 1994, SLEEP, V17, P265, DOI 10.1093/sleep/17.3.265; Hare TA, 2005, BIOL PSYCHIAT, V57, P624, DOI 10.1016/j.biopsych.2004.12.038; Hong SB, 2006, NEUROLOGY, V66, P1747, DOI 10.1212/01.wnl.0000218205.72668.ab; Kerrigan John F, 2005, Semin Pediatr Neurol, V12, P119, DOI 10.1016/j.spen.2005.04.002; KRIBBS NB, 1993, AM REV RESPIR DIS, V147, P1162, DOI 10.1164/ajrccm/147.5.1162; Lammers GJ, 2000, CLIN NEUROPHYSIOL, V111, P1276, DOI 10.1016/S1388-2457(00)00306-0; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maquet P, 1996, NATURE, V383, P163, DOI 10.1038/383163a0; MARCADET A, 1985, IMMUNOGENETICS, V22, P679, DOI 10.1007/BF00430317; Middleton FA, 2000, BRAIN COGNITION, V42, P183, DOI 10.1006/brcg.1999.1099; Mignot E, 2004, SLEEP MED, V5, pS2, DOI 10.1016/S1389-9457(04)90001-9; Mignot E, 2002, ARCH NEUROL-CHICAGO, V59, P1553, DOI 10.1001/archneur.59.10.1553; Mignot E, 2001, ARCH ITAL BIOL, V139, P207; Mobbs D, 2005, P NATL ACAD SCI USA, V102, P16502, DOI 10.1073/pnas.0408457102; Mobbs D, 2003, NEURON, V40, P1041, DOI 10.1016/S0896-6273(03)00751-7; Moran JM, 2004, NEUROIMAGE, V21, P1055, DOI 10.1016/j.neuroimage.2003.10.017; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Okun MS, 2004, NEUROCASE, V10, P271, DOI 10.1080/13554790490507632; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Schwartz S, 2008, BRAIN, V131, P514, DOI 10.1093/brain/awm292; Talairach J., 1988, COPLANAR STEREOTAXIC; WATSON KK, 2006, BRAIN ACTIVATION SIG; Wild B, 2006, NEUROLOGY, V66, P887, DOI 10.1212/01.wnl.0000203123.68747.02	32	50	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2225	10.1371/journal.pone.0002225	http://dx.doi.org/10.1371/journal.pone.0002225			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493621	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000262258700033
J	van der Veen, R; Koehl, M; Abrous, DN; de Kloet, ER; Piazza, PV; Deroche-Gamonet, V				van der Veen, Rixt; Koehl, Muriel; Abrous, D. Nora; de Kloet, E. Ronald; Piazza, Pier-Vincenzo; Deroche-Gamonet, Veronique			Maternal Environment Influences Cocaine Intake in Adulthood in a Genotype-Dependent Manner	PLOS ONE			English	Article							SELF-MEDICATION HYPOTHESIS; SUBSTANCE USE DISORDERS; ANXIETY-LIKE BEHAVIOR; OLFACTORY BULBECTOMY; ANIMAL-MODELS; MOUSE STRAINS; C57BL/6 MICE; LIFE STRESS; DRUG-ABUSE; RAT MODEL	Background: Accumulating epidemiological evidence points to the role of genetic background as a modulator of the capacity of adverse early experiences to give rise to mental illness. However, direct evidence of such gene-environment interaction in the context of substance abuse is scarce. In the present study we investigated whether the impact of early life experiences on cocaine intake in adulthood depends on genetic background. In addition, we studied other behavioral dimensions associated with drug abuse, i.e. anxiety- and depression-related behaviors. Methodology/Principal Findings: For this purpose, we manipulated the maternal environment of two inbred mouse strains, the C57BL/6J and DBA/2J by fostering them with non-related mothers, i.e. the C3H/HeN and AKR strains. These mother strains show respectively high and low pup-oriented behavior. As adults, C57BL/6J and DBA/2J were tested either for cocaine intravenous self-administration or in the elevated plus-maze and forced swim test (FST). We found that the impact of maternal environment on cocaine use and a depression-related behavior depends upon genotype, as cocaine self-administration and behavior in the FST were influenced by maternal environment in DBA/2J, but not in C57BL/6J mice. Anxiety was not influenced by maternal environment in either strain. Conclusions/Significance: Our experimental approach could contribute to the identification of the psychobiological factors determining the susceptibility or the resilience of certain individuals to develop psychopathologies.	[van der Veen, Rixt; Koehl, Muriel; Abrous, D. Nora; Piazza, Pier-Vincenzo; Deroche-Gamonet, Veronique] INSERM, U862, Bordeaux, France; [van der Veen, Rixt; de Kloet, E. Ronald] Leiden Univ, Med Ctr, Amsterdam Ctr Drug Res, Div Med Pharmacol, Leiden, Netherlands	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van der Veen, R (corresponding author), INSERM, U862, Bordeaux, France.	deroche@bordeaux.inserm.fr	Koehl, Muriel/ABI-2043-2020; Koehl, Muriel/C-3698-2011; Deroche-Gamonet, Véronique/E-5728-2010; van der Veen, Rixt/F-1673-2018; de Kloet, Edo Ronald/H-3278-2011; Abrous, Nora-Djoher/N-6977-2017	Koehl, Muriel/0000-0002-7601-1422; Koehl, Muriel/0000-0002-7601-1422; de Kloet, Ron/0000-0001-9176-1830; van der Veen, Rixt/0000-0002-0808-7396; abrous, nora/0000-0002-8589-305X; Deroche-Gamonet, Veronique/0000-0002-9704-6624	NWO/INSERM/ZON [AH002G, 985-10-014]; University of Bordeaux 2	NWO/INSERM/ZON(Institut National de la Sante et de la Recherche Medicale (Inserm)Netherlands Organization for Scientific Research (NWO)); University of Bordeaux 2	This research was supported by the NWO/INSERM/ZON grants AH002G and 985-10-014 and the university of Bordeaux 2. Funders had no role in design and conduct of the study, they had no role in collection, analysis and interpretation of the data, in the preparation, review or approval of the manuscript.	Anisman H, 1998, INT J DEV NEUROSCI, V16, P149, DOI 10.1016/S0736-5748(98)00025-2; Ator NA, 2003, DRUG ALCOHOL DEPEN, V70, pS55, DOI 10.1016/S0376-8716(03)00099-1; Brady Kathleen T, 2007, Curr Psychiatry Rep, V9, P374, DOI 10.1007/s11920-007-0048-0; CADORET RJ, 1995, ARCH GEN PSYCHIAT, V52, P916; Calcagnetti DJ, 1996, PHYSIOL BEHAV, V59, P597, DOI 10.1016/0031-9384(95)02119-1; CALDJI C, 2004, MAT BEHAV REGULATES; Caspi A, 2005, BIOL PSYCHIAT, V57, P1117, DOI 10.1016/j.biopsych.2005.01.026; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925; CUTRONA CE, 1994, COMPR PSYCHIAT, V35, P171, DOI 10.1016/0010-440X(94)90188-0; De Bellis MD, 2002, PSYCHONEUROENDOCRINO, V27, P155, DOI 10.1016/S0306-4530(01)00042-7; Deroche-Gamonet V, 2003, J NEUROSCI, V23, P4785; File SE, 2001, BEHAV BRAIN RES, V125, P151, DOI 10.1016/S0166-4328(01)00292-3; Foley DL, 2004, ARCH GEN PSYCHIAT, V61, P738, DOI 10.1001/archpsyc.61.7.738; Francis DD, 2003, NAT NEUROSCI, V6, P445, DOI 10.1038/nn1038; Friedman E, 2006, DEV PSYCHOBIOL, V48, P169, DOI 10.1002/dev.20119; GAWIN FH, 1991, SCIENCE, V251, P1580, DOI 10.1126/science.2011738; Gordon HW, 2002, PSYCHONEUROENDOCRINO, V27, P115, DOI 10.1016/S0306-4530(01)00039-7; Heim C, 2004, NEUROPSYCHOPHARMACOL, V29, P641, DOI 10.1038/sj.npp.1300397; Jaffee SR, 2005, DEV PSYCHOPATHOL, V17, P67, DOI 10.1017/S0954579405050042; Kendler KS, 2005, AM J PSYCHIAT, V162, P1243, DOI 10.1176/appi.ajp.162.7.1243; Khantzian EJ, 1997, HARVARD REV PSYCHIAT, V4, P231, DOI 10.3109/10673229709030550; KHANTZIAN EJ, 1985, AM J PSYCHIAT, V142, P1259; LUMIA AR, 1992, BRAIN RES, V587, P181, DOI 10.1016/0006-8993(92)90995-L; MARKOU A, 1992, NEUROPSYCHOPHARMACOL, V7, P213; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; Millstein RA, 2006, GENES BRAIN BEHAV, V5, P346, DOI 10.1111/j.1601-183X.2005.00172.x; Millstein RA, 2007, NEUROSCI BIOBEHAV R, V31, P3, DOI 10.1016/j.neubiorev.2006.05.003; Moffitt TE, 2006, PERSPECT PSYCHOL SCI, V1, P5, DOI 10.1111/j.1745-6916.2006.00002.x; Newport DJ, 2002, AM J PSYCHIAT, V159, P1265, DOI 10.1176/appi.ajp.159.8.1265; OAKLEYBROWNE MA, 1995, J AFFECT DISORDERS, V34, P13, DOI 10.1016/0165-0327(94)00099-U; Parfitt DB, 2007, HORM BEHAV, V52, P417, DOI 10.1016/j.yhbeh.2007.06.002; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Priebe K, 2005, DEV PSYCHOBIOL, V47, P398, DOI 10.1002/dev.20098; RANDALL CL, 1975, J STUD ALCOHOL, V36, P973, DOI 10.15288/jsa.1975.36.973; Roman E, 2005, ALCOHOL CLIN EXP RES, V29, P591, DOI 10.1097/01.ALC.0000158933.70242.FC; Romeo RD, 2003, HORM BEHAV, V43, P561, DOI 10.1016/S0018-506X(03)00063-1; Rutter M, 2006, J CHILD PSYCHOL PSYC, V47, P226, DOI 10.1111/j.1469-7610.2005.01557.x; Sameroff AJ, 2000, DEV PSYCHOPATHOL, V12, P297, DOI 10.1017/S0954579400003035; Sigvardsson S, 1996, ARCH GEN PSYCHIAT, V53, P681; Silberg J, 2001, BRIT J PSYCHIAT, V179, P116, DOI 10.1192/bjp.179.2.116; Slattery DA, 2007, PSYCHOPHARMACOLOGY, V190, P555, DOI 10.1007/s00213-006-0630-x; Tienari P, 2004, BRIT J PSYCHIAT, V184, P216, DOI 10.1192/bjp.184.3.216; van der Kam EL, 2005, NEUROPHARMACOLOGY, V48, P685, DOI 10.1016/j.neuropharm.2004.12.014; van der Veen R, 2008, GENES BRAIN BEHAV, V7, P184, DOI 10.1111/j.1601-183X.2007.00337.x; van der Veen R, 2007, PSYCHOPHARMACOLOGY, V193, P179, DOI 10.1007/s00213-007-0777-0; Veenema AH, 2007, PSYCHONEUROENDOCRINO, V32, P437, DOI 10.1016/j.psyneuen.2007.02.008; Weiss RD, 2004, J SUBST ABUSE TREAT, V27, P307, DOI 10.1016/j.jsat.2004.10.001; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097; Willner P, 2002, BEHAV PHARMACOL, V13, P169, DOI 10.1097/00008877-200205000-00001	52	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2245	10.1371/journal.pone.0002245	http://dx.doi.org/10.1371/journal.pone.0002245			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	391UK	18493309	Green Published, gold			2022-12-25	WOS:000262258700053
J	Chae, YK; Woo, J; Kim, MJ; Kang, SK; Kim, MS; Lee, J; Lee, SK; Gong, G; Kim, YH; Soria, JC; Jang, SJ; Sidransky, D; Moon, C				Chae, Young Kwang; Woo, Janghee; Kim, Mi-Jung; Kang, Sung Koo; Kim, Myoung Sook; Lee, Juna; Lee, Seung Koo; Gong, Gyungyub; Kim, Yong Hee; Soria, Jean Charles; Jang, Se Jin; Sidransky, David; Moon, Chulso			Expression of Aquaporin 5 (AQP5) Promotes Tumor Invasion in Human Non Small Cell Lung Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; WATER; SRC; ANGIOGENESIS; LOCALIZATION; INVOLVEMENT; MIGRATION; PATHWAYS; GENES	The aquaporins (AQP) are water channel proteins playing a major role in transcellular and transepithelial water movement. Recently, the role of AQPs in human carcinogenesis has become an area of great interest. Here, by immunohistochemistry (IHC), we have found an expression of AQP5 protein in 35.3% (IHC-score: >= 1, 144/408) of the resected NSCLC tissue samples. Cases with AQP5-positive status (IHC-score: >= 2) displayed a higher rate of tumor recurrence than negative ones in NSCLC (54.7% vs. 35.1%, p = 0.005) and worse disease-free survival (p = 0.033; OR = 1.52; 95% CI: 1.04-2.23). Further in vitro invasion assay using BEAS-2B and NIH3T3 cells stably transfected with overexpression constructs for full length wild-type AQP5 (AQP5) and its two mutants, N185D which blocks membrane trafficking and S156A which blocks phosphorylation on Ser156, showed that AQP5 induced cell invasions while both mutants did not. In BEAS-2B cells, the expression of AQP5 caused a spindle-like and fibroblastic morphologic change and losses of cell-cell contacts and cell polarity. Only cells with AQP5, not either of two mutants, exhibited a loss of epithelial cell markers and a gain of mesenchymal cell markers. In a human SH3-domains protein array, cellular extracts from BEAS-2B with AQP5 showed a robust binding activity to SH3-domains of the c-Src, Lyn, and Grap2 C-terminal. Furthermore, in immunoprecipitation assay, activated c-Src, phosphorylated on Tyr416, showed a stronger binding activity to cellular extracts from BEAS-2B with AQP5 compared with N185D or S156A mutant. Fluorescence in situ hybridization (FISH) analysis failed to show evidence of genomic amplification, suggesting AQP5 expression as a secondary event. Based on these clinical and molecular observations, we conclude that AQP5, through its phosphorylation on Ser156 and subsequent interaction with c-Src, plays an important role in NSCLC invasion and, therefore, may provide a unique opportunity for developing a novel therapeutic target as well as a prognostic marker in NSCLC.	[Chae, Young Kwang; Woo, Janghee; Kang, Sung Koo; Kim, Myoung Sook; Lee, Juna; Gong, Gyungyub; Sidransky, David; Moon, Chulso] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea; [Kim, Mi-Jung; Lee, Seung Koo; Gong, Gyungyub; Kim, Yong Hee; Jang, Se Jin] Ulsan Univ, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea; [Lee, Juna; Moon, Chulso] Johns Hopkins Univ, Grad Program Human Genet, Baltimore, MD USA; [Moon, Chulso] Johns Hopkins Univ, Dept Oncol, Baltimore, MD USA; [Soria, Jean Charles] Gustave Roussy Inst, Dept Med, Villejuif, France	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Johns Hopkins University; Johns Hopkins University; UNICANCER; Gustave Roussy	Chae, YK (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea.	jangsejin@amc.seoul.kr; cmoon5@jhmi.edu	Soria, Jean-Charles/F-3619-2014; woo, janghee/CAG-2114-2022		SPORE [P50 CA96784-01]; Pyung-Ya Foundation; KOSEF [R01-2004-000-10670-0]; Korea Research Foundation [KFR-2004-041-E00064]; NATIONAL CANCER INSTITUTE [P50CA096784] Funding Source: NIH RePORTER	SPORE; Pyung-Ya Foundation; KOSEF(Korea Science and Engineering Foundation); Korea Research Foundation(National Research Foundation of Korea); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by the SPORE grant P50 CA96784-01 (to C.M.), Cancer Research Grant from Pyung-Ya Foundation (to C.M.), and KOSEF research grant R01-2004-000-10670-0 and Korea Research Foundation grant KFR-2004-041-E00064 (to S.J.J).	Avizienyte E, 2005, CELLS TISSUES ORGANS, V179, P73, DOI 10.1159/000084511; Avizienyte E, 2005, CURR OPIN CELL BIOL, V17, P542, DOI 10.1016/j.ceb.2005.08.007; Boyer B, 1997, EMBO J, V16, P5904, DOI 10.1093/emboj/16.19.5904; Boyer B, 2002, ONCOGENE, V21, P2347, DOI 10.1038/sj.onc.1205298; Burghardt B, 2003, GUT, V52, P1008, DOI 10.1136/gut.52.7.1008; D'Amico TA, 1999, J THORAC CARDIOV SUR, V117, P736, DOI 10.1016/S0022-5223(99)70294-1; Guarino M, 2007, PATHOLOGY, V39, P305, DOI 10.1080/00313020701329914; Herbst RS, 2003, CLIN CANCER RES, V9, P5813; Hoque MO, 2006, AM J PATHOL, V168, P1345, DOI 10.2353/ajpath.2006.050596; Kageyama Y, 1996, J UROLOGY, V156, P291, DOI 10.1016/S0022-5347(01)66019-1; KANG SK, 2008, AM J PATHOL IN PRESS; KE Y, 1988, DIFFERENTIATION, V38, P60, DOI 10.1111/j.1432-0436.1988.tb00592.x; King LS, 1996, ANNU REV PHYSIOL, V58, P619, DOI 10.1146/annurev.ph.58.030196.003155; Kreda SM, 2001, AM J RESP CELL MOL, V24, P224, DOI 10.1165/ajrcmb.24.3.4367; Mayer BJ, 2001, J CELL SCI, V114, P1253; Moon C, 2003, ONCOGENE, V22, P6699, DOI 10.1038/sj.onc.1206762; Moon C, 2004, AM J HEMATOL, V75, P128, DOI 10.1002/ajh.10476; MOON C, 1995, GENOMICS, V30, P354, DOI 10.1006/geno.1995.0029; Pastorino U, 1997, J CLIN ONCOL, V15, P2858, DOI 10.1200/JCO.1997.15.8.2858; RAINA S, 1995, J BIOL CHEM, V270, P1908, DOI 10.1074/jbc.270.4.1908; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; Saadoun S, 2002, BRIT J CANCER, V87, P621, DOI 10.1038/sj.bjc.6600512; Saadoun S, 2005, J CELL SCI, V118, P5691, DOI 10.1242/jcs.02680; Singhal S, 2005, CLIN CANCER RES, V11, P3974, DOI 10.1158/1078-0432.CCR-04-2661; Vacca A, 2001, BRIT J HAEMATOL, V113, P415, DOI 10.1046/j.1365-2141.2001.02738.x; Verkman AS, 1996, AM J PHYSIOL-CELL PH, V270, pC12, DOI 10.1152/ajpcell.1996.270.1.C12; Vielh P, 2005, CRIT REV ONCOL HEMAT, V53, P193, DOI 10.1016/j.critrevonc.2004.10.007; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; WOO J, 2008, CANC LETT IN PRESS; Woo J, 2008, BIOCHEM BIOPH RES CO, V367, P291, DOI 10.1016/j.bbrc.2007.12.073; Woo J, 2008, BIOCHEM BIOPH RES CO, V366, P321, DOI 10.1016/j.bbrc.2007.11.078; Yang BX, 1997, J BIOL CHEM, V272, P16140, DOI 10.1074/jbc.272.26.16140; Yang JH, 2006, GYNECOL ONCOL, V100, P294, DOI 10.1016/j.ygyno.2005.08.054; Zhang J, 2007, AM J PATHOL, V170, P366, DOI 10.2353/ajpath.2007.060706	34	101	109	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2162	10.1371/journal.pone.0002162	http://dx.doi.org/10.1371/journal.pone.0002162			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478076	gold, Green Published, Green Submitted			2022-12-25	WOS:000262172800027
J	Kleinlogel, S; White, AG				Kleinlogel, Sonja; White, Andrew G.			The Secret World of Shrimps: Polarisation Vision at Its Best	PLOS ONE			English	Article							CIRCULAR-POLARIZATION; COMPOUND EYES; E-VECTOR; LIGHT; SENSITIVITY; NAVIGATION; PATTERN; COLOR	Background: Animal vision spans a great range of complexity, with systems evolving to detect variations in light intensity, distribution, colour, and polarisation. Polarisation vision systems studied to date detect one to four channels of linear polarisation, combining them in opponent pairs to provide intensity-independent operation. Circular polarisation vision has never been seen, and is widely believed to play no part in animal vision. Methodology/Principal Findings: Polarisation is fully measured via Stokes' parameters-obtained by combined linear and circular polarisation measurements. Optimal polarisation vision is the ability to see Stokes' parameters: here we show that the crustacean Gonodactylus smithii measures the exact components required. Conclusions/Significance: This vision provides optimal contrast-enhancement and precise determination of polarisation with no confusion states or neutral points-significant advantages. Linear and circular polarisation each give partial information about the polarisation of light-but the combination of the two, as we will show here, results in optimal polarisation vision. We suggest that linear and circular polarisation vision not be regarded as different modalities, since both are necessary for optimal polarisation vision; their combination renders polarisation vision independent of strongly linearly or circularly polarised features in the animal's environment.	[Kleinlogel, Sonja] Max Planck Inst Biophys, Dept Biophys Chem, Frankfurt, Germany; [Kleinlogel, Sonja] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [White, Andrew G.] Univ Queensland, Ctr Quantum Comp Technol, Dept Phys, Brisbane, Qld, Australia	Max Planck Society; University of Queensland; University of Queensland	Kleinlogel, S (corresponding author), Max Planck Inst Biophys, Dept Biophys Chem, Frankfurt, Germany.	Sonja.Kleinlogel@mpibp-frankfurt.mpg.de	White, Andrew G./AAI-1062-2020; White, Andrew G/A-1088-2009	White, Andrew G/0000-0001-9639-5200	Australian Research Council; American Air Force; Swiss National Science Foundation	Australian Research Council(Australian Research Council); American Air Force; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Australian Research Council Federation Fellow program; American Air Force; Swiss National Science Foundation	BERNARD GD, 1977, VISION RES, V17, P1019, DOI 10.1016/0042-6989(77)90005-0; Born M., 1999, PRINCIPLES OPTICS; Cronin TW, 2001, J EXP BIOL, V204, P2461; Cronin TW, 2003, INTEGR COMP BIOL, V43, P549, DOI 10.1093/icb/43.4.549; GAFNI A, 1975, BIOCHIM BIOPHYS ACTA, V387, P256, DOI 10.1016/0005-2728(75)90108-5; Glantz RM, 2001, J EXP BIOL, V204, P2383; GODDARD SM, 1991, J COMP PHYSIOL A, V169, P479; Hecht E., 2001, OPTICS, V4th, P680; Hegedus R, 2007, P ROY SOC A-MATH PHY, V463, P1081, DOI 10.1098/rspa.2007.1811; Hegedus R, 2006, VISION RES, V46, P2786, DOI 10.1016/j.visres.2006.02.007; Horvath G, 2003, POLARIZED LIGHT ANIM; IVANOFF A, 1958, J MAR RES, V16, P255; James D.F.V., 2001, PHYS REV A; Kleinlogel S, 2005, CELL TISSUE RES, V321, P273, DOI 10.1007/s00441-005-1118-4; Kleinlogel S, 2006, J EXP BIOL, V209, P4262, DOI 10.1242/jeb.02499; Laughlin SB, 1975, PHOTORECEPTOR OPTICS, P479; Marshall J, 1999, NATURE, V401, P873, DOI 10.1038/44751; Marshall J, 1999, CURR BIOL, V9, P755, DOI 10.1016/S0960-9822(99)80336-4; MARSHALL NJ, 1988, NATURE, V333, P557, DOI 10.1038/333557a0; MENZEL R, 1986, J COMP PHYSIOL A, V158, P165, DOI 10.1007/BF01338560; NEVILLE AC, 1971, J INSECT PHYSIOL, V17, P519, DOI 10.1016/0022-1910(71)90030-8; Sabbah S, 2006, VISION RES, V46, P444, DOI 10.1016/j.visres.2005.05.017; Schechner YY, 2004, PROC CVPR IEEE, P536; Schwind R, 1999, J EXP BIOL, V202, P3631; SHAPIRO DB, 1991, P SOC PHOTO-OPT INS, V1537, P30, DOI 10.1117/12.49258; Shashar N, 2000, VISION RES, V40, P71, DOI 10.1016/S0042-6989(99)00158-3; Shashar N, 1998, NATURE, V393, P222, DOI 10.1038/30380; SHAW SR, 1966, NATURE, V211, P92, DOI 10.1038/211092a0; WATERMAN TH, 1970, Z VERGL PHYSIOL, V68, P154, DOI 10.1007/BF00297692; WEHNER R, 1981, NATURE, V293, P731, DOI 10.1038/293731a0; Wehner R, 2001, J EXP BIOL, V204, P2589; WYNBERG H, 1980, NATURE, V286, P641, DOI 10.1038/286641a0; [No title captured]	34	30	33	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2190	10.1371/journal.pone.0002190	http://dx.doi.org/10.1371/journal.pone.0002190			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478095	Green Published, gold, Green Submitted			2022-12-25	WOS:000262172800054
J	Lizarbe, TR; Garcia-Rama, C; Tarin, C; Saura, M; Calvo, E; Lopez, JA; Lopez-Otin, C; Folgueras, AR; Lamas, S; Zaragoza, C				Lizarbe, Tania R.; Garcia-Rama, Concepcion; Tarin, Carlos; Saura, Marta; Calvo, Enrique; Antonio Lopez, Juan; Lopez-Otin, Carlos; Folgueras, Alicia R.; Lamas, Santiago; Zaragoza, Carlos			Nitric oxide elicits functional MMP-13 protein-tyrosine nitration during wound repair	FASEB JOURNAL			English	Article						metalloproteinases; collagenase-3; inducible nitric oxide synthase; caveolin-1; wound healing	SMOOTH-MUSCLE-CELLS; MATRIX METALLOPROTEINASES; CAVEOLIN-1; MIGRATION; GROWTH; PROLIFERATION; EXPRESSION; PATHWAY; MICE	Nitric oxide (NO) plays a critical role in wound healing, in part by promoting angiogenesis. However, the precise repair pathways affected by NO are not well defined. We now show that NO regulates matrix metalloproteinase-13 (MMP-13) release during wound repair. We find that normally MMP-13 is kept inside endothelial cells by an association with caveolin-1. However, nitration of MMP-13 on tyrosine residue Y338 causes it to dissociate from caveolin-1 and be released from endothelial cells. We next explored the functional significance of MMP-13 nitration in vivo. Skin injury increases nitration of MMP-13 in mice. Skin wounds in inducible nitric oxide synthase knockout mice release less MMP-13 and heal more slowly than skin wounds in wild-type mice. Conversely, skin wounds in caveolin-1 knockout mice have increased NO production, increased MMP-13 nitration, and accelerated wound healing. Collectively, our data reveal a new pathway through which NO modulates wound repair: nitration of MMP-13 promotes its release from endothelial cells, where it accelerates angiogenesis and wound healing.	[Lizarbe, Tania R.; Garcia-Rama, Concepcion; Tarin, Carlos; Calvo, Enrique; Antonio Lopez, Juan; Zaragoza, Carlos] Ctr Nacl Invest Cardiovasc, Madrid, Spain; [Saura, Marta] Univ Alcala, Fac Med, Dept Fisiol, Madrid, Spain; [Lopez-Otin, Carlos; Folgueras, Alicia R.] Univ Oviedo, Inst Univ Oncol, Dept Bioquim, Oviedo, Spain; [Lamas, Santiago] Ctr Invest Biol, Inst Reina Sofia Invest Nefrol, E-28006 Madrid, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); Universidad de Alcala; University of Oviedo; Instituto Universitario de Oncologia de Asturias; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Zaragoza, C (corresponding author), Fdn CNIC, Melchor Fernandez Almagro 3, Madrid 28029, Spain.	czaragoza@cnic.es	Folgueras, Alicia/B-3281-2017; Lamas, Santiago/G-7308-2015; Lopez, Juan Antonio/G-7750-2015; Tarín, Carlos/ABE-4812-2020; Zaragoza, Carlos/AAH-9275-2019; López-Otín, Carlos/AAB-2106-2020; Zaragoza Sanchez, Carlos/G-8718-2011	Folgueras, Alicia/0000-0003-3426-9502; Lamas, Santiago/0000-0001-5166-4155; Lopez, Juan Antonio/0000-0002-9097-6060; López-Otín, Carlos/0000-0001-6964-1904; Zaragoza, Carlos/0000-0002-1706-8592	Ministerio de Educacion y Ciencia; Programa Ramon y Cajal; Plan Nacional de I + D + I [SAF 2005-06025, SAF 2006-02410]; European Union [FEDER 2FD97-1432]; Spanish Society of Nephrology; Ministerio de Sanidad y Consumo	Ministerio de Educacion y Ciencia(Spanish Government); Programa Ramon y Cajal(Spanish Government); Plan Nacional de I + D + I; European Union(European Commission); Spanish Society of Nephrology; Ministerio de Sanidad y Consumo(Instituto de Salud Carlos III)	This study was supported by the following institutions and agencies: Ministerio de Educacion y Ciencia, Programa Ramon y Cajal (to C.Z. and M.S.); Plan Nacional de I + D + I (SAF 2005-06025 to C.Z. and SAF 2006-02410 to S. L.); the European Union (FEDER 2FD97-1432, to S. L.); the Spanish Society of Nephrology (grant-in-aid 2001, to C.Z. and S.L.); and the Ministerio de Sanidad y Consumo (Red tematica de investigacion cooperativa RECAVA C03/01, to C.Z. and S.L.). We thank Dr. S. Bartlett for valuable and significant assistance with the manuscript.	Beare AHM, 2003, J INVEST DERMATOL, V120, P153, DOI 10.1046/j.1523-1747.2003.12019.x; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Ebadi M, 2005, MOL BRAIN RES, V134, P67, DOI 10.1016/j.molbrainres.2004.09.011; Galvez BG, 2004, MOL BIOL CELL, V15, P678, DOI 10.1091/mbc.E03-07-0516; Gerhardt H, 2005, EXP SUPPL, V94, P3; GomisRuth FX, 1996, J MOL BIOL, V264, P556, DOI 10.1006/jmbi.1996.0661; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Hartenstein B, 2006, J INVEST DERMATOL, V126, P486, DOI 10.1038/sj.jid.5700084; Hassan GS, 2006, AM J PHYSIOL-HEART C, V290, pH2393, DOI 10.1152/ajpheart.01161.2005; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Kim HP, 2005, P NATL ACAD SCI USA, V102, P11319, DOI 10.1073/pnas.0501345102; Kuzuya Masafumi, 2003, J Atheroscler Thromb, V10, P275; Labrecque L, 2004, J BIOL CHEM, V279, P52132, DOI 10.1074/jbc.M409617200; Lee PC, 1999, AM J PHYSIOL-HEART C, V277, pH1600, DOI 10.1152/ajpheart.1999.277.4.H1600; Lopez-Rivera E, 2005, P NATL ACAD SCI USA, V102, P3685, DOI 10.1073/pnas.0408217102; Lynch CC, 2002, DIFFERENTIATION, V70, P561, DOI 10.1046/j.1432-0436.2002.700909.x; Navarro A, 2004, FASEB J, V18, P1801, DOI 10.1096/fj.04-2516rev; Newby AC, 2006, CARDIOVASC RES, V69, P614, DOI 10.1016/j.cardiores.2005.08.002; Noiri E, 1998, AM J PHYSIOL-CELL PH, V274, pC236, DOI 10.1152/ajpcell.1998.274.1.C236; Pike LJ, 2005, BBA-MOL CELL RES, V1746, P260, DOI 10.1016/j.bbamcr.2005.05.005; Puyraimond A, 2001, EXP CELL RES, V262, P28, DOI 10.1006/excr.2000.5069; Ravanti L, 2000, INT J MOL MED, V6, P391; Razani B, 2001, J BIOL CHEM, V276, P38121; Stan RV, 2005, BBA-MOL CELL RES, V1746, P334, DOI 10.1016/j.bbamcr.2005.08.008; Turko IV, 2002, PHARMACOL REV, V54, P619, DOI 10.1124/pr.54.4.619; Weller R, 2003, CLIN EXP DERMATOL, V28, P511, DOI 10.1046/j.1365-2230.2003.01365.x; Williams TM, 2004, J BIOL CHEM, V279, P51630, DOI 10.1074/jbc.M409214200; Yamasaki K, 1998, J CLIN INVEST, V101, P967, DOI 10.1172/JCI2067; Ye YZ, 2007, J BIOL CHEM, V282, P6324, DOI 10.1074/jbc.M610800200; Yung Lai Ming, 2006, Cardiovascular & Hematological Disorders - Drug Targets, V6, P1; Zaragoza C, 2002, KIDNEY INT, V61, P804, DOI 10.1046/j.1523-1755.2002.00224.x; Zhang W, 2000, J BIOL CHEM, V275, P20717, DOI 10.1074/jbc.M909895199; Zucker S, 2000, ONCOGENE, V19, P6642, DOI 10.1038/sj.onc.1204097	33	37	39	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2008	22	9					3207	3215		10.1096/fj.07-103804	http://dx.doi.org/10.1096/fj.07-103804			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	342CD	18495757				2022-12-25	WOS:000258761300013
J	Liu, L; Chen, L; Chung, J; Huang, S				Liu, L.; Chen, L.; Chung, J.; Huang, S.			Rapamycin inhibits F-actin reorganization and phosphorylation of focal adhesion proteins	ONCOGENE			English	Article						rapamycin; mammalian target of rapamycin; F-actin; lamellipodia; focal adhesion kinase	RICTOR-MTOR COMPLEX; GROWTH-FACTOR; MAMMALIAN TARGET; TYROSINE PHOSPHORYLATION; CELL-GROWTH; SIGNALING PATHWAY; BINDING PARTNER; MUSCLE-CELLS; AMINO-ACID; KINASE	An early event of cell migration is characterized as the rapid reorganization of the actin cytoskeleton. Recently, we have demonstrated that rapamycin inhibits tumor cell motility. To understand the underlying mechanism, this study was set to determine whether rapamycin inhibition of cell motility is related to its prevention of F-actin reorganization. We found that rapamycin prevented type I insulin-like growth factor (IGF-I)-stimulated F-actin reorganization in human rhabdomyosarcoma (Rh30), Ewing sarcoma (Rh1), glioblastoma (U-373) and prostate carcinoma (PC-3) cells, and concurrently inhibited phosphorylation of focal adhesion proteins, including focal adhesion kinase (FAK), paxillin and p130(Cas) in the cells. The effect of rapamycin was blocked by expression of a rapamycin-resistant mutant of mTOR (mTORrr), but not a kinase-dead mTORrr. Downregulation of raptor mimicked the effect of rapamycin. Cells infected with a recombinant adenovirus expressing constitutively active and rapamycin-resistant mutant of p70 S6 kinase 1 (S6K1) conferred to resistance to rapamycin. Further, IGF-I failed to stimulate F-actin reorganization and phosphorylation of the focal adhesion proteins in the S6K1-downregulated cells. Expression of constitutively hypophosphorylated eukaryotic initiation factor 4E (eIF4E)-binding protein 1 (4E-BP1-5A) inhibited IGF-I-stimulated F-actin reorganization, but did not alter the cellular protein or phosphorylation levels of the focal adhesion proteins. The results suggest that rapamycin inhibits IGF-I-induced F-actin reorganization and phosphorylation of the focal adhesion proteins by disruption of mTOR-raptor complex. Both S6K1 and 4E-BP1 pathways, mediated by the mTOR-raptor complex, are involved in the regulation of IGF-I-stimulated F-actin reorganization, but only the former controls IGF-I-stimulated phosphorylation of the focal adhesion proteins.	[Liu, L.; Chen, L.; Chung, J.; Huang, S.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71130 USA; [Chung, J.; Huang, S.] Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Shreveport, LA 71130 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Huang, S (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, 1501 Kings Highway, Shreveport, LA 71130 USA.	shuan1@lsuhsc.edu	Huang, Shile/I-1632-2019	Huang, Shile/0000-0002-3239-1072	NIH [R01 CA115414]; Louisiana Board of Regents [LEQSF(2006-09)-RD-A-18]; Feist-Weiller Cancer Center Award; Louisiana State University Health Sciences Center, Shreveport, LA, USA; NATIONAL CANCER INSTITUTE [R01CA115414] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana Board of Regents; Feist-Weiller Cancer Center Award; Louisiana State University Health Sciences Center, Shreveport, LA, USA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs Robert T Abraham, Peter J Houghton, John C Lawrence, John Blenis and David M Sabatini for providing cell lines or constructs. This study was supported in part by NIH Grant R01 CA115414 ( SH), Louisiana Board of Regents (LEQSF(2006-09)-RD-A-18) (SH), and the Feist-Weiller Cancer Center Award (SH), Louisiana State University Health Sciences Center, Shreveport, LA, USA.	Berven LA, 2004, EXP CELL RES, V296, P183, DOI 10.1016/j.yexer.2003.12.032; Boffa DJ, 2004, CLIN CANCER RES, V10, P293, DOI 10.1158/1078-0432.CCR-0629-3; Casamassima A, 1998, J BIOL CHEM, V273, P26149, DOI 10.1074/jbc.273.40.26149; Erbay E, 2001, J BIOL CHEM, V276, P36079, DOI 10.1074/jbc.C100406200; Fonseca BD, 2007, J BIOL CHEM, V282, P24514, DOI 10.1074/jbc.M704406200; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Gan BY, 2006, J BIOL CHEM, V281, P37321, DOI 10.1074/jbc.M605241200; Govindarajan G, 2000, CIRC RES, V87, P710, DOI 10.1161/01.RES.87.8.710; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guvakova MA, 1999, EXP CELL RES, V251, P244, DOI 10.1006/excr.1999.4566; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hosoi H, 1999, CANCER RES, V59, P886; Huang S, 2003, MOL CELL, V11, P1491, DOI 10.1016/S1097-2765(03)00180-1; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; KADOWAKI T, 1986, J BIOL CHEM, V261, P6141; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Konstantopoulos N, 1996, BIOCHEM J, V314, P387, DOI 10.1042/bj3140387; Leopoldt D, 2001, J CELL PHYSIOL, V188, P106, DOI 10.1002/jcp.1102; LeRoith D, 2003, CANCER LETT, V195, P127, DOI 10.1016/S0304-3835(03)00159-9; Leventhal PS, 1997, J BIOL CHEM, V272, P5214, DOI 10.1074/jbc.272.8.5214; Liu L, 2006, ONCOGENE, V25, P7029, DOI 10.1038/sj.onc.1209691; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Luan FL, 2003, KIDNEY INT, V63, P917, DOI 10.1046/j.1523-1755.2003.00805.x; Malik RK, 1996, J BIOL CHEM, V271, P29785, DOI 10.1074/jbc.271.47.29785; Mothe-Satney I, 2000, MOL CELL BIOL, V20, P3558, DOI 10.1128/MCB.20.10.3558-3567.2000; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Pearce LR, 2007, BIOCHEM J, V405, P513, DOI 10.1042/BJ20070540; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schalm SS, 2005, J BIOL CHEM, V280, P11101, DOI 10.1074/jbc.M413995200; Sekulic A, 2000, CANCER RES, V60, P3504; Shu LL, 2002, J BIOL CHEM, V277, P16726, DOI 10.1074/jbc.M112285200; SMITH MA, 2006, PEDIAT BLOOD CANC, V50, P703; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Wan XL, 2005, CANCER RES, V65, P2406, DOI 10.1158/0008-5472.CAN-04-3135; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206	47	130	135	2	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 28	2008	27	37					4998	5010		10.1038/onc.2008.137	http://dx.doi.org/10.1038/onc.2008.137			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	344GL	18504440	Green Accepted			2022-12-25	WOS:000258914800003
J	Li, X; Lou, ZY; Li, XM; Zhou, WH; Ma, M; Cao, YJ; Geng, YQ; Bartlam, M; Zhang, XC; Rao, ZH				Li, Xin; Lou, Zhiyong; Li, Xuemei; Zhou, Weihong; Ma, Ming; Cao, Youjia; Geng, Yunqi; Bartlam, Mark; Zhang, Xuejun C.; Rao, Zihe			Structure of human cytosolic X-prolyl aminopeptidase - A double Mn(II)-dependent dimeric enzyme with a novel three-domain subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; SECONDARY-STRUCTURE; KIDNEY; PURIFICATION; BRADYKININ; INHIBITOR; PEPTIDES; APSTATIN; RECOGNITION; DEGRADATION	X-prolyl aminopeptidases catalyze the removal of a penultimate prolyl residue from the N termini of peptides. Mammalian X-prolyl aminopeptidases are shown to be responsible for the degradation of bradykinin, a blood pressure regulator peptide, and have been linked to myocardial infarction. The x-ray crystal structure of human cytosolic X-prolyl aminopeptidase (XPNPEP1) was solved at a resolution of 1.6 angstrom. The structure reveals a dimer with a unique three-domain organization in each subunit, rather than the two domains common to all other known structures of X-prolyl aminopeptidase and prolidases. The C-terminal catalytic domain of XPNPEP1 coordinates two metal ions and shares a similar fold with other prolyl aminopeptidases. Metal content analysis and activity assays confirm that the enzyme is double Mn(II) dependent for its activity, which contrasts with the previous notion that each XPNPEP1 subunit contains only one Mn(II) ion. Activity assays on an E41A mutant demonstrate that the acidic residue, which was considered as a stabilizing factor in the protonation of catalytic residue His(498), plays only a marginal role in catalysis. Further mutagenesis reveals the significance of the N-terminal domain and dimerization for the activity of XPNPEP1, and we provide putative structural explanations for their functional roles. Structural comparisons further suggest mechanisms for substrate selectivity in different X-prolyl peptidases.	[Li, Xin; Zhou, Weihong; Cao, Youjia; Geng, Yunqi; Bartlam, Mark; Rao, Zihe] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Li, Xin; Zhou, Weihong; Cao, Youjia; Geng, Yunqi; Bartlam, Mark; Rao, Zihe] Nankai Univ, Tianjin State Lab Prot Sci, Tianjin 300071, Peoples R China; [Li, Xin; Li, Xuemei; Ma, Ming; Zhang, Xuejun C.; Rao, Zihe] Chinese Acad Sci, Natl Lab Biol Macromol, Inst Biophys, Beijing 100101, Peoples R China; [Lou, Zhiyong; Bartlam, Mark; Rao, Zihe] Tsinghua Univ, Struct Biol Lab, Beijing 100084, Peoples R China; [Zhang, Xuejun C.] Oklahoma Med Res Fdn, Crystallog Res Program, Oklahoma City, OK 73104 USA	Nankai University; Nankai University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Tsinghua University; Oklahoma Medical Research Foundation	Cao, YJ (corresponding author), Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China.	caoyj@nankai.edu.cn; Cai-Zhang@omrf.org	li, xin/HHS-9461-2022; Li, Lambert LL/F-7146-2015; Rao, Zihe/HCH-6944-2022	Bartlam, Mark/0000-0001-5173-5080				BHOOLA KD, 1992, PHARMACOL REV, V44, P1; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Cottrell GS, 2000, BIOCHEMISTRY-US, V39, P15121, DOI 10.1021/bi001585c; DEHM P, 1970, EUR J BIOCHEM, V17, P372, DOI 10.1111/j.1432-1033.1970.tb01175.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENDO F, 1991, MOL BIOL MED, V8, P117; Gilmartin L, 1999, NEUROSCI RES, V34, P1, DOI 10.1016/S0168-0102(99)00025-5; Graham SC, 2006, BIOCHEMISTRY-US, V45, P964, DOI 10.1021/bi0518904; Graham SC, 2004, ACTA CRYSTALLOGR D, V60, P1770, DOI 10.1107/S0907444904018724; HARBECK HT, 1991, EUR J BIOCHEM, V198, P451, DOI 10.1111/j.1432-1033.1991.tb16035.x; HOOPER NM, 1990, BIOCHEM J, V267, P509, DOI 10.1042/bj2670509; Hyde RJ, 1996, BIOCHEM J, V319, P197, DOI 10.1042/bj3190197; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lloyd GS, 1996, BIOCHEM PHARMACOL, V52, P229, DOI 10.1016/0006-2952(96)00180-3; Maher MJ, 2004, BIOCHEMISTRY-US, V43, P2771, DOI 10.1021/bi0356451; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Prechel MM, 1995, J PHARMACOL EXP THER, V275, P1136; Regoli D, 1983, Adv Exp Med Biol, V156, P569; RUSU I, 1992, EUR J BIOCHEM, V210, P93, DOI 10.1111/j.1432-1033.1992.tb17395.x; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SIMMONS WH, 1992, J BIOL CHEM, V267, P4897; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; VANHOOF G, 1992, BIOCHEM PHARMACOL, V44, P479, DOI 10.1016/0006-2952(92)90439-P; Wilce MCJ, 1998, P NATL ACAD SCI USA, V95, P3472, DOI 10.1073/pnas.95.7.3472; Wolfrum S, 2001, BRIT J PHARMACOL, V134, P370, DOI 10.1038/sj.bjp.0704236	27	26	28	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22858	22866		10.1074/jbc.M710274200	http://dx.doi.org/10.1074/jbc.M710274200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18515364	hybrid			2022-12-25	WOS:000258321000053
J	Strom, AL; Shi, P; Zhang, FJ; Gal, J; Kilty, R; Hayward, LJ; Zhu, HN				Strom, Anna-Lena; Shi, Ping; Zhang, Fujian; Gal, Jozsef; Kilty, Renee; Hayward, Lawrence J.; Zhu, Haining			Interaction of amyotrophic lateral sclerosis (ALS)-related mutant copper-zinc superoxide dismutase with the dynein-dynactin complex contributes to inclusion formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALS-LINKED SOD1; FAST AXONAL-TRANSPORT; MOTOR-NEURON DISEASE; BODY-LIKE INCLUSIONS; HYALINE INCLUSIONS; TRANSGENIC MICE; CU,ZN-SUPEROXIDE DISMUTASE; MOLECULAR PATHOLOGY; CYTOPLASMIC DYNEIN; CLINICAL-FEATURES	An important consequence of protein misfolding related to neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), is the formation of proteinaceous inclusions or aggregates within the central nervous system. We have previously shown that several familial ALS-linked copper-zinc superoxide dismutase (SOD1) mutants (A4V, G85R, and G93A) interact and co-localize with the dynein-dynactin complex in cultured cells and affected tissues of ALS mice. In this study, we report that the interaction between mutant SOD1 and the dynein motor plays a critical role in the formation of large inclusions containing mutant SOD1. Disruption of the motor by overexpression of the p50 subunit of dynactin in neuronal and non-neuronal cell cultures abolished the association between aggregation-prone SOD1 mutants and the dynein-dynactin complex. The p50 overexpression also prevented mutant SOD1 inclusion formation and improved the survival of cells expressing A4V SOD1. Furthermore, we observed that two ALS-linked SOD1 mutants, H46R and H48Q, which showed a lower propensity to interact with the dynein motor, also produced less aggregation and fewer large inclusions. Overall, these data suggest that formation of large inclusions depends upon association of the abnormal SOD1s with the dynein motor. Whether the misfolded SOD1s directly perturb axonal transport or impair other functional properties of the dynein motor, this interaction could propagate a toxic effect that ultimately causes motor neuron death in ALS.	[Strom, Anna-Lena; Gal, Jozsef; Kilty, Renee; Zhu, Haining] Univ Kentucky, Dept Mol & Cellular Biochem, Coll Med, Lexington, KY 40536 USA; [Shi, Ping; Zhu, Haining] Univ Kentucky, Coll Med, Grad Ctr Toxicol, Lexington, KY 40536 USA; [Zhang, Fujian; Zhu, Haining] Univ Kentucky, Coll Med, Grad Ctr Nutr Sci, Lexington, KY 40536 USA; [Hayward, Lawrence J.] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01655 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Massachusetts System; University of Massachusetts Worcester	Zhu, HN (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Coll Med, 741 S Limestone, Lexington, KY 40536 USA.	haining@uky.edu	Zhu, Haining/A-6076-2008	Zhu, Haining/0000-0001-5498-6694; Gal, Jozsef/0000-0002-5865-6534; Hayward, Lawrence/0000-0003-0579-0358	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044170, R01NS049126] Funding Source: NIH RePORTER; NINDS NIH HHS [R01-NS44170, R01-NS49126, R01 NS044170] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aoki M, 1998, CELL MOL NEUROBIOL, V18, P639, DOI 10.1023/A:1020217818245; Arisato T, 2003, ACTA NEUROPATHOL, V106, P561, DOI 10.1007/s00401-003-0763-5; Banks GT, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-214; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; BREUER AC, 1987, NEUROLOGY, V37, P738, DOI 10.1212/WNL.37.5.738; BREUER AC, 1988, CELL MOTIL CYTOSKEL, V10, P321, DOI 10.1002/cm.970100136; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Chevalier-Larsen ES, 2008, HUM MOL GENET, V17, P1946, DOI 10.1093/hmg/ddn092; COLLARD JF, 1995, NATURE, V375, P61, DOI 10.1038/375061a0; Cudkowicz ME, 1997, ANN NEUROL, V41, P210, DOI 10.1002/ana.410410212; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Fanara P, 2007, J BIOL CHEM, V282, P23465, DOI 10.1074/jbc.M703434200; Gal J, 2007, J BIOL CHEM, V282, P11068, DOI 10.1074/jbc.M608787200; Gaudette M, 2000, AMYOTROPH LATERAL SC, V1, P83, DOI 10.1080/14660820050515377; Guzik BW, 2004, CURR OPIN CELL BIOL, V16, P443, DOI 10.1016/j.ceb.2004.06.002; He CZ, 2004, J NEUROL SCI, V217, P47, DOI 10.1016/j.jns.2003.08.016; Hirano A, 1996, NEUROLOGY, V47, pS63, DOI 10.1212/WNL.47.4_Suppl_2.63S; Ikemoto A, 2000, AMYOTROPH LATERAL SC, V1, P97, DOI 10.1080/14660820050515395; Johnston JA, 2002, CELL MOTIL CYTOSKEL, V53, P26, DOI 10.1002/cm.10057; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kabuta T, 2006, J BIOL CHEM, V281, P30524, DOI 10.1074/jbc.M603337200; Kato S, 2001, ACTA NEUROPATHOL, V102, P233; Kieran D, 2005, J CELL BIOL, V169, P561, DOI 10.1083/jcb.200501085; Lai C, 2007, J NEUROSCI, V27, P13982, DOI 10.1523/JNEUROSCI.4226-07.2007; Ligon LA, 2005, NEUROREPORT, V16, P533, DOI 10.1097/00001756-200504250-00002; Liu J, 2004, NEURON, V43, P5, DOI 10.1016/j.neuron.2004.06.016; Matsumoto S, 1996, CLIN NEUROPATHOL, V15, P41; Melkonian KA, 2007, J BIOL CHEM, V282, P19355, DOI 10.1074/jbc.M700003200; Menzies FM, 2002, BRAIN, V125, P1522, DOI 10.1093/brain/awf167; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; OGASAWARA M, 1993, NAT GENET, V5, P323, DOI 10.1038/ng1293-323; Ohi T, 2004, J NEUROL SCI, V225, P19, DOI 10.1016/j.jns.2004.06.008; Ohi T, 2002, J NEUROL SCI, V197, P73, DOI 10.1016/S0022-510X(02)00054-0; Pasinelli P, 2004, NEURON, V43, P19, DOI 10.1016/j.neuron.2004.06.021; Piao YS, 2003, BRAIN PATHOL, V13, P10; Ravikumar B, 2005, NAT GENET, V37, P771, DOI 10.1038/ng1591; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sasaki S, 1996, NEUROLOGY, V47, P535, DOI 10.1212/WNL.47.2.535; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Shaw CE, 1997, NEUROLOGY, V49, P1612, DOI 10.1212/WNL.49.6.1612; SHIBATA N, 1994, NEUROSCI LETT, V179, P149, DOI 10.1016/0304-3940(94)90956-3; Shibata N, 1998, ACTA NEUROPATHOL, V95, P136, DOI 10.1007/s004010050777; Strom AL, 2008, J NEUROCHEM, V106, P495, DOI 10.1111/j.1471-4159.2008.05393.x; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Teuchert M, 2006, EXP NEUROL, V198, P271, DOI 10.1016/j.expneurol.2005.12.005; Urushitani M, 2002, J NEUROCHEM, V83, P1030, DOI 10.1046/j.1471-4159.2002.01211.x; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Wang J, 2003, HUM MOL GENET, V12, P2753, DOI 10.1093/hmg/ddg312; Wang J, 2002, NEUROBIOL DIS, V10, P128, DOI 10.1006/nbdi.2002.0498; Watanabe M, 2001, NEUROBIOL DIS, V8, P933, DOI 10.1006/nbdi.2001.0443; Watanabe Y, 2005, MOL BRAIN RES, V135, P12, DOI 10.1016/j.molbrainres.2004.11.019; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Zhang FJ, 2006, BBA-GEN SUBJECTS, V1760, P404, DOI 10.1016/j.bbagen.2005.11.024; Zhang FJ, 2007, J BIOL CHEM, V282, P16691, DOI 10.1074/jbc.M609743200; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a	61	44	45	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22795	22805		10.1074/jbc.M800276200	http://dx.doi.org/10.1074/jbc.M800276200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18515363	Green Published, hybrid			2022-12-25	WOS:000258321000047
J	Becker, R; Lenter, MC; Vollkommer, T; Boos, AM; Pfaff, D; Augustin, HG; Christian, S				Becker, Renate; Lenter, Martin C.; Vollkommer, Tobias; Boos, Anja M.; Pfaff, Dennis; Augustin, Hellmut G.; Christian, Sven			Tumor stroma marker endosialin (Tem1) is a binding partner of metastasis-related protein Mac-2 BP/90K	FASEB JOURNAL			English	Article						activated fibroblasts; mural cells	C-ASSOCIATED PROTEIN; CYCLOPHILIN-C; MAC-2-BINDING PROTEIN; EXTRACELLULAR-MATRIX; MOLECULAR-CLONING; CELL-ADHESION; ENDOTHELIUM; RECEPTOR; CANCER; GLYCOPROTEIN	Tumor development involves complex bidirectional interactions between tumor cells and host stromal cells. Endosialin (Tem1) has been identified as a highly O-glycosylated transmembrane glycoprotein, which is specifically expressed by tumor vessel-associated pericytes and stromal fibroblasts of a wide range of human tumors. Recent experiments in endosialin-deficient mice have unraveled a critical role of endosialin in site-specific tumor progression and metastasis. To molecularly understand the mechanisms of endosialin function, we aimed to identify extracellular endosialin ligands and identified Mac-2 BP/90K as a specific interaction partner. Detailed biochemical analyses identified a C-terminal fragment of Mac-2 BP/90K, which was shown to contain binding sites for galectin- 3, and collagens as the structures responsible for endosialin binding. Subsequent expression analysis of Mac-2 BP/90K in vivo revealed weak or no expression in most normal tissues and strong up-regulation in tumor cells of human neoplastic tissues. Intriguingly, the expression patterns of Mac-2 BP/90K and endosialin were mutually exclusive in all human tissues. Correspondingly, loss-of-function adhesion experiments of Mac-2 BP/90K-expressing tumor cells on endosialin-expressing fibroblasts revealed a repulsive outcome of the Mac-2 BP/90K interaction. Taken together, the experiments identify a novel repulsive interaction between endosialin on stromal fibroblasts and Mac-2 BP/90K on tumor cells.	[Becker, Renate; Vollkommer, Tobias; Boos, Anja M.; Pfaff, Dennis; Augustin, Hellmut G.; Christian, Sven] German Canc Res Ctr, INF 581, D-69221 Heidelberg, Germany; [Becker, Renate; Vollkommer, Tobias; Boos, Anja M.; Pfaff, Dennis; Augustin, Hellmut G.; Christian, Sven] Univ Heidelberg, Fac Med, Joint Res Div Vasc Biol, D-69221 Heidelberg, Germany; [Lenter, Martin C.] Boehringer Ingelheim Pharma GmbH & Co KG, Genom Grp Prote, Biberach, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Boehringer Ingelheim	Christian, S (corresponding author), BHC GDD TD TIV, POB 10709, D-42096 Wuppertal, Germany.	augustin@angiogenese.de; sven.christian@bayerhealthcare.com	Augustin, Hellmut/AAA-5246-2020	Augustin, Hellmut/0000-0002-7173-4242				BEVILACQUA MP, 1993, J CLIN INVEST, V91, P379, DOI 10.1172/JCI116210; Christian S, 2001, J BIOL CHEM, V276, P48588, DOI 10.1074/jbc.M106152200; Christian S, 2001, J BIOL CHEM, V276, P7408, DOI 10.1074/jbc.M009604200; Christian S, 2008, AM J PATHOL, V172, P486, DOI 10.2353/ajpath.2008.070623; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Fiedler U, 2003, J BIOL CHEM, V278, P1721, DOI 10.1074/jbc.M208550200; FRIEDMAN J, 1993, P NATL ACAD SCI USA, V90, P6815, DOI 10.1073/pnas.90.14.6815; Halloran MC, 2006, CURR OPIN CELL BIOL, V18, P533, DOI 10.1016/j.ceb.2006.08.010; Hellstern S, 2002, J BIOL CHEM, V277, P15690, DOI 10.1074/jbc.M200386200; IACOBELLI S, 1994, BRIT J CANCER, V69, P172, DOI 10.1038/bjc.1994.29; INOHARA H, 1994, BIOCHEM BIOPH RES CO, V201, P1366, DOI 10.1006/bbrc.1994.1854; Inohara H, 1996, CANCER RES, V56, P4530; Kong WY, 2007, J CELL PHYSIOL, V210, P153, DOI 10.1002/jcp.20830; KOTHS K, 1993, J BIOL CHEM, V268, P14245; MacFadyen JR, 2005, FEBS LETT, V579, P2569, DOI 10.1016/j.febslet.2005.03.071; Marchetti A, 2002, CANCER RES, V62, P2535; Nanda A, 2006, P NATL ACAD SCI USA, V103, P3351, DOI 10.1073/pnas.0511306103; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pfaff D, 2006, J LEUKOCYTE BIOL, V80, P719, DOI 10.1189/jlb.1105652; RETTIG WJ, 1992, P NATL ACAD SCI USA, V89, P10832, DOI 10.1073/pnas.89.22.10832; Sasaki T, 1998, EMBO J, V17, P1606, DOI 10.1093/emboj/17.6.1606; Shimizu T, 2005, J CEREBR BLOOD F MET, V25, P325, DOI 10.1038/sj.jcbfm.9600029; St Croix B, 2000, SCIENCE, V289, P1197; Teicher BA, 2007, INT J ONCOL, V30, P305; Tomkowicz B, 2007, P NATL ACAD SCI USA, V104, P17965, DOI 10.1073/pnas.0705647104; Trahey M, 1999, P NATL ACAD SCI USA, V96, P3006, DOI 10.1073/pnas.96.6.3006; Ulmer TA, 2006, J CELL BIOCHEM, V98, P1351, DOI 10.1002/jcb.20784; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301	28	45	50	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	AUG	2008	22	8					3059	3067		10.1096/fj.07-101386	http://dx.doi.org/10.1096/fj.07-101386			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	332NI	18490383				2022-12-25	WOS:000258089300045
J	Hellwig, CT; Kohler, BF; Lehtivarjo, AK; Dussmann, H; Courtney, MJ; Prehn, JHM; Rehm, M				Hellwig, Christian T.; Kohler, Barbara F.; Lehtivarjo, Anna-Kaisa; Dussmann, Heiko; Courtney, Michael J.; Prehn, Jochen H. M.; Rehm, Markus			Real time analysis of tumor necrosis factor-related apoptosis-inducing ligand/cycloheximide-induced caspase activities during apoptosis initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-CELL ANALYSIS; CYTOCHROME-C; LINKED INHIBITOR; ACTIVATION; TRAIL; CLEAVAGE; RELEASE; CD95; PROTEIN; PHOSPHORYLATION	Employing fluorescence resonance energy transfer (FRET) imaging, we previously demonstrated that effector caspase activation is often an all-or-none response independent of drug choice or dose administered. We here investigated the signaling dynamics during apoptosis initiation via the tumor necrosis factor related apoptosis-inducing ligand (TRAIL) receptor pathway to investigate how variability in drug exposure can be translated into largely kinetically invariant cell death execution pathways. FRET-based microscopy demonstrated dose-dependent responses of caspase-8 activation and activity within individual living HeLa cells. Caspase-8 on average was activated 45-600 min after TRAIL/cycloheximide addition. Caspase-8 like activities persisted for 15-60 min before eventually inducing mitochondrial outer membrane permeabilization. Independent of the TRAIL concentrations used or the resulting caspase-8-like activities, mitochondrial outer membrane permeabilization was induced when 10% of the FRET substrate was cleaved. In contrast, in Bid-depleted cells, caspase-8-like activity persisted for hours without causing immediate cell death. Our findings provide detailed insight into the intracellular signaling kinetics during apoptosis initiation and describe a threshold mechanism controlling the induction of apoptosis execution.	[Hellwig, Christian T.; Kohler, Barbara F.; Dussmann, Heiko; Prehn, Jochen H. M.; Rehm, Markus] RCSI York House, Royal Coll Surg Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland; [Lehtivarjo, Anna-Kaisa; Courtney, Michael J.] Univ Kuopio, Dept Neurobiol, Kuopio 70210, Finland	Royal College of Surgeons - Ireland; University of Eastern Finland	Rehm, M (corresponding author), RCSI York House, Royal Coll Surg Ireland, Dept Physiol & Med Phys, York St, Dublin 2, Ireland.	mrehm@rcsi.ie	Prehn, Jochen HM/A-3928-2010; Rehm, Markus/C-3398-2012; Courtney, Michael J/D-6648-2016	Prehn, Jochen HM/0000-0003-3479-7794; Rehm, Markus/0000-0001-6149-9261; Courtney, Michael J/0000-0001-8693-3933; Dussmann, Heiko/0000-0002-3582-8057				Bentele M, 2004, J CELL BIOL, V166, P839, DOI 10.1083/jcb.200404158; Black S, 2004, CELL DEATH DIFFER, V11, P90, DOI 10.1038/sj.cdd.4401307; Chang DW, 2002, EMBO J, V21, P3704, DOI 10.1093/emboj/cdf356; Clancy L, 2005, P NATL ACAD SCI USA, V102, P18099, DOI 10.1073/pnas.0507329102; Desagher S, 2001, MOL CELL, V8, P601, DOI 10.1016/S1097-2765(01)00335-5; Dussmann H, 2003, J CELL SCI, V116, P525, DOI 10.1242/jcs.00236; Eberhardt O, 2000, J NEUROSCI, V20, P9126; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Engels IH, 2000, ONCOGENE, V19, P4563, DOI 10.1038/sj.onc.1203824; Esposti MD, 2003, J BIOL CHEM, V278, P15749, DOI 10.1074/jbc.M209208200; Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007; FernandesAlnemri T, 1996, P NATL ACAD SCI USA, V93, P7464, DOI 10.1073/pnas.93.15.7464; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Goldstein JC, 2005, CELL DEATH DIFFER, V12, P453, DOI 10.1038/sj.cdd.4401596; Kang TB, 2004, J IMMUNOL, V173, P2976, DOI 10.4049/jimmunol.173.5.2976; Kischkel FC, 2001, J BIOL CHEM, V276, P46639, DOI 10.1074/jbc.M105102200; Korsmeyer SJ, 2000, CELL DEATH DIFFER, V7, P1166, DOI 10.1038/sj.cdd.4400783; Koschny R, 2007, J MOL MED, V85, P923, DOI 10.1007/s00109-007-0194-1; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; Lavrik IN, 2007, J BIOL CHEM, V282, P13664, DOI 10.1074/jbc.M700434200; Legewie S, 2006, PLOS COMPUT BIOL, V2, P1061, DOI 10.1371/journal.pcbi.0020120; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; McStay GP, 2008, CELL DEATH DIFFER, V15, P322, DOI 10.1038/sj.cdd.4402260; Merino D, 2006, MOL CELL BIOL, V26, P7046, DOI 10.1128/MCB.00520-06; Messam CA, 1998, EXP CELL RES, V238, P389, DOI 10.1006/excr.1997.3845; Rehm M, 2003, J CELL BIOL, V162, P1031, DOI 10.1083/jcb.200303123; Rehm M, 2002, J BIOL CHEM, V277, P24506, DOI 10.1074/jbc.M110789200; Rehm M, 2006, EMBO J, V25, P4338, DOI 10.1038/sj.emboj.7601295; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Seol DW, 2001, CANCER RES, V61, P1138; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Smyth MJ, 2003, IMMUNITY, V18, P1, DOI 10.1016/S1074-7613(02)00502-2; Sordet O, 2002, BLOOD, V100, P4446, DOI 10.1182/blood-2002-06-1778; Sprick MR, 2002, EMBO J, V21, P4520, DOI 10.1093/emboj/cdf441; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; Tait SWG, 2007, J CELL BIOL, V179, P1453, DOI 10.1083/jcb.200707063; Takemoto K, 2003, J CELL BIOL, V160, P235, DOI 10.1083/jcb.200207111; Tepper CG, 1999, BLOOD, V94, P1727, DOI 10.1182/blood.V94.5.1727.417k03_1727_1737; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Tyas L, 2000, EMBO REP, V1, P266, DOI 10.1093/embo-reports/kvd050; Vincenz C, 1997, J BIOL CHEM, V272, P6578, DOI 10.1074/jbc.272.10.6578; Vogel A, 2006, GASTROENTEROLOGY, V130, P104, DOI 10.1053/j.gastro.2005.10.012; Ward MW, 2006, J BIOL CHEM, V281, P5837, DOI 10.1074/jbc.M511562200; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Yamada H, 1999, BIOCHEM BIOPH RES CO, V265, P130, DOI 10.1006/bbrc.1999.1641	48	51	52	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21676	21685		10.1074/jbc.M802889200	http://dx.doi.org/10.1074/jbc.M802889200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18522940	hybrid			2022-12-25	WOS:000257898800041
J	Wan, GH; Zhaorigetu, S; Liu, ZH; Kaini, R; Jiang, ZY; Hu, CAA				Wan, Guanghua; Zhaorigetu, Siqin; Liu, Zhihe; Kaini, Ramesh; Jiang, Zeyu; Hu, Chien-an A.			Apolipoprotein L1, a novel Bcl-2 homology domain 3-only lipid-binding protein, induces autophagic cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BH3-ONLY PROTEINS; L GENE; APOPTOSIS; FAMILY; BECLIN-1; DEGRADATION; OVEREXPRESSION; IDENTIFICATION; TUMORIGENESIS; MECHANISMS	The Bcl-2 family proteins are important regulators of type I programmed cell death apoptosis; however, their role in autophagic cell death (AuCD) or type II programmed cell death is still largely unknown. Here we report the cloning and characterization of a novel Bcl-2 homology domain 3 (BH3)-only protein, apolipoprotein L1 (apoL1), that, when overexpressed and accumulated intracellularly, induces AuCD in cells as characterized by the increasing formation of autophagic vacuoles and activating the translocation of LC3-II from the cytosol to the autophagic vacuoles. Wortmannin and 3-methyladenine, inhibitors of class III phosphatidylinostol 3-kinase and, subsequently, autophagy, blocked apoL1-induced AuCD. In addition, apoL1 failed to induce AuCD in autophagy-deficient ATG5(-/-) and ATG7(-/-) mouse embryonic fibroblast cells, suggesting that apoL1-induced cell death is indeed autophagy-dependent. Furthermore, a BH3 domain deletion construct of apoL1 failed to induce AuCD, demonstrating that apoL1 is a bona fide BH3-only pro-death protein. Moreover, we showed that apoL1 is inducible by p53 in p53-induced cell death and is a lipid-binding protein with high affinity for phosphatidic acid (PA) and cardiolipin (CL). Previously, it has been shown that PA directly interacted with mammalian target of rapamycin and positively regulated the ability of mammalian target of rapamycin to activate downstream effectors. In addition, CL has been shown to activate mitochondria-mediated apoptosis. Sequestering of PA and CL with apoL1 may alter the homeostasis between survival and death leading to AuCD. To our knowledge, this is the first BH3-only protein with lipid binding activity that, when overproduced intracellularly, induces AuCD.	[Wan, Guanghua; Zhaorigetu, Siqin; Liu, Zhihe; Kaini, Ramesh; Jiang, Zeyu; Hu, Chien-an A.] Univ New Mexico, Dept Biochem & Mol Biol, Sch Med, Albuquerque, NM 87131 USA	University of New Mexico	Hu, CAA (corresponding author), Univ New Mexico, Dept Biochem & Mol Biol, Sch Med, MSC08 4670,1, Albuquerque, NM 87131 USA.	Ahu@salud.unm.edu			NATIONAL CANCER INSTITUTE [R01CA106644] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016480] Funding Source: NIH RePORTER; NCI NIH HHS [5R01 CA 106644-01A1, R01 CA106644, R01 CA106644-05] Funding Source: Medline; NCRR NIH HHS [P20 RR 016480-04] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004; Anglade P, 1997, HISTOL HISTOPATHOL, V12, P25; Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Berry DL, 2007, CELL, V131, P1137, DOI 10.1016/j.cell.2007.10.048; Bystroff C, 2000, J MOL BIOL, V301, P173, DOI 10.1006/jmbi.2000.3837; Bystroff Christopher, 2002, Bioinformatics, V18 Suppl 1, pS54; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P1396, DOI 10.1038/sj.cdd.4401963; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P994, DOI 10.1038/sj.cdd.4401908; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Duchateau PN, 2001, J LIPID RES, V42, P620; Duchateau PN, 1997, J BIOL CHEM, V272, P25576, DOI 10.1074/jbc.272.41.25576; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Fei PW, 2004, CANCER CELL, V6, P597, DOI 10.1016/j.ccr.2004.10.012; Gonzalvez F, 2007, APOPTOSIS, V12, P877, DOI 10.1007/s10495-007-0718-8; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Gu S, 2004, MOL CELL PROTEOMICS, V3, P998, DOI 10.1074/mcp.M400033-MCP200; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936; Hu CAA, 2007, MOL CELL BIOCHEM, V295, P85, DOI 10.1007/s11010-006-9276-6; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaneda D, 2003, NEUROLOGY, V61, P128, DOI 10.1212/01.WNL.0000069605.00498.BD; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lamparska-Przybysz M, 2005, J Physiol Pharmacol, V56 Suppl 3, P159; Levine AJ, 2006, GENE DEV, V20, P267, DOI 10.1101/gad.1363206; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liu ZH, 2005, CANCER RES, V65, P1647, DOI 10.1158/0008-5472.CAN-04-1754; Liu ZH, 2005, MOL CANCER RES, V3, P21; Liu ZH, 2007, MOL CELL BIOCHEM, V297, P179, DOI 10.1007/s11010-006-9345-x; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Maiuri MC, 2007, AUTOPHAGY, V3, P374, DOI 10.4161/auto.4237; Mimmack ML, 2002, P NATL ACAD SCI USA, V99, P4680, DOI 10.1073/pnas.032069099; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Page NM, 2001, GENOMICS, V74, P71, DOI 10.1006/geno.2001.6534; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2006, CANCER RES, V66, P2885, DOI 10.1158/0008-5472.CAN-05-4412; Perez-Morga D, 2005, SCIENCE, V309, P469, DOI 10.1126/science.1114566; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Sasaki T, 2007, BIOL PHARM BULL, V30, P1599, DOI 10.1248/bpb.30.1599; Scorrano L, 2003, BIOCHEM BIOPH RES CO, V304, P437, DOI 10.1016/S0006-291X(03)00615-6; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Tsujimoto Y, 2003, J CELL PHYSIOL, V195, P158, DOI 10.1002/jcp.10254; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; Vanhamme L, 2003, NATURE, V422, P83, DOI 10.1038/nature01461; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	63	164	175	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21540	21549		10.1074/jbc.M800214200	http://dx.doi.org/10.1074/jbc.M800214200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18505729	hybrid, Green Published			2022-12-25	WOS:000257898800027
J	Emter, R; Natsch, A				Emter, Roger; Natsch, Andreas			The sequential action of a dipeptidase and a beta-lyase is required for the release of the human body odorant 3-methyl-3-sulfanylhexan-1-ol from a secreted Cys-Gly-(S) conjugate by Corynebacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN AXILLA-SWEAT; BACTERIAL AMINOACYLASE; ESCHERICHIA-COLI; FELIS-CATUS; IDENTIFICATION; CARBOXYPEPTIDASE-G2; DEACETYLASE; PRECURSORS; PHEROMONE; PROTEIN	Human axillary odor is formed by the action of Corynebacteria on odorless axilla secretions. Sulfanylalkanols, 3-methyl-3sulfanylhexan-1-ol in particular, form one key class of the odoriferous compounds. A conjugate with the dipeptide Cys-Gly has been reported as the secreted precursor for 3-methyl-3-sulfanylhexan-1-ol. Here, we confirm the Cys-Gly-(S) conjugate as the major precursor of this odorant, with lower levels of the Cys-(S) conjugate being present in axilla secretions. The enzymatic release of 3-methyl-3-sulfanylhexan-1-ol from the Cys-Gly-(S) conjugate by the axilla isolate Corynebacterium Ax20 was thus investigated. Cellular extracts of Ax20 released 3-methyl-3-sulfanylhexan-1-ol from the Cys-Gly-(S) conjugate and from the Cys-(S) conjugate, whereas the previously isolated C-S lyase of this bacterial strain was only able to cleave the Cys-(S) conjugate. o-Phenanthroline blocked the release from the Cys-Gly-(S) conjugate but did not affect cleavage of the Cys-(S) conjugate, indicating that in a first step, a metal-dependent dipeptidase hydrolyzes the Cys-Gly bond. This enzyme was purified by four chromatographic steps and gel electrophoresis, and the partial amino acid sequence was determined. The corresponding gene was cloned and expressed in Escherichia coli. It codes for a novel dipeptidase with a high affinity toward the Cys-Gly-(S) conjugate of 3-methyl-3-sulfanylhexan-1-ol. Co-incubating either the synthetic Cys-Gly-(S) conjugate or fresh axilla secretions with both the C-S lyase and the novel dipeptidase did release 3-methyl-3-sulfanylhexan-1-ol, proving that the sequential action of these two enzymes from the skin bacterium Corynebacterium Ax20 does release the odorant from the key secreted precursor.	[Emter, Roger; Natsch, Andreas] Givaudan Schweiz AG, Dept Biosci, CH-8600 Dubendorf, Switzerland	Givaudan SA	Natsch, A (corresponding author), Ueberlandstr 138, CH-8600 Dubendorf, Switzerland.	andreas.natsch@givaudan.com	natsch, andreas/AAM-7042-2020	Natsch, Andreas/0000-0003-2231-2489				BIRD S, 1981, J STEROID BIOCHEM, V14, P213, DOI 10.1016/0022-4731(81)90176-X; BOUVIER J, 1992, J BACTERIOL, V174, P5265, DOI 10.1128/JB.174.16.5265-5271.1992; BOYEN A, 1992, GENE, V116, P1, DOI 10.1016/0378-1119(92)90621-U; BROOKSBA.BW, 1974, EXPERIENTIA, V30, P864, DOI 10.1007/BF01938327; CLAUS R, 1976, J ENDOCRINOL, V68, P483, DOI 10.1677/joe.0.0680483; Gonzalez W, 1996, CARDIOVASC DRUG REV, V14, P166, DOI 10.1111/j.1527-3466.1996.tb00225.x; Hasegawa Y, 2004, CHEM BIODIVERS, V1, P2042, DOI 10.1002/cbdv.200490157; Hendriks WH, 2004, COMP BIOCHEM PHYS B, V139, P245, DOI 10.1016/j.cbpc.2004.07.007; JACKMAN PJH, 1983, CLIN EXP DERMATOL, V8, P259, DOI 10.1111/j.1365-2230.1983.tb01778.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEYDEN JJ, 1981, J INVEST DERMATOL, V77, P413, DOI 10.1111/1523-1747.ep12494624; McGregor WC, 2005, J AM CHEM SOC, V127, P14100, DOI 10.1021/ja054081g; MINTON NP, 1984, GENE, V31, P31, DOI 10.1016/0378-1119(84)90192-6; Miyazaki M, 2003, BIOCHEM J, V370, P101, DOI 10.1042/BJ20021446; Miyazaki M, 2006, CHEM BIOL, V13, P1071, DOI 10.1016/j.chembiol.2006.08.013; Moore DD, 1995, GLOB MOB SURV; Natsch A, 2006, CHEM BIODIVERS, V3, P1, DOI 10.1002/cbdv.200690015; Natsch A, 2004, CHEM BIODIVERS, V1, P1058, DOI 10.1002/cbdv.200490079; Natsch A, 2003, J BIOL CHEM, V278, P5718, DOI 10.1074/jbc.M210142200; Rowsell S, 1997, STRUCTURE, V5, P337, DOI 10.1016/S0969-2126(97)00191-3; Shehadeh N, 1963, J INVEST DERMATOL, V41, P1; SHELLEY WB, 1953, AMA ARCH DERM SYPH, V68, P430, DOI 10.1001/archderm.1953.01540100070012; Starkenmann C, 2005, CHEM BIODIVERS, V2, P705, DOI 10.1002/cbdv.200590048; STARKENMANN C, 2006, Patent No. 2006079934; Tauch A, 2005, J BACTERIOL, V187, P4671, DOI 10.1128/JB.187.13.4671-4682.2005; Taylor D., 2003, International Journal of Cosmetic Science, V25, P137, DOI 10.1046/j.1467-2494.2003.00181.x; Troccaz M, 2004, CHEM BIODIVERS, V1, P1022, DOI 10.1002/cbdv.200490077; WESTALL RG, 1953, BIOCHEM J, V55, P244, DOI 10.1042/bj0550244; ZENG XN, 1991, J CHEM ECOL, V17, P1469, DOI 10.1007/BF00983777	29	45	50	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20645	20652		10.1074/jbc.M800730200	http://dx.doi.org/10.1074/jbc.M800730200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18515361	Green Published, hybrid			2022-12-25	WOS:000257746100005
J	Fox, D; Le Trong, I; Rajagopal, P; Brzovic, PS; Stenkamp, RE; Klevit, RE				Fox, David, III; Le Trong, Isolde; Rajagopal, Ponni; Brzovic, Peter S.; Stenkamp, Ronald E.; Klevit, Rachel E.			Crystal structure of the BARD1 ankyrin repeat domain and its functional consequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; MOLECULAR REPLACEMENT; DNA-DAMAGE; IDENTIFICATION; MUTATIONS; CYS557SER; BRCA1; COMPLEX; VARIANT; RISK	BARD1 is the constitutive nuclear partner to the breast and ovarian cancer-specific tumor suppressor BRCA1. Together, they form a heterodimeric complex responsible for maintaining genomic stability through nuclear functions involving DNA damage signaling and repair, transcriptional regulation, and cell cycle control. We report the 2.0 angstrom structure of the BARD1 ankyrin repeat domain. The structure includes four ankyrin repeats with a non-canonical C-terminal capping ankyrin repeat and a well ordered extended loop preceding the first repeat. Conserved surface features show an acidic patch and an acidic pocket along the surface typically used by ankyrin repeat domains for binding cognate proteins. We also demonstrate that two reported mutations, N470S and V507M, in the ankyrin repeat domain do not result in observable structural defects. These results provide a structural basis for exploring the biological function of the ankyrin repeat domain and for modeling BARD1 isoforms.	[Fox, David, III; Rajagopal, Ponni; Brzovic, Peter S.; Stenkamp, Ronald E.; Klevit, Rachel E.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Le Trong, Isolde; Stenkamp, Ronald E.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Le Trong, Isolde; Stenkamp, Ronald E.] Univ Washington, Biomol Struct Ctr, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Klevit, RE (corresponding author), Univ Washington, Dept Biochem, Box 357350, Seattle, WA 98195 USA.	klevit@u.washington.edu	Klevit, Rachel/AAI-7038-2021	Klevit, Rachel/0000-0002-3476-969X	NCI NIH HHS [1R01 CA 79963] Funding Source: Medline; NIGMS NIH HHS [T32 GM 008268-17-19] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008268] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Batchelor AH, 1998, SCIENCE, V279, P1037, DOI 10.1126/science.279.5353.1037; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Birrane G, 2007, BIOCHEMISTRY-US, V46, P7706, DOI 10.1021/bi700323t; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Deng CX, 2006, NUCLEIC ACIDS RES, V34, P1416, DOI 10.1093/nar/gkl010; Ehebauer MT, 2005, BIOCHEM J, V392, P13, DOI 10.1042/BJ20050515; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Irminger-Finger I, 2006, NAT REV CANCER, V6, P382, DOI 10.1038/nrc1878; Irminger-Finger I, 2001, MOL CELL, V8, P1255, DOI 10.1016/S1097-2765(01)00406-3; Ishitobi M, 2003, CANCER LETT, V200, P1, DOI 10.1016/S0304-3835(03)00387-2; Jefford CE, 2004, ONCOGENE, V23, P3509, DOI 10.1038/sj.onc.1207427; Karppinen SM, 2006, J MED GENET, V43, P856, DOI 10.1136/jmg.2006.041731; Kleiman FE, 2001, CELL, V104, P743, DOI 10.1016/S0092-8674(02)07059-9; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Li L, 2007, CANCER RES, V67, P11876, DOI 10.1158/0008-5472.CAN-07-2370; Li L, 2007, INT J BIOCHEM CELL B, V39, P1659, DOI 10.1016/j.biocel.2007.04.018; Lombardi G, 2007, GENE CHROMOSOME CANC, V46, P791, DOI 10.1002/gcc.20460; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Nakamura Y, 2007, STRUCTURE, V15, P179, DOI 10.1016/j.str.2006.11.015; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Stacey SN, 2006, PLOS MED, V3, P1103, DOI 10.1371/journal.pmed.0030217; Thai TH, 1998, HUM MOL GENET, V7, P195, DOI 10.1093/hmg/7.2.195; Tsuzuki M, 2006, CANCER LETT, V233, P108, DOI 10.1016/j.canlet.2005.03.012; US Cancer Statistics Working Group, 2007, US CANC STAT 2004 IN; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vahteristo P, 2006, EUR J HUM GENET, V14, P167, DOI 10.1038/sj.ejhg.5201542; Walsh T, 2006, JAMA-J AM MED ASSOC, V295, P1379, DOI 10.1001/jama.295.12.1379; Williams RS, 2003, J BIOL CHEM, V278, P53007, DOI 10.1074/jbc.M310182200	34	30	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21179	21186		10.1074/jbc.M802333200	http://dx.doi.org/10.1074/jbc.M802333200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18480049	hybrid, Green Published			2022-12-25	WOS:000257746100060
J	Hussainzada, N; Da Silva, TC; Zhang, EY; Swaan, PW				Hussainzada, Naissan; Da Silva, Tatiana Claro; Zhang, Eric Y.; Swaan, Peter W.			Conserved aspartic acid residues lining the extracellular loop I of sodium-coupled bile acid transporter ASBT interact with Na+ and 7 alpha-OH moieties on the ligand cholestane skeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED ALKYLATION; ALPHA-OST-BETA; SCANNING MUTAGENESIS; HEPATIC CHOLESTEROL; LACTOSE PERMEASE; GUINEA-PIGS; ILEAL; COTRANSPORTER; INHIBITOR; SLC10A2	Functional contributions of residues Val-99-Ser-126 lining extracellular loop (EL) 1 of the apical sodium-dependent bile acid transporter were determined via cysteine-scanning mutagenesis, thiol modification, and in silico interpretation. Despite membrane expression for all but three constructs (S112C, Y117C, S126C), most EL1 mutants (64%) were inactivated by cysteine mutation, suggesting a functional role during sodium/bile acid co-transport. A negative charge at conserved residues Asp-120 and Asp-122 is required for transport function, whereas neutralization of charge at Asp-124 yields a functionally active transporter. D124A exerts low affinity for common bile acids except deoxycholic acid, which uniquely lacks a 7 alpha-hydroxyl (OH) group. Overall, we conclude that (i) Asp-122 functions as a Na+ sensor, binding one of two co-transported Na+ ions, (ii) Asp-124 interacts with 7 alpha-OH groups of bile acids, and (iii) apolar EL1 residues map to hydrophobic ligand pharmacophore features. Based on these data, we propose a comprehensive mechanistic model involving dynamic salt bridge pairs and hydrogen bonding involving multiple residues to describe sodium-dependent bile acid transporter-mediated bile acid and cation translocation.	[Hussainzada, Naissan; Da Silva, Tatiana Claro; Zhang, Eric Y.; Swaan, Peter W.] Univ Maryland, Dept Pharmaceut Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Swaan, PW (corresponding author), Univ Maryland, Dept Pharmaceut Sci, 621 HSF 2,20 Penn St, Baltimore, MD 21201 USA.	pswaan@rx.umaryland.edu		Swaan, Peter/0000-0003-1767-1487	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061425] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK061425, DK 61425] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Alrefai WA, 2005, AM J PHYSIOL-GASTR L, V288, pG978, DOI 10.1152/ajpgi.00379.2004; Balakrishnan A, 2006, MOL PHARMACEUT, V3, P282, DOI 10.1021/mp0600135; Balakrishnan A, 2006, MOL PHARMACEUT, V3, P223, DOI 10.1021/mp060022d; Balakrishnan A, 2006, PHARM RES, V23, P1451, DOI 10.1007/s11095-006-0219-4; Ballatori N, 2005, HEPATOLOGY, V42, P1270, DOI 10.1002/hep.20961; Banerjee A, 2006, BIOCHEMISTRY-US, V45, P943, DOI 10.1021/bi052202j; Banerjee A, 2005, BIOCHEMISTRY-US, V44, P8908, DOI 10.1021/bi050553s; Banerjee A, 2008, BIOCHEM J, V410, P391, DOI 10.1042/BJ20071300; Baringhaus KH, 1999, J LIPID RES, V40, P2158; Chiang JYL, 2001, GENE, V262, P257, DOI 10.1016/S0378-1119(00)00518-7; Dawson PA, 2005, J BIOL CHEM, V280, P6960, DOI 10.1074/jbc.M412752200; Geyer J, 2006, N-S ARCH PHARMACOL, V372, P413, DOI 10.1007/s00210-006-0043-8; Guan L, 2007, NAT PROTOC, V2, P2012, DOI 10.1038/nprot.2007.275; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; Huang HC, 2005, J MED CHEM, V48, P5853, DOI 10.1021/jm0402162; Huff MW, 2002, ARTERIOSCL THROM VAS, V22, P1884, DOI 10.1161/01.ATV.0000035390.87288.26; Hussainzada N, 2008, MOL PHARMACOL, V73, P305, DOI 10.1124/mol.107.041640; Hussainzada N, 2006, MOL PHARMACOL, V70, P1565, DOI 10.1124/mol.106.028647; Kaback HR, 2007, P NATL ACAD SCI USA, V104, P491, DOI 10.1073/pnas.0609968104; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kitayama K, 2006, EUR J PHARMACOL, V539, P89, DOI 10.1016/j.ejphar.2006.04.005; Kramer W, 2001, J BIOL CHEM, V276, P36020, DOI 10.1074/jbc.M104665200; Li H, 2004, METABOLISM, V53, P927, DOI 10.1016/j.metabol.2004.01.017; Mitchell SM, 2004, J BIOL CHEM, V279, P24089, DOI 10.1074/jbc.M311173200; Pajor AM, 2005, J BIOL CHEM, V280, P18728, DOI 10.1074/jbc.M501265200; Pauli-Magnus C, 2005, J HEPATOL, V43, P342, DOI 10.1016/j.jhep.2005.03.017; Schlattjan JH, 2003, ARZNEIMITTEL-FORSCH, V53, P837; Sun AQ, 2006, J BIOL CHEM, V281, P16410, DOI 10.1074/jbc.M600034200; Swaan PW, 1997, J COMPUT AID MOL DES, V11, P581, DOI 10.1023/A:1007919704457; Swaan PW, 1997, BIOCONJUGATE CHEM, V8, P520, DOI 10.1021/bc970076t; Trauner M, 2003, PHYSIOL REV, V83, P633, DOI 10.1152/physrev.00027.2002; Weinman SA, 1998, J BIOL CHEM, V273, P34691, DOI 10.1074/jbc.273.52.34691; West KL, 2005, J NUTR BIOCHEM, V16, P722, DOI 10.1016/j.jnutbio.2005.06.009; West KL, 2002, J PHARMACOL EXP THER, V303, P293, DOI 10.1124/jpet.102.038711; WHITESIDE CH, 1966, P SOC EXP BIOL MED, V121, P153; WONG MH, 1995, J BIOL CHEM, V270, P27228, DOI 10.1074/jbc.270.45.27228; Zahner D, 2003, EUR J BIOCHEM, V270, P1117, DOI 10.1046/j.1432-1033.2003.03463.x; Zhang EY, 2004, BIOCHEMISTRY-US, V43, P11380, DOI 10.1021/bi049270a	39	12	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20653	20663		10.1074/jbc.M802885200	http://dx.doi.org/10.1074/jbc.M802885200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18508772	Green Published, hybrid			2022-12-25	WOS:000257746100006
J	Oh, DY; Yoon, JM; Moon, MJ; Hwang, JI; Choe, H; Lee, JY; Kim, JI; Kim, S; Rhim, H; O'Dell, DK; Walker, JM; Na, HS; Lee, MG; Kwon, HB; Kim, K; Seong, JY				Oh, Da Young; Yoon, Jung Min; Moon, Mi Jin; Hwang, Jong-Ik; Choe, Han; Lee, Ju Yeon; Kim, Jae Il; Kim, Sunoh; Rhim, Hyewhon; O'Dell, David K.; Walker, J. Michael; Na, Heung Sik; Lee, Min Goo; Kwon, Hyuk Bang; Kim, Kyungjin; Seong, Jae Young			Identification of farnesyl pyrophosphate and N-arachidonylglycine as endogenous ligands for GPR92	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; LYSOPHOSPHATIDIC ACID; CANNABINOID RECEPTOR; BRAIN; PAIN; MEMBRANE; CLONING; PLASMA; BINDS; GPR18	A series of small compounds acting at the orphan G protein-coupled receptor GPR92 were screened using a signaling pathway-specific reporter assay system. Lipid-derived molecules including farnesyl pyrophosphate (FPP), N-arachidonylglycine (NAG), and lysophosphatidic acid were found to activate GPR92. FPP and lysophosphatidic acid were able to activate both G(q/11)- and G(s)-mediated signaling pathways, whereas NAG activated only the G(q/11)-mediated signaling pathway. Computer-simulated modeling combined with site-directed mutagenesis of GPR92 indicated that Thr97, Gly98, Phe101, and Arg267 of GPR92 are responsible for the interaction of GPR92 with FPP and NAG. Reverse transcription-PCR analysis revealed that GPR92 mRNA is highly expressed in the dorsal root ganglia (DRG) but faint in other brain regions. Peripheral tissues including, spleen, stomach, small intestine, and kidney also expressed GPR92 mRNA. Immunohistochemical analysis revealed that GPR92 is largely co-localized with TRPV1, a nonspecific cation channel that responds to noxious heat, in mouse and human DRG. FPP and NAG increased intracellular Ca2+ levels in cultured DRG neurons. These results suggest that FPP and NAG play a role in the sensory nervous system through activation of GPR92.	[Oh, Da Young; Yoon, Jung Min; Moon, Mi Jin; Seong, Jae Young] Korea Univ, Coll Med, Lab G Prot Coupled Receptors, Seoul 136705, South Korea; [Na, Heung Sik; Lee, Min Goo] Korea Univ, Coll Med, Dept Physiol, Seoul 136705, South Korea; [Choe, Han] Univ Ulsan, Dept Physiol, Seoul 138736, South Korea; [Choe, Han] Univ Ulsan, Res Inst Biomacromol, Seoul 138736, South Korea; [Lee, Ju Yeon; Kim, Jae Il] Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju 500712, South Korea; [Kim, Sunoh] Chonnam Natl Univ, Biosafety Res Inst, Jeonju 561756, South Korea; [Kim, Sunoh] Chonnam Natl Univ, Coll Vet Med, Jeonju 561756, South Korea; [Rhim, Hyewhon] Korea Inst Sci & Technol, Div Life Sci, Seoul 136791, South Korea; [O'Dell, David K.; Walker, J. Michael] Indiana Univ, Gill Ctr Biomol Sci, Bloomington, IN 47405 USA; [O'Dell, David K.; Walker, J. Michael] Indiana Univ, Program Neurosci, Bloomington, IN 47405 USA; [Kwon, Hyuk Bang] Chonnam Natl Univ, Sch Biol Sci & Technol, Kwangju 500757, South Korea; [Kim, Kyungjin] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); University of Ulsan; University of Ulsan; Gwangju Institute of Science & Technology (GIST); Chonnam National University; Chonnam National University; Korea Institute of Science & Technology (KIST); Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Chonnam National University; Seoul National University (SNU)	Seong, JY (corresponding author), Korea Univ, Coll Med, Lab G Prot Coupled Receptors, Seoul 136705, South Korea.	jyseong@korea.ac.kr	choe, han/A-5679-2010; Seong, Jae Young/A-5794-2012; OH, DA YOUNG/B-2369-2008	choe, han/0000-0003-4604-647X; Seong, Jae Young/0000-0002-3312-6924; Hwang, Jong-Ik/0000-0002-0729-1782	NIDA NIH HHS [DA 16825, DA 018224] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA016825, R01DA018224] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Acharjee S, 2004, J BIOL CHEM, V279, P54445, DOI 10.1074/jbc.M408909200; Akgoz M, 2006, CELL SIGNAL, V18, P1758, DOI 10.1016/j.cellsig.2006.01.016; Burstein SH, 2002, BIOCHEM PHARMACOL, V64, P1147, DOI 10.1016/S0006-2952(02)01301-1; Canutescu AA, 2005, BIOINFORMATICS, V21, P2914, DOI 10.1093/bioinformatics/bti438; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Choi S, 2007, AM J PHYSIOL-GASTR L, V292, pG1366, DOI 10.1152/ajpgi.00516.2006; Civelli O, 2005, TRENDS PHARMACOL SCI, V26, P15, DOI 10.1016/j.tips.2004.11.005; Das S, 2007, MOL ENDOCRINOL, V21, P2672, DOI 10.1210/me.2007-0080; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Fumagalli M, 2004, BIOCHEM PHARMACOL, V68, P113, DOI 10.1016/j.bcp.2004.02.038; Gantz I, 1997, GENOMICS, V42, P462, DOI 10.1006/geno.1997.4752; Huang SM, 2001, J BIOL CHEM, V276, P42639, DOI 10.1074/jbc.M107351200; Kinloch RA, 2005, EXPERT OPIN THER TAR, V9, P685, DOI 10.1517/14728222.9.4.685; Kohno M, 2006, BIOCHEM BIOPH RES CO, V347, P827, DOI 10.1016/j.bbrc.2006.06.175; Konstantinopoulos PA, 2007, NAT REV DRUG DISCOV, V6, P540, DOI 10.1038/nrd2221; Kotarsky K, 2006, J PHARMACOL EXP THER, V318, P619, DOI 10.1124/jpet.105.098848; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; Lee DK, 2001, GENE, V275, P83, DOI 10.1016/S0378-1119(01)00651-5; Noguchi K, 2003, J BIOL CHEM, V278, P25600, DOI 10.1074/jbc.M302648200; Oh DY, 2006, INT REV CYTOL, V252, P163, DOI 10.1016/S0074-7696(06)52003-0; Oh DY, 2005, MOL ENDOCRINOL, V19, P722, DOI 10.1210/me.2004-0220; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Rhim H, 2002, EUR J PHARMACOL, V436, P151, DOI 10.1016/S0014-2999(01)01613-2; RUNQUIST M, 1995, J NEUROCHEM, V65, P2299; Saisho Y, 1997, ANAL BIOCHEM, V252, P89, DOI 10.1006/abio.1997.2314; Sheskin T, 1997, J MED CHEM, V40, P659, DOI 10.1021/jm960752x; Succar R, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-24; Taylor JS, 2003, EMBO J, V22, P5963, DOI 10.1093/emboj/cdg571; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wilson S, 2000, Drug Des Discov, V17, P105; Wise A, 2004, ANNU REV PHARMACOL, V44, P43, DOI 10.1146/annurev.pharmtox.44.101802.121419; Wong LAQ, 2008, NEUROPHARMACOLOGY, V54, P189, DOI 10.1016/j.neuropharm.2007.05.004	33	104	111	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21054	21064		10.1074/jbc.M708908200	http://dx.doi.org/10.1074/jbc.M708908200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18499677	Green Published, hybrid			2022-12-25	WOS:000257746100047
J	Schindl, R; Bergsmann, J; Frischauf, I; Derler, I; Fahrner, M; Muik, M; Fritsch, R; Groschner, K; Romanin, C				Schindl, Rainer; Bergsmann, Judith; Frischauf, Irene; Derler, Isabella; Fahrner, Marc; Muik, Martin; Fritsch, Reinhard; Groschner, Klaus; Romanin, Christoph			2-aminoethoxydiphenyl borate alters selectivity of Orai3 channels by increasing their pore size	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRAC CHANNEL; CA2+ CHANNELS; INHIBITION; POTENTIATION; 2-APB; STIM1; ATP	Stim1 in the endoplasmic reticulum and the three Orai (also termed CRACM) channels in the plasma-membrane are main components of native Ca2+ release-activated Ca2+ channels. A pharmacological hallmark of these channels is their distinct sensitivity to 2-aminoethoxydiphenyl borate (2-APB). Here we report that Orai3 currents can be robustly stimulated by 75 mu M 2-APB independent of Stim1, whereas 2-APB at similar concentrations inhibited store-operated Orai1 currents. 2-APB did not only promote currents through Orai3 channels but also dramatically altered ion selectivity of Orai3 channels. This allowed for permeation of monovalent cations both in the inward as well as outward direction, which is in sharp contrast to the high Ca2+ selectivity of store-operated Orai3 currents. An Orai3-R66W mutant, which lacked in analogy to the severe combined immune deficiency mutant Orai1-R91W store-operated activation, was also found to be resistant to 2-APB stimulation. The change in selectivity by 2-APB was associated with an increase in Orai3 minimum pore size from about 3.8 A to more than 5.34 A. In line with a potential interaction of 2-APB with the Orai3 pore, among three pore mutants tested, the Orai3 E165Q mutant particularly resembled in its permeation properties those of 2-APB stimulated Orai3 and additionally exhibited a reduced response to 2-APB. In aggregate, stimulation of Orai3 currents by 2-APB occurred along with an alteration of the permeation pathway that represents a unique mechanism for regulating ion channel selectivity by chemical compounds.	[Schindl, Rainer; Bergsmann, Judith; Frischauf, Irene; Derler, Isabella; Fahrner, Marc; Muik, Martin; Fritsch, Reinhard; Romanin, Christoph] Univ Linz, Inst Biophys, A-4040 Linz, Austria; [Groschner, Klaus] Graz Univ, Dept Pharm, A-8010 Graz, Austria	Johannes Kepler University Linz; University of Graz	Schindl, R (corresponding author), Univ Linz, Inst Biophys, A-4040 Linz, Austria.	rainer.schindl@jku.at; christoph.romanin@jku.at	Schindl, Rainer/E-3959-2013; Derler, Isabella/B-7871-2019; Schindl, Rainer/V-4205-2019; Fahrner, Marc/AAI-7927-2021; Romanin, Christoph/D-5399-2009; Frischauf, Irene/AAG-2007-2019; Groschner, Klaus/A-2550-2010	Schindl, Rainer/0000-0003-0896-8887; Derler, Isabella/0000-0002-4768-146X; Romanin, Christoph/0000-0003-3756-4136; Frischauf, Irene/0000-0003-0661-2932; Groschner, Klaus/0000-0002-8659-377X; Fahrner, Marc/0000-0002-2689-0158				Bilmen JG, 2002, EUR J BIOCHEM, V269, P3678, DOI 10.1046/j.1432-1033.2002.03060.x; Chinopoulos C, 2003, J BIOL CHEM, V278, P27382, DOI 10.1074/jbc.M303808200; DeHaven WI, 2007, J BIOL CHEM, V282, P17548, DOI 10.1074/jbc.M611374200; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Lioudyno MI, 2008, P NATL ACAD SCI USA, V105, P2011, DOI 10.1073/pnas.0706122105; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Liu DM, 2001, J PHYSIOL-LONDON, V534, P423, DOI 10.1111/j.1469-7793.2001.00423.x; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Parvez S, 2008, FASEB J, V22, P752, DOI 10.1096/fj.07-9449com; PEINELT C, 2008, J PHYSL, V283, P17662; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Prakriya M, 2006, J GEN PHYSIOL, V128, P373, DOI 10.1085/jgp.200609588; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Tao L, 2007, MOL PHARMACOL, V71, P570, DOI 10.1124/mol.106.027508; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Yamashita M, 2007, J GEN PHYSIOL, V130, P525, DOI 10.1085/jgp.200709872; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200	23	123	124	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20261	20267		10.1074/jbc.M803101200	http://dx.doi.org/10.1074/jbc.M803101200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18499656	hybrid			2022-12-25	WOS:000257565300042
J	Thebault, S; Cao, G; Venselaar, H; Xi, Q; Bindels, RJM; Hoenderop, JGJ				Thebault, Stephanie; Cao, Gang; Venselaar, Hanka; Xi, Qi; Bindels, Rene J. M.; Hoenderop, Joost G. J.			Role of the alpha-kinase domain in transient receptor potential melastatin 6 channel and regulation by intracellular ATP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY HYPOCALCEMIA; MIC CHANNELS; CARDIAC MYOCYTES; MG2+ HOMEOSTASIS; CATION CHANNEL; TRPM7 CHANNEL; MAGNESIUM; PROTEIN; HYPOMAGNESEMIA; CELLS	Transient receptor potential melastatin 6 (TRPM6) plays an essential role in epithelial Mg2+ transport. TRPM6 and its closest homologue, TRPM7, both combine a cation channel with an alpha-kinase domain. However, the role of this alpha-kinase domain in TRPM6 channel activity remains elusive. The aim of this study was to investigate the regulation of TRPM6 channel activity by intracellular ATP and the involvement of its alpha-kinase domain. We demonstrated that intracellular Na- and Mg-ATP decreased the TRPM6 current in HEK293 cells heterogeneously expressing the channel, whereas Na-CTP or Na-GTP had no effect on channel activity. Whole cell recordings in TRPM6-expressing HEK293 cells showed that deletion of the alpha-kinase domain prevented the inhibitory effect of intracellular ATP without abrogating channel activity. Mutation of the conserved putative ATP-binding motif GXG(A) XXG (G1955D) in the alpha-kinase domain of TRPM6 inhibited the ATP action, whereas this effect remained preserved in the TRPM6 phosphotransferase-deficient mutant K1804R. Mutation of the TRPM6 autophosphorylation site, Thr(1851), into either an alanine or an aspartate, resulted in functional channels that could still be inhibited by ATP. In conclusion, intracellular ATP regulates TRPM6 channel activity via its alpha-kinase domain independently of alpha-kinase activity.	[Thebault, Stephanie; Cao, Gang; Xi, Qi; Bindels, Rene J. M.; Hoenderop, Joost G. J.] Radboud Univ Nijmegen, Med Ctr, Physiol 286, Dept Physiol, NL-6500 HB Nijmegen, Netherlands; [Venselaar, Hanka] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Ctr Mol & Biomol Informat, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Hoenderop, JGJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Physiol 286, Dept Physiol, POB 9101, NL-6500 HB Nijmegen, Netherlands.	j.hoenderop@ncmls.ru.nl	Bindels, René JM/B-9824-2013; Thébault, Stéphanie/AAD-8350-2019; Hoenderop, Joost G.J./H-8047-2014; Venselaar, Hanka/D-2009-2016	Bindels, René JM/0000-0003-1167-1339; Hoenderop, Joost G.J./0000-0002-1816-8544; Venselaar, Hanka/0000-0001-9824-6559; Thebault, Stephanie/0000-0003-3233-282X				Cao G, 2008, CURR BIOL, V18, P168, DOI 10.1016/j.cub.2007.12.058; Chubanov V, 2004, P NATL ACAD SCI USA, V101, P2894, DOI 10.1073/pnas.0305252101; Demeuse P, 2006, J GEN PHYSIOL, V127, P421, DOI 10.1085/jgp.200509410; Groenestege WMT, 2007, J CLIN INVEST, V117, P2260, DOI 10.1172/JCI31680; Groenestege WMT, 2006, J AM SOC NEPHROL, V17, P1035, DOI 10.1681/ASN.2005070700; Grubbs RD, 2002, BIOMETALS, V15, P251, DOI 10.1023/A:1016026831789; Gwanyanya A, 2006, AM J PHYSIOL-CELL PH, V291, pC627, DOI 10.1152/ajpcell.00074.2006; Hermosura MC, 2005, P NATL ACAD SCI USA, V102, P11510, DOI 10.1073/pnas.0505149102; Hermosura MC, 2002, J PHYSIOL-LONDON, V539, P445, DOI 10.1113/jphysiol.2001.013361; Konrad M, 2004, AM J PHYSIOL-RENAL, V286, pF599, DOI 10.1152/ajprenal.00312.2003; Kozak JA, 2003, BIOPHYS J, V84, P922, DOI 10.1016/S0006-3495(03)74909-1; Kozak JA, 2002, J GEN PHYSIOL, V120, P221, DOI 10.1085/jgp.20028601; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Li M, 2006, J GEN PHYSIOL, V127, P525, DOI 10.1085/jgp.200609502; Li MJ, 2007, J BIOL CHEM, V282, P25817, DOI 10.1074/jbc.M608972200; MADSEN KM, 1988, J ELECTRON MICR TECH, V9, P187, DOI 10.1002/jemt.1060090206; Matsushita M, 2005, J BIOL CHEM, V280, P20793, DOI 10.1074/jbc.M413671200; MATTHEWS BW, 1987, P NATL ACAD SCI USA, V84, P6663, DOI 10.1073/pnas.84.19.6663; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Montell C, 2003, CURR BIOL, V13, pR799, DOI 10.1016/j.cub.2003.09.048; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Prakriya M, 2002, J GEN PHYSIOL, V119, P487, DOI 10.1085/jgp.20028551; Romani AMP, 2002, BIOMETALS, V15, P271, DOI 10.1023/A:1016082900838; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Ryazanov AG, 2002, FEBS LETT, V514, P26, DOI 10.1016/S0014-5793(02)02299-8; Ryazanov AG, 1999, CURR BIOL, V9, pR43, DOI 10.1016/S0960-9822(99)80006-2; Scharenberg AM, 2005, PFLUG ARCH EUR J PHY, V451, P220, DOI 10.1007/s00424-005-1444-0; Schlingmann KP, 2002, NAT GENET, V31, P166, DOI 10.1038/ng889; Schmitz C, 2005, J BIOL CHEM, V280, P37763, DOI 10.1074/jbc.M509175200; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Spitaler M, 2000, J BIOL CHEM, V275, P33289, DOI 10.1074/jbc.M002742200; Takezawa R, 2004, P NATL ACAD SCI USA, V101, P6009, DOI 10.1073/pnas.0307565101; Trouet D, 1997, PFLUG ARCH EUR J PHY, V434, P632, DOI 10.1007/s004240050445; Voets T, 2004, J BIOL CHEM, V279, P19, DOI 10.1074/jbc.M311201200; Walder RY, 2002, NAT GENET, V31, P171, DOI 10.1038/ng901; Wang M, 2004, J PHYSIOL-LONDON, V555, P383, DOI 10.1113/jphysiol.2003.048538; Wolf Federica I., 2003, Molecular Aspects of Medicine, V24, P11, DOI 10.1016/S0098-2997(02)00088-2; Yamaguchi H, 2001, MOL CELL, V7, P1047, DOI 10.1016/S1097-2765(01)00256-8	38	43	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					19999	20007		10.1074/jbc.M800167200	http://dx.doi.org/10.1074/jbc.M800167200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18490453	Green Published, hybrid			2022-12-25	WOS:000257565300015
J	Dehner, M; Hadjihannas, M; Weiske, J; Huber, O; Behrens, J				Dehner, Manuel; Hadjihannas, Michel; Weiske, Joerg; Huber, Otmar; Behrens, Juergen			Wnt signaling inhibits Forkhead box O3a-induced transcription and apoptosis through up-regulation of serum- and glucocorticoid-inducible kinase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THREONINE PROTEIN-KINASE; COLORECTAL-CANCER CELLS; APC TUMOR-SUPPRESSOR; BETA-CATENIN; DEPENDENT TRANSCRIPTION; FUNCTIONAL INTERACTION; NEGATIVE REGULATOR; EPITHELIAL-CELLS; COLON-CARCINOMA; NUCLEAR EXPORT	In human cancers, mutations in components of the Wnt signaling pathway lead to beta-catenin stabilization and result in augmented gene transcription. HCT116 colon cancer cells carry stabilizing mutations in beta-catenin and exhibit an elevated activation of Wnt signaling. To clarify the role of an overactive Wnt signaling, we used DNA microarray analysis to search for genes whose expression is up-regulated after knockdown of the wild type adenomatous polyposis coli (APC) tumor suppressor in HCT116 cells, which further enhances Wnt signaling activation. Serum and glucocorticoid-inducible kinase 1 (SGK1) was among the most up-regulated genes following APC knockdown through small interfering RNA. Up-regulation of SGK1 in response to small interfering RNA against APC was inhibited by concomitant knockdown of beta-catenin. Quantitative real time reverse transcription-PCR, Western blot, and chromatin immunoprecipitation analyses confirmed that SGK1 is a direct beta-catenin target gene. SGK1 negatively regulates the pro-apoptotic transcription factor Forkhead box O3a (FoxO3a) via phosphorylation and exclusion from the nucleus. We show that Wnt signaling activation results in FoxO3a exclusion from the nucleus and inhibits expression of FoxO3a target genes. Importantly, FoxO3a mutants that fail to be phosphorylated and therefore are regulated by SGK1 are not influenced by activation of Wnt signaling. In line, knockdown of SGK1 relieves the effects of Wnt signaling on FoxO3a localization and FoxO3a-dependent transcription. Finally, we show that induction of Wnt signaling inhibits FoxO3a-induced apoptosis. Collectively our results indicate that evasion of apoptosis is another feature employed by an overactive Wnt signaling.	[Dehner, Manuel; Hadjihannas, Michel; Behrens, Juergen] Univ Erlangen Nurnberg, Dept Expt Med 2, Nikolaus Fiebiger Ctr Mol Med, D-91054 Erlangen, Germany; [Weiske, Joerg; Huber, Otmar] Charite Univ Med Berlin, Dept Lab Med & Pathobiochem, D-12200 Berlin, Germany	University of Erlangen Nuremberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Behrens, J (corresponding author), Univ Erlangen Nurnberg, Dept Expt Med 2, Nikolaus Fiebiger Ctr Mol Med, Glueckstr 6, D-91054 Erlangen, Germany.	jbehrens@molmed.uni-erlangen.de	Huber, Otmar/AAA-4548-2021	Huber, Otmar/0000-0003-4359-1747				Barreyro FJ, 2007, J BIOL CHEM, V282, P27141, DOI 10.1074/jbc.M704391200; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Bhargava A, 2001, ENDOCRINOLOGY, V142, P1587, DOI 10.1210/en.142.4.1587; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chen SQ, 2001, J CELL BIOL, V152, P87, DOI 10.1083/jcb.152.1.87; Chen SY, 1999, P NATL ACAD SCI USA, V96, P2514, DOI 10.1073/pnas.96.5.2514; Cong F, 2004, P NATL ACAD SCI USA, V101, P2882, DOI 10.1073/pnas.0307344101; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Durig J, 2003, BLOOD, V101, P2748, DOI 10.1182/blood-2002-09-2683; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Giarre M, 1998, ANN NY ACAD SCI, V857, P43, DOI 10.1111/j.1749-6632.1998.tb10106.x; Hadjihannas MV, 2006, P NATL ACAD SCI USA, V103, P10747, DOI 10.1073/pnas.0604206103; Harte D, 1998, J NONLINEAR SCI, V8, P581, DOI 10.1007/s003329900060; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kadowaki M, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-77; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Kim PJ, 2003, LANCET, V362, P205, DOI 10.1016/S0140-6736(03)13910-4; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Krieghoff E, 2006, J CELL SCI, V119, P1453, DOI 10.1242/jcs.02864; Krueger C, 2003, NUCLEIC ACIDS RES, V31, P3050, DOI 10.1093/nar/gkg421; Kuphal F, 2006, EXP CELL RES, V312, P457, DOI 10.1016/j.yexcr.2005.11.007; Leong MLL, 2003, J BIOL CHEM, V278, P5871, DOI 10.1074/jbc.M211649200; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Mikosz CA, 2001, J BIOL CHEM, V276, P16649, DOI 10.1074/jbc.M010842200; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Naishiro Y, 2005, ONCOGENE, V24, P3141, DOI 10.1038/sj.onc.1208517; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Perreault N, 2001, J BIOL CHEM, V276, P43328, DOI 10.1074/jbc.M104366200; Polakis P, 2000, GENE DEV, V14, P1837; Roose J, 1999, BBA-REV CANCER, V1424, pM23, DOI 10.1016/S0304-419X(99)00026-8; Rosin-Arbesfeld R, 2000, NATURE, V406, P1009, DOI 10.1038/35023016; Rosin-Arbesfeld R, 2003, EMBO J, V22, P1101, DOI 10.1093/emboj/cdg105; Shelly C, 2002, J CELL SCI, V115, P1985; STRATFORDPERRICAUDET LD, 1992, J CLIN INVEST, V90, P626, DOI 10.1172/JCI115902; Tapia JC, 2006, P NATL ACAD SCI USA, V103, P15079, DOI 10.1073/pnas.0606845103; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Torres VA, 2006, J CELL SCI, V119, P1812, DOI 10.1242/jcs.02894; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; WEBSTER MK, 1993, J BIOL CHEM, V268, P11482; Weiske J, 2006, J BIOL CHEM, V281, P27356, DOI 10.1074/jbc.M513452200; Weiske J, 2007, P NATL ACAD SCI USA, V104, P20344, DOI 10.1073/pnas.0703664105; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; You H, 2004, P NATL ACAD SCI USA, V101, P14057, DOI 10.1073/pnas.0406286101; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4	59	100	103	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19201	19210		10.1074/jbc.M710366200	http://dx.doi.org/10.1074/jbc.M710366200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18487207	hybrid			2022-12-25	WOS:000257387600005
J	Ilagan, RP; Tiso, M; Konas, DW; Hemann, C; Durra, D; Hille, R; Stuehr, DJ				Ilagan, Robielyn P.; Tiso, Mauro; Konas, David W.; Hemann, Craig; Durra, Deborah; Hille, Russ; Stuehr, Dennis J.			Differences in a conformational equilibrium distinguish catalysis by the endothelial and neuronal nitric-oxide synthase flavoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CYTOCHROME-P450 REDUCTASE; AUTOINHIBITORY CONTROL ELEMENT; HUMAN METHIONINE SYNTHASE; ONE-ELECTRON TRANSFER; C-TERMINAL TAIL; FERREDOXIN-NADP(+) REDUCTASE; COENZYME BINDING; REDOX PROPERTIES; 2 FLAVINS; CRYSTAL-STRUCTURE	Nitric oxide (NO) is a physiological mediator synthesized by NO synthases (NOS). Despite their structural similarity, endothelial NOS (eNOS) has a 6-fold lower NO synthesis activity and 6-16-fold lower cytochrome c reductase activity than neuronal NOS (nNOS), implying significantly different electron transfer capacities. We utilized purified reductase domain constructs of either enzyme (bovine eNOSr and rat nNOSr) to investigate the following three mechanisms that may control their electron transfer: (i) the set point and control of a two-state conformational equilibrium of their FMN subdomains; (ii) the flavin midpoint reduction potentials; and (iii) the kinetics of NOSr-NADP(+) interactions. Although eNOSr and nNOSr differed in their NADP(H) interaction and flavin thermodynamics, the differences were minor and unlikely to explain their distinct electron transfer activities. In contrast, calmodulin (CaM)-free eNOSr favored the FMN-shielded (electron-accepting) conformation over the FMN-deshielded (electron-donating) conformation to a much greater extent than did CaM-free nNOSr when the bound FMN cofactor was poised in each of its three possible oxidation states. NADPH binding only stabilized the FMN-shielded conformation of nNOSr, whereas CaM shifted both enzymes toward the FMN-deshielded conformation. Analysis of cytochrome c reduction rates measured within the first catalytic turnover revealed that the rate of conformational change to the FMN-deshielded state differed between eNOSr and nNOSr and was rate-limiting for either CaM-free enzyme. We conclude that the set point and regulation of the FMN conformational equilibrium differ markedly in eNOSr and nNOSr and can explain the lower electron transfer activity of eNOSr.	[Ilagan, Robielyn P.; Durra, Deborah; Stuehr, Dennis J.] Cleveland Clin, Dept Pathobiol, Lerner Res Inst, Cleveland, OH 44195 USA; [Tiso, Mauro] NHLBI, Pulm & Vasc Med Branch, NIH, Bethesda, MD 20892 USA; [Konas, David W.] Montclair State Univ, Dept Chem & Biochem, Montclair, NJ 07043 USA; [Hemann, Craig] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Hille, Russ] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	Cleveland Clinic Foundation; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Montclair State University; University System of Ohio; Ohio State University; University of California System; University of California Riverside	Stuehr, DJ (corresponding author), Cleveland Clin, Dept Pathobiol, Lerner Res Inst, NC-22,9500 Euclid Ave, Cleveland, OH 44195 USA.	stuehrd@ccf.org		Hemann, Craig/0000-0002-7380-4072	NATIONAL CANCER INSTITUTE [R29CA053914, R01CA053914] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075036] Funding Source: NIH RePORTER; NCI NIH HHS [CA53914] Funding Source: Medline; NHLBI NIH HHS [HL76491] Funding Source: Medline; NIEHS NIH HHS [ES012658] Funding Source: Medline; NIGMS NIH HHS [GM075036] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABU SH, 1993, P NATL ACAD SCI USA, V90, P10769; Adak S, 2002, P NATL ACAD SCI USA, V99, P13516, DOI 10.1073/pnas.192283399; Adak S, 2001, J BIOL CHEM, V276, P1244, DOI 10.1074/jbc.M006857200; Adak S, 1999, J BIOL CHEM, V274, P22313, DOI 10.1074/jbc.274.32.22313; Aliverti A, 1998, J BIOL CHEM, V273, P34008, DOI 10.1074/jbc.273.51.34008; Chen PF, 1996, J BIOL CHEM, V271, P14631, DOI 10.1074/jbc.271.24.14631; Craig DH, 2002, J BIOL CHEM, V277, P33987, DOI 10.1074/jbc.M203118200; Daff S, 2003, BIOCHEM SOC T, V31, P502, DOI 10.1042/bst0310502; Daff S, 1999, J BIOL CHEM, V274, P30589, DOI 10.1074/jbc.274.43.30589; Daff SN, 1997, BIOCHEMISTRY-US, V36, P13816, DOI 10.1021/bi971085s; Deng Z, 1999, NAT STRUCT BIOL, V6, P847; DOLPHIN D, 1987, COENZYMES COFACTORS, P776; Dunford AJ, 2007, BIOCHEMISTRY-US, V46, P5018, DOI 10.1021/bi7001339; DUTTON PL, 1970, BIOCHEMISTRY-US, V9, P5077, DOI 10.1021/bi00828a006; Feng CJ, 2007, J AM CHEM SOC, V129, P5621, DOI 10.1021/ja068685b; Finn RD, 2003, EUR J BIOCHEM, V270, P1164, DOI 10.1046/j.1432-1033.2003.03474.x; Fulton D, 2001, J PHARMACOL EXP THER, V299, P818; Gachhui R, 1998, J BIOL CHEM, V273, P5451, DOI 10.1074/jbc.273.10.5451; Gachhui R, 1996, J BIOL CHEM, V271, P20594, DOI 10.1074/jbc.271.34.20594; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; Garnaud PE, 2004, BIOCHEMISTRY-US, V43, P11035, DOI 10.1021/bi049312v; Grunau A, 2006, BIOCHEMISTRY-US, V45, P1421, DOI 10.1021/bi052115r; Guan ZW, 2003, J BIOL CHEM, V278, P30859, DOI 10.1074/jbc.M301929200; Guan ZW, 2003, ARCH BIOCHEM BIOPHYS, V412, P65, DOI 10.1016/S0003-9861(03)00009-2; Gutierrez A, 2003, BIOCHEM SOC T, V31, P497, DOI 10.1042/BST0310497; Gutierrez A, 2003, EUR J BIOCHEM, V270, P2612, DOI 10.1046/j.1432-1033.2003.03633.x; Gutierrez A, 2002, BIOCHEMISTRY-US, V41, P4626, DOI 10.1021/bi0159433; Haque MM, 2007, P NATL ACAD SCI USA, V104, P9254, DOI 10.1073/pnas.0700332104; Higashimoto Y, 2005, J BIOL CHEM, V280, P729, DOI 10.1074/jbc.M406203200; Hubbard PA, 2001, J BIOL CHEM, V276, P29163, DOI 10.1074/jbc.M101731200; INNES JB, 1989, BIOCHEMISTRY-US, V28, P1116, DOI 10.1021/bi00429a028; Iwakiri Y, 2006, P NATL ACAD SCI USA, V103, P19777, DOI 10.1073/pnas.0605907103; Knight K, 2002, BIOCHEM J, V367, P19, DOI 10.1042/BJ20020667; Knudsen GM, 2003, J BIOL CHEM, V278, P31814, DOI 10.1074/jbc.M303267200; Konas DW, 2006, BIOCHEMISTRY-US, V45, P12596, DOI 10.1021/bi061011t; Konas DW, 2004, J BIOL CHEM, V279, P35412, DOI 10.1074/jbc.M400872200; Lane P, 2002, J BIOL CHEM, V277, P19087, DOI 10.1074/jbc.M200258200; Li HY, 2005, J INORG BIOCHEM, V99, P293, DOI 10.1016/j.jinorgbio.2004.10.016; Matsuda H, 1999, BBA-GEN SUBJECTS, V1473, P345, DOI 10.1016/S0304-4165(99)00193-2; McCabe TJ, 2000, J BIOL CHEM, V275, P6123, DOI 10.1074/jbc.275.9.6123; MCTIGUE MA, 1993, BIOCHEMISTRY-US, V32, P6855, DOI 10.1021/bi00078a008; Miyajima M, 2000, BIOCHEM BIOPH RES CO, V275, P752, DOI 10.1006/bbrc.2000.3367; Munro AW, 2002, TRENDS BIOCHEM SCI, V27, P250, DOI 10.1016/S0968-0004(02)02086-8; Munro AW, 2001, BIOCHEMISTRY-US, V40, P1956, DOI 10.1021/bi001718u; Nishida CR, 1999, J BIOL CHEM, V274, P14692, DOI 10.1074/jbc.274.21.14692; Nishino Y, 2007, ARCH BIOCHEM BIOPHYS, V465, P254, DOI 10.1016/j.abb.2007.05.021; Noble MA, 1999, BIOCHEMISTRY-US, V38, P16413, DOI 10.1021/bi992150w; Panda K, 2006, J BIOL CHEM, V281, P36819, DOI 10.1074/jbc.M606129200; Panda SP, 2006, J BIOL CHEM, V281, P34246, DOI 10.1074/jbc.M601041200; Piubelli L, 2000, J BIOL CHEM, V275, P10472, DOI 10.1074/jbc.275.14.10472; Ray SS, 2007, BIOCHEMISTRY-US, V46, P11865, DOI 10.1021/bi700805x; Roman LJ, 2006, J BIOL CHEM, V281, P23111, DOI 10.1074/jbc.M603671200; Roman LJ, 2000, J BIOL CHEM, V275, P29225, DOI 10.1074/jbc.M004766200; Roman LJ, 2002, CHEM REV, V102, P1179, DOI 10.1021/cr000661e; Salerno JC, 1997, J BIOL CHEM, V272, P29769, DOI 10.1074/jbc.272.47.29769; Siddhanta U, 1998, J BIOL CHEM, V273, P18950, DOI 10.1074/jbc.273.30.18950; Singh A, 2003, J BIOL CHEM, V278, P33208, DOI 10.1074/jbc.M303061200; Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X; Stuehr DJ, 2004, J BIOL CHEM, V279, P36167, DOI 10.1074/jbc.R400017200; Thomas DD, 2003, ANTIOXID REDOX SIGN, V5, P307, DOI 10.1089/152308603322110887; Tiso M, 2005, J BIOL CHEM, V280, P39208, DOI 10.1074/jbc.M507775200; Tiso M, 2007, BIOCHEMISTRY-US, V46, P14418, DOI 10.1021/bi701646k; Wolthers KR, 2007, BIOCHEMISTRY-US, V46, P6696, DOI 10.1021/bi700339v; Wolthers KR, 2003, BIOCHEMISTRY-US, V42, P3911, DOI 10.1021/bi027290b; Xu H, 2007, J BIOL CHEM, V282, P37567, DOI 10.1074/jbc.M706464200; Zhang J, 2001, J BIOL CHEM, V276, P37506, DOI 10.1074/jbc.M105503200; Zhao Q, 1999, PROTEIN SCI, V8, P298	67	41	42	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19603	19615		10.1074/jbc.M802914200	http://dx.doi.org/10.1074/jbc.M802914200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18487202	Green Published, hybrid			2022-12-25	WOS:000257387600046
J	Osawa, S; Funamoto, S; Nobuhara, M; Wada-Kakuda, S; Shimojo, M; Yagishita, S; Ihara, Y				Osawa, Satoko; Funamoto, Satoru; Nobuhara, Mika; Wada-Kakuda, Satoko; Shimojo, Masafumi; Yagishita, Sosuke; Ihara, Yasuo			Phosphoinositides suppress gamma-secretase in both the detergent-soluble and -insoluble states	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; PLECKSTRIN HOMOLOGY DOMAIN; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; BETA-PROTEIN; ALZHEIMERS-DISEASE; CRYSTAL-STRUCTURE; INTRAMEMBRANE CLEAVAGE; TERMINAL FRAGMENT; ASPARTIC PROTEASE; ACTIN DYNAMICS	gamma-Secretase is an aspartic protease that hydrolyzes type I membrane proteins within the hydrophobic environment of the lipid bilayer. Using the CHAPSO-solubilized gamma-secretase assay system, we previously found that gamma-secretase activity was sensitive to the concentrations of detergent and phosphatidylcholine. This strongly suggests that the composition of the lipid bilayer has a significant impact on the activity of gamma-secretase. Recently, level of secreted beta-amyloid protein was reported to be attenuated by increasing levels of phosphatidylinositol 4,5-diphosphate (PI(4,5)P-2) in cultured cells. However, it is not clear whether PI(4,5)P-2 has a direct effect on gamma-secretase activity. In this study, we found that phosphoinositides directly inhibited CHAPSO-solubilized gamma-secretase activity. Interestingly, neither phosphatidylinositol nor inositol triphosphate altered gamma-secretase activity. PI(4,5)P-2 was also found to inhibit gamma-secretase activity in CHAPSO-insoluble membrane microdomains (rafts). Kinetic analysis of beta-amyloid protein production in the presence of PI(4,5)P-2 suggested a competitive inhibition. Even though phosphoinositides are minor phospholipids of the membrane, the concentration of PI(4,5)P-2 within the intact membrane has been reported to be in the range of 4-8 mM. The presence of PI(4,5)P-2-rich rafts in the membrane has been reported in a range of cell types. Furthermore, gamma-secretase is enriched in rafts. Taking these data together, we propose that phosphoinositides potentially regulate gamma-secretase activity by suppressing its association with the substrate.	[Funamoto, Satoru; Nobuhara, Mika; Ihara, Yasuo] Doshisha Univ, Dept Neuropathol, Fac Life & Med Sci, Kyoto 6100394, Japan; [Osawa, Satoko; Funamoto, Satoru; Wada-Kakuda, Satoko; Ihara, Yasuo] Univ Tokyo, Dept Neuropathol, Fac Med, Bunkyo Ku, Tokyo 1130033, Japan; [Shimojo, Masafumi] RIKEN, Brain Sci Inst, Lab Alzheimers Dis, Wako, Saitama 3510198, Japan; [Yagishita, Sosuke] Univ Tokyo, Dept Life Sci, Grad Sch Arts & Sci, Tokyo 1538902, Japan	Doshisha University; University of Tokyo; RIKEN; University of Tokyo	Funamoto, S (corresponding author), Doshisha Univ, Dept Neuropathol, Fac Life & Med Sci, Kyoto 6100394, Japan.	sfunamot@mail.doshisha.ac.jp						Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; BUNCE CM, 1993, BIOCHEM J, V289, P667, DOI 10.1042/bj2890667; Dhe-Paganon S, 1999, P NATL ACAD SCI USA, V96, P8378, DOI 10.1073/pnas.96.15.8378; FERGUSON KM, 1994, CELL, V79, P199, DOI 10.1016/0092-8674(94)90190-2; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P323, DOI 10.1021/bi035748j; Funamoto S, 2004, BIOCHEMISTRY-US, V43, P13532, DOI 10.1021/bi049399k; Funamoto S, 2001, J CELL BIOL, V153, P795, DOI 10.1083/jcb.153.4.795; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Golub T, 2005, J CELL BIOL, V169, P151, DOI 10.1083/jcb.200407058; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; Hinchliffe KA, 1998, BBA-MOL CELL BIOL L, V1436, P87, DOI 10.1016/S0005-2760(98)00140-4; HYVONEN M, 1995, EMBO J, V14, P4676, DOI 10.1002/j.1460-2075.1995.tb00149.x; Janmey PA, 2004, NAT REV MOL CELL BIO, V5, P658, DOI 10.1038/nrm1434; Kakuda N, 2006, J BIOL CHEM, V281, P14776, DOI 10.1074/jbc.M513453200; Kanzaki M, 2004, J BIOL CHEM, V279, P30622, DOI 10.1074/jbc.M401443200; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; KOO EH, 1994, J BIOL CHEM, V269, P17386; Landman N, 2006, P NATL ACAD SCI USA, V103, P19524, DOI 10.1073/pnas.0604954103; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Martin TFJ, 2001, CURR OPIN CELL BIOL, V13, P493, DOI 10.1016/S0955-0674(00)00241-6; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Michailidis IE, 2007, J NEUROSCI, V27, P5523, DOI 10.1523/JNEUROSCI.4378-06.2007; Oliver D, 2004, SCIENCE, V304, P265, DOI 10.1126/science.1094113; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Rickert P, 2000, TRENDS CELL BIOL, V10, P466, DOI 10.1016/S0962-8924(00)01841-9; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Sato T, 2003, J BIOL CHEM, V278, P24294, DOI 10.1074/jbc.M211161200; Saxena MT, 2001, J BIOL CHEM, V276, P40268, DOI 10.1074/jbc.M107234200; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; SHEETZ MP, 1982, NATURE, V296, P91, DOI 10.1038/296091a0; Sheetz MP, 2001, NAT REV MOL CELL BIO, V2, P392, DOI 10.1038/35073095; SHIMOHAMA S, 1991, AM J PATHOL, V139, P737; Shimojo M, 2007, NEUROSCI RES, V57, P446, DOI 10.1016/j.neures.2006.12.005; Simonsen A, 2001, CURR OPIN CELL BIOL, V13, P485, DOI 10.1016/S0955-0674(00)00240-4; Soisson SM, 1998, CELL, V95, P259, DOI 10.1016/S0092-8674(00)81756-0; STEPHENS LR, 1991, NATURE, V351, P33, DOI 10.1038/351033a0; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Vetrivel KS, 2005, J BIOL CHEM, V280, P25892, DOI 10.1074/jbc.M503570200; Wada S, 2003, BIOCHEMISTRY-US, V42, P13977, DOI 10.1021/bi034904j; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Winks JS, 2005, J NEUROSCI, V25, P3400, DOI 10.1523/JNEUROSCI.3231-04.2005; Wrigley JDJ, 2005, J BIOL CHEM, V280, P12523, DOI 10.1074/jbc.M413086200	57	36	36	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19283	19292		10.1074/jbc.M705954200	http://dx.doi.org/10.1074/jbc.M705954200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18480063	hybrid			2022-12-25	WOS:000257387600014
J	Pask, AJ; McInnes, KJ; Webb, DR; Short, RV				Pask, Andrew J.; McInnes, Kerry J.; Webb, David R.; Short, Roger V.			Topical Oestrogen Keratinises The Human Foreskin and May Help Prevent HIV Infection	PLOS ONE			English	Article								With the growing incidence of HIV, there is a desperate need to develop simple, cheap and effective new ways of preventing HIV infection. Male circumcision reduces the risk of infection by about 60%, probably because of the removal of the Langerhans cells which are abundant in the inner foreskin and are the primary route by which HIV enters the penis. Langerhans cells form a vital part of the body's natural defence against HIV and only cause infection when they are exposed to high levels of HIV virions. Rather than removing this natural defence mechanism by circumcision, it may be better to enhance it by thickening the layer of keratin overlying the Langerhans cells, thereby reducing the viral load to which they are exposed. We have investigated the ability of topically administered oestrogen to induce keratinization of the epithelium of the inner foreskin. Histochemically, the whole of the foreskin is richly supplied with oestrogen receptors. The epithelium of the inner foreskin, like the vagina, responds within 24 hours to the topical administration of oestriol by keratinization, and the response persists for at least 5 days after the cessation of the treatment. Oestriol, a cheap, readily available natural oestrogen metabolite, rapidly keratinizes the inner foreskin, the site of HIV entry into the penis. This thickening of the overlying protective layer of keratin should reduce the exposure of the underlying Langerhans cells to HIV virions. This simple treatment could become an adjunct or alternative to surgical circumcision for reducing the incidence of HIV infection in men.	[Pask, Andrew J.] Univ Melbourne, Dept Zool, Melbourne, Vic, Australia; [McInnes, Kerry J.] Prince Henrys Inst Med Res, Clayton, Vic, Australia; [Webb, David R.] Univ Melbourne, Dept Surg, Melbourne, Vic, Australia; [Webb, David R.] Austin Hlth, Heidelberg, Vic, Australia; [Short, Roger V.] Univ Melbourne, Fac Med, Dent & Hlth Sci, Melbourne, Vic, Australia	University of Melbourne; Prince Henry's Institute of Medical Research; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Pask, AJ (corresponding author), Univ Melbourne, Dept Zool, Melbourne, Vic, Australia.	r.short@unimelb.edu.au	McInnes, Kerry/B-7893-2011	Pask, Andrew/0000-0002-1900-2263	National Health and Medical Research Council [RD Wright Fellowship]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Supported by a National Health and Medical Research Council RD Wright Fellowship to AJP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashcroft GS, 1997, NAT MED, V3, P1209, DOI 10.1038/nm1197-1209; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541; DEVINCENZI I, 1992, BRIT MED J, V304, P809; GERBALDO D, 1991, MATURITAS, V13, P269, DOI 10.1016/0378-5122(91)90235-I; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hladik F, 2007, IMMUNITY, V26, P257, DOI 10.1016/j.immuni.2007.01.007; Kelley Charlotte, 2007, Urol Nurs, V27, P40; Luna L, 1992, HISTOPATHOLOGIC METH; McCoombe SG, 2006, AIDS, V20, P1491, DOI 10.1097/01.aids.0000237364.11123.98; Mor Z, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000861; Morris BJ, 2007, BIOESSAYS, V29, P1147, DOI 10.1002/bies.20654; Newell ML, 2007, LANCET, V369, P617, DOI 10.1016/S0140-6736(07)60288-8; Quinn TC, 2007, CURR OPIN INFECT DIS, V20, P33, DOI 10.1097/QCO.0b013e328012c5bc; Robinson D, 2003, UROLOGY, V62, P45, DOI 10.1016/S0090-4295(03)00676-9; Schwartz O, 2007, NAT MED, V13, P245, DOI 10.1038/nm0307-245; Smith SA, 2004, AIDS, V18, P1637, DOI 10.1097/01.aids.0000131393.76221.cc; Weiss HA, 2008, AIDS, V22, P567, DOI 10.1097/QAD.0b013e3282f3f406; Wu WX, 2000, AM J PHYSIOL-CELL PH, V278, pC190, DOI 10.1152/ajpcell.2000.278.1.C190	20	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2308	10.1371/journal.pone.0002308	http://dx.doi.org/10.1371/journal.pone.0002308			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523637	gold, Green Published			2022-12-25	WOS:000262614300015
J	George, I; Cousillas, H; Richard, JP; Hausberger, M				George, Isabelle; Cousillas, Hugo; Richard, Jean-Pierre; Hausberger, Martine			A Potential Neural Substrate for Processing Functional Classes of Complex Acoustic Signals	PLOS ONE			English	Article							EUROPEAN STARLINGS; GENE-EXPRESSION; STURNUS-VULGARIS; CATEGORICAL PERCEPTION; COMMUNICATION SOUNDS; AUDITORY RESPONSES; CONSPECIFIC SONG; HUMAN SPEECH; ORGANIZATION; BIRDSONG	Categorization is essential to all cognitive processes, but identifying the neural substrates underlying categorization processes is a real challenge. Among animals that have been shown to be able of categorization, songbirds are particularly interesting because they provide researchers with clear examples of categories of acoustic signals allowing different levels of recognition, and they possess a system of specialized brain structures found only in birds that learn to sing: the song system. Moreover, an avian brain nucleus that is analogous to the mammalian secondary auditory cortex ( the caudo-medial nidopallium, or NCM) has recently emerged as a plausible site for sensory representation of birdsong, and appears as a well positioned brain region for categorization of songs. Hence, we tested responses in this non-primary, associative area to clear and distinct classes of songs with different functions and social values, and for a possible correspondence between these responses and the functional aspects of songs, in a highly social songbird species: the European starling. Our results clearly show differential neuronal responses to the ethologically defined classes of songs, both in the number of neurons responding, and in the response magnitude of these neurons. Most importantly, these differential responses corresponded to the functional classes of songs, with increasing activation from non-specific to species-specific and from species-specific to individual-specific sounds. These data therefore suggest a potential neural substrate for sorting natural communication signals into categories, and for individual vocal recognition of same-species members. Given the many parallels that exist between birdsong and speech, these results may contribute to a better understanding of the neural bases of speech.	[George, Isabelle; Cousillas, Hugo; Richard, Jean-Pierre; Hausberger, Martine] Univ Rennes 1, CNRS, UMR Ethol Anim & Humaine 6552, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes	George, I (corresponding author), Univ Rennes 1, CNRS, UMR Ethol Anim & Humaine 6552, Rennes, France.	isabelle.george@univ-rennes1.fr	George, Isabelle/A-7770-2008	George, Isabelle/0000-0002-4842-4959	French Ministry of Research	French Ministry of Research(Ministry of Research, FranceEuropean Commission)	Funding for the research was provided by grants of the French Ministry of Research (to IG and MH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRET-HAUSBERGER M, 1989, Bioacoustics, V2, P137; ADRETHAUSBERGER M, 1984, Z TIERPSYCHOL, V66, P309; ADRETHAUSBERGER M, 1982, BEHAV ECOL SOCIOBIOL, V11, P241, DOI 10.1007/BF00299300; ADRETHAUSBERGER M, 1984, IBIS, V126, P372, DOI 10.1111/j.1474-919X.1984.tb00258.x; ADRETHAUSBERGER M, 1990, ETHOLOGY, V84, P265; ADRETHAUSBERGER M, 1988, BEHAVIOUR, V107, P138, DOI 10.1163/156853988X00322; Amin N, 2004, J COMP PHYSIOL A, V190, P469, DOI 10.1007/s00359-004-0511-x; Ball GF, 1998, NEURON, V21, P271, DOI 10.1016/S0896-6273(00)80535-8; Bertin A, 2007, DEV PSYCHOBIOL, V49, P362, DOI 10.1002/dev.20223; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Bolhuis JJ, 2001, EUR J NEUROSCI, V13, P2165, DOI 10.1046/j.0953-816x.2001.01588.x; Brainard MS, 2002, NATURE, V417, P351, DOI 10.1038/417351a; CHAIKEN M, 1993, ANIM BEHAV, V46, P1079, DOI 10.1006/anbe.1993.1298; CHEW SJ, 1995, P NATL ACAD SCI USA, V92, P3406, DOI 10.1073/pnas.92.8.3406; Chew SJ, 1996, P NATL ACAD SCI USA, V93, P1950, DOI 10.1073/pnas.93.5.1950; Cousillas H, 2004, EUR J NEUROSCI, V19, P3343, DOI 10.1111/j.0953-816X.2004.03376.x; Cousillas H, 2006, NATURWISSENSCHAFTEN, V93, P588, DOI 10.1007/s00114-006-0148-4; DOOLING RJ, 1987, J COMP PSYCHOL, V101, P367, DOI 10.1037/0735-7036.101.4.367; Doupe AJ, 1997, J NEUROBIOL, V33, P694; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Duffy DL, 1999, BRAIN RES, V844, P78, DOI 10.1016/S0006-8993(99)01915-0; EENS M, 1989, ARDEA, V77, P75; Geissler DB, 2004, EUR J NEUROSCI, V19, P1027, DOI 10.1111/j.1460-9568.2004.03205.x; Gentner TQ, 2004, ANN NY ACAD SCI, V1016, P282, DOI 10.1196/annals.1298.008; Gentner TQ, 1998, ANIM BEHAV, V56, P579, DOI 10.1006/anbe.1998.0810; Gentner TQ, 2001, J NEUROBIOL, V46, P48, DOI 10.1002/1097-4695(200101)46:1<48::AID-NEU5>3.0.CO;2-3; Gentner TQ, 2000, J ACOUST SOC AM, V107, P3369, DOI 10.1121/1.429408; George I, 2005, NEUROSCIENCE, V136, P1, DOI 10.1016/j.neuroscience.2005.08.001; George I, 2005, BRAIN RES, V1047, P245, DOI 10.1016/j.brainres.2005.04.047; George I, 2003, J NEUROSCI METH, V125, P65, DOI 10.1016/S0165-0270(03)00025-6; Grace JA, 2003, J NEUROPHYSIOL, V89, P472, DOI 10.1152/jn.00088.2002; Hausberger M, 2000, BEHAV BRAIN RES, V114, P89, DOI 10.1016/S0166-4328(00)00191-1; HAUSBERGER M, 1991, BIRD BEHAV, V9, P81, DOI 10.3727/015613890791749127; HAUSBERGER M, 1995, J COMP PSYCHOL, V109, P222, DOI 10.1037/0735-7036.109.3.222; HAUSBERGER M, 1981, BIOL BEHAV, V6, P79; Hausberger Martine, 1997, P128, DOI 10.1017/CBO9780511758843.008; Henry L., 1994, Bioacoustics, V5, P261; Henry L, 1998, REV ECOL-TERRE VIE, V53, P347; HERRNSTEIN RJ, 1985, PHILOS T ROY SOC B, V308, P129, DOI 10.1098/rstb.1985.0015; Jarvis ED, 2004, ANN NY ACAD SCI, V1016, P749, DOI 10.1196/annals.1298.038; Jarvis ED, 2005, NAT REV NEUROSCI, V6, P151, DOI 10.1038/nrn1606; Kuhl P. K., 1987, CATEGORICAL PERCEPTI, P355; Kuhl PK, 2003, P NATL ACAD SCI USA, V100, P9645, DOI 10.1073/pnas.1733998100; Lewicki MS, 1996, J NEUROSCI, V16, P6987; LIBERMAN AM, 1957, J EXP PSYCHOL, V54, P358, DOI 10.1037/h0044417; MARGOLIASH D, 1986, J NEUROSCI, V6, P1643; MARGOLIASH D, 1983, J NEUROSCI, V3, P1039; Marler P, 2000, P NATL ACAD SCI USA, V97, P2965, DOI 10.1073/pnas.97.7.2965; MARLER P, 1970, AM SCI, V58, P669; MAY B, 1989, J ACOUST SOC AM, V85, P837, DOI 10.1121/1.397555; MCCASLAND JS, 1987, J NEUROSCI, V7, P23; MELLO C, 1995, J NEUROSCI, V15, P6919; Mello CV, 2002, J COMP PHYSIOL A, V188, P943, DOI 10.1007/s00359-002-0347-1; MELLO CV, 1994, J NEUROSCI, V14, P6652; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; NELSON DA, 1989, SCIENCE, V244, P976, DOI 10.1126/science.2727689; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; Park KHJ, 2002, BEHAV BRAIN RES, V136, P185, DOI 10.1016/S0166-4328(02)00129-8; Phan ML, 2006, P NATL ACAD SCI USA, V103, P1088, DOI 10.1073/pnas.0510136103; Poirier C, 2004, J COMP PSYCHOL, V118, P179, DOI 10.1037/0735-7036.118.2.179; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Reiner A, 2004, J COMP NEUROL, V473, P377, DOI 10.1002/cne.20118; ROITBLAT HL, 1992, ANNU REV PSYCHOL, V43, P671, DOI 10.1146/annurev.ps.43.020192.003323; Stripling R, 1997, J NEUROSCI, V17, P3883; Stripling R, 2001, J NEUROBIOL, V48, P163, DOI 10.1002/neu.1049; Terleph TA, 2006, J NEUROBIOL, V66, P281, DOI 10.1002/neu.20219; Theunissen FE, 1998, J NEUROSCI, V18, P3786; Theunissen FE, 2006, CURR OPIN NEUROBIOL, V16, P400, DOI 10.1016/j.conb.2006.07.003; Vignal C, 2004, BEHAV BRAIN RES, V153, P241, DOI 10.1016/j.bbr.2003.12.006; Volman SF, 1996, J COMP PHYSIOL A, V178, P849; WHEELER BC, 1999, CRC METH NEUROSCI S, P61; ZEIGLER HP, 2004, ANN NY ACAD SCI, V1016, P786	72	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2203	10.1371/journal.pone.0002203	http://dx.doi.org/10.1371/journal.pone.0002203			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	391UK	18493610	Green Published, gold, Green Submitted			2022-12-25	WOS:000262258700012
J	Kim, SC; McGowen, MR; Lubinsky, P; Barber, JC; Mort, ME; Santos-Guerra, A				Kim, Seung-Chul; McGowen, Michael R.; Lubinsky, Pesach; Barber, Janet C.; Mort, Mark E.; Santos-Guerra, Arnoldo			Timing and Tempo of Early and Successive Adaptive Radiations in Macaronesia	PLOS ONE			English	Article								The flora of Macaronesia, which encompasses five Atlantic archipelagos (Azores, Canaries, Madeira, Cape Verde, and Salvage), is exceptionally rich and diverse. Spectacular radiation of numerous endemic plant groups has made the Macaronesian islands an outstanding area for studies of evolution and speciation. Despite intensive investigation in the last 15 years, absolute age and rate of diversification are poorly known for the flora of Macaronesia. Here we report molecular divergence estimates and rates of diversification for five representative, putative rapid radiations of monophyletic endemic plant lineages across the core eudicot clade of flowering plants. Three discrete windows of colonization during the Miocene and early Pliocene are suggested for these lineages, all of which are inferred to have had a single colonization event followed by rapid radiation. Subsequent inter-archipelago dispersal events into Madeira and the Cape Verdes took place very recently during the late Pliocene and Pleistocene after initial diversification on the Canary Islands. The tempo of adaptive radiations differs among the groups, but is relatively rapid compared to continental and other island radiations. Our results demonstrate that opportunity for island colonization and successful radiation may have been constrained to discrete time periods of profound climatic and geological changes in northern African and the Mediterranean.	[Kim, Seung-Chul; Lubinsky, Pesach] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [McGowen, Michael R.] Univ Calif Riverside, Dept Biol, Riverside, CA USA; [Barber, Janet C.] St Louis Univ, Dept Biol, St Louis, MO USA; [Mort, Mark E.] Univ Kansas, Nat Hist Museum & Biodivers Res Ctr, Dept Ecol & Evolut Biol, Lawrence, KS USA; [Santos-Guerra, Arnoldo] Jardin Aclimatacion Orotava, Tenerife, Spain	University of California System; University of California Riverside; University of California System; University of California Riverside; Saint Louis University; University of Kansas	Kim, SC (corresponding author), Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA.	sckim@ucr.edu	Kim, Seung-Chul/AAR-6157-2020	Kim, Seung-Chul/0000-0003-0559-6782	National Science Foundation	National Science Foundation(National Science Foundation (NSF))	The National Science Foundation generously supported earlier molecular phylogenetic studies.	A Aldridge, 1979, PLANTS ISLANDS, P279; Allan GJ, 2004, MOL PHYLOGENET EVOL, V32, P123, DOI 10.1016/j.ympev.2003.11.018; Baldwin BG, 1998, P NATL ACAD SCI USA, V95, P9402, DOI 10.1073/pnas.95.16.9402; Barber JC, 2007, TAXON, V56, P74, DOI 10.2307/25065737; Bohle UR, 1996, P NATL ACAD SCI USA, V93, P11740, DOI 10.1073/pnas.93.21.11740; BORGEN L, 1984, PLANT BIOSYSTEMATICS, P477; Bramwell D., 1972, Taxonomy, phytogeography and evolution., P141; Bromham L, 2004, SYST BIOL, V53, P758, DOI 10.1080/10635150490522278; Carine MA, 2005, TAXON, V54, P895, DOI 10.2307/25065476; Carine MA, 2004, AM J BOT, V91, P1070, DOI 10.3732/ajb.91.7.1070; Carracedo J. C., 2002, GEOLOGY SPAIN, P439, DOI DOI 10.1144/GOSPP; Cronquist A., 1981, INTEGRATED SYSTEM CL; De Jong H, 1998, BIOL J LINN SOC, V65, P99, DOI 10.1006/bijl.1998.0239; Emerson BC, 2005, NATURE, V434, P1015, DOI 10.1038/nature03450; Emerson BC, 2002, MOL ECOL, V11, P951, DOI 10.1046/j.1365-294X.2002.01507.x; ERIKSSON O, 1992, EVOLUTION, V46, P258, DOI [10.2307/2409820, 10.1111/j.1558-5646.1992.tb02000.x]; Frahm JP, 2004, REV PALAEOBOT PALYNO, V129, P81, DOI 10.1016/j.revpalbo.2003.11.004; Francisco-Ortega J, 2002, AM J BOT, V89, P1984, DOI 10.3732/ajb.89.12.1984; Francisco-Ortega J, 2001, AM J BOT, V88, P161, DOI 10.2307/2657136; Francisco-Ortega J, 2000, AM J BOT, V87, P909, DOI 10.2307/2656988; Francisco-Ortega Javier, 1997, P407; FRANCISCOORTEGA J, 1995, AM J BOT, V82, P1321, DOI 10.2307/2446254; FranciscoOrtega J, 1996, P NATL ACAD SCI USA, V93, P4085, DOI 10.1073/pnas.93.9.4085; Fuertes-Aguilar J, 2002, SYST BOT, V27, P74; Garcia-Talavera F, 1995, REV ACAD CANARIA CIE, V7, P77; Geldmacher J, 2001, J VOLCANOL GEOTH RES, V111, P55, DOI 10.1016/S0377-0273(01)00220-7; Goertzen LR, 2002, SYST BOT, V27, P815; Good-Avila SV, 2006, P NATL ACAD SCI USA, V103, P9124, DOI 10.1073/pnas.0603312103; Graham A., 1996, COMPOSITAE SYSTEMATI, V1, P123; Helfgott DM, 2000, SYST BOT, V25, P82, DOI 10.2307/2666675; HSU KJ, 1977, NATURE, V267, P399, DOI 10.1038/267399a0; Hughes C, 2006, P NATL ACAD SCI USA, V103, P10334, DOI 10.1073/pnas.0601928103; HULBERT RC, 1993, PALEOBIOLOGY, V19, P216, DOI 10.1017/S0094837300015888; Humphries CJ, 1979, PLANTS ISLANDS, P171; Jolivet L, 2006, SEDIMENT GEOL, V188, P9, DOI 10.1016/j.sedgeo.2006.02.004; Juan C, 2000, TRENDS ECOL EVOL, V15, P104, DOI 10.1016/S0169-5347(99)01776-0; Kim SC, 1996, P NATL ACAD SCI USA, V93, P7743, DOI 10.1073/pnas.93.15.7743; Kim SC, 1999, PLANT SYST EVOL, V215, P101, DOI 10.1007/BF00984650; Kim SC, 2007, MOL PHYLOGENET EVOL, V44, P578, DOI 10.1016/j.ympev.2007.03.014; Kishino H, 2001, MOL BIOL EVOL, V18, P352, DOI 10.1093/oxfordjournals.molbev.a003811; Klak C, 2004, NATURE, V427, P63, DOI 10.1038/nature02243; Koch MA, 2000, MOL BIOL EVOL, V17, P1483, DOI 10.1093/oxfordjournals.molbev.a026248; Lee C, 2005, AM J BOT, V92, P2072, DOI 10.3732/ajb.92.12.2072; Lledo MD, 2005, AM J BOT, V92, P1189, DOI 10.3732/ajb.92.7.1189; Magallon S, 2001, EVOLUTION, V55, P1762, DOI 10.1111/j.0014-3820.2001.tb00826.x; Magallon S, 1999, ANN MO BOT GARD, V86, P297, DOI 10.2307/2666180; McCune Amy R., 1997, P585; Molero J, 2002, PLANT SYST EVOL, V231, P109, DOI 10.1007/s006060200014; Moore MJ, 2006, MOL PHYLOGENET EVOL, V39, P668, DOI 10.1016/j.ympev.2006.01.020; Mort ME, 2002, SYST BOT, V27, P271; Mort ME, 2001, AM J BOT, V88, P76, DOI 10.2307/2657129; Percy DM, 2002, AM J BOT, V89, P854, DOI 10.3732/ajb.89.5.854; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; ROSENZWEIG ML, 1992, EVOL ECOL, V6, P90, DOI 10.1007/BF02285336; SANTOSGUERRA A, 1999, ECOLOGIA CULTURA CAN, P107; Schuster M, 2006, SCIENCE, V311, P821, DOI 10.1126/science.1120161; Silvertown J, 2004, J ECOL, V92, P168, DOI 10.1111/j.1365-2745.2004.00853.x; STANLEY ES, 1979, MACROEVOLUTION; Sunding P., 1973, MONOGR BIOL CANARIEN, V4, P112; Sunding P., 1979, PLANTS ISLANDS, P13; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Thompson J., 2005, PLANT EVOLUTION MEDI, DOI DOI 10.1093/ACPROF:OSO/9780198515340.001.0001; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; Trusty JL, 2005, MOL ECOL, V14, P1177, DOI 10.1111/j.1365-294X.2005.02487.x; Vanderpoorten A, 2007, AM J BOT, V94, P625, DOI 10.3732/ajb.94.4.625; Vargas P, 1999, AM J BOT, V86, P724, DOI 10.2307/2656582; Vargas P, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P297, DOI 10.1007/1-4020-4904-8_11; Veith M, 2004, J BIOGEOGR, V31, P159, DOI 10.1111/j.1365-2699.2004.00957.x; Vrba ES, 1987, EVOL ECOL, V1, P283, DOI 10.1007/BF02071554; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782	71	110	115	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2139	10.1371/journal.pone.0002139	http://dx.doi.org/10.1371/journal.pone.0002139			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478126	Green Published, gold			2022-12-25	WOS:000262172800004
J	Liao, YL; Sun, YM; Chau, GY; Chau, YP; Lai, TC; Wang, JL; Horng, JT; Hsiao, M; Tsou, AP				Liao, Y-L; Sun, Y-M; Chau, G-Y; Chau, Y-P; Lai, T-C; Wang, J-L; Horng, J-T; Hsiao, M.; Tsou, A-P			Identification of SOX4 target genes using phylogenetic footprinting-based prediction from expression microarrays suggests that overexpression of SOX4 potentiates metastasis in hepatocellular carcinoma	ONCOGENE			English	Article						SOX4; HCC metastasis; synexpression; target prediction	BREAST-CANCER METASTASIS; TRANSCRIPTIONAL REGULATION; MOUSE GENOME; CELLS; MICE; GUIDANCE; FAMILY; SYNEXPRESSION; NEOPLASMS; PROTEINS	A comprehensive microarray analysis of hepatocellular carcinoma (HCC) revealed distinct synexpression patterns during intrahepatic metastasis. Recent evidence has demonstrated that synexpression group member genes are likely to be regulated by master control gene(s). Here we investigate the functions and gene regulation of the transcription factor SOX4 in intrahepatic metastatic HCC. SOX4 is important in tumor metastasis as RNAi knockdown reduces tumor cell migration, invasion, in vivo tumorigenesis and metastasis. A multifaceted approach integrating gene pro. ling, binding site computation and empirical veri. cation by chromatin immunoprecipitation and gene ablation refined the consensus SOX4 binding motif and identified 32 binding loci in 31 genes with high confidence. RNAi knockdown of two SOX4 target genes, neuropilin 1 and semaphorin 3C, drastically reduced cell migration activity in HCC cell lines suggesting that SOX4 exerts some of its action via regulation of these two downstream targets. The discovery of 31 previously unidentified targets expands our knowledge of how SOX4 modulates HCC progression and implies a range of novel SOX4 functions. This integrated approach sets a paradigm whereby a subset of member genes from a synexpression group can be regulated by one master control gene and this is exemplified by SOX4 and advanced HCC.	[Liao, Y-L; Tsou, A-P] Natl Yang Ming Univ, Dept Biotechnol & Lab Sci Med, Taipei 112, Taiwan; [Sun, Y-M; Horng, J-T] Natl Cent Univ, Inst Comp Sci & Informat Engn, Chungli 32054, Taiwan; [Chau, G-Y] Taipei Vet Gen Hosp, Dept Surg, Taipei, Taiwan; [Chau, Y-P] Natl Yang Ming Univ, Inst Anat & Cell Biol, Taipei 112, Taiwan; [Lai, T-C; Wang, J-L; Hsiao, M.] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan	National Yang Ming Chiao Tung University; National Central University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan	Tsou, AP (corresponding author), Natl Yang Ming Univ, Dept Biotechnol & Lab Sci Med, Taipei 112, Taiwan.	horng@db.csie.ncu.edu.tw; mhsiao@gate.sinica.edu.tw; aptsou@ym.edu.tw	Lai, Tsung-Ching/AAQ-9967-2021; Hsiao, Michael/U-6238-2019	Hsiao, Michael/0000-0001-8529-9213	National Research Program for Genomic Medicine (NRPGM); National Science Council; National Research Program for Genomic Medicine [NSC 94-3112-B-001-003, NSC 94-3112-B-001-018-Y]; National Science Council [NSC 95-2752-B-010-002-PAE]; Ministry of Education	National Research Program for Genomic Medicine (NRPGM)(Ministry of Science and Technology, Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); National Research Program for Genomic Medicine(Ministry of Science and Technology, Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education	We acknowledge the technical supports provided by the Microarray & Gene Expression Analysis Core Facility of the VGH National Yang-Ming University Genome Research Center (VYMGC). The Gene Expression Analysis Core Facility is supported by National Research Program for Genomic Medicine (NRPGM), National Science Council. RNAi reagents were obtained from the National RNAi Core Facility located at the Institute of Molecular Biology/Genomic Research Center, Academia Sinica (supported by the National Research Program for Genomic Medicine Grants of NSC (NSC 94-3112-B-001-003 and NSC 94-3112-B-001-018-Y). We thank Dr Hua-Chien Chen for providing the PCR primers for the RT-qPCR assays. This work was supported in part by grant (NSC 95-2752-B-010-002-PAE) from National Science Council (Program for Promoting Academic Excellence of Universities Phase II) and a grant from the Ministry of Education, Aim for the Top University Plan to APT and YPC.	Aaboe M, 2006, CANCER RES, V66, P3434, DOI 10.1158/0008-5472.CAN-05-3456; ATTIA MAM, 1966, CANCER RES, V26, P1787; Bielenberg DR, 2006, EXP CELL RES, V312, P584, DOI 10.1016/j.yexcr.2005.11.024; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Chau GY, 2007, HISTOPATHOLOGY, V51, P204, DOI 10.1111/j.1365-2559.2007.02738.x; Chen X, 2002, MOL BIOL CELL, V13, P1929, DOI 10.1091/mbc.02-02-0023; Cheung M, 2000, MOL BRAIN RES, V79, P180, DOI 10.1016/S0169-328X(00)00109-1; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Fickett JW, 2000, CURR OPIN BIOTECH, V11, P19, DOI 10.1016/S0958-1669(99)00049-X; Geijsen N, 2001, SCIENCE, V293, P1136, DOI 10.1126/science.1059157; Gonthier B, 2007, CEREB CORTEX, V17, P1712, DOI 10.1093/cercor/bhl082; Grizzi F, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-3; Guan KL, 2003, NAT REV NEUROSCI, V4, P941, DOI 10.1038/nrn1254; Hardison RC, 1997, GENOME RES, V7, P959, DOI 10.1101/gr.7.10.959; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Herman JG, 2007, INT J ONCOL, V30, P1231; Hong TM, 2007, CLIN CANCER RES, V13, P4759, DOI 10.1158/1078-0432.CCR-07-0001; Hunt SMN, 1999, BIOL REPROD, V61, P476, DOI 10.1095/biolreprod61.2.476; Hur EH, 2004, BIOCHEM BIOPH RES CO, V325, P59, DOI 10.1016/j.bbrc.2004.09.215; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Karaulanov E, 2004, EMBO J, V23, P844, DOI 10.1038/sj.emboj.7600101; Kim Y, 2005, TOXICOL PATHOL, V33, P175, DOI 10.1080/01926230590522130; Lee YC, 2003, J BIOL CHEM, V278, P39615, DOI 10.1074/jbc.M304095200; Liu PB, 2006, CANCER RES, V66, P4011, DOI 10.1158/0008-5472.CAN-05-3055; Lu YS, 2007, HEPATOLOGY, V46, P1119, DOI 10.1002/hep.21804; Maes T, 2002, GENOMICS, V80, P21, DOI 10.1006/geno.2002.6799; McCracken S, 1997, ONCOGENE, V15, P2929, DOI 10.1038/sj.onc.1201474; Mertin S, 1999, NUCLEIC ACIDS RES, V27, P1359, DOI 10.1093/nar/27.5.1359; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Nelson JD, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj004; Niehrs C, 1999, NATURE, V402, P483, DOI 10.1038/990025; Paget S., 1889, LANCET, V1, P571, DOI DOI 10.1016/S0140-6736(00)49915-0; Pramoonjago P, 2006, ONCOGENE, V25, P5626, DOI 10.1038/sj.onc.1209566; Remenyi A, 2004, NAT STRUCT MOL BIOL, V11, P812, DOI 10.1038/nsmb820; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; SHOUVAL D, 1988, VIRCHOWS ARCH A, V412, P595, DOI 10.1007/BF00844296; Tang ZY, 2004, J CANCER RES CLIN, V130, P187, DOI 10.1007/s00432-003-0511-1; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; VANDEWETERING M, 1993, EMBO J, V12, P3847, DOI 10.1002/j.1460-2075.1993.tb06063.x; Wasserman WW, 2000, NAT GENET, V26, P225, DOI 10.1038/79965; Wilson M, 2002, CURR OPIN GENET DEV, V12, P441, DOI 10.1016/S0959-437X(02)00323-4; WOTTON D, 1995, J BIOL CHEM, V270, P7515, DOI 10.1074/jbc.270.13.7515; Ya J, 1998, CIRC RES, V83, P986, DOI 10.1161/01.RES.83.10.986; Ye QH, 2003, NAT MED, V9, P416, DOI 10.1038/nm843	45	162	171	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP 18	2008	27	42					5578	5589		10.1038/onc.2008.168	http://dx.doi.org/10.1038/onc.2008.168			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	349KX	18504433				2022-12-25	WOS:000259280800004
J	Fornari, F; Gramantieri, L; Ferracin, M; Veronese, A; Sabbioni, S; Calin, GA; Grazi, GL; Giovannini, C; Croce, CM; Bolondi, L; Negrini, M				Fornari, F.; Gramantieri, L.; Ferracin, M.; Veronese, A.; Sabbioni, S.; Calin, G. A.; Grazi, G. L.; Giovannini, C.; Croce, C. M.; Bolondi, L.; Negrini, M.			MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma	ONCOGENE			English	Article						microRNA; cyclin-dependent kinase inhibitors; HCC	P27(KIP1); MICRORNAS; P57(KIP2); DIFFERENTIATION; PROTEIN; CANCER; PROLIFERATION; APOPTOSIS; LIVER	The identification of target mRNAs is a key step for assessing the role of aberrantly expressed microRNAs in human cancer. MiR-221 is upregulated in human hepatocellular carcinoma (HCC) as well as in other malignancies. One proven target of miR-221 is CDKN1B/p27, whose downregulation affects HCC prognosis. Here, we proved that the cyclin-dependent kinase inhibitor (CDKI) CDKN1C/p57 is also a direct target of miR-221. Indeed, downregulation of both CDKN1B/p27 and CDKN1C/p57 occurs in response to miR-221 transfection into HCC-derived cells and a significant upregulation of both CDKN1B/p27 and CDKN1C/p57 occurs in response to antimiR-221 transfection. A direct interaction of miR-221 with a target site on the 30 UTR of CDKN1C/p57 mRNA was also demonstrated. By controlling these two CDKIs, upregulation of miR-221 can promote growth of HCC cells by increasing the number of cells in S-phase. To assess the relevance of these studies in primary tumors, matched HCC and cirrhosis samples were assayed for miR-221, for CDKN1B/p27 and CDKN1C/p57 expression. MiR-221 was upregulated in 71% of HCCs, whereas CDKN1B/p27 and CDKN1C/p57 proteins were down-regulated in 77% of cases. A significant inverse correlation between miR-221 and both CDKN1B/p27 and CDKN1C/p57 was found in HCCs. In conclusion, we suggest that miR-221 has an oncogenic function in hepatocarcinogenesis by targeting CDKN1B/p27 and CDKN1C/p57, hence promoting proliferation by controlling cell-cycle inhibitors. These findings establish a basis toward the development of therapeutic strategies aimed at blocking miR-221 in HCC.	[Fornari, F.; Gramantieri, L.; Giovannini, C.; Bolondi, L.] Univ Bologna, Dipartimento Med Interna & Gastroenterol, Policlin S Orsola, I-40138 Bologna, Italy; [Fornari, F.; Gramantieri, L.; Giovannini, C.; Bolondi, L.] Univ Bologna, Ctr Ric Biomed Appl, Policlin S Orsola, I-40138 Bologna, Italy; [Ferracin, M.; Veronese, A.; Sabbioni, S.; Croce, C. M.; Negrini, M.] Univ Ferrara, Dipartimento Med Sperimentale & Diagnost, I-44100 Ferrara, Italy; [Ferracin, M.; Veronese, A.; Sabbioni, S.; Croce, C. M.; Negrini, M.] Univ Ferrara, Ctr Interdipartimentale Ric Cancro, I-44100 Ferrara, Italy; [Calin, G. A.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Grazi, G. L.] Univ Bologna, Dipartimento Chirurg & Trapianti, Policlin S Orsola, Bologna, Italy; [Croce, C. M.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Ferrara; University of Ferrara; University of Texas System; UTMD Anderson Cancer Center; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Gramantieri, L (corresponding author), Univ Bologna, Dipartimento Med Interna & Gastroenterol, Policlin S Orsola, Via Massarenti 9, I-40138 Bologna, Italy.	laura.gramantieri@aosp.bo.it; ngm@unife.it	Young, Richard A/F-6495-2012; Giovannini, Catia/K-7853-2016; Negrini, Massimo/J-2377-2016; Ferracin, Manuela/K-2097-2016; Veronese, Angelo/I-4292-2019; Calin, George/E-9390-2011; Gramantieri, Laura/J-3862-2019; Fornari, Francesca/K-6748-2016; Grazi, Gian Luca/J-7215-2018; Gramantieri, Laura/K-8603-2016	Young, Richard A/0000-0001-8855-8647; Giovannini, Catia/0000-0003-1904-1577; Negrini, Massimo/0000-0002-0007-1920; Ferracin, Manuela/0000-0002-1595-6887; Grazi, Gian Luca/0000-0002-3279-0313; Gramantieri, Laura/0000-0002-5187-9559; Veronese, Angelo/0000-0002-1451-1392; Fornari, Francesca/0000-0002-4302-4411; Calin, George/0000-0001-6704-5615	Associazione Italiana per la Ricerca sul Cancro (AIRC); Italian Ministero dell' Universita e della Ricerca Scientifica; Italian Ministero della Salute; Fondazione CARISBO; National Cancer Institute; Kimmel Foundation Scholar; Fondazione Italiana per la Ricerca sul Cancro (FIRC)	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministero dell' Universita e della Ricerca Scientifica(Ministry of Education, Universities and Research (MIUR)); Italian Ministero della Salute(Ministry of Health, Italy); Fondazione CARISBO(Fondazione Carisbo); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Kimmel Foundation Scholar; Fondazione Italiana per la Ricerca sul Cancro (FIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC regional grant), by grants from Italian Ministero dell' Universita e della Ricerca Scientifica and from Italian Ministero della Salute to MN; by Associazione Italiana per la Ricerca sul Cancro (AIRC regional grant) and Fondazione CARISBO to LB and by Program Project Grants from the National Cancer Institute to CMC and by a Kimmel Foundation Scholar award to GAC. FF is a recipient of a fellowship from Associazione Italiana per la Ricerca sul Cancro (AIRC) and MF is a recipient of a fellowship from Fondazione Italiana per la Ricerca sul Cancro (FIRC).	Abou-Alfa GK, 2006, J CLIN ONCOL, V24, P4293, DOI 10.1200/JCO.2005.01.3441; Bolondi L, 2003, J HEPATOL, V39, P1076, DOI 10.1016/S0168-8278(03)00349-0; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Diaz-Meyer N, 2003, J MED GENET, V40, P797, DOI 10.1136/jmg.40.11.797; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Gillies JK, 2007, CELL CYCLE, V6, P2005, DOI 10.4161/cc.6.16.4526; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; Hui AM, 1998, CANCER LETT, V132, P67, DOI 10.1016/S0304-3835(98)00164-5; Ito Y, 2001, ONCOLOGY-BASEL, V61, P221, DOI 10.1159/000055378; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Lee MH, 2001, CELL MOL LIFE SCI, V58, P1907, DOI 10.1007/PL00000826; Lei PP, 2005, WORLD J GASTROENTERO, V11, P4587, DOI 10.3748/wjg.v11.i29.4587; Lencioni R, 2005, SEMIN LIVER DIS, V25, P162, DOI 10.1055/s-2005-871196; LLOVET JM, 2007, ASCO M CHIC; Nakai S, 2002, INT J ONCOL, V20, P769; Nan KJ, 2005, WORLD J GASTROENTERO, V11, P1237, DOI 10.3748/wjg.v11.i8.1237; Nan KJ, 2004, WORLD J GASTROENTERO, V10, P1425; Negrini M, 2007, J CELL SCI, V120, P1833, DOI 10.1242/jcs.03450; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Sangiovanni A, 2004, GASTROENTEROLOGY, V126, P1005, DOI 10.1053/j.gastro.2003.12.049; Schwienbacher C, 2000, P NATL ACAD SCI USA, V97, P5445, DOI 10.1073/pnas.090087497; Soejima H, 2004, ONCOGENE, V23, P4380, DOI 10.1038/sj.onc.1207576; Tannapfel A, 2000, INT J CANCER, V89, P350, DOI 10.1002/1097-0215(20000720)89:4<350::AID-IJC6>3.0.CO;2-3; Visone R, 2007, ENDOCR-RELAT CANCER, V14, P791, DOI 10.1677/ERC-07-0129; Yan Y, 1997, GENE DEV, V11, P973, DOI 10.1101/gad.11.8.973; Zhang PM, 1997, NATURE, V387, P151, DOI 10.1038/387151a0	37	499	548	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	2008	27	43					5651	5661		10.1038/onc.2008.178	http://dx.doi.org/10.1038/onc.2008.178			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	352HM	18521080				2022-12-25	WOS:000259487100001
J	Jiang, PZ; Ko, LW; Jansen, KR; Golde, TE; Yen, SH				Jiang, Peizhou; Ko, Li-wen; Jansen, Karen R.; Golde, Todd E.; Yen, Shu-Hui			Using leucine zipper to facilitate alpha-synuclein assembly	FASEB JOURNAL			English	Article						aggregation; adeno-associated virus	PROTEIN-PROTEIN INTERACTIONS; GREEN FLUORESCENT PROTEIN; PARKINSONS-DISEASE; COILED-COIL; IN-VITRO; NACP/ALPHA-SYNUCLEIN; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; FIBRIL FORMATION; HELICAL PROTEIN	The accumulation of filamentous alpha-synuclein (alpha-S) is associated with Parkinson's disease. It remains controversial as to the mode (antiparallel or parallel) of alpha-S self-assembly and whether an exact alignment of the central hydrophobic region is essential. In the present study, we performed in vitro assembly using alpha-S with or without the attachment of artificial leucine zippers (Zips) capable of forming either parallel or antiparallel coiled coils and included a spacer in one derivative. Results showed that Zips accelerate filament assembly in both the parallel and antiparallel fashions, that a precise alignment of the central hydrophobic region is not essential, and that the antiparallel pairs displayed the highest thioflavin T signals. More importantly, cells expressing Zip-fused alpha-S, but not alpha-S alone, formed alpha-S immunopositive and thioflavin S-positive inclusions in 7 days. The results suggest that alpha-S can assemble in both parallel and antiparallel modes but have a higher tendency to assemble in the latter mode and that cells overexpressing Zip-fused alpha-S may be used to screen alpha-S assembly inhibitors due to enhanced ability to form inclusions.	[Jiang, Peizhou; Ko, Li-wen; Jansen, Karen R.; Golde, Todd E.; Yen, Shu-Hui] Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA; [Jiang, Peizhou] So Med Univ, Sch Basic Med Sci, Dept Histol & Embryol, Guangzhou, Guangdong, Peoples R China	Mayo Clinic; Southern Medical University - China	Yen, SH (corresponding author), Mayo Clin, Coll Med, Dept Neurosci, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	yen.shu-hui@mayo.edu			U. S. National Institutes of Health [P50-NS40256]; Mayo Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS040256] Funding Source: NIH RePORTER	U. S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Drs. Terrone Rosenberry and Vijayaraghavan Rangachari for assistance in CD analysis and valuable comments. We are grateful to Dr. Wen-Lang Lin for assistance in electron microscopy, to Dr. Tania Gendron for her critical reading, and to Ms. Carolina Ceballos-Diaz and Ms. Ena Causevic for technical assistance in AAV packaging and Western blot analysis. This study was supported by the U. S. National Institutes of Health (P50-NS40256) and the Mayo Foundation.	Antony T, 2003, J BIOL CHEM, V278, P3235, DOI 10.1074/jbc.M208249200; Arima K, 1998, BRAIN RES, V808, P93, DOI 10.1016/S0006-8993(98)00734-3; Arndt KM, 2000, J MOL BIOL, V295, P627, DOI 10.1006/jmbi.1999.3352; BRYSON JW, 1995, SCIENCE, V270, P935, DOI 10.1126/science.270.5238.935; Chen M, 2007, J BIOL CHEM, V282, P24970, DOI 10.1074/jbc.M700368200; Chen WY, 1997, P NATL ACAD SCI USA, V94, P5798, DOI 10.1073/pnas.94.11.5798; COHEN C, 1990, PROTEINS, V7, P1, DOI 10.1002/prot.340070102; Cole NB, 2002, J BIOL CHEM, V277, P6344, DOI 10.1074/jbc.M108414200; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Del Mar C, 2005, P NATL ACAD SCI USA, V102, P15477, DOI 10.1073/pnas.0507405102; Der-Sarkissian A, 2003, J BIOL CHEM, V278, P37530, DOI 10.1074/jbc.M305266200; DeVit M, 2005, GENOME RES, V15, P560, DOI 10.1101/gr.3259905; El-Agnaf OMA, 1998, FEBS LETT, V440, P67, DOI 10.1016/S0014-5793(98)01419-7; Galvin JE, 2001, ARCH NEUROL-CHICAGO, V58, P186, DOI 10.1001/archneur.58.2.186; Ghosh I, 2000, J AM CHEM SOC, V122, P5658, DOI 10.1021/ja994421w; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Goers J, 2003, PROTEIN SCI, V12, P702, DOI 10.1110/ps.0230903; Gorell JM, 1999, NEUROTOXICOLOGY, V20, P239; Hashimoto M, 1998, BRAIN RES, V799, P301, DOI 10.1016/S0006-8993(98)00514-9; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Kim BM, 2002, J AM CHEM SOC, V124, P8237, DOI 10.1021/ja020275+; Klucken J, 2006, FASEB J, V20, P2050, DOI 10.1096/fj.05-5422com; Kohn WD, 1997, J BIOL CHEM, V272, P2583, DOI 10.1074/jbc.272.5.2583; Kruger R, 2000, J NEURAL TRANSM, V107, P31, DOI 10.1007/s007020050002; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Levites Y, 2006, J NEUROSCI, V26, P11923, DOI 10.1523/JNEUROSCI.2795-06.2006; Lundvig D, 2005, MOL BRAIN RES, V134, P3, DOI 10.1016/j.molbrainres.2004.09.001; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; Magliery TJ, 2005, J AM CHEM SOC, V127, P146, DOI 10.1021/ja046699g; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Necula M, 2003, J BIOL CHEM, V278, P46674, DOI 10.1074/jbc.M308231200; Oakley MG, 1997, BIOCHEMISTRY-US, V36, P2544, DOI 10.1021/bi962391t; Oakley MG, 1998, BIOCHEMISTRY-US, V37, P12603, DOI 10.1021/bi981269m; OSHEA EK, 1989, SCIENCE, V243, P538, DOI 10.1126/science.2911757; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Pelletier JN, 1999, NAT BIOTECHNOL, V17, P683, DOI 10.1038/10897; Ramakrishnan M, 2006, BIOCHEMISTRY-US, V45, P3386, DOI 10.1021/bi052344d; Rangachari V, 2006, BIOCHEMISTRY-US, V45, P8639, DOI 10.1021/bi060323t; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Sharma A, 2003, MOL CELL PROTEOMICS, V2, P1217, DOI 10.1074/mcp.M300078-MCP200; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Tjernberg LO, 2002, BIOCHEM J, V366, P343, DOI 10.1042/BJ20020229; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Uversky VN, 2002, NEUROTOXICOLOGY, V23, P527, DOI 10.1016/S0161-813X(02)00067-0; Uversky VN, 2001, J BIOL CHEM, V276, P43495, DOI 10.1074/jbc.C100551200; Uversky VN, 2001, FEBS LETT, V500, P105, DOI 10.1016/S0014-5793(01)02597-2; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n	49	9	9	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2008	22	9					3165	3174		10.1096/fj.08-108365	http://dx.doi.org/10.1096/fj.08-108365			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	342CD	18492724	Green Published			2022-12-25	WOS:000258761300009
J	Mathew, S; George, SP; Wang, YH; Siddiqui, MR; Srinivasan, K; Tan, LZ; Khurana, S				Mathew, Sijo; George, Sudeep P.; Wang, Yaohong; Siddiqui, Mohammad Rizwan; Srinivasan, Kamalakkannan; Tan, Langzhu; Khurana, Seema			Potential molecular mechanism for C-Src kinase-mediated regulation of intestinal cell migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN COLON-CARCINOMA; TYROSINE-PHOSPHATASE SHP-2; COMMON GAMMA-CHAIN; MICE LACKING JAK3; FAMILY KINASES; PTP-PEST; PHOSPHOLIPASE C-GAMMA(1); COMPLEX-FORMATION; EPITHELIAL-CELLS; PROTEIN VILLIN	The ubiquitously expressed Src tyrosine kinases (c-Src, c-Yes, and c-Fyn) regulate intestinal cell growth and differentiation. Src activity is also elevated in the majority of malignant and premalignant tumors of the colon. The development of fibroblasts with the three ubiquitously expressed kinases deleted (SYF cells) has identified the role of Src proteins in the regulation of actin dynamics associated with increased cell migration and invasion. Despite this, unexpectedly nothing is known about the role of the individual Src kinases on intestinal cell cytoskeleton and/or cell migration. We have previously reported that villin, an epithelial cell-specific actin-modifying protein that regulates actin reorganization, cell morphology, cell migration, cell invasion, and apoptosis, is tyrosine-phosphorylated. In this report using the SYF cells reconstituted individually with c-Src, c-Yes, c-Fyn, and wild type or phosphorylation site mutants of villin, we demonstrate for the first time the absolute requirement for c-Src in villin-induced regulation of cell migration. The other major finding of our study is that contrary to previous reports, the nonreceptor tyrosine kinase, Jak3 (Janus kinase 3), does not regulate phosphorylation of villin or villin-induced cell migration and is, in fact, not expressed in intestinal epithelial cells. Further, we identify SHP-2 and PTPPEST (protein-tyrosine phosphatase proline-, glutamate-, serine, and threonine-rich sequence) as negative regulators of c-Src kinase and demonstrate a new function for these phosphatases in intestinal cell migration. Together, these data suggest that in colorectal carcinogenesis, elevation of c-Src or down-regulation of SHP-2 and/ or PTP-PEST may promote cancer metastases and invasion by regulating villin-induced cell migration and cell invasion.	[Mathew, Sijo; George, Sudeep P.; Wang, Yaohong; Siddiqui, Mohammad Rizwan; Srinivasan, Kamalakkannan; Tan, Langzhu; Khurana, Seema] Univ Tennessee, Dept Physiol, Hlth Sci Ctr, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Khurana, S (corresponding author), Univ Tennessee, Dept Physiol, Hlth Sci Ctr, Nash 402,894 Union Ave, Memphis, TN 38163 USA.	skhurana@utmem.edu		Khurana, Seema/0000-0002-6884-810X	NIDDK NIH HHS [DK-65006, DK-54755] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065006, R01DK054755] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allgayer H, 2002, CANCER, V94, P344, DOI 10.1002/cncr.10221; Angers-Loustau A, 1999, J CELL BIOL, V144, P1019, DOI 10.1083/jcb.144.5.1019; Athman R, 2005, CELL MICROBIOL, V7, P1109, DOI 10.1111/j.1462-5822.2005.00535.x; Barraclough J, 2007, NEOPLASIA, V9, P745, DOI 10.1593/neo.07442; Bodour K, 2004, J EXP MED, V199, P99, DOI 10.1084/jem.20030976; BOYCE BF, 1992, J CLIN INVEST, V90, P1622, DOI 10.1172/JCI116032; CARTWRIGHT CA, 1993, ONCOGENE, V8, P1033; CARTWRIGHT CA, 1994, J CLIN INVEST, V93, P509, DOI 10.1172/JCI117000; Cheng H, 2008, MOL CELL BIOL, V28, P2271, DOI 10.1128/MCB.01789-07; Corey SJ, 1999, BLOOD, V93, P1, DOI 10.1182/blood.V93.1.1; DiDomenico M, 1996, CANCER RES, V56, P4516; Doan T, 2004, CELL SIGNAL, V16, P301, DOI 10.1016/j.cellsig.2003.08.001; Emami S, 2001, FASEB J, V15, P351, DOI 10.1096/fj.00-0355com; Ferrary E, 1999, J CELL BIOL, V146, P819, DOI 10.1083/jcb.146.4.819; Fincham VJ, 1998, EMBO J, V17, P81, DOI 10.1093/emboj/17.1.81; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; FRANCK Z, 1990, J CELL BIOL, V111, P2475, DOI 10.1083/jcb.111.6.2475; FRIEDERICH E, 1989, CELL, V59, P461, DOI 10.1016/0092-8674(89)90030-5; Fuhrer DK, 1996, BIOCHEM BIOPH RES CO, V224, P289, DOI 10.1006/bbrc.1996.1023; George SP, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703617200; Guo HB, 2007, J BIOL CHEM, V282, P22150, DOI 10.1074/jbc.M611518200; Hall CL, 1996, ONCOGENE, V13, P2213; Han NM, 1996, CLIN CANCER RES, V2, P1397; Harder KW, 1998, J BIOL CHEM, V273, P31890, DOI 10.1074/jbc.273.48.31890; Hatakeyama M, 2006, INT J HEMATOL, V84, P301, DOI 10.1532/IJH97.06166; Hofmann SR, 2004, MOL CELL BIOL, V24, P5039, DOI 10.1128/MCB.24.11.5039-5049.2004; Huang CS, 2005, J NUTR, V135, P2119, DOI 10.1093/jn/135.9.2119; Inagaki K, 2000, ONCOGENE, V19, P75, DOI 10.1038/sj.onc.1203204; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; KAPLAN KB, 1995, GENE DEV, V9, P1505, DOI 10.1101/gad.9.12.1505; Khurana S, 1997, J BIOL CHEM, V272, P30115, DOI 10.1074/jbc.272.48.30115; Khurana S, 2006, ADV MOL CEL, V37, P89, DOI 10.1016/S1569-2558(06)37005-1; Khurana S, 2008, FEBS LETT, V582, P2128, DOI 10.1016/j.febslet.2008.02.040; Khurana S, 2008, EXP CELL RES, V314, P530, DOI 10.1016/j.yexcr.2007.10.028; KITAMURA N, 1982, NATURE, V297, P205, DOI 10.1038/297205a0; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kumar N, 2004, J BIOL CHEM, V279, P24915, DOI 10.1074/jbc.C400110200; Kumar N, 2007, J BIOL CHEM, V282, P30341, DOI 10.1074/jbc.C600319200; Li XH, 2004, J PHYSIOL-LONDON, V556, P791, DOI 10.1113/jphysiol.2004.060921; Lin Q, 2005, AM J PATHOL, V167, P969, DOI 10.1016/S0002-9440(10)61187-X; Louvard RAD, 2003, MOL BIOL CELL, V14, P4641, DOI 10.1091/mbc.E03-02-0091; Malaviya R, 1999, J BIOL CHEM, V274, P27028, DOI 10.1074/jbc.274.38.27028; Malaviya R, 2001, IMMUNITY, V15, P313, DOI 10.1016/S1074-7613(01)00184-4; Marchetti D, 1998, ONCOGENE, V16, P3253, DOI 10.1038/sj.onc.1201877; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; Murata T, 1995, J BIOL CHEM, V270, P30829, DOI 10.1074/jbc.270.51.30829; Murata T, 1996, J IMMUNOL, V156, P2972; Murata Y, 2002, INT IMMUNOL, V14, P627, DOI 10.1093/intimm/dxf031; Narisawa-Saito M, 1999, P NATL ACAD SCI USA, V96, P2461, DOI 10.1073/pnas.96.5.2461; NOSAKA T, 1995, SCIENCE, V270, P800, DOI 10.1126/science.270.5237.800; Panebra A, 2001, AM J PHYSIOL-CELL PH, V281, pC1046, DOI 10.1152/ajpcell.2001.281.3.C1046; PARK J, 1995, MOL CELL BIOL, V15, P2374; PARK JS, 1993, ONCOGENE, V8, P2627; Park SY, 1995, IMMUNITY, V3, P771, DOI 10.1016/1074-7613(95)90066-7; Playford MP, 2006, J BIOL CHEM, V281, P34104, DOI 10.1074/jbc.M606277200; Prasad N, 2001, MOL CELL BIOL, V21, P1416, DOI 10.1128/MCB.21.4.1416-1428.2001; Qiu L, 2006, BLOOD, V108, P2407, DOI 10.1182/blood-2006-04-020305; Rieger-Christ KM, 2005, BRIT J CANCER, V92, P2153, DOI 10.1038/sj.bjc.6602651; ROCHE S, 1995, SCIENCE, V269, P1567, DOI 10.1126/science.7545311; RODIER JM, 1995, J CELL BIOL, V131, P761, DOI 10.1083/jcb.131.3.761; Rossi L, 2007, PHARMACOL RES, V56, P248, DOI 10.1016/j.phrs.2007.07.001; Sastry SK, 2002, J CELL SCI, V115, P4305, DOI 10.1242/jcs.00105; STEIN PL, 1994, GENE DEV, V8, P1999, DOI 10.1101/gad.8.17.1999; Streit S, 2006, CANCER GENET CYTOGEN, V170, P48, DOI 10.1016/j.cancergencyto.2006.05.013; Summy JM, 2006, CLIN CANCER RES, V12, P1398, DOI 10.1158/1078-0432.CCR-05-2692; TALAMONTI MS, 1993, J CLIN INVEST, V91, P53, DOI 10.1172/JCI116200; Tebbutt NC, 2002, NAT MED, V8, P1089, DOI 10.1038/nm763; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; THOMIS DC, 1995, SCIENCE, V270, P794, DOI 10.1126/science.270.5237.794; Timpson P, 2001, CURR BIOL, V11, P1836, DOI 10.1016/S0960-9822(01)00583-8; Tomar A, 2004, MOL BIOL CELL, V15, P4807, DOI 10.1091/mbc.E04-05-0431; Tomar A, 2006, J BIOL CHEM, V281, P31972, DOI 10.1074/jbc.M604323200; Walter AO, 1999, ONCOGENE, V18, P1911, DOI 10.1038/sj.onc.1202513; Wang CZ, 2006, MOL BIOL CELL, V17, P2839, DOI 10.1091/mbc.E05-11-1068; Wang YH, 2008, J BIOL CHEM, V283, P9454, DOI 10.1074/jbc.M707962200; Wang YH, 2007, AM J PHYSIOL-CELL PH, V292, pC1775, DOI 10.1152/ajpcell.00420.2006; WHITE E, 1984, MOL CELL BIOL, V4, P2865, DOI 10.1128/MCB.4.12.2865; Zhai LW, 2002, BIOCHEMISTRY-US, V41, P11750, DOI 10.1021/bi0263762; ZHAO YH, 1993, MOL CELL BIOL, V13, P7507, DOI 10.1128/MCB.13.12.7507	79	38	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22709	22722		10.1074/jbc.M801319200	http://dx.doi.org/10.1074/jbc.M801319200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18482983	Green Published, hybrid			2022-12-25	WOS:000258321000040
J	Nirthanan, S; Garcia, G; Chiara, DC; Husain, SS; Cohen, JB				Nirthanan, Selvanayagam; Garcia, Galo, III; Chiara, David C.; Husain, S. Shaukat; Cohen, Jonathan B.			Identification of binding sites in the nicotinic acetylcholine receptor for TDBzl-etomidate, a photoreactive positive allosteric effector	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENERAL ANESTHETIC ETOMIDATE; LIPID-PROTEIN INTERFACE; GATED ION CHANNELS; NONCOMPETITIVE ANTAGONIST; MOLECULAR-MECHANISMS; SUBUNIT INTERFACES; AMINO-ACIDS; GABA(A); LIGAND; GALANTAMINE	Etomidate, one of the most potent general anesthetics used clinically, acts at micromolar concentrations as an anesthetic and positive allosteric modulator of gamma-aminobutyric acid responses, whereas it inhibits muscle-type nicotinic acetylcholine receptors (nAChRs) at concentrations above 10 mu M. We report here that TDBzl-etomidate, a photoreactive etomidate analog, acts as a positive allosteric nAChR modulator rather than an inhibitor, and we identify its binding sites by photoaffinity labeling. TDBzl-etomidate (> 10 mu M) increased the submaximal response to acetylcholine (10 mu M) with a 2.5-fold increase at 60 mu M. At higher concentrations, it inhibited the binding of the noncompetitive antagonists [H-3] tetracaine and [3H] phencyclidine to Torpedo nAChR-rich membranes (IC50 values of 0.8 mM). nAChR-rich membranes were photolabeled with [3H] TDBzl-etomidate, and labeled amino acids were identified by Edman degradation. For nAChRs photolabeled in the absence of agonist (resting state), there was tetracaine-inhibitable photolabeling of amino acids in the ion channel at positions M2-9 (delta Leu-265) and M2-13 (alpha Val-255 and delta Val-269), whereas labeling of alpha M2-10 (alpha Ser-252) was not inhibited by tetracaine but was enhanced 10-fold by proadifen or phencyclidine. In addition, there was labeling in gamma M3 (gamma Met-299), a residue that contributes to the same pocket in the nAChR structure as alpha M2-10. The pharmacological specificity of labeling of residues, together with their locations in the nAChR structure, indicate that TDBzl-etomidate binds at two distinct sites: one within the lumen of the ion channel (labeling of M2-9 and -13), an inhibitory site, and another at the interface between the alpha and gamma subunits (labeling of alpha M2-10 and gamma Met-299) likely to be a site for positive allosteric modulation.	[Nirthanan, Selvanayagam; Garcia, Galo, III; Chiara, David C.; Cohen, Jonathan B.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Husain, S. Shaukat] Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Cohen, JB (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	jonathan_cohen@hms.harvard.edu	Nirthanan, Selvanayagam/ABI-4281-2020	Nirthanan, S. Niru/0000-0001-9888-8447	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM058448] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [P01 GM058448, GM-58448] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akk G, 2005, J NEUROSCI, V25, P1992, DOI 10.1523/JNEUROSCI.4985-04.2005; Arevalo E, 2005, J BIOL CHEM, V280, P13631, DOI 10.1074/jbc.M413911200; Arias HR, 2006, INT J BIOCHEM CELL B, V38, P1254, DOI 10.1016/j.biocel.2006.01.006; Belelli D, 1997, P NATL ACAD SCI USA, V94, P11031, DOI 10.1073/pnas.94.20.11031; Bertrand D, 2007, BIOCHEM PHARMACOL, V74, P1155, DOI 10.1016/j.bcp.2007.07.011; Blanton MP, 1998, J BIOL CHEM, V273, P8659, DOI 10.1074/jbc.273.15.8659; Blanton MP, 1999, MOL PHARMACOL, V55, P269, DOI 10.1124/mol.55.2.269; BLANTON MP, 1994, BIOCHEMISTRY-US, V33, P2859, DOI 10.1021/bi00176a016; BOYD ND, 1984, BIOCHEMISTRY-US, V23, P4023, DOI 10.1021/bi00313a003; BRAUER AW, 1984, ANAL BIOCHEM, V137, P134, DOI 10.1016/0003-2697(84)90359-2; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Broad LM, 2006, J PHARMACOL EXP THER, V318, P1108, DOI 10.1124/jpet.106.104505; Changeux J-P, 2005, NICOTINIC ACETYLCHOL; CHARNET P, 1990, NEURON, V4, P87, DOI 10.1016/0896-6273(90)90445-L; Cromer BA, 2002, TRENDS BIOCHEM SCI, V27, P280, DOI 10.1016/S0968-0004(02)02092-3; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; Ernst M, 2005, MOL PHARMACOL, V68, P1291, DOI 10.1124/mol.105.015982; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; Gallagher MJ, 1999, MOL PHARMACOL, V56, P300, DOI 10.1124/mol.56.2.300; Garcia G, 2007, BIOCHEMISTRY-US, V46, P10296, DOI 10.1021/bi7008163; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hansen SB, 2007, J MOL BIOL, V369, P895, DOI 10.1016/j.jmb.2007.03.067; Hemmings HC, 2005, TRENDS PHARMACOL SCI, V26, P503, DOI 10.1016/j.tips.2005.08.006; Hosie AM, 2006, NATURE, V444, P486, DOI 10.1038/nature05324; Husain SS, 2006, J MED CHEM, V49, P4818, DOI 10.1021/jm051207b; Husain SS, 2003, J MED CHEM, V46, P1257, DOI 10.1021/jm020465v; KOTZYBAHIBERT F, 1995, ANGEW CHEM INT EDIT, V34, P1296, DOI 10.1002/anie.199512961; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Middleton RE, 1999, MOL PHARMACOL, V56, P290, DOI 10.1124/mol.56.2.290; MIDDLETON RE, 1991, BIOCHEMISTRY-US, V30, P6987, DOI 10.1021/bi00242a026; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; OKONJO KO, 1991, EUR J BIOCHEM, V200, P671, DOI 10.1111/j.1432-1033.1991.tb16231.x; OSWALD RE, 1983, BIOCHEMISTRY-US, V22, P3128, DOI 10.1021/bi00282a015; REVAH F, 1990, P NATL ACAD SCI USA, V87, P4675, DOI 10.1073/pnas.87.12.4675; Romanelli MN, 2007, CHEMMEDCHEM, V2, P746, DOI 10.1002/cmdc.200600207; Ryan SE, 2001, J BIOL CHEM, V276, P4796, DOI 10.1074/jbc.M007063200; Samochocki M, 2003, J PHARMACOL EXP THER, V305, P1024, DOI 10.1124/jpet.102.045773; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHRATTENHOLZ A, 1993, EUR J BIOCHEM, V216, P671, DOI 10.1111/j.1432-1033.1993.tb18187.x; SIGRIST H, 1990, J PHOTOCH PHOTOBIO B, V7, P277, DOI 10.1016/1011-1344(90)85162-P; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Vodovozova EL, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1, DOI 10.1134/S0006297907010014; WHITE BH, 1988, BIOCHEMISTRY-US, V27, P8741, DOI 10.1021/bi00424a009; WHITE BH, 1991, J BIOL CHEM, V266, P21595; WHITE BH, 1992, J BIOL CHEM, V267, P15770; Yamakura T, 2001, ANNU REV PHARMACOL, V41, P23, DOI 10.1146/annurev.pharmtox.41.1.23; Ziebell MR, 2004, J BIOL CHEM, V279, P17640, DOI 10.1074/jbc.M313886200	48	58	58	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22051	22062		10.1074/jbc.M801332200	http://dx.doi.org/10.1074/jbc.M801332200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18524766	Green Published, hybrid			2022-12-25	WOS:000258114700024
J	Saura-Valls, M; Faure, R; Brumer, H; Teeri, TT; Cottaz, S; Driguez, H; Planas, A				Saura-Valls, Marc; Faure, Regis; Brumer, Harry; Teeri, Tuula T.; Cottaz, Sylvain; Driguez, Hugues; Planas, Antoni			Active-site mapping of a Populus xyloglucan endo-transglycosylase with a library of xylogluco-oligosaccharides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANT-CELL WALL; GLYCOSYL-ENZYME INTERMEDIATE; ENDOXYLOGLUCAN TRANSFERASE; ENDOTRANSGLYCOSYLASE; MECHANISM; ACCEPTOR; BINDING; SEEDS; PURIFICATION; NOMENCLATURE	Restructuring the network of xyloglucan (XG) and cellulose during plant cell wall morphogenesis involves the action of xyloglucan endo-transglycosylases (XETs). They cleave the XG chains and transfer the enzyme-bound XG fragment to another XG molecule, thus allowing transient loosening of the cell wall and also incorporation of nascent XG during expansion. The substrate specificity of a XET from Populus (PttXET16-34) has been analyzed by mapping the enzyme binding site with a library of xylogluco-oligosaccharides as donor substrates using a labeled heptasaccharide as acceptor. The extended binding cleft of the enzyme is composed of four negative and three positive subsites (with the catalytic residues between subsites -1 and + 1). Donor binding is dominated by the higher affinity of the XXXGmoiety (G = Glc beta(1 -> 4) and X = Xyl alpha(1 -> 6)Glc beta(1 -> 4)) of the substrate for positive subsites, whereas negative subsites have a more relaxed specificity, able to bind (and transfer to the acceptor) a cello-oligosaccharyl moiety of hybrid substrates such as GGGGXXXG. Subsite mapping with k(cat)/K-m values for the donor substrates showed that a GG-unit on negative and-XXG on positive subsites are the minimal requirements for activity. Subsites -2 and -3 (for backbone Glc residues) and +2' (for Xyl substitution at Glc in subsite +2) have the largest contribution to transition state stabilization. GalGXXXGXXXG (Gal = Gal beta(1 -> 4)) is the best donor substrate with a "blocked" nonreducing end that prevents polymerization reactions and yields a single transglycosylation product. Its kinetics have unambiguously established that the enzyme operates by a ping-pong mechanism with competitive inhibition by the acceptor.	[Saura-Valls, Marc; Planas, Antoni] Univ Ramon Llull, Inst Quim Sarria, Biochem Lab, Barcelona 08017, Spain; [Faure, Regis; Cottaz, Sylvain; Driguez, Hugues] CNRS, Ctr Rech Macromol Vegetales, F-38041 Grenoble 9, France; [Brumer, Harry; Teeri, Tuula T.] AlbaNova Univ Ctr, Royal Inst Technol, Sch Biotechnol, SE-10691 Stockholm, Sweden	Universitat Ramon Llull; Institut Quimic de Sarria; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Royal Institute of Technology	Planas, A (corresponding author), Univ Ramon Llull, Inst Quim Sarria, Biochem Lab, Barcelona 08017, Spain.	antoni.planas@iqs.edu	Teeri, Tuula T/E-7509-2013; PLANAS, ANTONI/I-4803-2015; Fauré, Régis/ABB-4847-2021	PLANAS, ANTONI/0000-0001-7073-3320; Fauré, Régis/0000-0002-5107-9009; cottaz, sylvain/0000-0001-8674-0162				Alkazaz M, 1996, EUR J BIOCHEM, V241, P787, DOI 10.1111/j.1432-1033.1996.00787.x; Allen J D, 1980, Methods Enzymol, V64, P248; Baran R, 2000, GEN PHYSIOL BIOPHYS, V19, P427; Baumann MJ, 2007, PLANT CELL, V19, P1947, DOI 10.1105/tpc.107.051391; Buckeridge MS, 2000, PLANT PHYSIOL BIOCH, V38, P141, DOI 10.1016/S0981-9428(00)00162-5; Campbell P, 1999, TRENDS PLANT SCI, V4, P361, DOI 10.1016/S1360-1385(99)01468-5; Carpita N., 2000, BIOCH MOL BIOL PLANT, P52; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Cosgrove DJ, 2001, PLANT PHYSIOL, V125, P131, DOI 10.1104/pp.125.1.131; Coutinho PM, 1999, ROY SOC CH, P3; Fairweather JK, 2002, CHEMBIOCHEM, V3, P866, DOI 10.1002/1439-7633(20020902)3:9<866::AID-CBIC866>3.0.CO;2-R; FANUTTI C, 1993, PLANT J, V3, P691, DOI 10.1111/j.1365-313X.1993.00691.x; Fanutti C, 1996, PLANTA, V200, P221, DOI 10.1007/BF00208312; FARKAS V, 1992, ARCH BIOCHEM BIOPHYS, V298, P365, DOI 10.1016/0003-9861(92)90423-T; Farkas V, 2005, PLANT PHYSIOL BIOCH, V43, P431, DOI 10.1016/j.plaphy.2005.03.006; FAURE R, 2008, EUR J ORG CHEM, V26, P4313; Faure R, 2006, J ORG CHEM, V71, P5151, DOI 10.1021/jo0525682; FRY SC, 1992, BIOCHEM J, V282, P821, DOI 10.1042/bj2820821; Fry SC, 1997, PLANT J, V11, P1141, DOI 10.1046/j.1365-313X.1997.11051141.x; FRY SC, 1993, PHYSIOL PLANTARUM, V89, P1; Gilbert HJ, 2008, CURR OPIN PLANT BIOL, V11, P338, DOI 10.1016/j.pbi.2008.03.004; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; HIROMI K, 1970, BIOCHEM BIOPH RES CO, V40, P1, DOI 10.1016/0006-291X(70)91037-5; Hrmova M, 2007, J BIOL CHEM, V282, P12951, DOI 10.1074/jbc.M611487200; Johansson P, 2004, PLANT CELL, V16, P874, DOI 10.1105/tpc.020065; JUNCOSA M, 1994, J BIOL CHEM, V269, P14530; Kallas AM, 2005, BIOCHEM J, V390, P105, DOI 10.1042/BJ20041749; LORENCES EP, 1993, PHYSIOL PLANTARUM, V88, P105, DOI 10.1111/j.1399-3054.1993.tb01767.x; MACLACHLAN G, 1994, PLANT PHYSIOL, V105, P965, DOI 10.1104/pp.105.3.965; Malet C, 1997, BIOCHEMISTRY-US, V36, P13838, DOI 10.1021/bi9711341; Malet C, 1998, FEBS LETT, V440, P208, DOI 10.1016/S0014-5793(98)01448-3; Mohand FA, 2006, CARBOHYD RES, V341, P577, DOI 10.1016/j.carres.2006.01.018; Nishitani K, 1998, J PLANT RES, V111, P159, DOI 10.1007/BF02507162; NISHITANI K, 1992, J BIOL CHEM, V267, P21058; NISHITANI K, 1992, PLANT CELL PHYSIOL, V33, P1159; Pauly M, 1999, GLYCOBIOLOGY, V9, P93, DOI 10.1093/glycob/9.1.93; Piens K, 2008, J BIOL CHEM, V283, P21864, DOI 10.1074/jbc.M803057200; Piens K, 2007, ORG BIOMOL CHEM, V5, P3971, DOI 10.1039/b714570e; Planas N, 2000, BBA-PROTEIN STRUCT M, V1543, P361, DOI 10.1016/S0167-4838(00)00231-4; Reiter WD, 2002, CURR OPIN PLANT BIOL, V5, P536, DOI 10.1016/S1369-5266(02)00306-0; Rose JKC, 2002, PLANT CELL PHYSIOL, V43, P1421, DOI 10.1093/pcp/pcf171; Saura-Valls M, 2006, BIOCHEM J, V395, P99, DOI 10.1042/BJ20051396; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; Sulova Z, 1998, BIOCHEM J, V330, P1475, DOI 10.1042/bj3301475; Tabuchi A, 1997, PLANT CELL PHYSIOL, V38, P653, DOI 10.1093/oxfordjournals.pcp.a029217; Takeda T, 2008, PLANTA, V227, P893, DOI 10.1007/s00425-007-0665-1; Thompson JE, 1997, BIOCHEM J, V327, P699; Vincken JP, 1997, PLANT PHYSIOL, V114, P9, DOI 10.1104/pp.114.1.9	48	23	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					21853	21863		10.1074/jbc.M803058200	http://dx.doi.org/10.1074/jbc.M803058200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18511421	hybrid			2022-12-25	WOS:000258114700004
J	Zibouche, M; Vincent, M; Illien, F; Gallay, J; Ayala-Sanmartin, J				Zibouche, Malik; Vincent, Michel; Illien, Francoise; Gallay, Jacques; Ayala-Sanmartin, Jesus			The N-terminal domain of annexin 2 serves as a secondary binding site during membrane bridging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIME-RESOLVED FLUORESCENCE; TRYPTOPHAN RESIDUE TRP-59; HEART APOCYTOCHROME-C; MILDLY ACIDIC PH; CRYSTAL-STRUCTURE; SPECTRAL PROPERTIES; PENETRATION DEPTH; CHROMAFFIN CELLS; MODEL MEMBRANES; CORE DOMAIN	Annexin A2 (AnxA2) is a Ca2+- and acidic phospholipid-binding protein involved in many cellular processes. It undergoes Ca2+-mediated membrane bridging at neutral pH and has been demonstrated to be involved in an H+-mediated mechanism leading to a novel AnxA2-membrane complex structure. We used fluorescence techniques to characterize this H+-dependent mechanism at the molecular level; in particular, the involvement of the AnxA2 N-terminal domain. This domain was labeled at Cys-8 either with acrylodan or pyrene-maleimide fluorescent probes. Steady- state and time-resolved fluorescence analysis for acrylodan and fluorescence quenching by doxyl-labeled phospholipids revealed direct interaction between the N-terminal domain and the membrane. The absence of pyrene excimer suggested that interactions between N termini are not involved in the H+-mediated mechanism. These findings differ from those previously observed for the Ca2+-mediated mechanism. Protein titration experiments showed that the protein concentration for half-maximal membrane aggregation was twice for Ca2+-mediated compared with H+-mediated aggregation, suggesting that AnxA2 was able to bridge membranes either as a dimer or as a monomer, respectively. An N-terminally deleted AnxA2 was 2 - 3 times less efficient than the wild-type protein for H+-mediated membrane aggregation. We propose a model of AnxA2-membrane assemblies, highlighting the different roles of the N-terminal domain in the H+- and Ca2+-mediated membrane bridging mechanisms.	[Vincent, Michel; Gallay, Jacques] Univ Paris 11, CNRS, IBBMC, UMR8619, F-91405 Orsay, France; [Zibouche, Malik; Illien, Francoise; Ayala-Sanmartin, Jesus] CdR St Antoine, INSERM, UMRS893, F-75012 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Gallay, J (corresponding author), Univ Paris 11, CNRS, IBBMC, UMR8619, Batiment 430, F-91405 Orsay, France.	jacques.gallay@u-psud.fr; jayala@chusa.jussieu.fr		ILLIEN, Francoise/0000-0003-3414-8452				ABRAMS FS, 1993, BIOCHEMISTRY-US, V32, P10826, DOI 10.1021/bi00091a038; Ayala-Sanmartin J, 2001, BIOCHEM BIOPH RES CO, V283, P72, DOI 10.1006/bbrc.2001.4748; Ayala-Sanmartin J, 2001, BBA-BIOMEMBRANES, V1510, P18, DOI 10.1016/S0005-2736(00)00262-5; Ayala-Sanmartin J, 2000, BIOCHEMISTRY-US, V39, P15179, DOI 10.1021/bi000501x; Ayala-Sanmartin J, 2000, BIOCHEMISTRY-US, V39, P15190, DOI 10.1021/bi000764r; Ayala-Sanmartin J, 2008, BBA-BIOMEMBRANES, V1778, P472, DOI 10.1016/j.bbamem.2007.11.004; AYALASANMARTIN J, 2004, ANNEXINS, V1, P19; Bitto E, 2000, BIOCHEMISTRY-US, V39, P13469, DOI 10.1021/bi001275u; Bitto E, 1999, BIOCHEMISTRY-US, V38, P14094, DOI 10.1021/bi990457p; ChasserotGolaz S, 1996, J CELL BIOL, V133, P1217, DOI 10.1083/jcb.133.6.1217; CHATTOPADHYAY A, 1987, BIOCHEMISTRY-US, V26, P39, DOI 10.1021/bi00375a006; CONCHA NO, 1993, SCIENCE, V261, P1321, DOI 10.1126/science.8362244; DRUST DS, 1988, NATURE, V331, P88, DOI 10.1038/331088a0; Faure AV, 2002, EXP CELL RES, V276, P79, DOI 10.1006/excr.2002.5512; GALLA HJ, 1980, CHEM PHYS LIPIDS, V27, P199, DOI 10.1016/0009-3084(80)90036-5; Gallay J, 2004, EUR J BIOCHEM, V271, P821, DOI 10.1111/j.1432-1033.2004.03987.x; GENGE BR, 1991, J BIOL CHEM, V266, P10678; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Golczak Marcin, 2001, FASEB Journal, V15, P1083; Hong YH, 2003, J BIOCHEM, V134, P427, DOI 10.1093/jb/mvg160; Hu NJ, 2008, BIOPHYS J, V94, P1773, DOI 10.1529/biophysj.107.119685; Isas JM, 2000, BIOCHEMISTRY-US, V39, P3015, DOI 10.1021/bi9922401; JOHNSSON N, 1988, EMBO J, V7, P2435, DOI 10.1002/j.1460-2075.1988.tb03089.x; Jost M, 1997, J CELL SCI, V110, P221; Kim YE, 2005, J BIOL CHEM, V280, P32398, DOI 10.1074/jbc.M505017200; Kohler G, 1997, BIOCHEMISTRY-US, V36, P8189, DOI 10.1021/bi9703960; Ladokhin AS, 2005, BIOCHEMISTRY-US, V44, P3402, DOI 10.1021/bi047805u; Lamaziere A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001938; Lamaziere A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000201; Lambert O, 2004, J BIOL CHEM, V279, P10872, DOI 10.1074/jbc.M313657200; Lambert O, 1997, J MOL BIOL, V272, P42, DOI 10.1006/jmbi.1997.1183; Langen R, 1998, J BIOL CHEM, V273, P22453, DOI 10.1074/jbc.273.35.22453; Langen R, 1998, P NATL ACAD SCI USA, V95, P14060, DOI 10.1073/pnas.95.24.14060; LONDON E, 1981, BIOCHEMISTRY-US, V20, P1932, DOI 10.1021/bi00510a032; Monastyrskaya K, 2008, BIOCHEM J, V409, P65, DOI 10.1042/BJ20071116; Monastyrskaya K, 2007, CELL CALCIUM, V41, P207, DOI 10.1016/j.ceca.2006.06.008; Morel E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001118; MOSSER G, 1991, J MOL BIOL, V217, P241, DOI 10.1016/0022-2836(91)90538-H; Oling F, 2000, J MOL BIOL, V304, P561, DOI 10.1006/jmbi.2000.4183; PIGAULT C, 1990, BIOCHIM BIOPHYS ACTA, V1037, P106, DOI 10.1016/0167-4838(90)90108-R; PIGAULT C, 1994, J MOL BIOL, V236, P199, DOI 10.1006/jmbi.1994.1129; PRENDERGAST FG, 1983, J BIOL CHEM, V258, P7541; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Rety S, 1999, NAT STRUCT BIOL, V6, P89; Rosengarth A, 1998, FEBS LETT, V438, P279, DOI 10.1016/S0014-5793(98)01318-0; Rosengarth A, 2001, J MOL BIOL, V306, P489, DOI 10.1006/jmbi.2000.4423; Rosengarth A., 2004, ANNEXINS, V1, P129; Santos JSD, 2001, FEBS LETT, V493, P122, DOI 10.1016/S0014-5793(01)02285-2; SOPKOVA J, 1994, BIOCHEMISTRY-US, V33, P4490, DOI 10.1021/bi00181a008; SOPKOVA J, 1993, J MOL BIOL, V234, P816, DOI 10.1006/jmbi.1993.1627; Sopkova J, 1999, BIOCHEMISTRY-US, V38, P5447, DOI 10.1021/bi982760g; VINCENT M, 1988, BIOCHEMISTRY-US, V27, P8752, DOI 10.1021/bi00424a010; VINCENT M, 1991, EUR BIOPHYS J, V20, P183, DOI 10.1007/BF01561141; WANG W, 1994, BIOCHEMISTRY-US, V33, P275, DOI 10.1021/bi00167a036; WEBER G, 1979, BIOCHEMISTRY-US, V18, P3075, DOI 10.1021/bi00581a025	56	28	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22121	22127		10.1074/jbc.M801000200	http://dx.doi.org/10.1074/jbc.M801000200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18508775	hybrid, Green Submitted			2022-12-25	WOS:000258114700031
J	Hosokawa, N; Wada, I; Nagasawa, K; Moriyama, T; Okawa, K; Nagata, K				Hosokawa, Nobuko; Wada, Ikuo; Nagasawa, Koji; Moriyama, Tatsuya; Okawa, Katsuya; Nagata, Kazuhiro			Human XTP3-B forms an endoplasmic reticulum quality control scaffold with the HRD1-SEL1L ubiquitin ligase complex and BiP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; MANNOSIDASE-LIKE PROTEIN; MISFOLDED GLYCOPROTEINS; SECRETORY PATHWAY; IDENTIFIES YOS9P; OS-9; ALPHA-1-ANTITRYPSIN; MEMBRANE; GENE; EXTRACTION	The recognition of terminally misfolded proteins in the endoplasmic reticulum (ER) and the extraction of these proteins to the cytoplasm for proteasomal degradation are determined by a quality control mechanism in the ER. In yeast, Yos9p, an ER lectin containing a mannose 6-phosphate receptor homology (MRH) domain, enhances ER-associated degradation (ERAD) of glycoproteins. We show here that human XTP3-B (hXTP3-B), an ER lectin containing two MRH domains, has two transcriptional variants, and both isoforms retard ERAD of the human alpha(1)-antitrypsin variant null Hong Kong (NHK), a terminally misfolded glycoprotein. The hXTP3-B long isoform strongly inhibited ERAD of NHK-QQQ, which lacks all of the N-glycosylation sites of NHK, but the short transcriptional variant of hXTP3-B had almost no effect. Examination of complex formation by immunoprecipitation and by fractionation using sucrose density gradient centrifugation revealed that the hXTP3-B long isoform associates with the HRD1-SEL1L membrane-anchored ubiquitin ligase complex and BiP, forming a 27 S ER quality control scaffold complex. The hXTP3-B short isoform, however, is excluded from scaffold formation. Another MRH domain-containing ER lectin, hOS-9, is incorporated into this large complex, but gp78, another mammalian homolog of the yeast ubiquitin ligase Hrd1p, is not. Based on these results, we propose that this large ER quality control scaffold complex, containing ER lectins, a chaperone, and a ubiquitin ligase, provides a platform for the recognition and sorting of misfolded glycoproteins as well as nonglycosylated proteins prior to retrotranslocation into the cytoplasm for degradation.	[Hosokawa, Nobuko; Nagasawa, Koji; Nagata, Kazuhiro] Kyoto Univ, Inst Frontier Med Sci, Dept Mol & Cellular Biol, Sakyo Ku, Kyoto 6068397, Japan; [Wada, Ikuo] Fukushima Med Univ, Sch Med, Inst Biomed Sci, Dept Cell Sci, Fukushima 9601295, Japan; [Hosokawa, Nobuko; Wada, Ikuo; Nagasawa, Koji; Nagata, Kazuhiro] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Moriyama, Tatsuya] Kinki Univ, Grad Sch Agr, Dept Appl Cell Biol, Nara 6318505, Japan; [Okawa, Katsuya] Kyoto Univ, Grad Sch Med, Frontier Technol Ctr, Kyoto 6068501, Japan	Kyoto University; Fukushima Medical University; Japan Science & Technology Agency (JST); Kindai University (Kinki University); Kyoto University	Hosokawa, N (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Mol & Cellular Biol, Sakyo Ku, 53 Kawahara Cho, Kyoto 6068397, Japan.	nobuko@frontier.kyoto-u.ac.jp		Wada, Ikuo/0000-0001-5668-6994; Moriyama, Tatsuya/0000-0002-6861-926X	Grants-in-Aid for Scientific Research [19GS0314] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Amano T, 2003, GENE DEV, V17, P2436, DOI 10.1101/gad.1096603; Baek JH, 2005, MOL CELL, V17, P503, DOI 10.1016/j.molcel.2005.01.011; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; Buschhorn BA, 2004, FEBS LETT, V577, P422, DOI 10.1016/j.febslet.2004.10.039; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Cruciat CM, 2006, J BIOL CHEM, V281, P12986, DOI 10.1074/jbc.M511872200; Deak PM, 2001, J BIOL CHEM, V276, P10663, DOI 10.1074/jbc.M008608200; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; Hosokawa N, 2006, GENES CELLS, V11, P465, DOI 10.1111/j.1365-2443.2006.00957.x; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Jakob CA, 2001, EMBO REP, V2, P423; Jensen ON, 1996, RAPID COMMUN MASS SP, V10, P1371, DOI 10.1002/(SICI)1097-0231(199608)10:11<1371::AID-RCM682>3.0.CO;2-5; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kim W, 2005, MOL CELL, V19, P753, DOI 10.1016/j.molcel.2005.08.010; Kimura Y, 1998, J BIOCHEM-TOKYO, V123, P876; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Litovchick L, 2002, J BIOL CHEM, V277, P34413, DOI 10.1074/jbc.M203986200; Liu Y, 1999, J BIOL CHEM, V274, P5861, DOI 10.1074/jbc.274.9.5861; Mast SW, 2005, GLYCOBIOLOGY, V15, P421, DOI 10.1093/glycob/cwi014; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Munro S, 2001, CURR BIOL, V11, pR499, DOI 10.1016/S0960-9822(01)00302-5; Nakatsukasa K, 2001, J BIOL CHEM, V276, P8635, DOI 10.1074/jbc.C100023200; Nakayama T, 1999, FEBS LETT, V453, P77, DOI 10.1016/S0014-5793(99)00700-0; Olivari S, 2005, J BIOL CHEM, V280, P2424, DOI 10.1074/jbc.C400534200; SIFERS RN, 1988, J BIOL CHEM, V263, P7330; Su YA, 1996, MOL CARCINOGEN, V15, P270, DOI 10.1002/(SICI)1098-2744(199604)15:4<270::AID-MC4>3.0.CO;2-K; Szathmary R, 2005, MOL CELL, V19, P765, DOI 10.1016/j.molcel.2005.08.015; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949	38	134	140	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20914	20924		10.1074/jbc.M709336200	http://dx.doi.org/10.1074/jbc.M709336200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18502753	Green Published, hybrid			2022-12-25	WOS:000257746100034
J	Doherty, KR; Demonbreun, AR; Wallace, GQ; Cave, A; Posey, AD; Heretis, K; Pytel, P; McNally, EM				Doherty, Katherine R.; Demonbreun, Alexis R.; Wallace, Gregory Q.; Cave, Andrew; Posey, Avery D.; Heretis, Konstantina; Pytel, Peter; McNally, Elizabeth M.			The endocytic recycling protein EHD2 interacts with myoferlin to regulate myoblast fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C2 DOMAIN; MEMBRANE; RME-1; EPS15; COMPARTMENT; MOLECULES; FAMILY; GENE; CELL	Skeletal muscle is a multinucleated syncytium that develops and is maintained by the fusion of myoblasts to the syncytium. Myoblast fusion involves the regulated coalescence of two apposed membranes. Myoferlin is a membrane-anchored, multiple C2 domain-containing protein that is highly expressed in fusing myoblasts and required for efficient myoblast fusion to myotubes. We found that myoferlin binds directly to the eps15 homology domain protein, EHD2. Members of the EHD family have been previously implicated in endocytosis as well as endocytic recycling, a process where membrane proteins internalized by endocytosis are returned to the plasma membrane. EHD2 binds directly to the second C2 domain of myoferlin, and EHD2 is reduced in myoferlin null myoblasts. In contrast to normal myoblasts, myoferlin null myoblasts accumulate labeled transferrin and have delayed recycling. Introduction of dominant negative EHD2 into myoblasts leads to the sequestration of myoferlin and inhibition of myoblast fusion. The interaction of myoferlin with EHD2 identifies molecular overlap between the endocytic recycling pathway and the machinery that regulates myoblast membrane fusion.	[Doherty, Katherine R.] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Demonbreun, Alexis R.; McNally, Elizabeth M.] Univ Chicago, Comm Dev Biol, Chicago, IL 60637 USA; [Wallace, Gregory Q.; Cave, Andrew; McNally, Elizabeth M.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Posey, Avery D.; McNally, Elizabeth M.] Univ Chicago, Comm Genet, Chicago, IL 60637 USA; [Pytel, Peter] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [McNally, Elizabeth M.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago	McNally, EM (corresponding author), 5841 S Maryland Ave,MC6088, Chicago, IL 60632 USA.	emcnally@uchicago.edu	McNally, Elizabeth/W-4909-2019; Posey, Avery D./P-4890-2019; Sadleir, Katherine R/N-1199-2019	Posey, Avery D./0000-0001-8711-629X; Sadleir, Katherine R/0000-0001-8310-841X; Demonbreun, Alexis/0000-0001-6823-125X; McNally, Elizabeth/0000-0002-1221-719X	NHLBI NIH HHS [T32 HL 007381] Funding Source: Medline; NINDS NIH HHS [R01 NS047726, R01 NS 047726] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047726] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Achanzar WE, 1997, J CELL SCI, V110, P1073; Benes CH, 2005, CELL, V121, P271, DOI 10.1016/j.cell.2005.02.019; Blume JJ, 2007, EXP CELL RES, V313, P219, DOI 10.1016/j.yexcr.2006.10.006; Braun A, 2005, MOL BIOL CELL, V16, P3642, DOI 10.1091/mbc.E05-01-0076; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; Chan YM, 1997, FEBS LETT, V410, P153, DOI 10.1016/S0014-5793(97)00454-7; Chen EH, 2004, TRENDS CELL BIOL, V14, P452, DOI 10.1016/j.tcb.2004.07.008; Chen EH, 2003, CELL, V114, P751, DOI 10.1016/S0092-8674(03)00720-7; Confalonieri S, 2002, FEBS LETT, V513, P24, DOI 10.1016/S0014-5793(01)03241-0; Daumke O, 2007, NATURE, V449, P923, DOI 10.1038/nature06173; Davis DB, 2000, HUM MOL GENET, V9, P217, DOI 10.1093/hmg/9.2.217; Davis DB, 2002, J BIOL CHEM, V277, P22883, DOI 10.1074/jbc.M201858200; de Beer T, 2000, NAT STRUCT BIOL, V7, P1018, DOI 10.1038/80924; de Beer T, 1998, SCIENCE, V281, P1357, DOI 10.1126/science.281.5381.1357; Doberstein SK, 1997, J CELL BIOL, V136, P1249, DOI 10.1083/jcb.136.6.1249; Doherty KR, 2005, DEVELOPMENT, V132, P5565, DOI 10.1242/dev.02155; Erickson MRS, 1997, J CELL BIOL, V138, P589, DOI 10.1083/jcb.138.3.589; Galperin E, 2002, TRAFFIC, V3, P575, DOI 10.1034/j.1600-0854.2002.30807.x; Grant B, 2001, NAT CELL BIOL, V3, P573, DOI 10.1038/35078549; Guilherme A, 2004, J BIOL CHEM, V279, P10593, DOI 10.1074/jbc.M307702200; Horsley V, 2004, CELLS TISSUES ORGANS, V176, P67, DOI 10.1159/000075028; Hui EF, 2006, BIOPHYS J, V91, P1767, DOI 10.1529/biophysj.105.080325; KALDERON N, 1979, J CELL BIOL, V81, P411, DOI 10.1083/jcb.81.2.411; Kim S, 2007, DEV CELL, V12, P571, DOI 10.1016/j.devcel.2007.02.019; Krauss RS, 2005, J CELL SCI, V118, P2355, DOI 10.1242/jcs.02397; Lee DW, 2005, J BIOL CHEM, V280, P17213, DOI 10.1074/jbc.M412751200; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; Massarwa R, 2007, DEV CELL, V12, P557, DOI 10.1016/j.devcel.2007.01.016; Mayer BJ, 1999, CURR BIOL, V9, pR70, DOI 10.1016/S0960-9822(99)80014-1; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Naslavsky N, 2005, J CELL SCI, V118, P4093, DOI 10.1242/jcs.02595; Naslavsky N, 2004, MOL BIOL CELL, V15, P2410, DOI 10.1091/mbc.E03-10-0733; Ochoa WF, 2003, BIOCHEMISTRY-US, V42, P8774, DOI 10.1021/bi034713g; Pappa H, 1998, STRUCT FOLD DES, V6, P885, DOI 10.1016/S0969-2126(98)00090-2; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Picciano JA, 2003, AM J PHYSIOL-CELL PH, V285, pC1009, DOI 10.1152/ajpcell.00140.2003; Pohl U, 2000, GENOMICS, V63, P255, DOI 10.1006/geno.1999.6087; POLO S, 2003, SCI STKE, pRE17, DOI DOI 10.1126/STKE.2132003RE17; Rapaport D, 2006, TRAFFIC, V7, P52, DOI 10.1111/j.1600-0854.2005.00359.x; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; Santolini E, 1999, EXP CELL RES, V253, P186, DOI 10.1006/excr.1999.4694; Shao YF, 2002, J CELL BIOL, V157, P679, DOI 10.1083/jcb.200201063; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Taylor MV, 2003, CURR BIOL, V13, pR964, DOI 10.1016/j.cub.2003.11.044; Washington NL, 2006, J CELL SCI, V119, P2552, DOI 10.1242/jcs.02980; WONG WT, 1995, P NATL ACAD SCI USA, V92, P9530, DOI 10.1073/pnas.92.21.9530	46	80	85	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20252	20260		10.1074/jbc.M802306200	http://dx.doi.org/10.1074/jbc.M802306200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18502764	Green Published, hybrid			2022-12-25	WOS:000257565300041
J	Duverger, O; Lee, D; Hassan, MQ; Chen, SX; Jaisser, F; Lian, JB; Morasso, MI				Duverger, Olivier; Lee, Delia; Hassan, Mohammad Q.; Chen, Susie X.; Jaisser, Frederic; Lian, Jane B.; Morasso, Maria I.			Molecular consequences of a frameshifted DLX3 mutant leading to Tricho-Dento-Osseous syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISTAL-LESS GENE; HOMEODOMAIN PROTEINS; MUTATIONS; DIFFERENTIATION; TRANSCRIPTION; ACTIVATION; SEQUENCE; RECRUITMENT; PATTERN; BINDING	The homeodomain protein Distal-less-3 (Dlx3) plays a crucial role during embryonic development. This transcription factor is known to be essential for placental formation and to be involved in skin and skeletal organogenesis. In humans, a frameshift mutation in the coding sequence of the DLX3 gene results in an ectodermal dysplasia called Tricho-Dento-Osseous syndrome (TDO). The main features of this autosomal dominant disorder are defects in hair, teeth, and bone. To investigate the functional alterations caused by the mutated DLX3(TDO) isoform ex vivo, we used tetracycline-inducible osteoblastic and keratinocyte cell lines and calvarial derived osteoblasts in which the expression of DLX3(WT) and/ or DLX3(TDO) could be regulated and monitored. Immunocytochemical analysis revealed that both DLX3(WT) and DLX3(TDO) recombinant proteins are targeted to the nucleus. However, as demonstrated by electrophoresis mobility shift assay, DLX3(TDO) is not able to bind to the canonical Dlx3 binding site. Furthermore, we demonstrate that the frameshifted C-terminal domain in DLX3(TDO) is accountable for the loss of DNA binding activity because the C-terminal domain in DLX3(WT) is not required for DNA binding activity. Although DLX3(TDO) alone cannot bind to a Dlx3 responsive element, when DLX3(WT) and DLX3(TDO) are co-expressed they form a complex that can bind DNA. Concomitant with the inability to bind DNA, DLX3(TDO) has a defective transcriptional activity. Moreover, the transcriptional activity of DLX3(WT) is significantly reduced in the presence of the mutated isoform, indicating that DLX3(TDO) has a dominant negative effect on DLX3(WT) transcriptional activity.	[Duverger, Olivier; Lee, Delia; Chen, Susie X.; Morasso, Maria I.] NIAMS, Dev Skin Biol Unit, NIH, Bethesda, MD 20892 USA; [Hassan, Mohammad Q.; Lian, Jane B.] Univ Massachusetts, Sch Med, Worcester, MA 01655 USA; [Jaisser, Frederic] Univ Paris 05, Coll France, INSERM, U772, F-75005 Paris, France	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Massachusetts System; University of Massachusetts Worcester; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universite Paris Cite	Morasso, MI (corresponding author), NIAMS, Dev Skin Biol Unit, NIH, Bethesda, MD 20892 USA.	morassom@mail.nih.gov	Hassan, Mohammad/GZA-7507-2022; Jaisser, Frederic/P-4287-2017	Hassan, Mohammad/0000-0002-1712-0004; Jaisser, Frederic/0000-0001-9051-1901	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE012528] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIDCR NIH HHS [R37 DE 012528, R37 DE012528] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Barbacci E, 2004, HUM MOL GENET, V13, P3139, DOI 10.1093/hmg/ddh338; Bryan JT, 2000, J CELL SCI, V113, P4013; Choi SJ, 2008, BONE, V42, P162, DOI 10.1016/j.bone.2007.08.047; Depew MJ, 2005, J ANAT, V207, P501, DOI 10.1111/j.1469-7580.2005.00487.x; Espinoza HM, 2005, BIOCHEMISTRY-US, V44, P3942, DOI 10.1021/bi048362x; Feledy JA, 1999, NUCLEIC ACIDS RES, V27, P764, DOI 10.1093/nar/27.3.764; Ghoul-Mazgar S, 2005, BONE, V37, P799, DOI 10.1016/j.bone.2005.03.020; Haldeman RJ, 2004, BONE, V35, P988, DOI 10.1016/j.bone.2004.06.003; Hassan MQ, 2006, J BIOL CHEM, V281, P40515, DOI 10.1074/jbc.M604508200; Hassan MQ, 2004, MOL CELL BIOL, V24, P9248, DOI 10.1128/MCB.24.20.9248-9261.2004; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; Lines MA, 2002, HUM MOL GENET, V11, P1177, DOI 10.1093/hmg/11.10.1177; McGuinness T, 1996, GENOMICS, V35, P473, DOI 10.1006/geno.1996.0387; Morasso MI, 1996, J CELL BIOL, V135, P1879, DOI 10.1083/jcb.135.6.1879; Morasso MI, 1999, P NATL ACAD SCI USA, V96, P162, DOI 10.1073/pnas.96.1.162; MORASSO MI, 1995, P NATL ACAD SCI USA, V92, P3968, DOI 10.1073/pnas.92.9.3968; Nakamura S, 1996, GENOMICS, V38, P314, DOI 10.1006/geno.1996.0634; Newberry EP, 1998, BIOCHEMISTRY-US, V37, P16360, DOI 10.1021/bi981878u; Price JA, 1998, J MED GENET, V35, P825, DOI 10.1136/jmg.35.10.825; Price JA, 1998, HUM MOL GENET, V7, P563, DOI 10.1093/hmg/7.3.563; QUATTROMANI F, 1983, HUM GENET, V64, P116, DOI 10.1007/BF00327105; Roberson MS, 2001, J BIOL CHEM, V276, P10016, DOI 10.1074/jbc.M007481200; ROBINSON GW, 1994, MECH DEVELOP, V48, P199, DOI 10.1016/0925-4773(94)90060-4; Saadi I, 2006, BIRTH DEFECTS RES A, V76, P175, DOI 10.1002/bdra.20226; Singh S, 1998, J BIOL CHEM, V273, P21531, DOI 10.1074/jbc.273.34.21531; Sumiyama K, 2002, P NATL ACAD SCI USA, V99, P780, DOI 10.1073/pnas.012584999; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Vullhorst D, 2005, J BIOL CHEM, V280, P31722, DOI 10.1074/jbc.M500593200; WRIGHT JT, 1994, ORAL SURG ORAL MED O, V77, P487, DOI 10.1016/0030-4220(94)90228-3; Wright JT, 1997, AM J MED GENET, V72, P197; Yamagata K, 1998, DIABETES, V47, P1231, DOI 10.2337/diabetes.47.8.1231; YUSPA SH, 1980, CANCER RES, V40, P4694; Zhang HL, 1997, MOL CELL BIOL, V17, P2920, DOI 10.1128/MCB.17.5.2920	33	35	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20198	20208		10.1074/jbc.M709562200	http://dx.doi.org/10.1074/jbc.M709562200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18492670	hybrid, Green Published			2022-12-25	WOS:000257565300036
J	Adachi, N; Kobayashi, T; Takahashi, H; Kawasaki, T; Shirai, Y; Ueyama, T; Matsuda, T; Seki, T; Sakai, N; Saito, N				Adachi, Naoko; Kobayashi, Takeshi; Takahashi, Hideyuki; Kawasaki, Takumi; Shirai, Yasuhito; Ueyama, Takehiko; Matsuda, Toshio; Seki, Takahiro; Sakai, Norio; Saito, Naoaki			Enzymological analysis of mutant protein kinase C gamma causing spinocerebellar ataxia type 14 and dysfunction in Ca2+ homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPAIRED MOTOR COORDINATION; CLIMBING FIBER INNERVATION; PHORBOL ESTER BINDING; ATAXIA TYPE-14; TRPC3 CHANNELS; LIVING CELLS; PKC-GAMMA; SYNAPSE ELIMINATION; CEREBELLAR-ATAXIA; PLASMA-MEMBRANE	Spinocerebellar ataxia type 14 (SCA14) is an autosomal dominant neurodegenerative disease caused by mutations in protein kinase C gamma(PKC gamma). Interestingly, 18 of 22 mutations are concentrated in the C1 domain, which binds diacylglycerol and is necessary for translocation and regulation of PKC gamma kinase activity. To determine the effect of these mutations on PKC gamma function and the pathology of SCA14, we investigated the enzymological properties of the mutant PKC gamma s. We found that wild-type PKC gamma, but not C1 domain mutants, inhibits Ca2+ influx in response to muscarinic receptor stimulation. The sustained Ca2+ influx induced by muscarinic receptor ligation caused prolonged membrane localization of mutant PKC gamma. Pharmacological experiments showed that canonical transient receptor potential (TRPC) channels are responsible for the Ca2+ influx regulated by PKC gamma. Although in vitro kinase assays revealed that most C1 domain mutants are constitutively active, they could not phosphorylate TRPC3 channels in vivo. Single molecule observation by the total internal reflection fluorescence microscopy revealed that the membrane residence time of mutant PKC gamma s was significantly shorter than that of the wild-type. This fact indicated that, although membrane association of the C1 domain mutants was apparently prolonged, these mutants have a reduced ability to bind diacylglycerol and be retained on the plasma membrane. As a result, they fail to phosphorylate TRPC channels, resulting in sustained Ca2+ entry. Such an alteration in Ca2+ homeostasis and Ca2+-mediated signaling in Purkinje cells may contribute to the neurodegeneration characteristic of SCA14.	[Adachi, Naoko; Takahashi, Hideyuki; Kawasaki, Takumi; Shirai, Yasuhito; Ueyama, Takehiko; Saito, Naoaki] Kobe Univ, Biosignal Res Ctr, Mol Pharmacol Lab, Kobe, Hyogo 6578501, Japan; [Kobayashi, Takeshi] Nagoya Univ, Grad Sch Med, Dept Physiol, Nagoya, Aichi 4668550, Japan; [Matsuda, Toshio] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Med Pharmacol, Osaka 5650871, Japan; [Seki, Takahiro; Sakai, Norio] Hiroshima Univ, Grad Sch Biomed Sci, Dept Mol & Pharmacol Neurosci, Hiroshima 7348551, Japan	Kobe University; Nagoya University; Osaka University; Hiroshima University	Saito, N (corresponding author), Kobe Univ, Biosignal Res Ctr, Mol Pharmacol Lab, Kobe, Hyogo 6578501, Japan.	naosaito@kobe-u.ac.jp	Sakai, Norio/AAM-5822-2021; Shirai, Yasuhito/O-3255-2018; Saito, Nagahiro/I-6113-2014	Sakai, Norio/0000-0002-6648-8761; Saito, Nagahiro/0000-0001-8757-3933; Kobayashi, Takeshi/0000-0002-4372-5285; Seki, Takahiro/0000-0002-9894-4768; Adachi, Naoko/0000-0002-8797-0717				Adachi N, 2005, MOL BRAIN RES, V139, P288, DOI 10.1016/j.molbrainres.2005.06.007; AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; Chen C, 1995, CELL, V83, P1233, DOI 10.1016/0092-8674(95)90148-5; Chen DH, 2003, AM J HUM GENET, V72, P839, DOI 10.1086/373883; Dalski A, 2006, J NEUROL, V253, P1111, DOI 10.1007/s00415-006-0209-9; Duda JE, 2000, AM J PATHOL, V157, P1439, DOI 10.1016/S0002-9440(10)64781-5; Foster TC, 2007, AGING CELL, V6, P319, DOI 10.1111/j.1474-9726.2007.00283.x; Hiramoto K, 2006, MOVEMENT DISORD, V21, P1355, DOI 10.1002/mds.20970; Iino R, 2001, BIOPHYS J, V80, P2667, DOI 10.1016/S0006-3495(01)76236-4; Kano M, 1995, CELL, V83, P1223, DOI 10.1016/0092-8674(95)90147-7; Kano M, 1998, P NATL ACAD SCI USA, V95, P15724, DOI 10.1073/pnas.95.26.15724; Kim SJ, 2003, NATURE, V426, P285, DOI 10.1038/nature02162; Klebe S, 2007, ARCH NEUROL-CHICAGO, V64, P913, DOI 10.1001/archneur.64.6.913; KONNERTH A, 2007, CALCIUM BINDING PROT, V2, P60; Kwak S, 2006, CURR OPIN NEUROBIOL, V16, P281, DOI 10.1016/j.conb.2006.05.004; Martinez-Ruiz A, 2005, P NATL ACAD SCI USA, V102, P8525, DOI 10.1073/pnas.0407294102; Matsumoto M, 1996, NATURE, V379, P168, DOI 10.1038/379168a0; Mori Y, 1998, NEUROREPORT, V9, P507; Murakoshi H, 2004, P NATL ACAD SCI USA, V101, P7317, DOI 10.1073/pnas.0401354101; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; Nolte D, 2007, MOVEMENT DISORD, V22, P265, DOI 10.1002/mds.21269; Offermanns S, 1997, P NATL ACAD SCI USA, V94, P14089, DOI 10.1073/pnas.94.25.14089; ONO Y, 1989, P NATL ACAD SCI USA, V86, P4868, DOI 10.1073/pnas.86.13.4868; Oyasu M, 2008, J HISTOCHEM CYTOCHEM, V56, P253, DOI 10.1369/jhc.7A7291.2007; QUEST AFG, 1994, J BIOL CHEM, V269, P2961; Sakai N, 1997, J CELL BIOL, V139, P1465, DOI 10.1083/jcb.139.6.1465; Seki T, 2005, J BIOL CHEM, V280, P29096, DOI 10.1074/jbc.M501716200; Seki T, 2007, EUR J NEUROSCI, V26, P3126, DOI 10.1111/j.1460-9568.2007.05933.x; Smyth JT, 2006, J BIOL CHEM, V281, P11712, DOI 10.1074/jbc.M510541200; TANAKA C, 1992, NEUROCHEM INT, V21, P499, DOI 10.1016/0197-0186(92)90081-2; Tokunaga M, 1997, BIOCHEM BIOPH RES CO, V235, P47, DOI 10.1006/bbrc.1997.6732; Trebak M, 2005, MOL PHARMACOL, V67, P558, DOI 10.1124/mol.104.007252; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Uchino M, 2004, J BIOL CHEM, V279, P2254, DOI 10.1074/jbc.M309894200; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Usachev YM, 2002, NEURON, V33, P113, DOI 10.1016/S0896-6273(01)00557-8; Venkatachalam K, 2001, J BIOL CHEM, V276, P33980, DOI 10.1074/jbc.C100321200; Verbeek DS, 2005, BRAIN, V128, P436, DOI 10.1093/brain/awh378; Vlak MHM, 2006, MOVEMENT DISORD, V21, P1025, DOI 10.1002/mds.20851; Wieczorek S, 2007, MOVEMENT DISORD, V22, P2135, DOI 10.1002/mds.21673	42	82	83	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19854	19863		10.1074/jbc.M801492200	http://dx.doi.org/10.1074/jbc.M801492200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18499672	hybrid			2022-12-25	WOS:000257387600069
J	Emami, N; Deperthes, D; Malm, J; Diamandis, EP				Emami, Nashmil; Deperthes, David; Malm, Johan; Diamandis, Eleftherios P.			Major role of human KLK14 in seminal clot liquefaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-SPECIFIC ANTIGEN; PROTEIN-C INHIBITOR; FACTOR PATHWAY INHIBITOR; HUMAN-SEMEN; PLASMA BIOCHEMISTRY; SERINE-PROTEASE; SEMENOGELIN-I; TISSUE FACTOR; PREDOMINANT PROTEIN; PROTEOLYTIC CASCADE	Liquefaction of human semen involves proteolytic degradation of the seminal coagulum and release of motile spermatozoa. Several members of human kallikrein-related peptidases (KLKs) have been implicated in semen liquefaction, functioning through highly regulated proteolytic cascades. Among these, KLK3 (also known as prostate-specific antigen) is the main executor enzyme responsible for processing of the primary components of semen coagulum, semenogelins I and II. We have recently identified KLK14 as a potential activator of KLK3 and other KLKs. This study aims to elucidate the cascade-mediated role of KLK14 ex vivo. KLK14 expression was significantly lower (p = 0.0252) in individuals with clinically delayed liquefaction. Concordantly, KLK14 expression was significantly (p = 0.0478) lower in asthenospermic cases. Specific inhibition of KLK14 activity by the synthetic inhibitor ACT(G9) resulted in a significant delay in semen liquefaction, a drop in the "early" (30 min postejaculation) "chymotrypsin- like" and KLK1 activity, and an increase in the "late" (90 min postejaculation) chymotrypsin-like activity. Conversely, the addition of recombinant active KLK14 facilitated the liquefaction process, augmented the early chymotrypsin-like activity, and lowered late chymotrypsin-like activity. Given that the observed chymotrypsin-like activity was almost completely attributed to KLK3 activity, KLK3 seems to be regulated bidirectionally. Accordingly, a higher level of KLK3 fragmentation was observed in KLK14-induced coagula, suggesting an inactivation mechanism via internal cleavage. Finally, semenogelins I and II were directly cleaved by KLK14. Semenogelins were also able to reverse KLK14 inhibition by Zn2+, providing a novel regulatory mechanism for KLK14 activity. Our results show that KLK14 exerts a significant and dose-dependent effect in the process of semen liquefaction.	[Emami, Nashmil; Diamandis, Eleftherios P.] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada; [Emami, Nashmil; Diamandis, Eleftherios P.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1L5, Canada; [Deperthes, David] Med Discovery SA, Biopole, CH-1066 Epalinges, Switzerland; [Malm, Johan] Lund Univ, Malmo Univ Hosp, Dept Lab Med, Sect Clin Chem, SE-20502 Malmo, Sweden	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Lund University; Skane University Hospital	Diamandis, EP (corresponding author), Mt Sinai Hosp, Dept Pathol & Lab Med, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	ediamandis@mtsinai.on.ca		Diamandis, Eleftherios/0000-0002-1589-820X				AMELAR RD, 1962, J UROLOGY, V87, P187, DOI 10.1016/S0022-5347(17)64936-X; Amour A, 2004, BIOCHEM SOC T, V32, P15, DOI 10.1042/BST0320015; Balk SP, 2003, J CLIN ONCOL, V21, P383, DOI 10.1200/JCO.2003.02.083; Bhattacharyya AK, 2003, MOL CELL BIOCHEM, V253, P255, DOI 10.1023/A:1026024202288; Borgono CA, 2007, J BIOL CHEM, V282, P2405, DOI 10.1074/jbc.M608348200; CHRISTENSSON A, 1994, EUR J BIOCHEM, V220, P45, DOI 10.1111/j.1432-1033.1994.tb18597.x; COSENTINO MJ, 1986, UROL RES, V14, P229; DAUNTER B, 1981, ANDROLOGIA, V13, P131; De Jonge CJ, 1998, SEMIN REPROD ENDOCR, V16, P209, DOI 10.1055/s-2007-1016279; de Lamirande E, 2007, SEMIN THROMB HEMOST, V33, P60, DOI 10.1055/s-2006-958463; Denmeade SR, 2001, PROSTATE, V48, P122, DOI 10.1002/pros.1088; Deperthes D, 1996, J ANDROL, V17, P659; DUBE JY, 1989, ANDROLOGIA, V21, P136; Emami N, 2007, MOL ONCOL, V1, P269, DOI 10.1016/j.molonc.2007.09.003; Emami N, 2008, J BIOL CHEM, V283, P3031, DOI 10.1074/jbc.M707253200; Espana F, 2007, SEMIN THROMB HEMOST, V33, P41, DOI 10.1055/s-2006-958460; Felber LM, 2005, BIOL CHEM, V386, P291, DOI 10.1515/BC.2005.035; Felber LM, 2006, FEBS J, V273, P2505, DOI 10.1111/j.1742-4658.2006.05257.x; Fernandez JA, 2007, SEMIN THROMB HEMOST, V33, P13, DOI 10.1055/s-2006-958457; Goossens E, 2006, SEMIN REPROD MED, V24, P370, DOI 10.1055/s-2006-952158; HINRICHSENKOHANE AC, 1984, ANDROLOGIA, V16, P321; HOSKINS DD, 1978, FED PROC, V37, P2534; Jonsson M, 2005, BIOCHEM J, V387, P447, DOI 10.1042/BJ20041424; Kise H, 1996, EUR J BIOCHEM, V238, P88, DOI 10.1111/j.1432-1033.1996.0088q.x; KOREN E, 1979, J REPROD FERTIL, V56, P493; Kumar A, 1997, CANCER RES, V57, P3111; Leinonen J, 1996, J UROLOGY, V155, P1099, DOI 10.1016/S0022-5347(01)66399-7; LILJA H, 1987, J CLIN INVEST, V80, P281, DOI 10.1172/JCI113070; LILJA H, 1984, SCAND J CLIN LAB INV, V44, P447, DOI 10.3109/00365518409083836; LILJA H, 1985, J CLIN INVEST, V76, P1899, DOI 10.1172/JCI112185; LILJA H, 1985, SCAND J CLIN LAB INV, V45, P635, DOI 10.3109/00365518509155271; LUKAC J, 1979, J REPROD FERTIL, V56, P501; Lwaleed BA, 2005, THROMB HAEMOSTASIS, V93, P847, DOI 10.1160/TH04-09-0600; Lwaleed BA, 2004, THROMB HAEMOSTASIS, V92, P752, DOI 10.1160/TH04-03-0142; Lwaleed BA, 2007, SEMIN THROMB HEMOST, V33, P3, DOI 10.1055/s-2006-958456; LYNCH MJ, 1994, J PHARMACEUT BIOMED, V12, P5, DOI 10.1016/0731-7085(94)80004-9; MANDAL A, 1988, ARCH ANDROLOGY, V20, P141, DOI 10.3109/01485018808987065; Matsuda Y, 2002, ARCH ANDROLOGY, V48, P295, DOI 10.1080/01485010290031600; Michael IP, 2006, J BIOL CHEM, V281, P12743, DOI 10.1074/jbc.M600326200; Michael IP, 2005, J BIOL CHEM, V280, P14628, DOI 10.1074/jbc.M408132200; Michel S, 2005, J MOL RECOGNIT, V18, P225, DOI 10.1002/jmr.729; Mikhailichenko VV, 2005, FERTIL STERIL, V84, P256, DOI 10.1016/j.fertnstert.2004.11.086; POLAK B, 1990, EUR J OBSTET GYN R B, V35, P223, DOI 10.1016/0028-2243(90)90166-X; POLAK B, 1989, INT J ANDROL, V12, P187, DOI 10.1111/j.1365-2605.1989.tb01303.x; Robert M, 1997, BIOCHEMISTRY-US, V36, P3811, DOI 10.1021/bi9626158; Robert M, 1999, CELL MOL LIFE SCI, V55, P944, DOI 10.1007/s000180050346; SCHILL WB, 1992, ANDROLOGIA, V24, P69; Shaw JLV, 2007, CLIN CHEM, V53, P1423, DOI 10.1373/clinchem.2007.088104; Siems WE, 2003, ANDROLOGIA, V35, P44, DOI 10.1046/j.1439-0272.2003.00536.x; Suzuki K, 2007, SEMIN THROMB HEMOST, V33, P46, DOI 10.1055/s-2006-958461; TAUBER PF, 1981, BIOCH ANDROLOGY, P153; Thyzel E, 2003, THROMB RES, V109, P329, DOI 10.1016/S0049-3848(03)00210-X; Vaisanen V, 1999, PROSTATE CANCER P D, V2, P91, DOI 10.1038/sj.pcan.4500289; Van Dreden P, 2007, SEMIN THROMB HEMOST, V33, P21, DOI 10.1055/s-2006-958458; WILSON VB, 1975, J UROLOGY, V113, P509, DOI 10.1016/S0022-5347(17)59513-0; Wu P, 2004, PROSTATE, V58, P345, DOI 10.1002/pros.10337; Yoon H, 2007, J BIOL CHEM, V282, P31852, DOI 10.1074/jbc.M705190200; ZHANG WM, 1995, CLIN CHEM, V41, P1567	59	40	43	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19561	19569		10.1074/jbc.M801194200	http://dx.doi.org/10.1074/jbc.M801194200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18482984	hybrid			2022-12-25	WOS:000257387600042
J	Spitaleri, A; Mari, S; Curnis, F; Traversari, C; Longhi, R; Bordignon, C; Corti, A; Rizzardi, GP; Musco, G				Spitaleri, Andrea; Mari, Silvia; Curnis, Flavio; Traversari, Catia; Longhi, Renato; Bordignon, Claudio; Corti, Angelo; Rizzardi, Gian-Paolo; Musco, Giovanna			Structural basis for the interaction of isoDGR with the RGD-binding site of alpha v beta 3 integrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONTE-CARLO METHOD; BASEMENT-MEMBRANE; TUMOR VESSELS; FORCE-FIELD; AMINO-ACID; PROTEIN; FIBRONECTIN; DOCKING; AMINOPEPTIDASE; PEPTIDES	Asparagine deamidation at the NGR sequence in the 5th type I repeat of fibronectin (FN-I-5) generates isoDGR, an alpha v beta 3 integrin-binding motif regulating endothelial cell adhesion and proliferation. By NMR and molecular dynamics studies, we analyzed the structure of CisoDGRC (isoDGR-2C), a cyclic beta-peptide mimicking the FN-I-5 site, and compared it with NGR, RGD, or DGR-containing cyclopeptides. Docking experiments show that isoDGR, exploiting an inverted orientation as compared with RGD, favorably interacts with the RGD-binding site of alpha v beta 3, both recapitulating canonical RGD-alpha v beta 3 contacts and establishing additional polar interactions. Conversely, NGR and DGR motifs lack the fundamental pharmacophoric requirements for high receptor affinity. Therefore, unlike NGR and DGR, isoDGR is a new natural recognition motif of the RGD-binding pocket of alpha v beta 3. These findings contribute to explain the different functional properties of FN-I-5 before and after deamidation, and provide support for the hypothesis that NGR 3 isoDGR transition can work as a molecular timer for activating latent integrin-binding sites in proteins, thus regulating protein function.	[Traversari, Catia; Bordignon, Claudio; Corti, Angelo; Rizzardi, Gian-Paolo] MolMed SpA, I-20132 Milan, Italy; [Spitaleri, Andrea; Mari, Silvia; Musco, Giovanna] Ist Sci San Raffaele, Dulbecco Telethon Inst, Biomol NMR Lab, I-20132 Milan, Italy; [Curnis, Flavio; Corti, Angelo] Ist Sci San Raffaele, Dept Oncol, Canc Immunotherapy & Gene Therapy Program, I-20132 Milan, Italy; [Curnis, Flavio; Corti, Angelo] Ist Sci San Raffaele, Italian Inst Technol Network, Res Unit Mol Neurosci, I-20132 Milan, Italy; [Longhi, Renato] CNR, Ist Chim Riconoscimento Mol, I-20131 Milan, Italy	Fondazione Telethon; Dulbecco Telethon Institute (DTI); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Istituto Italiano di Tecnologia - IIT; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR)	Corti, A (corresponding author), MolMed SpA, Via Olgettina 58, I-20132 Milan, Italy.	corti.angelo@hsr.it; paolo.rizzardi@molmed.com; musco.giovanna@hsr.it	Corti, Angelo/F-7046-2012; Curnis, Flavio/AAK-3542-2020; musco, giovanna/I-7122-2012; Musco, Giovanna/Q-2756-2019; Spitaleri, Andrea/S-9368-2019	Corti, Angelo/0000-0002-0893-6191; Curnis, Flavio/0000-0002-7231-9569; musco, giovanna/0000-0002-0469-2994; Spitaleri, Andrea/0000-0003-3012-3557; Subba, Rajkrishna/0000-0003-0051-0062	Telethon [TCR07003] Funding Source: Medline	Telethon(Fondazione Telethon)		ARNAOUT MA, 1990, IMMUNOL REV, V114, P145, DOI 10.1111/j.1600-065X.1990.tb00564.x; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Belvisi L, 2005, MOL CANCER THER, V4, P1670, DOI 10.1158/1535-7163.MCT-05-0120; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Casiraghi G, 2005, J MED CHEM, V48, P7675, DOI 10.1021/jm050698x; Chen FH, 2005, J BIOL CHEM, V280, P32655, DOI 10.1074/jbc.M504778200; Curnis F, 2005, CANCER RES, V65, P2906, DOI 10.1158/0008-5472.CAN-04-4282; Curnis F, 2002, CANCER RES, V62, P867; Curnis F, 2006, J BIOL CHEM, V281, P36466, DOI 10.1074/jbc.M604812200; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; Daura X, 1999, PROTEINS, V36, P542, DOI 10.1002/(SICI)1097-0134(19990901)36:4<542::AID-PROT17>3.0.CO;2-M; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Dechantsreiter MA, 1999, J MED CHEM, V42, P3033, DOI 10.1021/jm970832g; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Di Matteo P, 2006, MOL IMMUNOL, V43, P1509, DOI 10.1016/j.molimm.2005.10.009; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Eliceiri BP, 1999, J CLIN INVEST, V103, P1227, DOI 10.1172/JCI6869; Ensslin MA, 2007, P NATL ACAD SCI USA, V104, P2715, DOI 10.1073/pnas.0610296104; Fernandez-Recio J, 2004, J MOL BIOL, V335, P843, DOI 10.1016/j.jmb.2003.10.069; Gottschalk KE, 2002, ANGEW CHEM INT EDIT, V41, P3767, DOI 10.1002/1521-3773(20021018)41:20<3767::AID-ANIE3767>3.0.CO;2-T; Hansmann UHE, 1997, PHYS REV E, V56, P2228, DOI 10.1103/PhysRevE.56.2228; Heckmann D, 2007, METHOD ENZYMOL, V426, P463, DOI 10.1016/S0076-6879(07)26020-3; Heckmann D, 2007, ANGEW CHEM INT EDIT, V46, P3571, DOI 10.1002/anie.200700008; HERMANS J, 1984, BIOPOLYMERS, V23, P1513, DOI 10.1002/bip.360230807; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hukushima K, 1996, J PHYS SOC JPN, V65, P1604, DOI 10.1143/JPSJ.65.1604; HUMPHRIES MJ, 1989, CANCER INVEST, V7, P373, DOI 10.3109/07357908909039866; Humphries MJ, 2000, BIOCHEM SOC T, V28, P311, DOI 10.1042/0300-5127:0280311; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Johansson Staffan, 1997, Frontiers in Bioscience (online), V2, pD126; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kiyozumi D, 2005, EXP CELL RES, V306, P9, DOI 10.1016/j.yexcr.2005.01.020; Kornblihtt AR, 1996, FASEB J, V10, P248, DOI 10.1096/fasebj.10.2.8641558; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Linge JP, 1999, J BIOMOL NMR, V13, P51, DOI 10.1023/A:1008365802830; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Luan YP, 2007, CURR MED CHEM, V14, P639, DOI 10.2174/092986707780059571; Marinelli L, 2003, J MED CHEM, V46, P4393, DOI 10.1021/jm020577m; MCLACHLAN AD, 1982, ACTA CRYSTALLOGR A, V38, P871, DOI 10.1107/S0567739482001806; Mohri H, 1997, PEPTIDES, V18, P899, DOI 10.1016/S0196-9781(97)00027-2; Moitessier N, 2004, J MED CHEM, V47, P4178, DOI 10.1021/jm0311386; Osada A, 2005, EXP CELL RES, V303, P148, DOI 10.1016/j.yexcr.2004.04.053; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Pasqualini R, 2000, CANCER RES, V60, P722; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Sato Y, 2004, BIOL PHARM BULL, V27, P772, DOI 10.1248/bpb.27.772; Scarborough RM, 1999, CURR MED CHEM, V6, P971; Steck E, 2007, MATRIX BIOL, V26, P30, DOI 10.1016/j.matbio.2006.09.006; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; Takagi J, 2007, CURR OPIN CELL BIOL, V19, P557, DOI 10.1016/j.ceb.2007.09.002; Takahashi S, 2007, J CELL BIOL, V178, P167, DOI 10.1083/jcb.200703021; TRAVERSARI C, 1992, IMMUNOGENETICS, V35, P145, DOI 10.1007/BF00185107; van Well RM, 2003, J AM CHEM SOC, V125, P10822, DOI 10.1021/ja035461+; Wermuth J, 1997, J AM CHEM SOC, V119, P1328, DOI 10.1021/ja961908l; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yamada KM, 1989, CURR OPIN CELL BIOL, V1, P956, DOI 10.1016/0955-0674(89)90065-3	59	79	82	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19757	19768		10.1074/jbc.M710273200	http://dx.doi.org/10.1074/jbc.M710273200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18480047	hybrid			2022-12-25	WOS:000257387600060
J	Su, SK; Cai, F; Si, A; Zhang, SW; Tautz, J; Chen, SL				Su, Songkun; Cai, Fang; Si, Aung; Zhang, Shaowu; Tautz, Juergen; Chen, Shenglu			East Learns from West: Asiatic Honeybees Can Understand Dance Language of European Honeybees	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; APIS; BEHAVIOR; ANIMALS; BRAINS	The honeybee waggle dance, through which foragers advertise the existence and location of a food source to their hive mates, is acknowledged as the only known form of symbolic communication in an invertebrate. However, the suggestion, that different species of honeybee might possess distinct 'dialects' of the waggle dance, remains controversial. Furthermore, it remains unclear whether different species of honeybee can learn from and communicate with each other. This study reports experiments using a mixed-species colony that is composed of the Asiatic bee Apis cerana cerana (Acc), and the European bee Apis mellifera ligustica (Aml). Using video recordings made at an observation hive, we first confirm that Acc and Aml have significantly different dance dialects, even when made to forage in identical environments. When reared in the same colony, these two species are able to communicate with each other: Acc foragers could decode the dances of Aml to successfully locate an indicated food source. We believe that this is the first report of successful symbolic communication between two honeybee species; our study hints at the possibility of social learning between the two honeybee species, and at the existence of a learning component in the honeybee dance language.	[Su, Songkun; Cai, Fang; Zhang, Shaowu; Chen, Shenglu] Zhejiang Univ, Coll Anim Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Si, Aung; Zhang, Shaowu] Australian Natl Univ, Ctr Excellence Vision Sci, Res Sch Biol Sci, Canberra, ACT, Australia; [Tautz, Juergen] Univ Wurzburg, Bioctr, BEE grp, Wurzburg, Germany	Zhejiang University; Australian National University; University of Wurzburg	Su, SK (corresponding author), Zhejiang Univ, Coll Anim Sci, Hangzhou 310003, Zhejiang, Peoples R China.	shaowu.zhang@anu.edu.au; slchen@zju.edu.cn		Si, Aung/0000-0001-8115-9176; Zhang, Shaowu/0000-0002-3551-5587	National Natural Science Foundation of China [30571409, 30671593]; ARC COE [CE0561903, DP-0450535]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); ARC COE(Australian Research Council)	This study was supported by the National Natural Science Foundation of China to SSK (No.30571409) and CSL (No.30671593), the ARC COE in Vision Science (CE0561903) and ARC DP-0450535 to SWZ.	Arias MC, 2005, MOL PHYLOGENET EVOL, V37, P25, DOI 10.1016/j.ympev.2005.02.017; Arias MC, 1996, MOL PHYLOGENET EVOL, V5, P557, DOI 10.1006/mpev.1996.0050; ATWAL AS, 1967, 21 INT BEEK C PREL S; Ayasse M, 2002, CHEMOECOLOGY OF INSECT EGGS AND EGG DEPOSITION, P117; Barron AB, 2007, P NATL ACAD SCI USA, V104, P1703, DOI 10.1073/pnas.0610506104; BOCH R, 1957, Z VERGL PHYSIOL, V40, P289, DOI 10.1007/BF00340572; Brockmann A, 2007, BRAIN BEHAV EVOLUT, V70, P125, DOI 10.1159/000102974; Chittka L, 2004, PLOS BIOL, V2, P898, DOI 10.1371/journal.pbio.0020216; Chittka L, 2003, NATURE, V424, P388, DOI 10.1038/424388a; DHALIWAL G S, 1970, Journal of Apicultural Research, V9, P53; Dornhaus A, 1999, NATURE, V401, P38, DOI 10.1038/43372; DYER FC, 1991, BEHAV ECOL SOCIOBIOL, V28, P227, DOI 10.1007/BF00175094; Dyer FC, 2002, ANNU REV ENTOMOL, V47, P917, DOI 10.1146/annurev.ento.47.091201.145306; Esch HE, 2001, NATURE, V411, P581, DOI 10.1038/35079072; Galef BG, 2005, BIOSCIENCE, V55, P489, DOI 10.1641/0006-3568(2005)055[0489:SLIAES]2.0.CO;2; GARNERY L, 1993, EXPERIENTIA, V49, P1016, DOI 10.1007/BF02125651; Giurfa M, 2001, NATURE, V410, P930, DOI 10.1038/35073582; Giurfa M, 2003, BEE WORLD, V84, P5, DOI 10.1080/0005772X.2003.11099566; GOULD JL, 1987, AM NAT, V130, P317, DOI 10.1086/284713; Griffin AS, 2004, LEARN BEHAV, V32, P131; Heyes Cecilia. M., 1996, SOCIAL LEARNING ANIM; HEYES CM, 1994, BIOL REV, V69, P207, DOI 10.1111/j.1469-185X.1994.tb01506.x; Hsu CY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000395; Johnson RN, 2002, J HERED, V93, P170, DOI 10.1093/jhered/93.3.170; Kiya T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000371; Leadbeater E, 2007, CURR BIOL, V17, pR703, DOI 10.1016/j.cub.2007.06.012; LINDAUER M, 1956, Z VERGL PHYSIOL, V38, P521, DOI 10.1007/BF00341108; MICHELSEN A, 1992, BEHAV ECOL SOCIOBIOL, V30, P143, DOI 10.1007/BF00166696; Nieh JC, 2000, J EXP BIOL, V203, P1573; OKU N, 1990, HONEYBEE SCI, V3, P121; OLDROYD BP, 1991, ANIM BEHAV, V42, P121, DOI 10.1016/S0003-3472(05)80612-8; POTICHOT S, 1993, ASIAN APICULTURE, P128; RINDERER TE, 1995, THEOR APPL GENET, V91, P727, DOI 10.1007/BF00220950; Sandeman DC, 1996, J EXP BIOL, V199, P2585; Seeley TD, 2000, J COMP PHYSIOL A, V186, P813, DOI 10.1007/s003590000134; Sen Sarma M, 2004, J COMP PHYSIOL A, V190, P49, DOI 10.1007/s00359-003-0470-7; SHEPPARD WS, 1989, APIDOLOGIE, V20, P419, DOI 10.1051/apido:19890507; Sherman G, 2002, NATURE, V419, P920, DOI 10.1038/nature01127; Sokal R. R., 2012, BIOMETRY; Srinivasan MV, 2000, SCIENCE, V287, P851, DOI 10.1126/science.287.5454.851; Su SK, 2005, APIDOLOGIE, V36, P389, DOI 10.1051/apido:2005026; Takenaka T, 1996, BIOSCI BIOTECH BIOCH, V60, P518, DOI 10.1271/bbb.60.518; Tan K, 2006, NATURWISSENSCHAFTEN, V93, P315, DOI 10.1007/s00114-006-0113-2; Tang Q.V., 1997, PRACTICAL STAT DPS D; Tautz J, 2004, PLOS BIOL, V2, P915, DOI 10.1371/journal.pbio.0020211; Tautz J, 2003, J COMP PHYSIOL A, V189, P293, DOI 10.1007/s00359-003-0402-6; Tautz J, 1996, NATURE, V382, P32, DOI 10.1038/382032a0; Thom C, 2007, PLOS BIOL, V5, P1862, DOI 10.1371/journal.pbio.0050228; Vergoz V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000288; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Winston, 1987, BIOL HONEYBEE; Zhang Shaowu, 2004, P41; Zhang SW, 2004, VISUAL NEUROSCIENCES, P1501	53	28	31	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2365	10.1371/journal.pone.0002365	http://dx.doi.org/10.1371/journal.pone.0002365			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523550	Green Published, gold, Green Submitted			2022-12-25	WOS:000262614300051
J	Kim, KW; Moretti, L; Lu, B				Kim, Kwang Woon; Moretti, Luigi; Lu, Bo			M867, a Novel Selective Inhibitor of Caspase-3 Enhances Cell Death and Extends Tumor Growth Delay in Irradiated Lung Cancer Models	PLOS ONE			English	Article							AUTOPHAGOSOME FORMATION; MAMMALIAN TARGET; FAS LIGAND; IN-VITRO; RADIATION; APOPTOSIS; SURVIVAL; INDUCTION; TUMORIGENESIS; EXPRESSION	Background: Lung cancer remains the leading cause of cancer death worldwide. Radioresistance of lung cancer cells results in unacceptable rate of loco-regional failure. Although radiation is known to induce apoptosis, our recent study showed that knockdown of pro-apoptotic proteins Bak and Bax resulted in an increase in autophagic cell death and lung cancer radiosensitivity in vitro. To further explore the potential of apoptosis inhibition as a way to sensitize lung cancer for therapy, we tested M867, a novel chemical and reversible caspase-3 inhibitor, in combination with ionizing radiation in vivo and in vitro. Methods and Findings: M867 reduced clonogenic survival in H460 lung cancer cells (DER = 1.27, p = 0.007) compared to the vehicle-treated treated cells. We found that administration of M867 with ionizing radiation in an in vivo mouse hind limb lung cancer model was well tolerated, and produced a significant tumor growth delay compared to radiation alone. A dramatic decrease in tumor vasculature was observed with M867 and radiation using von Willebrand factor staining. In addition, Ki67 index showed >5-fold reduction of tumor proliferation in the combination therapy group, despite the reduced levels of apoptosis observed with terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling staining. Radiosensitizing effect of M867 through inhibiting caspases was validated using caspase-3/-7 double-knockout (DKO) mouse embryonic fibroblasts (MEF) cell model. Consistent with our previous study, autophagy contributed to the mechanism of increased cell death, following inhibition of apoptosis. In addition, matrigel assay showed a decrease in in vitro endothelial tubule formation during the M867/radiation combination treatment. Conclusions: M867 enhances the cytotoxic effects of radiation on lung cancer and its vasculature both in vitro and in vivo. M867 has the potential to prolong tumor growth delay by inhibiting tumor proliferation. Clinical trials are needed to determine the potential of this combination therapy in patients with locally advanced lung cancer.	[Kim, Kwang Woon; Moretti, Luigi; Lu, Bo] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Dept Radiat Oncol, Nashville, TN 37212 USA	Vanderbilt University	Kim, KW (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Dept Radiat Oncol, Nashville, TN 37212 USA.	bo.lu@vanderbilt.edu	lu, bo/G-4573-2010		US National Cancer Institute (NCI) [1R01 CA125842-01A1]; NATIONAL CANCER INSTITUTE [R01CA125842] Funding Source: NIH RePORTER	US National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported in part by the US National Cancer Institute (NCI) Grant 1R01 CA125842-01A1. The funders had no role in the design and conduct of the study, in the data collection, analysis and interpretation, and decision to publish, review, approval, or preparation of the manuscript.	Abend M, 2003, INT J RADIAT BIOL, V79, P927, DOI 10.1080/09553000310001632958; Albertine KH, 2002, AM J PATHOL, V161, P1783, DOI 10.1016/S0002-9440(10)64455-0; Andriani F, 2006, NEOPLASIA, V8, P9, DOI 10.1593/neo.05517; Baehrecke EH, 2002, NAT REV MOL CELL BIO, V3, P779, DOI 10.1038/nrm931; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bursch W, 2001, CELL DEATH DIFFER, V8, P569, DOI 10.1038/sj.cdd.4400852; Cao C, 2006, CANCER RES, V66, P10040, DOI 10.1158/0008-5472.CAN-06-0802; Chau YP, 2003, HISTOL HISTOPATHOL, V18, P715, DOI 10.14670/HH-18.715; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; DeMasters G, 2006, MOL CANCER THER, V5, P2786, DOI 10.1158/1535-7163.MCT-06-0316; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Gdynia G, 2007, MOL CANCER RES, V5, P1232, DOI 10.1158/1541-7786.MCR-07-0343; Gorski DH, 1999, CANCER RES, V59, P3374; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Hagimoto N, 2002, J IMMUNOL, V168, P6470, DOI 10.4049/jimmunol.168.12.6470; HALL HM, 1902, U CALIFORNIA PUBLICA, V1, P1; Hallahan DE, 1997, P NATL ACAD SCI USA, V94, P6432, DOI 10.1073/pnas.94.12.6432; Hamada K, 2005, GENE DEV, V19, P2054, DOI 10.1101/gad.1308805; Han YX, 2005, BIOORG MED CHEM LETT, V15, P1173, DOI 10.1016/j.bmcl.2004.12.006; Hope AJ, 2006, INT J RADIAT ONCOL, V65, P112, DOI 10.1016/j.ijrobp.2005.11.046; Houchen CW, 1999, AM J PHYSIOL-GASTR L, V276, pG249, DOI 10.1152/ajpgi.1999.276.1.G249; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kim KW, 2006, J BIOL CHEM, V281, P36883, DOI 10.1074/jbc.M607094200; Kuwano K, 2000, CHEST, V118, P451, DOI 10.1378/chest.118.2.451; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liang XH, 2001, CANCER RES, V61, P3443; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Methot N, 2004, J EXP MED, V199, P199, DOI 10.1084/jem.20031791; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Nishio Kazuto, 1999, Current Opinion in Oncology, V11, P109, DOI 10.1097/00001622-199903000-00006; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Ohta Y, 1996, CLIN CANCER RES, V2, P1411; Paglin S, 2001, CANCER RES, V61, P439; Reggiori F, 2005, CURR OPIN CELL BIOL, V17, P415, DOI 10.1016/j.ceb.2005.06.007; Rube CE, 2000, INT J RADIAT ONCOL, V47, P1033, DOI 10.1016/S0360-3016(00)00482-X; Segura I, 2002, FASEB J, V16, DOI 10.1096/fj.01-0819com; Senft J, 2007, CANCER RES, V67, P11505, DOI 10.1158/0008-5472.CAN-07-5755; Shinohara ET, 2005, ONCOGENE, V24, P5414, DOI 10.1038/sj.onc.1208715; Thornton SC, 1996, CLIN EXP IMMUNOL, V103, P67, DOI 10.1046/j.1365-2249.1996.898598.x; Verheij M, 2000, CELL TISSUE RES, V301, P133, DOI 10.1007/s004410000188; Wang J, 2000, J CELL SCI, V113, P753; Wen SH, 2001, P NATL ACAD SCI USA, V98, P4622, DOI 10.1073/pnas.081063798	45	45	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2275	10.1371/journal.pone.0002275	http://dx.doi.org/10.1371/journal.pone.0002275			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509530	Green Published, Green Submitted, gold			2022-12-25	WOS:000262268500020
J	Hoekert, M; Bais, L; Kahn, RS; Aleman, A				Hoekert, Marjolijn; Bais, Leonie; Kahn, Rene S.; Aleman, Andre			Time Course of the Involvement of the Right Anterior Superior Temporal Gyrus and the Right Fronto-Parietal Operculum in Emotional Prosody Perception	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; RIGHT-HEMISPHERE; ACOUSTIC PARAMETERS; NEURAL RESPONSES; AUDITORY-CORTEX; SPEECH; FMRI; LANGUAGE; REGIONS; INTONATION	In verbal communication, not only the meaning of the words convey information, but also the tone of voice (prosody) conveys crucial information about the emotional state and intentions of others. In various studies right frontal and right temporal regions have been found to play a role in emotional prosody perception. Here, we used triple-pulse repetitive transcranial magnetic stimulation (rTMS) to shed light on the precise time course of involvement of the right anterior superior temporal gyrus and the right fronto-parietal operculum. We hypothesized that information would be processed in the right anterior superior temporal gyrus before being processed in the right fronto-parietal operculum. Right-handed healthy subjects performed an emotional prosody task. During listening to each sentence a triplet of TMS pulses was applied to one of the regions at one of six time points (400-1900 ms). Results showed a significant main effect of Time for right anterior superior temporal gyrus and right fronto-parietal operculum. The largest interference was observed half-way through the sentence. This effect was stronger for withdrawal emotions than for the approach emotion. A further experiment with the inclusion of an active control condition, TMS over the EEG site POz (midline parietal-occipital junction), revealed stronger effects at the fronto-parietal operculum and anterior superior temporal gyrus relative to the active control condition. No evidence was found for sequential processing of emotional prosodic information from right anterior superior temporal gyrus to the right fronto-parietal operculum, but the results revealed more parallel processing. Our results suggest that both right fronto-parietal operculum and right anterior superior temporal gyrus are critical for emotional prosody perception at a relatively late time period after sentence onset. This may reflect that emotional cues can still be ambiguous at the beginning of sentences, but become more apparent half-way through the sentence.	[Hoekert, Marjolijn; Bais, Leonie; Aleman, Andre] Univ Groningen, BCN Neuroimaging Ctr, Groningen, Netherlands; [Kahn, Rene S.] Univ Med Ctr Utrecht, Dept Psychiat, Utrecht, Netherlands	University of Groningen; Utrecht University; Utrecht University Medical Center	Hoekert, M (corresponding author), Univ Groningen, BCN Neuroimaging Ctr, Groningen, Netherlands.	L.m.hoekert@med.umcg.nl	Aleman, Andre/E-1341-2012		Netherlands organization for Scientific Research [400 04333, 016.026.027]	Netherlands organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	M.H. was supported by a research grant from the Netherlands organization for Scientific Research (400 04333). A.A. was also supported by a grant from the Netherlands organization for Scientific Research (016.026.027). This organization did not have any influence on the design and the conduct of the study.	Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Adolphs R, 2002, EMOTION, V2, P23, DOI 10.1037/1528-3542.2.1.23; Anderson AK, 2000, CURR BIOL, V10, pR551, DOI 10.1016/S0960-9822(00)00612-6; Beaucousin V, 2007, CEREB CORTEX, V17, P339, DOI 10.1093/cercor/bhj151; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Bos EH, 2005, J AFFECT DISORDERS, V87, P221, DOI 10.1016/j.jad.2005.04.001; Buchanan TW, 2000, COGNITIVE BRAIN RES, V9, P227, DOI 10.1016/S0926-6410(99)00060-9; Callan DE, 2006, NEUROIMAGE, V31, P1327, DOI 10.1016/j.neuroimage.2006.01.036; Damasio A.R., 1994, DESCARTES ERROR EMOT; Damasio A. R., 1999, FEELING WHAT HAPPENS; Ethofer T, 2006, NEUROIMAGE, V30, P580, DOI 10.1016/j.neuroimage.2005.09.059; Ethofer T, 2006, NEUROREPORT, V17, P249, DOI 10.1097/01.wnr.0000199466.32036.5d; George MS, 1996, ARCH NEUROL-CHICAGO, V53, P665, DOI 10.1001/archneur.1996.00550070103017; GORELICK PB, 1987, J NEUROL NEUROSUR PS, V50, P553, DOI 10.1136/jnnp.50.5.553; HEILMAN KM, 1975, J NEUROL NEUROSUR PS, V38, P69, DOI 10.1136/jnnp.38.1.69; Hornak J, 2003, BRAIN, V126, P1691, DOI 10.1093/brain/awg168; JOHNSTONE T, 2006, SOCIAL COGNITIVE AFF; Kotz SA, 2003, BRAIN LANG, V86, P366, DOI 10.1016/S0093-934X(02)00532-1; Kriegstein KV, 2004, NEUROIMAGE, V22, P948, DOI 10.1016/j.neuroimage.2004.02.020; Meyer M, 2002, HUM BRAIN MAPP, V17, P73, DOI 10.1002/hbm.10042; Mitchell RLC, 2003, NEUROPSYCHOLOGIA, V41, P1410, DOI 10.1016/S0028-3932(03)00017-4; Mitchell RLC, 2005, BRAIN, V128, P963, DOI 10.1093/brain/awh466; Morris JS, 1999, NEUROPSYCHOLOGIA, V37, P1155, DOI 10.1016/S0028-3932(99)00015-9; Neggers SFW, 2004, NEUROIMAGE, V21, P1805, DOI 10.1016/j.neuroimage.2003.12.006; Paulmann S, 2008, NEUROREPORT, V19, P209, DOI 10.1097/WNR.0b013e3282f454db; Phillips ML, 1998, P ROY SOC B-BIOL SCI, V265, P1809, DOI 10.1098/rspb.1998.0506; Pourtois G, 2004, EUR J NEUROSCI, V20, P3507, DOI 10.1111/j.1460-9568.2004.03794.x; Pridmore S, 1998, J ECT, V14, P25; Roelfsema PR, 2002, J COGNITIVE NEUROSCI, V14, P525, DOI 10.1162/08989290260045756; Sack AT, 2005, SCIENCE, V308, P702, DOI 10.1126/science.1107784; Schirmer A, 2005, NEUROREPORT, V16, P635, DOI 10.1097/00001756-200504250-00024; Schirmer A, 2006, TRENDS COGN SCI, V10, P24, DOI 10.1016/j.tics.2005.11.009; Schneider W., 2002, E PRIME USERS GUIDE; Talairach J., 1988, COPLANAR STEREOTAXIC; TUCKER DM, 1977, NEUROLOGY, V27, P947, DOI 10.1212/WNL.27.10.947; van Rijn S, 2005, EUR J NEUROSCI, V21, P3195, DOI 10.1111/j.1460-9568.2005.04130.x; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Vingerhoets G, 2003, NEUROPSYCHOLOGY, V17, P93, DOI 10.1037/0894-4105.17.1.93; VROOMEN J, 1993, P 3 EUR C SPEECH COM, P577; Walsh V, 2003, BRADFORD BOOKS, P1; Walsh V, 2000, NAT REV NEUROSCI, V1, P73, DOI 10.1038/35036239; Wambacq IJA, 2004, NEUROREPORT, V15, P555, DOI 10.1097/00001756-200403010-00034; Warren JE, 2006, J NEUROSCI, V26, P13067, DOI 10.1523/JNEUROSCI.3907-06.2006; Wassermann EM, 1996, NEUROIMAGE, V3, P1, DOI 10.1006/nimg.1996.0001; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wiethoff S, 2008, NEUROIMAGE, V39, P885, DOI 10.1016/j.neuroimage.2007.09.028; Wildgruber D, 2005, NEUROIMAGE, V24, P1233, DOI 10.1016/j.neuroimage.2004.10.034; Wildgruber D, 2004, CEREB CORTEX, V14, P1384, DOI 10.1093/cercor/bhh099; Wildgruber D, 2002, NEUROIMAGE, V15, P856, DOI 10.1006/nimg.2001.0998	49	31	31	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2244	10.1371/journal.pone.0002244	http://dx.doi.org/10.1371/journal.pone.0002244			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	391UK	18493307	Green Published, Green Submitted, gold			2022-12-25	WOS:000262258700052
J	Pask, AJ; Behringer, RR; Renfree, MB				Pask, Andrew J.; Behringer, Richard R.; Renfree, Marilyn B.			Resurrection of DNA Function In Vivo from an Extinct Genome	PLOS ONE			English	Article								There is a burgeoning repository of information available from ancient DNA that can be used to understand how genomes have evolved and to determine the genetic features that defined a particular species. To assess the functional consequences of changes to a genome, a variety of methods are needed to examine extinct DNA function. We isolated a transcriptional enhancer element from the genome of an extinct marsupial, the Tasmanian tiger (Thylacinus cynocephalus or thylacine), obtained from 100 year-old ethanol-fixed tissues from museum collections. We then examined the function of the enhancer in vivo. Using a transgenic approach, it was possible to resurrect DNA function in transgenic mice. The results demonstrate that the thylacine Col2A1 enhancer directed chondrocyte-specific expression in this extinct mammalian species in the same way as its orthologue does in mice. While other studies have examined extinct coding DNA function in vitro, this is the first example of the restoration of extinct non-coding DNA and examination of its function in vivo. Our method using transgenesis can be used to explore the function of regulatory and protein-coding sequences obtained from any extinct species in an in vivo model system, providing important insights into gene evolution and diversity.	[Pask, Andrew J.; Behringer, Richard R.] Univ Texas MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA; [Pask, Andrew J.; Renfree, Marilyn B.] Univ Melbourne, Dept Zool, Melbourne, Vic, Australia	University of Texas System; UTMD Anderson Cancer Center; University of Melbourne	Pask, AJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA.	rrb@mdanderson.org		Renfree, Marilyn/0000-0002-4589-0436; Pask, Andrew/0000-0002-1900-2263	NSF [IBN 0220458]; Ben F. Love Endowment; NHMRC CJ Martin; RD Wright Research Fellowships; ARC Federation Fellowship; NIH [CA16672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Ben F. Love Endowment; NHMRC CJ Martin(National Health and Medical Research Council (NHMRC) of Australia); RD Wright Research Fellowships; ARC Federation Fellowship(Australian Research Council); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by NSF grant IBN 0220458 and the Ben F. Love Endowment to RRB, NHMRC CJ Martin and RD Wright Research Fellowships to AJP, and an ARC Federation Fellowship to MBR. DNA sequencing and veterinary animal care was supported by the NIH Cancer Center Support Grant CA16672.	Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; CARROLL SB, 1995, NATURE, V376, P479, DOI 10.1038/376479a0; Coyne JA, 2007, CURR BIOL, V17, pR1014, DOI 10.1016/j.cub.2007.10.009; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; Hilton-Taylor C., 2000, 2000 IUCN RED LIST T; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Lalueza-Fox C, 2007, SCIENCE, V318, P1453, DOI 10.1126/science.1147417; Lefebvre V, 1996, MOL CELL BIOL, V16, P4512; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Leung KKH, 1998, J CELL BIOL, V141, P1291, DOI 10.1083/jcb.141.6.1291; Luo ZX, 2003, SCIENCE, V302, P1934, DOI 10.1126/science.1090718; Nagy A., 2002, MANIPULATING MOUSE E; Novacek MJ, 2001, P NATL ACAD SCI USA, V98, P5466, DOI 10.1073/pnas.091093698; PAABO S, 1989, P NATL ACAD SCI USA, V86, P1939, DOI 10.1073/pnas.86.6.1939; Paddle R., 2000, LAST TASMANIAN TIGER; Prud'homme B, 2007, P NATL ACAD SCI USA, V104, P8605, DOI 10.1073/pnas.0700488104; Rompler H, 2006, SCIENCE, V313, P62, DOI 10.1126/science.1128994; Wible JR, 2007, NATURE, V447, P1003, DOI 10.1038/nature05854; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; YEE SP, 1993, GENE DEV, V7, P1277, DOI 10.1101/gad.7.7a.1277; ZHOU G, 1995, J CELL SCI, V108, P3677	24	17	18	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2240	10.1371/journal.pone.0002240	http://dx.doi.org/10.1371/journal.pone.0002240			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493600	gold, Green Published, Green Submitted			2022-12-25	WOS:000262258700048
J	Barthel, KKB; Liu, XD				Barthel, Kristen K. B.; Liu, Xuedong			A Transcriptional Enhancer from the Coding Region of ADAMTS5	PLOS ONE			English	Article								Background: The revelation that the human genome encodes only similar to 25,000 genes and thus cannot account for phenotypic complexity has been one of the biggest surprises in the post-genomic era. However, accumulating evidence suggests that transcriptional regulation may be in large part responsible for this observed mammalian complexity. Consequently, there has been a strong drive to locate cis-regulatory regions in mammalian genomes in order to understand the unifying principles governing these regions, including their genomic distribution. Although a number of systematic approaches have been developed, these all discount coding sequence. Methodology/Principal Findings: Using the computational tool PRI (Pattern-defined Regulatory Islands), which does not mask coding sequence, we identified a regulatory region associated with the gene ADAMTS5 that encompasses the entirety of the essential coding exon 2. We demonstrate through a combination of chromatin immunoprecipitation and reporter gene studies that this region can not only bind the myogenic transcription factors MYOD and myogenin and the E-protein HEB but can also function as a very strong myogenic transcriptional enhancer. Conclusions/Significance: Thus, we report the identification and detailed characterization of an exonic enhancer. Ultimately, this leads to the interesting question of why evolution would be so parsimonious in the functional assignment of sequence.	[Barthel, Kristen K. B.; Liu, Xuedong] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Barthel, KKB (corresponding author), Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA.	liux@colorado.edu		BJORKMAN, KRISTEN/0000-0002-9540-6657; LIU, XUEDONG/0000-0001-7209-4964	NIH [CA107098, T32GM08759]; NATIONAL CANCER INSTITUTE [R01CA107098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008759] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is support by a NIH grant CA107098 to XL and a NIH predoctoral training grant T32GM08759 to KKB.	BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; Bergstrom DA, 2002, MOL CELL, V9, P587, DOI 10.1016/S1097-2765(02)00481-1; Blanchette M, 2006, GENOME RES, V16, P656, DOI 10.1101/gr.4866006; Chen IHB, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-38; Cheung TH, 2007, P NATL ACAD SCI USA, V104, P10116, DOI 10.1073/pnas.0704028104; Chiquet M, 1998, EUR J BIOCHEM, V257, P362, DOI 10.1046/j.1432-1327.1998.2570362.x; DAHLMANWRIGHT K, 1990, J BIOL CHEM, V265, P14030; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Hill RE, 2003, J ANAT, V202, P13, DOI 10.1046/j.1469-7580.2003.00148.x; Hua XX, 1998, GENE DEV, V12, P3084, DOI 10.1101/gad.12.19.3084; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; MAJELLO B, 1990, EMBO J, V9, P457, DOI 10.1002/j.1460-2075.1990.tb08131.x; McLellan AS, 2006, AM J PHYSIOL-CELL PH, V291, pC300, DOI 10.1152/ajpcell.00345.2005; Neznanov N, 1997, J BIOL CHEM, V272, P27549, DOI 10.1074/jbc.272.44.27549; NICOLAIDES NC, 1991, MOL CELL BIOL, V11, P6166, DOI 10.1128/MCB.11.12.6166; Parker MH, 2006, MOL CELL BIOL, V26, P5771, DOI 10.1128/MCB.02404-05; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Sagai T, 2005, DEVELOPMENT, V132, P797, DOI 10.1242/dev.01613; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; WEINTRAUB H, 1990, P NATL ACAD SCI USA, V87, P5623, DOI 10.1073/pnas.87.15.5623	25	20	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2184	10.1371/journal.pone.0002184	http://dx.doi.org/10.1371/journal.pone.0002184			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478108	gold, Green Published, Green Submitted			2022-12-25	WOS:000262172800049
J	Heisel, SM; Ketter, R; Keller, A; Klein, V; Pallasch, CP; Lenhof, HP; Meese, E				Heisel, Sabrina M.; Ketter, Ralf; Keller, Andreas; Klein, Veronika; Pallasch, Christian P.; Lenhof, Hans-Peter; Meese, Eckart			Increased Seroreactivity to Glioma-Expressed Antigen 2 in Brain Tumor Patients under Radiation	PLOS ONE			English	Article								Background: Surgery and radiation are the mainstays of therapy for human gliomas that are the most common primary brain tumors. Most recently, cell culture and animal studies provided the first convincing evidence that radiation not only eliminates tumor cells, but also modulates the immune response and likely improves anti-tumor immunotherapy. Methology/Pricipal Findings: We present an in vivo study that analyzes the effects of radiation on the immune response in tumor patients. As readout system, we utilized the reactivity of glioma patients' sera against antigen GLEA2 as the most frequent antigen immunogenic in glioblastoma patients. We established an ELISA assay to analyze reactivity of 24 glioblastoma patients over a period of several months. As control we used 30 sera from healthy donors as well as 30 sera from lung cancer patients. We compared the course of GLEA2 seroreactivity at different times prior, during and after radiation. The GLEA2 seroreactivity was increased by the time of surgery, decreased after surgery, increased again under radiation, and slightly decreased after radiation. Conclusions/Significance: Our results provide in vivo evidence for an increased antibody response against tumor antigens under radiation. Antigens that become immunogenic with an increased antibody response as result of radiation can serve as ideal targets for immunotherapy of human tumors.	[Heisel, Sabrina M.; Klein, Veronika; Meese, Eckart] Univ Saarland, Sch Med, Dept Human Genet, D-6650 Homburg, Germany; [Ketter, Ralf] Saarland Univ, Med Sch, Neurosurg Clin, Homburg, Germany; [Keller, Andreas; Lenhof, Hans-Peter] Saarland Univ, Ctr Bioinformat, Saarbrucken, Germany; [Pallasch, Christian P.] Univ Cologne, Med Sch, Internal Med Clin I, Cologne, Germany	Saarland University; Universitatsklinikum des Saarlandes; Saarland University; University of Cologne	Heisel, SM (corresponding author), Univ Saarland, Sch Med, Dept Human Genet, D-6650 Homburg, Germany.	hgemee@uniklinik-saarland.de	Pallasch, Christian Philipp/T-3088-2018; Meese, Eckart Ulrich/ABD-1983-2021; Keller, Andreas/ABB-6412-2021	Keller, Andreas/0000-0002-5361-0895; Pallasch, Christian P./0000-0001-5675-6905	Forschungsforderungsprogramm HOMFOR	Forschungsforderungsprogramm HOMFOR	This study was funded by Forschungsforderungsprogramm HOMFOR 2007. The sponsors were not involved in the study design, in the collection, analysis and interpretation of data, and in the preparation, review, or approval of the manuscript.	Afra D, 2002, LANCET, V359, P1011; Behrends U, 2003, INT J CANCER, V106, P244, DOI 10.1002/ijc.11208; Burnet NG, 2006, CLIN ONCOL-UK, V18, P93, DOI 10.1016/j.clon.2005.08.017; Fischer U, 2001, CLIN EXP IMMUNOL, V126, P206, DOI 10.1046/j.1365-2249.2001.01635.x; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; OHGAKI HKP, 2005, ACTA NEUROPATHOL BER, V109, P479; Pallasch CP, 2005, INT J CANCER, V117, P456, DOI 10.1002/ijc.20929; Reits EA, 2006, J EXP MED, V203, P1259, DOI 10.1084/jem.20052494; Sahin U, 2000, CLIN CANCER RES, V6, P3916; SCHAICH KM, 1980, CRC CR REV FOOD SCI, V13, P89, DOI 10.1080/10408398009527286; Schmits R, 2002, INT J CANCER, V98, P73, DOI 10.1002/ijc.10170; Schneider JP, 2005, NEURORADIOLOGY, V47, P489, DOI 10.1007/s00234-005-1397-1; Smorodin E. P., 2007, Experimental Oncology, V29, P61; Struss AK, 2001, ONCOGENE, V20, P4107, DOI 10.1038/sj.onc.1204552; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Taniwaki M, 2006, INT J ONCOL, V29, P567	17	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2164	10.1371/journal.pone.0002164	http://dx.doi.org/10.1371/journal.pone.0002164			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478111	Green Submitted, gold, Green Published			2022-12-25	WOS:000262172800029
J	Winnen, B; Schlumberger, MC; Sturm, A; Schupbach, K; Siebenmann, S; Jenny, P; Hardt, WD				Winnen, Brit; Schlumberger, Markus C.; Sturm, Alexander; Schuepbach, Kaspar; Siebenmann, Stefan; Jenny, Patrick; Hardt, Wolf-Dietrich			Hierarchical Effector Protein Transport by the Salmonella Typhimurium SPI-1 Type III Secretion System	PLOS ONE			English	Article								Background: Type III secretion systems (TTSS) are employed by numerous pathogenic and symbiotic bacteria to inject a cocktail of different "effector proteins'' into host cells. These effectors subvert host cell signaling to establish symbiosis or disease. Methodology/Principal Findings: We have studied the injection of SipA and SptP, two effector proteins of the invasion-associated Salmonella type III secretion system (TTSS-1). SipA and SptP trigger different host cell responses. SipA contributes to triggering actin rearrangements and invasion while SptP reverses the actin rearrangements after the invasion has been completed. Nevertheless, SipA and SptP were both pre-formed and stored in the bacterial cytosol before host cell encounter. By time lapse microscopy, we observed that SipA was injected earlier than SptP. Computer modeling revealed that two assumptions were sufficient to explain this injection hierarchy: a large number of SipA and SptP molecules compete for transport via a limiting number of TTSS; and the TTSS recognize SipA more efficiently than SptP. Conclusions/Significance: This novel mechanism of hierarchical effector protein injection may serve to avoid functional interference between SipA and SptP. An injection hierarchy of this type may be of general importance, allowing bacteria to precisely time the host cell manipulation by type III effectors.	[Winnen, Brit; Schlumberger, Markus C.; Sturm, Alexander; Hardt, Wolf-Dietrich] ETH, Inst Mikrobiol, CH-8092 Zurich, Switzerland; [Schuepbach, Kaspar; Siebenmann, Stefan; Jenny, Patrick] Swiss Fed Inst Technol, Inst Fluid Dynam, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Winnen, B (corresponding author), ETH, Inst Mikrobiol, Schmelzbergstr 7, CH-8092 Zurich, Switzerland.	hardt@micro.biol.ethz.ch		Sturm, Alexander/0000-0002-3818-0428; Winnen, Brit/0000-0003-1958-335X; Hardt, Wolf-Dietrich/0000-0002-9892-6420	Boehringer Ingelheim Foundation; ETH research foundation [TH-10 06-1]	Boehringer Ingelheim Foundation(Boehringer Ingelheim); ETH research foundation	This work was funded by a scholarship from the Boehringer Ingelheim Foundation to BW and a grant from the ETH research foundation (TH-10 06-1) to WDH.	Bakshi CS, 2000, J BACTERIOL, V182, P2341, DOI 10.1128/JB.182.8.2341-2344.2000; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Ehrbar K, 2006, MOL MICROBIOL, V59, P248, DOI 10.1111/j.1365-2958.2005.04931.x; Ehrbar K, 2004, J BACTERIOL, V186, P1215, DOI 10.1128/JB.186.4.1215-1219.2004; Ellermeier JR, 2007, CURR OPIN MICROBIOL, V10, P24, DOI 10.1016/j.mib.2006.12.002; Enninga J, 2005, NAT METHODS, V2, P959, DOI 10.1038/NMETH804; Fraser GM, 2003, MOL MICROBIOL, V48, P1043, DOI 10.1046/j.1365-2958.2003.03487.x; Fu YX, 1999, NATURE, V401, P293, DOI 10.1038/45829; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Hapfelmeier S, 2005, TRENDS MICROBIOL, V13, P497, DOI 10.1016/j.tim.2005.08.008; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Higashide W, 2002, CELL MICROBIOL, V4, P357, DOI 10.1046/j.1462-5822.2002.00196.x; Jepson MA, 2001, CELL MICROBIOL, V3, P417, DOI 10.1046/j.1462-5822.2001.00124.x; KANIGA K, 1994, MOL MICROBIOL, V13, P555, DOI 10.1111/j.1365-2958.1994.tb00450.x; Kaniga K, 1996, MOL MICROBIOL, V21, P633, DOI 10.1111/j.1365-2958.1996.tb02571.x; Karlinsey JE, 2000, MOL MICROBIOL, V37, P1220, DOI 10.1046/j.1365-2958.2000.02081.x; Kubori T, 2003, CELL, V115, P333, DOI 10.1016/S0092-8674(03)00849-3; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; Lavander M, 2002, J BACTERIOL, V184, P4500, DOI 10.1128/JB.184.16.4500-4509.2002; LEE CA, 1990, P NATL ACAD SCI USA, V87, P4304, DOI 10.1073/pnas.87.11.4304; Lostroh CP, 2000, MOL MICROBIOL, V37, P300, DOI 10.1046/j.1365-2958.2000.01991.x; MACBETH KJ, 1993, INFECT IMMUN, V61, P1544, DOI 10.1128/IAI.61.4.1544-1546.1993; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; McGhie EJ, 2004, MOL CELL, V13, P497, DOI 10.1016/S1097-2765(04)00053-X; McGhie EJ, 2001, EMBO J, V20, P2131, DOI 10.1093/emboj/20.9.2131; MICHIELS T, 1990, INFECT IMMUN, V58, P2840, DOI 10.1128/IAI.58.9.2840-2849.1990; Minamino T, 2000, J BACTERIOL, V182, P4906, DOI 10.1128/JB.182.17.4906-4914.2000; Mirold S, 2001, J BACTERIOL, V183, P2348, DOI 10.1128/JB.183.7.2348-2358.2001; Rudolph MG, 1998, J BIOL CHEM, V273, P18067, DOI 10.1074/jbc.273.29.18067; Schlumberger MC, 2006, CURR OPIN MICROBIOL, V9, P46, DOI 10.1016/j.mib.2005.12.006; Schlumberger MC, 2005, P NATL ACAD SCI USA, V102, P12548, DOI 10.1073/pnas.0503407102; Sorg JA, 2006, P NATL ACAD SCI USA, V103, P16490, DOI 10.1073/pnas.0605974103; Stecher B, 2004, INFECT IMMUN, V72, P4138, DOI 10.1128/IAI.72.7.4138-4150.2004; Stender S, 2000, MOL MICROBIOL, V36, P1206, DOI 10.1046/j.1365-2958.2000.01933.x; STOCKER BAD, 1982, DEV BIOLOGICALS, V53, P47; Thomas NA, 2007, J BIOL CHEM, V282, P29634, DOI 10.1074/jbc.M706019200; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623; Zhou D, 1999, SCIENCE, V283, P2092, DOI 10.1126/science.283.5410.2092; Zhou DG, 2001, MOL MICROBIOL, V39, P248, DOI 10.1046/j.1365-2958.2001.02230.x; Zhou DG, 1999, P NATL ACAD SCI USA, V96, P10176, DOI 10.1073/pnas.96.18.10176	41	61	62	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2178	10.1371/journal.pone.0002178	http://dx.doi.org/10.1371/journal.pone.0002178			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478101	Green Published, gold, Green Submitted			2022-12-25	WOS:000262172800043
J	Hanashiro, K; Kanai, M; Geng, Y; Sicinski, P; Fukasawa, K				Hanashiro, K.; Kanai, M.; Geng, Y.; Sicinski, P.; Fukasawa, K.			Roles of cyclins A and E in induction of centrosome amplification in p53-compromised cells	ONCOGENE			English	Article						centrosome; cyclin A; cyclin E; CDK2; p53; centrosome amplification	CHROMOSOME INSTABILITY; E OVEREXPRESSION; DNA-SYNTHESIS; P53 MUTATION; CANCER; DUPLICATION; HYPERAMPLIFICATION; ACTIVATION; EXPRESSION; EXPOSURE	Abnormal amplification of centrosomes, which occurs frequently in cancers, leads to high frequencies of mitotic defect and chromosome segregation error, profoundly affecting the rate of tumor progression. Centrosome amplification results primarily from overduplication of centrosomes, and p53 is involved in the regulation of centrosome duplication partly through controlling the activity of cyclin-dependent kinase (CDK) 2-cyclin E, a kinase complex critical for the initiation of centrosome duplication. Thus, loss or mutational inactivation of p53 leads to an increased frequency of centrosome amplification. Moreover, the status of cyclin E greatly influences the frequency of centrosome amplification in cells lacking functional p53. Here, we dissected the roles of CDK2-associating cyclins, namely cyclins E and A, in centrosome amplification in the p53-negative cells. We found that loss of cyclin E was readily compensated by cyclin A for triggering the initiation of centrosome duplication, and thus the centrosome duplication kinetics was not significantly altered in cyclin E-deficient cells. It has been shown that cells lacking functional p53, when arrested in either early S-phase or late G(2) phase, continue to reduplicate centrosomes, resulting in centrosome amplification. In cells arrested in early S phase, cyclin E, but not cyclin A, is important in centrosome amplification, whereas in the absence of cyclin E, cyclin A is important for centrosome amplification. In late G(2)-arrested cells, cyclin A is important in centrosome amplification irrespective of the cyclin E status. These findings advance our understandings of the mechanisms underlying the numeral abnormality of centrosomes and consequential genomic instability associated with loss of p53 function and aberrant expression of cyclins E and A in cancer cells.	[Hanashiro, K.; Kanai, M.; Fukasawa, K.] H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, Tampa, FL 33612 USA; [Geng, Y.; Sicinski, P.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Geng, Y.; Sicinski, P.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	H Lee Moffitt Cancer Center & Research Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Fukasawa, K (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, 12902 Magnolia Dr,SRB-2, Tampa, FL 33612 USA.	kenji.fukasawa@mof.tt.org	Kanai, Motomu/J-6807-2016	Kanai, Motomu/0000-0003-1977-7648	National Institutes of Health, USA [CA90522, CA108950]; NATIONAL CANCER INSTITUTE [R01CA108950, R01CA090522] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank C French, A Wilson and M Crowe for technical assistance, and Drs Z Andrysik and S Schwemberger for FACS analysis. This research is supported by the grants from National Institutes of Health, USA (CA90522 to KF and CA108950 to PS).	BALCZON R, 1995, J CELL BIOL, V130, P105, DOI 10.1083/jcb.130.1.105; Bennett RA, 2004, ONCOGENE, V23, P6823, DOI 10.1038/sj.onc.1207561; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Carroll PE, 1999, ONCOGENE, V18, P1935, DOI 10.1038/sj.onc.1202515; Coverley D, 2002, NAT CELL BIOL, V4, P523, DOI 10.1038/ncb813; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; Desdouets C, 1995, Prog Cell Cycle Res, V1, P115; Dodson H, 2004, EMBO J, V23, P3864, DOI 10.1038/sj.emboj.7600393; Fukasawa K, 2005, CANCER LETT, V230, P6, DOI 10.1016/j.canlet.2004.12.028; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; Fukasawa K, 2007, NAT REV CANCER, V7, P911, DOI 10.1038/nrc2249; Geng Y, 2003, CELL, V114, P431, DOI 10.1016/S0092-8674(03)00645-7; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; HOFFMAN BD, 1991, CYTOMETRY, V12, P26, DOI 10.1002/cyto.990120105; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; JOSHI HC, 1994, CURR OPIN CELL BIOL, V6, P55, DOI 10.1016/0955-0674(94)90116-3; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kawamura K, 2006, CANCER SCI, V97, P252, DOI 10.1111/j.1349-7006.2006.00168.x; Kawamura K, 2004, CANCER RES, V64, P4800, DOI 10.1158/0008-5472.CAN-03-3908; Lacey KR, 1999, P NATL ACAD SCI USA, V96, P2817, DOI 10.1073/pnas.96.6.2817; Mussman JG, 2000, ONCOGENE, V19, P1635, DOI 10.1038/sj.onc.1203460; Ossovskaya VS, 1996, P NATL ACAD SCI USA, V93, P10309, DOI 10.1073/pnas.93.19.10309; Pihan GA, 1998, CANCER RES, V58, P3974; Sweeney C, 1996, DEVELOPMENT, V122, P53; Tarapore P, 2001, ONCOGENE, V20, P3173, DOI 10.1038/sj.onc.1204424; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Tokuyama Y, 2001, J BIOL CHEM, V276, P21529, DOI 10.1074/jbc.M100014200; Wang XJ, 1998, MOL CARCINOGEN, V23, P185, DOI 10.1002/(SICI)1098-2744(199811)23:3<185::AID-MC7>3.0.CO;2-5; Wong C, 2003, NAT CELL BIOL, V5, P539, DOI 10.1038/ncb993	29	32	33	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 11	2008	27	40					5288	5302		10.1038/onc.2008.161	http://dx.doi.org/10.1038/onc.2008.161			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	346UW	18490919	Green Accepted			2022-12-25	WOS:000259096100002
J	Petrie, K; Guidez, F; Zhu, J; Howell, L; Owen, G; Chew, YP; Parks, S; Waxman, S; Licht, J; Mittnacht, S; Zelent, A				Petrie, K.; Guidez, F.; Zhu, J.; Howell, L.; Owen, G.; Chew, Y. P.; Parks, S.; Waxman, S.; Licht, J.; Mittnacht, S.; Zelent, A.			Retinoblastoma protein and the leukemia-associated PLZF transcription factor interact to repress target gene promoters	ONCOGENE			English	Article						PLZF; Rb; E2F1	ACUTE PROMYELOCYTIC LEUKEMIA; ZINC-FINGER PROTEIN; PML-RAR-ALPHA; HISTONE DEACETYLASE; PROGENITOR CELLS; FUSION PROTEINS; SELF-RENEWAL; E2F FUNCTION; DNA-BINDING; STEM-CELLS	Translocations of the retinoic acid receptor-alpha (RAR alpha) locus with the promyelocytic leukemia zinc-finger (PLZF) or PML genes lead to expression of oncogenic PLZF RAR alpha or PML-RAR alpha fusion proteins, respectively. These fusion oncoproteins constitutively repress RAR alpha target genes, in large part through aberrant recruitment of multiprotein co-repressor complexes. PML and PML RAR alpha have previously been shown to associate with the retinoblastoma (Rb) tumour suppressor protein in its hypophosphorylated state. Here, we demonstrate that PLZF also interacts with Rb in vitro and in vivo. The interaction between PLZF and Rb is mediated through the Rb pocket and the region of PLZF that lies between its transcriptional repression (poxvirus and zinc-finger, POZ) and DNA-binding (zinc-finger) domains. In addition, Rb can simultaneously interact with PLZF and the E2F1 S phase-inducing transcription factor, suggesting that these proteins can exist in the same multiprotein complex. In contrast to the interaction of Rb with PML or E2F1, the PLZF-Rb interaction is not dependent on hypophosphorylation of Rb. These data are supported by chromatin immunoprecipitation analysis, which indicates that PLZF associates with the promoter region of CDC6, a known E2F/Rb target gene. Co-expression of PLZF and Rb results in enhancement of transcriptional repression of PLZF and E2F/Rb target genes, indicating functional co-operation between the two proteins. Both PLZF and Rb have been shown to function in stem cells and taken together these data suggest that interactions between PLZF and Rb could be important in stem cell biology.	[Petrie, K.; Howell, L.; Zelent, A.] Inst Canc Res, Sect Haemato Oncol, Sutton SM2 5NG, Surrey, England; [Guidez, F.; Parks, S.] Kings Coll London, Dept Med & Mol Genet, London WC2R 2LS, England; [Zhu, J.] Shanghai Med Univ 2, Ruijin Hosp, Shanghai Inst Hematol, Shanghai, Peoples R China; [Owen, G.] Catholic Univ Chile, Fac Biol Sci, Dept Physiol, Santiago, Chile; [Chew, Y. P.; Mittnacht, S.] Inst Canc Res, Canc Res UK Ctr Cell & Mol Biol, London, England; [Waxman, S.] Mt Sinai Sch Med, Div Hematol & Med Oncol, New York, NY 10029 USA; [Licht, J.] Northwestern Univ, Feinberg Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA	University of London; Institute of Cancer Research - UK; University of London; King's College London; Shanghai Jiao Tong University; Pontificia Universidad Catolica de Chile; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Icahn School of Medicine at Mount Sinai; Northwestern University; Feinberg School of Medicine	Zelent, A (corresponding author), Inst Canc Res, Sect Haemato Oncol, 15 Cotswold Rd, Sutton SM2 5NG, Surrey, England.	arthur.zelent@icr.ac.uk	Zelent, Arthur/B-3532-2009; Petrie, Kevin/I-7115-2015; Guidez, Fabien/P-4220-2019; Licht, Jonathan/L-4239-2019; Owen, Gareth Ivor/A-5100-2013; Licht, Jonathan/AAL-9184-2020; Guidez, Fabien/B-3750-2009	Petrie, Kevin/0000-0002-9805-9152; Guidez, Fabien/0000-0003-1380-4473; Licht, Jonathan/0000-0002-3942-1369; Zelent, Arthur/0000-0002-7968-9888	Leukaemia Research Fund of Great Britain; Samuel Waxman Cancer Research Foundation; Kay Kendall Leukaemia Fund; Cancer Research UK; National Institute of Health [CA59936]; NATIONAL CANCER INSTITUTE [R01CA059936] Funding Source: NIH RePORTER	Leukaemia Research Fund of Great Britain; Samuel Waxman Cancer Research Foundation; Kay Kendall Leukaemia Fund; Cancer Research UK(Cancer Research UK); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge support from the Leukaemia Research Fund of Great Britain (AZ and FG), the Samuel Waxman Cancer Research Foundation, the Kay Kendall Leukaemia Fund (KP), Cancer Research UK (SM) and the National Institute of Health (CA59936, AZ, JL and SW). We also thank Drs Angela Barrett and Manuel Boix-Chornet for critical reading of the article.	Alcalay M, 1998, MOL CELL BIOL, V18, P1084, DOI 10.1128/MCB.18.2.1084; Barna M, 2002, DEV CELL, V3, P499, DOI 10.1016/S1534-5807(02)00289-7; Barna M, 2000, NAT GENET, V25, P166, DOI 10.1038/76014; Bergh G, 1999, BLOOD, V94, P1971; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; CHEN Z, 1994, P NATL ACAD SCI USA, V91, P1178, DOI 10.1073/pnas.91.3.1178; Chew YP, 1998, ONCOGENE, V17, P2177, DOI 10.1038/sj.onc.1202443; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; CROOK T, 1991, ONCOGENE, V6, P873; Dai MS, 2002, J BIOL CHEM, V277, P26327, DOI 10.1074/jbc.M201834200; Dong S, 1996, P NATL ACAD SCI USA, V93, P3624, DOI 10.1073/pnas.93.8.3624; Felsani A, 2006, ONCOGENE, V25, P5277, DOI 10.1038/sj.onc.1209621; Galderisi U, 2006, ONCOGENE, V25, P5250, DOI 10.1038/sj.onc.1209736; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Giangrande PH, 2004, EMBO J, V23, P1336, DOI 10.1038/sj.emboj.7600134; Grignani F, 1998, NATURE, V391, P815, DOI 10.1038/35901; Guidez F, 2005, MOL CELL BIOL, V25, P5552, DOI 10.1128/MCB.25.13.5552-5566.2005; Guidez F, 1998, BLOOD, V91, P2634, DOI 10.1182/blood.V91.8.2634.2634_2634_2642; He LZ, 1998, NAT GENET, V18, P126, DOI 10.1038/ng0298-126; Hong SH, 1997, P NATL ACAD SCI USA, V94, P9028, DOI 10.1073/pnas.94.17.9028; Hsieh JK, 1997, GENE DEV, V11, P1840, DOI 10.1101/gad.11.14.1840; Ivins S, 2003, ONCOGENE, V22, P3685, DOI 10.1038/sj.onc.1206328; Kelly KF, 2006, TRENDS CELL BIOL, V16, P578, DOI 10.1016/j.tcb.2006.09.003; Khan MM, 2001, J BIOL CHEM, V276, P43491, DOI 10.1074/jbc.C100532200; Koken MHM, 1997, P NATL ACAD SCI USA, V94, P10255, DOI 10.1073/pnas.94.19.10255; Korenjak M, 2004, CELL, V119, P181, DOI 10.1016/j.cell.2004.09.034; Labbaye C, 1999, ONCOGENE, V18, P3529, DOI 10.1038/sj.onc.1202682; Licht JD, 1996, ONCOGENE, V12, P323; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; Macaluso M, 2006, ONCOGENE, V25, P5263, DOI 10.1038/sj.onc.1209680; McConnell MJ, 2003, MOL CELL BIOL, V23, P9375, DOI 10.1128/MCB.23.24.9375-9388.2003; Morris EJ, 2001, ADV CANCER RES, V82, P1, DOI 10.1016/S0065-230X(01)82001-7; MUDRYJ M, 1990, EMBO J, V9, P2179, DOI 10.1002/j.1460-2075.1990.tb07387.x; Petrie K, 2003, J BIOL CHEM, V278, P16059, DOI 10.1074/jbc.M212935200; Piazza F, 2004, MOL CELL BIOL, V24, P10456, DOI 10.1128/MCB.24.23.10456-10469.2004; REID A, 1995, BLOOD, V86, P4544, DOI 10.1182/blood.V86.12.4544.bloodjournal86124544; Schlisio S, 2002, EMBO J, V21, P5775, DOI 10.1093/emboj/cdf577; Shaknovich R, 1998, MOL CELL BIOL, V18, P5533, DOI 10.1128/MCB.18.9.5533; Sivertsen EA, 2006, BRIT J HAEMATOL, V135, P117, DOI 10.1111/j.1365-2141.2006.06252.x; Walkley CR, 2006, P NATL ACAD SCI USA, V103, P9057, DOI 10.1073/pnas.0603389103; Warrell RP, 1997, INT J CANCER, V70, P496, DOI 10.1002/(SICI)1097-0215(19970207)70:4<496::AID-IJC25>3.3.CO;2-P; Yan Z, 1998, P NATL ACAD SCI USA, V95, P3603, DOI 10.1073/pnas.95.7.3603; YAVUZER U, 1995, ONCOGENE, V10, P123; Yeyati PL, 1999, ONCOGENE, V18, P925, DOI 10.1038/sj.onc.1202375; Yoshimoto T, 2006, EXP CELL RES, V312, P2040, DOI 10.1016/j.yexcr.2006.03.001; Zarkowska T, 1997, J BIOL CHEM, V272, P12738, DOI 10.1074/jbc.272.19.12738; Zelent A, 2001, ONCOGENE, V20, P7186, DOI 10.1038/sj.onc.1204766	47	8	8	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	2008	27	39					5260	5266		10.1038/onc.2008.159	http://dx.doi.org/10.1038/onc.2008.159			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	344GO	18504436				2022-12-25	WOS:000258915100010
J	Bruss, MD; Richter, W; Horner, K; Jin, SLC; Conti, M				Bruss, Matthew D.; Richter, Wito; Horner, Kathleen; Jin, S-L Catherine; Conti, Marco			Critical role of PDE4D in beta(2)-adrenoceptor-dependent cAMP signaling in mouse embryonic fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; BETA-ADRENERGIC-RECEPTOR; CYCLIC-AMP; BETA(2)-ADRENERGIC RECEPTOR; CARDIAC MYOCYTES; CROSS-TALK; PHOSPHODIESTERASE; PHOSPHORYLATION; ADRENOCEPTOR; ACTIVATION	One of the defining properties of beta(2)-adrenergic receptor (beta(2)AR) signaling is the transient and rapidly reversed accumulation of cAMP. Here we have investigated the contribution of different PDE4 proteins to the generation of this transient response. To this aim, mouse embryonic fibroblasts deficient in PDE4A, PDE4B, or PDE4D were generated, and the regulation of PDE activity, the accumulation of cAMP, and CREB phosphorylation in response to isoproterenol were monitored. Ablation of PDE4D, but not PDE4A or PDE4B, had a major effect on the beta-agonist-induced PDE activation, with only a minimal increase in PDE activity being retained in PDE4D knock-out (KO) cells. Accumulation of cAMP was markedly enhanced, and the kinetics of cAMP accumulation were altered in their properties in PDE4DKO but not PDE4BKO cells. Modest effects were observed in PDE4AKO mouse embryonic fibroblasts. The return to basal levels of both cAMP accumulation and CREB phosphorylation was greatly delayed in the PDE4DKO cells, suggesting that PDE4D is critical for dissipation of the beta(2)AR stimulus. This effect of PDE4D ablation was in large part due to inactivation of a negative feedback mechanism consisting of the PKA-mediated activation of PDE4D in response to elevated cAMP levels, as indicated by experiments using the cAMP-dependent protein kinase inhibitors H89 and PKI. Finally, PDE4D ablation affected the kinetics of beta(2)AR desensitization as well as the interaction of the receptor with G alpha(i). These findings demonstrate that PDE4D plays a major role in shaping the beta(2)AR signal.	[Richter, Wito; Horner, Kathleen; Conti, Marco] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Bruss, Matthew D.; Jin, S-L Catherine] Stanford Univ, Sch Med, Div Reprod Biol, Dept Obstet & Gynecol, Stanford, CA 94305 USA	University of California System; University of California San Francisco; Stanford University	Conti, M (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, 513 Parnassus Ave,HSW 1656,Box 0556, San Francisco, CA 94143 USA.	contim@obgyn.ucsf.edu		Richter, Wito/0000-0001-5588-9060	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD020788] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092788] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL092788] Funding Source: Medline; NICHD NIH HHS [HD20788] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Baillie GS, 2003, P NATL ACAD SCI USA, V100, P940, DOI 10.1073/pnas.262787199; BENOVIC JL, 1985, J BIOL CHEM, V260, P7094; BRECHLER V, 1992, J BIOL CHEM, V267, P15496; Conner DA, 1997, CIRC RES, V81, P1021; CONTI M, 1995, ENDOCR REV, V16, P370, DOI 10.1210/er.16.3.370; Conti M, 2003, J BIOL CHEM, V278, P5493, DOI 10.1074/jbc.R200029200; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Devic E, 2001, MOL PHARMACOL, V60, P577; Dodge KL, 2001, EMBO J, V20, P1921, DOI 10.1093/emboj/20.8.1921; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; Fischmeister R, 2006, CIRC RES, V99, P816, DOI 10.1161/01.RES.0000246118.98832.04; HARPER JF, 1975, J CYCLIC NUCL PROT, V1, P207; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Jin S.L.C., 2006, CYCLIC NUCLEOTIDE PH, P323; Jin SLC, 1999, P NATL ACAD SCI USA, V96, P11998, DOI 10.1073/pnas.96.21.11998; Jin SLC, 2005, J IMMUNOL, V175, P1523, DOI 10.4049/jimmunol.175.3.1523; Jin SLC, 2002, P NATL ACAD SCI USA, V99, P7628, DOI 10.1073/pnas.122041599; Johnson M, 1998, AM J RESP CRIT CARE, V158, pS146, DOI 10.1164/ajrccm.158.supplement_2.13tac110; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lynch MJ, 2005, J BIOL CHEM, V280, P33178, DOI 10.1074/jbc.M414316200; Mehats C, 2003, FASEB J, V17, P1831, DOI 10.1096/fj.03-0274com; Mongillo M, 2006, BIOCHEM SOC T, V34, P510, DOI 10.1042/BST0340510; Oki N, 2000, J BIOL CHEM, V275, P10831, DOI 10.1074/jbc.275.15.10831; Park JY, 2003, MOL ENDOCRINOL, V17, P1117, DOI 10.1210/me.2002-0435; Parker D, 1996, MOL CELL BIOL, V16, P694; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; Rich TC, 2007, AM J PHYSIOL-CELL PH, V292, pC319, DOI 10.1152/ajpcell.00121.2006; Richter W, 2002, J BIOL CHEM, V277, P40212, DOI 10.1074/jbc.M203585200; Richter W, 2008, EMBO J, V27, P384, DOI 10.1038/sj.emboj.7601968; ROTH NS, 1991, P NATL ACAD SCI USA, V88, P6201, DOI 10.1073/pnas.88.14.6201; Sette C, 1996, J BIOL CHEM, V271, P16526, DOI 10.1074/jbc.271.28.16526; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Tasken KA, 2001, J BIOL CHEM, V276, P21999, DOI 10.1074/jbc.C000911200; THOMPSON WJ, 1971, BIOCHEMISTRY-US, V10, P311; Tran TM, 2004, MOL PHARMACOL, V65, P196, DOI 10.1124/mol.65.1.196; Tran TM, 2007, MOL PHARMACOL, V71, P47, DOI 10.1124/mol.106.028456; Willoughby D, 2007, J BIOL CHEM, V282, P34235, DOI 10.1074/jbc.M706765200; Xiang Y, 2005, P NATL ACAD SCI USA, V102, P909, DOI 10.1073/pnas.0405263102; Xiao R P, 2001, Sci STKE, V2001, pre15, DOI 10.1126/stke.2001.104.re15; Xiao RP, 2000, CIRC RES, V87, P635, DOI 10.1161/01.RES.87.8.635; Xin WK, 2008, J GEN PHYSIOL, V131, P349, DOI 10.1085/jgp.200709881; Zamah AM, 2002, J BIOL CHEM, V277, P31249, DOI 10.1074/jbc.M202753200	45	36	36	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22430	22442		10.1074/jbc.M803306200	http://dx.doi.org/10.1074/jbc.M803306200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18508768	Green Published, hybrid			2022-12-25	WOS:000258321000011
J	Cebotaru, L; Vij, N; Ciobanu, I; Wright, J; Flotte, T; Guggino, WB				Cebotaru, Liudmila; Vij, Neeraj; Ciobanu, Igor; Wright, Jerry; Flotte, Terence; Guggino, William B.			Cystic fibrosis transmembrane regulator missing the first four transmembrane segments increases wild type and Delta F508 processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; CONDUCTANCE REGULATOR; CFTR; PROTEIN; GENE; CHAPERONES; EXPRESSION; MUTATION; VECTOR	We previously generated an adenoassociated viral gene therapy vector, rAAV-Delta 264 cystic fibrosis transmembrane conductance regulator (CFTR), missing the first four transmembrane domains of CFTR. When infected into monkey lungs, Delta 264 CFTR increased the levels of endogenous wild type CFTR protein. To understand this process, we transfected Delta 264 CFTR plasmid cDNA into COS7 cells, and we noted that protein expression from the truncation mutant is barely detectable when compared with wild type or Delta F508 CFTR. Delta 264 CFTR protein expression increases dramatically when cells are treated with proteasome inhibitors. Cycloheximide experiments show that Delta 264 CFTR is degraded faster than Delta F508 CFTR. VCP and HDAC6, two proteins involved in retrograde translocation from endoplasmic reticulum to cytosol for proteasomal and aggresomal degradation, coimmunoprecipitate with Delta 264 CFTR. In cotransfection studies in COS7 cells and in transfection of Delta 264 CFTR into cells stably expressing wild type and Delta F508 CFTR, Delta 264 CFTR increases wild type CFTR protein and increases levels of maturation of immature band B to mature band C of Delta F508 CFTR. Thus the adenoassociated viral vector, rAAV-Delta 264 CFTR, is a highly promising cystic fibrosis gene therapy vector because it increases the amount of mature bandC protein both from wild type and Delta F508 CFTR and associates with key elements in quality control mechanism of CFTR.	[Cebotaru, Liudmila; Ciobanu, Igor; Wright, Jerry; Guggino, William B.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Cebotaru, Liudmila] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Vij, Neeraj] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Flotte, Terence] Univ Massachusetts, Sch Med, Worcester, MA 01605 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Massachusetts System; University of Massachusetts Worcester	Guggino, WB (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Wood Basic Sci Bldg 214A,725 N Wolfe St, Baltimore, MD 21205 USA.	wguggino@jhmi.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051811] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL51811-06] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alberti S, 2004, MOL BIOL CELL, V15, P4003, DOI 10.1091/mbc.E04-04-0293; Amaral MD, 2004, J MOL NEUROSCI, V23, P41, DOI 10.1385/JMN:23:1-2:041; Bebok Z, 2005, J PHYSIOL-LONDON, V569, P601, DOI 10.1113/jphysiol.2005.096669; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; Brooks DA, 1999, SEMIN CELL DEV BIOL, V10, P441, DOI 10.1006/scdb.1999.0314; CARROLL TP, 1995, J BIOL CHEM, V270, P11941, DOI 10.1074/jbc.270.20.11941; Cheng J, 2002, J BIOL CHEM, V277, P3520, DOI 10.1074/jbc.M110177200; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cormet-Boyaka E, 2004, P NATL ACAD SCI USA, V101, P8221, DOI 10.1073/pnas.0400459101; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Farinha Carlos M, 2004, J Cyst Fibros, V3 Suppl 2, P73, DOI 10.1016/j.jcf.2004.05.017; Fischer AC, 2007, MOL THER, V15, P756, DOI 10.1038/sj.mt.6300059; FULLER CM, 1992, AM J PHYSIOL, V263, pC267, DOI 10.1152/ajpcell.1992.263.2.C267; Gelman MS, 2002, J BIOL CHEM, V277, P11709, DOI 10.1074/jbc.M111958200; Goldstein RF, 2007, AM J RESP CELL MOL, V36, P706, DOI 10.1165/rcmb.2006-0365OC; Gruenert D C, 2004, J Cyst Fibros, V3 Suppl 2, P191, DOI 10.1016/j.jcf.2004.05.040; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Lu Y, 1998, J BIOL CHEM, V273, P568, DOI 10.1074/jbc.273.1.568; Mendoza JL, 2007, J BIOENERG BIOMEMBR, V39, P499, DOI 10.1007/s10863-007-9117-7; Moyer BD, 1998, J BIOL CHEM, V273, P21759, DOI 10.1074/jbc.273.34.21759; Mueller C, 2008, J GENE MED, V10, P51, DOI 10.1002/jgm.1119; Muller C, 2006, LAB INVEST, V86, P130, DOI 10.1038/labinvest.3700379; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Sirninger J, 2004, HUM GENE THER, V15, P832, DOI 10.1089/1043034041839262; Vij N, 2006, J BIOL CHEM, V281, P17369, DOI 10.1074/jbc.M600509200; YANG YP, 1993, P NATL ACAD SCI USA, V90, P9480, DOI 10.1073/pnas.90.20.9480; Zeitlin Pamela L, 2003, Expert Opin Emerg Drugs, V8, P523, DOI 10.1517/eoed.8.2.523.21136; ZEITLIN PL, 1991, AM J RESP CELL MOL, V4, P313, DOI 10.1165/ajrcmb/4.4.313	33	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					21926	21933		10.1074/jbc.M709156200	http://dx.doi.org/10.1074/jbc.M709156200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18508776	Green Published, hybrid			2022-12-25	WOS:000258114700012
J	Schroeder, CI; Ekberg, J; Nielsen, KJ; Adams, D; Loughnan, ML; Thomas, L; Adams, DJ; Alewood, PF; Lewis, RJ				Schroeder, Christina I.; Ekberg, Jenny; Nielsen, Katherine J.; Adams, Denise; Loughnan, Marion L.; Thomas, Linda; Adams, David J.; Alewood, Paul F.; Lewis, Richard J.			Neuronally selective mu-conotoxins from Conus striatus utilize an alpha-helical motif to target mammalian sodium channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-MECHANISMS; POTENT INHIBITOR; GIIIA; PEPTIDE; BLOCKER; NMR; PROTEINS; ANALOGS; TOXINS; PIIIA	mu-Conotoxins are small peptide inhibitors of muscle and neuronal tetrodotoxin (TTX)-sensitive voltage-gated sodium channels (VGSCs). Here we report the isolation of mu-conotoxins SIIIA and SIIIB by I-125-TIIIA-guided fractionation of milked Conus striatus venom. SIIIA and SIIIB potently displaced I-125-TIIIA from native rat brain Na(v)1.2 (IC50 values 10 and 5 nM, respectively) and muscle Na(v)1.4 (IC50 values 60 and 3 nM, respectively) VGSCs, and both inhibited current through Xenopus oocyte-expressed Na(v)1.2 and Na(v)1.4. An alanine scan of SIIIA-(2-20), a pyroglutamate-truncated analogue with enhanced neuronal activity, revealed residues important for affinity and selectivity. Alanine replacement of the solvent-exposed Trp-12, Arg-14, His-16, Arg-18 resulted in large reductions in SIIIA-(2-20) affinity, with His-16 replacement affecting structure. In contrast, [D15A]SIIIA-(2-20) had significantly enhanced neuronal affinity (IC50 0.65 nM), while the double mutant [D15A/H16R]SIIIA-(2-20) showed greatest Na(v)1.2 versus 1.4 selectivity (136-fold). H-1 NMR studies revealed that SIIIA adopted a single conformation in solution comprising a series of turns and an alpha-helical motif across residues 11-16 that is not found in larger mu-conotoxins. The structure of SIIIA provides a new structural template for the development of neuronally selective inhibitors of TTX-sensitive VGSCs based on the smaller mu-conotoxin pharmacophore.	[Schroeder, Christina I.; Adams, Denise; Loughnan, Marion L.; Thomas, Linda; Alewood, Paul F.; Lewis, Richard J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Ekberg, Jenny; Adams, David J.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Nielsen, Katherine J.] Xenome Ltd, Indooroopilly, Qld 4069, Australia	University of Queensland; University of Queensland	Lewis, RJ (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	r.lewis@imb.uq.edu.au	Loughnan, Marion/B-4508-2009; Schroeder, Cristina I./K-2042-2014; Lewis, Richard/T-8763-2019; Alewood, Paul F/J-2412-2014; Adams, David John/K-3578-2019; Lewis, Richard J/E-8674-2013; Ekberg, Jenny/AAV-2006-2020; Adams, David/J-9125-2014	Schroeder, Cristina I./0000-0002-6737-6374; Lewis, Richard/0000-0003-3470-923X; Adams, David John/0000-0002-7030-2288; Lewis, Richard J/0000-0003-3470-923X; Adams, David/0000-0002-7030-2288; Ekberg, Jenny/0000-0001-5151-4966; Alewood, Paul/0000-0001-7454-6522				BECKER S, 1992, BIOCHEMISTRY-US, V31, P8229, DOI 10.1021/bi00150a016; Boucher TJ, 2000, SCIENCE, V290, P124, DOI 10.1126/science.290.5489.124; Brunger AT, 1997, STRUCTURE, V5, P325, DOI 10.1016/S0969-2126(97)00190-1; Bulaj G, 2005, BIOCHEMISTRY-US, V44, P7259, DOI 10.1021/bi0473408; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Cestele S, 2000, BIOCHIMIE, V82, P883, DOI 10.1016/S0300-9084(00)01174-3; Chahine M, 1995, RECEPTOR CHANNEL, V3, P161; CHANG G, 1989, J AM CHEM SOC, V111, P4379, DOI 10.1021/ja00194a035; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; CRUZ LJ, 1985, J BIOL CHEM, V260, P9280; Daly NL, 2004, J BIOL CHEM, V279, P25774, DOI 10.1074/jbc.M313002200; Fertleman CR, 2006, NEURON, V52, P767, DOI 10.1016/j.neuron.2006.10.006; French RJ, 2004, CURR MED CHEM, V11, P3053, DOI 10.2174/0929867043363866; Goddard T.D., 2004, SPARKY 3; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hill JM, 1996, BIOCHEMISTRY-US, V35, P8824, DOI 10.1021/bi960073o; Kalso E, 2005, CURR PHARM DESIGN, V11, P3005, DOI 10.2174/1381612054865028; LANCELIN JM, 1991, BIOCHEMISTRY-US, V30, P6908, DOI 10.1021/bi00242a014; Lewis RJ, 2007, MOL PHARMACOL, V71, P676, DOI 10.1124/mol.106.028225; Luy Y.S., 2000, BRAIN RES, V871, P98; Moffatt F, 2000, J CHROMATOGR A, V891, P235, DOI 10.1016/S0021-9673(00)00620-8; Nakamura M, 2001, FEBS LETT, V503, P107, DOI 10.1016/S0014-5793(01)02714-4; Nassar MA, 2004, P NATL ACAD SCI USA, V101, P12706, DOI 10.1073/pnas.0404915101; Nielsen KJ, 1999, J MOL BIOL, V289, P1405, DOI 10.1006/jmbi.1999.2817; Nielsen KJ, 2002, J BIOL CHEM, V277, P27247, DOI 10.1074/jbc.M201611200; OTT KH, 1991, FEBS LETT, V278, P160, DOI 10.1016/0014-5793(91)80107-E; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Rosengren KJ, 2003, J BIOL CHEM, V278, P8606, DOI 10.1074/jbc.M211147200; Safo P, 2000, J NEUROSCI, V20, P76, DOI 10.1523/JNEUROSCI.20-01-00076.2000; SATO K, 1991, J BIOL CHEM, V266, P16989; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Shon KJ, 1998, J BIOL CHEM, V273, P33, DOI 10.1074/jbc.273.1.33; Shon KJ, 1998, J NEUROSCI, V18, P4473; WAKAMATSU K, 1992, BIOCHEMISTRY-US, V31, P12577, DOI 10.1021/bi00165a006; Wang CZ, 2006, TOXICON, V47, P122, DOI 10.1016/j.toxicon.2005.10.008; West PJ, 2002, BIOCHEMISTRY-US, V41, P15388, DOI 10.1021/bi0265628; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wood JN, 2004, J NEUROBIOL, V61, P55, DOI 10.1002/neu.20094; Zhang MM, 2007, J BIOL CHEM, V282, P30699, DOI 10.1074/jbc.M704616200; Zhang MM, 2006, BIOCHEMISTRY-US, V45, P3723, DOI 10.1021/bi052162j	41	38	41	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21621	21628		10.1074/jbc.M802852200	http://dx.doi.org/10.1074/jbc.M802852200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18522941	hybrid			2022-12-25	WOS:000257898800035
J	Chi, RJ; Simon, AR; Bienkiewicz, EA; Felix, A; Keller, TCS				Chi, Richard J.; Simon, Alanna R.; Bienkiewicz, Ewa A.; Felix, Augustine; Keller, Thomas C. S., III			Smooth muscle titin Zq domain interaction with the smooth muscle alpha-actinin central rod	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							Z-DISC; MOLECULAR-MECHANISMS; EXPRESSION; ISOFORM; BINDING; PROTEINS; IDENTIFICATION; CYTOSKELETON; PLASTICITY; NONMUSCLE	Actin-myosin II filament-based contractile structures in striated muscle, smooth muscle, and nonmuscle cells contain the actin filament-cross-linking protein alpha-actinin. In striated muscle Z-disks, alpha-actinin interacts with N-terminal domains of titin to provide a structural linkage crucial for the integrity of the sarcomere. We previously discovered a long titin isoform, originally smitin, hereafter sm-titin, in smooth muscle and demonstrated that native sm-titin interacts with C-terminal EF hand region and central rod R2-R3 spectrin-like repeat region sites in alpha-actinin. Reverse transcription-PCR analysis of RNA from human adult smooth muscles and cultured rat smooth muscle cells and Western blot analysis with a domain-specific antibody presented here revealed that sm-titin contains the titin gene-encoded Zq domain that may bind to the alpha-actinin R2-R3 central rod domain as well as Z-repeat domains that bind to the EF hand region. We investigated whether the sm-titin Zq domain binds to alpha-actinin R2 and R3 spectrin repeat-like domain loops that lie in proximity with two-fold symmetry on the surface of the central rod. Mutations in alpha-actinin R2 and R3 domain loop residues decreased interaction with expressed sm-titin Zq domain in glutathione S-transferase pull-down and solid phase binding assays. Alanine mutation of a region of the Zq domain with high propensity for alpha-helix formation decreased apparent Zq domain dimer formation and decreased Zq interaction with the alpha-actinin R2-R3 region in surface plasmon resonance assays. We present a model in which two sm-titin Zq domains interact with each other and with the two R2-R3 sites in the alpha-actinin central rod.	[Bienkiewicz, Ewa A.] Florida State Univ, Coll Med, BIO 303, Tallahassee, FL 32306 USA; [Chi, Richard J.; Simon, Alanna R.; Keller, Thomas C. S., III] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Felix, Augustine] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Bienkiewicz, EA (corresponding author), Florida State Univ, Coll Med, BIO 303, Tallahassee, FL 32306 USA.	tkeller@bio.fsu.edu		Bienkiewicz, Ewa (Ava)/0000-0002-5282-6360	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006158] Funding Source: NIH RePORTER; NIBIB NIH HHS [R01 EB 006158] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Atkinson RA, 2001, NAT STRUCT BIOL, V8, P853, DOI 10.1038/nsb1001-853; Atkinson RA, 2000, BIOCHEMISTRY-US, V39, P5255, DOI 10.1021/bi991891u; Ayoob JC, 2000, CELL MOTIL CYTOSKEL, V45, P67, DOI 10.1002/(SICI)1097-0169(200001)45:1<67::AID-CM7>3.3.CO;2-K; Bang ML, 2001, CIRC RES, V89, P1065, DOI 10.1161/hh2301.100981; Cavnar PJ, 2007, CELL MOTIL CYTOSKEL, V64, P418, DOI 10.1002/cm.20193; Chi RJ, 2005, INT J BIOCHEM CELL B, V37, P1470, DOI 10.1016/j.biocel.2005.02.014; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; Dixson JD, 2003, J MOL EVOL, V56, P1, DOI 10.1007/s00239-002-2374-5; EILERTSEN KJ, 1992, J CELL BIOL, V119, P549, DOI 10.1083/jcb.119.3.549; Faulkner G, 2001, IUBMB LIFE, V51, P275, DOI 10.1080/152165401317190761; FORD LE, 1994, CAN J PHYSIOL PHARM, V72, P1320, DOI 10.1139/y94-190; Gerthoffer WT, 2001, J APPL PHYSIOL, V91, P963, DOI 10.1152/jappl.2001.91.2.963; Granzier HL, 2005, ADV PROTEIN CHEM, V71, P89, DOI 10.1016/S0065-3233(04)71003-7; Gregorio CC, 1998, J CELL BIOL, V143, P1013, DOI 10.1083/jcb.143.4.1013; Halayko AJ, 2001, J APPL PHYSIOL, V90, P358, DOI 10.1152/jappl.2001.90.1.358; Herrera AM, 2005, J CELL SCI, V118, P2381, DOI 10.1242/jcs.02368; Joseph C, 2001, BIOCHEMISTRY-US, V40, P4957, DOI 10.1021/bi002739r; Keller TCS, 2000, ADV EXP MED BIOL, V481, P265; Kim K, 2002, J CELL BIOL, V156, P101, DOI 10.1083/jcb.200107037; Labeit S, 2006, J MOL BIOL, V362, P664, DOI 10.1016/j.jmb.2006.07.077; Lange S, 2005, SCIENCE, V308, P1599, DOI 10.1126/science.1110463; Lee EH, 2006, STRUCTURE, V14, P497, DOI 10.1016/j.str.2005.12.005; Linke WA, 2008, CARDIOVASC RES, V77, P637, DOI 10.1016/j.cardiores.2007.03.029; Liu J, 2004, J MOL BIOL, V338, P115, DOI 10.1016/j.jmb.2004.02.034; Nakamura A, 1998, MICROVASC RES, V55, P14, DOI 10.1006/mvre.1997.2050; Newby AC, 2000, J PATHOL, V190, P300, DOI 10.1002/(SICI)1096-9896(200002)190:3<300::AID-PATH596>3.0.CO;2-I; Orford JL, 2000, AM J CARDIOL, V86, p6H, DOI 10.1016/S0002-9149(00)01094-8; Salloum DS, 2005, BIOMACROMOLECULES, V6, P161, DOI 10.1021/bm0497015; Sanger JW, 2000, ADV EXP MED BIOL, V481, P89; Seow CY, 2000, J APPL PHYSIOL, V89, P2065, DOI 10.1152/jappl.2000.89.5.2065; Seow CY, 2000, J APPL PHYSIOL, V89, P869, DOI 10.1152/jappl.2000.89.3.869; Small JV, 1998, ACTA PHYSIOL SCAND, V164, P341; Sorimachi H, 1997, J MOL BIOL, V270, P688, DOI 10.1006/jmbi.1997.1145; Tskhovrebova L, 2005, NAT MED, V11, P478, DOI 10.1038/nm0505-478; Young P, 1998, EMBO J, V17, P1614, DOI 10.1093/emboj/17.6.1614; Young P, 2000, EMBO J, V19, P6331, DOI 10.1093/emboj/19.23.6331; ZANELLATO AMC, 1990, ARTERIOSCLEROSIS, V10, P996, DOI 10.1161/01.ATV.10.6.996	37	9	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20959	20967		10.1074/jbc.M709621200	http://dx.doi.org/10.1074/jbc.M709621200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18519573	Green Published, hybrid			2022-12-25	WOS:000257746100038
J	Jiang, W; Betson, M; Mulloy, R; Foster, R; Levay, M; Ligeti, E; Settleman, J				Jiang, Wei; Betson, Martha; Mulloy, Roseann; Foster, Rosemary; Levay, Magdolna; Ligeti, Erzsebet; Settleman, Jeffrey			p190A RhoGAP is a glycogen synthase kinase-3-beta substrate required for polarized cell migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATES CELL; DIRECTIONAL MIGRATION; MEMBRANE PROTRUSION; FAMILY GTPASES; RHOA ACTIVITY; BETA-CATENIN; LIPID RAFTS; C-SRC; P190RHOGAP; ADHESION	The Rho GTPases are critical regulators of the actin cytoskeleton and are required for cell adhesion, migration, and polarity. Among the key Rho regulatory proteins in the context of cell migration are the p190 RhoGAPs (p190A and p190B), which function to modulate Rho signaling in response to integrin engagement. The p190 RhoGAPs undergo complex regulation, including phosphorylation by several identified kinases, interactions with phospholipids, and association with a variety of cellular proteins. Here, we have identified an additional regulatory mechanism unique to p190A RhoGAP that involves priming-dependent phosphorylation by glycogen synthase-3-beta (GSK-3 beta), a kinase previously implicated in establishing cell polarity. We found that p190A-deficient fibroblasts exhibit a defect in directional cell migration reflecting a requirement for GSK-3 beta-mediated phosphorylation of amino acids in the C-terminal "tail" of p190A. This phosphorylation leads to inhibition of p190A RhoGAP activity in vitro and in vivo. These studies identify p190A as a novel GSK-3 beta substrate and reveal a mechanism by which GSK-3 beta contributes to cellular polarization in directionally migrating cells via effects on Rho GTPase activity.	[Jiang, Wei; Betson, Martha; Mulloy, Roseann; Settleman, Jeffrey] Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; [Jiang, Wei; Betson, Martha; Mulloy, Roseann; Foster, Rosemary; Settleman, Jeffrey] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Levay, Magdolna] Semmelweis Univ, Dept Physiol, H-1444 Budapest, Hungary	Harvard University; Massachusetts General Hospital; Harvard University; Semmelweis University	Settleman, J (corresponding author), Massachusetts Gen Hosp, Ctr Canc, 149 13th St, Charlestown, MA 02129 USA.	settleman@helix.mgh.harvard.edu	Betson, Martha/D-3818-2014	Betson, Martha/0000-0002-4220-3290	NCI NIH HHS [R01 CA 62142] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA062142] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; Arthur WT, 2000, CURR BIOL, V10, P719, DOI 10.1016/S0960-9822(00)00537-6; Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; Bradley WD, 2006, MOL BIOL CELL, V17, P4827, DOI 10.1091/mbc.E06-02-0132; Brouns MR, 2000, DEVELOPMENT, V127, P4891; Brouns MR, 2001, NAT CELL BIOL, V3, P361, DOI 10.1038/35070042; Burbelo PD, 1995, J BIOL CHEM, V270, P30919, DOI 10.1074/jbc.270.52.30919; Dumenil G, 2000, J CELL SCI, V113, P71; Etienne-Manneville S, 2003, CURR OPIN CELL BIOL, V15, P67, DOI 10.1016/S0955-0674(02)00005-4; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Foster R, 1996, MOL CELL BIOL, V16, P2689; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Grande-Garcia A, 2007, J CELL BIOL, V177, P683, DOI 10.1083/jcb.200701006; Harwood AJ, 2002, DEV CELL, V2, P384, DOI 10.1016/S1534-5807(02)00156-9; Haskell MD, 2001, J CELL SCI, V114, P1699; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kim JS, 2006, BLOOD, V108, P1821, DOI 10.1182/blood-2005-10-009191; Kim L, 2006, CURR DRUG TARGETS, V7, P1411, DOI 10.2174/1389450110607011411; Kulkarni SV, 2000, J CELL BIOL, V149, P457, DOI 10.1083/jcb.149.2.457; Kusama T, 2006, CANCER SCI, V97, P848, DOI 10.1111/j.1349-7006.2006.00242.x; Li R, 2005, CURR BIOL, V15, pR198, DOI 10.1016/j.cub.2005.03.008; Liang XQ, 2004, J NEUROSCI, V24, P7140, DOI 10.1523/JNEUROSCI.5319-03.2004; Ligeti E, 2006, METHOD ENZYMOL, V406, P104, DOI 10.1016/S0076-6879(06)06009-5; Mammoto A, 2007, J CELL SCI, V120, P456, DOI 10.1242/jcs.03353; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Peacock JG, 2007, MOL BIOL CELL, V18, P3860, DOI 10.1091/mbc.E07-01-0075; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Sastry SK, 2006, J BIOL CHEM, V281, P11627, DOI 10.1074/jbc.M600897200; Sordella R, 2002, DEV CELL, V2, P553, DOI 10.1016/S1534-5807(02)00162-4; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; Tatsis N, 1998, J BIOL CHEM, V273, P34631, DOI 10.1074/jbc.273.51.34631; Wickstrom SA, 2003, J BIOL CHEM, V278, P37895, DOI 10.1074/jbc.M303569200; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zhang HY, 2008, DEV CELL, V14, P216, DOI 10.1016/j.devcel.2007.11.020	36	32	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20978	20988		10.1074/jbc.M802588200	http://dx.doi.org/10.1074/jbc.M802588200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18502760	hybrid, Green Published			2022-12-25	WOS:000257746100040
J	Ponguta, LA; Gregory, CW; French, FS; Wilson, EM				Ponguta, Liliana A.; Gregory, Christopher W.; French, Frank S.; Wilson, Elizabeth M.			Site-specific androgen receptor serine phosphorylation linked to epidermal growth factor-dependent growth of castration-recurrent prostate cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING DOMAIN; GLUCOCORTICOID-RECEPTOR; PROTEIN-KINASE; TRANSCRIPTIONAL ACTIVATION; RESPONSE ELEMENTS; TYROSINE PHOSPHORYLATION; NUCLEAR RECEPTORS; REGULATED GENES; TERMINAL DOMAIN; KU AUTOANTIGEN	The androgen receptor (AR) is required for prostate cancer development and contributes to tumor progression after remission in response to androgen deprivation therapy. Epidermal growth factor (EGF) increases AR transcriptional activity at low levels of androgen in the CWR-R1 prostate cancer cell line derived from the castration-recurrent CWR22 prostate cancer xenograft. Here we report that knockdown of AR decreases EGF stimulation of prostate cancer cell growth and demonstrate a mechanistic link between EGF and AR signaling. The EGF-induced increase in AR transcriptional activity is dependent on phosphorylation at mitogen-activated protein kinase consensus site Ser-515 in the AR NH2-terminal region and at protein kinase C consensus site Ser-578 in the AR DNA binding domain. Phosphorylation at these sites alters the nuclear-cytoplasmic shuttling of AR and AR interaction with the Ku-70/80 regulatory subunits of DNA-dependent protein kinase. Abolishing AR Ser-578 phosphorylation by introducing an S578A mutation eliminates the AR transcriptional response to EGF and increases both AR binding of Ku-70/80 and nuclear retention of AR in association with hyperphosphorylation of AR Ser-515. The results support a model in which AR transcriptional activity increases castration-recurrent prostate cancer cell growth in response to EGF by site-specific serine phosphorylation that regulates nuclear- cytoplasmic shuttling through interactions with the Ku-70/80 regulatory complex.	[Ponguta, Liliana A.; Gregory, Christopher W.; French, Frank S.; Wilson, Elizabeth M.] Univ N Carolina, Labs Reprod Biol, Chapel Hill, NC 27599 USA; [Ponguta, Liliana A.; Gregory, Christopher W.; French, Frank S.; Wilson, Elizabeth M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Ponguta, Liliana A.; Gregory, Christopher W.; Wilson, Elizabeth M.] Univ N Carolina, Dept Pathol, Chapel Hill, NC 27599 USA; [French, Frank S.; Wilson, Elizabeth M.] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA; [Wilson, Elizabeth M.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Wilson, EM (corresponding author), Univ N Carolina, Labs Reprod Biol, CB7500, Chapel Hill, NC 27599 USA.	emw@med.unc.edu			NCI NIH HHS [P01 CA 77739, P01 CA077739] Funding Source: Medline; NICHD NIH HHS [R01 HD016910, HD 16910] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD016910, R01HD016910] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA077739] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abreu-Martin MT, 1999, MOL CELL BIOL, V19, P5143; Askew EB, 2007, J BIOL CHEM, V282, P25801, DOI 10.1074/jbc.M703268200; Bai S, 2008, MOL CELL BIOL, V28, P1947, DOI 10.1128/MCB.01672-07; Berrevoets CA, 1998, MOL ENDOCRINOL, V12, P1172, DOI 10.1210/me.12.8.1172; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; CARPENTER G, 1990, J BIOL CHEM, V265, P7709; Carrigan A, 2007, J BIOL CHEM, V282, P10963, DOI 10.1074/jbc.M602931200; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; CULIG Z, 1994, CANCER RES, V54, P5474; Dehm SM, 2006, J BIOL CHEM, V281, P27882, DOI 10.1074/jbc.M605002200; FREEDMAN LP, 1992, ENDOCR REV, V13, P129, DOI 10.1210/er.13.2.129; Furutani T, 2005, BIOSCI BIOTECH BIOCH, V69, P2236, DOI 10.1271/bbb.69.2236; Galigniana MD, 1999, J BIOL CHEM, V274, P16222, DOI 10.1074/jbc.274.23.16222; Giffin W, 1999, MOL CELL BIOL, V19, P4065; Giffin W, 1997, J BIOL CHEM, V272, P5647, DOI 10.1074/jbc.272.9.5647; Giffin W, 1996, NATURE, V380, P265, DOI 10.1038/380265a0; Gioeli D, 2006, MOL ENDOCRINOL, V20, P503, DOI 10.1210/me.2005-0351; Gioeli D, 2002, J BIOL CHEM, V277, P29304, DOI 10.1074/jbc.M204131200; Giwercman YL, 2000, HORM RES, V53, P83, DOI 10.1159/000023519; GLASS CK, 1994, ENDOCR REV, V15, P391, DOI 10.1210/er.15.3.391; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Gregory CW, 2005, CLIN CANCER RES, V11, P1704, DOI 10.1158/1078-0432.CCR-04-1158; Gregory CW, 2004, J BIOL CHEM, V279, P7119, DOI 10.1074/jbc.M307649200; Gregory CW, 1998, CANCER RES, V58, P5718; Gregory CW, 2001, CANCER RES, V61, P2892; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Hamy F, 2003, PROSTATE CANCER P D, V6, P27, DOI 10.1038/sj.pcan.4500603; He B, 2004, J BIOL CHEM, V279, P30643, DOI 10.1074/jbc.M403117200; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; He B, 2001, J BIOL CHEM, V276, P42293, DOI 10.1074/jbc.M107492200; Huang WB, 1999, J BIOL CHEM, V274, P25756, DOI 10.1074/jbc.274.36.25756; Ilagan R, 2005, MOL CANCER THER, V4, P1662, DOI 10.1158/1535-7163.MCT-05-0197; JENSTER G, 1995, J BIOL CHEM, V270, P7341, DOI 10.1074/jbc.270.13.7341; Kaarbo M, 2007, BIOESSAYS, V29, P1227, DOI 10.1002/bies.20676; KEMPPAINEN JA, 1992, J BIOL CHEM, V267, P968; Klokk TI, 2007, MOL CELL BIOL, V27, P1823, DOI 10.1128/MCB.01297-06; KUNKEL GR, 1989, NUCLEIC ACIDS RES, V17, P7371, DOI 10.1093/nar/17.18.7371; Li TH, 2007, NUCLEIC ACIDS RES, V35, P2767, DOI 10.1093/nar/gkm198; Lin HK, 2001, P NATL ACAD SCI USA, V98, P7200, DOI 10.1073/pnas.121173298; Linja MJ, 2001, CANCER RES, V61, P3550; LUBAHN DB, 1988, MOL ENDOCRINOL, V2, P1265, DOI 10.1210/mend-2-12-1265; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; MADER S, 1989, NATURE, V338, P271, DOI 10.1038/338271a0; Mahajan NP, 2007, P NATL ACAD SCI USA, V104, P8438, DOI 10.1073/pnas.0700420104; MARSCHKE KB, 1995, ENDOCRINE, V3, P819, DOI 10.1007/BF02935687; Mayeur GL, 2005, J BIOL CHEM, V280, P10827, DOI 10.1074/jbc.M413336200; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Mellinghoff IK, 2004, CANCER CELL, V6, P517, DOI 10.1016/j.ccr.2004.09.031; Mohler JL, 2004, CLIN CANCER RES, V10, P440, DOI 10.1158/1078-0432.CCR-1146-03; Myslinski E, 2001, NUCLEIC ACIDS RES, V29, P2502, DOI 10.1093/nar/29.12.2502; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; QUIGLEY CA, 1995, ENDOCR REV, V16, P271, DOI 10.1210/er.16.3.271; Sartorius CA, 2000, J MOL ENDOCRINOL, V24, P165, DOI 10.1677/jme.0.0240165; Schauwaers K, 2007, P NATL ACAD SCI USA, V104, P4961, DOI 10.1073/pnas.0610814104; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; SCHER HI, 1993, J CLIN ONCOL, V11, P1566, DOI 10.1200/JCO.1993.11.8.1566; Schoenmakers E, 1999, BIOCHEM J, V341, P515, DOI 10.1042/0264-6021:3410515; Shaffer PL, 2004, P NATL ACAD SCI USA, V101, P4758, DOI 10.1073/pnas.0401123101; Shank LC, 2008, J BIOL CHEM, V283, P10568, DOI 10.1074/jbc.M800810200; SHAW PE, 1989, CELL, V56, P563, DOI 10.1016/0092-8674(89)90579-5; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; Stavreva DA, 2004, MOL CELL BIOL, V24, P2682, DOI 10.1128/MCB.24.7.2682-2697.2004; Sun K, 2007, MOL ENDOCRINOL, V21, P1297, DOI 10.1210/me.2006-0300; Tan J, 1997, MOL ENDOCRINOL, V11, P450, DOI 10.1210/me.11.4.450; Taneja SS, 2005, J BIOL CHEM, V280, P40916, DOI 10.1074/jbc.M508442200; Titus MA, 2005, CLIN CANCER RES, V11, P4653, DOI 10.1158/1078-0432.CCR-05-0525; TUTEJA N, 1994, EMBO J, V13, P4991, DOI 10.1002/j.1460-2075.1994.tb06826.x; Ueda T, 2002, J BIOL CHEM, V277, P38087, DOI 10.1074/jbc.M203313200; UMESONO K, 1989, CELL, V57, P1139, DOI 10.1016/0092-8674(89)90051-2; WILSON EM, 1976, J BIOL CHEM, V251, P5620; Wong HY, 2004, BIOCHEM J, V383, P267, DOI 10.1042/BJ20040683; Xiao X, 1998, J VIROL, V72, P2224, DOI 10.1128/JVI.72.3.2224-2232.1998; Xin L, 2006, P NATL ACAD SCI USA, V103, P7789, DOI 10.1073/pnas.0602567103; Yang L, 2005, J BIOL CHEM, V280, P33558, DOI 10.1074/jbc.M504461200; Yeh SY, 1999, P NATL ACAD SCI USA, V96, P5458, DOI 10.1073/pnas.96.10.5458; Yuan X, 2006, AM J PATHOL, V169, P682, DOI 10.2353/ajpath.2006.051047; Zhang LQ, 2003, CANCER RES, V63, P4552; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P605, DOI 10.1210/me.9.5.605; ZHOU ZX, 1994, J BIOL CHEM, V269, P13115; ZILLIACUS J, 1994, P NATL ACAD SCI USA, V91, P4175, DOI 10.1073/pnas.91.10.4175; ZILLIACUS J, 1995, MOL ENDOCRINOL, V9, P389, DOI 10.1210/me.9.4.389	81	78	80	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20989	21001		10.1074/jbc.M802392200	http://dx.doi.org/10.1074/jbc.M802392200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18511414	hybrid, Green Published			2022-12-25	WOS:000257746100041
J	Rajala, A; Tanito, M; Le, YZ; Kahn, CR; Rajala, RVS				Rajala, Ammaji; Tanito, Masaki; Le, Yun Z.; Kahn, C. Ronald; Rajala, Raju V. S.			Loss of neuroprotective survival signal in mice lacking insulin receptor gene in rod photoreceptor cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT DAMAGE; PHOSPHOINOSITIDE 3-KINASE; BRAIN INSULIN; IN-VIVO; KNOCKOUT; PHOSPHORYLATION; DEATH; APOPTOSIS; RESISTANCE; MUSCLE	Insulin receptor (IR) signaling provides a trophic signal for transformed retinal neurons in culture, but the role of IR activity in vivo is unknown. We previously reported that light causes increased tyrosine phosphorylation of the IR in vivo, which leads to the downstream activation of the phosphoinositide 3-kinase and Akt pathway in rod photoreceptor cells. The functional role of IR in rod photoreceptor cells is not known. We observed that light stress induced tyrosine phosphorylation of the IR in rod photoreceptor cells, and we hypothesized that IR activation is neuroprotective. To determine whether IR has a neuroprotective role on rod photoreceptor cells, we used the Cre/ lox system to specifically inactivate the IR gene in rod photoreceptors. Rod-specific IR knock-out mice have reduced the phosphoinositide 3-kinase and Akt survival signal in rod photoreceptors. The resultant mice exhibited no detectable phenotype when they were raised in dim cyclic light. However, reduced IR expression in rod photoreceptors significantly decreased retinal function and caused the loss of photoreceptors in mice exposed to bright light stress. These results indicate that reduced expression of IR in rod photoreceptor cells increases their susceptibility to light-induced photoreceptor degeneration. These data suggest that the IR pathway is important for photoreceptor survival and that activation of the IR may be an essential element of photoreceptor neuroprotection.	[Rajala, Ammaji; Tanito, Masaki; Rajala, Raju V. S.] Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK 73104 USA; [Le, Yun Z.; Rajala, Raju V. S.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Rajala, Ammaji; Tanito, Masaki; Rajala, Raju V. S.] Univ Oklahoma, Hlth Sci Ctr, Dean A McGee Eye Inst, Oklahoma City, OK 73104 USA; [Tanito, Masaki] Shimane Univ, Fac Med, Dept Ophthalmol, Izumo, Shimane 6938501, Japan; [Le, Yun Z.] Univ Oklahoma, Hlth Sci Ctr, Dept Med & Endocrinol, Oklahoma City, OK 73104 USA; [Kahn, C. Ronald] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA; [Kahn, C. Ronald] Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Shimane University; University of Oklahoma System; University of Oklahoma Health Sciences Center; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School	Rajala, RVS (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, 608 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.	raju-rajala@ouhsc.edu	Kahn, Ronald/AAY-2435-2021	Kahn, Ronald/0000-0002-7583-9228	NCRR NIH HHS [P20-RR17703] Funding Source: Medline; NEI NIH HHS [EY016507, EY00871] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017703] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY016507, R01EY000871] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; Barber AJ, 2001, J BIOL CHEM, V276, P32814, DOI 10.1074/jbc.M104738200; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Danciger M, 2005, MOL VIS, V11, P374; DATTA K, 1995, MOL CELL BIOL, V15, P2304; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Farese RV, 2007, J CLIN INVEST, V117, P2289, DOI 10.1172/JCI31408; Frolich L, 1998, J NEURAL TRANSM, V105, P423, DOI 10.1007/s007020050068; Guerra C, 2001, J CLIN INVEST, V108, P1205, DOI 10.1172/JCI200113103; Hafezi F, 1997, EXP EYE RES, V64, P963, DOI 10.1006/exer.1997.0288; Hahn P, 2004, CELL DEATH DIFFER, V11, P1192, DOI 10.1038/sj.cdd.4401486; Hetman M, 2000, J NEUROSCI, V20, P2567; Joshi RL, 1996, EMBO J, V15, P1542, DOI 10.1002/j.1460-2075.1996.tb00498.x; KAPLAN DR, 1987, CELL, V50, P1021, DOI 10.1016/0092-8674(87)90168-1; Kitamura T, 2003, ANNU REV PHYSIOL, V65, P313, DOI 10.1146/annurev.physiol.65.092101.142540; Kondo T, 2003, J CLIN INVEST, V111, P1835, DOI 10.1172/JCI200317455; Kondo T, 2004, J BIOL CHEM, V279, P37997, DOI 10.1074/jbc.M401339200; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Krishnamoorthy RR, 1999, J BIOL CHEM, V274, P3734, DOI 10.1074/jbc.274.6.3734; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Lauro D, 1998, NAT GENET, V20, P294, DOI 10.1038/3112; LaVail M M, 1987, Prog Clin Biol Res, V247, P439; LAVAIL MM, 1987, INVEST OPHTH VIS SCI, V28, P1043; LAVAIL MM, 1987, CURR EYE RES, V6, P825, DOI 10.3109/02713688709034850; Lawlor MA, 2001, J CELL SCI, V114, P2903; Le YZ, 2006, MOL VIS, V12, P389; Li GY, 2007, J NEUROSCI, V27, P203, DOI 10.1523/JNEUROSCI.0445-06.2007; Luo J, 2005, MOL CELL BIOL, V25, P9491, DOI 10.1128/MCB.25.21.9491-9502.2005; Marti A, 1998, INVEST OPHTH VIS SCI, V39, P846; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Noell W K, 1966, Invest Ophthalmol, V5, P450; Organisciak DT, 1998, INVEST OPHTH VIS SCI, V39, P1107; Ouwens DM, 2001, BBA-MOL CELL RES, V1540, P97, DOI 10.1016/S0167-4889(01)00126-4; Rajala A, 2007, J BIOL CHEM, V282, P9865, DOI 10.1074/jbc.M608845200; Rajala RVS, 2004, BIOCHEMISTRY-US, V43, P5637, DOI 10.1021/bi035913v; Rajala RVS, 2002, J BIOL CHEM, V277, P43319, DOI 10.1074/jbc.M206355200; RAPP LM, 1992, INVEST OPHTH VIS SCI, V33, P3367; Reiter CEN, 2006, DIABETES, V55, P1148, DOI 10.2337/diabetes.55.04.06.db05-0744; Reme CE, 1998, PROG RETIN EYE RES, V17, P443, DOI 10.1016/S1350-9462(98)00009-3; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; RUDERMAN NB, 1990, P NATL ACAD SCI USA, V87, P1411, DOI 10.1073/pnas.87.4.1411; Schubert M, 2004, P NATL ACAD SCI USA, V101, P3100, DOI 10.1073/pnas.0308724101; Song JB, 2003, SCIENCE, V300, P502, DOI 10.1126/science.1081203; Takahashi M, 1996, NEUROSCI LETT, V204, P201, DOI 10.1016/0304-3940(96)12357-0; Tanito M, 2007, FREE RADICAL BIO MED, V42, P1838, DOI 10.1016/j.freeradbiomed.2007.03.018; Tanito M, 2007, INVEST OPHTH VIS SCI, V48, P1864, DOI 10.1167/iovs.06-1065; Wenzel A, 2003, INVEST OPHTH VIS SCI, V44, P2798, DOI 10.1167/iovs.02-1134; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; Wetzel RK, 1999, J NEUROSCI, V19, P9878; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Yi XJ, 2005, J NEUROSCI, V25, P1240, DOI 10.1523/JNEUROSCI.3664-04.2005; Yu XR, 2004, J BIOL CHEM, V279, P13086, DOI 10.1074/jbc.M313283200; Zheng LX, 2006, INVEST OPHTH VIS SCI, V47, P5583, DOI 10.1167/iovs.06-0163	58	71	71	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19781	19792		10.1074/jbc.M802374200	http://dx.doi.org/10.1074/jbc.M802374200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18480052	Green Published, hybrid			2022-12-25	WOS:000257387600062
J	Ratnaparkhi, A; Lawless, GM; Schweizer, FE; Golshani, P; Jackson, GR				Ratnaparkhi, Anuradha; Lawless, George M.; Schweizer, Felix E.; Golshani, Peyman; Jackson, George R.			A Drosophila Model of ALS: Human ALS-Associated Mutation in VAP33A Suggests a Dominant Negative Mechanism	PLOS ONE			English	Article								ALS8 is caused by a dominant mutation in an evolutionarily conserved protein, VAPB (vesicle-associated membrane protein (VAMP)-associated membrane protein B)/ALS8). We have established a fly model of ALS8 using the corresponding mutation in Drosophila VAPB (dVAP33A) and examined the effects of this mutation on VAP function using genetic and morphological analyses. By simultaneously assessing the effects of VAP(wt) and VAP(P58S) on synaptic morphology and structure, we demonstrate that the phenotypes produced by neuronal expression of VAP(P58S) resemble VAP loss of function mutants and are opposite those of VAP overexpression, suggesting that VAP(P58S) may function as a dominant negative. This is brought about by aggregation of VAP(P58S) and recruitment of wild type VAP into these aggregates. Importantly, we also demonstrate that the ALS8 mutation in dVAP33A interferes with BMP signaling pathways at the neuromuscular junction, identifying a new mechanism underlying pathogenesis of ALS8. Furthermore, we show that mutant dVAP33A can serve as a powerful tool to identify genetic modifiers of VAPB. This new fly model of ALS, with its robust pathological phenotypes, should for the first time allow the power of unbiased screens in Drosophila to be applied to study of motor neuron diseases.	[Ratnaparkhi, Anuradha; Lawless, George M.; Golshani, Peyman; Jackson, George R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Schweizer, Felix E.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA USA; [Jackson, George R.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Ctr Neurobehav Genet, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Ratnaparkhi, A (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA.	Grjackson@mednet.ucla.edu			NIH [NS046489]; American Health Assistance Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046489] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation(BrightFocus Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by NIH NS046489 and the American Health Assistance Foundation(G.R.J.).	Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Amarilio R, 2005, J BIOL CHEM, V280, P5934, DOI 10.1074/jbc.M409566200; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Cairns NJ, 2004, J PATHOL, V204, P438, DOI 10.1002/path.1650; Chai A, 2008, HUM MOL GENET, V17, P266, DOI 10.1093/hmg/ddm303; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; COLLARD JF, 1995, NATURE, V375, P61, DOI 10.1038/375061a0; Dudu V, 2006, CURR BIOL, V16, P625, DOI 10.1016/j.cub.2006.02.061; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Foster LJ, 2000, TRAFFIC, V1, P512, DOI 10.1034/j.1600-0854.2000.010609.x; Frey D, 2000, J NEUROSCI, V20, P2534; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Haerry TE, 1998, DEVELOPMENT, V125, P3977; Hoang B, 2001, DEV BIOL, V229, P55, DOI 10.1006/dbio.2000.9983; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Italiano JE, 2001, INT REV CYTOL, V202, P1, DOI 10.1016/S0074-7696(01)02002-2; Kagiwada S, 1998, J BACTERIOL, V180, P1700, DOI 10.1128/JB.180.7.1700-1708.1998; Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010; Kanekura K, 2006, J BIOL CHEM, V281, P30223, DOI 10.1074/jbc.M605049200; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Marques G, 2003, DEVELOPMENT, V130, P5457, DOI 10.1242/dev.00772; Marques VD, 2006, MUSCLE NERVE, V34, P731, DOI 10.1002/mus.20657; Massague J, 1996, CELL, V85, P947, DOI 10.1016/S0092-8674(00)81296-9; McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Nishimura Y, 1999, BIOCHEM BIOPH RES CO, V254, P21, DOI 10.1006/bbrc.1998.9876; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Pennetta G, 2002, NEURON, V35, P291, DOI 10.1016/S0896-6273(02)00769-9; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Ross CA, 2004, TRENDS CELL BIOL, V14, P703, DOI 10.1016/j.tcb.2004.10.006; Sang TK, 2007, J NEUROSCI, V27, P981, DOI 10.1523/JNEUROSCI.4810-06.2007; Sasaki S, 1996, NEUROLOGY, V47, P535, DOI 10.1212/WNL.47.2.535; Sherwood NT, 2004, PLOS BIOL, V2, P2094, DOI 10.1371/journal.pbio.0020429; Shimizu K, 1999, P NATL ACAD SCI USA, V96, P6791, DOI 10.1073/pnas.96.12.6791; SKEHEL PA, 1995, SCIENCE, V269, P1580, DOI 10.1126/science.7667638; Soto C, 2006, TRENDS BIOCHEM SCI, V31, P150, DOI 10.1016/j.tibs.2006.01.002; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Tesseur I, 2006, J CLIN INVEST, V116, P3060, DOI 10.1172/JCI27341; Teuling E, 2007, J NEUROSCI, V27, P9801, DOI 10.1523/JNEUROSCI.2661-07.2007; Tsuda H, 2005, CELL, V122, P633, DOI 10.1016/j.cell.2005.06.012; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Weir ML, 1998, BIOCHEM J, V333, P247, DOI 10.1042/bj3330247; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553	50	95	97	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2334	10.1371/journal.pone.0002334	http://dx.doi.org/10.1371/journal.pone.0002334			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523548	Green Published, Green Submitted, gold			2022-12-25	WOS:000262614300029
J	Schooling, CM; Wenjie, S; Ho, SY; Chan, WM; Tham, MK; Ho, KS; Leung, GM; Lam, TH				Schooling, C. Mary; Wenjie, Sun; Ho, Sai Yin; Chan, Wai Man; Tham, May Ked; Ho, Kin Sang; Leung, Gabriel M.; Lam, Tai Hing			Moderate Alcohol Use and Mortality from Ischaemic Heart Disease: A Prospective Study in Older Chinese People	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; MIDDLE-AGED MEN; HONG-KONG; COMPETING RISKS; BLOOD-PRESSURE; SOCIAL-STATUS; LUNG-CANCER; FOLLOW-UP; CONSUMPTION; METAANALYSIS	Background: Moderate alcohol use is generally associated with lower ischaemic heart disease (IHD) mortality but it is difficult to ascertain whether this is due to attributes of moderate alcohol users or the properties of alcohol itself. Evidence from populations with different patterns of alcohol use and IHD can provide crucial evidence. We assessed the association of moderate alcohol use with IHD mortality in older Chinese people from Hong Kong. Methodology: We used Cox regression to determine whether moderate alcohol use was associated with IHD mortality in a prospective, population-based cohort study of all 56167 attendees, aged 65 years or over, from July 1998 to December 2000 at all 18 Elderly Health Centers operated by the Department of Health in Hong Kong. Principal Findings: After a median follow-up of 4.2 years, there were 406 (188 in men, 218 in women) deaths from IHD in 54,090 subjects (96.3% successful follow-up). Moderate alcohol use in men was not associated with IHD mortality adjusted only for age [Hazard Ratio, HR 1.01 (95% CI 0.55 to 1.84) compared with never drinkers] or additionally adjusted for socioeconomic status and lifestyle. Almost all women were occasional drinkers and their current alcohol use was not significantly associated with IHD mortality [HR 0.88, (95% CI 0.51 to 1.53)]. Conclusions: Moderate alcohol use had no effect on IHD mortality in older Chinese men. Lack of replication of the usual protective effect of moderate alcohol use in a setting with a different pattern of alcohol use and IHD could be due to chance or could suggest that the protective effect of alcohol on IHD does not extend to all populations.	[Schooling, C. Mary; Wenjie, Sun; Ho, Sai Yin; Leung, Gabriel M.; Lam, Tai Hing] Univ Hong Kong, Sch Publ Hlth, Dept Community Med, Hong Kong, Hong Kong, Peoples R China; [Chan, Wai Man; Tham, May Ked; Ho, Kin Sang] Gov Hong Kong Special Adm Region, Dept Hlth, Hong Kong, Peoples R China	University of Hong Kong	Schooling, CM (corresponding author), Univ Hong Kong, Sch Publ Hlth, Dept Community Med, Hong Kong, Hong Kong, Peoples R China.	gmleung@hku.hk	Leung, Gabriel Matthew/C-4336-2009; Sun, Wenjie/I-7692-2013; Schooling, Catherine Mary/C-4386-2009; sun, wenjie/J-8928-2013; Lam, Tai Hing/C-4317-2009; Ho, Daniel Sai Yin/C-4307-2009	Lam, Tai Hing/0000-0002-2033-9971; Leung, Gabriel/0000-0002-2503-6283; Ho, Daniel Sai Yin/0000-0001-9485-0273; Schooling, Mary/0000-0001-9933-5887	Health Care & Promotion Fund Committee in Hong Kong [HSRC#S111016]	Health Care & Promotion Fund Committee in Hong Kong	This project was funded by the Health Care & Promotion Fund Committee in Hong Kong (Grant: HSRC#S111016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen PK, 2002, STAT METHODS MED RES, V11, P203, DOI 10.1191/0962280202sm281ra; Bagnardi V, 2001, ALCOHOL RES HEALTH, V25, P263; Bandera EV, 2001, CANCER EPIDEM BIOMAR, V10, P813; Bartley M, 1999, SOC SCI MED, V49, P831, DOI 10.1016/S0277-9536(99)00192-6; Barzi F, 2007, J EPIDEMIOL COMMUN H, V61, P115, DOI 10.1136/jech.2005.044842; Boffetta P, 2006, LANCET ONCOL, V7, P149, DOI 10.1016/S1470-2045(06)70577-0; Cochrane J, 2003, ALCOHOL ALCOHOLISM, V38, P537, DOI 10.1093/alcalc/agg111; Corrao G, 2000, ADDICTION, V95, P1505, DOI 10.1046/j.1360-0443.2000.951015056.x; Corrao G, 1999, ADDICTION, V94, P1551, DOI 10.1046/j.1360-0443.1999.9410155111.x; Deev A, 1998, ANN EPIDEMIOL, V8, P147, DOI 10.1016/S1047-2797(98)00004-0; Dickinson HO, 2006, J HYPERTENS, V24, P215, DOI 10.1097/01.hjh.0000199800.72563.26; Doll R, 2005, INT J EPIDEMIOL, V34, P199, DOI 10.1093/ije/dyh369; Fillmore KM, 2006, ADDICT RES THEORY, V14, P101, DOI 10.1080/16066350500497983; Fillmore KM, 1998, ADDICTION, V93, P183, DOI 10.1046/j.1360-0443.1998.9321834.x; Fuchs FD, 2004, AM J EPIDEMIOL, V160, P466, DOI 10.1093/aje/kwh229; Gronbaek M, 2003, J CARDIOVASC RISK, V10, P5, DOI 10.1097/00043798-200302000-00002; Gronbaek M, 2002, ANN NY ACAD SCI, V957, P16, DOI 10.1111/j.1749-6632.2002.tb02902.x; Hart CL, 1999, BMJ-BRIT MED J, V318, P1725, DOI 10.1136/bmj.318.7200.1725; Higuchi S, 2007, ADDICTION, V102, P1849, DOI 10.1111/j.1360-0443.2007.01902.x; Jackson R, 2005, LANCET, V366, P1911, DOI 10.1016/S0140-6736(05)67770-7; Janghorbani M, 2003, ADDICTION, V98, P215, DOI 10.1046/j.1360-0443.2003.00268.x; Jiang R, 2003, AM J EPIDEMIOL, V158, P760, DOI 10.1093/aje/kwg221; Korte JE, 2002, AM J EPIDEMIOL, V155, P496, DOI 10.1093/aje/155.6.496; Kunst AE, 1999, AM J PUBLIC HEALTH, V89, P47, DOI 10.2105/AJPH.89.1.47; Lam TH, 2001, BRIT MED J, V323, P361, DOI 10.1136/bmj.323.7309.361; Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; MARMOT MG, 1984, INT J EPIDEMIOL, V13, P160, DOI 10.1093/ije/13.2.160; McFadden CB, 2005, AM J HYPERTENS, V18, P276, DOI 10.1016/j.amjhyper.2004.07.020; Mortensen EL, 2006, SCAND J PSYCHOL, V47, P387, DOI 10.1111/j.1467-9450.2006.00520.x; Mukamal KJ, 2006, J AM GERIATR SOC, V54, P30, DOI 10.1111/j.1532-5415.2005.00561.x; Naimi TS, 2005, AM J PREV MED, V28, P369, DOI 10.1016/j.amepre.2005.01.011; Reynolds K, 2003, JAMA-J AM MED ASSOC, V289, P579, DOI 10.1001/jama.289.5.579; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Satagopan JM, 2004, BRIT J CANCER, V91, P1229, DOI 10.1038/sj.bjc.6602102; Schooling CM, 2006, ARCH INTERN MED, V166, P1498, DOI 10.1001/archinte.166.14.1498; Serdula MK, 2004, AM J PREV MED, V26, P294, DOI 10.1016/j.amepre.2003.12.017; Shaper AG, 2000, HEART, V83, P394, DOI 10.1136/heart.83.4.394; Strandberg AY, 2004, AM J CLIN NUTR, V80, P1366, DOI 10.1093/ajcn/80.5.1366; WONG SL, 1992, J EPIDEMIOL COMMUN H, V46, P148, DOI 10.1136/jech.46.2.148; Wray LA, 2005, J GERONTOL B-PSYCHOL, V60, P85; Xu WH, 2007, PREV MED, V45, P313, DOI 10.1016/j.ypmed.2007.05.015; Yoon YS, 2004, AM J CLIN NUTR, V80, P217; Yuan JM, 1997, BRIT MED J, V314, P18, DOI 10.1136/bmj.314.7073.18	44	25	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2370	10.1371/journal.pone.0002370	http://dx.doi.org/10.1371/journal.pone.0002370			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	396TO	18523644	Green Published, gold			2022-12-25	WOS:000262614300056
J	Buchinsky, FJ; Donfack, J; Derkay, CS; Choi, SS; Conley, SF; Myer, CM; McClay, JE; Campisi, P; Wiatrak, BJ; Sobol, SE; Schweinfurth, JM; Tsuji, DH; Hu, FZ; Rockette, HE; Ehrlich, GD; Post, JC				Buchinsky, Farrel J.; Donfack, Joseph; Derkay, Craig S.; Choi, Sukgi S.; Conley, Stephen F.; Myer, Charles M., III; McClay, John E.; Campisi, Paolo; Wiatrak, Brian J.; Sobol, Steven E.; Schweinfurth, John M.; Tsuji, Domingos H.; Hu, Fen Z.; Rockette, Howard E.; Ehrlich, Garth D.; Post, J. Christopher			Age of Child, More than HPV Type, Is Associated with Clinical Course in Recurrent Respiratory Papillomatosis	PLOS ONE			English	Article								Background: RRP is a devastating disease in which papillomas in the airway cause hoarseness and breathing difficulty. The disease is caused by human papillomavirus (HPV) 6 or 11 and is very variable. Patients undergo multiple surgeries to maintain a patent airway and in order to communicate vocally. Several small studies have been published in which most have noted that HPV 11 is associated with a more aggressive course. Methodology/Principal Findings: Papilloma biopsies were taken from patients undergoing surgical treatment of RRP and were subjected to HPV typing. 118 patients with juvenile-onset RRP with at least 1 year of clinical data and infected with a single HPV type were analyzed. HPV 11 was encountered in 40% of the patients. By our definition, most of the patients in the sample (81%) had run an aggressive course. The odds of a patient with HPV 11 running an aggressive course were 3.9 times higher than that of patients with HPV 6 (Fisher's exact p = 0.017). However, clinical course was more closely associated with age of the patient (at diagnosis and at the time of the current surgery) than with HPV type. Patients with HPV 11 were diagnosed at a younger age (2.4y) than were those with HPV 6 (3.4y) (p = 0.014). Both by multiple linear regression and by multiple logistic regression HPV type was only weakly associated with metrics of disease course when simultaneously accounting for age. Conclusions/Significance Abstract: The course of RRP is variable and a quarter of the variability can be accounted for by the age of the patient. HPV 11 is more closely associated with a younger age at diagnosis than it is associated with an aggressive clinical course. These data suggest that there are factors other than HPV type and age of the patient that determine disease course.	[Buchinsky, Farrel J.; Donfack, Joseph; Hu, Fen Z.; Ehrlich, Garth D.; Post, J. Christopher] Allegheny Gen Hosp, Allegheny Singer Res Inst, Ctr Genom Sci, Pittsburgh, PA 15212 USA; [Derkay, Craig S.] E Virginia Med Sch, Norfolk, VA USA; [Choi, Sukgi S.] Childrens Natl Med Ctr, Washington, DC USA; [Conley, Stephen F.] Childrens Hosp Wisconsin, Milwaukee, WI USA; [Myer, Charles M., III] Cincinnati Childrens Hosp, Med Ctr, Cincinnati, OH USA; [McClay, John E.] Childrens Med Ctr Dallas, Dallas, TX USA; [Campisi, Paolo] Hosp Sick Children, Toronto, ON, Canada; [Hu, Fen Z.; Ehrlich, Garth D.; Post, J. Christopher] Drexel Univ, Coll Med, Dept Human Genet, Microbiol & Immunol, Pittsburgh, PA USA; [Wiatrak, Brian J.] Childrens Hosp Alabama, Birmingham, AL USA; [Sobol, Steven E.] Emory Univ, Sch Med, Atlanta, GA USA; [Schweinfurth, John M.] Univ Mississippi, Med Ctr, Jackson, MS USA; [Tsuji, Domingos H.] Univ Sao Paulo, Med Sch, Hosp Clin, Sao Paulo, Brazil; [Rockette, Howard E.] Univ Pittsburgh, Biostat Dept, Pittsburgh, PA USA	Allegheny General Hospital; Eastern Virginia Medical School; Children's National Health System; Children's Hospital of Wisconsin; Cincinnati Children's Hospital Medical Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Drexel University; Emory University; University of Mississippi; University of Mississippi Medical Center; Universidade de Sao Paulo; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Buchinsky, FJ (corresponding author), Allegheny Gen Hosp, Allegheny Singer Res Inst, Ctr Genom Sci, Pittsburgh, PA 15212 USA.	fjbuch@gmail.com	Buchinsky, Farrel/AAC-2080-2020; Choi, Sukgi/AAF-6482-2019	Buchinsky, Farrel/0000-0002-2830-6023; Choi, Sukgi/0000-0002-5448-1546; Ehrlich, Garth/0000-0003-1140-6594; Tsuji, Domingos/0000-0002-8219-7550	National Institute on Deafness and Other Communication Disorders [K08DC005819, R01DC008841]; American Laryngological, Rhinological and Otological Society; Inc-Triological Society Research Career Development Award; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K08DC005819, R01DC008841] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); American Laryngological, Rhinological and Otological Society; Inc-Triological Society Research Career Development Award; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The National Institute on Deafness and Other Communication Disorders-K08DC005819, R01DC008841. The American Laryngological, Rhinological and Otological Society, Inc-Triological Society Research Career Development Award.	Armstrong LR, 1999, ARCH OTOLARYNGOL, V125, P743, DOI 10.1001/archotol.125.7.743; Buchinsky FJ, 2004, LARYNGOSCOPE, V114, P349, DOI 10.1097/00005537-200402000-00032; DERKAY CS, 1995, ARCH OTOLARYNGOL, V121, P1386; Donfack J, 2006, INT J PEDIATR OTORHI, V70, P1235, DOI 10.1016/j.ijporl.2006.01.001; DOYLE DJ, 1994, LARYNGOSCOPE, V104, P523, DOI 10.1002/lary.5541040503; Draganov P, 2006, INT J PEDIATR OTORHI, V70, P469, DOI 10.1016/j.ijporl.2005.07.018; Gabbott M, 1997, J CLIN MICROBIOL, V35, P3098, DOI 10.1128/JCM.35.12.3098-3103.1997; Gerein V, 2005, ANN OTO RHINOL LARYN, V114, P463, DOI 10.1177/000348940511400608; GISSMANN L, 1982, J VIROL, V44, P393, DOI 10.1128/JVI.44.1.393-400.1982; GOMEZ MA, 1995, MEDICINA-BUENOS AIRE, V55, P213; HARTLEY C, 1994, J LARYNGOL OTOL, V108, P226, DOI 10.1017/S0022215100126350; KASHIMA HK, 1991, OTOLARYNG HEAD NECK, V104, P191, DOI 10.1177/019459989110400206; Maloney EM, 2006, ARCH OTOLARYNGOL, V132, P711, DOI 10.1001/archotol.132.7.711; MOUNTS P, 1984, LARYNGOSCOPE, V94, P28, DOI 10.1002/lary.5540940106; MYER CM, 1994, ANN OTO RHINOL LARYN, V103, P319, DOI 10.1177/000348949410300410; PADAYACHEE A, 1993, INT J PEDIATR OTORHI, V26, P141, DOI 10.1016/0165-5876(93)90019-Y; Penaloza-Plascencia M, 2000, ARCH OTOLARYNGOL, V126, P1119, DOI 10.1001/archotol.126.9.1119; POU AM, 1995, ANN OTO RHINOL LARYN, V104, P758, DOI 10.1177/000348949510401002; Pou AM, 2004, ANN OTO RHINOL LARYN, V113, P180, DOI 10.1177/000348940411300302; Rabah R, 2001, PEDIATR DEVEL PATHOL, V4, P68, DOI 10.1007/s100240010105; Reeves WC, 2003, ARCH OTOLARYNGOL, V129, P976, DOI 10.1001/archotol.129.9.976; Reidy PM, 2004, LARYNGOSCOPE, V114, P1906, DOI 10.1097/01.mlg.0000147918.81733.49; RESNICK RM, 1990, JNCI-J NATL CANCER I, V82, P1477, DOI 10.1093/jnci/82.18.1477; Rimell FL, 1997, LARYNGOSCOPE, V107, P915, DOI 10.1097/00005537-199707000-00015; Schraff S, 2004, ARCH OTOLARYNGOL, V130, P1039, DOI 10.1001/archotol.130.9.1039; Sherwood ML, 2006, OTOLARYNG HEAD NECK, V135, P189, DOI 10.1016/j.otohns.2006.03.028; Silverberg MJ, 2004, ARCH OTOLARYNGOL, V130, P711, DOI 10.1001/archotol.130.6.711; Szeps M, 2005, J GEN VIROL, V86, P1695, DOI 10.1099/vir.0.80849-0; Wiatrak BJ, 2004, LARYNGOSCOPE, V114, P1, DOI 10.1097/01.mlg.000148224.83491.0f	29	52	55	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2263	10.1371/journal.pone.0002263	http://dx.doi.org/10.1371/journal.pone.0002263			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509465	Green Published, Green Accepted, gold			2022-12-25	WOS:000262268500011
J	Ying, E; Li, D; Guo, S; Dong, S; Wang, J				Ying, Erbo; Li, Dan; Guo, Shaojun; Dong, Shaojun; Wang, Jin			Synthesis and Bio-Imaging Application of Highly Luminescent Mercaptosuccinic Acid-Coated CdTe Nanocrystals	PLOS ONE			English	Article							HIGH-QUALITY CDTE; ONE-POT SYNTHESIS; STABILIZED CDSE; PHOTOLUMINESCENCE; ENHANCEMENT	Here we present a facile one-pot method to prepare high-quality CdTe nanocrystals in aqueous phase. In contrast to the use of oxygen-sensitive NaHTe or H2Te as Te source in the current synthetic methods, we employ more stable sodium tellurite as the Te source for preparing highly luminescent CdTe nanocrystals in aqueous solution. By selecting mercaptosuccinic acid (MSA) as capping agent and providing the borate-citrate acid buffering solution, CdTe nanocrystals with high quantum yield (QY > 70% at pH range 5.0-8.0) can be conveniently prepared by this method. The influence of parameters such as the pH value of the precursor solution and the molar ratio of Cd2+ to Na2TeO3 on the QY of CdTe nanocrystals was systematically investigated in our experiments. Under optimal conditions, the QY of CdTe nanocrystals is even high up to 83%. The biological application of luminescent MSA-CdTe to HEK 293 cell imaging was also illustrated.	[Ying, Erbo; Li, Dan; Guo, Shaojun; Dong, Shaojun] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Elect Chem, Changchun 130022, Jilin, Peoples R China; [Wang, Jin] SUNY Stony Brook, Dept Chem, Stony Brook, NY USA	Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Ying, E (corresponding author), Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Elect Chem, Changchun 130022, Jilin, Peoples R China.	dongsj@ciac.jl.cn; jin.wang.1@stonybrook.edu	李, 丹/O-1545-2017; Guo, Shaojun/A-8449-2011	李, 丹/0000-0001-5904-871X; Guo, Shaojun/0000-0002-5941-414X	National Natural Science Foundation of China [20575064, 20475076]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (No. 20575064, 20475076).	Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933; Bao HB, 2004, CHEM MATER, V16, P3853, DOI 10.1021/cm049172b; Bao HF, 2006, SMALL, V2, P476, DOI 10.1002/smll.200500346; Barnham K, 2000, APPL PHYS LETT, V76, P1197, DOI 10.1063/1.125981; BOWENKATARI JE, 1994, J PHYS CHEM-US, V98, P4109, DOI DOI 10.1021/J100066A034); Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; Byrne SJ, 2006, J MATER CHEM, V16, P2896, DOI 10.1039/b605333e; Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; Coe S, 2002, NATURE, V420, P800, DOI 10.1038/nature01217; DEMAS JN, 1971, J PHYS CHEM-US, V75, P991, DOI 10.1021/j100678a001; Gao MY, 1998, J PHYS CHEM B, V102, P8360, DOI 10.1021/jp9823603; Gaponik N, 2002, J PHYS CHEM B, V106, P7177, DOI 10.1021/jp025541k; Gerion D, 2002, J AM CHEM SOC, V124, P7070, DOI 10.1021/ja017822w; Gong YJ, 2005, CHEM MATER, V17, P2648, DOI 10.1021/cm047932c; Guo J, 2005, J PHYS CHEM B, V109, P17467, DOI 10.1021/jp044770z; He Y, 2007, CHEM MATER, V19, P359, DOI 10.1021/cm061863f; Ho YP, 2005, NANO LETT, V5, P1693, DOI 10.1021/nl050888v; JAILSWAIL JK, 2003, NAT BIOTECHNOL, V21, P47; Jiang W, 2006, CHEM MATER, V18, P872, DOI 10.1021/cm051393+; Li CL, 2005, CHEM LETT, V34, P92, DOI 10.1246/cl.2005.92; Li L, 2006, J LUMIN, V116, P59, DOI 10.1016/j.jlumin.2005.03.001; Li L, 2005, CHEM COMMUN, P528, DOI 10.1039/b412686f; MURRAY CB, 1993, J AM CHEM SOC, V115, P8706, DOI 10.1021/ja00072a025; Nirmal M, 1999, ACCOUNTS CHEM RES, V32, P407, DOI 10.1021/ar9700320; Peng ZA, 2001, J AM CHEM SOC, V123, P183, DOI 10.1021/ja003633m; Qian HF, 2006, SMALL, V2, P747, DOI 10.1002/smll.200500530; Qu LH, 2002, J AM CHEM SOC, V124, P2049, DOI 10.1021/ja017002j; Rogach AL, 1996, BER BUNSEN PHYS CHEM, V100, P1772, DOI 10.1002/bbpc.19961001104; Rogach AL, 1999, J PHYS CHEM B, V103, P3065, DOI 10.1021/jp984833b; Schrock E, 1996, SCIENCE, V273, P494, DOI 10.1126/science.273.5274.494; Shavel A, 2006, J PHYS CHEM B, V110, P19280, DOI 10.1021/jp063351u; Stephens DJ, 2003, SCIENCE, V300, P82, DOI 10.1126/science.1082160; SWAYAMBUNATHAN V, 1990, J AM CHEM SOC, V112, P3831, DOI 10.1021/ja00166a017; Talapin DV, 2002, COLLOID SURFACE A, V202, P145, DOI 10.1016/S0927-7757(01)01078-0; VOSSMEYER T, 1994, J PHYS CHEM-US, V98, P7665, DOI 10.1021/j100082a044; Wang CL, 2007, J PHYS CHEM C, V111, P2465, DOI 10.1021/jp066601f; Wang Y, 2004, J PHYS CHEM B, V108, P15461, DOI 10.1021/jp048948t; Weijer CJ, 2003, SCIENCE, V300, P96, DOI 10.1126/science.1082830; Wu XY, 2003, NAT BIOTECHNOL, V21, P41, DOI 10.1038/nbt764; Wuister SF, 2003, NANO LETT, V3, P503, DOI 10.1021/nl034054t; Yu WW, 2003, CHEM MATER, V15, P4300, DOI 10.1021/cm034729t; Yu WW, 2003, CHEM MATER, V15, P2854, DOI 10.1021/cm034081k; Zhang H, 2003, ADV MATER, V15, P1712, DOI 10.1002/adma.200305653; Zhang H, 2003, J PHYS CHEM B, V107, P8, DOI 10.1021/jp025910c; Zheng R, 2007, INORG CHEM, V46, P6920, DOI 10.1021/ic700502v; Zheng YG, 2007, ADV MATER, V19, P376, DOI 10.1002/adma.200600342	46	83	85	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2222	10.1371/journal.pone.0002222	http://dx.doi.org/10.1371/journal.pone.0002222			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493618	Green Submitted, Green Published, gold			2022-12-25	WOS:000262258700030
J	Dinur-Mills, M; Tal, M; Pines, O				Dinur-Mills, Maya; Tal, Merav; Pines, Ophry			Dual Targeted Mitochondrial Proteins Are Characterized by Lower MTS Parameters and Total Net Charge	PLOS ONE			English	Article								Background: In eukaryotic cells, identical proteins can be located in different subcellular compartments (termed dual-targeted proteins). Methodology/Principal Findings: We divided a reference set of mitochondrial proteins (published single gene studies) into two groups: i) Dual targeted mitochondrial proteins and ii) Exclusive mitochondrial proteins. Mitochondrial proteins were considered dual-targeted if they were also found or predicted to be localized to the cytosol, the nucleus, the endoplasmic reticulum (ER) or the peroxisome. We found that dual localized mitochondrial proteins have i) A weaker mitochondrial targeting sequence (MitoProtII score, hydrophobic moment and number of basic residues) and ii) a lower whole-protein net charge, when compared to exclusive mitochondrial proteins. We have also generated an annotation list of dual-targeted proteins within the predicted yeast mitochondrial proteome. This considerably large group of dual-localized proteins comprises approximately one quarter of the predicted mitochondrial proteome. We supported this prediction by experimental verification of a subgroup of the predicted dual targeted proteins. Conclusions/Significance: Taken together, these results establish dual targeting as a widely abundant phenomenon that should affect our concepts of gene expression and protein function. Possible relationships between the MTS/mature sequence traits and protein dual targeting are discussed.	[Dinur-Mills, Maya; Tal, Merav; Pines, Ophry] Hebrew Univ Jerusalem, Sch Med, Dept Mol Biol, IL-91010 Jerusalem, Israel	Hebrew University of Jerusalem	Dinur-Mills, M (corresponding author), Hebrew Univ Jerusalem, Sch Med, Dept Mol Biol, IL-91010 Jerusalem, Israel.	ophryp@ekmd.huji.ac.il	pines, ophry/C-4086-2011	pines, ophry/0000-0001-7126-2575	Israel Science Foundation (ISF); German Israeli Foundation (GIF); German Israeli Project Cooperation	Israel Science Foundation (ISF)(Israel Science Foundation); German Israeli Foundation (GIF)(German-Israeli Foundation for Scientific Research and Development); German Israeli Project Cooperation	This research was supported by the Israel Science Foundation (ISF) and the German Israeli Foundation (GIF) and the German Israeli Project Cooperation (DIP).F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas-Terki T, 1999, EUR J BIOCHEM, V266, P517, DOI 10.1046/j.1432-1327.1999.00881.x; Andreoli C, 2004, NUCLEIC ACIDS RES, V32, pD459, DOI 10.1093/nar/gkh137; Bandlow W, 1998, BIOCHEM J, V329, P359, DOI 10.1042/bj3290359; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; DANPURE CJ, 1995, TRENDS CELL BIOL, V5, P230, DOI 10.1016/S0962-8924(00)89016-9; HARTMANN C, 1991, NATURE, V352, P762, DOI 10.1038/352762b0; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; JAUSSI R, 1995, EUR J BIOCHEM, V228, P551, DOI 10.1111/j.1432-1033.1995.tb20294.x; Karniely S, 2005, EMBO REP, V6, P420, DOI 10.1038/sj.embor.7400394; Karniely S, 2006, EXP CELL RES, V312, P3835, DOI 10.1016/j.yexcr.2006.08.021; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; MAGDOLEN V, 1992, FEBS LETT, V299, P267, DOI 10.1016/0014-5793(92)80129-5; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Prokisch H, 2006, NUCLEIC ACIDS RES, V34, pD705, DOI 10.1093/nar/gkj127; Prokisch H, 2004, PLOS BIOL, V2, P795, DOI 10.1371/journal.pbio.0020160; ROISE D, 1988, EMBO J, V7, P649, DOI 10.1002/j.1460-2075.1988.tb02859.x; Schricker R, 2002, J BIOL CHEM, V277, P28757, DOI 10.1074/jbc.M201561200; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Small I, 1998, PLANT MOL BIOL, V38, P265, DOI 10.1023/A:1006081903354; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; Zhang SF, 2004, CELL, V119, P137, DOI 10.1016/j.cell.2004.09.012	23	48	48	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2161	10.1371/journal.pone.0002161	http://dx.doi.org/10.1371/journal.pone.0002161			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478128	gold, Green Published, Green Submitted			2022-12-25	WOS:000262172800026
J	Gentile, A; D'Alessandro, L; Lazzari, L; Martinoglio, B; Bertotti, A; Mira, A; Lanzetti, L; Comoglio, PM; Medico, E				Gentile, A.; D'Alessandro, L.; Lazzari, L.; Martinoglio, B.; Bertotti, A.; Mira, A.; Lanzetti, L.; Comoglio, P. M.; Medico, E.			Met-driven invasive growth involves transcriptional regulation of Arhgap12	ONCOGENE			English	Article						HGF; Rac1; scatter; GTPase activating protein; Rho family; gene trapping	GTPASE-ACTIVATING PROTEINS; CELL-CELL ADHESION; HEPATOCYTE GROWTH; SCATTER-FACTOR; TYROSINE KINASE; RHO GTPASES; PHOSPHATIDYLINOSITOL 3-KINASE; EPITHELIAL-CELLS; FACTOR-RECEPTOR; IN-VITRO	Invasive growth is a complex biological program triggered by hepatocyte growth factor (HGF) through its tyrosine kinase receptor encoded by the Met proto-oncogene. The program involves-besides proliferation-cell dissociation, motility and invasiveness, controlled by intracellular signals impinging on PI3K and on the small G-proteins of the Rac/Rho family. The mechanism(s) unbalancing Rac/Rho activation are still not completely clarified. Here, we describe a functional link between HGF and Arhgap12, a gene encoding a previously uncharacterized protein of the RhoGAP family. We identified Arhgap12 as a transcriptional target of HGF, through a novel gene trapping strategy. We found that Arhgap12 mRNA and protein are robustly suppressed by HGF treatment, but not by serum. Arhgap12 displayed GTPase activating protein (GAP) activity towards Rac1 and, upon overexpression, impaired cell scattering, invasion and adhesion to fibronectin in response to HGF. Consistently, Arhgap12 silencing by RNA interference selectively increased the scatter and adhesion responses. These data show that HGF-driven invasive growth involves transcriptional regulation of a Rac1-specific GAP.	[Gentile, A.; D'Alessandro, L.; Lazzari, L.; Martinoglio, B.; Mira, A.; Medico, E.] Univ Turin, Sch Med, Lab Funct Genom, Oncogenom Ctr,Inst Canc Res & Treatment, I-10060 Turin, Italy; [Bertotti, A.; Comoglio, P. M.] Univ Turin, Sch Med, Div Mol Oncol, Inst Canc Res & Treatment, I-10060 Turin, Italy; [Lanzetti, L.] Univ Turin, Sch Med, Div Mol Angiogenesis, Inst Canc Res & Treatment, I-10060 Turin, Italy	University of Turin; University of Turin; University of Turin	Medico, E (corresponding author), Univ Turin, Sch Med, Lab Funct Genom, Oncogenom Ctr,Inst Canc Res & Treatment, Str Prov 142 Km 3,95, I-10060 Turin, Italy.	enzo.medico@ircc.it	Medico, Enzo/AAC-3185-2021; gentile, alessandra/L-4299-2013; Lazzari, Luca/AAH-6475-2020	Medico, Enzo/0000-0002-3917-2438; gentile, alessandra/0000-0002-3367-8833; MARTINOGLIO, BARBARA/0000-0002-2342-2500; Lazzari, Luca/0000-0001-6841-4240; Mira, Alessia/0000-0002-8456-8159; Comoglio, Paolo/0000-0002-7056-5328; Bertotti, Andrea/0000-0001-8196-7608; LANZETTI, Letizia/0000-0001-7541-5524	AIRC; EC; FIRB; MIUR; Ricerca Finalizzata; Regione Piemonte and San Paolo to EM and PMC	AIRC(Fondazione AIRC per la ricerca sul cancro); EC(European CommissionEuropean Commission Joint Research Centre); FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); MIUR(Ministry of Education, Universities and Research (MIUR)); Ricerca Finalizzata(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Finalizzata (MOH-RF)); Regione Piemonte and San Paolo to EM and PMC	We thank Antonella Cignetto and Michela Bruno for secretarial assistance; Daniela Cantarella, Raffaella Albano, Laura Palmas and Solange Tienga for technical assistance and Giorgio Scita, Livio Trusolino and Lucia Biondi for helpful discussion and feedback. A particular thank to Luigi Naldini and Michele De Palma for early feedback on the design of viral traps. AG and AB are recipients of a fellowship from FIRC. This work was supported by grants from AIRC, EC (TRANSFOG EC Integrated project contract no. 503438), FIRB, MIUR, Ricerca Finalizzata, Regione Piemonte and San Paolo to EM and PMC.	Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Bertotti A, 2003, TRENDS BIOCHEM SCI, V28, P527, DOI 10.1016/j.tibs.2003.09.001; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Boccaccio C, 1998, NATURE, V391, P285, DOI 10.1038/34657; Bosse T, 2007, MOL CELL BIOL, V27, P6615, DOI 10.1128/MCB.00367-07; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; CICCHETTI P, 1995, EMBO J, V14, P3127, DOI 10.1002/j.1460-2075.1995.tb07315.x; Comoglio PM, 2002, J CLIN INVEST, V109, P857, DOI 10.1172/JCI200215392; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Finkielstein CV, 2006, J BIOL CHEM, V281, P27317, DOI 10.1074/jbc.M605560200; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Furge KA, 2000, ONCOGENE, V19, P5582, DOI 10.1038/sj.onc.1203859; Furukawa Y, 2001, BIOCHEM BIOPH RES CO, V284, P643, DOI 10.1006/bbrc.2001.5022; Grisendi S, 2001, J BIOL CHEM, V276, P46632, DOI 10.1074/jbc.M104323200; Gual P, 2000, ONCOGENE, V19, P1509, DOI 10.1038/sj.onc.1203514; Guo FK, 2006, J BIOL CHEM, V281, P18652, DOI 10.1074/jbc.M603508200; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hordijk PL, 1997, SCIENCE, V278, P1464, DOI 10.1126/science.278.5342.1464; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; Kurokawa K, 2004, MOL BIOL CELL, V15, P1003, DOI 10.1091/mbc.E03-08-0609; Ma PC, 2003, CANCER METAST REV, V22, P309, DOI 10.1023/A:1023768811842; Matsuda M, 2008, EXP CELL RES, V314, P939, DOI 10.1016/j.yexcr.2007.11.009; Medico E, 2001, CANCER RES, V61, P5861; Medico E, 1996, MOL BIOL CELL, V7, P495, DOI 10.1091/mbc.7.4.495; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; NALDINI L, 1995, J BIOL CHEM, V270, P603, DOI 10.1074/jbc.270.2.603; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; PARKER PJ, 1995, CURR BIOL, V5, P577, DOI 10.1016/S0960-9822(95)00113-8; Peck J, 2002, FEBS LETT, V528, P27, DOI 10.1016/S0014-5793(02)03331-8; Ponzetto C, 1996, J BIOL CHEM, V271, P14119, DOI 10.1074/jbc.271.24.14119; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; RIDLEY AJ, 1995, MOL CELL BIOL, V15, P1110; RIDLEY AJ, 1993, EMBO J, V12, P5151, DOI 10.1002/j.1460-2075.1993.tb06210.x; ROSEN EM, 1990, J CELL SCI, V96, P639; Royal I, 2000, MOL BIOL CELL, V11, P1709, DOI 10.1091/mbc.11.5.1709; ROYAL I, 1995, J BIOL CHEM, V270, P27780, DOI 10.1074/jbc.270.46.27780; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Seoh ML, 2003, FEBS LETT, V539, P131, DOI 10.1016/S0014-5793(03)00213-8; Takenawa T, 2001, J CELL SCI, V114, P1801; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; Wheeler AP, 2006, J CELL SCI, V119, P2749, DOI 10.1242/jcs.03024; Zandy NL, 2007, P NATL ACAD SCI USA, V104, P17686, DOI 10.1073/pnas.0703077104; Zeng QH, 2002, J BIOL CHEM, V277, P25203, DOI 10.1074/jbc.M201598200; Zhang Z, 2002, INT J BIOCHEM CELL B, V34, P325, DOI 10.1016/S1357-2725(01)00134-0	49	26	26	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP 18	2008	27	42					5590	5598		10.1038/onc.2008.173	http://dx.doi.org/10.1038/onc.2008.173			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	349KX	18504429	Green Submitted			2022-12-25	WOS:000259280800005
J	Chourbaji, S; Vogt, MA; Fumagalli, F; Sohr, R; Frasca, A; Brandwein, C; Hortnagl, H; Riva, MA; Sprengel, R; Gass, P				Chourbaji, S.; Vogt, M. A.; Fumagalli, F.; Sohr, R.; Frasca, A.; Brandwein, C.; Hoertnagl, H.; Riva, M. A.; Sprengel, R.; Gass, P.			AMPA receptor subunit 1 (GluR-A) knockout mice model the glutamate hypothesis of depression	FASEB JOURNAL			English	Article						learned helplessness; serotonin; hippocampus	PERFORMANCE LIQUID-CHROMATOGRAPHY; RESISTANT MAJOR DEPRESSION; GAMMA-AMINOBUTYRIC-ACID; NMDA RECEPTOR; AFFECTIVE-DISORDERS; THERAPEUTIC TARGET; TEMPORAL CORTEX; RAT; HIPPOCAMPUS; PLASTICITY	Recent evidence indicates that glutamate homeostasis and neurotransmission are altered in major depressive disorder, but the nature of the disruption and the mechanisms by which it contributes to the syndrome are unclear. Glutamate can act via AMPA, NMDA, or metabotropic receptors. Using targeted mutagenesis, we demonstrate here that mice with deletion of the main AMPA receptor subunit GluR-A represent a depression model with good face and construct validity, showing behavioral and neurochemical features of depression also postulated for human patients. GluR-A(-/-) mice display increased learned helplessness, decreased serotonin and norepinephrine levels, and disturbed glutamate homeostasis with increased glutamate levels and increased NMDA receptor expression. These results correspond well with current concepts regarding the role of AMPA and NMDA receptors in depression, postulating that compounds that augment AMPA receptor signaling or decrease NMDA receptor functions have antidepressant effects. GluR-A(-/-) mice represent a model to investigate the pathophysiology underlying the depressive phenotype and to identify changes in neural plasticity and resilience evoked by the genetic alterations in glutamatergic function. Furthermore, GluR-A(-/-) mice may be a valuable tool to study biological mechanisms of AMPA receptor modulators and the efficacy of NMDA antagonists in reducing behavioral or biochemical changes that correlate with increased helplessness.	[Chourbaji, S.; Vogt, M. A.; Brandwein, C.; Gass, P.] Univ Heidelberg, Cent Inst Mental Hlth, D-68159 Mannheim, Germany; [Fumagalli, F.; Frasca, A.; Riva, M. A.] Univ Milan, Dept Pharmacol Sci, Milan, Italy; [Sohr, R.; Hoertnagl, H.] Charite Univ Med Berlin, Inst Pharmacol, D-13353 Berlin, Germany; [Sprengel, R.] Max Planck Inst Med Res, Heidelberg, Germany	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Milan; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society	Gass, P (corresponding author), Univ Heidelberg, Cent Inst Mental Hlth, J 5, D-68159 Mannheim, Germany.	peter.gass@zi-mannheim.de	Fumagalli, Fabio/E-8992-2012; Riva, Marco Andrea/N-7418-2017	Riva, Marco Andrea/0000-0002-1699-5060; Fumagalli, Fabio/0000-0002-8814-7706; Frasca, Angelisa/0000-0002-0963-9789; Vogt, Miriam Annika/0000-0002-3400-5067	Deutsche Forschungsgemeinschaft [GA427/8-1, SP602/2-1]; University of Heidelberg [GK791/2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Heidelberg	This work was supported by grants from the Deutsche Forschungsgemeinschaft (GA427/8-1 to P. G. and SP602/2-1 to R. S.). M. A. V. holds a scholarship from the GK791/2 of the University of Heidelberg.	Amiel Jonathan M, 2007, Curr Psychiatry Rep, V9, P278, DOI 10.1007/s11920-007-0033-7; Aston C, 2005, MOL PSYCHIATR, V10, P309, DOI 10.1038/sj.mp.4001565; Bannerman DM, 2004, BEHAV NEUROSCI, V118, P643, DOI 10.1037/0735-7044.118.3.643; Bleakman D., 2007, CNS & Neurological Disorders-Drug Targets, V6, P117, DOI 10.2174/187152707780363258; Bonanno G, 2005, J NEUROSCI, V25, P3270, DOI 10.1523/JNEUROSCI.5033-04.2005; Charney DS, 1998, J CLIN PSYCHIAT, V59, P11; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; FELICE LJ, 1978, J NEUROCHEM, V31, P1461, DOI 10.1111/j.1471-4159.1978.tb06573.x; Fumagalli F, 2008, MOL PHARMACOL, V73, P1484, DOI 10.1124/mol.107.043786; Garcia LSB, 2008, PROG NEURO-PSYCHOPH, V32, P140, DOI 10.1016/j.pnpbp.2007.07.027; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Javitt DC, 2004, MOL PSYCHIATR, V9, P984, DOI 10.1038/sj.mp.4001551; Kugaya A, 2005, CNS SPECTRUMS, V10, P808, DOI 10.1017/S1092852900010403; Maeng S, 2008, BIOL PSYCHIAT, V63, P349, DOI 10.1016/j.biopsych.2007.05.028; MAIER SF, 1984, PROG NEURO-PSYCHOPH, V8, P435, DOI 10.1016/S0278-5846(84)80032-9; Maltese TM, 1999, AM J PSYCHIAT, V156, P1833; MARTIN JV, 1990, J NEUROCHEM, V55, P1142, DOI 10.1111/j.1471-4159.1990.tb03117.x; McEwen BS, 2001, ANN NY ACAD SCI, V933, P265, DOI 10.1111/j.1749-6632.2001.tb05830.x; McEwen BS, 2001, HUM PSYCHOPHARM CLIN, V16, pS7, DOI 10.1002/hup.266; Newton SS, 2002, J NEUROSCI, V22, P10883; Nudmamud-Thanoi S, 2004, NEUROSCI LETT, V372, P173, DOI 10.1016/j.neulet.2004.09.035; Paul IA, 2003, ANN NY ACAD SCI, V1003, P250, DOI 10.1196/annals.1300.016; Piepponen TP, 2001, J CHROMATOGR B, V757, P277, DOI 10.1016/S0378-4347(01)00156-6; Pittenger Christopher, 2007, CNS & Neurological Disorders-Drug Targets, V6, P101, DOI 10.2174/187152707780363267; Ridder S, 2005, J NEUROSCI, V25, P6243, DOI 10.1523/JNEUROSCI.0736-05.2005; Sanacora G, 2004, ARCH GEN PSYCHIAT, V61, P705, DOI 10.1001/archpsyc.61.7.705; SCHOEPFER R, 1994, PROG NEUROBIOL, V42, P353, DOI 10.1016/0301-0082(94)90076-0; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Skolnick P, 2002, J CLIN PSYCHIAT, V63, P19; SPERK G, 1982, J NEUROCHEM, V38, P840, DOI 10.1111/j.1471-4159.1982.tb08708.x; SPERK G, 1981, EUR J PHARMACOL, V74, P279, DOI 10.1016/0014-2999(81)90046-7; TRULLAS R, 1989, PHARMACOL BIOCHEM BE, V34, P313, DOI 10.1016/0091-3057(89)90317-1; TRULLAS R, 1990, EUR J PHARMACOL, V185, P1, DOI 10.1016/0014-2999(90)90204-J; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zarate CA, 2004, AM J PSYCHIAT, V161, P171, DOI 10.1176/appi.ajp.161.1.171; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856	36	117	124	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2008	22	9					3129	3134		10.1096/fj.08-106450	http://dx.doi.org/10.1096/fj.08-106450			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	342CD	18492725				2022-12-25	WOS:000258761300005
J	Friedland, RP; Tedesco, JM; Wilson, AC; Atwood, CS; Smith, MA; Perry, G; Zagorski, MG				Friedland, Robert P.; Tedesco, Johnathan M.; Wilson, Andrea C.; Atwood, Craig S.; Smith, Mark A.; Perry, George; Zagorski, Michael G.			Antibodies to potato virus Y bind the amyloid beta peptide - Immunohistochemical and NMR studies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE PATIENTS; A-BETA; MOUSE MODEL; NEUROFIBRILLARY TANGLES; APOLIPOPROTEIN-E; COAT PROTEIN; AUTOANTIBODIES; IMMUNIZATION; PATHOGENESIS; AGGREGATION	Studies in transgenic mice bearing mutated human Alzheimer disease (AD) genes show that active vaccination with the amyloid beta(A beta) protein or passive immunization with anti-A beta antibodies has beneficial effects on the development of disease. Although a trial of A beta vaccination in humans was halted because of autoimmune meningoencephalitis, favorable effects on A beta deposition in the brain and on behavior were seen. Conflicting results have been observed concerning the relationship of circulating anti-A beta antibodies and AD. Although these autoantibodies are thought to arise from exposure to A beta, it is also possible that homologous proteins may induce antibody synthesis. We propose that the long-standing presence of anti-A beta antibodies or antibodies to immunogens homologous to the A beta protein may produce protective effects. The amino acid sequence of the potato virus Y (PVY) nuclear inclusion b protein is highly homologous to the immunogenic N-terminal region of A beta. PVY infects potatoes and related crops worldwide. Here, we show through immunocytochemistry, enzyme-linked immunosorbent assay, and NMR studies that mice inoculated with PVY develop antibodies that bind to A beta in both neuritic plaques and neurofibrillary tangles, whereas antibodies to material from uninfected potato leaf show only modest levels of background immunoreactivity. NMR data show that the anti-PVY antibody binds to A beta within the Phe(4) - Ser(8) and His(13)-Leu(17) regions. Immune responses generated from dietary exposure to proteins homologous to A beta may induce antibodies that could influence the normal physiological processing of the protein and the development or progression of AD.	[Friedland, Robert P.] Case Western Reserve Univ, Dept Neurol, Cleveland, OH 44106 USA; [Tedesco, Johnathan M.; Zagorski, Michael G.] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA; [Smith, Mark A.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Wilson, Andrea C.; Atwood, Craig S.] Univ Wisconsin, Dept Med, Madison, WI 53705 USA; [Wilson, Andrea C.; Atwood, Craig S.] William S Middleton Mem Vet Adm Med Ctr, Ctr Geriatr Res Educ & Clin, Madison, WI 53705 USA; [Perry, George] Univ Texas San Antonio, Coll Sci, San Antonio, TX 78249 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University of Wisconsin System; University of Wisconsin Madison; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; University of Texas System; University of Texas at San Antonio (UTSA)	Friedland, RP (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurol, 10900 Euclid Ave,T504 SOM, Cleveland, OH 44122 USA.	robert.friedland@case.edu	Perry, George/A-8611-2009; Friedland, Robert/A-2834-2010; Smith, Mark A/A-9053-2009; , Craig/AAB-3963-2022	Perry, George/0000-0002-6547-0172; Friedland, Robert/0000-0001-5721-1843; 	NIA NIH HHS [R01 AG017173-07, R01-AG027853, R01-AG017173] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG017173, R01AG027853] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Agadjanyan MG, 2005, J IMMUNOL, V174, P1580, DOI 10.4049/jimmunol.174.3.1580; [Anonymous], 1994, POTYVIRIDAE; Asuni AA, 2007, J NEUROSCI, V27, P9115, DOI 10.1523/JNEUROSCI.2361-07.2007; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; Baratova LA, 2001, J VIROL, V75, P9696, DOI 10.1128/JVI.75.20.9696-9702.2001; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; DOUGHERTY WG, 1988, ANNU REV PHYTOPATHOL, V26, P123, DOI 10.1146/annurev.py.26.090188.001011; Du Y, 2001, NEUROLOGY, V57, P801, DOI 10.1212/WNL.57.5.801; Esler WP, 1996, BIOCHEMISTRY-US, V35, P13914, DOI 10.1021/bi961302+; EVANS KC, 1995, P NATL ACAD SCI USA, V92, P763, DOI 10.1073/pnas.92.3.763; Fanigliulo A, 2005, ARCH VIROL, V150, P709, DOI 10.1007/s00705-004-0449-x; Faria AMC, 1999, ADV IMMUNOL, V73, P153, DOI 10.1016/S0065-2776(08)60787-7; FEDEROFF HJ, 2005, SCI AGING KNOWLEDGE, V46, pPE35; Furlan R, 2003, BRAIN, V126, P285, DOI 10.1093/brain/awg031; GEARING M, 1995, NEUROLOGY, V45, P461, DOI 10.1212/WNL.45.3.461; Ghiso J, 2004, J BIOL CHEM, V279, P45897, DOI 10.1074/jbc.M407668200; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hara H, 2004, J ALZHEIMERS DIS, V6, P483; HILBICH C, 1992, J MOL BIOL, V228, P460, DOI 10.1016/0022-2836(92)90835-8; Hock C, 2003, NEURON, V38, P547, DOI 10.1016/S0896-6273(03)00294-0; Hock C, 2005, NEURODEGENER DIS, V2, P273, DOI 10.1159/000090368; Hou LM, 2004, J AM CHEM SOC, V126, P1992, DOI 10.1021/ja036813f; Hyman BT, 2001, ANN NEUROL, V49, P808, DOI 10.1002/ana.1061; Inouye H, 1996, CIBA F SYMP, V199, P22; Johnstone EM, 1996, BIOCHEM BIOPH RES CO, V220, P710, DOI 10.1006/bbrc.1996.0469; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Levine H, 2005, AMYLOID, V12, P5, DOI 10.1080/13506120500032295; LeVine H, 2002, CURR MED CHEM, V9, P1121, DOI 10.2174/0929867023370167; Lichtlen P, 2008, J NEUROCHEM, V104, P859, DOI 10.1111/j.1471-4159.2007.05064.x; Lv JP, 2006, ALZ DIS ASSOC DIS, V20, P127, DOI 10.1097/00002093-200607000-00001; Maier M, 2005, NEURODEGENER DIS, V2, P267, DOI 10.1159/000090367; McLaurin J, 2002, NAT MED, V8, P1263, DOI 10.1038/nm790; Milojevic J, 2007, J AM CHEM SOC, V129, P4282, DOI 10.1021/ja067367+; Moir RD, 2005, J BIOL CHEM, V280, P17458, DOI 10.1074/jbc.M414176200; Mostafae S, 2006, Commun Agric Appl Biol Sci, V71, P1335; Mouri A, 2007, FASEB J, V21, P2135, DOI 10.1096/fj.06-7685com; Moury B, 2002, J GEN VIROL, V83, P2563, DOI 10.1099/0022-1317-83-10-2563; Mruthinti S, 2004, NEUROBIOL AGING, V25, P1023, DOI 10.1016/j.neurobiolaging.2003.11.001; Myers RH, 1996, NEUROLOGY, V46, P673, DOI 10.1212/WNL.46.3.673; Nath A, 2003, NEUROMOL MED, V3, P29, DOI 10.1385/NMM:3:1:29; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Pallitto MM, 1999, BIOCHEMISTRY-US, V38, P3570, DOI 10.1021/bi982119e; PERRY G, 1993, AM J PATHOL, V143, P1586; Petrushina I, 2007, J NEUROSCI, V27, P12721, DOI 10.1523/JNEUROSCI.3201-07.2007; RIECHMANN JL, 1992, J GEN VIROL, V73, P1, DOI 10.1099/0022-1317-73-1-1; Rogaeva E, 2006, J ALZHEIMERS DIS, V9, P381; Rosenmann H, 2006, NEUROSCI LETT, V410, P90, DOI 10.1016/j.neulet.2006.01.072; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schenk DB, 2005, NEURODEGENER DIS, V2, P255, DOI 10.1159/000090365; Taguchi H, 2008, J BIOL CHEM, V283, P4714, DOI 10.1074/jbc.M707983200; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Weksler ME, 2002, EXP GERONTOL, V37, P943, DOI 10.1016/S0531-5565(02)00029-3; Yan YL, 2006, J MOL BIOL, V364, P853, DOI 10.1016/j.jmb.2006.09.046; Yan YL, 2007, BIOCHEMISTRY-US, V46, P1724, DOI 10.1021/bi061314n; Youm JW, 2005, FEBS LETT, V579, P6737, DOI 10.1016/j.febslet.2005.11.003; Zeng H, 2001, BIOL PSYCHIAT, V49, P248, DOI 10.1016/S0006-3223(00)01111-2	60	19	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	2008	283	33					22550	22556		10.1074/jbc.M802088200	http://dx.doi.org/10.1074/jbc.M802088200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	335VR	18505725	Green Submitted, hybrid, Green Published			2022-12-25	WOS:000258321000023
J	Sobczak, I; Galabova-Kovacs, G; Sadzak, I; Kren, A; Christofori, G; Baccarini, M				Sobczak, I.; Galabova-Kovacs, G.; Sadzak, I.; Kren, A.; Christofori, G.; Baccarini, M.			B-Raf is required for ERK activation and tumor progression in a mouse model of pancreatic beta-cell carcinogenesis	ONCOGENE			English	Article						Raf kinases; ERK pathway; angiogenesis; tumor progression	MULTISTAGE CARCINOGENESIS; ANGIOGENIC SWITCH; REGULATED KINASE; GROWTH; MICE; GENE; EXPRESSION; PATHWAY; CANCER; P53	Activation of the Raf/MEK/ERK pathway, often by gain-of-function mutations of RAS or RAF, is observed in many human cancers. The extracellular signal-regulated kinase (ERK) pathway is required for the proliferation of cancer cell lines harboring activating BRAF or, to a lesser extent, activating RAS mutations. It is still unclear, however, whether the pathway is required in vivo for tumor development, particularly in tumors in which B-Raf is not mutationally activated. During embryonic development, B-Raf is essential for angiogenesis in the placenta. To address the question of whether B-Raf contributed to tumor angiogenesis in vivo we conditionally ablated B-Raf in a model of pancreatic islet carcinoma driven by the functional inactivation of tumor suppressors (RIP1Tag2), which critically depends on angiogenesis for growth. We find that B-Raf is dispensable for the proliferation of tumor cells in culture, but necessary for ERK activation and for the expression of angiogenic factors by tumor cells in vivo and in vitro. In vivo, these defects result in the formation of hollow tumors with decreased vessel density and strongly reduced proliferation. The progression from adenoma to carcinoma is also significantly impaired. Thus, endogenous B-Raf contributes to the development of RIP1Tag2 tumors by supporting the stromal response and tumor progression.	[Sobczak, I.; Galabova-Kovacs, G.; Sadzak, I.; Baccarini, M.] Univ Vienna, Dept Microbiol & Immunol, Max F Perutz Labs, A-1030 Vienna, Austria; [Kren, A.; Christofori, G.] Univ Basel, Ctr Biomed, Inst Biochem & Genet, Dept Clin Biol Sci, Basel, Switzerland	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Basel	Baccarini, M (corresponding author), Univ Vienna, Dept Microbiol & Immunol, Max F Perutz Labs, Dr Bohr Gasse 9, A-1030 Vienna, Austria.	manuela.baccarini@univie.ac.at	Baccarini, Manuela/B-6481-2014	Baccarini, Manuela/0000-0002-3033-391X				Abdulkadir SA, 2001, NAT MED, V7, P101, DOI 10.1038/83231; Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Baron V, 2006, CANCER GENE THER, V13, P115, DOI 10.1038/sj.cgt.7700896; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bergers G, 1999, SCIENCE, V284, P808, DOI 10.1126/science.284.5415.808; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Cavallaro U, 2001, BBA-REV CANCER, V1552, P39, DOI 10.1016/S0304-419X(01)00038-5; Chen AP, 2006, J NEUROSCI RES, V83, P28, DOI 10.1002/jnr.20703; Compagni A, 2000, CANCER RES, V60, P7163; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Downward J, 2006, NATURE, V439, P274, DOI 10.1038/439274a; Dumaz N, 2006, CANCER RES, V66, P9483, DOI 10.1158/0008-5472.CAN-05-4227; EFRAT S, 1988, P NATL ACAD SCI USA, V85, P9037, DOI 10.1073/pnas.85.23.9037; Eid MA, 1998, CANCER RES, V58, P2461; Emuss V, 2005, CANCER RES, V65, P9719, DOI 10.1158/0008-5472.CAN-05-1683; Galabova-Kovacs G, 2006, P NATL ACAD SCI USA, V103, P1325, DOI 10.1073/pnas.0507399103; Galabova-Kovacs G, 2006, CELL CYCLE, V5, P1514, DOI 10.4161/cc.5.14.2981; Garnett MJ, 2004, CANCER CELL, V6, P313, DOI 10.1016/j.ccr.2004.09.022; Gavert N, 2005, J CELL BIOL, V168, P633, DOI 10.1083/jcb.200408051; Gomez E, 2002, J BIOL CHEM, V277, P48146, DOI 10.1074/jbc.M209165200; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; Hashizume H, 2000, AM J PATHOL, V156, P1363, DOI 10.1016/S0002-9440(10)65006-7; Herbert TP, 2002, J BIOL CHEM, V277, P11591, DOI 10.1074/jbc.M110367200; Herzig M, 1999, BIOL CHEM, V380, P203, DOI 10.1515/BC.1999.028; Inoue M, 2002, CANCER CELL, V1, P193, DOI 10.1016/S1535-6108(02)00031-4; Krones-Herzig A, 2005, CANCER RES, V65, P5133, DOI 10.1158/0008-5472.CAN-04-3742; Krones-Herzig A, 2003, P NATL ACAD SCI USA, V100, P3233, DOI 10.1073/pnas.2628034100; Lee CG, 2004, J EXP MED, V200, P377, DOI 10.1084/jem.20040104; Lim KH, 2005, CANCER CELL, V8, P381, DOI 10.1016/j.ccr.2005.10.014; Mikula M, 2001, EMBO J, V20, P1952, DOI 10.1093/emboj/20.8.1952; Morrison TB, 1998, BIOTECHNIQUES, V24, P954; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Pannu J, 2007, J BIOL CHEM, V282, P10405, DOI 10.1074/jbc.M611742200; Perl AK, 1999, NAT MED, V5, P286, DOI 10.1038/6502; Rolli-Derkinderen M, 2003, J BIOL CHEM, V278, P18859, DOI 10.1074/jbc.M211696200; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Sugimoto H, 2006, CANCER BIOL THER, V5, P1640, DOI 10.4161/cbt.5.12.3354; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Wang XM, 2007, METHOD ENZYMOL, V431, P113, DOI 10.1016/S0076-6879(07)31007-0; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Xian XJ, 2006, J CLIN INVEST, V116, P642, DOI 10.1172/JCI25705	44	16	17	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG 14	2008	27	35					4779	4787		10.1038/onc.2008.128	http://dx.doi.org/10.1038/onc.2008.128			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	337OJ	18490924				2022-12-25	WOS:000258445100003
J	Ren, JH; Pashkova, N; Winistorfer, S; Piper, RC				Ren, Jihui; Pashkova, Natasha; Winistorfer, Stanley; Piper, Robert C.			Doa1/Ufd3 plays a role in sorting ubiquitinated membrane proteins into multivesicular bodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; SACCHAROMYCES-CEREVISIAE; PREVACUOLAR COMPARTMENT; PROTEASOME SYSTEM; DIVERSE FUNCTIONS; BUDDING YEAST; SH3 DOMAINS; WD REPEAT; ESCRT-I; DEGRADATION	Ubiquitin (Ub) is a sorting signal that targets integral membrane proteins to the interior of the vacuole/lysosome by directing them into lumenal vesicles of multivesicular bodies ( MVBs). The Vps27-Hse1 complex, which is homologous to the Hrs-STAM complex in mammalian cells, serves as a Ub-sorting receptor at the surface of early endosomes. We have found that Hse1 interacts with Doa1/Ufd3. Doa1 is known to interact with Cdc48/p97 and Ub and is required for maintaining Ub levels. We find that the Hse1 Src homology 3 domain binds directly to the central PFU domain of Doa1. Mutations in Doa1 that block Hse1 binding but not Ub binding do not alter Ub levels but do result in the missorting of the MVB cargo GFP-Cps1. Loss of Doa1 also causes a synthetic growth defect when combined with loss of Vps27. Unlike the loss of Doa1 alone, the doa1 Delta vps27 Delta double mutant phenotype is not suppressed by Ub overexpression, demonstrating that the effect is not due to indirect consequence of lowered Ub levels. Loss of Doa1 results in a defect in the accumulation of GFP-Ub within yeast vacuoles, implying that there is a reduction in the flux of ubiquitinated membrane proteins through the MVB pathway. This defect was also reflected by an inability to properly sort Vph1-GFP-Ub, a modified subunit of the multiprotein vacuolar ATPase complex, which carries an in-frame fusion of Ub as an MVB sorting signal. These results reveal novel roles for Doa1 in helping to process ubiquitinated membrane proteins for sorting into MVBs.	[Ren, Jihui; Pashkova, Natasha; Winistorfer, Stanley; Piper, Robert C.] Univ Iowa, Iowa City, IA 52242 USA	University of Iowa	Piper, RC (corresponding author), Univ Iowa, 5-660 BSB Mol Physiol & Biophys, Iowa City, IA 52242 USA.	Robert-Piper@uiowa.edu		Piper, Robert/0000-0001-9995-5699; Pashkova, Natalya/0000-0002-2191-4683	NIGMS NIH HHS [R01 GM 58202, R01 GM058202] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058202] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amerik A, 2006, J CELL BIOL, V175, P825, DOI 10.1083/jcb.200605134; Amerik AY, 2000, MOL BIOL CELL, V11, P3365, DOI 10.1091/mbc.11.10.3365; Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; Balakirev MY, 2003, EMBO REP, V4, P517, DOI 10.1038/sj.embor.embor824; Bilodeau PS, 2003, J CELL BIOL, V163, P237, DOI 10.1083/jcb.200305007; Bilodeau PS, 2002, NAT CELL BIOL, V4, P534, DOI 10.1038/ncb815; Bishop N, 2002, J CELL BIOL, V157, P91, DOI 10.1083/jcb.200112080; Bishop N, 2000, MOL BIOL CELL, V11, P227, DOI 10.1091/mbc.11.1.227; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; Brachmann CB, 1998, YEAST, V14, P115; Brandina I, 2007, FEBS LETT, V581, P4248, DOI 10.1016/j.febslet.2007.08.013; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; Dupre S, 2001, MOL CELL BIOL, V21, P4482, DOI 10.1128/MCB.21.14.4482-4494.2001; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Halawani D, 2006, MOL CELL, V22, P713, DOI 10.1016/j.molcel.2006.06.003; Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; HOCHSTRASSER M, 1990, CELL, V61, P697, DOI 10.1016/0092-8674(90)90481-S; Hochstrasser M, 1999, PHILOS T ROY SOC B, V354, P1513, DOI 10.1098/rstb.1999.0495; Hu JH, 2007, MOL BIOL CELL, V18, P3277, DOI 10.1091/mbc.E07-03-0239; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Iyer LM, 2004, CELL CYCLE, V3, P1440, DOI 10.4161/cc.3.11.1206; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Katzmann DJ, 2004, MOL BIOL CELL, V15, P468, DOI 10.1091/mbc.E03-07-0473; Katzmann DJ, 2003, J CELL BIOL, V162, P413, DOI 10.1083/jcb.200302136; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Keil RL, 1996, MOL CELL BIOL, V16, P3446; Kobayashi T, 2007, GENES CELLS, V12, P889, DOI 10.1111/j.1365-2443.2007.01099.x; Kunze D, 2007, MICROBIOL-SGM, V153, P1026, DOI 10.1099/mic.0.2006/002741-0; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lis ET, 2006, MOL CELL BIOL, V26, P4122, DOI 10.1128/MCB.01640-05; Losko S, 2001, MOL BIOL CELL, V12, P1047, DOI 10.1091/mbc.12.4.1047; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; McCullough J, 2006, CURR BIOL, V16, P160, DOI 10.1016/j.cub.2005.11.073; Mullally JE, 2006, MOL CELL BIOL, V26, P822, DOI 10.1128/MCB.26.3.822-830.2006; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; Ogiso Y, 2004, MOL CELL BIOL, V24, P2324, DOI 10.1128/MCB.24.6.2324-2331.2004; PIPER RC, 1995, J CELL BIOL, V131, P603, DOI 10.1083/jcb.131.3.603; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Piper RC, 2007, CURR OPIN CELL BIOL, V19, P459, DOI 10.1016/j.ceb.2007.07.002; Qian SB, 2002, J BIOL CHEM, V277, P38818, DOI 10.1074/jbc.M205547200; Raiborg C, 2008, EXP CELL RES, V314, P801, DOI 10.1016/j.yexcr.2007.10.014; Rayala SK, 2006, J BIOL CHEM, V281, P4395, DOI 10.1074/jbc.M510368200; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Reggiori F, 2002, NAT CELL BIOL, V4, P117, DOI 10.1038/ncb743; Ren JH, 2007, MOL BIOL CELL, V18, P324, DOI 10.1091/mbc.E06-06-0557; Richter C, 2007, EMBO J, V26, P2454, DOI 10.1038/sj.emboj.7601692; Roxrud I, 2008, J CELL BIOL, V180, P1205, DOI 10.1083/jcb.200708115; Rumpf S, 2006, MOL CELL, V21, P261, DOI 10.1016/j.molcel.2005.12.014; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shcherbik N, 2007, MOL CELL, V25, P385, DOI 10.1016/j.molcel.2007.01.024; SMITH DB, 1988, MOL BIOCHEM PARASIT, V27, P249, DOI 10.1016/0166-6851(88)90044-8; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Springael JY, 1999, J CELL SCI, V112, P1375; Stern KA, 2007, MOL CELL BIOL, V27, P888, DOI 10.1128/MCB.02356-05; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Tu D, 2007, P NATL ACAD SCI USA, V104, P15599, DOI 10.1073/pnas.0701369104; Urbanowski JL, 1999, J BIOL CHEM, V274, P38061, DOI 10.1074/jbc.274.53.38061; Urbanowski JL, 2001, TRAFFIC, V2, P622, DOI 10.1034/j.1600-0854.2001.20905.x; Wilson TE, 2002, GENETICS, V162, P677; Yan Q, 2005, MOL BIOL CELL, V16, P2470, DOI 10.1091/mbc.e04-11-1014; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0; Zhao G, 2007, P NATL ACAD SCI USA, V104, P8785, DOI 10.1073/pnas.0702966104	71	38	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21599	21611		10.1074/jbc.M802982200	http://dx.doi.org/10.1074/jbc.M802982200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18508771	hybrid, Green Published			2022-12-25	WOS:000257898800033
J	Whelan, SA; Lane, MD; Hart, GW				Whelan, Stephen A.; Lane, M. Daniel; Hart, Gerald W.			Regulation of the O-linked beta-N-acetylglucosamine transferase by insulin signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLCNAC TRANSFERASE; POSTTRANSLATIONAL MODIFICATION; NUCLEOCYTOPLASMIC PROTEINS; CYTOPLASMIC PROTEINS; TERMINAL DOMAIN; X-CHROMOSOME; GLYCOSYLATION; ACTIVATION; NUCLEAR; PHOSPHORYLATION	O-Linked beta-N-acetylglucosamine (O-GlcNAc) transferase (OGT) catalyzes the addition of O-linked beta-N-acetylglucosamine (O-GlcNAc) onto serine and threonine residues in response to stimuli or stress analogous to phosphorylation by Ser/Thr-kinases. Like protein phosphatases, OGT appears to be targeted to myriad specific substrates by transiently interacting with specific targeting subunits. Here, we show that OGT is activated by insulin signaling. Insulin treatment of 3T3-L1 adipocytes stimulates both tyrosine phosphorylation and catalytic activity of OGT. A subset of OGT co-immunoprecipitates with the insulin receptor. Insulin stimulates purified insulin receptor to phosphorylate OGT in vitro. OGT is a competitive substrate with reduced and carboxyamidomethylated lysozyme (RCAM-lysozyme), a well characterized insulin receptor substrate. Insulin stimulation of 3T3-L1 adipocytes results in a partial translocation of OGT from the nucleus to the cytoplasm. The insulin activation of OGT results in increased O-GlcNAc modification of OGT and other proteins including, signal transducer and activator of transcription 3 (STAT3). We conclude that insulin stimulates the tyrosine phosphorylation and activity of OGT.	[Whelan, Stephen A.; Lane, M. Daniel; Hart, Gerald W.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Hart, GW (corresponding author), 725 N Wolfe St, Baltimore, MD 21205 USA.	gwhart@jhmi.edu	Whelan, Stephen A/I-9502-2012	Whelan, Stephen A/0000-0002-4740-0795; Whelan, Stephen A/0000-0002-5439-6501; Hart, Gerald/0000-0001-7812-4351	NHLBI NIH HHS [N01 HV 28180] Funding Source: Medline; NIDDK NIH HHS [R01 DK 61671] Funding Source: Medline; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061671] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akimoto Y, 1999, DIABETES, V48, P2407, DOI 10.2337/diabetes.48.12.2407; Arnold CS, 1996, J BIOL CHEM, V271, P28741, DOI 10.1074/jbc.271.46.28741; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Buettner C, 2006, CELL METAB, V4, P49, DOI 10.1016/j.cmet.2006.04.014; Cernkovich ER, 2008, ENDOCRINOLOGY, V149, P1581, DOI 10.1210/en.2007-1148; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961; Comer FI, 2001, BIOCHEMISTRY-US, V40, P7845, DOI 10.1021/bi0027480; Deng JB, 2000, ENDOCRINOLOGY, V141, P2370, DOI 10.1210/en.141.7.2370; Federici M, 2002, CIRCULATION, V106, P466, DOI 10.1161/01.CIR.0000023043.02648.51; Gewinner C, 2004, J BIOL CHEM, V279, P3563, DOI 10.1074/jbc.M306449200; HALTIWANGER RS, 1990, J BIOL CHEM, V265, P2563; HALTIWANGER RS, 1992, J BIOL CHEM, V267, P9005; Hanover JA, 2005, P NATL ACAD SCI USA, V102, P11266, DOI 10.1073/pnas.0408771102; Hanover JA, 2001, FASEB J, V15, P1865, DOI 10.1096/fj.01-0094rev; Hawkins M, 1997, J CLIN INVEST, V99, P2173, DOI 10.1172/JCI119390; Ishizuka K, 2007, ENDOCRINOLOGY, V148, P2994, DOI 10.1210/en.2006-1702; Iyer SPN, 2003, J BIOL CHEM, V278, P5399, DOI 10.1074/jbc.M209384200; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; KELLY WG, 1993, J BIOL CHEM, V268, P10416; KOHANSKI RA, 1986, J BIOL CHEM, V261, P2272; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Kudlow JE, 2006, J CELL BIOCHEM, V98, P1062, DOI 10.1002/jcb.20926; LAMB JR, 1995, TRENDS BIOCHEM SCI, V20, P257, DOI 10.1016/S0968-0004(00)89037-4; Lazarus BD, 2006, GLYCOBIOLOGY, V16, P415, DOI 10.1093/glycob/cwj078; Lefebvre T, 1999, BBA-GEN SUBJECTS, V1472, P71, DOI 10.1016/S0304-4165(99)00105-1; Love, 2005, SCI STKE, V2005, DOI DOI 10.1126/STKE.3122005RE13; Love DC, 2003, J CELL SCI, V116, P647, DOI 10.1242/jcs.00246; Lubas WA, 2000, J BIOL CHEM, V275, P10983, DOI 10.1074/jbc.275.15.10983; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Marshall S, 2005, BIOCHEM BIOPH RES CO, V332, P263, DOI 10.1016/j.bbrc.2005.04.122; Modan-Moses D, 1998, BIOCHEM J, V333, P825, DOI 10.1042/bj3330825; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Okuyama R, 2004, BIOL PHARM BULL, V27, P1293, DOI 10.1248/bpb.27.1293; Patti ME, 1999, DIABETES, V48, P1562, DOI 10.2337/diabetes.48.8.1562; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Slawson C, 2006, J CELL BIOCHEM, V97, P71, DOI 10.1002/jcb.20676; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Slawson C, 2002, BBA-GEN SUBJECTS, V1573, P121, DOI 10.1016/S0304-4165(02)00369-0; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; Tao GZ, 2006, BIOCHEM BIOPH RES CO, V351, P708, DOI 10.1016/j.bbrc.2006.10.092; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Wells L, 2003, BIOCHEM BIOPH RES CO, V302, P435, DOI 10.1016/S0006-291X(03)00175-X; Wells L, 2003, CELL MOL LIFE SCI, V60, P222, DOI 10.1007/s000180300017; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Whelan SA, 2003, CIRC RES, V93, P1047, DOI 10.1161/01.RES.0000103190.20260.37; Whelan SA, 2006, METHOD ENZYMOL, V415, P113, DOI 10.1016/S0076-6879(06)15008-9; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zachara NE, 2004, TRENDS CELL BIOL, V14, P218, DOI 10.1016/j.tcb.2004.03.005	52	120	123	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21411	21417		10.1074/jbc.M800677200	http://dx.doi.org/10.1074/jbc.M800677200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18519567	hybrid, Green Published			2022-12-25	WOS:000257898800012
J	Cunningham, CN; Krukenberg, KA; Agard, DA				Cunningham, Christian N.; Krukenberg, Kristin A.; Agard, David A.			Intra- and intermonomer interactions are required to synergistically facilitate ATP hydrolysis in Hsp90	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI HSP90; MOLECULAR CHAPERONES; CRYSTAL-STRUCTURE; STEROID-RECEPTOR; PROTEIN-KINASE; CYCLE; DIMERIZATION; MECHANISM; BINDING; MACHINERY	Nucleotide-dependent conformational changes of the constitutively dimeric molecular chaperone Hsp90 are integral to its molecular mechanism. Recent full-length crystal structures (Protein Data Bank codes 2IOQ, 2CG9, AND 2IOP) of Hsp90 homologs reveal large scale quaternary domain rearrangements upon the addition of nucleotides. Although previous work has shown the importance of C-terminal domain dimerization for efficient ATP hydrolysis, which should imply cooperativity, other studies suggest that the two ATPases function independently. Using the crystal structures as a guide, we examined the role of intra- and intermonomer interactions in stabilizing the ATPase activity of a single active site within an intact dimer. This was accomplished by creating heterodimers that allow us to differentially mutate each monomer, probing the context in which particular residues are important for ATP hydrolysis. Although the ATPase activity of each monomer can function independently, we found that the activity of one monomer could be inhibited by the mutation of hydrophobic residues on the trans N-terminal domain ( opposite monomer). Furthermore, these trans interactions are synergistically mediated by a loop on the cis middle domain. This loop contains hydrophobic residues as well as a critical arginine that provides a direct linkage to the gamma-phosphate of bound ATP. Small angle x-ray scattering demonstrates that deleterious mutations block domain closure in the presence of AMPPNP (5'-adenylyl-beta, gamma-imidodiphosphate), providing a direct linkage between structural changes and functional consequences. Together, these data indicate that both the cis monomer and the trans monomer and the intradomain and interdomain interactions cooperatively stabilize the active conformation of each active site and help explain the importance of dimer formation.	[Krukenberg, Kristin A.] Univ Calif San Francisco, Grad Program Chem & Chem Biol, San Francisco, CA 94158 USA; [Cunningham, Christian N.] Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94158 USA; [Agard, David A.] Univ Calif San Francisco, Dept Biochem & Biophys, Howard Hughes Med Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Agard, DA (corresponding author), 600 16th St,MC2240,Rm S412D, San Francisco, CA 94158 USA.	agard@msg.ucsf.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008284] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [T32 GM 08284] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Felts SJ, 2000, J BIOL CHEM, V275, P3305, DOI 10.1074/jbc.275.5.3305; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; Harris SF, 2004, STRUCTURE, V12, P1087, DOI 10.1016/j.str.2004.03.020; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Maloney A, 2002, EXPERT OPIN BIOL TH, V2, P3, DOI 10.1517/14712598.2.1.3; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; McLaughlin SH, 2006, J MOL BIOL, V356, P746, DOI 10.1016/j.jmb.2005.11.085; McLaughlin SH, 2004, J MOL BIOL, V344, P813, DOI 10.1016/j.jmb.2004.09.055; Meyer P, 2004, EMBO J, V23, P511, DOI 10.1038/sj.emboj.7600060; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; Neckers Len, 2002, Expert Opin Emerg Drugs, V7, P277, DOI 10.1517/14728214.7.2.277; Neckers Len, 2003, Current Opinion in Oncology, V15, P419, DOI 10.1097/00001622-200311000-00003; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Richter K, 2004, J MOL BIOL, V342, P1403, DOI 10.1016/j.jmb.2004.07.064; Richter K, 2003, J BIOL CHEM, V278, P10328, DOI 10.1074/jbc.M213094200; Richter K, 2001, J BIOL CHEM, V276, P33689, DOI 10.1074/jbc.M103832200; Roe SM, 2004, CELL, V116, P87, DOI 10.1016/S0092-8674(03)01027-4; Shiau AK, 2006, CELL, V127, P329, DOI 10.1016/j.cell.2006.09.027; Siligardi G, 2004, J BIOL CHEM, V279, P51989, DOI 10.1074/jbc.M410562200; Siligardi G, 2002, J BIOL CHEM, V277, P20151, DOI 10.1074/jbc.M201287200; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Wegele H, 2003, J BIOL CHEM, V278, P39303, DOI 10.1074/jbc.M305751200; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Zhang W, 2004, J MOL BIOL, V340, P891, DOI 10.1016/j.jmb.2004.05.007	32	81	81	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21170	21178		10.1074/jbc.M800046200	http://dx.doi.org/10.1074/jbc.M800046200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18492664	Green Published, hybrid			2022-12-25	WOS:000257746100059
J	Fernandes, AF; Zhou, JL; Zhang, XY; Bian, QN; Sparrow, J; Taylor, A; Pereira, P; Shang, F				Fernandes, Alexandre F.; Zhou, Jilin; Zhang, Xinyu; Bian, Qingning; Sparrow, Janet; Taylor, Allen; Pereira, Paulo; Shang, Fu			Oxidative inactivation of the proteasome in retinal pigment epithelial cells - A potential link between oxidative stress and up-regulation of interleukin-8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; UBIQUITIN-CONJUGATING ENZYMES; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; PROTEOLYTIC PATHWAY; HISTONE ACETYLATION; CYTOKINE EXPRESSION; IL-8 RELEASE; INHIBITION	Oxidative stress and inflammation are implicated in the pathogenesis of many age-related diseases. Stress-induced overproduction of inflammatory cytokines, such as interleukin-8 (IL-8), is one of the early events of inflammation. The objective of this study was to elucidate mechanistic links between oxidative stress and overproduction of IL-8 in retinal pigment epithelial (RPE) cells. We found that exposure of RPE cells to H2O2, paraquat, or A(2)E-mediated photooxidation resulted in increased expression and secretion of IL-8. All of these oxidative stressors also inactivated the proteasome in RPE cells. In contrast, tert-butylhydroperoxide (TBH), a lipophilic oxidant that did not stimulate IL-8 production, also did not inactivate the proteasome. Moreover, prolonged treatment of RPE cells with proteasome-specific inhibitors recapitulated the stimulation of IL-8 production. These data suggest that oxidative inactivation of the proteasome is a potential mechanistic link between oxidative stress and up-regulation of the proinflammatory IL-8. The downstream signaling pathways that govern the production of IL-8 include NF-kappa B and p38 MAPK. Proteasome inhibition both attenuated the activation and delayed the turnoff of NF-kappa B, resulting in biphasic effects on the production of IL-8. Prolonged proteasome inhibition (> 2 h) resulted in activation of p38 MAPK via activation of MKK3/6 and increased the production of IL-8. Chemically inhibiting the p38 MAPK blocked the proteasome inhibition-induced up-regulation of IL-8. Together, these data indicate that oxidative inactivation of the proteasome and the related activation of the p38 MAPK pathway provide a potential link between oxidative stress and overproduction of proinflammatory cytokines, such as IL-8.	[Fernandes, Alexandre F.; Zhang, Xinyu; Bian, Qingning; Taylor, Allen; Shang, Fu] Tufts Univ, USDA, Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Fernandes, Alexandre F.; Pereira, Paulo] Univ Coimbra, Fac Med, IBILI, Ctr Ophthalmol, P-3000354 Coimbra, Portugal; [Zhou, Jilin; Sparrow, Janet] Columbia Univ, Dept Ophthalmol, New York, NY 10032 USA	Tufts University; United States Department of Agriculture (USDA); Universidade de Coimbra; Columbia University	Shang, F (corresponding author), 711 Washington St, Boston, MA 02111 USA.	fu.shang@tufts.edu	Pereira, Paulo/AAD-8375-2022	Pereira, Paulo/0000-0002-9908-2290; Fernandes, Alexandre/0000-0001-9489-6167	NATIONAL EYE INSTITUTE [R29EY011717, R01EY011717, R01EY013250, R01EY012951] Funding Source: NIH RePORTER; NEI NIH HHS [EY 11717, EY 12951, EY 13250] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adachi M, 2003, FEBS LETT, V554, P77, DOI 10.1016/S0014-5793(03)01109-8; Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Biagioli MC, 1999, FREE RADICAL BIO MED, V26, P454, DOI 10.1016/S0891-5849(98)00233-0; Boulton M, 2004, GRAEF ARCH CLIN EXP, V242, P76, DOI 10.1007/s00417-003-0812-8; Brat DJ, 2005, NEURO-ONCOLOGY, V7, P122, DOI 10.1215/S1152851704001061; Bulteau AL, 2001, J BIOL CHEM, V276, P30057, DOI 10.1074/jbc.M100142200; Caballero M, 2003, BIOCHEM BIOPH RES CO, V308, P346, DOI 10.1016/S0006-291X(03)01385-8; Campochiaro P A, 1999, Mol Vis, V5, P34; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Chung HY, 2006, ANTIOXID REDOX SIGN, V8, P572, DOI 10.1089/ars.2006.8.572; Ciechanover A, 2003, BIOCHEM SOC T, V31, P474, DOI 10.1042/BST0310474; Cocheme HM, 2008, J BIOL CHEM, V283, P1786, DOI 10.1074/jbc.M708597200; Conconi M, 1998, BIOCHEM J, V333, P407, DOI 10.1042/bj3330407; Cuschieri J, 2004, CELL IMMUNOL, V227, P140, DOI 10.1016/j.cellimm.2004.03.005; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Donoso LA, 2006, SURV OPHTHALMOL, V51, P137, DOI 10.1016/j.survophthal.2005.12.001; Dudek EJ, 2005, FASEB J, V19, P1707, DOI 10.1096/fj.05-4049fje; Dudek EJ, 2001, FREE RADICAL BIO MED, V31, P651, DOI 10.1016/S0891-5849(01)00634-7; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Fernandes AF, 2006, EXP EYE RES, V83, P1472, DOI 10.1016/j.exer.2006.07.024; Fiedler MA, 1998, AM J RESP CELL MOL, V19, P259, DOI 10.1165/ajrcmb.19.2.3149; Fukuoka Y, 2001, CURR EYE RES, V23, P320, DOI 10.1076/ceyr.23.5.320.5437; Fukuoka Y, 2003, CLIN EXP IMMUNOL, V131, P248, DOI 10.1046/j.1365-2249.2003.02087.x; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Gerber A, 2004, EUR RESPIR J, V24, P40, DOI 10.1183/09031936.04.00079203; Gilmour PS, 2003, AM J PHYSIOL-LUNG C, V284, pL533, DOI 10.1152/ajplung.00277.2002; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; Higgins GT, 2003, INVEST OPHTH VIS SCI, V44, P1775, DOI 10.1167/iovs.02-0742; Hipp MS, 2002, EUR J IMMUNOL, V32, P2208, DOI 10.1002/1521-4141(200208)32:8<2208::AID-IMMU2208>3.0.CO;2-2; Ho AK, 2005, BIOCHEM PHARMACOL, V70, P1840, DOI 10.1016/j.bcp.2005.09.013; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Hope AD, 2003, J NEUROCHEM, V86, P394, DOI 10.1046/j.1471-4159.2003.01844.x; Ishii T, 2005, BIOCHEMISTRY-US, V44, P13893, DOI 10.1021/bi051336u; Ito K, 2004, BIOCHEM BIOPH RES CO, V315, P240, DOI 10.1016/j.bbrc.2004.01.046; JAHNGENHODGE J, 1992, EXP EYE RES, V55, P897, DOI 10.1016/0014-4835(92)90016-L; JahngenHodge J, 1997, J BIOL CHEM, V272, P28218, DOI 10.1074/jbc.272.45.28218; Joshi-Barve S, 2003, HEPATOLOGY, V38, P1178, DOI 10.1053/jhep.2003.50470; Kalayoglu MV, 2005, GRAEF ARCH CLIN EXP, V243, P1080, DOI 10.1007/s00417-005-1169-y; Kamat AM, 2004, MOL CANCER THER, V3, P279; Kaur S, 2005, J BIOL CHEM, V280, P38599, DOI 10.1074/jbc.M505671200; Kloetzel PM, 2004, NAT IMMUNOL, V5, P661, DOI 10.1038/ni1090; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lavrovsky Y, 2000, EXP GERONTOL, V35, P521, DOI 10.1016/S0531-5565(00)00118-2; Liang FQ, 2003, EXP EYE RES, V76, P397, DOI 10.1016/S0014-4835(03)00023-X; Maniatis T, 1999, GENE DEV, V13, P505, DOI 10.1101/gad.13.5.505; McGeer EG, 2005, NEUROBIOL AGING, V26, pS94, DOI 10.1016/j.neurobiolaging.2005.08.008; Medina EA, 2005, ENDOCRINOLOGY, V146, P2726, DOI 10.1210/en.2004-1074; Meriin AB, 1998, J BIOL CHEM, V273, P6373, DOI 10.1074/jbc.273.11.6373; Newcomb DC, 2005, J BIOL CHEM, V280, P36952, DOI 10.1074/jbc.M502449200; Nie L, 2006, BIOCHEM BIOPH RES CO, V339, P603, DOI 10.1016/j.bbrc.2005.11.055; Obin M, 1998, FASEB J, V12, P561, DOI 10.1096/fasebj.12.7.561; Okada K, 1999, J BIOL CHEM, V274, P23787, DOI 10.1074/jbc.274.34.23787; Osawa Y, 2002, INFECT IMMUN, V70, P6294, DOI 10.1128/IAI.70.11.6294-6301.2002; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Qureshi N, 2005, IMMUNOL RES, V31, P243, DOI 10.1385/IR:31:3:243; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Roebuck KA, 1999, J INTERF CYTOK RES, V19, P429, DOI 10.1089/107999099313866; Rozanowska M, 1998, FREE RADICAL BIO MED, V24, P1107, DOI 10.1016/S0891-5849(97)00395-X; ROZANOWSKA M, 1995, J BIOL CHEM, V270, P18825, DOI 10.1074/jbc.270.32.18825; Shang F, 2004, EXP EYE RES, V78, P1, DOI 10.1016/j.exer.2003.10.003; Shang F, 1997, EXP EYE RES, V64, P21, DOI 10.1006/exer.1996.0176; Shang F, 2001, EXP EYE RES, V73, P229, DOI 10.1006/exer.2001.1029; Shang F, 2005, J BIOL CHEM, V280, P20365, DOI 10.1074/jbc.M414356200; Shi YY, 2006, BREAST CANCER RES TR, V100, P33, DOI 10.1007/s10549-006-9232-x; Sparrow JR, 1999, INVEST OPHTH VIS SCI, V40, P2988; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200; Tomita K, 2003, BIOCHEM BIOPH RES CO, V301, P572, DOI 10.1016/S0006-291X(02)03029-2; Verhasselt V, 1998, EUR J IMMUNOL, V28, P3886; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Wen XF, 2006, ONCOGENE, V25, P6986, DOI 10.1038/sj.onc.1209685; Wu HM, 2002, AM J RESP CELL MOL, V27, P234, DOI 10.1165/ajrcmb.27.2.4792; Wu HM, 2002, FEBS LETT, V526, P101, DOI 10.1016/S0014-5793(02)03151-4; Wu WT, 2004, BIOCHEM J, V379, P587, DOI 10.1042/BJ20031579; Yamamoto K, 2003, INFLAMMATION, V27, P123, DOI 10.1023/A:1023813710941; Yan D, 2006, J CELL BIOL, V174, P415, DOI 10.1083/jcb.200511028; Yoshida A, 1998, INVEST OPHTH VIS SCI, V39, P1097; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598; ZHANG X, 2008, INVESTIG OP IN PRESS, V49; Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103; Zhou JL, 2005, EXP EYE RES, V80, P567, DOI 10.1016/j.exer.2004.11.009	86	61	64	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20745	20753		10.1074/jbc.M800268200	http://dx.doi.org/10.1074/jbc.M800268200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18502748	Green Published, hybrid			2022-12-25	WOS:000257746100015
J	Hu, TC; Wu, DL; Chen, J; Ding, JP; Jiang, HL; Shen, X				Hu, Tiancen; Wu, Dalei; Chen, Jing; Ding, Jianping; Jiang, Hualiang; Shen, Xu			The catalytic intermediate stabilized by a "Down" active site loop for diaminopimelate decarboxylase from Helicobacter pylori - Enzymatic characterization with crystal structure analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-STRUCTURE; BRUCEI ORNITHINE-DECARBOXYLASE; TRYPANOSOMA-BRUCEI; ANTIBIOTIC-RESISTANCE; REACTION SPECIFICITY; ALANINE RACEMASE; ACID; CARBOXYLATE; INHIBITION; MECHANISM	The meso-diaminopimelate decarboxylase (DAPDC, EC 4.1.1.20) catalyzes the final step of L-lysine biosynthesis in bacteria and is regarded as a target for the discovery of antibiotics. Here we report the 2.3 angstrom crystal structure of DAPDC from Helicobacter pylori (HpDAPDC). The structure, in which the product L-lysine forms a Schiff base with the cofactor pyridoxal 5'-phosphate, provides structural insight into the substrate specificity and catalytic mechanism of the enzyme, and implies that the carboxyl to be cleaved locates at the si face of the cofactor. To our knowledge, this might be the first reported external aldimine of DAPDC. Moreover, the active site loop of HpDAPDC is in a "down" conformation and shields the ligand from solvent. Mutations of Ile(148) from the loop greatly impaired the catalytic efficiency. Combining the structural analysis of the I148L mutant, we hypothesize that HpDAPDC adopts an induced-fit catalytic mechanism in which this loop cycles through "down" and "up" conformations to stabilize intermediates and release product, respectively. Our work is expected to provide clues for designing specific inhibitors of DAPDC.	[Hu, Tiancen; Wu, Dalei; Chen, Jing; Jiang, Hualiang; Shen, Xu] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Drug Discovery & Design Ctr, Shanghai 201203, Peoples R China; [Ding, Jianping] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 20031, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Jiang, HL (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Drug Discovery & Design Ctr, Shanghai 201203, Peoples R China.	hljiang@mail.shcnc.ac.cn; xshen@mail.shcnc.ac.cn		ding, jian ping/0000-0001-7029-7346				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Brooks HB, 1997, BIOCHEMISTRY-US, V36, P15147, DOI 10.1021/bi971652b; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Christen P, 2001, CHEM REC, V1, P436, DOI 10.1002/tcr.10005; De Lencastre H, 1999, MICROB DRUG RESIST, V5, P163, DOI 10.1089/mdr.1999.5.163; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dufe VT, 2007, BIOCHEM J, V405, P261, DOI 10.1042/BJ20070188; DUNATHAN HC, 1966, P NATL ACAD SCI USA, V55, P712, DOI 10.1073/pnas.55.4.712; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P. R., 1993, P CCP4 STUD WEEK DAT, P114; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Gokulan K, 2003, J BIOL CHEM, V278, P18588, DOI 10.1074/jbc.M301549200; Grishin NV, 1999, BIOCHEMISTRY-US, V38, P15174, DOI 10.1021/bi9915115; Jackson LK, 2000, BIOCHEMISTRY-US, V39, P11247, DOI 10.1021/bi001209s; Jackson LK, 2003, J BIOL CHEM, V278, P22037, DOI 10.1074/jbc.M300188200; Jackson LK, 2003, BIOCHEMISTRY-US, V42, P2933, DOI 10.1021/bi026795z; Jackson LK, 2004, BIOCHEMISTRY-US, V43, P12990, DOI 10.1021/bi048933l; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kern AD, 1999, STRUCTURE, V7, P567, DOI 10.1016/S0969-2126(99)80073-2; Kidron H, 2007, MOL BIOL EVOL, V24, P79, DOI 10.1093/molbev/msl133; LABER B, 1989, ANAL BIOCHEM, V181, P297, DOI 10.1016/0003-2697(89)90246-7; Lee J, 2007, J BIOL CHEM, V282, P27115, DOI 10.1074/jbc.M704066200; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Liu WZ, 2006, FEBS LETT, V580, P697, DOI 10.1016/j.febslet.2005.12.085; Liu WZ, 2005, BIOCHEM BIOPH RES CO, V333, P1078, DOI 10.1016/j.bbrc.2005.05.197; MISONO H, 1986, AGR BIOL CHEM TOKYO, V50, P1329, DOI 10.1080/00021369.1986.10867567; Momany C, 2002, ACTA CRYSTALLOGR D, V58, P549, DOI 10.1107/S0907444902000148; Morollo AA, 1999, BIOCHEMISTRY-US, V38, P3293, DOI 10.1021/bi9822729; Myers DP, 2001, BIOCHEMISTRY-US, V40, P13230, DOI 10.1021/bi0155908; Osterman AL, 1999, BIOCHEMISTRY-US, V38, P11814, DOI 10.1021/bi9906221; Ray SS, 2002, STRUCTURE, V10, P1499, DOI 10.1016/S0969-2126(02)00880-8; ROMAN A, 1993, J APPL CRYSTALLOGR, V26, P283; SANDMEIER E, 1994, EUR J BIOCHEM, V221, P997, DOI 10.1111/j.1432-1033.1994.tb18816.x; Schilling CH, 2002, J BACTERIOL, V184, P4582, DOI 10.1128/JB.184.16.4582-4593.2002; Shah R, 2007, BIOCHEMISTRY-US, V46, P2831, DOI 10.1021/bi6023447; Shaw JP, 1997, BIOCHEMISTRY-US, V36, P1329, DOI 10.1021/bi961856c; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Stamper CGF, 1998, BIOCHEMISTRY-US, V37, P10438, DOI 10.1021/bi980692s; SUNDHARA.G, 1967, J BIOL CHEM, V242, P3983; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; White P., 1971, METHODS ENZYMOLOGY B, V17, P140	44	17	39	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21284	21293		10.1074/jbc.M801823200	http://dx.doi.org/10.1074/jbc.M801823200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18508763	Green Published, hybrid			2022-12-25	WOS:000257746100070
J	Wang, ZQ; Cao, N; Nantajit, D; Fan, M; Liu, YS; Li, JJ				Wang, Zhaoqing; Cao, Ning; Nantajit, Danupon; Fan, Ming; Liu, Yusen; Li, Jian Jian			Mitogen-activated protein kinase phosphatase-1 represses c-Jun NH2-terminal kinase-mediated apoptosis via NF-kappa B regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUAL-SPECIFICITY PHOSPHATASE; CELL LUNG-CANCER; IONIZING-RADIATION; MAP KINASE; JNK ACTIVATION; SIGNAL-TRANSDUCTION; OXIDATIVE STRESS; MKP-1; RESPONSES; PATHWAYS	The mechanism regulating radiation-induced anti-apoptotic response, a limiting factor in improving cell radiosensitivity, remains elusive. Mitogen-activated protein kinase (MAPK) phosphatase (MKP)-1 is the major member of MKPs that dephosphorylates and inactivates MAPK. Here we provide the evidence that MKP-1 was negatively bridging between NF-kappa B-mediated prosurvival pathway and c-Jun N-terminal kinase (JNK)-mediated proapoptotic response. MKP-1 was induced by gamma-radiation and repressed radiation-induced pro-apoptotic status. NF-kappa B RelA/p50 heterodimer was recruited to MKP-1 gene promoter to induce MKP-1 transcription. Deletion of the NF-kappa B-binding site or inactivation of NF-kappa B by its small interfering RNA significantly decreased the radiation-induced MKP-1 promoter activity. In addition, MKP-1-deficient mouse embryonic fibroblasts exhibited a prolonged activation of JNK but not p38 or extracellular signal-regulated kinase subfamilies of MAPKs. The prolonged activation of JNK was not induced by treatment with tumor necrosis factor alpha or interleukin-6, and inactivation of JNK but not p38 or ERK abolished radiation-induced proapoptotic status, indicating that JNK is specifically inhibited by radiation-induced MKP-1. Three MKP-1 wild type human tumor cell lines treated with MKP-1 small interfering RNA showed an increased proapoptotic response that can be rescued by overexpression of wild type mouse MKP-1. Together, these results suggest that MKP-1 is a NF-kappa B-mediated prosurvival effector in attenuating JNK-mediated pro-apoptotic response; NF-kappa B/MKP-1-mediated negative JNK regulation represents a potential therapeutic target for adjusting cell radiosensitivity.	[Wang, Zhaoqing; Cao, Ning; Nantajit, Danupon; Fan, Ming; Li, Jian Jian] Purdue Univ, Sch Hlth Sci, Div Mol Radiobiol, W Lafayette, IN 47907 USA; [Liu, Yusen] Ohio State Univ, Childrens Res Inst, Dept Pediat, Columbus, OH 43205 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	Li, JJ (corresponding author), Purdue Univ, Sch Hlth Sci, Div Mol Radiobiol, Rm 1279 Civil Engn Bldg,550 Stadium Mall Dr, W Lafayette, IN 47907 USA.	jjli@purdue.edu	Liu, Yusen/E-3527-2011; Cao, Ning/I-3094-2013; Cao, Ning/F-9480-2013; Nantajit, Danupon/CAF-7353-2022	Li, Jian Jian/0000-0003-3694-9675; Liu, Yusen/0000-0002-0994-0109; Cao, Ning/0000-0002-3929-8604	PHS HHS [R01 101990] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ahmed KM, 2008, FREE RADICAL BIO MED, V44, P1, DOI 10.1016/j.freeradbiomed.2007.09.022; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bradbury CM, 2001, CANCER RES, V61, P7689; Brondello JM, 1999, SCIENCE, V286, P2514, DOI 10.1126/science.286.5449.2514; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Chattopadhyay S, 2006, ONCOGENE, V25, P3335, DOI 10.1038/sj.onc.1209364; Chen XF, 2002, CANCER RES, V62, P1213; Choi SY, 2006, J BIOL CHEM, V281, P7049, DOI 10.1074/jbc.M512000200; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; DEWEY WC, 1995, INT J RADIAT ONCOL, V33, P781, DOI 10.1016/0360-3016(95)00214-8; Dong G, 2001, CANCER RES, V61, P4797; Fan M, 2007, CANCER RES, V67, P3220, DOI 10.1158/0008-5472.CAN-06-2728; Franklin CC, 1998, P NATL ACAD SCI USA, V95, P3014, DOI 10.1073/pnas.95.6.3014; Guo GZ, 2003, MOL CELL BIOL, V23, P2362, DOI 10.1128/MCB.23.7.2362-2378.2003; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hunter I, 2006, J BIOL CHEM, V281, P34705, DOI 10.1074/jbc.M605738200; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Jung M, 2001, SEMIN RADIAT ONCOL, V11, P346, DOI 10.1053/srao.2001.26034; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; KEYSE SM, 1992, NATURE, V359, P644, DOI 10.1038/359644a0; Kiegerl S, 2000, PLANT CELL, V12, P2247, DOI 10.1105/tpc.12.11.2247; Kim JJ, 2005, NAT REV CANCER, V5, P516, DOI 10.1038/nrc1650; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Kondoh K, 2007, BBA-MOL CELL RES, V1773, P1227, DOI 10.1016/j.bbamcr.2006.12.002; Kondoh K, 2007, J BIOL CHEM, V282, P3058, DOI 10.1074/jbc.M607630200; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Li J, 2001, MOL CELL BIOL, V21, P8213, DOI 10.1128/MCB.21.23.8213-8224.2001; Li ZK, 2001, RADIAT RES, V155, P543, DOI 10.1667/0033-7587(2001)155[0543:EGAIMH]2.0.CO;2; Lin YW, 2006, J BIOL CHEM, V281, P915, DOI 10.1074/jbc.M508720200; Magne N, 2006, CANCER LETT, V231, P158, DOI 10.1016/j.canlet.2005.01.022; Nakajima A, 2008, ONCOGENE, V27, P76, DOI 10.1038/sj.onc.1210624; Ozeki M, 2004, ANTICANCER RES, V24, P2657; Pajonk F, 1999, J NATL CANCER I, V91, P1956, DOI 10.1093/jnci/91.22.1956; Sakon S, 2003, EMBO J, V22, P3898, DOI 10.1093/emboj/cdg379; Salvi M, 2005, FREE RADICAL BIO MED, V38, P1267, DOI 10.1016/j.freeradbiomed.2005.02.006; Sanchez-Perez I, 2000, ONCOGENE, V19, P5142, DOI 10.1038/sj.onc.1203887; Schmidt-Ullrich RK, 2000, RADIAT RES, V153, P245, DOI 10.1667/0033-7587(2000)153[0245:STACRR]2.0.CO;2; Small GW, 2007, CANCER RES, V67, P4459, DOI 10.1158/0008-5472.CAN-06-2644; Spitz DR, 2004, CANCER METAST REV, V23, P311, DOI 10.1023/B:CANC.0000031769.14728.bc; STRASSER A, 1994, CELL, V79, P329, DOI 10.1016/0092-8674(94)90201-1; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Wang JL, 2007, CANCER RES, V67, P6737, DOI 10.1158/0008-5472.CAN-06-4402; Wang ZQ, 2006, CANCER RES, V66, P8870, DOI 10.1158/0008-5472.CAN-06-1280; Wu JJ, 2005, J BIOL CHEM, V280, P16461, DOI 10.1074/jbc.M501762200	51	38	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					21011	21023		10.1074/jbc.M802229200	http://dx.doi.org/10.1074/jbc.M802229200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18508759	Green Published, hybrid			2022-12-25	WOS:000257746100043
J	Fronz, K; Otto, S; Kolbel, K; Kuhn, U; Friedrich, H; Schierhorn, A; Beck-Sickinger, AG; Ostareck-Lederer, A; Wahle, E				Fronz, Katharina; Otto, Silke; Koelbel, Knut; Kuehn, Uwe; Friedrich, Henning; Schierhorn, Angelika; Beck-Sickinger, Annette G.; Ostareck-Lederer, Antje; Wahle, Elmar			Promiscuous modification of the nuclear poly(A)-binding protein by multiple protein-arginine methyltransferases does not affect the aggregation behavior	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY(A) BINDING-PROTEIN; RNA-POLYMERASE-II; N-METHYLTRANSFERASE; LENGTH CONTROL; SM PROTEINS; HISTONE H4; IN-VIVO; METHYLATION; SUBSTRATE; COMPLEX	The mammalian nuclear poly(A)-binding protein, PABPN1, carries 13 asymmetrically dimethylated arginine residues in its C-terminal domain. By fractionation of cell extracts, we found that protein-arginine methyltransferases (PRMTs)-1, -3, and -6 are responsible for the modification of PABPN1. Recombinant PRMT1, -3, and -6 also methylated PABPN1. Our data suggest that these enzymes act on their own, and additional polypeptides are not involved in recognizing PABPN1 as a substrate. PRMT1 is the predominant methyltransferase acting on PABPN1. Nevertheless, PABPN1 was almost fully methylated in a Prmt1(-/-) cell line; thus, PRMT3 and -6 suffice for methylation. In contrast to PABPN1, the heterogeneous nuclear ribonucleoprotein (hnRNP) K is selectively methylated only by PRMT1. Efficient methylation of synthetic peptides derived from PABPN1 or hnRNP K suggested that PRMT1, -3, and -6 recognize their substrates by interacting with local amino acid sequences and not with additional domains of the substrates. However, the use of fusion proteins suggested that the inability of PRMT3 and -6 to modify hnRNP K is because of structural masking of the methyl-accepting amino acid sequences by neighboring domains. Mutations leading to intracellular aggregation of PABPN1 cause the disease oculopharyngeal muscular dystrophy. The C-terminal domain containing the methylated arginine residues is known to promote PAPBN1 self-association, and arginine methylation has been reported to inhibit self-association of an orthologous protein. Thus, arginine methylation might be relevant for oculopharyngeal muscular dystrophy. However, in two different types of assays we have been unable to detect any effect of arginine methylation on the aggregation of bovine PABPN1.	[Fronz, Katharina; Otto, Silke; Koelbel, Knut; Kuehn, Uwe; Friedrich, Henning; Schierhorn, Angelika; Ostareck-Lederer, Antje; Wahle, Elmar] Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06120 Halle, Germany; [Beck-Sickinger, Annette G.] Univ Leipzig, Inst Biochem, D-04103 Leipzig, Germany	Martin Luther University Halle Wittenberg; Leipzig University	Wahle, E (corresponding author), Univ Halle Wittenberg, Inst Biochem & Biotechnol, Kurt Mothes Str 3, D-06120 Halle, Germany.	ewahle@biochemtech.uni-halle.de		Ostareck-Lederer, Antje/0000-0003-0733-7071; Wahle, Elmar/0000-0003-2504-0677				Bachand F, 2004, EMBO J, V23, P2641, DOI 10.1038/sj.emboj.7600265; Bachand F, 2007, EUKARYOT CELL, V6, P889, DOI 10.1128/EC.00099-07; Bear DG, 2003, EXP CELL RES, V286, P332, DOI 10.1016/S0014-4827(03)00123-X; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Benoit B, 2005, DEV CELL, V9, P511, DOI 10.1016/j.devcel.2005.09.002; BIENROTH S, 1993, EMBO J, V12, P585, DOI 10.1002/j.1460-2075.1993.tb05690.x; Brahms H, 2000, J BIOL CHEM, V275, P17122, DOI 10.1074/jbc.M000300200; Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164; Calado A, 2000, HUM MOL GENET, V9, P2321, DOI 10.1093/oxfordjournals.hmg.a018924; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Cote J, 2003, MOL BIOL CELL, V14, P274, DOI 10.1091/mbc.E02-08-0484; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Fan XP, 2001, HUM MOL GENET, V10, P2341, DOI 10.1093/hmg/10.21.2341; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; GARY JD, 1998, NUCLEIC ACIDS RES, V98, P65; Guccione E, 2007, NATURE, V449, P933, DOI 10.1038/nature06166; Huang SM, 2005, GENE DEV, V19, P1885, DOI 10.1101/gad.1333905; Hyllus D, 2007, GENE DEV, V21, P3369, DOI 10.1101/gad.447007; Keller RW, 2000, J MOL BIOL, V297, P569, DOI 10.1006/jmbi.2000.3572; Kerwitz Y, 2003, EMBO J, V22, P3705, DOI 10.1093/emboj/cdg347; Kim S, 1997, BIOCHEMISTRY-US, V36, P5185, DOI 10.1021/bi9625509; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; KRAUSE S, 1994, EXP CELL RES, V214, P75, DOI 10.1006/excr.1994.1235; Kuhn U, 2003, J BIOL CHEM, V278, P16916, DOI 10.1074/jbc.M209886200; Lakowski TM, 2008, J BIOL CHEM, V283, P10015, DOI 10.1074/jbc.M710176200; Lee DY, 2005, ENDOCR REV, V26, P147, DOI 10.1210/er.2004-0008; Lee J, 2005, J BIOL CHEM, V280, P32890, DOI 10.1074/jbc.M506944200; Lee J, 2002, EMBO REP, V3, P268, DOI 10.1093/embo-reports/kvf052; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Meister G, 2002, TRENDS CELL BIOL, V12, P472, DOI 10.1016/S0962-8924(02)02371-1; NAJBAUER J, 1993, J BIOL CHEM, V268, P10501; NEMETH A, 1995, NUCLEIC ACIDS RES, V23, P4034, DOI 10.1093/nar/23.20.4034; Osborne TC, 2007, BIOCHEMISTRY-US, V46, P13370, DOI 10.1021/bi701558t; Ostareck-Lederer A, 2006, J BIOL CHEM, V281, P11115, DOI 10.1074/jbc.M513053200; Pahlich S, 2005, PROTEINS, V61, P164, DOI 10.1002/prot.20579; Pahlich S, 2006, BBA-PROTEINS PROTEOM, V1764, P1890, DOI 10.1016/j.bbapap.2006.08.008; Pawlak MR, 2000, MOL CELL BIOL, V20, P4859, DOI 10.1128/MCB.20.13.4859-4869.2000; Perreault A, 2007, J BIOL CHEM, V282, P7552, DOI 10.1074/jbc.M610512200; Rappsilber J, 2003, ANAL CHEM, V75, P3107, DOI 10.1021/ac026283q; Rennert R, 2006, BBA-BIOMEMBRANES, V1758, P347, DOI 10.1016/j.bbamem.2005.10.006; Ruegsegger U, 1996, J BIOL CHEM, V271, P6107; Scheuermann T, 2003, PROTEIN SCI, V12, P2685, DOI 10.1110/ps.03214703; Schurter BT, 2001, BIOCHEMISTRY-US, V40, P5747, DOI 10.1021/bi002631b; Scorilas A, 2000, BIOCHEM BIOPH RES CO, V278, P349, DOI 10.1006/bbrc.2000.3807; Smith JJ, 1999, J BIOL CHEM, V274, P13229, DOI 10.1074/jbc.274.19.13229; Suckau D, 2003, ANAL BIOANAL CHEM, V376, P952, DOI 10.1007/s00216-003-2057-0; Swiercz R, 2007, J BIOL CHEM, V282, P16917, DOI 10.1074/jbc.M609778200; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Tang J, 1998, J BIOL CHEM, V273, P16935, DOI 10.1074/jbc.273.27.16935; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; Troffer-Charlier N, 2007, EMBO J, V26, P4391, DOI 10.1038/sj.emboj.7601855; Verheesen P, 2006, BBA-PROTEINS PROTEOM, V1764, P1307, DOI 10.1016/j.bbapap.2006.05.011; WAHLE E, 1993, J BIOL CHEM, V268, P2937; WAHLE E, 1991, CELL, V66, P759, DOI 10.1016/0092-8674(91)90119-J; WAHLE E, 1995, J BIOL CHEM, V270, P2800, DOI 10.1074/jbc.270.6.2800; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Weiss VH, 2000, NAT STRUCT BIOL, V7, P1165; Xu W, 2004, GENE DEV, V18, P144, DOI 10.1101/gad.1141704; Yadav N, 2003, P NATL ACAD SCI USA, V100, P6464, DOI 10.1073/pnas.1232272100; Yu MC, 2004, GENE DEV, V18, P2024, DOI 10.1101/gad.1223204; Yue WW, 2007, EMBO J, V26, P4402, DOI 10.1038/sj.emboj.7601856; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zhang X, 2000, EMBO J, V19, P3509, DOI 10.1093/emboj/19.14.3509	63	38	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20408	20420		10.1074/jbc.M802329200	http://dx.doi.org/10.1074/jbc.M802329200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18495660	hybrid			2022-12-25	WOS:000257565300056
J	Lowey, S; Lesko, LM; Rovner, AS; Hodges, AR; White, SL; Low, RB; Rincon, M; Gulick, J; Robbins, J				Lowey, Susan; Lesko, Leanne M.; Rovner, Arthur S.; Hodges, Alex R.; White, Sheryl L.; Low, Robert B.; Rincon, Mercedes; Gulick, James; Robbins, Jeffrey			Functional effects of the hypertrophic cardiomyopathy R403Q mutation are different in an alpha- or beta-myosin heavy chain backbone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE MYOSIN; CARDIAC MYOSIN; LIGHT-CHAIN; MOUSE MODEL; MECHANICAL PERFORMANCE; MOLECULAR-BASIS; GENETIC-BASIS; POWER STROKE; ACTIN; ISOFORMS	The R403Q mutation in the beta-myosin heavy chain (MHC) was the first mutation to be linked to familial hypertrophic cardiomyopathy (FHC), a primary disease of heart muscle. The initial studies with R403Q myosin, isolated from biopsies of patients, showed a large decrease in myosin motor function, leading to the hypothesis that hypertrophy was a compensatory response. The introduction of the mouse model for FHC (the mouse expresses predominantly alpha-MHC as opposed to the beta-isoform in larger mammals) created a new paradigm for FHC based on finding enhanced motor function for R403Q alpha-MHC. To help resolve these conflicting mechanisms, we used a transgenic mouse model in which the endogenous alpha-MHC was largely replaced with transgenically encoded beta-MHC. A His(6) tag was cloned at the N terminus of the alpha-and beta-MHC to facilitate protein isolation by Ni2+-chelating chromatography. Characterization of the R403Q alpha-MHC by the in vitro motility assay showed a 30-40% increase in actin filament velocity compared with wild type, consistent with published studies. In contrast, the R403Q mutation in a beta-MHC backbone showed no enhancement in velocity. Cleavage of the His-tagged myosin by chymotrypsin made it possible to isolate homogeneous myosin sub-fragment 1 (S1), uncontaminated by endogenous myosin. We find that the actin-activated MgAT Pase activity for R403Q alpha-S1 is similar to 30% higher than for wild type, whereas the enzymatic activity for R403Q beta-S1 is reduced by similar to 10%. Thus, the functional consequences of the mutation are fundamentally changed depending upon the context of the cardiac MHC isoform.	[Lowey, Susan; Lesko, Leanne M.; Rovner, Arthur S.; Hodges, Alex R.; White, Sheryl L.; Low, Robert B.] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA; [Rincon, Mercedes] Univ Vermont, Dept Med, Burlington, VT 05405 USA; [Gulick, James; Robbins, Jeffrey] Univ Cincinnati, Childrens Hosp, Med Ctr, Div Mol Cardiovasc Biol, Cincinnati, OH 45229 USA	University of Vermont; University of Vermont; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Lowey, S (corresponding author), Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA.	lowey@physiology.med.uvm.edu			NCRR NIH HHS [P20 RR 16435] Funding Source: Medline; NHLBI NIH HHS [HL 074728, HL 087862, HL 69799, HL 077101, HL 59408] Funding Source: Medline; NIAMS NIH HHS [AR 053975] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016435] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL074728, P01HL059408, R01HL087862, P50HL077101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053975] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Alpert NR, 2002, AM J PHYSIOL-HEART C, V283, pH1446, DOI 10.1152/ajpheart.00274.2002; BARANY M, 1967, J GEN PHYSIOL, V50, P197, DOI 10.1085/jgp.50.6.197; Blanchard E, 1999, CIRC RES, V84, P475, DOI 10.1161/01.RES.84.4.475; BOURDIEU L, 1995, PHYS REV E, V52, P6573, DOI 10.1103/PhysRevE.52.6573; Cuda G, 1997, J MUSCLE RES CELL M, V18, P275, DOI 10.1023/A:1018613907574; CUDA G, 1993, J CLIN INVEST, V91, P2861, DOI 10.1172/JCI116530; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; Debold EP, 2007, AM J PHYSIOL-HEART C, V293, pH284, DOI 10.1152/ajpheart.00128.2007; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Fujita H, 1997, J CLIN INVEST, V99, P1010, DOI 10.1172/JCI119228; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; GeisterferLowrance AAT, 1996, SCIENCE, V272, P731, DOI 10.1126/science.272.5262.731; Jones WK, 1996, J CLIN INVEST, V98, P1906, DOI 10.1172/JCI118992; Kinose F, 1996, J CELL BIOL, V134, P895, DOI 10.1083/jcb.134.4.895; Krenz M, 2003, J BIOL CHEM, V278, P17466, DOI 10.1074/jbc.M210804200; Krenz M, 2007, J BIOL CHEM, V282, P24057, DOI 10.1074/jbc.M704574200; LANKFORD EB, 1995, J CLIN INVEST, V95, P1409, DOI 10.1172/JCI117795; Lowey S, 2002, TRENDS CARDIOVAS MED, V12, P348, DOI 10.1016/S1050-1738(02)00181-0; Malinchik S, 1997, J MOL CELL CARDIOL, V29, P667, DOI 10.1006/jmcc.1996.0309; Malmqvist UP, 2004, BIOCHEMISTRY-US, V43, P15058, DOI 10.1021/bi0495329; Marian AJ, 2001, J MOL CELL CARDIOL, V33, P655, DOI 10.1006/jmcc.2001.1340; Marian AJ, 1999, J CLIN INVEST, V104, P1683, DOI 10.1172/JCI7956; MCNALLY EM, 1989, J MOL BIOL, V210, P665, DOI 10.1016/0022-2836(89)90141-1; Milligan RA, 1996, P NATL ACAD SCI USA, V93, P21, DOI 10.1073/pnas.93.1.21; Palmer BM, 2004, AM J PHYSIOL-HEART C, V287, pH91, DOI 10.1152/ajpheart.01015.2003; Palmer BM, 2008, AM J PHYSIOL-HEART C, V294, pH1939, DOI 10.1152/ajpheart.00644.2007; Palmiter KA, 2000, J MUSCLE RES CELL M, V21, P609, DOI 10.1023/A:1005678905119; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Pereira JS, 2001, J BIOL CHEM, V276, P4409, DOI 10.1074/jbc.M006441200; Roopnarine O, 1998, BIOPHYS J, V75, P3023, DOI 10.1016/S0006-3495(98)77743-4; Rovner AS, 2003, J BIOL CHEM, V278, P26938, DOI 10.1074/jbc.M303122200; Sata M, 1996, J CLIN INVEST, V98, P2866, DOI 10.1172/JCI119115; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Sherwood JJ, 2004, P NATL ACAD SCI USA, V101, P10973, DOI 10.1073/pnas.0401699101; SWEENEY HL, 1994, J BIOL CHEM, V269, P1603; Tardiff JC, 2005, HEART FAIL REV, V10, P237, DOI 10.1007/s10741-005-5253-5; TOBACMAN LS, 1984, J BIOL CHEM, V259, P1226; Trybus KM, 2000, METHODS, V22, P327, DOI 10.1006/meth.2000.1085; Tyska MJ, 2000, CIRC RES, V86, P737, DOI 10.1161/01.RES.86.7.737; Tyska MJ, 2002, CELL MOTIL CYTOSKEL, V51, P1, DOI 10.1002/cm.10014; Volkmann N, 2005, MOL CELL, V19, P595, DOI 10.1016/j.molcel.2005.07.015; Volkmann N, 2003, P NATL ACAD SCI USA, V100, P3227, DOI 10.1073/pnas.0536510100; Volkmann N, 2000, NAT STRUCT BIOL, V7, P1147; Volkmann N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001123; WAGNER PD, 1979, EUR J BIOCHEM, V99, P385, DOI 10.1111/j.1432-1033.1979.tb13267.x; WORK SS, 1992, ANAL BIOCHEM, V202, P275, DOI 10.1016/0003-2697(92)90106-H; Yamashita H, 2000, J BIOL CHEM, V275, P28045	47	61	61	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20579	20589		10.1074/jbc.M800554200	http://dx.doi.org/10.1074/jbc.M800554200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18480046	hybrid, Green Published			2022-12-25	WOS:000257565300070
J	Roberts, JA; Digby, HR; Kara, M; El Ajouz, S; Sutcliffe, MJ; Evans, RJ				Roberts, Jonathan A.; Digby, Helen R.; Kara, Madina; El Ajouz, Sam; Sutcliffe, Michael J.; Evans, Richard J.			Cysteine substitution mutagenesis and the effects of methanethiosulfonate reagents at P2X(2) and P2X(4) receptors support a core common mode of ATP action at P2X receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-PROPERTIES; BINDING-SITE; AMINO-ACIDS; GATED P2X; RESIDUES; IDENTIFICATION; CHANNELS; DOMAIN; PURINOCEPTOR; PAIN	The agonist binding site of ATP-gated P2X receptors is distinct from other ATP-binding proteins. Mutagenesis on P2X(1) receptors of conserved residues in mammalian P2X receptors has established the paradigm that three lysine residues, as well as FT and NFR motifs, play an important role in mediating ATP action. In this study we have determined whether cysteine substitution mutations of equivalent residues in P2X(2) and P2X(4) receptors have similar effects and if these mutant receptors can be regulated by charged methanethiosulfonate (MTS) compounds. All the mutants (except the P2X(2) K69C and K71C that were expressed, but non-functional) showed a significant decrease in ATP potency, with > 300-fold decreases for mutants of the conserved asparagine, arginine, and lysine residues close to the end of the extracellular loop. MTS reagents had no effect at the phenylalanine of the FT motif, in contrast, cysteine mutation of the threonine was sensitive to MTS reagents and suggested a role of this residue in ATP action. The lysine-substituted receptors were sensitive to the charge of the MTS reagent consistent with the importance of positive charge at this position for coordination of the negatively charged phosphate of ATP. At the NFR motif the asparagine and arginine residues were sensitive to MTS reagents, whereas the phenylalanine was either unaffected or showed only a small decrease. These results support a common site of ATP action at P2X receptors and suggest that non-conserved residues also play a regulatory role in agonist action.	[Roberts, Jonathan A.; Digby, Helen R.; Kara, Madina; El Ajouz, Sam; Evans, Richard J.] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England; [Sutcliffe, Michael J.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England	University of Leicester; University of Leicester	Evans, RJ (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Henry Wellcome Bldg, Leicester LE1 9HN, Leics, England.	rje6@le.ac.uk	Roberts, Jon/A-6771-2012	Sutcliffe, Mike/0000-0003-0414-1700	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; BO XN, 1995, FEBS LETT, V375, P129, DOI 10.1016/0014-5793(95)01203-Q; Bobanovic LK, 2002, J NEUROSCI, V22, P4814, DOI 10.1523/JNEUROSCI.22-12-04814.2002; Buell G, 1996, EMBO J, V15, P55, DOI 10.1002/j.1460-2075.1996.tb00333.x; Burnstock G, 2006, PHARMACOL REV, V58, P58, DOI 10.1124/pr.58.1.5; Cao LS, 2007, J NEUROSCI, V27, P12916, DOI 10.1523/JNEUROSCI.4036-07.2007; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Clyne JD, 2002, J NEUROSCI, V22, P3873, DOI 10.1523/JNEUROSCI.22-10-03873.2002; Cockayne DA, 2000, NATURE, V407, P1011, DOI 10.1038/35039519; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Egan TM, 1998, J NEUROSCI, V18, P2350; Ennion S, 2000, J BIOL CHEM, V275, P29361, DOI 10.1074/jbc.M003637200; Ennion SJ, 2002, MOL PHARMACOL, V61, P303, DOI 10.1124/mol.61.2.303; EVANS RJ, 1995, MOL PHARMACOL, V48, P178; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; Fountain SJ, 2007, NATURE, V448, P200, DOI 10.1038/nature05926; Fountain SJ, 2006, J BIOL CHEM, V281, P15044, DOI 10.1074/jbc.M600442200; Hechler B, 2003, J EXP MED, V198, P661, DOI 10.1084/jem.20030144; Jiang LH, 2000, J BIOL CHEM, V275, P34190, DOI 10.1074/jbc.M005481200; Jiang LH, 2001, J BIOL CHEM, V276, P14902, DOI 10.1074/jbc.M011327200; Ke HZ, 2003, MOL ENDOCRINOL, V17, P1356, DOI 10.1210/me.2003-0021; Marquez-Klaka B, 2007, J NEUROSCI, V27, P1456, DOI 10.1523/JNEUROSCI.3105-06.2007; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Rassendren F, 1997, EMBO J, V16, P3446, DOI 10.1093/emboj/16.12.3446; Roberts JA, 2004, J BIOL CHEM, V279, P9043, DOI 10.1074/jbc.M308964200; Roberts JA, 2007, J NEUROSCI, V27, P4072, DOI 10.1523/JNEUROSCI.2310-06.2007; Roberts JA, 2006, PFLUG ARCH EUR J PHY, V452, P486, DOI 10.1007/s00424-006-0073-6; Royle SJ, 2005, J CELL SCI, V118, P3073, DOI 10.1242/jcs.02451; Royle SJ, 2002, J BIOL CHEM, V277, P35378, DOI 10.1074/jbc.M204844200; Silberberg SD, 2005, J GEN PHYSIOL, V125, P347, DOI 10.1085/jgp.200409221; Souslova V, 2000, NATURE, V407, P1015, DOI 10.1038/35039526; Stojilkovic SS, 2005, ANN NY ACAD SCI, V1048, P116, DOI 10.1196/annals.1342.011; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Vial C, 2004, TRENDS PHARMACOL SCI, V25, P487, DOI 10.1016/j.tips.2004.07.008; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Yan ZH, 2005, MOL PHARMACOL, V67, P1078, DOI 10.1124/mol.104.010108; Zemkova H, 2007, J NEUROCHEM, V102, P1139, DOI 10.1111/j.1471-4159.2007.04616.x	37	50	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20126	20136		10.1074/jbc.M800294200	http://dx.doi.org/10.1074/jbc.M800294200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18487206	hybrid, Green Published			2022-12-25	WOS:000257565300029
J	Xia, H; Nho, R; Kleidon, J; Kahm, J; Henke, CA				Xia, Hong; Nho, Richard; Kleidon, Jill; Kahm, Judy; Henke, Craig A.			Polymerized collagen inhibits fibroblast proliferation via a mechanism involving the formation of a beta 1 integrin-protein phosphatase 2A-tuberous sclerosis complex 2 complex that suppresses S6K1 activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; VIABILITY SIGNALING PATHWAY; GROWTH-FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE; CELL-GROWTH; EXTRACELLULAR-MATRIX; KINASE ACTIVATION; REGULATED KINASES; DEPENDENT PATHWAY; INDUCED APOPTOSIS	Polymerized type I collagen suppresses fibroblast proliferation. Previous studies have implicated inhibition of fibroblast proliferation with polymerized collagen-mediated suppression of S6K1, but the molecular mechanism of the critical negative feedback loop has not yet been fully elucidated. Here, we demonstrate that polymerized collagen suppresses G(1)/S phase transition and fibroblast proliferation by a novel mechanism involving the formation of a beta 1 integrin-protein phosphatase 2A (PP2A)-tuberous sclerosis complex 2 (TSC2) complex that represses S6K1 activity. In response to fibroblast interaction with polymerized collagen, beta 1 integrin forms a complex with PP2A that targets TSC2 as a substrate. PP2A represses the level of TSC2 phosphorylation and maintains TSC2 in an activated state. Activated TSC2 negatively regulates the downstream kinase S6K1 and inhibits G(1)/S transit. Knockdown of TSC2 enables fibroblasts to overcome the anti-proliferative properties of polymerized collagen. Furthermore, we show that this reduction in TSC2 and S6K1 phosphorylation occurs largely independent of Akt. Although S6K1 activity was markedly suppressed by polymerized collagen, we found that minimal changes in Akt activity occurred. We demonstrate that up-regulation of Akt by overexpression of constitutively active phosphatidylinositol 3-kinase p110 subunit had minor effects on TSC2 and S6K1 phosphorylation. These findings demonstrate that polymerized collagen represses fibroblast proliferation by a mechanism involving the formation of a beta 1 integrin-PP2A-TSC2 complex that negatively regulates S6K1 and inhibits G(1)/S phase transition.	[Xia, Hong; Nho, Richard; Kleidon, Jill; Kahm, Judy; Henke, Craig A.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Henke, CA (corresponding author), Univ Minnesota, Dept Med, Box 276,420 Delaware St SE, Minneapolis, MN 55455 USA.	henke002@umn.edu			NHLBI NIH HHS [R01 HL114662] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BITTERMAN PB, 1991, CHEST, V99, pS81, DOI 10.1378/chest.99.3_Supplement.81S; Castro AF, 2003, J BIOL CHEM, V278, P32493, DOI 10.1074/jbc.C300226200; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Chen RH, 1998, ONCOGENE, V17, P1959, DOI 10.1038/sj.onc.1202111; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Crowder RJ, 1998, J NEUROSCI, V18, P2933; Dan HC, 2002, J BIOL CHEM, V277, P35364, DOI 10.1074/jbc.M205838200; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Fang F, 1996, SCIENCE, V271, P499, DOI 10.1126/science.271.5248.499; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; GUADAGNO TM, 1993, SCIENCE, V262, P1572, DOI 10.1126/science.8248807; HANSEN LK, 1994, MOL BIOL CELL, V5, P967, DOI 10.1091/mbc.5.9.967; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Ivaska J, 2002, MOL CELL BIOL, V22, P1352, DOI 10.1128/MCB.22.5.1352-1359.2002; Jokinen J, 2004, J BIOL CHEM, V279, P31956, DOI 10.1074/jbc.M401409200; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Kiely PA, 2006, MOL CELL BIOL, V26, P4041, DOI 10.1128/MCB.01868-05; Koyama H, 1996, CELL, V87, P1069, DOI 10.1016/S0092-8674(00)81801-2; Lee JW, 2000, MOL BIOL CELL, V11, P1973, DOI 10.1091/mbc.11.6.1973; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; MATSUSHIME H, 1994, MOL CELL BIOL, V14, P2066, DOI 10.1128/MCB.14.3.2066; Nho RS, 2005, J BIOL CHEM, V280, P26630, DOI 10.1074/jbc.M411798200; Pankov R, 2003, J BIOL CHEM, V278, P18671, DOI 10.1074/jbc.M300879200; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; RHUDY RW, 1988, J CELL PHYSIOL, V137, P185, DOI 10.1002/jcp.1041370123; Saraf A, 2007, J BIOL CHEM, V282, P573, DOI 10.1074/jbc.M607407200; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Schild A, 2006, MECH DEVELOP, V123, P362, DOI 10.1016/j.mod.2006.03.003; SCHOR SL, 1980, J CELL SCI, V41, P159; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Strack S, 2002, J BIOL CHEM, V277, P20750, DOI 10.1074/jbc.M202992200; Tian B, 2002, J BIOL CHEM, V277, P24667, DOI 10.1074/jbc.M203565200; Van Kanegan MJ, 2005, J BIOL CHEM, V280, P36029, DOI 10.1074/jbc.M506986200; Westphal RS, 1999, J BIOL CHEM, V274, P687, DOI 10.1074/jbc.274.2.687; Xia H, 2004, J BIOL CHEM, V279, P33024, DOI 10.1074/jbc.M313265200; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999; Zhou J, 2003, BIOCHEM J, V369, P387, DOI 10.1042/BJ20021244	41	18	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20350	20360		10.1074/jbc.M707489200	http://dx.doi.org/10.1074/jbc.M707489200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18487611	hybrid			2022-12-25	WOS:000257565300051
J	Tiainen, P; Pasanen, A; Sormunen, R; Myllyharju, J				Tiainen, Paivi; Pasanen, Annika; Sormunen, Raija; Myllyharju, Johanna			Characterization of recombinant human prolyl 3-hydroxylase isoenzyme 2, an enzyme modifying the basement membrane collagen IV	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARTILAGE-ASSOCIATED PROTEIN; DISULFIDE-ISOMERASE SUBUNIT; HUMAN PROLYL 4-HYDROXYLASE; OSTEOGENESIS IMPERFECTA; TRIPLE-HELIX; IDENTIFICATION; LEPRECAN; 2-OXOGLUTARATE; 3-HYDROXYLASE; BIOSYNTHESIS	The single 3-hydroxyproline residue in the collagen I polypeptides is essential for proper fibril formation and bone development as its deficiency leads to recessive osteogenesis imperfecta. The vertebrate prolyl 3-hydroxylase (P3H) family consists of three members, P3H1 being responsible for the hydroxylation of collagen I. We expressed human P3H2 as an active recombinant protein in insect cells. Most of the recombinant polypeptide was insoluble, but small amounts were also present in the soluble fraction. P3H1 forms a complex with the cartilage-associated protein (CRTAP) that is required for prolyl 3-hydroxylation of fibrillar collagens. However, coexpression with CRTAP did not enhance the solubility or activity of the recombinant P3H2. A novel assay for P3H activity was developed based on that used for collagen prolyl 4-hydroxylases (C-P4H) and lysyl hydroxylases (LH). A large amount of P3H activity was found in the P3H2 samples with (Gly-Pro-4Hyp) 5 as a substrate. The K-m and K-i values of P3H2 for 2-oxoglutarate and its certain analogues resembled those of the LHs rather than the C-P4Hs. Unlike P3H1, P3H2 was strongly expressed in tissues rich in basement membranes, such as the kidney. P3H2 hydroxylated more effectively two synthetic peptides corresponding to sequences that are hydroxylated in collagen IV than a peptide corresponding to the 3-hydroxylation site in collagen I. These findings suggest that P3H2 is responsible for the hydroxylation of collagen IV, which has the highest 3-hydroxyproline content of all collagens. It is thus possible that P3H2 mutations may lead to a disease with changes in basement membranes.	[Tiainen, Paivi; Pasanen, Annika; Myllyharju, Johanna] Univ Oulu, Oulu Ctr Cell Matrix Res, FIN-90014 Oulu, Finland; [Tiainen, Paivi; Pasanen, Annika; Sormunen, Raija; Myllyharju, Johanna] Univ Oulu, Bioctr Oulu, FIN-90014 Oulu, Finland; [Tiainen, Paivi; Pasanen, Annika; Myllyharju, Johanna] Univ Oulu, Dept Med Biochem & Mol Biol, FIN-90014 Oulu, Finland; [Sormunen, Raija] Univ Oulu, Dept Pathol, FIN-90014 Oulu, Finland	University of Oulu; University of Oulu; University of Oulu; University of Oulu	Myllyharju, J (corresponding author), Univ Oulu, Oulu Ctr Cell Matrix Res, POB 5000, FIN-90014 Oulu, Finland.	johanna.myllyharju@oulu.fi						Barnes AM, 2006, NEW ENGL J MED, V355, P2757, DOI 10.1056/NEJMoa063804; Byers P, 2002, CONNECTIVE TISSUE IT, P385, DOI DOI 10.1002/0471221929.CH8; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; CROSSEN R, 1998, BACULOVIRUS EXPRESSI; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Jarnum S, 2004, BIOCHEM BIOPH RES CO, V317, P342, DOI 10.1016/j.bbrc.2004.03.060; Jenkins CL, 2003, J AM CHEM SOC, V125, P6422, DOI 10.1021/ja034015j; Kaul SC, 2000, ONCOGENE, V19, P3576, DOI 10.1038/sj.onc.1203696; KEFALIDES NA, 1975, J INVEST DERMATOL, V65, P85, DOI 10.1111/1523-1747.ep12598062; Kivirikko K. I., 1992, POSTTRANSLATIONAL MO, P1; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; Kivirikko KI, 1998, ADV ENZYMOL RAMB, V72, P325; Kukkola L, 2003, J BIOL CHEM, V278, P47685, DOI 10.1074/jbc.M306806200; Miner JH, 1999, KIDNEY INT, V56, P2016, DOI 10.1046/j.1523-1755.1999.00785.x; Mizuno K, 2004, J BIOL CHEM, V279, P282, DOI 10.1074/jbc.M308181200; Morello R, 1999, MATRIX BIOL, V18, P319, DOI 10.1016/S0945-053X(99)00002-5; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Myllyharju J, 2005, TOP CURR CHEM, V247, P115, DOI 10.1007/b103821; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Myllyharju J, 1997, EMBO J, V16, P1173, DOI 10.1093/emboj/16.6.1173; Passoja K, 1998, FEBS LETT, V434, P145, DOI 10.1016/S0014-5793(98)00966-1; RISTELI J, 1977, EUR J BIOCHEM, V73, P485, DOI 10.1111/j.1432-1033.1977.tb11341.x; Schumacher MA, 2006, J BIOL CHEM, V281, P27566, DOI 10.1074/jbc.M602797200; SCHUPPAN D, 1982, EUR J BIOCHEM, V123, P505; Tryggvason K, 2006, NEW ENGL J MED, V354, P1387, DOI 10.1056/NEJMra052131; TRYGGVASON K, 1979, BIOCHEM J, V183, P303, DOI 10.1042/bj1830303; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; VUORI K, 1992, P NATL ACAD SCI USA, V89, P7467, DOI 10.1073/pnas.89.16.7467; Wassnehove-McCarthy DJ, 1999, J BIOL CHEM, V274, P25004, DOI 10.1074/jbc.274.35.25004	32	59	62	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19432	19439		10.1074/jbc.M802973200	http://dx.doi.org/10.1074/jbc.M802973200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18487197	hybrid			2022-12-25	WOS:000257387600029
J	Elsea, CR; Roberts, DA; Druker, BJ; Wood, LJ				Elsea, Collin R.; Roberts, Daniel A.; Druker, Brian J.; Wood, Lisa J.			Inhibition of p38 MAPK Suppresses Inflammatory Cytokine Induction by Etoposide, 5-Fluorouracil, and Doxorubicin without Affecting Tumoricidal Activity	PLOS ONE			English	Article								Cancer patients undergoing treatment with systemic cancer chemotherapy drugs often experience debilitating fatigue similar to sickness behavior, a normal response to infection or tissue damage caused by the production of the inflammatory cytokines IL-1 beta, TNF-alpha, and IL-6. The p38 mitogen activated protein kinase (p38 MAPK) plays a central role in the production of these cytokines and consequently the development of sickness behavior. Targeted inhibitors of p38 MAPK can reduce systemic inflammatory cytokine production and the development of sickness behavior. Several systemic cancer chemotherapy drugs have been shown to stimulate inflammatory cytokine production, yet whether this response is related to a common ability to activate p38 MAPK is not known and is the focus of this study. This understanding may present the possibility of using p38 MAPK inhibitors to reduce chemotherapy-induced inflammatory cytokine production and consequently treatment-related fatigue. One caveat of this approach is a potential reduction in chemotherapeutic efficacy as some believe that p38 MAPK activity is required for chemotherapy-induced cytotoxicity of tumor cells. The purpose of this study was to demonstrate proof of principal that p38 MAPK inhibition can block chemotherapy-induced inflammatory cytokine production without inhibiting drug-induced cytotoxicity using murine peritoneal macrophages and Lewis Lung Carcinoma (LLC1) cells as model cell systems. Using these cells we assessed the requirement of etoposide, doxorubicin, 5-flourouracil, and docetaxel for p38 MAPK in inflammatory cytokine production and cytotoxicity. Study findings demonstrate that clinically relevant doses of etoposide, doxorubicin, and 5-FU activated p38 MAPK in both macrophages and LLC1 cells. In contrast, docetaxel failed to activate p38 MAPK in either cell type. Activation of p38 MAPK mediated the drug's effects on inflammatory cytokine production in macrophages but not LLC1 cytotoxicity and this was confirmed with inhibitor studies.	[Elsea, Collin R.; Roberts, Daniel A.; Wood, Lisa J.] Oregon Hlth & Sci Univ, Sch Nursing, Portland, OR 97201 USA; [Druker, Brian J.] Howard Hughes Med Inst, Boston, MA USA; [Druker, Brian J.] Oregon Hlth & Sci Univ, Canc Inst, Div Hematol & Med Oncol, Portland, OR USA; [Wood, Lisa J.] Oregon Hlth & Sci Univ, Canc Inst, Sch Med, Dept Radiat Med, Portland, OR USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University; Oregon Health & Science University	Elsea, CR (corresponding author), Oregon Hlth & Sci Univ, Sch Nursing, Portland, OR 97201 USA.	woodl@ohsu.edu		Wood, Lisa/0000-0003-1145-3649; Druker, Brian/0000-0001-8331-8206	National Institute of Nursing Research Exploratory Nursing Research Center [1P20NR07807-03]; American Cancer Society; NATIONAL INSTITUTE OF NURSING RESEARCH [P20NR007807] Funding Source: NIH RePORTER	National Institute of Nursing Research Exploratory Nursing Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work was supported in part by pilot funding awarded to L.J.W. from the National Institute of Nursing Research Exploratory Nursing Research Center Grant 1P20NR07807-03, which was awarded to L.M.N. L.J.W is a recipient of an American Cancer Society Research Scholar Grant. Funding agencies were not involved in the design, conduct, data collection, analysis, data interpretation, or preparation, review, or approval of the manuscript.	Badger AM, 1996, J PHARMACOL EXP THER, V279, P1453; Berthiaume JM, 2007, CELL BIOL TOXICOL, V23, P15, DOI 10.1007/s10565-006-0140-y; BERTRAM JS, 1980, CANCER LETT, V11, P63, DOI 10.1016/0304-3835(80)90130-5; Boldt S, 2002, CARCINOGENESIS, V23, P1831, DOI 10.1093/carcin/23.11.1831; BORUT BSP, 2004, PAIN, V107, P7; Branger J, 2002, J IMMUNOL, V168, P4070, DOI 10.4049/jimmunol.168.8.4070; Bryniarski K, 1996, IMMUNOPHARMACOLOGY, V34, P73, DOI 10.1016/0162-3109(96)00130-0; BURKHART CA, 1994, CANCER RES, V54, P5779; Byrd-Leifer CA, 2001, EUR J IMMUNOL, V31, P2448, DOI 10.1002/1521-4141(200108)31:8&lt;2448::AID-IMMU2448&gt;3.0.CO;2-N; CHRISTENSEN LV, 1992, J ORAL REHABIL, V19, P39, DOI 10.1111/j.1365-2842.1992.tb01589.x; de Vries P, 2000, EXP HEMATOL, V28, P916, DOI 10.1016/S0301-472X(00)00493-8; Deacon K, 2003, MOL BIOL CELL, V14, P2071, DOI 10.1091/mbc.e02-10-0653; DING AH, 1990, SCIENCE, V248, P370, DOI 10.1126/science.1970196; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Goldstein DM, 2005, CURR TOP MED CHEM, V5, P1017, DOI 10.2174/1568026054985939; Harden LM, 2006, PHYSIOL BEHAV, V89, P146, DOI 10.1016/j.physbeh.2006.05.016; Hempel G, 2002, CANCER CHEMOTH PHARM, V49, P133, DOI 10.1007/s00280-001-0392-4; HUANG Y, 2007, NEUROBIOL AGING; JACOBSEN S, 1993, SCAND J RHEUMATOL, V22, P69, DOI 10.3109/03009749309095118; Janicki-Deverts D, 2007, BRAIN BEHAV IMMUN, V21, P301, DOI 10.1016/j.bbi.2006.09.002; Losa JH, 2003, ONCOGENE, V22, P3998, DOI 10.1038/sj.onc.1206608; Ma SF, 2007, KIDNEY INT, V72, P1474, DOI 10.1038/sj.ki.5002556; MANTHEY CL, 1993, J EXP MED, V178, P695, DOI 10.1084/jem.178.2.695; Moos PJ, 1999, J IMMUNOL, V162, P467; Moos PJ, 1998, P NATL ACAD SCI USA, V95, P3896, DOI 10.1073/pnas.95.7.3896; Morse SMJ, 2006, BIOTECHNIQUES, V40, P54, DOI 10.2144/000112100; Muhl H, 1999, EUR J IMMUNOL, V29, P3225, DOI 10.1002/(SICI)1521-4141(199910)29:10<3225::AID-IMMU3225>3.0.CO;2-0; Offidani M, 2004, EUR J HAEMATOL, V72, P403, DOI 10.1111/j.1600-0609.2004.00238.x; Olson JM, 2004, TRENDS MOL MED, V10, P125, DOI 10.1016/j.molmed.2004.01.007; Peifer C, 2006, CURR TOP MED CHEM, V6, P113, DOI 10.2174/156802606775270323; POGREBNIAK HW, 1991, SURGERY, V110, P231; Ramesh G, 2005, AM J PHYSIOL-RENAL, V289, pF166, DOI 10.1152/ajprenal.00401.2004; Ramesh G, 2002, J CLIN INVEST, V110, P835, DOI 10.1172/JCI200215606; SALEEM A, 1995, CELL GROWTH DIFFER, V6, P1651; Schindler JF, 2007, J DENT RES, V86, P800, DOI 10.1177/154405910708600902; Shishodia S, 1997, INT J IMMUNOPHARMACO, V19, P683; Shishodia S, 1998, IMMUNOL LETT, V61, P179, DOI 10.1016/S0165-2478(98)00017-0; SINGH RK, 1991, IMMUNOL LETT, V28, P127, DOI 10.1016/0165-2478(91)90110-V; SINGH RK, 1991, NAT IMMUN CELL GROW, V10, P105; SODHI A, 1992, IMMUNOL LETT, V34, P183, DOI 10.1016/0165-2478(92)90211-6; SURESH A, 1991, IMMUNOL LETT, V30, P93, DOI 10.1016/0165-2478(91)90095-R; TEELING JL, 2007, BRAIN BEHAV IMMUN; THOMPSON DS, 1995, CLIN PHARMACOL THER, V57, P499, DOI 10.1016/0009-9236(95)90034-9; Ujhazy P, 2003, CANCER IMMUNOL IMMUN, V52, P463, DOI 10.1007/s00262-003-0391-x; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Vollmer-Conna U, 2004, PSYCHOL MED, V34, P1289, DOI 10.1017/S0033291704001953; Wang LCS, 2006, ONCOL RES, V16, P1; White CM, 1998, CANCER IMMUNOL IMMUN, V46, P104, DOI 10.1007/s002620050468; WILLETTE AA, 2007, BRAIN BEHAV IMMUN; Wood LJ, 2006, ONCOL NURS FORUM, V33, P535, DOI 10.1188/06.ONF.535-542; WOOD LJ, 2006, BIOL RES NURS, P7; Zaks-Zilberman M, 2001, CYTOKINE, V15, P156, DOI 10.1006/cyto.2001.0935; Zanke BW, 1996, CURR BIOL, V6, P606, DOI 10.1016/S0960-9822(02)00547-X	53	54	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2355	10.1371/journal.pone.0002355	http://dx.doi.org/10.1371/journal.pone.0002355			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523641	Green Published, gold, Green Submitted			2022-12-25	WOS:000262614300042
J	Zhang, W; Liu, S; Zhou, YQ				Zhang, Wei; Liu, Song; Zhou, Yaoqi			SP5: Improving Protein Fold Recognition by Using Torsion Angle Profiles and Profile-Based Gap Penalty Model	PLOS ONE			English	Article							SECONDARY STRUCTURE PREDICTION; HIDDEN MARKOV-MODELS; SOLVENT ACCESSIBILITY; STRUCTURE ALIGNMENT; LOCAL-STRUCTURE; SEQUENCE; DATABASE; SERVER; IDENTIFICATION; INFORMATION	How to recognize the structural fold of a protein is one of the challenges in protein structure prediction. We have developed a series of single (non-consensus) methods (SPARKS, SP2, SP3, SP4) that are based on weighted matching of two to four sequence and structure-based profiles. There is a robust improvement of the accuracy and sensitivity of fold recognition as the number of matching profiles increases. Here, we introduce a new profile-profile comparison term based on real-value dihedral torsion angles. Together with updated real-value solvent accessibility profile and a new variable gap-penalty model based on fractional power of insertion/deletion profiles, the new method (SP5) leads to a robust improvement over previous SP method. There is a 2% absolute increase (5% relative improvement) in alignment accuracy over SP4 based on two independent benchmarks. Moreover, SP5 makes 7% absolute increase (22% relative improvement) in success rate of recognizing correct structural folds, and 32% relative improvement in model accuracy of models within the same fold in Lindahl benchmark. In addition, modeling accuracy of top-1 ranked models is improved by 12% over SP4 for the difficult targets in CASP 7 test set. These results highlight the importance of harnessing predicted structural properties in challenging remote-homolog recognition. The SP5 server is available at http://sparks.informatics.iupui.edu.	[Zhang, Wei; Zhou, Yaoqi] Indiana Univ, Sch Informat, Indianapolis, IN 46204 USA; [Zhang, Wei] Inst Appl Phys & Computat Math, Beijing, Peoples R China; [Liu, Song] SUNY Buffalo, Univ Buffalo, Center of Excellence Bioinformat & Life Sci, Dept Biostat, Buffalo, NY USA; [Liu, Song] Roswell Park Canc Inst, Dept Biostat, Buffalo, NY USA; [Liu, Song] SUNY Buffalo, Univ Buffalo, Howard Hughes Med Inst, Dept Physiol & Biophys, Buffalo, NY USA	Indiana University System; Indiana University-Purdue University Indianapolis; Chinese Academy of Sciences; Institute of Applied Physics & Computational Mathematics - China; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute; Howard Hughes Medical Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Zhang, W (corresponding author), Indiana Univ, Sch Informat, Indianapolis, IN 46204 USA.	yqzhou@iupui.edu	Zhou, Yaoqi/B-3284-2009	Zhou, Yaoqi/0000-0002-9958-5699	NIH;  [R01 GM 966049];  [R01 GM 068530]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068530] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH (R01 GM 966049 and R01 GM 068530).	Adamczak R, 2005, PROTEINS, V59, P467, DOI 10.1002/prot.20441; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Battey JND, 2007, PROTEINS, V69, P68, DOI 10.1002/prot.21761; Bystroff C, 2000, J MOL BIOL, V301, P173, DOI 10.1006/jmbi.2000.3837; Cheng JL, 2006, BIOINFORMATICS, V22, P1456, DOI 10.1093/bioinformatics/btl102; Chivian D, 2003, PROTEINS, V53, P524, DOI 10.1002/prot.10529; CHOTHIA C, 1976, J MOL BIOL, V105, P1, DOI 10.1016/0022-2836(76)90191-1; de Brevern AG, 2000, PROTEINS, V41, P271, DOI 10.1002/1097-0134(20001115)41:3<271::AID-PROT10>3.0.CO;2-Z; Domingues FS, 2000, J MOL BIOL, V297, P1003, DOI 10.1006/jmbi.2000.3615; Dor O, 2007, PROTEINS, V68, P76, DOI 10.1002/prot.21408; Dor O, 2007, PROTEINS, V66, P838, DOI 10.1002/prot.21298; Dunbrack RL, 2006, CURR OPIN STRUC BIOL, V16, P374, DOI 10.1016/j.sbi.2006.05.006; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Etchebest C, 2004, SILICO BIOL, V4, P31; Fischer D, 1996, Pac Symp Biocomput, P300; Goonesekere NCW, 2004, NUCLEIC ACIDS RES, V32, P2838, DOI 10.1093/nar/gkh610; HOLM L, 1994, NUCLEIC ACIDS RES, V22, P3600; Huang YM, 2006, BIOINFORMATICS, V22, P413, DOI 10.1093/bioinformatics/bti828; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KANG HS, 1993, J MOL BIOL, V229, P448, DOI 10.1006/jmbi.1993.1045; Karchin R, 2003, PROTEINS, V51, P504, DOI 10.1002/prot.10369; Karplus K, 1998, BIOINFORMATICS, V14, P846, DOI 10.1093/bioinformatics/14.10.846; Kihara D, 2003, J MOL BIOL, V334, P793, DOI 10.1016/j.jmb.2003.10.027; Kim D, 2003, PROTEIN ENG, V16, P641, DOI 10.1093/protein/gzg081; Kuang R, 2004, BIOINFORMATICS, V20, P1612, DOI 10.1093/bioinformatics/bth136; LESK AM, 1986, PROTEIN ENG, V1, P77, DOI 10.1093/protein/1.1.77; Lindahl E, 2000, J MOL BIOL, V295, P613, DOI 10.1006/jmbi.1999.3377; Liu S, 2007, PROTEINS, V68, P636, DOI 10.1002/prot.21459; Madhusudhan MS, 2006, PROTEIN ENG DES SEL, V19, P129, DOI 10.1093/protein/gzj005; MARKSTEIN P, 2007, IMPROVEMENT PROTEIN, V6; Marti-Renom MA, 2004, PROTEIN SCI, V13, P1071, DOI 10.1110/ps.03379804; Mooney C, 2006, J COMPUT BIOL, V13, P1489, DOI 10.1089/cmb.2006.13.1489; Moult J, 2007, PROTEINS, V69, P3, DOI 10.1002/prot.21767; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Siew N, 2000, BIOINFORMATICS, V16, P776, DOI 10.1093/bioinformatics/16.9.776; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Terashi G, 2007, PROTEINS, V69, P98, DOI 10.1002/prot.21785; Tress M, 2005, PROTEINS, V61, P27, DOI 10.1002/prot.20720; Wallner B, 2007, NUCLEIC ACIDS RES, V35, pW369, DOI 10.1093/nar/gkm319; XU J, 2003, PAC S BIOCOMPUT, V8, P264; Xue B, 2008, PROTEINS, V72, P427, DOI 10.1002/prot.21940; Zhang Y, 2006, P NATL ACAD SCI USA, V103, P2605, DOI 10.1073/pnas.0509379103; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702; Zhou HY, 2007, PROTEINS, V69, P90, DOI 10.1002/prot.21649; Zhou HY, 2007, PROTEIN SCI, V16, P947, DOI 10.1110/ps.062597307; Zhou HY, 2005, PROTEINS, V61, P152, DOI 10.1002/prot.20732; Zhou HY, 2005, PROTEINS, V58, P321, DOI 10.1002/prot.20308; Zhou HY, 2004, PROTEINS, V55, P1005, DOI 10.1002/prot.20007; Zimmermann O, 2006, BIOINFORMATICS, V22, P3009, DOI 10.1093/bioinformatics/btl489	55	60	60	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2325	10.1371/journal.pone.0002325	http://dx.doi.org/10.1371/journal.pone.0002325			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523556	Green Published, gold			2022-12-25	WOS:000262614300020
J	Derelle, E; Ferraz, C; Escande, ML; Eychenie, S; Cooke, R; Piganeau, G; Desdevises, Y; Bellec, L; Moreau, H; Grimsley, N				Derelle, Evelyne; Ferraz, Conchita; Escande, Marie-Line; Eychenie, Sophie; Cooke, Richard; Piganeau, Gwenael; Desdevises, Yves; Bellec, Laure; Moreau, Herve; Grimsley, Nigel			Life-Cycle and Genome of OtV5, a Large DNA Virus of the Pelagic Marine Unicellular Green Alga Ostreococcus tauri	PLOS ONE			English	Article								Large DNA viruses are ubiquitous, infecting diverse organisms ranging from algae to man, and have probably evolved from an ancient common ancestor. In aquatic environments, such algal viruses control blooms and shape the evolution of biodiversity in phytoplankton, but little is known about their biological functions. We show that Ostreococcus tauri, the smallest known marine photosynthetic eukaryote, whose genome is completely characterized, is a host for large DNA viruses, and present an analysis of the life-cycle and 186,234 bp long linear genome of OtV5. OtV5 is a lytic phycodnavirus which unexpectedly does not degrade its host chromosomes before the host cell bursts. Analysis of its complete genome sequence confirmed that it lacks expected site-specific endonucleases, and revealed the presence of 16 genes whose predicted functions are novel to this group of viruses. OtV5 carries at least one predicted gene whose protein closely resembles its host counterpart and several other host-like sequences, suggesting that horizontal gene transfers between host and viral genomes may occur frequently on an evolutionary scale. Fifty seven percent of the 268 predicted proteins present no similarities with any known protein in Genbank, underlining the wealth of undiscovered biological diversity present in oceanic viruses, which are estimated to harbour 200Mt of carbon.	[Derelle, Evelyne; Escande, Marie-Line; Piganeau, Gwenael; Desdevises, Yves; Bellec, Laure; Moreau, Herve; Grimsley, Nigel] Univ Paris 06, Lab Arago, Banyuls Sur Mer, France; [Derelle, Evelyne; Escande, Marie-Line; Piganeau, Gwenael; Moreau, Herve; Grimsley, Nigel] Lab Arago, CNRS, UMR7628, Banyuls sur Mer, France; [Ferraz, Conchita; Eychenie, Sophie] Genopole Montpellier Languedoc Roussillon, Inst Genet Humaine, UPR1142, Montpellier, France; [Cooke, Richard] Genopole Languedoc Roussillon, Genome Dev Plantes, UMR5096, Perpignan, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Derelle, E (corresponding author), Univ Paris 06, Lab Arago, Banyuls Sur Mer, France.	nigel.grimsley@obs-banyuls.fr	Desdevises, Yves/D-5528-2011; Desdevises, Yves/AAH-2097-2019; Desdevises, Yves/H-5334-2019; Grimsley, Nigel/O-1359-2015; Piganeau, Gwenael V/C-7600-2011	Desdevises, Yves/0000-0001-9774-0336; Desdevises, Yves/0000-0001-9774-0336; Grimsley, Nigel/0000-0001-9323-417X; Piganeau, Gwenael V/0000-0002-9992-4187; bellec, laure/0000-0002-1954-9867; Cooke, Richard/0000-0001-6335-1092; Derelle, Evelyne/0000-0002-1499-4240	Agence National de Recherche [PICOVIR]; European Network of Excellence Marine Genomics Europe [GOCE-CT-2004-505403]; GDR 1928 Genomique des Populations	Agence National de Recherche(French National Research Agency (ANR)); European Network of Excellence Marine Genomics Europe; GDR 1928 Genomique des Populations	This work was supported partly by an Agence National de Recherche grant PICOVIR (coordinator N.G.), partly by the European Network of Excellence Marine Genomics Europe (no. GOCE-CT-2004-505403, coordinator H.M.) and the isolation of new strains was partly supported by a GDR 1928 Genomique des Populations grant to G. P.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Agarkova IV, 2006, J VIROL, V80, P8114, DOI 10.1128/JVI.00486-06; Allen MJ, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-15; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Attoui H, 2006, J GEN VIROL, V87, P1375, DOI 10.1099/vir.0.81584-0; Baudoux AC, 2005, VIROLOGY, V341, P80, DOI 10.1016/j.virol.2005.07.002; Bidle KD, 2004, NAT REV MICROBIOL, V2, P643, DOI 10.1038/nrmicro956; Borevitz JO, 2007, P NATL ACAD SCI USA, V104, P12057, DOI 10.1073/pnas.0705323104; Bouvier T, 2007, ENVIRON MICROBIOL, V9, P287, DOI 10.1111/j.1462-2920.2006.01137.x; Bratbak G, 1996, J MARINE SYST, V9, P75, DOI 10.1016/0924-7963(96)00018-8; Brown CM, 2007, ENVIRON MICROBIOL, V9, P2720, DOI 10.1111/j.1462-2920.2007.01384.x; Brussaard CPD, 2004, J EUKARYOT MICROBIOL, V51, P125, DOI 10.1111/j.1550-7408.2004.tb00537.x; Brussaard CPD, 2004, VIROLOGY, V319, P280, DOI 10.1016/j.virol.2003.10.033; Brussaard CPD, 2004, APPL ENVIRON MICROB, V70, P1506, DOI 10.1128/AEM.70.3.1506-1513.2004; BUTCHER RW, 1952, J MAR BIOL ASSOC UK, V31, P175, DOI 10.1017/S0025315400003751; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; CHEN F, 1995, APPL ENVIRON MICROB, V61, P1274, DOI 10.1128/AEM.61.4.1274-1278.1995; Cho KY, 1996, MOL MICROBIOL, V22, P1025, DOI 10.1046/j.1365-2958.1996.01524.x; CHRETIENNOTDINET MJ, 1995, PHYCOLOGIA, V34, P285, DOI 10.2216/i0031-8884-34-4-285.1; COTTRELL MT, 1991, MAR ECOL PROG SER, V78, P1, DOI 10.3354/meps078001; COTTRELL MT, 1995, APPL ENVIRON MICROB, V61, P3088, DOI 10.1128/AEM.61.8.3088-3091.1995; COTTRELL MT, 1995, LIMNOL OCEANOGR, V40, P730, DOI 10.4319/lo.1995.40.4.0730; Countway PD, 2006, APPL ENVIRON MICROB, V72, P2496, DOI 10.1128/AEM.72.4.2496-2506.2006; COURTIES C, 1994, NATURE, V370, P255, DOI 10.1038/370255a0; Delaroque N, 2003, J MOL EVOL, V57, P613, DOI 10.1007/s00239-003-2501-y; Delaroque N, 2001, VIROLOGY, V287, P112, DOI 10.1006/viro.2001.1028; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; Dunigan DD, 2006, VIRUS RES, V117, P119, DOI 10.1016/j.virusres.2006.01.024; DuRand MD, 2002, J PHYCOL, V38, P1132, DOI 10.1046/j.1529-8817.2002.02008.x; Evans C, 2003, AQUAT MICROB ECOL, V30, P207, DOI 10.3354/ame030207; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fitzgerald LA, 2007, VIROLOGY, V358, P459, DOI 10.1016/j.virol.2006.08.034; Fitzgerald LA, 2007, VIROLOGY, V358, P472, DOI 10.1016/j.virol.2006.08.033; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Fuller NJ, 2006, AQUAT MICROB ECOL, V43, P79, DOI 10.3354/ame043079; Guillou L, 2004, PROTIST, V155, P193, DOI 10.1078/143446104774199592; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Henderson GP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000749; Hoekstra FA, 2001, TRENDS PLANT SCI, V6, P431, DOI 10.1016/S1360-1385(01)02052-0; Iyer LA, 2006, VIRUS RES, V117, P156, DOI 10.1016/j.virusres.2006.01.009; Iyer LM, 2001, J VIROL, V75, P11720, DOI 10.1128/JVI.75.23.11720-11734.2001; KNIGHTJONES EW, 1951, NATURE, V167, P445, DOI 10.1038/167445a0; KOHL DH, 1988, P NATL ACAD SCI USA, V85, P2036, DOI 10.1073/pnas.85.7.2036; La Scola B, 2003, SCIENCE, V299, P2033; Lefkowitz EJ, 2006, VIRUS RES, V117, P105, DOI 10.1016/j.virusres.2006.01.016; LI WKW, 1994, LIMNOL OCEANOGR, V39, P169, DOI 10.4319/lo.1994.39.1.0169; MEAD JR, 1988, J PARASITOL, V74, P366, DOI 10.2307/3282039; Nagasaki Keizo, 2005, Uirusu, V55, P127, DOI 10.2222/jsv.55.127; O'Kelly CJ, 2003, J PHYCOL, V39, P850, DOI 10.1046/j.1529-8817.2003.02201.x; Oliveira IC, 2001, BRAZ J MED BIOL RES, V34, P567, DOI 10.1590/S0100-879X2001000500003; Palenik B, 2007, P NATL ACAD SCI USA, V104, P7705, DOI 10.1073/pnas.0611046104; Parada V, 2007, APPL ENVIRON MICROB, V73, P4429, DOI 10.1128/AEM.00029-07; PATEL DD, 1986, VIROLOGY, V149, P174, DOI 10.1016/0042-6822(86)90119-4; Piganeau G, 2007, GENE, V406, P184, DOI 10.1016/j.gene.2007.09.015; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pringle CR, 1998, ARCH VIROL, V143, P203, DOI 10.1007/s007050050280; Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485; Renesto P, 2006, J VIROL, V80, P11678, DOI 10.1128/JVI.00940-06; Rocha EPC, 2002, TRENDS GENET, V18, P291, DOI 10.1016/S0168-9525(02)02690-2; Rodriguez F, 2005, ENVIRON MICROBIOL, V7, P853, DOI 10.1111/j.1462-2920.2005.00758.x; ROHOZINSKI J, 1989, VIROLOGY, V168, P363, DOI 10.1016/0042-6822(89)90277-8; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Ryabova LA, 2002, PROG NUCLEIC ACID RE, V72, P1, DOI 10.1016/S0079-6603(02)72066-7; Schroeder DC, 2003, APPL ENVIRON MICROB, V69, P2484, DOI 10.1128/AEM.69.5.2484-2490.2003; Schroeder DC, 2002, ARCH VIROL, V147, P1685, DOI 10.1007/s00705-002-0841-3; Silva P, 2003, PLANT CELL, V15, P2152, DOI 10.1105/tpc.012609; Simek K, 2007, ENVIRON MICROBIOL, V9, P789, DOI 10.1111/j.1462-2920.2006.01201.x; STRASSER P, 1991, VIROLOGY, V180, P763, DOI 10.1016/0042-6822(91)90089-T; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TRASK BJ, 1982, CYTOMETRY, V2, P258; Van Etten JL, 1999, ANNU REV MICROBIOL, V53, P447, DOI 10.1146/annurev.micro.53.1.447; Van Etten JL, 2002, ARCH VIROL, V147, P1479, DOI 10.1007/s00705-002-0822-6; Vaulot D, 2004, NOVA HEDWIGIA, V79, P49, DOI 10.1127/0029-5035/2004/0079-0049; WATERS RE, 1982, J GEN VIROL, V63, P199, DOI 10.1099/0022-1317-63-1-199; Weinbauer MG, 2007, ENVIRON MICROBIOL, V9, P777, DOI 10.1111/j.1462-2920.2006.01200.x; Weinbauer MG, 2004, ENVIRON MICROBIOL, V6, P1, DOI 10.1046/j.1462-2920.2003.00539.x; Wilson WH, 2005, SCIENCE, V309, P1090, DOI 10.1126/science.1113109; Wilson WH, 2002, J MAR BIOL ASSOC UK, V82, P369, DOI 10.1017/S002531540200560X; Worden AZ, 2004, LIMNOL OCEANOGR, V49, P168, DOI 10.4319/lo.2004.49.1.0168; XIA YN, 1986, MOL CELL BIOL, V6, P1430, DOI 10.1128/MCB.6.5.1430; Yamada T, 2006, ADV VIRUS RES, V66, P293, DOI 10.1016/S0065-3527(06)66006-5; Zhang R, 2007, ENVIRON MICROBIOL, V9, P3008, DOI 10.1111/j.1462-2920.2007.01410.x; ZHANG YP, 1994, VIROLOGY, V202, P1079, DOI 10.1006/viro.1994.1444	90	88	89	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2250	10.1371/journal.pone.0002250	http://dx.doi.org/10.1371/journal.pone.0002250			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509524	Green Published, Green Submitted, gold			2022-12-25	WOS:000262268500004
J	Fournier, PE; Belghazi, L; Robert, C; Elkarkouri, K; Richards, AL; Greub, G; Collyn, F; Ogawa, M; Portillo, A; Oteo, JA; Psaroulaki, A; Bitam, I; Raoult, D				Fournier, Pierre-Edouard; Belghazi, Lokmane; Robert, Catherine; Elkarkouri, Khalid; Richards, Allen L.; Greub, Gilbert; Collyn, Francois; Ogawa, Motohiko; Portillo, Arantxa; Oteo, Jose A.; Psaroulaki, Anna; Bitam, Idir; Raoult, Didier			Variations of Plasmid Content in Rickettsia felis	PLOS ONE			English	Article								Background: Since its first detection, characterization of R. felis has been a matter of debate, mostly due to the contamination of an initial R. felis culture by R. typhi. However, the first stable culture of R. felis allowed its precise phenotypic and genotypic characterization, and demonstrated that this species belonged to the spotted fever group rickettsiae. Later, its genome sequence revealed the presence of two forms of the same plasmid, physically confirmed by biological data. In a recent article, Gillespie et al. (PLoS One. 2007; 2(3): e266.) used a bioinformatic approach to refute the presence of the second plasmid form, and proposed the creation of a specific phylogenetic group for R. felis. Methodology/Principal Findings: In the present report, we, and five independent international laboratories confirmed unambiguously by PCR the presence of two plasmid forms in R. felis strain URRWXCal(2)(T), but observed that the plasmid content of this species, from none to 2 plasmid forms, may depend on the culture passage history of the studied strain. We also demonstrated that R. felis does not cultivate in Vero cells at 37 degrees C but generates plaques at 30 degrees C. Finally, using a phylogenetic study based on 667 concatenated core genes, we demonstrated the position of R. felis within the spotted fever group. Significance: We demonstrated that R. felis, which unambiguously belongs to the spotted fever group rickettsiae, may contain up to two plasmid forms but this plasmid content is unstable.	[Fournier, Pierre-Edouard; Belghazi, Lokmane; Robert, Catherine; Elkarkouri, Khalid; Raoult, Didier] Univ Aix Marseille 2, Fac Med, CNRS, Unite Rickettsies,IFR 48,IRD UMR 6236, Marseille, France; [Richards, Allen L.] Naval Med Res Ctr, Silver Spring, MD USA; [Greub, Gilbert; Collyn, Francois] Univ Lausanne, Univ Hosp Ctr, Inst Microbiol, Ctr Res Intracellular Bacteria, Lausanne, Switzerland; [Ogawa, Motohiko] Natl Inst Infect Dis, Dept Virol 1, Tokyo, Japan; [Portillo, Arantxa; Oteo, Jose A.] Hosp San Pedro, CIBIR, Logrono, Spain; [Psaroulaki, Anna] Univ Crete, Labo Clin Bacteriol, Parasitol, Zoonoses, Iraklion, Greece; [Bitam, Idir] Inst Pasteur, Serv Eco Epidemiol Parasitaire, Unite Entomol Med, Algiers, Algeria	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Naval Medical Research Center (NMRC); University of Lausanne; National Institute of Infectious Diseases (NIID); University of Crete	Fournier, PE (corresponding author), Univ Aix Marseille 2, Fac Med, CNRS, Unite Rickettsies,IFR 48,IRD UMR 6236, Marseille, France.	Didier.Raoult@gmail.com	Portillo, Arantza/ABH-7807-2020; Oteo, Jose A./AAB-3134-2020; Greub, Gilbert GG/K-5804-2017; Fournier, Pierre-Edouard/AAC-6155-2021; RAOULT, Didier/A-8434-2008	Portillo, Arantza/0000-0002-2055-1825; Oteo, Jose A./0000-0001-7080-6542; Greub, Gilbert GG/0000-0001-9529-3317; Fournier, Pierre-Edouard/0000-0001-8463-8885; RAOULT, Didier/0000-0002-0633-5974				Abergel C, 2006, MOL BIOL EVOL, V23, P2112, DOI 10.1093/molbev/msl082; ADAMS JR, 1990, AM J TROP MED HYG, V43, P400, DOI 10.4269/ajtmh.1990.43.400; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AZAD AF, 1992, P NATL ACAD SCI USA, V89, P43, DOI 10.1073/pnas.89.1.43; Azad AF, 1997, EMERG INFECT DIS, V3, P319, DOI 10.3201/eid0303.970308; BALDRIDGE GD, 2007, APPL ENV MICROBIOL; Bitam I, 2006, AM J TROP MED HYG, V74, P532, DOI 10.4269/ajtmh.2006.74.532; Blanc G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030014; Bouyer DH, 2001, INT J SYST EVOL MICR, V51, P339, DOI 10.1099/00207713-51-2-339; BOZEMAN FM, 1975, NATURE, V255, P545, DOI 10.1038/255545a0; BOZEMAN FM, 1970, J INFECT DIS, V121, P367, DOI 10.1093/infdis/121.4.367; Choi YJ, 2007, MICROBIOL IMMUNOL, V51, P307, DOI 10.1111/j.1348-0421.2007.tb03912.x; Deng W, 2002, J BACTERIOL, V184, P4601, DOI 10.1128/JB.184.16.4601-4611.2002; Fang R, 2003, CLIN DIAGN LAB IMMUN, V10, P221, DOI 10.1128/CDLI.10.2.221-228.2003; FOURNIER PE, 2007, RICKETTSIAL DIS, P1, DOI DOI 10.3109/9781420019971.001; Gillespie JJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000266; HEBERT GA, 1980, ANN INTERN MED, V92, P45, DOI 10.7326/0003-4819-92-1-45; HENDERSON G, 1993, J MED ENTOMOL, V30, P619, DOI 10.1093/jmedent/30.3.619; Higgins J. A., 1994, Insect Molecular Biology, V3, P27, DOI 10.1111/j.1365-2583.1994.tb00147.x; Higgins JA, 1996, J CLIN MICROBIOL, V34, P671, DOI 10.1128/JCM.34.3.671-674.1996; Horta MC, 2006, APPL ENVIRON MICROB, V72, P1705, DOI 10.1128/AEM.72.2.1705-1707.2006; Houhamdi L, 2006, AM J TROP MED HYG, V74, P521, DOI 10.4269/ajtmh.2006.74.521; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; La Scola B, 2002, INT J SYST EVOL MICR, V52, P2035, DOI [10.1099/ijs.0.02070-0, 10.1099/00207713-52-6-2035]; Medina-Sancheza A, 2005, ANN NY ACAD SCI, V1063, P327, DOI 10.1196/annals.1355.052; Ngwamidiba M, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-12; Noden BH, 1998, J MED ENTOMOL, V35, P410, DOI 10.1093/jmedent/35.4.410; Ogata H, 2005, PLOS BIOL, V3, P1391, DOI 10.1371/journal.pbio.0030248; Ogata H, 2006, PLOS GENET, V2, P733, DOI 10.1371/journal.pgen.0020076; Paddock CD, 2004, CLIN INFECT DIS, V38, P805, DOI 10.1086/381894; Parola P, 2005, CLIN MICROBIOL REV, V18, P719, DOI 10.1128/CMR.18.4.719-756.2005; Parola P, 2003, EMERG INFECT DIS, V9, P592, DOI 10.3201/eid0905.020511; Pornwiroon W, 2006, APPL ENVIRON MICROB, V72, P5589, DOI 10.1128/AEM.00532-06; Radulovic S, 1996, ANTIMICROB AGENTS CH, V40, P2912; RADULOVIC S, 1995, ANTIMICROB AGENTS CH, V39, P2564, DOI 10.1128/AAC.39.11.2564; RADULOVIC S, 1995, INFECT IMMUN, V63, P4826, DOI 10.1128/IAI.63.12.4826-4829.1995; Raoult D, 2001, EMERG INFECT DIS, V7, P73, DOI 10.3201/eid0701.010112; REISSGUTFREUND RJ, 1966, AM J TROP MED HYG, V15, P943, DOI 10.4269/ajtmh.1966.15.943; Richter J, 2002, EMERG INFECT DIS, V8, P207, DOI 10.3201/eid0802.010293; Rolain JM, 2002, ANTIMICROB AGENTS CH, V46, P2747, DOI 10.1128/AAC.46.9.2747-2751.2002; Rolain JM, 1998, ANTIMICROB AGENTS CH, V42, P1537, DOI 10.1128/AAC.42.7.1537; Roux V, 1999, RICKETTSIAE RICKETTS, P52; SCHRIEFER ME, 1994, J CLIN MICROBIOL, V32, P949, DOI 10.1128/JCM.32.4.949-954.1994; Sekeyova Z, 2001, INT J SYST EVOL MICR, V51, P1353, DOI 10.1099/00207713-51-4-1353; Stenos J, 2000, INT J SYST EVOL MICR, V50, P1775, DOI 10.1099/00207713-50-5-1775; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000; Wolf YI, 1999, TRENDS GENET, V15, P173, DOI 10.1016/S0168-9525(99)01704-7; Zavala-Velazquez JE, 2000, LANCET, V356, P1079, DOI 10.1016/S0140-6736(00)02735-5	51	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2289	10.1371/journal.pone.0002289	http://dx.doi.org/10.1371/journal.pone.0002289			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509454	Green Published, Green Submitted, gold			2022-12-25	WOS:000262268500030
J	Busso, N; Karababa, M; Nobile, M; Rolaz, A; Van Gool, F; Galli, M; Leo, O; So, A; De Smedt, T				Busso, Nathalie; Karababa, Mahir; Nobile, Massimo; Rolaz, Aline; Van Gool, Frederic; Galli, Mara; Leo, Oberdan; So, Alexander; De Smedt, Thibaut			Pharmacological Inhibition of Nicotinamide Phosphoribosyltransferase/Visfatin Enzymatic Activity Identifies a New Inflammatory Pathway Linked to NAD	PLOS ONE			English	Article								Nicotinamide phosphoribosyltransferase (NAMPT), also known as visfatin, is the rate-limiting enzyme in the salvage pathway of NAD biosynthesis from nicotinamide. Since its expression is upregulated during inflammation, NAMPT represents a novel clinical biomarker in acute lung injury, rheumatoid arthritis, and Crohn's disease. However, its role in disease progression remains unknown. We report here that NAMPT is a key player in inflammatory arthritis. Increased expression of NAMPT was confirmed in mice with collagen-induced arthritis, both in serum and in the arthritic paw. Importantly, a specific competitive inhibitor of NAMPT effectively reduced arthritis severity with comparable activity to etanercept, and decreased proinflammatory cytokine secretion in affected joints. Moreover, NAMPT inhibition reduced intracellular NAD concentration in inflammatory cells and circulating TNF alpha levels during endotoxemia in mice. In vitro pharmacological inhibition of NAMPT reduced the intracellular concentration of NAD and pro-inflammatory cytokine secretion by inflammatory cells. Thus, NAMPT links NAD metabolism to inflammatory cytokine secretion by leukocytes, and its inhibition might therefore have therapeutic efficacy in immune-mediated inflammatory disorders.	[Busso, Nathalie; Karababa, Mahir; So, Alexander] CHU Vaudois, Dept Med, Serv Rheumatol, CH-1011 Lausanne, Switzerland; [Nobile, Massimo; Rolaz, Aline; De Smedt, Thibaut] TopoTarget Switzerland SA, Lausanne, Switzerland; [Van Gool, Frederic; Galli, Mara; Leo, Oberdan] Free Univ Brussels, Lab Physiol Anim, Brussels, Belgium	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Universite Libre de Bruxelles; Vrije Universiteit Brussel	Busso, N (corresponding author), CHU Vaudois, Dept Med, Serv Rheumatol, CH-1011 Lausanne, Switzerland.	desmedtt@mac.com	Van Gool, Frederic/V-4638-2019		Swiss National Scientific Research Funds [3200-067231.01, K-32K1-116460]; TopoTarget Switzerland SA	Swiss National Scientific Research Funds; TopoTarget Switzerland SA	This work was supported by the Swiss National Scientific Research Funds (grant 3200-067231.01 and K-32K1-116460 to N.B.) and by TopoTarget Switzerland SA. Thibaut De Smedt, Massimo Nobile and Aline Rolaz are TopoTarget Switzerland SA employees.	Andreakos ET, 2002, CYTOKINE GROWTH F R, V13, P299, DOI 10.1016/S1359-6101(02)00018-7; Bae SK, 2006, FEBS LETT, V580, P4105, DOI 10.1016/j.febslet.2006.06.052; Brentano F, 2007, ARTHRITIS RHEUM, V56, P2829, DOI 10.1002/art.22833; Drevs J, 2003, ANTICANCER RES, V23, P4853; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Fukuhara A, 2007, SCIENCE, V318, P565, DOI 10.1126/science.318.5850.565b; Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486; Hasmann M, 2003, CANCER RES, V63, P7436; Hassa PO, 2002, CELL MOL LIFE SCI, V59, P1534, DOI 10.1007/s00018-002-8527-2; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Iqbal J, 2006, BIOCHEM BIOPH RES CO, V342, P1312, DOI 10.1016/j.bbrc.2006.02.109; Jia SH, 2004, J CLIN INVEST, V113, P1318, DOI [10.1172/JCI19930, 10.1172/JCI200419930]; Khan JA, 2006, NAT STRUCT MOL BIOL, V13, P582, DOI 10.1038/nsmb1105; Kim MK, 2006, J MOL BIOL, V362, P66, DOI 10.1016/j.jmb.2006.06.082; Kim SR, 2007, BIOCHEM BIOPH RES CO, V357, P150, DOI 10.1016/j.bbrc.2007.03.105; LeClaire RD, 1996, TOXICOLOGY, V107, P69, DOI 10.1016/0300-483X(95)03202-Q; LEE YA, 2007, CLIN RHEUMATOL; Leoni F, 2005, MOL MED, V11, P1, DOI 10.2119/2006-00005.Dinarello; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Moller B, 2006, SPRINGER SEMIN IMMUN, V27, P391, DOI 10.1007/s00281-006-0012-9; Mohammed FF, 2003, ANN RHEUM DIS, V62, P43; Moschen AR, 2007, J IMMUNOL, V178, P1748, DOI 10.4049/jimmunol.178.3.1748; Muruganandham M, 2005, CLIN CANCER RES, V11, P3503, DOI 10.1158/1078-0432.CCR-04-1399; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Nowell MA, 2006, ARTHRITIS RHEUM-US, V54, P2084, DOI 10.1002/art.21942; Ognjanovic S, 2001, J MOL ENDOCRINOL, V26, P107, DOI 10.1677/jme.0.0260107; Otero M, 2006, ANN RHEUM DIS, V65, P1198, DOI 10.1136/ard.2005.046540; PEACOCK DJ, 1992, J EXP MED, V175, P1135, DOI 10.1084/jem.175.4.1135; Pero RW, 1999, MOL CELL BIOCHEM, V193, P119, DOI 10.1023/A:1006932714982; Pogrebniak A, 2006, EUR J MED RES, V11, P313; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Revollo JR, 2007, CURR OPIN GASTROEN, V23, P164, DOI 10.1097/MOG.0b013e32801b3c8f; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rongvaux A, 2003, BIOESSAYS, V25, P683, DOI 10.1002/bies.10297; Rongvaux A, 2002, EUR J IMMUNOL, V32, P3225, DOI 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Segawa K, 2006, BIOCHEM BIOPH RES CO, V349, P875, DOI 10.1016/j.bbrc.2006.07.083; Swierkot J, 2006, PHARMACOL REP, V58, P473; Tanaka M, 2007, BIOCHEM BIOPH RES CO, V359, P194, DOI 10.1016/j.bbrc.2007.05.096; Taylor PC, 2005, CURR OPIN RHEUMATOL, V17, P293, DOI 10.1097/01.bor.0000155361.83990.5b; Veale DJ, 2006, BEST PRACT RES CL RH, V20, P941, DOI 10.1016/j.berh.2006.05.004; WAGNER TC, 1994, ANAL BIOCHEM, V222, P417, DOI 10.1006/abio.1994.1511; Wosikowski K, 2002, CANCER RES, V62, P1057; Ye SQ, 2005, AM J RESP CRIT CARE, V171, P361, DOI 10.1164/rccm.200404-563OC; Ziegler M, 2000, EUR J BIOCHEM, V267, P1550, DOI 10.1046/j.1432-1327.2000.01187.x	45	190	216	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2267	10.1371/journal.pone.0002267	http://dx.doi.org/10.1371/journal.pone.0002267			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493620	Green Published, Green Submitted, gold			2022-12-25	WOS:000262258700061
J	Takashima, A; Takahata, M				Takashima, Akira; Takahata, Masakazu			Effects of Active Conductance Distribution over Dendrites on the Synaptic Integration in an Identified Nonspiking Interneuron	PLOS ONE			English	Article							LOCAL INTERNEURONS; PURKINJE-CELLS; CRAYFISH; MEMBRANE; NEURONS; ULTRASTRUCTURE; INPUT; SYNAPSES; CHANNELS; CURRENTS	The synaptic integration in individual central neuron is critically affected by how active conductances are distributed over dendrites. It has been well known that the dendrites of central neurons are richly endowed with voltage- and ligand-regulated ion conductances. Nonspiking interneurons (NSIs), almost exclusively characteristic to arthropod central nervous systems, do not generate action potentials and hence lack voltage- regulated sodium channels, yet having a variety of voltage- regulated potassium conductances on their dendritic membrane including the one similar to the delayed-rectifier type potassium conductance. It remains unknown, however, how the active conductances are distributed over dendrites and how the synaptic integration is affected by those conductances in NSIs and other invertebrate neurons where the cell body is not included in the signal pathway from input synapses to output sites. In the present study, we quantitatively investigated the functional significance of active conductance distribution pattern in the spatio-temporal spread of synaptic potentials over dendrites of an identified NSI in the crayfish central nervous system by computer simulation. We systematically changed the distribution pattern of active conductances in the neuron's multicompartment model and examined how the synaptic potential waveform was affected by each distribution pattern. It was revealed that specific patterns of nonuniform distribution of potassium conductances were consistent, while other patterns were not, with the waveform of compound synaptic potentials recorded physiologically in the major input-output pathway of the cell, suggesting that the possibility of nonuniform distribution of potassium conductances over the dendrite cannot be excluded as well as the possibility of uniform distribution. Local synaptic circuits involving input and output synapses on the same branch or on the same side were found to be potentially affected under the condition of nonuniform distribution while operation of the major input-output pathway from the soma side to the one on the opposite side remained the same under both conditions of uniform and nonuniform distribution of potassium conductances over the NSI dendrite.	[Takashima, Akira; Takahata, Masakazu] Hokkaido Univ, Fac Sci, Dept Biol Sci, Sapporo, Hokkaido 060, Japan	Hokkaido University	Takashima, A (corresponding author), Hokkaido Univ, Fac Sci, Dept Biol Sci, Sapporo, Hokkaido 060, Japan.	takashim@sci.hokudai.ac.jp	Takashima, Akira/B-8295-2015	Takashima, Akira/0000-0003-1422-6820	Japan Society for the Promotion of Science [17370024, 18657025]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by the Research Fellowship for Young Scientists (AT) and Grants-in-Aid (MT) from the Japan Society for the Promotion of Science (17370024, 18657025).	Achard P, 2006, PLOS COMPUT BIOL, V2, P794, DOI 10.1371/journal.pcbi.0020094; BHALLA US, 1992, TRENDS NEUROSCI, V15, P453, DOI 10.1016/0166-2236(92)90009-W; Chen XX, 2006, PFLUG ARCH EUR J PHY, V453, P397, DOI 10.1007/s00424-006-0097-y; DESCHUTTER E, 1994, J NEUROPHYSIOL, V71, P401, DOI 10.1152/jn.1994.71.1.401; DiCaprio RA, 2004, J NEUROPHYSIOL, V92, P302, DOI 10.1152/jn.01176.2003; EDWARDS DH, 1987, J NEUROPHYSIOL, V57, P1425, DOI 10.1152/jn.1987.57.5.1425; EVOY WH, 1977, IDENTIFIED NEURONS B, P67; Gulledge AT, 2005, J NEUROBIOL, V64, P75, DOI 10.1002/neu.20144; Gurkiewicz M, 2006, PFLUG ARCH EUR J PHY, V453, P283, DOI 10.1007/s00424-006-0076-3; GWILLIAM GF, 1980, J EXP BIOL, V86, P49; Hama N, 2005, J COMP PHYSIOL A, V191, P747, DOI 10.1007/s00359-005-0630-z; Hikosaka R, 1996, ZOOL SCI, V13, P69, DOI 10.2108/zsj.13.69; Hikosaka R, 1998, J COMP NEUROL, V392, P373, DOI 10.1002/(SICI)1096-9861(19980316)392:3<373::AID-CNE7>3.0.CO;2-Z; HINES M, 1984, INT J BIOMED COMPUT, V15, P69, DOI 10.1016/0020-7101(84)90008-4; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Keren N, 2005, J NEUROPHYSIOL, V94, P3730, DOI 10.1152/jn.00408.2005; Koch Christof, 1999, P1; KONDOH Y, 1986, J COMP NEUROL, V254, P259, DOI 10.1002/cne.902540209; KONDOH Y, 1986, J COMP NEUROL, V251, P334, DOI 10.1002/cne.902510305; Korngreen A, 2000, J PHYSIOL-LONDON, V525, P621, DOI 10.1111/j.1469-7793.2000.00621.x; KRENZ WD, 1985, J COMP PHYSIOL A, V157, P499, DOI 10.1007/BF00615151; LLINAS R, 1971, J NEUROPHYSIOL, V34, P532, DOI 10.1152/jn.1971.34.4.532; Llinas R.R., 2004, SYNAPTIC ORG BRAIN, DOI [10.1093/acprof:oso/9780195159561.003.0007, DOI 10.1093/ACPR0F:0S0/9780195159561.003.0007, DOI 10.1093/ACPROF:OSO/9780195159561.003.0007]; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Magee J. C., 1999, DENDRITES, P139; Marder E, 2001, CURR BIOL, V11, pR986, DOI 10.1016/S0960-9822(01)00581-4; Martina M, 2003, J NEUROSCI, V23, P5698; NADIM F, 1995, J COMPUT NEUROSCI, V2, P215, DOI 10.1007/BF00961435; NELSON M, 1997, BOOK GENESIS, P29; OKADA Y, 1988, J COMP PHYSIOL A, V162, P705, DOI 10.1007/BF00610960; PERKEL DH, 1981, NEUROSCIENCE, V6, P823, DOI 10.1016/0306-4522(81)90165-2; RALL W, 1992, PHYSIOL REV, V72, pS159, DOI 10.1152/physrev.1992.72.suppl_4.S159; RALL W, 1969, BIOPHYS J, V9, P1483, DOI 10.1016/S0006-3495(69)86467-2; RALL W, 1981, NEURONES IMPULSES, P223; REICHERT H, 1983, J COMP PHYSIOL, V151, P261, DOI 10.1007/BF00623903; ROSS WN, 1987, J PHYSIOL-LONDON, V389, P319, DOI 10.1113/jphysiol.1987.sp016659; Schiller J, 2001, CURR OPIN NEUROBIOL, V11, P343, DOI 10.1016/S0959-4388(00)00217-8; Segev I., 1998, BOOK GENESIS EXPLORI, P51, DOI [10.1007/978-1-4612-1634-6_5, DOI 10.1007/978-1-4612-1634-6_5]; Segev I, 1998, METHODS NEURONAL MOD, P93; SEGEV I, 1999, DENDRITES, P205; SPRUSTON N, 1994, TRENDS NEUROSCI, V17, P161, DOI 10.1016/0166-2236(94)90094-9; Takahashi M, 1995, J NEUROPHYSIOL, V74, P2242, DOI 10.1152/jn.1995.74.6.2242; Takashima A, 1996, J COMP PHYSIOL A, V179, P447; Takashima A, 2000, J COMPUT NEUROSCI, V9, P187, DOI 10.1023/A:1008924025488; Takashima A, 2006, J NEUROPHYSIOL, V96, P3157, DOI 10.1152/jn.00680.2006; TANK DW, 1988, SCIENCE, V242, P773, DOI 10.1126/science.2847315; TRAUB RD, 1991, J NEUROPHYSIOL, V66, P635, DOI 10.1152/jn.1991.66.2.635; WATSON AHD, 1982, J COMP NEUROL, V205, P383, DOI 10.1002/cne.902050407; WATSON AHD, 1983, J COMP NEUROL, V214, P154, DOI 10.1002/cne.902140205; Wilson MA, 1989, ADV NEURAL INFORMATI, V1989, P485	51	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2217	10.1371/journal.pone.0002217	http://dx.doi.org/10.1371/journal.pone.0002217			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493322	Green Published, gold			2022-12-25	WOS:000262258700025
J	Jaing, C; Gardner, S; McLoughlin, K; Mulakken, N; Alegria-Hartman, M; Banda, P; Williams, P; Gu, P; Wagner, M; Manohar, C; Slezak, T				Jaing, Crystal; Gardner, Shea; McLoughlin, Kevin; Mulakken, Nisha; Alegria-Hartman, Michelle; Banda, Phillip; Williams, Peter; Gu, Pauline; Wagner, Mark; Manohar, Chitra; Slezak, Tom			A Functional Gene Array for Detection of Bacterial Virulence Elements	PLOS ONE			English	Article							MICROARRAY	Emerging known and unknown pathogens create profound threats to public health. Platforms for rapid detection and characterization of microbial agents are critically needed to prevent and respond to disease outbreaks. Available detection technologies cannot provide broad functional information about known or novel organisms. As a step toward developing such a system, we have produced and tested a series of high-density functional gene arrays to detect elements of virulence and antibiotic resistance mechanisms. Our first generation array targets genes from Escherichia coli strains K12 and CFT073, Enterococcus faecalis and Staphylococcus aureus. We determined optimal probe design parameters for gene family detection and discrimination. When tested with organisms at varying phylogenetic distances from the four target strains, the array detected orthologs for the majority of targeted gene families present in bacteria belonging to the same taxonomic family. In combination with whole-genome amplification, the array detects femtogram concentrations of purified DNA, either spiked in to an aerosol sample background, or in combinations from one or more of the four target organisms. This is the first report of a high density NimbleGen microarray system targeting microbial antibiotic resistance and virulence mechanisms. By targeting virulence gene families as well as genes unique to specific biothreat agents, these arrays will provide important data about the pathogenic potential and drug resistance profiles of unknown organisms in environmental samples.	[Jaing, Crystal; Alegria-Hartman, Michelle; Banda, Phillip; Manohar, Chitra] Lawrence Livermore Natl Lab, Chem, Mat, Earth & Life Sci, Livermore, CA 94550 USA; [Gardner, Shea; McLoughlin, Kevin; Mulakken, Nisha; Williams, Peter; Gu, Pauline; Wagner, Mark; Slezak, Tom] Lawrence Livermore Natl Lab, Comp, Livermore, CA USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Jaing, C (corresponding author), Lawrence Livermore Natl Lab, Chem, Mat, Earth & Life Sci, Livermore, CA 94550 USA.	jaing2@llnl.gov		Jaing, Crystal/0000-0001-9933-3005; McLoughlin, Kevin/0000-0001-9651-4951	Department of Homeland Security; U.S. Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]	Department of Homeland Security(United States Department of Homeland Security (DHS)); U.S. Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE))	The funding was provided by the Department of Homeland Security. The funding agency was not involved in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript. This work was performed under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344.	Arriola E, 2007, LAB INVEST, V87, P75, DOI 10.1038/labinvest.3700495; Benson DA, 2000, NUCLEIC ACIDS RES, V28, P15, DOI 10.1093/nar/28.1.15; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Burden C.J., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1095, DOI 10.2202/1544-6115.1095]; Gentry TJ, 2006, MICROB ECOL, V52, P159, DOI 10.1007/s00248-006-9072-6; He ZL, 2007, ISME J, V1, P67, DOI 10.1038/ismej.2007.2; He ZL, 2005, APPL ENVIRON MICROB, V71, P3753, DOI 10.1128/AEM.71.7.3753-3760.2005; Jackson SA, 2007, FORENSIC SCI INT, V168, P183, DOI 10.1016/j.forsciint.2006.06.079; Kane MD, 2000, NUCLEIC ACIDS RES, V28, P4552, DOI 10.1093/nar/28.22.4552; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; MAURELLI AT, 2007, MICROBE, V2, P388; Nuwaysir EF, 2002, GENOME RES, V12, P1749, DOI 10.1101/gr.362402; Palacios G, 2007, EMERG INFECT DIS, V13, P73, DOI 10.3201/eid1301.060837; Radosevich JL, 2002, LETT APPL MICROBIOL, V34, P162, DOI 10.1046/j.1472-765x.2002.01048.x; Rhee SK, 2004, APPL ENVIRON MICROB, V70, P4303, DOI 10.1128/AEM.70.7.4303-4317.2004; Rozen S, 2000, Methods Mol Biol, V132, P365; Singh-Gasson S, 1999, NAT BIOTECHNOL, V17, P974, DOI 10.1038/13664; SWAN KA, 2005, ANN IC POSTD RES FEL; Wu LY, 2006, APPL ENVIRON MICROB, V72, P4931, DOI 10.1128/AEM.02738-05	19	30	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2163	10.1371/journal.pone.0002163	http://dx.doi.org/10.1371/journal.pone.0002163			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478124	Green Submitted, gold, Green Published			2022-12-25	WOS:000262172800028
J	Shiraiwa, T				Shiraiwa, Takashi			Multimodal Chemosensory Integration through the Maxillary Palp in Drosophila	PLOS ONE			English	Article							MUSHROOM BODIES; MOLECULAR-BASIS; INTRAPOPULATIONAL VARIATION; OLFACTORY PHYSIOLOGY; RECEPTOR EXPRESSION; COURTSHIP BEHAVIOR; FEEDING-BEHAVIOR; GENETIC-ANALYSIS; ANTENNAL LOBE; MELANOGASTER	Drosophila melanogaster has an olfactory organ called the maxillary palp. It is smaller and numerically simpler than the antenna, and its specific role in behavior has long been unclear. Because of its proximity to the mouthparts, I explored the possibility of a role in taste behavior. Maxillary palp was tuned to mediate odor-induced taste enhancement: a sucrose solution was more appealing when simultaneously presented with the odorant 4-methylphenol. The same result was observed with other odors that stimulate other types of olfactory receptor neuron in the maxillary palp. When an antennal olfactory receptor was genetically introduced in the maxillary palp, the fly interpreted a new odor as a sweet-enhancing smell. These results all point to taste enhancement as a function of the maxillary palp. It also opens the door for studying integration of multiple senses in a model organism.	[Shiraiwa, Takashi] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University	Shiraiwa, T (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	takashi.shiraiwa@yale.edu			National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was funded by the the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCORTA E, 1989, BEHAV GENET, V19, P285, DOI 10.1007/BF01065911; ALCORTA E, 1988, HEREDITY, V60, P7, DOI 10.1038/hdy.1988.2; Armstrong JD, 1998, LEARN MEMORY, V5, P102; AYER RK, 1991, P NATL ACAD SCI USA, V88, P5467, DOI 10.1073/pnas.88.12.5467; AYER RK, 1992, J NEUROBIOL, V23, P965, DOI 10.1002/neu.480230804; Bagley KR, 2006, ANIM BEHAV, V71, P1439, DOI 10.1016/j.anbehav.2006.01.003; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Cayirlioglu P, 2008, SCIENCE, V319, P1256, DOI 10.1126/science.1149483; CHARRO MJ, 1994, J COMP PHYSIOL A, V175, P761; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Couri M. S., 2003, Braz. J. Biol., V63, P223, DOI 10.1590/S1519-69842003000200007; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Cytowic R. E., 2002, SYNESTHESIA UNION SE; D'Haese CA, 2003, ZOOL SCR, V32, P563, DOI 10.1046/j.1463-6409.2003.00134.x; Dahanukar A, 2001, NAT NEUROSCI, V4, P1182, DOI 10.1038/nn765; Dalton P, 2000, NAT NEUROSCI, V3, P431, DOI 10.1038/74797; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; de Carvalho C. J. B., 2003, PERSPECTIVA LATINOAM, P263; de Gelder B, 2003, SCHIZOPHR RES, V59, P211, DOI 10.1016/S0920-9964(01)00344-9; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; FRANK RA, 1988, CHEM SENSES, V13, P445, DOI 10.1093/chemse/13.3.445; FUYAMA Y, 1978, BEHAV GENET, V8, P399, DOI 10.1007/BF01067937; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Goldman AL, 2005, NEURON, V45, P661, DOI 10.1016/j.neuron.2005.01.025; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; HAMMER M, 1993, NATURE, V366, P59, DOI 10.1038/366059a0; Heimbeck G, 2001, P NATL ACAD SCI USA, V98, P15336, DOI 10.1073/pnas.011314898; HERSHBERGER WA, 1967, ANIM BEHAV, V15, P259, DOI 10.1016/0003-3472(67)90008-5; HEY J, 1993, MOL BIOL EVOL, V10, P804; HIGA I, 1993, GENETICA, V88, P129, DOI 10.1007/BF02424469; HULTIN HO, 1961, FOOD TECHNOL-CHICAGO, V15, P440; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; KENT KS, 1986, CELL TISSUE RES, V245, P237; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; Kreher SA, 2005, NEURON, V46, P445, DOI 10.1016/j.neuron.2005.04.007; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; LILLY M, 1990, GENETICS, V124, P293; MCKENZIE JA, 1972, OECOLOGIA, V10, P373, DOI 10.1007/BF00345738; MCKENZIE JA, 1974, OECOLOGIA, V15, P1, DOI 10.1007/BF00345225; Melcher C, 2005, PLOS BIOL, V3, P1618, DOI 10.1371/journal.pbio.0030305; MONTE P, 1989, BEHAV GENET, V19, P267, DOI 10.1007/BF01065910; Nisimura T, 2005, J NEUROSCI, V25, P7507, DOI 10.1523/JNEUROSCI.1862-05.2005; PROKOP A, 1994, DEV BIOL, V161, P321, DOI 10.1006/dbio.1994.1034; Richards S, 2005, GENOME RES, V15, P1, DOI 10.1101/gr.3059305; Rowe C, 1999, ANIM BEHAV, V58, P921, DOI 10.1006/anbe.1999.1242; ROZIN P, 1982, PERCEPT PSYCHOPHYS, V31, P397, DOI 10.3758/BF03202667; Schifferstein HNJ, 1996, ACTA PSYCHOL, V94, P87, DOI 10.1016/0001-6918(95)00040-2; Schroter U, 2003, J COMP NEUROL, V465, P168, DOI 10.1002/cne.10843; Schulte BA, 1999, ANIM BEHAV, V57, P1265, DOI 10.1006/anbe.1999.1092; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; SHIRAIWA T, 2007, PROBOSCIS EXTENSION, DOI DOI 10.3791/193; Snodgrass RE, 1935, PRINCIPLES INSECT MO; Stein BE, 2002, NEUROSCIENTIST, V8, P306, DOI 10.1177/107385840200800406; STOCKER RF, 1983, CELL TISSUE RES, V232, P237, DOI 10.1007/BF00213783; STOCKER RF, 1989, BEHAV GENET, V19, P371, DOI 10.1007/BF01066165; Stocker RF, 2001, MICROSC RES TECHNIQ, V55, P284, DOI 10.1002/jemt.1178; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; Thum AS, 2007, J NEUROSCI, V27, P11132, DOI 10.1523/JNEUROSCI.2712-07.2007; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; *VCF, 2000, VOL COMP FOOD DATABA; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; WOODARD C, 1989, GENETICS, V123, P315; Yao CA, 2005, J NEUROSCI, V25, P8359, DOI 10.1523/JNEUROSCI.2432-05.2005	71	32	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2191	10.1371/journal.pone.0002191	http://dx.doi.org/10.1371/journal.pone.0002191			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	390OE	18478104	Green Published, Green Submitted, gold			2022-12-25	WOS:000262172800055
J	Ou, WB; Zhu, MJ; Demetri, GD; Fletcher, CDM; Fletcher, JA				Ou, W-b; Zhu, M-j; Demetri, G. D.; Fletcher, C. D. M.; Fletcher, J. A.			Protein kinase C-theta regulates KIT expression and proliferation in gastrointestinal stromal tumors	ONCOGENE			English	Article						PRKCQ; KIT; shRNA; gastrointestinal neoplasm; sarcoma; imatinib	RECEPTOR TYROSINE KINASES; KAPPA-B ACTIVATION; RETINOID-X-RECEPTOR; T-CELL-ACTIVATION; PKC-THETA; INTESTINAL EPITHELIUM; ANTICANCER THERAPY; IMATINIB MESYLATE; MOLECULAR-CLONING; GENE-EXPRESSION	Oncogenic KIT or PDGFRA receptor tyrosine kinase mutations are compelling therapeutic targets in gastrointestinal stromal tumors (GISTs), and the KIT/PDGFRA kinase inhibitor, imatinib, is standard of care for patients with metastatic GIST. However, most of these patients eventually develop clinical resistance to imatinib and other KIT/PDGFRA kinase inhibitors and there is an urgent need to identify novel therapeutic strategies. We reported previously that protein kinase C-theta (PKC theta) is activated in GIST, irrespective of KIT or PDGFRA mutational status, and is expressed at levels unprecedented in other mesenchymal tumors, therefore serving as a diagnostic marker of GIST. Herein, we characterize biological functions of PKC theta in imatinib-sensitive and imatinib-resistant GISTs, showing that lentivirus-mediated PKC theta knockdown is accompanied by inhibition of KIT expression in three KIT+/PKC theta+ GIST cell lines, but not in a comparator KIT+/PKCh theta-Ewing's sarcoma cell line. PKC theta knockdown in the KIT+ GISTs was associated with inhibition of the phosphatidylinositol-3-kinase/AKT signaling pathway, upregulation of the cyclin-dependent kinase inhibitors p21 and p27, antiproliferative effects due to G(1) arrest and induction of apoptosis, comparable to the effects seen after direct knockdown of KIT expression by KIT short-hairpin RNA. These novel findings highlight that PKC theta warrants clinical evaluation as a potential therapeutic target in GISTs, including those cases containing mutations that confer resistance to KIT/PDGFRA kinase inhibitors.	[Ou, W-b; Zhu, M-j; Fletcher, C. D. M.; Fletcher, J. A.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Demetri, G. D.] Dana Farber Harvard Canc Ctr, Ludwig Ctr, Boston, MA USA; [Demetri, G. D.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Ou, WB (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	wou@rics.bwh.harvard.edu; jfletcher@partners.org	Ou, Wen-Bin/J-1142-2019	, Wenbin/0000-0002-6311-9442	GI SPORE [1P50CA127003-01]; Life Raft Group; Cesarini Team for the Pan-Massachusetts Challenge; Virginia and Daniel K Ludwig Trust for Cancer Research; Ronald O Perelman Fund; Stutman GIST Cancer Research Fund; Rubenstein Foundation; NATIONAL CANCER INSTITUTE [P50CA127003] Funding Source: NIH RePORTER	GI SPORE; Life Raft Group; Cesarini Team for the Pan-Massachusetts Challenge; Virginia and Daniel K Ludwig Trust for Cancer Research; Ronald O Perelman Fund; Stutman GIST Cancer Research Fund; Rubenstein Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from an anonymous donor, GI SPORE 1P50CA127003-01, the Life Raft Group, Cesarini Team for the Pan-Massachusetts Challenge, the Virginia and Daniel K Ludwig Trust for Cancer Research, the Ronald O Perelman Fund for Cancer Research, the Stutman GIST Cancer Research Fund, the Rubenstein Foundation and Leslie's Links. We thank Sarah E Bulmer and William Hahn for providing shRNA constructs.	Allander SV, 2001, CANCER RES, V61, P8624; Altman A, 2003, IMMUNOL REV, V192, P53, DOI 10.1034/j.1600-065X.2003.00027.x; Ashton AW, 1999, J BIOL CHEM, V274, P20805, DOI 10.1074/jbc.274.30.20805; BAIER G, 1993, J BIOL CHEM, V268, P4997; Banan A, 2005, J PHARMACOL EXP THER, V313, P962, DOI 10.1124/jpet.104.083428; Banan A, 2004, AM J PHYSIOL-CELL PH, V287, pC218, DOI 10.1152/ajpcell.00575.2003; Bauer B, 2001, J BIOL CHEM, V276, P31627, DOI 10.1074/jbc.M103098200; Bauer S, 2007, ONCOGENE, V26, P7560, DOI 10.1038/sj.onc.1210558; Bi K, 2001, NAT IMMUNOL, V2, P556, DOI 10.1038/88765; Blay JY, 2005, ANN ONCOL, V16, P566, DOI 10.1093/annonc/mdi127; Blay P, 2004, CLIN CANCER RES, V10, P4089, DOI 10.1158/1078-0432.CCR-04-0630; BLUMEJENSEN P, 1995, J BIOL CHEM, V270, P14192, DOI 10.1074/jbc.270.23.14192; BLUMEJENSEN P, 1993, EMBO J, V12, P4199, DOI 10.1002/j.1460-2075.1993.tb06104.x; BLUMEJENSEN P, 1994, J BIOL CHEM, V269, P21793; Cerda SR, 2006, ONCOGENE, V25, P3123, DOI 10.1038/sj.onc.1209360; CHANG JD, 1993, J BIOL CHEM, V268, P14208; Corless CL, 2005, J CLIN ONCOL, V23, P5357, DOI 10.1200/JCO.2005.14.068; Corless CL, 2004, J CLIN ONCOL, V22, P3813, DOI 10.1200/JCO.2004.05.140; Debiec-Rychter M, 2005, GASTROENTEROLOGY, V128, P270, DOI 10.1053/j.gastro.2004.11.020; Deeds L, 2003, J BIOL CHEM, V278, P39782, DOI 10.1074/jbc.M306854200; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Drevs J, 2003, CURR DRUG TARGETS, V4, P113, DOI 10.2174/1389450033346885; Duensing A, 2004, ONCOGENE, V23, P3999, DOI 10.1038/sj.onc.1207525; Duensing A, 2004, CANCER RES, V64, P5127, DOI 10.1158/0008-5472.CAN-04-0559; Fletcher CDM, 2002, HUM PATHOL, V33, P459, DOI 10.1053/hupa.2002.123545; Frey MR, 1997, J BIOL CHEM, V272, P9424; Gschwind A, 2004, NAT REV CANCER, V4, P361, DOI 10.1038/nrc1360; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Heinrich MC, 2006, J CLIN ONCOL, V24, P4764, DOI 10.1200/JCO.2006.06.2265; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Ishaq M, 2002, J IMMUNOL, V169, P732, DOI 10.4049/jimmunol.169.2.732; Janeway KA, 2007, CANCER RES, V67, P9084, DOI 10.1158/0008-5472.CAN-07-1938; Jiang XH, 2002, ONCOGENE, V21, P6113, DOI 10.1038/sj.onc.1205778; Lee KY, 2005, SCIENCE, V308, P114, DOI 10.1126/science.1107107; Liu YH, 2000, J BIOL CHEM, V275, P3603, DOI 10.1074/jbc.275.5.3603; Lux ML, 2000, AM J PATHOL, V156, P791, DOI 10.1016/S0002-9440(10)64946-2; Medeiros F, 2004, AM J SURG PATHOL, V28, P889, DOI 10.1097/00000478-200407000-00007; Medinger M, 2005, CURR PHARM DESIGN, V11, P1139, DOI 10.2174/1381612053507611; Motegi A, 2005, PATHOL INT, V55, P106, DOI 10.1111/j.1440-1827.2005.01806.x; Nielsen TO, 2002, LANCET, V359, P1301, DOI 10.1016/S0140-6736(02)08270-3; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Rastinejad F, 2001, CURR OPIN STRUC BIOL, V11, P33, DOI 10.1016/S0959-440X(00)00165-2; Rossi F, 2006, P NATL ACAD SCI USA, V103, P12843, DOI 10.1073/pnas.0511076103; Rubin BP, 2001, CANCER RES, V61, P8118; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Southwell BR, 2003, NEUROGASTROENT MOTIL, V15, P139, DOI 10.1046/j.1365-2982.2003.00394.x; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Tarn C, 2006, CANCER RES, V66, P5477, DOI 10.1158/0008-5472.CAN-05-3906; Teixeira C, 2003, BLOOD, V102, P1414, DOI 10.1182/blood-2002-11-3621; Tuveson DA, 2001, ONCOGENE, V20, P5054, DOI 10.1038/sj.onc.1204704; Villalba M, 1999, J IMMUNOL, V163, P5813; Villalba M, 2002, J CELL BIOL, V157, P253, DOI 10.1083/jcb.200201097; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003; Zhu MJ, 2007, ONCOGENE, V26, P6386, DOI 10.1038/sj.onc.1210464	54	61	63	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 18	2008	27	42					5624	5634		10.1038/onc.2008.177	http://dx.doi.org/10.1038/onc.2008.177			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	349KX	18521081	Green Accepted			2022-12-25	WOS:000259280800008
J	Kirk, R; Laman, H; Knowles, PP; Murray-Rust, J; Lomonosov, M; Meziane, EK; McDonald, NQ				Kirk, Rebecca; Laman, Heike; Knowles, Phillip P.; Murray-Rust, Judith; Lomonosov, Mikhail; Meziane, El Kahina; McDonald, Neil Q.			Structure of a conserved dimerization domain within the F-box protein Fbxo7 and the PI31 proteasome inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; SEDIMENTATION-VELOCITY; UBIQUITIN LIGASES; ESCHERICHIA-COLI; CDNA CLONING; PROTEOLYSIS; BINDING; ULTRACENTRIFUGATION; RECOGNITION; ORIENTATION	F-box proteins are the substrate-recognition components of the Skp1-Cul1-F box protein (SCF) E3 ubiquitin ligases. Here we report a structural relationship between Fbxo7, a component of the SCFFbxo7 E3 ligase, and the proteasome inhibitor PI31. SCFFbxo7 is known to catalyze the ubiquitination of hepatoma-up-regulated protein (HURP) and the inhibitor of apoptosis (IAP) protein but also functions as an activator of cyclin D-Cdk6 complexes. We identify PI31 as an Fbxo7 center dot Skp1 binding partner and show that this interaction requires an N-terminal domain present in both proteins that we term the FP (Fbxo7/PI31) domain. The crystal structure of the PI31 FP domain reveals a novel alpha/beta-fold. Biophysical and mutational analyses are used to map regions of the PI31 FP domain mediating homodimerization and required for heterodimerization with Fbxo7 center dot Skp1. Equivalent mutations in Fbxo7 ablate interaction with PI31 and also block Fbxo7 homodimerization. Knockdown of Fbxo7 does not affect PI31 levels arguing against PI31 being a substrate for SCFFbxo7. We present a model for FP domain-mediated dimerization of SCFFbxo7 and PI31.	[Laman, Heike; Lomonosov, Mikhail; Meziane, El Kahina] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Kirk, Rebecca; Knowles, Phillip P.; Murray-Rust, Judith; McDonald, Neil Q.] Canc Res UK, Struct Biol Lab, London Res Inst, London WC2A 3PX, England; [McDonald, Neil Q.] Univ London Birkbeck Coll, Sch Crystallog, London WC1E 7HX, England	University of Cambridge; Cancer Research UK; University of London; Birkbeck University London	Laman, H (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	hl316@cam.ac.uk; neil.mcdonald@cancer.org.uk		Laman, Heike/0000-0002-6089-171X; Kostenko, Anna/0000-0002-6372-778X; Kirk, Rebecca/0000-0003-3541-0168	Cancer Research UK Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Chang YF, 2006, BIOCHEM BIOPH RES CO, V342, P1022, DOI 10.1016/j.bbrc.2006.02.061; Cho SJ, 2000, P NATL ACAD SCI USA, V97, P8932, DOI 10.1073/pnas.160270897; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; d'Azzo A, 2005, TRAFFIC, V6, P429, DOI 10.1111/j.1600-0854.2005.00294.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Hao B, 2005, MOL CELL, V20, P9, DOI 10.1016/j.molcel.2005.09.003; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Hershko A, 1997, CURR OPIN CELL BIOL, V9, P788, DOI 10.1016/S0955-0674(97)80079-8; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hsu JM, 2004, J BIOL CHEM, V279, P32592, DOI 10.1074/jbc.M404950200; Ilyin GP, 2000, GENOMICS, V67, P40, DOI 10.1006/geno.2000.6211; James P, 1996, GENETICS, V144, P1425; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Kofler M, 2005, J BIOL CHEM, V280, P33397, DOI 10.1074/jbc.M503989200; Laman H, 2006, CELL CYCLE, V5, P279, DOI 10.4161/cc.5.3.2403; Laman H, 2005, EMBO J, V24, P3104, DOI 10.1038/sj.emboj.7600775; MA CP, 1992, BIOCHIM BIOPHYS ACTA, V1119, P303, DOI 10.1016/0167-4838(92)90218-3; McCutchen-Maloney SL, 2000, J BIOL CHEM, V275, P18557, DOI 10.1074/jbc.M001697200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Tang X, 2007, CELL, V129, P1165, DOI 10.1016/j.cell.2007.04.042; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Zaiss DMW, 1999, FEBS LETT, V457, P333, DOI 10.1016/S0014-5793(99)01072-8; Zaiss DMW, 2002, P NATL ACAD SCI USA, V99, P14344, DOI 10.1073/pnas.212257299	38	62	65	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22325	22335		10.1074/jbc.M709900200	http://dx.doi.org/10.1074/jbc.M709900200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18495667	hybrid			2022-12-25	WOS:000258114700051
J	Li, LS; Morales, JC; Hwang, A; Wagner, MW; Boothman, DA				Li, Long Shan; Morales, Julio C.; Hwang, Arlene; Wagner, Mark W.; Boothman, David A.			DNA mismatch repair-dependent activation of c-Abl/p73 alpha/GADD45 alpha-mediated apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONPOLYPOSIS COLON-CANCER; CELL-CYCLE CHECKPOINT; KINASE C-ABL; MICROSATELLITE INSTABILITY; IONIZING-RADIATION; METHYLATING AGENTS; G(2) CHECKPOINT; ATR KINASE; P53; DAMAGE	Cells with functional DNA mismatch repair (MMR) stimulate G(2) cell cycle checkpoint arrest and apoptosis in response to N-methyl-N'-nitro-N-nitrosoguanidine ( MNNG). MMR-deficient cells fail to detect MNNG-induced DNA damage, resulting in the survival of "mutator" cells. The retrograde (nucleus-to-cytoplasm) signaling that initiates MMR-dependent G(2) arrest and cell death remains undefined. Since MMR-dependent phosphorylation and stabilization of p53 were noted, we investigated its role(s) in G(2) arrest and apoptosis. Loss of p53 function by E6 expression, dominant-negative p53, or stable p53 knockdown failed to prevent MMR-dependent G(2) arrest, apoptosis, or lethality. MMR-dependent c-Abl-mediated p73 alpha and GADD45 alpha protein up-regulation after MNNG exposure prompted us to examine c-Abl/p73/alpha GADD45 alpha signaling in cell death responses. STI571 (Gleevec, a c-Abl tyrosine kinase inhibitor) and stable c-Abl, p73 alpha, and GADD45 alpha knockdown prevented MMR-dependent apoptosis. Interestingly, stable p73 alpha knockdown blocked MMR-dependent apoptosis, but not G(2) arrest, thereby uncoupling G(2) arrest from lethality. Thus, MMR-dependent intrinsic apoptosis is p53-independent, but stimulated by hMLH1/c-Abl/p73 alpha/GADD45 alpha retrograde signaling.	[Li, Long Shan; Morales, Julio C.; Hwang, Arlene; Boothman, David A.] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Program Cell Stress & Canc Nanomed, Lab Mol Stress Responses,Dept Oncol, Dallas, TX 75390 USA; [Li, Long Shan; Morales, Julio C.; Hwang, Arlene; Boothman, David A.] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Program Cell Stress & Canc Nanomed, Lab Mol Stress Responses,Dept Pharmacol, Dallas, TX 75390 USA; [Li, Long Shan; Morales, Julio C.; Hwang, Arlene; Boothman, David A.] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Program Cell Stress & Canc Nanomed, Lab Mol Stress Responses,Dept Radiat Oncol, Dallas, TX 75390 USA; [Wagner, Mark W.] Case Western Reserve Univ, Dept Environm Hlth Sci, Cleveland, OH 44106 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Case Western Reserve University	Boothman, DA (corresponding author), Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Program Cell Stress & Canc Nanomed, Lab Mol Stress Responses,Dept Oncol, 5323 Harry Hines Blvd,ND2-210K, Dallas, TX 75390 USA.	David.Boothman@UTSouthwestern.edu	Boothman, David/Q-7776-2019	Morales, Julio/0000-0002-0854-7866	NCI NIH HHS [R01 CA102792, P30 CA142543, R01 CA139217, CA 102792-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA102792, R01CA083196, P30CA142543, R01CA139217] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agami R, 1999, NATURE, V399, P809; Ashcroft M, 1999, MOL CELL BIOL, V19, P1751; Bao Q, 2007, CELL DEATH DIFFER, V14, P56, DOI 10.1038/sj.cdd.4402028; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Burma S, 1999, J BIOL CHEM, V274, P17139, DOI 10.1074/jbc.274.24.17139; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Choi YR, 2003, CANCER RES, V63, P2188; Davis TW, 1998, CANCER RES, V58, P767; Dimri GP, 2005, CANCER CELL, V7, P505, DOI 10.1016/j.ccr.2005.05.025; Duckett DR, 1999, P NATL ACAD SCI USA, V96, P12384, DOI 10.1073/pnas.96.22.12384; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Gerson SL, 2002, J CLIN ONCOL, V20, P2388, DOI 10.1200/JCO.2002.06.110; Gong JG, 1999, NATURE, V399, P806; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; HAWN MT, 1995, CANCER RES, V55, P3721; Hickman MJ, 2004, MOL CELL, V14, P105, DOI 10.1016/S1097-2765(04)00162-5; Hirose Y, 2003, MOL CELL BIOL, V23, P8306, DOI 10.1128/MCB.23.22.8306-8315.2003; Hollander MC, 1999, NAT GENET, V23, P176, DOI 10.1038/13802; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Karran P, 2001, CARCINOGENESIS, V22, P1931, DOI 10.1093/carcin/22.12.1931; KAT A, 1993, P NATL ACAD SCI USA, V90, P6424, DOI 10.1073/pnas.90.14.6424; Kim H, 2003, J PATHOL, V200, P23, DOI 10.1002/path.1325; Kim WJ, 2005, TOXICOL APPL PHARM, V202, P84, DOI 10.1016/j.taap.2004.06.009; Kumar S, 2003, MOL PHARMACOL, V63, P276, DOI 10.1124/mol.63.2.276; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li LS, 2003, AM J PATHOL, V163, P1429, DOI 10.1016/S0002-9440(10)63500-6; Meyers M, 2004, ENVIRON MOL MUTAGEN, V44, P249, DOI 10.1002/em.20056; Meyers M, 2001, CANCER RES, V61, P5193; Nyman U, 2005, J BIOL CHEM, V280, P34159, DOI 10.1074/jbc.M500394200; Patenaude A, 2007, CANCER RES, V67, P2306, DOI 10.1158/0008-5472.CAN-06-3824; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Schaetzlein S, 2007, CELL, V130, P863, DOI 10.1016/j.cell.2007.08.029; Shimodaira H, 2003, P NATL ACAD SCI USA, V100, P2420, DOI 10.1073/pnas.0438031100; Stojic L, 2004, GENE DEV, V18, P1331, DOI 10.1101/gad.294404; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Tsai KKC, 2003, CANCER RES, V63, P3418; Wagner MW, 2008, J BIOL CHEM, V283, P21382, DOI 10.1074/jbc.M709953200; Wajant H, 2002, SCIENCE, V296, P1635, DOI 10.1126/science.1071553; Yan T, 2003, CLIN CANCER RES, V9, P2327; Yanamadala S, 2003, MOL CANCER RES, V1, P747; Yoshioka K, 2006, MOL CELL, V22, P501, DOI 10.1016/j.molcel.2006.04.023; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704; Zeng XH, 2007, CLIN CANCER RES, V13, P1315, DOI 10.1158/1078-0432.CCR-06-1517; Zhang H, 1999, CANCER RES, V59, P3021	46	28	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21394	21403		10.1074/jbc.M709954200	http://dx.doi.org/10.1074/jbc.M709954200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18480060	Green Published, hybrid			2022-12-25	WOS:000257898800010
J	Hu, XH; Murata, LB; Weichsel, A; Brailey, JL; Roberts, SA; Nighorn, A; Montfort, WR				Hu, Xiaohui; Murata, Lauren B.; Weichsel, Andrzej; Brailey, Jacqueline L.; Roberts, Sue A.; Nighorn, Alan; Montfort, William R.			Allostery in recombinant soluble guanylyl cyclase from Manduca sexta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE ACTIVATION; ANTENNAL-LOBE; FUNCTIONAL-CHARACTERIZATION; YC-1 ACTIVATION; DISTAL POCKET; BINDING-SITE; NO; HEME; KINETICS; CO	Soluble guanylyl/guanylate cyclase (sGC), the primary biological receptor for nitric oxide, is required for proper development and health in all animals. We have expressed heterodimeric full-length and N-terminal fragments of Manduca sexta sGC in Escherichia coli, the first time this has been accomplished for any sGC, and have performed the first functional analyses of an insect sGC. Manduca sGC behaves much like its mammalian counterparts, displaying a 170-fold stimulation by NO and sensitivity to compound YC-1. YC-1 reduces the NO and CO off-rates for the similar to 100-kDa N-terminal heterodimeric fragment and increases the CO affinity by similar to 50-fold to 1.7 mu M. Binding of NO leads to a transient six-coordinate intermediate, followed by release of the proximal histidine to yield a five-coordinate nitrosyl complex (k(6-5) = 12.8 s(-1)). The conversion rate is insensitive to nucleotides, YC-1, and changes in NO concentration up to similar to 30 mu M. NO release is biphasic in the absence of YC-1 (k(off1) = 0.10 s(-1) and k(off2) = 0.0015 s(-1)); binding of YC-1 eliminates the fast phase but has little effect on the slower phase. Our data are consistent with a model for allosteric activation in which sGC undergoes a simple switch between two conformations, with an open or a closed heme pocket, integrating the influence of numerous effectors to give the final catalytic rate. Importantly, YC-1 binding occurs in the N-terminal two-thirds of the protein. Homology modeling and mutagenesis experiments suggest the presence of an H-NOX domain in the alpha subunit with importance for heme binding.	[Hu, Xiaohui; Murata, Lauren B.; Brailey, Jacqueline L.; Roberts, Sue A.; Montfort, William R.] Univ Arizona, Dept Biochem & Mol Biophys, Tucson, AZ 85721 USA; [Hu, Xiaohui; Murata, Lauren B.; Weichsel, Andrzej; Brailey, Jacqueline L.; Roberts, Sue A.; Montfort, William R.] Univ Arizona, Arizona Res Labs, Tucson, AZ 85721 USA; [Nighorn, Alan] Univ Arizona, Div Neurobiol, Tucson, AZ 85721 USA	University of Arizona; University of Arizona; University of Arizona	Montfort, WR (corresponding author), Univ Arizona, Dept Biochem & Mol Biophys, Tucson, AZ 85721 USA.	montfort@email.arizona.edu	Hu, Xiaohui/M-1389-2019		NATIONAL CANCER INSTITUTE [T32CA009213] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004292] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA 09213] Funding Source: Medline; NHLBI NIH HHS [R01 HL062969, R01 HL 62969] Funding Source: Medline; NIDCD NIH HHS [R01 DC004292-08, R01 DC004292, R01 DC 004292] Funding Source: Medline; NIGMS NIH HHS [R01 GM 077390] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersen JF, 2000, BIOCHEMISTRY-US, V39, P10118, DOI 10.1021/bi000766b; Balashova N, 2005, J BIOL CHEM, V280, P2186, DOI 10.1074/jbc.M411545200; Ballou DP, 2002, P NATL ACAD SCI USA, V99, P12097, DOI 10.1073/pnas.192209799; Boon EM, 2005, J INORG BIOCHEM, V99, P892, DOI 10.1016/j.jinorgbio.2004.12.016; Brandish PE, 1998, BIOCHEMISTRY-US, V37, P16898, DOI 10.1021/bi9814989; Cary SPL, 2005, P NATL ACAD SCI USA, V102, P13064, DOI 10.1073/pnas.0506289102; Chang FJ, 2005, J BIOL CHEM, V280, P11513, DOI 10.1074/jbc.M412203200; Collmann C, 2004, J NEUROSCI, V24, P6070, DOI 10.1523/JNEUROSCI.0710-04.2004; Evgenov OV, 2006, NAT REV DRUG DISCOV, V5, P755, DOI 10.1038/nrd2038; Friebe A, 1999, BIOCHEMISTRY-US, V38, P15253, DOI 10.1021/bi9908944; Friebe A, 1996, EMBO J, V15, P6863, DOI 10.1002/j.1460-2075.1996.tb01078.x; Friebe A, 1998, MOL PHARMACOL, V53, P123, DOI 10.1124/mol.53.1.123; Friebe A, 1997, BIOCHEMISTRY-US, V36, P1194, DOI 10.1021/bi962047w; Gibson NJ, 2001, DEV BIOL, V240, P326, DOI 10.1006/dbio.2001.0463; Gibson NJ, 2000, J COMP NEUROL, V422, P191, DOI 10.1002/(SICI)1096-9861(20000626)422:2<191::AID-CNE4>3.0.CO;2-C; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Hanafy KA, 2004, J BIOL CHEM, V279, P46946, DOI 10.1074/jbc.M404134200; Hoenicka M, 1999, J MOL MED-JMM, V77, P14, DOI 10.1007/s001090050292; Ignarro LJ, 2000, NITRIC OXIDE BIOL PA; Iyer LM, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-5; Karow DS, 2005, BIOCHEMISTRY-US, V44, P16266, DOI 10.1021/bi051601b; Kazerounian S, 2002, BIOCHEMISTRY-US, V41, P3396, DOI 10.1021/bi0110894; Kharitonov VG, 1999, BIOCHEMISTRY-US, V38, P10699, DOI 10.1021/bi990277f; Kharitonov VG, 1997, BIOCHEMISTRY-US, V36, P6814, DOI 10.1021/bi970201o; Kharitonov VG, 1997, BIOCHEM BIOPH RES CO, V239, P284, DOI 10.1006/bbrc.1997.7470; Kim DE, 2005, PROTEINS, V61, P193, DOI 10.1002/prot.20737; KO FN, 1994, BLOOD, V84, P4226, DOI 10.1182/blood.V84.12.4226.bloodjournal84124226; Kondrashov DA, 2007, J PHYS CHEM B, V111, P9244, DOI 10.1021/jp071136n; Lamothe M, 2004, BIOCHEMISTRY-US, V43, P3039, DOI 10.1021/bi0360051; Lawson DM, 2000, EMBO J, V19, P5661, DOI 10.1093/emboj/19.21.5661; Lee YC, 2000, P NATL ACAD SCI USA, V97, P10763, DOI 10.1073/pnas.190333697; Liu Y, 1997, P NATL ACAD SCI USA, V94, P13414, DOI 10.1073/pnas.94.25.13414; Ma XL, 2008, J BIOL CHEM, V283, P1167, DOI 10.1074/jbc.M706218200; Ma XL, 2007, EMBO J, V26, P578, DOI 10.1038/sj.emboj.7601521; Maes EM, 2005, BIOCHEMISTRY-US, V44, P12690, DOI 10.1021/bi0506573; Maes EM, 2004, BIOCHEMISTRY-US, V43, P6679, DOI 10.1021/bi049748a; MARAGOS CM, 1991, J MED CHEM, V34, P3242, DOI 10.1021/jm00115a013; Martin E, 2005, METHOD ENZYMOL, V396, P478, DOI 10.1016/S0076-6879(05)96040-0; Martin E, 2001, P NATL ACAD SCI USA, V98, P12938, DOI 10.1073/pnas.231486198; Meurer S, 2005, J BIOL CHEM, V280, P33149, DOI 10.1074/jbc.M507565200; Nighorn A, 1998, J NEUROSCI, V18, P7244; Nioche P, 2004, SCIENCE, V306, P1550, DOI 10.1126/science.1103596; Olson JS, 1997, J BIOL INORG CHEM, V2, P544, DOI 10.1007/s007750050169; Pellicena P, 2004, P NATL ACAD SCI USA, V101, P12854, DOI 10.1073/pnas.0405188101; Phillips GN, 1999, J PHYS CHEM B, V103, P8817, DOI 10.1021/jp9918205; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Poulos TL, 2006, CURR OPIN STRUC BIOL, V16, P736, DOI 10.1016/j.sbi.2006.09.006; Pyriochou A, 2005, CELL SIGNAL, V17, P407, DOI 10.1016/j.cellsig.2004.09.008; RIBEIRO JMC, 1993, SCIENCE, V260, P539, DOI 10.1126/science.8386393; Roy B, 2006, P NATL ACAD SCI USA, V103, P12185, DOI 10.1073/pnas.0602544103; Ruiz-Stewart I, 2004, P NATL ACAD SCI USA, V101, P37, DOI 10.1073/pnas.0305080101; Russwurm M, 2004, EMBO J, V23, P4443, DOI 10.1038/sj.emboj.7600422; Russwurm M, 2004, BIOCHEM SOC SYMP, V71, P51; Russwurm M, 2002, J BIOL CHEM, V277, P24883, DOI 10.1074/jbc.M110570200; Russwurm M, 2001, J BIOL CHEM, V276, P44647, DOI 10.1074/jbc.M105587200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sayed N, 2007, P NATL ACAD SCI USA, V104, P12312, DOI 10.1073/pnas.0703944104; Sharma VS, 1999, BIOCHEM BIOPH RES CO, V254, P188, DOI 10.1006/bbrc.1998.9812; Stasch JP, 2001, NATURE, V410, P212, DOI 10.1038/35065611; Stengl M, 2001, CELL TISSUE RES, V304, P409, DOI 10.1007/s004410000336; Stone JR, 1998, CHEM BIOL, V5, P255, DOI 10.1016/S1074-5521(98)90618-4; Sunahara RK, 1998, J BIOL CHEM, V273, P16332, DOI 10.1074/jbc.273.26.16332; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Venema RC, 2003, AM J PHYSIOL-HEART C, V285, pH669, DOI 10.1152/ajpheart.01025.2002; Weichsel A, 2000, NAT STRUCT BIOL, V7, P551, DOI 10.1038/76769; Weichsel A, 2007, BIOCHEMISTRY-US, V46, P1219, DOI 10.1021/bi061878r; Wilson CH, 2007, J COMP PHYSIOL A, V193, P715, DOI 10.1007/s00359-007-0227-9; Winger JA, 2007, J BIOL CHEM, V282, P897, DOI 10.1074/jbc.M606327200; Yazawa S, 2006, J BIOL CHEM, V281, P21763, DOI 10.1074/jbc.M508983200; Zayas RM, 2000, J COMP NEUROL, V419, P422; Zhao Y, 1999, P NATL ACAD SCI USA, V96, P14753, DOI 10.1073/pnas.96.26.14753; Zhao Y, 1997, BIOCHEMISTRY-US, V36, P15959, DOI 10.1021/bi971825x	72	33	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20968	20977		10.1074/jbc.M801501200	http://dx.doi.org/10.1074/jbc.M801501200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18515359	Green Published, hybrid			2022-12-25	WOS:000257746100039
J	Kopycki, JG; Stubbs, MT; Brandt, W; Hagemann, M; Porzel, A; Schmidt, J; Schliemann, W; Zenk, MH; Vogt, T				Kopycki, Jakub Grzegorz; Stubbs, Milton T.; Brandt, Wolfgang; Hagemann, Martin; Porzel, Andrea; Schmidt, Juergen; Schliemann, Willibald; Zenk, Meinhart H.; Vogt, Thomas			Functional and structural characterization of a cation-dependent O-methyltransferase from the cyanobacterium Synechocystis sp strain PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; LIGNIN; METHYLATION; COENZYME; ACID; GENE; MODULATION; 3-O-METHYLTRANSFERASE; CRYSTALLOGRAPHY; METABOLISM	The coding sequence of the cyanobacterium Synechocystis sp. strain PCC 6803 slr0095 gene was cloned and functionally expressed in Escherichia coli. The corresponding enzyme was classified as a cation- and S-adenosyl-L-methionine-dependent O-methyltransferase (SynOMT), consistent with considerable amino acid sequence identities to eukaryotic O-methyltransferases (OMTs). The substrate specificity of SynOMT was similar with those of plant and mammalian CCoAOMT-like proteins accepting a variety of hydroxycinnamic acids and flavonoids as substrates. In contrast to the known mammalian and plant enzymes, which exclusively methylate the meta-hydroxyl position of aromatic di- and trihydroxy systems, SynOMT also methylates the para-position of hydroxycinnamic acids like 5-hydroxyferulic and 3,4,5-trihydroxycinnamic acid, resulting in the formation of novel compounds. The x-ray structure of SynOMT indicates that the active site allows for two alternative orientations of the hydroxylated substrates in comparison to the active sites of animal and plant enzymes, consistent with the observed preferred para-methylation and position promiscuity. Lys3 close to the N terminus of the recombinant protein appears to play a key role in the activity of the enzyme. The possible implications of these results with respect to modifications of precursors of polymers like lignin are discussed.	[Schliemann, Willibald; Vogt, Thomas] Leibniz Inst Plant Biochem, Dept Metab 2, D-06120 Halle, Saale, Germany; [Kopycki, Jakub Grzegorz; Stubbs, Milton T.] Univ Halle Wittenberg, Inst Biochem & Biotechnol, Dept Phys Biotechnol, D-06099 Halle, Saale, Germany; [Brandt, Wolfgang; Hagemann, Martin; Schmidt, Juergen] Leibniz Inst Plant Biochem, Dept Bioorgan Chem, D-06120 Halle, Saale, Germany; [Hagemann, Martin] Univ Rostock, Inst Biol Sci, D-18051 Rostock, Germany; [Zenk, Meinhart H.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA	Leibniz Institut fur Pflanzenbiochemie; Martin Luther University Halle Wittenberg; Leibniz Institut fur Pflanzenbiochemie; University of Rostock; Donald Danforth Plant Science Center	Vogt, T (corresponding author), Leibniz Inst Plant Biochem, Dept Metab 2, D-06120 Halle, Saale, Germany.	tvogt@ipb-halle.de	Porzel, Andrea/B-1423-2014; Schliemann, Willibald/AAB-5499-2022; Stubbs, Milton/ABC-7585-2020	Porzel, Andrea/0000-0002-8148-6895; Stubbs, Milton/0000-0003-1278-9013				Anterola AM, 2002, PHYTOCHEMISTRY, V61, P221, DOI 10.1016/S0031-9422(02)00211-X; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chabannes M, 2001, PLANT J, V28, P257, DOI 10.1046/j.1365-313X.2001.01140.x; *CHEM COMP GROUP I, 2007, MOE MOL OP ENV; Chen F, 2006, PLANT J, V48, P113, DOI 10.1111/j.1365-313X.2006.02857.x; Eggen M, 2002, MED RES REV, V22, P85, DOI 10.1002/med.10002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferrer JL, 2005, PLANT PHYSIOL, V137, P1009, DOI 10.1104/pp.104.048751; Guo DG, 2001, TRANSGENIC RES, V10, P457, DOI 10.1023/A:1012278106147; Hagemann M, 1997, J BACTERIOL, V179, P1727, DOI 10.1128/jb.179.5.1727-1733.1997; HARA O, 1992, J BACTERIOL, V174, P5141, DOI 10.1128/JB.174.15.5141-5144.1992; Hou XW, 2007, J STRUCT BIOL, V159, P523, DOI 10.1016/j.jsb.2007.04.007; Ibdah M, 2003, J BIOL CHEM, V278, P43961, DOI 10.1074/jbc.M304932200; Ibrahim RK, 2000, RECENT ADV PHYTOCHEM, V34, P349, DOI 10.1016/S0079-9920(00)80012-X; JONES PG, 1993, ACTA CRYSTALLOGR C, V49, P1148, DOI 10.1107/S0108270192012484; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kaneko T, 1996, DNA Res, V3, P185, DOI 10.1093/dnares/3.3.185; Kopycki JG, 2008, J MOL BIOL, V378, P154, DOI 10.1016/j.jmb.2008.02.019; Korb Oliver, 2007, Swarm Intelligence, V1, P115, DOI 10.1007/s11721-007-0006-9; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; Mannisto PT, 1999, PHARMACOL REV, V51, P593; Marita JM, 2003, PHYTOCHEMISTRY, V62, P53, DOI 10.1016/S0031-9422(02)00434-X; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Milkowski C, 2000, PLANTA, V211, P883, DOI 10.1007/s004250000411; Morreel K, 2004, PLANT PHYSIOL, V136, P3537, DOI 10.1104/pp.104.049304; Nelson JT, 2007, APPL ENVIRON MICROB, V73, P3575, DOI 10.1128/AEM.00011-07; Niemetz R, 2005, PHYTOCHEMISTRY, V66, P2001, DOI 10.1016/j.phytochem.2005.01.009; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAKUSCH AE, 1989, ARCH BIOCHEM BIOPHYS, V271, P488, DOI 10.1016/0003-9861(89)90299-3; Schliemann W, 2008, PHYTOCHEMISTRY, V69, P112, DOI 10.1016/j.phytochem.2007.06.032; SCHLUCKEBIER G, 1995, J MOL BIOL, V247, P16, DOI 10.1006/jmbi.1994.0117; Schroder G, 2004, PHYTOCHEMISTRY, V65, P1085, DOI 10.1016/j.phytochem.2004.02.010; STOCKIGT J, 1975, Z NATURFORSCH C, V30, P352; STRACK D, 1987, J PLANT PHYSIOL, V131, P61, DOI 10.1016/S0176-1617(87)80268-7; VANDEPEER Y, 1994, COMPUT APPL BIOSCI, V10, P569; Vidgren J, 1998, Adv Pharmacol, V42, P328; VIDGREN J, 1994, NATURE, V368, P354, DOI 10.1038/368354a0; Vogt T, 2004, FEBS LETT, V561, P159, DOI 10.1016/S0014-5793(04)00163-2; WOLLENWEBER E, 1988, FLAVONOIDS, P283; YOSHIDA T, 1991, CHEM PHARM BULL, V39, P2247, DOI 10.1248/cpb.39.2247; Zhou JM, 2006, BBA-GEN SUBJECTS, V1760, P1115, DOI 10.1016/j.bbagen.2006.02.008; Zhu BT, 2002, CURR DRUG METAB, V3, P321, DOI 10.2174/1389200023337586; Zubieta C, 2002, PLANT CELL, V14, P1265, DOI 10.1105/tpc.001412	44	31	32	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2008	283	30					20888	20896		10.1074/jbc.M801943200	http://dx.doi.org/10.1074/jbc.M801943200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	327RL	18502765	hybrid, Green Published			2022-12-25	WOS:000257746100031
J	Malanga, M; Czubaty, A; Girstun, A; Staron, K; Althaus, FR				Malanga, Maria; Czubaty, Alicja; Girstun, Agnieszka; Staron, Krzysztof; Althaus, Felix R.			Poly(ADP-ribose) binds to the splicing factor ASF/SF2 and regulates its phosphorylation by DNA topoisomerase I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; PROTEIN-PHOSPHORYLATION; MAMMALIAN-CELLS; GENE-EXPRESSION; SERINE-RICH; SR PROTEINS; TRANSCRIPTION; NUCLEAR; DOMAINS; LACKING	Human DNA topoisomerase I plays a dual role in transcription, by controlling DNA supercoiling and by acting as a specific kinase for the SR-protein family of splicing factors. The two activities are mutually exclusive, but the identity of the molecular switch is unknown. Here we identify poly(ADP-ribose) as a physiological regulator of the two topoisomerase I functions. We found that, in the presence of both DNA and the alternative splicing factor/splicing factor 2 (ASF/SF2, a prototypical SR-protein), poly(ADP-ribose) affected topoisomerase I substrate selection and gradually shifted enzyme activity from protein phosphorylation to DNA cleavage. A likely mechanistic explanation was offered by the discovery that poly(ADP-ribose) forms a high affinity complex with ASF/SF2 thereby leaving topoisomerase I available for directing its action onto DNA. We identified two functionally important domains, RRM1 and RS, as specific poly(ADP-ribose) binding targets. Two independent lines of evidence emphasize the potential biological relevance of our findings: (i) in HeLa nuclear extracts, ASF/SF2, but not histone, phosphorylation was inhibited by poly(ADP-ribose); (ii) an in silico study based on gene expression profiling data revealed an increased incidence of alternative splicing within a subset of inflammatory response genes that are dysregulated in cells lacking a functional poly(ADP-ribose) polymerase-1. We propose that poly(ADP-ribose) targeting of topoisomerase I and ASF/SF2 functions may participate in the regulation of gene expression.	[Malanga, Maria] Univ Naples Federico 2, Dept Struct & Funct Biol, I-80126 Naples, Italy; [Czubaty, Alicja; Girstun, Agnieszka; Staron, Krzysztof] Univ Warsaw, Inst Biochem, PL-02096 Warsaw, Poland; [Malanga, Maria; Althaus, Felix R.] Univ Zurich Vetsuisse, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland	University of Naples Federico II; University of Warsaw; University of Zurich	Malanga, M (corresponding author), Univ Naples Federico 2, Dept Struct & Funct Biol, Via Cinthia,Monte S Angelio, I-80126 Naples, Italy.	malanga@unina.it		Girstun, Agnieszka/0000-0001-6618-1383				Aguilera A, 2005, CURR OPIN CELL BIOL, V17, P242, DOI 10.1016/j.ceb.2005.03.001; ALTHAUS FR, 1987, ADP RIBOSYLATION PRO, P3; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Andersen FF, 2002, J MOL BIOL, V322, P677, DOI 10.1016/S0022-2836(02)00815-X; Aubol BE, 2003, P NATL ACAD SCI USA, V100, P12601, DOI 10.1073/pnas.1635129100; Bauer PI, 2001, FEBS LETT, V506, P239, DOI 10.1016/S0014-5793(01)02919-2; Baumann C, 2006, NUCLEIC ACIDS RES, V34, P1036, DOI 10.1093/nar/gkj509; Blaustein M, 2005, NAT STRUCT MOL BIOL, V12, P1037, DOI 10.1038/nsmb1020; Blenn C, 2006, BIOCHEM J, V396, P419, DOI 10.1042/BJ20051696; Burkle A, 2005, FEBS J, V272, P4576, DOI 10.1111/j.1742-4658.2005.04864.x; Carrillo A, 2004, NUCLEIC ACIDS RES, V32, P757, DOI 10.1093/nar/gkh239; Carty SM, 2002, MOL CELL PROTEOMICS, V1, P598, DOI 10.1074/mcp.M200029-MCP200; Chen HJ, 1999, EUR J BIOCHEM, V265, P367, DOI 10.1046/j.1432-1327.1999.00741.x; Colwill K, 1996, J BIOL CHEM, V271, P24569, DOI 10.1074/jbc.271.40.24569; Czubaty A, 2005, BBA-PROTEINS PROTEOM, V1749, P133, DOI 10.1016/j.bbapap.2005.03.007; Deschenes F, 2005, HUM MOL GENET, V14, P3293, DOI 10.1093/hmg/ddi362; Gagne JP, 2005, BIOCHEM J, V392, P499, DOI 10.1042/BJ20050792; Gagne JP, 2003, BIOCHEM J, V371, P331, DOI 10.1042/BJ20021675; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Huang YQ, 2005, MOL CELL, V17, P613, DOI 10.1016/j.molcel.2005.02.020; JESSER M, 1993, BIOCHEM BIOPH RES CO, V195, P558, DOI 10.1006/bbrc.1993.2082; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Khobta A, 2006, J MOL BIOL, V357, P127, DOI 10.1016/j.jmb.2005.12.069; Kim N, 2007, NUCLEIC ACIDS RES, V35, pD93, DOI 10.1093/nar/gkl884; Kowalska-Loth B, 2005, BIOCHEM BIOPH RES CO, V331, P398, DOI 10.1016/j.bbrc.2005.03.180; Kowalska-Loth B, 2002, EUR J BIOCHEM, V269, P3504, DOI 10.1046/j.1432-1033.2002.03037.x; Labourier E, 1998, NUCLEIC ACIDS RES, V26, P2955, DOI 10.1093/nar/26.12.2955; Leppard JB, 2005, CHROMOSOMA, V114, P75, DOI 10.1007/s00412-005-0345-5; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Listerman I, 2006, NAT STRUCT MOL BIOL, V13, P815, DOI 10.1038/nsmb1135; Lonskaya I, 2005, J BIOL CHEM, V280, P17076, DOI 10.1074/jbc.M413483200; MALANGA M, 1994, J BIOL CHEM, V269, P17691; Malanga M, 2005, BIOCHEM CELL BIOL, V83, P354, DOI 10.1139/o05-038; Malanga M, 2004, J BIOL CHEM, V279, P5244, DOI 10.1074/jbc.C300437200; Mondal N, 2003, NUCLEIC ACIDS RES, V31, P5016, DOI 10.1093/nar/gkg705; Ogino H, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-41; PANZETER PL, 1993, J BIOL CHEM, V268, P17662; Parent M, 2005, J BIOL CHEM, V280, P448, DOI 10.1074/jbc.M408435200; Patel NA, 2005, J BIOL CHEM, V280, P14302, DOI 10.1074/jbc.M411485200; Pilch B, 2001, CANCER RES, V61, P6876; Pleschke JM, 2000, J BIOL CHEM, V275, P40974, DOI 10.1074/jbc.M006520200; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Rossi F, 1996, NATURE, V381, P80, DOI 10.1038/381080a0; Sanford JR, 2005, BIOCHEM SOC T, V33, P443, DOI 10.1042/BST0330443; Sanford JR, 2005, P NATL ACAD SCI USA, V102, P15042, DOI 10.1073/pnas.0507827102; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Shen HH, 2004, MOL CELL, V13, P367, DOI 10.1016/S1097-2765(04)00025-5; Simbulan-Rosenthal CM, 2000, P NATL ACAD SCI USA, V97, P11274, DOI 10.1073/pnas.200285797; Soret J, 2003, CANCER RES, V63, P8203; Stamm S, 2008, J BIOL CHEM, V283, P1223, DOI 10.1074/jbc.R700034200; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Yung TMC, 2004, J BIOL CHEM, V279, P39686, DOI 10.1074/jbc.M402729200; ZHANG H, 1988, P NATL ACAD SCI USA, V85, P1060, DOI 10.1073/pnas.85.4.1060; Zingarelli B, 2004, AM J PHYSIOL-HEART C, V286, pH1408, DOI 10.1152/ajpheart.00953.2003	55	62	63	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					19991	19998		10.1074/jbc.M709495200	http://dx.doi.org/10.1074/jbc.M709495200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18495665	Green Accepted, hybrid			2022-12-25	WOS:000257565300014
J	Wang, C; Norton, JT; Ghosh, S; Kim, J; Fushimi, K; Wu, JY; Stack, MS; Huang, S				Wang, Chen; Norton, John T.; Ghosh, Supurna; Kim, Julie; Fushimi, Kazuo; Wu, Jane Y.; Stack, M. Sharon; Huang, Sui			Polypyrimidine tract-binding protein (PTB) differentially affects malignancy in a cell line-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; PERINUCLEOLAR COMPARTMENT; PLASMINOGEN ACTIVATION; SPLICING REPRESSION; EXON DEFINITION; IN-VITRO; INCLUSION; EXPRESSION; CANCER; POLYADENYLATION	RNA processing is altered during malignant transformation, and expression of the polypyrimidine tract-binding protein (PTB) is often increased in cancer cells. Although some data support that PTB promotes cancer, the functional contribution of PTB to the malignant phenotype remains to be clarified. Here we report that although PTB levels are generally increased in cancer cell lines from multiple origins and in endometrial adenocarcinoma tumors, there appears to be no correlation between PTB levels and disease severity or metastatic capacity. The three isoforms of PTB increase heterogeneously among different tumor cells. PTB knockdown in transformed cells by small interfering RNA decreases cellular growth in monolayer culture and to a greater extent in semi-solid media without inducing apoptosis. Down- regulation of PTB expression in a normal cell line reduces proliferation even more significantly. Reduction of PTB inhibits the invasive behavior of two cancer cell lines in Matrigel invasion assays but enhances the invasive behavior of another. At the molecular level, PTB in various cell lines differentially affects the alternative splicing pattern of the same substrates, such as caspase 2. Furthermore, overexpression of PTB does not enhance proliferation, anchorage-independent growth, or invasion in immortalized or normal cells. These data demonstrate that PTB is not oncogenic and can either promote or antagonize a malignant trait dependent upon the specific intra-cellular environment.	[Wang, Chen; Norton, John T.; Stack, M. Sharon; Huang, Sui] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Ghosh, Supurna] Northwestern Univ, Breast Ctr, Dept Med, Chicago, IL 60611 USA; [Kim, Julie] Northwestern Univ, Prentice Hosp, Dept Med Obstet & Gynecol, Chicago, IL 60611 USA; [Fushimi, Kazuo; Wu, Jane Y.] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Northwestern University; Northwestern University; Feinberg School of Medicine	Huang, S (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Ward Bldg 11-240,303 E Chicago Ave, Chicago, IL 60611 USA.	s-huang2@northwestern.edu		Kim, J Julie/0000-0001-9834-8213	NATIONAL CANCER INSTITUTE [R33CA097761, R21CA127674] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070967, R01GM078555] Funding Source: NIH RePORTER; NCI NIH HHS [R21 CA127674, R21 CA127674-01A2, CA 097761] Funding Source: Medline; NIGMS NIH HHS [GM 078555-01, GM 070967] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Castelo-Branco P, 2004, MOL CELL BIOL, V24, P4174, DOI 10.1128/MCB.24.10.4174-4183.2004; Cote J, 2001, J BIOL CHEM, V276, P8535, DOI 10.1074/jbc.M008924200; Cote J, 2001, P NATL ACAD SCI USA, V98, P938, DOI 10.1073/pnas.031564098; Dano K, 2005, THROMB HAEMOSTASIS, V93, P676, DOI 10.1160/TH05-01-0054; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; GHETTI A, 1992, NUCLEIC ACIDS RES, V20, P3671, DOI 10.1093/nar/20.14.3671; Ghosh S, 2000, J BIOL CHEM, V275, P23869, DOI 10.1074/jbc.M000935200; Ghosh S, 2002, CANCER-AM CANCER SOC, V95, P2524, DOI 10.1002/cncr.10997; GIL A, 1991, GENE DEV, V5, P1224, DOI 10.1101/gad.5.7.1224; Gromak N, 2003, RNA, V9, P443, DOI 10.1261/rna.2191903; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; He X, 2007, ONCOGENE, V26, P4961, DOI 10.1038/sj.onc.1210307; He XL, 2004, CLIN CANCER RES, V10, P4652, DOI 10.1158/1078-0432.CCR-03-0439; HELLEN CUT, 1994, J VIROL, V68, P941, DOI 10.1128/JVI.68.2.941-950.1994; Huang S, 1997, J CELL BIOL, V137, P965, DOI 10.1083/jcb.137.5.965; Jin W, 2000, CANCER RES, V60, P1221; Jin W, 2003, CANCER RES, V63, P6154; Kamath RV, 2001, MOL BIOL CELL, V12, P3808, DOI 10.1091/mbc.12.12.3808; Kaminski A, 1995, RNA, V1, P924; Kopp K, 2005, J CELL BIOCHEM, V95, P217, DOI 10.1002/jcb.20403; KOZLOWSKI JM, 1984, CANCER RES, V44, P3522; Lou H, 1999, MOL CELL BIOL, V19, P78; Lou H, 1996, GENE DEV, V10, P208, DOI 10.1101/gad.10.2.208; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; MAYEDA A, 1993, MOL CELL BIOL, V13, P2993, DOI 10.1128/MCB.13.5.2993; McCutcheon IE, 2004, NEURO-ONCOLOGY, V6, P9, DOI 10.1215/S1152851703000279; Oh YL, 1998, BIOCHEM J, V331, P169, DOI 10.1042/bj3310169; PATTON JG, 1991, GENE DEV, V5, P1237, DOI 10.1101/gad.5.7.1237; Perez I, 1997, BIOCHEMISTRY-US, V36, P11881, DOI 10.1021/bi9711745; Perez I, 1997, RNA, V3, P764; Pettaway CA, 1996, CLIN CANCER RES, V2, P1627; Pickering BM, 2003, NUCLEIC ACIDS RES, V31, P639, DOI 10.1093/nar/gkg146; Rideau AP, 2006, NAT STRUCT MOL BIOL, V13, P839, DOI 10.1038/nsmb1137; Robinson F, 2006, J BIOL CHEM, V281, P800, DOI 10.1074/jbc.M510578200; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sauliere J, 2006, MOL CELL BIOL, V26, P8755, DOI 10.1128/MCB.00893-06; Schneider R, 2001, MOL CELL BIOL, V21, P8238, DOI 10.1128/MCB.21.23.8238-8246.2001; Spellman R, 2006, TRENDS BIOCHEM SCI, V31, P73, DOI 10.1016/j.tibs.2005.12.003; STACK S, 1990, BIOCHEMISTRY-US, V29, P4966, DOI 10.1021/bi00472a029; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Valcarcel J, 1997, CURR BIOL, V7, pR705, DOI 10.1016/S0960-9822(06)00361-7; Venables JP, 2006, BIOESSAYS, V28, P378, DOI 10.1002/bies.20390; Wagner EJ, 1999, ELECTROPHORESIS, V20, P1082, DOI 10.1002/(SICI)1522-2683(19990101)20:4/5<1082::AID-ELPS1082>3.0.CO;2-#; Wagner EJ, 2002, MOL CELL, V10, P943, DOI 10.1016/S1097-2765(02)00645-7; Wagner EJ, 2001, MOL CELL BIOL, V21, P3281, DOI 10.1128/MCB.21.10.3281-3288.2001; Wang C, 2003, MOL BIOL CELL, V14, P2425, DOI 10.1091/mbc.E02-12-0818; WANG L, 1994, CELL, V78, P739, DOI 10.1016/S0092-8674(94)90422-7; Watahiki A, 2004, NAT METHODS, V1, P233, DOI 10.1038/NMETH719; Witherell GW, 1995, VIROLOGY, V214, P660, DOI 10.1006/viro.1995.0081; Wollerton MC, 2001, RNA, V7, P819, DOI 10.1017/S1355838201010214; Xie JY, 2003, P NATL ACAD SCI USA, V100, P8776, DOI 10.1073/pnas.1432696100; Zhang WJ, 1996, MOL CELL BIOL, V16, P5400	53	49	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20277	20287		10.1074/jbc.M803682200	http://dx.doi.org/10.1074/jbc.M803682200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18499661	Green Published, hybrid			2022-12-25	WOS:000257565300044
J	Liao, AP; Petrof, EO; Kuppireddi, S; Zhao, Y; Xia, YL; Claud, EC; Sun, J				Liao, Anne P.; Petrof, Elaine O.; Kuppireddi, Sumalatha; Zhao, Yun; Xia, Yinglin; Claud, Erika C.; Sun, Jun			Salmonella Type III Effector AvrA Stabilizes Cell Tight Junctions to Inhibit Inflammation in Intestinal Epithelial Cells	PLOS ONE			English	Article								Salmonella Typhimurium is a major cause of human gastroenteritis. The Salmonella type III secretory system secretes virulence proteins, called effectors. Effectors are responsible for the alteration of tight junction (TJ) structure and function in intestinal epithelial cells. AvrA is a newly described bacterial effector found in Salmonella. We report here that AvrA expression stabilizes cell permeability and tight junctions in intestinal epithelial cells. Cells colonized with an AvrA-deficient bacterial strain (AvrA(-)) displayed decreased cell permeability, disruption of TJs, and an increased inflammatory response. Western blot data showed that TJ proteins, such as ZO-1, claudin-1, decreased after AvrA- colonization for only 1 hour. In contrast, cells colonized with AvrA- sufficient bacteria maintained cell permeability with stabilized TJ structure. This difference was confirmed in vivo. Fluorescent tracer studies showed increased fluorescence in the blood of mice infected with AvrA- compared to those infected with the AvrA- sufficient strains. AvrA- disrupted TJ structure and function and increased inflammation in vivo, compared to the AvrA- sufficient strain. Additionally, AvrA overexpression increased TJ protein expression when transfected into colonic epithelial cells. An intriguing aspect of this study is that AvrA stabilized TJs, even though the other TTSS proteins, SopB, SopE, and SopE2, are known to disrupt TJs. AvrA may play a role in stabilizing TJs and balancing the opposing action of other bacterial effectors. Our findings indicate an important role for the bacterial effector AvrA in regulation of intestinal epithelial cell TJs during inflammation. The role of AvrA represents a highly refined bacterial strategy that helps the bacteria survive in the host and dampen the inflammatory response.	[Liao, Anne P.; Kuppireddi, Sumalatha; Zhao, Yun; Xia, Yinglin; Sun, Jun] Univ Rochester, Dept Med, Div Gastroenterol & Hepatol, Rochester, NY 14627 USA; [Petrof, Elaine O.] Queens Univ, Dept Med, Div Infect Dis, GI Dis Res Unit, Kingston, ON, Canada; [Claud, Erika C.] Univ Chicago, Med Ctr, Dept Paediat, Chicago, IL USA	University of Rochester; Queens University - Canada; University of Chicago; University of Chicago Medical Center	Liao, AP (corresponding author), Univ Rochester, Dept Med, Div Gastroenterol & Hepatol, Rochester, NY 14627 USA.	jun_sun@umrc.rochester.edu	Sun, Jun/S-7440-2019	Sun, Jun/0000-0001-7465-3133	NIDDK;  [KO1 DK075386]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK075386] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK KO1 DK075386 to J. S. The funder played no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Anderson JM, 2004, CURR OPIN CELL BIOL, V16, P140, DOI 10.1016/j.ceb.2004.01.005; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Ben-Barak Z, 2006, INT J MED MICROBIOL, V296, P25, DOI 10.1016/j.ijmm.2005.08.004; Berkes J, 2003, GUT, V52, P439, DOI 10.1136/gut.52.3.439; Boyle EC, 2006, CELL MICROBIOL, V8, P1946, DOI 10.1111/j.1462-5822.2006.00762.x; Caplan MS, 1999, GASTROENTEROLOGY, V117, P577, DOI 10.1016/S0016-5085(99)70450-6; Collier-Hyams LS, 2002, J IMMUNOL, V169, P2846, DOI 10.4049/jimmunol.169.6.2846; Duan YL, 2007, LAB INVEST, V87, P613, DOI 10.1038/labinvest.3700545; FINLAY BB, 1990, J INFECT DIS, V162, P1096, DOI 10.1093/infdis/162.5.1096; Friebel A, 2001, J BIOL CHEM, V276, P34035, DOI 10.1074/jbc.M100609200; Galan JE, 2000, P NATL ACAD SCI USA, V97, P8754, DOI 10.1073/pnas.97.16.8754; Galan JE, 1999, CURR OPIN MICROBIOL, V2, P46, DOI 10.1016/S1369-5274(99)80008-3; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Hapfelmeier S, 2004, INFECT IMMUN, V72, P795, DOI 10.1128/IAI.72.2.795-809.2004; Hardt WD, 1997, P NATL ACAD SCI USA, V94, P9887, DOI 10.1073/pnas.94.18.9887; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Huang FC, 2004, INFECT IMMUN, V72, P5052, DOI 10.1128/IAI.72.9.5052-5062.2004; JEPSON MA, 1995, INFECT IMMUN, V63, P356, DOI 10.1128/IAI.63.1.356-359.1995; Jepson MA, 2000, INFECT IMMUN, V68, P7202, DOI 10.1128/IAI.68.12.7202-7208.2000; Kohler H, 2007, AM J PHYSIOL-GASTR L, V293, pG178, DOI 10.1152/ajpgi.00535.2006; Landau D, 2006, CURR OPIN NEPHROL HY, V15, P425, DOI 10.1097/01.mnh.0000232883.43093.76; MCCORMICK BA, 1993, J CELL BIOL, V123, P895, DOI 10.1083/jcb.123.4.895; MILLER SI, 1990, J BACTERIOL, V172, P2485, DOI 10.1128/jb.172.5.2485-2490.1990; Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560; Orth K, 2000, SCIENCE, V290, P1594, DOI 10.1126/science.290.5496.1594; Orth K, 1999, SCIENCE, V285, P1920, DOI 10.1126/science.285.5435.1920; Reed KA, 2002, J BIOL CHEM, V277, P13346, DOI 10.1074/jbc.M200149200; Schesser K, 2000, MICROB PATHOGENESIS, V28, P59, DOI 10.1006/mpat.1999.0324; Soong G, 2008, J BACTERIOL, V190, P2814, DOI 10.1128/JB.01567-07; Sousa S, 2005, CURR OPIN CELL BIOL, V17, P489, DOI 10.1016/j.ceb.2005.08.013; Steele-Mortimer O, 2000, J BIOL CHEM, V275, P37718, DOI 10.1074/jbc.M008187200; Streckel W, 2004, MOL NUTR FOOD RES, V48, P496, DOI 10.1002/mnfr.200400035; Sun J, 2004, AM J PHYSIOL-GASTR L, V287, pG220, DOI 10.1152/ajpgi.00498.2003; Tafazoli F, 2003, INFECT IMMUN, V71, P872, DOI 10.1128/IAI.71.2.872-881.2003; Traweger A, 2002, J BIOL CHEM, V277, P10201, DOI 10.1074/jbc.M111384200; Turner JR, 1997, AM J PHYSIOL-CELL PH, V273, pC1378, DOI 10.1152/ajpcell.1997.273.4.C1378; Turner JR, 2000, AM J PHYSIOL-CELL PH, V279, pC1918, DOI 10.1152/ajpcell.2000.279.6.C1918; Ye ZD, 2007, AM J PATHOL, V171, P882, DOI 10.2353/ajpath.2007.070220; Zhang SP, 2003, INFECT IMMUN, V71, P1, DOI 10.1128/IAI.71.1.1-12.2003; Zhang SP, 2002, INFECT IMMUN, V70, P3843, DOI 10.1128/IAI.70.7.3843-3855.2002; Zhou DG, 2001, MOL MICROBIOL, V39, P248, DOI 10.1046/j.1365-2958.2001.02230.x	41	85	89	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2369	10.1371/journal.pone.0002369	http://dx.doi.org/10.1371/journal.pone.0002369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523661	Green Published, Green Submitted, gold			2022-12-25	WOS:000262614300055
J	Berno, V; Amazit, L; Hinojos, C; Zhong, J; Mancini, MG; Sharp, ZD; Mancini, MA				Berno, Valeria; Amazit, Larbi; Hinojos, Cruz; Zhong, Jeannie; Mancini, Maureen G.; Sharp, Zelton Dave; Mancini, Michael A.			Activation of Estrogen Receptor-alpha by E2 or EGF Induces Temporally Distinct Patterns of Large-Scale Chromatin Modification and mRNA Transcription	PLOS ONE			English	Article								Estrogen receptor-alpha (ER) transcription function is regulated in a ligand-dependent (e. g., estradiol, E2) or ligand-independent (e. g., growth factors) manner. Our laboratory seeks to understand these two modes of action. Using a cell line that contains a visible prolactin enhancer/promoter array (PRL-HeLa) regulated by ER, we analyzed ER response to E2 and EGF by quantifying image-based results. Data show differential recruitment of GFP-ER to the array, with the AF1 domain playing a vital role in EGF-mediated responsiveness. Temporal analyses of large-scale chromatin dynamics, and accumulation of array-localized reporter mRNA over 24 hours showed that the EGF response consists of a single pulse of reporter mRNA accumulation concomitant with transient increase in array decondensation. Estradiol induced a novel cyclical pattern of mRNA accumulation with a sustained increase in array decondensation. Collectively, our work shows that there is a stimuli-specific pattern of large-scale chromatin modification and transcript levels by ER.	[Berno, Valeria; Amazit, Larbi; Hinojos, Cruz; Zhong, Jeannie; Mancini, Maureen G.; Mancini, Michael A.] Baylor Coll Med, Houston, TX 77030 USA; [Sharp, Zelton Dave] Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, San Antonio, TX USA	Baylor College of Medicine; University of Texas System; University of Texas Health San Antonio	Berno, V (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.	mancini@bcm.tmc.edu	Berno, Valeria/AAN-3997-2020	Berno, Valeria/0000-0001-5848-494X	NIH [DK55622]; Department of Defense Synergistic Idea Award [GRANT00210313]; Center for Reproductive Biology [HD-07495]; Baylor College of Medicine Dan L. Duncan Cancer Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD007495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055622] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Synergistic Idea Award; Center for Reproductive Biology; Baylor College of Medicine Dan L. Duncan Cancer Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported from NIH grants DK55622 (M.A.M.), and a Department of Defense Synergistic Idea Award GRANT00210313 to MAM and ZDS; Integrated Microscopy Core support was provided by HD-07495 (Center for Reproductive Biology, B.W. O'Malley) and the Baylor College of Medicine Dan L. Duncan Cancer Center.	Ahmad K, 2002, CELL, V111, P281, DOI 10.1016/S0092-8674(02)01081-4; ALI S, 1993, EMBO J, V12, P1153, DOI 10.1002/j.1460-2075.1993.tb05756.x; Amazit L, 2007, MOL CELL BIOL, V27, P6913, DOI 10.1128/MCB.01695-06; Berno V, 2006, METHOD ENZYMOL, V414, P188, DOI 10.1016/s0076-6879(06)14011-2; Bosisio D, 2006, EMBO J, V25, P798, DOI 10.1038/sj.emboj.7600977; Britton DJ, 2006, BREAST CANCER RES TR, V96, P131, DOI 10.1007/s10549-005-9070-2; Bunone G, 1996, EMBO J, V15, P2174, DOI 10.1002/j.1460-2075.1996.tb00571.x; CARRILLO AJ, 1987, ENDOCRINOLOGY, V121, P1993, DOI 10.1210/endo-121-6-1993; Carter RE, 1998, J BIOL CHEM, V273, P35000, DOI 10.1074/jbc.273.52.35000; Cenni B, 1999, TRENDS ENDOCRIN MET, V10, P41, DOI 10.1016/S1043-2760(98)00121-0; CHEN WS, 1989, CELL, V59, P33, DOI 10.1016/0092-8674(89)90867-2; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Curtis SW, 1996, P NATL ACAD SCI USA, V93, P12626, DOI 10.1073/pnas.93.22.12626; de Mora JF, 2000, MOL CELL BIOL, V20, P5041, DOI 10.1128/MCB.20.14.5041-5047.2000; ElTanani MKK, 1997, MOL ENDOCRINOL, V11, P928, DOI 10.1210/me.11.7.928; FEY EG, 1986, J CELL SCI, P99; Gee JMW, 2005, BREAST CANCER RES, V7, P187, DOI 10.1186/bcr1289; Gorski S, 2005, J CELL SCI, V118, P4083, DOI 10.1242/jcs.02596; IGNARTROWBRIDGE DM, 1995, ENVIRON HEALTH PERSP, V103, P35, DOI 10.2307/3432505; IgnarTrowbridge DM, 1996, ENDOCRINOLOGY, V137, P1735, DOI 10.1210/en.137.5.1735; IGNARTROWBRIDGE DM, 1993, MOL ENDOCRINOL, V7, P992, DOI 10.1210/me.7.8.992; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Karpova TS, 2008, SCIENCE, V319, P466, DOI 10.1126/science.1150559; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Klokk TI, 2007, MOL CELL BIOL, V27, P1823, DOI 10.1128/MCB.01297-06; Levin ER, 2003, MOL ENDOCRINOL, V17, P309, DOI 10.1210/me.2002-0368; Lipfert L, 2006, MOL ENDOCRINOL, V20, P516, DOI 10.1210/me.2005-0190; Manfroid I, 2005, MOL CELL ENDOCRINOL, V229, P127, DOI 10.1016/j.mce.2004.08.009; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Murphy L, 2004, CLIN CANCER RES, V10, P1354, DOI 10.1158/1078-0432.CCR-03-0112; Murphy LC, 2004, CLIN CANCER RES, V10, P5902, DOI 10.1158/1078-0432.CCR-04-0191; Osborne CK, 2003, BREAST, V12, P362, DOI 10.1016/S0960-9776(03)00137-1; Osborne CK, 2005, CLIN CANCER RES, V11, p865S; Rayasam GV, 2005, MOL CELL BIOL, V25, P2406, DOI 10.1128/MCB.25.6.2406-2418.2005; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Sharp ZD, 2006, J CELL SCI, V119, P4101, DOI 10.1242/jcs.03161; Shav-Tal Y, 2006, EMBO J, V25, P3469, DOI 10.1038/sj.emboj.7601226; SHOPLAND RLS, APPL RNA FISH VISUAL; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; Smith CL, 1998, BIOL REPROD, V58, P627, DOI 10.1095/biolreprod58.3.627; Stenoien DL, 2000, MOL ENDOCRINOL, V14, P518, DOI 10.1210/me.14.4.518; Stenoien DL, 2000, J CELL BIOCHEM, P99; Stenoien DL, 2001, MOL CELL BIOL, V21, P4404, DOI 10.1128/MCB.21.13.4404-4412.2001; Takahashi T, 2005, ENDOCRINOLOGY, V146, P4082, DOI 10.1210/en.2005-0302; Voogt J L, 2001, Prog Brain Res, V133, P173; Voss TC, 2006, MOL ENDOCRINOL, V20, P2641, DOI 10.1210/me.2006-0091; Warren CM, 2006, CELL SIGNAL, V18, P923, DOI 10.1016/j.cellsig.2005.12.007; Weitsman GE, 2006, CANCER RES, V66, P10162, DOI 10.1158/0008-5472.CAN-05-4111	51	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2286	10.1371/journal.pone.0002286	http://dx.doi.org/10.1371/journal.pone.0002286			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509470	gold, Green Published, Green Submitted			2022-12-25	WOS:000262268500028
J	McNally, BA; Trgovcich, J; Maul, GG; Liu, Y; Zheng, P				McNally, Beth A.; Trgovcich, Joanne; Maul, Gerd G.; Liu, Yang; Zheng, Pan			A Role for Cytoplasmic PML in Cellular Resistance to Viral Infection	PLOS ONE			English	Article								PML gene was discovered as a fusion partner with retinoic acid receptor (RAR) alpha in the t(15:17) chromosomal translocation associated with acute promyelocytic leukemia (APL). Nuclear PML protein has been implicated in cell growth, tumor suppression, apoptosis, transcriptional regulation, chromatin remodeling, DNA repair, and anti-viral defense. The localization pattern of promyelocytic leukemia (PML) protein is drastically altered during viral infection. This alteration is traditionally viewed as a viral strategy to promote viral replication. Although multiple PML splice variants exist, we demonstrate that the ratio of a subset of cytoplasmic PML isoforms lacking exons 5 & 6 is enriched in cells exposed to herpes simplex virus-1 (HSV-1). In particular, we demonstrate that a PML isoform lacking exons 5 & 6, called PML Ib, mediates the intrinsic cellular defense against HSV-1 via the cytoplasmic sequestration of the infected cell protein (ICP) 0 of HSV-1. The results herein highlight the importance of cytoplasmic PML and call for an alternative, although not necessarily exclusive, interpretation regarding the redistribution of PML that is seen in virally infected cells.	[McNally, Beth A.; Trgovcich, Joanne; Liu, Yang; Zheng, Pan] Ohio State Univ, Med Ctr, Dept Pathol, Div Canc Immunol, Columbus, OH 43210 USA; [McNally, Beth A.; Liu, Yang; Zheng, Pan] Univ Michigan, Comprehensive Canc Ctr, Dept Surg, Program Mol Mechanism Dis, Ann Arbor, MI USA; [Maul, Gerd G.] Wistar Inst Anat & Biol, Philadelphia, PA USA	University System of Ohio; Ohio State University; University of Michigan System; University of Michigan; The Wistar Institute	McNally, BA (corresponding author), Ohio State Univ, Med Ctr, Dept Pathol, Div Canc Immunol, Columbus, OH 43210 USA.	panz@umich.edu	Zheng, Pan/E-8691-2011	Zheng, Pan/0000-0003-2598-3544; Liu, Yang/0000-0002-9442-700X	National Institute of Health [CA82355]; Department of Defense [DAMD 17-03-1-0013]; NATIONAL CANCER INSTITUTE [R01CA082355] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study is supported by Grants from the National Institute of Health (CA82355 to PZ) and Department of Defense (DAMD 17-03-1-0013 to PZ).	Ahn JH, 2000, VIROLOGY, V274, P39, DOI 10.1006/viro.2000.0448; Ahn JH, 1997, J VIROL, V71, P4599, DOI 10.1128/JVI.71.6.4599-4613.1997; Bell P, 2000, J VIROL, V74, P5329, DOI 10.1128/JVI.74.11.5329-5336.2000; Bell P, 2000, J VIROL, V74, P11800, DOI 10.1128/JVI.74.24.11800-11810.2000; Bellodi C, 2006, CELL CYCLE, V5, P2688, DOI 10.4161/cc.5.22.3504; Blondel D, 2002, ONCOGENE, V21, P7957, DOI 10.1038/sj.onc.1205931; Bonilla WV, 2002, J VIROL, V76, P3810, DOI 10.1128/JVI.76.8.3810-3818.2002; Borden KLB, 2002, MOL CELL BIOL, V22, P5259, DOI 10.1128/MCB.22.15.5259-5269.2002; Borden KLB, 1998, J VIROL, V72, P758, DOI 10.1128/JVI.72.1.758-766.1998; Boulware SL, 2000, J GEN VIROL, V81, P1773, DOI 10.1099/0022-1317-81-7-1773; Brasier AR, 2004, J VIROL, V78, P11461, DOI 10.1128/JVI.78.21.11461-11476.2004; Bruno S, 2003, BLOOD, V101, P3514, DOI 10.1182/blood-2002-11-3335; Burkham J, 1998, J VIROL, V72, P10100, DOI 10.1128/JVI.72.12.10100-10107.1998; Burkham J, 2001, J VIROL, V75, P2353, DOI 10.1128/JVI.75.5.2353-2367.2001; Chee AV, 2003, J VIROL, V77, P7101, DOI 10.1128/JVI.77.12.7101-7105.2003; Chelbi-Alix MK, 1998, J VIROL, V72, P1043, DOI 10.1128/JVI.72.2.1043-1051.1998; Chelbi-Alix MK, 1999, ONCOGENE, V18, P935, DOI 10.1038/sj.onc.1202366; ChelbiAlix MK, 1995, LEUKEMIA, V9, P2027; Condemine W, 2006, CANCER RES, V66, P6192, DOI 10.1158/0008-5472.CAN-05-3792; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; DETHE H, 1990, NATURE, V347, P558, DOI 10.1038/347558a0; Doucas V, 1996, GENE DEV, V10, P196, DOI 10.1101/gad.10.2.196; Ehmann GL, 2000, VIROLOGY, V267, P335, DOI 10.1006/viro.1999.0147; EJERCITO PM, 1968, J GEN VIROL, V2, P357, DOI 10.1099/0022-1317-2-3-357; EVERETT RD, 1987, ANTICANCER RES, V7, P589; Everett RD, 2004, J VIROL, V78, P11411, DOI 10.1128/JVI.78.20.11411-11415.2004; EVERETT RD, 1994, EMBO J, V13, P5062, DOI 10.1002/j.1460-2075.1994.tb06835.x; Everett RD, 1999, J CELL SCI, V112, P4581; Everett RD, 1998, J VIROL, V72, P6581, DOI 10.1128/JVI.72.8.6581-6591.1998; Everett RD, 2006, J VIROL, V80, P7995, DOI 10.1128/JVI.00734-06; FAGIOLI M, 1992, ONCOGENE, V7, P1083; GODDARD AD, 1991, SCIENCE, V254, P1371, DOI 10.1126/science.1720570; Halford WP, 2001, J VIROL, V75, P3240, DOI 10.1128/JVI.75.7.3240-3249.2001; HARDWICKE MA, 1994, J VIROL, V68, P4797, DOI 10.1128/JVI.68.8.4797-4810.1994; HARDY WR, 1994, J VIROL, V68, P7790, DOI 10.1128/JVI.68.12.7790-7799.1994; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Jensen K, 2001, ONCOGENE, V20, P7223, DOI 10.1038/sj.onc.1204765; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; KASTNER P, 1992, EMBO J, V11, P629, DOI 10.1002/j.1460-2075.1992.tb05095.x; Kawaguchi Y, 1997, J VIROL, V71, P7328, DOI 10.1128/JVI.71.10.7328-7336.1997; KOKEN MHM, 1994, EMBO J, V13, P1073, DOI 10.1002/j.1460-2075.1994.tb06356.x; Korioth F, 1996, EXP CELL RES, V229, P155, DOI 10.1006/excr.1996.0353; Larralde O, 2006, J VIROL, V80, P1588, DOI 10.1128/JVI.80.3.1588-1591.2006; Le XF, 1996, J BIOL CHEM, V271, P130, DOI 10.1074/jbc.271.1.130; Lin HK, 2004, NATURE, V431, P205, DOI 10.1038/nature02783; Lopez P, 2002, J VIROL, V76, P9355, DOI 10.1128/JVI.76.18.9355-9367.2002; MAUL GG, 1994, J GEN VIROL, V75, P1223, DOI 10.1099/0022-1317-75-6-1223; MAUL GG, 1993, J GEN VIROL, V74, P2679, DOI 10.1099/0022-1317-74-12-2679; Maul GG, 1995, J CELL BIOCHEM, V59, P498, DOI 10.1002/jcb.240590410; Phelan A, 1997, J GEN VIROL, V78, P3327, DOI 10.1099/0022-1317-78-12-3327; PRESTON CM, 1976, J GEN VIROL, V33, P471, DOI 10.1099/0022-1317-33-3-471; PUVIONDUTILLEUL F, 1995, EXP CELL RES, V218, P9, DOI 10.1006/excr.1995.1125; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; ROLLER RJ, 1992, J VIROL, V66, P3624, DOI 10.1128/JVI.66.6.3624-3632.1992; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Seo SR, 2006, MOL CELL, V23, P547, DOI 10.1016/j.molcel.2006.06.018; STUURMAN N, 1992, J CELL SCI, V101, P773; Turelli P, 2001, MOL CELL, V7, P1245, DOI 10.1016/S1097-2765(01)00255-6; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Wang ZG, 1998, SCIENCE, V279, P1547; Xu ZX, 2005, MOL CELL, V17, P721, DOI 10.1016/j.molcel.2005.02.014; Zheng P, 1998, NATURE, V396, P373, DOI 10.1038/24628; Zhong S, 2000, NAT CELL BIOL, V2, pE85, DOI 10.1038/35010583; Zhong S, 2000, BLOOD, V95, P2748, DOI 10.1182/blood.V95.9.2748.009k31a_2748_2752	66	38	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2277	10.1371/journal.pone.0002277	http://dx.doi.org/10.1371/journal.pone.0002277			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509536	Green Submitted, gold, Green Published			2022-12-25	WOS:000262268500021
J	Moron, B; Bethune, MT; Comino, I; Manyani, H; Ferragud, M; Lopez, MC; Cebolla, A; Khosla, C; Sousa, C				Moron, Belen; Bethune, Michael T.; Comino, Isabel; Manyani, Hamid; Ferragud, Marina; Lopez, Manuel Carlos; Cebolla, Angel; Khosla, Chaitan; Sousa, Carolina			Toward the Assessment of Food Toxicity for Celiac Patients: Characterization of Monoclonal Antibodies to a Main Immunogenic Gluten Peptide	PLOS ONE			English	Article							COMBINATION ENZYME THERAPY; GLIADIN PEPTIDES; RATIONAL DESIGN; T-CELLS; DISEASE; SAFE; INTERLEUKIN-15; INTOLERANCE; EXPRESSION; THRESHOLD	Background and Aims: Celiac disease is a permanent intolerance to gluten prolamins from wheat, barley, rye and, in some patients, oats. Partially digested gluten peptides produced in the digestive tract cause inflammation of the small intestine. High throughput, immune-based assays using monoclonal antibodies specific for these immunotoxic peptides would facilitate their detection in food and enable monitoring of their enzymatic detoxification. Two monoclonal antibodies, G12 and A1, were developed against a highly immunotoxic 33-mer peptide. The potential of each antibody for quantifying food toxicity for celiac patients was studied. Methods: Epitope preferences of G12 and A1 antibodies were determined by ELISA with gluten-derived peptide variants of recombinant, synthetic or enzymatic origin. Results: The recognition sequences of G12 and A1 antibodies were hexameric and heptameric epitopes, respectively. Although G12 affinity for the 33-mer was superior to A1, the sensitivity for gluten detection was higher for A1. This observation correlated to the higher number of A1 epitopes found in prolamins than G12 epitopes. Activation of T cell from gluten digested by glutenases decreased equivalently to the detection of intact peptides by A1 antibody. Peptide recognition of A1 included gliadin peptides involved in the both the adaptive and innate immunological response in celiac disease. Conclusions: The sensitivity and epitope preferences of the A1 antibody resulted to be useful to detect gluten relevant peptides to infer the potential toxicity of food for celiac patients as well as to monitor peptide modifications by transglutaminase 2 or glutenases.	[Moron, Belen; Comino, Isabel; Manyani, Hamid; Sousa, Carolina] Univ Seville, Fac Farm, Dept Microbiol & Parasitol, Seville, Spain; [Moron, Belen; Khosla, Chaitan] Stanford Univ, Dept Chem, Stanford, CA USA; [Bethune, Michael T.; Khosla, Chaitan] Stanford Univ, Dept Biochem, Stanford, CA USA; [Ferragud, Marina; Cebolla, Angel] Biomedal SL, Seville, Spain; [Lopez, Manuel Carlos] CSIC, Inst Parasitol Biomed Lopez Neyra, Dept Biol Mol, Granada, Spain; [Khosla, Chaitan] Stanford Univ, Dept Chem Engn, Stanford, CA USA	University of Sevilla; Stanford University; Stanford University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Stanford University	Moron, B (corresponding author), Univ Seville, Fac Farm, Dept Microbiol & Parasitol, Seville, Spain.	csoumar@us.es	Lopez, Manuel/Z-5641-2019; Manyani, Hamid/AFE-8060-2022; Manyani, Hamid/AAE-9636-2022	Sousa Martin, Carolina/0000-0002-9235-9496; Manyani Charroudi, Hamid/0000-0001-6129-2092; Lopez, Manuel Carlos/0000-0003-0002-3678; Khosla, Chaitan/0000-0001-6529-495X; Moron, Belen/0000-0003-4815-7536	Asociacion de Celiacos de Madrid; Corporacion Tecnologica de Andalucia; Agencia de Innovacion y Desarrollo de Andalucia; Plan Nacional de Investigacion cientifica, Desarrollo e Innovacion tecnologica [BFU2007-64999, RICET-RD06/0021-0014]; Consejo Andaluz de Colegios Oficiales de Farmaceuticos [fellowship]	Asociacion de Celiacos de Madrid; Corporacion Tecnologica de Andalucia; Agencia de Innovacion y Desarrollo de Andalucia; Plan Nacional de Investigacion cientifica, Desarrollo e Innovacion tecnologica; Consejo Andaluz de Colegios Oficiales de Farmaceuticos	This work was supported by the Asociacion de Celiacos de Madrid (to Carolina Sousa), by the CTA (Corporacion Tecnologica de Andalucia) and IDEA (Agencia de Innovacion y Desarrollo de Andalucia) (to Angel Cebolla) and by grants BFU2007-64999 from Plan Nacional de Investigacion cientifica, Desarrollo e Innovacion tecnologica (Miniterio de Educacion y Ciencia) and RICET-RD06/0021-0014, Spain (to Manuel C. Lopez). Belen Moron was supported by a fellowship from Consejo Andaluz de Colegios Oficiales de Farmaceuticos. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaedini A, 2005, ANN INTERN MED, V142, P289, DOI 10.7326/0003-4819-142-4-200502150-00011; Anderson RP, 2000, NAT MED, V6, P337, DOI 10.1038/73200; Arentz-Hansen H, 2004, PLOS MED, V1, P84, DOI 10.1371/journal.pmed.0010001; Arentz-Hansen H, 2000, J EXP MED, V191, P603, DOI 10.1084/jem.191.4.603; Bernardo D, 2007, GUT, V56, P889, DOI 10.1136/gut.2006.118265; Bethune MT, 2006, CHEM BIOL, V13, P637, DOI 10.1016/j.chembiol.2006.04.008; Catassi C, 2007, AM J CLIN NUTR, V85, P160, DOI 10.1093/ajcn/85.1.160; Cebolla A, 2002, APPL ENVIRON MICROB, V68, P5034, DOI 10.1128/AEM.68.10.5034-5041.2002; Cebolla A, 2001, NUCLEIC ACIDS RES, V29, P759, DOI 10.1093/nar/29.3.759; Cerf-Bensussan N, 2007, GUT, V56, P157, DOI 10.1136/gut.2005.090498; Collin P, 2004, ALIMENT PHARM THER, V19, P1277, DOI 10.1111/j.1365-2036.2004.01961.x; ELLIS HJ, 1994, INT ARCH ALLERGY IMM, V104, P308, DOI 10.1159/000236683; ELLIS HJ, 1990, CLIN CHIM ACTA, V189, P123, DOI 10.1016/0009-8981(90)90082-4; Fasano A, 2001, GASTROENTEROLOGY, V120, P636, DOI 10.1053/gast.2001.22123; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; Gass J, 2007, GASTROENTEROLOGY, V133, P472, DOI 10.1053/j.gastro.2007.05.028; Gass J, 2006, J PHARMACOL EXP THER, V318, P1178, DOI 10.1124/jpet.106.104315; Gianfrani C, 2007, GASTROENTEROLOGY, V133, P780, DOI 10.1053/j.gastro.2007.06.023; Hill ID, 2005, J PEDIATR GASTR NUTR, V40, P1, DOI 10.1097/00005176-200501000-00001; Kagnoff MF, 2007, J CLIN INVEST, V117, P41, DOI 10.1172/JCI30253; Khosla C, 2005, GASTROENTEROLOGY, V129, P1362, DOI 10.1053/j.gastro.2005.08.044; Kumar V, 2001, CLIN DIAGN LAB IMMUN, V8, P678, DOI 10.1128/CDLI.8.4.678-685.2001; LOGAN RFA, 1983, BMJ-BRIT MED J, V286, P95, DOI 10.1136/bmj.286.6359.95; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; Moron B, 2008, AM J CLIN NUTR, V87, P405, DOI 10.1093/ajcn/87.2.405; Robins G, 2005, CURR OPIN GASTROEN, V21, P152, DOI 10.1097/01.mog.0000153312.05457.8d; Shan L, 2004, BIOCHEM J, V383, P311, DOI 10.1042/BJ20040907; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Shewry P., 1992, COELIAC DIS, P305; Siegel M, 2006, CHEM BIOL, V13, P649, DOI 10.1016/j.chembiol.2006.04.009; Skovbjerg H, 2004, BBA-MOL BASIS DIS, V1690, P220, DOI 10.1016/j.bbadis.2004.06.009; Sollid LM, 2005, NAT CLIN PRACT GASTR, V2, P140, DOI 10.1038/ncpgasthep0111; Spaenij-Dekking EHA, 2004, GUT, V53, P1267, DOI 10.1136/gut.2003.037952; Stepniak D, 2006, HUM IMMUNOL, V67, P460, DOI 10.1016/j.humimm.2006.03.011; Stern M, 2001, EUR J GASTROEN HEPAT, V13, P741, DOI 10.1097/00042737-200106000-00023; *TEPN BIOS, GLUT ASS KIT QUANT D; Valdes I, 2003, EUR J GASTROEN HEPAT, V15, P465, DOI 10.1097/01.meg.0000059119.41030.df; van de Wal Y, 1998, J IMMUNOL, V161, P1585; Vora H, 2007, BIOTECHNOL BIOENG, V98, P177, DOI 10.1002/bit.21423; WIESER H, 1995, BAILLIERE CLIN GASTR, V9, P191, DOI 10.1016/0950-3528(95)90027-6; Xia J, 2005, BIOCHEMISTRY-US, V44, P4442, DOI 10.1021/bi047747c	41	123	129	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2294	10.1371/journal.pone.0002294	http://dx.doi.org/10.1371/journal.pone.0002294			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509534	Green Published, gold			2022-12-25	WOS:000262268500033
J	Hallett, TB; Singh, K; Smith, JA; White, RG; Abu-Raddad, LJ; Garnett, GP				Hallett, Timothy B.; Singh, Kanwarjit; Smith, Jennifer A.; White, Richard G.; Abu-Raddad, Laith J.; Garnett, Geoff P.			Understanding the Impact of Male Circumcision Interventions on the Spread of HIV in Southern Africa	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; COMMUNITY RANDOMIZED-TRIALS; SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; MATHEMATICAL-MODELS; BEHAVIOR-CHANGE; PREVENTION; INFECTION; TRANSMISSION; RAKAI	Background: Three randomised controlled trials have clearly shown that circumcision of adult men reduces the chance that they acquire HIV infection. However, the potential impact of circumcision programmes - either alone or in combination with other established approaches - is not known and no further field trials are planned. We have used a mathematical model, parameterised using existing trial findings, to understand and predict the impact of circumcision programmes at the population level. Findings: Our results indicate that circumcision will lead to reductions in incidence for women and uncircumcised men, as well as those circumcised, but that even the most effective intervention is unlikely to completely stem the spread of the virus. Without additional interventions, HIV incidence could eventually be reduced by 25-35%, depending on the level of coverage achieved and whether onward transmission from circumcised men is also reduced. However, circumcision interventions can act synergistically with other types of prevention programmes, and if efforts to change behaviour are increased in parallel with the scale-up of circumcision services, then dramatic reductions in HIV incidence could be achieved. In the long-term, this could lead to reduced AIDS deaths and less need for anti-retroviral therapy. Any increases in risk behaviours following circumcision, i.e. 'risk compensation', could offset some of the potential benefit of the intervention, especially for women, but only very large increases would lead to more infections overall. Conclusions: Circumcision will not be the silver bullet to prevent HIV transmission, but interventions could help to substantially protect men and women from infection, especially in combination with other approaches.	[Hallett, Timothy B.; Smith, Jennifer A.; Garnett, Geoff P.] Imperial Coll London, Dept Infect Dis Epidemiol, London, England; [Singh, Kanwarjit] Bill & Melinda Gates Fdn, Seattle, WA USA; [White, Richard G.] London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, London, England; [Abu-Raddad, Laith J.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Inst, Seattle, WA USA	Imperial College London; Bill & Melinda Gates Foundation; University of London; London School of Hygiene & Tropical Medicine; Fred Hutchinson Cancer Center	Hallett, TB (corresponding author), Imperial Coll London, Dept Infect Dis Epidemiol, London, England.	timothy.hallett@imperial.ac.uk	Abu-Raddad, Laith J/AAY-1441-2020; White, Richard G/D-5407-2009; Hallett, Timothy/A-2390-2011; Garnett, Geoffrey P/A-9312-2008	Abu-Raddad, Laith J/0000-0003-0790-0506; White, Richard G/0000-0003-4410-6635; Hallett, Timothy/0000-0002-9681-0424; Smith, Jennifer/0000-0002-8809-8553	Wellcome Trust; UK Medical Research Council; Puget Sound Partners for Global Healt; UNAIDS; Medical Research Council [G0600719B] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Puget Sound Partners for Global Healt; UNAIDS; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	For funding support TBH thanks the Wellcome Trust; RGW thanks the UK Medical Research Council and the Wellcome Trust; LJA-R thanks the Puget Sound Partners for Global Health; and, GPG thanks UNAIDS, the Wellcome Trust and the UK Medical Research Council.	Agot KE, 2007, JAIDS-J ACQ IMM DEF, V44, P66, DOI 10.1097/01.qai.0000242455.05274.20; *AIDSM, 2007, WOM MAY BE NEIGHT HI; Alary M, 2003, AIDS, V17, P2661, DOI 10.1097/00002030-200312050-00014; ANDERSON R M, 1991; ANDERSON RM, 1992, PHILOS T R SOC B, V336, P135, DOI 10.1098/rstb.1992.0052; ANDERSON RM, 1991, NATURE, V352, P581, DOI 10.1038/352581a0; Autier P, 1998, JNCI-J NATL CANCER I, V90, P1873, DOI 10.1093/jnci/90.24.1873; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Baggaley RF, 2005, EMERG THEMES EPIDEMI, V2, DOI 10.1186/1742-7622-2-9; Baggaley RF, 2006, PLOS MED, V3, P493, DOI 10.1371/journal.pmed.0030124; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Blower SM, 2000, SCIENCE, V287, P650, DOI 10.1126/science.287.5453.650; Boerma JT, 2003, SEX TRANSM DIS, V30, P779, DOI 10.1097/01.OLQ.0000078820.62897.A6; deGourville EM, 1998, INT J STD AIDS, V9, P151, DOI 10.1258/0956462981921918; Ferry B, 2001, AIDS, V15, pS41, DOI 10.1097/00002030-200108004-00005; GARNETT GP, 1993, PHILOS T R SOC B, V342, P137, DOI 10.1098/rstb.1993.0143; Garnett GP, 2002, NAT MED, V8, P651, DOI 10.1038/nm0702-651; Garnett GP, 2002, SEX TRANSM INFECT, V78, P7, DOI 10.1136/sti.78.1.7; Ghani AC, 2000, SEX TRANSM DIS, V27, P579, DOI 10.1097/00007435-200011000-00006; Grassly NC, 2001, B WORLD HEALTH ORGAN, V79, P1121; Gray RH, 2000, AIDS, V14, P2371, DOI 10.1097/00002030-200010200-00019; Gray RH, 2007, AIDS, V21, P845, DOI 10.1097/QAD.0b013e3280187544; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Gregson S, 2002, LANCET, V359, P1896, DOI 10.1016/S0140-6736(02)08780-9; Gregson S, 2002, AIDS, V16, P643, DOI 10.1097/00002030-200203080-00017; Gregson S, 2007, PLOS MED, V4, P545, DOI 10.1371/journal.pmed.0040102; Grosskurth H, 2000, LANCET, V355, P1981, DOI 10.1016/S0140-6736(00)02336-9; GROSSKURTH H, 1995, LANCET, V346, P530, DOI 10.1016/S0140-6736(95)91380-7; Hallett TB, 2008, INT J EPIDEMIOL, V37, P77, DOI 10.1093/ije/dym232; Hallett TB, 2006, LANCET, V368, P116, DOI 10.1016/S0140-6736(06)68997-6; Hallett TB, 2006, SEX TRANSM INFECT, V82, pI1, DOI 10.1136/sti.2005.016014; Hallett TB, 2007, SEX TRANSM INFECT, V83, pI55, DOI 10.1136/sti.2006.023663; Halperin DT, 2004, LANCET, V364, P1913, DOI 10.1016/S0140-6736(04)17487-4; Kahn JG, 2006, PLOS MED, V3, P2349, DOI 10.1371/journal.pmed.0030517; Kamali A, 2003, LANCET, V361, P645, DOI 10.1016/S0140-6736(03)12598-6; Kapiga SH, 1998, AIDS, V12, P75, DOI 10.1097/00002030-199801000-00009; Kilian AHD, 1999, AIDS, V13, P391, DOI 10.1097/00002030-199902250-00012; Lagarde E, 2001, AIDS, V15, pS71, DOI 10.1097/00002030-200108004-00008; MCNEIL DG, 2007, TIME RETHINK AIDSS G; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; Nagelkerke NJD, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-16; Padian NS, 2007, LANCET, V370, P251, DOI 10.1016/S0140-6736(07)60950-7; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Salomon JA, 2005, PLOS MED, V2, P50, DOI 10.1371/journal.pmed.0020016; Stoneburner RL, 2004, SCIENCE, V304, P714, DOI 10.1126/science.1093166; Stover J, 2006, SCIENCE, V311, P1474, DOI 10.1126/science.1121176; Stover J, 2002, LANCET, V360, P73, DOI 10.1016/S0140-6736(02)09339-X; Susser M, 1996, AM J PUBLIC HEALTH, V86, P1713, DOI 10.2105/AJPH.86.12.1713; Tshehlo R, 2007, COSTING MALE CIRCUMC; Turner AN, 2007, AIDS, V21, P1779, DOI 10.1097/QAD.0b013e32827b144c; UNAIDS, 1999, TRENDS HIV INC PREV; *UNAIDS, 2007, SAF VOL INF MAL CIRC; *UNAIDS, 2007, WHO UNAIDS ANN REC E; *UNAIDS WHO, 2007, AIDS EP UPD; *UNAIDS WHO LOND S, 2007, MAL CIRC GLOB TRENDS; WATSONJONES D, 2007, IMPACT HSV 2 SUPPRES; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Wawer MJ, 1999, LANCET, V353, P525, DOI 10.1016/S0140-6736(98)06439-3; WEISS H, PERSISTING IN PRESS; Weiss HA, 2000, AIDS, V14, P2361, DOI 10.1097/00002030-200010200-00018; Wellings K, 2006, LANCET, V368, P1706, DOI 10.1016/S0140-6736(06)69479-8; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; White RG, 2004, JAIDS-J ACQ IMM DEF, V37, P1500, DOI 10.1097/01.qai.0000127062.94627.31; WHITE RG, J ACQUIR IM IN PRESS; WHITE RG, 2007, MALE CIRCUMCISION HI; *WHO UNAIDS, 2007, NW DAT MAL CIRC HIV; *WHO UNAIDS UNICEF, 2007, U ACC SCAL PRIOR HIV; Williams BG, 2006, PLOS MED, V3, P1032, DOI 10.1371/journal.pmed.0030262	70	104	104	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2212	10.1371/journal.pone.0002212	http://dx.doi.org/10.1371/journal.pone.0002212			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493593	Green Accepted, gold, Green Submitted, Green Published			2022-12-25	WOS:000262258700021
J	Antezana, MA; Jordan, IK				Antezana, Marcos A.; Jordan, I. King			Highly Conserved Regimes of Neighbor-Base-Dependent Mutation Generated the Background Primary-Structural Heterogeneities along Vertebrate Chromosomes	PLOS ONE			English	Article							TRANSCRIPTION-COUPLED REPAIR; SPECIALIZED DNA-POLYMERASES; DOUBLE-STRAND BREAKS; GC-CONTENT; HOMOLOGOUS RECOMBINATION; MOLECULAR EVOLUTION; DIFFERENT RATES; REPLICATION; GENE; GENOME	The content of guanine+cytosine varies markedly along the chromosomes of homeotherms and great effort has been devoted to studying this heterogeneity and its biological implications. Already before the DNA-sequencing era, however, it was established that the dinucleotides in the DNA of mammals in particular, and of most organisms in general, show striking over- and under-representations that cannot be explained by the base composition. Here we show that in the coding regions of vertebrates both GC content and codon occurrences are strongly correlated with such "motif preferences" even though we quantify the latter using an index that is not affected by the base composition, codon usage, and protein-sequence encoding. These correlations are likely to be the result of the long-term shaping of the primary structure of genic and non-genic DNA by a regime of mutation of which central features have been maintained by natural selection. We find indeed that these preferences are conserved in vertebrates even more rigidly than codon occurrences and we show that the occurrence-preference correlations are stronger in intronic and non-genic DNA, with the R(2)s reaching 99% when GC content is similar to 0.5. The mutation regime appears to be characterized by rates that depend markedly on the bases present at the site preceding and at that following each mutating site, because when we estimate such rates of neighbor-base-dependent mutation (NBDM) from substitutions retrieved from alignments of coding, intronic, and non-genic mammalian DNA sorted and grouped by GC content, they suffice to simulate DNA sequences in which motif occurrences and preferences as well as the correlations of motif preferences with GC content and with motif occurrences, are very similar to the mammalian ones. The best fit, however, is obtained with NBDM regimes lacking strand effects, which indicates that over the long term NBDM switches strands in the germline as one would expect for effects due to loosely contained background transcription. Finally, we show that human coding regions are less mutable under the estimated NBDM regimes than under matched context-independent mutation and that this entails marked differences between the spectra of amino-acid mutations that either mutation regime should generate. In the Discussion we examine the mechanisms likely to underlie NBDM heterogeneity along chromosomes and propose that it reflects how the diversity and activity of lesion-bypass polymerases (LBPs) track the landscapes of scheduled and non-scheduled genome repair, replication, and transcription during the cell cycle. We conclude that the primary structure of vertebrate genic DNA at and below the trinucleotide level has been governed over the long term by highly conserved regimes of NBDM which should be under direct natural selection because they alter drastically missense-mutation rates and hence the somatic and the germline mutational loads. Therefore, the non-coding DNA of vertebrates may have been shaped by NBDM only epiphenomenally, with non-genic DNA being affected mainly when found in the proximity of genes.	[Antezana, Marcos A.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Jordan, I. King] Georgia Inst Technol, Atlanta, GA USA	University of Chicago; University System of Georgia; Georgia Institute of Technology	Antezana, MA (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.	marcos.antezana@gmail.com		Antezana, marcos/0000-0001-5052-2219				Aboussekhra A, 2005, EMBO J, V24, P1999, DOI 10.1038/sj.emboj.7600665; AGUILERA A, 2006, NATURE STRUCTURAL MO, V12, P737; Antezana M, 2003, J MOL EVOL, V56, P198, DOI 10.1007/s00239-002-2394-1; Antezana MA, 1999, J MOL EVOL, V49, P36, DOI 10.1007/PL00006532; ANTEZANA MA, 2005, J MOL EVOL, V61, P1; BARRAI I, 1995, INT J PEPT PROT RES, V45, P326; Bernardi G, 2000, GENE, V259, P31, DOI 10.1016/S0378-1119(00)00441-8; Bernardi G., 2005, STRUCTURAL EVOLUTION; Bielas JH, 2000, P NATL ACAD SCI USA, V97, P11391, DOI 10.1073/pnas.190330997; Bielas JH, 2003, P NATL ACAD SCI USA, V100, P12853, DOI 10.1073/pnas.2235595100; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; CACCIO S, 1994, J MOL EVOL, V39, P331, DOI 10.1007/BF00160265; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Drake JW, 2006, GENETICS, V173, P1; Duan JB, 2003, J MOL EVOL, V57, P694, DOI 10.1007/s00239-003-2519-1; Dufton MJ, 1997, J THEOR BIOL, V187, P165, DOI 10.1006/jtbi.1997.0443; Duret L, 2006, J MOL EVOL, V62, P803, DOI 10.1007/s00239-005-0228-7; DYKHUIZEN D, 1978, EVOLUTION, V32, P125, DOI 10.1111/j.1558-5646.1978.tb01103.x; ESPOSITO MS, 1993, CURR GENET, V23, P430, DOI 10.1007/BF00312630; Farah JA, 2005, GENETICS, V169, P1261, DOI 10.1534/genetics.104.037515; Friedberg EC, 2002, SCIENCE, V296, P1627, DOI 10.1126/science.1070236; Fujii S, 2007, J MOL BIOL, V372, P883, DOI 10.1016/j.jmb.2007.07.036; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Gowrishankar J, 2004, MOL MICROBIOL, V54, P598, DOI 10.1111/j.1365-2958.2004.04289.x; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; Hanawalt PC, 2001, ENVIRON MOL MUTAGEN, V38, P89, DOI 10.1002/em.1057; HAND R, 1978, CELL, V15, P317, DOI 10.1016/0092-8674(78)90001-6; Heddle JA, 2005, ENVIRON MOL MUTAGEN, V45, P143, DOI 10.1002/em.20112; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; HOLMQUIST G, 1982, CELL, V31, P121, DOI 10.1016/0092-8674(82)90411-1; Holmquist GP, 2006, CYTOGENET GENOME RES, V114, P96, DOI 10.1159/000093326; Holmquist GP, 2002, MUTAT RES-FUND MOL M, V510, P1, DOI 10.1016/S0027-5107(02)00247-6; HOLMQUIST GP, 1992, AM J HUM GENET, V51, P17; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Janoueix-Lerosey I, 2005, CELL CYCLE, V4, P1842, DOI 10.4161/cc.4.12.2257; Jaroudi S, 2007, MUTAT RES-REV MUTAT, V635, P53, DOI 10.1016/j.mrrev.2006.09.002; Jeon Y, 2005, P NATL ACAD SCI USA, V102, P6419, DOI 10.1073/pnas.0405088102; Jiricny J, 2004, MOL CELL, V13, P768, DOI 10.1016/S1097-2765(04)00149-2; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; Jordan IK, 2001, GENOME BIOL, V2; Jordan IK, 2005, GENE, V345, P119, DOI 10.1016/j.gene.2004.11.034; Karlin S, 1996, J MOL BIOL, V262, P459, DOI 10.1006/jmbi.1996.0528; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kawamoto T, 2005, MOL CELL, V20, P793, DOI 10.1016/j.molcel.2005.10.016; Keeney S, 2006, BIOCHEM SOC T, V34, P523, DOI 10.1042/BST0340523; KING JL, 1969, SCIENCE, V164, P788, DOI 10.1126/science.164.3881.788; Kleckner N, 2006, CHROMOSOMA, V115, P175, DOI 10.1007/s00412-006-0055-7; KONDRASHOV FA, 2005, J THEOR BIOL; Langston LD, 2006, MOL CELL, V23, P155, DOI 10.1016/j.molcel.2006.05.034; Lehmann AR, 2006, MOL CELL, V24, P493, DOI 10.1016/j.molcel.2006.10.021; Lehmann AR, 2006, DNA REPAIR, V5, P1495, DOI 10.1016/j.dnarep.2006.07.002; Lettier G, 2006, PLOS GENET, V2, P1773, DOI 10.1371/journal.pgen.0020194; Li WH, 2002, CURR OPIN GENET DEV, V12, P650, DOI 10.1016/S0959-437X(02)00354-4; Li XL, 2006, GENE DEV, V20, P1838, DOI 10.1101/gad.1438306; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; MAGNI GE, 1962, GENETICS, V47, P1097; McIlwraith MJ, 2005, MOL CELL, V20, P783, DOI 10.1016/j.molcel.2005.10.001; Mellon I, 2005, MUTAT RES-FUND MOL M, V577, P155, DOI 10.1016/j.mrfmmm.2005.03.016; MELLON I, 1986, P NATL ACAD SCI USA, V83, P8878, DOI 10.1073/pnas.83.23.8878; Meunier J, 2004, MOL BIOL EVOL, V21, P984, DOI 10.1093/molbev/msh070; MINDEN JS, 1989, J CELL BIOL, V109, P505, DOI 10.1083/jcb.109.2.505; MIYATA T, 1987, P JPN ACAD B-PHYS, V63, P327, DOI 10.2183/pjab.63.327; Monroe JJ, 2001, MUTAT RES-FUND MOL M, V476, P1, DOI 10.1016/S0027-5107(01)00081-1; Nouspikel T, 2000, MOL CELL BIOL, V20, P1562, DOI 10.1128/MCB.20.5.1562-1570.2000; NUSSINOV R, 1981, J MOL BIOL, V149, P125, DOI 10.1016/0022-2836(81)90264-3; NUSSINOV R, 1984, NUCLEIC ACIDS RES, V12, P1749, DOI 10.1093/nar/12.3.1749; NUSSINOV R, 1981, J BIOL CHEM, V256, P8458; Pavlov YI, 2003, CURR BIOL, V13, P744, DOI 10.1016/S0960-9822(03)00284-7; Pavlov YI, 2002, MOL CELL, V10, P207, DOI 10.1016/S1097-2765(02)00567-1; Prado F, 2005, MOL CELL BIOL, V25, P1526, DOI 10.1128/MCB.25.4.1526-1536.2005; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Rattray AJ, 2003, ANNU REV GENET, V37, P31, DOI 10.1146/annurev.genet.37.042203.132748; Rattray AJ, 2005, MOL CELL, V20, P658, DOI 10.1016/j.molcel.2005.11.018; Rattray AJ, 2001, GENETICS, V158, P109; Schleiermacher G, 2003, CANCER GENET CYTOGEN, V141, P32, DOI 10.1016/S0165-4608(02)00644-1; Schmegner C, 2005, GENOMICS, V86, P439, DOI 10.1016/j.ygeno.2005.06.011; SETLOW P, 1976, HDB BIOCH MOL BIOL N, V2, P312; Stoltzfus A, 2006, EVOL DEV, V8, P304, DOI 10.1111/j.1525-142X.2006.00101.x; Symington LS, 2005, EMBO REP, V6, P512, DOI 10.1038/sj.embor.7400438; Tang H, 2006, MOL BIOL EVOL, V23, P372, DOI 10.1093/molbev/msj043; Tang H, 2004, MOL BIOL EVOL, V21, P1548, DOI 10.1093/molbev/msh158; VANHOFFEN A, 1995, EMBO J, V14, P360, DOI 10.1002/j.1460-2075.1995.tb07010.x; Versteeg R, 2003, GENOME RES, V13, P1998, DOI 10.1101/gr.1649303; Vilenchik MM, 2003, P NATL ACAD SCI USA, V100, P12871, DOI 10.1073/pnas.2135498100; Walter CA, 1998, P NATL ACAD SCI USA, V95, P10015, DOI 10.1073/pnas.95.17.10015; Willingham AT, 2006, CELL, V125, P1215, DOI 10.1016/j.cell.2006.06.009; Woodfine K, 2004, HUM MOL GENET, V13, P191, DOI 10.1093/hmg/ddh016; Wright S, 1931, GENETICS, V16, P0097; Xu GG, 2005, BIOL REPROD, V73, P123, DOI 10.1095/biolreprod.104.039123; Yampolsky LY, 2005, GENETICS, V170, P1459, DOI 10.1534/genetics.104.039107; Yi SJ, 2005, MOL BIOL EVOL, V22, P1223, DOI 10.1093/molbev/msi106; Zink D, 2006, CHROMOSOMA, V115, P273, DOI 10.1007/s00412-006-0062-8	94	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2145	10.1371/journal.pone.0002145	http://dx.doi.org/10.1371/journal.pone.0002145			51	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478116	Green Published, gold, Green Submitted			2022-12-25	WOS:000262172800010
J	Chiou, SH; Kao, CL; Chen, YW; Chien, CS; Hung, SC; Lo, JF; Chen, YJ; Ku, HH; Hsu, MT; Wong, TT				Chiou, Shih-Hwa; Kao, Chung-Lan; Chen, Yi-Wei; Chien, Chien-Shu; Hung, Shih-Chieh; Lo, Jeng-Fan; Chen, Yann-Jang; Ku, Hung-Hai; Hsu, Ming-Ta; Wong, Tai-Tong			Identification of CD133-Positive Radioresistant Cells in Atypical Teratoid/Rhabdoid Tumor	PLOS ONE			English	Article								Atypical teratoid/rhabdoid tumor (AT/RT) is an extremely malignant neoplasm in the central nervous system (CNS) which occurs in infancy and childhood. Recent studies suggested that CD133 could be considered a marker for brain cancer stemlike cells (CSCs). However, the role of CD133 in AT/RT has never been investigated. Herein we report the isolation of CD133-positive cells (CD133(+)), found to have the potential to differentiate into three germ layer tissues, from tissues of nine AT/RT patients. The migration/invasion/malignancy and radioresistant capabilities of CD133(+) were significantly augmented when compared to CD133(-). The clinical data showed that the amount of CD133(+) in AT/RTs correlated positively with the degree of resistance to radiation therapy. Using cDNA microarray analysis, the genotoxic -response profiles of CD133(+) and CD133(-) irradiated with 10 Gy ionizing radiation (IR) were analyzed 0.5, 2, 6, 12 and 24 h post-IR. We then validated these microarray data and showed increased phosphorylation after IR of p-ATM, p-RAD17, and p-CHX2 as well as increased expression of BCL-2 protein in CD133(+) compared to CD133(-). Furthermore, we found that CD133(+) can effectively resist IR with cisplatin-and/or TRAIL-induced apoptosis. Immunohistochemical analysis confirmed the up-regulated expression of p-ATM and BCL-2 proteins in IR-treated CD133(+) xenotransgrafts in SCID mice but not in IR-treated CD133(-). Importantly, the effect of IR in CD133(+) transplanted mice can be significantly improved by a combination of BCL-2 siRNA with debromohymenialdisine, an inhibitor of checkpoint kinases. In sum, this is the first report indicating that CD133(+) AT/RT cells demonstrate the characteristics of CSCs. The IR-resistant and anti-apoptotic properties in CD133(+) may reflect the clinical refractory malignancy of AT/RTs and thus the activated p-ATM pathway and BCL-2 expression in CD133(+) could be possible targets to improve future treatment of deadly diseases like AT/RT.	[Chiou, Shih-Hwa; Hung, Shih-Chieh] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Kao, Chung-Lan] Natl Yang Ming Univ, Dept Med Res & Educ, Taipei, Taiwan; [Chen, Yi-Wei] Taipei Vet Gen Hosp, Dept Phys Med & Rehab, Taipei, Taiwan; [Wong, Tai-Tong] Natl Yang Ming Univ, Dept Phys Med & Rehab, Taipei, Taiwan; [Chiou, Shih-Hwa; Chien, Chien-Shu; Lo, Jeng-Fan] Taipei Vet Gen Hosp, Canc Ctr, Taipei, Taiwan; [Chen, Yann-Jang; Hsu, Ming-Ta; Wong, Tai-Tong] Natl Yang Ming Univ, Canc Ctr, Taipei, Taiwan; [Ku, Hung-Hai] Taipei Vet Gen Hosp, Neurol Inst, Sect Neuropediat Surg, Taipei, Taiwan; [Chiou, Shih-Hwa; Kao, Chung-Lan; Chen, Yi-Wei; Hung, Shih-Chieh] Natl Yang Ming Univ, Neurol Inst, Sect Neuropediat Surg, Taipei, Taiwan; Natl Yang Ming Univ, Inst Oral Biol, Taipei, Taiwan; Natl Yang Ming Univ, VYM Genomic Res Ctr, Taipei, Taiwan; Natl Yang Ming Univ, Inst Anat & Cell Biol, Taipei, Taiwan; Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Chiou, SH (corresponding author), Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan.	shchiou@vghtpe.gov.tw	Lo, Jeng-Fan/AAE-9626-2020; Chien, Chian-Shiu/AAT-3192-2020; Lo, Jeng-Fan/ABB-2820-2020	Lo, Jeng-Fan/0000-0001-7188-9140; Lo, Jeng-Fan/0000-0001-7188-9140; Wong, Tai-Tong/0000-0003-4075-6227	National Science Council [NSC-96-3111-B-075-001-MY3, 95-2314-B-075-055-MY2, 96-2628-B-010-006-MY3, 96-2314-B-075-024]; Taipei Veterans General Hospital [V96C1-151, V96E1-004, V96ER2-016, V96E2-010]; Joint Projects of UTVGH [VGHUST96-P1-07]; VGHUST96-P1-07; Yen-Tjing-Ling Medical Foundation; Taipei City Hospital [96001-62-014, 96001-62-018, 96002-62-092]; National Yang-Ming University (Ministry of Education, Aim for the Top University Plan), Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); Joint Projects of UTVGH; VGHUST96-P1-07; Yen-Tjing-Ling Medical Foundation; Taipei City Hospital; National Yang-Ming University (Ministry of Education, Aim for the Top University Plan), Taiwan(Ministry of Education, Taiwan)	This study was supported by research grants from the National Science Council (NSC-96-3111-B-075-001-MY3, 95-2314-B-075-055-MY2, 96-2628-B-010-006-MY3, 96-2314-B-075-024), Taipei Veterans General Hospital (V96C1-151, V96E1-004, V96ER2-016, V96E2-010), the Joint Projects of UTVGH (VGHUST96-P1-07), Yen-Tjing-Ling Medical Foundation, Taipei City Hospital (96001-62-014, 96001-62-018, 96002-62-092), and National Yang-Ming University (Ministry of Education, Aim for the Top University Plan), Taiwan.	BAO S, 2006, ACTA NEUROCHIR WIEN, V139, P961; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; BERGMANN M, 1997, PRIMARY MALIGNANT RH; BIEGEL JA, 1992, GENE CHROMOSOME CANC, V5, P104, DOI 10.1002/gcc.2870050203; Biegel JA, 1996, GENE CHROMOSOME CANC, V16, P94, DOI 10.1002/(SICI)1098-2264(199606)16:2<94::AID-GCC3>3.0.CO;2-Y; Biegel JA, 1999, CANCER RES, V59, P74; BIEGEL JA, 1989, NEW ENGL J MED, V321, P906; Blazek ER, 2007, INT J RADIAT ONCOL, V67, P1, DOI 10.1016/j.ijrobp.2006.09.037; Burger PC, 1998, AM J SURG PATHOL, V22, P1083, DOI 10.1097/00000478-199809000-00007; Ch'ang HJ, 2005, NAT MED, V11, P484, DOI 10.1038/nm1237; CHEN YW, 2006, INT J RADIAT ONCOL, V64, P3843; Cheng YC, 2005, ACTA RADIOL, V46, P89, DOI 10.1080/02841850510020987; Chiou SH, 2006, J IMMUNOL, V177, P6199, DOI 10.4049/jimmunol.177.9.6199; Chiou SH, 2006, BRIT J PHARMACOL, V148, P587, DOI 10.1038/sj.bjp.0706766; Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937; Duan WR, 2006, EXP CELL RES, V312, P3370, DOI 10.1016/j.yexcr.2006.07.005; Fan C, 2006, BBA-MOL CELL RES, V1763, P1090, DOI 10.1016/j.bbamcr.2006.08.026; Gartel AL, 2002, MOL CANCER THER, V1, P639; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Lin HL, 2007, INT J CANCER, V121, P2547, DOI 10.1002/ijc.22963; Hilden JM, 2004, J CLIN ONCOL, V22, P2877, DOI 10.1200/jco.2004.07.073; Ho DMT, 2000, ACTA NEUROPATHOL, V99, P482, DOI 10.1007/s004010051149; Kao CL, 2005, MODERN PATHOL, V18, P769, DOI 10.1038/modpathol.3800270; Mirzayans R, 2006, INT J RADIAT ONCOL, V66, P1498, DOI 10.1016/j.ijrobp.2006.08.064; Neuzil J, 2007, BIOCHEM BIOPH RES CO, V355, P855, DOI 10.1016/j.bbrc.2007.01.159; Nix P, 2005, BRIT J CANCER, V92, P2185, DOI 10.1038/sj.bjc.6602647; Packer RJ, 2002, J PEDIAT HEMATOL ONC, V24, P337, DOI 10.1097/00043426-200206000-00004; Parwani AV, 2005, CANCER CYTOPATHOL, V105, P65, DOI 10.1002/cncr.20872; Peng CH, 2008, EUR NEUROPSYCHOPHARM, V18, P128, DOI 10.1016/j.euroneuro.2007.05.002; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rorke LB, 1996, J NEUROSURG, V85, P56, DOI 10.3171/jns.1996.85.1.0056; Schwartz JL, 2007, INT J RADIAT BIOL, V83, P153, DOI 10.1080/09553000601146949; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Tekautz TM, 2005, J CLIN ONCOL, V23, P1491, DOI 10.1200/JCO.2005.05.187; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Weiss E, 1998, INT J RADIAT ONCOL, V41, P1013, DOI 10.1016/S0360-3016(98)00106-0; Wong TT, 2005, CANCER, V104, P2156, DOI 10.1002/cncr.21430; Yang MH, 2007, ONCOGENE, V26, P1459, DOI 10.1038/sj.onc.1209929; Yu J, 2005, BIOCHEM BIOPH RES CO, V331, P851, DOI 10.1016/j.bbrc.2005.03.189; Zeppernick F, 2008, CLIN CANCER RES, V14, P123, DOI 10.1158/1078-0432.CCR-07-0932; Zgheib O, 2005, RADIOTHER ONCOL, V76, P119, DOI 10.1016/j.radonc.2005.06.026	45	95	96	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2090	10.1371/journal.pone.0002090	http://dx.doi.org/10.1371/journal.pone.0002090			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18509505	Green Published, gold			2022-12-25	WOS:000261642400013
J	Cahill, CM; Rogers, JT				Cahill, Catherine M.; Rogers, Jack T.			Interleukin (IL) 1 beta induction of IL-6 is mediated by a novel phosphatidylinositol 3-kinase-dependent AKT/I kappa B kinase alpha pathway targeting activator protein-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; IKK-ALPHA; UP-REGULATION; C-FOS; SIGNAL-TRANSDUCTION; EPITHELIAL-CELLS; GENE-EXPRESSION; INNATE IMMUNITY; NF; RECEPTOR	Here we describe a novel role for the phosphatidylinositol 3-kinase/AKT pathway in mediating induction of interleukin-6 (IL-6) in response to IL-1. Pharmacological inhibition of phosphatidylinositol 3-kinase (PI3K) inhibited IL-6 mRNA and protein production. Overexpression of either dominant-negative AKTor I kappa Bkinase alpha mutant, IKK alpha T23A, containing a mutation in a functional AKT phosphorylation site, shown previously to be important for NF kappa B activation, completely abrogated IL-6 promoter activation in response to IL-1. However, mutation of the consensus NF kappa B site on the IL-6 promoter did not abrogate promoter activation by IL-1 in contrast to the AP-1 site mutation. IL-1 induces phosphorylation of IKK alpha on the NF kappa B inducing kinase (NIK) phosphorylation sites Ser(176)/Ser(180) and on the Thr(23) site, and although phosphorylation of IKK alpha T23 is inhibited both by LY294002 and wortmannin, phosphorylation of Ser(176)/Ser(180) is not. Neither inhibition of PI 3-kinase/AKT nor IKK alpha T23A overexpression affected I kappa B alpha degradation in response to IL-1. Only partial inhibition by dominant-negative AKT and no inhibitory effect of IKK alpha T23A was observed on an IL-6 promoter-specific NF kappa B site in contrast to significant inhibitory effects on the AP-1 site. Taken together, we have discovered a novel PI 3-kinase/AKT-dependent pathway in response to IL-1, encompassing PI 3-kinase/AKT/IKK alpha T23 upstream of AP-1. This novel pathway is a parallel pathway to the PI 3-kinase/AKT upstream of NF kappa B and both are involved in IL-6 gene transcription in response to IL-1.	[Cahill, Catherine M.; Rogers, Jack T.] Massachusetts Gen Hosp East, Aging Res Unit, Charlestown, MA 02129 USA; [Cahill, Catherine M.; Rogers, Jack T.] Massachusetts Gen Hosp East, Neurochem Lab, Dept Psychiat Neurosci & Genet, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Cahill, CM (corresponding author), MA Gen Hosp, CNY 149,Rm 2510,13th St, Charlestown, MA 02129 USA.	ccahill@rics.bwh.harvard.edu		Rogers, Jack/0000-0003-1262-8578	National Institutes of Health [R01 AG20181]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AG20181. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. Section 1734 solely to indicate this fact.	Albanese C, 2003, MOL BIOL CELL, V14, P585, DOI 10.1091/mbc.02-06-0101; Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; An JB, 2002, BLOOD, V99, P649, DOI 10.1182/blood.V99.2.649; Anest V, 2004, J BIOL CHEM, V279, P31183, DOI 10.1074/jbc.M404380200; Arsura M, 2003, ONCOGENE, V22, P412, DOI 10.1038/sj.onc.1206132; Atreya R, 2005, CLIN REV ALLERG IMMU, V28, P187, DOI 10.1385/CRIAI:28:3:187; Bang OS, 2000, BIOCHEM BIOPH RES CO, V278, P306, DOI 10.1006/bbrc.2000.3805; BEAGLEY KW, 1989, J EXP MED, V169, P2133, DOI 10.1084/jem.169.6.2133; Belluco C, 2003, CLIN CANCER RES, V9, P2173; Blanco S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001660; Brikos C, 2007, MOL CELL PROTEOMICS, V6, P1551, DOI 10.1074/mcp.M600455-MCP200; Brozek W, 2005, EUR J CANCER, V41, P2347, DOI 10.1016/j.ejca.2005.07.014; Cahill CM, 2001, J BIOL CHEM, V276, P13402, DOI 10.1074/jbc.M010042200; Chou CH, 2005, CARCINOGENESIS, V26, P45, DOI 10.1093/carcin/bgh301; Coffer PJ, 1998, BIOCHEM J, V335, P1; Dahle MK, 2004, INFECT IMMUN, V72, P5704, DOI 10.1128/IAI.72.10.5704-5711.2004; Dan HC, 2007, CANCER RES, V67, P6263, DOI 10.1158/0008-5472.CAN-07-1232; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; de Haij S, 2005, J AM SOC NEPHROL, V16, P1603, DOI 10.1681/ASN.2004090781; Eickelberg O, 1999, J BIOL CHEM, V274, P12933, DOI 10.1074/jbc.274.18.12933; Fujioka S, 2004, MOL CELL BIOL, V24, P7806, DOI 10.1128/MCB.24.17.7806-7819.2004; Garat C, 2003, CYTOKINE, V23, P31, DOI 10.1016/S1043-4666(03)00182-0; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Guo FK, 2000, INFLAMMATION, V24, P305, DOI 10.1023/A:1007040813331; Gustin JA, 2004, J BIOL CHEM, V279, P1615, DOI 10.1074/jbc.M306976200; Gustin JA, 2006, J BIOL CHEM, V281, P16473, DOI 10.1074/jbc.M507373200; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hefler LA, 2005, CLIN CANCER RES, V11, P5718, DOI 10.1158/1078-0432.CCR-05-0001; Hirano T, 1998, Int Rev Immunol, V16, P249; Huang CS, 1996, MOL CELL BIOL, V16, P6427; Huang WC, 2007, MOL CELL, V26, P75, DOI 10.1016/j.molcel.2007.02.019; Jiang QQ, 1999, AM J PHYSIOL-REG I, V276, pR1653; Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Kinoshita T, 1999, CANCER, V85, P2526, DOI 10.1002/(SICI)1097-0142(19990615)85:12<2526::AID-CNCR6>3.0.CO;2-3; Koul D, 2001, J BIOL CHEM, V276, P11402, DOI 10.1074/jbc.M007806200; Koul D, 2007, MOL CELL BIOCHEM, V300, P77, DOI 10.1007/s11010-006-9371-8; Krappmann D, 2004, MOL CELL BIOL, V24, P6488, DOI 10.1128/MCB.24.14.6488-6500.2004; Li JX, 2004, J CELL BIOL, V165, P77, DOI 10.1083/jcb.200401004; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; Manning AM, 2003, NAT REV DRUG DISCOV, V2, P554, DOI 10.1038/nrd1132; Marmiroli S, 1998, FEBS LETT, V438, P49, DOI 10.1016/S0014-5793(98)01270-8; Martin MU, 2002, BBA-MOL CELL RES, V1592, P265, DOI 10.1016/S0167-4889(02)00320-8; Matsuo K, 2003, J INT MED RES, V31, P69, DOI 10.1177/147323000303100202; Mitsuyama K, 2006, CYTOKINE GROWTH F R, V17, P451, DOI 10.1016/j.cytogfr.2006.09.003; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Neumann D, 2002, EUR J IMMUNOL, V32, P3689, DOI 10.1002/1521-4141(200212)32:12<3689::AID-IMMU3689>3.0.CO;2-X; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Nishimoto N, 2006, NAT CLIN PRACT RHEUM, V2, P619, DOI 10.1038/ncprheum0338; O'Neill L, 2000, BIOCHEM SOC T, V28, P557, DOI 10.1042/bst0280557; O'Neill LAJ, 2000, IMMUNOL TODAY, V21, P206, DOI 10.1016/S0167-5699(00)01611-X; Okuno Y, 2002, BLOOD, V100, P4420, DOI 10.1182/blood-2002-03-0788; Ozes ON, 1999, NATURE, V401, P82; Park HS, 2002, J BIOL CHEM, V277, P2573, DOI 10.1074/jbc.M110299200; Patil C, 2004, IMMUNOL INVEST, V33, P213, DOI 10.1081/IMM-120034231; Peloponese JM, 2006, J BIOL CHEM, V281, P8927, DOI 10.1074/jbc.M510598200; Plaisance S, 1997, MOL CELL BIOL, V17, P3733, DOI 10.1128/MCB.17.7.3733; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; RAY A, 1989, MOL CELL BIOL, V9, P5537, DOI 10.1128/MCB.9.12.5537; Reddy SAG, 1997, J BIOL CHEM, V272, P29167, DOI 10.1074/jbc.272.46.29167; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Ruffolo C, 2007, J GASTROINTEST SURG, V11, P16, DOI 10.1007/s11605-006-0021-y; Samuel S, 2005, BIOCHEM J, V388, P921, DOI 10.1042/BJ20041497; Schneider MR, 2000, CANCER LETT, V151, P31, DOI 10.1016/S0304-3835(99)00401-2; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; SHER ME, 1995, AM J SURG, V169, P133, DOI 10.1016/S0002-9610(99)80121-4; Sizemore N, 1999, MOL CELL BIOL, V19, P4798; Solt LA, 2007, J BIOL CHEM, V282, P8724, DOI 10.1074/jbc.M609613200; Song JJ, 2005, J CELL BIOL, V170, P61, DOI 10.1083/jcb.200502070; STEIN B, 1995, MOL CELL BIOL, V15, P4971; Stylianou E, 1998, INT J BIOCHEM CELL B, V30, P1075, DOI 10.1016/S1357-2725(98)00081-8; Suto R, 2004, GENE THER, V11, P187, DOI 10.1038/sj.gt.3302158; Swank GM, 1996, WORLD J SURG, V20, P411, DOI 10.1007/s002689900065; Vanden Berghe W, 1998, J BIOL CHEM, V273, P3285, DOI 10.1074/jbc.273.6.3285; Vanden Berghe W, 2000, BIOCHEM PHARMACOL, V60, P1185, DOI 10.1016/S0006-2952(00)00412-3; Vanden Berghe W, 1999, J BIOL CHEM, V274, P32091, DOI 10.1074/jbc.274.45.32091; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wang KZQ, 2006, J CELL SCI, V119, P1579, DOI 10.1242/jcs.02889; Wang WY, 1998, J SURG RES, V79, P39, DOI 10.1006/jsre.1998.5385; Watters TM, 2007, IMMUNOL CELL BIOL, V85, P411, DOI 10.1038/sj.icb.7100095; Wietek C, 2007, TRENDS BIOCHEM SCI, V32, P311, DOI 10.1016/j.tibs.2007.05.003; Xiao GT, 2004, J BIOL CHEM, V279, P30099, DOI 10.1074/jbc.M401428200; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yang HT, 2008, CELL SIGNAL, V20, P375, DOI 10.1016/j.cellsig.2007.10.025	86	159	165	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 19	2008	283	38					25900	25912		10.1074/jbc.M707692200	http://dx.doi.org/10.1074/jbc.M707692200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	348GX	18515365	Green Published, hybrid			2022-12-25	WOS:000259200100017
J	Shiota, M; Izumi, H; Onitsuka, T; Miyamoto, N; Kashiwagi, E; Kidani, A; Hirano, G; Takahashi, M; Naito, S; Kohno, K				Shiota, M.; Izumi, H.; Onitsuka, T.; Miyamoto, N.; Kashiwagi, E.; Kidani, A.; Hirano, G.; Takahashi, M.; Naito, S.; Kohno, K.			Twist and p53 reciprocally regulate target genes via direct interaction	ONCOGENE			English	Article						YB-1; Twist; p53; GST-fusion protein array; membrane pull-down assay	SAETHRE-CHOTZEN SYNDROME; BOX-BINDING-PROTEIN; BHLH PROTEIN; CANCER-CELLS; DRUG-RESISTANCE; NEURAL-TUBE; EXPRESSION; DNA; MORPHOGENESIS; CISPLATIN	Twist is basic helix-loop-helix transcription factor that binds to E-boxes in gene promoters. Twist possesses an oncogenic function by interfering with the tumor suppressor function of p53. Using a membrane pull-down assay, we found that Twist directly interacts with p53 and that this interaction underlies the inhibitory effects on p53 target gene expression. Twist interacted with the DNA-binding domain of p53 and suppressed the DNA-binding activity of p53. Transcriptional activation of the p21 promoter by p53 was significantly repressed by the expression of Twist. On the other hand, p53 interacted with the N-terminal domain of Twist and repressed Twist-dependent YB-1 promoter activity. Importantly, we found that p53-dependent growth suppression was canceled by the expression of either Twist or YB-1. Thus, our data suggest that Twist inhibits p53 function via a direct interaction with p53.	[Shiota, M.; Izumi, H.; Onitsuka, T.; Miyamoto, N.; Kashiwagi, E.; Kidani, A.; Hirano, G.; Takahashi, M.; Kohno, K.] Univ Occupat & Environm Hlth, Sch Med, Dept Mol Biol, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan; [Shiota, M.; Kashiwagi, E.; Naito, S.] Kyushu Univ, Grad Sch Med Sci, Dept Urol, Fukuoka 812, Japan	University of Occupational & Environmental Health - Japan; Kyushu University	Kohno, K (corresponding author), Univ Occupat & Environm Hlth, Sch Med, Dept Mol Biol, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	k-kohno@med.uoeh-u.ac.jp	Shiota, Masaki/Q-9387-2019	Shiota, Masaki/0000-0002-3306-4858	Ministry of Education, Culture, Sports, Science, and Technology of Japan (Mext) [13218132, 17590257]; Kobayashi Institute for Innovative Cancer Chemotherapy; grant-in-aid for Cancer Research from the Fukuoka Cancer Society, Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan (Mext)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kobayashi Institute for Innovative Cancer Chemotherapy; grant-in-aid for Cancer Research from the Fukuoka Cancer Society, Japan	This work was supported in part by the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Mext), Kakenhi (13218132 and 17590257), the Kobayashi Institute for Innovative Cancer Chemotherapy and a grant-in-aid for Cancer Research from the Fukuoka Cancer Society, Japan. We thank Satoko Takazaki and Yukiko Yoshiura for their technical assistance.	Alexander NR, 2006, CANCER RES, V66, P3365, DOI 10.1158/0008-5472.CAN-05-3401; Castanon I, 2001, DEVELOPMENT, V128, P3145; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; ELDEIRY WS, 1994, CANCER RES, V54, P1169; ElGhouzzi V, 1997, NAT GENET, V15, P42; Funato N, 2001, MOL CELL BIOL, V21, P7416, DOI 10.1128/MCB.21.21.7416-7428.2001; Hamamori Y, 1997, MOL CELL BIOL, V17, P6563, DOI 10.1128/MCB.17.11.6563; Hamamori Y, 1999, CELL, V96, P405, DOI 10.1016/S0092-8674(00)80553-X; Howard TD, 1997, NAT GENET, V15, P36, DOI 10.1038/ng0197-36; Igarashi T, 2007, ONCOGENE, V26, P4749, DOI 10.1038/sj.onc.1210289; Imamura T, 2001, J BIOL CHEM, V276, P7534, DOI 10.1074/jbc.M008143200; Izumi H, 2003, BIOCHEM J, V373, P713, DOI 10.1042/BJ20021902; Izumi H, 2001, NUCLEIC ACIDS RES, V29, P1200, DOI 10.1093/nar/29.5.1200; Jayaraman L, 1998, GENE DEV, V12, P462, DOI 10.1101/gad.12.4.462; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Kohno K, 2005, EUR J CANCER, V41, P2577, DOI 10.1016/j.ejca.2005.08.007; Lee YM, 1997, J BIOL CHEM, V272, P17531, DOI 10.1074/jbc.272.28.17531; Liu L, 1999, MOL CELL BIOL, V19, P1202; Maestro R, 1999, GENE DEV, V13, P2207, DOI 10.1101/gad.13.17.2207; Ohga T, 1996, CANCER RES, V56, P4224; Okamoto T, 2000, ONCOGENE, V19, P6194, DOI 10.1038/sj.onc.1204029; QUERTERMOUS EE, 1994, P NATL ACAD SCI USA, V91, P7066, DOI 10.1073/pnas.91.15.7066; Shiota M, 2008, CANCER RES, V68, P98, DOI 10.1158/0008-5472.CAN-07-2981; Soo K, 2002, DEV BIOL, V247, P251, DOI 10.1006/dbio.2002.0699; Stasinopoulos IA, 2005, J BIOL CHEM, V280, P2294, DOI 10.1074/jbc.M411018200; THISSE B, 1988, EMBO J, V7, P2175, DOI 10.1002/j.1460-2075.1988.tb03056.x; Torigoe Takayuki, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P15, DOI 10.2174/1568011053352587; Uramoto H, 2003, BIOCHEM J, V371, P301, DOI 10.1042/BJ20021646; Uramoto H, 2002, J BIOL CHEM, V277, P31694, DOI 10.1074/jbc.M200266200; Valsesia-Wittmann S, 2004, CANCER CELL, V6, P625, DOI 10.1016/j.ccr.2004.09.033; Wakasugi T, 2007, ONCOGENE, V26, P5194, DOI 10.1038/sj.onc.1210326; Wang XH, 2004, ONCOGENE, V23, P474, DOI 10.1038/sj.onc.1207128; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006	33	92	95	3	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP 18	2008	27	42					5543	5553		10.1038/onc.2008.176	http://dx.doi.org/10.1038/onc.2008.176			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	349KX	18504427				2022-12-25	WOS:000259280800001
J	Imperial, JS; Chen, P; Sporning, A; Terlau, H; Daly, NL; Craik, DJ; Alewood, PF; Olivera, BM				Imperial, Julita S.; Chen, Ping; Sporning, Annett; Terlau, Heinrich; Daly, Norelle L.; Craik, David J.; Alewood, Paul F.; Olivera, Baldomero M.			Tyrosine-rich conopeptides affect voltage-gated K+ channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; KAPPA-CONOTOXIN PVIIA; VENOMOUS CONE SNAILS; SODIUM-CHANNELS; PEPTIDE; FAMILY; GEOGRAPHUS; INHIBITOR; EVOLUTION; ORIGINS	Two venom peptides, CPY-Pl1 (EU000528) and CPY-Fe1 (EU000529), characterized from the vermivorous marine snails Conus planorbis and Conus ferrugineus, define a new class of conopeptides, the conopeptide Y (CPY) family. The peptides have no disulfide cross-links and are 30 amino acids long; the high content of tyrosine is unprecedented for any native gene product. The CPY peptides were chemically synthesized and shown to be biologically active upon injection into both mice and Caenorhabditis elegans; activity on mammalian Kv1 channel isoforms was demonstrated using an oocyte heterologous expression system, and selectivity for Kv1.6 was found. NMR spectroscopy revealed that the peptides were unstructured in aqueous solution; however, a helical region including residues 12-18 for one peptide, CPY-Pl1, formed in trifluoroethanol buffer. Clones obtained from cDNA of both species encoded prepropeptide precursors that shared a unique signal sequence, indicating that these peptides are encoded by a novel gene family. This is the first report of tyrosine-rich bioactive peptides in Conus venom.	[Imperial, Julita S.; Chen, Ping; Olivera, Baldomero M.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Sporning, Annett; Terlau, Heinrich] Max Planck Inst Expt Med, Mol & Cellular Neuropharmacol Grp, D-37075 Gottingen, Germany; [Terlau, Heinrich] Univ Klinikum Schleswig Holstein, Inst Expt & Clin Pharmacol & Toxicol, D-23538 Lubeck, Germany; [Daly, Norelle L.; Craik, David J.; Alewood, Paul F.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia	Utah System of Higher Education; University of Utah; Max Planck Society; University of Kiel; Schleswig Holstein University Hospital; University of Queensland	Imperial, JS (corresponding author), Univ Utah, Dept Biol, 257 South 1400 East, Salt Lake City, UT 84112 USA.	imperial@biology.utah.edu	Craik, David/B-1695-2010; Daly, Norelle L/D-4302-2013; Alewood, Paul F/J-2412-2014	Craik, David/0000-0003-0007-6796; Daly, Norelle L/0000-0002-4697-6602; Terlau, Heinrich/0000-0002-2206-1221	National Institutes of Health [GM48667]; German Ministry of Education and Research Biofuture Prize [Forderkennzeichen 0311859]; Australian Research Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048667] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Ministry of Education and Research Biofuture Prize; Australian Research Council(Australian Research Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM48667 (B.M.O.). This work was also supported by the German Ministry of Education and Research Biofuture Prize (Forderkennzeichen 0311859, to H.T.) and the Australian Research Council (to P.F.A. and D.J.C.).	Al-Sabi A, 2004, BIOCHEMISTRY-US, V43, P8625, DOI 10.1021/bi0495681; Bayrhuber M, 2005, J BIOL CHEM, V280, P23766, DOI 10.1074/jbc.C500064200; Cerda-Reverter JM, 2000, BIOCHEM CELL BIOL, V78, P371, DOI 10.1139/bcb-78-3-371; Craig AG, 1999, J BIOL CHEM, V274, P13752, DOI 10.1074/jbc.274.20.13752; CRUZ LJ, 1987, J BIOL CHEM, V262, P15821; Daly NL, 2004, J BIOL CHEM, V279, P25774, DOI 10.1074/jbc.M313002200; Duda TF, 2001, BIOL J LINN SOC, V73, P391, DOI 10.1006/bijl.2001.0544; Ellison M, 2003, J BIOL CHEM, V278, P757, DOI 10.1074/jbc.M204565200; Espiritu DJD, 2001, TOXICON, V39, P1899, DOI 10.1016/S0041-0101(01)00175-1; Frohman M.A., 1990, PCR PROTOCOLS GUIDE, P28; HOPKINS C, 1995, J BIOL CHEM, V270, P22361, DOI 10.1074/jbc.270.38.22361; HORTON RM, 1993, NEUROLOGY, V43, P983, DOI 10.1212/WNL.43.5.983; Imperial JS, 2006, BIOCHEMISTRY-US, V45, P8331, DOI 10.1021/bi060263r; IMPERIAL JS, 2007, THESIS U QUEENSLAND; Imperial JS, 2007, P AM PHILOS SOC, V151, P185; Jacobsen RB, 2000, J BIOL CHEM, V275, P24639, DOI 10.1074/jbc.C900990199; Jimenez EC, 1996, J BIOL CHEM, V271, P28002, DOI 10.1074/jbc.271.45.28002; Maillo M, 2002, TOXICON, V40, P401, DOI 10.1016/S0041-0101(01)00176-3; MELLO CC, 1991, EMBO J, V10, P2959; OLIVERA BM, 1985, TOXICON, V23, P277, DOI 10.1016/0041-0101(85)90150-3; Rosengren KJ, 2003, J BIOL CHEM, V278, P8606, DOI 10.1074/jbc.M211147200; Sharpe IA, 2001, NAT NEUROSCI, V4, P902, DOI 10.1038/nn0901-902; Shon KJ, 1997, BIOCHEMISTRY-US, V36, P9581, DOI 10.1021/bi970235w; Shon KJ, 1998, J BIOL CHEM, V273, P33, DOI 10.1074/jbc.273.1.33; Sudarslal S, 2004, BIOCHEM BIOPH RES CO, V317, P682, DOI 10.1016/j.bbrc.2004.03.100; Teichert RW, 2007, J BIOL CHEM, V282, P36905, DOI 10.1074/jbc.M706611200; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Zhang MM, 2007, J BIOL CHEM, V282, P30699, DOI 10.1074/jbc.M704616200	30	23	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23026	23032		10.1074/jbc.M800084200	http://dx.doi.org/10.1074/jbc.M800084200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18505731	hybrid, Green Published			2022-12-25	WOS:000258455400015
J	Mrinal, N; Nagaraju, J				Mrinal, Nirotpal; Nagaraju, Javaregowda			Intron loss is associated with gain of function in the evolution of the gloverin family of antibacterial genes in Bombyx mori	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR CF2; MESSENGER-RNA; IMMUNE-RESPONSE; DROSOPHILA; PROTEIN; SEQUENCE; RELISH; PSEUDOGENES; DEFENSE; HEMOLIN	Gene duplication is a characteristic feature of eukaryotic genomes. Here we investigated the role of gene duplication in the evolution of the gloverin family of antibacterial genes (Bmglv1, Bmglv2, Bmglv3, and Bmglv4) in Bombyx mori. We observed the following two significant changes during the first duplication event: (i) loss of intronV, located in the 3'-untranslated region (UTR) of the ancestral gene Bmglv1, and (ii) 12-bp deletion in exon3. We show that loss of intronV during Bmglv1 to Bmglv2 duplication was associated with embryonic expression of Bmglv2. Gel mobility shift, chromatin immunoprecipitation, and immunodepletion assays identified chorion factor 2, a zinc finger protein, as the repressor molecule that bound to a 10-bp regulatory motif in intronV of Bmglv1 and repressed its transcription. gloverin paralogs that lacked intronV were independent of chorion factor 2 regulation and expressed in embryo. These results suggest that change in cis-regulation because of intron loss resulted in embryonic expression of Bmglv2-4, a gain of function over Bmglv1. Studies on the significance of intron loss have focused on introns present within the coding sequences for their potential effect on the open reading frame, whereas introns present in the UTRs of the genes were not given due attention. This study emphasizes the regulatory function of the 3'-UTR intron. In addition, we also studied the genomic loss and show that "in-frame" deletion of 12 nucleotides led to loss of amino acids IHDF resulting in the generation of a prepro-processing site in BmGlv2. As a result, the N-terminal pro-part of BmGlv2, but not of BmGlv1, gets processed in an infection-dependent manner suggesting that prepro-processing is an evolved feature in Gloverins.	[Mrinal, Nirotpal; Nagaraju, Javaregowda] Ctr DNA Fingerprinting & Diagnost, Ctr Excellence Genet & Genom Silkmoths, Mol Genet Lab, Hyderabad 500076, Andhra Pradesh, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD)	Nagaraju, J (corresponding author), Ctr DNA Fingerprinting & Diagnost, Ctr Excellence Genet & Genom Silkmoths, Mol Genet Lab, ECIL Rd, Hyderabad 500076, Andhra Pradesh, India.	jnagaraju@cdfd.org.in						Axen A, 1997, EUR J BIOCHEM, V247, P614, DOI 10.1111/j.1432-1033.1997.00614.x; BERNSTEIN LB, 1983, CELL, V32, P461, DOI 10.1016/0092-8674(83)90466-X; Bettencourt R, 2002, INSECT MOL BIOL, V11, P267, DOI 10.1046/j.1365-2583.2002.00334.x; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; BOMAN HG, 1981, TRENDS BIOCHEM SCI, V6, P306, DOI 10.1146/annurev.mi.41.100187.000535; Bourdon V, 2001, EMBO REP, V2, P394, DOI 10.1093/embo-reports/kve090; Carmel L, 2007, GENOME RES, V17, P1045, DOI 10.1101/gr.5978207; Carmel L, 2007, GENOME RES, V17, P1034, DOI 10.1101/gr.6438607; Derr LK, 1998, GENETICS, V148, P937; Dushay MS, 1996, P NATL ACAD SCI USA, V93, P10343, DOI 10.1073/pnas.93.19.10343; FINK GR, 1987, CELL, V49, P5, DOI 10.1016/0092-8674(87)90746-X; Gebauer F, 1999, EMBO J, V18, P6146, DOI 10.1093/emboj/18.21.6146; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; Gogos JA, 1996, P NATL ACAD SCI USA, V93, P2159, DOI 10.1073/pnas.93.5.2159; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Hsu T, 1996, GENE DEV, V10, P1411, DOI 10.1101/gad.10.11.1411; HSU T, 1992, SCIENCE, V257, P1946, DOI 10.1126/science.1411512; IP YT, 1993, CELL, V75, P753, DOI 10.1016/0092-8674(93)90495-C; Jeffares DC, 2006, TRENDS GENET, V22, P16, DOI 10.1016/j.tig.2005.10.006; Kanginakudru S, 2007, INSECT MOL BIOL, V16, P635, DOI 10.1111/j.1365-2583.2007.00753.x; Lanoix J, 1999, EMBO J, V18, P4935, DOI 10.1093/emboj/18.18.4935; Larizza A, 2002, COMPUT CHEM, V26, P479, DOI 10.1016/S0097-8485(02)00009-8; Le Hir H, 2003, TRENDS BIOCHEM SCI, V28, P215, DOI 10.1016/S0968-0004(03)00052-5; Lee KY, 2002, INSECT BIOCHEM MOLEC, V32, P1457, DOI 10.1016/S0965-1748(02)00066-8; Lemaitre B, 2004, NAT REV IMMUNOL, V4, P521, DOI 10.1038/nri1390; Leulier F, 2000, EMBO REP, V1, P353, DOI 10.1093/embo-reports/kvd073; Leulier F, 2002, CURR BIOL, V12, P996, DOI 10.1016/S0960-9822(02)00873-4; LEWIN R, 1983, SCIENCE, V219, P1052, DOI 10.1126/science.6186029; Llopart A, 2002, P NATL ACAD SCI USA, V99, P8121, DOI 10.1073/pnas.122570299; LONG MY, 1993, SCIENCE, V260, P91, DOI 10.1126/science.7682012; Lundstrom A, 2002, INSECT BIOCHEM MOLEC, V32, P795, DOI 10.1016/S0965-1748(01)00162-X; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Mackintosh JA, 1998, DEV COMP IMMUNOL, V22, P387, DOI 10.1016/S0145-305X(98)00025-1; Mantrova EY, 1998, GENE DEV, V12, P1166; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; Mita K, 2003, P NATL ACAD SCI USA, V100, P14121, DOI 10.1073/pnas.2234984100; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; Mourier T, 2003, SCIENCE, V300, P1393, DOI 10.1126/science.1080559; Naitza S, 2002, IMMUNITY, V17, P575, DOI 10.1016/S1074-7613(02)00454-5; Nott A, 2003, RNA, V9, P607, DOI 10.1261/rna.5250403; Pesole G, 2001, GENE, V276, P73, DOI 10.1016/S0378-1119(01)00674-6; Ptashne M, 2001, ESSAYS BIOCHEM, V37, P1; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; Sakurai A, 2002, GENE, V300, P89, DOI 10.1016/S0378-1119(02)01035-1; SAKURAI H, 1995, VITRO TRANSCRIPTION, P233; SHEA MJ, 1990, GENE DEV, V4, P1128, DOI 10.1101/gad.4.7.1128; Silverman N, 2000, GENE DEV, V14, P2461, DOI 10.1101/gad.817800; Stoven S, 2000, EMBO REP, V1, P347, DOI 10.1093/embo-reports/kvd072; SUN SC, 1990, SCIENCE, V250, P1729, DOI 10.1126/science.2270488; SUZUKI Y, 1986, P NATL ACAD SCI USA, V83, P9522, DOI 10.1073/pnas.83.24.9522; Tingvall TO, 2001, P NATL ACAD SCI USA, V98, P3884, DOI 10.1073/pnas.061230198; Vidal S, 2001, GENE DEV, V15, P1900, DOI 10.1101/gad.203301; WEINER AM, 1986, ANNU REV BIOCHEM, V55, P631, DOI 10.1146/annurev.bi.55.070186.003215; Wilkie GS, 2003, TRENDS BIOCHEM SCI, V28, P182, DOI 10.1016/S0968-0004(03)00051-3; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210	57	30	33	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 22	2008	283	34					23376	23387		10.1074/jbc.M801080200	http://dx.doi.org/10.1074/jbc.M801080200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	337SI	18524767	hybrid			2022-12-25	WOS:000258455400048
J	Piens, K; Faure, R; Sundqvist, G; Baumann, MJ; Saura-Valls, M; Teeri, TT; Cottaz, S; Planas, A; Driguez, H; Brumer, H				Piens, Kathleen; Faure, Regis; Sundqvist, Gustav; Baumann, Martin J.; Saura-Valls, Marc; Teeri, Tuula T.; Cottaz, Sylvain; Planas, Antoni; Driguez, Hugues; Brumer, Harry			Mechanism-based labeling defines the free energy change for formation of the covalent glycosyl-enzyme intermediate in a xyloglucan endo-transglycosylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL WALL COMPOSITION; ACTIVE-SITE; CRYSTAL-STRUCTURES; BACILLUS-SUBTILIS; ENDOTRANSGLYCOSYLASE; EVOLUTION; IDENTIFICATION; OLIGOSACCHARIDES; LEVANSUCRASE; NUCLEOPHILE	Xyloglucan endo-transglycosylases (XETs) are key enzymes involved in the restructuring of plant cell walls during morphogenesis. As members of glycoside hydrolase family 16 (GH16), XETs are predicted to employ the canonical retaining mechanism of glycosyl transfer involving a covalent glycosyl-enzyme intermediate. Here, we report the accumulation and direct observation of such intermediates of PttXET16-34 from hybrid aspen by electrospray mass spectrometry in combination with synthetic "blocked" substrates, which function as glycosyl donors but are incapable of acting as glycosyl acceptors. Thus, GalGXXXGGG and GalGXXXGXXXG react with the wild-type enzyme to yield relatively stable, kinetically competent, covalent GalG-enzyme and GalGXXXG-enzyme complexes, respectively (Gal = Gal beta(1 -> 4), G = Glc beta(1 -> 4), and X = Xyl alpha(1 -> 6) Glc beta(1 -> 4)). Quantitation of ratios of protein and saccharide species at pseudo-equilibrium allowed us to estimate the free energy change (Delta G(0)) for the formation of the covalent GalGXXXG-enzyme as 6.3-8.5 kJ/mol (1.5-2.0 kcal/mol). The data indicate that the free energy of the beta(1 -> 4) glucosidic bond in xyloglucans is preserved in the glycosyl-enzyme intermediate and harnessed for religation of the polysaccharide in vivo.	[Piens, Kathleen; Sundqvist, Gustav; Baumann, Martin J.; Teeri, Tuula T.; Brumer, Harry] AlbaNova Univ Ctr, Royal Inst Technol, Sch Biotechnol, SE-10691 Stockholm, Sweden; [Faure, Regis; Cottaz, Sylvain; Driguez, Hugues] CNRS, Ctr Rech Macromol Vegetales, F-38041 Grenoble 9, France; [Saura-Valls, Marc; Planas, Antoni] Univ Ramon Llull, Inst Quim Sarria, Biochem Lab, Barcelona 08017, Spain	Royal Institute of Technology; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universitat Ramon Llull; Institut Quimic de Sarria	Brumer, H (corresponding author), AlbaNova Univ Ctr, Royal Inst Technol, Sch Biotechnol, SE-10691 Stockholm, Sweden.	harry@biotech.kth.se	PLANAS, ANTONI/I-4803-2015; Fauré, Régis/ABB-4847-2021; Teeri, Tuula T/E-7509-2013	PLANAS, ANTONI/0000-0001-7073-3320; Fauré, Régis/0000-0002-5107-9009; cottaz, sylvain/0000-0001-8674-0162				Baran R, 2000, GEN PHYSIOL BIOPHYS, V19, P427; Baumann MJ, 2007, PLANT CELL, V19, P1947, DOI 10.1105/tpc.107.051391; Bourquin V, 2002, PLANT CELL, V14, P3073, DOI 10.1105/tpc.007773; Braun C, 1996, BIOCHEMISTRY-US, V35, P5458, DOI 10.1021/bi9526488; CHAMBERT R, 1976, EUR J BIOCHEM, V71, P493, DOI 10.1111/j.1432-1033.1976.tb11138.x; CHAMBERT R, 1976, EUR J BIOCHEM, V62, P55, DOI 10.1111/j.1432-1033.1976.tb10097.x; Faure R, 2006, J ORG CHEM, V71, P5151, DOI 10.1021/jo0525682; Gloster TM, 2007, J BIOL CHEM, V282, P19177, DOI 10.1074/jbc.M700224200; Henriksson H, 2003, BIOCHEM J, V375, P61, DOI 10.1042/BJ20030485; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Hoffman M, 2005, CARBOHYD RES, V340, P1826, DOI 10.1016/j.carres.2005.04.016; Jensen MH, 2004, BIOCHEMISTRY-US, V43, P3104, DOI 10.1021/bi0357762; Johansson P, 2004, PLANT CELL, V16, P874, DOI 10.1105/tpc.020065; Kallas AM, 2005, BIOCHEM J, V390, P105, DOI 10.1042/BJ20041749; Kirby AJ, 2001, NAT STRUCT BIOL, V8, P737, DOI 10.1038/nsb0901-737; Krishnan S, 1995, BIOCHEM J, V312, P971, DOI 10.1042/bj3120971; Martinez-Fleites C, 2006, J BIOL CHEM, V281, P24922, DOI 10.1074/jbc.M603583200; Michel G, 2001, STRUCTURE, V9, P513, DOI 10.1016/S0969-2126(01)00612-8; Mosi R, 1997, BIOCHEMISTRY-US, V36, P9927, DOI 10.1021/bi970618u; Mosi RM, 2002, METHOD ENZYMOL, V354, P64; Najmudin S, 2006, J BIOL CHEM, V281, P8815, DOI 10.1074/jbc.M510559200; Nishikubo N, 2007, PLANT CELL PHYSIOL, V48, P843, DOI 10.1093/pcp/pcm055; Notenboom V, 1998, NAT STRUCT BIOL, V5, P812, DOI 10.1038/1852; Nothnagel AL, 2007, J INTEGR PLANT BIOL, V49, P1271, DOI 10.1111/j.1672-9072.2007.00519.x; Piens K, 2007, ORG BIOMOL CHEM, V5, P3971, DOI 10.1039/b714570e; Popper ZA, 2004, NEW PHYTOL, V164, P165, DOI 10.1111/j.1469-8137.2004.01146.x; Popper ZA, 2003, ANN BOT-LONDON, V91, P1, DOI 10.1093/aob/mcg013; Rose JKC, 2002, PLANT CELL PHYSIOL, V43, P1421, DOI 10.1093/pcp/pcf171; Saura-Valls M, 2006, BIOCHEM J, V395, P99, DOI 10.1042/BJ20051396; Saura-Valls M, 2008, J BIOL CHEM, V283, P21853, DOI 10.1074/jbc.M803058200; SILVERSTEIN R, 1967, J BIOL CHEM, V242, P1338; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; Sulova Z, 1998, BIOCHEM J, V330, P1475, DOI 10.1042/bj3301475; Sundqvist G, 2007, J CHROMATOGR B, V852, P188, DOI 10.1016/j.jchromb.2007.01.011; Vocadlo DJ, 2001, NATURE, V412, P835, DOI 10.1038/35090602; Wicki J, 2002, METHOD ENZYMOL, V354, P84; Williams SJ, 2000, CARBOHYD RES, V327, P27, DOI 10.1016/S0008-6215(00)00041-0; WITHERS SG, 1995, PROTEIN SCI, V4, P361; Yoon SH, 2007, CARBOHYD RES, V342, P55, DOI 10.1016/j.carres.2006.10.028; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+	40	17	17	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					21864	21872		10.1074/jbc.M803057200	http://dx.doi.org/10.1074/jbc.M803057200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18508770	hybrid			2022-12-25	WOS:000258114700005
J	Ugolev, Y; Berdichevsky, Y; Weinbaum, C; Pick, E				Ugolev, Yelena; Berdichevsky, Yevgeny; Weinbaum, Carolyn; Pick, Edgar			Dissociation of Rac1(GDP)center dot RhoGDI complexes by the cooperative action of anionic liposomes containing phosphatidylinositol 3,4,5-trisphosphate, rac guanine nucleotide exchange factor, and GTP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADPH-OXIDASE ACTIVATION; CELL-FREE SYSTEM; DEPENDENT SUPEROXIDE PRODUCTION; PLECKSTRIN HOMOLOGY DOMAINS; RESPIRATORY BURST OXIDASE; SODIUM DODECYL-SULFATE; BETA-GAMMA-SUBUNITS; MEMBRANE TRANSLOCATION; RHO-GTPASES; PHOSPHOINOSITIDE 3-KINASE	Rac plays a pivotal role in the assembly of the superoxide-generating NADPH oxidase of phagocytes. In resting cells, Rac is found in the cytosol in complex with Rho GDP dissociation inhibitor (RhoGDI). NADPH oxidase assembly involves dissociation of the Rac center dot RhoGDI complex and translocation of Rac to the membrane. We reported that liposomes containing high concentrations of monovalent anionic phospholipids cause Rac center dot RhoGDI complex dissociation (Ugolev, Y., MolshanskiMor, S., Weinbaum, C., and Pick, E. (2006) J. Biol. Chem. 281, 19204 - 19219). We now designed an in vitro model mimicking membrane phospholipid remodeling during phagocyte stimulation in vivo. We showed that liposomes of "resting cell membrane" composition (less than 20 mol % monovalent anionic phospholipids), supplemented with 1 mol % of polyvalent anionic phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P-3) in conjunction with constitutively active forms of the guanine nucleotide exchange factors (GEFs) for Rac, Trio, or Tiam1 and a non-hydrolyzable GTP analogue, cause dissociation of Rac1(GDP)center dot RhoGDI complexes, GDP to GTP exchange on Rac1, and binding of Rac1(GTP) to the liposomes. Complexes were not dissociated in the absence of GEF and GTP, and optimal dissociation required the presence of PtdIns(3,4,5) P-3 in the liposomes. Dissociation of Rac1(GDP)center dot RhoGDI complexes was correlated with the affinity of particular GEF constructs, via the N-terminal pleckstrin homology domain, for PtdIns(3,4,5) P-3 and involved GEF-mediated GDP to GTP exchange on Rac1. Phagocyte membranes enriched in PtdIns(3,4,5) P-3 responded by NADPH oxidase activation upon exposure in vitro to Rac1(GDP)center dot RhoGDI complexes, p67(phox), GTP, and Rac GEF constructs with affinity for PtdIns( 3,4,5) P3 at a level superior to that of native membranes.	[Pick, Edgar] Tel Aviv Univ, Sackler Sch Med, Dept Human Microbiol, Julius Friedrich Cohnheim Minerva Ctr Phagocyte R, IL-69978 Tel Aviv, Israel; [Ugolev, Yelena; Berdichevsky, Yevgeny; Pick, Edgar] Tel Aviv Univ, Sackler Sch Med, Ela Kodesz Inst Host Def Infect Dis, IL-69978 Tel Aviv, Israel; [Weinbaum, Carolyn] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Duke University	Pick, E (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Human Microbiol, Julius Friedrich Cohnheim Minerva Ctr Phagocyte R, IL-69978 Tel Aviv, Israel.	epick@post.tau.ac.il	Pick, Edgar/B-1795-2008	Pick, Edgar/0000-0003-4625-3233; Berdichevsky, Yevgeny/0000-0002-5038-6816	NIGMS NIH HHS [GM46372] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046372] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABO A, 1991, J BIOL CHEM, V266, P23577; ABO A, 1994, BIOCHEM J, V298, P585, DOI 10.1042/bj2980585; Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; Barber MA, 2007, J BIOL CHEM, V282, P29967, DOI 10.1074/jbc.M701877200; Baumeister MA, 2006, BIOCHEM J, V400, P563, DOI 10.1042/BJ20061020; Bellanger JM, 2003, BIOL CELL, V95, P625, DOI 10.1016/j.biolcel.2003.10.002; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bokoch GM, 2006, ANTIOXID REDOX SIGN, V8, P1533, DOI 10.1089/ars.2006.8.1533; Bokoch GM, 2005, TRENDS CELL BIOL, V15, P163, DOI 10.1016/j.tcb.2005.01.002; BOKOCH GM, 1994, J BIOL CHEM, V269, P31674; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROMBERG Y, 1984, CELL IMMUNOL, V88, P213, DOI 10.1016/0008-8749(84)90066-2; Ceccarelli DFJ, 2007, J BIOL CHEM, V282, P13864, DOI 10.1074/jbc.M700505200; CHUANG TH, 1993, J BIOL CHEM, V268, P26206; Das B, 2000, J BIOL CHEM, V275, P15074, DOI 10.1074/jbc.M907269199; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Estrach S, 2002, CURR BIOL, V12, P307, DOI 10.1016/S0960-9822(02)00658-9; Faure J, 1999, EUR J BIOCHEM, V262, P879, DOI 10.1046/j.1432-1327.1999.00458.x; Fleming IN, 2000, BIOCHEM J, V351, P173, DOI 10.1042/0264-6021:3510173; Gao Y, 2001, J BIOL CHEM, V276, P47530, DOI 10.1074/jbc.M108865200; Gorzalczany Y, 2002, J BIOL CHEM, V277, P18605, DOI 10.1074/jbc.M202114200; Gorzalczany Y, 2000, J BIOL CHEM, V275, P40073, DOI 10.1074/jbc.M006013200; Groemping Y, 2005, BIOCHEM J, V386, P401, DOI 10.1042/BJ20041835; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hill K, 2005, J BIOL CHEM, V280, P4166, DOI 10.1074/jbc.M411262200; Isakoff SJ, 1998, EMBO J, V17, P5374, DOI 10.1093/emboj/17.18.5374; JOSEPH G, 1994, J BIOL CHEM, V269, P29024; JOUAN A, 1993, ANAL BIOCHEM, V214, P252, DOI 10.1006/abio.1993.1485; Kreck ML, 1996, BIOCHEMISTRY-US, V35, P15683, DOI 10.1021/bi962064l; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; MASON RJ, 1972, J CLIN INVEST, V51, P2399, DOI 10.1172/JCI107052; Michiels F, 1997, J CELL BIOL, V137, P387, DOI 10.1083/jcb.137.2.387; Missy K, 1998, J BIOL CHEM, V273, P30279, DOI 10.1074/jbc.273.46.30279; Mizrahi A, 2005, J BIOL CHEM, V280, P3802, DOI 10.1074/jbc.M410257200; Moissoglu K, 2006, MOL BIOL CELL, V17, P2770, DOI 10.1091/mbc.E06-01-0005; Molshanski-Mor Shahar, 2007, V412, P385, DOI 10.1007/978-1-59745-467-4_25; Muroya K, 2007, BIOCHEM BIOPH RES CO, V355, P85, DOI 10.1016/j.bbrc.2007.01.131; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; Nimnual AS, 1998, SCIENCE, V279, P560, DOI 10.1126/science.279.5350.560; Pechlivanis M, 2007, BIOCHEMISTRY-US, V46, P5341, DOI 10.1021/bi602353k; Perisic O, 2004, ADV ENZYME REGUL, V44, P279, DOI 10.1016/j.advenzreg.2003.11.003; PICK E, 1993, EUR J BIOCHEM, V217, P441, DOI 10.1111/j.1432-1033.1993.tb18264.x; PICK E, 1987, J BIOL CHEM, V262, P16476; Price MO, 2002, J BIOL CHEM, V277, P19220, DOI 10.1074/jbc.M200061200; Quinn MT, 2004, J LEUKOCYTE BIOL, V76, P760, DOI 10.1189/jlb.0404216; Quinn Peter J, 2002, Subcell Biochem, V36, P39; Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059; Robbe K, 2003, J BIOL CHEM, V278, P4756, DOI 10.1074/jbc.M210412200; Rossman KL, 2002, EMBO J, V21, P1315, DOI 10.1093/emboj/21.6.1315; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Russo C, 2001, J BIOL CHEM, V276, P19524, DOI 10.1074/jbc.M009742200; Sarfstein R, 2004, J BIOL CHEM, V279, P16007, DOI 10.1074/jbc.M312394200; SASAKI T, 1993, J BIOL CHEM, V268, P23959; SHPUNGIN S, 1989, J BIOL CHEM, V264, P9195; Sigal N, 2003, INFLAMMATION, V27, P147, DOI 10.1023/A:1023869828688; Snyder JT, 2001, J BIOL CHEM, V276, P45868, DOI 10.1074/jbc.M106731200; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; STEPHENS LR, 1993, BIOCHIM BIOPHYS ACTA, V1179, P27, DOI 10.1016/0167-4889(93)90072-W; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; Ueyama T, 2005, J IMMUNOL, V175, P2381, DOI 10.4049/jimmunol.175.4.2381; Ugolev Y, 2006, J BIOL CHEM, V281, P19204, DOI 10.1074/jbc.M600042200; Welch HCE, 2003, FEBS LETT, V546, P93, DOI 10.1016/S0014-5793(03)00454-X; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Yeung T, 2007, IMMUNOL REV, V219, P17, DOI 10.1111/j.1600-065X.2007.00546.x; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551	67	33	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2008	283	32					22257	22271		10.1074/jbc.M800734200	http://dx.doi.org/10.1074/jbc.M800734200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	332WV	18505730	hybrid, Green Published			2022-12-25	WOS:000258114700045
J	Aqeilan, RI; Hassan, MQ; de Bruin, A; Hagan, JP; Volinia, S; Palumbo, T; Hussain, S; Lee, SH; Gaur, T; Stein, GS; Lian, JB; Croce, CM				Aqeilan, Rami I.; Hassan, Mohammad Q.; de Bruin, Alain; Hagan, John P.; Volinia, Stefano; Palumbo, Titziana; Hussain, Sadiq; Lee, Suk-Hee; Gaur, Tripti; Stein, Gary S.; Lian, Jane B.; Croce, Carlo M.			The WWOX tumor suppressor is essential for postnatal survival and normal bone metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; TRANSCRIPTION FACTOR; BREAST-CANCER; GROWTH; DIFFERENTIATION; PROTEIN; RUNX2; GENE; BINDING; MICE	The WW domain-containing oxidoreductase ( WWOX) gene encodes a tumor suppressor. We have previously shown that targeted ablation of the Wwox gene in mouse increases the incidence of spontaneous and chemically induced tumors. To investigate WWOX function in vivo, we examined Wwox-deficient (Wwox(-/-)) mice for phenotypical abnormalities. Wwox(-/-) mice are significantly reduced in size, die at the age of 2-3 weeks, and suffer a metabolic disorder that affects the skeleton. Wwox(-/-) mice exhibit a delay in bone formation from a cell autonomous defect in differentiation beginning at the mineralization stage shown in calvarial osteoblasts ex vivo and supported by significantly decreased bone formation parameters in Wwox(-/-) mice by microcomputed tomography analyses. Wwox(-/-) mice develop metabolic bone disease, as a consequence of reduced serum calcium, hypoproteinuria, and hypoglycemia leading to increased osteoclast activity and bone resorption. Interestingly, we find WWOX physically associates with RUNX2, the principal transcriptional regulator of osteoblast differentiation, and on osteocalcin chromatin. We show WWOX functionally suppresses RUNX2 transactivation ability in osteoblasts. In breast cancer MDA-MB-242 cells that lack endogenous WWOX protein, restoration of WWOX expression inhibited Runx2 and RUNX2 target genes related to metastasis. Affymetrix mRNA profiling revealed common gene targets in multiple tissues. In Wwox(-/-) mice, genes related to nucleosome assembly and cell growth genes were down-regulated, and negative regulators of skeletal metabolism exhibited increased expression. Our results demonstrate an essential requirement for the WWOX tumor suppressor in postnatal survival, growth, and metabolism and suggest a central role for WWOX in regulation of bone tissue formation.	[Aqeilan, Rami I.; de Bruin, Alain; Hagan, John P.; Volinia, Stefano; Palumbo, Titziana; Croce, Carlo M.] Ohio State Univ, Human Canc Genet Program, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Aqeilan, Rami I.; de Bruin, Alain; Hagan, John P.; Volinia, Stefano; Palumbo, Titziana; Croce, Carlo M.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Hassan, Mohammad Q.; Hussain, Sadiq; Lee, Suk-Hee; Gaur, Tripti; Stein, Gary S.; Lian, Jane B.] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA; [Hassan, Mohammad Q.; Hussain, Sadiq; Lee, Suk-Hee; Gaur, Tripti; Stein, Gary S.; Lian, Jane B.] Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA 01655 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Aqeilan, RI (corresponding author), Ohio State Univ, Human Canc Genet Program, Dept Mol Virol Immunol & Med Genet, Biomed Res Tower,Rm 1088,460 W 12th Ave, Columbus, OH 43210 USA.	rami.aqeilan@osumc.edu; jane.lian@umassmed.edu	Young, Richard A/F-6495-2012; Volinia, Stefano/AAA-9264-2019; Aqeilan, Rami/AAT-7785-2020; Aqeilan, Rami/R-4443-2016; Volinia, Stefano/A-3029-2010; de Bruin, Alain/AAL-9195-2020; Hassan, Mohammad/GZA-7507-2022	Young, Richard A/0000-0001-8855-8647; Volinia, Stefano/0000-0003-0910-3893; Aqeilan, Rami/0000-0002-6034-023X; Volinia, Stefano/0000-0003-0910-3893; Hassan, Mohammad/0000-0002-1712-0004; Hagan, John/0000-0003-0295-4898; de Bruin, Alain/0000-0001-8579-2649	NATIONAL CANCER INSTITUTE [P01CA082834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR048818] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA 082834] Funding Source: Medline; NIAMS NIH HHS [P01 AR048818, P01 AR 048818] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Aqeilan RI, 2007, J CELL PHYSIOL, V212, P307, DOI 10.1002/jcp.21099; Aqeilan RI, 2007, CANCER RES, V67, P5606, DOI 10.1158/0008-5472.CAN-07-1081; Aqeilan RI, 2007, P NATL ACAD SCI USA, V104, P3949, DOI 10.1073/pnas.0609783104; Aqeilan RI, 2005, CANCER RES, V65, P6764, DOI 10.1158/0008-5472.CAN-05-1150; Aqeilan RI, 2004, P NATL ACAD SCI USA, V101, P4401, DOI 10.1073/pnas.0400805101; Aqeilan RI, 2004, CANCER RES, V64, P8256, DOI 10.1158/0008-5472.CAN-04-2055; Bassett JHD, 2003, TRENDS ENDOCRIN MET, V14, P356, DOI 10.1016/S1043-2760(03)00144-90; Bednarek AK, 2000, CANCER RES, V60, P2140; Bednarek AK, 2001, CANCER RES, V61, P8068; Blyth K, 2005, NAT REV CANCER, V5, P376, DOI 10.1038/nrc1607; CENTRELLA M, 1992, J CLIN INVEST, V89, P1076, DOI 10.1172/JCI115687; Chang NS, 2007, TRENDS MOL MED, V13, P12, DOI 10.1016/j.molmed.2006.11.006; Cui CB, 2003, MOL CELL BIOL, V23, P1004, DOI 10.1128/MCB.23.3.1004-1013.2003; Dabovic B, 2005, BONE, V37, P25, DOI 10.1016/j.bone.2005.02.021; Dabovic B, 2002, J ENDOCRINOL, V175, P129, DOI 10.1677/joe.0.1750129; Fabbri M, 2005, P NATL ACAD SCI USA, V102, P15611, DOI 10.1073/pnas.0505485102; Galindo M, 2005, J BIOL CHEM, V280, P20274, DOI 10.1074/jbc.M413665200; Gaudio E, 2006, CANCER RES, V66, P11585, DOI 10.1158/0008-5472.CAN-06-3376; Hassan MQ, 2006, J BIOL CHEM, V281, P40515, DOI 10.1074/jbc.M604508200; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Javed A, 1999, MOL CELL BIOL, V19, P7491; Javed A, 2005, P NATL ACAD SCI USA, V102, P1454, DOI 10.1073/pnas.0409121102; Jin CJ, 2006, BIOCHEM BIOPH RES CO, V341, P784, DOI 10.1016/j.bbrc.2006.01.023; Jones DC, 2006, SCIENCE, V312, P1223, DOI 10.1126/science.1126313; Kim IS, 1999, MECH DEVELOP, V80, P159, DOI 10.1016/S0925-4773(98)00210-X; Leger J, 2007, EUR J ENDOCRINOL, V157, P685, DOI 10.1530/EJE-07-0402; Lian JB, 2004, CRIT REV EUKAR GENE, V14, P1; Ludes-Meyers JH, 2004, ONCOGENE, V23, P5049, DOI 10.1038/sj.onc.1207680; Ludes-Meyers JH, 2007, GENE CHROMOSOME CANC, V46, P1129, DOI 10.1002/gcc.20497; McCabe LR, 1996, ENDOCRINOLOGY, V137, P4398, DOI 10.1210/en.137.10.4398; Ohbayashi N, 2002, GENE DEV, V16, P870, DOI 10.1101/gad.965702; Paige AJW, 2001, P NATL ACAD SCI USA, V98, P11417, DOI 10.1073/pnas.191175898; Pratap J, 2006, CANCER METAST REV, V25, P589, DOI 10.1007/s10555-006-9032-0; Pratap J, 2003, CANCER RES, V63, P5357; Ried K, 2000, HUM MOL GENET, V9, P1651, DOI 10.1093/hmg/9.11.1651; Silha JV, 2003, J BONE MINER RES, V18, P1834, DOI 10.1359/jbmr.2003.18.10.1834; Sulzbacher I, 2003, MODERN PATHOL, V16, P66, DOI 10.1097/01.MP.0000043522.76788.0A; Sun L, 2006, ANN NY ACAD SCI, V1068, P309, DOI 10.1196/annals.1346.033; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Zaidi SK, 2004, EMBO J, V23, P790, DOI 10.1038/sj.emboj.7600073; Zhao M, 2003, J BIOL CHEM, V278, P27939, DOI 10.1074/jbc.M304132200	41	103	105	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 1	2008	283	31					21629	21639		10.1074/jbc.M800855200	http://dx.doi.org/10.1074/jbc.M800855200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	329VN	18487609	Green Published, hybrid			2022-12-25	WOS:000257898800036
J	Kaminski, PA; Dacher, P; Dugue, L; Pochet, S				Kaminski, Pierre Alexandre; Dacher, Priscilla; Dugue, Laurence; Pochet, Sylvie			In vivo reshaping the catalytic site of nucleoside 2 '-deoxyribosyltransferase for dideoxy- and didehydronucleosides via a single amino acid substitution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-N-DEOXYRIBOSYLASE; SUBSTRATE-ASSISTED CATALYSIS; ANTI-HIV ACTIVITY; ENZYMATIC-SYNTHESIS; LACTOBACILLUS-HELVETICUS; ESCHERICHIA-COLI; ACTIVE-SITE; ANTIVIRAL ACTIVITY; 2-DEOXYRIBOSYLTRANSFERASE; PURIFICATION	Nucleoside 2'-deoxyribosyltransferases catalyze the transfer of 2-deoxyribose between bases and have been widely used as biocatalysts to synthesize a variety of nucleoside analogs. The genes encoding nucleoside 2'-deoxyribosyltransferase (ndt) from Lactobacillus leichmannii and Lactobacillus fermentum underwent random mutagenesis to select variants specialized for the synthesis of 2', 3'-dideoxynucleosides. An Escherichia coli strain, auxotrophic for uracil and unable to use 2', 3'-dideoxyuridine, cytosine, and 2', 3'-dideoxycytidine as a source of uracil was constructed. Randomly mutated lactobacilli ndt libraries from two species, L. leichmannii and L. fermentum, were screened for the production of uracil with 2', 3'-dideoxyuridine as a source of uracil. Several mutants suitable for the synthesis of 2', 3'-dideoxynucleosides were isolated. The nucleotide sequence of the corresponding genes revealed a single mutation (G -> A transition) leading to the substitution of a small aliphatic amino acid by a nucleophilic one, A15T (L. fermentum) or G9S (L. leichmannii), respectively. We concluded that the " adaptation" of the nucleoside 2'-deoxyribosyltransferase activity to 2,3-dideoxyribosyl transfer requires an additional hydroxyl group on a key amino acid side chain of the protein to overcome the absence of such a group in the corresponding substrate. The evolved proteins also display significantly improved nucleoside 2', 3'-didehydro-2', 3'-dideoxyribosyltransferase activity.	[Kaminski, Pierre Alexandre; Dacher, Priscilla; Dugue, Laurence; Pochet, Sylvie] Inst Pasteur, Unite Chim Organ, CNRS, URA2128, F-75724 Paris 15, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Kaminski, PA (corresponding author), Inst Pasteur, Unite Chim Organ, CNRS, URA2128, 28 Rue Dr Roux, F-75724 Paris 15, France.	akaminsk@pasteur.fr		Kaminski, Pierre Alexandre/0000-0001-9841-6837				ABDELMEGIED AES, 1991, ACTA CHEM SCAND, V45, P1060, DOI 10.3891/acta.chem.scand.45-1060; Anand R, 2004, BIOCHEMISTRY-US, V43, P2384, DOI 10.1021/bi035723k; Armstrong SR, 1996, STRUCTURE, V4, P97, DOI 10.1016/S0969-2126(96)00013-5; Astatke M, 1998, J MOL BIOL, V278, P147, DOI 10.1006/jmbi.1998.1672; BARTOLOME B, 1991, GENE, V102, P75, DOI 10.1016/0378-1119(91)90541-I; BEAUSSIRE JJ, 1995, NUCLEOS NUCLEOT, V14, P805, DOI 10.1080/15257779508012476; BECK W, 1963, J BIOL CHEM, V238, P702; Becker J, 1996, BIOL CHEM H-S, V377, P357, DOI 10.1515/bchm3.1996.377.6.357; BETBEDER D, 1991, NUCLEOS NUCLEOT, V10, P465, DOI 10.1080/07328319108046499; BETBEDER D, 1989, NUCLEIC ACIDS RES, V17, P4217, DOI 10.1093/nar/17.11.4217; BETBEDER D, 1990, NUCLEOS NUCLEOT, V9, P569, DOI 10.1080/07328319008045188; Bosch J, 2006, J MED CHEM, V49, P5939, DOI 10.1021/jm060429m; CARSON DA, 1988, BIOCHEM BIOPH RES CO, V155, P829, DOI 10.1016/S0006-291X(88)80570-9; CARTER P, 1987, SCIENCE, V237, P394, DOI 10.1126/science.3299704; Catherinot V, 2004, BIOINFORMATICS, V20, P3694, DOI 10.1093/bioinformatics/bth429; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; CHAWDHRI RF, 1991, ARCH MICROBIOL, V155, P409, DOI 10.1007/BF00243463; CHU CK, 1989, J ORG CHEM, V54, P2217, DOI 10.1021/jo00270a036; DANZIN C, 1976, EUR J BIOCHEM, V62, P365, DOI 10.1111/j.1432-1033.1976.tb10168.x; DANZIN C, 1974, EUR J BIOCHEM, V48, P255, DOI 10.1111/j.1432-1033.1974.tb03763.x; FREEMAN GA, 1995, BIOORGAN MED CHEM, V3, P447, DOI 10.1016/0968-0896(95)00030-K; Gallois-Montbrun S, 2002, J BIOL CHEM, V277, P39953, DOI 10.1074/jbc.M206360200; Hammer-Jespersen K., 1983, METABOLISM NUCLEOTID, P203; HICKS N, 1992, ANTIVIR CHEM CHEMOTH, V3, P153, DOI 10.1177/095632029200300304; HOLGUIN J, 1975, EUR J BIOCHEM, V54, P505, DOI 10.1111/j.1432-1033.1975.tb04163.x; HOLGUINH.J, 1972, FEBS LETT, V20, P171, DOI 10.1016/0014-5793(72)80785-3; HUANG MC, 1983, ARCH BIOCHEM BIOPHYS, V222, P133, DOI 10.1016/0003-9861(83)90510-6; HUARD CN, 1992, BIOCATALYSIS, V6, P201; Kaminski PA, 2002, J BIOL CHEM, V277, P14400, DOI 10.1074/jbc.M111995200; KATI WM, 1989, SCIENCE, V243, P1591, DOI 10.1126/science.2928795; LinGoerke JL, 1997, BIOTECHNIQUES, V23, P409, DOI 10.2144/97233bm12; Muller M, 1996, CHEM RES TOXICOL, V9, P1140, DOI 10.1021/tx9600661; Okuyama K, 2003, BIOSCI BIOTECH BIOCH, V67, P989, DOI 10.1271/bbb.67.989; POCHET S, 1995, BIOORG MED CHEM LETT, V5, P1679, DOI 10.1016/0960-894X(95)00280-7; Pochet S., 2007, Enzymatic synthesis of deoxyribonucleosides, Patent No. [7229797B1, 7229797]; Poncet-Montange G, 2007, J BIOL CHEM, V282, P33925, DOI 10.1074/jbc.M701394200; PORTER DJT, 1995, J BIOL CHEM, V270, P15551, DOI 10.1074/jbc.270.26.15551; RICHAUD C, 1993, J BIOL CHEM, V268, P26827; Sala M, 1996, NUCLEIC ACIDS RES, V24, P3302, DOI 10.1093/nar/24.17.3302; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHNETZBOUTAUD NC, 2001, CURRENT PROTOCOLS NU; Sheng J, 2008, J ORG CHEM, V73, P3725, DOI 10.1021/jo7025806; Short SA, 1996, J BIOL CHEM, V271, P4978; Slater MJ, 1996, BIOORG MED CHEM LETT, V6, P2787, DOI 10.1016/S0960-894X(96)00514-8; STEENKAMP DJ, 1992, BIOCHEM J, V287, P125, DOI 10.1042/bj2870125; UERKVITZ W, 1971, EUR J BIOCHEM, V23, P387, DOI 10.1111/j.1432-1033.1971.tb01632.x; VanDraanen NA, 1996, J MED CHEM, V39, P538, DOI 10.1021/jm950701k; Vorbruggen H., 2001, HDB NUCLEOSIDE SYNTH; Wang JH, 1998, ANTIMICROB AGENTS CH, V42, P2620, DOI 10.1128/AAC.42.10.2620	50	28	30	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2008	283	29					20053	20059		10.1074/jbc.M802706200	http://dx.doi.org/10.1074/jbc.M802706200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	325CH	18487606	hybrid			2022-12-25	WOS:000257565300021
J	Jin, J; Ang, XL; Ye, X; Livingstone, M; Harper, JW				Jin, Jianping; Ang, Xiaolu L.; Ye, Xin; Livingstone, Mark; Harper, J. Wade			Differential roles for checkpoint kinases in DNA damage-dependent degradation of the Cdc25A protein phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-LIGASE COMPLEX; S-PHASE CHECKPOINT; F-BOX PROTEINS; BETA-TRCP; MAMMARY TUMORIGENESIS; 14-3-3 BINDING; CELL-CYCLE; IN-VITRO; CHK1; PHOSPHORYLATION	In response to DNA damage, cells activate a signaling pathway that promotes cell cycle arrest and degradation of the cell cycle regulator Cdc25A. Cdc25A degradation occurs via the SCF beta-TRCP pathway and phosphorylation of Ser-76. Previous work indicates that the checkpoint kinase Checkpoint kinase 1 (Chk1) is capable of phosphorylating Ser-76 in Cdc25A, thereby promoting its degradation. In contrast, other experiments involving overexpression of dominant Chk2 mutant proteins point to a role for Chk2 in Cdc25A degradation. However, loss-of-function studies that implicate Chk2 in Cdc25A turnover are lacking, and there is no evidence that Chk2 is capable of phosphorylating Ser-76 in Cdc25A despite the finding that Chk1 and Chk2 sometimes share overlapping primary specificity. We find that although Chk2 can phosphorylate many of the same sites in Cdc25A that Chk1 phosphorylates, albeit with reduced efficiency, Chk2 is unable to efficiently phosphorylate Ser-76. Consistent with this, Chk2, unlike Chk1, is unable to support SCF beta-TRCP mediated ubiquitination of Cdc25A in vitro. In CHK2(-/-) HCT116 cells, the kinetics of Cdc25A degradation in response to ionizing radiation is comparable with that seen in HCT116 cells containing Chk2, indicating that Chk2 is not generally required for timely DNA damage-dependent Cdc25A turnover. In contrast, depletion of Chk1 by RNA interference in CHK2(-/-) cells leads to Cdc25A stabilization in response to ionizing radiation. These data support the idea that Chk1 is the primary signal transducer linking activation of the ATM/ATR kinases to Cdc25A destruction in response to ionizing radiation.	[Jin, Jianping; Ang, Xiaolu L.; Ye, Xin; Harper, J. Wade] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Livingstone, Mark] Cell Signaling Technol, Danvers, MA USA	Harvard University; Harvard Medical School	Harper, JW (corresponding author), 77 Ave Louis Pasteur,NRB Rm 940, Boston, MA 02115 USA.	wade_harper@hms.harvard.edu	Cambronne, Xiaolu Ang/GRY-7149-2022; Jin, Jianping/K-5002-2018; Livingstone, Mark/H-1709-2011	Cambronne, Xiaolu Ang/0000-0002-3547-448X; Jin, Jianping/0000-0003-4175-9104; Harper, Jeffrey/0000-0002-6944-7236; Livingstone, Mark/0000-0002-2757-7008	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS054507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER; NIA NIH HHS [AG011085] Funding Source: Medline; NIGMS NIH HHS [GM054137, R01 GM054137] Funding Source: Medline; NINDS NIH HHS [F31 NS054507-01, F31 NS054507] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Chen MS, 2003, MOL CELL BIOL, V23, P7488, DOI 10.1128/MCB.23.21.7488-7497.2003; Donzelli M, 2003, EMBO REP, V4, P671, DOI 10.1038/sj.embor.embor887; Donzelli M, 2004, CELL CYCLE, V3, P469; ELDEIRY WS, 1994, CANCER RES, V54, P1169; Falck J, 2002, NAT GENET, V30, P290, DOI 10.1038/ng845; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Ferguson AM, 2005, MOL CELL BIOL, V25, P2853, DOI 10.1128/MCB.25.7.2853-2860.2005; Furnari B, 1999, MOL BIOL CELL, V10, P833, DOI 10.1091/mbc.10.4.833; Furnari B, 1997, SCIENCE, V277, P1495, DOI 10.1126/science.277.5331.1495; Goloudina A, 2003, CELL CYCLE, V2, P473, DOI 10.4161/cc.2.5.482; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; HARPER JW, 1993, CELL, V75, P805; Hassepass I, 2003, J BIOL CHEM, V278, P29824, DOI 10.1074/jbc.M302704200; Jallepalli PV, 2003, J BIOL CHEM, V278, P20475, DOI 10.1074/jbc.M213159200; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kang T, 2008, CANCER CELL, V13, P36, DOI 10.1016/j.ccr.2007.12.002; Kumagai A, 1998, MOL BIOL CELL, V9, P345, DOI 10.1091/mbc.9.2.345; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; O'Neill T, 2002, J BIOL CHEM, V277, P16102, DOI 10.1074/jbc.M111705200; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Ray D, 2007, CANCER RES, V67, P6605, DOI 10.1158/0008-5472.CAN-06-4815; Ray D, 2007, CANCER RES, V67, P984, DOI 10.1158/0008-5472.CAN-06-3927; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Weng QP, 1998, J BIOL CHEM, V273, P16621, DOI 10.1074/jbc.273.26.16621; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Xiao Z, 2003, J BIOL CHEM, V278, P21767, DOI 10.1074/jbc.M300229200; Zeng Y, 1998, NATURE, V395, P507, DOI 10.1038/26766; Zeng Y, 1999, MOL CELL BIOL, V19, P7410; Zhao H, 2002, P NATL ACAD SCI USA, V99, P14795, DOI 10.1073/pnas.182557299; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	38	39	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2008	283	28					19322	19328		10.1074/jbc.M802474200	http://dx.doi.org/10.1074/jbc.M802474200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	322PK	18480045	hybrid, Green Published			2022-12-25	WOS:000257387600018
J	Baverstock, K; Ronkko, M				Baverstock, Keith; Ronkko, Mauno			Epigenetic Regulation of the Mammalian Cell	PLOS ONE			English	Article							INDUCED GENOMIC INSTABILITY; IONIZING-RADIATION; GENE-EXPRESSION; CHROMATIN; NETWORK; ORGANIZATION; EXPOSURE; DOMAINS; ISSUES; YEAST	Background: Understanding how mammalian cells are regulated epigenetically to express phenotype is a priority. The cellular phenotypic transition, induced by ionising radiation, from a normal cell to the genomic instability phenotype, where the ability to replicate the genotype accurately is compromised, illustrates important features of epigenetic regulation. Based on this phenomenon and earlier work we propose a model to describe the mammalian cell as a self assembled open system operating in an environment that includes its genotype, neighbouring cells and beyond. Phenotype is represented by high dimensional attractors, evolutionarily conditioned for stability and robustness and contingent on rules of engagement between gene products encoded in the genetic network. Methodology/Findings: We describe how this system functions and note the indeterminacy and fluidity of its internal workings which place it in the logical reasoning framework of predicative logic. We find that the hypothesis is supported by evidence from cell and molecular biology. Conclusions: Epigenetic regulation and memory are fundamentally physical, as opposed to chemical, processes and the transition to genomic instability is an important feature of mammalian cells with probable fundamental relevance to speciation and carcinogenesis. A source of evolutionarily selectable variation, in terms of the rules of engagement between gene products, is seen as more likely to have greater prominence than genetic variation in an evolutionary context. As this epigenetic variation is based on attractor states phenotypic changes are not gradual; a phenotypic transition can involve the changed contribution of several gene products in a single step.	[Baverstock, Keith] Univ Kuopio, Dept Environm Sci, FIN-70211 Kuopio, Finland; [Ronkko, Mauno] Univ Kuopio, Dept Comp Sci, Kuopio, Finland	University of Eastern Finland; University of Eastern Finland	Baverstock, K (corresponding author), Univ Kuopio, Dept Environm Sci, FIN-70211 Kuopio, Finland.	keith.baverstock@uku.fi; mauno.ronkko@uku.fi						Aldana M, 2003, P NATL ACAD SCI USA, V100, P8710, DOI 10.1073/pnas.1536783100; Aldana M, 2007, J THEOR BIOL, V245, P433, DOI 10.1016/j.jtbi.2006.10.027; Back R.-J., 1998, REFINEMENT CALCULUS; Barber RC, 2006, MUTAT RES-FUND MOL M, V598, P50, DOI 10.1016/j.mrfmmm.2006.01.009; Bateson P, 2002, J GENET, V81, P49, DOI 10.1007/BF02715900; Baverstock K, 2000, MUTAT RES-FUND MOL M, V454, P89, DOI 10.1016/S0027-5107(00)00100-7; BAVERSTOCK KF, 1991, INT J RADIAT BIOL, V60, P581, DOI 10.1080/09553009114552421; Bielas JH, 2006, P NATL ACAD SCI USA, V103, P18238, DOI 10.1073/pnas.0607057103; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Bouffler SD, 2006, RADIAT RES, V165, P249, DOI 10.1667/RR3506.1; Chang HH, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-11; Chen JW, 2006, J PROTEOME RES, V5, P888, DOI 10.1021/pr060049p; Cremer M, 2001, CHROMOSOME RES, V9, P541, DOI 10.1023/A:1012495201697; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Davidich MI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001672; DELBRUCK M, 1949, UNITES BIOL DOUEES C, P33; DUPRE J, 2008, CONSTITUENTS LIFE; ELSASSER WM, 1981, J THEOR BIOL, V89, P131, DOI 10.1016/0022-5193(81)90182-X; Falt S, 2003, CARCINOGENESIS, V24, P1837, DOI 10.1093/carcin/bgg134; FELSENFELD G, 1992, NATURE, V355, P219, DOI 10.1038/355219a0; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; GOULD SJ, 1993, NATURE, V366, P223, DOI 10.1038/366223a0; Gould SJ, 2002, STRUCTURE EVOLUTIONA; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Huang Sui, 2004, Briefings in Functional Genomics & Proteomics, V2, P279, DOI 10.1093/bfgp/2.4.279; ILLMENSEE K, 1976, P NATL ACAD SCI USA, V73, P549, DOI 10.1073/pnas.73.2.549; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; KADHIM MA, 1992, NATURE, V355, P738, DOI 10.1038/355738a0; Kashiwagi A, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000049; Kauffman S.A., 1993, ORIGINS ORDER; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Kosak ST, 2007, PLOS BIOL, V5, P2602, DOI 10.1371/journal.pbio.0050309; Krawetz SA, 2005, NAT REV GENET, V6, P633, DOI 10.1038/nrg1654; Krishnan A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000562; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Li L, 2003, CANCER RES, V63, P2733; Li WH, 2005, NATURE, V437, P50, DOI 10.1038/437050a; Mayr E., 2002, WHAT EVOLUTION IS; McFall-Ngai MJ, 2002, DEV BIOL, V242, P1, DOI 10.1006/dbio.2001.0522; Miller D, 2005, TRENDS MOL MED, V11, P156, DOI 10.1016/j.molmed.2005.02.006; MINTZ B, 1975, P NATL ACAD SCI USA, V72, P3585, DOI 10.1073/pnas.72.9.3585; Morgan WF, 2003, RADIAT RES, V159, P567, DOI 10.1667/0033-7587(2003)159[0567:NADEOE]2.0.CO;2; Morgan WF, 2003, RADIAT RES, V159, P581, DOI 10.1667/0033-7587(2003)159[0581:NADEOE]2.0.CO;2; NANNEY DL, 1958, P NATL ACAD SCI USA, V44, P712, DOI 10.1073/pnas.44.7.712; O'Malley MA, 2005, BIOESSAYS, V27, P1270, DOI 10.1002/bies.20323; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Romero Pedro, 2004, Appl Bioinformatics, V3, P105, DOI 10.2165/00822942-200403020-00005; Rosen R, 1991, LIFE ITSELF COMPREHE; Rosen R., 2000, ESSAYS LIFE ITSELF; Rousseaux S, 2005, GENE, V345, P139, DOI 10.1016/j.gene.2004.12.004; Schrodinger E, 1944, WHAT IS LIFE; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Tarski A., 1955, PAC J MATH, V5, P285, DOI DOI 10.2140/PJM.1955.5.285; von Bertalanffy Ludwig, 1950, BRIT J PHILOS SCI, V1, P134, DOI [DOI 10.1093/BJPS/I.2.134, 10.1093/bjps/I.2.134]; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Watson A, 2004, MOL BIOL CELL, V15, P851, DOI 10.1091/mbc.E03-08-0569; Weinhold B, 2006, ENVIRON HEALTH PERSP, V114, pA160, DOI 10.1289/ehp.114-a160; Wykes SM, 2003, J BIOL CHEM, V278, P29471, DOI 10.1074/jbc.M304545200; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	63	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2290	10.1371/journal.pone.0002290	http://dx.doi.org/10.1371/journal.pone.0002290			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523589	Green Published, gold, Green Submitted			2022-12-25	WOS:000262614300008
J	Muttukrishna, S; Suri, S; Groome, N; Jauniaux, E				Muttukrishna, Shanthi; Suri, Sangeeta; Groome, Nigel; Jauniaux, Eric			Relationships between TGF beta Proteins and Oxygen Concentrations Inside the First Trimester Human Gestational Sac	PLOS ONE			English	Article							ACTIVIN-A; OXIDATIVE STRESS; GROWTH-FACTOR; INHIBIN-A; IN-VITRO; TROPHOBLAST INVASION; FLUID COMPARTMENTS; ANGIOGENIC FACTORS; TYROSINE KINASE-1; HUMAN PLACENTA	In early pregnancy, the O-2 gradient between the maternal circulation and the gestational sac tissues modulates trophoblast biological functions. The aim was to evaluate if placental partial pressure of oxygen (PaO2) modulates in vivo synthesis of specific placental proteins inside the first trimester gestational sac. Matched samples of peripheral venous blood, blood from the placental bed (PB), coelomic fluid (CF) and placental tissue were obtained in 37 normal pregnancies at 6-12 weeks gestation. PaO2 was measured in PB and CF using an IRMA blood gas monitor. Inhibin A, activin A, sEng, PlGF, sFlt-1 and free VEGF concentrations were measured in all samples. HSP 70 was measured in placental extracts. ANOVA showed similar to 60% increase in PB PaO2 (P=0.02) between after 10 weeks gestation. Unpaired Student's T-test between two groups (6-9 weeks vs 9-12 weeks) shows a significant increase in MS Activin A (P=0.001), CF activin A (P < 0.001), MS P1GF (P=0.001), CF PIGF (P < 0.001), MS sFLT-1 (P=0.03), CF sFLT-1 (P=0.01), HSP 70 in placental extracts (P=0.04) and a significant decrease in PB inhibin A levels (P < 0.001) and PB sFLT-1 (P=0.02). Multiple correlation analysis showed a significant negative correlation between PB inhibin A levels and gestation (r= -0.45, P < 0.05) and PB PaO2 (r= -.5, P=0.008) and also between sFLT-1 and PB PaO2 (P=0.03). There was a positive correlation (P < 0.01) between PIGF, sEng and VEGF levels in the placental extracts. Our results indicate a direct relationship in the early intrauterine PaO2 in vivo and inhibin A and sFLT-1 concentrations confirming our hypothesis that specific placental proteins are regulated by intrauterine O-2 tension.	[Muttukrishna, Shanthi; Suri, Sangeeta; Jauniaux, Eric] UCL, EGA, Inst Womens Hlth, London, England; [Groome, Nigel] Oxford Brookes Univ, Sch Biol & Mol Sci, Oxford, England	University of London; University College London; Oxford Brookes University	Muttukrishna, S (corresponding author), UCL, EGA, Inst Womens Hlth, London, England.	s.muttukrishna@ucl.ac.uk			UCLH	UCLH	UCLH charities for early pregnancy	Baumann MU, 2007, MOL ASPECTS MED, V28, P227, DOI 10.1016/j.mam.2007.04.002; Bearfield C, 2005, EUR J ENDOCRINOL, V152, P909, DOI 10.1530/eje.1.01928; Burton Graham J, 2003, Reprod Biomed Online, V6, P84; Caniggia I, 1997, ENDOCRINOLOGY, V138, P3976, DOI 10.1210/en.138.9.3976; Charnock-Jones DS, 2000, BEST PRACT RES CL OB, V14, P953, DOI 10.1053/beog.2000.0137; Clark DE, 1998, BIOL REPROD, V59, P1540, DOI 10.1095/biolreprod59.6.1540; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Genbacev O, 1997, SCIENCE, V277, P1669, DOI 10.1126/science.277.5332.1669; He YL, 1999, MOL ENDOCRINOL, V13, P537, DOI 10.1210/me.13.4.537; Hung TH, 2004, AM J PATHOL, V164, P1049, DOI 10.1016/S0002-9440(10)63192-6; Hung TH, 2001, AM J PATHOL, V159, P1031, DOI 10.1016/S0002-9440(10)61778-6; Jauniaux E, 2005, J CLIN ENDOCR METAB, V90, P1171, DOI 10.1210/jc.2004-1513; Jauniaux E, 2004, J CLIN ENDOCR METAB, V89, P1452, DOI 10.1210/jc.2003-031332; Jauniaux E, 2003, PLACENTA, V24, pS86, DOI 10.1053/plac.2002.0932; Jauniaux E, 2003, AM J PATHOL, V162, P115, DOI 10.1016/S0002-9440(10)63803-5; Jauniaux E, 2000, HUM REPROD UPDATE, V6, P268, DOI 10.1093/humupd/6.3.268; Jauniaux E, 2006, HUM REPROD UPDATE, V12, P747, DOI 10.1093/humupd/dml016; Kaufmann Peter, 1994, P441; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Lyall F, 2001, AM J PATHOL, V158, P1713, DOI 10.1016/S0002-9440(10)64127-2; Maeshima K, 2004, ENDOCRINOLOGY, V145, P3739, DOI 10.1210/en.2004-0213; MEEKINS JW, 1994, BRIT J OBSTET GYNAEC, V101, P669, DOI 10.1111/j.1471-0528.1994.tb13182.x; Muttukrishna S, 1996, J CLIN ENDOCR METAB, V81, P3328, DOI 10.1210/jc.81.9.3328; Muttukrishna S, 2004, SEMIN REPROD MED, V 22, P227, DOI 10.1055/s-2004-831898; Muttukrishna S, 2000, HUM REPROD, V15, P1640, DOI 10.1093/humrep/15.7.1640; MUTTUKRISHNA S, 1995, CLIN ENDOCRINOL, V42, P391, DOI 10.1111/j.1365-2265.1995.tb02648.x; Muttukrishna S, 2002, HUM REPROD, V17, P3072, DOI 10.1093/humrep/17.12.3072; Nagamatsu T, 2004, ENDOCRINOLOGY, V145, P4838, DOI 10.1210/en.2004-0533; Nevo O, 2006, AM J PHYSIOL-REG I, V291, pR1085, DOI 10.1152/ajpregu.00794.2005; Raab U, 1999, BIOCHEM J, V339, P579, DOI 10.1042/0264-6021:3390579; Rana S, 2007, HYPERTENSION, V50, P137, DOI 10.1161/HYPERTENSIONAHA.107.087700; Robertson W B, 1985, Obstet Gynecol Annu, V14, P411; RODESCH F, 1992, OBSTET GYNECOL, V80, P283; Roy H, 2006, FEBS LETT, V580, P2879, DOI 10.1016/j.febslet.2006.03.087; Thadhani R, 2004, J CLIN ENDOCR METAB, V89, P770, DOI 10.1210/jc.2003-031244; Venkatesha S, 2006, NAT MED, V12, P862, DOI 10.1038/nm0706-862c; Widmer M, 2007, OBSTET GYNECOL, V109, P168, DOI 10.1097/01.AOG.0000249609.04831.7c; Zhou Y, 2003, DEV BIOL, V263, P114, DOI 10.1016/S0012-1606(03)00449-4	40	19	20	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2008	3	6							e2302	10.1371/journal.pone.0002302	http://dx.doi.org/10.1371/journal.pone.0002302			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	396TO	18523681	Green Submitted, gold, Green Published			2022-12-25	WOS:000262614300013
J	Fang, LQ; de Vlas, SJ; Liang, S; Looman, CWN; Gong, P; Xu, B; Yan, L; Yang, H; Richardus, JH; Cao, WC				Fang, Li-Qun; de Vlas, Sake J.; Liang, Song; Looman, Caspar W. N.; Gong, Peng; Xu, Bing; Yan, Lei; Yang, Hong; Richardus, Jan Hendrik; Cao, Wu-Chun			Environmental Factors Contributing to the Spread of H5N1 Avian Influenza in Mainland China	PLOS ONE			English	Article								Background: Since late 2003, highly pathogenic avian influenza (HPAI) outbreaks caused by infection with H5N1 virus has led to the deaths of millions of poultry and more than 10 thousands of wild birds, and as of 18-March 2008, at least 373 laboratory-confirmed human infections with 236 fatalities, have occurred. The unrestrained worldwide spread of this disease has caused great anxiety about the potential of another global pandemic. However, the effect of environmental factors influencing the spread of HPAI H5N1 virus is unclear. Methodology/Principal Findings: A database including incident dates and locations was developed for 128 confirmed HPAI H5N1 outbreaks in poultry and wild birds, as well as 21 human cases in mainland China during 2004-2006. These data, together with information on wild bird migration, poultry densities, and environmental variables (water bodies, wetlands, transportation routes, main cities, precipitation and elevation), were integrated into a Geographical Information System (GIS). A case-control design was used to identify the environmental factors associated with the incidence of the disease. Multivariate logistic regression analysis indicated that minimal distance to the nearest national highway, annual precipitation and the interaction between minimal distance to the nearest lake and wetland, were important predictive environmental variables for the risk of HPAI. A risk map was constructed based on these factors. Conclusions/Significance: Our study indicates that environmental factors contribute to the spread of the disease. The risk map can be used to target countermeasures to stop further spread of the HPAI H5N1 at its source.	[Fang, Li-Qun; Yan, Lei; Yang, Hong; Cao, Wu-Chun] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Fang, Li-Qun; de Vlas, Sake J.; Looman, Caspar W. N.; Richardus, Jan Hendrik] Univ Med Ctr Rotterdam, Erasmus Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Liang, Song] Ohio State Univ, Coll Publ Hlth, Columbus, OH USA; [Gong, Peng] Beijing Normal Univ, Chinese Acad Sci, State Key Lab Remote Sensing Sci, Beijing, Peoples R China; [Gong, Peng] Univ Calif, Dept Env Sci Policy & Management, Berkeley, CA USA; [Xu, Bing] Univ Utah, Dept Geography, Salt Lake City, UT USA	Beijing Institute of Microbiology & Epidemiology; Erasmus University Rotterdam; Erasmus MC; University System of Ohio; Ohio State University; Beijing Normal University; Chinese Academy of Sciences; University of California System; University of California Berkeley; Utah System of Higher Education; University of Utah	Fang, LQ (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	caowc@nic.bmi.ac.cn	Gong, Peng/AAM-1516-2021; Xu, Bing/C-7732-2015; Fang, Li-Qun/GWD-0296-2022; Richardus, Jan Hendrik/AAE-1278-2021	Gong, Peng/0000-0003-1513-3765; Richardus, Jan Hendrik/0000-0003-0564-6313; de Vlas, Sake J./0000-0002-1830-5668	National Science Fund for Distinguished Young Scholars [30725032]; National Natural Science Foundation of China [30590374]; Commission of the European Community [003824]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Commission of the European Community(European Commission)	This study was supported by grants from the National Science Fund for Distinguished Young Scholars (No. 30725032), National Natural Science Foundation of China (No. 30590374) and the Commission of the European Community, as part of the project Effective and Acceptable Strategies for the Control of SARS and New Emerging Infections in China and Europe (No. 003824). The founders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 1990, OPTIMAL BIRD MIGRATI, P331; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Chen HL, 2006, J VIROL, V80, P5976, DOI 10.1128/JVI.00110-06; deJong JC, 1997, NATURE, V389, P554, DOI 10.1038/39218; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; *FOOD AGR ORG UN, 2007, DAT POULTR WOLD; Harder B., 2005, SCI NEWS, V168, P171; Hoyo J., 1996, HDB BIRDS WORLD, V3; Hoyo JD, 1996, HDB BIRDS WORLD, V1; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Liu CM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000191; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; *MIN AGR CHIN, 2007, REP AN INF DIS; *MIN AGR CHIN, 2007, OFF VET B; *MIN RAILW CHIN, 1982, REG TRANSP RAILR FRE; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; *RAMS CONV SECR, 2005, INF SHEET RAMS WETL; Shaw S. P., 1956, 39 US FISH WILDL SER; WEBSTER RG, 1978, VIROLOGY, V84, P268, DOI 10.1016/0042-6822(78)90247-7; WHO, 2021, CUM NUMB CONF HUM CA; *WHO, 2004, WAT ZOON; World Health Organization, 2006, DIR IND FACT FAC SPR; *WORLD ORG AN HLTH, 2008, SUMM IMM NOT FOLL UP; *WORLD ORG AN HLTH, 2008, AV INFL FACTS FIG; ZHANG F, 1997, BIRD MIGRATION CHINA; 2007, LENCET INFECT DIS, V7, P175	27	120	130	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2268	10.1371/journal.pone.0002268	http://dx.doi.org/10.1371/journal.pone.0002268			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509468	Green Published, gold, Green Submitted			2022-12-25	WOS:000262268500014
J	Luo, ZL; Zhao, XJ; Zhang, SG				Luo, Zhongli; Zhao, Xiaojun; Zhang, Shuguang			Structural Dynamic of a Self-Assembling Peptide d-EAK16 Made of Only D-Amino Acids	PLOS ONE			English	Article							BETA-SHEET; ALPHA-HELIX; CONFORMATIONAL TRANSITIONS; COMPLEMENTARY OLIGOPEPTIDE; PROTEIN; RECOGNITION; CONVERSION; BINDING; MODEL	We here report systematic study of structural dynamics of a 16-residue self-assembling peptide d-EAK16 made of only D-amino acids. We compare these results with its chiral counterpart L-form, I-EAK16. Circular dichroism was used to follow the structural dynamics under various temperature and pH conditions. At 25 degrees C the d-EAK16 peptide displayed a typical beta-sheet spectrum. Upon increasing the temperature above 70 degrees C, there was a spectrum shift as the 218 nm valley widens toward 210 nm. Above 80 degrees C, the d-EAK16 peptide transformed into a typical alpha-helix CD spectrum without going through a detectable random-coil intermediate. When increasing the temperature from 4 degrees C to 110 degrees C then cooling back from 110 degrees C to 4 degrees C, there was a hysteresis: the secondary structure from beta-sheet to alpha-helix and then from alpha-helix to beta-sheet occurred. d-EAK16 formed an alpha-helical conformation at pH0.76 and pH12 but formed a beta-sheet at neutral pH. The effects of various pH conditions, ionic strength and denaturing agents were also noted. Since D-form peptides are resistant to natural enzyme degradation, such drastic structural changes may be exploited for fabricating molecular sensors to detect minute environmental changes. This provides insight into the behaviors of self-assembling peptides made of D-amino acids and points the way to designing new peptide materials for biomedical engineering and nanobiotechnology.	[Luo, Zhongli; Zhao, Xiaojun; Zhang, Shuguang] Sichuan Univ, W China Hosp, Lab Nanobiomed Technol, Chengdu 610064, Sichuan, Peoples R China	Sichuan University	Luo, ZL (corresponding author), Sichuan Univ, W China Hosp, Lab Nanobiomed Technol, Chengdu 610064, Sichuan, Peoples R China.	shuguang@mit.edu		Luo, Zhongli/0000-0003-4041-7807; Zhang, Shuguang/0000-0002-3856-3752	China National 985 project at Sichuan University	China National 985 project at Sichuan University	This work was supported through the China National 985 project at Sichuan University. SZ is a founder of 3-DMatrix USA and receives stock options. SZ is also a founder of NZ3, USA and receive stock options. SZ is also scientific advisor for 3DM-Japan, NZ3, Inc. and receive consulting fees.	Altman M, 2000, PROTEIN SCI, V9, P1095, DOI 10.1110/ps.9.6.1095; Avetisov V, 1996, P NATL ACAD SCI USA, V93, P11435, DOI 10.1073/pnas.93.21.11435; BARROW CJ, 1991, SCIENCE, V253, P179, DOI 10.1126/science.1853202; Branden C., 1999, INTRO PROTEIN STRUCT; Buschmann H, 2000, ANGEW CHEM INT EDIT, V39, P4033, DOI 10.1002/1521-3773(20001117)39:22<4033::AID-ANIE4033>3.0.CO;2-2; Caplan MR, 2000, BIOMACROMOLECULES, V1, P627, DOI 10.1021/bm005586w; Chin J, 1999, NATURE, V401, P254, DOI 10.1038/45751; Chockalingam K, 2007, PROTEIN ENG DES SEL, V20, P155, DOI 10.1093/protein/gzm008; Ciani B, 2002, J BIOL CHEM, V277, P10150, DOI 10.1074/jbc.M107663200; DADO GP, 1993, J AM CHEM SOC, V115, P12609, DOI 10.1021/ja00079a060; FASMAN GD, 1994, P NATL ACAD SCI USA, V91, P11232, DOI 10.1073/pnas.91.23.11232; FLOURET G, 1965, J AM CHEM SOC, V87, P3775, DOI 10.1021/ja01094a045; Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Hancock REW, 2000, P NATL ACAD SCI USA, V97, P8856, DOI 10.1073/pnas.97.16.8856; Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728; HOUGHTEN RA, 1991, NATURE, V354, P84, DOI 10.1038/354084a0; Kammerer RA, 2004, P NATL ACAD SCI USA, V101, P4435, DOI 10.1073/pnas.0306786101; Kauffmann E, 2001, P NATL ACAD SCI USA, V98, P6646, DOI 10.1073/pnas.101122898; Kuhlbrandt W, 2002, SCIENCE, V297, P1692, DOI 10.1126/science.1072574; KURODA Y, 1995, J AM CHEM SOC, V117, P10950, DOI 10.1021/ja00149a018; LAKE JA, 1988, NATURE, V331, P184, DOI 10.1038/331184a0; MARQUSEE S, 1987, P NATL ACAD SCI USA, V84, P8898, DOI 10.1073/pnas.84.24.8898; MARQUSEE S, 1989, P NATL ACAD SCI USA, V86, P5286, DOI 10.1073/pnas.86.14.5286; MASON S, 1988, CHEM SOC REV, V17, P347, DOI 10.1039/cs9881700347; MILTON RCD, 1992, SCIENCE, V256, P1445, DOI 10.1126/science.1604320; MONTELIONE GT, 1986, P NATL ACAD SCI USA, V83, P8594, DOI 10.1073/pnas.83.22.8594; MUTTER M, 1990, ANGEW CHEM INT EDIT, V29, P185, DOI 10.1002/anie.199001851; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Robert F, 2006, NATURE, V443, P969, DOI 10.1038/nature05239; SHEMYAKI.MM, 1967, NATURE, V213, P412, DOI 10.1038/213412a0; Stanger HE, 2001, P NATL ACAD SCI USA, V98, P12015, DOI 10.1073/pnas.211536998; STEWART JM, 1965, NATURE, V206, P619, DOI 10.1038/206619b0; Still WC, 1996, ACCOUNTS CHEM RES, V29, P155, DOI 10.1021/ar950166i; Takahashi Y, 1999, BIOORGAN MED CHEM, V7, P177, DOI 10.1016/S0968-0896(98)00236-3; VOGLER K, 1965, HELV CHIM ACTA, V48, P1407, DOI 10.1002/hlca.19650480621; Yashima E, 1999, NATURE, V399, P449, DOI 10.1038/20900; Yokoi H, 2005, P NATL ACAD SCI USA, V102, P8414, DOI 10.1073/pnas.0407843102; Zhang SG, 1999, REACT FUNCT POLYM, V41, P91, DOI 10.1016/S1381-5148(99)00031-0; ZHANG SG, 1992, EMBO J, V11, P3787, DOI 10.1002/j.1460-2075.1992.tb05464.x; ZHANG SG, 1994, BIOPOLYMERS, V34, P663, DOI 10.1002/bip.360340508; Zhang SG, 1997, P NATL ACAD SCI USA, V94, P23, DOI 10.1073/pnas.94.1.23; ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334; ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y; Zhang XX, 1997, CHEM REV, V97, P3313, DOI 10.1021/cr960144p	45	61	66	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2364	10.1371/journal.pone.0002364	http://dx.doi.org/10.1371/journal.pone.0002364			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509542	Green Published, gold			2022-12-25	WOS:000262268500049
J	Cousillas, H; George, I; Henry, L; Richard, JP; Hausberger, M				Cousillas, Hugo; George, Isabelle; Henry, Laurence; Richard, Jean-Pierre; Hausberger, Martine			Linking Social and Vocal Brains: Could Social Segregation Prevent a Proper Development of a Central Auditory Area in a Female Songbird?	PLOS ONE			English	Article							FUNCTIONAL-ORGANIZATION; EUROPEAN STARLINGS; ZEBRA FINCHES; HUMAN SPEECH; EXPERIENCE; FOREBRAIN; BIRDSONG; SPECIALIZATION; RESPONSES; CENTERS	Direct social contact and social interaction affect speech development in human infants and are required in order to maintain perceptual abilities; however the processes involved are still poorly known. In the present study, we tested the hypothesis that social segregation during development would prevent the proper development of a central auditory area, using a "classical" animal model of vocal development, a songbird. Based on our knowledge of European starling, we raised young female starlings with peers and only adult male tutors. This ensured that female would show neither social bond with nor vocal copying from males. Electrophysiological recordings performed when these females were adult revealed perceptual abnormalities: they presented a larger auditory area, a lower proportion of specialized neurons and a larger proportion of generalist sites than wild-caught females, whereas these characteristics were similar to those observed in socially deprived (physically separated) females. These results confirmed and added to earlier results for males, suggesting that the degree of perceptual deficiency reflects the degree of social separation. To our knowledge, this report constitutes the first evidence that social segregation can, as much as physical separation, alter the development of a central auditory area.	[Cousillas, Hugo; George, Isabelle; Henry, Laurence; Richard, Jean-Pierre; Hausberger, Martine] Univ Rennes 1, UMR 6552, CNRS, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes	Cousillas, H (corresponding author), Univ Rennes 1, UMR 6552, CNRS, Rennes, France.	hugo.cousillas@univ-rennes1.fr	George, Isabelle/A-7770-2008	George, Isabelle/0000-0002-4842-4959	French Research Ministry [COG169b]	French Research Ministry(Ministry of Research, France)	This study was supported by a grant from the French Research Ministry, COG169b, Perception, plasticite et vie sociale: Perturbation et recuperation du traitement de l'information auditive. Perspective comparative animal/humain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRET-HAUSBERGER M, 1989, Bioacoustics, V2, P137; ADRETHAUSBERGER M, 1982, BEHAV ECOL SOCIOBIOL, V11, P241, DOI 10.1007/BF00299300; ADRETHAUSBERGER M, 1990, ETHOLOGY, V84, P265; ADRETHAUSBERGER M, 1988, BEHAVIOUR, V107, P138, DOI 10.1163/156853988X00322; Allen R E, 1982, Child Abuse Negl, V6, P299, DOI 10.1016/0145-2134(82)90033-3; Bahrick LE, 2000, DEV PSYCHOL, V36, P190, DOI 10.1037//0012-1649.36.2.190; Baptista Luis F., 1997, P23, DOI 10.1017/CBO9780511758843.003; BERTIN A, 2007, DEV PSYCHOBIOL, DOI DOI 10.1002/DEV:362-374; BISCHOF HJ, 1985, BRAIN RES, V326, P370, DOI 10.1016/0006-8993(85)90048-4; Bolhuis JJ, 1999, ANIM BEHAV, V58, P1285, DOI 10.1006/anbe.1999.1266; Brooks R, 2002, DEV PSYCHOL, V38, P958, DOI 10.1037//0012-1649.38.6.958; Capsius B, 1999, HEARING RES, V136, P91, DOI 10.1016/S0378-5955(99)00112-4; Capsius B, 1996, HEARING RES, V96, P59, DOI 10.1016/0378-5955(96)00038-X; Ceponiene R, 2003, P NATL ACAD SCI USA, V100, P5567, DOI 10.1073/pnas.0835631100; Cousillas H, 2005, HEARING RES, V207, P10, DOI 10.1016/j.heares.2005.01.008; Cousillas H, 2004, EUR J NEUROSCI, V19, P3343, DOI 10.1111/j.0953-816X.2004.03376.x; Cousillas H, 2006, NATURWISSENSCHAFTEN, V93, P588, DOI 10.1007/s00114-006-0148-4; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; EENS M, 1989, ARDEA, V77, P75; George I, 2004, J PHYSIOL-PARIS, V98, P385, DOI 10.1016/j.jphysparis.2005.09.021; George I, 2005, J COMP NEUROL, V488, P48, DOI 10.1002/cne.20584; Gervais H, 2004, NAT NEUROSCI, V7, P801, DOI 10.1038/nn1291; Goldstein MH, 2003, P NATL ACAD SCI USA, V100, P8030, DOI 10.1073/pnas.1332441100; HAUSBERGER M, 1991, BIRD BEHAV, V9, P81, DOI 10.3727/015613890791749127; HAUSBERGER M, 1995, J COMP PSYCHOL, V109, P222, DOI 10.1037/0735-7036.109.3.222; Hausberger M, 1995, BEHAV PROCESS, V35, P83, DOI 10.1016/0376-6357(95)00053-4; Hausberger Martine, 1997, P128, DOI 10.1017/CBO9780511758843.008; Henry L, 2001, CR ACAD SCI III-VIE, V324, P1167, DOI 10.1016/S0764-4469(01)01394-4; HMCCARTNEY K, 1984, DEV PSYCHOL, V20, P244; Houx BB, 1999, ANIM BEHAV, V57, P837; Hultsch DF, 1999, PSYCHOL AGING, V14, P245, DOI 10.1037/0882-7974.14.2.245; Kuhl PK, 2003, P NATL ACAD SCI USA, V100, P9096, DOI 10.1073/pnas.1532872100; Kuhl PK, 2003, P NATL ACAD SCI USA, V100, P9645, DOI 10.1073/pnas.1733998100; LEPPELSACK HJ, 1976, J COMP PHYSIOL, V107, P263, DOI 10.1007/BF00656737; LOGAN JS, 1991, J ACOUST SOC AM, V89, P874, DOI 10.1121/1.1894649; Poirier C, 2004, J COMP PSYCHOL, V118, P179, DOI 10.1037/0735-7036.118.2.179; PUEL JL, 1988, BRAIN RES, V447, P380, DOI 10.1016/0006-8993(88)91144-4; Revelle W., 1992, HDB EMOTION MEMORY R, P113; RICHARD JP, 1995, J NEUROSCI METH, V61, P99, DOI 10.1016/0165-0270(95)00029-T; ROUSSEAU F, 2008, SELECTIVE ATTE UNPUB; SNOWDON CT, 1997, EDS SOCIAL INFLUENCE; Sturdy CB, 2001, ANIM BEHAV, V62, P1207, DOI 10.1006/anbe.2001.1864; Theunissen FE, 1998, J NEUROSCI, V18, P3786; WEST MJ, 1983, WILSON BULL, V95, P635; Zhang LI, 2001, NAT NEUROSCI, V4, P1123, DOI 10.1038/nn745	45	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2194	10.1371/journal.pone.0002194	http://dx.doi.org/10.1371/journal.pone.0002194			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	391UK	18493580	Green Published, gold, Green Submitted			2022-12-25	WOS:000262258700003
